<SEC-DOCUMENT>0001193125-20-192936.txt : 20200715
<SEC-HEADER>0001193125-20-192936.hdr.sgml : 20200715
<ACCEPTANCE-DATETIME>20200715070047
ACCESSION NUMBER:		0001193125-20-192936
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		36
FILED AS OF DATE:		20200715
DATE AS OF CHANGE:		20200715

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Relay Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001812364
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-239412
		FILM NUMBER:		201028248

	BUSINESS ADDRESS:	
		STREET 1:		399 BINNEY STREET
		STREET 2:		2ND FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		617-370-8837

	MAIL ADDRESS:	
		STREET 1:		399 BINNEY STREET
		STREET 2:		2ND FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>d904779ds1a.htm
<DESCRIPTION>FORM S-1/A
<TEXT>
<HTML><HEAD>
<TITLE>Form S-1/A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on July 15, 2020. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right"><B>Registration No.&nbsp;333-239412 </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES
AND EXCHANGE COMMISSION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>  <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Amendment
No. 3 </B></P>  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>to </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">S-1</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><I>Under </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><I>The
Securities Act of 1933 </I></B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>RELAY THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>2836</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">47-3923475</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Primary Standard Industrial</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Classification Code Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification Number)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>399 Binney Street, 2<SUP STYLE="font-size:85%; vertical-align:top">nd</SUP> Floor </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Cambridge, MA 02139 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(617) <FONT
STYLE="white-space:nowrap">370-8837</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>(Address, including zip code, and telephone number, including area code, of
registrant&#146;s principal executive offices) </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Sanjiv K.
Patel, M.D. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>President and Chief Executive Officer </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Relay Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>399 Binney Street, 2<SUP STYLE="font-size:85%; vertical-align:top">nd</SUP> Floor </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Cambridge, MA 02139 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(617) <FONT
STYLE="white-space:nowrap">370-8837</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>(Name, address, including zip code, and telephone number, including area code, of agent
for service) </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><I>Copies to: </I></B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Mitchell S. Bloom, Esq.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>William D. Collins, Esq.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Gabriela Morales-Rivera, Esq.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Goodwin Procter LLP</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>100
Northern Avenue</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Boston, MA 02210</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(617) <FONT STYLE="white-space:nowrap">570-1000</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Brian R. Adams, Esq.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>General Counsel</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Relay
Therapeutics, Inc.</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>399 Binney Street, 2<SUP STYLE="font-size:85%; vertical-align:top">nd</SUP> Floor</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Cambridge, MA 02139</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(617) <FONT
STYLE="white-space:nowrap">370-8837</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Patrick O&#146;Brien, Esq.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Michael S. Pilo, Esq.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Ropes&nbsp;&amp; Gray LLP</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>800 Boylston Street</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Boston,
MA 02199-3600</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(617) <FONT STYLE="white-space:nowrap">951-7000</FONT></B></P></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Approximate date of commencement of proposed sale to the public:</B> As soon as practicable after the effective date of this registration statement. </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule&nbsp;415 under the Securities Act of
1933, as amended, check the following box.&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If this Form is filed to register additional securities for an offering pursuant to
Rule&nbsp;462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If this Form is a post-effective amendment filed pursuant to Rule&nbsp;462(c) under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If this Form is a post-effective
amendment filed pursuant to Rule&nbsp;462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a <FONT STYLE="white-space:nowrap">non-accelerated</FONT>
filer, a smaller reporting company or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company&#148; and &#147;emerging growth company&#148; in Rule <FONT
STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">Large&nbsp;Accelerated&nbsp;Filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;Filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-Accelerated&nbsp;Filer</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;Reporting&nbsp;Company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;Growth&nbsp;Company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
</TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided to Section&nbsp;7(a)(2)(B) of the Securities Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>CALCULATION OF
REGISTRATION FEE </B></P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Title of Each Class&nbsp;of<BR>Securities to be Registered</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Amount<BR>to be</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Registered(1)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Proposed</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Maximum</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Offering
Price</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Per Share(2)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Proposed</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Maximum</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Aggregate</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Offering Price(3)</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Amount of </B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Registration Fee(4)</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Common Stock, par value $0.001 per share</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">23,000,000</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$19.00</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$437,000,000</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$56,722.60</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Includes 3,000,000 shares that the underwriters have the option to purchase. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Estimated solely for the purpose of computing the registration fee in accordance with Rule 457(a) under the
Securities Act of 1933, as amended. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Includes the aggregate offering price of 3,000,000 shares that the underwriters have the option to purchase to
cover over-allotments. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Calculated pursuant to Rule 457(a) under the Securities Act of 1933, as amended. $39,496.85 of this registration
fee was previously paid by the Registrant in connection with the filing of its Registration Statement on Form S-1 on June 24, 2020 and July 9, 2020. </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow"><FONT COLOR="#eb0029"><B>The information in this preliminary prospectus is not complete and may be changed.
These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell nor does it seek an offer to buy these securities in any
jurisdiction where the offer or sale is not permitted. </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#eb0029"><B>SUBJECT TO COMPLETION, DATED JULY 15, 2020 </B></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>20,000,000 Shares </B></P>  <P STYLE="font-size:15pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g904779g96c16.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:15pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This is the initial public
offering of shares of our common stock. Prior to this offering, there has been no public market for our common stock. We are selling 20,000,000 shares of our common stock. The initial public offering price of our common stock is expected to be
between $18.00 and $19.00 per share. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have been approved to list our common stock on the Nasdaq Global Market under the symbol &#147;RLAY.&#148;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging growth company&#148; as that term is used in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and, as such, we
have elected to comply with certain reduced public company reporting requirements for this prospectus and future filings. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>Investing in our common
stock involves risks. See &#147;<A HREF="#rom904779_4">Risk Factors</A>&#148; on page&nbsp;12. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="55%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Price&nbsp;to<BR>Public</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Underwriting<BR>Discounts&nbsp;and<BR>Commissions</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Proceeds&nbsp;to<BR>Company</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Per Share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">See &#147;Underwriting&#148; beginning on page 198 of this prospectus for additional information regarding
underwriting compensation. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Delivery of the shares of common stock will be made on or about
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither the Securities and Exchange Commission
nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriters have an option to purchase up to 3,000,000 additional shares of common stock from us. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Joint Book-Running Managers </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:14pt">


<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="36%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:14pt">
<TD VALIGN="top" NOWRAP><B>J.P.&nbsp;Morgan</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center"><B>Goldman&nbsp;Sachs&nbsp;&amp;&nbsp;Co.&nbsp;LLC</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="right"><B>Cowen</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="right"><B>Guggenheim&nbsp;Securities</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The date of this prospectus is
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="96%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_1">PROSPECTUS SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_2">THE OFFERING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_3">SUMMARY CONSOLIDATED FINANCIAL DATA</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_4">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_5">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_6">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_7">DIVIDEND POLICY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_8">CAPITALIZATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_9">DILUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_10">SELECTED CONSOLIDATED FINANCIAL DATA</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_11">MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
 OF OPERATIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_12">BUSINESS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_13">MANAGEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">157</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_14">EXECUTIVE COMPENSATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">167</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_15">DIRECTOR COMPENSATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_16">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">181</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_17">PRINCIPAL STOCKHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_18">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">187</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_19">SHARES ELIGIBLE FOR FUTURE SALE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">192</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_20">MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS FOR <FONT
STYLE="white-space:nowrap">NON-U.S.&nbsp;HOLDERS</FONT> OF COMMON STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_21">UNDERWRITING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">198</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_22">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_23">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_24">WHERE YOU CAN FIND MORE INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom904779_25">INDEX TO FINANCIAL STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-i- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Through and including &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020 (25 days after the commencement of
this offering), all dealers effecting transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This delivery requirement is in addition to the obligation of dealers to deliver a
prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should rely only on the information contained in
this prospectus or in any free writing prospectus we file with the Securities and Exchange Commission, or the SEC. Neither we nor the underwriters have authorized anyone to provide you with information other than that contained in this prospectus or
any free writing prospectus prepared by or on behalf of us or to which we have referred you. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We and the
underwriters are offering to sell, and seeking offers to buy, common stock only in jurisdictions where offers and sales are permitted. The information contained in this prospectus is accurate only as of the date on the front cover page of this
prospectus, or other earlier date stated in this prospectus, regardless of the time of delivery of this prospectus or of any sale of our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The market data and certain other statistical information used throughout this prospectus are based on independent industry publications, governmental
publications, reports by market research firms, or other independent sources that we believe to be reliable sources. Industry publications and third-party research, surveys, and studies generally indicate that their information has been obtained
from sources believed to be reliable, although they do not guarantee the accuracy or completeness of such information. We are responsible for all of the disclosure contained in this prospectus, and we believe that these sources are reliable;
however, we have not independently verified the information contained in such publications. While we are not aware of any misstatements regarding any third-party information presented in this prospectus, their estimates, in particular, as they
relate to projections, involve numerous assumptions, are subject to risks and uncertainties, and are subject to change based on various factors, including those discussed under the section entitled &#147;Risk Factors&#148; and elsewhere in this
prospectus. Some data are also based on our good faith estimates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-ii- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_1"></A>PROSPECTUS SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This summary highlights information contained elsewhere in this prospectus and does not contain all of the information that you should consider in making your
investment decision. Before investing in our common stock, you should carefully read this entire prospectus, including our consolidated financial statements and the related notes included elsewhere in this prospectus. You should also consider, among
other things, the matters described under &#147;Risk Factors&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations,&#148; in each case appearing elsewhere in this prospectus. Unless the context
otherwise requires, the terms &#147;Relay,&#148; &#147;Relay Therapeutics,&#148; &#147;the Company,&#148; &#147;we,&#148; &#147;us,&#148; and &#147;our&#148; in this prospectus refer to Relay Therapeutics, Inc. and its subsidiary. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a clinical-stage precision medicines
company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Our company is built upon unparalleled insights into protein motion and how this dynamic behavior relates
to protein function. These insights may enable us to more effectively drug protein targets that previously have been intractable (i.e. inadequately drugged or undruggable). We believe we have a differentiated approach to drug these protein targets
based on their motion, which enables us to select and advance unique product candidates. We built our Dynamo platform to integrate an array of leading edge experimental and computational approaches, which allows us to apply our understanding of
protein structure and motion to drug discovery. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are advancing a pipeline of medicines to address targets in precision oncology, including our lead
product candidates, RLY-1971 and RLY-4008, as well as our PI3K&#945; mutant selective program (RLY-PI3K1047 program). To date, we have not entered into partnerships to clinically develop or commercialize any of these programs. We initiated a Phase 1
clinical trial for RLY-1971, our inhibitor of Src homology region 2 domain-containing phosphatase-2 (SHP2), in patients with advanced solid tumors in the first quarter of 2020. We have completed Investigational New Drug, or IND, enabling activities
for RLY-4008, our inhibitor of fibroblast growth factor receptor 2 (FGFR2) and expect to initiate a Phase&nbsp;1 clinical trial for RLY-4008 in patients with advanced solid tumors having oncogenic FGFR2 alterations in the second half of 2020. We
anticipate the <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> program, our program for molecules targeting cancer-associated mutant variants of phosphoinostide <FONT STYLE="white-space:nowrap">3-kinase</FONT> alpha (PI3K&#945;), to be in IND
enabling studies in 2021. While our initial focus is on precision oncology, we believe our Dynamo platform may also be broadly applied to other areas of precision medicine, such as genetic disease. In addition to the three product candidates
described above, we have five discovery stage programs across precision oncology and genetic disease. We are focused on using the novel insights derived from our approach to transform the lives of patients suffering from debilitating and
life-threatening diseases through the discovery, development and commercialization of our therapies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Precision medicine aims to specifically and potently
drug genetically validated target proteins (i.e., genetic variants potentially implicated in biology of disease). However, some target proteins thus far have been intractable using conventional drug discovery tools, such as structure-based drug
design (SBDD). While SBDD is well-suited to solving some drug discovery problems such as orthosteric site kinase inhibitors, its reliance on static images of protein fragments limits its ability to gain accurate insights into the dynamic behavior of
proteins in their natural state, which in turn limits its ability to discover medicines with exquisite specificity. Our approach pivots the understanding of protein targets from the industry-standard, static view, to a novel paradigm based on
fundamental insights into protein motion. We then apply these novel insights into protein motion to drug discovery and design, which we term Motion Based Drug Design (MBDD). </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Our Dynamo Platform </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Dynamo platform puts protein motion at the center of drug discovery and design, integrating a broad and tailored array of leading-edge experimental and
computational approaches <B>(Figure&nbsp;1)</B>. This includes leveraging new experimental techniques such as room-temperature crystallography, and deploying the Anton 2 supercomputer, which was custom-built by D. E. Shaw Research to perform
molecular dynamic simulations of proteins. We have access to the Anton 2 supercomputer, which we believe to be the only resource of computational power of its caliber, through our collaboration with D. E. Shaw Research, LLC, , or D. E. Shaw
Research, pursuant to which we collaborate with D. E. Shaw Research to rapidly develop various protein models. Our use of the Anton 2 supercomputer and our collaboration with D. E. Shaw Research, LLC is subject to the terms and conditions of the
Amended and Restated Collaboration and License Agreement with D. E. Shaw Research, or the DESRES Agreement. See &#147;Business&#151;Collaboration and License Agreement with D. E. Shaw Research, LLC.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 1: Dynamo drug-discovery platform integrates leading-edge experimental and computational tools. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g904779g88e30.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We deploy the power of our Dynamo platform in three key phases of MBDD discovery: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Target Modulation Hypothesis. </B>By generating fundamental insights into the structure and conformational
dynamics of full-length proteins, our Dynamo platform enables us to model a target protein&#146;s function, to develop unique motion-based hypotheses for how to modulate the protein&#146;s behavior, and to identify potential novel binding sites for
new therapeutic agents. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Hit Finding and Lead Generation. </B>The integration of our computational and experimental platforms affords a
deeper functional understanding of our targets and enables the design of physiologically relevant activity-based, ligand-centric and computational screens. These highly differentiated screens have the ability to yield a larger number of chemical
series and potential therapies to proceed into lead optimization than conventional experimental techniques alone. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Lead Optimization. </B>Our Dynamo platform uses advanced computational models in tight integration with our
medicinal chemistry, structural biology, enzymology and biophysics capabilities to predict, design and experimentally evaluate compounds that will achieve the most desirable characteristics, including potency, selectivity, bioavailability, and
drug-like properties. We believe our approach enables us to converge on optimized compounds with much greater efficiency than conventional approaches, which are typically highly iterative over an extended timeframe. </P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Dynamo platform has the potential to address a diverse range of disease targets, including those
proteins that have not been addressed selectively and potently with existing therapies. While we have initially focused our Dynamo platform on small molecule drug discovery in the area of precision oncology, we believe it could be readily deployed
across broader precision and genetic medicine areas as well as other therapeutic modalities, such as protein therapeutics and antibody design. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our
Programs </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have deployed our technology platform to build a wholly owned pipeline of product candidates to address targets in precision oncology,
where there is clear evidence linking target proteins to disease and where molecular diagnostics can unambiguously identify relevant patients for treatment. We believe this approach will increase the likelihood of successfully translating a specific
pharmacological mechanism into clinical benefit. The targets associated with all of our current programs are Category&nbsp;1 Targets under the DESRES Agreement. See &#147;Business&#151;Collaboration and License Agreement with D. E. Shaw Research,
LLC.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g904779g94v79.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">RLY-1971</FONT> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">RLY-1971</FONT> binds and stabilizes SHP2 in its inactive conformation. SHP2 promotes cancer cell survival and growth through
the RAS pathway by transducing signals downstream from receptor tyrosine kinases (RTKs). Additionally, activating SHP2 mutations causes enhanced signaling in the absence of ligand stimulation and has been identified as an oncogenic driver in a range
of tumors. As a critical signaling node and regulator, SHP2 drives cancer cell proliferation and plays a key role in the way cancer cells develop resistance to targeted therapies. We believe that inhibition of SHP2 could be effective as a
monotherapy in cancers with specific alterations and could block a common path that cancer cells exploit to resist other antitumor agents, thus overcoming or delaying the onset of resistance to those therapies. We are currently evaluating the safety
and tolerability of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> in a Phase&nbsp;1 dose escalation study in patients with advanced or metastatic solid tumors. We have dosed 10 patients as of July&nbsp;8, 2020 and plan to enroll approximately 52
patients in this study. We anticipate providing an update on clinical data and the clinical development plan in 2021. Given the range of cancers that are related to SHP2 dependence, in addition to its potential use in monotherapy settings, we
believe <FONT STYLE="white-space:nowrap">RLY-1971</FONT> could serve as a backbone for compelling combination therapies. We believe SHP2-mediated cancers affect approximately 125,000 late-line patients annually in both monotherapy and combination
therapy settings in the U.S. In the future, if <FONT STYLE="white-space:nowrap">RLY-1971</FONT> advances to earlier lines of treatment, we believe it could potentially have applicability to approximately 290,000 patients annually in the U.S. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">RLY-4008</FONT> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">RLY-4008</FONT> is designed to be an oral, small molecule, selective inhibitor of fibroblast growth factor receptor&nbsp;2, or FGFR2, a receptor tyrosine kinase that is frequently altered in certain cancers. FGFR2 is one
of four members of </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the FGFR family, a set of closely related proteins with highly similar protein sequences and properties. <FONT STYLE="white-space:nowrap">RLY-4008</FONT> demonstrates FGFR2-dependent killing in
cancer cell lines, while showing minimal inhibition of other targets, including other members of the FGFR family. We plan to initiate a Phase 1 clinical trial for <FONT STYLE="white-space:nowrap">RLY-4008</FONT> in patients with solid tumors having
oncogenic FGFR2 alterations in the second half of 2020. We believe FGFR2-mediated cancers affect approximately 8,000 late-line patients annually in the U.S. In the future, if <FONT STYLE="white-space:nowrap">RLY-4008</FONT> advances to earlier lines
of treatment, we believe it could potentially address approximately 20,000 patients annually in the U.S. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Mutant-PI3K</I>&#945;<I></I><I> Inhibitor
Program </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> is a lead compound in our franchise of programs targeting cancer-associated mutant
variants of phosphoinositide <FONT STYLE="white-space:nowrap">3-kinase</FONT> alpha, or PI3K&#945;. <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> is a small molecule inhibitor of PI3K&#945; that we designed specifically to target PI3K&#945;
H1047X mutants via a previously undescribed allosteric mechanism. Oral dosing of <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> resulted in tumor growth inhibition in mouse xenograft models of PI3K&#945; H1047R mutant carcinoma. We expect to
begin <FONT STYLE="white-space:nowrap">IND-enabling</FONT> studies for a differentiated PI3K&#945; H1047X mutant-selective inhibitor in 2021. We believe PI3K&#945; H1047X mutant cancers affect approximately 10,000 late-line patients annually in the
U.S. In the future, if <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> advances to earlier lines of treatment, we believe it could potentially be suitable for use in approximately 50,000 patients annually in the U.S. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Two additional mutations of interest for our PI3K&#945; franchise are E542X and E545X. We estimate there are approximately 15,000 late-line and 60,000 total
patients annually in the United States who might benefit from a PI3K&#945; targeted inhibitor that targets the mutations at E542 and E545. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Discovery
Programs </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are deploying our Dynamo platform and MBDD approach to advance multiple discovery-stage precision oncology programs. As with our lead
programs, these programs leverage insights into protein conformational dynamics to address high-value, genetically validated oncogenes that previously have been intractable to conventional drug-discovery approaches. Our Dynamo platform&#146;s
protein visualization capabilities can be applied to multiple therapeutic areas beyond precision oncology. To further diversify our pipeline, we are leveraging our Dynamo platform to address validated targets in monogenic diseases, where genetic
alterations lead to disease-causing defects in protein motion. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Strategy </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our mission is to leverage unique insights into protein motion to transform the lives of patients suffering from debilitating and life-threatening diseases
through the discovery, development and commercialization of small molecule therapies. We believe that, by placing protein motion at the heart of MBDD discovery, our unique Dynamo platform has the potential to address previously intractable precision
medicine targets. To accomplish this, we intend to continue building a team that shares our commitment to patients, to continue to enhance our platform, and to rapidly advance our precision medicine pipeline of product candidates. The key elements
of our strategy are to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Rapidly advance our lead precision oncology programs, RLY-1971, RLY-4008,
<FONT STYLE="white-space:nowrap">RLY-PI3K1047,</FONT> through clinical development and regulatory approval </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Continue to enhance our unique drug-discovery platform </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Harness the insights and data generated from our platform against intractable targets in oncology and other
therapeutic areas </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Selectively enter into strategic collaborations to maximize the value of our platform and pipeline
</P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Team </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our company was founded and continues to be supported by world-class scientific advisors, including: Dr.&nbsp;Matt Jacobson, Dr.&nbsp;Mark Murcko and,
Dr.&nbsp;Dorothee Kern, as well as by D.&nbsp;E.&nbsp;Shaw Research, led by chief scientist Dr.&nbsp;David&nbsp;E. Shaw. We are leaders in leveraging insights into the dynamic behavior of proteins in drug discovery. We have assembled a scientific
team with extensive expertise in leading-edge experimental and computational drug discovery approaches, as well as a development team with extensive experience in the <FONT STYLE="white-space:nowrap">pre-clinical</FONT> development, translational
medicine, clinical development, and commercialization of precision oncology medicines. In aggregate, our team has previously submitted over 70 INDs and 20 NDAs and contributed to the development of more than 20 approved products. Our President and
Chief Executive Officer, Dr.&nbsp;Sanjiv K. Patel, has more than 15 years of experience in the biopharmaceutical industry, and has led our key business operations and strategic corporate planning activities since 2017. Dr.&nbsp;Don Bergstrom, our
Head of Research and Development, has more than 15 years of experience in the biopharmaceutical industry and has held various leadership positions at other companies in oncology drug discovery, development, and translational medicine. Members of our
management team have held leadership positions at companies that have successfully discovered, developed and commercialized therapies for various cancers and devastating rare diseases. These companies include Allergan, Algeta, Blueprint Medicines,
Eli Lilly, Merck, Novartis, Sanofi, and Vertex. Through March 31, 2020, we have raised approximately $520&nbsp;million supported by a leading syndicate of investors, including SoftBank Vision Fund, Third Rock Ventures, an affiliate of D. E. Shaw
Research, BVF Partners, Casdin Capital, EcoR1 Capital, Foresite Capital, GV, Perceptive Advisors, Alexandria Equities, Tavistock, and Section&nbsp;32. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Developments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since it was first reported to have
emerged in December 2019, a novel strain of coronavirus, which causes <FONT STYLE="white-space:nowrap">COVID-19,</FONT> has spread around the world, including Cambridge, Massachusetts where our primary office and laboratory space are located. The
coronavirus pandemic is evolving, and to date has led to the implementation of various responses, including government-imposed quarantines, travel restrictions and other public health safety measures. The extent to which the coronavirus impacts our
operations or those of our third-party partners, including our preclinical studies, clinical trials or manufacturing operations, will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the
duration of the outbreak, new information that will emerge concerning the severity of the coronavirus and the actions to contain the coronavirus or treat its impact, among others. We have taken temporary precautionary measures intended to help
minimize the risk of the virus to our employees, including temporarily requiring all employees to work remotely, other than those performing or supporting business-critical functions, such as certain members of our laboratory staff, suspending all <FONT
STYLE="white-space:nowrap">non-essential</FONT> travel worldwide for our employees and employee attendance at industry events and <FONT STYLE="white-space:nowrap">in-person</FONT> work-related meetings, which could negatively affect our business.
For those employees that are performing or supporting business-critical functions, we have implemented stringent safety measures designed to comply with applicable federal, state and local guidelines instituted in response to the COVID-19 pandemic.
We cannot presently predict the scope and severity of the planned and potential shutdowns or disruptions of businesses and government agencies, such as the Securities and Exchange Commission, or SEC, or FDA. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Associated with Our Business </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our ability to
implement our business strategy is subject to numerous risks that you should be aware of before making an investment decision. These risks are described more fully in the section entitled &#147;Risk Factors&#148; in this prospectus. These risks
include, among others: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We are a clinical-stage biopharmaceutical company with a limited operating history and have not generated any
revenue to date from drug sales, and may never become profitable. </P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We have incurred significant operating losses since our inception and anticipate that we will incur continued
losses for the foreseeable future. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Even if we consummate this offering, we will need to raise substantial additional funding. If we are unable to
raise capital when needed, we would be forced to delay, reduce or eliminate some of our product development programs or commercialization efforts. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We cannot be certain that we will be able to obtain regulatory approval for, or successfully commercialize, any
of our current or future product candidates. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Business interruptions resulting from the coronavirus disease <FONT STYLE="white-space:nowrap">(COVID-19)</FONT>
outbreak or similar public health crises could cause a disruption of the development of our product candidates and adversely impact our business. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If we experience delays or difficulties in the enrollment of patients in clinical trials, our receipt of
necessary regulatory approvals could be delayed or prevented. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If the market opportunities for our product candidates are smaller than we estimate or if any approval that we
obtain is based on a narrower definition of the patient population, our revenue and ability to achieve profitability will be adversely affected, possibly materially. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our current or future product candidates may cause adverse or other undesirable side effects that could delay or
prevent their regulatory approval, limit the commercial profile of an approved label, or result in significant negative consequences following marketing approval, if any. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Even if we receive regulatory approval for any of our current or future product candidates, we will be subject to
ongoing obligations and continued regulatory review, which may result in significant additional expense. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We rely, and expect to continue to rely, on D. E. Shaw Research for certain capabilities of our Dynamo platform,
and other third parties to conduct our ongoing and planned clinical trials for our current and future product candidates. If these third parties do not successfully carry out their contractual duties, comply with regulatory requirements or meet
expected deadlines, we may not be able to obtain marketing approval for or commercialize our current and potential future product candidates and our business could be substantially harmed. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If we are unable to obtain and maintain patent and other intellectual property protection for our technology and
product candidates or if the scope of the intellectual property protection obtained is not sufficiently broad, our competitors could develop and commercialize technology and drugs similar or identical to ours, and our ability to successfully
commercialize our technology and drugs may be impaired. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate history </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We were incorporated under the laws of the State of Delaware on May&nbsp;4, 2015 under the name &#147;Allostery, Inc.&#148; Our principal corporate office is
located at 399 Binney Street, 2<SUP STYLE="font-size:85%; vertical-align:top">nd</SUP> Floor, Cambridge, MA 02139, and our telephone number is (617) <FONT STYLE="white-space:nowrap">370-8837.</FONT> Our website address is www.relaytx.com. We do not
incorporate the information on or accessible through our website into this prospectus, and you should not consider any information on, or that can be accessed through, our website as part of this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We own various U.S. federal trademark applications and unregistered trademarks, including our company name. All other trademarks or trade names referred to in
this prospectus are the property of their respective owners. Solely for convenience, the trademarks and trade names in this prospectus are referred to without the symbols <SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> and <SUP
STYLE="font-size:85%; vertical-align:top">&#153;</SUP>, but such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Implications of Being an Emerging Growth Company and a Smaller Reporting Company </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We qualify as an &#147;emerging growth company&#148; as defined in the Jumpstart Our Business Startups Act of 2012, as amended. As an emerging
growth company, we may take advantage of specified reduced disclosure and other requirements that are otherwise applicable generally to public companies. These provisions include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">being permitted to only two years of audited financial statements in addition to any required unaudited interim
financial statements with correspondingly reduced &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; disclosure; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduced disclosure about our executive compensation arrangements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not being required to hold advisory votes on executive compensation or to obtain stockholder approval of any
golden parachute arrangements not previously approved; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an exemption from the auditor attestation requirement in the assessment of our internal control over financial
reporting. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may take advantage of these exemptions for up to five years or such earlier time that we are no longer an
emerging growth company. We would cease to be an emerging growth company on the date that is the earliest of (i)&nbsp;the last day of the fiscal year in which we have total annual gross revenues of $1.07&nbsp;billion or more; (ii)&nbsp;the last day
of our fiscal year following the fifth anniversary of the date of the completion of this offering; (iii)&nbsp;the date on which we have issued more than $1.0&nbsp;billion in nonconvertible debt during the previous three years; or (iv)&nbsp;the last
day of the fiscal year in which we are deemed to be a large accelerated filer under the rules of the Securities and Exchange Commission, or SEC, which means the market value of our common stock that is held by
<FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeds $700&nbsp;million as of the prior June&nbsp;30th. We may choose to take advantage of some but not all of these exemptions. We have taken advantage of reduced reporting requirements in
this prospectus. Accordingly, the information contained herein may be different from the information you receive from other public companies in which you hold stock. We are in the process of evaluating the benefits of relying on other exemptions and
reduced reporting requirements under the JOBS Act. Subject to certain conditions, as an emerging growth company, we may rely on certain of these exemptions, including without limitation, providing an auditor&#146;s attestation report on our system
of internal controls over financial reporting pursuant to Section&nbsp;404(b) of the Sarbanes-Oxley Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are also a &#147;smaller
reporting company&#148; as defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller
reporting companies until the fiscal year following the determination that our voting and <FONT STYLE="white-space:nowrap">non-voting</FONT> common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> is more than $250&nbsp;million
measured on the last business day of our second fiscal quarter, or our annual revenues are more than $100&nbsp;million during the most recently completed fiscal year and our voting and <FONT STYLE="white-space:nowrap">non-voting</FONT> common stock
held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> is more than $700&nbsp;million measured on the last business day of our second fiscal quarter. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_2"></A>THE OFFERING </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock offered by us </P></TD>
<TD>20,000,000 shares. </TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock to be outstanding immediately after this offering </P></TD>
<TD>86,875,742 shares (89,875,742&nbsp;shares if the underwriters exercise their option to purchase additional shares in full). </TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Underwriters&#146; option to purchase additional shares </P></TD>
<TD>We have granted a <FONT STYLE="white-space:nowrap">30-day</FONT> option to the underwriters to purchase up to an aggregate of 3,000,000 additional shares of common stock from us at the initial public offering price, less underwriting discounts
and commissions on the same terms as set forth in this prospectus. </TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of proceeds </P></TD>
<TD>We estimate that our net proceeds from the sale of shares of our common stock in this offering will be approximately $341.1&nbsp;million, or $392.7&nbsp;million if the underwriters exercise in full their option to purchase additional shares,
assuming an initial public offering price of $18.50&nbsp;per share, the midpoint of the price range set forth on the cover page of this prospectus, and after deducting estimated underwriting discounts and commissions and estimated offering expenses
payable by us. We currently intend to use the net proceeds from this offering to fund drug discovery and clinical development efforts as well as further expansion of our manufacturing platform and capabilities, and infrastructure to support our
pipeline. See &#147;Use of Proceeds&#148; for additional information. </TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Directed share program </P></TD>
<TD>At our request, the underwriters have reserved up to 441,000 shares, or 2.2% of the shares being offered by this prospectus, for sale, at the initial public offering price, to certain of our directors, officers, employees and persons having
business relationships with us. The number of shares of common stock available for sale to the general public will be reduced to the extent these parties purchase any of such reserved shares. Any reserved shares of common stock that are not so
purchased will be offered by the underwriters to the general public on the same terms as the other shares offered by this prospectus. Please see &#147;Underwriting.&#148; </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk factors </P></TD>
<TD>You should carefully read the &#147;Risk Factors&#148; section of this prospectus for a discussion of factors that you should consider before deciding to invest in our common stock. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Nasdaq Global Market symbol </P></TD>
<TD>RLAY </TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The number of shares of our common stock to be outstanding after this offering is based on
4,883,208&nbsp;shares of our common stock outstanding as of June 30, 2020, including 290,477 shares of <FONT STYLE="white-space:nowrap">non-vested</FONT> restricted common stock, and 61,992,534 shares of our common stock issuable upon the automatic
conversion of all outstanding shares of our preferred stock immediately prior to the completion of this offering, and excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">7,471,087 shares of common stock issuable upon the exercise of stock options outstanding as of June 30, 2020, at
a weighted average exercise price of $5.05 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">769,354<B> </B>shares of common stock reserved for future issuance as of June 30, 2020 under our 2016 Relay
Therapeutics, Inc. Stock Option and Grant Plan, as amended, or 2016 Plan, which will cease to be available for issuance at the time that our 2020 Stock Option and Incentive Plan, or 2020 Stock Plan, becomes effective; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">8,376,080 shares of our common stock that will become available for future issuance under our 2020<B> </B>Stock
Plan, which includes 769,354 shares of common stock available for issuance as of June 30, 2020 under our 2016 Plan and which will become effective in connection with the completion of this offering; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1,092,532 shares of our common stock that will become available for future issuance under our 2020<B>
</B>Employee Stock Purchase Plan, or ESPP, which will become effective in connection with the completion of this offering. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as
otherwise indicated, all information in this prospectus assumes or gives effect to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the conversion of all outstanding shares of our convertible preferred stock into an aggregate of 61,992,534
shares of our common stock immediately prior to the completion of this offering; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no exercise of the outstanding options described above; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no exercise by the underwriters of their option to purchase up to an additional 3,000,000 shares of our common
stock in this offering; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-3.55092</FONT></FONT> reverse split
of our common stock effected on July 8, 2020; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the filing of our fourth amended and restated certificate of incorporation and the adoption of our amended and
restated bylaws, which will occur immediately prior to the completion of this offering. </P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_3"></A>SUMMARY CONSOLIDATED FINANCIAL DATA </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should read the following summary financial data together with our consolidated financial statements and the related notes appearing at the end of this
prospectus and the &#147;Selected Consolidated Financial Data&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; sections of this prospectus. We have derived the statement of operations
data for the years ended December&nbsp;31, 2018 and 2019 from our audited consolidated financial statements appearing at the end of this prospectus. The statement of operations data for the three months ended March&nbsp;31, 2019 and 2020 and the
balance sheet data as of March&nbsp;31, 2020 have been derived from our unaudited financial statements appearing at the end of this prospectus and have been prepared on the same basis as the audited financial statements. In the opinion of
management, the unaudited data reflect all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the financial information in those statements. Our historical results are not necessarily indicative of
results that should be expected in any future period, and our results for any interim period are not necessarily indicative of results that should be expected for any full year. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended</B><br><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended</B><br><B>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(in thousands, except share and per share data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Statement of Operations Data</B>:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD COLSPAN="5" VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 41,034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 70,306</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 21,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,855</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,067</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,889</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84,048</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,402</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49,889</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(84,048</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(16,402</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26,458</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,220</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(48,785</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(75,305</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(14,182</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(24,886</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share, basic and diluted(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(19.63</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(21.82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.59</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(5.99</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average shares of common stock, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,485,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,450,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,087,779</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,153,791</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per share, basic and diluted (unaudited)(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1.15</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.38</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma weighted average shares of common stock, basic and diluted (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65,428,521</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66,146,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">See Note 11 to our consolidated financial statements appearing at the end of this prospectus for details on the
calculation of basic and diluted net loss per share. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">See Note 12 to our consolidated financial statements appearing at the end of this prospectus for details on the
calculation of basic and diluted pro forma net loss per share. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth summary balance sheet
data as of March&nbsp;31, 2020: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on an actual basis; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on a pro forma basis to give effect to (i) the automatic conversion of all outstanding shares of our preferred
stock into an aggregate of 61,992,534 shares of common stock immediately prior to the completion of this offering and (ii)&nbsp;the exercise of options to purchase 95,573 shares of common stock at a weighted average exercise price of $3.84 per share
from April 1, 2020 through June 30, 2020 under our 2016 Plan as if the exercises had occurred on March 31, 2020; </P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on a pro forma as adjusted basis to give further effect to our issuance and sale of 20,000,000 shares of our
common stock in this offering at an assumed initial public offering price of $18.50 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, after deducting estimated underwriting discounts and commissions
and estimated offering expenses payable by us. </P></TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of March&nbsp;31, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro&nbsp;Forma</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma<BR>As&nbsp;Adjusted(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>(in&nbsp;thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance Sheet Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents, restricted cash, and investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 335,081</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">335,448</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">676,548</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Working capital(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">327,118</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">327,485</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">668,585</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">370,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">370,641</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">711,741</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">537,781</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; equity (deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(202,351</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">335,797</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">676,897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">We define working capital as current assets less current liabilities. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A $1.00 increase or decrease in the assumed initial public offering price of $18.50 per share, which is the
midpoint of the price range set forth on the cover page of this prospectus, would increase or decrease the pro forma as adjusted amount of each of cash, cash equivalents, restricted cash and investments, working capital, total assets and total
stockholders&#146; equity by $18.6 million, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting estimated underwriting discounts and commissions. An increase or
decrease of 1,000,000 shares in the number of shares offered by us, as set forth on the cover page of this prospectus, would increase or decrease the pro forma as adjusted amount of each of cash, cash equivalents, restricted cash and investments,
working capital, total assets and total stockholders&#146; equity by $17.2 million, assuming no change in the assumed initial public offering price per share and after deducting estimated underwriting discounts and commissions. This pro forma as
adjusted information is illustrative only and will depend on the actual initial public offering price and other terms of this offering determined at pricing. </P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_4"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Investing in our common stock involves a high degree of risk. You should carefully consider the risks described below, as well as the other information in
this prospectus, including our consolidated financial statements and the related notes and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations,&#148; before deciding whether to invest in our common stock.
The occurrence of any of the events or developments described below could harm our business, financial condition, results of operations and growth prospects. In such an event, the market price of our common stock could decline and you may lose all
or part of your investment. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operations. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Financial Position, Business, Technology, and Industry </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are a biopharmaceutical company with a limited operating history. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a biopharmaceutical company with a limited operating history and have incurred net losses in each year since our inception. Our net losses were
$48.8&nbsp;million, $75.3&nbsp;million, $14.2&nbsp;million and $24.9&nbsp;million for the years ended December&nbsp;31, 2018 and 2019 and the three months ended March&nbsp;31, 2019 and 2020, respectively. We had an accumulated deficit of
$214.4&nbsp;million as of March&nbsp;31, 2020. Biopharmaceutical product development is a highly speculative undertaking and involves a substantial degree of risk. We commenced operations in May 2015. Since inception, we have focused substantially
all of our efforts and financial resources on developing our drug discovery platform and initial product candidates. We have no products approved for commercial sale and therefore have never generated any revenue from product sales, and we do not
expect to in the foreseeable future. We have not obtained regulatory approvals for any of our product candidates and there is no assurance that we will obtain approvals in the future. We expect to continue to incur significant expenses and operating
losses over the next several years and for the foreseeable future. Our prior losses, combined with expected future losses, have had and will continue to have an adverse effect on our stockholders&#146; deficit and working capital. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have incurred significant operating losses since our inception and anticipate that we will incur continued losses for the foreseeable future.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Substantially all of our operating losses have resulted from costs incurred in connection with our research and development programs and from
general and administrative costs associated with our operations. We expect our research and development expenses to significantly increase in connection with the commencement and continuation of clinical trials of our product candidates. In
addition, if we obtain marketing approval for our product candidates, we will incur significant sales, marketing and outsourced-manufacturing expenses. Once we are a public company, we will incur additional costs associated with operating as a
public company. As a result, we expect to continue to incur significant and increasing operating losses for the foreseeable future. Because of the numerous risks and uncertainties associated with developing pharmaceutical products, we are unable to
predict the extent of any future losses or when we will become profitable, if at all. Even if we do become profitable, we may not be able to sustain or increase our profitability on a quarterly or annual basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The amount of our future losses is uncertain and our quarterly operating results may fluctuate significantly or may fall below the expectations of investors
or securities analysts, each of which may cause our stock price to fluctuate or decline. Our quarterly and annual operating results may fluctuate significantly in the future due to a variety of factors, many of which are outside of our control and
may be difficult to predict, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing and success or failure of clinical trials for our product candidates or competing product candidates,
or any other change in the competitive landscape of our industry, including consolidation among our competitors or partners; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to successfully recruit and retain subjects for clinical trials, and any delays caused by
difficulties in such efforts; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to obtain marketing approval for our product candidates, and the timing and scope of any such
approvals we may receive; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing and cost of, and level of investment in, research and development activities relating to our product
candidates, which may change from time to time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of manufacturing our product candidates, which may vary depending on the quantity of production and the
terms of our agreements with manufacturers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to attract, hire and retain qualified personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expenditures that we will or may incur to develop additional product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the level of demand for our product candidates should they receive approval, which may vary significantly;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk/benefit profile, cost and reimbursement policies with respect to our product candidates, if approved,
and existing and potential future therapeutics that compete with our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the changing and volatile U.S. and global economic environments, including as a result of the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">future accounting pronouncements or changes in our accounting policies. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The cumulative effects of these factors could result in large fluctuations and unpredictability in our quarterly and annual operating results.
As a result, comparing our operating results on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">period-to-period</FONT></FONT> basis may not be meaningful. This variability and unpredictability could also result in our failing to
meet the expectations of industry or financial analysts or investors for any period. If our revenue or operating results fall below the expectations of analysts or investors or below any forecasts we may provide to the market, or if the forecasts we
provide to the market are below the expectations of analysts or investors, the price of our common stock could decline substantially. Such a stock price decline could occur even when we have met any previously publicly stated guidance we may
provide. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have no products approved for commercial sale and have not generated any revenue from product sales </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our ability to become profitable depends upon our ability to generate revenue. To date, we have not generated any revenue from our product candidates and we do
not expect to generate any revenue from the sale of products in the near future. We do not expect to generate significant revenue unless and until we obtain marketing approval of, and begin to sell one or more of our product candidates. Our ability
to generate revenue depends on a number of factors, including, but not limited to, our ability to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">successfully complete preclinical studies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">successfully enroll subjects in, and complete, clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">have our IND applications go into effect for our planned clinical trials or future clinical trials;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">receive regulatory approvals from applicable regulatory authorities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">initiate and successfully complete all safety studies required to obtain U.S. and foreign marketing approval for
our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establish commercial manufacturing capabilities or make arrangements with third-party manufacturers for clinical
supply and commercial manufacturing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtain and maintain patent and trade secret protection or regulatory exclusivity for our product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">launch commercial sales of our product candidates, if and when approved, whether alone or in collaboration with
others; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtain and maintain acceptance of the product candidates, if and when approved, by patients, the medical
community and third party payors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">effectively compete with other therapies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtain and maintain healthcare coverage and adequate reimbursement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">enforce and defend intellectual property rights and claims; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">take temporary precautionary measures to help minimize the risk of the
<FONT STYLE="white-space:nowrap">COVID-19</FONT> to our employees; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">maintain a continued acceptable safety profile of the product candidates following approval.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we do not achieve one or more of these factors in a timely manner or at all, we could experience significant delays or an inability
to successfully commercialize our product candidates, which would materially harm our business. If we do not receive regulatory approvals for our product candidates, we may not be able to continue our operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Even if we consummate this offering, we will need to raise substantial additional funding. If we are unable to raise capital when needed, we would be
forced to delay, reduce or eliminate some of our product development programs or commercialization efforts. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The development of pharmaceutical
products is capital-intensive. We have only initiated a Phase 1 monotherapy dose escalation Phase 1 clinical trial of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> in patients with advanced solid tumors. We are currently advancing most of our
product candidates through preclinical development and anticipate beginning a Phase 1 clinical trial for <FONT STYLE="white-space:nowrap">RLY-4008</FONT> in the second half of 2020. We expect our expenses to increase in connection with our ongoing
activities, particularly as we continue the research and development of, initiate clinical trials of, and seek marketing approval for, our product candidates. In addition, depending on the status of regulatory approval or, if we obtain marketing
approval for any of our product candidates, we expect to incur significant commercialization expenses related to product sales, marketing, manufacturing and distribution. We may also need to raise additional funds sooner if we choose to pursue
additional indications and/or geographies for our product candidates or otherwise expand more rapidly than we presently anticipate. Furthermore, upon the closing of this offering, we expect to incur additional costs associated with operating as a
public company. Accordingly, we will need to obtain substantial additional funding in connection with our continuing operations. If we are unable to raise capital when needed or on attractive terms, we would be forced to delay, reduce or eliminate
certain of our research and development programs or future commercialization efforts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expect that the net proceeds from this offering, together with
our existing cash and cash equivalents and investments will be sufficient to fund our operations through at least 2023. Our future capital requirements will depend on and could increase significantly as a result of many factors, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope, progress, results and costs of product discovery, preclinical and clinical development, laboratory
testing and clinical trials for our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential additional expenses attributable to adjusting our development plans (including any supply related
matters) to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope, prioritization and number of our research and development programs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs, timing and outcome of regulatory review of our product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to establish and maintain additional collaborations on favorable terms, if at all;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the achievement of milestones or occurrence of other developments that trigger payments under any additional
collaboration agreements we obtain; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the extent to which we are obligated to reimburse, or entitled to reimbursement of, clinical trial costs under
future collaboration agreements, if any; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual
property rights and defending intellectual property-related claims; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the extent to which we acquire or <FONT STYLE="white-space:nowrap">in-license</FONT> other product candidates and
technologies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs of securing manufacturing arrangements for commercial production; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs of establishing or contracting for sales and marketing capabilities if we obtain regulatory approvals
to market our product candidates. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Identifying potential product candidates and conducting preclinical development testing and clinical
trials is a time-consuming, expensive and uncertain process that takes years to complete, and we may never generate the necessary data or results required to obtain marketing approval and achieve product sales. In addition, our product candidates,
if approved, may not achieve commercial success. Our commercial revenues, if any, will be derived from sales of products that we do not expect to be commercially available for many years, if at all. Accordingly, we will need to continue to rely on
additional financing to achieve our business objectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any additional fundraising efforts may divert our management from their <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> activities, which may adversely affect our ability to develop and commercialize our product candidates. Disruptions in the financial markets in general and more
recently due to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic have made equity and debt financing more difficult to obtain, and may have a material adverse effect on our ability to meet our fundraising needs. We cannot guarantee that
future financing will be available in sufficient amounts or on terms acceptable to us, if at all. Moreover, the terms of any financing may adversely affect the holdings or the rights of our stockholders and the issuance of additional securities,
whether equity or debt, by us, or the possibility of such issuance, may cause the market price of our shares to decline. The sale of additional equity or convertible securities would dilute all of our stockholders. The incurrence of indebtedness
would result in increased fixed payment obligations and we may be required to agree to certain restrictive covenants, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual
property rights and other operating restrictions that could adversely impact our ability to conduct our business. We could also be required to seek funds through arrangements with collaborators or otherwise at an earlier stage than otherwise would
be desirable and we may be required to relinquish rights to some of our technologies or product candidates or otherwise agree to terms unfavorable to us, any of which may have a material adverse effect on our business, operating results and
prospects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we are unable to obtain funding on a timely basis, we may be required to significantly curtail, delay or discontinue one or more of our
research or development programs or the commercialization of any product candidate or be unable to expand our operations or otherwise capitalize on our business opportunities, as desired, which could materially affect our business, financial
condition and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Raising additional capital may cause dilution to our stockholders, including purchasers of common -stock in
this offering, restrict our operations or require us to relinquish rights to our technologies or product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Until such time, if ever, as
we can generate substantial product revenues, we expect to finance our cash needs through a combination of private and public equity offerings, debt financings, collaborations, strategic alliances and licensing arrangements. We do not have any
committed external source of funds. To the extent that we raise additional capital through the sale of common stock or securities convertible or exchangeable into common stock, your ownership interest will be diluted, and the terms of those
securities may include liquidation or other preferences that materially adversely affect your rights as a common stockholder. Debt financing, if available, would increase our fixed payment obligations and may involve agreements that include
covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we raise funds through additional collaborations, strategic alliances or licensing arrangements with third parties, we may have to relinquish valuable
rights to our intellectual property, future revenue streams, research </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
programs or product candidates or to grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings when needed, we may be
required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have never successfully completed any clinical trials, and we may be unable to do so for any product candidates we develop. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have not yet demonstrated our ability to successfully complete any clinical trials, including large-scale, pivotal clinical trials, obtain regulatory
approvals, manufacture a commercial scale product, or arrange for a third party to do so on our behalf, or conduct sales and marketing activities necessary for successful commercialization. We only have one product candidate, a SHP2 inhibitor <FONT
STYLE="white-space:nowrap">(RLY-1971),</FONT> in Phase 1 clinical development. We filed an IND application and received clearance to begin a Phase 1 clinical trial for our FGFR2 program in the second half of 2020. We expect to be in IND-enabling
studies for our PI3K program by the end of 2021. We may not be able to file such IND or INDs for any of our other product candidates on the timelines we expect, if at all. For example, we may experience manufacturing delays with <FONT
STYLE="white-space:nowrap">IND-enabling</FONT> studies. Moreover, we cannot be sure that submission of an IND will result in the FDA allowing further clinical trials to begin, or that, once begun, issues will not arise that require us to suspend or
terminate clinical trials. Commencing each of these clinical trials is subject to finalizing the trial design based on discussions with the FDA and other regulatory authorities. Any guidance we receive from the FDA or other regulatory authorities is
subject to change. These regulatory authorities could change their position, including, on the acceptability of our trial designs or the clinical endpoints selected, which may require us to complete additional clinical trials or impose stricter
approval conditions than we currently expect. Successful completion of our clinical trials is a prerequisite to submitting a new drug application, or NDA, to the FDA and a Marketing Authorization Application, or MAA, to the European Medicines
Agency, or EMA, for each product candidate and, consequently, the ultimate approval and commercial marketing of each product candidate. We have initiated our Phase 1 <FONT STYLE="white-space:nowrap">RLY-1971</FONT> clinical trial, but we do not know
whether any of our future clinical trials will begin on time or ever be completed on schedule, if at all. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we are required to conduct additional
clinical trials or other testing of our product candidates beyond those that we currently contemplate, if we are unable to successfully complete clinical trials of our product candidates or other testing, if the results of these trials or tests are
not positive or are only modestly positive or if there are safety concerns, we may: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">be delayed in obtaining marketing approval for our product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not obtain marketing approval at all; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtain approval for indications or patient populations that are not as broad as intended or desired;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">be subject to post-marketing testing requirements; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">have the product removed from the market after obtaining marketing approval. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Clinical product development involves a lengthy and expensive process, with an uncertain outcome. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">It is impossible to predict when or if any of our product candidates will prove effective and safe in humans or will receive regulatory approval. Before
obtaining marketing approval from regulatory authorities for the sale of any product candidate, we must complete preclinical studies and then conduct extensive clinical trials to demonstrate the safety and efficacy of our product candidates in
humans. Clinical testing is expensive, difficult to design and implement, can take many years to complete and is uncertain as to outcome. A failure of one or more clinical trials can occur at any stage of testing. The outcome of preclinical
development testing and early clinical trials may not be predictive of the success of later clinical trials, and interim results of a clinical trial do not necessarily predict final results. Moreover, preclinical and clinical data are often
susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain marketing approval of their
product candidates. Our preclinical studies and future clinical trials may not be successful. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From time to time, we may publish interim <FONT STYLE="white-space:nowrap">top-line</FONT> or preliminary
data from our clinical trials. Interim data from clinical trials are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available. Preliminary or <FONT
STYLE="white-space:nowrap">top-line</FONT> data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, interim and
preliminary data should be viewed with caution until the final data are available. Adverse differences between preliminary or interim data and final data could significantly harm our business prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may incur additional costs or experience delays in completing, or ultimately be unable to complete, the development and commercialization of our
product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may experience delays in completing our preclinical studies and initiating or completing clinical trials, and we may
experience numerous unforeseen events during, or as a result of, any future clinical trials that we could conduct that could delay or prevent our ability to receive marketing approval or commercialize our product candidates, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulators or institutional review boards, or IRBs, or ethics committees may not authorize us or our
investigators to commence a clinical trial or conduct a clinical trial at a prospective trial site; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may experience delays in reaching, or fail to reach, agreement on acceptable terms with prospective trial
sites and prospective contract research organizations, or CROs, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">clinical trials of our product candidates may produce negative or inconclusive results, and we may decide, or
regulators may require us, to conduct additional preclinical studies or clinical trials or we may decide to abandon product development programs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of patients required for clinical trials of our product candidates may be larger than we anticipate,
enrollment in these clinical trials may be slower than we anticipate or participants may drop out of these clinical trials or fail to return for post-treatment <FONT STYLE="white-space:nowrap">follow-up</FONT> at a higher rate than we anticipate;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our third party contractors may fail to comply with regulatory requirements or meet their contractual obligations
to us in a timely manner, or at all, or may deviate from the clinical trial protocol or drop out of the trial, which may require that we add new clinical trial sites or investigators; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may elect to, or regulators or IRBs or ethics committees may require us or our investigators to, suspend or
terminate clinical research for various reasons, including noncompliance with regulatory requirements or a finding that the participants are being exposed to unacceptable health risks; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of clinical trials of our product candidates may be greater than we anticipate; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the supply or quality of our product candidates or other materials necessary to conduct clinical trials of our
product candidates may be insufficient or inadequate; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our product candidates may have undesirable side effects or other unexpected characteristics, causing us or our
investigators, regulators or IRBs or ethics committees to suspend or terminate the trials, or reports may arise from preclinical or clinical testing of other cancer therapies that raise safety or efficacy concerns about our product candidates.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We could encounter delays if a clinical trial is suspended or terminated by us, by the IRBs of the institutions at which such trials
are being conducted, by the Data Safety Monitoring Board, or DSMB, for such trial or by the FDA or other regulatory authorities. Such authorities may impose such a suspension or termination or clinical hold due to a number of factors, including
failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by the FDA or other regulatory authorities, unforeseen safety issues or adverse
side effects, failure to demonstrate a benefit from </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
using a product, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial. Many of the factors that cause, or lead to, a delay in
the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates. Further, the FDA may disagree with our clinical trial design and our interpretation of data from clinical
trials, or may change the requirements for approval even after it has reviewed and commented on the design for our clinical trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our product
development costs will also increase if we experience delays in testing or regulatory approvals. We do not know whether any of our future clinical trials will begin as planned, or whether any of our current or future clinical trials will need to be
restructured or will be completed on schedule, if at all. Significant preclinical study or clinical trial delays, including those caused by the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, also could shorten any periods during which we
may have the exclusive right to commercialize our product candidates or allow our competitors to bring products to market before we do and impair our ability to successfully commercialize our product candidates and may harm our business and results
of operations. Any delays in our preclinical or future clinical development programs may harm our business, financial condition and prospects significantly. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we experience delays or difficulties in the enrollment of patients in clinical trials, our receipt of necessary regulatory approvals could be delayed
or prevented. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may not be able to initiate or continue clinical trials for our product candidates if we are unable to locate and enroll a
sufficient number of eligible patients to participate in these trials as required by the FDA or similar regulatory authorities outside the United States. In particular, because we will be deploying our drug discovery platform across a broad target
space, our ability to enroll eligible patients may be limited or may result in slower enrollment than we anticipate. In addition, some of our competitors have ongoing clinical trials for product candidates that treat the same indications as our
product candidates, and patients who would otherwise be eligible for our clinical trials may instead enroll in clinical trials of our competitors&#146; product candidates. Furthermore, our ability to enroll patients may be significantly delayed by
the evolving <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and we do not know the extent and scope of such delays at this point. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition
to the competitive trial environment, the eligibility criteria of our planned clinical trials will further limit the pool of available study participants as we will require that patients have specific characteristics that we can measure to assure
their cancer is either severe enough or not too advanced to include them in a study. Additionally, the process of finding patients may prove costly. We also may not be able to identify, recruit and enroll a sufficient number of patients to complete
our clinical studies because of the perceived risks and benefits of the product candidates under study, the availability and efficacy of competing therapies and clinical trials, the proximity and availability of clinical trial sites for prospective
patients, and the patient referral practices of physicians. If patients are unwilling to participate in our studies for any reason, the timeline for recruiting patients, conducting studies and obtaining regulatory approval of potential products may
be delayed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may also engage third parties to develop companion diagnostics for use in our clinical trials, but such third parties may not be
successful in developing such companion diagnostics, furthering the difficulty in identifying patients with the targeted genetic mutations for our clinical trials. Further, if we are required to develop companion diagnostics and are unable to
include patients with the targeted genetic mutations, this could compromise our ability to seek participation in the FDA&#146;s expedited review and development programs, including Breakthrough Therapy Designation and Fast Track Designation, or
otherwise to seek to accelerate clinical development and regulatory timelines. The FDA has indicated that if we continue RLY-4008 in a specific biomarker-defined population, a companion diagnostic device will be required to ensure its safe and
effective use. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Patient enrollment may be affected by other factors including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the severity of the disease under investigation; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the eligibility criteria for the clinical trial in question; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of an appropriate genomic screening test; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the perceived risks and benefits of the product candidate under study; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the efforts to facilitate timely enrollment in clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the patient referral practices of physicians; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to monitor patients adequately during and after treatment; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the proximity and availability of clinical trial sites for prospective patients; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">factors we may not be able to control, such as current or potential pandemics that may limit patients, principal
investigators or staff or clinical site availability (e.g., outbreak of <FONT STYLE="white-space:nowrap">COVID-19).</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Positive results from early preclinical studies of our product candidates are not necessarily predictive of the results of later preclinical studies and
any future clinical trials of our product candidates. If we cannot replicate the positive results from our earlier preclinical studies of our product candidates in our later preclinical studies and future clinical trials, we may be unable to
successfully develop, obtain regulatory for and commercialize our product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any positive results from our preclinical studies of our
product candidates may not necessarily be predictive of the results from required later preclinical studies and clinical trials. Similarly, even if we are able to complete our planned preclinical studies or any future clinical trials of our product
candidates according to our current development timeline, the positive results from such preclinical studies and clinical trials of our product candidates may not be replicated in subsequent preclinical studies or clinical trial results. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Many companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in late-stage clinical trials after achieving positive
results in early-stage development and we cannot be certain that we will not face similar setbacks. These setbacks have been caused by, among other things, preclinical and other nonclinical findings made while clinical trials were underway, or
safety or efficacy observations made in preclinical studies and clinical trials, including previously unreported adverse events. Moreover, preclinical, nonclinical and clinical data are often susceptible to varying interpretations and analyses and
many companies that believed their product candidates performed satisfactorily in preclinical studies and clinical trials nonetheless failed to obtain FDA or EMA approval. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our planned clinical trials or those of our future collaborators may reveal significant adverse events not seen in our preclinical or nonclinical
studies and may result in a safety profile that could inhibit regulatory approval or market acceptance of any of our product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Before
obtaining regulatory approvals for the commercial sale of any products, we must demonstrate through lengthy, complex and expensive preclinical studies and clinical trials that our product candidates are both safe and effective for use in each target
indication. Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Failure can occur at any time during the clinical trial process. The results of preclinical studies and early clinical trials of
our product candidates may not be predictive of the results of later-stage clinical trials. In addition, initial success in clinical trials may not be indicative of results obtained when such trials are completed. There is typically an extremely
high rate of attrition from the failure of product candidates proceeding through clinical trials. Product candidates in later stages of clinical trials also may fail to show the desired safety and efficacy profile despite having progressed through
nonclinical studies and initial clinical trials. A number of companies in the biopharmaceutical industry have suffered significant setbacks in advanced clinical trials due to lack of efficacy or unacceptable safety issues, notwithstanding promising
results in earlier trials. Most product candidates that commence clinical trials are never approved as products and there can be no assurance that any of our current or future clinical trials will ultimately be successful or support further clinical
development of any of our product candidates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may develop future product candidates, in combination with one or more cancer therapies. The uncertainty
resulting from the use of our product candidates in combination with other cancer therapies may make it difficult to accurately predict side effects in future clinical trials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As is the case with many treatments for cancer and rare diseases, it is likely that there may be side effects associated with the use of our product
candidates. If significant adverse events or other side effects are observed in any of our current or future clinical trials, we may have difficulty recruiting patients to our clinical trials, patients may drop out of our trials, or we may be
required to abandon the trials or our development efforts of one or more product candidates altogether. We, the FDA or other applicable regulatory authorities, or an IRB may suspend or terminate clinical trials of a product candidate at any time for
various reasons, including a belief that subjects in such trials are being exposed to unacceptable health risks or adverse side effects. Some potential therapeutics developed in the biotechnology industry that initially showed therapeutic promise in
early-stage trials have later been found to cause side effects that prevented their further development. Even if the side effects do not preclude the product from obtaining or maintaining marketing approval, undesirable side effects may inhibit
market acceptance of the approved product due to its tolerability versus other therapies. Any of these developments could materially harm our business, financial condition and prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We intend to develop our SHP2 program, our FGFR2 program, our PI3K program, and potentially future product candidates, in combination with other
therapies, which exposes us to additional risks. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to develop our SHP2 program, our FGFR2 program, or our PI3K program, and may develop
future product candidates, for use in combination with one or more currently approved cancer therapies. Even if any product candidate we develop was to receive marketing approval or be commercialized for use in combination with other existing
therapies, we would continue to bear the risks that the FDA or similar foreign regulatory authorities could revoke approval of the therapy used in combination with our product candidate or that safety, efficacy, manufacturing or supply issues could
arise with these existing therapies. Combination therapies are commonly used for the treatment of cancer, and we would be subject to similar risks if we develop any of our product candidates for use in combination with other drugs or for indications
other than cancer. This could result in our own products being removed from the market or being less successful commercially. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may also evaluate our
SHP2 program, our FGFR2 program, or our PI3K program or any other future product candidates in combination with one or more other cancer therapies that have not yet been approved for marketing by the FDA or similar foreign regulatory authorities. We
will not be able to market and sell our SHP2 program, our FGFR2 program, or our PI3K program or any product candidate we develop in combination with any such unapproved cancer therapies that do not ultimately obtain marketing approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the FDA or similar foreign regulatory authorities do not approve these other drugs or revoke their approval of, or if safety, efficacy, manufacturing, or
supply issues arise with, the drugs we choose to evaluate in combination with our SHP2 program, our FGFR2 program,<B><I> </I></B>or our PI3K program or any product candidate we develop, we may be unable to obtain approval of or market our SHP2
program, our FGFR2 program, or our PI3K program or any product candidate we develop. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our product candidates utilize a novel mechanism of action and
novel binding locations, which may result in greater research and development expenses, regulatory issues that could delay or prevent approval, or discovery of unknown or unanticipated adverse effects. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our product candidates utilize novel mechanisms of action and novel binding locations, which may result in greater research and development expenses,
regulatory issues that could delay or prevent approval, or discovery of unknown or unanticipated adverse effects. Our Dynamo platform uses advanced computational models in tight integration with our medicinal chemistry, structural biology,
enzymology and biophysics capabilities to predict and design the compounds that will achieve the most desirable characteristics, including potency, selectivity, bioavailability, and drug-like properties. A disruption in any of these capabilities may
have significant adverse </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
effects in our abilities to expand our Dynamo platform, and we cannot predict whether we will continue to have access to these capabilities in the future to support our Dynamo platform. In
addition, there can be no assurance that we will be able to rapidly identify, design and synthesize the necessary compounds or that these or other problems related to the development of this novel mechanism will not arise in the future, which may
cause significant delays or we raise problems we may not be able to resolve. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Regulatory approval of novel product candidates such as ours can be more
expensive, riskier and take longer than for other, more well-known or extensively studied pharmaceutical or biopharmaceutical product candidates due to our and regulatory agencies&#146; lack of experience with them. The novelty of our mechanism of
action may lengthen the regulatory review process, require us to conduct additional studies or clinical trials, increase our development costs, lead to changes in regulatory positions and interpretations, delay or prevent approval and
commercialization of our product candidates or lead to significant post-approval limitations or restrictions. The novel mechanism of action also means that fewer people are trained in or experienced with product candidates of this type, which may
make it more difficult to find, hire and retain personnel for research, development and manufacturing positions. Because our inhibitors utilize a novel mechanism of action that has not been the subject of extensive study compared to more well-known
product candidates, there is also an increased risk that we may discover previously unknown or unanticipated adverse effects during our preclinical studies and clinical trials. Any such events could adversely impact our business prospects, financial
condition and results of </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may in the
future conduct clinical trials for our product candidates outside the United States, and the FDA and similar foreign regulatory authorities may not accept data from such trials. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may in the future choose to conduct additional clinical trials outside the United States, including in Australia, Europe, Asia or other foreign
jurisdictions. The acceptance of trial data from clinical trials conducted outside the United States by the FDA may be subject to certain conditions. In cases where data from clinical trials conducted outside the United States are intended to serve
as the sole basis for marketing approval in the United States, the FDA will generally not approve the application on the basis of foreign data alone unless (i)&nbsp;the data are applicable to the United States population and United States medical
practice; (ii)&nbsp;the trials were performed by clinical investigators of recognized competence and (iii)&nbsp;the data may be considered valid without the need for an <FONT STYLE="white-space:nowrap">on-site</FONT> inspection by the FDA or, if the
FDA considers such an inspection to be necessary, the FDA is able to validate the data through an <FONT STYLE="white-space:nowrap">on-site</FONT> inspection or other appropriate means. Additionally, the FDA&#146;s clinical trial requirements,
including sufficient size of patient populations and statistical powering, must be met. Many foreign regulatory bodies have similar approval requirements. In addition, such foreign trials would be subject to the applicable local laws of the foreign
jurisdictions where the trials are conducted. There can be no assurance that the FDA or any similar foreign regulatory authority will accept data from trials conducted outside of the United States or the applicable jurisdiction. If the FDA or any
similar foreign regulatory authority does not accept such data, it would result in the need for additional trials, which would be costly and time-consuming and delay aspects of our business plan, and which may result in our product candidates not
receiving approval or clearance for commercialization in the applicable jurisdiction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The incidence and prevalence for target patient populations
of our product candidates have not been established with precision. If the market opportunities for our product candidates are smaller than we estimate or if any approval that we obtain is based on a narrower definition of the patient population,
our revenue and ability to achieve profitability will be adversely affected, possibly materially. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are currently evaluating the safety and
tolerability of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> in a Phase 1 dose escalation study in patients with advanced or metastatic solid tumors. We estimate that, across all solid tumors, there are approximately 68,000 late-line patients
annually in the U.S. who might benefit from a SHP2 targeted inhibitor as a monotherapy. Additionally, we estimate there are more than 56,000 late-line patients annually in the U.S. with advanced lung cancer who might benefit from a combination of <FONT
STYLE="white-space:nowrap">RLY-1971</FONT> with another targeted inhibitor. This results in approximately 125,000 late-line cancer patients annually in the U.S. that could benefit from <FONT STYLE="white-space:nowrap">RLY-1971.</FONT>
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
In the future, if <FONT STYLE="white-space:nowrap">RLY-1971</FONT> advances to earlier lines of treatment, it could potentially address approximately 290,000 patients annually in the U.S. We plan
to initiate a Phase 1 clinical trial for <FONT STYLE="white-space:nowrap">RLY-4008</FONT> in solid tumor patients with oncogenic FGFR2 alterations in the second half of 2020. We believe FGFR2-mediated cancers affect approximately 8,000 late-line
patients annually in the U.S., of which fusions represent approximately 2,700, amplifications 1,600, and mutations 3,800. In the future, if <FONT STYLE="white-space:nowrap">RLY-4008</FONT> advances to earlier lines of treatment, it could potentially
address approximately 20,000 patients annually in the U.S. Our projections of both the number of people who have these diseases, as well as the subset of people with these diseases who have the potential to benefit from treatment with RLY-1971,
RLY-4008 or our product candidates, are based on estimates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The total addressable market opportunity will ultimately depend upon, among other things, the
diagnosis criteria included in the final label, if our product candidates are approved for sale for these indications, acceptance by the medical community and patient access, product pricing and reimbursement. The number of patients with cancers and
solid tumors may turn out to be lower than expected, patients may not be otherwise amenable to treatment with our products, or new patients may become increasingly difficult to identify or gain access to, all of which would adversely affect our
results of operations and our business. We may not be successful in our efforts to identify additional product candidates. Due to our limited resources and access to capital, we must prioritize development of certain product candidates, which may
prove to be the wrong choice and may adversely affect our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Although we intend to explore other therapeutic opportunities, in addition to
the product candidates that we are currently developing, we may fail to identify viable new product candidates for clinical development for a number of reasons. If we fail to identify additional potential product candidates, our business could be
materially harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research programs to pursue the development of our existing and planned product candidates for additional indications and to
identify new product candidates and disease targets require substantial technical, financial and human resources whether or not they are ultimately successful. For example, pursuant to our Amended and Restated Collaboration and License Agreement
with D. E. Shaw Research, LLC, or the DESRES Agreement, we collaborate with D.&nbsp;E. Shaw Research, LLC, or D. E. Shaw Research, to develop various protein models and make predictions as to how molecules might move, with subsequent validation
efforts in our and our CROs&#146; labs. There can be no assurance that we will find potential additional targets using this approach, that any such targets will be tractable, or that such clinical validations will be successful. Our research
programs may initially show promise in identifying potential indications and/or product candidates, yet fail to yield results for clinical development for a number of reasons, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the research methodology used may not be successful in identifying potential indications and/or product
candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">potential product candidates may, after further study, be shown to have harmful adverse effects or other
characteristics that indicate they are unlikely to be effective products; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it may take greater human and financial resources than we will possess to identify additional therapeutic
opportunities for our product candidates or to develop suitable potential product candidates through internal research programs, thereby limiting our ability to develop, diversify and expand our product portfolio. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because we have limited financial and human resources, we intend to initially focus on research programs and product candidates for a limited set of
indications. As a result, we may forgo or delay pursuit of opportunities with other product candidates or for other indications that later prove to have greater commercial potential or a greater likelihood of success. Our resource allocation
decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accordingly, there can be no assurance
that we will ever be able to identify additional therapeutic opportunities for our product candidates or to develop suitable potential product candidates through internal research programs, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
which could materially adversely affect our future growth and prospects. We may focus our efforts and resources on potential product candidates or other potential programs that ultimately prove
to be unsuccessful. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we are not able to obtain, or if there are delays in obtaining, required regulatory approvals for our product candidates, we
will not be able to commercialize, or will be delayed in commercializing, our product candidates, and our ability to generate revenue will be materially impaired. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our product candidates and the activities associated with their development and commercialization, including their design, testing, manufacture, safety,
efficacy, recordkeeping, labeling, storage, approval, advertising, promotion, sale, distribution, import and export are subject to comprehensive regulation by the FDA and other regulatory agencies in the United States and by comparable authorities
in other countries. Before we can commercialize any of our product candidates, we must obtain marketing approval. Currently, all of our product candidates are in development, and we have not received approval to market any of our product candidates
from regulatory authorities in any jurisdiction. It is possible that our product candidates, including any product candidates we may seek to develop in the future, will never obtain regulatory approval. We have only limited experience in filing and
supporting the applications necessary to gain regulatory approvals and expect to rely on third-party CROs and/or regulatory consultants to assist us in this process. Securing regulatory approval requires the submission of extensive preclinical and
clinical data and supporting information to the various regulatory authorities for each therapeutic indication to establish the product candidate&#146;s safety and efficacy. Securing regulatory approval also requires the submission of information
about the product manufacturing process to, and inspection of manufacturing facilities by, the relevant regulatory authority. Our product candidates may not be effective, may be only moderately effective or may prove to have undesirable or
unintended side effects, toxicities or other characteristics that may preclude our obtaining marketing approval or prevent or limit commercial use. In addition, regulatory authorities may find fault with our manufacturing process or facilities or
that of third-party contract manufacturers. We may also face greater than expected difficulty in manufacturing our product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The process of
obtaining regulatory approvals, both in the United States and abroad, is expensive and often takes many years. If the FDA or a comparable foreign regulatory authority requires that we perform additional preclinical or clinical trials, approval, if
obtained at all, may be delayed. The length of such a delay varies substantially based upon a variety of factors, including the type, complexity and novelty of the product candidates involved. Changes in marketing approval policies during the
development period, changes in or the enactment of additional statutes or regulations, or changes in regulatory review for each submitted NDA, 510(k), premarket approval application, or PMA, or equivalent application types, may cause delays in the
approval or rejection of an application. The FDA and comparable authorities in other countries have substantial discretion in the approval process and may refuse to accept any application or may decide that our data are insufficient for approval and
require additional preclinical, clinical or other studies. Our product candidates could be delayed in receiving, or fail to receive, regulatory approval for many reasons, including the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA or comparable foreign regulatory authorities may disagree with the design or implementation of our
clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may not be able to enroll a sufficient number of patients in our clinical studies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may be unable to demonstrate to the satisfaction of the FDA or comparable foreign regulatory authorities that
a product candidate is safe and effective for its proposed indication or a related companion diagnostic is suitable to identify appropriate patient populations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the results of clinical trials may not meet the level of statistical significance required by the FDA or
comparable foreign regulatory authorities for approval; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may be unable to demonstrate that a product candidate&#146;s clinical and other benefits outweigh its safety
risks; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA or comparable foreign regulatory authorities may disagree with our interpretation of data from
preclinical studies or clinical trials; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the data collected from clinical trials of our product candidates may not be sufficient to support the submission
of an NDA or other submission or to obtain regulatory approval in the United States or elsewhere; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA or comparable foreign regulatory authorities may find deficiencies with or fail to approve the
manufacturing processes or facilities of third-party manufacturers with which we contract for clinical and commercial supplies; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the approval policies or regulations of the FDA or comparable foreign regulatory authorities may significantly
change such that our clinical data are insufficient for approval. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Even if we were to obtain approval, regulatory authorities may
approve any of our product candidates for fewer or more limited indications than we request, thereby narrowing the commercial potential of the product candidate. In addition, regulatory authorities may grant approval contingent on the performance of
costly post-marketing clinical trials, or may approve a product candidate with a label that does not include the labeling claims necessary or desirable for the successful commercialization of that product candidate. Any of the foregoing scenarios
could materially harm the commercial prospects for our product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we experience delays in obtaining approval or if we fail to obtain approval
of our product candidates, the commercial prospects for our product candidates may be harmed and our ability to generate revenues will be materially impaired. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our business and operations would suffer in the event of computer system failures, cyber-attacks or deficiencies in our or related parties&#146; cyber
security. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Given our limited operating history, we are still in the process of implementing our internal security measures. Our internal computer
systems and those of current and future third parties on which we rely may fail and are vulnerable to damage from computer viruses and unauthorized access. Our information technology and other internal infrastructure systems, including corporate
firewalls, servers, leased lines and connection to the Internet, face the risk of systemic failure that could disrupt our operations. If such an event were to occur and cause interruptions in our operations, it could result in a material disruption
of our development programs and our business operations. For example, the loss of clinical trial data from completed or future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover
or reproduce the data. Likewise, we rely on third parties for the manufacture of our product candidate or any future product candidates and to conduct clinical trials, and similar events relating to their computer systems could also have a material
adverse effect on our business. To the extent that any disruption or security breach were to result in a loss of, or damage to, our data or applications, or inappropriate disclosure of confidential or proprietary information, we could incur
liability, our competitive position could be harmed and the further development and commercialization of our product candidate or any future product candidates could be hindered or delayed. In addition, in response to the ongoing <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic, a majority of our workforce is currently working remotely. This could increase our cyber security risk, create data accessibility concerns, and make us more susceptible to communication
disruptions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or
incur costs that could have a material adverse effect on the success of our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are subject to numerous environmental, health and safety
laws and regulations, including those governing laboratory procedures and the handling, use, storage, treatment and disposal of hazardous materials and wastes. Our operations involve the use of hazardous and flammable materials, including chemicals
and biological and radioactive materials. Our operations also produce hazardous waste products. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from
these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated
with civil or criminal fines and penalties. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we maintain workers&#146; compensation insurance to cover us for costs and expenses we may incur
due to injuries to our employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities. We do not maintain insurance for environmental liability or toxic tort claims that may be
asserted against us in connection with our storage or disposal of biological, hazardous or radioactive materials </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Unfavorable global economic
conditions could adversely affect our business, financial condition or results of operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our results of operations could be adversely
affected by general conditions in the global economy and in the global financial markets. For example, in 2008, the global financial crisis caused extreme volatility and disruptions in the capital and credit markets and the current <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic has caused significant volatility and uncertainty in U.S. and international markets. See &#147;<I>&#151;A pandemic, epidemic, or outbreak of an infectious disease, such <FONT
STYLE="white-space:nowrap">as&nbsp;COVID-19,</FONT> or coronavirus, may materially and adversely affect our business and our financial results and could cause a disruption to the development of our product candidates.</I>&#148;<I> </I>A severe or
prolonged economic downturn could result in a variety of risks to our business, including, weakened demand for our product candidates and our ability to raise additional capital when needed on acceptable terms, if at all. A weak or declining economy
could also strain our suppliers, possibly resulting in supply disruption, or cause our customers to delay making payments for our services. Any of the foregoing could harm our business and we cannot anticipate all of the ways in which the current
economic climate and financial market conditions could adversely impact our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our current operations are located in Massachusetts; and we
or the third parties upon whom we depend may be adversely affected by natural disasters and our business continuity and disaster recovery plans may not adequately protect us from a serious disaster. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our current operations are located in Massachusetts. Any unplanned event, such as flood, fire, explosion, earthquake, extreme weather condition, medical
epidemics, including any potential effects from the current global spread <FONT STYLE="white-space:nowrap">of&nbsp;COVID-19,</FONT> power shortage, telecommunication failure or other natural or <FONT STYLE="white-space:nowrap">man-made</FONT>
accidents or incidents that result in us being unable to fully utilize our facilities, or the manufacturing facilities of our third-party contract manufacturers, may have a material and adverse effect on our ability to operate our business,
particularly on a daily basis, and have significant negative consequences on our financial and operating conditions. Loss of access to these facilities may result in increased costs, delays in the development of our product candidates or
interruption of our business operations. Natural disasters or pandemics such as <FONT STYLE="white-space:nowrap">the&nbsp;COVID-19&nbsp;outbreak</FONT> could further disrupt our operations, and have a material and adverse effect on our business,
financial condition, results of operations and prospects. For example, we have instituted a temporary work from home policy for <FONT STYLE="white-space:nowrap">non-essential</FONT> office personnel and it is possible that this could have a negative
impact on the execution of our business plans and operations. If a natural disaster, power outage or other event occurred that prevented us from using all or a significant portion of our headquarters, that damaged critical infrastructure, such as
our research facilities or the manufacturing facilities of our third-party contract manufacturers, or that otherwise disrupted operations, it may be difficult or, in certain cases, impossible, for us to continue our business for a substantial period
of time. The disaster recovery and business continuity plans we have in place may prove inadequate in the event of a serious disaster or similar event. We may incur substantial expenses as a result of the limited nature of our disaster recovery and
business continuity plans, which could have a material adverse effect on our business. As part of our risk management policy, we maintain insurance coverage at levels that we believe are appropriate for our business. However, in the event of an
accident or incident at these facilities, we cannot assure our investors that the amounts of insurance will be sufficient to satisfy any damages and losses. If our facilities or the manufacturing facilities of our third-party contract manufacturers
are unable to operate because of an accident or incident or for any other reason, even for a short period of time, any or all of our research and development programs may be harmed. Any business interruption may have a material and adverse effect on
our business, financial condition, results of operations and prospects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>A pandemic, epidemic, or outbreak of an infectious disease, such
<FONT STYLE="white-space:nowrap">as&nbsp;COVID-19,</FONT> may materially and adversely affect our business and our financial results and could cause a disruption to the development of our product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Public health crises such as pandemics or similar outbreaks could adversely impact our business. Recently, a novel strain of a virus named <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> (severe acute respiratory syndrome coronavirus 2), or coronavirus, which causes <FONT STYLE="white-space:nowrap">COVID-19</FONT> has spread to most countries across
the world, including all 50 states within the U.S., including specifically Cambridge, Massachusetts where our primary office and laboratory space is located. The coronavirus pandemic is evolving, and to date has led to the implementation of various
responses, including government-imposed quarantines, travel restrictions and other public health safety measures. The extent to which the coronavirus impacts our operations or those of our third party partners, including our preclinical studies or
clinical trial operations, will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the outbreak, new information that will emerge concerning the severity of the coronavirus
and the actions to contain the coronavirus or treat its impact, among others. The continued spread <FONT STYLE="white-space:nowrap">of&nbsp;COVID-19&nbsp;globally</FONT> could adversely impact our preclinical or clinical trial operations in the
U.S., including our ability to recruit and retain patients and principal investigators and site staff who, as healthcare providers, may have heightened exposure <FONT STYLE="white-space:nowrap">to&nbsp;COVID-19&nbsp;if</FONT> an outbreak occurs in
their geography.&nbsp;For example, similar to other biopharmaceutical companies, we may experience delays in initiating <FONT STYLE="white-space:nowrap">IND-enabling</FONT> studies, protocol deviations, enrolling our clinical trials, or dosing of
patients in our clinical trials as well as in activating new trial sites. <FONT STYLE="white-space:nowrap">COVID-19</FONT> may also affect employees of third-party CROs located in affected geographies that we rely upon to carry out our clinical
trials. In addition, as a result of medical complications associated with SDC and mCPRC, the patient populations that our lead core and other core product candidates target may be particularly susceptible to
<FONT STYLE="white-space:nowrap">COVID-19,</FONT> which may make it more difficult for us to identify patients able to enroll in our current and future clinical trials and may impact the ability of enrolled patients to complete any such trials. Any
negative <FONT STYLE="white-space:nowrap">impact&nbsp;COVID-19&nbsp;has</FONT> to patient enrollment or treatment or the execution of our product candidates could cause costly delays to clinical trial activities, which could adversely affect our
ability to obtain regulatory approval for and to commercialize our product candidates, increase our operating expenses, and have a material adverse effect on our financial results. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, timely enrollment in planned clinical trials is dependent upon clinical trial sites which could be adversely affected by global health matters,
such as pandemics. We plan to conduct clinical trials for our product candidates in geographies which are currently being affected by the coronavirus. Some factors from the coronavirus outbreak that will delay or otherwise adversely affect
enrollment in the clinical trials of our product candidates, as well as our business generally, include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential diversion of healthcare resources away from the conduct of clinical trials to focus on pandemic
concerns, including the attention of physicians serving as our clinical trial investigators, hospitals serving as our clinical trial sites and hospital staff supporting the conduct of our prospective clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limitations on travel that could interrupt key trial and business activities, such as clinical trial site
initiations and monitoring, domestic and international travel by employees, contractors or patients to clinical trial sites, including any government-imposed travel restrictions or quarantines that will impact the ability or willingness of patients,
employees or contractors to travel to our clinical trial sites or secure visas or entry permissions, a loss of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">face-to-face</FONT></FONT> meetings and other interactions with
potential partners, any of which could delay or adversely impact the conduct or progress of our prospective clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential negative affect on the operations of our third-party manufacturers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">interruption in global shipping affecting the transport of clinical trial materials, such as patient samples,
investigational drug product and conditioning drugs and other supplies used in our prospective clinical trials; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">business disruptions caused by potential workplace, laboratory and office closures and an increased reliance on
employees working from home, disruptions to or delays in ongoing laboratory experiments </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
and operations, staffing shortages, travel limitations or mass transit disruptions, any of which could adversely impact our business operations or delay necessary interactions with local
regulators, ethics committees and other important agencies and contractors. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have taken temporary precautionary measures intended to
help minimize the risk of the virus to our employees, including temporarily requiring all employees to work remotely, suspending all <FONT STYLE="white-space:nowrap">non-essential</FONT> travel worldwide for our employees and discouraging employee
attendance at industry events and <FONT STYLE="white-space:nowrap">in-person</FONT> work-related meetings, which could negatively affect our business. We cannot presently predict the scope and severity of the planned and potential shutdowns or
disruptions of businesses and government agencies, such as the Securities and Exchange Commission, or the SEC, or FDA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These and other factors arising
from the coronavirus could worsen in countries that are already afflicted with the coronavirus or could continue to spread to additional countries. Any of these factors, and other factors related to any such disruptions that are unforeseen, could
have a material adverse effect on our business and our results of operation and financial condition. Further, uncertainty around these and related issues could lead to adverse effects on the economy of the United States and other economies, which
could impact our ability to raise the necessary capital needed to develop and commercialize our product candidates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Reliance on
Third Parties </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Under the DESRES Agreement, we collaborate with D. E. Shaw Research to rapidly develop various protein models, a process that
depends on D. E. Shaw Research&#146;s use of their proprietary supercomputer, Anton 2. A termination of the DESRES Agreement could have a material adverse effect on our business, financial condition, results of operations, and prospects.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the DESRES Agreement, we collaborate with D. E. Shaw Research to develop various protein models to make predictions as to how molecules
might move in connection with identifying potential new biological targets and prospective drug compounds. There can be no assurance these protein models, or the technology used by D.&nbsp;E. Shaw Research to develop them (including the Anton 2
supercomputer), will provide reliable data or target information, or that the findings from these activities and our subsequent validation efforts will translate into the ability to develop therapeutically effective compounds. Our collaboration with
D. E. Shaw Research is our key computational collaboration, and there can be no assurance that this collaboration will continue past the current term of the DESRES Agreement, on favorable terms or at all, or that at any time while the collaboration
is in effect D. E. Shaw Research will provide a level of service that benefits our programs in a meaningfully positive manner. While we also have other computational collaborations, mostly focused on developing machine learning models, such
collaborations do not provide a substitute for the technology made available through our collaboration with D. E. Shaw Research. The termination of the DESRES Agreement or any reduction in our collaboration with D. E. Shaw Research would require us
to rely more heavily on these other collaborations and our own internal resources, and may delay or impair our development efforts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, while
the termination of the DESRES Agreement would not directly impact the development of our lead product candidates, we cannot predict the effects such termination could have on our preclinical studies and development efforts and our ability to
discover and develop additional product candidates. In particular, the technologies accessed through D. E. Shaw Research, including the Anton 2 supercomputer, are important aspects of our Dynamo platform, and we do not currently have access to
another source of computational power comparable to that provided by the Anton 2 supercomputer. Currently, not only is our collaboration with D.&nbsp;E.&nbsp;Shaw Research for a limited time period, but it is also limited in the current
collaboration year to collaboration across a total of eleven target proteins (with such number subject to increases or decreases from year to year, with any increase in such number of targets in each collaboration year capped at four more than the
highest number of such targets in the previous year, and with the number of targets capped at twenty, subject to some limitations), which could restrict our ability to broaden our platform across a larger number of targets and programs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the DESRES Agreement, D. E. Shaw Research controls the rights to its technology, we control the rights
to certain compounds, and we jointly own with D. E. Shaw Research any other work product created by D.&nbsp;E.&nbsp;Shaw Research and us. Any work product we jointly own with D. E. Shaw Research and any other information that we or D. E. Shaw
Research share is subject to a <FONT STYLE="white-space:nowrap">non-exclusive</FONT> cross-license between us and D.&nbsp;E. Shaw Research, subject to certain exceptions. In some instances, D. E. Shaw Research is required to assign to us some of the
work product created by D. E. Shaw Research. Disputes may arise between us and D. E. Shaw Research, as well as any future potential collaborators, regarding intellectual property subject to the DESRES Agreement. If disputes over intellectual
property that we <FONT STYLE="white-space:nowrap">co-own</FONT> or we own individually prevent or impair our ability to maintain our current collaboration arrangements on acceptable terms, or undermine our ability to successfully control the
intellectual property necessary to protect our product candidates, we may be unable to successfully develop and commercialize the affected product candidates. Uncertainties or disagreements around our rights under any such intellectual property may
undermine our ability to partner our programs with third parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the DESRES Agreement is complex and certain provisions may be susceptible
to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could be adverse to us, for example by narrowing what we believe to be the scope of our rights to certain intellectual property, or increasing
what we believe to be our financial or other obligations under the DESRES Agreement, and any such outcome could have a material adverse effect on our business, financial condition, results of operations, and prospects. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are generally also subject to all of the same risks with respect to protection of intellectual property that we
<FONT STYLE="white-space:nowrap">co-own,</FONT> as we are for intellectual property that we own, which are described below. If we or D. E. Shaw Research fail to adequately protect this intellectual property, our ability to commercialize products
could suffer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, we are subject to certain payment obligations under the DESRES Agreement, including payments to D. E. Shaw Research in connection
with certain transactions. These payment obligations may decrease the value to us of certain transactional opportunities or otherwise burden our ability to enter into such transactions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We rely on third parties to conduct our Phase 1 clinical trial of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> and expect to rely on third parties
to conduct future clinical trials, as well as investigator-sponsored clinical trials of our product candidates. If these third parties do not successfully carry out their contractual duties, comply with regulatory requirements or meet expected
deadlines, we may not be able to obtain regulatory approval for or commercialize our product candidates and our business could be substantially harmed. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not have the ability to independently conduct clinical trials. We rely and expect to continue to rely on medical institutions, clinical investigators,
contract laboratories and other third parties, such as CROs, to conduct or otherwise support clinical trials for our product candidates, including our Phase 1 clinical trial of <FONT STYLE="white-space:nowrap">RLY-1971.</FONT> We may also rely on
academic and private <FONT STYLE="white-space:nowrap">non-academic</FONT> institutions to conduct and sponsor clinical trials relating to our product candidates. We will not control the design or conduct of the investigator-sponsored trials, and it
is possible that the FDA or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> regulatory authorities will not view these investigator-sponsored trials as providing adequate support for future clinical trials, whether controlled by us or third
parties, for any one or more reasons, including elements of the design or execution of the trials or safety concerns or other trial results. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Such
arrangements will likely provide us certain information rights with respect to the investigator-sponsored trials, including access to and the ability to use and reference the data, including for our own regulatory filings, resulting from the
investigator-sponsored trials. However, we would not have control over the timing and reporting of the data from investigator-sponsored trials, nor would we own the data from the investigator-sponsored trials. If we are unable to confirm or
replicate the results from the investigator-sponsored trials or if negative results are obtained, we would likely be further delayed or prevented from advancing further clinical development of our product candidates. Further, if investigators or
institutions breach their obligations with respect to the clinical development of our product candidates, or if the data proves to be inadequate compared to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the first-hand knowledge we might have gained had the investigator-sponsored trials been sponsored and conducted by us, then our ability to design and conduct any future clinical trials ourselves
may be adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We rely and expect to continue to rely heavily on these parties for execution of clinical trials for our product candidates
and control only certain aspects of their activities. Nevertheless, we are responsible for ensuring that each of our clinical trials is conducted in accordance with the applicable protocol, legal and regulatory requirements and scientific standards,
and our reliance on CROs will not relieve us of our regulatory responsibilities. For any violations of laws and regulations during the conduct of our clinical trials, we could be subject to warning letters or enforcement action that may include
civil penalties up to and including criminal prosecution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We, our principal investigators and our CROs are required to comply with regulations, including
Good Clinical Practices, or GCPs, for conducting, monitoring, recording and reporting the results of clinical trials to ensure that the data and results are scientifically credible and accurate, and that the trial patients are adequately informed of
the potential risks of participating in clinical trials and their rights are protected. These regulations are enforced by the FDA, the Competent Authorities of the Member States of the European Economic Area and comparable foreign regulatory
authorities for any products in clinical development. The FDA enforces GCP regulations through periodic inspections of clinical trial sponsors, principal investigators and trial sites. If we, our principal investigators or our CROs fail to comply
with applicable GCPs, the clinical data generated in our clinical trials may be deemed unreliable and the FDA or comparable foreign regulatory authorities may require us to perform additional clinical trials before approving our marketing
applications. We cannot assure you that, upon inspection, the FDA will determine that any of our future clinical trials will comply with GCPs. In addition, our clinical trials must be conducted with product candidates produced under current Good
Manufacturing Practice, or cGMP, regulations. Our failure or the failure of our principal investigators or CROs to comply with these regulations may require us to repeat clinical trials, which would delay the regulatory approval process and could
also subject us to enforcement action. We also are required to register ongoing clinical trials and post the results of completed clinical trials on a government-sponsored database, ClinicalTrials.gov, within certain timeframes. Failure to do so can
result in fines, adverse publicity and civil and criminal sanctions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we designed our Phase 1 clinical trial of
<FONT STYLE="white-space:nowrap">RLY-1971</FONT> and intend to design the future clinical trials for our product candidates, we expect that CROs will conduct all of our clinical trials. As a result, many important aspects of our development
programs, including their conduct and timing, are outside of our direct control. Our reliance on third parties to conduct future clinical trials also results in less direct control over the management of data developed through clinical trials than
would be the case if we were relying entirely upon our own staff. Communicating with outside parties can also be challenging, potentially leading to mistakes as well as difficulties in coordinating activities. Outside parties may: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">have staffing difficulties; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fail to comply with contractual obligations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">experience regulatory compliance issues; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">undergo changes in priorities or become financially distressed; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">form relationships with other entities, some of which may be our competitors. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These factors may materially adversely affect the willingness or ability of third parties to conduct our clinical trials and may subject us to unexpected cost
increases that are beyond our control. If the principal investigators or CROs do not perform clinical trials in a satisfactory manner, breach their obligations to us or fail to comply with regulatory requirements, the development, regulatory
approval and commercialization of our product candidates may be delayed, we may not be able to obtain regulatory approval and commercialize our product candidates, or our development program materially and irreversibly harmed. If we are unable to
rely on clinical data collected </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by our principal investigators or CROs, we could be required to repeat, extend the duration of, or increase the size of any clinical trials we conduct and this could significantly delay
commercialization and require significantly greater expenditures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any of our relationships with these third-party principal investigators or CROs
terminate, we may not be able to enter into arrangements with alternative CROs. If principal investigators or CROs do not successfully carry out their contractual duties or obligations or meet expected deadlines, if they need to be replaced or if
the quality or accuracy of the clinical data they obtain is compromised due to the failure to adhere to our clinical protocols, regulatory requirements or for other reasons, any clinical trials such principal investigators or CROs are associated
with may be extended, delayed or terminated, and we may not be able to obtain regulatory approval for or successfully commercialize our product candidates. As a result, we believe that our financial results and the commercial prospects for our
product candidates in the subject indication would be harmed, our costs could increase and our ability to generate revenue could be delayed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We
contract with third parties for the manufacture of our product candidates for preclinical development, clinical testing, and expect to continue to do so for commercialization. This reliance on third parties increases the risk that we will not have
sufficient quantities of our product candidates or products or such quantities at an acceptable cost, which could delay, prevent or impair our development or commercialization efforts. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not currently own or operate, nor do we have any plans to establish in the future, any manufacturing facilities or personnel. We rely, and expect to
continue to rely, on third parties for the manufacture of our product candidates for preclinical development and clinical testing, as well as for the commercial manufacture of our products if any of our product candidates receive marketing approval.
This reliance on third parties increases the risk that we will not have sufficient quantities of our product candidates or products or such quantities at an acceptable cost or quality, which could delay, prevent or impair our development or
commercialization efforts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The facilities used by our contract manufacturers to manufacture our product candidates must be inspected by the FDA pursuant
to <FONT STYLE="white-space:nowrap">pre-approval</FONT> inspections that will be conducted after we submit our marketing applications to the FDA. We do not control the manufacturing process of, and will be completely dependent on, our contract
manufacturers for compliance with cGMPs in connection with the manufacture of our product candidates. If our contract manufacturers cannot successfully manufacture material that conforms to our specifications and the strict regulatory requirements
of the FDA or others, they will not be able to pass regulatory inspections and/or maintain regulatory compliance for their manufacturing facilities. In addition, we have no control over the ability of our contract manufacturers to maintain adequate
quality control, quality assurance and qualified personnel. If the FDA or a comparable foreign regulatory authority finds deficiencies with or does not approve these facilities for the manufacture of our product candidates or if it finds
deficiencies or withdraws any such approval in the future, we may need to find alternative manufacturing facilities, which would significantly impact our ability to develop, obtain regulatory approval for or market our product candidates, if
approved. Further, our failure, or the failure of our third party manufacturers, to comply with applicable regulations could result in sanctions being imposed on us, including clinical holds, fines, injunctions, civil penalties, delays, suspension
or withdrawal of approvals, license revocation, seizures or recalls of product candidates or products, if approved, operating restrictions and criminal prosecutions, any of which could significantly and adversely affect our business and supplies of
our product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may be unable to establish any agreements with third-party manufacturers or to do so on acceptable terms. Even if we are able
to establish agreements with third-party manufacturers, reliance on third -party manufacturers entails additional risks, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reliance on the third party for regulatory compliance and quality assurance; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the possible breach of the manufacturing agreement by the third party; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the possible misappropriation of our proprietary information, including our trade secrets and <FONT
STYLE="white-space:nowrap">know-how;</FONT> and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the possible termination or nonrenewal of the agreement by the third party at a time that is costly or
inconvenient for us. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our product candidates and any products that we may develop may compete with other product candidates and approved
products for access to manufacturing facilities. There are a limited number of manufacturers that operate under cGMP regulations and that might be capable of manufacturing for us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any performance failure on the part of our existing or future manufacturers could delay clinical development or marketing approval. If our current contract
manufacturers cannot perform as agreed, we may be required to replace such manufacturers. We may incur added costs and delays in identifying and qualifying any such replacement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our current and anticipated future dependence upon others for the manufacture of our product candidates or products may adversely affect our future profit
margins and our ability to commercialize any products that receive marketing approval on a timely and competitive basis. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The third parties upon
whom we rely for the supply of the active pharmaceutical ingredient used in our product candidates are our sole source of supply, and the loss of any of these suppliers could significantly harm our business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The active pharmaceutical ingredients, or API, used in our product candidates are supplied to us from single-source suppliers. Our ability to successfully
develop our product candidates, and to ultimately supply our commercial products in quantities sufficient to meet the market demand, depends in part on our ability to obtain the API for these products in accordance with regulatory requirements and
in sufficient quantities for clinical testing and commercialization. We do not currently have arrangements in place for a redundant or second-source supply of any such API in the event any of our current suppliers of such API cease their operations
for any reason. We are also unable to predict how changing global economic conditions or potential global health concerns such as the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic&nbsp;will affect our third-party suppliers and
manufacturers. Any negative impact of such matters on our third-party suppliers and manufacturers may also have an adverse impact on our results of operations or financial condition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For all of our product candidates, we intend to identify and qualify additional manufacturers to provide such API prior to submission of an NDA to the FDA
and/or an MAA to the EMA. We are not certain, however, that our single-source suppliers will be able to meet our demand for their products, either because of the nature of our agreements with those suppliers, our limited experience with those
suppliers or our relative importance as a customer to those suppliers. It may be difficult for us to assess their ability to timely meet our demand in the future based on past performance. While our suppliers have generally met our demand for their
products on a timely basis in the past, they may subordinate our needs in the future to their other customers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Establishing additional or replacement
suppliers for the API used in our product candidates, if required, may not be accomplished quickly. If we are able to find a replacement supplier, such replacement supplier would need to be qualified and may require additional regulatory inspection
or approval, which could result in further delay. While we seek to maintain adequate inventory of the API used in our product candidates, any interruption or delay in the supply of components or materials, or our inability to obtain such API from
alternate sources at acceptable prices in a timely manner could impede, delay, limit or prevent our development efforts, which could harm our business, results of operations, financial condition and prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may seek to establish additional collaborations, and, if we are not able to establish them on commercially reasonable terms, or at all, we may have
to alter our development and commercialization plans. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our product development programs and the potential commercialization of our product
candidates will require substantial additional cash to fund expenses. For some of our product candidates, we may decide to collaborate </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with additional pharmaceutical and biotechnology companies for the development and potential commercialization of those product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We face significant competition in seeking appropriate collaborators. Whether we reach a definitive agreement for a collaboration will depend, among other
things, upon our assessment of the collaborator&#146;s resources and expertise, the terms and conditions of the proposed collaboration and the proposed collaborator&#146;s evaluation of a number of factors. Those factors may include the design or
results of clinical trials, the likelihood of approval by the FDA or similar regulatory authorities outside the United States, the potential market for the subject product candidate, the costs and complexities of manufacturing and delivering such
product candidate to patients, the potential of competing products, the existence of uncertainty with respect to our ownership of technology, which can exist if there is a challenge to such ownership without regard to the merits of the challenge and
industry and market conditions generally. The collaborator may also consider alternative product candidates or technologies for similar indications that may be available to collaborate on and whether such a collaboration could be more attractive
than the one with us for our product candidate. The terms of any additional collaborations or other arrangements that we may establish may not be favorable to us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may also be restricted under collaboration agreements from entering into future agreements on certain terms with potential collaborators. Collaborations
are complex and time-consuming to negotiate and document. In addition, there have been a significant number of recent business combinations among large pharmaceutical companies that have resulted in a reduced number of potential future
collaborators. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may not be able to negotiate additional collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we
may have to curtail the development of the product candidate for which we are seeking to collaborate, reduce or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce the scope
of any sales or marketing activities, or increase our expenditures and undertake development or commercialization activities at our own expense. If we elect to increase our expenditures to fund development or commercialization activities on our own,
we may need to obtain additional capital, which may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we may not be able to further develop our product candidates or bring them to market and generate product
revenue. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, any future collaborations that we enter into may not be successful. The success of our collaboration arrangements will depend
heavily on the efforts and activities of our collaborators. Collaborators generally have significant discretion in determining the efforts and resources that they will apply to these collaborations. Disagreements between parties to a collaboration
arrangement regarding clinical development and commercialization matters can lead to delays in the development process or commercializing the applicable product candidate and, in some cases, termination of the collaboration arrangement. These
disagreements can be difficult to resolve if neither of the parties has final decision-making authority. Collaborations with pharmaceutical or biotechnology companies and other third parties often are terminated or allowed to expire by the other
party. Any such termination or expiration would adversely affect us financially and could harm our business reputation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our
Intellectual Property </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we are unable to adequately protect our proprietary technology or obtain and maintain patent protection for our
technology and products or if the scope of the patent protection obtained is not sufficiently broad, our competitors could develop and commercialize technology and products similar or identical to ours, and our ability to successfully commercialize
our technology and products may be impaired. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our commercial success will depend in part on our ability to obtain and maintain proprietary or
intellectual property protection in the United States and other countries for our product candidates, and our core technologies, including our novel target discovery technology and our proprietary compound library and other
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<FONT STYLE="white-space:nowrap">know-how.</FONT> We seek to protect our proprietary and intellectual property position by, among other methods, filing patent applications in the United States
and abroad related to our proprietary technology, inventions and improvements that are important to the development and implementation of our business. We also rely on trade secrets, <FONT STYLE="white-space:nowrap">know-how</FONT> and continuing
technological innovation to develop and maintain our proprietary and intellectual property position. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We <FONT STYLE="white-space:nowrap">co-own</FONT>
with D. E. Shaw Research pending United States, PCT, Argentine, and Taiwanese patent applications, which relate to <FONT STYLE="white-space:nowrap">RLY-1971</FONT> composition of matter and methods of treatment. We solely own a pending provisional
patent application which relates to <FONT STYLE="white-space:nowrap">RLY-1971</FONT> solid forms and methods of manufacture. We <FONT STYLE="white-space:nowrap">co-own</FONT> with D. E. Shaw Research pending unpublished PCT, Argentine, and Taiwanese
applications which relate to <FONT STYLE="white-space:nowrap">RLY-4008</FONT> composition of matter and methods of treatment. We <FONT STYLE="white-space:nowrap">co-own</FONT> with D. E. Shaw Research a pending provisional patent application which
relates to the composition of matter of and methods of treatment using our PI3K lead series. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Most of the research and development for our programs has
been performed under the DESRES Agreement. Under the DESRES Agreement, D. E. Shaw Research controls the rights to its technology (including its supercomputer and software, each of which are important aspects of our Dynamo platform), we control the
rights to certain compounds, and we jointly own with D. E. Shaw Research any other work product created by D. E. Shaw Research and us. Subject to certain limits, we have the right to have the following work product assigned to us: the composition of
matter, method of use, and method of manufacture of certain compounds directed to a Category&nbsp;1 Target, as set forth in the DESRES Agreement. For more information regarding the DESRES Agreement, see &#147;Business&#151;Collaboration and License
Agreement with D. E. Shaw Research, LLC.&#148; We have not yet designated all of the compounds for which we will have this right of assignment, and thus, we do not yet know the scope of exclusivity we will enjoy under our patent rights for our
product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After any work product is assigned to us, we will have the right to prepare, file, prosecute and maintain patents that cover such
assigned work product. We also have the implicit right to defend patents that cover work product owned by us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To date, much of the work product created
under our agreement with D. E. Shaw Research has been created by D.&nbsp;E. Shaw Research and us, together, and is thus <FONT STYLE="white-space:nowrap">co-owned.</FONT> We have the first right to prepare, file, prosecute, maintain and defend
patents that cover work product created by D. E. Shaw Research and us, together. If we choose not to exercise those rights with respect to patents and patent applications that cover joint work product, D. E. Shaw Research will have the right to take
over such activities. The party that is preparing, filing, prosecuting and maintaining a patent that covers joint work product also has the right to enforce such patent against infringers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not currently own or <FONT STYLE="white-space:nowrap">in-license</FONT> any issued patents relating to our platform, our SHP2 program, our FGFR2
program, or our PI3K program We own patent applications relating to our SHP2 program, and <FONT STYLE="white-space:nowrap">RLY-1971</FONT> specifically, and a patent application relating to our PI3K program. We also own patent applications that
relate to our FGFR2 program, and <FONT STYLE="white-space:nowrap">RLY-4008</FONT> specifically. All of these patent applications are <FONT STYLE="white-space:nowrap">co-owned</FONT> with D. E. Shaw Research. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions and has in
recent years been the subject of much litigation. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The degree of patent protection we require to successfully commercialize our product candidates
may be unavailable or severely limited in some cases and may not adequately protect our rights or permit us to gain or keep any competitive advantage. We cannot provide any assurances that any of our pending patent applications will issue, or that
any of our pending patent applications that mature into issued patents will include claims with a scope sufficient to protect <FONT STYLE="white-space:nowrap">RLY-1971,</FONT> <FONT STYLE="white-space:nowrap">RLY-4008</FONT> or our other product
candidates. In addition, the laws of foreign </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
countries may not protect our rights to the same extent as the laws of the United States. Furthermore, patents have a limited lifespan. In the United States, the natural expiration of a patent is
generally twenty years after it is filed. Various extensions may be available; however, the life of a patent, and the protection it affords, is limited. Given the amount of time required for the development, testing and regulatory review of new
product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our owned patent portfolio and any patent portfolio we may license in the future may not provide us with
adequate and continuing patent protection sufficient to exclude others from commercializing products similar or identical to our product candidates, including generic versions of such products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other parties have developed technologies that may be related or competitive to our own, and such parties may have filed or may file patent applications, or
may have received or may receive patents, claiming inventions that may overlap or conflict with those claimed in our own patent applications, with respect to either the same methods or formulations or the same subject matter, in either case that we
may rely upon to dominate our patent position in the market. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not
published until 18 months after filing, or in some cases not at all. Therefore, we cannot know with certainty whether we were the first to make the inventions claimed in our owned or licensed pending patent applications, or that we were the first to
file for patent protection of such inventions. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights cannot be predicted with any certainty. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the patent prosecution process is expensive and time-consuming, and we may not be able to file and prosecute all necessary or desirable patent
applications at a reasonable cost or in a timely manner. Further, with respect to most of the pending patent applications covering our product candidates, prosecution has yet to commence. Patent prosecution is a lengthy process, during which the
scope of the claims initially submitted for examination by the U.S. Patent and Trademark Office, or USPTO, have been significantly narrowed by the time they issue, if at all. It is also possible that we will fail to identify patentable aspects of
our research and development output before it is too late to obtain patent protection. Moreover, in some circumstances, we do not have the right to control the preparation, filing and prosecution of patent applications, or to maintain the patents,
covering technology that we license from third parties. Therefore, these patents and applications may not be prosecuted and enforced in a manner consistent with the best interests of our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Even if we acquire patent protection that we expect should enable us to maintain such competitive advantage, third parties may challenge the validity,
enforceability or scope thereof, which may result in such patents being narrowed, invalidated or held unenforceable. The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our owned and licensed
patents may be challenged in the courts or patent offices in the United States and abroad. For example, we may be subject to a third-party submission of prior art to the USPTO challenging the priority of an invention claimed within one of our
patents, which submissions may also be made prior to a patent&#146;s issuance, precluding the granting of any of our pending patent applications. We may become involved in opposition, derivation, reexamination, inter parties review, post-grant
review or interference proceedings challenging our patent rights or the patent rights of others from whom we have obtained licenses to such rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Competitors may claim that they invented the inventions claimed in our issued patents or patent applications prior to us, or may file patent applications
before we do. Competitors may also claim that we are infringing on their patents and that we therefore cannot practice our technology as claimed under our patents, if issued. Competitors may also contest our patents, if issued, by showing the patent
examiner that the invention was not original, was not novel or was obvious. In litigation, a competitor could claim that our patents, if issued, are not valid for a number of reasons. If a court agrees, we would lose our rights to those challenged
patents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we may in the future be subject to claims by our former employees or consultants asserting an ownership right in our patents or
patent applications, as a result of the work they performed on our behalf. Although we generally require all of our employees, consultants and advisors and any other third parties who </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
have access to our proprietary know-how, information or technology to assign or grant similar rights to their inventions to us, we cannot be certain that we have executed such agreements with all
parties who may have contributed to our intellectual property, nor can we be certain that our agreements with such parties will be upheld in the face of a potential challenge, or that they will not be breached, for which we may not have an adequate
remedy. With respect to intellectual property arising in the course of our collaboration with D.&nbsp;E.&nbsp;Shaw Research, disagreements between us and D.&nbsp;E.&nbsp;Shaw Research may impact our exclusive control of intellectual property
important for protecting our product candidates and proprietary position. A loss of exclusivity, in whole or in part, could allow others to compete with us and harm our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An adverse determination in any such submission or proceeding may result in loss of exclusivity or freedom to operate or in patent claims being narrowed,
invalidated or held unenforceable, in whole or in part, which could limit our ability to stop others from using or commercializing similar or identical technology and products, without payment to us, or could limit the duration of the patent
protection covering our technology and product candidates. Such challenges may also result in our inability to manufacture or commercialize our product candidates without infringing third party patent rights. In addition, if the breadth or strength
of protection provided by our patents and patent applications is threatened, it could dissuade companies from collaborating with us to license, develop or commercialize current or future product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Even if they are unchallenged, our owned patent portfolio and any patent portfolio we may license in the future may not provide us with any meaningful
protection or prevent competitors from designing around our patent claims to circumvent our owned or licensed patents by developing similar or alternative technologies or products in a <FONT STYLE="white-space:nowrap">non-infringing</FONT> manner.
For example, a third party may develop a competitive product that provides benefits similar to one or more of our product candidates but that has a different composition that falls outside the scope of our patent protection. If the patent protection
provided by the patents and patent applications we hold or pursue with respect to our product candidates is not sufficiently broad to impede such competition, our ability to successfully commercialize our product candidates could be negatively
affected, which would harm our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Obtaining and maintaining patent protection depends on compliance with various procedural, document
submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for <FONT STYLE="white-space:nowrap">non-compliance</FONT> with these requirements. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar
provisions during the patent application process. In addition, periodic maintenance fees on issued patents often must be paid to the USPTO and foreign patent agencies over the lifetime of the patent. While an unintentional lapse can in many cases be
cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of
patent rights in the relevant jurisdiction. <FONT STYLE="white-space:nowrap">Non-compliance</FONT> events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to official
actions within prescribed time limits, <FONT STYLE="white-space:nowrap">non-payment</FONT> of fees and failure to properly legalize and submit formal documents. If we fail to maintain the patents and patent applications covering our products or
procedures, we may not be able to stop a competitor from marketing products that are the same as or similar to our product candidates, which would have a material adverse effect on our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we are unable to protect the confidentiality of our trade secrets, our business and competitive position may be harmed. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the protection afforded by patents, we rely upon unpatented trade secret protection, unpatented <FONT STYLE="white-space:nowrap">know-how</FONT>
and continuing technological innovation to develop and maintain our competitive position. With respect to the building of our proprietary compound library, we consider trade secrets and <FONT STYLE="white-space:nowrap">know-how</FONT> to be our
primary intellectual property. We seek to protect our proprietary technology and processes, in part, by entering into confidentiality agreements with our collaborators, scientific advisors, employees and consultants, and invention assignment
agreements with our consultants and employees. We may not be able to prevent the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
unauthorized disclosure or use of our technical <FONT STYLE="white-space:nowrap">know-how</FONT> or other trade secrets by the parties to these agreements, however, despite the existence
generally of confidentiality agreements and other contractual restrictions. Monitoring unauthorized uses and disclosures is difficult, and we do not know whether the steps we have taken to protect our proprietary technologies will be effective. If
any of the collaborators, scientific advisors, employees and consultants who are parties to these agreements breaches or violates the terms of any of these agreements, we may not have adequate remedies for any such breach or violation, and we could
lose our trade secrets as a result. Enforcing a claim that a third party illegally obtained and is using our trade secrets, like patent litigation, is expensive and time consuming, and the outcome is unpredictable. In addition, courts outside the
United States are sometimes less willing to protect trade secrets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our trade secrets could otherwise become known or be independently discovered by our
competitors. Competitors could purchase our product candidates and attempt to replicate some or all of the competitive advantages we derive from our development efforts, willfully infringe our intellectual property rights, design around our
protected technology or develop their own competitive technologies that fall outside of our intellectual property rights. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to
prevent them, or those to whom they communicate it, from using that technology or information to compete with us. If our trade secrets are not adequately protected so as to protect our market against competitors&#146; products, our competitive
position could be adversely affected, as could our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Third parties may initiate legal proceedings alleging that we are infringing their
intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on the success of our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our
commercial success depends upon our ability and the ability of our collaborators to develop, manufacture, market and sell our product candidates and use our proprietary technologies without infringing the proprietary rights and intellectual property
of third parties. The biotechnology and pharmaceutical industries are characterized by extensive and frequent litigation regarding patents and other intellectual property rights. We may in the future become party to, or threatened with, adversarial
proceedings or litigation regarding intellectual property rights with respect to our product candidates and technology, including interference proceedings before the USPTO. Our competitors or other third parties may assert infringement claims
against us, alleging that our products or technologies are covered by their patents. Given the vast number of patents in our field of technology, we cannot be certain that we do not infringe existing patents or that we will not infringe patents that
may be granted in the future. Many companies have filed, and continue to file, patent applications related to SHP2 inhibitors, FGFR2 inhibitors, and PI3K inhibitors. Some of these patent applications have already been allowed or issued, and others
may issue in the future. Since these areas are competitive and of strong interest to pharmaceutical and biotechnology companies, there will likely be additional patent applications filed and additional patents granted in the future, as well as
additional research and development programs expected in the future. Furthermore, because patent applications can take many years to issue and may be confidential for 18 months or more after filing, and because pending patent claims can be revised
before issuance, there may be applications now pending which may later result in issued patents that may be infringed by the manufacture, use or sale of our product candidates, or the practice of our technology. If a patent holder believes our
product or product candidate infringes on its patent, the patent holder may sue us even if we have received patent protection for our technology. Moreover, we may face patent infringement claims from
<FONT STYLE="white-space:nowrap">non-practicing</FONT> entities that have no relevant product revenue and against whom our owned patent portfolio and any patent portfolio we may license in the future may thus have no deterrent effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we are found to infringe a third party&#146;s intellectual property rights, we could be required to obtain a license from such third party to continue
developing and marketing our product candidates and technology. We may choose to obtain a license, even in the absence of an action or finding of infringement. In either case, we may not be able to obtain any required license on commercially
reasonable terms or at all. Even if we were able to obtain such a license, it could be granted on <FONT STYLE="white-space:nowrap">non-exclusive</FONT> terms, thereby providing our competitors and other third parties access to the same technologies
licensed to us. Without such a license, we could be forced, including by court order, to cease developing and commercializing the infringing technology or product candidates. In addition, we could be found liable for monetary damages, including
treble damages and attorneys&#146; fees if we are </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
found to have willfully infringed such third-party patent rights. A finding of infringement could prevent us from commercializing our product candidates or force us to cease some of our business
operations, which could materially harm our business. If we lose a foreign patent lawsuit, alleging our infringement of a competitor&#146;s patents, we could be prevented from marketing our products in one or more foreign countries, which would have
a materially adverse effect on our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may be subject to damages resulting from claims that we or our employees have wrongfully used or
disclosed alleged trade secrets of our competitors or are in breach of <FONT STYLE="white-space:nowrap">non-competition</FONT> or <FONT STYLE="white-space:nowrap">non-solicitation</FONT> agreements with our competitors. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We could in the future be subject to claims that we or our employees have inadvertently or otherwise used or disclosed alleged trade secrets or other
proprietary information of former employers or competitors. Although we try to ensure that our employees and consultants do not use the intellectual property, proprietary information, <FONT STYLE="white-space:nowrap">know-how</FONT> or trade secrets
of others in their work for us, we may in the future be subject to claims that we caused an employee to breach the terms of his or her <FONT STYLE="white-space:nowrap">non-competition</FONT> or
<FONT STYLE="white-space:nowrap">non-solicitation</FONT> agreement, or that we or these individuals have, inadvertently or otherwise, used or disclosed the alleged trade secrets or other proprietary information of a former employer or competitor.
Litigation may be necessary to defend against these claims. Even if we are successful in defending against these claims, litigation could result in substantial costs and could be a distraction to management. If our defenses to these claims fail, in
addition to requiring us to pay monetary damages, a court could prohibit us from using technologies or features that are essential to our product candidates, if such technologies or features are found to incorporate or be derived from the trade
secrets or other proprietary information of the former employers. An inability to incorporate such technologies or features would have a material adverse effect on our business, and may prevent us from successfully commercializing our product
candidates. In addition, we may lose valuable intellectual property rights or personnel as a result of such claims. Moreover, any such litigation or the threat thereof may adversely affect our ability to hire employees or contract with independent
sales representatives. A loss of key personnel or their work product could hamper or prevent our ability to commercialize our product candidates, which would have an adverse effect on our business, results of operations and financial condition. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may become involved in lawsuits to protect or enforce our patents and other intellectual property rights, which could be expensive, time consuming
and unsuccessful. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Competitors and other third parties may infringe, misappropriate or otherwise violate our patents and other intellectual
property rights. To counter infringement or unauthorized use, we may be required to file infringement claims. A court may disagree with our allegations, however, and may refuse to stop the other party from using the technology at issue on the
grounds that our patents do not cover the third-party technology in question. Further, such third parties could counterclaim that we infringe their intellectual property or that a patent we have asserted against them is invalid or unenforceable. In
patent litigation in the United States, defendant counterclaims challenging the validity, enforceability or scope of asserted patents are commonplace. In addition, third parties may initiate legal proceedings against us to assert such challenges to
our intellectual property rights. The outcome of any such proceeding is generally unpredictable. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness or <FONT
STYLE="white-space:nowrap">non-enablement.</FONT> Patents may be unenforceable if someone connected with prosecution of the patent withheld relevant information from the USPTO or made a misleading statement during prosecution. It is possible that
prior art of which we and the patent examiner were unaware during prosecution exists, which could render any patents that may issue invalid. Moreover, it is also possible that prior art may exist that we are aware of but do not believe is relevant
to our future patents, should they issue, but that could nevertheless be determined to render our patents invalid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">An adverse result in any litigation
proceeding could put one or more of our patents at risk of being invalidated or interpreted narrowly. If a defendant were to prevail on a legal assertion of invalidity or unenforceability of our patents covering one of our product candidates, we
would lose at least part, and perhaps all, of the patent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
protection covering such product candidate. Competing products may also be sold in other countries in which our patent coverage might not exist or be as strong. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Intellectual property litigation could cause us to spend substantial resources and distract our personnel from their normal responsibilities.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Litigation or other legal proceedings relating to intellectual property claims, with or without merit, is unpredictable and generally expensive
and time consuming and is likely to divert significant resources from our core business, including distracting our technical and management personnel from their normal responsibilities. Furthermore, because of the substantial amount of discovery
required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. In addition, there could be public announcements of the
results of hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Such litigation or
proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing or distribution activities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may not have sufficient financial or other resources to adequately conduct such litigation or proceedings. Some of our competitors may be able to sustain
the costs of such litigation or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property portfolios. Accordingly, despite our efforts, we may not be able to prevent
third parties from infringing upon or misappropriating or from successfully challenging our intellectual property rights. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a material
adverse effect on our ability to compete in the marketplace. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be able to effectively enforce our intellectual property rights throughout
the world. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filing, prosecuting and defending patents on our product candidates in all countries throughout the world would be prohibitively
expensive. The requirements for patentability may differ in certain countries, particularly in developing countries. Moreover, our ability to protect and enforce our intellectual property rights may be adversely affected by unforeseen changes in
foreign intellectual property laws. Additionally, the patent laws of some foreign countries do not afford intellectual property protection to the same extent as the laws of the United States. Many companies have encountered significant problems in
protecting and defending intellectual property rights in certain foreign jurisdictions. The legal systems of some countries, particularly developing countries, do not favor the enforcement of patents and other intellectual property rights. This
could make it difficult for us to stop the infringement of our patents or the misappropriation of our other intellectual property rights. For example, many foreign countries have compulsory licensing laws under which a patent owner must grant
licenses to third parties. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States. Competitors may use our technologies in jurisdictions where we have not obtained patent
protection to develop their own products and, further, may export otherwise infringing products to territories where we have patent protection, if our ability to enforce our patents to stop infringing activities is inadequate. These products may
compete with our product candidates, and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proceedings to enforce our patent rights in foreign jurisdictions, whether or not successful, could result in substantial costs and divert our efforts and
resources from other aspects of our business. Furthermore, while we intend to protect our intellectual property rights in the major markets for our product candidates, we cannot ensure that we will be able to initiate or maintain similar efforts in
all jurisdictions in which we may wish to market our product candidates. Accordingly, our efforts to protect our intellectual property rights in such countries may be inadequate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we do not obtain patent term extension and data exclusivity for any product candidates we may
develop, our business may be materially harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Depending upon the timing, duration and specifics of any FDA marketing approval of any product
candidates we may develop, one or more of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Action of 1984, or Hatch-Waxman Amendments. The Hatch-Waxman Amendments permit
a patent extension term of up to five years as compensation for patent term lost during the FDA regulatory review process. A patent term extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product
approval, only one patent may be extended and only those claims covering the approved drug, a method for using it or a method for manufacturing it may be extended. However, we may not be granted an extension because of, for example, failing to
exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents or otherwise failing to satisfy applicable requirements. Moreover,
the applicable time period or the scope of patent protection afforded could be less than we request. If we are unable to obtain patent term extension or term of any such extension is less than we request, our competitors may obtain approval of
competing products following our patent expiration, and our business, financial condition, results of operations and prospects could be materially harmed. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may need to license certain intellectual property from third parties, and such licenses may not be available or may not be available on commercially
reasonable terms. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A third party may hold intellectual property, including patent rights, that are important or necessary to the development of our
products. It may be necessary for us to use the patented or proprietary technology of third parties to commercialize our products, in which case we would be required to obtain a license from these third parties on commercially reasonable terms, or
our business could be harmed, possibly materially. Although we believe that licenses to these patents are available from these third parties on commercially reasonable terms, if we were not able to obtain a license, or were not able to obtain a
license on commercially reasonable terms, our business could be harmed, possibly materially. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to comply with our obligations in the
agreements under which we collaborate with or license intellectual property rights from third parties, or otherwise experience disruptions to our business relationships with our collaborators or licensors, we could lose rights that are important to
our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expect our future license agreements will impose, various development, diligence, commercialization, and other obligations on us
in order to maintain the licenses. In spite of our efforts, a future licensor might conclude that we have materially breached our obligations under such license agreements and seek to terminate the license agreements, thereby removing or limiting
our ability to develop and commercialize products and technology covered by these license agreements. If these in-licenses are terminated, or if the underlying patent rights licensed thereunder fail to provide the intended exclusivity, competitors
or other third parties would have the freedom to seek regulatory approval of, and to market, products identical to ours and we may be required to cease our development and commercialization of certain of our product candidates. Any of the foregoing
could have a material adverse effect on our competitive position, business, financial conditions, results of operations, and prospects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover,
disputes may arise regarding intellectual property subject to a licensing agreement, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope of rights granted under the license agreement and other interpretation-related issues;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the extent to which our technology and processes infringe on intellectual property of the licensor that is not
subject to the licensing agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the sublicensing of patent and other rights under our collaborative development relationships;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our diligence obligations under the license agreement and what activities satisfy those diligence obligations;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inventorship and ownership of inventions and know-how resulting from the joint creation or use of
intellectual property by our licensors and us and our partners; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the priority of invention of patented technology. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The agreements under which we may license intellectual property or technology from third parties may be complex, and certain provisions in such agreements may
be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or increase what we
believe to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations, and prospects. Moreover, if disputes over intellectual
property that we have licensed prevent or impair our ability to maintain our licensing arrangements on commercially acceptable terms, we may be unable to successfully develop and commercialize the affected product candidates, which could have a
material adverse effect on our business, financial conditions, results of operations, and prospects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These and similar issues may arise with respect to
our collaboration agreements, such as our DESRES Agreement. Our collaboration with D. E. Shaw Research is our key computational collaboration, and there can be no assurance that this collaboration will continue past the current term of the DESRES
Agreement, on favorable terms or at all, or that at any time while the collaboration is in effect D. E. Shaw Research will provide any particular level of services or that the parties will operate under the agreement without disputes. These disputes
may involve ownership or control of intellectual property rights, exclusivity obligations, diligence and payment obligations, for example. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The DESRES
Agreement imposes certain exclusivity obligations on us during the term of the agreement with respect to Category 2 targets, and certain exclusivity obligations on DESRES during and after the term of the agreement. While we have some degree of
control over how we designate various targets under the DESRES Agreement, D. E. Shaw Research has some degree of control over such designations as well, and our exclusivity obligations limit or delay our ability to conduct research on selected
targets with third parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the DESRES Agreement, D. E. Shaw Research controls the rights to its technology, we control the rights to certain
compounds, and we jointly own with D. E. Shaw Research any other work product created by D.&nbsp;E.&nbsp;Shaw Research and us. Any work product we jointly own with D.&nbsp;E.&nbsp;Shaw Research and any other information that we or D. E. Shaw
Research share is subject to a non-exclusive cross-license between us and D.&nbsp;E.&nbsp;Shaw Research, subject to certain exceptions. In some instances, D. E. Shaw Research is required to assign to us some of the work product created by D. E. Shaw
Research. Disputes may arise between us and D.&nbsp;E.&nbsp;Shaw Research, as well as any future potential collaborators, regarding intellectual property subject to the DESRES Agreement. If disputes over intellectual property that we co-own or we
own individually prevent or impair our ability to maintain our current collaboration arrangements on acceptable terms, or undermine our ability to successfully control the intellectual property necessary to protect our product candidates, we may be
unable to successfully develop and commercialize the affected product candidates. Uncertainties or disagreements around our rights under any such intellectual property may undermine our ability to partner our programs with third parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the DESRES Agreement is complex and certain provisions may be susceptible to multiple interpretations. The resolution of any contract
interpretation disagreement that may arise could be adverse to us, for example by narrowing what we believe to be the scope of our rights to certain intellectual property, or increasing what we believe to be our financial or other obligations under
the DESRES Agreement, and any such outcome could have a material adverse effect on our business, financial condition, results of operations, and prospects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Changes to the patent law in the United States and other jurisdictions could diminish the value of
patents in general, thereby impairing our ability to protect our product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As is the case with other biopharmaceutical companies, our
success is heavily dependent on intellectual property, particularly patents. Obtaining and enforcing patents in the biopharmaceutical industry involve both technological and legal complexity and is therefore costly, time consuming and inherently
uncertain. Recent patent reform legislation in the United States and other countries, including the Leahy-Smith America Invents Act, or Leahy-Smith Act, signed into law on September&nbsp;16, 2011, could increase those uncertainties and costs. The
Leahy-Smith Act includes a number of significant changes to U.S. patent law. These include provisions that affect the way patent applications are prosecuted, redefine prior art and provide more efficient and cost-effective avenues for competitors to
challenge the validity of patents. In addition, the Leahy-Smith Act has transformed the U.S. patent system into a &#147;first to file&#148; system. The <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-to-file</FONT></FONT>
provisions, however, only became effective on March&nbsp;16, 2013. Accordingly, it is not yet clear what, if any, impact the Leahy-Smith Act will have on the operation of our business. However, the Leahy-Smith Act and its implementation could make
it more difficult to obtain patent protection for our inventions and increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could harm our
business, results of operations and financial condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The U.S. Supreme Court has ruled on several patent cases in recent years, either narrowing the
scope of patent protection available in certain circumstances or weakening the rights of patent owners in certain situations. Additionally, there have been recent proposals for additional changes to the patent laws of the United States and other
countries that, if adopted, could impact our ability to obtain patent protection for our proprietary technology or our ability to enforce rights in our proprietary technology. Depending on future actions by the U.S. Congress, the U.S. courts, the
USPTO and the relevant <FONT STYLE="white-space:nowrap">law-making</FONT> bodies in other countries, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce any
patents that we may obtain in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Intellectual property rights do not necessarily address all potential threats. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations and may not
adequately protect our business or permit us to maintain our competitive advantage. For example: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">others may be able to make products that are similar to our product candidates or utilize similar technology but
that are not covered by the claims of the patents that we license or may own; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or our licensors or collaborators, might not have been the first to make the inventions covered by the issued
patent or pending patent application that we license or own now or in the future; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or our licensors or collaborators, might not have been the first to file patent applications covering certain
of our or their inventions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">others may independently develop similar or alternative technologies or duplicate any of our technologies without
infringing our owned or licensed intellectual property rights; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it is possible that our present or future pending patent applications (whether owned or licensed) will not lead
to issued patents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issued patents that we hold rights to may be held invalid or unenforceable, including as a result of legal
challenges by our competitors or other third parties; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our competitors or other third parties might conduct research and development activities in countries where we do
not have patent rights and then use the information learned from such activities to develop competitive products for sale in our major commercial markets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may not develop additional proprietary technologies that are patentable; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the patents of others may harm our business; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may choose not to file a patent in order to maintain certain trade secrets or
<FONT STYLE="white-space:nowrap">know-how,</FONT> and a third party may subsequently file a patent covering such intellectual property. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Should any of these events occur, they could have a material adverse effect on our business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Government Regulation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Even if we
receive regulatory approval for any of our product candidates, we will be subject to ongoing regulatory obligations and continued regulatory review, which may result in significant additional expense. Additionally, our product candidates, if
approved, could be subject to post-market study requirements, marketing and labeling restrictions, and even recall or market withdrawal if unanticipated safety issues are discovered following approval. In addition, we may be subject to penalties or
other enforcement action if we fail to comply with regulatory requirements. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the FDA or a comparable foreign regulatory authority approves any
of our product candidates, the manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage, advertising, promotion and recordkeeping for the product will be subject to extensive and ongoing regulatory requirements.
These requirements include submissions of safety and other post-marketing information and reports, establishment registration and listing, as well as continued compliance with cGMPs and GCPs for any clinical trials that we conduct post-approval. Any
regulatory approvals that we receive for our product candidates may also be subject to limitations on the approved indicated uses for which the product may be marketed or to the conditions of approval, or contain requirements for potentially costly
post-marketing studies, including Phase 4 clinical trials, and surveillance to monitor the safety and efficacy of the product. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or
frequency, or with our third-party manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may result in, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">restrictions on the marketing or manufacturing of the product, withdrawal of the product from the market, or
voluntary or mandatory product recalls; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">clinical trial holds </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fines, warning letters or other regulatory enforcement action; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">refusal by the FDA to approve pending applications or supplements to approved applications filed by us;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product seizure or detention, or refusal to permit the import or export of products; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">injunctions or the imposition of civil or criminal penalties. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA&#146;s policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product
candidates. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained,
which would adversely affect our business, prospects and ability to achieve or sustain profitability. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The FDA and other regulatory agencies
actively enforce the laws and regulations prohibiting the promotion of <FONT STYLE="white-space:nowrap">off-label</FONT> uses. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any of our
product candidates are approved and we are found to have improperly promoted <FONT STYLE="white-space:nowrap">off-label</FONT> uses of those products, we may become subject to significant liability. The FDA and other regulatory agencies strictly
regulate the promotional claims that may be made about approved prescription drug products. In particular, while </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the FDA permits the dissemination of truthful and <FONT STYLE="white-space:nowrap">non-misleading</FONT> information about an approved product, a manufacturer may not promote a product for uses
that are not approved by the FDA. If we are found to have promoted such <FONT STYLE="white-space:nowrap">off-label</FONT> uses, we may become subject to significant liability. The federal government has levied large civil and criminal fines against
companies for alleged improper promotion of regulated products for <FONT STYLE="white-space:nowrap">off-label</FONT> uses and has enjoined several companies from engaging in <FONT STYLE="white-space:nowrap">off-label</FONT> promotion. The FDA has
also requested that companies enter into consent decrees, corporate integrity agreements or permanent injunctions under which specified promotional conduct must be changed or curtailed. If we cannot successfully manage the promotion of our product
candidates, if approved, we could become subject to significant liability, which would materially adversely affect our business and financial condition. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>European data collection is governed by restrictive regulations governing the use, processing and cross-border transfer of personal information.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event we decide to conduct clinical trials or continue to enroll subjects in our ongoing or future clinical trials, we may be subject to
additional privacy restrictions. The collection, use, storage, disclosure, transfer, or other processing of personal data regarding individuals in the EU, including personal health data, is subject to the EU General Data Protection Regulation, or
GDPR. The GDPR is wide-ranging in scope and imposes numerous requirements on companies that process personal data, including requirements relating to processing health and other sensitive data, obtaining consent of the individuals to whom the
personal data relates, providing information to individuals regarding data processing activities, implementing safeguards to protect the security and confidentiality of personal data, providing notification of data breaches, and taking certain
measures when engaging third-party processors. Compliance with the GDPR will be a rigorous and time-intensive process that may increase our cost of doing business or require us to change our business practices, and despite those efforts, there is a
risk that we may be subject to fines and penalties, litigation, and reputational harm in connection with our European activities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Obtaining and
maintaining regulatory approval of our product candidates in one jurisdiction does not mean that we will be successful in obtaining regulatory approval of our product candidates in other jurisdictions. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may also submit marketing applications in other countries. Regulatory authorities in jurisdictions outside of the United States have requirements for
approval of product candidates with which we must comply prior to marketing in those jurisdictions. Obtaining foreign regulatory approvals and compliance with foreign regulatory requirements could result in significant delays, difficulties and costs
for us and could delay or prevent the introduction of our products in certain countries. If we fail to comply with the regulatory requirements in international markets and/or receive applicable marketing approvals, our target market will be reduced
and our ability to realize the full market potential of our product candidates will be harmed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Obtaining and maintaining regulatory approval of our
product candidates in one jurisdiction does not guarantee that we will be able to obtain or maintain regulatory approval in any other jurisdiction, while a failure or delay in obtaining regulatory approval in one jurisdiction may have a negative
effect on the regulatory approval process in others. For example, even if the FDA grants marketing approval of a product candidate, comparable regulatory authorities in foreign jurisdictions must also approve the manufacturing, marketing and
promotion of the product candidate in those countries. Approval procedures vary among jurisdictions and can involve requirements and administrative review periods different from, and greater than, those in the United States, including additional
nonclinical studies or clinical trials as clinical trials conducted in one jurisdiction may not be accepted by regulatory authorities in other jurisdictions. In short, the foreign regulatory approval process involves all of the risks associated with
FDA approval. In many jurisdictions outside the United States, a product candidate must be approved for reimbursement before it can be approved for sale in that jurisdiction. In some cases, the price that we may intend to charge for our products
will also be subject to approval. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we are unable to successfully validate, develop and obtain regulatory approval for companion
diagnostic tests for our product candidates that require or would commercially benefit from such tests, or experience significant delays in doing so, we may not realize the full commercial potential of these product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the clinical development of our product candidates for certain indications, we may engage third parties to develop or obtain access to <I>in
vitro</I> companion diagnostic tests to identify patient subsets within a disease category who may derive selective and meaningful benefit from our product candidates. Further, the FDA has indicated that if we continue RLY-4008 in a specific
biomarker-defined population, a companion diagnostic device will be required to ensure its safe and effective use. Such companion diagnostics would be used during our clinical trials as well as in connection with the commercialization of our product
candidates. To be successful, we or our collaborators will need to address a number of scientific, technical, regulatory and logistical challenges. The FDA and comparable foreign regulatory authorities regulate <I>in vitro</I> companion diagnostics
as medical devices and, under that regulatory framework, will likely require the conduct of clinical trials to demonstrate the safety and effectiveness of any diagnostics we may develop, which we expect will require separate regulatory clearance or
approval prior to commercialization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to rely on third parties for the design, development and manufacture of companion diagnostic tests for our
therapeutic product candidates that may require such tests. If we enter into such collaborative agreements, we will be dependent on the sustained cooperation and effort of our future collaborators in developing and obtaining approval for these
companion diagnostics. It may be necessary to resolve issues such as selectivity/specificity, analytical validation, reproducibility, or clinical validation of companion diagnostics during the development and regulatory approval processes. Moreover,
even if data from preclinical studies and early clinical trials appear to support development of a companion diagnostic for a product candidate, data generated in later clinical trials may fail to support the analytical and clinical validation of
the companion diagnostic. We and our future collaborators may encounter difficulties in developing, obtaining regulatory approval for, manufacturing and commercializing companion diagnostics similar to those we face with respect to our therapeutic
candidates themselves, including issues with achieving regulatory clearance or approval, production of sufficient quantities at commercial scale and with appropriate quality standards, and in gaining market acceptance. If we are unable to
successfully develop companion diagnostics for these therapeutic product candidates, or experience delays in doing so, the development of these therapeutic product candidates may be adversely affected, these therapeutic product candidates may not
obtain marketing approval, and we may not realize the full commercial potential of any of these therapeutics that obtain marketing approval. As a result, our business, results of operations and financial condition could be materially harmed. In
addition, a diagnostic company with whom we contract may decide to discontinue selling or manufacturing the companion diagnostic test that we anticipate using in connection with development and commercialization of our product candidates or our
relationship with such diagnostic company may otherwise terminate. We may not be able to enter into arrangements with another diagnostic company to obtain supplies of an alternative diagnostic test for use in connection with the development and
commercialization of our product candidates or do so on commercially reasonable terms, which could adversely affect and/or delay the development or commercialization of our therapeutic candidates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Laws and regulations governing any international operations we may have in the future may preclude us from developing, manufacturing and selling certain
products outside of the United States and require us to develop and implement costly compliance programs. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we expand our operations outside of
the United States, we must dedicate additional resources to comply with numerous laws and regulations in each jurisdiction in which we plan to operate. The Foreign Corrupt Practices Act, or FCPA, prohibits any U.S. individual or business from
paying, offering, authorizing payment or offering of anything of value, directly or indirectly, to any foreign official, political party or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the
individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the United States to comply with certain accounting provisions requiring the company to maintain books and records that
accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Compliance with the FCPA is expensive and difficult, particularly in countries in which corruption is a
recognized problem. In addition, the FCPA presents particular challenges in the pharmaceutical industry, because, in many countries, hospitals are operated by the government, and doctors and other hospital employees are considered foreign officials.
Certain payments to hospitals in connection with clinical trials and other work have been deemed to be improper payments to government officials and have led to FCPA enforcement actions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Various laws, regulations and executive orders also restrict the use and dissemination outside of the United States, or the sharing with certain <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> nationals, of information classified for national security purposes, as well as certain products and technical data relating to those products. If we expand our presence outside of the United States, it
will require us to dedicate additional resources to comply with these laws, and these laws may preclude us from developing, manufacturing, or selling certain products and product candidates outside of the United States, which could limit our growth
potential and increase our development costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The failure to comply with laws governing international business practices may result in substantial civil
and criminal penalties and suspension or debarment from government contracting. The Securities and Exchange Commission, or SEC, also may suspend or bar issuers from trading securities on U.S. exchanges for violations of the FCPA&#146;s accounting
provisions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are subject to certain U.S. and foreign anti-corruption, anti-money laundering, export control, sanctions, and other trade laws and
regulations. We can face serious consequences for violations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Among other matters, U.S. and foreign anti-corruption, anti-money laundering, export
control, sanctions, and other trade laws and regulations, which are collectively referred to as Trade Laws, prohibit companies and their employees, agents, clinical research organizations, legal counsel, accountants, consultants, contractors, and
other partners from authorizing, promising, offering, providing, soliciting, or receiving directly or indirectly, corrupt or improper payments or anything else of value to or from recipients in the public or private sector. Violations of Trade Laws
can result in substantial criminal fines and civil penalties, imprisonment, the loss of trade privileges, debarment, tax reassessments, breach of contract and fraud litigation, reputational harm, and other consequences. We have direct or indirect
interactions with officials and employees of government agencies or government-affiliated hospitals, universities, and other organizations. We also expect our <FONT STYLE="white-space:nowrap">non-U.S.</FONT> activities to increase in time. We plan
to engage third parties for clinical trials and/or to obtain necessary permits, licenses, patent registrations, and other regulatory approvals and we can be held liable for the corrupt or other illegal activities of our personnel, agents, or
partners, even if we do not explicitly authorize or have prior knowledge of such activities </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may seek priority review designation for one or more
of our other product candidates, but we might not receive such designation, and even if we do, such designation may not lead to a faster regulatory review or approval process. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the FDA determines that a product candidate offers a treatment for a serious condition and, if approved, the product would provide a significant improvement
in safety or effectiveness, the FDA may designate the product candidate for priority review. A priority review designation means that the goal for the FDA to review an application is six months, rather than the standard review period of ten months.
We may request priority review for our product candidates. The FDA has broad discretion with respect to whether or not to grant priority review status to a product candidate, so even if we believe a particular product candidate is eligible for such
designation or status, the FDA may decide not to grant it. Moreover, a priority review designation does not necessarily result in an expedited regulatory review or approval process or necessarily confer any advantage with respect to approval
compared to conventional FDA procedures. Receiving priority review from the FDA does not guarantee approval within the <FONT STYLE="white-space:nowrap">six-month</FONT> review cycle or at all. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may seek orphan drug designation for certain of our product candidates, and we may be unsuccessful
or may be unable to maintain the benefits associated with orphan drug designation, including the potential for market exclusivity. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of our
business strategy, we may seek orphan drug designation for certain of our product candidates, and we may be unsuccessful. Regulatory authorities in some jurisdictions, including the United States and Europe, may designate drugs for relatively small
patient populations as orphan drugs. Under the Orphan Drug Act, the FDA may designate a drug as an orphan drug if it is a drug intended to treat a rare disease or condition, which is generally defined as a patient population of fewer than 200,000
individuals annually in the United States, or a patient population of 200,000 or more in the United States where there is no reasonable expectation that the cost of developing the drug will be recovered from sales in the United States. In the United
States, orphan drug designation entitles a party to financial incentives such as opportunities for grant funding towards clinical trial costs, tax advantages and <FONT STYLE="white-space:nowrap">user-fee</FONT> waivers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Similarly, in Europe, the European Commission, upon the recommendation of the EMA&#146;s Committee for Orphan Medicinal Products, grants orphan drug
designation to promote the development of drugs that are intended for the diagnosis, prevention or treatment of life-threatening or chronically debilitating conditions affecting not more than 5 in 10,000 persons in Europe and for which no
satisfactory method of diagnosis, prevention, or treatment has been authorized (or the product would be a significant benefit to those affected). Additionally, designation is granted for drugs intended for the diagnosis, prevention, or treatment of
a life-threatening, seriously debilitating or serious and chronic condition and when, without incentives, it is unlikely that sales of the drug in Europe would be sufficient to justify the necessary investment in developing the drug. In Europe,
orphan drug designation entitles a party to financial incentives such as reduction of fees or fee waivers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, if a drug with an orphan drug
designation subsequently receives the first marketing approval for the indication for which it has such designation, the drug is entitled to a period of marketing exclusivity, which precludes the FDA or the EMA from approving another marketing
application for the same drug and indication for that time period, except in limited circumstances. The applicable period is seven years in the United States and ten years in Europe. The European exclusivity period can be reduced to six years if a
drug no longer meets the criteria for orphan drug designation or if the drug is sufficiently profitable so that market exclusivity is no longer justified. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Even if we obtain orphan drug exclusivity for a drug, that exclusivity may not effectively protect the drug from competition because different drugs can be
approved for the same condition. Even after an orphan drug is approved, the FDA can subsequently approve the same drug for the same condition if the FDA concludes that the later drug is clinically superior in that it is shown to be safer, more
effective or makes a major contribution to patient care. In addition, a designated orphan drug may not receive orphan drug exclusivity if it is approved for a use that is broader than the indication for which it received orphan designation.
Moreover, orphan drug exclusive marketing rights in the United States may be lost if the FDA later determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantity of the drug to
meet the needs of patients with the rare disease or condition or if another drug with the same active moiety is determined to be safer, more effective, or represents a major contribution to patient care. Orphan drug designation neither shortens the
development time or regulatory review time of a drug nor gives the drug any advantage in the regulatory review or approval process. While we may seek orphan drug designation for our product candidates, we may never receive such designations. Even if
we do receive such designations, there is no guarantee that we will enjoy the benefits of those designations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Breakthrough therapy designation and fast track designation by the FDA, even if granted for any of our
product candidates, may not lead to a faster development, regulatory review or approval process, and each designation does not increase the likelihood that any of our product candidates will receive marketing approval in the United States.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may seek a breakthrough therapy designation for some of our product candidates. A breakthrough therapy is defined as a drug that is intended,
alone or in combination with one or more other drugs, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or
more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. For drugs that have been designated as breakthrough therapies, interaction and communication between the FDA and the sponsor of the
trial can help to identify the most efficient path for clinical development while minimizing the number of patients placed in ineffective control regimens. Drugs designated as breakthrough therapies by the FDA may also be eligible for priority
review and accelerated approval. Designation as a breakthrough therapy is within the discretion of the FDA. Accordingly, even if we believe one of our product candidates meets the criteria for designation as a breakthrough therapy, the FDA may
disagree and instead determine not to make such designation. In any event, the receipt of a breakthrough therapy designation for a product candidate may not result in a faster development process, review or approval compared to therapies considered
for approval under conventional FDA procedures and does not assure ultimate approval by the FDA. In addition, even if one or more of our product candidates qualify as breakthrough therapies, the FDA may later decide that such product candidates no
longer meet the conditions for qualification or decide that the time period for FDA review or approval will not be shortened. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may seek fast track
designation for some of our product candidates. If a drug is intended for the treatment of a serious or life-threatening condition and the drug demonstrates the potential to address unmet medical needs for this condition, the drug sponsor may apply
for fast track designation. The FDA has broad discretion whether or not to grant this designation, so even if we believe a particular product candidate is eligible for this designation, we cannot assure you that the FDA would decide to grant it.
Even if we do receive fast track designation, we may not experience a faster development process, review or approval compared to conventional FDA procedures. The FDA may withdraw fast track designation if it believes that the designation is no
longer supported by data from our clinical development program. Fast track designation alone does not guarantee qualification for the FDA&#146;s priority review procedures. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Accelerated approval by the FDA, even if granted for our FGFR2 program or our PI3K program or any other future product candidates, may not lead to a
faster development or regulatory review or approval process and it does not increase the likelihood that our product candidates will receive marketing approval. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may seek accelerated approval of our FGFR2 program or our PI3K program and for future product candidates. A product may be eligible for accelerated approval
if it treats a serious or life-threatening condition and generally provides a meaningful advantage over available therapies. In addition, it must demonstrate an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit or
on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, or IMM, that is reasonably likely to predict an effect on IMM or other clinical benefit. As a condition of approval, the FDA may require that a sponsor of
a drug or biologic receiving accelerated approval perform adequate and well-controlled post-marketing clinical trials. In addition, the FDA currently requires as a condition for accelerated approval
<FONT STYLE="white-space:nowrap">pre-approval</FONT> of promotional materials, which could adversely impact the timing of the commercial launch of the product. Even if we do receive accelerated approval, we may not experience a faster development or
regulatory review or approval process, and receiving accelerated approval does not provide assurance of ultimate FDA approval. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The FDA, the EMA and other regulatory authorities may implement additional regulations or restrictions
on the development and commercialization of our product candidates, and such changes can be difficult to predict. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA, the EMA and regulatory
authorities in other countries have each expressed interest in further regulating biotechnology products. Agencies at both the federal and state level in the United States, as well as the U.S. Congressional committees and other governments or
governing agencies, have also expressed interest in further regulating the biotechnology industry. Such action may delay or prevent commercialization of some or all of our product candidates. Adverse developments in clinical trials of products
conducted by others may cause the FDA or other oversight bodies to change the requirements for approval of any of our product candidates. These regulatory review agencies and committees and the new requirements or guidelines they promulgate may
lengthen the regulatory review process, require us to perform additional studies or trials, increase our development costs, lead to changes in regulatory positions and interpretations, delay or prevent approval and commercialization of our product
candidates or lead to significant post-approval limitations or restrictions. As we advance our product candidates, we will be required to consult with these regulatory agencies and comply with applicable requirements and guidelines. If we fail to do
so, we may be required to delay or discontinue development of such product candidates. These additional processes may result in a review and approval process that is longer than we otherwise would have expected. Delays as a result of an increased or
lengthier regulatory approval process or further restrictions on the development of our product candidates can be costly and could negatively impact our ability to complete clinical trials and commercialize our current and future product candidates
in a timely manner, if at all. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Healthcare legislative reform measures may have a material adverse effect on our business and results of operations.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The U.S. and many foreign jurisdictions have enacted or proposed legislative and regulatory changes affecting the healthcare system that could
prevent or delay marketing approval of our current or future product candidates or any future product candidates, restrict or regulate post-approval activities and affect our ability to profitably sell a product for which we obtain marketing
approval. Changes in regulations, statutes or the interpretation of existing regulations could impact our business in the future by requiring, for example: (i)&nbsp;changes to our manufacturing arrangements, (ii)&nbsp;additions or modifications to
product labeling, (iii)&nbsp;the recall or discontinuation of our products or (iv)&nbsp;additional record-keeping requirements. If any such changes were to be imposed, they could adversely affect the operation of our business. In the U.S., there
have been and continue to be a number of legislative initiatives to contain healthcare costs. For example, in March 2010, the Affordable Care Act, or the ACA, was passed, which substantially changed the way healthcare is financed by both
governmental and private insurers, and significantly impacted the U.S. pharmaceutical industry. The ACA, among other things, subjects biological products to potential competition by lower-cost biosimilars, addresses a new methodology by which
rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected, increases the minimum Medicaid rebates owed by manufacturers under the Medicaid Drug Rebate
Program and extends the rebate program to individuals enrolled in Medicaid managed care organizations, establishes annual fees and taxes on manufacturers of certain branded prescription drugs, and creates a new Medicare Part D coverage gap discount
program, in which manufacturers must agree to offer 70% (increased pursuant to the Bipartisan Budget Act of 2018, effective as of 2019) <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">point-of-sale</FONT></FONT> discounts off
negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturer&#146;s outpatient drugs to be covered under Medicare Part&nbsp;D. Since then, the ACA risk adjustment program
payment parameters have been updated annually. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Members of the U.S. Congress and the current administration have expressed intent to pass legislation or
adopt executive orders to fundamentally change or repeal parts of the ACA. While Congress has not passed repeal legislation to date, the TCJA, repealed, effective January&nbsp;1, 2019, the <FONT STYLE="white-space:nowrap">tax-based</FONT> shared
responsibility payment imposed by the ACA on certain individuals who fail to maintain qualifying health coverage for all or part of a year that is commonly referred to as the &#147;individual mandate.&#148; On December&nbsp;14, 2018, a federal
district court in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Texas ruled the individual mandate is a critical and inseverable feature of the ACA, and therefore, because it was repealed as part of the TCJA, the remaining provisions of the ACA are invalid as
well. The current administration and Centers for Medicare&nbsp;&amp; Medicaid Services, or CMS, have both stated that the ruling will have no immediate effect, and on December&nbsp;18, 2019, the Fifth Circuit U.S. Court of Appeals held that the
individual mandate is unconstitutional, and remanded the case to the lower court to reconsider its earlier invalidation of the full ACA. Pending review, the ACA remains in effect, but it is unclear at this time what effect the latest ruling will
have on the status of the ACA. Litigation and legislation over the ACA are likely to continue, with unpredictable and uncertain results. We will continue to evaluate the effect that the ACA and its possible repeal and replacement has on our
business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, on January&nbsp;20, 2017, an Executive Order was signed directing federal agencies with authorities and responsibilities under the ACA
to waive, defer, grant exemptions from, or delay the implementation of any provision of the ACA that would impose a fiscal burden on states or a cost, fee, tax, penalty or regulatory burden on individuals, healthcare providers, health insurers, or
manufacturers of pharmaceuticals or medical devices. On October&nbsp;13, 2017, an Executive Order was signed terminating the cost-sharing subsidies that reimburse insurers under the ACA. The current administration has concluded that cost-sharing
reduction, or CSR, payments to insurance companies required under the ACA have not received necessary appropriations from Congress and announced that it will discontinue these payments immediately until those appropriations are made. The loss of the
CSR payments is expected to increase premiums on certain policies issued by qualified health plans under the ACA. Several state Attorneys General filed suit to stop the administration from terminating the subsidies, but their request for a
restraining order was denied by a federal judge in California on October&nbsp;25, 2017. The loss of the cost share reduction payments is expected to increase premiums on certain policies issued by qualified health plans under the ACA. Further, on
June&nbsp;14, 2018, the U.S. Court of Appeals for the Federal Circuit ruled that the federal government was not required to pay to third-party payors more than $12&nbsp;billion in ACA risk corridor payments that they argued were owed to them. The
effects of this gap in reimbursement on third-party payors, the viability of the ACA marketplace, providers, and potentially our business, are not yet known. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, on January&nbsp;22, 2018, a continuing resolution on appropriations for fiscal year 2018 was approved that delayed the implementation of certain <FONT
STYLE="white-space:nowrap">ACA-mandated</FONT> fees, including the so called &#147;Cadillac&#148; tax on certain high cost employer-sponsored insurance plans, the annual fee imposed on certain health insurance providers based on market share, and
the medical device excise tax on <FONT STYLE="white-space:nowrap">non-exempt</FONT> medical devices; however on December&nbsp;20, 2019, the Further Consolidated Appropriations Act (H.R. 1865) was signed into law, which repeals the Cadillac tax, the
health insurance provider tax, and the medical device excise tax. It is impossible to determine whether similar taxes could be instated in the future. The Bipartisan Budget Act of 2018, also amended the ACA, effective January&nbsp;1, 2019, by
increasing the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">point-of-sale</FONT></FONT> discount that is owed by pharmaceutical manufacturers who participate in Medicare Part D and closing the coverage gap in most Medicare drug
plans, commonly referred to as the &#147;donut hole.&#148; CMS published a final rule permitting further collections and payments to and from certain ACA qualified health plans and health insurance issuers under the ACA risk adjustment program in
response to the outcome of federal district court litigation regarding the method CMS uses to determine this risk adjustment. In addition, CMS has recently published a final rule that would give states greater flexibility, starting in 2020, in
setting benchmarks for insurers in the individual and small group marketplaces, which may have the effect of relaxing the essential health benefits required under the ACA for plans sold through such marketplaces. Other legislative changes have been
proposed and adopted in the U.S. since the ACA was enacted. In August 2011, the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with
recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#146;s automatic reduction to several government programs. This includes
aggregate reductions of Medicare payments to providers up to 2% per fiscal year, and, due to subsequent legislative amendments, will remain in effect through 2029 unless additional Congressional action is taken. The American Taxpayer Relief Act of
2012 among other things, reduced Medicare payments to several providers, including hospitals, imaging centers and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from
three to five years. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There has been increasing legislative and enforcement interest in the U.S. with respect to specialty drug
pricing practices. Specifically, there have been several recent U.S. Congressional inquiries and proposed federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs
under Medicare, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drugs. At the federal level, the current administration&#146;s budget for fiscal years 2019 and
2020 contain further drug price control measures that could be enacted during the budget process or in other future legislation, including, for example, measures to permit Medicare Part D plans to negotiate the price of certain drugs under Medicare
Part B, to allow some states to negotiate drug prices under Medicaid, and to eliminate cost sharing for generic drugs for low income patients. Additionally, the current administration released a &#147;Blueprint&#148; to lower drug prices and reduce
out of pocket costs of drugs that contains additional proposals to increase manufacturer competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of their products and
reduce the out of pocket costs of product candidates paid by consumers. The U.S. Department of Health and Human Services, or HHS, has already started the process of soliciting feedback on some of these measures and, at the same time, is immediately
implementing others under its existing authority. For example, in May 2019, CMS issued a final rule to allow Medicare Advantage Plans the option of using step therapy, a type of prior authorization, for Part B drugs beginning January&nbsp;1, 2020.
This final rule codified CMS&#146;s policy change that was effective January&nbsp;1, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, on May&nbsp;30, 2018, the Right to Try Act, was
signed into law. The law, among other things, provides a federal framework for certain patients to access certain investigational new product candidates that have completed a Phase 1 clinical trial and that are undergoing investigation for FDA
approval. Under certain circumstances, eligible patients can seek treatment without enrolling in clinical trials and without obtaining FDA permission under the FDA expanded access program. There is no obligation for a pharmaceutical manufacturer to
make its product candidates available to eligible patients as a result of the Right to Try Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the state level, individual states are increasingly
aggressive in passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing
cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. In addition, regional health care authorities and individual hospitals are increasingly using bidding
procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other health care programs. These measures could reduce the ultimate demand for our products, once approved, or put pressure on
our product pricing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expect that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit the
amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for our current or future product candidates or additional pricing pressures. In particular any policy changes through CMS
as well as local state Medicaid programs could have a significant impact on our business in light of the higher proportion of SCD patients that utilize Medicare and Medicaid programs to pay for treatments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our revenue prospects could be affected by changes in healthcare spending and policy in the U.S. and abroad. We operate in a highly regulated industry and new
laws, regulations or judicial decisions, or new interpretations of existing laws, regulations or decisions, related to healthcare availability, the method of delivery or payment for healthcare products and services could negatively impact our
business, operations and financial condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There have been, and likely will continue to be, legislative and regulatory proposals at the foreign,
federal and state levels directed at broadening the availability of healthcare and containing or lowering the cost of healthcare. We cannot predict the initiatives that may be adopted in the future, including repeal, replacement or significant
revisions to the ACA. The continuing efforts of the government, insurance companies, managed care </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
organizations and other payors of healthcare services to contain or reduce costs of healthcare and/or impose price controls may adversely affect: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>the demand for our current or future product candidates, if we obtain regulatory approval;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>our ability to set a price that we believe is fair for our products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>our ability to obtain coverage and reimbursement approval for a product; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>our ability to generate revenue and achieve or maintain profitability; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>the level of taxes that we are required to pay; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>the availability of capital. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors, which may
adversely affect our future profitability. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our relationships with customers and third-party payors will be subject to applicable anti-kickback,
fraud and abuse and other healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties, exclusion from government healthcare programs, contractual damages, reputational harm and diminished profits and future
earnings. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we do not currently have any products on the market, once we begin commercializing our product candidates, we will be subject
to additional healthcare statutory and regulatory requirements and enforcement by the federal government and the states and foreign governments in which we conduct our business. Healthcare providers, physicians and third-party payors play a primary
role in the recommendation and prescription of any product candidates for which we obtain marketing approval. Our future arrangements with third-party payors and customers may expose us to broadly applicable fraud and abuse and other healthcare laws
and regulations that may constrain the business or financial arrangements and relationships through which we market, sell and distribute our product candidates for which we obtain marketing approval. Restrictions under applicable federal and state
healthcare laws and regulations, include the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Anti-Kickback Statute prohibits, among other things, persons from knowingly and willfully soliciting,
offering, receiving or providing remuneration, directly or indirectly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, order or recommendation of, any good or service, for which payment may be made
under federal and state healthcare programs such as Medicare and Medicaid. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal civil and criminal false claims and civil monetary penalties laws, including the federal False Claims
Act, or FCA, imposes criminal and civil penalties, including through civil whistleblower or qui tam actions, against individuals or entities for knowingly presenting, or causing to be presented, to the federal government, claims for payment that are
false or fraudulent or making a false statement to avoid, decrease or conceal an obligation to pay money to the federal government. In addition, the government may assert that a claim including items and services resulting from a violation of the
federal Anti-Kickback Statute constitutes a false of fraudulent claim for purposes of the False Claims Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, imposes criminal and civil
liability for executing a scheme to defraud any healthcare benefit program, or knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false statement in connection with the delivery of or payment for
healthcare benefits, items or services; similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal physician payment transparency requirements, sometimes referred to as the &#147;Sunshine Act&#148;
under the Affordable Care Act, require manufacturers of drugs, devices, biologics and medical supplies </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
that are reimbursable under Medicare, Medicaid, or the Children&#146;s Health Insurance Program to report to the Department of Health and Human Services information related to transfers of value
made to physicians (currently defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, as well as ownership and investment interests of such physicians and their immediate family members. Effective
January&nbsp;1, 2022, these reporting obligations will extend to include transfers of value made to certain <FONT STYLE="white-space:nowrap">non-physician</FONT> providers such as physician assistants and nurse practitioners; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009 and its
implementing regulations, impose obligations on certain covered entity healthcare providers, health plans, and healthcare clearinghouses as well as their business associates that perform certain services involving the use or disclosure of
individually identifiable health information, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually identifiable health information; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">analogous state laws and regulations, such as state anti-kickback and false claims laws may apply to sales or
marketing arrangements and claims involving healthcare items or services reimbursed by <FONT STYLE="white-space:nowrap">non-governmental</FONT> third-party payors, including private insurers. Some state laws require pharmaceutical companies to
comply with the pharmaceutical industry&#146;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government in addition to requiring drug manufacturers to report information related to payments to
physicians and other health care providers or marketing expenditures. Further, many state laws governing the privacy and security of health information in certain circumstances, differ from each other in significant ways and often are not preempted
by HIPAA, thus complicating compliance efforts. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ensuring that our future business arrangements with third parties comply with
applicable healthcare laws and regulations could involve substantial costs. It is possible that governmental authorities will conclude that our business practices do not comply with current or future statutes, regulations or case law involving
applicable fraud and abuse or other healthcare laws and regulations. If our operations, including anticipated activities to be conducted by our sales team, were to be found to be in violation of any of these laws or any other governmental
regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, fines, imprisonment, exclusion from government funded healthcare programs, such as Medicare and Medicaid, and the curtailment
or restructuring of our operations. If any of the physicians or other providers or entities with whom we expect to do business is found not to be in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions,
including exclusions from government funded healthcare programs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Relating to Employee Matters and Managing Growth </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our future success depends on our ability to retain key executives and experienced scientists and to attract, retain and motivate qualified personnel.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are highly dependent on the research and development, clinical and business development expertise of Sanjiv K. Patel, our President and Chief
Executive Officer, Don Bergstrom, our Executive Vice President, Head of Research and Development, Brian Adams, our General Counsel, Andy Porter, our Executive Vice President, Chief People Experience Officer, Tom Catinazzo, our Vice President, Head
of Finance and Ben Wolf, our Chief Medical Officer as well as the other principal members of our management, scientific and clinical team. Although we have entered into employment letter agreements with our executive officers, each of them may
terminate their employment with us at any time. We do not maintain &#147;key person&#148; insurance for any of our executives or other employees. In addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist
us in formulating our research and development and commercialization strategy. Our consultants and advisors may be employed by employers other than us and may have commitments under consulting or advisory contracts with other entities that may limit
their availability to us. If we are unable to continue to attract and retain high quality personnel, our ability to pursue our growth strategy will be limited. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Recruiting and retaining qualified scientific, clinical, manufacturing and sales and marketing personnel
will also be critical to our success. The loss of the services of our executive officers or other key employees, including temporary loss due to illness, could impede the achievement of our research, development and commercialization objectives and
seriously harm our ability to successfully implement our business strategy. Furthermore, replacing executive officers and key employees may be difficult and may take an extended period of time because of the limited number of individuals in our
industry with the breadth of skills and experience required to successfully develop, gain regulatory approval of and commercialize products. Competition to hire from this limited pool is intense, and we may be unable to hire, train, retain or
motivate these key personnel on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from
universities and research institutions. Failure to succeed in clinical trials may make it more challenging to recruit and retain qualified scientific personnel. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In particular, we have experienced a very competitive hiring environment in Cambridge, Massachusetts, where we are headquartered. Many of the other
pharmaceutical companies that we compete against for qualified personnel have greater financial and other resources, different risk profiles and a longer history in the industry than we do. They also may provide more diverse opportunities and better
chances for career advancement. Some of these characteristics may be more appealing to high-quality candidates than what we have to offer. If we are unable to continue to attract and retain high-quality personnel, the rate and success with which we
can discover and develop product candidates and our business will be limited. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our employees, principal investigators, CROs and consultants may
engage in misconduct or other improper activities, including <FONT STYLE="white-space:nowrap">non-compliance</FONT> with regulatory standards and requirements and insider trading. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are exposed to the risk that our employees, principal investigators, CROs and consultants may engage in fraudulent conduct or other illegal activity.
Misconduct by these parties could include intentional, reckless and/or negligent conduct or disclosure of unauthorized activities to us that violate the regulations of the FDA and other regulatory authorities, including those laws requiring the
reporting of true, complete and accurate information to such authorities; healthcare fraud and abuse laws and regulations in the United States and abroad; or laws that require the reporting of financial information or data accurately. In particular,
sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict
or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Activities subject to these laws also involve the improper use of information obtained in the
course of clinical trials or creating fraudulent data in our preclinical studies or clinical trials, which could result in regulatory sanctions and cause serious harm to our reputation. We intend to adopt, prior to the completion of this offering, a
code of conduct applicable to all of our employees, but it is not always possible to identify and deter misconduct by employees and other third parties, and the precautions we take to detect and prevent this activity may not be effective in
controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. Additionally, we are subject to the risk that a
person could allege such fraud or other misconduct, even if none occurred. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our
business, including the imposition of civil, criminal and administrative penalties, damages, monetary fines, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm,
diminished profits and future earnings, and curtailment of our operations, any of which could adversely affect our ability to operate our business and our results of operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We expect to expand our development and regulatory capabilities and potentially implement sales,
marketing and distribution capabilities, and as a result, we may encounter difficulties in managing our growth, which could disrupt our operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of April&nbsp;30, 2020, we had 122 full-time employees. We expect to experience significant growth in the number of our employees and the scope of our
operations, particularly as we function as a public company and in the areas of product development, regulatory affairs and, if any of our product candidates receives marketing approval, sales, marketing and distribution. To manage our anticipated
future growth, we must continue to implement and improve our managerial, operational and financial systems, expand our facilities and continue to recruit and train additional qualified personnel. Due to our limited financial resources and the
limited experience of our management team in managing a company with such anticipated growth, we may not be able to effectively manage the expansion of our operations or recruit and train additional qualified personnel. The expansion of our
operations may lead to significant costs and may divert our management and business development resources. Any inability to manage growth could delay the execution of our business plans or disrupt our operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may acquire additional businesses or products, form strategic alliances or create joint ventures with third parties that we believe will complement or
augment our existing business. If we acquire businesses with promising markets or technologies, we may not be able to realize the benefit of acquiring such businesses if we are unable to successfully integrate them with our existing operations and
company culture. We may encounter numerous difficulties in developing, manufacturing and marketing any new products resulting from a strategic alliance or acquisition that delay or prevent us from realizing their expected benefits or enhancing our
business. We cannot assure you that, following any such acquisition, we will achieve the expected synergies to justify the transaction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We face
substantial competition, which may result in others discovering, developing or commercializing products before or more successfully than we do. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The development and commercialization of new products in the biopharmaceutical and related industries is highly competitive. We compete in the segments of the
pharmaceutical, biotechnology, and other related markets that address computationally focused structure-based drug design in cancer and genetic diseases. There are other companies focusing on structure-based drug design to develop therapies in the
fields of cancer and other diseases. Some of these competitive products and therapies are based on scientific approaches that are the same as or similar to our approach, and others are based on entirely different approaches. These companies include
divisions of large pharmaceutical companies and biotechnology companies of various sizes. We face competition with respect to our current product candidates, and will face competition with respect to any product candidates that we may seek to
develop or commercialize in the future, from major pharmaceutical companies, specialty pharmaceutical companies and biotechnology companies worldwide. Potential competitors also include academic institutions, government agencies and other public and
private research organizations that conduct research, seek patent protection and establish collaborative arrangements for research, development, manufacturing and commercialization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any product candidates that we successfully develop and commercialize will compete with currently approved therapies and new therapies that may become
available in the future from segments of the pharmaceutical, biotechnology and other related markets that pursue precision medicines. Key product features that would affect our ability to effectively compete with other therapeutics include the
efficacy, safety and convenience of our products. We believe principal competitive factors to our business include, among other things, the accuracy of our computations and predictions, ability to integrate experimental and computational
capabilities, ability to successfully transition research programs into clinical development, ability to raise capital, and the scalability of the platform, pipeline, and business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Many of the companies that we compete against or against which we may compete in the future have significantly greater financial resources and expertise in
research and development, manufacturing, preclinical </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
testing, conducting clinical trials, obtaining regulatory approvals and marketing approved products than we do. Mergers and acquisitions in the pharmaceutical, biotechnology and diagnostic
industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller or early stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and
established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring
technologies complementary to, or necessary for, our programs. In addition, we cannot predict whether our current competitive advantages, such as our ability to leverage our Dynamo platform and our relationship with D. E. Shaw Research, will remain
in place in the future. If these or other barriers to entry do not remain in place, other companies may be able to more directly or effectively compete with us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or
less severe side effects, are more convenient or are less expensive than any products that we or our collaborators may develop. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may obtain
approval for ours, which could result in our competitors establishing a strong market position before we or our collaborators are able to enter the market. The key competitive factors affecting the success of all of our product candidates, if
approved, are likely to be their efficacy, safety, convenience, price, the level of generic competition and the availability of reimbursement from government and other third-party payors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Common Stock and This Offering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are an &#147;emerging growth company&#148; as defined in the JOBS Act and a &#147;smaller reporting company&#148; as defined in the Securities
Exchange Act of 1934, as amended, or the Exchange Act, and will be able to avail ourselves of reduced disclosure requirements applicable to emerging growth companies and smaller reporting companies, which could make our common stock less attractive
to investors and adversely affect the market price of our common stock. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging growth company,&#148; as defined in the Jumpstart
Our Business Startups Act of 2012, or the JOBS Act. We will remain an emerging growth company until the earlier of (i)&nbsp;the last day of the fiscal year in which we have total annual gross revenues of $1.07&nbsp;billion or more; (ii)&nbsp;the
last day of the fiscal year following the fifth anniversary of the date of the completion of this offering; (iii)&nbsp;the date on which we have issued more than $1&nbsp;billion in nonconvertible debt during the previous three years; or
(iv)&nbsp;the date on which we are deemed to be a large accelerated filer under the rules of the Securities and Exchange Commission, which means the market value of our common stock that is held by
<FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeds $700&nbsp;million as of the prior June 30th. For so long as we remain an emerging growth company, we are permitted and intend to rely on exemptions from certain disclosure requirements
that are applicable to other public companies that are not emerging growth companies. These exemptions include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not being required to comply with the auditor attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley
Act of 2002, or Section&nbsp;404; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight
Board regarding mandatory audit firm rotation or a supplement to the auditor&#146;s report providing additional information about the audit and the financial statements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">providing only two years of audited financial statements in addition to any required unaudited interim financial
statements and a correspondingly reduced &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; disclosure; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduced disclosure obligations regarding executive compensation; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder
approval of any golden parachute payments not previously approved. In this prospectus, we have not included all of the executive compensation-related information that would be required if we were not an emerging growth company.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may choose to take advantage of some, but not all, of the available exemptions. We have taken advantage
of reduced reporting burdens in this prospectus. In particular, we have provided only two years of audited financial statements and have not included all of the executive compensation information that would be required if we were not an emerging
growth company. We cannot predict whether investors will find our common stock less attractive if we rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our
common stock and our stock price may be more volatile. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the JOBS Act provides that an emerging growth company can take advantage of an
extended transition period for complying with new or revised accounting standards. This allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have
elected to use the extended transition period for new or revised accounting standards during the period in which we remain an emerging growth company; however, we may adopt certain new or revised accounting standards early. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are also a &#147;smaller reporting company&#148; as defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no
longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies until the fiscal year following the determination that our voting and
<FONT STYLE="white-space:nowrap">non-voting</FONT> common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> is more than $250&nbsp;million measured on the last business day of our second fiscal quarter, or our annual revenues are
more than $100&nbsp;million during the most recently completed fiscal year and our voting and <FONT STYLE="white-space:nowrap">non-voting</FONT> common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> is more than
$700&nbsp;million measured on the last business day of our second fiscal quarter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we are still evaluating the JOBS Act, we currently intend to
take advantage of some, but not all, of the reduced regulatory and reporting requirements that will be available to us so long as we qualify as an &#147;emerging growth company&#148; and &#147;smaller reporting company.&#148; We have elected to
avail ourselves of this exemption and, therefore, we are not subject to the same new or revised accounting standards as other public companies that are not emerging growth companies or smaller reporting company. As a result, changes in rules of U.S.
generally accepted accounting principles or their interpretation, the adoption of new guidance or the application of existing guidance to changes in our business could significantly affect our financial position and results of operations. In
addition, our independent registered public accounting firm will not be required to provide an attestation report on the effectiveness of our internal control over financial reporting so long as we qualify as an &#147;emerging growth company,&#148;
which may increase the risk that material weaknesses or significant deficiencies in our internal control over financial reporting go undetected. Likewise, so long as we qualify as a &#147;smaller reporting company&#148; or an &#147;emerging growth
company,&#148; we may elect not to provide you with certain information, including certain financial information and certain information regarding compensation of our executive officers, that we would otherwise have been required to provide in
filings we make with the SEC, which may make it more difficult for investors and securities analysts to evaluate our company. We cannot predict if investors will find our common stock less attractive because we may rely on these exemptions. If some
investors find our common stock less attractive as a result, there may be a less active trading market for our common stock, and our stock price may be more volatile and may decline. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The price of our common stock may be volatile and fluctuate substantially, which could result in substantial losses for purchasers of our common stock
in this offering. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our stock price is likely to be volatile. The stock market in general and the market for biopharmaceutical companies in
particular have experienced extreme volatility that has often been unrelated to the operating performance of particular companies. As a result of this volatility, you may not be able to sell your common stock at or above the initial public offering
price. The market price for our common stock may be influenced by many factors, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the success of competitive products or technologies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">results of clinical trials of our product candidates or those of our competitors; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory or legal developments in the United States and other countries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developments or disputes concerning patent applications, issued patents or other proprietary rights;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the recruitment or departure of key personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the level of expenses related to any of our product candidates or clinical development programs;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the results of our efforts to discover, develop, acquire or <FONT STYLE="white-space:nowrap">in-license</FONT>
additional product candidates or products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">actual or anticipated changes in estimates as to financial results, development timelines or recommendations by
securities analysts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">variations in our financial results or those of companies that are perceived to be similar to us;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the structure of healthcare payment systems; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">market conditions in the pharmaceutical and biotechnology sectors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">general economic, industry and market conditions; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the other factors described in this &#147;Risk Factors&#148; section. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, at our request, the underwriters have reserved up to 441,000 shares, or 2.2% of the shares being offered by this prospectus, for sale to certain of
our directors, officers, employees and persons having a business relationship with us. To the extent these persons purchase reserved shares in this offering, fewer shares may be actively traded in the public market because these stockholders may be
restricted from selling the shares by restrictions under applicable securities laws and the lock-up agreements described in the &#147;Shares eligible for future sale&#148; and &#147;Underwriting&#148; sections of this prospectus, which would reduce
the liquidity of the market for our common stock. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sales of a substantial number of shares of our common stock in the public market could cause
our stock price to fall. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If our existing stockholders sell, or indicate an intention to sell, substantial amounts of our common stock in the
public market after the <FONT STYLE="white-space:nowrap">lock-up</FONT> and other legal restrictions on resale discussed in this prospectus lapse, the market price of our common stock could decline. Based upon the number of shares of common stock,
on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, outstanding as of June 30, 2020, upon the completion of this offering, we will have outstanding a total of 86,875,742 shares of common stock, including 290,477 shares of <FONT
STYLE="white-space:nowrap">non-vested</FONT> restricted common stock, and assuming no exercise of the underwriters&#146; option to purchase additional shares. Of these shares, as of the date of this prospectus, approximately 8,159,425 shares of our
common stock, plus any shares sold upon exercise of the underwriters&#146; option to purchase additional shares, will be freely tradable, without restriction, in the public market immediately following this offering, assuming that current
stockholders do not purchase shares in this offering. The representatives of the underwriters, however, may, in their sole discretion, permit our officers, directors and other stockholders who are subject to these
<FONT STYLE="white-space:nowrap">lock-up</FONT> agreements to sell shares prior to the expiration of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements pertaining to this offering will expire 180 days from the date of this prospectus. After the <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreements expire, based upon the number of shares of common stock, on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, outstanding as of June 30, 2020, up to an additional 66,187,404 shares of
common stock will be eligible for sale in the public market, 70.4% of which shares are held by directors, executive officers and other affiliates and will be subject to certain limitations of Rule 144 under the Securities Act of 1933, as amended, or
the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon completion of this offering, 16,939,699 shares of common stock that are either subject to outstanding options or reserved for
future issuance under our equity incentive plans will become eligible for sale in the public market to the extent permitted by the provisions of various vesting schedules, the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements and
Rule&nbsp;144 and Rule 701 under the Securities Act. If these additional shares of common stock are sold, or if it is perceived that they will be sold, in the public market, the market price of our common stock could decline. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After this offering, the holders of approximately 61,992,534 shares of our common stock will be entitled to
rights with respect to the registration of their shares under the Securities Act, subject to the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements described above. Registration of these shares under the Securities Act would result in the
shares becoming freely tradable without restriction under the Securities Act, except for shares purchased by affiliates. Any sales of securities by these stockholders could have a material adverse effect on the market our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>An active trading market for our common stock may not develop, and you may not be able to resell your shares at or above the initial public offering
price. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to this offering, there has been no public market for shares of our common stock. While our common stock has been approved for
listing on The Nasdaq Global Market, or Nasdaq, an active trading market for our shares may never develop or be sustained following this offering. The initial public offering price of our common stock will be determined through negotiations between
us and the underwriters. This initial public offering price may not be indicative of the market price of our common stock after this offering. In the absence of an active trading market for our common stock, investors may not be able to sell their
common stock at or above the initial public offering price or at the time that they would like to sell. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our executive officers, directors,
principal stockholders and their affiliates will continue to exercise significant control over our company after this offering, which will limit your ability to influence corporate matters and could delay or prevent a change in corporate control.
</I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Immediately following the completion of this offering, and disregarding any shares of common stock that they purchase in this offering, the
existing holdings of our executive officers, directors, principal stockholders and their affiliates, including entities affiliated with SoftBank Vision Fund and Third Rock Ventures, will represent beneficial ownership, in the aggregate, of
approximately 55.0% of our outstanding common stock, assuming no exercise of the underwriters&#146; option to acquire additional common stock in this offering and assuming we issue the number of shares of common stock as set forth on the cover page
of this prospectus. As a result, these stockholders, if they act together, will be able to influence our management and affairs and control the outcome of matters submitted to our stockholders for approval, including the election of directors and
any sale, merger, consolidation, or sale of all or substantially all of our assets. These stockholders acquired their shares of common stock for substantially less than the price of the shares of common stock being acquired in this offering, and
these stockholders may have interests, with respect to their common stock, that are different from those of investors in this offering and the concentration of voting power among these stockholders may have an adverse effect on the price of our
common stock. In addition, this concentration of ownership might adversely affect the market price of our common stock by: </P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delaying, deferring or preventing a change of control of us; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">impeding a merger, consolidation, takeover or other business combination involving us; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">discouraging a potential acquirer from making a tender offer or otherwise attempting to obtain control of us.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See &#147;Principal Stockholders&#148; in this prospectus for more information regarding the ownership of our outstanding common stock
by our executive officers, directors, principal stockholders and their affiliates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If you purchase our common stock in this offering, you will
incur immediate and substantial dilution in the book value of your shares. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You will suffer immediate and substantial dilution in the net
tangible book value of the common stock you purchase in this offering. Assuming an initial public offering price of $18.50 per share, the midpoint of the price range set forth on the cover page of this prospectus, purchasers of common stock in this
offering will experience immediate dilution of $10.71 per share in net tangible book value of the common stock. In addition, investors </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purchasing common stock in this offering will contribute 32.4% of the total amount invested by stockholders since inception but will only own 18.0% of the shares of common stock outstanding. In
the past, we issued options and other securities to acquire common stock at prices significantly below the initial public offering price. To the extent these outstanding securities are ultimately exercised, investors purchasing common stock in this
offering will sustain further dilution. See &#147;Dilution&#148; for a more detailed description of the dilution to new investors in the offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have broad discretion in how we use the proceeds of this offering and may not use these proceeds effectively, which could affect our results of
operations and cause our stock price to decline. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will have considerable discretion in the application of the net proceeds of this offering. We
intend to use the net proceeds from this offering to fund discovery and clinical development efforts as well as further expansion of our manufacturing platform and capabilities, and infrastructure to support our pipeline, and to fund new and ongoing
research activities, working capital and other general corporate purposes, which may include funding for the hiring of additional personnel, capital expenditures and the costs of operating as a public company. As a result, investors will be relying
upon management&#146;s judgment with only limited information about our specific intentions for the use of the balance of the net proceeds of this offering. We may use the net proceeds for purposes that do not yield a significant return or any
return at all for our stockholders. In addition, pending their use, we may invest the net proceeds from this offering in a manner that does not produce income or that loses value. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under Section&nbsp;382 of the Internal Revenue Code of 1986, as amended, or the IRC, if a corporation undergoes an &#147;ownership change&#148; (generally
defined as a greater than 50% change (by value) in the ownership of its equity over a three year period), the corporation&#146;s ability to use its <FONT STYLE="white-space:nowrap">pre-change</FONT> net operating loss carryforwards and certain other
<FONT STYLE="white-space:nowrap">pre-change</FONT> tax attributes to offset its post-change income may be limited. We may have experienced such ownership changes in the past, and we may experience ownership changes in the future as a result of this
offering or subsequent shifts in our stock ownership, some of which are outside the Company&#146;s control. As of December&nbsp;31, 2019, we had federal net operating loss carryforwards of approximately $154.3&nbsp;million, and our ability to
utilize those net operating loss carryforwards could be limited by an &#147;ownership change&#148; as described above, which could result in increased tax liability to the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comprehensive tax reform legislation could adversely affect our business and financial condition. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&nbsp;22, 2017, the Tax Cuts and Jobs Act, or TCJA, was signed into law, which significantly reformed the IRC. The TCJA, among other things,
contains significant changes to corporate and individual taxation, some of which could adversely impact an investment in our common stock. You are urged to consult your tax adviser regarding the implications of the TCJA on an investment in our
common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Because we do not anticipate paying any cash dividends on our capital stock in the foreseeable future, capital appreciation, if any,
will be your sole source of gain. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have never declared or paid cash dividends on our capital stock. We currently intend to retain all of our
future earnings, if any, to finance the growth and development of our business. In addition, the terms of any future debt agreements may preclude us from paying dividends. As a result, capital appreciation, if any, of our common stock will be your
sole source of gain for the foreseeable future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We will incur increased costs as a result of operating as a public company, and our management will
be required to devote substantial time to new compliance initiatives. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a public company, and particularly after we are no longer an
&#147;emerging growth company,&#148; we will incur significant legal, accounting and other expenses that we did not incur as a private company. In addition, the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Sarbanes-Oxley Act of 2002 and rules subsequently implemented by the Securities and Exchange Commission and Nasdaq have imposed various requirements on public companies, including establishment
and maintenance of effective disclosure and financial controls and corporate governance practices. Our management and other personnel will need to devote a substantial amount of time to these compliance initiatives. Moreover, these rules and
regulations will increase our legal and financial compliance costs and will make some activities more time-consuming and costly. For example, we expect that these rules and regulations may make it more difficult and more expensive for us to obtain
director and officer liability insurance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to Section&nbsp;404, we will be required to furnish a report by our management on our internal control
over financial reporting, including an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. However, while we remain an emerging growth company, we will not be required to
include an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. To achieve compliance with Section&nbsp;404 within the prescribed period, we will be engaged in a process to
document and evaluate our internal control over financial reporting, which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants and adopt a detailed work plan
to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement a continuous reporting
and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that neither we nor our independent registered public accounting firm will be able to conclude within the prescribed timeframe that our
internal control over financial reporting is effective as required by Section&nbsp;404. This could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial statements. In additional, if
we are not able to continue to meet these requirements, we may not be able to remain listed on Nasdaq. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Anti-takeover provisions in our charter
documents and under Delaware law could make an acquisition of us, which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our fourth amended and restated certificate of incorporation and amended and restated bylaws, which are to become effective at or prior to the completion of
this offering, contain provisions that could delay or prevent a change of control of our company or changes in our board of directors that our stockholders might consider favorable. Some of these provisions include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a board of directors divided into three classes serving staggered three-year terms, such that not all members of
the board will be elected at one time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a prohibition on stockholder action through written consent, which requires that all stockholder actions be taken
at a meeting of our stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a requirement that special meetings of the stockholders may be called only by the board of directors acting
pursuant to a resolution approved by the affirmative vote of a majority of the directors then in office, and special meetings of stockholders may not be called by any other person or persons; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">advance notice requirements for stockholder proposals and nominations for election to our board of directors;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a requirement that no member of our board of directors may be removed from office by our stockholders except for
cause and, in addition to any other vote required by law, upon the approval of not less than <FONT STYLE="white-space:nowrap">two-thirds</FONT> (2/3) of all outstanding shares of our voting stock then entitled to vote in the election of directors;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a requirement of approval of not less than a majority of all outstanding shares of our voting stock to amend any
bylaws by stockholder action and not less than <FONT STYLE="white-space:nowrap">two-thirds</FONT> (2/3) of all outstanding shares of our voting stock to amend specific provisions of our fourth amended and restated certificate of incorporation; and
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the authority of the board of directors to issue preferred stock on terms determined by the board of directors
without stockholder approval, which preferred stock may include rights superior to the rights of the holders of common stock. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
addition, because we are incorporated in Delaware, we are governed by the provisions of Section&nbsp;203 of the Delaware General Corporate Law, which may prohibit certain business combinations with stockholders owning 15% or more of our outstanding
voting stock. These anti-takeover provisions and other provisions in our fourth amended and restated certificate of incorporation and amended and restated bylaws could make it more difficult for stockholders or potential acquirers to obtain control
of our board of directors or initiate actions that are opposed by the then-current board of directors and could also delay or impede a merger, tender offer or proxy contest involving our company. These provisions could also discourage proxy contests
and make it more difficult for you and other stockholders to elect directors of your choosing or cause us to take other corporate actions you desire. Any delay or prevention of a change of control transaction or changes in our board of directors
could cause the market price of our common stock to decline. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our disclosure controls and procedures may not prevent or detect all errors or acts of
fraud. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon completion of this offering, we will become subject to the periodic reporting requirements of the Exchange Act. We designed our
disclosure controls and procedures to reasonably assure that information we must disclose in reports we file or submit under the Exchange Act is accumulated and communicated to management, and recorded, processed, summarized and reported within the
time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well-conceived and operated, can provide only reasonable, not absolute, assurance
that the objectives of the control system are met. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be
circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements due to error or fraud may
occur and not be detected. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our amended and restated bylaws designate specific courts as the exclusive forum for certain litigation that may be
initiated by the Combined Company&#146;s stockholders, which could limit its stockholders&#146; ability to obtain a favorable judicial forum for disputes with us. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to our amended and restated bylaws, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of
Delaware is the sole and exclusive forum for any state law claims for (1)&nbsp;any derivative action or proceeding brought on our behalf; (2)&nbsp;any action asserting a claim of or based on a breach of a fiduciary duty owed by any director, officer
or other employee of ours to us or our stockholders; (3)&nbsp;any action asserting a claim pursuant to any provision of the Delaware General Corporation Law, our fourth amended and restated certificate of incorporation or our amended and restated
bylaws; or (4)&nbsp;any action asserting a claim governed by the internal affairs doctrine, or the Delaware Forum Provision. The Delaware Forum Provision will not apply to any causes of action arising under the Securities Act or the Exchange Act.
Our amended and restated bylaws further provide that unless we consent in writing to the selection of an alternative forum, the United States District Court for the District of Massachusetts shall be the sole and exclusive forum for resolving any
complaint asserting a cause of action arising under the Securities Act, or the Federal Forum Provision. In addition, our amended and restated bylaws provide that any person or entity purchasing or otherwise acquiring any interest in shares of our
capital stock is deemed to have notice of and consented to the Delaware Forum Provision and the Federal Forum Provision; provided, however, that stockholders cannot and will not be deemed to have waived our compliance with the federal securities
laws and the rules and regulations thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We recognize that the Delaware Forum Provision and the Federal Forum Provision in our amended and restated
bylaws may impose additional litigation costs on stockholders in pursuing any such claims, particularly if the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stockholders do not reside in or near the State of Delaware or the Commonwealth of Massachusetts. Additionally, the forum selection clauses in our amended and restated bylaws may limit our
stockholders&#146; ability to bring a claim in a judicial forum that they find favorable for disputes with us or our directors, officers or employees, which may discourage the filing of lawsuits against us and our directors, officers and employees,
even though an action, if successful, might benefit our stockholders. In addition, while the Delaware Supreme Court ruled in March 2020 that federal forum selection provisions purporting to require claims under the Securities Act be brought in
federal court are &#147;facially valid&#148; under Delaware law, there is uncertainty as to whether other courts will enforce our Federal Forum Provision. If the Federal Forum Provision is found to be unenforceable, we may incur additional costs
associated with resolving such matters. The Federal Forum Provision may also impose additional litigation costs on stockholders who assert that the provision is not enforceable or invalid. The Court of Chancery of the State of Delaware and the
United States District Court for the District of Massachusetts may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the
action, and such judgments may be more or less favorable to us than our stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If securities analysts do not publish research or reports
about our business or if they publish negative evaluations of our stock, the price of our stock could decline. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The trading market for our common
stock will rely in part on the research and reports that industry or financial analysts publish about us or our business. We may never obtain research coverage by industry or financial analysts. If no or few analysts commence coverage of us, the
trading price of our stock would likely decrease. Even if we do obtain analyst coverage, if one or more of the analysts covering our business downgrade their evaluations of our stock, the price of our stock could decline. If one or more of these
analysts cease to cover our stock, we could lose visibility in the market for our stock, which in turn could cause our stock price to decline. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We
may be subject to securities litigation, which is expensive and could divert management attention. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The market price of our common stock may be
volatile. The stock market in general, and Nasdaq and biopharmaceutical companies in particular, have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of these
companies. In the past, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Securities litigation
against us could result in substantial costs and divert our management&#146;s attention from other business concerns, which could seriously harm our business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_5"></A>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus, including the sections entitled &#147;Prospectus Summary,&#148; &#147;Risk Factors,&#148; &#147;Management&#146;s Discussion and Analysis of
Financial Condition and Results of Operations,&#148; and &#147;Business,&#148; contains express or implied forward-looking statements that are based on our management&#146;s belief and assumptions and on information currently available to our
management. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future operational or financial performance, and involve known and unknown risks,
uncertainties, and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Forward-looking
statements in this prospectus include, but are not limited to, statements about: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the initiation, timing, progress, results, and cost of our research and development programs and our current and
future preclinical and clinical studies, including statements regarding the timing of initiation and completion of studies or trials and related preparatory work, the period during which the results of the trials will become available, and our
research and development programs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to identify research priorities and apply a risk-mitigated strategy to efficiently discover and
develop product candidates, including by applying learnings from one program to other programs and from one modality to our other modalities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability and the potential to successfully manufacture our drug substances, delivery vehicles, and product
candidates for preclinical use, for clinical trials and on a larger scale for commercial use, if approved; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability and willingness of our third-party strategic collaborators to continue research and development
activities relating to our development candidates and product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to obtain funding for our operations necessary to complete further development and commercialization
of our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to obtain and maintain regulatory approval of our product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to commercialize our products, if approved; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the pricing and reimbursement of our product candidates, if approved; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the implementation of our business model, and strategic plans for our business, product candidates, and
technology; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope of protection we are able to establish and maintain for intellectual property rights covering our
product candidates and technology; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">estimates of our future expenses, revenues, capital requirements, and our needs for additional financing;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential benefits of strategic collaboration agreements, our ability to enter into strategic collaborations
or arrangements, and our ability to attract collaborators with development, regulatory and commercialization expertise; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">future agreements with third parties in connection with the commercialization of product candidates and any other
approved product; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the size and growth potential of the markets for our product candidates, and our ability to serve those markets;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our financial performance; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rate and degree of market acceptance of our product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory developments in the United States and foreign countries; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to contract with third-party suppliers and manufacturers and their ability to perform adequately;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to produce our products or product candidates with advantages in turnaround times or manufacturing
cost; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the success of competing therapies that are or may become available; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to attract and retain key scientific or management personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of laws and regulations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our use of the proceeds from this offering; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developments relating to our competitors and our industry; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the effect of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, including mitigation efforts and
economic effects, on any of the foregoing or other aspects of our business operations, including but not limited to our preclinical studies and future clinical trials; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other risks and uncertainties, including those listed under the caption &#147;Risk Factors.&#148;
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In some cases, forward-looking statements can be identified by terminology such as &#147;may,&#148; &#147;should,&#148;
&#147;expects,&#148; &#147;intends,&#148; &#147;plans,&#148; &#147;anticipates,&#148; &#147;believes,&#148; &#147;estimates,&#148; &#147;predicts,&#148; &#147;potential,&#148; &#147;continue,&#148; or the negative of these terms or other comparable
terminology. These statements are only predictions. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond our control and
which could materially affect results. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed under the section entitled &#147;Risk Factors&#148; and elsewhere in this
prospectus. If one or more of these risks or uncertainties occur, or if our underlying assumptions prove to be incorrect, actual events or results may vary significantly from those implied or projected by the forward-looking statements. No
forward-looking statement is a guarantee of future performance. You should read this prospectus and the documents that we reference in this prospectus and have filed with the SEC as exhibits to the registration statement, of which this prospectus is
a part, completely and with the understanding that our actual future results may be materially different from any future results expressed or implied by these forward-looking statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The forward-looking statements in this prospectus represent our views as of the date of this prospectus. We anticipate that subsequent events and developments
will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should therefore not
rely on these forward-looking statements as representing our views as of any date subsequent to the date of this prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus includes
statistical and other industry and market data that we obtained from industry publications and research, surveys and studies conducted by third parties. Industry publications and third-party research, surveys and studies generally indicate that
their information has been obtained from sources believed to be reliable, although they do not guarantee the accuracy or completeness of such information. We are responsible for all of the disclosure contained in this prospectus, and we believe that
these sources are reliable; however, we have not independently verified the information contained in such publications. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_6"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We estimate that our net proceeds from the sale of shares of our common stock in this offering will be approximately $341.1 million, or $392.7 million if the
underwriters exercise in full their option to purchase additional shares, assuming an initial public offering price of $18.50 per share, the midpoint of the price range set forth on the cover page of this prospectus, and after deducting estimated
underwriting discounts and commissions and estimated offering expenses payable by us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A $1.00 increase (decrease) in the assumed initial public offering
price of $18.50 per share, the midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) our net proceeds from this offering by $18.6 million, assuming the number of shares offered by us, as set forth on
the cover page of this prospectus, remains the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. A 1.0&nbsp;million share increase (decrease) in the number of shares offered by
us, as set forth on the cover page of this prospectus, would increase (decrease) our net proceeds from this offering by $17.2 million, assuming no change in the assumed initial public offering price per share and after deducting estimated
underwriting discounts and commissions and estimated offering expenses payable by us. This information is illustrative only and will depend on the actual initial public offering price and other terms of this offering determined at pricing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We currently expect to use our net proceeds from this offering, together with our existing cash, cash equivalents and marketable securities, as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approximately $100.0 million to $120.0 million to fund the remainder of our Phase 1 and Phase 1b exploratory
trials for RLY-1971 and a portion of our confirmatory Phase&nbsp;2/3 trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approximately $130.0 million to $155.0 million to fund our Phase&nbsp;1 exploratory trial for RLY-4008 and a
portion of our confirmatory Phase&nbsp;2/3 trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approximately $70.0 million to $85.0 million to identify a lead development candidate and conduct IND-enabling
studies for RLY-PI3K1047 and a portion of our Phase&nbsp;1 and Phase&nbsp;1b exploratory trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approximately $115.0 million to $135.0 million for the continued development of our discovery programs; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the remaining proceeds for general corporate purposes, which may include the hiring of additional personnel,
capital expenditures and the costs of operating as a public company. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our expected use of the net proceeds from this offering represents
our intentions based upon our current plans and business conditions. As of the date of this prospectus, we cannot predict with certainty all of the particular uses for the net proceeds to be received upon the completion of this offering or the
amounts that we will actually spend on the uses set forth above and we expect that we will require additional funds in order to fully accomplish the specified uses of the proceeds of this offering. We may also use a portion of the net proceeds to <FONT
STYLE="white-space:nowrap">in-license,</FONT> acquire, or invest in complementary businesses or technologies to continue to build our pipeline, research and development capabilities and our intellectual property position, although we currently have
no agreements, commitments, or understandings with respect to any such transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Due to the many inherent uncertainties in the development of our
product candidates, the amounts and timing of our actual expenditures may vary significantly depending on numerous factors, including the progress of our research and development, the timing of patient enrollment and evolving regulatory
requirements, the timing and success of preclinical studies, our ongoing clinical study or clinical studies we may commence in the future, the timing of regulatory submissions, any strategic alliances that we may enter into with third parties for
our product candidates or strategic opportunities that become available to us, and any unforeseen cash needs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pending our use of the net proceeds from this offering, we intend to invest the net proceeds in a variety of
capital preservation instruments, including short-term and long-term interest-bearing instruments, investment-grade securities, and direct or guaranteed obligations of the U.S. government. We cannot predict whether the proceeds invested will yield a
favorable return. Our management will retain broad discretion in the application of the net proceeds we receive from our initial public offering, and investors will be relying on the judgment of our management regarding the application of the net
proceeds. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_7"></A>DIVIDEND POLICY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have never declared or paid any cash dividends on our capital stock. We currently intend to retain all available funds and any future earnings to fund the
growth and development of our business. We do not intend to pay cash dividends to our stockholders in the foreseeable future. Any future determination to declare dividends will be made at the discretion of our board of directors and will depend on
our financial condition, operating results, capital requirements, general business conditions, and other factors that our board of directors may deem relevant. Investors should not purchase our common stock with the expectation of receiving cash
dividends. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_8"></A>CAPITALIZATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth our cash, cash equivalents, restricted cash, and investments and our capitalization as of March&nbsp;31, 2020: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on an actual basis; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on a pro forma basis to give effect to (i)&nbsp;the reduction in the conversion price of the Series C preferred
stock from $3.21 to $3.027603, which became effective on July&nbsp;8, 2020, (ii) the conversion of all outstanding shares of our preferred stock into an aggregate of&nbsp;61,992,534 shares of common stock immediately prior to the completion of this
offering, (iii) the exercise of options to purchase 95,573 shares of common stock at a weighted average exercise price of $3.84 per share from April 1, 2020 through June 30, 2020 under our 2016 Plan as if the exercises had occurred on March 31,
2020, and (iv)&nbsp;the filing and effectiveness of our fourth amended and restated certificate of incorporation, which will occur upon the closing of this offering; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on a pro forma as adjusted basis to give further effect to our sale in this offering of 20,000,000 shares of
common stock at an assumed initial public offering price of $18.50 per share, the midpoint of the price range set forth on the cover page of this prospectus, after deducting the estimated underwriting discounts and commissions and estimated offering
expenses payable by us. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The pro forma as adjusted information below is illustrative only, and our capitalization following the
completion of this offering will be adjusted based on the actual initial public offering price and other terms of this offering determined at pricing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table should be read together with &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations,&#148;
&#147;Description of Capital Stock,&#148; and the consolidated financial statements and related notes appearing elsewhere in this prospectus. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of March&nbsp;31, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro&nbsp;Forma</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro&nbsp;Forma&nbsp;As<BR>Adjusted(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in&nbsp;thousands,&nbsp;except&nbsp;share&nbsp;and&nbsp;per&nbsp;share&nbsp;data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents, restricted cash, and investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">335,081</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">335,448</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">676,548</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible preferred stock (Series A, Series B, and Series C), $0.001 par value;
337,272,859&nbsp;shares authorized; 212,642,857 shares issued and outstanding, actual; no shares authorized, issued or outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">537,781</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; (deficit) equity:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred stock, $0.001 par value; no shares authorized, issued or outstanding, actual; 10,000,000
shares authorized, no shares issued or outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, $0.001 par value; 260,000,000 shares authorized, 4,787,635 shares issued and
4,333,837 shares outstanding, actual; 150,000,000 shares authorized, 66,875,742 shares issued and 66,421,944 shares outstanding, pro forma; 150,000,000 shares authorized, 86,875,742 shares issued and 86,421,944 shares outstanding, pro forma as
adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">548,705</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">889,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(214,368</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(214,368</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(214,368</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; (deficit) equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(202,351</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">335,797</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">676,897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">335,430</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">335,797</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">676,897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A $1.00 increase (decrease) in the assumed initial public offering price of $18.50 per share, the midpoint of
the price range set forth on the cover page of this prospectus, would increase (decrease) the pro forma as adjusted amount of cash, cash equivalents, restricted cash and investments, common stock and additional
<FONT STYLE="white-space:nowrap">paid-in</FONT> capital, total stockholders&#146; equity, and total capitalization by approximately $18.6 million, assuming the number of shares offered by us, as set forth on the cover page of this prospectus,
remains the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. Similarly, each increase (decrease) of 1.0&nbsp;million shares in the number of shares offered by us would increase
(decrease) the pro forma as adjusted amount of cash, cash equivalents, restricted cash and investments common stock and additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital, total stockholders&#146; equity and total capitalization by
approximately $17.2 million, assuming an initial public offering price of $18.50 per share, the midpoint of the price range set forth on the cover page of this prospectus, remains the same, and after deducting estimated underwriting discounts and
commissions and estimated offering expenses payable by us. The pro forma as adjusted information is illustrative only, and our capitalization following the completion of this offering will be adjusted based on the actual initial public offering
price and other terms of this offering determined at pricing. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The actual, pro forma, and pro forma as adjusted information set
forth in the table excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">7,471,087 shares of common stock issuable upon the exercise of stock options outstanding as of June 30, 2020, at
a weighted average exercise price of $5.05 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">769,354<B> </B>shares of common stock reserved for future issuance as of June 30, 2020 under our 2016 Plan, which
will cease to be available for issuance at the time that our 2020 Stock Plan becomes effective; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">8,376,080 shares of our common stock that will become available for future issuance under our 2020<B> </B>Stock
Plan, which includes 769,354 shares of common stock available for issuance as of June 30, 2020 under our 2016 Plan and which will become effective in connection with the completion of this offering; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1,092,532 shares of our common stock that will become available for future issuance under our ESPP, which will
become effective in connection with the completion of this offering. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_9"></A>DILUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you invest in our common stock in this offering, your ownership interest will be diluted immediately to the extent of the difference between the initial
public offering price per share of our common stock and the pro forma as adjusted net tangible book value per share of our common stock after this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our historical net tangible book value (deficit) as of March&nbsp;31, 2020 was $(202.4) million, or $(42.27) per share of our common stock. Our historical net
tangible book value (deficit) is the amount of our total tangible assets less our total liabilities and preferred stock, which is not included within stockholders&#146; equity (deficit). Historical net tangible book value (deficit) per share
represents our historical net tangible book value (deficit) divided by the 4,787,635 shares of our common stock, which includes 453,798 shares of <FONT STYLE="white-space:nowrap">non-vested</FONT> restricted common stock, as of March&nbsp;31, 2020.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our pro forma net tangible book value as of March&nbsp;31, 2020 was $335.8&nbsp;million, or $5.02 per share of our common stock. Pro forma net tangible
book value represents the amount of our total tangible assets less our total liabilities, after giving effect to (i) the automatic conversion of all outstanding shares of our preferred stock into an aggregate of 61,992,534&nbsp;shares of our common
stock immediately prior to the completion of this offering and (ii) the exercise of options to purchase 95,573 shares of common stock at a weighted average exercise price of $3.84 per share from April 1, 2020 through June 30, 2020 under our 2016
Plan as if the exercises had occurred on March 31, 2020. Pro forma net tangible book value per share represents pro forma net tangible book value divided by the total number of shares outstanding as of March&nbsp;31, 2020, after giving effect to (i)
the automatic conversion of all outstanding shares of our preferred stock into common stock immediately prior to the completion of this offering and (ii) the exercise of options to purchase 95,573 shares of common stock at a weighted average
exercise price of $3.84 per share from April 1, 2020 through June 30, 2020 under our 2016 Plan as if the exercises had occurred on March 31, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After giving further effect to our issuance and sale of 20,000,000 shares of our common stock in this offering at an assumed initial public offering price of
$18.50 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us, our pro forma as adjusted
net tangible book value as of March&nbsp;31, 2020 would have been $676.9 million, or $7.79 per share. This represents an immediate increase in pro forma as adjusted net tangible book value per share of $2.77 to existing stockholders and immediate
dilution of $10.71 in pro forma as adjusted net tangible book value per share to new investors purchasing common stock in this offering. Dilution per share to new investors is determined by subtracting pro forma as adjusted net tangible book value
per share after this offering from the assumed initial public offering price per share paid by new investors. The following table illustrates this dilution on a per share basis: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assumed initial public offering price per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Historical net tangible book value (deficit) per share as of March&nbsp;31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(42.27</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase per share attributable to the automatic conversion of preferred stock upon the closing of
this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net tangible book value per share as of March&nbsp;31, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.02</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase in pro forma as adjusted net tangible book value per share attributable to new investors
purchasing shares in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma as adjusted net tangible book value per share after this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dilution per share to new investors purchasing shares in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10.71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A $1.00 increase or decrease in the assumed initial public offering price of $18.50 per share, which is the midpoint
of the price range set forth on the cover page of this prospectus, would increase or decrease our pro forma as adjusted net tangible book value by $18.6 million, our pro forma as adjusted net tangible book value per
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
share after this offering by $0.22 and dilution per share to new investors purchasing shares in this offering by $0.78, assuming that the number of shares offered by us, as set forth on the cover
page of this prospectus, remains the same and after deducting estimated underwriting discounts and commissions. An increase of 1.0&nbsp;million shares in the number of shares offered by us, as set forth on the cover page of this prospectus, would
increase the pro forma as adjusted net tangible book value per share after this offering by $0.11 and decrease the dilution per share to new investors participating in this offering by $0.11, assuming no change in the assumed initial public offering
price and after deducting estimated underwriting discounts and commissions. A decrease of 1.0&nbsp;million shares in the number of shares offered by us, as set forth on the cover page of this prospectus, would decrease the pro forma as adjusted net
tangible book value per share after this offering by $0.11 and increase the dilution per share to new investors participating in this offering by $ 0.11 assuming no change in the assumed initial public offering price and after deducting estimated
underwriting discounts and commissions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the underwriters exercise their option to purchase additional shares in full, our pro forma as adjusted net
tangible book value per share after this offering would be $8.11 per share, representing an immediate increase in pro forma as adjusted net tangible book value per share of $0.32 to existing stockholders and immediate dilution in pro forma as
adjusted net tangible book value per share of $0.32 to new investors purchasing common stock in this offering, assuming an initial public offering price of $18.50 per share, which is the midpoint of the price range set forth on the cover page of
this prospectus, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. If any shares are issued upon exercise of outstanding options, you will experience further dilution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes, on the pro forma as adjusted basis described above, the differences between the number of shares of common stock purchased
from us, the total consideration paid to us and the average price per share paid by existing stockholders and by new investors purchasing shares of common stock in this offering. The calculation below is based on an assumed initial public offering
price of $18.50 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, before deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="55%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares Purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;Consideration</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Average&nbsp;Price<BR>Per Share</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Existing stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66,875,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">522,074</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7.81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New investors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">370,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86,875,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">892,074</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A $1.00 increase or decrease in the assumed initial public offering price of $18.50 per share, which is the midpoint
of the price range set forth on the cover page of this prospectus, would increase or decrease the total consideration paid by new investors by $20.0 million and, in the case of an increase, would increase the percentage of total consideration paid
by new investors by 1.3 percentage points and, in the case of a decrease, would decrease the percentage of total consideration paid by new investors by 1.3 percentage points, assuming that the number of shares offered by us, as set forth on the
cover page of this prospectus, remains the same. An increase or decrease of 1.0&nbsp;million shares in the number of shares offered by us, as set forth on the cover page of this prospectus, would increase or decrease the total consideration paid by
new investors by $18.5 million and, in the case of an increase, would increase the percentage of total consideration paid by new investors by 1.2 percentage points and, in the case of a decrease, would decrease the percentage of total consideration
paid by new investors by 1.2 percentage points, assuming no change in the assumed initial public offering price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table above assumes no exercise of
the underwriters&#146; option to purchase additional shares in this offering. If the underwriters&#146; option to purchase additional shares is exercised in full, the number of shares of our common stock held by existing stockholders would be
reduced to 74.4% of the total number of shares of our common stock outstanding after this offering, and the number of shares of common stock held by new investors participating in the offering would be increased to 25.6% of the total number of
shares of our common stock outstanding after this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The number of shares purchased from us by existing stockholders is based on 4,787,635 shares of our common
stock, which includes 453,798 shares of <FONT STYLE="white-space:nowrap">non-vested</FONT> restricted common stock, as of March 31, 2020, after giving effect to the automatic conversion of all outstanding shares of our preferred stock into an
aggregate of 61,992,534&nbsp;shares of common stock immediately prior to the completion of this offering, and excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">7,471,087 shares of common stock issuable upon the exercise of stock options outstanding as of June&nbsp;30,
2020, at a weighted average exercise price of $5.05 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">769,354<B> </B>shares of common stock reserved for future issuance as of June 30, 2020 under the 2016 Plan, which
will cease to be available for issuance at the time that our 2020 Stock Plan becomes effective; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">8,376,080 shares of our common stock that will become available for future issuance under our 2020<B> </B>Stock
Plan, which includes 769,354 shares of common stock available for issuance as of June 30, 2020 under our 2016 Plan and which will become effective in connection with the completion of this offering; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1,092,532 shares of our common stock that will become available for future issuance under our ESPP, which will
become effective in connection with the completion of this offering. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the extent that outstanding options are exercised or shares are
issued under our 2020 Stock Option and Incentive Plan, you will experience further dilution. In addition, we may choose to raise additional capital due to market conditions or strategic considerations even if we believe we have sufficient funds for
our current or future operating plans. To the extent that additional capital is raised through the sale of equity or convertible debt securities, the issuance of these securities may result in further dilution to our stockholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_10"></A>SELECTED CONSOLIDATED FINANCIAL DATA </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>You should read the following summary financial data together with our consolidated financial statements and the related notes appearing at the end of this
prospectus and the &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; section of this prospectus. We have derived the statement of operations data for the years ended December&nbsp;31, 2018 and
2019 and the balance sheet data as of December&nbsp;31, 2018 and 2019 from our audited financial statements appearing at the end of this prospectus. The statement of operations data for the three months ended March&nbsp;31, 2019 and 2020 and the
balance sheet data as of March&nbsp;31, 2020 have been derived from our unaudited financial statements appearing at the end of this prospectus and have been prepared on the same basis as the audited financial statements. In the opinion of
management, the unaudited data reflect all adjustments, consisting only of normal recurring adjustments, necessary for a fair statement of the financial information in those statements. Our historical results are not necessarily indicative of
results that should be expected in any future period, and our results for any interim period are not necessarily indicative of results that should be expected for any full year. </I></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended</B><br><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended</B><br><B>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands, except share and per share data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Statement of Operations Data</B>:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD COLSPAN="5" VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 41,034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 70,306</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 21,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,855</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,067</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,889</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84,048</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,402</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49,889</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(84,048</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(16,402</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26,458</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense), net:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,113</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,801</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,277</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(58</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(57</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,220</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(48,785</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(75,305</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(14,182</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(24,886</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share, basic and diluted(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(19.63</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(21.82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.59</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(5.99</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average shares of common stock, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,485,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,450,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,087,779</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,153,791</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per share, basic and diluted (unaudited)(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1.15</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.38</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma weighted average shares of common stock, basic and diluted (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65,428,521</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66,146,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">See Note 11 to our consolidated financial statements appearing at the end of this prospectus for details on the
calculation of basic and diluted net loss per share. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">See Note 12 to our consolidated financial statements appearing at the end of this prospectus for details on the
calculation of basic and diluted pro forma net loss per share. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As&nbsp;of&nbsp;March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance Sheet Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents, restricted cash and investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">422,383</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">356,694</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">335,081</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Working capital<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">417,237</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">348,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">327,118</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">428,611</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,068</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">370,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">532,120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">537,781</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">537,781</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(110,927</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(180,438</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(202,351</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">We define working capital as current assets less current liabilities. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_11"></A>MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>You should read the following discussion and analysis of our financial condition and results of operations
together with the &#147;Selected Consolidated Financial Data&#148; section of this prospectus and our consolidated financial statements and the related notes included at the end of this prospectus. This discussion and other parts of this prospectus
contain forward-looking statements that involve risks and uncertainties, such as statements of our plans, objectives, expectations and intentions. As a result of many factors, including those factors set forth in the &#147;Risk Factors&#148; section
of this prospectus, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a clinical-stage precision medicines
company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Our company is built upon unparalleled insights into protein motion and how this dynamic behavior relates
to protein function. We built our Dynamo platform to integrate an array of leading edge experimental and computational approaches, which allows us to apply our understanding of protein structure and motion to drug discovery. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are advancing our lead product candidates, <FONT STYLE="white-space:nowrap">RLY-1971</FONT> and <FONT STYLE="white-space:nowrap">RLY-4008,</FONT> and a
development candidate selection for a PI3K&#945; selective mutant program <FONT STYLE="white-space:nowrap">(RLY-PI3K1047</FONT> program) for the treatment of patients with advanced solid tumors. We initiated a Phase 1 clinical trial for <FONT
STYLE="white-space:nowrap">RLY-1971,</FONT> our inhibitor of Src homology region&nbsp;2 domain-containing <FONT STYLE="white-space:nowrap">phosphatase-2</FONT> (SHP2), in patients with advanced solid tumors in the first quarter of 2020. We have
completed Investigational New Drug, or IND, enabling activities for <FONT STYLE="white-space:nowrap">RLY-4008,</FONT> our inhibitor of fibroblast growth factor receptor 2 (FGFR2) and expect to initiate a Phase&nbsp;1 clinical trial for <FONT
STYLE="white-space:nowrap">RLY-4008</FONT> in patients with advanced solid tumors having oncogenic FGFR2 alterations in the second half of 2020. We anticipate the <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> program to be in IND-enabling
studies in 2021. While our initial focus is on precision oncology, we believe our Dynamo platform may also be broadly applied to other areas of precision medicine, such as genetic disease. Across both precision oncology and genetic disease, we have
five additional discovery stage programs. We are focused on using the novel insights derived from our approach to transform the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and
commercialization of our therapies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We were incorporated in May 2015. We have devoted substantially all of our resources to developing our lead product
candidates developing our innovative experimental and computational approaches on protein motion platform, building our intellectual property portfolio, business planning, raising capital and providing general and administrative support for these
operations. To date, we have principally financed our operations through private placements of preferred stock and convertible debt. Through December&nbsp;31, 2019 and March 31, 2020, we had received gross proceeds of approximately $520&nbsp;million
from sales of our preferred stock and our issuance of convertible debt. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since it was reported to have surfaced in December 2019, <FONT
STYLE="white-space:nowrap">COVID-19</FONT> has spread across the world and has been declared a pandemic by the World Health Organization. Efforts to contain the spread of <FONT STYLE="white-space:nowrap">COVID-19</FONT> have intensified and the
United States, Europe and Asia have implemented severe travel restrictions, social distancing requirements, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">stay-at-home</FONT></FONT> orders and have delayed the commencement of <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">non-COVID-19-related</FONT></FONT></FONT> clinical trials, among other restrictions. As a result, the current
<FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic has presented a substantial public health and economic challenge around the world and is affecting our employees, patients, communities and business operations, as well as contributing to
significant volatility and negative pressure on the U.S. economy and in financial markets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While we are currently continuing the clinical trials we have
underway, we expect that <FONT STYLE="white-space:nowrap">COVID-19</FONT> precautions may directly or indirectly impact the timeline for some of our clinical trials. To date, we have been able to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
continue to enroll our patients in phase 1 of our clinical trials for <FONT STYLE="white-space:nowrap">RLY-1971</FONT> and currently do not anticipate any interruptions of clinical enrollment.
However, we are continuing to assess the potential impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on our current and future business and operations, including our expenses and clinical trials, as well as on our industry and
the healthcare system. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since our inception, we have incurred significant operating losses on an aggregate basis. Our ability to generate product revenue
sufficient to achieve profitability will depend on the successful development and eventual commercialization of one or more of our current or future product candidates. Our net losses were $48.8&nbsp;million and $75.3&nbsp;million for the years
ended December&nbsp;31, 2018 and 2019, respectively, and $14.2&nbsp;million and $24.9&nbsp;million for the three months ended March&nbsp;31, 2019 and 2020, respectively. As of March&nbsp;31, 2020, we had an accumulated deficit of
$214.4&nbsp;million. These losses have resulted primarily from costs incurred in connection with research and development activities, licensing and patent investment, and general and administrative costs associated with our operations. We expect to
continue to incur significant expenses and increasing operating losses for at least the next several years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We anticipate that our expenses will increase
substantially if and as we: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">conduct our current and future clinical trials of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> and <FONT
STYLE="white-space:nowrap">RLY-4008,</FONT> and <FONT STYLE="white-space:nowrap">pre-clinical</FONT> research of our <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> program; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">initiate and continue research and preclinical and clinical development of our other product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">utilize our platform to seek to identify additional product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pursue marketing approvals for any of our product candidates that successfully complete clinical trials, if any;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establish a sales, marketing and distribution infrastructure to commercialize any products for which we may
obtain marketing approval; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establish agreements with contract research organizations, or CROs, and contract manufacturing organizations, or
CMOs, in connection with our preclinical studies and clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">require the manufacture of larger quantities of our product candidates for clinical development and potentially
commercialization; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">maintain, expand and protect our intellectual property portfolio; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">acquire or <FONT STYLE="white-space:nowrap">in-license</FONT> other drugs and technologies;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">hire and retain additional clinical, quality control and scientific personnel; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">commence operating as a public company, which will require us to add operational, financial and management
information systems and personnel, including personnel to support our drug development, any future commercialization efforts and our transition to a public company. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, if we obtain marketing approval for any of our lead product candidates, we expect to incur significant commercialization expenses related to
product manufacturing, marketing, sales and distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As a result, we will need additional financing to support our continuing operations. Until such
time as we can generate significant revenue from product sales, if ever, we expect to finance our operations through a combination of public or private equity or debt financings or other sources, which may include collaborations with third parties.
We may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If we fail to raise capital or enter into such agreements as and when needed, we may have to significantly
delay, scale back or discontinue the development or commercialization of one or more of our product candidates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because of the numerous risks and uncertainties associated with product development, we are unable to
predict the timing or amount of increased expenses or when or if we will be able to achieve or maintain profitability. Even if we are able to generate revenue from product sales, we may not become profitable. If we fail to become profitable or are
unable to sustain profitability on a continuing basis, then we may be unable to continue our operations at planned levels and be forced to reduce or terminate our operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of March&nbsp;31, 2020, we had cash, cash equivalents and investments of $334.2&nbsp;million. We believe that the anticipated net proceeds from this
offering, together with our existing cash, cash equivalents and investments, will enable us to fund our operating expenses and capital expenditure requirements into 2023. We have based this estimate on assumptions that may prove to be wrong, and we
could exhaust our available capital resources sooner than we expect. See &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#151;Liquidity and Capital Resources.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Components of our Results of Operations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Operating
Expenses </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our operating expenses since inception have consisted solely of research and development costs and general and administrative costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Research and Development Expenses</I><I>. </I>Research and development expenses include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">salaries, benefits and other employee related costs, including stock-based compensation expense, for personnel
engaged in research and development functions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs of outside consultants, including their fees, stock-based compensation and related travel expenses;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expenses incurred under agreements with CROs, CMOs, and other vendors that conduct our clinical trials and
preclinical activities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs of acquiring, developing, and manufacturing clinical trial materials and lab supplies;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs related to compliance with regulatory requirements; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">facility costs, depreciation, and other expenses, which include direct and allocated expenses for rent and
maintenance of facilities, insurance, and other supplies. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expense research and development costs as the services are performed or
the goods are received. We recognize costs for certain development activities, such as clinical trials, based on an evaluation of the progress to completion of specific tasks using data such as patient enrollment, clinical site activations, or
information provided to us by our vendors and our clinical investigative sites. Payments for these activities are based on the terms of the individual agreements, which may differ from the pattern of costs incurred, and are reflected in our
financial statements as prepaid or accrued research and development expenses. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We began tracking external development costs by program on January&nbsp;1, 2020 for programs that have
entered clinical trials.<I></I><I>&nbsp;</I>We do not allocate internal costs, facilities costs, or other overhead costs to specific programs.&nbsp;The following summarizes our costs by program based on their status in development: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="20%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;Months&nbsp;Ended<BR>March 31,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">External costs for program in Phase 1 clinical trials</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">External costs for all programs in discovery and
<FONT STYLE="white-space:nowrap">pre-clinical</FONT> studies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,396</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">External costs for platform research and other research and development activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,046</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee related expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our most advanced development program <FONT STYLE="white-space:nowrap">RLY-1971</FONT> is in Phase 1 clinical trials. Programs
in discovery and <FONT STYLE="white-space:nowrap">pre-clinical</FONT> are <FONT STYLE="white-space:nowrap">RLY-4008</FONT> and <FONT STYLE="white-space:nowrap">RLY-P13K1047</FONT> as well as other earlier stage programs. Costs incurred for these
programs include costs incurred to support our discovery research and translational science efforts up to the initiation of Phase 1 clinical development. Platform research and other research and development activities include costs that are not
specifically allocated to active product candidates, including facilities costs, depreciation expense, and other costs. Employee related expenses includes salary, wages, stock-based compensation and other costs related to our personnel, which are
not allocated to specific programs or activities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We cannot determine with certainty the duration and costs of future clinical trials of <FONT
STYLE="white-space:nowrap">RLY-1971</FONT> and future development costs of <FONT STYLE="white-space:nowrap">RLY-4008</FONT> and our <FONT STYLE="white-space:nowrap">RLY-P13K1047</FONT> program, if, when or to what extent we will generate revenue
from the commercialization and sale of any our product candidates for which we obtain marketing approval or our other research and development costs. We may never succeed in obtaining marketing approval for any of our product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The duration, costs and timing of clinical trials and development of our product candidates will depend on a variety of factors, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope, rate of progress, expense and results of our preclinical development activities, any future clinical
trials of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> and <FONT STYLE="white-space:nowrap">RLY-4008,</FONT> and our <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> program or other product candidates and other research and development
activities that we may conduct; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">uncertainties in clinical trial design and patient enrollment or drop out or discontinuation rates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing an appropriate safety and efficacy profile with IND-enabling studies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the initiation and completion of future clinical trial results; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing, receipt and terms of any approvals from applicable regulatory authorities including the U.S. Food and
Drug Administration, or FDA, and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> regulators; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">significant and changing government regulation and regulatory guidance; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">potential additional studies requested by regulatory agencies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing clinical and commercial manufacturing capabilities or making arrangements with third-party
manufacturers in order to ensure that we or our third-party manufacturers are able to make product successfully; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of any business interruptions to our operations, including the timing and enrollment of patients in
our planned clinical trials, or to those of our manufacturers, suppliers, or other vendors resulting from the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic or similar public health crisis; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the expense of filing, prosecuting, defending and enforcing any patent claims and other intellectual property
rights; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">maintaining a continued acceptable safety profile of our product candidates following approval, if any, of our
product candidates. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research and development activities are central to our business model. Product candidates in later stages of
clinical development generally have higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials. We expect that our research and development expenses
will continue to increase for the foreseeable future as we continue clinical trials of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> and continued development of <FONT STYLE="white-space:nowrap">RLY-4008</FONT> our
<FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> program and continue to identify and develop additional product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A change in the outcome
of any of these variables with respect to the development of a product candidate could mean a significant change in the costs and timing associated with the development of that product candidate. For example, if the U.S. Food and Drug
Administration, or FDA, or another regulatory authority were to require us to conduct clinical trials beyond those that we anticipate will be required for the completion of clinical development of a product candidate, or if we experience significant
trial delays due to patient enrollment or other reasons, we would be required to expend significant additional financial resources and time on the completion of clinical development. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>General and Administrative Expenses </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">General and
administrative expenses consist primarily of salaries and other related costs, including stock-based compensation, for personnel in our executive, finance, corporate and business development and administrative functions. General and administrative
expenses also include legal fees relating to patent and corporate matters; professional fees for accounting, auditing, tax and consulting services; insurance costs; travel expenses; and facility-related expenses, which include direct depreciation
costs and allocated expenses for rent and maintenance of facilities and other operating costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expect that our general and administrative expenses
will increase in the future as we increase our general and administrative personnel headcount to support personnel in research and development and to support our operations generally as we increase our research and development activities and
activities related to the potential commercialization of our product candidates. We also expect to incur increased expenses associated with operating as a public company, including costs of accounting, audit, legal, regulatory and <FONT
STYLE="white-space:nowrap">tax-related</FONT> services associated with maintaining compliance with exchange listing and Securities and Exchange Commission, or SEC, requirements, director and officer insurance costs, and investor and public relations
costs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Income, Net </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other income, net
consists of interest income primarily interest earned on our cash, cash equivalents and investments. We anticipate that our interest income will increase in the future as we expect our investment balances to be higher due to anticipated cash
proceeds from this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Income Taxes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since our inception in 2015, we have not recorded any U.S. federal or state income tax benefits for the net losses we have incurred in any year or for our
earned research and development tax credits, due to our uncertainty of realizing a benefit from those items. As of December&nbsp;31, 2019, we had federal NOL carryforwards of $154.3&nbsp;million available to reduce taxable income, of which
$43.2&nbsp;million expire beginning in 2035 and $111.1&nbsp;million do not expire. We have state NOL carryforwards of $162.2&nbsp;million as of December&nbsp;31, 2019 available to reduce future state taxable income, which expire at various dates
beginning in 2035. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019, we also had federal and state research and development tax credit
carryforwards of $4.8&nbsp;million and $1.9&nbsp;million, respectively, which begin to expire in 2035 and 2030, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Results of Operations
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the three months ended March&nbsp;31, 2019 and 2020 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes our results of operations for the three months ended March&nbsp;31, 2019 and 2020: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended<BR>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change<BR></B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 13,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 21,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 8,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,067</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,691</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,402</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,056</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(16,402</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26,458</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,056</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,220</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(648</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(14,182</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(24,886</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(10,704</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development Expenses </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months&nbsp;Ended<BR>March 31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in&nbsp;thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee related expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,342</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 6,228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,886</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outside and consulting services</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,933</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Clinical trial expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">141</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laboratory supplies and other costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,282</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">735</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Facilities and other allocated expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,421</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">215</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research and development expenses were $13.3&nbsp;million for the three months ended March&nbsp;31, 2019, compared to
$21.7&nbsp;million for the three months ended March&nbsp;31, 2020. The increase of $8.4&nbsp;million was primarily due to $4.4&nbsp;million of outside and consulting services for our <FONT STYLE="white-space:nowrap">pre-clinical</FONT> candidates
due to an increased number of discovery programs and more programs in later stage <FONT STYLE="white-space:nowrap">pre-clinical</FONT> trials. The increase also includes $1.9&nbsp;million of additional employee related costs, including stock-based
compensation of $0.3&nbsp;million and $0.7&nbsp;million for increased laboratory supplies primarily due to higher headcount, as well as $1.0&nbsp;million of clinical trial expenses as we commenced phase 1 of our clinical study for <FONT
STYLE="white-space:nowrap">RLY-1971</FONT> during the three months ended March&nbsp;31, 2020. While we currently do not anticipate any interruptions in our operations due to <FONT STYLE="white-space:nowrap">COVID-19,</FONT> it is possible that the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic and response efforts could delay our development programs and plans and increase our associated costs. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>General and Administrative Expenses </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">General and
administrative expenses were $3.1&nbsp;million for the three months ended March&nbsp;31, 2019, compared to $4.8&nbsp;million for the three months ended March&nbsp;31, 2020. The increase of $1.7&nbsp;million was due to $0.8&nbsp;million of increased
personnel costs, including an additional $0.3&nbsp;million of share-based compensation, to support our infrastructure, $0.4&nbsp;million of additional professional fees and $0.5&nbsp;million of increased facilities related and other expenses
primarily attributed to our new corporate and laboratory space in 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Income, Net </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other income, net, decreased from $2.2&nbsp;million for the three months ended March&nbsp;31, 2019 to $1.6&nbsp;million for the three months ended
March&nbsp;31, 2020 due primarily to lower amounts of cash equivalents and investments as well as a decrease in interest. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of years ended
December&nbsp;31, 2018 and 2019 </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes our results of operations for the years ended December&nbsp;31, 2018 and 2019: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 41,034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 70,306</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 29,272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,855</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,887</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,889</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84,048</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49,889</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(84,048</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34,159</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income and other expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,639</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(48,785</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(75,305</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(26,520</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development Expenses </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in&nbsp;thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Employee related expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,829</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19,914</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 8,085</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outside and consulting services</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,753</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,585</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,832</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation of laboratory equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,705</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">705</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laboratory supplies and other costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,881</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,408</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Facilities and other allocated expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,866</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">41,034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">70,306</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">29,272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research and development expenses were $41.0&nbsp;million for the year ended December&nbsp;31, 2018, compared to
$70.3&nbsp;million for the year ended December&nbsp;31, 2019. The increase of $29.3&nbsp;million was primarily due to an increase of $12.8&nbsp;million in outside and consulting research expenses associated with our
<FONT STYLE="white-space:nowrap">pre-clinical</FONT> candidates, $8.1&nbsp;million of increased personnel related costs, primarily due to increased headcount, including $0.8&nbsp;million of additional stock-based compensation, $4.2&nbsp;million of
increased facilities related and other expenses primarily attributable to our new corporate and laboratory space in 2019 and $3.4&nbsp;million of laboratory supplies and other costs. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>General and Administrative Expenses </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">General and
administrative expenses were $8.9&nbsp;million for the year ended December&nbsp;31, 2018 compared to $13.7&nbsp;million for the year ended December&nbsp;31, 2019. The increase of $4.9&nbsp;million was primarily due to $2.7&nbsp;million in increased
personnel related costs, including $0.7&nbsp;million of additional share-based compensation expense, primarily due to increased general and administrative headcount to support the growth of our research and development organization,
$1.1&nbsp;million in increased professional fees, which were primarily legal and outside consultant costs, and $1.0&nbsp;million in increased facilities related and other expenses attributed to our new corporate and laboratory space in 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Income (Expense), Net </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other income, net, increased from $1.1&nbsp;million for the year ended December&nbsp;31, 2018 to $8.8&nbsp;million for the year ended December&nbsp;31, 2019
due primarily to interest income generated from proceeds from the issuance of Series C convertible preferred stock in December 2018 and in January 2019. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidity and Capital Resources </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since our inception, we
have not generated any revenue from product sales or any other sources, and have incurred significant operating losses. We have not yet commercialized any products and we do not expect to generate revenue from sales of any product candidates for
several years, if ever. To date, we have financed our operations through private placements of preferred stock and convertible debt. Through March&nbsp;31, 2020, we had received gross proceeds of $519.8&nbsp;million from sales of our preferred stock
and our issuance of convertible debt. As of March&nbsp;31, 2020, we had cash, cash equivalents and investments of $334.2&nbsp;million. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Flows
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes our sources and uses of cash for each of the periods presented: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended<BR>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(44,135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(66,133</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(10,816</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(22,334</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash provided by (used in) investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,680</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(319,024</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,144</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,371</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">394,972</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,606</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,047</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">351</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net increase (decrease) in cash, cash equivalents and restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">349,157</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(379,551</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(8,913</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 28,388</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Times New Roman"><I>Operating Activities. </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the three months ended March&nbsp;31, 2020, operating activities used $22.3&nbsp;million of cash, primarily resulting from our net loss of
$24.9&nbsp;million, partially offset by <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of $2.0&nbsp;million and cash provided by changes in our operating assets and liabilities of $0.6&nbsp;million. Net cash provided by changes in our
operating assets and liabilities of $0.6&nbsp;million during the three months ended March&nbsp;31, 2020 consisted of an increase of $0.2&nbsp;million in accounts payable, accrued expenses and other liabilities as well as a decrease of
$0.3&nbsp;million in prepaid expenses and other current assets, and $0.1&nbsp;million of operating lease assets, net. The increase in accounts payable, accrued expenses and other current liabilities was largely due to the timing of payments related
to research and development costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the three months ended March&nbsp;31, 2019, operating activities used $10.8&nbsp;million of cash, primarily
resulting from our net loss of $14.2&nbsp;million, partially offset by <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of $1.5&nbsp;million and cash provided by changes in our operating assets and liabilities of $1.9&nbsp;million. Net cash
provided by changes in our operating assets and liabilities of $1.9&nbsp;million during the three months ended March&nbsp;31, 2019 consisted of an increase of $1.5&nbsp;million in accounts payable, accrued expenses and other liabilities as well as a
decrease of $0.6&nbsp;million of operating lease assets, net, partially offset by an increase of $0.2&nbsp;million in prepaid expenses and other current assets. The increase in accounts payable, accrued expenses and other liabilities was largely due
to an increase in external research and development costs. The increase in prepaid expenses and other current assets was due to an increase in external research and development costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2019, operating activities used $66.1&nbsp;million of cash, primarily resulting from our net loss of
$75.3&nbsp;million, partially offset by <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of $4.9&nbsp;million and cash provided by changes in our operating assets and liabilities of $4.3&nbsp;million. Net cash provided by changes in our
operating </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
assets and liabilities of $4.3&nbsp;million during the year ended December&nbsp;31, 2019 consisted of an increase of $5.2&nbsp;million in accounts payable, accrued expense and other current
liabilities as well as a decrease of $1.2&nbsp;million of operating lease assets, net, partially offset by an increase of $2.1&nbsp;million in prepaid expenses and other current assets. The increase in accounts payable, accrued expenses and other
current liabilities was largely due to an increase in external research and development costs. The increase in prepaid expenses and other current assets was due to an increase in external research and development costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2018, operating activities used $44.1&nbsp;million of cash, primarily resulting from our net loss of
$48.8&nbsp;million and $0.4&nbsp;million of cash used from changes in our operating assets, partially offset by <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of $5.1&nbsp;million. Net cash used from changes in operating assets and
liabilities of $0.4&nbsp;million during the year ended December&nbsp;31, 2018 consisted of an increase in prepaid expenses and other current assets of $1.2&nbsp;million and an increase in operating leases assets, net, of $0.5&nbsp;million, partially
offset by an increase in accounts payable, accrued expenses and other current liabilities of $1.3&nbsp;million. The increase in prepaid expenses and other current assets was due to an increase in external research and development costs. The increase
in accounts payable, accrued expenses and other current liabilities was largely due to an increase in external research and development costs and to a lesser extent an increase in professional fees associated with the Series C convertible preferred
stock financing in December 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Investing Activities</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the three months ended March&nbsp;31, 2020, investing activities provided $50.4&nbsp;million, consisting of $51.4&nbsp;million of net investment
maturities, partially offset by $1.0&nbsp;million for the acquisition of property and equipment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the three months ended March&nbsp;31, 2019,
investing activities used $3.1&nbsp;million, consisting of purchase of property and equipment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2019, investing
activities used $319.0&nbsp;million, consisting primarily of $311.0&nbsp;million of net investment purchases and $8.0&nbsp;million for the purchase of property and equipment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2018, investing activities used $1.7&nbsp;million of cash, consisting primarily of purchases of property and
equipment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Financing Activities</I>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the three months ended March&nbsp;31, 2020, net cash provided by financing activities was $0.4&nbsp;million, consisting primarily of net proceeds from
the exercise of stock options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the three months ended March&nbsp;31, 2019, net cash provided by financing activities was $5.0&nbsp;million,
consisting of net proceeds from our sales of Series C convertible preferred stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2019, net cash provided by
financing activities was $5.6&nbsp;million, consisting of net proceeds from our sales of Series C convertible preferred stock of $5.0&nbsp;million and proceeds from the exercise of stock options of $0.6&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2018, net cash provided by financing activities was $395.0&nbsp;million, consisting primarily of net proceeds from our
sales of Series C convertible preferred stock of $394.3&nbsp;million and proceeds from the issuance of restricted stock of $0.7&nbsp;million, net of repurchases. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Funding Requirements </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expect our expenses to
increase substantially in connection with our ongoing clinical development activities related to <FONT STYLE="white-space:nowrap">RLY-1971,</FONT> which is still in the early stages of clinical trials, the potential clinical development
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
activities of <FONT STYLE="white-space:nowrap">RLY-4008</FONT> and the ongoing <FONT STYLE="white-space:nowrap">pre-clinical</FONT> development activities of our
<FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> program. In addition, commencing upon the closing of this offering, we expect to incur additional costs associated with operating as a public company. We expect that our expenses will increase
substantially if and as we: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">conduct our current and future clinical trials of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> and <FONT
STYLE="white-space:nowrap">RLY-4008,</FONT> and additional preclinical research and development of our <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> program, and other early-stage programs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">initiate and continue research and preclinical and clinical development of our other product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">seek to identify additional product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">pursue marketing approvals for any of our product candidates that successfully complete clinical trials, if any;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establish a sales, marketing and distribution infrastructure to commercialize any products for which we may
obtain marketing approval; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">require the manufacture of larger quantities of our product candidates for clinical development and potentially
commercialization; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtain, maintain, expand and protect our intellectual property portfolio; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">acquire or <FONT STYLE="white-space:nowrap">in-license</FONT> other drugs and technologies;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">hire and retain additional clinical, quality control and scientific personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">build out new facilities or expand existing facilities to support our ongoing development activity; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">add operational, financial and management information systems and personnel, including personnel to support our
drug development, any future commercialization efforts and our transition to a public company. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of March&nbsp;31, 2020, we had cash,
cash equivalents and investments of $334.2&nbsp;million. We believe that the anticipated net proceeds from this offering, together with our existing cash, cash equivalents and investments, will enable us to fund our operating expenses and capital
expenditure requirements into 2023. We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Because of the numerous risks and uncertainties associated with the development of RLY-1971, RLY-4008, and our
<FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> programs and other product candidates and programs and because the extent to which we may enter into collaborations with third parties for development of our product candidates is unknown, we are
unable to estimate the timing and amounts of increased capital outlays and operating expenses associated with completing the research and development of our product candidates. Our future capital requirements will depend on many factors, including:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact of any business interruptions to our operations, including the timing and enrollment of patients in
our planned clinical trials, or to those of our manufacturers, suppliers, or other vendors resulting from the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic or similar public health crisis; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope, progress, results and costs of our current and future clinical trials of <FONT
STYLE="white-space:nowrap">RLY-1971</FONT> and <FONT STYLE="white-space:nowrap">RLY-4008</FONT> and additional preclinical research of our <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> program; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope, progress, results and costs of our current and future clinical trials of <FONT
STYLE="white-space:nowrap">RLY-1971</FONT> and additional preclinical research of <FONT STYLE="white-space:nowrap">RLY-4008</FONT> and <FONT STYLE="white-space:nowrap">RLY-PI3K1047;</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope, progress, results and costs of drug discovery, preclinical research and clinical trials for our other
product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of future product candidates that we pursue and their development requirements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs, timing and outcome of regulatory review of our product candidates; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to establish and maintain collaborations on favorable terms, if at all; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the success of any collaborations that we may enter into with third parties; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the extent to which we acquire or invest in businesses, products and technologies, including entering into
licensing or collaboration arrangements for product candidates, although we currently have no commitments or agreements to complete any such transactions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs and timing of future commercialization activities, including drug sales, marketing, manufacturing and
distribution, for any of our product candidates for which we receive marketing approval, to the extent that such sales, marketing, manufacturing and distribution are not the responsibility of any collaborator that we may have at such time;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amount of revenue, if any, received from commercial sales of our product candidates, should any of our
product candidates receive marketing approval; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual
property rights and defending intellectual property-related claims; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our headcount growth and associated costs as we expand our business operations and our research and development
activities; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs of operating as a public company. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Developing pharmaceutical products, including conducting preclinical studies and clinical trials, is a time-consuming, expensive and uncertain process that
takes years to complete, and we may never generate the necessary data or results required to obtain marketing approval for any product candidates or generate revenue from the sale of any product candidate for which we may obtain marketing approval.
In addition, our product candidates, if approved, may not achieve commercial success. Our commercial revenues, if any, will be derived from sales of drugs that we do not expect to be commercially available for many years, if ever. Accordingly, we
will need to obtain substantial additional funds to achieve our business objectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Adequate additional funds may not be available to us on acceptable
terms, or at all. We do not currently have any committed external source of funds. To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership interest may be diluted, and the terms of
these securities may include liquidation or other preferences and anti-dilution protections that could adversely affect your rights as a common stockholder. Additional debt or preferred equity financing, if available, may involve agreements that
include restrictive covenants that may limit our ability to take specific actions, such as incurring debt, making capital expenditures or declaring dividends, which could adversely impact our ability to conduct our business, and may require the
issuance of warrants, which could potentially dilute your ownership interest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If we raise additional funds through collaborations, strategic alliances or
licensing arrangements with third parties, we may have to relinquish valuable rights to our technology, future revenue streams, research programs, or product candidates or grant licenses on terms that may not be favorable to us. If we are unable to
raise additional funds through equity or debt financings or collaborations, strategic alliances or licensing arrangements with third parties when needed, we may be required to delay, limit, reduce and/or terminate our product development programs or
any future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contractual Obligations and Commitments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes our contractual obligations at December&nbsp;31, 2019, and the effect that such obligations are expected to have on our
liquidity and cash flows in future periods: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Payments Due by Period</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Less&nbsp;Than<BR>1 Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>1&nbsp;-&nbsp;3<BR>Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>3&nbsp;-&nbsp;5<BR>Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>More&nbsp;Than<BR>5 Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease commitments<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39,685</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,767</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19,733</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and license agreement
obligations<SUP STYLE="font-size:85%; vertical-align:top">(2)}</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Letter of credit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">878</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">878</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">44,363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,567</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,611</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents minimum payments due for our lease of office and laboratory space in Cambridge, Massachusetts under
an operating lease agreement that expires in April 2029. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents the aggregate license maintenance fees payable under our existing research and licensing agreements
with third parties. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have an Amended and Restated Collaboration and License Agreement with D.&nbsp;E.&nbsp;Shaw Research, LLC, or the
DESRES Agreement, which provides that the parties will jointly conduct research efforts with the goal of identifying and developing product candidates. On a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">product-by-product</FONT></FONT> basis, we have agreed to pay D.&nbsp;E.&nbsp;Shaw Research milestone payments upon the achievement of certain development and regulatory milestone
events for products we develop under the DESRES Agreement that are directed to a Category&nbsp;1 Target or any target that was a Category 1 Target. Such payments for achievement of development and regulatory milestones total up to $7.25&nbsp;million
in the aggregate for each of the first three products we develop, and up to $6.25&nbsp;million in the aggregate for each product we develop after the first three.&nbsp;In addition, we are obligated to pay D.&nbsp;E.&nbsp;Shaw Research, LLC royalty
payments as defined in the agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also have certain research and license arrangements with other third parties, which provide us with research
services with the goal of identifying and developing product candidates until all payment obligations by the Company to the third party have expired. The Company has the right to terminate these agreements with a reasonable period of notice. We are
also obligated to pay development milestone payments for up to four targets, each in the range of $4.0&nbsp;million to $7.0&nbsp;million, upon the achievement of certain specified contingent events. The Company assessed the milestones at
December&nbsp;31, 2018 and 2019 and March 31, 2020 (unaudited) and concluded no such milestone payments were due. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We enter into contracts in the normal
course of business with CROs and CMOs for clinical trials, preclinical research studies and testing, manufacturing and other services and products for operating purposes. These contracts do not contain any minimum purchase commitments and are
cancelable by us upon prior notice of 30&nbsp;days and, as a result, are not included in the table of contractual obligations above. Payments due upon cancelation consist only of payments for services provided and expenses incurred up to the date of
cancelation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Critical Accounting Policies and Use of Estimates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our management&#146;s discussion and analysis of financial condition and results of operations is based on our financial statements, which have been prepared
in accordance with generally accepted accounting principles in the United States, or GAAP. The preparation of our consolidated financial statements and related disclosures requires us to make estimates and assumptions that affect the reported
amounts of assets and liabilities, costs and expenses and the disclosure of contingent assets and liabilities in our financial statements. We base our estimates on historical experience, known trends and events and various other factors that we
believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions
on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The full extent to which the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic will directly or
indirectly impact our business, results of operations and financial condition, including expenses, clinical trials and research and development costs, will depend on future developments that are highly uncertain, including as a result of new
information that may emerge concerning <FONT STYLE="white-space:nowrap">COVID-19</FONT> and the actions taken to contain or treat <FONT STYLE="white-space:nowrap">COVID-19,</FONT> as well as the economic impact on local, regional, national and
international markets. We have made estimates of the impact of <FONT STYLE="white-space:nowrap">COVID-19</FONT> within our financial statements and there may be changes to those estimates in future periods. Actual results could differ from our
estimates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While our significant accounting policies are described in more detail in the notes to our consolidated financial statements appearing at the
end of this prospectus, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our consolidated financial statements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Accrued Research and Development Expenses </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part
of the process of preparing our consolidated financial statements, we are required to estimate our accrued research and development and manufacturing expenses. This process involves reviewing open contract and purchase orders, communicating with our
personnel to identify services that have been performed on our behalf and estimating the level of service performed and the associated costs incurred for the services when we have not yet been invoiced or otherwise notified of the actual costs. The
majority of our service providers invoice us in arrears for services performed on a <FONT STYLE="white-space:nowrap">pre-determined</FONT> schedule or when contractual milestones are met; however, some require advanced payments. We make estimates of
our accrued expenses as of each balance sheet date in our financial statements based on facts and circumstances known to us at that time. Examples of estimated accrued research and development expenses include fees paid to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">CROs in connection with performing research activities on our behalf and conducting preclinical studies and
clinical trials on our behalf; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">investigative sites or other service providers in connection with clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">vendors in connection with preclinical and clinical development activities; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">vendors related to product manufacturing and development and distribution of preclinical and clinical supplies.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We base our expenses related to preclinical studies and clinical trials on our estimates of the services received and efforts expended
pursuant to quotes and contracts with multiple CROs that conduct and manage preclinical studies and clinical trials on our behalf. The financial terms of these agreements are subject to negotiation and vary from contract to contract, which may
result in uneven payment flows. There may be instances in which payments made to our vendors will exceed the level of services provided and result in a prepayment of the expense. Payments under some of these contracts depend on factors such as the
successful enrollment of patients and the completion of clinical trial milestones. In accruing fees, we estimate the time period over which services will be performed, enrollment of patients, number of sites activated and the level of effort to be
expended in each period. If the actual timing of the performance of services or the level of effort varies from our estimate, we adjust the accrual or amount of prepaid expense accordingly. Although we do not expect our estimates to be materially
different from amounts actually incurred, our understanding of the status and timing of services performed relative to the actual status and timing of services performed may vary and may result in us reporting amounts that are too high or too low in
any particular period. To date, we have not made any material adjustments to our prior estimates of accrued research and development expenses. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock-Based Compensation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We measure stock options
and other stock-based awards granted to employees, directors and <FONT STYLE="white-space:nowrap">non-employees</FONT> based on their fair value on the date of grant and recognize compensation expense of those awards over the requisite service
period, which is generally the vesting period of the respective award. We recognize the impact </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of forfeitures on stock-based compensation expense as forfeitures occur. We apply the straight-line method of expense recognition to all awards with only service-based vesting conditions. For
awards with performance-based vesting conditions, we assess the probability that the performance conditions will be achieved at each reporting period. We use the accelerated attribution method to expense the awards over the requisite service period
when the performance conditions are deemed probable of achievement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have certain options with performance-based vesting conditions whereby the service
inception date precedes the accounting grant date and therefore we apply variable accounting such that the stock-based compensation expense to be recognized for the options will ultimately be based on the fair value of the awards on the accounting
grant date. Expense is recognized over the implied service period when achievement of the performance based milestones is deemed probable. We use judgement to determine whether and, if so, how many awards are deemed probable of vesting at each
reporting period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We estimate the fair value of each stock option grant on the date of grant using the Black-Scholes option-pricing model, which uses as
inputs the fair value of our common stock and assumptions we make for the volatility of our common stock, the expected term of our stock options, the risk-free interest rate for a period that approximates the expected term of our stock options and
our expected dividend yield. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Determination of Fair Value of Common Stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As there has been no public market for our common stock to date, the estimated fair value of our common stock has been determined by our board of directors, or
compensation committee thereof as of the date of each option grant, with input from management, considering our most recently available third-party valuations of common stock and our board of directors&#146; assessment of additional objective and
subjective factors that it believed were relevant and which may have changed from the date of the most recent valuation through the date of the grant. Historically, these independent third party valuations of our equity instruments were performed
contemporaneously with identified value inflection points. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These third-party valuations were performed in accordance with the guidance outlined in the
American Institute of Certified Public Accountants&#146; Accounting and Valuation Guide, <I>Valuation of Privately-Held-Company Equity Securities Issued as Compensation or the Practice Aid</I>. The Practice Aid identifies various available methods
for allocating the enterprise value across classes of series of capital stock in determining the fair value of our common stock at each valuation date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with the Practice Aid, the probability-weighed expected return method, or PWERM and the Option Pricing Method or OPM were the most appropriate
methods for determining the fair value of our common stock based on our stage of development and other relevant factors. Our valuation as of May 2020 contemplated the hybrid method which is a combination of the PWERM and the OPM to allocate the
value to the securities. Our valuations in November 2018 and November 2019 were based on the OPM utilizing either the Recent Transactions Method utilizing a Backsolve methodology or Guideline Merger and Acquisition Transaction Method from the
Practice Aid. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to considering the results of these third-party valuations, our board of directors considered various objective and subjective
factors to determine the fair value of our common stock as of each grant date, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The prices of our convertible preferred stock sold to or exchanged between outside investors in arm&#146;s length
transactions and the rights, preferences, and privileges or our redeemable preferred securities as compared to those of our common stock, including liquidation preferences of our preferred stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the progress of our research and development programs, including the status and results of preclinical studies
and clinical trials for our product candidates </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our stage of development and commercialization of our product candidates and our business strategy;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">external market conditions affecting the biopharmaceutical industry and trends within the biopharmaceutical
industry; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our financial position, including cash on hand, and our historical and forecasted performance and operating
results; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the lack of an active public market for our common stock and our preferred stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the likelihood of achieving a liquidity event, such as an initial public offering, or IPO, or sale of our company
in light of prevailing market conditions; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the analysis of IPOs and the market performance of similar companies in the biopharmaceutical industry.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our valuations were performed using the OPM or hybrid method. The method selected was based on availability and the quality of
information to develop the assumptions for the methodology. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">OPM &#150; The OPM treats common stock and preferred stock as call options on the total
equity value of a company, with exercise prices based on the value thresholds at which the allocation among the various holders of a company&#146;s securities changes. Under this method, the common stock has value on if the funds available for
distribution to stockholders exceed the value of the liquidation preferences at the time of a liquidity event, such as a strategic sale or merger. The common stock is modeled as a call option on the underlying equity value at a predetermined
exercise price. In the model, the exercise price is based on a comparison with the total equity value rather than, as in the case of a regular option, a comparison with a per share stock price. Thus, common stock is considered to be a call option
with a claim on the enterprise at an exercise price equal to the remaining value immediately after the preferred stock liquidation preference is paid. The OPM uses the Black-Scholes option pricing model to price the call options. This model defines
the fair value of securities as functions of the current fair value of a company and uses assumptions such as the anticipated timing of a potential liquidity event and the estimated volatility of the equity securities. The OPM method was used for
our November 2018 and November 2019 valuations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PWERM &#150; Under the PWERM methodology, the fair value of the common stock is estimated based upon an
analysis of future values for the company, assuming various outcomes. The common stock value is based on the probability weighted present value of expected future investment returns considering each of the possible outcomes available as well as the
rights of each class of stock. The future value of the common stock under each outcome is discounted back to the valuation date at an appropriate risk adjusted discount rate and probability to arrive at an indication of the value for common stock.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Hybrid Method &#150; The Hybrid method is a PWERM where the equity value in one of the scenarios is calculated using an OPM. In the hybrid method used by
us for our May 2020 valuation, two types of future event scenarios were considered: an IPO and a trade sale. The enterprise value for the IPO scenario was determined using a market approach, the Guideline IPO Transactions Method. The IPO scenario
assumes all of our then outstanding preferred stock would convert into common stock as of the IPO effective date. The enterprise value for the Trade Sale scenario is determined based on the Guideline Merger and Acquisitions Transaction Method and
OPM allocation method. The relative probability of each type of future-event scenario was determined by our board of directors based on an analysis of performance and market conditions at the time, including then current IPO valuations of similarly
situated companies and expectations as to the timing and likely prospects of future event scenarios. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The assumptions underlying these valuations
represented management&#146;s best estimates, which involved inherent uncertainties and the application of management&#146;s judgment. As a result, if we had used significantly different assumptions or estimates, the fair value of our common stock
and our stock-based compensation expense could have been materially different. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Once a public trading market for our common stock has been established in connection with the closing of
this offering, it will no longer be necessary for our board of directors to estimate the fair value of our common stock in connection with our accounting for granted stock options and other such awards we may grant, as the fair value of our common
stock will be determined based on the quoted market price of our common stock. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Grant date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>shares&nbsp;subject<BR>to&nbsp;option</B><br><B>grants</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;share<BR>exercise</B><br><B>price&nbsp;of<BR>options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair&nbsp;value&nbsp;of<BR>common&nbsp;stock<BR>per&nbsp;share&nbsp;on</B><br><B>date of</B><br><B>option&nbsp;grant</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March 15, 2019 &#150; November 18, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,923,246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">December 2, 2019 &#150; May 11, 2020 </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">515,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">March 2, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,960,547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">June 23, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">188,683</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14.06</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14.06</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents options to purchase 1,960,547 shares of common stock at a per share exercise price of $5.22, which
were authorized on March 2, 2020, for which the commencement of vesting is based on the achievement of certain scientific and operational milestones during a two-year period. The achievement of these milestones is discretionary and subject to
approval by our board of directors. As a result, the grant date for accounting purposes will not be determined until the board of directors approves the achievement of the specified milestones. The Company will therefore apply variable accounting
for these awards and the stock-based compensation expense to be recognized for the options will ultimately be based on the fair value of the awards on the accounting grant date. The Company determined that the awards were not probable of vesting at
March&nbsp;31, 2020, and therefore no stock-based compensation expense was recorded in the three months ended March&nbsp;31, 2020. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On June&nbsp;23, 2020, the Company&#146;s board of directors, in its discretion, determined that the performance milestones related to 25% of
the performance-based awards, as discussed above, had been achieved. The four year vesting term of awards to purchase 490,136 shares of common stock therefore commenced on June 23, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Emerging growth company and smaller reporting company status </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April 2012, the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, was enacted. Section&nbsp;107 of the JOBS Act provides that an &#147;emerging
growth company,&#148; or an EGC, can take advantage of the extended transition period provided in Section&nbsp;7(a)(2)(B) of the Securities Act of 1933, as amended, or the Securities Act, for complying with new or revised accounting standards. Thus,
an EGC can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to use the extended transition period for new or revised accounting standards during the period in which
we remain an emerging growth company; however, we may adopt certain new or revised accounting standards early. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will remain an emerging growth company
until the earliest to occur of: (1)&nbsp;the last day of the fiscal year in which we have more than $1.07&nbsp;billion in annual revenue; (2)&nbsp;the date we qualify as a &#147;large accelerated filer,&#148; with at least $700.0&nbsp;million of
equity securities held <FONT STYLE="white-space:nowrap">by&nbsp;non-affiliates;&nbsp;(3)&nbsp;the</FONT> date on which we have issued more than $1.0&nbsp;billion <FONT STYLE="white-space:nowrap">in&nbsp;non-convertible&nbsp;debt</FONT> securities
during the prior three-year period; and (4)&nbsp;the last day of the fiscal year ending after the fifth anniversary of our initial public offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We
are also a &#147;smaller reporting company&#148; meaning that the market value of our stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> plus the proposed aggregate amount of gross proceeds to us as a result of this offering is
less than $700&nbsp;million and our annual revenue was less than $100&nbsp;million during the most recently completed fiscal year. We may continue to be a smaller reporting company after this offering if either (i)&nbsp;the market value of our stock
held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> is less than $250&nbsp;million or (ii)&nbsp;our annual revenue was less than $100&nbsp;million during the most recently completed fiscal year and the market value of our stock held by <FONT
STYLE="white-space:nowrap">non-affiliates</FONT> is less than $700&nbsp;million. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company we may choose to present only the two
most recent fiscal years of audited financial statements in our Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K</FONT> and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations
regarding executive compensation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Off-Balance</FONT> Sheet Arrangements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We did not have during the periods presented, and we do not currently have, any <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet arrangements, as
defined in the rules and regulations of the Securities and Exchange Commission. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recently Issued and Adopted Accounting Pronouncements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A description of recently issued accounting pronouncements that may potentially impact our financial position and results of operations is disclosed in
Note&nbsp;2 to our consolidated financial statements appearing at the end of this prospectus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Quantitative and Qualitative Disclosures about Market
Risks </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Interest rate risk </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are exposed
to market risk related to changes in interest rates of our investment portfolio of cash equivalents and short-term investments. As of March 31, 2020, our cash equivalents consisted of money market funds. As of December&nbsp;31, 2020, our investments
consisted of investments in U.S. Treasury Bills, United States Treasury Bonds, and agency bonds that have contractual maturities of less than one year. Our primary exposure to market risk is interest income sensitivity, which is affected by changes
in the general level of U.S. interest rates. The fair value of our marketable securities is subject to change as a result of potential changes in market interest rates, including changes resulting from the impact of the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic. The potential change in fair value for interest rate sensitive instruments has been assessed on a hypothetical 100 basis point adverse movement across all maturities. As of March 31, 2020 and
December&nbsp;31, 2019, we estimate that such hypothetical 100 basis point adverse movement would not result in a material impact on our consolidated results of operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of March 31, 2020, we had no debt outstanding and are therefore not exposed to interest rate risk with respect to debt. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Foreign currency exchange risk </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of our
employees and our operations are currently located in the United States and our expenses are generally denominated in U.S. dollars. However, we have entered into a limited number of contracts with vendors for research and development services that
permit us to satisfy our payment obligations in U.S. dollars (at prevailing exchange rates) but have underlying payment obligations denominated in foreign currencies, including the Euro. We are subject to foreign currency transaction gains or losses
on our contracts denominated in foreign currencies. To date, foreign currency transaction gains and losses have not been material to our financial statements, and we have not had a formal hedging program with respect to foreign currency. A 10%
increase or decrease in current exchange rates would not have a material effect on our financial results for the years ended December&nbsp;31, 2019 and 2018 and the three months ended March 31, 2019 and 2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_12"></A>BUSINESS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are a clinical-stage precision medicines
company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Our company is built upon unparalleled insights into protein motion and how this dynamic behavior relates
to protein function. These insights may enable us to more effectively drug protein targets that previously have been intractable (i.e. inadequately drugged or undruggable). We believe we have a differentiated approach to drug these protein targets
based on their motion, which enables us to select and advance unique product candidates. We built our Dynamo platform to integrate an array of leading edge experimental and computational approaches, which allows us to apply our understanding of
protein structure and motion to drug discovery. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are advancing a pipeline of medicines to address targets in precision oncology, including our lead
product candidates, RLY-1971 and RLY-4008, as well as our PI3K&#945; mutant selective program (RLY-PI3K1047 program).&nbsp;To date, we have not entered into partnerships to clinically develop or commercialize any of these programs. We initiated a
Phase 1 clinical trial for <FONT STYLE="white-space:nowrap">RLY-1971,</FONT> our inhibitor of Src homology region 2 domain-containing <FONT STYLE="white-space:nowrap">phosphatase-2</FONT> (SHP2), in patients with advanced solid tumors in the first
quarter of 2020. We have completed Investigational New Drug, or IND, enabling activities for <FONT STYLE="white-space:nowrap">RLY-4008,</FONT> our inhibitor of fibroblast growth factor receptor 2 (FGFR2) and expect to initiate a Phase 1 clinical
trial for <FONT STYLE="white-space:nowrap">RLY-4008</FONT> in patients with advanced solid tumors having oncogenic FGFR2 alterations in the second half of 2020. We anticipate the <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> program, our
program for molecules targeting cancer-associated mutant variants of phosphoinostide <FONT STYLE="white-space:nowrap">3-kinase</FONT> alpha (PI3K&#945;), to be in IND enabling studies in 2021. While our initial focus is on precision oncology, we
believe our Dynamo platform may also be broadly applied to other areas of precision medicine, such as genetic disease. In addition to the three product candidates described above, we have five discovery stage programs across precision oncology and
genetic disease. We are focused on using the novel insights derived from our approach to transform the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of our
therapies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Precision medicine emerged as an approach for disease treatment as the understanding of the link between genetic alterations, protein
dysfunction and diseases evolved. Precision medicine aims to specifically and potently drug genetically validated target proteins (i.e., genetic variants potentially implicated in biology of disease). However, some target proteins thus far have been
intractable using conventional drug discovery tools, such as structure-based drug design (SBDD). While SBDD is well-suited to solving some drug discovery problems such as orthosteric site kinase inhibitors, its reliance on static images of protein
fragments limits its ability to gain accurate insights into the dynamic behavior of proteins in their natural state, which in turn limits its ability to discover medicines with exquisite specificity. Our approach pivots the understanding of protein
targets from the industry-standard, static view, to a novel paradigm based on fundamental insights into protein motion. We then apply these novel insights into protein motion to drug discovery and design, which we term Motion Based Drug Design
(MBDD). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The confluence of three forces - the proliferation of readily available genomic data, the evolution of experimental techniques, and advancements
in computational power and speed - led to the founding of Relay Therapeutics. We believe we are uniquely situated in our ability to consolidate these advances and, when combined with our world-class team of both experimental and computational
experts, integrate these solutions into MBDD to create medicines that will make a transformative difference for patients. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Key drug discovery steps of
Our Dynamo Platform </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Dynamo platform puts protein motion at the center of drug discovery and design, integrating a broad and tailored array of
leading-edge experimental and computational approaches, including deploying the Anton&nbsp;2 supercomputer, which was custom-built by D. E. Shaw Research, LLC, or D. E. Shaw Research, to perform </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
molecular dynamic simulations of proteins. We have access to the Anton&nbsp;2 supercomputer, which we believe to be the only resource of computational power of its caliber, through our
collaboration with D. E. Shaw Research, LLC, or D.E. Shaw Research, pursuant to which we collaborate with D.&nbsp;E.&nbsp;Shaw Research to rapidly develop various protein models. Our use of the Anton&nbsp;2 supercomputer and our collaboration with
D.E.&nbsp;Shaw Research is subject to the terms and conditions of the Amended and Restated Collaboration and License Agreement with D. E. Shaw Research, or the DESRES Agreement. See &#147;&#151;Collaboration and License Agreement with
D.&nbsp;E.&nbsp;Shaw Research, LLC.&#148; We deploy the power of the platform in three key phases of MBDD discovery: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Target Modulation Hypothesis. </B>By generating fundamental insights into the structure and conformational
dynamics of full-length proteins, our Dynamo platform enables us to model a target protein&#146;s function, to develop unique motion-based hypotheses for how to modulate the protein&#146;s behavior, and to identify potential novel binding sites for
new therapeutic agents. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Hit Finding and Lead Generation. </B>The integration of our computational and experimental platforms affords a
deeper functional understanding of our targets and enables the design of physiologically relevant activity-based, ligand-centric and computational screens. These highly differentiated screens have the ability to yield a larger number of chemical
series and potential therapies to proceed into lead optimization than conventional experimental techniques alone. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Lead Optimization. </B>Our Dynamo platform uses advanced computational models in tight integration with our
medicinal chemistry, structural biology, enzymology and biophysics capabilities to predict, design and experimentally evaluate compounds that will achieve the most desirable characteristics, including potency, selectivity, bioavailability, and
drug-like properties. We believe our approach enables us to converge on optimized compounds with much greater efficiency than conventional approaches, which are typically highly iterative over an extended timeframe. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Dynamo platform has the potential to address a diverse range of disease targets, including those proteins that have not been addressed selectively and
potently with existing therapies. While we have initially focused our Dynamo platform on small molecule drug discovery in the area of precision oncology, we believe it could be readily deployed across broader precision and genetic medicine areas as
well as other therapeutic modalities, such as protein therapeutics and antibody design. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Programs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have deployed our technology platform to build a pipeline of product candidates to address targets in precision oncology, where there is clear evidence
linking target proteins to disease and where molecular diagnostics can unambiguously identify relevant patients for treatment. We believe this approach will increase the likelihood of successfully translating a specific pharmacological mechanism
into clinical benefit. The targets associated with all of our current programs are Category 1 Targets under our Amended and Restated Collaboration and License Agreement with D. E. Shaw Research. See &#147;Business&#151;Collaboration and License
Agreement with D. E. Shaw Research, LLC.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g904779g94v79.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">RLY-1971</FONT> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">RLY-1971</FONT> binds and stabilizes SHP2 in its inactive conformation. SHP2 promotes cancer cell survival and growth through
the RAS pathway by transducing signals downstream from receptor tyrosine kinases (RTKs). Additionally, activating SHP2 mutations causes enhanced signaling in the absence of ligand stimulation and has been identified as an oncogenic driver in a range
of tumors. As a critical signaling node and regulator, SHP2 drives cancer cell proliferation and plays a key role in the way cancer cells develop resistance to targeted therapies. We believe that inhibition of SHP2 could be effective as a
monotherapy in cancers with specific alterations and could block a common path that cancer cells exploit to resist other antitumor agents, thus overcoming or delaying the onset of resistance to those therapies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are currently evaluating the safety and tolerability of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> in a Phase 1 dose escalation study in patients
with advanced or metastatic solid tumors. We have dosed 10 patients as of July&nbsp;8, 2020 and plan to enroll approximately 52 patients in this study. We anticipate providing an update on clinical data and the clinical development plan in 2021.
Given the range of cancers that are related to SHP2 dependence, in addition to its potential use in monotherapy settings, we believe <FONT STYLE="white-space:nowrap">RLY-1971</FONT> could serve as a backbone for compelling combination therapies. We
believe SHP2-mediated cancers affect approximately 125,000 late-line patients annually in both monotherapy and combination therapy settings in the U.S. In the future, if <FONT STYLE="white-space:nowrap">RLY-1971</FONT> advances to earlier lines of
treatment, we believe it could potentially have applicability to approximately 290,000 patients annually in the U.S.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">RLY-4008</FONT> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">RLY-4008</FONT> is designed to be an oral, small molecule, selective inhibitor of fibroblast growth factor receptor 2, or FGFR2, a receptor tyrosine kinase that is frequently altered in certain cancers. FGFR2 is one of
four members of the FGFR family, a set of closely related proteins with highly similar protein sequences and properties. <FONT STYLE="white-space:nowrap">RLY-4008</FONT> demonstrates FGFR2-dependent killing in cancer cell lines, while showing
minimal inhibition of other targets, including other members of the FGFR family. We plan to initiate a Phase 1 clinical trial for <FONT STYLE="white-space:nowrap">RLY-4008</FONT> in patients with solid tumors having oncogenic FGFR2 alterations in
the second half of 2020. We believe FGFR2-mediated cancers affect approximately 8,000 late-line patients annually in the U.S. In the future, if <FONT STYLE="white-space:nowrap">RLY-4008</FONT> advances to earlier lines of treatment, we believe it
could potentially address approximately 20,000 patients annually in the U.S.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Mutant-PI3K</I>&#945;<I></I><I> Inhibitor Program </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">RLY-PI3K1047</FONT> is a lead compound in our franchise of programs targeting cancer-associated mutant variants of phosphoinositide <FONT STYLE="white-space:nowrap">3-kinase</FONT> alpha, or PI3K&#945;. <FONT
STYLE="white-space:nowrap">RLY-PI3K1047</FONT> is a small molecule inhibitor of PI3K&#945; that we designed specifically to target PI3K&#945; H1047X mutants via a previously undescribed allosteric mechanism. Oral dosing of <FONT
STYLE="white-space:nowrap">RLY-PI3K1047</FONT> resulted in tumor growth inhibition in mouse xenograft models of PI3K&#945; H1047R mutant carcinoma. We expect to begin <FONT STYLE="white-space:nowrap">IND-enabling</FONT> studies for a differentiated
PI3K&#945; H1047X mutant-selective inhibitor in 2021. We believe PI3K&#945; H1047X mutant cancers affect approximately 10,000 late-line patients annually in the U.S. In the future, if <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> advances to
earlier lines of treatment, we believe it could potentially be suitable for use in approximately 50,000 patients annually in the U.S.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Two additional mutations of interest for our PI3K&#945; franchise are E542X and E545X. We estimate there are approximately 15,000 late-line and 60,000 total
patients annually in the United States who might benefit from a PI3K&#945; targeted inhibitor that targets the mutations at E542 and E545. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Discovery
Programs </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are deploying our Dynamo platform and MBDD approach to advance multiple discovery-stage precision oncology programs. As with our lead
programs, these programs leverage insights into protein conformational dynamics to address high-value, genetically validated oncogenes that previously have been intractable to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conventional drug-discovery approaches. Our Dynamo platform&#146;s protein visualization capabilities can be applied to multiple therapeutic areas beyond precision oncology. To further diversify
our pipeline, we are leveraging our Dynamo platform to address validated targets in monogenic diseases, where genetic alterations lead to disease-causing defects in protein motion. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Strategy </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our mission is to leverage unique
insights into protein motion to transform the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of small molecule therapies. We believe that, by placing protein
motion at the heart of MBDD discovery, our unique Dynamo platform has the potential to address previously intractable precision medicine targets. To accomplish this, we intend to continue building a team that shares our commitment to patients, to
continue to enhance our platform, and to rapidly advance our precision medicine pipeline of product candidates. The key elements of our strategy are to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rapidly advance our lead precision oncology programs, <FONT STYLE="white-space:nowrap">RLY-1971,</FONT> <FONT STYLE="white-space:nowrap">RLY-4008,</FONT> <FONT
STYLE="white-space:nowrap">RLY-PI3K1047,</FONT> through clinical development and regulatory approval. </B>We believe our lead precision oncology programs have the potential to treat a wide variety of cancers either as monotherapy or in combination
regimens. In the first quarter of 2020, we initiated a Phase 1 clinical trial of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> and expect to initiate a Phase 1 clinical trial for <FONT STYLE="white-space:nowrap">RLY-4008</FONT> in the second half
of 2020. In 2021, we expect to have early safety and efficacy data for <FONT STYLE="white-space:nowrap">RLY-4008,</FONT> to have additional clinical data for <FONT STYLE="white-space:nowrap">RLY-1971</FONT> informing future development plans and to
be in <FONT STYLE="white-space:nowrap">IND-enabling</FONT> studies for our <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> program. We plan to conduct our clinical studies in genetically-defined patient populations. To potentially mitigate
development risks, we will leverage learnings from recently approved precision oncology drugs to inform the clinical and regulatory pathways for our lead oncology programs. If we are successful in achieving clinically meaningful anti-tumor activity
across solid tumor types, we plan to meet with regulatory authorities to discuss expedited regulatory approval strategies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Continue to enhance our
unique drug-discovery platform.</B> Our Dynamo platform uniquely integrates a broad range of leading-edge experimental and computational technologies and tools, providing us with fundamental insights into the conformational dynamics of target
proteins. We are committed to continuously integrating new computational and experimental tools, technologies and capabilities to enhance the power of our Dynamo platform. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Harness the insights and data generated from our platform against intractable targets in oncology and other therapeutic areas. </B>We have built a drug
discovery process that leverages our collaboration with D. E.&nbsp;Shaw Research and their access to the Anton 2 supercomputer and our proprietary computational workflows. We are committed to deploying our Dynamo platform against targets in
additional therapeutic areas beyond oncology. Our next focus, outside of oncology, is on rare genetic diseases where protein targets are genetically validated, where defects in protein conformational dynamics are abundant, and where we believe our
approach is well-suited to identify therapies with the potential to have transformative impact for patients. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Selectively enter into strategic
collaborations to maximize the value of our platform and pipeline. </B>We retain full development and commercialization rights to our pipeline of precision medicine programs. We intend to build a fully integrated biopharmaceutical company and
independently pursue the development and commercialization of our key product candidates. Given our potential to generate novel product candidates addressing a wide variety of therapeutic indications, we may enter into strategic partnerships around
certain targets, product candidates, disease areas or geographies, if we believe these collaborations could accelerate the development and commercialization of our product candidates, and allow us to realize additional potential in our product
candidates and our platform. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Team </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our
company was founded and continues to be supported by world-class scientific advisors, including Dr.&nbsp;Matt Jacobson, Dr.&nbsp;Mark Murcko and Dr.&nbsp;Dorothee Kern, as well as by D. E. Shaw Research, led by chief scientist
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">95 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Dr.&nbsp;David&nbsp;E. Shaw. We are leaders in leveraging insights into the dynamic behavior of proteins in drug discovery. We have assembled a scientific team with extensive expertise in
leading-edge experimental and computational drug discovery approaches, as well as a development team with extensive experience in the <FONT STYLE="white-space:nowrap">pre-clinical</FONT> development, translational medicine and clinical development
of precision oncology medicines. In aggregate, our team has previously submitted over 70 INDs and 20 NDAs and contributed to the development of more than 20 approved products. Our President and Chief Executive Officer, Dr.&nbsp;Sanjiv K. Patel, has
more than 15 years of experience in the biopharmaceutical industry, and has led our key business operations and strategic corporate planning activities since 2017. Dr.&nbsp;Don Bergstrom, our Head of Research and Development has more than 15 years
of experience in the biopharmaceutical industry and has held various leadership positions at other companies in oncology drug discovery, development, and translational medicine. Members of our management team have held leadership positions at
companies that have successfully discovered, developed and commercialized therapies for various cancers and devastating rare diseases. These companies include Allergan, Algeta, Blueprint Medicines, Eli Lilly, Merck, Novartis, Sanofi, and Vertex.
Through March 31, 2020, we have raised approximately $520&nbsp;million supported by a leading syndicate of investors, including SoftBank Vision Fund, Third Rock Ventures, an affiliate of D. E. Shaw Research, BVF Partners, Casdin Capital, EcoR1
Capital, Foresite Capital, GV, Perceptive Advisors, Alexandria Equities, Tavistock, and Section&nbsp;32. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Background of Precision
Medicine </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For most of the past 50 years, the study of the link between genes and disease was focused predominantly on rare, single-gene, inherited
diseases. This was primarily due to the limitations of the available tools to interrogate the genome. The completion of the Human Genome Project in 2003, however, began to transform our understanding of genetic alterations, protein dysfunction and
disease pathobiology, thereby marking the advent of precision medicine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The successful sequencing of the human genome relied upon critical advances in
computing power and experimental techniques. The constant evolution of these foundational computational and experimental capabilities has led to exponential growth in the molecular understanding of disease, that is, the ability to elucidate a
disease&#146;s underlying biological dysfunction on a genetic level. For example, over 125 specific genetic alterations across 10 key cellular signaling pathways have been identified across 89% of solid tumors. In addition, we now know that over
4,000 individual genetic alterations, and their associated protein defects, cause over 7,000 rare inherited diseases. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The ever-deeper insights into the
molecular basis of disease have ushered in the current era of precision medicine and, more specifically, precision oncology. The pioneering success in precision oncology was the approval of Gleevec, which is used to treat a rare type of leukemia
called chronic myelogenous leukemia (CML). In the late 2000&#146;s and early 2010&#146;s, clinical evidence began to emerge implicating specific target proteins such as ALK, EGFR, RET, ROS, TRK and others in causing cancer. When the industry
progressed from first-generation multi-kinase inhibitors of these target proteins to subsequent generation inhibitors, we learned another important lesson: the ability of a drug to specifically and deeply inhibit the protein target of interest while
minimizing the inhibition of other closely related protein targets can result in a profound difference in outcome. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe the slow progress against
the large list of genetically validated targets is fundamentally due to the reliance on conventional drug discovery tools, such as structure-based drug design (SBDD). While SBDD is well-suited to solving some drug discovery problems such as
orthosteric site kinase inhibitors, its reliance on static images of protein fragments limits its ability to gain accurate insights into the dynamic behavior of proteins in their natural state, which in turn limits its ability to discover medicines
with exquisite specificity. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Protein Motion in Disease </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The human genome encodes tens of thousands of different proteins. Proteins are molecular machines that control our most vital cellular functions and to adopt
unique structures as determined by their amino acid sequence. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">96 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
However, proteins are not static objects. They are in constant motion, dynamically adopting ensembles of different conformations. The concept that appropriate protein conformational dynamics, or
protein motion, are essential to healthy biological function dates to the 1960s with the understanding that certain proteins have to adopt multiple conformations to carry out their function within the body. For example, in the case of hemoglobin, a
well-studied oxygen carrier protein, it was observed that binding of an oxygen molecule modulated hemoglobin&#146;s conformation to increase its affinity for additional oxygen molecules. The transition between protein conformations can either occur
at relatively short timescales (nanoseconds) or long timescales (seconds) and across varying scales of distance (angstroms to micrometers). Importantly, subtle differences in protein conformational dynamics (on the order of a few angstroms) have
been observed in otherwise structurally similar proteins. In addition to these small-scale changes, global motion of proteins can create on and <FONT STYLE="white-space:nowrap">off-states</FONT> that can be dynamically regulated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Defects in the conformational dynamics of proteins have been implicated in up to 40% of all diseases. For example, in oncology, gene fusions of receptor
tyrosine kinases can result in aberrant protein conformations, such as stable dimerization, which then lead to elevated kinase activity and cancer cell growth. Protein conformational defects can also decrease the activity of proteins. Despite the
well-accepted importance of protein conformational dynamics in health and disease, tools to study dynamics have only recently matured. Typical efforts to understand protein structure rely on studying proteins in highly ordered crystals with
structural data collected at cryogenic temperatures <FONT STYLE="white-space:nowrap">(-173</FONT> &deg;C), resulting in the observation of proteins as static, rigid molecules. However, because proteins can adopt a multitude of conformational states,
their biologically active conformations may be poorly represented by a crystal structure. Therefore, these rigid structures do not accurately represent the dynamic nature of a protein in its biological context, which could impede drug design. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Our Dynamo Platform </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The continued and
rapid development of new experimental techniques, such as room-temperature crystallography, and computational techniques, such as molecular dynamics and machine learning, is now enabling the deep understanding of protein motion to discover new
therapeutic agents. Dynamo was built to capitalize on these recent advances to develop medicines against protein targets with greater specificity and potency. Using our Dynamo platform, we pivot from industry standard SBDD, which is based on static
structures and often relies on incomplete protein fragments, to a novel drug-discovery paradigm based on fundamental insights into protein motion, which we term Motion Based Drug Design (MBDD). We leverage insights from our platform to develop
novel, motion-based hypotheses for how to drug target proteins. We can then more rapidly identify and optimize effective lead compounds by integrating powerful experimental and computational tools to sample a much broader range of chemical space
than is possible using conventional approaches, which are labor intensive and require significant experimental effort. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">97 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2016, the confluence of three forces - the proliferation of readily available genomic data, the evolution
of experimental techniques, and advances in computational power and speed - led to the founding of Relay Therapeutics.&nbsp;We believe we are uniquely positioned to consolidate these advances and, when combined with our world-class team of
experimental and computational experts, integrate these solutions in motion-based drug discovery. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g904779g64h56.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our platform integrates a broad and tailored array of leading-edge experimental and computational approaches to gain
fundamental insights into protein function (<B>Figure 1</B>). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 1: Dynamo drug-discovery platform integrates leading-edge experimental and
computational tools. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g88e30.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We deploy the power of our Dynamo platform in three key phases of MBDD discovery (<B>Figure 2</B>). We first generate a
target modulation hypothesis by developing a detailed mechanistic understanding of the dynamic behavior of the target protein and by identifying pockets where binding of a small molecule can impact protein function. Our platform then aids in the
efficient generation of lead compounds through an integrated system of experimental and virtual screens. This enables rapid lead optimization by computationally prioritizing compounds for experimental evaluation. And, because each cycle generates
new learnings for both our team and our underlying machine learning models, our successful iteration of this process continuously improves our understanding of protein motion which leads to a more effective and efficient drug discovery process. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">98 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 2: Dynamo can be deployed across the various stages of drug discovery to provide novel insights
and accelerate drug discovery. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g78h69.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Target Modulation Hypothesis </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our first step is to establish a <I>target modulation hypothesis</I> for our protein target of interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For each target, the initial goal is to better understand the structure and conformational dynamics of all domains of a protein to generate the target
modulation hypothesis. The process typically begins by expressing full-length proteins so we can fully understand the roles of specific domains and accurately capture the differences between the wild-type and mutant forms of the protein (or of
different isoforms, etc.). We use a range of leading-edge structural biology techniques (e.g., room temperature <FONT STYLE="white-space:nowrap">X-ray</FONT> crystallography, <FONT STYLE="white-space:nowrap">Cryo-EM)</FONT> to visualize these
protein conformations in the most physiologically representative context possible. The resulting data allow us to better visualize full-length proteins at atomic resolution. This comprehensive and dynamic visualization enables us to identify
potential areas of interest in a protein target that can be exploited in the drug discovery process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Using a range of protein visualization methods, we
can generate a rich experimental understanding of the dynamic conformations of the target protein of interest. We can deploy these experimental data sets in an industry-leading computational platform to generate virtual simulations (molecular
dynamics) of the full-length protein moving over long timescales. Long timescale molecular dynamics simulations informed by the experimentally derived protein structural data help us better understand how proteins move and change shape over time.
Our collaboration with D. E. Shaw Research, provides us with access to Anton&nbsp;2, their proprietary supercomputer that was custom-built for performing molecular dynamics simulations &#150; a technique that calculates the forces between each atom
and every other atom in a given system at discrete time points in order to model behavior over time. We use MD simulations to predict the behavior of a given protein system, and with our collaborators we have simulated systems of up to
1&nbsp;million atoms at time slices of 2.5 x10<SUP STYLE="font-size:85%; vertical-align:top">-15</SUP> seconds. The individual time slices are then stitched together to create a high definition movie of the target protein over biologically relevant
timescales, typically tens of microseconds. Other drug discovery approaches may use molecular dynamics, but they are limited to less than 1/100<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the timescale of our simulations. A 10
microsecond simulation of a 1&nbsp;million atom benchmark protein (satellite tobacco mosaic virus), which requires one day of processing on the Anton 2, would require 271 days on conventional hardware (Nvidia V100) (<B>Figure 3</B>). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">99 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 3: The Anton 2 supercomputer enables Relay Therapeutics to simulate the motion of significantly
larger biomolecules in far shorter periods of time compared to conventional forms of computation (e.g., GPUs and cloud computing). </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g06w59.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After understanding the dynamics of the target protein, we focus on identifying mechanisms to modulate the protein with a
small molecule drug. There are multiple ways that a small molecule drug may bind to a target protein to impact its function. Molecules bind to a protein by interacting with amino acids which are often situated in a cavity on the protein&#146;s
surface, called a pocket. Most small molecule drugs modulate the function of the target protein by binding to the pocket that directly mediates the protein&#146;s activity (&#147;active&#148; site). We leverage our platform to identify novel pockets
that are not the active site but do impact protein function, so called &#147;allosteric&#148; sites. These binding sites are often part of an allosteric regulatory network that we can elucidate through a combination of computationally derived
hypotheses and laboratory experiments on full-length proteins. Our ability to identify novel druggable pockets that have not previously been observed provides new handles for gaining isoform or mutant selectivity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our understanding of protein motion and modulation from our Dynamo platform informs the strategy and tools we employ for hit finding and lead generation
phases. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Hit Finding and Lead Generation </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Once we
have identified potential binding pockets and established a target modulation hypothesis, we then transition into hit finding and lead generation, where the goal is to identify a molecule that can serve as the starting point for a new drug. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Dynamo platform leverages our motion-based functional understanding of target proteins to enable the design of physiologically relevant activity-based and
ligand-centric screens. These experimental measurements of biochemical or biophysical activity are then used to identify molecules to modulate our protein targets. Our Dynamo platform encompasses a variety of screening techniques to identify
chemical starting points. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In parallel to our experimental screening efforts, we have made investments in our infrastructure that enables us to use
cloud-computing to screen billions of molecules from a virtual compound library in days. The vast number of virtual molecules enables us to sample a much wider diversity of chemical space than would be possible through conventional methods. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Given the powerful hit finding approaches we utilize, we are able to generate a broad diversity of novel small molecules that act via our motion-based target
modulation hypothesis and are ready to progress into lead optimization. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">100 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Lead Optimization </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Once we have identified a chemical starting point and generated a lead compound, optimization is necessary to obtain a molecule that has the desired
characteristics. Our Dynamo platform uses advanced computational models in tight integration with our medicinal chemistry, structural biology, enzymology and biophysics capabilities to predict and design the compounds that will achieve the most
desirable characteristics, including potency, selectivity, bioavailability, and drug-like properties. Conventional optimization of small molecule lead compounds involves a highly iterative process that includes designing and synthesizing thousands
of closely related compounds and experimentally testing them in the lab. This process is time consuming and requires significant experimental effort and expense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During optimization, we leverage long timescale MD simulations to study binding pocket dynamics and to test analogs of our lead compound to prioritize which
ones to synthesize and test experimentally. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Once we have made and tested compounds in the lab, we can compare them to our computational predictions. Over
time we can improve our computational predictions using the data that we generate experimentally. We believe that this integration of our long timescale molecular dynamics simulations with experimental data accelerates our lead optimization process.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Anton 2 supercomputer, that we access through our collaboration with D. E. Shaw Research, makes it possible to run thousands of simulations, which
generate vast datasets. To take maximum advantage of this data, we use machine learning algorithms to establish relationships between molecular interactions observed in the simulations and biological activity observed in experiments. In <B>Figure
4</B> we show how a machine learning model can be trained based on multiple parameters, including ligand motion, protein-ligand interactions and protein conformation, collected during long timescale MD simulations of molecules interacting with our
target protein. This model can then be used to make predictions to prioritize the synthesis of new molecules. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 4: Data from long timescale
molecular dynamics simulations are used to train machine learning models that can prioritize the next set of molecules to test. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g11t65.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Benefits of Dynamo Platform </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Dynamo platform was built with the belief that integrating leading-edge computational and experimental approaches would unlock new insight about protein
dynamics and ultimately the drug discovery process. We have shown multiple times that we can use this approach to develop novel target modulation hypotheses, generate a broad range of molecular starting points, and rapidly optimize potential drugs.
<B>Figure 5</B> illustrates the timelines for our first two programs relative to conventional drug discovery. In general, it takes 3 to 5+ years to advance from a validated hit to a development candidate (DC). For our programs, however, we were able
to advance from hit to DC in 2 years for <FONT STYLE="white-space:nowrap">RLY-1971</FONT> and 18 months for <FONT STYLE="white-space:nowrap">RLY-4008.</FONT> In addition to the advantage of speed, as compared to conventional SBDD, our platform
enables us to explore a greater diversity of chemical </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">101 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
space, as illustrated by the number of chemical series. This breadth increases the intellectual property landscape that we cover and improves our ability to identify development candidates with
optimal drug-like properties. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 5: The Relay Therapeutics Dynamo platform compared to conventional drug discovery approaches. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g57c13.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Our Therapeutic Opportunity </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While our Dynamo platform could potentially be applied to a wide range of disease-associated protein targets, we currently focus on precision medicine
targets, for which alterations in specific genes are known to cause disease. The genetic diseases we pursue include cancers with clear genetic driver alterations in the tumor genome, as well as monogenic diseases where the causal mutations are
present at birth. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Precision Oncology </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our initial
focus is in the area of precision oncology where we have seen initial proof of platform in our leading precision oncology pipeline. Over 125 genetic driver alterations across 10 canonical cellular signaling pathways have been identified in 89% of
tumors. Targeting these genetic drivers could lead to clinically meaningful responses in patients. However, most of these targets have been intractable to conventional drug discovery approaches or are inadequately drugged by approved therapies. We
believe our platform has the potential to address many of these targets by leveraging novel insights into protein dynamics. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Monogenic Diseases
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Thousands of monogenic (change in a single gene) diseases exist and affect millions of individuals worldwide. Over 4,000 individual genetic drivers,
and their associated protein defects, cause over 7,000 rare monogenic phenotypes. However, since 1996, the FDA has approved fewer than 70 therapies to specifically treat these conditions, presenting a vast unmet therapeutic need. We believe our
Dynamo platform has the potential to address many of these targets. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Other Precision Medicines Opportunities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The decreasing cost and increasing resolution of genomic data have identified hundreds of additional actionable genetic targets beyond precision oncology and
monogenic disease. These include genetically-defined </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">102 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
subpopulations of more common diseases in neurology, immunology and other therapeutic areas. We believe that there are multiple genetically-validated targets in these disease areas that are
unaddressed by approved therapies, representing an area of significant unmet need. We believe our Dynamo platform has the potential to address many of these targets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our focus on addressing the genetic drivers of disease, also referred to as genetically validated targets, confers several advantages, including: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Clear causal link to disease</B>: Genetic diseases offer an unambiguous causal link between the mutational alteration in a specific gene, disease biology,
and a patient&#146;s symptoms, such that the translational medicine hypothesis is well-validated at the beginning of a drug discovery program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Precision medicine opportunity: </B>Because of the strong link between specific genetic alterations and disease symptoms, it is possible to precisely
target therapy to genetically identifiable patients who are most likely to respond favorably to a precision medicine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Increased translational
success:</B> We believe that the ability to precisely target therapy to patients who are most likely to respond favorably to treatment will, in turn, increase the likelihood of successfully translating a specific pharmacological mechanism into
clinical benefit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While we have initially focused our efforts on small molecule therapies, our Dynamo platform could also be readily deployed towards the
discovery of other therapy types, such as large molecules including peptide or protein therapeutics. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Our Product Pipeline and Programs
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have deployed our Dynamo platform to initially focus on the area of precision oncology. To date, we have generated several promising precision
oncology, orally available, small molecule product candidates that address previously intractable oncogenic targets. Our lead programs are targeting a range of driver alterations to treat various cancers that we believe can have a greater
probability of translational success because they are genetically or clinically validated. The targets associated with all of our current programs are Category 1 Targets under our Amended and Restated Collaboration and License Agreement with D. E.
Shaw Research. See &#147;Business&#151;Collaboration and License Agreement with D. E. Shaw Research, LLC.&#148; In addition, we are also advancing several early programs focused on other precision oncology and rare genetic disease targets. We retain
worldwide development and commercialization rights to all our programs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes our current portfolio of product candidates and
programs. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g94v79.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">103 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Our Programs </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">RLY-1971,</FONT> an inhibitor of SHP2 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Overview </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">RLY-1971</FONT>
is designed to be an oral, small molecule inhibitor of the protein tyrosine phosphatase SHP2 that binds and stabilizes SHP2 in its inactive conformation. SHP2 promotes cancer cell survival and growth through the RAS pathway by transducing signals
downstream from receptor tyrosine kinases (RTKs). Additionally, activating SHP2 mutations result in enhanced signaling in the absence of ligand stimulation and has been identified as oncogenic drivers in a range of tumors. As a critical signaling
node and regulator, SHP2 drives cancer cell proliferation and plays a key role in the way cancer cells develop resistance to targeted therapies. We believe that inhibition of SHP2 could be effective as a monotherapy in cancers with specific
alterations and could block a common path that cancer cells exploit to avoid killing by other antitumor agents, thus overcoming or delaying the onset of resistance to those therapies. We are currently evaluating the safety and tolerability of <FONT
STYLE="white-space:nowrap">RLY-1971</FONT> in a Phase 1 dose escalation study in patients with advanced or metastatic solid tumors. We anticipate providing an update on clinical data and the clinical development plan in 2021. Given the range of
cancers that are related to SHP2 dependence, we believe, in addition to its use in monotherapy settings, our therapy has the potential to serve as a combination backbone therapy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We estimate that, across all solid tumors, there are approximately 68,000 late-line patients annually in the U.S. who might benefit from a SHP2 targeted
inhibitor as a monotherapy. Additionally, we estimate there are more than 56,000 late-line patients annually in the U.S. with advanced lung cancer who might benefit from a combination of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> with another
targeted inhibitor. This results in approximately 120,000 late-line cancer patients annually in the U.S. that may benefit from <FONT STYLE="white-space:nowrap">RLY-1971.</FONT> In the future, if <FONT STYLE="white-space:nowrap">RLY-1971</FONT>
advances to earlier lines of treatment, we believe it could be applied in the treatment of approximately 290,000 patients annually in the U.S. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure
6: SHP2 monotherapy and combination therapy addressable patient populations </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g34x62.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>1) Data reflects our estimate of biomarker frequency in advanced solid tumors (monotherapy) and advanced lung cancer
(combination). Estimated frequency percentages are based on counts of known/likely functional alterations in the Foundation Medicine Insights database. 2) Based on projected cancer deaths in all solid tumors from the National Cancer Society&#146;s
SEER database as a proxy for late-line cancer patient incidence. 3) These data are based on projections from the National Cancer Society&#146;s SEER program for estimated new cases of advanced solid tumors and advanced lung cancer. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>SHP2: a central regulator of cell signaling </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SHP2 is a
protein tyrosine phosphatase that plays a critical role in the transduction of intracellular signals downstream from receptor tyrosine kinases (RTKs), promoting cell survival and growth through the RAS
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">104 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
pathway. SHP2 was the first phosphatase identified as a recurrently mutated oncogene, providing genetic support for the importance of SHP2 activation in promoting cancer. In addition to the
central role of SHP2 in RTK signaling, some alterations in the RAS signaling pathway amplify signals transmitted by SHP2 and can therefore be suppressed by SHP2 inhibition. These include specific mutant forms of RAS (KRAS G12C and KRAS G12A),
genomic amplification of wild-type KRAS, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">loss-of-function</FONT></FONT> mutations in NF1, and class 3 mutations in BRAF. Consequently, there are multiple cancer genetic contexts where
SHP2 inhibition could be beneficial as a monotherapy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A key feature of SHP2 as an oncology target is its ability to regulate cell signaling that arises
from multiple RTKs (<B>Figure 7</B>). Therapies targeted to these RTKs, and therapies targeting downstream nodes such as PI3K, KRAS and MEK, are often unable to durably inhibit tumor growth because these tumors are able to bypass the targeted RTK
and shift growth factor signaling to an alternate RTK, rendering them less sensitive to the targeted therapy. This is generally referred to as bypass resistance. Because SHP2 regulates the activity of multiple RTKs, inhibition of SHP2 is an
effective way to overcome bypass resistance as confirmed by cellular and animal model experiments. Indeed, added benefit of SHP2 inhibition has been demonstrated <FONT STYLE="white-space:nowrap">pre-clinically</FONT> in combination with multiple
agents, such as those targeting MEK, KRAS<SUP STYLE="font-size:85%; vertical-align:top">G12C</SUP>, EGFR, and ALK. We believe our SHP2 inhibitor has the potential to become a commonly used combination partner with multiple targeted therapies
including those in our own pipeline. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 7: SHP2 regulates the activity of multiple receptor tyrosine kinases (RTKs). </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g43f80.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Our solution, <FONT STYLE="white-space:nowrap">RLY-1971</FONT> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">RLY-1971</FONT> is a small molecule inhibitor of SHP2 that binds and stabilizes SHP2 in its inactive conformation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We utilized a combination of experimental and computational techniques to identify unique inhibitors. For example, using long timescale MD simulations we were
able to understand changes in the dynamics of the binding pocket over time that would not have been appreciated with shorter timescale simulations (<B>Figure 8</B>). Informed by high-resolution room-temperature
<FONT STYLE="white-space:nowrap">x-ray</FONT> crystallographic data, we created a virtual representation of our lead molecule bound to the SHP2 protein. We then simulated this system over long timescales. As shown in Figure 20, we observed that a
loop (green) to the left of the small molecule (orange) moves down towards the molecule over the course of the simulation. Our medicinal chemists were then able to leverage this understanding in their designs to create an inhibitor of SHP2.
Importantly, this loop cannot be resolved using conventional <FONT STYLE="white-space:nowrap">x-ray</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">105 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
crystallography. Therefore, relying on standard techniques could deprive medicinal chemists of a critical insight as they attempt to design improved compounds. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure&nbsp;8: We depict a small molecule docked in a representation of the SHP2 protein where there is a green loop visible to the left of the small
molecule (orange). A 500 ns MD simulation (0.5 &micro;s) shows that the green loop is far away from the small molecule (left). A longer simulation (10.0 &micro;s), reveals that the loop flips downwards, close to where the small molecule binds
(right). </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g52v64.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We then prioritized compounds with the best predicted binding to SHP2 over a 10 &micro;s molecular dynamics simulation and
tested the most stable compounds in our biochemical assay. This enabled filtering and prioritization of candidate molecules, resulting in the identification of <FONT STYLE="white-space:nowrap">RLY-1971,</FONT> our clinical-stage compound. <FONT
STYLE="white-space:nowrap">RLY-1971</FONT> inhibits SHP2 phosphatase activity (750 pM IC<SUB STYLE="font-size:85%; vertical-align:bottom">50</SUB>) in a biochemical assay designed to monitor dephosphorylation of a probe substrate. <FONT
STYLE="white-space:nowrap">RLY-1971</FONT> also inhibits SHP2 in cellular assays, as measured by inhibition of ERK1/2 phosphorylation at Thr202/Tyr204 (1.3 nM IC<SUB STYLE="font-size:85%; vertical-align:bottom">50</SUB> in <FONT
STYLE="white-space:nowrap">KYSE-520,</FONT> an EGFR amplified gastric cancer cell line), and by inhibition of cancer cell proliferation (70 nM IC<SUB STYLE="font-size:85%; vertical-align:bottom">50</SUB> in
<FONT STYLE="white-space:nowrap">KYSE-520</FONT> and 11 nM IC50 in <FONT STYLE="white-space:nowrap">NCI-H358,</FONT> a KRAS<SUP STYLE="font-size:85%; vertical-align:top">G12C</SUP> mutant NSCLC cell line) (<B>Figure&nbsp;9</B>). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure&nbsp;9: <FONT STYLE="white-space:nowrap">RLY-1971</FONT> potently inhibits SHP2 in biochemical and cellular assays. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g69i17.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>*The biochemical potency of RLY-1971 was assessed in duplicate by determining activity of SHP2 in prompt fluorescence
assay format. The inhibition of SHP2 by RLY-1971 was monitored using an assay in which SHP2 was incubated with a SHP2-activating peptide. After a 60 minute incubation period, the surrogate SHP2 substrate DiFMUP was added to the reaction. The
conversion of DiFMUP to DiFMU was monitored continuously for 10 minutes using an EnVision Reader microplate reader (Perkin Elmer). </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>**KYSE-520
cells were plated at a density of 5000 cells/well of 384-well flat-bottom plate (Corning) and allowed to adhere at 37&deg;C, 5% CO2 incubator. After overnight incubation, compound was added to cells and returned to
</I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">106 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>
incubator for two hours. After incubation, cells were washed, lysed, and abundance of pERK was determined using the AlphaLISA SureFire Ultra p-ERK1/2 Assay Kit (Perkin Elmer) and read on an
EnVision Reader (Perkin Elmer) using standard settings. Compound was tested in duplicate in three independent assays. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>*** NCI-H358 cells were
plated at a density of 2000 cells/well of 384-well round bottom ultra-low attachment plate (Corning) and cells were allowed to form three-dimensional structures at 37&deg;C, 5% CO2 incubator for 48&nbsp;hours. Compounds were added to plates and
cells are returned to incubator for 120 hours. After incubation, CellTiter-Glo 3D reagent (Promega) was added into each well and incubated at room temperature for 30&nbsp;minutes followed by reading on an EnVision Reader (Perkin Elmer) using
standard conditions. Assay data was normalized to untreated (DMSO) values, and dose response curve fitting and IC50 values were determined using Genedata analyzer. All doses were tested in triplicate. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>**** KYSE-520 cells were plated at 250 cells per well of 384-well plate and cells were allowed to adhere at 37&deg;C, 5% CO2 incubator. After overnight
incubation, cells were then treated in triplicate with serial 3-fold dilutions of inhibitor in complete growth media and cells were returned to incubator for an additional 120 hours. CellTiter-Glo 3D reagent (Promega) was added into each well and
incubated at room temperature for 30 minutes followed by reading on an EnVision Reader (Perkin Elmer) using standard conditions. Assay data was normalized to untreated controls, and dose response curve fitting and IC50 values were determined using
Genedata analyzer. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">RLY-1971</FONT> shows minimal inhibition of targets other than SHP2. <FONT
STYLE="white-space:nowrap">RLY-1971</FONT> has bioavailability suitable for oral dosing, is metabolically stable, and demonstrates favorable pharmacokinetic properties in preclinical <I>in vivo</I> models. We do not predict that <FONT
STYLE="white-space:nowrap">RLY-1971</FONT> will have significant drug-drug interactions based on weak inhibition of drug metabolizing enzymes. It is readily synthesized in bulk, can be formulated for oral delivery, and was well-tolerated in animal
models. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe the key differentiating features of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> from other SHP2 inhibitors in clinical
development are: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Chemical distinctiveness: it is chemically distinct from other SHP2 inhibitors in clinical development
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Potency: demonstrated 750 pM IC<SUB STYLE="font-size:85%; vertical-align:bottom">50</SUB> inhibition of SHP2
phosphatase in biochemical assays </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Dosing potential: projections of human pharmacokinetics suggest <FONT STYLE="white-space:nowrap">RLY-1971</FONT>
will be amenable to continuous once daily dosing at relatively low active doses </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">RLY-1971</FONT> as
a monotherapy </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Given the known cancer mutations in SHP2 and previous studies using SHP2 inhibitors, SHP2 inhibition may be active as a monotherapy in
certain genetic alterations. SHP2 inhibition has been shown in third party studies to result in tumor stasis or regression in preclinical xenograft models of tumors harboring KRAS genomic amplification, KRAS<SUP
STYLE="font-size:85%; vertical-align:top">G12C</SUP> mutations<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>, NF1<SUP STYLE="font-size:85%; vertical-align:top">LOF</SUP> mutations, or
BRAF<SUP STYLE="font-size:85%; vertical-align:top">Class3</SUP> mutations. Consistent with these findings, in our internal <FONT STYLE="white-space:nowrap">pre-clinical</FONT> studies, <FONT STYLE="white-space:nowrap">RLY-1971</FONT> inhibited the
proliferation of a panel of cancer cell lines driven by KRAS mutations that require signals transmitted by SHP2 (KRAS<SUP STYLE="font-size:85%; vertical-align:top">G12C</SUP> and KRAS<SUP STYLE="font-size:85%; vertical-align:top">G12A</SUP>) but was
inactive in cancer cell lines driven by other KRAS mutations that do not require SHP2 signals (KRAS<SUP STYLE="font-size:85%; vertical-align:top">G12D</SUP>) (<B>Figure&nbsp;10</B>). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">107 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure&nbsp;10: Inhibition of proliferation by <FONT STYLE="white-space:nowrap">RLY-1971</FONT> in cancer
cell lines driven by KRAS mutations. Mutations that require SHP2 signals are potently inhibited by <FONT STYLE="white-space:nowrap">RLY-1971,</FONT> whereas mutations that do not require SHP2 signals are insensitive to
<FONT STYLE="white-space:nowrap">RLY-1971.</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g904779g58g31.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>A panel of KRAS-G12 mutant cancer cell lines were grown in 3D spheroids and treated with RLY-1971 in a proliferation
assay. KRAS-G12C and G12A mutations retain intrinsic GTPase activity and therefore require SHP2 signaling, whereas the KRAS-G12D mutation does not. For cell lines indicated, cells were plated at a density of 2000 cells/well in round bottom ultra-low
attachment 384-well plates (Corning) in growth media and cells are allowed to form three-dimensional structures at 37&deg;C, 5% CO2 incubator for 48 hours. After a 48&nbsp;hour incubation period, cells were then treated in triplicate with serial
3-fold dilutions of inhibitor in complete growth media and cells were returned to incubator for an additional 120 hours. CellTiter-Glo 3D reagent (Promega) was then added into each well and incubated are room temperature for 30 minutes followed by
reading on an EnVision Reader (Perkin Elmer) using standard conditions. Assay data was normalized to DMSO control wells. Dose response curve fitting and IC50 values were determined using Genedata analyzer. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">108 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To demonstrate activity of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> as a single agent <I>in
vivo</I>, we tested it in multiple cancer xenograft mouse models. Consistent with our <I>in vitro</I> data and the role of SHP2 as a critical mediator of RTK signaling, we observed that <FONT STYLE="white-space:nowrap">RLY-1971</FONT> induced
regression in cancer xenograft models harboring a KRAS<SUP STYLE="font-size:85%; vertical-align:top">G12C</SUP> mutation or genomic amplification of EGFR when administered on a continuous dosing schedule (<B>Figure&nbsp;11</B>). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure&nbsp;11: <FONT STYLE="white-space:nowrap">RLY-1971</FONT> induces regression in KRAS G12C mutant and EGFR amplified cancer xenograft models.
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g90x31.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Anti-tumor activity of the SHP2 inhibitor RLY-1971 dosed twice daily by oral administration (PO BID) in
</I><B><I>(a)</I></B><I></I><B> </B><I>the KRAS G12C mutant NSCLC xenograft model NCIH358 after 28 days on treatment and </I><B><I>(b)</I></B><I></I><B> </B><I>the EGFR amplified gastric cancer xenograft model KYSE-520 after 21 days on treatment.
Treatment with RLY-1971 resulted in dose-dependent anti-tumor activity and regression in both models. Data represent waterfall plots of individual end of study tumors, with tumor volume expressed as percentage change relative to initial tumor
volume. Each animal is represented as a separate bar (number of mice per group = 8). For each of the studies the statistical difference between the vehicle treated and RLY-1971 treated groups was assessed by one-way analysis of variance (ANOVA). In
both studies the RLY-1971 treated groups were determined to be significantly different than the vehicle treated group with a P value &lt; 0.001. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
addition, <FONT STYLE="white-space:nowrap">RLY-1971</FONT> inhibited the proliferation of cancer cell lines engineered to express known cancer mutations in SHP2 (<B>Figure&nbsp;12</B>). These mutations bias SHP2 towards an open, active conformation
in direct opposition to the allosteric inhibition effected by <FONT STYLE="white-space:nowrap">RLY-1971.</FONT> <FONT STYLE="white-space:nowrap">RLY-1971</FONT> retains nanomolar potency against activating mutations of SHP2. This could facilitate
development of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> in rare patient populations carrying SHP2 mutations. We also anticipate, based on experience with other precision oncology small molecule agents, that emergence of <FONT
STYLE="white-space:nowrap">on-target</FONT> mutations can be a method of acquired drug resistance in the clinic. We hypothesize that the activity of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> against activating mutations of SHP2 could result
in more durable benefit by suppressing the emergence of resistant cell populations with SHP2 resistance mutations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">109 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure&nbsp;12: <FONT STYLE="white-space:nowrap">RLY-1971</FONT> inhibits the proliferation of cells
expressing known SHP2 activating mutations. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g91e11.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Inhibition of proliferation by RLY-1971 in TF1 cancer cells expressing known cancer mutations in SHP2. TF1 cells were
engineered to express the SHP2 mutations </I><B><I>(a)</I></B><I></I><B> </B><I>E69K (IC50 = 18.4 nM) or </I><B><I>(b)</I></B><I></I><B> </B><I>A461T (IC50 = 7 nM) and treated with RLY-1971 in a proliferation assay. 500 cells/well were seeded in
round bottom ultra-low attachment 384-well plates (Corning) in growth media and incubated for 48 hours at 37&deg;C in 5% CO2. Cells were then treated in triplicate with serial 3-fold dilutions of inhibitor in growth media. Following incubation in
the presence of compound for an additional 120 hours, cell viability was determined using the CellTiter-Glo 3D assay kit (Promega) following the manufacturer&#146;s instructions. Luminescence was read in an EnVision Multimode Plate Reader (Perkin
Elmer). Assay data was normalized to DMSO values, and dose response curve fitting was performed using Genedata analyzer. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT
STYLE="white-space:nowrap">RLY-1971</FONT> as a combination therapy </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Given the role of SHP2 in mediating bypass resistance, we believe that SHP2
inhibitors have significant therapeutic potential when given in combination with other targeted therapies. Due to the increased potency and broader mutational coverage of next-generation targeted therapies, lower rates of <FONT
STYLE="white-space:nowrap">on-target</FONT> resistance have been observed in the clinic, with a greater number of patients progressing due to bypass resistance. An example of this is seen with EGFR inhibitors, where first-generation inhibitors
(erlotinib and gefinitib) have greater <FONT STYLE="white-space:nowrap">on-target</FONT> resistance compared to a third-generation inhibitor (osimertinib). As SHP2 is involved in signaling for numerous oncogenes, including EGFR, KRAS<SUP
STYLE="font-size:85%; vertical-align:top">G12C</SUP>, ALK and MET, combination therapy with <FONT STYLE="white-space:nowrap">RLY-1971</FONT> represents a potential significant therapeutic opportunity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Consistent with the role of SHP2 in RTK signaling in NSCLC, in our <FONT STYLE="white-space:nowrap">pre-clinical</FONT> experiments, <FONT
STYLE="white-space:nowrap">RLY-1971</FONT> demonstrated combination benefit in cell culture experiments when <FONT STYLE="white-space:nowrap">co-administered</FONT> with inhibitors of MEK, ALK, or EGFR. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To demonstrate combination benefit with our SHP2 inhibitor <I>in vivo</I>, we combined <FONT STYLE="white-space:nowrap">RLY-1971</FONT> with the ALK inhibitor
alectinib in an <FONT STYLE="white-space:nowrap">ALK-translocated</FONT> NSCLC xenograft mouse model (NCIH3122) that was derived <I>in vitro</I> to have reduced sensitivity to ALK inhibition (<B>Figure&nbsp;13</B>). DNA sequencing did not reveal new
ALK mutations in the cell line. Therefore, these cells likely have reduced sensitivity due to a bypass mechanism. The combination of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> with alectinib resulted in tumor regressions in all treated
animals. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">110 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure&nbsp;13: Anti-tumor activity of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> and the ALK
inhibitor alectinib as single agents or in combination in an ALK translocated NSCLC xenograft model <FONT STYLE="white-space:nowrap">(NCI-H3122)</FONT> derived </B><B><I>in vitro</I></B><B> to have reduced sensitivity to ALK inhibition. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g904779g52z03.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Daily oral administration of RLY-1971 at 30mpk BID in combination with alectinib at 10mpk QD (green) resulted in
increased efficacy compared to alectinib at 10mpk QD (red) or RLY-1971 at 30mpk BID (orange) alone in an ALK translocated NSCLC xenograft model (NCI-H3122) derived in vitro to be less sensitive to ALK inhibition. Data represent waterfall plots of
individual tumors after 27 days of treatment with compounds, with tumor volume expressed as percentage change relative to initial tumor volume. Each animal is represented as a separate bar (number of mice per group = 9). The statistical difference
between the combination treated group and the RLY-1971 or alectinib single agent groups was assessed using an unpaired t-test. The combination treated group with significant with P-value &lt;0.001 compared to either single agent group. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to RTK inhibitors, combination benefit for SHP2 inhibition has been demonstrated with other targeted agents including MEK inhibitors and KRAS<SUP
STYLE="font-size:85%; vertical-align:top">G12C</SUP> inhibitors in cancer xenograft models harboring KRAS<SUP STYLE="font-size:85%; vertical-align:top">G12C</SUP> mutations or KRAS amplifications. The efficacy of direct KRAS<SUP
STYLE="font-size:85%; vertical-align:top">G12C </SUP>inhibition may be limited by adaptive feedback reactivation of the <FONT STYLE="white-space:nowrap">RAS-MAPK</FONT> pathway through upregulation of multiple RTKs. Activation of these RTKs leads to
compensatory activation of wild-type RAS isoforms, which cannot be inhibited by KRAS<SUP STYLE="font-size:85%; vertical-align:top">G12C</SUP>-specific inhibitors, thus leading to resistance. SHP2 is unique in that it transmits signals from multiple
RTKs and is therefore critical in mediating feedback reactivation of the RAS pathway during KRAS<SUP STYLE="font-size:85%; vertical-align:top">G12C</SUP> inhibition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Consistent with these observations, <FONT STYLE="white-space:nowrap">RLY-1971</FONT> demonstrated synergistic inhibition with the KRAS<SUP
STYLE="font-size:85%; vertical-align:top">G12C</SUP> specific inhibitor <FONT STYLE="white-space:nowrap">ARS-1620</FONT> in a KRAS<SUP STYLE="font-size:85%; vertical-align:top">G12C</SUP> lung cancer model (<B>Figure&nbsp;14</B>). Specifically, the
inhibitory effect of both compounds was greater than the additive effect of each compound individually, suggesting SHP2 inhibition abrogates compensatory <FONT STYLE="white-space:nowrap">RAS-MAPK</FONT> pathway activation during KRAS<SUP
STYLE="font-size:85%; vertical-align:top">G12C</SUP> inhibition. Molecular characterization of <FONT STYLE="white-space:nowrap">phosphorylated-ERK</FONT> (pERK), a downstream marker of <FONT STYLE="white-space:nowrap">RAS-MAPK</FONT> pathway
activity, supports this conclusion. The combination of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> and the KRAS<SUP STYLE="font-size:85%; vertical-align:top">G12C</SUP>-specific inhibitor <FONT STYLE="white-space:nowrap">ARS-1620</FONT> was
able to fully suppress pERK in this model, while each inhibitor individually only partially suppressed pERK. Based on these data, we believe that the combination of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> with KRAS<SUP
STYLE="font-size:85%; vertical-align:top">G12C</SUP>-specific inhibitors warrants clinical studies in patients with tumors harboring KRAS<SUP STYLE="font-size:85%; vertical-align:top">G12C </SUP>mutations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">111 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure&nbsp;14: <FONT STYLE="white-space:nowrap">RLY-1971</FONT> and the KRAS<SUP
STYLE="font-size:85%; vertical-align:top">G12C</SUP>-specific inhibitor <FONT STYLE="white-space:nowrap">ARS-1620</FONT> demonstrate synergy when used in combination in the KRAS<SUP STYLE="font-size:85%; vertical-align:top">G12C</SUP> NCIH23 lung
cancer cell line. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g92o51.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Synergy of RLY-1971 and the KRAS<SUP STYLE="font-size:85%; vertical-align:top">G12C</SUP>-specific inhibitor ARS-1620.
</I><B></B><B><I> </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I></I><B></B><B><I>(a)</I></B><B> </B><I>The Loewe model of drug combination synergy uses cellular potency data to calculate
the additive nature of drug combinations. Higher synergy is represented graphically when the isobologram line (red) approaches the origin and quantified numerically by the Loewe score (higher Loewe score means more synergy). </I><B></B><B><I>
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I></I><B></B><B><I>(b)</I></B><B> </B><I>Combining RLY-1971 with the KRAS<SUP STYLE="font-size:85%; vertical-align:top">G12C</SUP>-specific
inhibitor ARS-1620 in a cellular proliferation assay in the KRAS<SUP STYLE="font-size:85%; vertical-align:top">G12C</SUP> mutant NCIH23 lung cancer cell line shows the relationship is synergistic based on the isobologram line (blue) and high Loewe
score (11.5). Cells were plated at a density of 2000 cells per well in ultra-low attachment 384-well plates (Corning) and allowed to form three-dimensional structures at 37&deg;C, 5% CO2 incubator for 48 hours. After a 48 hour incubation period,
cells were then treated in triplicate with serial 3-fold dilutions of a matrix of both compounds in complete growth media and cells were returned to incubator for an additional 120 hours. CellTiter-Glo 3D reagent (Promega) was then added into each
well and incubated are room temperature for 30 minutes followed by reading on EnVision Reader (Perkin Elmer) using standard conditions. Assay data was normalized to DMSO values, and dose response curve fitting and Loewe synergy score were determined
using Genedata analyzer. </I><B></B><B><I> </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I></I><B></B><B><I>(c)</I></B><B> </B><I>The synergistic effect of both compounds (1uM of ARS-1620 and
100nM of RLY-1971) can be observed by measuring the impact on ERK signaling (pERK) after 24 hours. To treat cells with compound and collect lysates for characterization, 2000 cells were plated per well in ultralow attachment 384-well plates
(Corning) and allowed to form three-dimensional structures at 37&deg;C, 5% CO2 incubator for 48 hours. After incubation and growth of three-dimensional structures compounds were added to the cells either as single compounds or in combination with
the final concentrations for test compounds are 1uM ARS-1620 and 0.1uM RLY-1971. Cells were returned to 37&deg;C, 5% CO2 incubator for 24 hours. Cells are collected, lysed, and run on WES (Protein Simple) with antibodies directed toward the antigens
of interest. Data was analyzed using Compass software (Protein Simple). </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the therapeutic opportunity associated with combining with
other targeted therapies, we believe <FONT STYLE="white-space:nowrap">RLY-1971</FONT> has the potential to be a combination partner with the product candidates in our own precision oncology portfolio <FONT STYLE="white-space:nowrap">(RLY-4008</FONT>
and <FONT STYLE="white-space:nowrap">RLY-PI3K1047).</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Our clinical development plan </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our clinical development plan aims to advance <FONT STYLE="white-space:nowrap">RLY-1971</FONT> as a monotherapy in SHP2-dependent tumors and in combination
with other targeted agents to prevent and overcome adaptive resistance mechanisms in order to achieve more durable clinical benefit. First, we will look to rapidly define the optimal dose and schedule of
<FONT STYLE="white-space:nowrap">RLY-1971</FONT> as a monotherapy and then we will pursue rational studies including combinations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">112 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the first quarter of 2020, we began evaluating the safety and tolerability of <FONT
STYLE="white-space:nowrap">RLY-1971</FONT> in a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> dose escalation study in patients with advanced or metastatic solid tumors. We have dosed 10 patients as
of July&nbsp;8, 2020 and plan to enroll approximately 52 patients in this study. The primary objectives are to determine the maximum tolerated dose (MTD)/recommended phase 2 dose (RP2D), and to define the overall safety profile of <FONT
STYLE="white-space:nowrap">RLY-1971.</FONT> Secondary objectives are to assess the pharmacokinetics, pharmacodynamics, and to explore preliminary anti-tumor activity of <FONT STYLE="white-space:nowrap">RLY-1971.</FONT> Patients will receive <FONT
STYLE="white-space:nowrap">RLY-1971</FONT> administered orally, once daily. Once daily oral dosing was selected based on projected human pharmacokinetics and exposures calculated from multi-species pharmacokinetics and allometric scaling. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> monotherapy data will facilitate subsequent clinical
evaluation and development of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> as a monotherapy for patients with SHP2-dependent tumors or in combination with other targeted therapies in indications where SHP2 inhibition may exert synergistic
antitumor effects. This may include combinations with selected approved receptor tyrosine kinase inhibitors (e.g., inhibitors of ALK, EGFR or HER2), MAPK/RAS pathway inhibitors (including KRAS G12C inhibitors) and/or combinations with
investigational agents being developed by Relay Therapeutics, including <FONT STYLE="white-space:nowrap">RLY-4008</FONT> and <FONT STYLE="white-space:nowrap">RLY-PI3K1047.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Development of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> in monotherapy and combination therapy indications will require identification of appropriate
patients for treatment using molecular diagnostic tests. In early phase clinical trials, patients will be identified using local testing performed at clinical trial sites, with retrospective centralized testing to confirm the tumor genetic status.
In later phase trials, we will likely collaborate with a diagnostic partner to identify patients for clinical trial enrollment using an analytically validated investigational molecular diagnostic. The tumor genetic contexts that we are considering
for development of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> can currently be detected using <FONT STYLE="white-space:nowrap">FDA-approved</FONT> next generation sequencing based panel diagnostics (e.g. Foundation One, Guardant 360). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">RLY-4008,</FONT> a selective inhibitor of FGFR2 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Overview </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">RLY-4008</FONT>
is designed to be an oral, small molecule, selective inhibitor of fibroblast growth factor receptor 2, or FGFR2, a receptor tyrosine kinase that is frequently altered in cancer. FGFR2 is one of four members of the FGFR family, a set of closely
related proteins with highly similar protein sequences and properties. <FONT STYLE="white-space:nowrap">RLY-4008</FONT> minimally inhibits targets other than FGFR2 and demonstrates FGFR2-dependent cell-killing in cancer cell lines. We plan to
initiate a Phase 1 clinical trial for <FONT STYLE="white-space:nowrap">RLY-4008</FONT> in patients having solid tumors with oncogenic FGFR2 alterations in the second half of 2020. We believe FGFR2-mediated cancers affect approximately 8,000
late-line patients annually in the U.S., of which fusions represent approximately 2,700, amplifications approximately 1,600, and other mutations approximately 3,800. In the future, if <FONT STYLE="white-space:nowrap">RLY-4008</FONT> advances to
earlier lines of treatment, we believe it could potentially address approximately 20,000 patients annually in the U.S.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Role of FGFR in cellular proliferation and differentiation </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each of the FGFRs has an important role in normal physiology and the inhibition of FGFR2 is a well-validated pathway in disrupting cancer proliferation and
growth. Two <FONT STYLE="white-space:nowrap">non-selective</FONT> FGFR inhibitors have been approved (erdafitinib and pemigatinib) and several are in clinical development. However, these inhibitors as a class cause several dose-limiting,
FGFR2-unrelated toxicities in patients leading to dose reductions and altered dosing schedules. One of the most common dose limiting toxicities of these agents is hyperphosphatemia (buildup of excess phosphate in the bloodstream), which causes soft
tissue mineralization and requires active management. Hyperphosphatemia has been shown to be driven by inhibition of another member of the FGFR family known as FGFR1 (<B>Figure&nbsp;15</B>). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">113 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure&nbsp;15: <FONT STYLE="white-space:nowrap">RLY-4008</FONT> is a selective inhibitor of FGFR2. FGFR1
is required for phosphate resorption in the kidney. Inhibition of FGFR1 by <FONT STYLE="white-space:nowrap">non-selective</FONT> FGFR inhibitors results in increased serum phosphate and toxicity. This results in decreased efficacy by requiring dose
reductions. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g31s17.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that the toxicity attributable to inhibition of other FGFR family members, and other closely related kinases,
limits the ability of the <FONT STYLE="white-space:nowrap">non-selective</FONT> FGFR inhibitors to achieve optimal and durable inhibition of FGFR2, limiting the efficacy of these agents in patients with FGFR2-altered tumors. In addition to the lack
of selectivity, these inhibitors are unable to overcome <FONT STYLE="white-space:nowrap">on-target</FONT> resistance, which has been observed in patients treated with <FONT STYLE="white-space:nowrap">non-selective</FONT> FGFR inhibitors. Our belief
is that a selective inhibitor of FGFR2 that retains activity against resistance mutations will enable improved clinical efficacy. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Limitations of
current FGFR inhibitors </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-selective</FONT> FGFR inhibitors produced by other companies have demonstrated clinical <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> in patients with intrahepatic cholangiocarcinoma, or ICC, bearing FGFR2 gene fusions. These gene fusions result in a constitutively active FGFR2, which
promotes oncogenic transformation. Genetic alterations in FGFR2, including gene fusions, amplifications, and point mutations, are also found in other solid tumor indications. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Patients with genetic alterations in FGFR2, primarily gene fusions in ICC, have been treated with FGFR inhibitors in investigational clinical trials. To date,
these trials provide support for the critical role of FGFR2 for tumor survival with a response rate of up to 36% (<B>Figure&nbsp;16)</B>. A key limiting factor for existing FGFR therapies is that, as a class, they are associated with a dose-limiting
side effect, hyperphosphatemia, which has been shown to be caused by FGFR1 inhibition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">114 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure&nbsp;16: Hyperphosphatemia is a dose-limiting adverse event associated with <FONT
STYLE="white-space:nowrap">non-selective</FONT> FGFR inhibitors. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g58z58.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>ICC disease background </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Intrahepatic Cholangiocarcinoma (ICC) is a form of cancer that originates in the bile ducts of the liver. ICC is a rare tumor, accounting for 3% of worldwide
gastrointestinal malignancies. Patients diagnosed with ICC are routinely treated <FONT STYLE="white-space:nowrap">off-label</FONT> with chemotherapeutic agents such as gemcitabine and cisplatin. There are no approved therapies for ICC. Complete
surgical resection remains the only potential curative option but is associated with a substantial risk of post-operative morbidity and mortality, and recurrence is common. The median overall survival for all patients diagnosed with ICC is reported
to be 16.1 months. The median overall survival for patients diagnosed with late stage disease is less than one year. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Our solution, <FONT
STYLE="white-space:nowrap">RLY-4008</FONT> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">RLY-4008</FONT> is an oral, small molecule inhibitor of FGFR2 designed to
inhibit FGFR2 with high potency while minimizing inhibition of other FGFR family members. In our initial assessment of the challenge of obtaining a highly selective inhibitor of FGFR2, we determined that there is a high degree of structural
similarity between FGFR1 and FGFR2 when comparing static <FONT STYLE="white-space:nowrap">X-ray</FONT> crystal structures. This similarity precluded the development of a structure-based selectivity hypothesis using conventional approaches. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We therefore set out to identify motion-based differences between FGFR2 and other FGFR family members by applying our expertise in computational modeling and
experimental structural analyses. We discovered that there were segments of FGFR2 which displayed differential dynamics compared to the corresponding segments of FGFR1 (<B>Figure&nbsp;17</B>). We predicted these dynamic differences could be
exploited to achieve selective inhibition of FGFR2. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">115 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure&nbsp;17: Using MD simulations, we predicted that a segment in FGFR1 was more dynamic than FGFR2,
as represented by the schematic below where the segment opens &#147;Up&#148; more frequently in FGFR1 compared to FGFR2. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g98k65.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We embarked on a process using computational methods such as long timescale molecular dynamics simulations, virtual docking
and specialized experimental techniques to design, select, synthesize, and evaluate inhibitors. Our discovery process culminated with the selection of <FONT STYLE="white-space:nowrap">RLY-4008</FONT> as a product candidate based on its ability to
meet our predetermined criteria for potency, selectivity and activity in animal models. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As described below, we have conducted a number of head-to-head
preclinical experiments utilizing cellular <I>in vitro</I> assays and mouse models using equivalent methods on all compounds tested. We compared RLY-4008 across a number of parameters against two approved molecules as well as three molecules in
clinical development. We believe that the results of these preclinical experiments have demonstrated that RLY-4008 could potentially be a differentiated molecule warranting testing in clinical studies. However, RLY-4008 is only in preclinical
development and has neither been subjected to the extensive testing in clinical trials nor the scrutiny of FDA review to which the two approved molecules and the three molecules in clinical development we used as comparators have been subject.
Ultimately, extensive clinical studies of RLY-4008 will be required to determine if the differentiation we observed in the preclinical studies described below translates into clinical benefit for patients. The clinical data that we expect to
generate in any such clinical studies will constitute the bulk of the data needed to support an application for marketing approval of RLY-4008. Unless we conduct head-to-head studies of RLY-4008 against other molecules as part of our future clinical
trials, we would not expect to rely upon RLY-4008&#146;s potential differentiation from any other molecules in connection with submissions to the FDA or other regulatory agencies, as applicable, for approval or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, in our head-to head preclinical experiments utilizing cellular <I>in vitro</I> assays and mouse models, we selected dose levels for the other
molecules to match human exposure of the approved dose or the dose being used in its clinical studies, as applicable, and we used the proportional dose levels of RLY-4008 that we believe are comparable to what we expect to utilize in our future
clinical studies. The differences in these dose levels may have had an impact on the differentiation in the preclinical results we observed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We
demonstrated in enzymatic and cellular assays that <FONT STYLE="white-space:nowrap">RLY-4008</FONT> was over <FONT STYLE="white-space:nowrap">200-fold</FONT> more potent at inhibiting FGFR2 compared to FGFR1 (<B>Figure&nbsp;18</B>). In addition to
selectivity over FGFR1, <FONT STYLE="white-space:nowrap">RLY-4008</FONT> is also selective over the other members of the FGFR family, FGFR3 <FONT STYLE="white-space:nowrap">(&gt;80-fold)</FONT> and FGFR4 (&gt;4,000 fold) in biochemical assays. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">116 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure&nbsp;18: <FONT STYLE="white-space:nowrap">RLY-4008</FONT> is selective for FGFR2 over FGFR1.</B>
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g904779g47h68.jpg" ALT="LOGO">
<B></B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The selectivity of RLY-4008 for FGFR2 over FGFR1 was determined by comparing the potency (IC50) of <FONT
STYLE="white-space:nowrap">RLY-4008</FONT> and other clinical non-selective FGFR inhibitors in biochemical assays using Caliper technology (PerkinElmer). Human FGFR1 and FGFR2 (Carna Biosciences) were incubated with a peptide substrate (PerkinElmer)
in the presence of varying concentrations of the indicated inhibitor for 30 minutes. Reactions were carried out in the presence of 100 mM ATP and 10 mM MgCl2 for 90 minutes. Non-selective FGFR inhibitors were obtained from vendors that provide
compounds based on chemical structures published in the patent literature (Cayman Chemical, MedChemExpress, Selleckchem). Fold change in potency was calculated using the average IC50 obtained for each inhibitor in three independent experiments.
RLY-4008 showed greater than 200-fold selectivity for FGFR2 over FGFR1. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">RLY-4008</FONT> has minimal inhibition of
targets other than FGFR2 and demonstrates FGFR2-dependent cell-killing in cancer cell lines. It has bioavailability suitable for oral dosing, is metabolically stable, and has demonstrated good pharmacokinetics in preclinical <I>in vivo</I> models.
Human pharmacokinetic projections are consistent with once or twice daily oral dosing. <FONT STYLE="white-space:nowrap">RLY-4008</FONT> is predicted to have low risk of drug-drug interactions based on weak inhibition of drug metabolizing enzymes. It
is readily synthesized in bulk, can be formulated for oral delivery, and exposures at the highest <FONT STYLE="white-space:nowrap">non-severely</FONT> toxic dose were several fold in excess of the predicted human efficacious exposures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In a patient-derived xenograft (PDX) mouse model of ICC harboring a FGFR2 fusion, treatment with <FONT STYLE="white-space:nowrap">RLY-4008</FONT> led to tumor
regression at doses as low as 10 mg/kg delivered twice a day (<B>Figure 19</B>). <FONT STYLE="white-space:nowrap">Non-selective</FONT> inhibitors, pemigatinib and <FONT STYLE="white-space:nowrap">TAS-120,</FONT> also resulted in tumor volume
reductions in this model when dosed at levels selected to match their human exposure in clinical studies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To preclinically validate our effort to
engineer selectivity for FGFR2 as a means of reducing the risk of hyperphosphatemia, we examined the effect of <FONT STYLE="white-space:nowrap">RLY-4008</FONT> in an industry standard rat model of hyperphosphatemia. No evidence of hyperphosphatemia
was seen with doses of <FONT STYLE="white-space:nowrap">RLY-4008</FONT> that resulted in exposures leading to tumor regression in our FGFR2 gene fusion ICC PDX mouse model (<B>Figure&nbsp;19</B>). By contrast, when dosed at levels selected to match
human exposure in clinical studies, <FONT STYLE="white-space:nowrap">TAS-120</FONT> led to increased hyperphosphatemia. Additionally, in <FONT STYLE="white-space:nowrap">28-day</FONT> GLP toxicology studies in rats and dogs, neither
hyperphosphatemia nor tissue mineralization were observed with <FONT STYLE="white-space:nowrap">RLY-4008</FONT> at exposures in the animal corresponding to the predicted human efficacious exposures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">117 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure&nbsp;19: <FONT STYLE="white-space:nowrap">RLY-4008</FONT> leads to tumor regression in an FGFR2
fusion positive ICC PDX model and does not cause hyperphosphatemia. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g904779g13p61.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I></I><B>(a)</B><I> Anti-tumor activity of RLY-4008 dosed twice daily (BID) by oral administration in an FGFR2
fusion-positive ICC PDX model. RLY-4008 induced dose-dependent regression when administered at 10 or 30 mpk BID. <FONT STYLE="white-space:nowrap">TAS-120</FONT> at 2 mpk TID (red) and pemigatinib at 0.5 mpk BID (pink) were dosed at levels selected
to match their clinical exposures. Data points indicate mean tumor volume (n=6 per group) and error bars represent standard error of the mean. All treatment groups are statistically significant when compared to vehicle with p&lt;0.001 as determined
by two-sided t-test. </I><B> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I></I><B>(b)</B><I></I><B> </B><I>Serum phosphate measurements in rats dosed twice daily with RLY-4008 (blue) or TAS-120
(red) by oral administration. Doses of RLY-4008 (100 and 200 mpk BID) resulting in exposures leading to tumor regression in our FGFR2 gene fusion ICC PDX model do not cause significant hyperphosphatemia. Doses of TAS-120 (3 mpk BID and 10 mpk QD)
selected to match human exposures in clinical studies cause significant hyperphosphatemia. Data indicate the mean serum phosphate level (n=5 per group), and error bars represent standard deviation. TAS-120 treatment groups are statistically
significant when compared to vehicle with p&lt;0.01 as determined by one-way ANOVA. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Another predicted advantage of
<FONT STYLE="white-space:nowrap">RLY-4008</FONT> concerns resistance mutations. These new mutations in FGFR2 arise during treatment, reducing the potency of <FONT STYLE="white-space:nowrap">non-selective</FONT> FGFR inhibitors and making tumors
resistant to treatment. In the limited resistance studies to date, multiple FGFR2 resistance mutations have been reported, with gatekeeper mutations at position V565 being most common. Gatekeeper mutations sterically block access to the binding site
of <FONT STYLE="white-space:nowrap">non-selective</FONT> FGFR inhibitors. Among gatekeeper mutations, V565F is the most prevalent. In preclinical experiments, we have shown that <FONT STYLE="white-space:nowrap">RLY-4008</FONT> retains activity
against a broad panel of mutations known to be associated with resistance to <FONT STYLE="white-space:nowrap">non-selective</FONT> FGFR inhibitors (<B>Figure&nbsp;20)</B>. For example, while the V565F or V565L gatekeeper mutations are resistant to
all <FONT STYLE="white-space:nowrap">non-selective</FONT> FGFR inhibitors we tested, <FONT STYLE="white-space:nowrap">RLY-4008</FONT> retains activity against these resistance mutations with no loss in potency. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">118 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure&nbsp;20: <FONT STYLE="white-space:nowrap">RLY-4008</FONT> retains potency against common FGFR2
resistance mutations. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g904779g55h65.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Heatmap showing fold change in potency (IC50) on FGFR2 mutations compared to FGFR2 WT. Human FGFR2 cDNA (NCBI Reference
Sequence: NM_022970.3) was cloned into pLenti-P2A-Puro vector, site-directed mutagenesis was performed for the indicated mutations, and plasmid purification was conducted at GenScript. Lentivirus for each vector was prepared using Lenti-vpak
Lentiviral Packaging Kit, and FGFR2 WT or FGFR2 mutants were expressed in HEK-293 cells via lentiviral transduction. Cells were incubated with various concentrations of the indicated inhibitors for 2 hours and potency of FGFR2 was determined using a
pFGFR2 (Tyr 653/654) HTRF assay (Cisbio) per the manufacter&#146;s protocol. Colors indicate the fold loss in potency for the mutant FGFR2 vs WT. Gatekeeper mutations block access to the binding site of non-selective inhibitors. Molecular brake
mutations disrupt an autoinhibitory conformation of FGFR2, resulting in kinase activation. Other mutations listed have various reported mechanisms of kinase activation. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further supporting the activity of <FONT STYLE="white-space:nowrap">RLY-4008</FONT> against FGFR2 resistance mutations, we used genetic engineering to
introduce the V565F gatekeeper mutation in FGFR2 fusion positive ICC cells. The ability of <FONT STYLE="white-space:nowrap">non-selective</FONT> FGFR inhibitors or <FONT STYLE="white-space:nowrap">RLY-4008</FONT> to inhibit the proliferation of
these cells was then tested. <FONT STYLE="white-space:nowrap">RLY-4008</FONT> was more potent in V565F mutant cells compared to <FONT STYLE="white-space:nowrap">non-selective</FONT> FGFR inhibitors, with an IC50 of 760 pM (<B>Figure 21</B>). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 21: <FONT STYLE="white-space:nowrap">RLY-4008</FONT> retains potency on the FGFR2 gatekeeper mutation V565F in a cellular proliferation assay.
</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g904779g67o69.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Anti-proliferative effect of RLY-4008 and non-selective FGFR inhibitors in V565F mutant FGFR2 fusion-positive ICC cells
tested in a 2D proliferation assay. The FGFR2 V565F mutation was introduced into an FGFR2 fusion-</I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">119 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<I></I><I></I><I></I><I></I><I>positive ICC cell line via CRISPR-mediated gene editing and confirmed by sequencing. Cells were incubated in the presence of the indicated concentrations of
inhibitors for 120 h and assayed for viability with CellTiter-Glo (Promega). The hill slope sigmoidal four-parameter logistic curve (4PL) in GraphPad Prism was used to generate dose-response curves from normalized measurements of viability. Data
points indicate the average of duplicate samples and error bars represent standard deviation. RLY-4008 dose-response curve is statistically significant when compared to pan-FGFRi dose-response curves with p&lt;0.001 as determined by two-way
ANOVA.</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">RLY-4008</FONT> was able to achieve <I>in vivo</I> efficacy in mouse models of FGFR2-fusion gastric cancer,
FGFR2-amplified gastric cancer, and FGFR2-mutant endometrial cancer. Treatment with <FONT STYLE="white-space:nowrap">RLY-4008</FONT> led to tumor regression at 3 mg/kg delivered twice a day in a FGFR2 gene fusion gastric cancer model, and at 10
mg/kg delivered twice a day in a FGFR2-amplified gastric cancer or FGFR2-mutant endometrial cancer models (<B>Figure&nbsp;22</B>). All of these doses result in exposures that do not cause hyperphosphatemia in an industry standard rat model.
Importantly, <FONT STYLE="white-space:nowrap">RLY-4008</FONT> achieved complete regression in an FGFR2-mutant endometrial cancer model (AN3CA) harboring the N550K mutation that reduced the potency of pemigatinib by
<FONT STYLE="white-space:nowrap">185-fold.</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure&nbsp;22: <FONT STYLE="white-space:nowrap">RLY-4008</FONT> leads to tumor regression in an
FGFR2-fusion gastric cancer PDX, the FGFR2-amplified gastric cancer SNU16 xenograft model, and the FGFR2 N550K-mutant endometrial cancer AN3CA xenograft model. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g16b17.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Anti-tumor activity of RLY-4008 dosed twice daily (BID) by oral administration in </I><B>(a)&nbsp;</B><I>an FGFR2 fusion
gastric cancer PDX model, </I><B>(b)&nbsp;</B><I>the FGFR2-amplified SNU16 gastric cancer xenograft model, and </I><B>(c)&nbsp;</B><I>the FGFR2 K310R; N550K mutant AN3CA endometrial cancer xenograft model. Data points indicate mean tumor volume and
error bars represent standard error of the mean. Statistical analyses were performed using one-way ANOVA. (a)&nbsp;n=8&nbsp;per group; treatment groups are statistically significant when compared to vehicle with p&lt;0.001. (b)&nbsp;n=7&nbsp;per
group; treatment groups are statistically significant when compared to vehicle with p=0.001 for 10&nbsp;mpk BID group and p&lt;0.001 for 30&nbsp;mpk BID group. (c) n=8&nbsp;per group; two high-dose groups are statistically significant when compared
to vehicle with p=0.003 for 30&nbsp;mpk BID group and p=0.005 for 10&nbsp;mpk BID group. p=0.627 for 3&nbsp;mpk BID group.</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To further evaluate the
activity of <FONT STYLE="white-space:nowrap">RLY-4008</FONT> against FGFR2 resistance mutations, the <I>in vivo </I>activity of <FONT STYLE="white-space:nowrap">RLY-4008</FONT> was compared to pemigatinib in the AN3CA endometrial cancer model. As
described above, this model harbors the FGFR2 N550K mutation, which reduces the potency of pemigatinib by <FONT STYLE="white-space:nowrap">185-fold.</FONT> <FONT STYLE="white-space:nowrap">RLY-4008</FONT> was able to achieve complete regression in
this model at doses resulting in exposures that do not cause hyperphosphatemia in an industry standard rat model. By contrast, when dosed at levels selected to match human exposure in clinical studies, pemigatinib showed no anti-tumor activity
(<B>Figure&nbsp;23</B>). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">120 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure&nbsp;23: <FONT STYLE="white-space:nowrap">RLY-4008</FONT> leads to complete tumor regression in
the FGFR2 N550K-mutant endometrial cancer AN3CA xenograft model, while pemigatinib is inactive. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g904779g31s50.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Anti-tumor activity of RLY-4008 and pemigatinib dosed twice daily (BID) by oral administration in the FGFR2 K310R;N550K
mutant AN3CA endometrial cancer xenograft model. RLY-4008 induced complete regression when administered at 30 mpk BID. Pemigatinib was dosed at 0.5 mpk BID, a dose selected to match clinical exposure. (a) Data points indicate mean tumor volume (n=8
per group) and error bars represent standard error of the mean. RLY-4008 cohort is statistically significant when compared to vehicle with p=0.009 as determined by one-way ANOVA. (b) Waterfall plot of individual end-of-study (Day 14) tumors; each
bar represents one animal. Tumor volume is expressed as percentage change relative to tumor volume on Day&nbsp;0.</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although <FONT
STYLE="white-space:nowrap">RLY-4008</FONT> retains activity preclinically against common FGFR2 resistance mutations, tumors may develop bypass resistance by shifting growth factor signaling to an alternate receptor, rendering them less sensitive to
the targeted therapy. SHP2, a protein tyrosine phosphatase, regulates the activity of multiple RTKs, and may be an effective way to overcome bypass resistance to <FONT STYLE="white-space:nowrap">RLY-4008.</FONT> To demonstrate the potential for <FONT
STYLE="white-space:nowrap">RLY-1971</FONT> as a combination partner for <FONT STYLE="white-space:nowrap">RLY-4008</FONT> we tested a population of four patient-derived FGFR2-fusion positive ICC cell lines. These cells were derived from patients that
initially responded to <FONT STYLE="white-space:nowrap">non-selective</FONT> FGFR inhibitors, but then acquired bypass resistance to FGFR inhibition during their treatment. While these cell lines were resistant to treatment with our FGFR2 inhibitor <FONT
STYLE="white-space:nowrap">RLY-4008,</FONT> all resistant cells were sensitive to <FONT STYLE="white-space:nowrap">RLY-1971</FONT> with IC50s of less than 100 nM (<B>Figure&nbsp;24</B>). Given the role of SHP2 in mediating bypass resistance to
multiple targeted therapies, we intend to investigate the clinical potential of the combination of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> with <FONT STYLE="white-space:nowrap">RLY-4008.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">121 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure&nbsp;24: <FONT STYLE="white-space:nowrap">RLY-1971</FONT> overcomes bypass resistance to FGFR2
inhibition in patient-derived FGFR2 fusion positive ICC cell lines. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g16v88.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Anti-proliferative effect of <FONT STYLE="white-space:nowrap">RLY-1971</FONT> in patient-derived FGFR2 fusion positive ICC
cells tested in a 2D proliferation assay. These cell models were derived from patients that initially responded to <FONT STYLE="white-space:nowrap">non-selective</FONT> FGFR inhibitors, but then progressed during their treatment (the specific FGFR2
fusion present in the cells is indicated). These cells are resistant to treatment with our FGFR2 inhibitor <FONT STYLE="white-space:nowrap">RLY-4008</FONT> (blue lines), whereas <FONT STYLE="white-space:nowrap">RLY-1971</FONT> demonstrates
anti-proliferative and cytotoxic activity (red lines), with IC50s as follows: <B>(a)</B> 13 nM, <B>(b)</B> 20 nM, <B>(c)</B> 39 nM, and<B> (d)</B> 91 nM. The dotted line at 0 indicates complete growth suppression, with values below 0 indicating
cytotoxicity. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Our clinical development plan </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The <FONT
STYLE="white-space:nowrap">RLY-4008</FONT> clinical development plan seeks to leverage the unique potential for enhanced tolerability and broad FGFR2 mutational coverage to rapidly generate <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> in molecularly defined patient subsets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We plan to initiate a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">first-in-human</FONT></FONT> clinical trial for <FONT STYLE="white-space:nowrap">RLY-4008</FONT> in solid tumor patients enriched for oncogenic FGFR2 alterations in the second half of 2020. The primary objectives are to
determine the maximum tolerated dose (MTD)/recommended phase 2 dose (RP2D) and to define the overall safety profile of <FONT STYLE="white-space:nowrap">RLY-4008.</FONT> Secondary objectives are to assess the pharmacokinetics, pharmacodynamics and to
explore anti-tumor activity of <FONT STYLE="white-space:nowrap">RLY-4008.</FONT> Patients will initially receive <FONT STYLE="white-space:nowrap">RLY-4008</FONT> administered orally, twice daily. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The first trial will employ a <FONT STYLE="white-space:nowrap">2-part</FONT> dose escalation/dose-expansion design. Given
<FONT STYLE="white-space:nowrap">RLY-4008&#146;s</FONT> strong preclinical activity against both primary oncogenic alterations and acquired <FONT STYLE="white-space:nowrap">pan-FGFR</FONT> inhibitor resistance mutations, the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">122 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
trial will include patients that are na&iuml;ve to <FONT STYLE="white-space:nowrap">pan-FGFR</FONT> inhibitors, as well as those that have progressed on
<FONT STYLE="white-space:nowrap">pan-FGFR</FONT> inhibitors. Observation of significant clinical activity in one or more patient populations in this exploratory
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> trial would support further trials to confirm the risk-benefit profile of <FONT STYLE="white-space:nowrap">RLY-4008</FONT> in patients with oncogenic
FGFR2 alterations. These trials may include continued evaluation of <FONT STYLE="white-space:nowrap">RLY-4008</FONT> as a monotherapy in single arm trials in patient populations without an established <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">standard-of-care</FONT></FONT> therapy available, which could be used to support filings for marketing authorization for <FONT STYLE="white-space:nowrap">RLY-4008.</FONT> The development program for <FONT
STYLE="white-space:nowrap">RLY-4008</FONT> may also include randomized trials of <FONT STYLE="white-space:nowrap">RLY-4008</FONT> compared to a relevant <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">standard-of-care</FONT></FONT>
therapy. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure&nbsp;25: Planned <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> clinical trial for <FONT
STYLE="white-space:nowrap">RLY-4008</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g75g00.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Development of <FONT STYLE="white-space:nowrap">RLY-4008</FONT> will require identification of appropriate patients for
treatment with FGFR2 alterations using molecular diagnostic tests. In early phase clinical trials, patients will be identified using local testing performed at clinical trial sites, with retrospective centralized testing to confirm the tumor genetic
status. In later phase trials, we will likely collaborate with a diagnostic partner to identify patients for clinical trial enrollment using an analytically validated investigational molecular diagnostic. The tumor genetic contexts that we are
considering for development of <FONT STYLE="white-space:nowrap">RLY-4008</FONT> (FGFR2 fusions, amplifications and mutations) can currently be detected using <FONT STYLE="white-space:nowrap">FDA-approved</FONT> next generation sequencing based panel
diagnostics (e.g. Foundation One, Guardant 360). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Mutant-PI3K</I></B>&#945;<B><I></I></B><B><I> Inhibitor Programs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Overview </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> is the lead compound in our franchise of programs targeting cancer-associated mutant variants of
phosphoinositide <FONT STYLE="white-space:nowrap">3-kinase</FONT> alpha, or PI3K&#945;. <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> is a small molecule inhibitor of PI3K&#945; that we designed to specifically target PI3K&#945; H1047X mutant
via a previously undescribed allosteric mechanism. Oral dosing of <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> resulted in tumor growth inhibition in a mouse xenograft model of PI3K&#945; H1047R mutant carcinoma. We expect to begin <FONT
STYLE="white-space:nowrap">IND-enabling</FONT> studies for a differentiated PI3K&#945; H1047X mutant-selective inhibitor in 2021. We believe PI3K&#945; H1047X mutant cancers affect approximately 10,000 late-line patients annually in the U.S. In the
future, if <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> advances to earlier lines of treatment, it could potentially address approximately 48,000 patients annually in the U.S.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Two additional mutations of interest for our PI3K&#945; franchise are E542X and E545X. We estimate there are approximately 15,000 late-line and 57,000 total
patients annually in the United States who might benefit from a PI3K&#945; targeted inhibitor that targets the mutations at E542 and E545. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">123 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 26: PI3K</B>&#945;<B></B><B> addressable patient populations </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g93o58.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>1) Estimated frequency percentages are based on counts of known/likely functional alterations in the Foundation Medicine
Insights database. 2) Based on projected cancer deaths in all solid tumors from the National Cancer Society&#146;s SEER database as a proxy for late-line cancer patient incidence. 3) These data are based on projections from the National Cancer
Society&#146;s SEER program for estimated new cases of advanced solid tumors. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Role of PI3K</I>&#945;<I></I><I> in cellular proliferation and
differentiation </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mutations at amino acid H1047 of PI3K&#945; are among the most common kinase mutations in cancer and are believed to be a primary
driver of carcinogenesis. There are no approved therapies that selectively target mutant versions of PI3K&#945;. Inhibitors that are not mutant-selective are associated with dose-limiting toxicities resulting in frequent discontinuations that
restrict their therapeutic potential. Additionally, these inhibitors also can inhibit other isoforms of PI3K, including PI3K<FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>, which can further result in toxicity. Our belief is that selectively
targeting mutant PI3K&#945; could result in improved target inhibition and increased clinical efficacy (<B>Figure 27</B>). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">124 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 27: <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> is a selective inhibitor of H1047X mutant
PI3K</B>&#945;<B></B><B></B>.<B> WT PI3K</B>&#945;<B></B><B> plays a critical role in normal cellular signaling and function, including glucose uptake and insulin regulation. Inhibition of WT PI3K</B>&#945;<B></B><B> by <FONT
STYLE="white-space:nowrap">non-mutant</FONT> selective PI3K inhibitors results in hyperglycemia, hyperinsulinemia and other toxicities. This results in decreased efficacy by requiring dose reductions.</B> </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g904779g31j36.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Leveraging our structural biology capabilities, we solved what we believe to be the first full-length structure of
PI3K&#945; using cyrogenic electron microscopy <FONT STYLE="white-space:nowrap">(Cryo-EM)</FONT> and utilized a range of experimental techniques to understand both H1047R mutant and wild-type conformations. We used this rich experimental data set to
power molecular dynamics simulations of H1047R mutant PI3K&#945; to identify a series of dynamic structural changes caused by the mutation, which were not elucidated by prior structural studies of either H1047R mutant or wild-type PI3K&#945;. The
lead compound in this program, which we refer to as <FONT STYLE="white-space:nowrap">RLY-PI3K1047,</FONT> was designed to exploit these dynamic differences and bind to a novel allosteric site to achieve heightened mutant selectivity. We intend to
initiate <FONT STYLE="white-space:nowrap">IND-enabling</FONT> studies for our first PI3K&#945; mutant selective inhibitor, which is focused on H1047X, in 2021. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>PI3K</I>&#945;<I></I><I> mutations drive the development of cancer </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PI3K&#945; is the central regulator of a cellular signaling pathway that has been linked to a diverse group of cellular functions related to cancer including
cell growth, proliferation and survival. Data collected as a part of Foundation Medicine Insights and other data sources identifies PI3K&#945; as the most frequently mutated kinase in cancer.<SUP STYLE="font-size:85%; vertical-align:top">,</SUP>
(<B>Figure 28</B>). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">125 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 28: PI3K</B>&#945;<B></B><B> is a common mutation in cancer. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g904779g27g29.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Approximately 80% of the mutations in PI3K&#945; cluster at three amino acids, or locations. These are E542 and E545 in the
helical domain, and H1047 in the kinase domain. The most common mutation at amino acid H1047 is H1047R, but other H1047 mutations (such as H1047L, H1047Y, and others) are also observed across cancers. The abbreviation &#147;H1047X&#148; is used to
refer to any H1047 mutation. Similarly, the most common mutations in the helical domain are E542K and E545K, but other mutations (such as E542Q, E545A, and others) are also observed across cancers. The abbreviation &#147;E542/E545X&#148; is used to
refer to any helical domain mutation. The H1047R mutation has been shown to induce extensive and diverse cellular changes in <FONT STYLE="white-space:nowrap">pre-clinical</FONT> models of breast cancer, demonstrating how a single mutation at amino
acid H1047 can have large consequences and induce a cancer phenotype. The E5452K and E545K mutations have also been shown to increase PI3K&#945; activity, promote cell growth and invasion in vitro, and induce tumorigenesis in vivo. While H1047X and
E542/E545X mutations have been shown to result in aberrant PI3K&#945; activity, they do so through distinct biological mechanisms. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Limitations of
current PI3K</I>&#945;<I></I><I> inhibitors </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Given the large number of patients with PI3K&#945; mutations, several small-molecule inhibitors of
PI3K&#945; are in development for oncology indications. However, these inhibitors have to our knowledge been largely ineffective when used as monotherapy in cancer. All of these inhibitors target the catalytic (orthosteric) site of PI3K&#945;. One
challenge faced by these inhibitors has been drug intolerance, especially at the high doses routinely used in cancer trials. Alpelisib, marketed as Piqray<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> by Novartis, is the only <FONT
STYLE="white-space:nowrap">FDA-approved</FONT> inhibitor for cancers with mutated PI3K&#945;. However, alpelisib is not a selective inhibitor for mutant forms of PI3K&#945;; it is a potent inhibitor of both the wild-type form of PI3K&#945; as well
as the mutant form. Nonetheless, alpelisib is approved to be used in combination with fulvestrant, an estrogen receptor degrader, in PI3K&#945;-mutated breast cancer. When used in combination with fulvestrant, alpelisib was associated with
significant adverse events, including severe hypersensitivity, diarrhea and severe pneumonitis. Hyperglycemia was reported in 64% of patients and over 36% of patients experienced Grade 3 or Grade 4 hyperglycemia. To manage hyperglycemia, insulin
along with other anti-diabetic medication was used in 87% of patients. Gastrointestinal toxicity was reported in 93% of patients, with 9% experiencing Grade&nbsp;3 gastrointestinal toxicity. Additionally, 36% of patients experienced rash, with
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">126 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
10% experiencing Grade 3 rash. The combination of these adverse events resulted in 64% of patients requiring dose reductions and 25% of patients discontinuing treatment. Despite 11&nbsp;month
progression-free survival (PFS) in the <FONT STYLE="white-space:nowrap">SOLAR-1</FONT> Phase 3 trial of alpelisib, the median duration of dosing in the alpelisib arm was 5.5&nbsp;months, indicating the majority of patients discontinued dosing prior
to disease progression. The observed hyperglycemia is believed to be caused by inhibition of wild-type PI3K&#945; and are therefore is considered an <FONT STYLE="white-space:nowrap">on-target</FONT> toxicity for alpelisib. In addition to causing
dose-limiting toxicity, systemic glucose-insulin feedback caused by inhibiting wild-type PI3K results in elevated insulin that can activate PI3K signaling and subsequently limit the efficacy of PI3K inhibitors. While these factors limit the clinical
utility of alpelisib, these data nonetheless establish mutant PI3K&#945; as a clinically validated target in breast cancer. Because these toxicities result in suboptimal doses and dosing schedules that result in incomplete PI3K&#945; inhibition, we
believe that a H1047X or E542/E545K mutant selective inhibitor will enable improved target inhibition, and therefore improved clinical efficacy. Additionally, overcoming hyperinsulinemia and hyperglycemia could increase efficacy by preventing
insulin feedback that activates PI3K signaling. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Our solution, mutant selective inhibition of </I>PI3K&#945; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Given the existence of mutations in PI3K&#945; with different biological mechanisms underlying aberrant activity, we believe there are multiple opportunities
to develop distinct mutant selective inhibitors of PI3K&#945;. Addressing the challenge of mutant selectivity required us to express and then solve the structure of the full-length PI3K&#945; protein. This structure, which to our knowledge had
previously not been solved, represented a technical challenge because PI3K&#945; is a membrane-bound protein. This type of protein is typically difficult both to purify in large quantities and to crystallize. Nonetheless, we were able to obtain the
structure of full-length PI3K&#945; using <FONT STYLE="white-space:nowrap">Cryo-EM.</FONT> The three-dimensional structure of PI3K&#945; was determined by collecting data from <FONT STYLE="white-space:nowrap">two-dimensional</FONT> electron
microscopic projections of thin layers of protein. The resulting three-dimensional protein structure provided us with fundamental insights into the mechanism of activation of PI3K&#945; and the impact of mutations on its function. Through the
integration of these structural insights with a combination of experimental and computational techniques, our aim is to develop a franchise of mutant selective PI3K&#945; inhibitors. The first lead molecule derived from these efforts, which is
focused on H1047X, is described below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Current lead molecule for PI3K-H1047X Mutations, <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> is a small molecule inhibitor of PI3K&#945; that we designed to specifically target PI3K&#945; H1047X
mutant via a previously undescribed allosteric mechanism.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>As described above, adverse events such as hyperglycemia are common among PI3K inhibitors that have been tested in the clinic, leading us
to focus on identifying an inhibitor that bound to a novel site on PI3K&#945;. Our intent was to obtain a molecule that could selectively bind to the mutant form of PI3K&#945;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Structural analyses of PI3K&#945; showed that mutations at amino acid H1047 cause structural alterations that are located away from the catalytic site, the
place where other PI3K inhibitors bind. We then performed long timescale molecular dynamics simulations of wild-type and H1047R mutant PI3K&#945; to identify a series of dynamic structural changes caused by the mutation that are not present in the
wild-type protein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Utilizing this structural information, we designed inhibitors to target a novel allosteric binding site on the PI3K&#945; H1047R
mutant protein that our computational and experimental approaches exposed. This process led to the discovery of <FONT STYLE="white-space:nowrap">RLY-PI3K1047,</FONT> which is approximately <FONT STYLE="white-space:nowrap">5-fold</FONT> selective for
the H1047R mutant form of PI3K&#945; compared to the wild-type protein in biochemical assays (<B>Figure 29</B>). In contrast, alpelisib and GDC-0077 (an orthosteric PI3K&#945; inhibitor currently in development) biochemically inhibited the mutant
and wild-type proteins with approximately equivalent potency. In addition, we found that <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> is selective for PI3K&#945; over other PI3K isoforms, including PI3K&szlig; and PI3K<FONT
STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT>, showing no measurable inhibition. In contrast, alpelisib and GDC-0077 inhibited the PI3K<FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT> isoform with IC50 &lt; 1&micro;M. Given toxicities associated with
inhibitors that target PI3K isoforms other than PI3K&#945; and GDC-0077, including gastrointestinal side effects and transaminitis, we believe that <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> provides a dual advantage of isoform and mutant
selectivity, which could result in increased clinical efficacy compared alpelisib or other orthosteric PI3K&#945; inhibitors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">127 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 29: Compared to alpelisib and GDC-0077, <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> is
more selective for the PI3K</B>&#945;<B></B><B> mutant (H1047R) compared to wild-type (a)&nbsp;and more selective for the PI3K</B>&#945;<B></B><B> isoform compared to other PI3K isoforms PI3K&szlig; and
PI3K</B><FONT STYLE="FONT-FAMILY:SYMBOL">&#100;</FONT><B></B><B> (b). </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g904779g16m00.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Biochemical potency for <FONT
STYLE="white-space:nowrap">RLY-PI3K1047</FONT> compared to alpelisib and GDC-0077. IC50 values are shown for inhibition of the PI3K</I>&#945;<I></I><I> mutant (H1047R) compared to wild-type </I><B></B><B><I>(a)</I></B><B></B><I>&nbsp;and for
PI3K</I>&#945;<I></I><I> compared to other PI3K isoforms </I><B></B><B><I>(b)</I></B><B></B><I>. Phosphotransfer activity (PtdIns(3,4,5)P3 production in liposomes using diC8-PtdIns(4,5)P2 as a substrate in the presence of 100uM ATP and titrated
compounds after a 120min incubation) was measured by ADP-Glo. All samples were run in duplicate and data represent the mean. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This increased
biochemical potency for PI3K&#945; H1047R mutant protein translates into an increased potency in cellular pharmacodynamic assays. <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> was approximately <FONT STYLE="white-space:nowrap">10-fold</FONT>
more potent for inhibition of phosphorylated AKT (pAKT), a key substrate of PI3K&#945;, in transformed breast epithelial cells expressing PI3K&#945; H1047R compared to the same cells expressing wild-type PI3K&#945;. RTX-2, an example of another lead
compound generated in this program, also showed approximately <FONT STYLE="white-space:nowrap">10-fold</FONT> increased potency for inhibition of pAKT in transformed breast epithelial cells expressing PI3K&#945; H1047R (<B>Figure 30</B>). In
contrast, alpelisib and <FONT STYLE="white-space:nowrap">GDC-0077</FONT> (an orthosteric PI3K&#945; inhibitor currently in development) showed approximately equal potencies in cells expressing either the mutant or wild-type forms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">128 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 30: Compared to other clinical PI3K</B>&#945;<B></B><B> inhibitors (alpelisib and <FONT
STYLE="white-space:nowrap">GDC-0077),</FONT> Relay compounds more potently inhibits pAKT in cells expressing H1047R mutant PI3K</B>&#945;<B></B><B> compared to cells expressing wild-type PI3K</B>&#945;<B></B><B>. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g904779g10p14.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Inhibition of pAKT by Relay compounds RLY-PI3K1047 and RTX-2 in a pharmacodynamic assay. MCF10A immortalized breast
epithelial cells endogenously expressing wild-type PI3K</I>&#945;<I></I><I> </I><B></B><B><I>(a)</I></B><B></B><I>&nbsp;or engineered to express the PI3K</I>&#945;<I></I><I> H1047R mutation </I><B></B><B><I>(b)</I></B><B></B><I>&nbsp;were treated
with alpelisib, <FONT STYLE="white-space:nowrap">GDC-0077</FONT> or Relay compounds. After 2&nbsp;hours cell lysates were collected and the impact on pAKT levels was assessed using an HTRF assay (three fold dilution dose response was run in
duplicate, data represented as mean +/- standard error of the mean). Half maximal effective concentrations (EC50) from the dose response curves (a, b) are plotted in </I><B></B><B><I>(c)</I></B><B>.</B><I> </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The selectivity of <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> was then evaluated <I>in vivo</I>. Oral dosing of
<FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> resulted in tumor growth inhibition in a mouse xenograft model of PI3K&#945; H1047R carcinoma at doses of 100 mg/kg delivered once or twice daily or 50 mg/kg delivered twice daily. (<B>Figure
31</B>). An important validation of our efforts to avoid the dose-limiting toxicities associated with other PI3K inhibitors is the effect of <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> on hyperinsulinemia. As discussed above,
hyperinsulinemia and hyperglycemia can lead to decreased efficacy of PI3K inhibitors. In a study evaluating the effects of alpelisib or <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> treatment on insulin levels,
<FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> led to minimal changes in serum insulin (p=0.116 compared to vehicle by 2-way ANOVA) when administered orally at all doses tested for the duration of the study. In contrast, alpelisib treatment
resulted in increases in serum insulin (p&lt;0.0001 compared to vehicle by 2-way ANOVA). Additionally, in an oral glucose tolerance test (OGTT) assessing insulin response after dosing of compounds, alpelisib treatment at 50 mg/kg once daily lead to
larger increases in serum insulin compared to all doses of <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> tested (p&lt;0.0001 by 2-way ANOVA). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">129 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Figure 31: <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> inhibits tumor growth in vivo with
minimal increases in serum insulin levels. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g904779g27u11.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Anti-tumor activity and impact on serum insulin levels in response to treatment with RLY-PI3K1047.</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I></I><B><I>(a)</I></B><I> The CAL33 xenograft model was dosed once or twice daily (12 hour interval) with RLY-PI3K1047 by oral administration or alpelisib
once daily by oral administration, and tumor growth was evaluated. Data represent mean tumor volume over time, and error bars represent standard error of the mean. (n=8 per group). </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I></I><B><I>(b)</I></B><I> RLY-PI3K1047 dosed at 100 mg/kg twice daily led to reduction in tumor volume in most animals compared to vehicle (p&lt;0.0001 as
measured by 2-way ANOVA). </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I></I><B><I>(c)</I></B><I> Insulin levels in serum were measured one hour before and one hour after drug administration in
non-tumor bearing animals throughout an 8 day dosing period (measurements were taken specifically on day 1, 3, 5 and 8, n=8 per group). Data presented as mean +/- standard error of the mean. </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I></I><B><I>(d)</I></B><I> In the oral glucose tolerance test (OGTT), animals were fasted overnight for 16 hours prior to compound treatment. Animals were
then allowed to recover after compound dosing for 1 hour. After the 1 hour recovery, a 2&nbsp;g/kg glucose solution was administered orally. Insulin levels were measured at time 0 (prior to glucose administration), 10, 30, 60, 120, and 360 minutes
post dosing (n=8 per group, data presented as mean +/- standard error of the mean). </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> is one
lead molecule generated in this franchise, we are continuing lead optimization to identify mutant selective inhibitors of PI3K&#945; meeting our criteria to enter <FONT STYLE="white-space:nowrap">IND-enabling</FONT> studies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Our clinical development plan </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expect to begin <FONT
STYLE="white-space:nowrap">IND-enabling</FONT> studies for a differentiated PI3K&#945; H1047X mutant-selective inhibitor in 2021. With this profile, we will look to advance a precision medicine program that quickly establishes safety, tolerability,
and preliminary efficacy, in patients with advanced solid tumors with H1047X mutations. Upon completion of dose escalation, the mutant PI3K&#945; inhibitor will be tested as a monotherapy in advanced cancer
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">130 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
patients with PI3K&#945; H1047X mutations in a tumor-agnostic study. We will also pursue disease-specific development paths including combination with endocrine therapy +/- CDK4/6 inhibitors in
hormone-receptor positive breast cancer and a PI3K&#945; H1047X mutation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Our Discovery Programs </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are deploying our Dynamo platform to advance an additional three discovery-stage precision oncology programs. As with our lead programs, these programs
leverage insights into protein conformational dynamics to address high-value, genetically validated oncogenes that previously have been intractable to conventional drug-discovery approaches. The capabilities for our Dynamo platform in protein
visualization can be applied to multiple therapeutic areas beyond precision oncology. We are continuing to leverage the power of our Dynamo platform to further diversify our pipeline by extending our approach to address genetically validated targets
in monogenic diseases with two discovery-stage programs, where genetic alterations lead to disease-causing defects in protein conformational dynamics. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Our Key Scientific Collaborations </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While
we have invested extensively in our <FONT STYLE="white-space:nowrap">in-house</FONT> capabilities and <FONT STYLE="white-space:nowrap">know-how,</FONT> we selectively work with key collaborators and field experts on certain emerging technologies.
Most of our experimental collaborations are focused on the technologies we use to visualize protein structure at the atomic level. For example, we work with Professor James Fraser from UCSF on performing and analyzing room temperature <FONT
STYLE="white-space:nowrap">X-ray</FONT> crystallography experiments and Professor Adam Frost from UCSF on <FONT STYLE="white-space:nowrap">Cryo-EM</FONT> image analysis. Both are world leading experts on these technologies, and they provide
important <FONT STYLE="white-space:nowrap">know-how</FONT> and insights in collaboration with our scientists. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since our firm&#146;s founding we have
collaborated with D.&nbsp;E. Shaw Research, a computational biochemistry research firm operating under the scientific leadership of Dr.&nbsp;David&nbsp;E. Shaw, which has developed proprietary software and hardware to perform long timescale
molecular dynamics simulations. Through an affiliate, D.&nbsp;E.&nbsp;Shaw Research is also one of our investors. We collaborate with D.&nbsp;E. Shaw Research scientists to research certain protein targets on an exclusive basis, with a focus on the
dynamic behavior of proteins, through the use of D.&nbsp;E. Shaw Research&#146;s computational modeling capabilities, such as the Anton 2 supercomputer and proprietary algorithms and software developed specifically by D.&nbsp;E. Shaw Research for
processing long timescale molecular dynamics simulations. Our scientists work closely with D.&nbsp;E. Shaw Research scientists on each of our programs, especially in the discovery stage as we develop motion-based hypotheses and identify lead
compounds. See &#147;Business&#151;Collaboration and License Agreement with D.&nbsp;E. Shaw Research, LLC&#148; for more detail on the terms of the DESRES Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While our key computational collaboration is with D. E. Shaw Research, we also have other collaborations mostly focused on developing machine learning models.
Specifically, we collaborate with Google on machine learning models to generate novel molecules with specific activity, and with Professor Tim Cernak from the University of Michigan on machine learning models focused on chemical synthesis and high
throughput experimentation. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Competition </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The biotechnology and pharmaceutical industries are characterized by rapid innovation of new technologies, fierce competition and strong defense of
intellectual property. While we believe that our platform and our knowledge, experience and scientific resources provide us with competitive advantages, we face competition from major pharmaceutical and biotechnology companies, academic
institutions, governmental agencies and public and private research institutions, among others. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">131 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We compete in the segments of the pharmaceutical, biotechnology, and other related markets that address
experimentally and computationally driven structure-based drug design in cancer and genetic diseases. There are other companies focusing on structure-based drug design to develop therapies in the fields of cancer and other diseases. These companies
include divisions of large pharmaceutical companies and biotechnology companies of various sizes. Any product candidates that we successfully develop and commercialize will compete with currently approved therapies and new therapies that may become
available in the future from segments of the pharmaceutical, biotechnology and other related markets that pursue precision medicines. Key product features that would affect our ability to effectively compete with other therapeutics include the
efficacy, safety and convenience of our products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe principal competitive factors to our business include, among other things, the rich protein
structural data sets we are able to generate, the power and accuracy of our computations and predictions, ability to integrate experimental and computational capabilities, ability to successfully transition research programs into clinical
development, ability to raise capital, and the scalability of the platform, pipeline, and business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While there are many pharmaceutical and biotechnology
companies that use some of the same tools that we use in our platform, we believe we compete favorably on the basis of these factors. The effort and investment required to develop a highly integrated experimental and computational platform similar
to ours will hinder new entrants that are unable to invest the necessary capital and time and lack the breadth and depth of technical expertise required to develop competing capabilities. Our ability to remain competitive will largely depend on our
ability to continue to augment our integrated experimental and computational platform and demonstrate success in our drug discovery efforts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our
competitors may obtain regulatory approval of their products more rapidly than we may or may obtain patent protection or other intellectual property rights that limit our ability to develop or commercialize our product candidates. Our competitors
may also develop drugs that are more effective, more convenient, more widely used and less costly or have a better safety profile than our products and these competitors may also be more successful than us in manufacturing and marketing their
products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we will need to develop our product candidates in collaboration with diagnostic companies, and we will face competition from other
companies in establishing these collaborations. Our competitors will also compete with us in recruiting and retaining qualified scientific, management and commercial personnel, establishing clinical trial sites and patient registration for clinical
trials, as well as in acquiring technologies complementary to, or necessary for, our programs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Furthermore, we also face competition more broadly across
the market for cost-effective and reimbursable cancer treatments. The most common methods of treating patients with cancer are surgery, radiation and drug therapy, including chemotherapy, hormone therapy and targeted drug therapy or a combination of
such methods. There are a variety of available drug therapies marketed for cancer. In many cases, these drugs are administered in combination to enhance efficacy. While our product candidates, if any are approved, may compete with these existing
drug and other therapies, to the extent they are ultimately used in combination with or as an adjunct to these therapies, our product candidates may not be competitive with them. Some of these drugs are branded and subject to patent protection, and
others are available on a generic basis. Insurers and other third-party payors may also encourage the use of generic products or specific branded products. We expect that if our product candidates are approved, they will be priced at a significant
premium over competitive generic, including branded generic, products. As a result, obtaining market acceptance of, and gaining significant share of the market for, any of our product candidates that we successfully introduce to the market will pose
challenges. In addition, many companies are developing new therapeutics, and we cannot predict what the standard of care will be as our product candidates progress through clinical development. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">132 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">RLY-1971</FONT> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While there are currently no approved products targeting SHP2, we are aware of other companies in clinical trials developing therapeutics that target SHP2,
including Revolution Medicines in partnership with Sanofi, Novartis AG, and Jacobio Pharmaceuticals in partnership with AbbVie. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT
STYLE="white-space:nowrap">RLY-4008</FONT> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">While there are currently no approved products that selectively target FGFR2, we are aware of other
companies developing therapeutics that selectively target FGFR2, which include, but are not limited to: Five Prime Therapeutics and Russian Pharmaceutical Technologies. Specifically, we expect <FONT STYLE="white-space:nowrap">RLY-4008</FONT> to
compete with approved development stage <FONT STYLE="white-space:nowrap">non-selective</FONT> inhibitors of the FGFR receptor family that are being tested in patients with FGFR2 alterations, including but not limited to: Incyte Corporation
(pemigatinib), QED Therapeutics (infigratinib), Basilea Pharmaceutica (derazantinib), Janssen (erdafitinib), Otsuka Holdings through its subsidiary Taiho Pharmaceutical <FONT STYLE="white-space:nowrap">(TAS-120),</FONT> Debiopharm (Debio1347), Eisai
Co <FONT STYLE="white-space:nowrap">(E-7090),</FONT> and InnoCare Pharma <FONT STYLE="white-space:nowrap">(ICP-192).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The development of <FONT
STYLE="white-space:nowrap">RLY-4008</FONT> will focus on solid tumor patients with FGFR2 alterations, including intrahepatic cholangiocarcinoma (ICC) patients harboring FGFR2 gene fusions. While there are no approved systemic therapies for ICC, the
current standard of care for unresectable or metastatic patients is first-line gemcitabine/cisplatin chemotherapy. In addition, there are other companies developing potentially competitive drug candidates in ICC including, but not limited to:
Merck&nbsp;&amp; Co, Astrazeneca plc, Merck KGaA, and NuCana plc. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Mutant-PI3K</I>&#945;<I></I><I> Inhibitor Program </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We expect that our mutant-selective PI3K&#945; inhibitor program will compete against an approved drug, Piqray (alpelisib), a
<FONT STYLE="white-space:nowrap">non-selective</FONT> PI3K&#945; inhibitor marketed by Novartis for the treatment of PI3K&#945; mutated breast cancer. We are aware of other companies developing therapeutics that target both wild-type and mutant
PI3K&#945;, including but not limited to: Roche Holding AG through its subsidiary Genentech, Petra Pharma, Menarini Group, and Shanghai Haihe Pharma. Petra Pharma also has a preclinical development program for a mutant-selective PI3K&#945;
inhibitor. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Collaboration and License Agreement with D. E. Shaw Research, LLC </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June 15, 2020, we entered into an Amended and Restated Collaboration and License Agreement with D.&nbsp;E.&nbsp;Shaw Research, LLC, or D.&nbsp;E.&nbsp;Shaw
Research, extending the term and otherwise modifying the terms of a Collaboration and License Agreement originally entered into on August 17, 2016, as amended. We refer to this amended and restated agreement as the DESRES Agreement. Under the DESRES
Agreement, we agreed to collaborate with D.&nbsp;E.&nbsp;Shaw Research to research certain biological targets through the use of D.&nbsp;E.&nbsp;Shaw Research computational modeling capabilities focused on analysis of protein motion, with an aim to
develop and commercialize compounds and products directed to such targets. After completing the computational modeling with D.&nbsp;E. Shaw Research and naming a compound development candidate, we develop and commercialize such compounds and
products. D.&nbsp;E. Shaw Research has no involvement with the clinical development or potential commercialization of these compounds and products, regardless of any co-ownership rights pursuant to the terms of the DESRES Agreement, and instead
receives solely milestone and royalty payments as described below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the DESRES Agreement, there are three categories of targets: Category 1 Targets,
Category 2 Targets and Category 3 Targets. We and D. E. Shaw Research agreed on a list of Category 1 Targets and Category 2 Targets as part of the DESRES Agreement. Category 1 Targets are targets that, among other things, we collaborate on with
D.&nbsp;E. Shaw Research, D.&nbsp;E. Shaw Research has exclusivity obligations with respect to, and we may owe royalties on; Category 2 Targets are targets in connection with the potential re-categorization of which into a Category 1 Target, we may,
among other things, perform in vitro non-clinical research and development (but not </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">133 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
in vivo non-clinical development, clinical development or commercialization), and Category 3 Targets are all targets other than Category 1 Targets and Category 2 Targets. There are mechanisms for
re-categorizing targets, and we and D. E. Shaw Research have re-categorized a number of targets during the first four years of our collaboration. Our rights and obligations, and D. E. Shaw Research&#146;s rights and obligations, with respect to
targets vary by the category of each target. However, the parties only conduct collaborative activities together for Category 1 Targets, and we are limited to a maximum of eleven Category 1 Targets in the current collaboration year (with such number
potentially changing from year to year, with any increase in such number of targets subject to the collaboration in each collaboration year capped at four more than the highest number of such targets in the previous year). The sum of the number of
Category 1 Targets and the number of Category 2 Targets is capped at twenty, in any event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Work product that is jointly developed with D. E. Shaw
Research is initially co-owned with them. Specifically, intellectual property rights covering the composition of matter for RLY-1971 are currently co-owned by D. E. Shaw Research and us under this arrangement. We have the right to have patents
claiming certain product candidates (including one claiming RLY-1971) assigned to us upon issuance of those patents. Although other compounds in our FGFR2 and PI3K&#945; programs were jointly conceived with D. E. Shaw Research, RLY-4008 and
RLY-PI3K1047 were conceived solely by Relay Therapeutics inventors. For each Category 1 Target there is a limit of up to 10 core compounds and a total of 500 compounds including derivatives of those core compounds that can be designated as solely
owned by us, provided that if D. E. Shaw Research provides us with notice that certain compounds cannot be designated as solely owned by us due to concerns in respect of a Category&nbsp;3 Target, then the limit on Category&nbsp;1 Target core
compounds will increase by one and the limit on total compounds will increase by fifty, but subject to a maximum of 15 and 750, respectively, for each Category 1 Target. Each of we and D. E. Shaw Research grants to the other a perpetual,
irrevocable, non-exclusive license for jointly held intellectual property, subject to certain exclusions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the initial research term, which is
expected to last until August 2025, unless extended by mutual agreement, D. E. Shaw Research will not, and will cause its subsidiaries not to, research any Category 1 Target (or grant certain rights with respect to such target) with the aim of
pursuing any compound designed to interact with or bind to such Category&nbsp;1 Target, subject to some exceptions. Following the end of the initial research term, D. E. Shaw Research will not, and will cause its subsidiaries not to, research a
Category 1 Target (or grant certain rights with respect to such target) with the aim of pursuing any compound designed to interact with or bind to any target that was a Category 1 Target at the end of the initial research term, subject to some
exceptions. D. E. Shaw Research will not be bound by such exclusivity provisions with respect to a particular Category 1 Target if we, and parties acting on our behalf, stop using commercially reasonable efforts to research, develop or commercialize
any products against such Category 1 Target. Further, D. E. Shaw Research will be released from such exclusivity obligations with respect to a particular Category 1 Target if, at least 24 months after the end of the initial research term, D. E. Shaw
Research informs us that D. E. Shaw Research will forgo all future payments with respect to such Category 1 Target. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the initial research term,
neither D. E. Shaw Research nor we will, and we will each cause our subsidiaries not to, research a Category 2 Target (or grant certain rights with respect to such target) with the aim of pursuing any compound designed to interact with or bind to
such Category 2 Target, subject to some exceptions. These exclusivity restrictions do not extend past the initial research term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is no exclusivity
with respect to Category 3 Targets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Through May&nbsp;31, 2020, we have made cash payments to D. E. Shaw Research totaling $3.5&nbsp;million in the
aggregate. On a product-by-product basis, we have also agreed to pay D. E. Shaw Research milestone payments upon the achievement of certain development and regulatory milestone events for products we develop under the DESRES Agreement that are
directed to a Category 1 Target or any target that was a Category 1 Target. Our SHP2, FGFR2 and PI3K programs are each directed to Category 1 Targets. Such payments for achievement of development and regulatory milestones total up to $7.25 million
in the aggregate for each of the first three products we develop, and up to $6.25 million in the aggregate for each product we develop after the first three. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">134 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, we have agreed to pay D. E. Shaw Research, on a product-by-product basis, with respect to
products directed to Category 1 Targets or any target that was a Category 1 Target, royalties in the low single digits on worldwide net sales of products that we commercialize directed to the targets selected for development under the DESRES
Agreement, subject to certain reductions. Royalties are payable on a product-by-product and country-by-country basis until the later of twelve years after first commercial sale in such country or the expiration of all applicable regulatory
exclusivities in such country. On a product-by-product basis, we also agreed to pay D. E. Shaw Research sales milestone payments up to $36.0 million in the aggregate based on sales of each product directed to a Category 1 Target or any target that
was a Category 1 Target. Further, if we enter into transactions granting third parties rights to a Category 1 Target or a compound or product directed to a Category 1 Target or any target that was a Category 1 Target, but subject to certain
exclusions, we will share with D. E. Shaw Research a percentage of the proceeds of such transactions ranging from the low- to high-single digits, depending on the stage of development of compounds or products directed to such target at the time we
enter into such transaction. We have also agreed to pay D. E. Shaw Research an annual collaboration fee in August of each year during the initial research term, such fee to be $7,900,000 for each year between 2020 and 2025. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless earlier terminated, the DESRES Agreement will continue at least until the end of the initial research term and thereafter on a target-by-target basis
until all payment obligations have expired. D. E. Shaw Research has the right to terminate the DESRES Agreement due to non-payment. We and D. E. Shaw Research each have the right to terminate the DESRES Agreement due to an uncured material breach by
the other party, or in the event the other party becomes insolvent or enters into bankruptcy or dissolution proceedings. Our payment obligations to D.&nbsp;E. Shaw Research survive termination of the DESRES Agreement. If D.&nbsp;E.&nbsp;Shaw
Research terminates the DESRES Agreement, the exclusivity obligations will terminate. If we terminate the DESRES Agreement, D.&nbsp;E.&nbsp;Shaw Research remains bound by its exclusivity obligations with respect to certain targets until, on a
target-by-target basis, there are no further payment obligations due to D.&nbsp;E.&nbsp;Shaw Research in respect of such targets. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Intellectual Property </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We seek to protect
the intellectual property and proprietary technology that we consider important to our business, including by pursuing patent applications that cover our product candidates and methods of using the same, as well as any other relevant inventions and
improvements that we believe to be commercially important to the development of our business. We also rely on trade secrets, <FONT STYLE="white-space:nowrap">know-how</FONT> and continuing technological innovation to develop and maintain our
proprietary and intellectual property position. Our commercial success depends, in part, on our ability to obtain, maintain, enforce and protect our intellectual property and other proprietary rights for the technology, inventions and improvements
we consider important to our business, and to defend any patents we may own or <FONT STYLE="white-space:nowrap">in-license</FONT> in the future, prevent others from infringing any patents we may own or
<FONT STYLE="white-space:nowrap">in-license</FONT> in the future, preserve the confidentiality of our trade secrets, and operate without infringing, misappropriating or otherwise violating the valid and enforceable patents and proprietary rights of
third parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As with other biotechnology and pharmaceutical companies, our ability to maintain and solidify our proprietary and intellectual property
position for our product candidates and technologies will depend on our success in obtaining effective patent claims and enforcing those claims if granted. However, our pending provisional and PCT patent applications, and any patent applications
that we may in the future file or license from third parties, may not result in the issuance of patents and any issued patents we may obtain do not guarantee us the right to practice our technology or commercialize our product candidates. We also
cannot predict the breadth of claims that may be allowed or enforced in any patents we may own or <FONT STYLE="white-space:nowrap">in-license</FONT> in the future. Any issued patents that we may own or
<FONT STYLE="white-space:nowrap">in-license</FONT> in the future may be challenged, invalidated, circumvented or have the scope of their claims narrowed. In addition, because of the extensive time required for clinical development and regulatory
review of a product candidate we may develop, it is possible that, before any of our product candidates can be commercialized, any related patent may expire or remain in force for only a short period following
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">135 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
commercialization, thereby limiting the protection such patent would afford the respective product and any competitive advantage such patent may provide. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The term of individual patents depends upon the date of filing of the patent application, the date of patent issuance and the legal term of patents in the
countries in which they are obtained. In most countries, including the United States, the patent term is 20&nbsp;years from the earliest filing date of a <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent application. In the United
States, a patent&#146;s term may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the USPTO in examining and granting a patent, or may be shortened if a patent is terminally disclaimed over an
earlier expiring patent. The term of a patent claiming a new drug product may also be eligible for a limited patent term extension when FDA approval is granted, provided statutory and regulatory requirements are met. The restoration period granted
on a patent covering a product is typically <FONT STYLE="white-space:nowrap">one-half</FONT> the time between the effective date of a clinical investigation involving human beings is begun and the submission date of an application, plus the time
between the submission date of an application and the ultimate approval date. The restoration period cannot be longer than five years, and the restoration period may not extend the patent term beyond 14 years from the date of FDA approval. Only one
patent applicable to an approved product is eligible for the extension, and only those claims covering the approved product, a method for using it, or a method for manufacturing it may be extended. Additionally, the application for the extension
must be submitted prior to the expiration of the patent in question. A patent that covers multiple products for which approval is sought can only be extended in connection with one of the approvals. The United States Patent and Trademark Office
reviews and approves the application for any patent term extension or restoration in consultation with the FDA. In the future, if our product candidates receive approval by the FDA, we expect to apply for patent term extensions on one issued patent
covering each of those products, depending upon the length of the clinical studies for each product and other factors. There can be no assurance that patents will issue from our current or future pending patent applications, or that we will benefit
from any patent term extension or favorable adjustments to the terms of any patents we may own or <FONT STYLE="white-space:nowrap">in-license</FONT> in the future. In addition, the actual protection afforded by a patent varies on a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">product-by-product</FONT></FONT> basis, from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-to-country,</FONT></FONT> and depends upon many factors, including the
type of patent, the scope of its coverage, the availability of regulatory-related extensions, the availability of legal remedies in a particular country and the validity and enforceability of the patent. Patent term may be inadequate to protect our
competitive position on our products for an adequate amount of time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;15, 2020, we owned four pending U.S. provisional patent
applications, four pending U.S. <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent applications, and six pending Patent Cooperation Treaty, or PCT, patent applications, two pending Argentina
<FONT STYLE="white-space:nowrap">non-provisional</FONT> patent applications, and two pending Taiwan <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent applications. We currently do not own or
<FONT STYLE="white-space:nowrap">in-license</FONT> any issued patents or <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent applications with respect to <FONT STYLE="white-space:nowrap">RLY-4008,</FONT> our platform technology, or our
PI3K Program, and our intellectual property portfolio is in its very early stages. We do not currently own or <FONT STYLE="white-space:nowrap">in-license</FONT> any issued patents or provisional or
<FONT STYLE="white-space:nowrap">non-provisional</FONT> patent applications covering our other product candidates or technology. Presently, all of the patent applications we own are <FONT STYLE="white-space:nowrap">co-owned</FONT> with D. E. Shaw,
with the exception of one of our U.S. provisional patent applications relating to RLY-1971 solid forms and methods of manufacture, which are wholly owned by us. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">RLY-1971</FONT> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of
June&nbsp;15, 2020, we owned one U.S. non-provisional patent application, one PCT patent application, one Argentina patent application, and one Taiwan patent application that cover the composition of matter for
<FONT STYLE="white-space:nowrap">RLY-1971,</FONT> as well as methods of using and making <FONT STYLE="white-space:nowrap">RLY-1971.</FONT> Any U.S. or foreign patent that may issue from these patent applications would be scheduled to expire in 2039,
excluding any additional term for patent term adjustment or patent term extension, if applicable. As of June&nbsp;15, 2020, we wholly own one U.S. provisional patent application that covers RLY-1971 solid forms and methods of manufacture. Any U.S.
or foreign patent that may issue from a <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent application claiming priority to this patent application would be scheduled to expire in 2040, excluding any additional term for patent term
adjustment or patent term extension, if applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">136 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">RLY-4008</FONT> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;15, 2020, we owned two pending U.S. provisional applications, one PCT patent application, one Argentina patent application and one Taiwan
patent application that cover the composition of matter for <FONT STYLE="white-space:nowrap">RLY-4008,</FONT> as well as methods of using and making <FONT STYLE="white-space:nowrap">RLY-4008.</FONT> Any U.S. or foreign patent that may issue from a <FONT
STYLE="white-space:nowrap">non-provisional</FONT> patent application claiming priority to these applications would be scheduled to expire in 2040, excluding any additional term for patent term adjustment or patent term extension, if applicable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>PI3K Program </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;15, 2020, we owned one
pending U.S. provisional patent application that cover our PI3K Program, which is directed to the composition of matter for the drug candidates of the program, analogs thereof, as well as methods of making and using these compounds. Any U.S. or
foreign patent that may issue from a <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent application claiming priority to this application would be scheduled to expire in 2041. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prosecution of the PCT patent application covering <FONT STYLE="white-space:nowrap">RLY-4008</FONT> and the provisional patent application covering our PI3K
Program has not commenced, and will not commence unless and until they are timely converted into U.S. <FONT STYLE="white-space:nowrap">non-provisional</FONT> or national stage applications. Prosecution is a lengthy process, during which the scope of
the claims initially submitted for examination by the USPTO or other foreign jurisdiction are often significantly narrowed by the time they issue, if they issue at all. Any U.S. or foreign patent issuing from these provisional, PCT, or foreign
patent applications (assuming they are timely converted into <FONT STYLE="white-space:nowrap">non-provisional</FONT> applications, and such <FONT STYLE="white-space:nowrap">non-provisional</FONT> applications are granted as issued patents) would be
scheduled to expire in 2040 (for <FONT STYLE="white-space:nowrap">RLY-4008)</FONT> or 2041 (for our PI3K application), excluding any additional term for patent term adjustment or patent term extension, and assuming national phase entries are timely
made based upon the pending PCT application, and payment of all applicable maintenance or annuity fees. Any of our pending PCT patent applications are not eligible to become issued patents until, among other things, we file national stage patent
applications within 30 months in the countries in which we seek patent protection. If we do not timely file any national stage patent applications, we may lose our priority date with respect to our PCT patent applications and any patent protection
on the inventions disclosed in such PCT patent applications. Our provisional patent applications may never result in issued patents and are not eligible to become issued patents until, among other things, we file a
<FONT STYLE="white-space:nowrap">non-provisional</FONT> patent application and/or PCT patent application within 12 months of filing the related provisional patent application. If we do not timely file
<FONT STYLE="white-space:nowrap">non-provisional</FONT> patent applications, we may lose our priority date with respect to our provisional patent applications and any patent protection on the inventions disclosed in our provisional patent
applications. While we intend to timely file <FONT STYLE="white-space:nowrap">non-provisional</FONT> and national stage patent applications relating to our provisional and PCT patent applications, we cannot predict whether any of our current or
future patent applications for <FONT STYLE="white-space:nowrap">RLY-1971,</FONT> <FONT STYLE="white-space:nowrap">RLY-4008,</FONT> or any of our other product candidates or technology, will issue as patents. If we do not successfully obtain patent
protection, or, even if we do obtain patent protection, if the scope of the patent protection we, or our potential licensors, obtain with respect to <FONT STYLE="white-space:nowrap">RLY-1971,</FONT> <FONT STYLE="white-space:nowrap">RLY-4008,</FONT>
or our other product candidates or technology is not sufficiently broad, we will be unable to prevent others from using our technology or from developing or commercializing technology and products similar or identical to ours or other competing
products and technologies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to patent applications, we rely on unpatented trade secrets, <FONT STYLE="white-space:nowrap">know-how</FONT> and
continuing technological innovation to develop and maintain our competitive position. However, trade secrets and confidential <FONT STYLE="white-space:nowrap">know-how</FONT> are difficult to protect. In particular, we anticipate that with respect
to the building of our compound library, our trade secrets and <FONT STYLE="white-space:nowrap">know-how</FONT> will over time be disseminated within the industry through independent development and public presentations describing the methodology.
We seek to protect our proprietary information, in part, by executing confidentiality agreements with our collaborators and scientific advisors and <FONT STYLE="white-space:nowrap">non-competition,</FONT>
<FONT STYLE="white-space:nowrap">non-solicitation,</FONT> confidentiality and invention assignment agreements with our employees and consultants. We have also executed agreements requiring assignment of inventions with selected consultants,
scientific advisors and collaborators. The confidentiality agreements we enter into are designed to protect our proprietary information and the agreements or clauses requiring assignment of inventions to us are designed to grant us
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">137 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
ownership of technologies that are developed through our relationship with the respective counterparty. We cannot guarantee that we will have executed such agreements with all applicable
employees and contractors, or that these agreements will afford us adequate protection of our intellectual property and proprietary information rights. In addition, our trade secrets and/or confidential
<FONT STYLE="white-space:nowrap">know-how</FONT> may become known or be independently developed by a third party or misused by any collaborator to whom we disclose such information. These agreements may also be breached, and we may not have an
adequate remedy for any such breach. Despite any measures taken to protect our intellectual property, unauthorized parties may attempt to copy aspects of our products or to obtain or use information that we regard as proprietary. Although we take
steps to protect our proprietary information, third parties may independently develop the same or similar proprietary information or may otherwise gain access to our proprietary information. As a result, we may be unable to meaningfully protect our
trade secrets and proprietary information. For more information regarding the risks related to our intellectual property, please see &#147;Risk Factors&#151;Risks Related to our Intellectual Property.&#148; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commercialization </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to receiving
marketing approvals, we expect to commence commercialization activities by building a focused sales and marketing organization in the United States to sell our products. We believe that such an organization will be able to address the community of
oncologists who are the key specialists in treating the patient populations for which our product candidates are being developed. Outside the United States, we expect to enter into distribution and other marketing arrangements with third parties for
any of our product candidates that obtain marketing approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also plan to build a marketing and sales management organization to create and implement
marketing strategies for any products that we market through our own sales organization and to oversee and support our sales force. The responsibilities of the marketing organization would include developing educational initiatives with respect to
approved products and establishing relationships with researchers and practitioners in relevant fields of medicine. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Manufacturing
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We do not have any manufacturing facilities or personnel. We currently rely, and expect to continue to rely, on third parties for the manufacture of
our product candidates undergoing preclinical testing, as well as for clinical testing and commercial manufacture if our product candidates receive marketing approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All of our drug candidates are small molecules and are manufactured in synthetic processes from available starting materials. The chemistry appears amenable
to <FONT STYLE="white-space:nowrap">scale-up</FONT> and does not currently require unusual equipment in the manufacturing process. We expect to continue to develop product candidates that can be produced cost-effectively at contract manufacturing
facilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We generally expect to rely on third parties for the manufacture of companion diagnostics for our products, which are assays or tests to
identify an appropriate patient population. Depending on the technology solutions we choose, we may rely on multiple third parties to manufacture and sell a single test. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Governmental Regulation </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA and
other regulatory authorities at federal, state and local levels, as well as in foreign countries, extensively regulate, among other things, the research, development, testing, manufacture, quality control, import, export, safety, effectiveness,
labeling, packaging, storage, distribution, recordkeeping, approval, advertising, promotion, marketing, post-approval monitoring and post-approval reporting of drugs. We, along </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">138 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with our vendors, contract research organizations and contract manufacturers, will be required to navigate the various preclinical, clinical, manufacturing and commercial approval requirements of
the governing regulatory agencies of the countries in which we wish to conduct studies or seek approval of our product candidates. The process of obtaining regulatory approvals of drugs and ensuring subsequent compliance with appropriate federal,
state, local and foreign statutes and regulations requires the expenditure of substantial time and financial resources. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the United States, where we
are initially focusing our drug development, the FDA regulates drug products under the Federal Food, Drug, and Cosmetic Act, or FD&amp;C Act, as amended, its implementing regulations and other laws. If we fail to comply with applicable FDA or other
requirements at any time with respect to product development, clinical testing, approval or any other legal requirements relating to product manufacture, processing, handling, storage, quality control, safety, marketing, advertising, promotion,
packaging, labeling, export, import, distribution, or sale, we may become subject to administrative or judicial sanctions or other legal consequences. These sanctions or consequences could include, among other things, the FDA&#146;s refusal to
approve pending applications, issuance of clinical holds for ongoing studies, suspension or revocation of approved applications, warning or untitled letters, product withdrawals or recalls, product seizures, relabeling or repackaging, total or
partial suspensions of manufacturing or distribution, injunctions, fines, civil penalties or criminal prosecution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The process required by the FDA before
our product candidates are approved as drugs for therapeutic indications and may be marketed in the United States generally involves the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">completion of extensive preclinical studies in accordance with applicable regulations, including studies
conducted in accordance with good laboratory practice, or GLP, requirements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">completion of the manufacture, under current Good Manufacturing Practices, or cGMP, conditions, of the drug
substance and drug product that the sponsor intends to use in human clinical trials along with required analytical and stability testing; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">submission to the FDA of an investigational new drug application, or IND, which must become effective before
clinical trials may begin; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approval by an institutional review board, or IRB, or independent ethics committee at each clinical trial site
before each trial may be initiated; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">performance of adequate and well-controlled clinical trials in accordance with applicable IND regulations, good
clinical practice, or GCP, requirements and other clinical trial-related regulations to establish the safety and efficacy of the investigational product for each proposed indication; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">submission to the FDA of a New Drug Application, or NDA; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a determination by the FDA within 60 days of its receipt of an NDA, to accept the filing for review;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">satisfactory completion of one or more FDA <FONT STYLE="white-space:nowrap">pre-approval</FONT> inspections of
the manufacturing facility or facilities where the drug will be produced to assess compliance with cGMP requirements to assure that the facilities, methods and controls are adequate to preserve the drug&#146;s identity, strength, quality and purity;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">potentially, satisfactory completion of FDA audit of the clinical trial sites that generated the data in support
of the NDA; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">payment of user fees for FDA review of the NDA; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">FDA review and approval of the NDA, including consideration of the views of any FDA advisory committee, prior to
any commercial marketing or sale of the drug in the United States. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Preclinical studies and clinical trials for drugs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Before testing any drug in humans, the product candidate must undergo rigorous preclinical testing. Preclinical studies include laboratory evaluations of drug
chemistry, formulation and stability, as well as<I></I><I>&nbsp;in vitro</I>&nbsp;and animal </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">139 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
studies to assess safety and in some cases to establish the rationale for therapeutic use. The conduct of preclinical studies is subject to federal and state regulation, including GLP
requirements for safety/toxicology studies. The results of the preclinical studies, together with manufacturing information and analytical data, must be submitted to the FDA as part of an IND. An IND is a request for authorization from the FDA to
administer an investigational product to humans and must become effective before clinical trials may begin. Some long-term preclinical testing may continue after the IND is submitted. The IND automatically becomes effective 30&nbsp;days after
receipt by the FDA, unless the FDA, within the <FONT STYLE="white-space:nowrap">30-day</FONT> time period, raises concerns or questions about the conduct of the clinical trial, including concerns that human research subjects will be exposed to
unreasonable health risks, and imposes a full or partial clinical hold. FDA must notify the sponsor of the grounds for the hold and any identified deficiencies must be resolved before the clinical trial can begin. Submission of an IND may result in
the FDA not allowing clinical trials to commence or not allowing clinical trials to commence on the terms originally specified in the IND. A clinical hold can also be imposed once a trial has already begun, thereby halting the trial until the
deficiencies articulated by FDA are corrected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The clinical stage of development involves the administration of the product candidate to healthy
volunteers or patients under the supervision of qualified investigators, who generally are physicians not employed by or under the trial sponsor&#146;s control, in accordance with GCP requirements, which include the requirements that all research
subjects provide their informed consent for their participation in any clinical trial. Clinical trials are conducted under protocols detailing, among other things, the objectives of the clinical trial, dosing procedures, subject selection and
exclusion criteria and the parameters and criteria to be used in monitoring safety and evaluating effectiveness. Each protocol, and any subsequent amendments to the protocol, must be submitted to the FDA as part of the IND. Furthermore, each
clinical trial must be reviewed and approved by an IRB for each institution at which the clinical trial will be conducted to ensure that the risks to individuals participating in the clinical trials are minimized and are reasonable compared to the
anticipated benefits. The IRB also approves the informed consent form that must be provided to each clinical trial subject or his or her legal representative and must monitor the clinical trial until completed. The FDA, the IRB, or the sponsor may
suspend or discontinue a clinical trial at any time on various grounds, including a finding that the subjects are being exposed to an unacceptable health risk. There also are requirements governing the reporting of ongoing clinical trials and
completed clinical trials to public registries. Information about clinical trials, including results for clinical trials other than Phase 1 investigations, must be submitted within specific timeframes for publication on www.ClinicalTrials.gov, a
clinical trials database maintained by the National Institutes of Health. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A sponsor who wishes to conduct a clinical trial outside of the United States
may, but need not, obtain FDA authorization to conduct the clinical trial under an IND. If a foreign clinical trial is not conducted under an IND, FDA will nevertheless accept the results of the study in support of an NDA if the study was conducted
in accordance with GCP requirements, and the FDA is able to validate the data through an onsite inspection if deemed necessary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Clinical trials to
evaluate therapeutic indications to support NDAs for marketing approval are typically conducted in three sequential phases, which may overlap. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Phase</I><I></I><I>&nbsp;1</I>&#151;Phase&nbsp;1 clinical trials involve initial introduction of the
investigational product into healthy human volunteers or patients with the target disease or condition. These studies are typically designed to test the safety, dosage tolerance, absorption, metabolism and distribution of the investigational product
in humans, excretion the side effects associated with increasing doses, and, if possible, to gain early evidence of effectiveness. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Phase</I><I></I><I>&nbsp;2</I>&#151;Phase&nbsp;2 clinical trials typically involve administration of the
investigational product to a limited patient population with a specified disease or condition to evaluate the drug&#146;s potential efficacy, to determine the optimal dosages and dosing schedule and to identify possible adverse side effects and
safety risks. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Phase</I><I></I><I>&nbsp;3</I>&#151;Phase&nbsp;3 clinical trials typically involve administration of the
investigational product to an expanded patient population to further evaluate dosage, to provide statistically significant evidence of </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">140 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
clinical efficacy and to further test for safety, generally at multiple geographically dispersed clinical trial sites. These clinical trials are intended to establish the overall risk/benefit
ratio of the investigational product and to provide an adequate basis for product approval and physician labeling. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In August 2018, the
FDA released a draft guidance entitled &#147;Expansion Cohorts: Use in <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">First-In-Human</FONT></FONT> Clinical Trials to Expedite Development of Oncology Drugs and Biologics,&#148;
which outlines how drug developers can utilize an adaptive trial design commonly referred to as a seamless trial design in early stages of oncology drug development (i.e., the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> clinical trial) to compress the traditional three phases of trials into one continuous trial called an expansion cohort trial. Information to support the
design of individual expansion cohorts are included in IND applications and assessed by FDA. Expansion cohort trials can potentially bring efficiency to drug development and reduce development costs and time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Post-approval trials, sometimes referred to as Phase&nbsp;4 clinical trials or post-marketing studies, may be conducted after initial marketing approval.
These trials are used to gain additional experience from the treatment of patients in the intended therapeutic indication and are commonly intended to generate additional safety data regarding use of the product in a clinical setting. In certain
instances, the FDA may mandate the performance of Phase&nbsp;4 clinical trials as a condition of NDA approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Progress reports detailing the results of
the clinical trials, among other information, must be submitted at least annually to the FDA. Written IND safety reports must be submitted to the FDA and the investigators fifteen days after the trial sponsor determines the information qualifies for
reporting for serious and unexpected suspected adverse events, findings from other studies or animal or<I></I><I>&nbsp;in vitro</I>&nbsp;testing that suggest a significant risk for human volunteers and any clinically important increase in the rate
of a serious suspected adverse reaction over that listed in the protocol or investigator brochure. The sponsor must also notify the FDA of any unexpected fatal or life-threatening suspected adverse reaction as soon as possible but in no case later
than seven calendar days after the sponsor&#146;s initial receipt of the information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Concurrent with clinical trials, companies usually complete
additional animal studies and must also develop additional information about the chemistry and physical characteristics of the product candidate and finalize a process for manufacturing the drug product in commercial quantities in accordance with
cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the product candidate and manufacturers must develop, among other things, methods for testing the identity, strength, quality and purity of the
final drug product. Additionally, appropriate packaging must be selected and tested, and stability studies must be conducted to demonstrate that the product candidate does not undergo unacceptable deterioration over its shelf life. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>U.S. marketing approval for drugs </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Assuming
successful completion of the required clinical testing, the results of the preclinical studies and clinical trials, together with detailed information relating to the product&#146;s chemistry, manufacture, controls and proposed labeling, among other
things, are submitted to the FDA as part of an NDA package requesting approval to market the product for one or more indications. An NDA is a request for approval to market a new drug for one or more specified indications and must contain proof of
the drug&#146;s safety and efficacy for the requested indications. The marketing application is required to include both negative and ambiguous results of preclinical studies and clinical trials, as well as positive findings. Data may come from
company-sponsored clinical trials intended to test the safety and efficacy of a product&#146;s use or from a number of alternative sources, including studies initiated by investigators. To support marketing approval, the data submitted must be
sufficient in quality and quantity to establish the safety and efficacy of the investigational product to the satisfaction of the FDA. FDA must approve an NDA before a drug may be marketed in the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA reviews all submitted NDAs before it accepts them for filing and may request additional information rather than accepting the NDA for filing. The FDA
must make a decision on accepting an NDA for filing within </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">141 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
60 days of receipt, and such decision could include a refusal to file by the FDA. Once the submission is accepted for filing, the FDA begins an <FONT STYLE="white-space:nowrap">in-depth</FONT>
substantive review of the NDA. The FDA reviews an NDA to determine, among other things, whether the drug is safe and effective for the indications sought and whether the facility in which it is manufactured, processed, packaged or held meets
standards designed to assure the product&#146;s continued safety, quality and purity. Under the goals and polices agreed to by the FDA under the Prescription Drug User Fee Act, or PDUFA, the FDA targets ten months, from the filing date, in which to
complete its initial review of a new molecular entity NDA and respond to the applicant, and six months from the filing date of a new molecular entity NDA for priority review. The FDA does not always meet its PDUFA goal dates for standard or priority
NDAs, and the review process is often extended by FDA requests for additional information or clarification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further, under PDUFA, as amended, each NDA
must be accompanied by a substantial user fee. The FDA adjusts the PDUFA user fees on an annual basis. Fee waivers or reductions are available in certain circumstances, including a waiver of the application fee for the first application filed by a
small business. Additionally, no user fees are assessed on NDAs for products designated as orphan drugs, unless the product also includes a <FONT STYLE="white-space:nowrap">non-orphan</FONT> indication. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA also may require submission of a Risk Evaluation and Mitigation Strategy, or REMS, if it believes that a risk evaluation and mitigation strategy is
necessary to ensure that the benefits of the drug outweigh its risks. A REMS can include use of risk evaluation and mitigation strategies like medication guides, physician communication plans, assessment plans, and/or elements to assure safe use,
such as restricted distribution methods, patient registries, or other risk-minimization tools. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA may refer an application for a novel drug to an
advisory committee. An advisory committee is a panel of independent experts, including clinicians and other scientific experts, which reviews, evaluates and provides a recommendation as to whether the application should be approved and under what
conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Before approving an NDA, the FDA typically will inspect the facility or facilities where the product is manufactured. The FDA will not approve an application
unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and are adequate to assure consistent production of the product within required specifications. Additionally, before approving an NDA, the
FDA may inspect one or more clinical trial sites to assure compliance with GCP and other requirements and the integrity of the clinical data submitted to the FDA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">After evaluating the NDA and all related information, including the advisory committee recommendation, if any, and inspection reports regarding the
manufacturing facilities and clinical trial sites, the FDA may issue an approval letter, or, in some cases, a complete response letter. A complete response letter generally contains a statement of specific conditions that must be met in order to
secure final approval of the NDA and may require additional clinical or preclinical testing in order for the FDA to reconsider the application. Even with submission of this additional information, the FDA ultimately may decide that the application
does not satisfy the regulatory criteria for approval. If and when those conditions have been met to the FDA&#146;s satisfaction, the FDA will typically issue an approval letter. An approval letter authorizes commercial marketing of the drug with
specific prescribing information for specific indications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Even if the FDA approves a product, depending on the specific risk(s) to be addressed it may
limit the approved indications for use of the product, require that contraindications, warnings or precautions be included in the product labeling, require that post-approval studies, including Phase&nbsp;4 clinical trials, be conducted to further
assess a drug&#146;s safety after approval, require testing and surveillance programs to monitor the product after commercialization, or impose other conditions, including distribution and use restrictions or other risk management mechanisms under a
REMS, which can materially affect the potential market and profitability of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">142 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
product. The FDA may prevent or limit further marketing of a product based on the results of post-marketing studies or surveillance programs. After approval, some types of changes to the approved
product, such as adding new indications, manufacturing changes, and additional labeling claims, are subject to further testing requirements and FDA review and approval. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Orphan drug designation and exclusivity </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the
Orphan Drug Act, the FDA may grant orphan designation to a drug intended to treat a rare disease or condition, which is a disease or condition that affects fewer than 200,000 individuals in the United States, or if it affects more than 200,000
individuals in the United States, there is no reasonable expectation that the cost of developing and making the product available in the United States for the disease or condition will be recovered from sales of the product. Orphan designation must
be requested before submitting an NDA. Orphan designation does not convey any advantage in or shorten the duration of the regulatory review and approval process, though companies developing orphan products are eligible for certain incentives,
including tax credits for qualified clinical testing and waiver of application fees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a product that has orphan designation subsequently receives the
first FDA approval for the disease or condition for which it has such designation, the product is entitled to a seven-year period of marketing exclusivity during which the FDA may not approve any other applications to market the same therapeutic
agent for the same indication, except in limited circumstances, such as a subsequent product&#146;s showing of clinical superiority over the product with orphan exclusivity or where the original applicant cannot produce sufficient quantities of
product. Competitors, however, may receive approval of different therapeutic agents for the indication for which the orphan product has exclusivity or obtain approval for the same therapeutic agent for a different indication than that for which the
orphan product has exclusivity. Orphan product exclusivity could block the approval of one of our products for seven years if a competitor obtains approval for the same therapeutic agent for the same indication before we do, unless we are able to
demonstrate that our product is clinically superior. If an orphan designated product receives marketing approval for an indication broader than what is designated, it may not be entitled to orphan exclusivity. Further, orphan drug exclusive
marketing rights in the United States may be lost if the FDA later determines that the request for designation was materially defective or the manufacturer of the approved product is unable to assure sufficient quantities of the product to meet the
needs of patients with the rare disease or condition. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Rare pediatric disease designation and priority review vouchers </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the FD&amp;C Act, the FDA incentivizes the development of drugs that meet the definition of a &#147;rare pediatric disease,&#148; defined to mean a
serious or life-threatening disease in which the serious or life-threatening manifestations primarily affect individuals aged from birth to 18 years and the disease affects fewer than 200,000 individuals in the United States or affects more than
200,000 in the United States and for which there is no reasonable expectation that the cost of developing and making in the United States a drug for such disease or condition will be received from sales in the United States of such drug. The sponsor
of a product candidate for a rare pediatric disease may be eligible for a voucher that can be used to obtain a priority review for a subsequent human drug application after the date of approval of the rare pediatric disease drug product, referred to
as a priority review voucher, or PRV. A sponsor may request rare pediatric disease designation from the FDA prior to the submission of its NDA. A rare pediatric disease designation does not guarantee that a sponsor will receive a PRV upon approval
of its NDA. Moreover, a sponsor who chooses not to submit a rare pediatric disease designation request may nonetheless receive a PRV upon approval of its marketing application if it requests such a voucher in its original marketing application and
meets all of the eligibility criteria. If a PRV is received, it may be sold or transferred an unlimited number of times. Congress has extended the PRV program until September&nbsp;30, 2020, with the potential for PRVs to be granted until 2022. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">143 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Expedited development and review programs for drugs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA maintains several programs intended to facilitate and expedite development and review of new drugs to address unmet medical needs in the treatment of
serious or life-threatening diseases or conditions. These programs include Fast Track designation, Breakthrough Therapy designation, Priority Review and Accelerated Approval, and the purpose of these programs is to either expedite the development or
review of important new drugs to get them to patients more quickly than standard FDA review timelines typically permit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A new drug is eligible for Fast
Track designation if it is intended to treat a serious or life-threatening disease or condition and demonstrates the potential to address unmet medical needs for such disease or condition. Fast Track designation provides increased opportunities for
sponsor interactions with the FDA during preclinical and clinical development, in addition to the potential for rolling review once a marketing application is filed. Rolling review means that the agency may review portions of the marketing
application before the sponsor submits the complete application. In addition, a new drug may be eligible for Breakthrough Therapy designation if it is intended to treat a serious or life-threatening disease or condition and preliminary clinical
evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. Breakthrough Therapy
designation provides all the features of Fast Track designation in addition to intensive guidance on an efficient drug development program beginning as early as Phase&nbsp;1, and FDA organizational commitment to expedited development, including
involvement of senior managers and experienced review staff in a cross-disciplinary review, where appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any product submitted to the FDA for
approval, including a product with Fast Track or Breakthrough Therapy designation, may also be eligible for additional FDA programs intended to expedite the review and approval process, including Priority Review designation and Accelerated Approval.
A product is eligible for Priority Review, once an NDA or BLA is submitted, if the drug that is the subject of the marketing application has the potential to provide a significant improvement in safety or effectiveness in the treatment, diagnosis or
prevention of a serious disease or condition. Under priority review, the FDA&#146;s goal date to take action on the marketing application is six months compared to ten months for a standard review. Products are eligible for Accelerated Approval if
they can be shown to have an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit, or an effect on a clinical endpoint that can be measured earlier than an effect on irreversible morbidity or mortality, which is
reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accelerated Approval is usually contingent on a sponsor&#146;s agreement to conduct additional post-approval studies to verify and describe the product&#146;s
clinical benefit. The FDA may withdraw approval of a drug or an indication approved under Accelerated Approval if, for example, the confirmatory trial fails to verify the predicted clinical benefit of the product. In addition, the FDA generally
requires, as a condition for Accelerated Approval, that all advertising and promotional materials intended for dissemination or publication within 120&nbsp;days of marketing approval be submitted to the agency for review during the <FONT
STYLE="white-space:nowrap">pre-approval</FONT> review period. After the <FONT STYLE="white-space:nowrap">120-day</FONT> period has passed, all advertising and promotional materials must be submitted at least 30&nbsp;days prior to the intended time
of initial dissemination or publication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no
longer meets the conditions for qualification or the time period for FDA review or approval may not be shortened. Furthermore, Fast Track designation, Breakthrough Therapy designation, Priority Review and Accelerated Approval do not change the
scientific or medical standards for approval or the quality of evidence necessary to support approval, though they may expedite the development or review process. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Pediatric information and pediatric exclusivity </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Pediatric Research Equity Act, or PREA, as amended, certain NDAs and NDA supplements must contain data that can be used to assess the safety and
efficacy of the drug for the claimed indications in all </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">144 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. The FDA may grant deferrals for submission
of pediatric data or full or partial waivers. The FD&amp;C Act requires that a sponsor who is planning to submit a marketing application for a drug that includes a new active ingredient, new indication, new dosage form, new dosing regimen or new
route of administration submit an initial Pediatric Study Plan, or PSP, within 60 days of an <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">end-of-Phase</FONT></FONT> 2 meeting or, if there is no such meeting, as early as
practicable before the initiation of the Phase 3 or Phase 2/3 study. The initial PSP must include an outline of the pediatric study or studies that the sponsor plans to conduct, including study objectives and design, age groups, relevant endpoints
and statistical approach, or a justification for not including such detailed information, and any request for a deferral of pediatric assessments or a full or partial waiver of the requirement to provide data from pediatric studies along with
supporting information. The FDA and the sponsor must reach an agreement on the PSP. A sponsor can submit amendments to an agreed-upon initial PSP at any time if changes to the pediatric plan need to be considered based on data collected from
preclinical studies, early phase clinical trials and/or other clinical development programs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A drug can also obtain pediatric market exclusivity in the
United States. Pediatric exclusivity, if granted, adds six months to existing exclusivity periods and patent terms. This <FONT STYLE="white-space:nowrap">six-month</FONT> exclusivity, which runs from the end of other exclusivity protection or patent
term, may be granted based on the voluntary completion of a pediatric study in accordance with an <FONT STYLE="white-space:nowrap">FDA-issued</FONT> &#147;Written Request&#148; for such a study. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>U.S. post-approval requirements for drugs </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Drugs
manufactured or distributed pursuant to FDA approvals are subject to continuing regulation by the FDA, including, among other things, requirements relating to recordkeeping, periodic reporting, product sampling and distribution, reporting of adverse
experiences with the product, complying with promotion and advertising requirements, which include restrictions on promoting products for unapproved uses or patient populations (known as <FONT STYLE="white-space:nowrap">&#147;off-label</FONT>
use&#148;) and limitations on industry-sponsored scientific and educational activities. Although physicians may prescribe legally available products for <FONT STYLE="white-space:nowrap">off-label</FONT> uses, manufacturers may not market or promote
such uses. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of <FONT STYLE="white-space:nowrap">off-label</FONT> uses, and a company that is found to have improperly promoted <FONT
STYLE="white-space:nowrap">off-label</FONT> uses may be subject to significant liability, including investigation by federal and state authorities. Prescription drug promotional materials must be submitted to the FDA in conjunction with their first
use or first publication. Further, if there are any modifications to the drug, including changes in indications, labeling or manufacturing processes or facilities, the applicant may be required to submit and obtain FDA approval of a new NDA or NDA
supplement, which may require the development of additional data or preclinical studies and clinical trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA may impose a number of post-approval
requirements as a condition of approval of an NDA. For example, the FDA may require post-market testing, including Phase 4 clinical trials, and surveillance to further assess and monitor the product&#146;s safety and effectiveness after
commercialization. In addition, drug manufacturers and their subcontractors involved in the manufacture and distribution of approved drugs are required to register their establishments with the FDA and certain state agencies and are subject to
periodic unannounced inspections by the FDA and certain state agencies for compliance with ongoing regulatory requirements, including cGMPs, which impose certain procedural and documentation requirements. Failure to comply with statutory and
regulatory requirements may subject a manufacturer to legal or regulatory action, such as warning letters, suspension of manufacturing, product seizures, injunctions, civil penalties or criminal prosecution. There is also a continuing, annual
prescription drug product program user fee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Later discovery of previously unknown problems with a product, including adverse events of unanticipated
severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information, requirements for post-market studies or clinical trials to
assess new safety risks, or imposition of distribution or other restrictions under a REMS. Other potential consequences include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market
or product recalls; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">145 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the issuance of safety alerts, Dear Healthcare Provider letters, press releases or other communications
containing warnings or other safety information about the product; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fines, warning letters or holds on post-approval clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">refusal of the FDA to approve applications or supplements to approved applications, or suspension or revocation
of product approvals; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product seizure or detention, or refusal to permit the import or export of products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">injunctions or the imposition of civil or criminal penalties; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">consent decrees, corporate integrity agreements, debarment or exclusion from federal healthcare programs; or
mandated modification of promotional materials and labeling and issuance of corrective information. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Regulation of companion
diagnostics </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Companion diagnostics identify patients who are most likely to benefit from a particular therapeutic product; identify patients likely
to be at increased risk for serious side effects as a result of treatment with a particular therapeutic product; or monitor response to treatment with a particular therapeutic product for the purpose of adjusting treatment to achieve improved safety
or effectiveness. Companion diagnostics are regulated as medical devices by the FDA. In the United States, the FD&amp;C Act, and its implementing regulations, and other federal and state statutes and regulations govern, among other things, medical
device design and development, preclinical and clinical testing, premarket clearance or approval, registration and listing, manufacturing, labeling, storage, advertising and promotion, sales and distribution, export and import, and post-market
surveillance. Unless an exemption or FDA exercise of enforcement discretion applies, diagnostic tests generally require marketing clearance or approval from the FDA prior to commercialization. The two primary types of FDA marketing authorization
applicable to a medical device are clearance of a premarket notification, or 510(k), and approval of a premarket approval application, or PMA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To obtain
510(k) clearance for a medical device, or for certain modifications to devices that have received 510(k) clearance, a manufacturer must submit a premarket notification demonstrating that the proposed device is substantially equivalent to a
previously cleared 510(k) device or to a <FONT STYLE="white-space:nowrap">pre-amendment</FONT> device that was in commercial distribution before May&nbsp;28, 1976, or a predicate device, for which the FDA has not yet called for the submission of a
PMA. In making a determination that the device is substantially equivalent to a predicate device, the FDA compares the proposed device to the predicate device and assesses whether the subject device is comparable to the predicate device with respect
to intended use, technology, design and other features which could affect safety and effectiveness. If the FDA determines that the subject device is substantially equivalent to the predicate device, the subject device may be cleared for marketing.
The 510(k) premarket notification pathway generally takes from three to twelve months from the date the application is completed, but can take significantly longer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A PMA must be supported by valid scientific evidence, which typically requires extensive data, including technical, preclinical, clinical and manufacturing
data, to demonstrate to the FDA&#146;s satisfaction the safety and effectiveness of the device. For diagnostic tests, a PMA typically includes data regarding analytical and clinical validation studies. As part of its review of the PMA, the FDA will
conduct a <FONT STYLE="white-space:nowrap">pre-approval</FONT> inspection of the manufacturing facility or facilities to ensure compliance with the quality system regulation, or QSR, which requires manufacturers to follow design, testing, control,
documentation and other quality assurance procedures. The FDA&#146;s review of an initial PMA is required by statute to take between six to ten months, although the process typically takes longer, and may require several years to complete. If the
FDA evaluations of both the PMA and the manufacturing facilities are favorable, the FDA will either issue an approval letter or an approvable letter, which usually contains a number of conditions that must be met in order to secure the final
approval of the PMA. If the FDA&#146;s evaluation of the PMA or manufacturing facilities is not favorable, the FDA will deny the approval of the PMA or issue a not approvable letter. A not approvable letter will outline the deficiencies in the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">146 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
application and, where practical, will identify what is necessary to make the PMA approvable. Once granted, PMA approval may be withdrawn by the FDA if compliance with post-approval requirements,
conditions of approval or other regulatory standards is not maintained or problems are identified following initial marketing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&nbsp;31, 2014, the
FDA issued a final guidance document addressing the development and approval process for &#147;In Vitro Companion Diagnostic Devices.&#148; According to the guidance document, for novel therapeutic products that depend on the use of a diagnostic
test and where the diagnostic device could be essential for the safe and effective use of the corresponding therapeutic product, the companion diagnostic device should be developed and approved or cleared contemporaneously with the therapeutic,
although the FDA recognizes that there may be cases when contemporaneous development may not be possible. However, in cases where a drug cannot be used safely or effectively without the companion diagnostic, the FDA&#146;s guidance indicates it will
generally not approve the drug without the approval or clearance of the diagnostic device. The FDA also issued a draft guidance in July 2016 setting forth the principles for <FONT STYLE="white-space:nowrap">co-development</FONT> of an in vitro
companion diagnostic device with a therapeutic product. The draft guidance describes principles to guide the development and contemporaneous marketing authorization for the therapeutic product and its corresponding in vitro companion diagnostic.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Once cleared or approved, the companion diagnostic device must adhere to post-marketing requirements including the requirements of the FDA&#146;s QSR,
adverse event reporting, recalls and corrections along with product marketing requirements and limitations. Like drug makers, companion diagnostic makers are subject to unannounced FDA inspections at any time during which the FDA will conduct an
audit of the product(s) and the company&#146;s facilities for compliance with its authorities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other regulatory matters </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Manufacturing, sales, promotion and other activities of product candidates following product approval, where applicable, or commercialization are also subject
to regulation by numerous regulatory authorities in the United States in addition to the FDA, which may include the Centers for Medicare&nbsp;&amp; Medicaid Services, or CMS, other divisions of the U.S. Department of Health and Human Services, the
Department of Justice, the Drug Enforcement Administration, the Consumer Product Safety Commission, the Federal Trade Commission, the Occupational Safety&nbsp;&amp; Health Administration, the Environmental Protection Agency and state and local
governments and governmental agencies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other healthcare laws </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Healthcare providers, physicians, and third-party payors will play a primary role in the recommendation and prescription of any products for which we obtain
marketing approval. Our business operations and any current or future arrangements with third-party payors, healthcare providers and physicians may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations that may
constrain the business or financial arrangements and relationships through which we develop, market, sell and distribute any drugs for which we obtain marketing approval. In the United States, these laws include, without limitation, state and
federal anti-kickback, false claims, physician transparency, and patient data privacy and security laws and regulations, including but not limited to those described below. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The federal Anti-Kickback Statute prohibits, among other things, persons and entities from knowingly and
willfully soliciting, offering, paying, receiving or providing any remuneration (including any kickback, bribe, or certain rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward, or in return for, either the
referral of an individual for, or the purchase, order or recommendation of, any good or service, for which payment may be made, in whole or in part, under a federal healthcare program such as Medicare and Medicaid; a person or entity need not have
actual knowledge of the federal Anti-Kickback Statute or specific intent to violate it in order to have committed a violation. Violations are subject to civil and criminal fines and penalties for each violation, plus up to three times the
remuneration involved, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">147 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
imprisonment, and exclusion from government healthcare programs. In addition, the government may assert that a claim that includes items or services resulting from a violation of the federal
Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the civil False Claims Act. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The federal civil and criminal false claims laws, including the civil False Claims Act, or FCA, prohibit
individuals or entities from, among other things, knowingly presenting, or causing to be presented, to the federal government, claims for payment or approval that are false, fictitious or fraudulent; knowingly making, using, or causing to be made or
used, a false statement or record material to a false or fraudulent claim or obligation to pay or transmit money or property to the federal government; or knowingly concealing or knowingly and improperly avoiding or decreasing an obligation to pay
money to the federal government. Manufacturers can be held liable under the FCA even when they do not submit claims directly to government payors if they are deemed to &#147;cause&#148; the submission of false or fraudulent claims. The FCA also
permits a private individual acting as a &#147;whistleblower&#148; to bring actions on behalf of the federal government alleging violations of the FCA and to share in any monetary recovery. When an entity is determined to have violated the federal
civil False Claims Act, the government may impose civil fines and penalties for each false claim, plus treble damages, and exclude the entity from participation in Medicare, Medicaid and other federal healthcare programs. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The federal civil monetary penalties laws impose civil fines for, among other things, the offering or transfer or
remuneration to a Medicare or state healthcare program beneficiary, if the person knows or should know it is likely to influence the beneficiary&#146;s selection of a particular provider, practitioner, or supplier of services reimbursable by
Medicare or a state health care program, unless an exception applies. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Health Insurance Portability and Accountability Act of 1996, or HIPAA, imposes criminal and civil liability
for knowingly and willfully executing a scheme, or attempting to execute a scheme, to defraud any healthcare benefit program, including private payors, knowingly and willfully embezzling or stealing from a healthcare benefit program, willfully
obstructing a criminal investigation of a healthcare offense, or falsifying, concealing or covering up a material fact or making any materially false statements in connection with the delivery of or payment for healthcare benefits, items or
services. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH,
and their respective implementing regulations, impose, among other things, specified requirements on covered entities and their business associates relating to the privacy and security of individually identifiable health information including
mandatory contractual terms and required implementation of technical safeguards of such information. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business
associates in some cases, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys&#146; fees and costs associated with pursuing federal
civil actions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Physician Payments Sunshine Act, enacted as part of the Patient Protection and Affordable Care Act, as
amended by the Health Care and Education Reconciliation Act of 2010, or collectively, the ACA, imposed new annual reporting requirements for certain manufacturers of drugs, devices, biologics, and medical supplies for which payment is available
under Medicare, Medicaid, or the Children&#146;s Health Insurance Program, for certain payments and &#147;transfers of value&#148; provided to physicians (currently defined to include doctors, dentists, optometrists, podiatrists and chiropractors)
and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members.&nbsp;In addition, many states also require reporting of payments or other transfers of value, many of which differ from each
other in significant ways, are often not <FONT STYLE="white-space:nowrap">pre-empted,</FONT> and may have a more prohibitive effect than the Sunshine Act, thus further complicating compliance efforts. Effective January&nbsp;1, 2022, these reporting
obligations will extend to include transfers of value made in the previous year to certain <FONT STYLE="white-space:nowrap">non-physician</FONT> providers such as physician assistants and nurse practitioners. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Federal consumer protection and unfair competition laws broadly regulate marketplace activities and activities
that potentially harm consumers. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">148 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Analogous state and foreign laws and regulations may be broader in scope than the provisions described above and
may apply regardless of payor. Some state laws require pharmaceutical companies to comply with the pharmaceutical industry&#146;s voluntary compliance guidelines and relevant federal government compliance guidance; require drug manufacturers to
report information related to payments and other transfers of value to physicians and other healthcare providers; restrict marketing practices or require disclosure of marketing expenditures and pricing information. State and foreign laws may govern
the privacy and security of health information in some circumstances. These data privacy and security laws may differ from each other in significant ways and often are not <FONT STYLE="white-space:nowrap">pre-empted</FONT> by HIPAA, which may
complicate compliance efforts. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current
environment of healthcare reform, especially in light of the lack of applicable precedent and regulations. Federal and state enforcement bodies have recently increased their scrutiny of interactions between healthcare companies and healthcare
providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. It is possible that governmental authorities will conclude that our business practices do not comply with current or future
statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of these laws or any other related governmental regulations that may apply to us,
we may be subject to significant civil, criminal and administrative penalties, damages, fines, imprisonment, disgorgement, exclusion from government funded healthcare programs, such as Medicare and Medicaid, reputational harm, additional oversight
and reporting obligations if we become subject to a corporate integrity agreement or similar settlement to resolve allegations of <FONT STYLE="white-space:nowrap">non-compliance</FONT> with these laws and the curtailment or restructuring of our
operations. If any of the physicians or other healthcare providers or entities with whom we expect to do business is found not to be in compliance with applicable laws, they may be subject to similar actions, penalties and sanctions. Ensuring
business arrangements comply with applicable healthcare laws, as well as responding to possible investigations by government authorities, can be time- and resource-consuming and can divert a company&#146;s attention from its business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Insurance Coverage and Reimbursement </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the
United States and markets in other countries, patients who are prescribed treatments for their conditions and providers performing the prescribed services generally rely on third-party payors to reimburse all or part of the associated healthcare
costs. Thus, even if a product candidate is approved, sales of the product will depend, in part, on the extent to which third-party payors, including government health programs in the United States such as Medicare and Medicaid, commercial health
insurers and managed care organizations, provide coverage, and establish adequate reimbursement levels for, the product. In the United States, the principal decisions about reimbursement for new medicines are typically made by the Centers for
Medicare&nbsp;&amp; Medicaid Services, or CMS, an agency within the U.S. Department of Health and Human Services. CMS decides whether and to what extent a new medicine will be covered and reimbursed under Medicare and private payors tend to follow
CMS to a substantial degree. No uniform policy of coverage and reimbursement for drug products exists among third-party payors. Therefore, coverage and reimbursement for drug products can differ significantly from payor to payor. The process for
determining whether a third-party payor will provide coverage for a product may be separate from the process for setting the price or reimbursement rate that the payor will pay for the product once coverage is approved. Third-party payors are
increasingly challenging the prices charged, examining the medical necessity, reviewing the cost-effectiveness of medical products and services and imposing controls to manage costs. Third-party payors may limit coverage to specific products on an
approved list, also known as a formulary, which might not include all of the approved products for a particular indication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In order to secure coverage
and reimbursement for any product that might be approved for sale, a company may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost-effectiveness of the product, which will require additional
expenditure above and beyond the costs required to obtain FDA or other comparable regulatory approvals. Additionally, companies may also need to provide discounts to purchasers, private health plans or government healthcare programs. Nonetheless,
product </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">149 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
candidates may not be considered medically necessary or cost effective. A decision by a third-party payor not to cover a product could reduce physician utilization once the product is approved
and have a material adverse effect on sales, our operations and financial condition. Additionally, a third-party payor&#146;s decision to provide coverage for a product does not imply that an adequate reimbursement rate will be approved. Further,
one payor&#146;s determination to provide coverage for a product does not assure that other payors will also provide coverage and reimbursement for the product, and the level of coverage and reimbursement can differ significantly from payor to
payor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The containment of healthcare costs has become a priority of federal, state and foreign governments, and the prices of products have been a focus
in this effort. Governments have shown significant interest in implementing cost-containment programs, including price controls, restrictions on reimbursement and requirements for substitution of generic products. Adoption of price controls and
cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit a company&#146;s revenue generated from the sale of any approved products. Coverage policies and
third-party payor reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products for which a company or its collaborators receive regulatory approval, less favorable coverage
policies and reimbursement rates may be implemented in the future. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Current and future healthcare reform legislation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the United States and some foreign jurisdictions, there have been, and likely will continue to be, a number of legislative and regulatory changes and
proposed changes regarding the healthcare system directed at broadening the availability of healthcare, improving the quality of healthcare, and containing or lowering the cost of healthcare. For example, in March 2010, the United States Congress
enacted the Affordable Care Act, which, among other things, includes changes to the coverage and payment for products under government health care programs. The Affordable Care Act includes provisions of importance to our potential product
candidates that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">created an annual, nondeductible fee on any entity that manufactures or imports specified branded prescription
drugs and biologic products, apportioned among these entities according to their market share in certain government healthcare programs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expanded eligibility criteria for Medicaid programs by, among other things, allowing states to offer Medicaid
coverage to certain individuals with income at or below 133% of the federal poverty level, thereby potentially increasing a manufacturer&#146;s Medicaid rebate liability; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expanded manufacturers&#146; rebate liability under the Medicaid Drug Rebate Program by increasing the minimum
rebate for both branded and generic drugs and revising the definition of &#147;average manufacturer price,&#148; or AMP, for calculating and reporting Medicaid drug rebates on outpatient prescription drug prices; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">addressed a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are
calculated for drugs that are inhaled, infused, instilled, implanted or injected; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expanded the types of entities eligible for the 340B drug discount program; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">established the Medicare Part D coverage gap discount program by requiring manufacturers to provide <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">point-of-sale-discounts</FONT></FONT> off the negotiated price of applicable brand drugs to eligible beneficiaries during their coverage gap period as a condition for the
manufacturers&#146; outpatient drugs to be covered under Medicare Part D; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">created a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct
comparative clinical effectiveness research, along with funding for such research. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since its enactment, there have been numerous
judicial, administrative, executive, and legislative challenges to certain aspects of the Affordable Care Act, and we expect there will be additional challenges and amendments to the Affordable Care Act in the future. For example, various portions
of the Affordable Care Act are currently </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">150 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
facing legal and constitutional challenges in the Fifth Circuit Court of Appeals and the United States Supreme Court. Additionally, the current administration has issued various Executive Orders
which eliminated cost sharing subsidies and various provisions that would impose a fiscal burden on states or a cost, fee, tax, penalty or regulatory burden on individuals, healthcare providers, health insurers, or manufacturers of pharmaceuticals
or medical devices, and Congress has introduced several pieces of legislation aimed at significantly revising or repealing the Affordable Care Act. It is unclear whether the Affordable Care Act will be overturned, repealed, replaced, or further
amended. We cannot predict what effect further changes to the Affordable Care Act would have on our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other legislative changes have been
proposed and adopted in the United States since the Affordable Care Act was enacted. In August 2011, the Budget Control Act of 2011, among other things, included aggregate reductions of Medicare payments to providers of 2% per fiscal year, which
went into effect in April 2013 and, due to subsequent legislative amendments to the statute, will remain in effect through 2030 unless additional Congressional action is taken. The Coronavirus Aid, Relief and Economic Security Act, or CARES Act,
which was signed into law in March 2020 and is designed to provide financial support and resources to individuals and businesses affected by the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, suspended these reductions from May&nbsp;1,
2020 through December&nbsp;31, 2020. In January 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, further reduced Medicare payments to several providers, including hospitals, imaging centers and cancer
treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Moreover, payment methodologies may be subject to changes in healthcare legislation and regulatory initiatives. For example, CMS may develop new payment and
delivery models, including bundled payment models. In addition, recently there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their commercial products, which has resulted in several Congressional
inquiries and proposed and enacted state and federal legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program
reimbursement methodologies for pharmaceutical products. For example, at the federal level, the current administration&#146;s budgets for fiscal years 2019 and 2020 contained further drug price control measures that could be enacted in future
legislation, including, for example, measures to permit Medicare Part D plans to negotiate the price of certain drugs under Medicare Part B, to allow some states to negotiate drug prices under Medicaid, and to eliminate cost sharing for generic
drugs for <FONT STYLE="white-space:nowrap">low-income</FONT> patients. Additionally, the current administration released a &#147;Blueprint&#148; to lower drug prices and reduce out of pocket costs of drugs that contains additional proposals to
increase drug manufacturer competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of their products, and reduce the out of pocket costs of drug products paid by
consumers. The U.S. Department of Health and Human Services has already started the process of soliciting feedback on some of these measures and, at the same time, is immediately implementing others under its existing authority. For example, in May
2019, CMS issued a final rule to allow Medicare Advantage Plans the option of using step therapy, a type of prior authorization, for Part B drugs beginning January&nbsp;1, 2020. This final rule codified CMS&#146;s policy change that was effective
January&nbsp;1, 2019. Although a number of these and other measures may require additional authorization to become effective, Congress and the current administration have each indicated that it will continue to seek new legislative and/or
administrative measures to control drug costs. Additionally, in December 2019, the FDA issued a notice of proposed rulemaking that, if finalized, would allow for the importation of certain prescription drugs from Canada. If finalized, the FDA would
allow for two potential pathways: the first would allow federal or state entities to partner with pharmacists or wholesalers to submit proposals to the FDA to allow them to import drugs sold at retail pharmacies, while the other pathway would allow
for manufacturers to obtain an additional National Drug Code, or NDC, for an <FONT STYLE="white-space:nowrap">FDA-approved</FONT> drug that was originally intended to be marketed in a foreign country and that was authorized for sale in that foreign
country and to sell it in the United States. The regulatory and market implications of the notice of proposed rulemaking and draft guidance are unknown at this time, but legislation, regulations or policies allowing the reimportation of drugs, if
enacted and implemented, could decrease the price we receive for our products and adversely affect our future revenues and prospects for profitability. Individual </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">151 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
states in the United States have also increasingly passed legislation and implemented regulations designed to control pharmaceutical product pricing, including price or patient reimbursement
constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&nbsp;30, 2018, the Right to Try Act was signed into law. The law, among other things, provides a federal framework for certain patients to access
certain investigational new drug products that have completed a Phase 1 clinical trial and that are undergoing investigation for FDA approval. Under certain circumstances, eligible patients can seek treatment without enrolling in clinical trials and
without obtaining FDA permission under the FDA expanded access program. There is no obligation for a drug manufacturer to make its drug products available to eligible patients as a result of the Right to Try Act, but the manufacturer must develop an
internal policy and respond to patient requests according to that policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Outside the United States, ensuring coverage and adequate payment for a product
also involves challenges. Pricing of prescription pharmaceuticals is subject to government control in many countries. Pricing negotiations with government authorities can extend well beyond the receipt of regulatory approval for a product and may
require a clinical trial that compares the cost-effectiveness of a product to other available therapies. The conduct of such a clinical trial could be expensive and result in delays in commercialization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the European Union, pricing and reimbursement schemes vary widely from country to country. Some countries provide that products may be marketed only after
a reimbursement price has been agreed upon. Some countries may require the completion of additional studies that compare the cost-effectiveness of a particular product candidate to currently available therapies or
<FONT STYLE="white-space:nowrap">so-called</FONT> health technology assessments, in order to obtain reimbursement or pricing approval. For example, the European Union provides options for its member states to restrict the range of products for which
their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. European Union member states may approve a specific price for a product or it may instead adopt a system of direct or
indirect controls on the profitability of the company placing the product on the market. Other member states allow companies to fix their own prices for products, but monitor and control prescription volumes and issue guidance to physicians to limit
prescriptions. Recently, many countries in the European Union have increased the amount of discounts required on pharmaceuticals and these efforts could continue as countries attempt to manage healthcare expenditures, especially in light of the
severe fiscal and debt crises experienced by many countries in the European Union. The downward pressure on healthcare costs in general, particularly prescription products, has become intense. As a result, increasingly high barriers are being
erected to the entry of new products. Political, economic and regulatory developments may further complicate pricing negotiations, and pricing negotiations may continue after reimbursement has been obtained. Reference pricing used by various
European Union member states, and parallel trade, i.e., arbitrage between <FONT STYLE="white-space:nowrap">low-priced</FONT> and high-priced member states, can further reduce prices. There can be no assurance that any country that has price controls
or reimbursement limitations for pharmaceutical products will allow favorable reimbursement and pricing arrangements for any products, if approved in those countries. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Compliance with other federal and state laws or requirements; changing legal requirements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any products that we may develop are made available to authorized users of the Federal Supply Schedule of the General Services Administration, additional
laws and requirements apply. Products must meet applicable child-resistant packaging requirements under the U.S. Poison Prevention Packaging Act. Manufacturing, labeling, packaging, distribution, sales, promotion and other activities also are
potentially subject to federal and state consumer protection and unfair competition laws, among other requirements to which we may be subject. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
distribution of pharmaceutical products is subject to additional requirements and regulations, including extensive recordkeeping, licensing, storage and security requirements intended to prevent the unauthorized sale of pharmaceutical products. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">152 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The failure to comply with any of these laws or regulatory requirements may subject firms to =legal or
regulatory action. Depending on the circumstances, failure to meet applicable regulatory requirements can result in criminal prosecution, fines or other penalties, injunctions, exclusion from federal healthcare programs, requests for recall, seizure
of products, total or partial suspension of production, denial or withdrawal of product approvals, relabeling or repackaging, or refusal to allow a firm to enter into supply contracts, including government contracts. Any claim or action against us
for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#146;s attention from the operation of our business. Prohibitions or restrictions on marketing,
sales or withdrawal of future products marketed by us could materially affect our business in an adverse way. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Changes in regulations, statutes or the
interpretation of existing regulations could impact our business in the future by requiring, for example: (i)&nbsp;changes to our manufacturing arrangements; (ii)&nbsp;additions or modifications to product labeling or packaging; (iii)&nbsp;the
recall or discontinuation of our products; or (iv)&nbsp;additional recordkeeping requirements. If any such changes were to be imposed, they could adversely affect the operation of our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other U.S. environmental, health and safety laws and regulations </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may be subject to numerous environmental, health and safety laws and regulations, including those governing laboratory procedures and the handling, use,
storage, treatment and disposal of hazardous materials and wastes. From time to time and in the future, our operations may involve the use of hazardous and flammable materials, including chemicals and biological materials, and may also produce
hazardous waste products. Even if we contract with third parties for the disposal of these materials and waste products, we cannot completely eliminate the risk of contamination or injury resulting from these materials. In the event of contamination
or injury resulting from the use or disposal of our hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. We also could incur significant costs associated with civil or criminal fines
and penalties for failure to comply with such laws and regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We maintain workers&#146; compensation insurance to cover us for costs and expenses
we may incur due to injuries to our employees, but this insurance may not provide adequate coverage against potential liabilities. However, we do not maintain insurance for environmental liability or toxic tort claims that may be asserted against
us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, we may incur substantial costs in order to comply with current or future environmental, health and safety laws and regulations. Current
or future environmental laws and regulations may impair our research, development or production efforts. In addition, failure to comply with these laws and regulations may result in substantial fines, penalties or other sanctions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Government regulation of drugs outside of the United States </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To market any product outside of the United States, we would need to comply with numerous and varying regulatory requirements of other countries regarding
safety and efficacy and governing, among other things, clinical trials, marketing authorization or identification of an alternate regulatory pathway, manufacturing, commercial sales and distribution of our products. For instance, in the United
Kingdom and the European Economic Area, or the EEA (comprised of the 27 EU Member States plus Iceland, Liechtenstein and Norway), medicinal products must be authorized for marketing by using either the centralized authorization procedure or national
authorization procedures. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Centralized procedure</I>&#151;If pursuing marketing authorization of a product candidate for a therapeutic
indication under the centralized procedure, following the opining of the EMA&#146;s Committee for Medicinal Products for Human Use, or, CHMP, the European Commission issues a single marketing authorization valid across the EEA. The centralized
procedure is compulsory for human medicines derived from biotechnology processes or advanced therapy medicinal products (such as gene therapy, somatic cell therapy </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">153 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
and tissue engineered products), products that contain a new active substance indicated for the treatment of certain diseases, such as HIV/AIDS, cancer, neurodegenerative disorders, diabetes,
autoimmune diseases and other immune dysfunctions, viral diseases, and officially designated orphan medicines. For medicines that do not fall within these categories, an applicant has the option of submitting an application for a centralized
marketing authorization to the EMA, as long as the medicine concerned contains a new active substance not yet authorized in the EEA, is a significant therapeutic, scientific or technical innovation, or if its authorization would be in the interest
of public health in the EEA. Under the centralized procedure the maximum timeframe for the evaluation of an MAA by the EMA is 210&nbsp;days, excluding clock stops, when additional written or oral information is to be provided by the applicant in
response to questions asked by the CHMP. Accelerated assessment might be granted by the CHMP in exceptional cases, when a medicinal product is expected to be of major public health interest, particularly from the point of view of therapeutic
innovation. The timeframe for the evaluation of an MAA under the accelerated assessment procedure is 150&nbsp;days, excluding clock stops. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>National authorization procedures</I>&#151;There are also two other possible routes to authorize products for
therapeutic indications in several countries, which are available for products that fall outside the scope of the centralized procedure: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Decentralized procedure</I>&#151;Using the decentralized procedure, an applicant may apply for simultaneous
authorization in more than one EU country of medicinal products that have not yet been authorized in any EU country and that do not fall within the mandatory scope of the centralized procedure. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Mutual recognition procedure</I>&#151;In the mutual recognition procedure, a medicine is first authorized in
one EU Member State, in accordance with the national procedures of that country. Following this, additional marketing authorizations can be sought from other EU countries in a procedure whereby the countries concerned recognize the validity of the
original, national marketing authorization. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the EEA, new products for therapeutic indications that are authorized for marketing
(i.e.,&nbsp;reference products) qualify for eight years of data exclusivity and an additional two years of market exclusivity upon marketing authorization. The data exclusivity period prevents generic or biosimilar applicants from relying on the
preclinical and clinical trial data contained in the dossier of the reference product when applying for a generic or biosimilar marketing authorization in the EU during a period of eight years from the date on which the reference product was first
authorized in the EU. The market exclusivity period prevents a successful generic or biosimilar applicant from commercializing its product in the EU until ten years have elapsed from the initial authorization of the reference product in the EU. The <FONT
STYLE="white-space:nowrap">ten-year</FONT> market exclusivity period can be extended to a maximum of eleven years if, during the first eight years of those ten years, the marketing authorization holder obtains an authorization for one or more new
therapeutic indications which, during the scientific evaluation prior to their authorization, are held to bring a significant clinical benefit in comparison with existing therapies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The criteria for designating an &#147;orphan medicinal product&#148; in the EEA are similar in principle to those in the United States. In the EEA a medicinal
product may be designated as orphan if (1)&nbsp;it is intended for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition; (2)&nbsp;either (a)&nbsp;such condition affects no more than five in 10,000
persons in the EU when the application is made, or (b)&nbsp;the product, without the benefits derived from orphan status, would not generate sufficient return in the EU to justify investment; and (3)&nbsp;there exists no satisfactory method of
diagnosis, prevention or treatment of such condition authorized for marketing in the EU, or if such a method exists, the product will be of significant benefit to those affected by the condition. Orphan medicinal products are eligible for financial
incentives such as reduction of fees or fee waivers and are, upon grant of a marketing authorization, entitled to ten years of market exclusivity for the approved therapeutic indication. During this <FONT STYLE="white-space:nowrap">ten-year</FONT>
orphan market exclusivity period, no marketing authorization application shall be accepted, and no marketing authorization shall be granted for a similar medicinal product for the same indication. An orphan product can also obtain an additional two
years of market exclusivity in the EU for pediatric studies. The <FONT STYLE="white-space:nowrap">ten-year</FONT> market exclusivity may be reduced to six years if, at the end of the fifth year, it is established that the product no longer meets the
criteria for orphan designation, for example, if the product is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">154 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
sufficiently profitable not to justify maintenance of market exclusivity. Additionally, marketing authorization may be granted to a similar product for the same indication at any time if
(i)&nbsp;the second applicant can establish that its product, although similar, is safer, more effective or otherwise clinically superior; (ii)&nbsp;the applicant consents to a second orphan medicinal product application; or (iii)&nbsp;the applicant
cannot supply enough orphan medicinal product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Similar to the United States, the various phases of <FONT STYLE="white-space:nowrap">non-clinical</FONT>
and clinical research in the European Union are subject to significant regulatory controls. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Clinical Trials Directive 2001/20/EC, the Directive
2005/28/EC on GCP and the related national implementing provisions of the individual EU Member States govern the system for the approval of clinical trials in the European Union. Under this system, an applicant must obtain prior approval from the
competent national authority of the EU Member States in which the clinical trial is to be conducted. Furthermore, the applicant may only start a clinical trial at a specific study site after the competent ethics committee has issued a favorable
opinion. The clinical trial application must be accompanied by, among other documents, an investigational medicinal product dossier (the Common Technical Document) with supporting information prescribed by Directive 2001/20/EC, Directive 2005/28/EC,
where relevant the implementing national provisions of the individual EU Member States and further detailed in applicable guidance documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April
2014, the new Clinical Trials Regulation, (EU) No 536/2014 (Clinical Trials Regulation) was adopted. It is expected that the new Clinical Trials Regulation (EU) No 536/2014 will apply following confirmation of full functionality of the Clinical
Trials Information System (CTIS), the centralized European Union portal and database for clinical trials foreseen by the regulation, through an independent audit. The regulation becomes applicable six months after the European Commission publishes
notice of this confirmation. The Clinical Trials Regulation will be directly applicable in all the EU Member States, repealing the current Clinical Trials Directive 2001/20/EC. Conduct of all clinical trials performed in the European Union will
continue to be bound by currently applicable provisions until the new Clinical Trials Regulation becomes applicable. The extent to which ongoing clinical trials will be governed by the Clinical Trials Regulation will depend on when the Clinical
Trials Regulation becomes applicable and on the duration of the individual clinical trial. If a clinical trial continues for more than three years from the day on which the Clinical Trials Regulation becomes applicable the Clinical Trials Regulation
will at that time begin to apply to the clinical trial. The new Clinical Trials Regulation aims to simplify and streamline the approval of clinical trials in the European Union. The main characteristics of the regulation include: a streamlined
application procedure via a single-entry point, the &#147;EU portal&#148;; a single set of documents to be prepared and submitted for the application as well as simplified reporting procedures for clinical trial sponsors; and a harmonized procedure
for the assessment of applications for clinical trials, which is divided in two parts. Part&nbsp;I is assessed by the competent authorities of all EU Member States in which an application for authorization of a clinical trial has been submitted
(Member States concerned). Part&nbsp;II is assessed separately by each Member State concerned. Strict deadlines have been established for the assessment of clinical trial applications. The role of the relevant ethics committees in the assessment
procedure will continue to be governed by the national law of the concerned EU Member State. However, overall related timelines will be defined by the Clinical Trials Regulation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Government regulation of data collection outside of the United States </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event we conduct clinical trials in the European Union, we will be subject to additional privacy restrictions. The collection and use of personal health
data in the European Economic Area, or EEA (being the European Union plus Norway, Iceland, and Liechtenstein), is governed by the General Data Protection Regulation, or the GDPR, which became effective on May&nbsp;25, 2018. The GDPR applies to the
processing of personal data by any company established in the EEA and to companies established outside the EEA to the extent they process personal data in connection with the offering of goods or services to data subjects in the EEA or the
monitoring of the behavior of data subjects in the EEA. The GDPR enhances data protection obligations for data controllers of personal data, including stringent requirements relating to the consent of data subjects, expanded disclosures about how
personal data is used, requirements to conduct privacy impact assessments for &#147;high risk&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">155 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
processing, limitations on retention of personal data, mandatory data breach notification and &#147;privacy by design&#148; requirements, and creates direct obligations on service providers
acting as processors. The GDPR also imposes strict rules on the transfer of personal data outside of the EEA to countries that do not ensure an adequate level of protection, like the United States (which, while deemed a third country, has the
benefit of the Privacy Shield regime for transatlantic data transfers). Failure to comply with the requirements of the GDPR and the related national data protection laws of the European Union Member States and Norway, Iceland and Liechtenstein,
which may deviate slightly from the GDPR, may result in fines of up to 4% of a company&#146;s global revenues for the preceding financial year, or &#128;20,000,000, whichever is greater. Moreover, the GDPR grants data subjects the right to claim
material and <FONT STYLE="white-space:nowrap">non-material</FONT> damages resulting from infringement of the GDPR. Given the breadth and depth of changes in data protection obligations, maintaining compliance with the GDPR will require significant
time, resources and expense, and we may be required to put in place additional controls and processes ensuring compliance with the new data protection rules. There has been limited enforcement of the GDPR to date, particularly in biopharmaceutical
development, so we face uncertainty as to the exact interpretation of the new requirements on any future trials and we may be unsuccessful in implementing all measures required by data protection authorities or courts in interpretation of the new
law. Further, the United Kingdom&#146;s decision to leave the European Union, often referred to as Brexit, has created uncertainty with regard to data protection regulation in the United Kingdom. In particular, it is unclear how data transfers to
and from the United Kingdom will be regulated now that the United Kingdom has left the European Union. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is significant uncertainty related to the
manner in which data protection authorities will seek to enforce compliance with GDPR. For example, it is not clear if the authorities will conduct random audits of companies doing business in the EU, or if the authorities will wait for complaints
to be filed by individuals who claim their rights have been violated. Enforcement uncertainty and the costs associated with ensuring GDPR compliance are onerous and may adversely affect our business, financial condition, results of operations and
prospects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Should we utilize third party distributors, compliance with such foreign governmental regulations would generally be the responsibility of
such distributors, who may be independent contractors over whom we have limited control. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of April&nbsp;30, 2020, we had 122 full-time employees. Sixty of our employees have M.D. or Ph.D. degrees. Within our workforce, 91 employees are engaged in
research and development and 31 are engaged in business development, finance, legal, and general management and administration. None of our employees are represented by labor unions or covered by collective bargaining agreements. We consider our
relationship with our employees to be good. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Facilities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our corporate headquarters is located in Cambridge, Massachusetts, where we lease and occupy approximately 44,336 square feet of office and laboratory space.
The current term of our Cambridge lease expires April 30<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>, 2029, with an option to extend the term five additional years with 12 &#150; 15 months&#146; notice at agreed upon market rate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe our existing facilities are sufficient for our needs for the foreseeable future. To meet the future needs of our business, we may lease additional
or alternate space, and we believe suitable additional or alternative space will be available in the future on commercially reasonable terms. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Legal
proceedings </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From time to time, we may become involved in litigation or other legal proceedings. We are not currently a party to any litigation or
legal proceedings that, in the opinion of our management, are probable to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on our business, financial condition, results of operations and
prospects because of defense and settlement costs, diversion of management resources and other factors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">156 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_13"></A>MANAGEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executives and directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth
the name, age (as of June 30, 2020)<B> </B>and position of each of our executives and directors. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="60%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Age</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Position</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B><I>Executive Officers:</I></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sanjiv K. Patel, M.D.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">46</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">President and Chief Executive Officer, and Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Donald Bergstrom, M.D., Ph.D.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">48</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Executive Vice President, Head of Research &amp; Development</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Brian R. Adams</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">46</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">General Counsel</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Tom Catinazzo</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">44</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Vice President, Finance</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B><I>Non-Executive Directors:</I></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Alexis Borisy(1)(2)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">48</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Linda A. Hill, Ph.D.(2)(3)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">63</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Douglas S. Ingram(2)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">57</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Christoph Lengauer, Ph.D.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">55</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Mark Murcko, Ph.D.(3)(4)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">60</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dipchand (Deep) Nishar(2)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">51</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jami Rubin(1)(3)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">56</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Laura Shawver, Ph.D.(1)(4)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">63</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the Audit Committee </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the Compensation Committee </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the Nominating and Corporate Governance Committee </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of Research and Development Committee </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Executive team </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sanjiv K. Patel,
M.D</I></B>. has served as a member of our board of directors and as our President and Chief Executive Officer since March 2017. Before joining the Company, Dr.&nbsp;Patel served in various roles at Allergen from 2006 to 2017. He most recently
served as Allergan&#146;s Executive Vice President, Chief Strategy Officer from March 2015 to March 2017 and previously as Corporate Vice President, Global Strategic Marketing and Global Health Outcomes from July 2013 to March 2015. Prior to this he
was a management consultant at The Boston Consulting Group and practiced as a surgeon within the UK&#146;s National Health Service. Dr.&nbsp;Patel holds a MBBS from University of London, a MA in Medical Sciences from the University of Cambridge, a
MRCS from the Royal College of Surgeons of England, and a MBA from INSEAD. We believe Dr.&nbsp;Patel is qualified to serve as a member of our board of directors due to his extensive experience in the life sciences industry as well as an executive at
various pharmaceutical companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Donald Bergstrom, M.D., Ph.D</I></B>. has served as our Executive Vice President, Head of Research&nbsp;&amp;
Development since April 2018. Dr.&nbsp;Bergstrom previously served as Chief Medical Officer of Mersana Therapeutics, Inc., a publicly traded biotechnology company, from January 2014 through March 2018. Before that, Dr.&nbsp;Bergstrom served as
Global Head of Translational Medicine at Sanofi Genzyme, Oncology from May 2010 through January 2014. Dr.&nbsp;Bergstrom holds a B.A. in biophysics from The Johns Hopkins University, an M.D. from the University of Washington, Seattle and a Ph.D.
from the University of Washington &#150; Fred Hutchinson Cancer Research Center. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Brian R. Adams</I></B> has served as our General Counsel and
Secretary since March 2018. Mr.&nbsp;Adams previously served as the Senior Vice President, General Counsel&nbsp;&amp; Secretary at Keryx Biopharmaceuticals, Inc. from March 2014 to March 2018. Before joining Keryx, Mr.&nbsp;Adams served as General
Counsel of Algeta ASA from March </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">157 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
2012 to March 2014 prior to its acquisition by Bayer AG. Mr.&nbsp;Adams holds a B.A. from Harvard University and a J.D. from the Catholic University of America&#146;s Columbus School of Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Tom</I></B><B><I></I></B><B><I>&nbsp;Catinazzo</I></B> has served as our Vice President, Finance since April 2018. From June 2013 to April 2018,
Mr.&nbsp;Catinazzo held several roles at Foundation Medicine, Inc., a biotechnology company, including as the Vice President, Financial Planning&nbsp;&amp; Analysis from January 2017 to April 2018, the Senior Director, Financial Planning&nbsp;&amp;
Analysis from April 2015 to December 2016, and the Director, Financial Planning&nbsp;&amp; Analysis from June 2013 to March 2015.&nbsp;Mr.&nbsp;Catinazzo received his B.S. from Boston College. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-executive</FONT> directors </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Alexis Borisy</I></B> has served as a member of our board of directors since our founding in April 2015. Since June 2019, Mr.&nbsp;Borisy has served as
Chief Executive Officer and chairman of EQRx, Inc., a biotechnology company. From 2010 to June 2019, Mr.&nbsp;Borisy was a partner at Third Rock Ventures, a series of venture capital funds investing in life science companies. Mr.&nbsp;Borisy <FONT
STYLE="white-space:nowrap">co-founded</FONT> Blueprint Medicines Corporation, a biopharmaceutical company, and served as its Interim Chief Executive Officer from 2013 to 2014 and has served as a member of its board of directors since 2011.
Mr.&nbsp;Borisy <FONT STYLE="white-space:nowrap">co-founded</FONT> Foundation Medicine, Inc. and served as its Interim Chief Executive Officer from 2009 to 2011 and served as a member of its board of directors from 2009 to July 2018, until its
acquisition by Roche. In addition, during the past five years Mr.&nbsp;Borisy has served as a member of the board of directors of various public companies, including Revolution Medicines, Inc., Magenta Therapeutics, Inc., Editas Medicine, Inc.
Mr.&nbsp;Borisy received an A.B. in Chemistry from the University of Chicago and an A.M. in Chemistry and Chemical Biology from Harvard University. We believe Mr.&nbsp;Borisy&#146;s extensive experience as an executive of, and working with and
serving on the boards of directors of, multiple biopharmaceutical and life sciences companies, his educational background and his experience working in the venture capital industry provide him with the qualifications and skills necessary to serve as
a member of our board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Linda A. Hill, Ph.D</I></B>. has served as a member of our board of directors since October 2018. Dr.&nbsp;Hill
has served as the Wallace Brett Donham Professor of Business Administration at the Harvard Business School since July 1984 and is the author of several leadership books and articles. Her research focuses on building innovative organizations and
ecosystems and the role of the board in governing innovation. Dr.&nbsp;Hill is also a Founding Partner of Paradox Strategies, a leadership and advisory firm. In the past five years, Dr.&nbsp;Hill has also served as member of the board of directors
of publicly traded companies, State Streep Corp., from 2000 to October 2018, and Eaton Corp plc., from 2012 to April 2017. Dr.&nbsp;Hill is also a member of the board of directors of Harvard Business Publishing and the Global Citizens Initiative,
Inc. She also serves on the Advisory Board of the Aspen Institute Business and Society Program and the Advisory Board for the California Institute for Telecommunications and Information Technology.&nbsp;Dr.&nbsp;Hill holds a B.A. in psychology from
Bryn Mawr College, and a M.A. in educational psychology and a Ph.D. in behavioral sciences from the University of Chicago. Dr.&nbsp;Hill has also completed a post-doctoral research fellowship at the Harvard Business School. We believe
Dr.&nbsp;Hill&#146;s experience in leadership and organizational innovation provide her with the qualifications and skills necessary to serve as a member of our board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Douglas S. Ingram</I></B> has served as a member of our board of directors since June 2019. Mr.&nbsp;Ingram has served as President and Chief Executive
Officer of Sarepta Therapeutics, Inc., a publicly traded biotechnology company, and a member of its board of directors since June 2017. From December 2015 until November 2016, he served as President and Chief Executive Officer of Chase
Pharmaceuticals Corporation and as a member of its board of directors. Prior to joining Chase Pharmaceuticals, Mr.&nbsp;Ingram served as the President of Allergan, Inc. from July 2013 until it was acquired by Actavis in March 2015. At Allergan, he
also served as President, Europe, Africa and Middle East from August 2010 to June 2013, and Executive Vice President, Chief Administrative Officer, and Secretary from October 2006 to July 2010. During the past five years, Mr.&nbsp;Ingram has also
served as a member of the board of directors of Endo International plc and Emerald Bioscience, Inc. Mr.&nbsp;Ingram holds a B.S. from Arizona State University and a J.D. from the University of Arizona. We believe Mr.&nbsp;Ingram&#146;s extensive
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">158 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
experience leading large pharmaceutical companies provides him with the qualifications and skills necessary to serve as a member of our board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Christoph Lengauer, Ph.D</I></B><I></I><B><I>., MBA</I></B><I></I>, has served as a member of our board of directors since November 2019.
Dr.&nbsp;Lengauer has served as a member of the board of directors of Hookipa Pharma Inc. since June 2018. Dr.&nbsp;Lengauer is currently a partner at Third Rock Ventures, where he has worked since March 2016. He also currently serves as the Chief
Innovation Officer at Thrive Earlier Detection, since April 2019 and Chief Scientific Officer of MOMA Therapeutics, Inc. since April 2020. He previously served as Chief Scientific Officer at Celsius Therapeutics, Inc. from May 2018 through April
2020. He currently serves as the Executive Vice President, but additionally was the Chief Scientific Officer and Chief Drug Hunter at Blueprint Medicines from January 2012 to November 2016, the Vice President and Global Head of Oncology Drug
Discovery and Preclinical Development at Sanofi S.A. from May 2008 to January 2012 and Executive Director and Senior Unit Head of Oncology Discovery at the Novartis Institutes for Biomedical Research from July 2005 to May 2008. Prior to his
experience at Novartis, Dr.&nbsp;Lengauer was a member of the faculty at the Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins University School of Medicine from 1997 to 2005. During the past five years, Dr.&nbsp;Lengauer has served as
a member of the board of directors of HOOKIPA Pharma Inc., Celsius Therapeutics, Thrive Earlier Detection, MOMA Therapeutics, and Presage Biosciences. Dr.&nbsp;Lengauer holds a MBA from the Johns Hopkins Carey Business School and a Ph.D. in biology
from the University of Heidelberg. We believe that Dr.&nbsp;Lengauer&#146;s experience in biopharmaceutical research and development and his experience in venture capital qualify him to serve on our board of directors. Dr. Lengauer has notified us
that he will resign from our board of directors immediately prior to the effectiveness of the registration statement of which this prospectus forms a part. Dr. Lengauer&#146;s resignation is not due to any disagreement with the Company or any
matters relating to our operations, policies or practices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Mark Murcko, Ph.D</I></B>. is a <FONT STYLE="white-space:nowrap">co-founder</FONT> of
Relay and has served as a member of our board of directors since July 2016. Dr.&nbsp;Murcko was also our interim Chief Scientific Officer from February 2016 to January 2018.&nbsp;Since July 2012, Dr.&nbsp;Murcko has been a senior lecturer in the
Department of Biological Engineering at MIT.&nbsp;Since November 2018, Dr.&nbsp;Murcko has also been the Chief Scientific Officer and a member of the board of directors of Dewpoint Therapeutics, Inc.&nbsp;Until November 2011, Dr.&nbsp;Murcko served
as the Chief Technology Officer and chair of the scientific advisory board at Vertex Pharmaceuticals and was responsible for the identification, validation and implementation of disruptive technologies across R&amp;D.&nbsp;Dr.&nbsp;Murcko holds a
B.S. in chemistry and applied mathematics from Fairfield University and holds a Ph.D. in organic chemistry from Yale University.&nbsp;We believe Dr.&nbsp;Murcko&#146;s significant experience in the healthcare and biotechnology industry qualify him
to serve on our board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Dipchand (Deep) Nishar</I></B> has served as a member of our board of directors since June 2019. Since June
2015, Mr.&nbsp;Nishar has worked for SoftBank Investment Advisors and currently serves as Senior Managing Partner. From January 2009 to October 2014, Mr.&nbsp;Nishar served in various roles with LinkedIn Corporation, most recently as Senior Vice
President, Products and User Experience. From August 2003 to January 2009, Mr.&nbsp;Nishar served in various roles with Google Inc., most recently as the Senior Director of Products for the Asia-Pacific region. In addition, during the past five
years, Mr.&nbsp;Nishar has served as a member of the board of directors of various publicly traded companies, including Guardant Health, Inc., Vir Biotechnology, Inc., TripAdvisor, Inc., and OPower, Inc. Mr.&nbsp;Nishar holds a B. Tech from the
Indian Institute of Technology, a MSEE from the University of Illinois, Urbana-Champaign, and a MBA from the Harvard Business School. We believe Mr.&nbsp;Nishar is qualified to serve on our board of directors due to his extensive background in the
technology industry and his investment activities in the life science sector. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Jami Rubin</I></B> has served as a member of our board of directors
since October 2019. Ms.&nbsp;Rubin is currently a partner at PJT Partners, a global advisory-focused investment bank since May 2019. Prior to that, Ms.&nbsp;Rubin spent more than 25 years as an equity analyst following the pharmaceutical industry.
Most recently, Ms.&nbsp;Rubin was an equity research analyst and then partner at Goldman Sachs managing the global healthcare research team from September 2008 to October 2018. Ms.&nbsp;Rubin holds a B.A. from Vassar College. Ms.&nbsp;Rubin&#146;s
extensive </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">159 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
financial leadership in the life sciences industry and health care investment banking provide her with the experience and skills necessary to serve on our board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Laura Shawver, Ph.D</I></B>. has served as a member of our board of directors since&nbsp;March 2017.&nbsp;Since April 2020, Dr.&nbsp;Shawver has served
as the President and Chief Executive Officer of Silverback Therapeutics, Inc. and a member of its board of directors. Since March 2020, Dr.&nbsp;Shawver has also served as a member of the board of directors of Nkarta, Inc. From November 2017 until
its acquisition by Sanofi, Inc. in January 2020, Dr.&nbsp;Shawver served as the President and Chief Executive Officer of Synthorx, Inc., a publicly traded biotechnology company, and as a member of its board of directors.&nbsp;Dr.&nbsp;Shawver
currently serves on the board of directors of Cleave Therapeutics (formerly Cleave Biosciences) and was previously its Chief Executive Officer from September 2011 through November 2017.&nbsp;Prior to that, she was Entrepreneur in Residence for 5AM
Ventures from&nbsp;October 2010 through August 2011. In prior years, Dr.&nbsp;Shawver served as Chief Executive Officer of Phenomix Corporation, from&nbsp;2002 to 2010, and President of Sugen, Inc. from 2000 through 2002, after holding various
positions there since 1992. From June 2012 to February 2014, Dr.&nbsp;Shawver served on the board of directors of Cornerstone Therapeutics, Inc., a publicly traded specialty pharmaceutical company.&nbsp;She is the founder and director of The
Clearity Foundation, a <FONT STYLE="white-space:nowrap">non-profit</FONT> corporation. Dr.&nbsp;Shawver holds a B.S. in microbiology and a Ph.D. in pharmacology from the University of Iowa. Dr.&nbsp;Shawver&#146;s extensive experience leading
companies in the pharmaceutical industry qualifies her to serve on our board of directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Composition of our board of directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board consists of nine<B> </B>members, each of whom are members pursuant to the board composition provisions of our certificate of incorporation and
agreements with our stockholders. These board composition provisions will terminate upon the completion of this offering. Upon the termination of these provisions, there will be no further contractual obligations regarding the election of our
directors. Our nominating and corporate governance committee and our board of directors may therefore consider a broad range of factors relating to the qualifications and background of nominees. Our nominating and corporate governance
committee&#146;s and our board of directors&#146; priority in selecting board members is identification of persons who will further the interests of our stockholders through their established record of professional accomplishment, the ability to
contribute positively to the collaborative culture among board members, knowledge of our business, understanding of the competitive landscape, professional and personal experiences, and expertise relevant to our growth strategy. Our directors hold
office until their successors have been elected and qualified or until the earlier of their resignation or removal. Our fourth amended and restated certificate of incorporation that will become effective upon the closing of this offering and amended
and restated bylaws that will become effective upon the effectiveness of the registration statement of which this prospectus is a part, also provide that our directors may be removed only for cause by the affirmative vote of the holders of at least <FONT
STYLE="white-space:nowrap">two-thirds</FONT> of the votes that all our stockholders would be entitled to cast in an annual election of directors, and that any vacancy on our board of directors, including a vacancy resulting from an enlargement of
our board of directors, may be filled only by vote of a majority of our directors then in office. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Director independence </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have been approved to list our common stock on The Nasdaq Global Market. Under the Nasdaq listing rules, independent directors must comprise a majority of a
listed company&#146;s board of directors within twelve months from the date of listing. In addition, the Nasdaq listing rules require that, subject to specified exceptions, each member of a listed company&#146;s audit, compensation and nominating
and governance committees be independent within twelve months from the date of listing. Audit committee members must also satisfy additional independence criteria, including those set forth in Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> under
the Securities Exchange Act of 1934, as amended (the Exchange Act), and compensation committee members must also satisfy the independence criteria set forth in Rule <FONT STYLE="white-space:nowrap">10C-1</FONT> under the Exchange Act. Under Nasdaq
listing rules, a director will only qualify as an &#147;independent director&#148; if, in the opinion of that company&#146;s board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment
in carrying out the responsibilities of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">160 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
a director. In order to be considered independent for purposes of Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> under the Exchange Act, a member of an audit committee of a listed company may
not, other than in his or her capacity as a member of the audit committee, the board of directors, or any other board committee: (1)&nbsp;accept, directly or indirectly, any consulting, advisory, or other compensatory fee from the listed company or
any of its subsidiaries, other than compensation for board service; or (2)&nbsp;be an affiliated person of the listed company or any of its subsidiaries. In order to be considered independent for purposes of Rule
<FONT STYLE="white-space:nowrap">10C-1,</FONT> the board of directors must consider, for each member of a compensation committee of a listed company, all factors specifically relevant to determining whether a director has a relationship to such
company which is material to that director&#146;s ability to be independent from management in connection with the duties of a compensation committee member, including, but not limited to: the source of compensation of the director, including any
consulting advisory or other compensatory fee paid by such company to the director, and whether the director is affiliated with the company or any of its subsidiaries or affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors has determined that all members of the board of directors, except Sanjiv K. Patel, M.D. and Mark Murcko, Ph.D., are independent
directors, including for purposes of the rules of the Nasdaq Global Market and the SEC. In making such independence determination, our board of directors considered the relationships that each <FONT STYLE="white-space:nowrap">non-employee</FONT>
director has with us and all other facts and circumstances that our board of directors deemed relevant in determining their independence, including the beneficial ownership of our capital stock by each
<FONT STYLE="white-space:nowrap">non-employee</FONT> director. In considering the independence of the directors listed above, our board of directors considered the association of our directors with the holders of more than 5% of our common stock.
Upon the completion of this offering, we expect that the composition and functioning of our board of directors and each of our committees will comply with all applicable requirements of the Nasdaq Global Market and the rules and regulations of the
SEC. There are no family relationships among any of our directors or executive officers. Dr.&nbsp;Patel<B> </B>is not an independent director under these rules because he is an executive officer of the Company. Dr.&nbsp;Murcko is not an independent
director under these rules because he is a founder and receives compensation as a consultant of the Company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Staggered board </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In accordance with the terms of our fourth amended and restated certificate of incorporation that will become effective upon the closing of this offering and
amended and restated bylaws that will become effective upon the effectiveness of the registration statement of which this prospectus is a part, our board of directors will be divided into three staggered classes of directors and each will be
assigned to one of the three classes. At each annual meeting of the stockholders, a class of directors will be elected for a three-year term to succeed the directors of the same class whose terms are then expiring. The terms of the directors will
expire upon the election and qualification of successor directors at the annual meeting of stockholders to be held during the years 2021 for Class&nbsp;I directors, 2022 for Class&nbsp;II directors and 2023 for Class&nbsp;III directors. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Class&nbsp;I directors will be Sanjiv K. Patel, M.D. and Linda A. Hill, Ph.D.; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Class&nbsp;II directors will be Alexis Borisy, Laura Shawver, Ph.D. and Mark Murcko, Ph.D.; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Class&nbsp;III directors will be Dipchand Nishar, Douglas S. Ingram and Jami Rubin. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our fourth amended and restated certificate of incorporation that will become effective upon the closing of this offering and amended and restated <FONT
STYLE="white-space:nowrap">by-laws</FONT> that will become effective upon the effectiveness of the registration statement of which this prospectus is a part provide that the number of our directors shall be fixed from time to time by a resolution of
the majority of our board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The division of our board of directors into three classes with staggered three-year terms may delay or prevent
stockholder efforts to effect a change of our management or a change in control. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board leadership structure and board&#146;s role in risk oversight
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Currently, the role of chairman of the board of directors is separated from the role of Chief Executive Officer. Our Chief Executive Officer is
responsible for recommending strategic decisions and capital allocation to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">161 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
board of directors and to ensure the execution of the recommended plans. The chairman of the board of directors is responsible for leading the board of directors in its fundamental role of
providing advice to and independent oversight of management. Our board of directors recognizes the time, effort, and energy that the Chief Executive Officer is required to devote to his position in the current business environment, as well as the
commitment required to serve as our chairman, particularly as the board of directors&#146; oversight responsibilities continue to grow. While our amended and restated <FONT STYLE="white-space:nowrap">by-laws</FONT> and corporate governance
guidelines will not require that our chairman and Chief Executive Officer positions be separate, our board of directors believes that having separate positions is the appropriate leadership structure for us at this time and demonstrates our
commitment to good corporate governance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Risk is inherent with every business, and how well a business manages risk can ultimately determine its success.
We face a number of risks, including the four risks more fully discussed in the section entitled &#147;Business&#148; appearing elsewhere in this prospectus. Management is responsible for the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">day-to-day</FONT></FONT> management of risks we face, while our board of directors, as a whole and through its committees, has responsibility for the oversight of risk management. In its risk oversight role, our board of
directors has the responsibility to satisfy itself that the risk management processes designed and implemented by management are adequate and functioning as designed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The role of the board of directors in overseeing the management of our risks is conducted primarily through committees of the board of directors, as disclosed
in the descriptions of each of the committees below and in the charters of each of the committees. The full board of directors (or the appropriate board committee in the case of risks that are under the purview of a particular committee) discusses
with management our major risk exposures, their potential impact on us, and the steps we take to manage them. When a board committee is responsible for evaluating and overseeing the management of a particular risk or risks, the chairman of the
relevant committee reports on the discussion to the full board of directors during the committee reports portion of the next board meeting. This enables the board of directors and its committees to coordinate the risk oversight role, particularly
with respect to risk interrelationships. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Committees of our board of directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors has established an audit committee, a compensation committee, a nominating and corporate governance committee, and a research and
development committee, each of which will operate pursuant to a charter to be adopted by our board of directors and will be effective upon the effectiveness of the registration statement of which this prospectus is a part. The board of directors may
also establish other committees from time to time to assist the Company and the board of directors. Upon the effectiveness of the registration statement of which this prospectus is a part, the composition and functioning of all of our committees
will comply with all applicable requirements of the Sarbanes-Oxley Act of 2002, Nasdaq and SEC rules and regulations, if applicable. Upon our listing on Nasdaq, each committee&#146;s charter will be available on our website at www.relaytx.com. The
reference to our website address does not constitute incorporation by reference of the information contained at or available through our website, and you should not consider it to be part of this prospectus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Audit committee </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jami Rubin, Alexis Borisy and
Laura Shawver, Ph.D. serve on the audit committee, which is chaired by Jami Rubin. Our board of directors has determined that&nbsp;each are &#147;independent&#148; for audit committee purposes as that term is defined by the rules of the SEC and
Nasdaq, and that each has sufficient knowledge in financial and auditing matters to serve on the audit committee. Our board of directors has designated Jami Rubin as an &#147;audit committee financial expert,&#148; as defined under the applicable
rules of the SEC. The audit committee&#146;s responsibilities include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">appointing, approving the compensation of, and assessing the independence of our independent registered public
accounting firm; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">162 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">pre-approving</FONT> auditing and permissible
<FONT STYLE="white-space:nowrap">non-audit</FONT> services, and the terms of such services, to be provided by our independent registered public accounting firm; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing the overall audit plan with our independent registered public accounting firm and members of management
responsible for preparing our financial statements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and discussing with management and our independent registered public accounting firm our annual and
quarterly financial statements and related disclosures as well as critical accounting policies and practices used by us; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">coordinating the oversight and reviewing the adequacy of our internal control over financial reporting;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing policies and procedures for the receipt and retention of accounting-related complaints and concerns;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">recommending, based upon the audit committee&#146;s review and discussions with management and our independent
registered public accounting firm, whether our audited financial statements shall be included in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K;</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">monitoring the integrity of our financial statements and our compliance with legal and regulatory requirements as
they relate to our financial statements and accounting matters; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preparing the audit committee report required by SEC rules to be included in our annual proxy statement;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing all related person transactions for potential conflict of interest situations and approving all such
transactions; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing quarterly earnings releases. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Compensation committee </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Douglas S. Ingram, Linda
A. Hill, Ph.D., Dipchand Nishar and Alexis Borisy serve on the compensation and talent committee, or compensation committee, which is chaired by Douglas S. Ingram. Our board of directors has determined that each member of the compensation and talent
committee is &#147;independent&#148; as defined in the applicable Nasdaq rules. The compensation and talent committee&#146;s responsibilities include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">annually reviewing and recommending to the board of directors the corporate goals and objectives relevant to the
compensation of our Chief Executive Officer; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating the performance of our Chief Executive Officer in light of such corporate goals and objectives and,
based on such evaluation, recommending to the board of directors the cash compensation of our Chief Executive Officer; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">determining the cash compensation of our other executive officers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing and administering our compensation and similar plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the retention or termination of any consulting firm or outside advisor to assist in the
evaluation of compensation matters and evaluating and assessing potential and current compensation advisors in accordance with the independence standards identified in the applicable Nasdaq rules; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">retaining and approving the compensation of any compensation advisors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the grant of equity-based awards; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and recommending to the board of directors the compensation of our directors; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preparing the compensation committee report required by SEC rules, if and when required, to be included in our
annual proxy statement. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Nominating and corporate governance committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Linda A. Hill, Ph.D., Mark Murcko Ph.D. and Jami Rubin serve on the nominating and corporate governance committee, which is chaired by Linda A. Hill, Ph.D. Our
board of directors has determined that a majority of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">163 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
nominating and corporate governance committee is &#147;independent&#148; as defined in the applicable Nasdaq rules. The nominating and corporate governance committee&#146;s responsibilities
include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing and recommending to the board of directors criteria for board and committee membership;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing procedures for identifying and evaluating board of director candidates, including nominees
recommended by stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing the composition of the board of directors to ensure that it is composed of members containing the
appropriate skills and expertise to advise us; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identifying individuals qualified to become members of the board of directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">recommending to the board of directors the persons to be nominated for election as directors and to each of the
board&#146;s committees; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and recommending to the board of directors appropriate corporate governance guidelines; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing the evaluation of our board of directors. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and development committee </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mark Murcko,
Ph.D., and Laura Shawver, Ph.D. serve on the research and development committee, which is chaired by Mark Murcko, Ph.D. The research and development committee&#146;s responsibilities include reviewing and assessing personnel and research and
development program and recommending key discovery and development strategies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation committee interlocks and insider participation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2019, the compensation committee consisted of Mr.&nbsp;Borisy, Dr.&nbsp;Hill, Mr.&nbsp;Ingram, and Mr.&nbsp;Nishar. None of the members of our compensation
committee has at any time during the prior three years been one of our officers or employees. None of our executive officers currently serves, or in the past fiscal year has served, as a member of the board of directors or compensation committee of
any entity that has one or more executive officers serving on our board of directors or compensation committee. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Code of Business Conduct and Ethics
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors adopted a Code of Business Conduct and Ethics in connection with this offering. The Code of Business Conduct and Ethics applies
to our directors, officers, and employees, including our principal executive officer, principal financial officer, principal accounting officer, or controller, or persons performing similar functions. Following the effectiveness of the registration
statement of which this prospectus is a part, a current copy of this code will be posted on the Corporate Governance section of our website, which is located at www.relaytx.com. The information on our website is deemed not to be incorporated in this
prospectus or to be a part of this prospectus. If we make any substantive amendments to, or grant any waivers from, the code of business conduct and ethics for any officer or director, we will disclose the nature of such amendment or waiver on our
website or in a current report on Form <FONT STYLE="white-space:nowrap">8-K.</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitations on Liability and Indemnification Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As permitted by Delaware law, provisions in our fourth amended and restated certificate of incorporation, which will become effective immediately prior to the
closing of this offering, and amended and restated bylaws, which will become effective upon the effectiveness of this registration statement, limit or eliminate the personal liability of directors for a breach of their fiduciary duty of care as a
director. The duty of care generally requires that, when acting on behalf of the corporation, a director exercise an informed business judgment based on all material </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">164 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
information reasonably available to him or her. Consequently, a director will not be personally liable to us or our stockholders for monetary damages or breach of fiduciary duty as a director,
except for liability for: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any breach of the director&#146;s duty of loyalty to us or our stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any act related to unlawful stock repurchases, redemptions or other distributions or payments of dividends; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any transaction from which the director derived an improper personal benefit. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These limitations of liability do not limit or eliminate our rights or any stockholder&#146;s rights to seek
<FONT STYLE="white-space:nowrap">non-monetary</FONT> relief, such as injunctive relief or rescission. These provisions will not alter a director&#146;s liability under other laws, such as the federal securities laws or other state or federal laws.
Our fourth amended and restated certificate of incorporation that will become effective immediately prior to the closing of this offering also authorizes us to indemnify our officers, directors and other agents to the fullest extent permitted under
Delaware law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As permitted by Delaware law, our amended and restated bylaws to be effective upon the effectiveness of this registration statement will
provide that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we will indemnify our directors, officers, employees and other agents to the fullest extent permitted by law;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we must advance expenses to our directors and officers, and may advance expenses to our employees and other
agents, in connection with a legal proceeding to the fullest extent permitted by law; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rights provided in our amended and restated bylaws are not exclusive. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If Delaware law is amended to authorize corporate action further eliminating or limiting the personal liability of a director or officer, then the liability
of our directors or officers will be so eliminated or limited to the fullest extent permitted by Delaware law, as so amended. Our amended and restated bylaws will also permit us to secure insurance on behalf of any officer, director, employee or
other agent for any liability arising out of his or her actions in connection with their services to us, regardless of whether our bylaws permit such indemnification. We have obtained such insurance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the indemnification that will be provided for in our fourth amended and restated certificate of incorporation and amended and restated bylaws,
we plan to enter into separate indemnification agreements with each of our directors and executive officers, which may be broader than the specific indemnification provisions contained in the Delaware General Corporation Law. These indemnification
agreements may require us, among other things, to indemnify our directors and executive officers for some expenses, including attorneys&#146; fees, expenses, judgments, fines and settlement amounts incurred by a director or executive officer in any
action or proceeding arising out of his service as one of our directors or executive officers or any other company or enterprise to which the person provides services at our request. We believe that these provisions and agreements are necessary to
attract and retain qualified individuals to serve as directors and executive officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This description of the indemnification provisions of our fourth
amended and restated certificate of incorporation, our amended and restated bylaws and our indemnification agreements is qualified in its entirety by reference to these documents, each of which is attached as an exhibit to the registration statement
of which this prospectus forms a part. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">165 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our
directors, officers and controlling persons pursuant to the foregoing provisions, or otherwise, we have been advised that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act, and is,
therefore, unenforceable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There is no pending litigation or proceeding naming any of our directors or officers as to which indemnification is being
sought, nor are we aware of any pending or threatened litigation that may result in claims for indemnification by any director or officer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">166 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_14"></A>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following discussion contains
forward-looking statements that are based on our current plans and expectations regarding our future compensation programs. The actual amount and form of compensation that we pay and the compensation policies and practices that we adopt in the
future may differ materially from the currently-planned programs that are summarized in this discussion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our executive compensation program reflects our
continued focus on growth and development. To date, the compensation of our executive officers identified in the Summary Compensation Table below, who we refer to as our named executive officers, has consisted of a combination of base salary, annual
incentive bonuses and long-term incentive compensation. Our named executive officers, like all other full-time employees, are eligible to participate in our retirement and health welfare benefit plans. As we transition from a private company to a
publicly traded company, the compensation committee of our board of directors will evaluate our compensation values and philosophy and compensation plans and arrangements as circumstances require. At a minimum, the compensation committee expects to
review executive compensation annually with input from Radford, an AON Hewitt company, its external compensation consultant. As part of this review process, we expect the compensation committee to apply our values and philosophy, while considering
the compensation levels needed to ensure our executive compensation program remains competitive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The compensation provided to our named executive
officers for the fiscal year ended December, 31, 2019 is detailed in the 2019 Summary Compensation Table and accompanying footnotes and narrative that follow. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our named executive officers for the fiscal year ended December&nbsp;31, 2019, which consisted of our Chief Executive Officer and our two most
highly-compensated executive officers other than our Chief Executive Officer, were: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Sanjiv K. Patel, M.D., our President and Chief Executive Officer </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Donald Bergstrom, M.D., Ph.D., our Executive Vice President, Head of Research&nbsp;&amp; Development
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Brian R. Adams, our General Counsel </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary Compensation Table </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides
information regarding the total compensation awarded to, earned by, and paid to our named executive officers for services rendered to us in all capacities for the fiscal year ended December&nbsp;31, 2019. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name and Principal Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards<BR>($)(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-Equity</FONT><BR>Incentive Plan<BR>Compensation<BR>($)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sanjiv K. Patel M.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>President and Chief Executive Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">585,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,590,671</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">353,925</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,529,596</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Donald Bergstrom M.D., Ph.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><I>Executive Vice President, Head of Research &amp;&nbsp;Development</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">406,850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">330,652</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">179,014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">916,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian R. Adams</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>General Counsel</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">356,213</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">165,326</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97,958</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">619,497</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts reported represent the aggregate grant date fair value of the stock options awarded to our named
executive officers during fiscal year 2019, calculated in accordance with Financial Accounting Standards Board, or FASB Accounting Standards Codification, or ASC Topic 718. Such grant date fair value does not take into account any estimated
forfeitures. The assumptions used in calculating the grant </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">167 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
date fair value of the awards reported in this column are set forth in the notes to our consolidated financial statements included elsewhere in this prospectus. The amounts reported in this
column reflect the accounting cost for the stock options and do not correspond to the actual economic value that may be received upon exercise of the stock option or any sale of any of the underlying shares of common stock. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts represent actual bonuses earned for performance in 2019 by our named executive officers based on
the achievement of Company performance objectives, as described under &#147;Annual Bonuses&#148; below. The amounts were approved by our board of directors in December 2019. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Narrative to Summary Compensation Table </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Base
Salaries </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We&nbsp;use base salaries to recognize the experience, skills, knowledge, and responsibilities required of all our employees, including
our named executive officers. Base salaries are reviewed annually, typically in connection with our annual performance review process. From January&nbsp;1, 2019 until December&nbsp;31, 2019, the annual base salaries for Dr.&nbsp;Patel,
Dr.&nbsp;Bergstrom and Mr.&nbsp;Adams were $585,000, $406,850, and $356,213, respectively. In 2020, the annual base salaries of Dr.&nbsp;Bergstrom and Mr.&nbsp;Adams were increased in connection with their entering into new employment agreements
with us, described below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Annual Bonuses </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our
board of directors may approve annual bonuses for our named executive officers based on individual and/or Company performance objectives, as determined to be appropriate. In fiscal year 2019, Dr.&nbsp;Patel, Mr.&nbsp;Bergstrom and Mr.&nbsp;Adams
were all eligible to receive an annual cash bonus based solely upon the achievement of Company performance objectives,<B><I> </I></B>which consisted of <FONT STYLE="white-space:nowrap">pre-specified</FONT> milestones, including the progression of <FONT
STYLE="white-space:nowrap">pre-clinical</FONT> programs, and certain financial metrics. In fiscal year 2019, the target bonus opportunity for each of Dr.&nbsp;Patel, Mr.&nbsp;Bergstrom and Mr.&nbsp;Adams was equal to 55%, 40% and 25%, respectively,
of each executive officer&#146;s respective base salary. The corporate objectives for fiscal year 2019 also included advancement of the our scientific programs, further build out of our scientific platform, execution of a hiring plan approved by our
board of directors, and achievement of several operational goals intended to further mature our business operations. In late 2019, our board of directors evaluated the Company&#146;s performance in 2019 against these objectives, and determined that,
based upon the level of achievement in 2019, Dr.&nbsp;Patel, Dr.&nbsp;Bergstrom and Mr.&nbsp;Adams each earned cash bonuses of $353,925<B><I>, </I></B>$179,014, and $97,958, respectively. Mr.&nbsp;Adams&#146; target bonus opportunity was increased
to 35% pursuant to his new employment agreement, described below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Equity Compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although we do not have a formal policy with respect to the grant of equity incentive awards to our executive officers, we believe that equity grants provide
our executives with a strong link to our long-term performance, create an ownership culture, and help to align the interests of our executives and our stockholders. Accordingly, our board of directors periodically reviews the outstanding equity
incentive awards of our named executive officers and from time to time may grant additional equity incentive awards to them. In April 2019, our board of directors approved stock option grants to our employees, including our named executive officers.
Dr.&nbsp;Patel, Mr.&nbsp;Bergstrom and Mr.&nbsp;Adams were granted 772,268 stock options, 98,566 stock options, and 49,283 stock options, respectively, as described in more detail in the &#147;Outstanding equity awards at fiscal <FONT
STYLE="white-space:nowrap">2019&nbsp;year-end&#148;&nbsp;table.</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>March 2020 Stock Option Grants </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;2, 2020, our board of directors approved the grant of stock options to our named executive officers. Dr.&nbsp;Patel, Mr.&nbsp;Bergstrom and
Mr.&nbsp;Adams were granted 753,804 stock options, 126,727 stock options, and 67,588 stock options, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">168 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The stock options will vest in 16 equal quarterly installments commencing on the three month anniversary of
the determination by our board of directors that we have met, in whole or in part, certain specified performance criteria for 2020 and 2021 (and provided that no stock options shall be deemed to have vested unless and until our board of directors
makes such a determination with respect to such criteria). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Employment Arrangements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March and April 2020, we entered into employment agreements with each of our named executive officers. Each employment agreement sets forth such executive
officer&#146;s base salary, target bonus opportunity, and eligibility to participate in our benefit plans generally. Each of our executives is also subject to
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">a&nbsp;non-competition,&nbsp;non-solicitation,&nbsp;confidentiality,</FONT></FONT> and assignment agreement, which provides for a perpetual post-termination confidentiality covenant
as well as <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">non-competition&nbsp;and&nbsp;non-solicitation&nbsp;of</FONT></FONT> customers, employees and consultants covenants that apply during employment and for one year following
termination, subject to the type of termination in the case of the <FONT STYLE="white-space:nowrap">non-competition</FONT> provision. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sanjiv. K.
Patel </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;25, 2020, we entered into an employment agreement with Dr.&nbsp;Patel, who currently serves as our President and Chief
Executive Officer. The March&nbsp;25, 2020 employment agreement supersedes the prior letter agreement entered into between Dr.&nbsp;Patel and the Company on February&nbsp;11, 2017. The March&nbsp;25, 2020 employment agreement provides an annual base
salary of $585,000, an annual target bonus equal to 55% of Dr.&nbsp;Patel&#146;s annual base salary and eligibility to participate in our benefit plans generally. The March 26, 2020 employment agreement also provides that, while public, the Company
will cause Dr. Patel to be nominated for election to our board of directors and to be recommended to our stockholders for election to our board of directors. The equity awards previously held by Dr.&nbsp;Patel continue to be governed by the terms
and conditions of the Company&#146;s applicable equity incentive plan(s) and the applicable award agreement(s). Dr.&nbsp;Patel shall also be entitled to reimbursement for all reasonable business expenses incurred during the term of his employment,
in accordance with the policies and procedures then in effect and established by the Company for its executive officers. Dr.&nbsp;Patel&#146;s severance and change in control entitlements are described in the section titled &#147;Executive Severance
and Change in Control.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Donald Bergstrom </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On April&nbsp;7, 2020, we entered into an employment agreement with Dr.&nbsp;Bergstrom, who currently serves as our Executive Vice President, Head of
Research&nbsp;&amp; Development. The April&nbsp;7, 2020 employment agreement supersedes the prior letter agreement entered into between Dr.&nbsp;Bergstrom and the Company on February&nbsp;24, 2018. The April&nbsp;7, 2020 employment agreement
provides for an annual base salary of $440,000, an annual target bonus equal to 40% of Dr.&nbsp;Bergstrom&#146;s annual base salary, and eligibility to participate in our benefit plans generally. The equity awards previously held by
Dr.&nbsp;Bergstrom shall continue to be governed by the terms and conditions of the Company&#146;s applicable equity incentive plan(s) and the applicable award agreements(s). Dr.&nbsp;Bergstrom shall also be entitled to reimbursement for all
reasonable business expenses incurred during the term of his employment, in accordance with the policies and procedures then in effect and established by the Company for its executive officers. Dr.&nbsp;Bergstrom&#146;s severance and change in
control entitlements are described in the section titled &#147;Executive Severance and Change in Control.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Brian R. Adams </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On March&nbsp;25, 2020, we entered into an employment agreement with Mr.&nbsp;Adams, who currently serves as our General Counsel. The March&nbsp;25, 2020
employment agreement supersedes the prior letter agreement entered into between Mr.&nbsp;Adams and the Company on January&nbsp;29, 2018. The March&nbsp;25, 2020 employment agreement provides an annual base salary of $390,000, an annual target bonus
equal to 35% of Mr.&nbsp;Adam&#146;s annual base salary, and his eligibility to participate in our benefit plans generally. The equity awards previously held by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">169 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Mr.&nbsp;Adams shall continue to be governed by the terms and conditions of the Company&#146;s applicable equity incentive plan(s) and the applicable award agreements(s). Mr.&nbsp;Adams shall
also be entitled to reimbursement for all reasonable business expenses incurred during the term of his employment, in accordance with the policies and procedures then in effect and established by the Company for its executive officers.
Mr.&nbsp;Adams&#146; severance and change in control severance entitlements are described in the section titled &#147;Executive Severance and Change in Control.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Executive Severance and Change in Control </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the employment agreements described above, each of our named executive officers is subject to severance and change in control provisions. Each
employment agreement provides that upon (i)&nbsp;a termination of the executive&#146;s employment by us for any reason other than for &#147;cause&#148; (as defined in the respective employment agreement), death or disability or (ii)&nbsp;a
resignation for &#147;good reason&#148; (as defined in the respective employment agreement), in each case outside of the change in control period (i.e., in the case of Dr.&nbsp;Patel, the period beginning 60 days prior to and ending 18 months after,
a change in control of the Company (as defined in the letter agreement), and in the case of Dr.&nbsp;Bergstrom and Mr.&nbsp;Adams, the period beginning in anticipation of, and ending 12 months after, a change in control of the Company), such
executive will be entitled to receive, subject to the execution and delivery of an effective separation agreement and release, which shall include a release of claims in favor of the Company, (A) in the case of Dr. Patel, an amount equal to the sum
of 18 months of Dr. Patel&#146;s then current base salary, and in the case of Dr. Bergstrom and Mr. Adams, an amount equal to the sum of 12 months of each of their respective base salaries, (B)&nbsp;an amount equal to the executive&#146;s target
bonus opportunity for the then-current year, which amount shall be prorated in the case of Dr.&nbsp;Bergstrom and Mr.&nbsp;Adams, in the case of each of (A)&nbsp;and (B) payable in substantially equal installments over 12 months following the date
of termination of employment, (C)&nbsp;the employer portion of the premiums for health insurance benefits continuation under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, or COBRA, for up to 18 months in the case of Dr.
Patel and for up to 12 months in the case of Dr. Bergstrom and Mr. Adams, (D)&nbsp;for Dr.&nbsp;Patel, accelerated vesting of all stock options subject to time-based vesting and any other stock-based awards subject to time-based vesting that would
have otherwise vested in the <FONT STYLE="white-space:nowrap">12-month</FONT> period following such termination of employment, with such accelerated vesting to be effective as of the later (y)&nbsp;of the date of termination of employment and
(z)&nbsp;the effective date of the separation agreement and release, such acceleration to include pro rata vesting of that portion of the vesting quarter ending after expiration of the applicable 12-month period, based on number of days falling
within the applicable 12-month period during such quarter divided by 91, and (E)&nbsp;for Dr.&nbsp;Patel, reimbursement for the reasonable cost of outplacement services during the <FONT STYLE="white-space:nowrap">12-month</FONT> period immediately
following such termination of employment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each employment agreement also provides that upon (i)&nbsp;a termination of the executive&#146;s employment by
us other than for cause, death or disability or (ii)&nbsp;a resignation for good reason, in each case, within the change in control period described above, the executive will be entitled to receive, subject to the execution and delivery of an
effective separation agreement and release, which shall include a release of claims in favor of the Company, (A)&nbsp;a lump sum payment equal to 1.5x, in the case of Dr.&nbsp;Patel, or 1x, in the case of Dr.&nbsp;Bergstrom and Mr.&nbsp;Adams, the
sum of such executive&#146;s current base salary and target bonus opportunity, in the case of each of (A) and (B), payable or commencing payment within 60 days following the date of termination of employment, (B)&nbsp;the employer portion of the
premiums for health insurance benefits continuation under COBRA for up to 18 months for Dr.&nbsp;Patel and for up to 12 months for each of Dr.&nbsp;Bergstrom and Mr.&nbsp;Adams, (C)&nbsp;accelerated vesting of all stock options subject to time-based
vesting and any other stock-based awards subject to time-based vesting, as of the later of (y)&nbsp;the date of termination of employment and (z)&nbsp;the effective date of the separation agreement and release, and (D)&nbsp;for Dr.&nbsp;Patel,
reimbursement for the reasonable cost of outplacement services during the <FONT STYLE="white-space:nowrap">12-month</FONT> period immediately following such termination of employment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The payments and benefits provided under the applicable employment agreement in connection with a change in control may not be eligible for a federal income
tax deduction by us pursuant to Section&nbsp;280G of the Code, and may also subject the applicable named executive officer to an excise tax under Section&nbsp;4999 of the Code. If the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">170 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
payments or benefits payable in connection with a change in control would be subject to the excise tax imposed under Section&nbsp;4999 of the Code, then those payments or benefits will be reduced
if such reduction would result in a higher net <FONT STYLE="white-space:nowrap">after-tax</FONT> benefit to the executive officer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outstanding equity
awards at fiscal 2019 <FONT STYLE="white-space:nowrap">year-end</FONT> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding outstanding equity awards
held by our named executive officers as of December&nbsp;31, 2019: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Awards(1)</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:7pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Vesting<BR>Commencement<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities <BR>Underlying <BR>Unexercised<BR>Options <BR>(#) <BR>Exercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities <BR>Underlying <BR>Unexercised <BR>Options <BR>(#) <BR>Unexercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Exercise<BR>Price<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Expiration<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number<BR>of Shares<BR>or Units<BR>of Stock<BR>That<BR>Have Not<BR>Vested<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market<BR>Value of<BR>Shares or<BR>Units of<BR>Stock<BR>That<BR>Have Not<BR>Vested<BR>($)(2)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Sanjiv K. Patel M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/16/2017</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/16/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">344,325</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">506,158</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><I>President and Chief</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/23/2018</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/23/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">172,175</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">4.12</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">03/22/2028</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><I>Executive Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/23/2018</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/23/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">33,757</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">49,623</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">04/23/2019</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">04/23/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">56,869</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">675,735</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5.04</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">04/22/2029</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Donald Bergstrom M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">04/10/2018</TD>
<TD NOWRAP VALIGN="bottom">(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">04/02/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">394,264</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">4.12</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">04/09/2028</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"><I>Executive Vice President, Head of Research&nbsp;&amp; Development</I></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">04/23/2019</TD>
<TD NOWRAP VALIGN="top">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">04/23/2019</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">12,321</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">86,245</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">5.04</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">04/22/2029</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Brian R. Adams</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/23/2018</TD>
<TD NOWRAP VALIGN="bottom">(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">03/19/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">171,786</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">4.12</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">03/22/2028</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><I>General Counsel</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">04/23/2019</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">04/23/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6,160</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">43,123</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5.04</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">04/22/2029</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">&#151;&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Each equity award is subject to the terms of our 2016 Plan, the applicable award agreement and certain
acceleration of vesting provisions under each executive&#146;s employment agreement, described above. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">There was no public market for our common stock as of December&nbsp;31, 2019. The fair market value of our
common stock as of December&nbsp;31, 2019, as determined by an independent valuation firm, was $5.22 per share. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Represents an award of restricted shares, subject to repurchase by us at the original purchase price, which
repurchase right lapses as the shares vest as follows: 1/4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the restricted shares vest on the first anniversary of the vesting commencement date and an additional 1/12<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP> vests quarterly thereafter, generally subject to the executive&#146;s continued employment through each applicable vesting date. Pursuant to Dr. Patel&#146;s employment agreement with us, in the
event such award is not assumed or continued in connection with a change in control of the Company, 100% of the then-unvested shares shall accelerate in full. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Represents a stock option award of 366,102 shares that are subject to an early exercise&nbsp;provision and is
immediately exercisable for restricted shares. Restricted shares acquired upon the&nbsp;early exercise&nbsp;of options are subject to repurchase by us at the original exercise price, which repurchase right lapses consistent with the option&#146;s
original vesting schedule, which is as follows: as to 1/16 of the shares underlying the option on each of the first 16 equal quarters following the vesting commencement date, generally subject to the executive&#146;s continued employment through
each applicable vesting date. Dr. Patel early exercised the stock option with respect to 193,927 shares, of which 33,757 shares remain unvested as of December&nbsp;31, 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Represents stock options that vest in 16 equal quarterly installments following the vesting commencement date,
generally subject to the executive&#146;s continued employment through each applicable vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">Represents awards of stock options, subject to an&nbsp;early exercise&nbsp;provision and that are immediately
exercisable for restricted shares. Restricted shares acquired upon the&nbsp;early exercise&nbsp;of options are subject to repurchase by us at the original exercise price, which repurchase right lapses consistent with the option&#146;s original
vesting schedule, which is as follows: 1/4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>&nbsp;of the shares underlying the option vest on the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the vesting commencement date and
an additional 1/12<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>&nbsp;vests quarterly thereafter, subject to the executive&#146;s continued employment through each applicable vesting date. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">171 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employee benefits and equity compensation plans </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2020 Stock Option and Incentive Plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our 2020
Stock Option and Incentive Plan, or 2020 Stock Plan, was adopted by our board of directors in June 2020 and our stockholders in July 2020. The 2020<B> </B>Stock Plan will become effective on the date immediately prior to the date on which the
registration statement of which this prospectus is part is declared effective by the SEC. The 2020 Stock Plan is expected to replace our 2016<B> </B>Plan, as our board of directors has determined not to make additional awards under the 2016<B>
</B>Plan following the closing of this offering. The 2020<B> </B>Stock Plan will provide flexibility to our compensation committee to use various equity-based incentive awards as compensation tools to motivate our workforce. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will initially reserve 8,376,080 shares of our common stock, or the Initial Limit, for the issuance of awards under the 2020<B> </B>Stock Plan, which
includes 769,354 shares of common stock remaining available for issuance under our 2016 Plan as of the business day immediately prior to the effective date of the registration statement of which this prospectus forms a part. The 2020<B> </B>Stock
Plan will provide that the number of shares reserved and available for issuance under the plan will automatically increase each January&nbsp;1, beginning on January&nbsp;1, 2021, by 5% of the outstanding number of shares of our common stock on the
immediately preceding December&nbsp;31, or such lesser number of shares as determined by our compensation committee, or the Annual Increase. This number will be subject to adjustment in the event of a stock split, stock dividend or other change in
our capitalization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares we issue under the 2020<B> </B>Stock Plan will be authorized but unissued shares or shares that we reacquire. The shares
of common stock underlying any awards that are forfeited, cancelled, held back upon exercise or settlement of an award to satisfy the exercise price or tax withholding, reacquired by us prior to vesting, satisfied without any issuance of stock,
expire or are otherwise terminated (other than by exercise) under the 2020<B> </B>Stock Plan will be added back to the shares of common stock available for issuance under the 2020<B> </B>Stock Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The maximum aggregate number of shares that may be issued in the form of incentive stock options may not exceed the Initial Limit cumulatively increased on
January&nbsp;1, 2021, and on each January&nbsp;1 thereafter by the lesser of the Annual Increase for such year or 8,376,080 shares of common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
grant date fair value of all awards made under our 2020<B> </B>Stock Plan and all other cash compensation paid by us to any <FONT STYLE="white-space:nowrap">non-employee</FONT> director in any calendar year may not exceed $1 million for the first
year of service and $750,000 for each year of service thereafter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2020<B> </B>Stock Plan will be administered by our compensation committee. Our
compensation committee will have full power to select, from among the individuals eligible for awards, the individuals to whom awards will be granted, to make any combination of awards to participants, and to determine the specific terms and
conditions of each award, subject to the provisions of the 2020<B> </B>Stock Plan. Persons eligible to participate in the 2020<B> </B>Stock Plan will be those full or part-time employees, <FONT STYLE="white-space:nowrap">non-employee</FONT>
directors and consultants of the Company and its affiliates, as selected from time to time by our compensation committee in its discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2020<B>
</B>Stock Plan will permit the granting of both options to purchase common stock intended to qualify as incentive stock options under Section&nbsp;422 of the Internal Revenue Code and options that do not so qualify. The option exercise price of each
option will be determined by our compensation committee but may not be less than 100% of the fair market value of our common stock on the date of grant. The term of each option will be fixed by our compensation committee and may not exceed ten years
from the date of grant. Our compensation committee will determine at what time or times each option may be exercised. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our compensation committee may
award stock appreciation rights subject to such conditions and restrictions as it may determine in its discretion. Stock appreciation rights entitle the recipient to shares of common stock or cash, equal to the value of the appreciation in our stock
price over the exercise price. The exercise price of each stock appreciation right may not be less than 100% of the fair market value of the common stock on the date of grant. The term of each stock appreciation right will be fixed by our
compensation committee and may not exceed ten </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">172 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
years from the date of grant. Our compensation committee will determine at what time or times each stock appreciation right may be exercised. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our compensation committee will be permitted to award restricted shares of common stock and restricted stock units to participants subject to such conditions
and restrictions as it may determine. These conditions and restrictions may include the achievement of certain performance goals and/or continued employment or service relationship with us through a specified vesting period. Our compensation
committee will also be permitted to grant shares of common stock that are free from any restrictions under the 2020<B> </B>Stock Plan. Unrestricted stock may be granted to participants in recognition of past services or other valid consideration and
may be issued in lieu of cash compensation due to such participant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our compensation committee will be permitted to grant cash bonuses under the 2020<B>
</B>Stock Plan to participants, subject to the achievement of certain performance goals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2020<B> </B>Stock Plan will provide that upon the
effectiveness of a &#147;sale event,&#148; as defined in the 2020<B> </B>Stock Plan, an acquirer or successor entity may assume, continue or substitute outstanding awards under the 2020<B> </B>Stock Plan. To the extent that awards granted under our
2020<B> </B>Stock Plan are not assumed or continued or substituted by the successor entity, except as may be otherwise provided in the relevant award agreement, all awards with time-based vesting, conditions or restrictions will become fully vested
and nonforfeitable as of the effective time of the sale event, and all awards with conditions and restrictions relating to the attainment of performance goals may become vested and nonforfeitable in connection with a sale event in the compensation
committee&#146;s discretion or to the extent specified in the relevant award agreement. Upon the effective time of the sale event, all outstanding awards granted under the 2020<B> </B>Stock Plan will terminate to the extent not assumed or continued
or substituted by the successor entity. In the event of such termination, individuals holding options and stock appreciation rights will be permitted to exercise such options and stock appreciation rights (to the extent exercisable) within a
specified period of time prior to the sale event. In addition, in connection with the termination of the 2020<B> </B>Stock Plan upon a sale event, we may make or provide for a payment, in cash or in kind, to participants holding vested and
exercisable options and stock appreciation rights equal to the difference between the per share cash consideration payable to stockholders in the sale event and the exercise price of the options or stock appreciation rights and we may make or
provide for a payment, in cash or in kind, to participants holding other vested awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors will be permitted to amend or discontinue
the 2020 Stock Plan and our compensation committee will be permitted to amend the exercise price of options and amend or cancel outstanding awards for purposes of satisfying changes in law or any other lawful purpose but no such action may adversely
affect rights under an award without the holder&#146;s consent. Certain amendments to the 2020 Stock Plan will require the approval of our stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No awards will be granted under the 2020 Stock Plan after the date that is 10&nbsp;years from the date of stockholder approval. No awards under the 2020 Stock
Plan have been made prior to the date of this prospectus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2016 Stock Option and Grant Plan, as amended </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors adopted, and our stockholders approved our 2016 Plan on July&nbsp;6, 2016. Our 2016 Plan was most recently amended on November&nbsp;12,
2018. Our 2016 Plan allows for the grant of incentive stock options to our employees and any of our subsidiary corporations&#146; employees, and grants of <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock options, restricted stock awards,
unrestricted stock awards, and restricted stock units to the full- or part-time officers, employees, directors, consultants, and key persons of the Company and our subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Authorized Shares. </I>No shares will be available for future issuance under the 2016 Plan following the effectiveness of the registration statement of
which this prospectus forms a part. However, our 2016 Plan will continue to govern outstanding awards granted thereunder. As of June 30, 2020, we reserved an aggregate of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">173 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
10,951,156 shares of our common stock for the issuance of options and other equity awards under the 2016<B> </B>Plan. This number is subject to adjustment in the event of a reorganization,
recapitalization, reclassification, stock dividend, stock split, reverse stock split or other similar change in our capitalization. As of June&nbsp;30, 2020, stock options to purchase 7,471,087, shares of our common stock at a weighted average
exercise price of $5.05 per share, 290,477 shares of restricted stock, and no restricted stock units were outstanding under the 2016 Plan and 7,471,087 shares remained available for future issuance under the 2016 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares of common stock we have issued under the 2016<B> </B>Plan were authorized but unissued shares we reacquired. The shares of common stock underlying
any awards that are forfeited, canceled, reacquired by us prior to vesting, satisfied without the issuance of stock, or otherwise terminated (other than by exercise) and the shares of common stock that are withheld upon exercise of a stock option or
settlement of an award to cover the exercise price or tax withholding, are currently added back to the shares of common stock available for issuance under the 2016<B> </B>Plan. Following the effectiveness of the 2020 Stock Plan, any such shares of
Common Stock underlying outstanding awards that would otherwise return to the 2016 Plan will be added to the shares of common stock available for issuance under the 2020<B> </B>Stock Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Administration</I>. Our board of directors currently administers our 2016<B> </B>Plan. Subject to the provisions of our 2016 Plan, the administrator has
full authority and discretion to take any actions it deems necessary or advisable for the administration our 2016<B> </B>Plan, including but not limited to determining the individuals to whom awards may be granted; the number of shares to be covered
by any award; the price, exercise price, conversation ratio or other price relating thereto; the vesting schedule applicable to the awards together with any vesting acceleration and the terms of the award agreement for use under our 2016<B>
</B>Plan. The plan administrator is specifically authorized to exercise its discretion to reduce the exercise price of outstanding stock options or effect the repricing of stock options through cancellation and
<FONT STYLE="white-space:nowrap">re-grants</FONT> without stockholder approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Options</I>. Stock options may be granted under our 2016 Plan. The
2016<B> </B>Plan permits the granting of (i)&nbsp;stock options to purchase common stock intended to qualify as incentive stock options under Section&nbsp;422 of the Internal Revenue Code and (ii)&nbsp;stock options that do not so qualify. The stock
option exercise price per share of our common stock underlying each stock option was determined by our board or directors or a committee appointed by the board of directors, and must have been at least equal to 100% of the fair market value of a
share of our common stock on the date of grant. In the case of an incentive stock option granted to a participant who, at the time of grant of such stock option, owned stock representing more than 10% of the voting power of all classes of stock of
the Company, or a 10% owner, the exercise price per share of our common stock underlying each such stock option must have been at least equal to 110% of the fair market value of a share of our common stock on the date of grant. The term of each
stock option may not have exceeded 10 years from the date of grant (or five years for a 10% owner). The administrator will determine the methods of payment of the exercise price of a stock option , which may include cash or cash equivalents;
delivery of a promissory note from the optionee to the Company; surrender of shares of common stock or certain other forms of payment acceptable to the administrator and permitted by the Delaware General Corporation Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Stock Awards. </I>The 2016<B> </B>Plan allows for the grant of shares of restricted stock. Restricted stock awards are grants of shares of our common stock
that are subject to various restrictions, including restrictions on transferability and forfeiture provisions. Shares of restricted stock will vest, and the restrictions on such shares will lapse, in accordance with terms and conditions established
by the administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The 2016<B> </B>Plan also allows for the grant of shares of unrestricted stock. Unrestricted stock awards may be granted to
participants in recognition of past services or for other valid consideration and may be issued in lieu of cash compensation due to such participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Restricted Stock Units. </I>The 2016<B> </B>Plan permits the granting of restricted stock units. A restricted stock unit is an award that covers a number
of shares of our common stock that may be settled upon vesting in cash or shares of common stock. The administrator determines the terms and conditions of restricted stock units, including the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">174 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
number of units granted, the vesting criteria (which may include achievement of <FONT STYLE="white-space:nowrap">pre-established</FONT> performance goals or continued service to us), and the form
and timing of payment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Termination</I><I>. </I>After a participant&#146;s termination of service (other than a termination for cause), the participant
generally may exercise his or her stock options, to the extent vested as of such date of termination, for three months after termination or such longer period of time as specified in the applicable stock option agreement; provided, that if the
termination is due to death or disability, the stock option generally will remain exercisable, to the extent vested as of such date of termination, until the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of such termination. However,
in no event may a stock option be exercised later than the expiration of its term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Transferability or Assignability of Awards. </I>Our awards are
subject to transfer restrictions as the administrator may determine. The 2016<B> </B>Plan generally does not allow for the transfer or assignment of awards, other than, at the discretion of the plan administrator, by will or the laws of descent and
distribution, by gift to an immediate family member, or by instrument to an inter vivos or testamentary trust in which the award is passed to beneficiaries upon the death of the participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Sale Event. </I>The 2016<B> </B>Plan provides that upon the occurrence of a &#147;sale event&#148; (as defined in the 2016<B> </B>Plan), awards may be
assumed, substituted for new awards of a successor entity, or otherwise continued or terminated at the effective time of such sale event. In the case of the termination of outstanding stock options, such stock options may be exercised to the extent
then exercisable within a period of time prior to the consummation of the sale event. In the case of forfeiture of restricted stock, such awards may be repurchased by us for a price per share equal to the original per share purchase price paid by
the participant for the shares. We may also make or provide for a cash payment to holders of vested and exercisable stock options, in exchange for the cancellation thereof, equal to, for each share of our common stock underlying such stock option,
the difference between the per share cash consideration in the sale event, as determined by the compensation committee, and the per share exercise price, if any. We may make or provide for a cash payment to holders of restricted stock and restricted
stock unit awards, in exchange for the cancellation thereof, in an amount equal to the product of the per share cash consideration in the sale event and the number of shares subject to each such award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Certain Adjustments.</I> In the event of certain changes in our capitalization, the number of shares available for future grants, the number of shares
covered by each outstanding equity grant and the exercise price under each outstanding option will be proportionately adjusted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors
may amend, suspend, or terminate the 2016<B> </B>Plan at any time, subject to stockholder approval where such approval is required by applicable law. The board of directors may also amend, modify, or terminate any outstanding award, including the
exercise price of such award, provided that no amendment to an award may adversely affect any of the rights of a participant under any awards previously granted without his or her consent. We will not make any further grants under the 2016 Plan
following this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Employee Stock Purchase Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our 2020 Employee Stock Purchase Plan, or ESPP, was adopted by our board of directors in June 2020 and our stockholders in July 2020. The ESPP is intended to
qualify as an &#147;employee stock purchase plan&#148; within the meaning of Section&nbsp;423(b) of the Code. The ESPP initially reserves and authorizes the issuance of up to a total of 1,092,532 shares of common stock to participating employees.
The ESPP provides that the number of shares reserved and available for issuance will automatically increase each January&nbsp;1, beginning on January&nbsp;1, 2021 and January&nbsp;1 thereafter through January&nbsp;1, 2030, by the least of (i) 1% of
the outstanding number of shares of our common stock on the immediately preceding December&nbsp;31, (ii)&nbsp;2,185,064 shares or (iii)&nbsp;such number of shares as determined by the ESPP administrator. The number of shares reserved under the ESPP
is subject to adjustment in the event of a stock split, stock dividend or other change in our capitalization. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">175 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All employees whose customary employment is for more than 20 hours per week and have completed at least
thirty (30) days of employment are eligible to participate in the ESPP. However, any participating employee who would own 5% or more of the total combined voting power or value of all classes of stock after an option was granted under the ESPP would
not be eligible to purchase shares under the ESPP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may make one or more offerings each year to our employees to purchase shares under the ESPP.
Offerings will begin on such dates as determined by the compensation committee and, unless otherwise determined by the compensation committee, will continue for six (6) month periods, referred to as offering periods. The compensation committee may
provide for one or more purchase periods in each offering period. Each eligible employee may elect to participate in any offering by submitting an enrollment form at least 15 business days before the relevant offering date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each employee who is a participant in the ESPP may purchase shares by authorizing payroll deductions of between 1% and 15% of his or her base compensation
during each pay period. Unless the participating employee has previously withdrawn from the offering, his or her accumulated payroll deductions will be used to purchase shares on the last business day of the purchase period at a price equal to 85%
of the fair market value of the shares on the first business day or the last business day of the purchase period, whichever is lower. Under applicable tax rules, an employee may purchase no more than $25,000 worth of shares of common stock, valued
at the start of the offering period, under the ESPP in any calendar year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accumulated payroll deductions of any employee who is not a participant on
the last day of an offering period will be refunded. An employee&#146;s rights under the ESPP terminate upon voluntary withdrawal from the plan or when the employee ceases employment with us for any reason. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Senior Executive Cash Incentive Bonus Plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
June 2020,<B> </B>our board of directors adopted the Senior Executive Cash Incentive Bonus Plan, or the Bonus Plan. The Bonus Plan provides for cash bonus payments based upon the attainment of performance targets established by our compensation
committee. The payment targets will be related to financial and operational measures or objectives with respect to the Company, corporate performance goals, and individual performance objectives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our compensation committee may select corporate performance goals from among the following: developmental, publication, clinical or regulatory milestones;
cash flow (including, but not limited to, operating cash flow and free cash flow); revenue; corporate revenue; earnings before interest, taxes, depreciation and amortization; net income (loss) (either before or after interest, taxes, depreciation
and/or amortization); changes in the market price of our common stock; economic value-added; acquisitions, licenses or strategic transactions; financing or other capital raising transactions; operating income (loss); return on capital, assets,
equity, or investment; stockholder returns; return on sales; total shareholder return; gross or net profit levels; productivity; expense efficiency; margins; operating efficiency; customer satisfaction; working capital; earnings (loss) per share of
our common stock; bookings, new bookings or renewals; sales or market shares; number of prescriptions or prescribing physicians; coverage decisions; leadership development, employee retention, and recruiting and other human resources matters;
operating income and/or net annual recurring revenue, any of which may be measured in absolute terms, as compared to any incremental increase, in terms of growth, or as compared to results of a peer group. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each executive officer who is selected to participate in the Bonus Plan will have a target bonus opportunity set for each performance period. The bonus
formulas will be adopted in each performance period by the compensation committee and communicated to each executive. The corporate performance goals will be measured at the end of each performance period after our financial reports have been
published. If the corporate performance goals and individual performance objectives are met, payments will be made as soon as practicable following the end of each performance period, but not later than two and one-half months after the end of the
fiscal year in which such performance period ends. Subject to the rights contained in any agreement between the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">176 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
executive officer and us, an executive officer must generally be employed by us on the bonus payment date to be eligible to receive a bonus payment. If an executive officer was not employed for
an entire performance period, the compensation committee may pro rate the bonus based on the number of days employed during such period. The Bonus Plan also permits the compensation committee to approve additional bonuses to executive officers in
its sole discretion. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>401(k) Plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We maintain
a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> retirement plan that provides eligible U.S. employees with an opportunity to save for retirement on a <FONT STYLE="white-space:nowrap">tax-advantaged</FONT> basis. Plan participants are able to
defer eligible compensation subject to applicable annual Internal Revenue Code limits. Effective February 2020, we provide an employer-matching contribution of up to 3.5% of eligible compensation that a participant elects to defer, which is 100%
vested when contributed. The 401(k) plan is intended to be qualified under Section&nbsp;401(a) of the Internal Revenue Code with the 401(k) plan&#146;s related trust intended to be tax exempt under Section&nbsp;501(a) of the Internal Revenue Code.
As a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> retirement plan, contributions to the 401(k) plan and earnings on those contributions are not taxable to the employees until distributed from the 401(k) plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">177 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_15"></A>DIRECTOR COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-employee</FONT> director compensation program </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the fiscal year ended December&nbsp;31, 2019, we provided compensation to our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors in the form
of cash retainers and equity awards as set forth below, with cash retainers prorated for partial years of service: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual Retainer for service on the board of directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon initial election to our board of directors, each <FONT STYLE="white-space:nowrap">non-employee</FONT> director was
granted an option to purchase 150,000 <B>s</B>hares of our common stock, or the Initial Grant. In addition, for each year thereafter, each <FONT STYLE="white-space:nowrap">non-employee</FONT> director who continued as a member of the board of
directors was granted an option to purchase<B> </B>25,000<B> </B>shares of our common stock, or the Annual Grant. The Initial Grant and the Annual Grant each vest in full on the first anniversary of their respective grant dates, subject to continued
service as a director through such date. All of the foregoing options were granted with a per share exercise price equal to the fair market value of a share of our common stock on the date of grant and with a term of ten years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr. Murcko also receives compensation for the provision of certain scientific and strategic advisory services as requested by our Chief Executive Officer and
his designees pursuant to a consulting agreement that we entered into with him on January 2, 2018, which has subsequently been amended. Under his consulting agreement, Dr. Murcko receives four equal payments of $50,000, each payable at the end of
each calendar quarter. Dr. Murcko has agreed to certain confidentiality, intellectual property and non-competition obligations during and following his period of consultancy services. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Employee directors received no additional compensation for their service as a director and directors affiliated with our investors do not receive compensation
for their service as a director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We reimbursed all reasonable
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> business expenses incurred by directors for their attendance at meetings of our board of directors or any committee thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">178 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Non-Employee Director Compensation Policy </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2020, we adopted a non-employee director compensation policy that will become effective upon the effectiveness of the registration statement of which
this prospectus forms a part and will be designed to enable us to attract and retain, on a long-term basis, highly qualified non-employee directors. Under the policy, each director who is not an employee will be paid cash compensation from and after
the completion of this offering, as set forth below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Annual<BR>Retainer</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Board of Directors:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Members</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional retainer for non-executive chair</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Audit Committee:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Members (other than chair)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Retainer for chair</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Members (other than chair)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Retainer for chair</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Nominating and Corporate Governance Committee:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Members (other than chair)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Retainer for chair</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Research and Development Committee:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Members (other than chair)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Retainer for chair</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the non-employee director compensation policy provides that, upon initial election to our board of directors,
each non-employee director will be granted an option to purchase 36,610&nbsp;shares of our common stock (&#147;Initial Grant&#148;). The Initial Grant will vest ratably in 36&nbsp;equal monthly installments following the grant date, subject to
continued service as a director through the applicable vesting date. Furthermore, on the date of each annual meeting of stockholders following the completion of this offering, each non-employee director who continues as a non-employee director
following such meeting will be granted an option to purchase 18,305&nbsp;shares of our common stock (&#147;Annual Grant&#148;). The Annual Grant will vest in full on the earlier of (i)&nbsp;the first anniversary of the grant date and (ii)&nbsp;our
next annual meeting of stockholders, subject to continued service as a director through the vesting date. The Initial Grants and Annual Grants are subject to full accelerated vesting upon the sale of the company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will reimburse all reasonable out-of-pocket business expenses incurred by non-employee directors in attending meetings of the board of directors and
committees thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">179 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-employee</FONT> director compensation table </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides information regarding the total compensation that was earned by or paid to each of our
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors during the fiscal year ended December&nbsp;31, 2019. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees<BR>Earned<BR>or Paid<BR>in Cash<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards<BR>($)(1)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Compensation<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexis Borisy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">141,114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">158,614</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Linda A. Hill, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas S. Ingram</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">174,211</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">191,711</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christoph Lengauer, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark Murcko, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,618</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">258,618</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dipchand (Deep) Nishar</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jami Rubin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">139,644</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">148,394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laura Shawver, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,618</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,618</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven Kafka, Ph.D.(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts reported represent the aggregate grant date fair value of the stock options awarded to <FONT
STYLE="white-space:nowrap">the&nbsp;non-employee&nbsp;directors</FONT> during fiscal year 2019, calculated in accordance with Financial Accounting Standards Board, or FASB Accounting Standards Codification, or ASC Topic 718. Such grant date fair
value does not take into account any estimated forfeitures. The assumptions used in calculating the grant date fair value of the awards reported in this column are set forth in the notes to our consolidated financial statements included elsewhere in
this prospectus. The amounts reported in this column reflect the accounting cost for the stock options and do not correspond to the actual economic value that may be received upon exercise of the stock option or any sale of any of the underlying
shares of common stock. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of December&nbsp;31, 2019, each of our <FONT STYLE="white-space:nowrap">non-employee</FONT> members of our
board of directors held the following aggregate number of unexercised options as of such date: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexis Borisy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,640</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Linda A. Hill, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas S. Ingram</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,256</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christoph Lengauer, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark Murcko, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dipchand (Deep) Nishar</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jami Rubin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laura Shawver, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,960</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven Kafka, Ph.D.(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amount represents consulting fees paid to Dr.&nbsp;Murcko under his consulting agreement described above for
consulting services provided in 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Steven Kafka resigned from the board on November&nbsp;8, 2019. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">180 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_16"></A>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a description of transactions or series of transactions since January&nbsp;1, 2017, to which we were or will be a party, in
which: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amount involved in the transaction exceeds, or will exceed, the lesser of $120,000 or one percent of the
average of the Company&#146;s total assets for the last two completed fiscal years; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in which any of our executive officers, directors or holder of five percent or more of any class of our capital
stock, including their immediate family members or affiliated entities, had or will have a direct or indirect material interest. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Compensation arrangements for our named executive officers and our directors are described elsewhere in this prospectus under &#147;Executive
Compensation&#148; and &#147;Management&#151;Director Compensation.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sales of Securities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series A Convertible Preferred Stock Financing </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
August 2016, we sold an aggregate of 56,824,740 shares of our Series A convertible preferred stock at a purchase price of $1.00 per share pursuant to agreements entered into with investors. Each share of our Series A convertible preferred stock will
automatically convert into one share of our common stock immediately prior to the completion of this offering. The following table summarizes purchases of our Series A convertible preferred stock by related persons: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Participant</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Affiliated Director(s) or<BR>Officer(s)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Series A<BR>Preferred<BR>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Purchase<BR>Price</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third Rock Ventures III, L.P.(1)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Christoph&nbsp;Lengauer,&nbsp;Ph.D.</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,404,286</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,404,286</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third Rock Ventures IV, L.P.(2)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Christoph Lengauer, Ph.D.</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,920,455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,920,455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Third Rock Ventures III, L.P., or TRV III, is an affiliate of Third Rock Ventures, LLC, or TRV, and is a holder
of five percent or more of our capital stock. Dr. Lengauer is a Partner at TRV and a member of our board of directors. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Third Rock Ventures IV, L.P., or TRV IV, is an affiliate of TRV and is a holder of five percent or more of our
capital stock. Dr.&nbsp;Lengauer is a Partner at TRV and a member of our board of directors. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series B Preferred Stock Financing
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2017, we sold an aggregate of 31,188,115 shares of our Series B convertible preferred stock at a purchase price of $2.02 per share
pursuant to agreements entered into with investors. Each share of our Series B convertible preferred stock will automatically convert into one share of our common stock immediately prior to the completion of this offering. The following table
summarizes purchases of our Series B preferred stock by related persons: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Participant</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Affiliated Director(s) or<BR>Officer(s)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Series B<BR>Preferred<BR>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>Purchase</B><br><B>Price</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark Murcko, Ph.D.(1)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">990,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third Rock Ventures III, L.P.(2)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Christoph&nbsp;Lengauer,&nbsp;Ph.D.</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,881</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Third Rock Ventures IV, L.P.(3)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Christoph Lengauer, Ph.D.</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,881</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mark Murcko, Ph.D., is a cofounder and a member of our board of directors. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">TRV III is an affiliate of TRV and is a holder of five percent or more of our capital stock. Dr.&nbsp;Lengauer
is a Partner at TRV and a member of our board of directors. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">181 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">TRV IV is an affiliate of TRV and is a holder of five percent or more of our capital stock. Dr.&nbsp;Lengauer
is a Partner at TRV and a member of our board of directors. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series C Preferred Stock Financing </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2018, we sold an aggregate of 124,630,002 shares of our Series C and Series <FONT STYLE="white-space:nowrap">C-1</FONT> convertible preferred stock
at a purchase price of $3.2095 per share pursuant to agreements entered into with investors. Each share of our Series C and Series <FONT STYLE="white-space:nowrap">C-1</FONT> convertible preferred stock will automatically convert into one share of
our common stock immediately prior to the completion of this offering. The following table summarizes purchases of our Series C and Series <FONT STYLE="white-space:nowrap">C-1</FONT> preferred stock by related persons: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Participant</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Affiliated&nbsp;Director(s) or<BR>Officer(s)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Series C<BR>Preferred<BR>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Series <FONT STYLE="white-space:nowrap">C-1</FONT><BR>Preferred<BR>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>Purchase</B><br><B>Price</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexis Borisy(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">350,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,123,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SoftBank Vision Fund (AIV M2) L.P.(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Dipchand&nbsp;(Deep)&nbsp;Nishar</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,963,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">78,508,757</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">300,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Borisy is a member of our board of directors. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">SVF Pauling (Cayman) Limited, an affiliate of SoftBank Vision Fund (AIV M2) L.P., is a holder of five percent
or more of our capital stock. Dipchand (Deep) Nishar is a senior managing partner at SoftBank and a member of our board of directors. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Agreements with Our Stockholders </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with our
preferred stock financings, we entered into an investor rights agreement and stockholders agreement, in each case, with the purchasers of our preferred stock and certain holders of our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our third amended and restated investors&#146; rights agreement, or Investor Rights Agreement, provides certain holders of our preferred stock with a
participation right to purchase their pro rata share of new securities that we may propose to sell and issue, subject to certain exceptions. Such participation right will terminate upon the closing of this offering. The Investor Rights Agreement
further provides certain holders of our capital stock with the right to demand that we file a registration statement, subject to certain limitations, and to request that their shares be covered by a registration statement that we are otherwise
filing. See the section titled &#147;Description of Capital Stock&#151;Registration rights&#148; appearing elsewhere in this prospectus, for additional information regarding such registration rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our second amended and restated stockholders agreement, or Stockholders Agreement, provides for rights of first refusal and
<FONT STYLE="white-space:nowrap">co-sale</FONT> and drag along rights in respect of sales by certain holders of our capital stock. The Stockholders Agreement also contains provisions with respect to the elections of our board of directors and its
composition. The rights under the Stockholders Agreement will terminate upon the closing of this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Management and Consulting Services </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the years ended December&nbsp;31, 2017, 2018 and 2019, we received consulting, advisory and related services from TRV in the amount of $400,000,
$100,000, and $200,000, respectively. TRV is a management company that provides services to us and TRV III and TRV IV are the beneficial owners of more than 5% of our voting securities. Dr. Lengauer is a partner at TRV and a member of our board of
directors. Alexis Borisy was previously a partner at TRV during the time in which we received services from TRV and Mr.&nbsp;Borisy is currently a member of our board of directors. These consulting fees were paid to TRV in amounts mutually agreed
upon in advance by us and TRV in consideration of certain strategic and ordinary course business operations and such services were provided to us on an <FONT STYLE="white-space:nowrap">as-needed</FONT> basis, from time to time and at our request, by
individuals related to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">182 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
TRV. Such fees were payable pursuant to invoices submitted to us by TRV from time to time. None of these consulting fees were paid directly to Dr.&nbsp;Lengauer or Mr.&nbsp;Borisy. The consulting
fees paid to TRV did not exceed 5% of the consolidated gross revenue of TRV during any of these fiscal years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In January 2018, we entered into a
consulting agreement with Mark Murcko, Ph.D., under which we would provide payment to Dr.&nbsp;Murcko in exchange for certain consulting, advisory and related services. During the year ended December&nbsp;31, 2018, we received consulting, advisory
and related services from Dr. Murcko in the amount of $100,000. In June 2019, the consulting agreement with Dr.&nbsp;Murcko was amended and assigned to Disruptive Biomedical, LLC, an entity wholly owned by Dr.&nbsp;Murcko. During the year ended,
December&nbsp;31, 2019, we received consulting, advisory and related services from in the amount of $200,000 from Disruptive Biomedical, LLC. Dr.&nbsp;Murcko is a member of our board of directors. These consulting fees were paid to Dr.&nbsp;Murcko
and Disruptive Biomedical, LLC in amounts mutually agreed upon in advance by us and Dr.&nbsp;Murcko and Disruptive Biomedical, LLC in consideration of certain strategic and ordinary course business operations and such services were provided to us on
an <FONT STYLE="white-space:nowrap">as-needed</FONT> basis from time to time and at our requests, with Dr.&nbsp;Murcko devoting at least one working day per week to such services, by Dr, Murcko. Such fees were payable in equal quarterly
installments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Collaboration Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June 15,
2020, we entered into an amended and restated collaboration and license agreement with D. E. Shaw Research, LLC, or D.&nbsp;E. Shaw Research. We refer to this agreement as the DESRES Agreement. Under the DESRES Agreement, we agreed to collaborate
with D.&nbsp;E. Shaw Research to research certain biological targets through the use of D.&nbsp;E. Shaw Research&#146;s computational modeling capabilities focused on analysis of protein motion, with an aim to develop and commercialize compounds and
products directed to such targets. Picularium is an affiliate of D. E. Shaw Research and is a holder of five percent or more of our capital stock. For more information regarding the DESRES Agreement, see &#147;Business&#151;Collaboration and License
Agreement with D. E. Shaw Research, LLC.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have entered into agreements to indemnify our directors and executive officers. These agreements will, among other things, require us to indemnify these
individuals for certain expenses (including attorneys&#146; fees), judgments, fines and settlement amounts reasonably incurred by such person in any action or proceeding, including any action by or in our right, on account of any services undertaken
by such person on behalf of our Company or that person&#146;s status as a member of our board of directors to the maximum extent allowed under Delaware law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Policies for approval of related party transactions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our
board of directors reviews and approves transactions with directors, officers and holders of five percent or more of our voting securities and their affiliates, each a related party. Prior to this offering, the material facts as to the related
party&#146;s relationship or interest in the transaction are disclosed to our board of directors prior to their consideration of such transaction, and the transaction is not considered approved by our board of directors unless a majority of the
directors who are not interested in the transaction approve the transaction. Further, when stockholders are entitled to vote on a transaction with a related party, the material facts of the related party&#146;s relationship or interest in the
transaction are disclosed to the stockholders, who must approve the transaction in good faith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with this offering, we have adopted a
written related party transactions policy that such transactions must be approved by our audit committee. This policy will become effective on the date on which the registration statement of which this prospectus is part is declared effective by the
SEC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">183 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_17"></A><A NAME="rom904779_17"></A>PRINCIPAL STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth certain information known to us regarding beneficial ownership of our capital stock as of June 30, 2020, as adjusted to reflect
the sale of common stock offered by us in this offering, for: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each person or group of affiliated persons known by us to be the beneficial owner of more than five percent of
our capital stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our named executive officers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our directors; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all of our executive officers and directors as a group. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Under
those rules, beneficial ownership includes any shares as to which the individual or entity has sole or shared voting power or investment power. Except as noted by footnote, and subject to community property laws where applicable, we believe, based
on the information provided to us, that the persons and entities named in the table below have sole voting and investment power with respect to all common stock shown as beneficially owned by them. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each individual or entity shown on the table has furnished information with respect to beneficial ownership. Unless otherwise indicated, the address for each
beneficial owner is c/o Relay Therapeutics,&nbsp;Inc., 399 Binney Street, 2<SUP STYLE="font-size:85%; vertical-align:top">nd</SUP> Floor, Cambridge, MA 02139. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The percentage of beneficial ownership prior to this offering in the table below is based on 66,875,742 shares of common stock deemed to be outstanding as
of&nbsp;June 30, 2020, assuming the conversion of all outstanding shares of our preferred stock immediately prior to the completion of this offering, and assuming an initial public offering price of $18.50 per share, which is the midpoint of the
offering range set forth on the cover page of this prospectus, and the percentage of beneficial ownership at this offering in the table below is based on 86,875,742 shares of common stock assumed to be outstanding after the closing of the offering.
The information in the table below assumes no exercise of the underwriters&#146; option to purchase additional shares. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table also does
not include any shares of common stock that directors and executive officers may purchase in this offering through the directed share program described under &#147;Underwriting.&#148; </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name of Beneficial Owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares<BR>Beneficially<BR>Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage of Shares<BR>Outstanding<BR>Beneficially Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Before<BR>Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>After<BR>Offering</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Third Rock Ventures(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,362,312</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.98</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15.38</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SVF Pauling (Cayman) Limited(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,904,963</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41.73</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32.12</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Named Executive Officers and Directors:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sanjiv K. Patel, M.D.(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,549,103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.31</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.78</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Donald Bergstrom, M.D., Ph.D.(4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">252,574</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian R. Adams(5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alexis Borisy(6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">115,047</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Linda A. Hill, Ph.D.(7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas S. Ingram(8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,768</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christoph Lengauer, Ph.D.(9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,080</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark Murcko, Ph.D.(10)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,011,470</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.51</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dipchand (Deep) Nishar</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jami Rubin(11)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,920</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laura Shawver, Ph.D.(12)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All executive officers and directors as a group (12&nbsp;persons)(13)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,245,269</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.81</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.73</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">184 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Less than one percent. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 563,234 shares of common stock, (ii) 9,970,454 shares of common stock issuable upon conversion
of shares of Series A preferred stock held by Third Rock Ventures III, L.P., or TRV III LP, (iii) 2,793,770 shares of common stock issuable upon conversion of shares of Series A preferred stock held by Third Rock Ventures IV, L.P., or TRV IV LP,
(iv) 17,427 shares of common stock issuable upon conversion of shares of Series B preferred stock held by TRV III LP and (v) 17,427 shares of common stock issuable upon conversion of shares of Series B preferred stock held by TRV IV LP. Each of
Third Rock Ventures III GP, LP, or TRV III GP, the general partner of TRV III LP, Third Rock Ventures GP III, LLC, or TRV III LLC, the general partner of TRV III GP, and Mark Levin, Kevin Starr and Dr.&nbsp;Tepper, the managers of TRV II LLC, may be
deemed to share voting and investment power over the shares held of record by TRV III LP. Each of Third Rock Ventures III GP, LP, or TRV III GP, the general partner of TRV III LP, and Third Rock Ventures GP III, LLC, TRV III LLC, the general partner
of TRV III GP, and Mark Levin, Kevin Starr and Dr.&nbsp;Tepper, the managers of TRV III LLC, may be deemed to share voting and investment power over the shares held of record by TRV III LP. The general partner of TRV IV is Third Rock Ventures GP IV,
L.P., or TRV GP IV LP. The general partner of TRV GP IV LP is TRV GP IV, LLC, or TRV GP IV LLC. Abbie Celniker, Ph.D., Robert Tepper, M.D., Craig Muir and Cary Pfeffer, M.D. are the managing members of TRV GP IV LLC who collectively make voting and
investment decisions with respect to shares held by TRV IV. Dr.&nbsp;Lengauer is a partner at Third Rock Ventures, LLC, and a member of our board of directors. The address for each of TRV III LP and TRV IV LP is 29 Newbury Street, Suite 401, Boston,
MA 02116. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 27,904,963 shares of common stock issuable upon the conversion of Series C Preferred Stock held by
SVF Pauling (Cayman) Limited, a wholly owned subsidiary of SoftBank Vision Fund (AIV M2) L.P., or SVF. SVF GP (Jersey) Limited, or SVF GP, is the general partner of SVF. SB Investment Advisers (UK) Limited, or SBIA UK, has been appointed as
alternative investment fund manager, or AIFM, and is exclusively responsible for managing SVF in accordance with the Alternative Investment Fund Managers Directive and is authorized and regulated by the UK Financial Conduct Authority accordingly. As
AIFM of SVF, SBIA UK is exclusively responsible for making all decisions related to the acquisition, structuring, financing, voting and disposal of SVF&#146;s investments. SVF GP and SBIA UK are both wholly owned by SoftBank Group Corp.
Mr.&nbsp;Nishar, a member of our board of directors, is a Senior Managing Partner at SB Investment Advisers (U.S.) Inc., an affiliate of SBIA UK, but does not have voting or investment power over the shares held by SVF. The address of SVF is 251
Little Falls Drive, Wilmington, Delaware 19808. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 378,082 shares of common stock held by Dr.&nbsp;Patel, (ii) 524,548 shares of common stock held
by The Patel Family Irrevocable Trust of 2019, (iii) 432,801 shares of common stock held by The SSP Irrevocable Trust of 2020 and (iv) 904,779 shares subject to options held by Dr.&nbsp;Patel, of which 213,672 are vested and exercisable within 60
days of June 30, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 98,566 shares of common stock held by Dr.&nbsp;Bergstrom and (ii) 394,264 shares subject to
options held by Dr.&nbsp;Bergstrom, of which 154,008 are vested and exercisable within 60 days of June 30, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 221,069 shares subject to options held by Mr.&nbsp;Adams, of which 112,029 are vested and
exercisable within 60 days of June 30, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 104,487 shares of common stock issuable upon the conversion of Series C Preferred Stock held by
Mr.&nbsp;Borisy and (ii) 42,242 shares subject to options held by Mr.&nbsp;Borisy, of which 10,560 are vested and exercisable within 60 days of June 30, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 59,139 shares subject to options held by Dr.&nbsp;Hill, of which 24,112 are vested and exercisable
within 60 days of June 30, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 59,139 shares subject to options held by Mr.&nbsp;Ingram, of which 9,768 are vested and exercisable
within 60 days of June 30, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 14,080 shares of common stock held by Dr.&nbsp;Lengauer. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 436,506 shares of common stock held by Dr.&nbsp;Murcko, (ii) 281,617 shares of shares of common
stock issuable upon the conversion of Series A Preferred Stock held by Dr.&nbsp;Murcko, (iii) 278,829 shares of common stock issuable upon the conversion of Series B Preferred Stock held by Dr.&nbsp;Murcko and (iv) 35,200 shares subject to options
held by Dr.&nbsp;Murcko, of which 14,518 are vested and exercisable within 60 days of June&nbsp;30, 2020. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">185 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 42,242 shares subject to options held by Ms.&nbsp;Rubin, of which 7,920 are vested and exercisable
within 60 days of June&nbsp;30, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 52,099 shares of common stock held by Dr.&nbsp;Shawver and (ii) 21,120 shares subject to
options held by Dr.&nbsp;Shawver, of which 6,598 are vested and exercisable within 60 days of June&nbsp;30, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(13)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">See notes 4 through 12 above; also includes 185,866 shares subject to options held by Thomas Catinazzo, who is
our principal financial and accounting officer, but not named executive officer, of which 90,469 are vested and exercisable within 60 days of June&nbsp;30, 2020. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">186 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_18"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The following descriptions are summaries of the material terms of our fourth amended and restated certificate of incorporation, which will be effective
upon the closing of this offering and amended and restated bylaws, which will be effective upon the effectiveness of the registration statement of which this prospectus is a part. The descriptions of the common stock and preferred stock give effect
to changes to our capital structure that will occur immediately prior to the completion of this offering. We refer in this section to our fourth amended and restated certificate of incorporation as our certificate of incorporation, and we refer to
our amended and restated bylaws as our bylaws. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon completion of this offering, our authorized capital stock will consist of 150,000,000 shares of common stock, par value $0.001 per share, and 10,000,000
shares of preferred stock, par value $0.001 per share, all of which shares of preferred stock will be undesignated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2020, 66,875,742
shares of our common stock were outstanding and held by 61 stockholders of record. This amount assumes the conversion of all outstanding shares of our preferred stock into common stock, which will occur immediately prior to the closing of this
offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of our common
stock are entitled to one vote for each share held on all matters submitted to a vote of the stockholders. The holders of our common stock do not have any cumulative voting rights. Holders of our common stock are entitled to receive ratably any
dividends declared by our board of directors out of funds legally available for that purpose, subject to any preferential dividend rights of any outstanding preferred stock. Our common stock has no preemptive rights, conversion rights or other
subscription rights or redemption or sinking fund provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event of our liquidation, dissolution or winding up, holders of our common stock
will be entitled to share ratably in all assets remaining after payment of all debts and other liabilities and any liquidation preference of any outstanding preferred stock. The shares to be issued by us in this offering will be, when issued and
paid for, validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Immediately prior to the completion of this offering, all outstanding shares of our preferred stock will be converted into shares of our common stock. Upon the
consummation of this offering, our board of directors will have the authority, without further action by our stockholders, to issue up to 10,000,000 shares of preferred stock in one or more series and to fix the rights, preferences, privileges and
restrictions thereof. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund terms and the number of shares constituting, or the
designation of, such series, any or all of which may be greater than the rights of common stock. The issuance of our preferred stock could adversely affect the voting power of holders of common stock and the likelihood that such holders will receive
dividend payments and payments upon our liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing a change in control of our Company or other corporate action. Immediately after consummation
of this offering, no shares of preferred stock will be outstanding, and we have no present plan to issue any shares of preferred stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration
rights </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the completion of this offering, the holders of 61,992,534 shares of our common stock, constituting those issuable upon the conversion of
preferred stock, will be entitled to rights with respect to the registration of these </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">187 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
securities under the Securities Act. These rights are provided under the terms of our Investor Rights Agreement between us and the holders of our preferred stock. The Investor Rights Agreement
includes demand registration rights, short-form registration rights, and piggyback registration rights. All fees, costs and expenses of underwritten registrations under this agreement will be borne by us and all selling expenses, including
underwriting discounts and selling commissions, will be borne by the holders of the shares being registered. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Demand registration rights
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Beginning six months after the completion of this offering, the holders of 61,992,534 shares of our common stock, constituting those issuable upon
the conversion of shares of our preferred stock upon closing of this offering, will be entitled to demand registration rights. Under the terms of the Investor Rights Agreement, we will be required, upon the written request of a majority of holders
of the registrable securities then outstanding that would result in an aggregate offering price of at least $7.5&nbsp;million, to file a registration statement and to use commercially reasonable efforts to effect the registration of all or a portion
of these shares for public resale. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Short-form registration rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the completion of this offering, the holders of 61,992,534 shares of our common stock, constituting those issuable upon the conversion of shares of our
preferred stock upon closing of this offering, are also entitled to short-form registration rights. Pursuant to the Investor Rights Agreement, if we are eligible to file a registration statement on Form <FONT STYLE="white-space:nowrap">S-3,</FONT>
upon the written request of at least 10% in interest of these holders to sell registrable securities at an aggregate price of at least $1.0&nbsp;million, we will be required to use commercially reasonable efforts to effect a registration of such
shares. We are required to effect only two registrations in any twelve-month period pursuant to this provision of the investor rights agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Piggyback registration rights </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the completion
of this offering, the holders of 61,992,534 shares of our common stock, constituting those issuable upon the conversion of shares of our preferred stock upon closing of this offering, are entitled to piggyback registration rights. If we register any
of our securities either for our own account or for the account of other security holders, the holders of these shares are entitled to include their shares in the registration. Subject to certain exceptions contained in the Investor Rights
Agreement, we and the underwriters may limit the number of shares included in the underwritten offering to the number of shares which we and the underwriters determine in our sole discretion will not jeopardize the success of the offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Indemnification </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our investor rights agreement
contains customary cross-indemnification provisions, under which we are obligated to indemnify holders of registrable securities in the event of material misstatements or omissions in the registration statement attributable to us, and they are
obligated to indemnify us for material misstatements or omissions attributable to them. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Expiration of registration rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The demand registration rights and short-form registration rights granted under the Investor Rights Agreement will terminate on the fifth anniversary of the
completion of this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-takeover effects of our certificate of incorporation and bylaws and Delaware Law </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation and bylaws include a number of provisions that may have the effect of delaying, deferring or preventing another party from
acquiring control of us and encouraging persons considering unsolicited tender offers or other unilateral takeover proposals to negotiate with our board of directors rather than pursue <FONT STYLE="white-space:nowrap">non-negotiated</FONT> takeover
attempts. These provisions include the items described below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">188 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Board composition and filling vacancies </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation provides for the division of our board of directors into three classes serving staggered three-year terms, with one class
being elected each year. Our certificate of incorporation also provides that directors may be removed only for cause and then only by the affirmative vote of the holders of <FONT STYLE="white-space:nowrap">two-thirds</FONT> or more of the shares
then entitled to vote at an election of directors. Furthermore, any vacancy on our board of directors, however occurring, including a vacancy resulting from an increase in the size of our board, may only be filled by the affirmative vote of a
majority of our directors then in office even if less than a quorum. The classification of directors, together with the limitations on removal of directors and treatment of vacancies, has the effect of making it more difficult for stockholders to
change the composition of our board of directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>No written consent of stockholders </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation provides that all stockholder actions are required to be taken by a vote of the stockholders at an annual or special meeting,
and that stockholders may not take any action by written consent in lieu of a meeting. This limit may lengthen the amount of time required to take stockholder actions and would prevent the amendment of our bylaws or removal of directors by our
stockholders without holding a meeting of stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Meetings of stockholders </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation and bylaws provide that only a majority of the members of our board of directors then in office may call special meetings of
stockholders and only those matters set forth in the notice of the special meeting may be considered or acted upon at a special meeting of stockholders. Our bylaws limit the business that may be conducted at an annual meeting of stockholders to
those matters properly brought before the meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Advance notice requirements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our bylaws establish advance notice procedures with regard to stockholder proposals relating to the nomination of candidates for election as directors or new
business to be brought before meetings of our stockholders. These procedures provide that notice of stockholder proposals must be timely given in writing to our corporate secretary prior to the meeting at which the action is to be taken. Generally,
to be timely, notice must be received at our principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary date of the annual meeting for the preceding year. Our bylaws specify the requirements as to form
and content of all stockholders&#146; notices. These requirements may preclude stockholders from bringing matters before the stockholders at an annual or special meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Amendment to certificate of incorporation and bylaws </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any amendment of our certificate of incorporation must first be approved by a majority of our board of directors, and if required by law or our certificate of
incorporation, must thereafter be approved by a majority of the outstanding shares entitled to vote on the amendment and a majority of the outstanding shares of each class entitled to vote thereon as a class, except that the amendment of the
provisions relating to stockholder action, board composition, and limitation of liability must be approved by not less than <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding shares entitled to vote on the amendment, and not less
than <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding shares of each class entitled to vote thereon as a class. Our bylaws may be amended by the affirmative vote of a majority of the directors then in office, subject to any
limitations set forth in the bylaws; and may also be amended by the affirmative vote of a majority of the outstanding shares entitled to vote on the amendment, voting together as a single class, except that the amendment of the provisions relating
to notice of stockholder business and nominations and special meetings must be approved by not less than <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding shares entitled to vote on the amendment, and not less than <FONT
STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding shares of each class entitled to vote </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">189 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
thereon as a class, or, if our board of directors recommends that the stockholders approve the amendment, by the affirmative vote of the majority of the outstanding shares entitled to vote on the
amendment, in each case voting together as a single class. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Undesignated preferred stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our certificate of incorporation provides for 10,000,000 authorized shares of preferred stock. The existence of authorized but unissued shares of preferred
stock may enable our board of directors to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or otherwise. For example, if in the due exercise of its fiduciary obligations, our board of directors were to
determine that a takeover proposal is not in the best interests of our stockholders, our board of directors could cause shares of preferred stock to be issued without stockholder approval in one or more private offerings or other transactions that
might dilute the voting or other rights of the proposed acquirer or insurgent stockholder or stockholder group. In this regard, our certificate of incorporation grants our board of directors broad power to establish the rights and preferences of
authorized and unissued shares of preferred stock. The issuance of shares of preferred stock could decrease the amount of earnings and assets available for distribution to holders of shares of common stock. The issuance may also adversely affect the
rights and powers, including voting rights, of these holders and may have the effect of delaying, deterring or preventing a change in control of us. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Choice of Forum </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our by-laws provide that, unless we
consent in writing to the selection of an alternative form, the Court of Chancery of the State of Delaware (or, if the Chancery Court does not have jurisdiction, the federal district court for the District of Delaware or other state courts of the
State of Delaware) will be the sole and exclusive forum for: (1)&nbsp;any derivative action or proceeding brought on our behalf; (2)&nbsp;any action asserting a claim of breach of a fiduciary duty or other wrongdoing by any of our directors,
officers, employees or agents to us or our stockholders; (3)&nbsp;any action asserting a claim against us arising pursuant to any provision of the General Corporation Law of the State of Delaware or our certificate of incorporation or <FONT
STYLE="white-space:nowrap">by-laws;</FONT> (4)&nbsp;any action to interpret, apply, enforce or determine the validity of our certificate of incorporation or <FONT STYLE="white-space:nowrap">by-laws;</FONT> or (5)&nbsp;any action asserting a claim
governed by the internal affairs doctrine. Our by-laws of incorporation also provide that any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock will be deemed to have notice of and to have consented to
this choice of forum provision. It is possible that a court of law could rule that the choice of forum provision contained in our restated certificate of incorporation is inapplicable or unenforceable if it is challenged in a proceeding or
otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, our <FONT STYLE="white-space:nowrap">by-laws</FONT> provide that, unless we consent in writing to the selection of an alternative
forum, the United States District Court in the District of Massachusetts will be the exclusive forum for any private action asserting violations by us or any of our directors or officers of the Securities Act or the Exchange Act, or the rules and
regulations promulgated thereunder, and of all suits in equity and actions at law brought to enforce any liability or duty created by those statutes or the rules and regulations under such statutes. If any action the subject matter of which is
within the scope of the preceding sentence is filed in a court other than the United States District of Massachusetts, the plaintiff or plaintiffs shall be deemed by this provision of the bylaws (i)&nbsp;to have consented to removal of the action by
us to the United States District Court in the District of Massachusetts, in the case of an action filed in a state court, and (ii)&nbsp;to have consented to transfer of the action to the United States District Court in the District of Massachusetts.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;203 of the Delaware General Corporation Law </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon completion of this offering, we will be subject to the provisions of Section&nbsp;203 of the Delaware General Corporation Law. In general,
Section&nbsp;203 prohibits a publicly held Delaware corporation from engaging in a &#147;business combination&#148; with an &#147;interested stockholder&#148; for a three-year period following the time that this stockholder becomes an interested
stockholder, unless the business combination is approved in a prescribed </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">190 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
manner. Under Section&nbsp;203, a business combination between a corporation and an interested stockholder is prohibited unless it satisfies one of the following conditions: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">before the stockholder became interested, our board of directors approved either the business combination or the
transaction which resulted in the stockholder becoming an interested stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the
interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, shares owned by persons who are directors and
also officers, and employee stock plans, in some instances, but not the outstanding voting stock owned by the interested stockholder; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">at or after the time the stockholder became interested, the business combination was approved by our board of
directors and authorized at an annual or special meeting of the stockholders by the affirmative vote of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding voting stock which is not owned by the interested stockholder.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;203 defines a business combination to include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any merger or consolidation involving the corporation and the interested stockholder; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any sale, transfer, lease, pledge or other disposition involving the interested stockholder of 10% or more of the
assets of the corporation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock
of the corporation to the interested stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subject to exceptions, any transaction involving the corporation that has the effect of increasing the
proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges, or other
financial benefits provided by or through the corporation. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In general, Section&nbsp;203 defines an interested stockholder as any entity
or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by the entity or person. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nasdaq Global Market listing </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have been approved to
list our common stock on the Nasdaq Global Market under the trading symbol &#147;RLAY.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer agent and registrar </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transfer agent and registrar for our common stock will be Computershare Trust Company, N.A. The transfer agent and registrar&#146;s address is 250 Royall
Street, Canton, Massachusetts 02021, and its telephone number is (800) 962-4284. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">191 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_19"></A>SHARES ELIGIBLE FOR FUTURE SALE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to this offering, there has been no public market for our shares. Future sales of our common stock in the public market, or the availability of such
shares for sale in the public market, could adversely affect market prices prevailing from time to time. As described below, only a limited number of shares will be available for sale shortly after this offering due to contractual and legal
restrictions on resale. Nevertheless, sales of our common stock in the public market after such restrictions lapse, or the perception that those sales may occur, could adversely affect the prevailing market price at such time and our ability to
raise equity capital in the future. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based on the number of shares outstanding as of June&nbsp;30, 2020, upon the completion of this offering,
86,875,742 shares of our common stock will be outstanding, assuming no exercise of the underwriters&#146; option to purchase additional shares and no exercise of outstanding options. Of the outstanding shares, all of the shares sold in this offering
will be freely tradable, except that any shares held by our affiliates, as that term is defined in Rule&nbsp;144 under the Securities Act, may only be sold in compliance with the limitations described below, and 290,477 shares of our common stock
are restricted shares of common stock subject to time-based vesting terms. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule&nbsp;144 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In general, a person who has beneficially owned restricted stock for at least six months would be entitled to sell their securities provided that (i)&nbsp;such
person is not deemed to have been one of our affiliates at the time of, or at any time during the 90 days preceding, a sale and (ii)&nbsp;we are subject to the Securities Exchange Act of 1934, as amended, or the Exchange Act, periodic reporting
requirements for at least 90 days before the sale. Persons who have beneficially owned restricted shares for at least six months but who are our affiliates at the time of, or any time during the 90 days preceding, a sale, would be subject to
additional restrictions, by which such person would be entitled to sell within any three-month period only a number of securities that does not exceed the greater of either of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1% of the number of shares then outstanding, which will equal approximately 815,757 shares immediately after this
offering assuming no exercise of the underwriters&#146; option to purchase additional shares, based on the number of shares outstanding as of June 30, 2020; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the average weekly trading volume of our common stock on the Nasdaq Global Market during the four calendar weeks
preceding the filing of a notice on Form&nbsp;144 with respect to the sale; </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided, in each case, that we are subject to the Exchange
Act periodic reporting requirements for at least 90&nbsp;days before the sale. Such sales both by affiliates and by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> must also comply with the manner of sale, current public information and
notice provisions of Rule&nbsp;144. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule&nbsp;701 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Rule&nbsp;701 under the Securities Act, as in effect on the date of this prospectus, permits resales of shares in reliance upon Rule&nbsp;144 but without
compliance with certain restrictions of Rule&nbsp;144, including the holding period requirement. Most of our employees, executive officers, or directors who purchased shares under a written compensatory plan or contract may be entitled to rely on
the resale provisions of Rule&nbsp;701, but all holders of Rule&nbsp;701 shares are required to wait until 90 days after the date of this prospectus before selling their shares. However, substantially all Rule&nbsp;701 shares are subject to <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreements as described below and under &#147;Underwriting&#148; included elsewhere in this prospectus and will become eligible for sale upon the expiration of the restrictions set forth in those agreements.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We, all of our directors and executive officers, and the holders of substantially all of our capital stock and securities convertible into or exchangeable for
our capital stock have entered into <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements with the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">192 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
underwriters and/or are subject to market standoff agreements or other agreements with us, which prevents them from selling any of our common stock or any securities convertible into or
exercisable or exchangeable for common stock for a period of not less than 180&nbsp;days from the date of this prospectus without the prior written consent of the representatives, subject to certain exceptions. See the section entitled
&#147;Underwriting&#148; appearing elsewhere in this prospectus for more information. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon completion of this offering, certain holders of our securities will be entitled to various rights with respect to registration of their shares under the
Securities Act.&nbsp;Registration of these shares under the Securities Act would result in these shares becoming fully tradable without restriction under the Securities Act immediately upon the effectiveness of the registration.&nbsp;See the section
entitled &#147;Description of Capital Stock&#151;Registration rights&#148; appearing elsewhere in this prospectus for more information. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity
incentive plans </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We intend to file one or more registration statements on <FONT STYLE="white-space:nowrap">Form&nbsp;S-8</FONT> under the Securities
Act to register our shares issued or reserved for issuance under our equity incentive plans. The first such registration statement is expected to be filed soon after the date of this prospectus and will automatically become effective upon filing
with the SEC. Accordingly, shares registered under such registration statement will be available for sale in the open market, unless such shares are subject to vesting restrictions with us or the <FONT STYLE="white-space:nowrap">lock-up</FONT>
restrictions described above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">193 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_20"></A>MATERIAL U.S. FEDERAL INCOME TAX </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSIDERATIONS <FONT STYLE="white-space:nowrap">FOR&nbsp;NON-U.S.&nbsp;HOLDERS</FONT> OF COMMON STOCK </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following discussion is a summary of material U.S. federal income tax considerations applicable to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders
(as defined below) with respect to their ownership and disposition of shares of our common stock issued pursuant to this offering. For purposes of this discussion, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder means a beneficial owner of
our common stock that is, for U.S. federal income tax purposes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a <FONT STYLE="white-space:nowrap">non-resident</FONT> alien individual; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a foreign corporation or any other foreign organization taxable as a corporation for U.S. federal income tax
purposes; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a foreign estate or trust, the income of which is not subject to U.S. federal income tax on a net income basis.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This discussion does not address the tax treatment of partnerships or other entities or arrangements that are treated as pass-through
entities for U.S. federal income tax purposes or persons that hold their shares of our common stock through partnerships or such other pass-through entities. The tax treatment of a partner in a partnership or other entity or arrangement that is
treated as a pass-through entity for U.S. federal income tax purposes generally will depend upon the status of the partner and the activities of the partnership. A partner in a partnership or an investor in any other pass-through entity that will
hold our common stock should consult his, her or its tax advisor regarding the tax consequences of acquiring, holding and disposing of our common stock through a partnership or other pass-through entity, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This discussion is based on current provisions of the Internal Revenue Code of 1986, as amended, or the Code, existing and proposed U.S. Treasury regulations
promulgated thereunder, current administrative rulings and judicial decisions, all as in effect as of the date of this prospectus and, all of which are subject to change or to differing interpretation, possibly with retroactive effect. Any such
change or differing interpretation could alter the tax consequences to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders described in this prospectus. There can be no assurance that the Internal Revenue Service, or the IRS, will not challenge
one or more of the tax consequences described herein. We assume in this discussion that a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder holds shares of our common stock as a capital asset, which is generally property held for investment.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This discussion does not address all aspects of U.S. federal income taxation that may be relevant to a particular
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder in light of that <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s individual circumstances, including the alternative minimum tax, the Medicare tax on net investment income or the
rules relating to &#147;qualified small business stock.&#148; Any U.S. federal tax other than the income tax (including, for example, the estate tax), and it does not nor does it address any aspects of U.S. state, local or <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> taxes. This discussion also does not consider any specific facts or circumstances that may apply to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder and does not address the special tax rules
applicable to particular <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders, such as: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">insurance companies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">tax-exempt</FONT> or governmental organizations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">financial institutions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">brokers or dealers in securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">regulated investment companies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">pension plans; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;controlled foreign corporations,&#148; &#147;passive foreign investment companies,&#148; and corporations
that accumulate earnings to avoid U.S. federal income tax; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;qualified foreign pension funds,&#148; or entities wholly owned by a &#147;qualified foreign pension
fund&#148;; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">194 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes
(and partners and investors therein); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">persons that have a functional currency other than the U.S. dollar; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">persons deemed to sell our common stock under the constructive sale provisions of the Code;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">persons that hold our common stock as part of a straddle, hedge, conversion transaction, synthetic security or
other integrated investment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">persons that hold or receive our common stock pursuant to the exercise of any employee stock option or
otherwise as compensation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">14.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">investors in pass-through entities (or entities that are treated as disregarded entities for U.S. federal
income tax purposes); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">15.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">U.S. expatriates. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This discussion is for general information only and is not tax advice. Accordingly, all prospective <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders
of our common stock should consult their tax advisors with respect to the U.S. federal, state, local, estate and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax consequences of the purchase, ownership and disposition of our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Distributions on our common stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As described in the
&#147;Dividend Policy&#148; section above, we do not intend to pay any cash dividends on our common stock to our stockholders stock in the foreseeable future. Distributions, if any, on shares of our common stock generally will constitute dividends
for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. If a distribution exceeds our current and accumulated earnings and profits, the
excess will be treated as a <FONT STYLE="white-space:nowrap">tax-free</FONT> return of the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s investment, up to such holder&#146;s tax basis in the shares of common stock. Any remaining
excess will be treated as capital gain, subject to the tax treatment described below in &#147;Gain on sale or other taxable disposition of our shares of common stock.&#148; Any such distributions will also be subject to the discussion below under
the section titled &#147;Withholding and information reporting requirements&#151;FATCA.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the discussion in the following two paragraphs
in this section, dividends paid to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will be subject to withholding of U.S. federal income tax at a 30% rate or such lower rate specified by an applicable income tax treaty between
the United States and such holder&#146;s country of residence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dividends that are treated as effectively connected with a trade or business conducted by
a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder within the United States and, if an applicable income tax treaty so provides, that are attributable to a permanent establishment or a fixed base maintained by the <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder within the United States, are generally exempt from the 30% withholding tax if the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder satisfies applicable certification and disclosure
requirements. However, such U.S. effectively connected income, net of specified deductions and credits, is taxed at the same graduated U.S. federal income tax rates applicable to United States persons (as defined in the Code). Any U.S. effectively
connected income received by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that is a corporation may also, under certain circumstances, be subject to an additional &#147;branch profits tax&#148; at a 30% rate or such lower rate as
specified by an applicable income tax treaty between the United States and such holder&#146;s country of residence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder of shares of our common stock who claims the benefit of an applicable income tax treaty between the United States and such holder&#146;s country of residence generally will be required to
provide a properly executed IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN</FONT> or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> (or a successor form) to the applicable withholding agent and
satisfy applicable certification and other requirements. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders are urged to consult their tax advisors regarding their entitlement to benefits under a relevant income tax treaty. A <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder that is eligible for a reduced rate of U.S. withholding tax under an income tax treaty may obtain a refund or credit of any excess amounts withheld by timely filing an appropriate claim with the IRS.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">195 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gain on sale, exchange or other taxable disposition of shares of our common stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the discussion below under &#147;Withholding and information reporting requirements&#151;FATCA,&#148; a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will not be subject to any U.S. federal income tax on any gain realized upon such holder&#146;s sale, exchange or other taxable disposition of shares of our common stock unless: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the gain is effectively connected with the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s
conduct of a U.S. trade or business and, if an applicable income tax treaty so provides, is attributable to a permanent establishment or a fixed-base maintained by such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder in the United States, in
which case the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally will be taxed on a net income basis at the graduated U.S. federal income tax rates applicable to United States persons (as defined in the Code) and, if the <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder is a foreign corporation, the branch profits tax described above in &#147;Distributions on our common stock&#148; also may apply; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is a nonresident alien individual who is present in
the United States for a period or periods aggregating 183 days or more in the taxable year of the disposition and certain other conditions are met, in which case the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will be subject to a 30%
tax (or such lower rate as may be specified by an applicable income tax treaty between the United States and such holder&#146;s country of residence) on the net gain derived from the disposition, which may be offset by certain U.S. source capital
losses of the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder, if any (even though the individual is not considered a resident of the United States), provided that the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder has timely filed
U.S. federal income tax returns with respect to such losses; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">we are, or have been, at any time during the five-year period preceding such sale or other taxable disposition
(or the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s holding period, if shorter) a &#147;U.S. real property holding corporation,&#148; unless our common stock is regularly traded on an established securities market, within the
meaning of the relevant provisions of the Code, and the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder holds no more than 5% of our outstanding common stock, directly or indirectly, actually or constructively, during the shorter of the
five-year period ending on the date of the disposition or the period that the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder held our common stock. Generally, a corporation is a &#147;U.S. real property holding corporation&#148; only if the
fair market value of its &#147;U.S. real property interests&#148; (as defined in the Code and applicable U.S. Treasury regulations) equals or exceeds 50% of the sum of the fair market value of its worldwide real property interests plus its other
assets used or held for use in a trade or business. Although there can be no assurance, we do not believe that we are, or have been, a &#147;U.S. real property holding corporation&#148; for U.S. federal income tax purposes, or that we are likely to
become one in the future. No assurance can be provided that our common stock will be regularly traded on an established securities market for purposes of the rules described above. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Backup withholding and information reporting </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We must
report annually to the IRS and to each <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder the gross amount of the distributions on shares of our common stock paid to such holder and the tax withheld, if any, with respect to such distributions. <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> holders may have to comply with specific certification procedures to establish that the holder is not a United States person (as defined in the Code) in order to avoid backup withholding at the applicable
rate with respect to dividends on shares of our common stock. Generally, a non-U.S. holder will comply with such procedures if it provides a properly executed IRS Form W-8BEN or W-8BEN-E (or other applicable IRS Form W-8), or otherwise meets
documentary evidence requirements for establishing that it is a non-U.S. holder, or otherwise establishes an exemption. Dividends paid to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders subject to withholding of U.S. federal income tax, as
described above in &#147;Distributions on our common stock,&#148; generally will be exempt from U.S. backup withholding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Information reporting and backup
withholding will generally apply to the proceeds of a disposition of shares of our common stock by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder effected by or through the U.S. office of any broker, U.S. or non-U.S., unless the holder
certifies its status as a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder and satisfies certain other requirements, or otherwise establishes an exemption. Generally, information reporting and backup withholding will not apply to a payment
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">196 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of disposition proceeds to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder where the transaction is effected outside the United States through a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> office of a broker. However, for information reporting purposes, dispositions effected through a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> office of a broker with substantial U.S. ownership or
operations generally will be treated in a manner similar to dispositions effected through a U.S. office of a broker. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their tax advisors regarding the application of the
information reporting and backup withholding rules to them. Copies of information returns may be made available to the tax authorities of the country in which the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder resides or is incorporated
under the provisions of a specific treaty or agreement. Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules from a payment to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder can be refunded
or credited against the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s U.S. federal income tax liability, if any, provided that an appropriate claim is filed with the IRS in a timely manner. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Withholding and information reporting requirements&#151;FATCA </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Foreign Account Tax Compliance Act, or FATCA, generally imposes a U.S. federal withholding tax at a rate of 30% on payments of dividends on our common
stock paid to a foreign entity unless (i)&nbsp;if the foreign entity is a &#147;foreign financial institution,&#148; such foreign entity undertakes certain due diligence, reporting, withholding, and certification obligations, (ii)&nbsp;if the
foreign entity is not a &#147;foreign financial institution,&#148; such foreign entity identifies certain of its U.S. investors, if any, or (iii)&nbsp;the foreign entity is otherwise exempt under FATCA. Such withholding may also apply to payments of
gross proceeds of sales or other dispositions of shares of our common stock, although under proposed U.S. Treasury regulations (the preamble to which specifies that taxpayers, including withholding agents, are generally permitted to rely on them
pending finalization), no withholding will apply to payments of gross proceeds. Under certain circumstances, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder may be eligible for refunds or credits of this withholding tax. An
intergovernmental agreement between the United States and an applicable foreign country may modify the requirements described in this paragraph. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders should consult their tax advisors regarding the
possible implications of this legislation on their investment in our common stock and the entities through which they hold our shares of common stock, including, without limitation, the process and deadlines for meeting the applicable requirements
to prevent the imposition of the 30% withholding tax under FATCA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">197 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_21"></A>UNDERWRITING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are offering the shares of common stock described in this prospectus through a number of underwriters. J.P. Morgan Securities LLC, Goldman Sachs&nbsp;&amp;
Co. LLC, Cowen and Company, LLC and Guggenheim Securities, LLC are acting as joint <FONT STYLE="white-space:nowrap">book-running</FONT> managers of the offering and as representatives of the underwriters. We have entered into an underwriting
agreement with the underwriters. Subject to the terms and conditions of the underwriting agreement, we have agreed to sell to the underwriters, and each underwriter has severally agreed to purchase, at the public offering price less the underwriting
discounts and commissions set forth on the cover page of this prospectus, the number of shares of common stock listed next to its name in the following table: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cowen and Company, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Guggenheim Securities, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriters are committed to purchase all the shares of common stock offered by us if they purchase any shares. The
underwriting agreement also provides that if an underwriter defaults, the purchase commitments of <FONT STYLE="white-space:nowrap">non-defaulting</FONT> underwriters may also be increased or the offering may be terminated. The offering of the shares
by the underwriters is subject to receipt and acceptance, and is also subject to the underwriters&#146; right to reject any order in whole or in part. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriters propose to offer the shares of common stock directly to the public at the initial public offering price set forth on the cover page of this
prospectus and to certain dealers at that price less a concession not in excess of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. After the initial offering of the shares to the public,
if all of the shares of common stock are not sold at the initial public offering price, the underwriters may change the offering price and the other selling terms. Sales of any shares made outside of the United States may be made by affiliates of
the underwriters. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriters have an option to buy up to 3,000,000 additional shares of common stock from us to cover sales of shares by the
underwriters which exceed the number of shares specified in the table above. The underwriters have 30&nbsp;days from the date of this prospectus to exercise this option to purchase additional shares. If any shares are purchased with this option to
purchase additional shares, the underwriters will purchase shares in approximately the same proportion as shown in the table above. If any additional shares of common stock are purchased, the underwriters will offer the additional shares on the same
terms as those on which the shares are being offered. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriting fee is equal to the public offering price per share of common stock less the
amount paid by the underwriters to us per share of common stock. The underwriting fee is $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. The following table shows the per share and total
underwriting discounts and commissions to be paid to the underwriters assuming both no exercise and full exercise of the underwriters&#146; option to purchase additional shares. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Without<BR>option to<BR>purchase<BR>additional<BR>shares<BR>exercise</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>With full<BR>option to<BR>purchase<BR>additional<BR>shares<BR>exercise</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Per Share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">198 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We estimate that the total expenses of this offering, including registration, filing and listing fees,
printing fees and legal and accounting expenses, but excluding the underwriting discounts and commissions, will be approximately $3.0 million. We have agreed to reimburse the underwriters for expenses relating to the clearance of this offering with
the Financial Industry Regulatory Authority, Inc. in an amount up to $40,000. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At our request, the underwriters have reserved up to 441,000 shares, or
2.2% of the shares being offered by this prospectus, for sale, at the initial public offering price, to certain of our directors, officers, employees and persons having business relationships with us. If these persons purchase reserved shares, this
will reduce the number of shares available for sale to the general public. Any reserved shares that are not so purchased will be offered by the underwriters to the general public on the same terms as the other shares offered by this prospectus. Any
shares sold in the directed share program to our directors or officers who have entered into lock-up agreements described below shall be subject to the provisions of such lock-up agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A prospectus in electronic format may be made available on the web sites maintained by one or more underwriters, or selling group members, if any,
participating in the offering. The underwriters may agree to allocate a number of shares to underwriters and selling group members for sale to their online brokerage account holders. Internet distributions will be allocated by the representatives to
underwriters and selling group members that may make Internet distributions on the same basis as other allocations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We<I> </I>have agreed that, subject
to certain limited exceptions, we will not (i)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer
or dispose of, directly or indirectly, or submit to, or file with, the SEC a registration statement under the Securities Act relating to, any shares of our common stock or securities convertible into or exercisable or exchangeable for any shares of
our common stock, or publicly disclose the intention to make any offer, sale, pledge, loan, disposition or filing, or (ii)&nbsp;enter into any swap or other arrangement that transfers all or a portion of the economic consequences associated with the
ownership of any shares of common stock or any such other securities (regardless of whether any of these transactions are to be settled by the delivery of shares of common stock or such other securities, in cash or otherwise), in each case without
the prior written consent of J.P. Morgan Securities LLC and Goldman Sachs&nbsp;&amp; Co. LLC for a period of 180 days after the date of this prospectus, other than the shares of our common stock to be sold in this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our directors and executive officers, and substantially all of our shareholders (such persons, the <FONT STYLE="white-space:nowrap">&#147;lock-up</FONT>
parties&#148;) have entered into <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements with the underwriters prior to the commencement of this offering pursuant to which each <FONT STYLE="white-space:nowrap">lock-up</FONT> party, with limited
exceptions, for a period of 180&nbsp;days after the date of this prospectus (such period, the &#147;restricted period&#148;), may not (and may not cause any of their direct or indirect affiliates to), without the prior written consent of J.P. Morgan
Securities LLC and Goldman Sachs&nbsp;&amp; Co. LLC, (1)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise
transfer or dispose of, directly or indirectly, any shares of our common stock or any securities convertible into or exercisable or exchangeable for our common stock (including, without limitation, common stock or such other securities which may be
deemed to be beneficially owned by such <FONT STYLE="white-space:nowrap">lock-up</FONT> parties in accordance with the rules and regulations of the SEC and securities which may be issued upon exercise of a stock option or warrant (collectively with
the common stock, the <FONT STYLE="white-space:nowrap">&#147;lock-up</FONT> securities&#148;)), (2)&nbsp;enter into any hedging, swap or other agreement or transaction that transfers, in whole or in part, any of the economic consequences of
ownership of the <FONT STYLE="white-space:nowrap">lock-up</FONT> securities, whether any such transaction described in clause&nbsp;(1) or&nbsp;(2) above is to be settled by delivery of <FONT STYLE="white-space:nowrap">lock-up</FONT> securities, in
cash or otherwise, (3)&nbsp;make any demand for, or exercise any right with respect to, the registration of any <FONT STYLE="white-space:nowrap">lock-up</FONT> securities, or (4)&nbsp;publicly disclose the intention to do any of the foregoing. Such
persons or entities have further acknowledged that these undertakings preclude them from engaging in any hedging or other transactions or arrangements (including, without limitation, any short sale or the purchase or sale of, or entry into, any put
or call option, or combination thereof, forward, swap or any other derivative transaction or instrument, however described or defined) designed or intended, or which could reasonably be expected to lead to or result in, a sale or disposition or
transfer (by any person or entity, whether or not a signatory to such agreement) of any economic </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">199 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
consequences of ownership, in whole or in part, directly or indirectly, of any <FONT STYLE="white-space:nowrap">lock-up</FONT> securities, whether any such transaction or arrangement (or
instrument provided for thereunder) would be settled by delivery of <FONT STYLE="white-space:nowrap">lock-up</FONT> securities, in cash or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
restrictions described in the immediately preceding paragraph and contained in the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements between the underwriters and the <FONT STYLE="white-space:nowrap">lock-up</FONT> parties do not apply,
subject in certain cases to various conditions, to certain transactions, including (a)&nbsp;transfers of <FONT STYLE="white-space:nowrap">lock-up</FONT> securities: (i)&nbsp;as a bona fide gift or gifts, or for bona fide estate planning purposes,
(ii)&nbsp;by will or intestacy, (iii)&nbsp;to any trust for the direct or indirect benefit of the <FONT STYLE="white-space:nowrap">lock-up</FONT> party or any immediate family member of the <FONT STYLE="white-space:nowrap">lock-up</FONT> party, or,
if the <FONT STYLE="white-space:nowrap">lock-up</FONT> party is a trust, to a trustor or beneficiary of the trust or to the estate of a beneficiary of such trust, (iv)&nbsp;to a partnership, limited liability company or other entity of which the <FONT
STYLE="white-space:nowrap">lock-up</FONT> party and its immediate family members are the legal and beneficial owner of all of the outstanding equity securities or similar interests, (v)&nbsp;to a nominee or custodian of a person or entity to whom a
disposition or transfer would be permissible under clauses (i)&nbsp;through (iv), (vi) in the case of a corporation, partnership, limited liability company, trust or other business entity, (A)&nbsp;to another corporation, partnership, limited
liability company, trust or other business entity that is an affiliate of the <FONT STYLE="white-space:nowrap">lock-up</FONT> party, or to any investment fund or other entity controlling, controlled by, managing or managed by or under common control
with the <FONT STYLE="white-space:nowrap">lock-up</FONT> party or its affiliates or (B)&nbsp;as part of a distribution to members or stockholders of the <FONT STYLE="white-space:nowrap">lock-up</FONT> party; (vii)&nbsp;by operation of law,
(viii)&nbsp;to us from an employee upon death, disability or termination of employment of such employee, (ix)&nbsp;as part of a sale of <FONT STYLE="white-space:nowrap">lock-up</FONT> securities acquired in open market transactions after the
completion of this offering, (x)&nbsp;to us in connection with the vesting, settlement or exercise of restricted stock units, options, warrants or other rights to purchase shares of our common stock (including &#147;net&#148; or &#147;cashless&#148;
exercise), including for the payment of exercise price and tax and remittance payments, or (xi)&nbsp;pursuant to a bona fide third-party tender offer, merger, consolidation or other similar transaction approved by our board of directors and made to
all shareholders involving a change in control, provided that if such transaction is not completed, all such <FONT STYLE="white-space:nowrap">lock-up</FONT> securities would remain subject to the restrictions in the immediately preceding paragraph;
(b)&nbsp;exercise of the options, settlement of RSUs or other equity awards, or the exercise of warrants granted pursuant to plans described in this prospectus, provided that any <FONT STYLE="white-space:nowrap">lock-up</FONT> securities received
upon such exercise, vesting or settlement would be subject to restrictions similar to those in the immediately preceding paragraph; (c)&nbsp;the conversion of outstanding preferred stock, warrants to acquire preferred stock, or convertible
securities into shares of our common stock or warrants to acquire shares of our common stock, provided that any common stock or warrant received upon such conversion would be subject to restrictions similar to those in the immediately preceding
paragraph; and (d)&nbsp;the establishment by <FONT STYLE="white-space:nowrap">lock-up</FONT> parties of trading plans under Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act, provided that such plan does not provide for the
transfer of <FONT STYLE="white-space:nowrap">lock-up</FONT> securities during the restricted period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC and Goldman
Sachs&nbsp;&amp; Co. LLC, in their sole discretion, may release the securities subject to any of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements with the underwriters described above, in whole or in part at any time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have been approved to have our common stock approved for listing on the Nasdaq Global Market under the symbol &#147;RLAY.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with this offering, the underwriters may engage in stabilizing transactions, which involves making bids for, purchasing and selling shares of
common stock in the open market for the purpose of preventing or retarding a decline in the market price of the common stock while this offering is in progress. These stabilizing transactions may include making short sales of common stock, which
involves the sale by the underwriters of a greater number of shares of common stock than they are required to purchase in this offering, and purchasing shares of common stock on the open market to cover positions created by short sales. Short sales
may be &#147;covered&#148; shorts, which are short positions in an amount not greater than the underwriters&#146; option to purchase additional shares referred to above, or may be &#147;naked&#148; shorts, which are short positions in excess of that
amount. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">200 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
The underwriters may close out any covered short position either by exercising their option to purchase additional shares, in whole or in part, or by purchasing shares in the open market. In
making this determination, the underwriters will consider, among other things, the price of shares available for purchase in the open market compared to the price at which the underwriters may purchase shares through the option to purchase
additional shares. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the common stock in the open market that could adversely affect investors who purchase in
this offering. To the extent that the underwriters create a naked short position, they will purchase shares in the open market to cover the position. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
underwriters have advised us that, pursuant to Regulation&nbsp;M of the Securities Act, they may also engage in other activities that stabilize, maintain or otherwise affect the price of the common stock, including the imposition of penalty bids.
This means that if the representatives of the underwriters purchase common stock in the open market in stabilizing transactions or to cover short sales, the representatives can require the underwriters that sold those shares as part of this offering
to repay the underwriting discount received by them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These activities may have the effect of raising or maintaining the market price of the common stock
or preventing or retarding a decline in the market price of the common stock, and, as a result, the price of the common stock may be higher than the price that otherwise might exist in the open market. If the underwriters commence these activities,
they may discontinue them at any time. The underwriters may carry out these transactions on the Nasdaq Global Market, in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to this offering, there has been no public market for our common stock. The initial public offering price will be determined by negotiations between us
and the representatives of the underwriters. In determining the initial public offering price, we and the representatives of the underwriters expect to consider a number of factors including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the information set forth in this prospectus and otherwise available to the representatives;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our prospects and the history and prospects for the industry in which we compete; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an assessment of our management; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our prospects for future earnings; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the general condition of the securities markets at the time of this offering; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the recent market prices of, and demand for, publicly traded common stock of
generally&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; comparable companies; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other factors deemed relevant by the underwriters and us. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither we nor the underwriters can assure investors that an active trading market will develop for our common stock, or that the shares will trade in the
public market at or above the initial public offering price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriters and their respective affiliates are full service financial institutions
engaged in various activities, which may include sales and trading, commercial and investment banking, advisory, investment management, investment research, principal investment, hedging, market making, brokerage and other financial and
non-financial activities and services. Certain of the underwriters and their respective affiliates have provided, and may in the future provide, a variety of these services to the issuer and to persons and entities with relationships with the
issuer, for which they received or will receive customary fees and expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the ordinary course of their various business activities, the
underwriters and their respective affiliates, officers, directors and employees may purchase, sell or hold a broad array of investments and actively trade securities, derivatives, loans, commodities, currencies, credit default swaps and other
financial instruments for their own account and for the accounts of their customers, and such investment and trading activities may involve or relate </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">201 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to assets, securities and/or instruments of the issuer (directly, as collateral securing other obligations or otherwise) and/or persons and entities with relationships with the issuer. The
underwriters and their respective affiliates may also communicate independent investment recommendations, market color or trading ideas and/or publish or express independent research views in respect of such assets, securities or instruments and may
at any time hold, or recommend to clients that they should acquire, long and/or short positions in such assets, securities and instruments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Selling
restrictions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than in the United States, no action has been taken by us or the underwriters that would permit a public offering of the securities
offered by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or
advertisements in connection with the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction.
Persons into whose possession this prospectus comes are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus. This prospectus does not constitute an offer to sell or a
solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer or a solicitation is unlawful. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in the European Economic Area and the United Kingdom </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In relation to each member state of the European Economic Area and the United Kingdom (each, a &#147;Relevant State&#148;), no shares have been offered or will
be offered pursuant to the offering to the public in that Relevant State prior to the publication of a prospectus in relation to the shares which has been approved by the competent authority in that Relevant State or, where appropriate, approved in
another Relevant State and notified to the competent authority in that Relevant State, all in accordance with the Prospectus Regulation), except that offers of shares may be made to the public in that Relevant State at any time under the following
exemptions under the Prospectus Regulation: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) to any legal entity which is a qualified investor as defined under the Prospectus Regulation; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii) to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus Regulation), subject to obtaining the prior
consent of the underwriters for any such offer; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iii) in any other circumstances falling within Article 1(4) of the Prospectus Regulation, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided that no such offer of shares shall require the Company or any underwriter to publish a prospectus pursuant to Article 3 of the Prospectus Regulation
or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the purposes of this provision, the expression an &#147;offer to the
public&#148; in relation to any shares in any Relevant State means the communication in any form and by any means of sufficient information on the terms of the offer and any shares to be offered so as to enable an investor to decide to purchase or
subscribe for any shares, and the expression &#147;Prospectus Regulation&#148; means Regulation (EU) 2017/1129. References to the Prospectus Regulation includes, in relation to the United Kingdom, the Prospectus Regulation as it forms part of United
Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in the United Kingdom </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This document is for distribution only to persons who (i)&nbsp;have professional experience in matters relating to investments and who qualify as investment
professionals within the meaning of Article 19(5) of the Financial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">202 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Services and Markets Act 2000 (Financial Promotion) Order 2005 as amended the &#147;Financial Promotion Order&#148;, (ii) are persons falling within Article 49(2)(a) to (d) (&#147;high net worth
companies, unincorporated associations etc.&#148;) of the Financial Promotion Order, (iii)&nbsp;are outside the United Kingdom, or (iv)&nbsp;are persons to whom an invitation or inducement to engage in investment activity (within the meaning of
Section&nbsp;21 of the Financial Services and Markets Act 2000, as amended, or FSMA) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred
to as &#147;relevant persons&#148;) or otherwise in circumstances which have not resulted and will not result in an offer to the public of the shares in the United Kingdom within the meaning of the FSMA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any person in the United Kingdom that is not a relevant person should not act or rely on the information included in this document or use it as basis for
taking any action. In the United Kingdom, any investment or investment activity that this document relates to may be made or taken exclusively by relevant persons. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Canada </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
shares may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National <FONT STYLE="white-space:nowrap">Instrument&nbsp;45-106&nbsp;Prospectus</FONT> Exemptions or subsection
73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National <FONT STYLE="white-space:nowrap">Instrument&nbsp;31-103&nbsp;Registration</FONT> Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of
the shares must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus
(including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&#146;s province or
territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#146;s province or territory for particulars of these rights or consult with a legal advisor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to section 3A.3 of National <FONT STYLE="white-space:nowrap">Instrument&nbsp;33-105&nbsp;Underwriting</FONT> Conflicts
<FONT STYLE="white-space:nowrap">(NI&nbsp;33-105),&nbsp;the</FONT> underwriters are not required to comply with the disclosure requirements of <FONT STYLE="white-space:nowrap">NI&nbsp;33-105&nbsp;regarding</FONT> underwriter conflicts of interest in
connection with this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Switzerland </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (SIX), or on any other stock exchange or regulated
trading facility in Switzerland. This document does not constitute a prospectus within the meaning of, and has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of
Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering
or marketing material relating to the shares or the offering may be publicly distributed or otherwise made publicly available in Switzerland. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neither
this document nor any other offering or marketing material relating to the offering, the Company or the shares have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and
the offer of shares will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA, and the offer of shares has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes (CISA). The investor
protection afforded to acquirers of interests in collective investment schemes under the CISA does not extend to acquirers of shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">203 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in the Dubai International Financial Centre </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This document relates to an Exempt Offer in accordance with the Markets Rules 2012 of the Dubai Financial Services Authority (DFSA). This document is intended
for distribution only to persons of a type specified in the Markets Rules 2012 of the DFSA. It must not be delivered to, or relied on by, any other person. The DFSA has no responsibility for reviewing or verifying any documents in connection with
Exempt Offers. The DFSA has not approved this prospectus supplement nor taken steps to verify the information set forth herein and has no responsibility for this document. The securities to which this document relates may be illiquid and/or subject
to restrictions on their resale. Prospective purchasers of the securities offered should conduct their own due diligence on the securities. If you do not understand the contents of this document you should consult an authorized financial advisor.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In relation to its use in the Dubai International Financial Centre (DIFC), this document is strictly private and confidential and is being distributed to
a limited number of investors and must not be provided to any person other than the original recipient, and may not be reproduced or used for any other purpose. The interests in the securities may not be offered or sold directly or indirectly to the
public in the DIFC. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in the United Arab Emirates </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares have not been, and are not being, publicly offered, sold, promoted or advertised in the United Arab Emirates (including the Dubai International
Financial Centre) other than in compliance with the laws of the United Arab Emirates (and the Dubai International Financial Centre) governing the issue, offering and sale of securities. Further, this prospectus does not constitute a public offer of
securities in the United Arab Emirates (including the Dubai International Financial Centre) and is not intended to be a public offer. This prospectus has not been approved by or filed with the Central Bank of the United Arab Emirates, the Securities
and Commodities Authority or the Dubai Financial Services Authority. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Australia </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">does not constitute a disclosure document or a prospectus under Chapter 6D.2 of the Corporations Act 2001 (Cth)
(the Corporations Act); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">has not been, and will not be, lodged with the Australian Securities and Investments Commission (ASIC), as a
disclosure document for the purposes of the Corporations Act and does not purport to include the information required of a disclosure document for the purposes of the Corporations Act; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">may only be provided in Australia to select investors who are able to demonstrate that they fall within one or
more of the categories of investors, available under section 708 of the Corporations Act (Exempt Investors). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares may not be
directly or indirectly offered for subscription or purchased or sold, and no invitations to subscribe for or buy the shares may be issued, and no draft or definitive offering memorandum, advertisement or other offering material relating to any
shares may be distributed in Australia, except where disclosure to investors is not required under Chapter 6D of the Corporations Act or is otherwise in compliance with all applicable Australian laws and regulations. By submitting an application for
the shares, you represent and warrant to us that you are an Exempt Investor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As any offer of shares under this document will be made without disclosure
in Australia under Chapter 6D.2 of the Corporations Act, the offer of those securities for resale in Australia within 12 months may, under section 707 of the Corporations Act, require disclosure to investors under Chapter 6D.2 if none of the
exemptions in section 708 applies to that resale. By applying for the shares you undertake to us that you will not, for a period of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">204 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
12 months from the date of issue of the shares, offer, transfer, assign or otherwise alienate those shares to investors in Australia except in circumstances where disclosure to investors is not
required under Chapter 6D.2 of the Corporations Act or where a compliant disclosure document is prepared and lodged with ASIC. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to
prospective investors in Japan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares have not been and will not be registered pursuant to Article 4, Paragraph 1 of the Financial Instruments
and&nbsp;Exchange Act. Accordingly, none of the shares nor any interest therein may be offered or sold, directly or indirectly, in Japan or to, or for the benefit of, any &#147;resident&#148; of Japan (which term as used herein means any person
resident in Japan, including any corporation or other entity organized under the laws of Japan), or to others <FONT STYLE="white-space:nowrap">for&nbsp;re-offering&nbsp;or</FONT> resale, directly or indirectly, in Japan or to or for the benefit of a
resident of Japan, except pursuant to an exemption from the registration requirements of, and otherwise in compliance with, the Financial Instruments and&nbsp;Exchange Act&nbsp;and any other applicable laws, regulations and ministerial guidelines of
Japan in effect at the relevant time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to prospective investors in Hong Kong </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares have not been offered or sold and will not be offered or sold in Hong Kong, by means of any document, other than (1)&nbsp;to &#147;professional
investors&#148; as defined in the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong) (the SFO), of Hong Kong and any rules made thereunder; or (2)&nbsp;in other circumstances which do not result in the document being a
&#147;prospectus&#148; as defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32) of Hong Kong (the CO), or which do not constitute an offer to the public within the meaning of the CO. No advertisement, invitation or
document relating to the shares has been or may be issued or has been or may be in the possession of any person for the purposes of issue, whether in Hong Kong or elsewhere, which is directed at, or the contents of which are likely to be accessed or
read by, the public of Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to shares which are or are intended to be disposed of only to persons outside Hong Kong or only to &#147;professional
investors&#148; as defined in the SFO and any rules made thereunder. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to prospective investors in Singapore </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each representative has acknowledged that this prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, each
representative has represented and agreed that it has not offered or sold any shares or caused the shares to be made the subject of an invitation for subscription or purchase and will not offer or sell any shares or cause the shares to be made the
subject of an invitation for subscription or purchase, and has not circulated or distributed, nor will it circulate or distribute, this prospectus or any other document or material in connection with the offer or sale, or invitation for subscription
or purchase, of the shares, whether directly or indirectly, to any person in Singapore other than: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to an institutional investor (as defined in Section&nbsp;4A of the Securities and Futures Act (Chapter 289) of
Singapore, as modified or amended from time to time (the SFA)) pursuant to Section&nbsp;274 of the SFA; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to a relevant person (as defined in Section&nbsp;275(2) of the SFA) pursuant to Section&nbsp;275(1) of the SFA,
or any person pursuant to Section&nbsp;275(1A) of the SFA, and in accordance with the conditions specified in Section&nbsp;275 of the SFA; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where the shares are subscribed or purchased under Section&nbsp;275 of the SFA by a relevant person which is: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a corporation (which is not an accredited investor (as defined in Section&nbsp;4A of the SFA)) the sole
business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">205 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each
beneficiary of the trust is an individual who is an accredited investor, </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">securities or securities-based derivatives contracts (each
term as defined in Section&nbsp;2(1) of the SFA) of that corporation or the beneficiaries&#146; rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the
shares pursuant to an offer made under Section&nbsp;275 of the SFA except: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to an institutional investor or to a relevant person, or to any person arising from an offer referred to in
Section&nbsp;275(1A) or&nbsp;Section 276(4)(i)(B) of the SFA; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">where no consideration is or will be given for the transfer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">where the transfer is by operation of law; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as specified in Section&nbsp;276(7) of the SFA; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as specified in Regulation 37A of the Securities and Futures (Offers of Investments) (Securities and
Securities-based Derivatives Contracts) Regulations 2018. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Singapore SFA Product Classification&#151;In connection with
Section&nbsp;309B of the SFA and the CMP Regulations 2018, unless otherwise specified before an offer of the shares, we have determined, and hereby notify all relevant persons (as defined in Section&nbsp;309A(1) of the SFA), that the shares are
&#147;prescribed capital markets products&#148; (as defined in the CMP Regulations 2018) and Excluded Investment Products (as defined in MAS Notice <FONT STYLE="white-space:nowrap">SFA&nbsp;04-N12:&nbsp;Notice</FONT> on the Sale of Investment
Products and MAS <FONT STYLE="white-space:nowrap">Notice&nbsp;FAA-N16:&nbsp;Notice</FONT> on Recommendations on Investment Products). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to
prospective investors in Bermuda </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shares may be offered or sold in Bermuda only in compliance with the provisions of the Investment Business Act of
2003 of Bermuda which regulates the sale of securities in Bermuda. Additionally, <FONT STYLE="white-space:nowrap">non-Bermudian</FONT> persons (including companies) may not carry on or engage in any trade or business in Bermuda unless such persons
are permitted to do so under applicable Bermuda legislation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to prospective investors in Saudi Arabia </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This document may not be distributed in the Kingdom of Saudi Arabia except to such persons as are permitted under the Offers of Securities Regulations as
issued by the board of the Saudi Arabian Capital Market Authority (CMA) pursuant to resolution <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">number&nbsp;2-11-2004&nbsp;dated</FONT></FONT> 4&nbsp;October 2004 as amended by
resolution&nbsp;number <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-28-2008,&nbsp;as</FONT></FONT> amended. The CMA does not make any representation as to the accuracy or completeness of this document and expressly disclaims
any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this document. Prospective purchasers of the securities offered hereby should conduct their own due diligence on the accuracy of the information relating
to the securities. If you do not understand the contents of this document, you should consult an authorized financial adviser. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to
prospective investors in the British Virgin Islands </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares are not being, and may not be offered to the public or to any person in the
British Virgin Islands for purchase or subscription by or on behalf of us. The shares may be offered to companies incorporated under the BVI Business Companies Act, 2004 (British Virgin Islands) (BVI Companies), but only where the offer will be made
to, and received by, the relevant BVI Company entirely outside of the British Virgin Islands. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to prospective investors in China </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This prospectus will not be circulated or distributed in the PRC and the shares will not be offered or sold, and will not be offered or sold to any person <FONT
STYLE="white-space:nowrap">for&nbsp;re-offering&nbsp;or</FONT> resale directly or indirectly to any residents of the PRC </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">206 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
except pursuant to any applicable laws and regulations of the PRC. Neither this prospectus nor any advertisement or other offering material may be distributed or published in the PRC, except
under circumstances that will result in compliance with applicable laws and regulations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to prospective investors in Korea </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares have not been and will not be registered under the Financial Investments Services and Capital Markets Act of Korea and the decrees and regulations
thereunder (the FSCMA), and the shares have been and will be offered in Korea as a private placement under the FSCMA. None of the shares may be offered, sold or delivered directly or indirectly, or offered or sold to any person <FONT
STYLE="white-space:nowrap">for&nbsp;re-offering&nbsp;or</FONT> resale, directly or indirectly, in Korea or to any resident of Korea except pursuant to the applicable laws and regulations of Korea, including the FSCMA and the Foreign Exchange
Transaction Law of Korea and the decrees and regulations thereunder (the FETL). The shares have not been listed on any of the securities exchanges in the world including, without limitation, the Korea Exchange in Korea. Furthermore, the purchaser of
the shares shall comply with all applicable regulatory requirements (including but not limited to requirements under the FETL) in connection with the purchase of the shares. By the purchase of the shares, the relevant holder thereof will be deemed
to represent and warrant that if it is in Korea or is a resident of Korea, it purchased the shares pursuant to the applicable laws and regulations of Korea. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to prospective investors in Malaysia </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No
prospectus or other offering material or document in connection with the offer and sale of the shares has been or will be registered with the Securities Commission of Malaysia (or Commission), for the Commission&#146;s approval pursuant to the
Capital Markets and Services Act 2007. Accordingly, this prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the shares may not be circulated or distributed, nor may the
shares be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Malaysia other than (1)&nbsp;a closed end fund approved by the Commission; (2)&nbsp;a holder of a Capital
Markets Services License; (3)&nbsp;a person who acquires the shares, as principal, if the offer is on terms that the shares may only be acquired at a consideration of not less than RM250,000 (or its equivalent in foreign currencies) for each
transaction; (4)&nbsp;an individual whose total net personal assets or total net joint assets with his or her spouse exceeds RM3&nbsp;million (or its equivalent in foreign currencies), excluding the value of the primary residence of the individual;
(5)&nbsp;an individual who has a gross annual income exceeding RM300,000 (or its equivalent in foreign currencies) per annum in the preceding twelve months; (6)&nbsp;an individual who, jointly with his or her spouse, has a gross annual income of
RM400,000 (or its equivalent in foreign currencies), per annum in the preceding twelve months; (7)&nbsp;a corporation with total net assets exceeding RM10&nbsp;million (or its equivalent in a foreign currencies) based on the last audited accounts;
(8)&nbsp;a partnership with total net assets exceeding RM10&nbsp;million (or its equivalent in foreign currencies); (9) a bank licensee or insurance licensee as defined in the Labuan Financial Services and&nbsp;Securities Act&nbsp;2010; (10) an
Islamic bank licensee or takaful licensee as defined in the Labuan Financial Services and&nbsp;Securities Act&nbsp;2010; and (11)&nbsp;any other person as may be specified by the Commission; provided that, in the each of the preceding categories
(1)&nbsp;to (11), the distribution of the shares is made by a holder of a Capital Markets Services License who carries on the business of dealing in securities. The distribution in Malaysia of this prospectus is subject to Malaysian laws. This
prospectus does not constitute and may not be used for the purpose of public offering or an issue, offer for subscription or purchase, invitation to subscribe for or purchase any securities requiring the registration of a prospectus with the
Commission under the Capital Markets and Services Act 2007. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to prospective investors in Taiwan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The shares have not been and will not be registered with the Financial Supervisory Commission of Taiwan pursuant to relevant securities laws and regulations
and may not be sold, issued or offered within Taiwan through a public offering or in circumstances which constitutes an offer within the meaning of the Securities and Exchange Act of Taiwan that requires a registration or approval of the Financial
Supervisory Commission of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">207 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Taiwan. No person or entity in Taiwan has been authorized to offer, sell, give advice regarding or otherwise intermediate the offering and sale of the shares in Taiwan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to prospective investors in South Africa </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Due to restrictions under the securities laws of South Africa, no &#147;<I>offer to the public</I>&#148; (as such term is defined in the South African
Companies Act, No.&nbsp;71 of 2008 (as amended <FONT STYLE="white-space:nowrap">or&nbsp;re-enacted)&nbsp;(the</FONT> South African Companies Act)) is being made in connection with the issue of the shares in South Africa. Accordingly, this document
does not, nor is it intended to, constitute a &#147;<I>registered prospectus</I>&#148; (as that term is defined in the South African Companies Act) prepared and registered under the South African Companies Act and has not been approved by, and/or
filed with, the South African Companies and Intellectual Property Commission or any other regulatory authority in South Africa. The shares are not offered, and the offer shall not be transferred, sold, renounced or delivered, in South Africa or to a
person with an address in South Africa, unless one or other of the following exemptions stipulated in Section&nbsp;96(1) applies: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section the offer,
transfer, sale, renunciation or delivery is to: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">96(1)(a) </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(1) persons whose ordinary business, or part of whose ordinary business, is to deal in securities, as principal or agent; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(2) the South African Public Investment Corporation; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(3) persons or entities regulated by the Reserve Bank of South Africa; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(4) authorised financial service providers under South African law; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(5) financial institutions recognised as such under South African law; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(6) a wholly-owned subsidiary of any person or entity contemplated in (3), (4) or (5), acting as agent in the capacity of an authorized
portfolio manager for a pension fund, or as manager for a collective investment scheme (in each case duly registered as such under South African law); or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(7) any combination of the persons in (1)&nbsp;to (6); or </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">96(1)(b)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">the total contemplated acquisition cost of the securities, for a single addressee acting as principal is equal to or greater than ZAR1,000,000 or such higher amount as may be promulgated by notice in the Government Gazette of
South Africa pursuant to section 96(2)(a) of the South African Companies Act.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Information made available in this prospectus should not be considered as &#147;advice&#148; as defined in the South African
Financial Advisory and Intermediary Services Act, 2002. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to prospective investors in Israel </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This document does not constitute a prospectus under the Israeli Securities Law, 5728-1968, and has not been filed with or approved by the
Israel&nbsp;Securities Authority. In Israel, this prospectus is being distributed only to, and is directed only at, qualified investors listed in the first addendum, or the Addendum, to the Israeli Securities Law. Qualified investors may be required
to submit written confirmation that they fall within the scope of the Addendum. In addition, we may distribute and direct this document in Israel, at our sole discretion, to investors who are not considered qualified investors, provided that the
number of such investors in Israel&nbsp;shall be no greater than 35 in any <FONT STYLE="white-space:nowrap">12-month</FONT> period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">208 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_22"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The validity of the shares of common stock offered by this prospectus will be passed upon for us by Goodwin Procter LLP, Boston, Massachusetts. Certain legal
matters related to this offering will be passed upon for the underwriters by Ropes&nbsp;
&amp; Gray LLP, Boston, Massachusetts. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_23"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm, has audited our consolidated financial statements at December&nbsp;31, 2018 and
December&nbsp;31, 2019, and for each of the two years in the period ended December&nbsp;31, 2019, as set forth in their report. We&#146;ve included our financial statements in the prospectus and elsewhere in the registration statement in reliance on
Ernst&nbsp;&amp; Young LLP&#146;s report, given on their authority as experts in accounting and auditing. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_24"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (File Number
<FONT STYLE="white-space:nowrap">333-239412)</FONT> under the Securities Act with respect to the common stock we are offering by this prospectus. This prospectus does not contain all of the information included in the registration statement. For
further information pertaining to us and our common stock, you should refer to the registration statement and to its exhibits. Whenever we make reference in this prospectus to any of our contracts, agreements or other documents, the references are
not necessarily complete, and you should refer to the exhibits attached to the registration statement for copies of the actual contract, agreement or other document. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the completion of the offering, we will be subject to the informational requirements of the Exchange Act and will file annual, quarterly and current
reports, proxy statements and other information with the SEC. You can read our SEC filings, including the registration statement, at the SEC&#146;s website at www.sec.gov. We also maintain a website at www.relaytx.com. Upon completion of the
offering, you may access, free of charge, our annual reports on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> quarterly reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> current reports on Form
<FONT STYLE="white-space:nowrap">8-K</FONT> and amendment to those reported filed or furnished pursuant to Section&nbsp;13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after such material is electronically filed with, or
furnished to, the SEC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">209 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom904779_25"></A>Index to Consolidated Financial Statements </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="96%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin904779_1">Report of Independent Registered Public Accounting Firm </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-2</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consolidated Financial Statements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin904779_2">Consolidated Balance Sheets</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-3</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin904779_3">Consolidated Statements of Operations and Comprehensive Loss</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-4</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin904779_4">Consolidated Statements of Convertible Preferred Stock and Stockholders&#146;
 Equity (Deficit) </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin904779_5">Consolidated Statements of Cash Flows</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-6</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin904779_6">Notes to Consolidated Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-7</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin904779_1"></A>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the Stockholders and the Board of Directors of Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Opinion on the Financial Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have audited the
accompanying consolidated balance sheets of Relay Therapeutics, Inc. (the Company) as of December&nbsp;31, 2018 and 2019, the related consolidated statements of operations and comprehensive loss, convertible preferred stock and stockholders&#146;
equity (deficit), and cash flows for each of the two years in the period ended December&nbsp;31, 2019, and the related notes (collectively referred to as the &#147;consolidated financial statements&#148;). In our opinion, the consolidated financial
statements present fairly, in all material respects, the financial position of the Company at December&nbsp;31, 2018 and 2019, and the results of its operations and its cash flows for each of the two years in the period ended December&nbsp;31, 2019
in conformity with U.S. generally accepted accounting principles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis for Opinion </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These financial statements are the responsibility of the Company&#146;s management. Our responsibility is to express an opinion on the Company&#146;s financial
statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal
securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We conducted our audits in accordance
with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not
required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of
expressing an opinion on the effectiveness of the Company&#146;s internal control over financial reporting. Accordingly, we express no such opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test
basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the
financial statements. We believe that our audits provide a reasonable basis for our opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Ernst &amp; Young LLP </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have served as the Company&#146;s auditor since 2017. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Boston,
Massachusetts </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May 22, 2020, except for Notes 17(e) and (f) as to which the date is July 9, 2020 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><A NAME="fin904779_2"></A>Consolidated Balance Sheets </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share amounts) </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>March&nbsp;31,<BR>2020 </B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro forma</B><br><B>March&nbsp;31,<BR>2020 </B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(unaudited) </B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Current assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">421,505</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 41,954</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 70,342</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 70,342</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">313,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">263,861</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">263,861</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,597</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,720</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,459</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,459</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">424,102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">360,536</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">338,662</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">338,662</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,094</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,561</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,561</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Operating lease assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,560</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,173</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,173</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">878</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">878</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">878</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">878</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">428,611</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">393,068</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">370,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">370,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><B>Liabilities, Convertible Preferred Stock, and Stockholders&#146; Equity (Deficit)</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Current liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,705</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,991</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,958</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,958</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accrued expenses and other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,982</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,278</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,278</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Operating lease liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,249</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,865</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,986</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,544</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Operating lease liability, net of current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Restricted stock liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">553</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,725</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,844</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,844</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Commitments and contingencies (Note 13)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Convertible preferred stock (Series A, B and C), $0.001 par value; 337,272,859 shares authorized at
December&nbsp;31, 2018 and 2019 and March&nbsp;31, 2020 (unaudited); 210,863,764, 212,642,857, 212,642,857 and no shares issued and outstanding at December&nbsp;31, 2018, December&nbsp;31, 2019, March&nbsp;31, 2020 actual and pro forma (unaudited),
respectively (aggregate liquidation preference of $519,825 at December&nbsp;31, 2019 and March&nbsp;31, 2020 (unaudited))</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">532,120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">537,781</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">537,781</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Stockholders&#146; equity (deficit):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Preferred stock, $0.001 par value, no shares authorized, issued and outstanding at
December&nbsp;31, 2018, 2019 and March&nbsp;31, 2020 actual (unaudited) and 10,000,000 shares authorized and no shares issued and outstanding, March 31, 2020 pro forma (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Common stock, $0.001 par value; 260,000,000 shares authorized at December&nbsp;31, 2018 and 2019
and March&nbsp;31, 2020 (unaudited); 4,544,010, 4,716,634, 4,787,635 and 66,780,169 shares issued at December&nbsp;31, 2018, 2019 and March&nbsp;31, 2020 actual and pro forma (unaudited), respectively; 2,998,017, 4,037,476, 4,333,837 and 66,326,371
shares outstanding at December&nbsp;31, 2018 and 2019 and March&nbsp;31, 2020 actual and pro forma (unaudited), respectively</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">548,338</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accumulated other comprehensive income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(114,177</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(189,482</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(214,368</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(214,368</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total stockholders&#146; equity (deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(110,927</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(180,438</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(202,351</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">335,430</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Total liabilities, convertible preferred stock, and stockholders&#146; equity (deficit)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">428,611</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">393,068</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">370,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">370,274</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>See accompanying notes. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><A NAME="fin904779_3"></A>Consolidated Statements of Operations and Comprehensive Loss </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended<BR>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center">(unaudited) </TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 41,034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 70,306</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 21,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,855</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,742</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,067</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,889</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84,048</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,402</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(49,889</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(84,048</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(16,402</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26,458</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,113</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,801</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,277</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(58</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(57</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,220</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,572</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(48,785</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(75,305</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(14,182</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(24,886</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(19.63</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(21.82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.59</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(5.99</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average shares of common stock, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,485,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,450,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,087,779</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,153,791</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per share, basic and diluted (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1.15</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.38</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma weighted average shares of common stock, basic and diluted (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65,428,521</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66,146,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive income:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrealized holding gain</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,069</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other comprehensive income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,069</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(48,785</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(74,980</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(14,182</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(23,817</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>See accompanying notes. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><A NAME="fin904779_4"></A>Consolidated Statements of Convertible Preferred Stock and Stockholders&#146; Equity (Deficit) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Convertible Preferred<BR>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional<BR><FONT STYLE="white-space:nowrap">Paid-in</FONT><BR>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated<BR>Other<BR>Comprehensive<BR>Loss</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated<BR>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Stockholders&#146;<BR>Equity&nbsp;(Deficit)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Par&nbsp;value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Balances at December&nbsp;31, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,012,855</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">138,533</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,890,764</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(65,392</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(65,385</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Issuance of Series C convertible preferred stock, net of issuance costs of $764</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">122,850,909</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,587</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Vesting of restricted common stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,107,253</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">355</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">356</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,887</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,887</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(48,785</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(48,785</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; BORDER-RIGHT:1px solid #000000;border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Balances at December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">210,863,764</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">532,120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,998,017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(114,177</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(110,927</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Issuance of Series C convertible preferred stock, net of issuance costs of $50</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,779,093</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,661</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Issuance of common stock upon exercise of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">178,969</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">613</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">613</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Vesting of restricted common stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">860,490</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">399</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,456</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,456</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Unrealized gain on investments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(75,305</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(75,305</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Balances at December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">212,642,857</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">537,781</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,037,476</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(189,482</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(180,438</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Issuance of common stock upon exercise of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,845</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">351</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">351</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Vesting of restricted common stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">210,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,455</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Unrealized gain on investments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,069</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,069</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,886</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,886</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Balances at March&nbsp;31, 2020 (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">212,642,857</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">537,781</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,333,837</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,619</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(214,368</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(202,351</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Conversion of Series A-C convertible preferred stock upon completion of initial public
offering</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(212,642,857</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(537,781</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,992,534</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">537,719</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">537,781</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Pro forma balances at March&nbsp;31, 2020 (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66,326,371</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">548,338</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(214,368</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">335,430</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><A NAME="fin904779_5"></A>Consolidated Statements of Cash Flows </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands) </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended<BR>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">(unaudited) </P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from operating activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(48,785</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(75,305</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(14,182</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(24,886</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments to reconcile net loss to net cash used in operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,887</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,456</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,154</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,845</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">859</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net amortization of premiums and discounts on investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,495</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(321</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on sale of equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,280</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,123</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(208</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">261</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease assets and liabilities, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(466</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">622</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,232</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(16</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,338</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses and other liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,425</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,531</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(44,135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(66,133</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10,816</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(22,334</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from investing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchases of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,687</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,002</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,144</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,020</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from sale of equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchases of investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(553,517</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(55,609</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from maturities of investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">242,475</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by (used in) investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,680</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(319,024</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,144</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,371</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Cash flows from financing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of convertible preferred stock, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">394,255</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,993</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of common stock upon exercise of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">613</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">351</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of restricted common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">799</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repurchase of restricted common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">394,972</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,606</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,047</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">351</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net increase (decrease) in cash, cash equivalents and restricted cash</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">349,157</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(379,551</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,913</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,388</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents and restricted cash at beginning of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,226</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">422,383</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">422,383</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,832</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents and restricted cash at end of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">422,383</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">42,832</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">413,470</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">71,220</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Supplemental disclosure of <FONT STYLE="white-space:nowrap">non-cash</FONT> investing and
financing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment additions included in accounts payable and accrued expenses </P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,224</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">745</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Reclassification of restricted stock liability to additional paid in capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 356</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance costs for convertible preferred included in accounts payable and accrued
expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 668</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Recognition of right of use asset upon adoption of ASU
<FONT STYLE="white-space:nowrap">2018-11</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Right of use asset obtained in exchange for lease obligation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,936</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 24,936</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><A NAME="fin904779_6"></A>Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Nature of Business and Basis of Presentation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Relay
Therapeutics, Inc. (the Company) was incorporated in Delaware on May&nbsp;4, 2015. The Company is a clinical-stage precision medicines company transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic
discovery in targeted oncology. The Company is built upon unparalleled insights into protein motion and how this dynamic behavior relates to protein function. The Company&#146;s Dynamo platform integrates an array of leading edge experimental and
computational approaches, which allows the Company to apply the understanding of protein structure and motion to drug discovery. The Company is advancing its lead product candidates, <FONT STYLE="white-space:nowrap">RLY-4008</FONT> and <FONT
STYLE="white-space:nowrap">RLY-1971,</FONT> and a development candidate selection for a PI3K&#945; selective mutant program <FONT STYLE="white-space:nowrap">(RLY-PI3K1047</FONT> program) for the treatment of patients with advanced solid tumors. The
Company initiated a Phase 1 clinical trial for <FONT STYLE="white-space:nowrap">RLY-1971</FONT> in patients with advanced solid tumors in the first quarter of 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is subject to risks common to companies in the biotechnology industry including, but not limited to, new technological innovations, protection of
proprietary technology, dependence on key personnel, compliance with government regulations and the need to obtain additional financing. Product candidates currently under development will require significant additional research and development
efforts, including extensive <FONT STYLE="white-space:nowrap">pre-clinical</FONT> and clinical testing and regulatory approval, prior to commercialization. These efforts require significant amounts of additional capital, adequate personnel
infrastructure and extensive compliance-reporting capabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s product candidates are in development. There can be no assurance that
the Company&#146;s research and development will be successfully completed, that adequate protection for the Company&#146;s intellectual property will be obtained, that any products developed will obtain necessary government regulatory approval or
that any approved products will be commercially viable. Even if the Company&#146;s product development efforts are successful, it is uncertain when, if ever, the Company will generate significant revenue from product sales. The Company operates in
an environment of rapid change in technology and substantial competition from pharmaceutical and biotechnology companies. In addition, the Company is dependent upon the services of its employees and consultants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has devoted substantially all of its resources to developing our product candidates, including <FONT STYLE="white-space:nowrap">RLY-1971</FONT>
and <FONT STYLE="white-space:nowrap">RLY-4008,</FONT> and a <FONT STYLE="white-space:nowrap">RLY-PI3K1047</FONT> program developing its innovative experimental and computational approaches on protein motion platform, building its intellectual
property portfolio, business planning, raising capital and providing general and administrative support for these operations. Through December&nbsp;31, 2019 and March&nbsp;31, 2020 (unaudited), the Company had received gross proceeds of $519,825
from sales of its preferred stock and the issuance of convertible debt. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has experienced negative operating cash flows and had an accumulated
deficit of $189,482 and $214,368 as of December&nbsp;31, 2019 and March&nbsp;31, 2020 (unaudited), respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company expects that its cash, cash
equivalents and investments at March&nbsp;31, 2020 (unaudited) of $334,203 will enable it to fund its operating expenses and capital expenditure requirements for at least one year from the date of the issuance of these consolidated financial
statements, May&nbsp;22, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The future viability of the Company is dependent on its ability to generate cash from operating activities or to raise
additional capital to finance its operations. The Company&#146;s failure to raise capital as and when needed could have a negative impact on its financial condition and ability to pursue its business strategies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Nature of Business and Basis of Presentation&nbsp;(continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is seeking to complete an initial public offering of its common stock. Upon the closing of a
qualified public offering, the Company&#146;s outstanding convertible preferred stock will automatically convert into shares of common stock (see Note&nbsp;7). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company expects to seek funding from the proposed initial public offering of its common stock and <FONT STYLE="white-space:nowrap">follow-on</FONT> public
equity financings or in the event the initial public offering is not competed, through private equity financings. The Company may also seek funding through debt financing, collaboration agreements or government grants until it can generate
sufficient operating cash flows from its operations. The Company may not be able to obtain financing on acceptable terms, or at all, and the Company may not be able to enter into collaboration arrangements or obtain government grants. The terms of
any financing may adversely affect the holdings or the rights of the Company&#146;s stockholders. If the Company is unable to obtain funding, the Company could be forced to delay, reduce or eliminate its research and development programs, product
portfolio expansion or commercialization efforts, which could adversely affect its business prospects. Although management continues to pursue these plans, there is no assurance that the Company will be successful in obtaining sufficient funding on
terms acceptable to the Company to fund continuing operations, if at all. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Significant Accounting Policies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis of presentation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying consolidated
financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#147;GAAP&#148;). The Company&#146;s consolidated financial statements include the accounts of Relay Therapeutics,
Inc. and its wholly-owned subsidiary, Relay Therapeutics Securities Corporation. All intercompany balances and transactions have been eliminated. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Use
of Estimates </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting periods. Significant estimates and
assumptions reflected in these consolidated financial statements include, but are not limited to, the accrual of research and development and manufacturing expenses, the valuation of equity instruments, the probability of achieving milestones for
performance-based vesting of equity awards, and the incremental borrowing rate for determining the operating lease asset and liability. Estimates are periodically reviewed in light of changes in circumstances, facts and experience. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The full extent to which the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic will directly or indirectly impact the Company&#146;s business, results
of operations and financial condition, including expenses, clinical trials and research and development costs, will depend on future developments that are highly uncertain, including as a result of new information that may emerge concerning <FONT
STYLE="white-space:nowrap">COVID-19</FONT> and the actions taken to contain or treat <FONT STYLE="white-space:nowrap">COVID-19,</FONT> as well as the economic impact on local, regional, national and international markets. The Company has made
estimates of the impact of <FONT STYLE="white-space:nowrap">COVID-19</FONT> within its financial statements and there may be changes to those estimates in future periods. Actual results could differ from the Company&#146;s estimates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Significant Accounting Policies&nbsp;(continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Unaudited Interim Financial Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying condensed consolidated balance sheet as of March 31, 2020, the condensed consolidated statements of operations and comprehensive loss and of
cash flows for the three months ended March 31, 2019 and 2020, and the condensed consolidated statements of convertible preferred stock and stockholders&#146; equity (deficit) for the three months ended March 31, 2020 are unaudited. The unaudited
condensed consolidated interim financial statements have been prepared on the same basis as the audited annual consolidated financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring
adjustments, necessary for the fair statement of the Company&#146;s consolidated financial position as of March 31, 2020 and the consolidated results of its operations and cash flows for the three months ended March 31, 2019 and 2020. The
consolidated financial data and other information disclosed in these notes related to the three months ended March 31, 2019 and 2020 are unaudited. The consolidated results for the three months ended March 31, 2020 are not necessarily indicative of
results to be expected for the year ending December&nbsp;31, 2020, any other interim periods, or any future year or period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Unaudited Pro Forma
Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying unaudited pro forma condensed consolidated balance sheet and statement of convertible preferred stock and
stockholders&#146; equity (deficit) as of March 31, 2020 has been prepared to give effect to (i) the reduction in the conversion price of the Series C preferred stock from $3.21 to $3.027603, which became effective on July 8, 2020, as if the change
in conversion price had occurred on March 31, 2020 and (ii) the conversion of all outstanding shares of the Company&#146;s preferred stock into an aggregate of 61,992,534 shares of common stock as if the conversion had occurred on March 31, 2020.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the accompanying consolidated statements of operations and comprehensive loss, unaudited pro forma basic and diluted net loss per share for the year
ended December 31, 2019 and the three months ended March 31, 2020 have been prepared to give effect to the (i) the reduction in the conversion price of the Series C preferred stock from $3.21 to $3.027603 as if the change in conversion price had
occurred on the later of the first day of the period presented or the issuance date of the convertible preferred stock and (ii) the conversion of all outstanding shares of convertible preferred stock into shares of common stock as if the conversion
had occurred on the later of the first day of the period presented or the issuance date of the convertible preferred stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The changes to the conversion
feature for the Series C preferred stock are considered to be substantial changes to material terms of the instrument, and therefore the Company will account for the changes as an extinguishment and reissuance of a new instrument, consistent with
the Company&#146;s accounting policy. The loss on extinguishment will be recognized on July 8, 2020, and is therefore not reflected in the pro forma adjustments as of March 31, 2020 or for the year ended December 31, 2019 or three months ended March
31, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Segment Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company manages
its operations as a single segment for the purposes of assessing performance and making operating decisions. The Company&#146;s singular focus is on using innovative experimental and computational approaches on protein motion for making medicines
against intractable precision medicine targets. No significant revenue has been generated since inception, and all tangible assets are held in the United States. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Significant Accounting Policies&nbsp;(continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cash Equivalents </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company considers all short-term, highly liquid investments with original maturities of 90&nbsp;days or less at acquisition date to be cash equivalents.
Cash equivalents, which consist of money market funds, are stated at fair value. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Restricted Cash </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company deposited cash of $878 as of December&nbsp;31, 2018 and 2019 and March&nbsp;31, 2020 (unaudited) to secure a letter of credit in connection with
the lease of the Company&#146;s facilities (see Note 14). The Company has classified the restricted cash as a noncurrent asset on its consolidated balance sheets. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Investments in marketable debt securities
are classified as <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale.</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Available-for-sale</FONT></FONT> debt securities are measured and
reported at fair value using quoted prices in active markets for similar securities. Unrealized gains and losses on <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> debt securities are reported as a
separate component of stockholders&#146; equity (deficit). Premiums or discounts from par value are amortized to investment income over the life of the underlying investment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The cost of securities sold is determined on a specific identification basis, and realized gains and losses are included in other income (expense) within the
consolidated statement of operations and comprehensive loss. If any adjustment is required to reflect a decline in the value of the investment that the Company considers to be &#147;other than temporary&#146;, the Company recognizes a charge to the
consolidated statement of operations and comprehensive loss. No such adjustments were necessary during the periods presented. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Concentration of Credit
Risk and Significant Suppliers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash,
cash equivalents and investments. From time to time, the Company has maintained all of its cash, cash equivalents and investments at certain accredited financial institutions in amounts that exceed federally insured limits. The Company generally
invests its excess capital in money market funds, U.S. treasury bonds, U.S. treasury bills, and agency bonds that are subject to minimal credit and market risk. Management has established guidelines relative to credit ratings and maturities intended
to safeguard principal balances and maintain liquidity. The investment portfolio is maintained in accordance with the Company&#146;s investment policy, which defines allowable investments, specifies credit quality standards and limits the credit
exposure of any single issuer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company is dependent on third-party suppliers for research and development activities of its programs, including
preclinical and clinical testing. In particular, the Company relies and expects to continue to rely on a small number of these suppliers, including D. E. Shaw Research, LLC as discussed in Note 13, to meet its requirements for its programs. These
programs could be adversely affected by a significant interruption in <FONT STYLE="white-space:nowrap">pre-clinical</FONT> and clinical testing and a supply of active pharmaceutical ingredients and formulated drugs. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Deferred Offering Costs </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company capitalizes certain
legal, professional accounting and other third-party fees that are directly associated with <FONT STYLE="white-space:nowrap">in-process</FONT> financings as deferred offering costs until such financings are consummated. After consummation of the
financing, these costs are recorded as a reduction of the proceeds received from the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Significant Accounting Policies&nbsp;(continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
financing. If a planned financing is abandoned, the deferred offering costs are expensed immediately as a charge to operating expenses in the consolidated statement of operations and
comprehensive loss. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There were no deferred offering costs on the Company&#146;s consolidated balance sheets at December&nbsp;31, 2018 and 2019 and March
31, 2020 (unaudited). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fair Value Measurements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to
transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize
the use of observable inputs and minimize the use of unobservable inputs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial assets and liabilities carried at fair value are to be classified and
disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Level 1&#151;Quoted prices in active markets for identical assets or liabilities. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Level 2&#151;Observable inputs (other than Level&nbsp;1 quoted prices), such as quoted prices in active markets
for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Level 3&#151;Unobservable inputs that are supported by little or no market activity and that are significant to
determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Lease Agreements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under ASC 842 <I>Leases</I>, which was
adopted January&nbsp;1, 2018, the Company determines if an arrangement is or contains a lease at inception. For leases with a term of 12 months or less, the Company does not recognize a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset or lease liability. The Company&#146;s operating leases are recognized on its consolidated balance sheets as other noncurrent assets, other current
liabilities, and other noncurrent liabilities. The Company does not have any finance leases. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Right-of-use</FONT></FONT> assets represent the Company&#146;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#146;s obligation to make lease payments arising from the
lease. Operating lease <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease
term. As the Company&#146;s leases typically do not provide an implicit rate, the Company uses an estimate of its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease
payments. Operating lease <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets also include the effect of any lease payments made and excludes lease incentives. The lease terms may include options to
extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expense is recognized on a straight-line basis over the lease term. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has lease agreements with lease and <FONT STYLE="white-space:nowrap">non-lease</FONT> components, which are accounted for as a combined element.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Significant Accounting Policies&nbsp;(continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Property and Equipment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Property and equipment are stated at cost less accumulated depreciation. Depreciation expense is recognized using the straight-line method over the useful life
of the asset. Laboratory and computer equipment are depreciated over three years. Furniture and fixtures are depreciated over five years. Leasehold improvements are amortized over the shorter of the lease term or the estimated useful life of the
related asset. Expenditures for repairs and maintenance of assets are charged to expense as incurred. Upon retirement or sale, the cost and related accumulated depreciation of assets disposed of are removed from the accounts and any resulting gain
or loss is included in loss from operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Impairment of Long-Lived Assets </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company continually evaluates long-lived assets for potential impairment when events or changes in circumstances indicate the carrying value of the assets
may not be recoverable. Recoverability is measured by comparing the book values of the assets to the expected future net undiscounted cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment
to be recognized is measured by the amount by which the book values of the assets exceed their fair value. The Company did not recognize any impairment losses for the years ended December&nbsp;31, 2018 and 2019 and the three months ended
March&nbsp;31, 2019 and 2020 (unaudited). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Classification and Accretion of Convertible Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s convertible preferred stock is classified outside of stockholders&#146; equity (deficit) on the consolidated balance sheet because the
holders of such shares have liquidation rights in the event of a deemed liquidation that, in certain situations, are not solely within the control of the Company and would require the redemption of the then-outstanding convertible preferred stock.
The convertible preferred stock is not redeemable, except in the event of a deemed liquidation (see Note 7). Because the occurrence of a deemed liquidation event is not currently probable, the carrying values of the convertible preferred stock are
not being accreted to their redemption values. Subsequent adjustments to the carrying values of the convertible preferred stock would be made only when a deemed liquidation event becomes probable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stock-Based Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company measures all stock
options and other stock-based awards granted to employees and <FONT STYLE="white-space:nowrap">non-employees</FONT> based on the fair value on the date of the grant and recognizes compensation expense of those awards over the requisite service
period, which is generally the vesting period of the respective award. The Company records expense for awards with service-based vesting using the straight-line method and awards with performance conditions utilizing an accelerated attribution
method. The Company recognizes the impact of forfeiture of awards as the forfeitures occur. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company classifies stock-based compensation expense in
its consolidated statement of operations and comprehensive loss in the same manner in which the award recipient&#146;s payroll costs are classified or in which the award recipient&#146;s service payments are classified. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. As there is no active market for the
Company&#146;s common stock, the Company estimates the fair value of common stock on the date of grant based on the then current facts and circumstances. The Company historically </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Significant Accounting Policies&nbsp;(continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
has been a private company and lacks company-specific historical and implied volatility information. Therefore, it estimates its expected stock volatility based on the historical volatility of a
publicly traded set of guideline companies and expects to continue to do so until such time as it has adequate historical data regarding the volatility of its own traded stock price. The expected term of the Company&#146;s stock options has been
determined utilizing the &#147;simplified&#148; method for awards that qualify as &#147;plain-vanilla&#148; options. The expected term of stock options granted to <FONT STYLE="white-space:nowrap">non-employees</FONT> is equal to the contractual term
of the option award. The risk-free interest rate is determined by reference to the U.S. Treasury yield curve in effect at the time of grant of the award for time periods approximately equal to the expected term of the award. Expected dividend yield
is based on the fact that the Company has never paid cash dividends and does not expect to pay any cash dividends in the foreseeable future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company
has granted certain options with performance-based vesting conditions whereby the service inception date precedes the accounting grant date and therefore the Company applies variable accounting such that the stock-based compensation expense to be
recognized for the options will ultimately be based on the fair value of the awards on the accounting grant date. Expense is recognized over the implied service period when achievement of the performance based milestones is deemed probable. The
Company uses judgement to determine whether and, if so, how many awards are deemed probable of vesting at each reporting period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Research and
Development Costs </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research and development costs are expensed as incurred. Research and development expenses include salaries, stock-based
compensation and benefits of employees, third-party license fees and other operational costs related to the Company&#146;s research and development activities, including allocated facility-related expenses and external costs of outside vendors
engaged to conduct both <FONT STYLE="white-space:nowrap">pre-clinical</FONT> studies and clinical trials. Nonrefundable advance payments for goods and services that will be used in future research and development activities are expensed when the
activity has been performed or when the goods have been received rather than when the payment is made. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Research and Manufacturing Contracts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has entered into various research and development contracts with research institutions and other companies, whose costs are included in research
and development expense in the accompanying consolidated statements of operations and comprehensive loss. These agreements are generally cancelable, and related payments are recorded as research and development expenses as the underlying services
are performed. When evaluating the adequacy of the expense recognized, the Company analyzes progress of the services, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made
in determining the expense recognized, and the related prepaid or accrued balances at the end of any reporting period. Actual results could differ from the Company&#146;s estimates. The Company&#146;s historical estimates have not been materially
different from the actual costs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Patent Costs </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All
patent-related costs incurred in connection with filing and prosecuting patent applications are expensed as incurred due to the uncertainty about the recovery of the expenditure. Amounts incurred are classified as general and administrative
expenses. </P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Significant Accounting Policies&nbsp;(continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Income Taxes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company&#146;s
financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on differences between the financial statement carrying amounts and the tax bases of the assets and liabilities using the enacted tax
rates in effect in the years in which the differences are expected to reverse. A valuation allowance against deferred tax assets is recorded if, based on the weight of the available evidence, it is more likely than not that some or all of the
deferred tax assets will not be realized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for uncertainty in income taxes recognized in the financial statements by applying a <FONT
STYLE="white-space:nowrap">two-step</FONT> process to determine the amount of tax benefit to be recognized. First, the tax position must be evaluated to determine the likelihood that it will be sustained upon external examination by the taxing
authorities. If the tax position is deemed <FONT STYLE="white-space:nowrap">more-likely-than-not</FONT> to be sustained, the tax position is then assessed to determine the amount of benefit to recognize in the financial statements. The amount of the
benefit that may be recognized is the largest amount that has a greater than 50% likelihood of being realized upon ultimate settlement. The provision for income taxes includes the effects of any resulting tax reserves, or unrecognized tax benefits,
that are considered appropriate as well as the related net interest and penalties. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Comprehensive Loss </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Comprehensive loss includes net loss as well as other changes in stockholders&#146; equity (deficit) that result from transactions and economic events other
than those with stockholders. For the year ended December&nbsp;31, 2019 and the three months ended March 31, 2020 (unaudited), other comprehensive income consisted of changes in unrealized gains from <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">available-for-sale</FONT></FONT> debt investments. There was no difference between net loss and comprehensive loss for the year ended December&nbsp;31, 2018 and the three months ended March 31, 2019 (unaudited). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Net Loss Per Common Share </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s net loss is
equivalent to net loss attributable to common stockholders for all periods presented. Basic net loss per share is computed using the weighted average number of common shares outstanding during the period. Diluted net loss per share is computed using
the sum of the weighted average number of common shares outstanding during the period and the effect of dilutive securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company applies the <FONT
STYLE="white-space:nowrap">two-class</FONT> method to calculate its basic and diluted net loss per share as the Company has issued shares that meet the definition of participating securities. The <FONT STYLE="white-space:nowrap">two-class</FONT>
method is an earnings allocation formula that treats a participating security as having rights to earnings that otherwise would have been available to common stockholders. The Company&#146;s participating securities contractually entitle the holders
of such shares to participate in dividends; but do not contractually require the holders of such shares to participate in losses of the Company. Accordingly, in periods in which the Company reports a net loss, such losses are not allocated to such
participating securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accordingly, in periods in which the Company reports a net loss, diluted net loss per share is the same as basic net loss per
share, since dilutive common shares are not assumed to have been issued if their effect is anti-dilutive. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Significant Accounting Policies&nbsp;(continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recently Adopted Accounting Pronouncements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company adopted Accounting Standards Update (&#147;ASU&#148;) <FONT STYLE="white-space:nowrap">No.&nbsp;2016-18,</FONT> <I>Statement of Cash Flows,
Restricted Cash</I> (&#147;ASU <FONT STYLE="white-space:nowrap">2016-18&#148;),</FONT> as of January&nbsp;1, 2019 to retrospectively include restricted cash and restricted cash equivalents with cash and cash equivalents when reconciling the
beginning of period and end of period total amounts on the statement of cash flows. A reconciliation of the cash, cash equivalents, and restricted cash reported within the balance sheet that sum to the total of the same amounts shown in the
statement of cash flows is as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>March&nbsp;31,&nbsp;2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>March&nbsp;31,&nbsp;2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">421,505</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">41,954</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">412,592</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">70,342</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">878</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">878</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">878</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">878</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total cash, cash equivalents and restricted cash as shown on the consolidated statements of cash
flows</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">422,383</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">42,832</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">413,470</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">71,220</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the Company adopted ASU No <FONT STYLE="white-space:nowrap">2016-15,</FONT> <I>Statement of Cash Flow</I>
(&#147;ASU <FONT STYLE="white-space:nowrap">2016-15&#148;)</FONT> in 2019. The guidance reduces diversity in how certain cash receipts and cash payments are presented and classified in the consolidated statements of cash flows. The adoption of ASU <FONT
STYLE="white-space:nowrap">2016-15</FONT> did not have a material effect on the Company&#146;s consolidated financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company adopted ASU
<FONT STYLE="white-space:nowrap">No.&nbsp;2018-13,</FONT> <I>Fair Value Measurement (Topic 820): Disclosure Framework&#151;Changes to the Disclosure Requirements for Fair Value Measurement</I> on January&nbsp;1, 2020. This standard modifies certain
disclosure requirements on fair value measurements. The adoption of this standard did not have a material impact on the Company&#146;s disclosures. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recently Issued Accounting Pronouncements Not Yet Adopted </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2016, the FASB issued&nbsp;ASU No. <FONT STYLE="white-space:nowrap">2016-13,</FONT><I>&nbsp;Financial Instruments&#151;Credit Losses (Topic 326):
Measurement of Credit Losses on Financial Instruments</I>. This standard requires that credit losses be reported using an expected losses model rather than the incurred losses model that is currently used, and it establishes additional disclosure
requirements related to credit risks. For <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> debt securities with expected credit losses, this standard now requires allowances to be recorded instead of
reducing the amortized cost of the investment. This guidance was originally effective for fiscal years beginning after December&nbsp;15, 2019, including interim periods within those fiscal years, and early adoption was permitted. In November 2019,
the FASB subsequently issued ASU <FONT STYLE="white-space:nowrap">2019-10,</FONT> <I>Financial Instruments&#151;Credit Losses (Topic 326), Derivatives and Hedging</I> <I>(Topic 815), and Leases (Topic 842): Effective Dates</I>, whereby the effective
date of this standard for smaller reporting companies was deferred to fiscal years beginning after December&nbsp;15, 2022, including interim periods within those fiscal years, and early adoption is still permitted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies that the Company adopts as of the specified effective
date. The Company qualifies as an &#147;emerging growth company&#148; as defined in the Jumpstart Our Business Startups Act of 2012 and has elected not to &#147;opt out&#148; of the extended </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Significant Accounting Policies&nbsp;(continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">transition related to complying with new or revised accounting standards, which means that when a standard is
issued or revised and it has different application dates for public and nonpublic companies, the Company can adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and can do so until such time that the
Company either (i)&nbsp;irrevocably elects to &#147;opt out&#148; of such extended transition period or (ii)&nbsp;no longer qualifies as an emerging growth company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Fair Value of Financial Assets </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following tables
present information about the Company&#146;s financial assets measured at fair value on a recurring basis and indicate the level of the fair value hierarchy utilized to determine such fair values: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair Value Measurements as of<BR>December&nbsp;31, 2018 using:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level&nbsp;1</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level&nbsp;2</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level&nbsp;3</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>Assets</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash equivalents:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money market funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">421,017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">421,017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">421,017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">421,017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair Value Measurements as of<BR>December&nbsp;31, 2019 using:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level&nbsp;1</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level&nbsp;2</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level&nbsp;3</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>Assets</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash equivalents:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money market funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">41,658</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">41,658</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investments:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">US treasury bills</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">232,604</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">232,604</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">US agency securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81,258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81,258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">313,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">313,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">41,658</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">313,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">355,520</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Fair Value of Financial Assets&nbsp;(continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair Value Measurements as of<BR>March&nbsp;31, 2020 using:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level&nbsp;1</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level&nbsp;2</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Level&nbsp;3</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><U>Assets</U></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash equivalents:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money market funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">69,844</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">69,844</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investments:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">US treasury bills</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">186,856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">186,856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">US agency securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77,005</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77,005</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">263,861</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">263,861</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">69,844</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">263,861</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">333,705</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2018 and 2019 and March&nbsp;31, 2020 (unaudited), the Company&#146;s cash equivalents were invested
in money market funds and were valued based on Level&nbsp;1 inputs. As of December&nbsp;31, 2019 and March&nbsp;31, 2020 (unaudited), the Company&#146;s investments were made in U.S Treasury and agency securities and were valued based on
Level&nbsp;2 inputs. In determining the fair value of its investments at each date presented above, the Company relied on quoted prices for similar securities in active markets or using other inputs that are observable or can be corroborated by
observable market data. All <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> securities have contractual maturities of less than one year. The Company did not have any financial assets or liabilities
during any of the periods presented in the accompanying consolidated financial statements that required Level&nbsp;3 inputs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Investments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> investments by type of security was as
follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amortized<BR>Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized<BR>Gains</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized<BR>Losses</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investments:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD COLSPAN="13" VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S treasury bills</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">232,336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">268</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">232,604</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S agency securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81,201</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81,258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">313,537</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">313,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>March&nbsp;31, 2020 </B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amortized<BR>Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized<BR>Gains</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Unrealized<BR>Losses</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fair<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investments:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD COLSPAN="13" VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S treasury bills</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">185,797</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,059</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">186,856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S agency securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,670</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">77,005</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total investments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">262,467</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,394</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">263,861</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2018, the Company had no
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> investments. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Property and Equipment, Net </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Property and equipment, net consisted of the following: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>March&nbsp;31,&nbsp;2020</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B></B>(unaudited)<B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laboratory equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,003</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,643</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">443</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">886</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computer equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">827</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">827</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Furniture and fixtures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">895</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">895</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Construction in process</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">490</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,141</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,075</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,402</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: accumulated depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,649</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,981</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,841</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total property, plant and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 3,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,094</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,561</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recorded $2,154, $2,845, $667 and $859 of depreciation expense for the years ended December&nbsp;31, 2018 and 2019
and the three months ended March&nbsp;31, 2019 and 2020 (unaudited), respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Accrued Expenses and Other Current Liabilities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accrued expenses and other current liabilities consist of the following: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>March&nbsp;31,&nbsp;2020</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B></B>(unaudited)<B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">External research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,718</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Professional services</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">573</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">518</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payroll and related</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">844</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">118</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">198</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total accrued expenses and other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,982</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,746</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,278</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Convertible Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has issued Series A, Series B and Series C (collectively, the &#147;Convertible Preferred Stock&#148;). Upon issuance of each class of Convertible
Preferred Stock, the Company assessed the embedded conversion and liquidation features of the shares and determined that such features did not require the Company to separately account for these features. The Company also concluded that no
beneficial conversion feature existed on the issuance date of each class of Convertible Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to January&nbsp;1, 2018, the Company
issued a total of 56,824,740 shares of Series A convertible preferred stock (&#147;Series A preferred stock&#148;) and 31,188,115 shares of Series B convertible preferred stock (&#147;Series B preferred stock&#148;) in exchange for net proceeds of
$56,692 and $62,876, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2018, the Company issued 122,850,909 shares of Series C convertible preferred
stock (&#147;Series C preferred stock&#148;) at a per share price of $3.21 for proceeds of $393,587, net of issuance costs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Convertible Preferred Stock&nbsp;(continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2019, the Company issued an additional 1,779,093 shares of Series C
preferred stock at a per share price of $3.21 for proceeds of $5,661, net of issuance costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Convertible Preferred Stock consisted of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31, 2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Preferred<BR>Shares<BR>Authorized</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Preferred<BR>Shares<BR>Issued<BR>and<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Liquidation<BR>Preference</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common<BR>Stock<BR>Issuable<BR>Upon<BR>Conversion</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,824,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,824,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">75,657</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">56,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,002,820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,188,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,188,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,876</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,783,102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series C preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">249,260,004</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">122,850,909</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">393,587</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">394,290</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,596,923</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">337,272,859</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">210,863,764</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">532,120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">514,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,382,845</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Preferred<BR>Shares<BR>Authorized</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Preferred<BR>Shares<BR>Issued<BR>and<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Liquidation<BR>Preference</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common<BR>Stock<BR>Issuable<BR>Upon<BR>Conversion</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,824,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,824,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">75,657</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">56,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,002,820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,188,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,188,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,876</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,783,102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series C preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">249,260,004</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,630,002</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">399,248</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,097,955</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">337,272,859</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">212,642,857</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">537,781</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">519,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,883,877</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>March&nbsp;31, 2020 </B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Preferred<BR>Shares<BR>Authorized</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Preferred<BR>Shares<BR>Issued<BR>and<BR>Outstanding</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Carrying<BR>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Liquidation<BR>Preference</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common<BR>Stock<BR>Issuable<BR>Upon<BR>Conversion</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,824,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,824,740</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">75,657</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">56,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,002,820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,188,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,188,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,876</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,783,102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series C preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">249,260,004</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,630,002</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">399,248</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,097,955</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">337,272,859</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">212,642,857</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">537,781</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">519,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,883,877</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of the Convertible Preferred Stock have the following rights and preferences: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Voting </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of the Convertible Preferred
Stock have voting rights equivalent to the number of shares of common stock into which their shares of preferred stock convert. So long as any of the Convertible Preferred Stock is outstanding, a requisite vote of the Convertible Preferred
Stockholders, which is defined as a majority of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Convertible Preferred Stock&nbsp;(continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Convertible Preferred Stockholders, is required to affirm certain corporate actions, which include, but are not limited to the disposal of assets, the acquisition of assets or a business, and the
authorization of additional shares of the Company&#146;s capital. In addition, such actions require a requisite vote of the Series C preferred stockholders and a majority vote of the Series B preferred stockholders, as long as any of the respective
preferred stock is outstanding. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Dividends </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of the Convertible Preferred Stock are entitled to receive noncumulative dividends when and if declared by the Company&#146;s board of directors.
If the Company declares, pays or sets aside, on the same date, a dividend on shares of more than one class or series of capital stock of the Company, the dividend payable to the holders of the Convertible Preferred Stock are entitled to the same
dividend based on the number of common shares the Convertible Preferred Stock would convert into. No dividends have been declared or paid during the years ended December&nbsp;31, 2018 or 2019 and during the three months ended March 31, 2020
(unaudited). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Liquidation Rights </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event
of any voluntary or involuntary liquidation, dissolution or winding up of the corporation, holders of the Series C preferred stock then outstanding shall be entitled to be paid out of the assets of the Corporation available for distribution to its
stockholders before any payment shall be made to the holders of Series A and B preferred stock or common stock by reason of their ownership thereof, an amount per share equal to the greater of (i)&nbsp;the Series C preferred stock original issue
price ($3.21), plus any accrued but unpaid dividends declared, and (ii)&nbsp;an amount per share if the Series C preferred stock had been converted prior to the liquidation event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Next, the holders of the Series A preferred stock then outstanding together with holders of Series B preferred stock shall be entitled to be paid out of the
assets of the Corporation available for distribution to its stockholders before any payment shall be made to the common stockholders by reason of their ownership thereof, an amount per share equal to the greater of (i)&nbsp;their original issue
price, which is $1.00 and $2.02 for Series A and B preferred stock, respectively, plus any accrued but unpaid dividends declared, and (ii)&nbsp;an amount per share if the Series A and B preferred stock, respectively, had been converted prior to the
liquidation event. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Conversion </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Convertible Preferred Stock is convertible into common stock at any time at the option of the holder, and is subject to automatic conversion upon the closing of a firm commitment underwritten public offering with either a price per share of at least
$22.80 and proceeds of at least $100,000 or approval by a specified vote of the Convertible Preferred Stockholders. As of December&nbsp;31, 2019 and March 31, 2020 (unaudited), the Convertible Preferred Stock is convertible into 59,382,845 shares of
common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Protective Rights </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As long as
any of the Series C preferred stock is outstanding, a requisite vote of the Convertible Preferred Stockholders, is required to affirm a liquidation, dissolution, a merger or consolidation or any other deemed liquidation event if the per share
proceeds to the holders of the Series C preferred stock would be equal to or greater than $22.80 per share. In addition, both a requisite vote of the Convertible Preferred Stockholders and a majority of the Series C preferred stockholders is
required to affirm a liquidation, dissolution, a merger or consolidation or any other deemed liquidation event if the per share proceeds to the holders of the Series C preferred stock would be less than $22.80 per share. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each share of common stock entitles the holder to one vote on all matters submitted to a vote of the Company&#146;s stockholders. Common stockholders are
entitled to receive dividends, as may be declared by the Company&#146;s board of directors, however, holders of convertible preferred stock are entitled to any dividend received by the common shareholders if each preferred share were converted into
common stock. As of December&nbsp;31, 2018 and 2019 and March&nbsp;31, 2020 (unaudited), no dividends had been declared. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has issued
restricted shares of common stock to its founders and <FONT STYLE="white-space:nowrap">non-employees.</FONT> In addition, the Company has issued restricted shares of common stock upon the early exercise of stock options under the Company&#146;s 2016
Plan. The restrictions on the common shares generally lapse over four years. The Company has included the proceeds from the sale of the restricted shares of common stock as restricted stock liability in the accompanying consolidated balance sheets.
Amounts are reclassified to additional paid in capital as the restrictions lapse. The Company has the right to repurchase any unvested shares of restricted common stock at the original cost in the event of termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the restricted stock activity for the year ended December&nbsp;31, 2019 and the three months ended March&nbsp;31, 2020
(unaudited): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average<BR>Purchase<BR>Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested at December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,545,993</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(860,490</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cancelled</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,345</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested at December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">679,158</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(210,516</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cancelled (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,844</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested at March&nbsp;31, 2020 (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">453,798</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value of shares that vested during the year ended December&nbsp;31, 2019 and the three months ended March&nbsp;31,
2020 (unaudited) was $4,369 and $1,099, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has reserved the following shares of common stock: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>March&nbsp;31,</B><br><B>2020</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion of Series A preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,002,820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,002,820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,002,820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion of Series B preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,783,102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,783,102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,783,102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Conversion of Series C preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,596,923</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,097,955</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35,097,955</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares reserved under the compensation plan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,579,793</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,407,169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,336,169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total shares of common stock reserved for issuance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,962,638</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,291,046</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,220,046</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. Share-Based Payments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2016, the Company adopted the Relay Therapeutics, Inc. Stock Option and Grant Plan (the Plan). All of the Company&#146;s employees, officers, directors,
consultants and advisors are eligible to be granted options, restricted stock units, or RSUs, and other stock-based awards under the terms of the Plan. The Plan initially provided for the grant of awards for up to 2,783,785 shares of common stock.
During the year ended December&nbsp;31, 2017, the Company increased the number of shares issuable for grant by 1,899,808 to 4,683,593. During the year ended December&nbsp;31, 2018, the Company increased the number of shares issuable under the Plan
by 6,267,562 to 10,951,155. There were 3,100,839 and 946,235 share-based awards available for grant at December&nbsp;31, 2019 and March&nbsp;31, 2020 (unaudited), respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the stock option activity under the Plan for the year ended December&nbsp;31, 2019: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR></B><br><B>Stock<BR></B><br><B>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average<BR></B><br><B>Exercise<BR></B><br><B>Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR></B><br><B>Average<BR></B><br><B>Remaining<BR></B><br><B>Term&nbsp;(years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate<BR></B><br><B>Intrinsic<BR></B><br><B>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding at December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,672,298</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,068</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,087,711</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(178,969</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">318</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cancelled</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(274,864</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding at December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,306,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,214</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,276,381</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(85,845</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cancelled (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(106,942</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding at March&nbsp;31, 2020 (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,389,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,081</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested at December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">939,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,080</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested at March&nbsp;31, 2020 (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,216,298</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,172</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-vested</FONT> at December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,347,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,134</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-vested</FONT> at March&nbsp;31, 2020 (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,173,472</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,908</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the three months ended March&nbsp;31, 2020, the Company&#146;s board of directors approved the issuance of options with
performance-based vesting conditions to purchase 1,960,547 shares of common stock, which are included in the table above. The commencement of vesting is based on the achievement of certain scientific and operational milestones during a two-year
period, for which the achievement is discretionary and subject to the approval of the Company&#146;s board of directors. As a result, the Company has concluded a grant date for accounting purposes will not be determined until the date achievement of
the specified milestones is approved by the Board of Directors. The Company will therefore apply variable accounting for these awards. The service inception date precedes the grant date for these awards as the awards have been authorized, the
recipients are providing service prior to the grant date, and there is a performance condition that, if not met by the accounting grant date, would result in the forfeiture of the award. Therefore, the stock-based compensation expense to be
recognized for the options will ultimately be based on the fair value of the awards on the accounting grant date. The Company&#146;s board of directors had not approved the vesting of any of these awards as of March&nbsp;31, 2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. Share-Based Payments&nbsp;(continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company estimated the fair value of its stock options using the following assumptions: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;Months&nbsp;Ended<BR>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.3&nbsp;&#150;&nbsp;3.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.5&nbsp;&#150;&nbsp;2.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.5</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.6&nbsp;&#150;&nbsp;1.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67.6&nbsp;&#150;&nbsp;70.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72.8&nbsp;&#150;&nbsp;73.47</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73.2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73.5&nbsp;&#150;&nbsp;75.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The weighted average grant date fair value of stock options granted during the years ended December&nbsp;31, 2018 and 2019 and
the three months ended March&nbsp;31, 2019 and 2020 (unaudited) was $2.95 per share, $3.34 per share, $3.37 per share and $3.44 per share, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense included in the Company&#146;s consolidated statements of operations and comprehensive loss is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;Months&nbsp;Ended<BR>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,839</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,687</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">555</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,048</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,769</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">265</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">558</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,887</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,456</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,455</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019, total unrecognized compensation cost related to the unvested stock-based awards was $20,662,
which is expected to be recognized over a weighted average period of 3.09 years. As of March&nbsp;31, 2020 (unaudited), total unrecognized compensation cost related to the unvested stock-based awards was $20,280, which is expected to be recognized
over a weighted average period of 3.24 years. The Company did not recognize any stock-based compensation expense on the performance-based awards as of March 31, 2020 as achievement of the underlying milestones was not deemed probable. The amount of
stock-based compensation expense for these awards is variable and the Company will ultimately recognize stock-based compensation expense for the performance-based awards based on the fair value of the awards on the date the Company&#146;s board of
directors approves the vesting of such options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The four year vesting term of these awards will commence upon the board of director&#146;s approval of
the achievement of the specified milestones. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Income Taxes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the years ended December&nbsp;31, 2018 and 2019 and the three months ended March&nbsp;31, 2019 and 2020 (unaudited), the Company recorded no income tax
benefits due to the losses incurred due to the uncertainty of future taxable income. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Income Taxes&nbsp;(continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A reconciliation of the expected income tax (benefit) computed using the federal statutory income tax rate to
the Company&#146;s effective income tax rate is as follows for the year ended December&nbsp;31, 2018 and 2019: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax computed at federal statutory rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">State taxes, net of federal benefit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.8</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29.6</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(31.0</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R&amp;D credit carryovers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.1</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Permanent differences</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.9</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1.1</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s deferred tax assets at December&nbsp;31, 2018 and 2019, consist of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net operating losses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 24,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 42,647</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax credit carryforwards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,952</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,309</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,542</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangibles</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">623</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,498</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">212</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">534</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total gross deferred tax asset</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28,230</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(28,230</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(51,537</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net deferred tax asset</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,194</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total deferred tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,194</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has incurred net operating losses (NOL) since inception. As of December&nbsp;31, 2019, the Company had federal NOL
carryforwards of $154,262 available to reduce taxable income, of which $43,127 expire beginning in 2035 and $111,135 do not expire. The Company has state NOL carryforwards of $162,217 as of December&nbsp;31, 2019 available to reduce future state
taxable income, which expire at various dates beginning in 2035. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2019, the Company also had available federal research and
development tax credit carryforwards of $4,806 available to reduce future tax liabilities which begin to expire beginning in 2035. The Company also has state research and development tax credit carryforwards of $1,903, available to reduce future
state tax liabilities and which expire at various dates beginning in 2030. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Income Taxes&nbsp;(continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Utilization of the NOL carryforwards and research and development tax credit carryforwards may be subject to
a substantial annual limitation under Section&nbsp;382 of the Internal Revenue Code of 1986 due to ownership changes that have occurred previously or that could occur in the future. These ownership changes may limit the amount of carryforwards that
can be utilized annually to offset future taxable income. In general, an ownership change, as defined by Section&nbsp;382, results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by
more than 50% over a three-year period. The Company has not conducted a study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception due to the significant complexity and cost
associated with such a study. If the Company has experienced a change of control, as defined by Section&nbsp;382, at any time since inception, utilization of the net operating loss carryforwards or research and development tax credit carryforwards
would be subject to an annual limitation under Section&nbsp;382, which is determined by first multiplying the value of the Company&#146;s stock at the time of the ownership change by the applicable long-term
<FONT STYLE="white-space:nowrap">tax-exempt</FONT> rate, and then could be subject to additional adjustments, as required. Any limitation may result in expiration of a portion of the net operating loss carryforwards or research and development tax
credit carryforwards before utilization. Further, until a study is completed and any limitation is known, no amounts are being presented as an uncertain tax position. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has recorded a valuation allowance against its deferred tax assets for the years ended December&nbsp;31, 2018 and 2019, because the Company&#146;s
management believes that it is more likely than not that these assets will not be realized. The valuation allowance increased by approximately $14,439 and $23,307 for the years ended December&nbsp;31, 2018 and 2019, respectively, primarily as a
result of operating losses generated with no corresponding financial statement benefit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company had no unrecognized tax benefits as of
December&nbsp;31, 2018 and 2019 and March 31, 2020 (unaudited). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company files tax returns as prescribed by the tax laws of the jurisdictions in which
it operates. In the normal course of business, the Company is subject to examination by federal and state jurisdictions, where applicable. There are currently no pending tax examinations. The Company&#146;s tax years are still open under statute
from inception to the present. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In response to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, the Coronavirus Aid, Relief and Economic
Security Act (CARES Act) was signed into law in March 2020. The CARES Act lifts certain deduction limitations originally imposed by the Tax Cuts and Jobs Act of 2017 (2017 Tax Act). Corporate taxpayers may carryback NOLs originating during 2018
through 2020 for up to five years, which was not previously allowed under the 2017 Tax Act. The CARES Act also eliminates the 80% of taxable income limitations by allowing corporate entities to fully utilize NOL carryforwards to offset taxable
income in 2018, 2019 or 2020. Taxpayers may generally deduct interest up to the sum of 50% of adjusted taxable income plus business interest income (30% limit under the 2017 Tax Act) for tax years beginning January&nbsp;1, 2019 and 2020. The CARES
Act allows taxpayers with alternative minimum tax credits to claim a refund in 2020 for the entire amount of the credits instead of recovering the credits through refunds over a period of years, as originally enacted by the 2017 Tax Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the CARES Act raises the corporate charitable deduction limit to 25% of taxable income and makes qualified improvement property generally
eligible for <FONT STYLE="white-space:nowrap">15-year</FONT> cost-recovery and 100% bonus depreciation. The enactment of the CARES Act did not result in any adjustments to the Company&#146;s income tax provision for the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Income Taxes&nbsp;(continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
three months ended March&nbsp;31, 2020 (unaudited), or to the Company&#146;s net deferred tax assets as of March&nbsp;31, 2020 since the Company has not recorded any U.S. federal or state income
tax benefits for the net losses incurred in any year due to our uncertainty of realizing a benefit from those items. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. Net Loss Per Share </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the computation of basic and diluted net loss per share of the Company: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended<BR>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(48,785</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(75,305</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(14,182</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(24,886</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average common stock outstanding, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,485,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,450,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,087,779</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,153,791</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share &#150; basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(19.63</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(21.82</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4.59</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(5.99</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s potentially dilutive securities, which include convertible preferred stock, options to purchase common
stock and unvested restricted stock, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted average number of common shares outstanding used to calculate
both basic and diluted net loss per share is the same. The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods
indicated because including them would have had an anti-dilutive effect: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three Months Ended<BR>March&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,382,845</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,883,877</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,883,877</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,883,877</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options to purchase common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,672,298</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,306,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,039,812</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,389,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested restricted stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,545,993</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">679,158</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,546,111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">453,798</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,601,136</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65,869,211</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64,469,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,727,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. Pro Forma Net Loss Per Share (unaudited) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pro forma net loss per common share, basic and diluted, for the year ended December&nbsp;31, 2019 and the three months ended March&nbsp;31, 2020 is calculated
as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Three&nbsp;Months&nbsp;Ended</B><br><B>March&nbsp;31, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Numerator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(75,305</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(24,886</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Denominator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average common shares outstanding &#150; basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,450,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,153,791</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Add: Conversion of convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,978,021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR></TD>
<TD VALIGN="bottom" ALIGN="right">61,992,534<BR></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma weighted average common shares outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65,428,521</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66,146,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per common share &#150; basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1.15</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(0.38</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13. Commitments and Contingencies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Intellectual Property License </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has a
Collaboration and License Agreement with D. E. Shaw Research, LLC (&#147;D. E. Shaw Research&#148;), which holds 9,999,999 shares of Series A and 1,557,875 shares of Series C Preferred Stock in the Company at December&nbsp;31, 2019. The agreement
provides that the parties will jointly conduct research efforts with the goal of identifying and developing product candidates. The term of the agreement is three years and requires the Company to pay an annual fee of $1,000. The Company is also
obligated to pay potential development milestone payments under the terms of the agreement up to $7,300 per target, plus sales milestones and royalties, upon the achievement of certain specified contingent events. The Company assessed the milestone
and royalty events at December&nbsp;31, 2018 and 2019 and March&nbsp;31, 2020 (unaudited), and concluded no such payments were required. The Company recorded research and development expense of $1,000, $1,500, $250 and $250 under this agreement in
the years ended December&nbsp;31, 2018 and 2019 and the three months ended March&nbsp;31, 2019 and 2020 (unaudited), respectively. At December&nbsp;31, 2018 and 2019 and March&nbsp;31, 2020 (unaudited), the Company had an accrued expense balance to
D. E. Shaw Research of approximately $372, $372 and $622, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Research Arrangements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has certain other research and license arrangements with third-parties, which provide the Company with research services with the goal of
identifying and developing product candidates. The Company is obligated to pay development milestone payments for up to four targets, each in the range of $4,000 to $7,000 upon the achievement of certain specified contingent events. The Company
assessed the milestones at December&nbsp;31, 2018 and 2019 and March&nbsp;31, 2020 (unaudited) and concluded no such milestone payments were due. The Company incurred approximately $881, $3,493, $246 and $1,195 of research and development expense
under these agreements in the years ended December&nbsp;31, 2018 and 2019 and the three months ended March&nbsp;31, 2019 and 2020 (unaudited), respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. Leases </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>215 First Street </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company leased office and
laboratory space at 215 First Street in Cambridge, Massachusetts (&#147;First Lease&#148;) under an operating lease, which commenced in November 2015 and was originally set to expire in December 2020. As discussed below, the Company executed a lease
at 399 Binney Street (&#147;Binney Lease&#148;) whereby the Company vacated the 215 First Street lease in January 2019 and the future lease commitments terminated at no cost once the Binney Lease commenced. The lease included certain tenant
improvement allowances, which the Company amortized through January 2019, the termination of the lease. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>399 Binney Street </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2017, the Company entered into a facility lease agreement for approximately 44,336 square feet of office and laboratory space at 399 Binney Street,
Cambridge, Massachusetts. The Company did not have access to and did not control the facility at any time in 2018 and therefore, no operating lease asset or liability amounts associated with this lease were recorded in the accompanying consolidated
balance sheet as of December&nbsp;31, 2018. The Company gained control of the space in January 2019 and the lease expires in April 2029, subject to certain renewal options, which have not been included in the Company&#146;s right of use asset and
liability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As discussed in Note 2, the Company provided a letter of credit in the amount of $878 with a financial institution, which expires
September&nbsp;30, 2028. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the presentation in the Company&#146;s consolidated balance sheets of its operating leases: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Balance sheet location</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assets:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Operating lease assets</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23,560</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current operating lease liability</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Operating lease liability</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,249</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-current</FONT> operating lease liability</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Operating&nbsp;lease&nbsp;liability,&nbsp;net&nbsp;of&nbsp;current&nbsp;portion</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Total lease liabilities</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right">178</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">$</TD>
<TD VALIGN="top" ALIGN="right">24,832</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the effect of lease costs in the Company&#146;s consolidated statements of operations and
comprehensive loss for the years ended December&nbsp;31, 2018 and 2019: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Statement of operations and<BR>comprehensive loss
location</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Year Ended<BR>December&nbsp;31<BR>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Year Ended<BR>December&nbsp;31, 2019</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Research&nbsp;and&nbsp;development</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$646</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$3,216</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">General&nbsp;and&nbsp;administrative</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">170</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">581</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Total operating lease cost</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$816</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$3,797</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. Leases&nbsp;(continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the effect of lease costs in the Company&#146;s consolidated statements of
operations and comprehensive loss for the three months ended March&nbsp;31, 2019 and 2020 (unaudited): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Statement of operations and<BR>comprehensive loss
location</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Three&nbsp;Months<BR>Ended<BR>March&nbsp;31&nbsp;2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Three Months
Ended<BR>March&nbsp;31,&nbsp;2020</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"><B>(unaudited)</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Research&nbsp;and&nbsp;development</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$703</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">$827</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">General&nbsp;and&nbsp;administrative</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">169</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Total operating lease cost</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">$820</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">$996</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company made cash payments of $1,290, $2,602, $203 and $924 under the lease agreements during the years ended
December&nbsp;31, 2018 and 2019 and the three months ended March&nbsp;31, 2019 and 2020 (unaudited), respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The minimum lease payments as of
December&nbsp;31, 2019 for the next five years and thereafter is expected to be as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Year Ending December&nbsp;31,</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Amount</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,767</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,987</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thereafter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,733</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39,685</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,853</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Present value of operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">24,832</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The weighted average remaining lease term and weighted average discount rate of our operating leases were 9.3 years and 10.4%,
respectively, at December&nbsp;31, 2019. The weighted average discount rate was not material to the Company&#146;s consolidated financial statements at December&nbsp;31, 2018 since the lease expired in January 2019. The weighted average remaining
lease term and weighted average discount rate of our operating leases were 9.1 years and 10.4%, respectively, at March&nbsp;31, 2020 (unaudited). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15.
Employee Benefits </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In 2016, the Company established a defined-contribution plan under Section&nbsp;401(k) of the Internal Revenue Code (the
&#147;401(k) Plan&#148;). The 401(k) Plan covers all employees who meet defined minimum age and service requirements and allows participants to defer a portion of their annual compensation on a <FONT STYLE="white-space:nowrap">pre-tax</FONT> basis.
The Company is not required to make and has not made any matching contributions to the 401(k) Plan for the years ended December&nbsp;31, 2018 and 2019 and the three months ended March&nbsp;31, 2019 and 2020 (unaudited). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>16. Related Party Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From inception to December&nbsp;31, 2019, the Company received consulting and management services from Third Rock Ventures LLP (&#147;TRV&#148;), an entity
affiliated with certain of the Company&#146;s investors. The Company incurred approximately $100 and $200 for these services during the years ended December&nbsp;31, 2018 and 2019, respectively. At December&nbsp;31, 2019, $80 was due to TRV for
these services. There were no amounts due for these services as of December&nbsp;31, 2018 and March 31, 2020 (unaudited). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>17. Subsequent Events
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In preparing the financial statements as of and for the year ended December 31, 2019 the Company has evaluated subsequent events for recognition and
measurement purposes through May 22, 2020, the date the consolidated financial statements were issued, and July 9, 2020, the date the revised consolidated financial statements were issued. In preparing the condensed consolidated interim financial
statements as of March 31, 2020 and for the three-month period then ended (unaudited), the Company has evaluated subsequent events for recognition and measurement purposes through June 24, 2020, the date the condensed consolidated interim financial
statements were issued and July 9, 2020, the date the revised condensed consolidated financial statements were issued. The Company has concluded that no events or transactions have occurred that require disclosure in the accompanying consolidated
financial statements, other than the following. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(a) D. E. Shaw Research Agreement Amendment (unaudited) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June 15, 2020, the Company and D.E. Shaw Research agreed to amend the Collaboration and License Agreement (Amended and Restated Collaboration and License
Agreement) discussed in Note&nbsp;13. The Amended and Restated Collaboration and License Agreement extended the term of the agreement to August&nbsp;16, 2025 and increased the annual fee from $1,000 to $7,900, commencing on August 16, 2020. The
Amended and Restated Collaboration and License Agreement automatically renews for successive one year periods unless either party provides at least one year notice of non-renewal, and the annual fee during each of the one year renewal terms is
subject to the mutual agreement of the Company and D.E. Shaw Research. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(b) Performance-Based award vesting approval (unaudited) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June 23, 2020, the Company&#146;s board of directors, in its discretion, determined that the performance milestones related to 25% of the performance-based
awards, as discussed in Note&nbsp;9, had been achieved. The four year vesting term of awards to purchase 490,136 shares of common stock therefore commenced on June&nbsp;23, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(c) Authorization of Preferred Stock (unaudited) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On June
23, 2020, the Company&#146;s board of directors approved the authorization of 10,000,000 shares of blank check preferred stock with a par value of $0.001, which was approved by the Company&#146;s stockholders on July 8, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(d) Increase in Authorization of Common Stock (unaudited) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&nbsp;8, 2020, the Company&#146;s stockholders approved a decrease in the number of authorized shares of common stock from 260,000,000 to 150,000,000.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Relay Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Notes to Consolidated Financial Statements </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In thousands, except share and per share data) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>17. Subsequent Events&nbsp;(continued) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(e) Amendments to Convertible Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July 8, 2020, the Company&#146;s board of directors and its Series C preferred stockholders approved a reduction in the conversion price of the Series C
preferred stock from $3.21 to $3.027603 and the Series C preferred stockholders relinquished their protective right with respect to the approval of an automatic conversion of preferred stock in a firm commitment underwritten public offering if the
per share price is less than $22.80. As a result of the change in the conversion price, the outstanding shares of Series C preferred stock are convertible into 37,206,604 shares of common stock. The changes to the conversion feature are considered
to be substantial changes to material terms of the instrument, and, therefore, the Company will account for the changes as an extinguishment and reissuance of a new instrument for accounting purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition on July 8, 2020, the required Convertible Preferred Stockholders authorized the automatic conversion of all shares of Convertible Preferred Stock
in an initial public offering, regardless of the price per share or total proceeds raised, as long as the initial public offering is completed on or before September 30, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(f) Reverse Stock Split </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&nbsp;8, 2020, the
Company effected a one-for-3.55092 reverse stock split of its issued and outstanding shares of common stock and a proportional adjustment to the existing conversion ratios for each series of the Company&#146;s Preferred Stock. Accordingly, all share
and per share amounts for all periods presented in the accompanying financial statements and notes thereto have been adjusted retroactively, where applicable, to reflect this reverse stock split and adjustment of the preferred stock conversion
ratios. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(g) 2020 Stock Option and Incentive Plan (unaudited) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&nbsp;8, 2020, the Company&#146;s shareholders approved the 2020 Stock Option and Incentive Plan (the 2020 Stock Plan), was will become effective on the
date immediately prior to the effectiveness of Company&#146;s registration statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> for its proposed IPO. The 2020 Stock Plan provides for the issuance of up to 8,376,080 of share-based awards.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>(h) Employee Stock Purchase Plan (unaudited) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On
July&nbsp;8, 2020, the Company&#146;s shareholders approved the 2020 Employee Stock Purchase Plan (the ESPP). The ESPP will become effective on the date immediately prior to the effectiveness of Company&#146;s registration statement on Form <FONT
STYLE="white-space:nowrap">S-1</FONT> for its proposed IPO. The ESPP provides for the issuance of up to 1,092,532 of share-based awards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>  <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>20,000,000 Shares </B></P>
<P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g904779g96c16.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PRELIMINARY
PROSPECTUS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:48pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>Joint Book-Running Managers </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:14pt" ALIGN="center">


<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:14pt">
<TD VALIGN="top"><B>J.P.&nbsp;Morgan</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><B>Goldman&nbsp;Sachs&nbsp;&amp;&nbsp;Co.&nbsp;LLC</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Cowen</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Guggenheim&nbsp;Securities</B></TD></TR>
</TABLE> <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:48pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Until
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020, all dealers that effect transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus.
This is in addition to the dealers&#146; obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions. </I></P> <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:48pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2020 </B></P>
<P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Information Not Required in Prospectus </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;13.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Other Expenses of Issuance and Distribution. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the fees and expenses, other than underwriting discounts and commissions, payable in connection with the registration of the
common stock hereunder. All amounts are estimates except the SEC registration fee. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount<BR>to&nbsp;be&nbsp;Paid</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC registration fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">56,723</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FINRA filing fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nasdaq Global Market listing fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">295,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Printing and mailing expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">415,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">950,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer agent and registrar fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,227</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To be completed by amendment. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;14.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Indemnification of Directors and Officers. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&nbsp;145 of the Delaware General Corporation Law, or DGCL, authorizes a corporation to indemnify its directors and officers against liabilities arising
out of actions, suits and proceedings to which they are made or threatened to be made a party by reason of the fact that they have served or are currently serving as a director or officer to a corporation. The indemnity may cover expenses (including
attorneys&#146; fees) judgments, fines and amounts paid in settlement actually and reasonably incurred by the director or officer in connection with any such action, suit or proceeding. Section&nbsp;145 permits corporations to pay expenses
(including attorneys&#146; fees) incurred by directors and officers in advance of the final disposition of such action, suit or proceeding. In addition, Section&nbsp;145 provides that a corporation has the power to purchase and maintain insurance on
behalf of its directors and officers against any liability asserted against them and incurred by them in their capacity as a director or officer, or arising out of their status as such, whether or not the corporation would have the power to
indemnify the director or officer against such liability under Section&nbsp;145. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have adopted provisions in our fourth certificate of incorporation to
be in effect upon the closing of this offering and amended and restated <FONT STYLE="white-space:nowrap">by-laws</FONT> to be in effect upon the effectiveness of this registration statement that limit or eliminate the personal liability of our
directors to the fullest extent permitted by the DGCL, as it now exists or may in the future be amended. Consequently, a director will not be personally liable to us or our stockholders for monetary damages or breach of fiduciary duty as a director,
except for liability for: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any breach of the director&#146;s duty of loyalty to us or our stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any unlawful payments related to dividends or unlawful stock purchases, redemptions or other distributions; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any transaction from which the director derived an improper personal benefit. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These limitations of liability do not alter director liability under the federal securities laws and do not
affect the availability of equitable remedies such as an injunction or rescission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, the <FONT STYLE="white-space:nowrap">by-laws</FONT> to be
in effect upon the effectiveness of this registration statement provide that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we will indemnify our directors, officers and, in the discretion of our board of directors, certain employees to
the fullest extent permitted by the DGCL, as it now exists or may in the future be amended; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we will advance reasonable expenses, including attorneys&#146; fees, to our directors and, in the discretion of
our board of directors, to our officers and certain employees, in connection with legal proceedings relating to their service for or on behalf of us, subject to limited exceptions. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have entered into indemnification agreements with each of our directors and intend to enter into such agreements with our executive officers. These
agreements provide that we will indemnify each of our directors, our executive officers and, at times, their affiliates to the fullest extent permitted by Delaware law. We will advance expenses, including attorneys&#146; fees (but excluding
judgments, fines and settlement amounts), to each indemnified director, executive officer or affiliate in connection with any proceeding in which indemnification is available and we will indemnify our directors and officers for any action or
proceeding arising out of that person&#146;s services as a director or officer brought on behalf of us or in furtherance of our rights. Additionally, certain of our directors or officers may have certain rights to indemnification, advancement of
expenses or insurance provided by their affiliates or other third parties, which indemnification relates to and might apply to the same proceedings arising out of such director&#146;s or officer&#146;s services as a director referenced herein.
Nonetheless, we have agreed in the indemnification agreements that our obligations to those same directors or officers are primary and any obligation of such affiliates or other third parties to advance expenses or to provide indemnification for the
expenses or liabilities incurred by those directors are secondary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We also maintain general liability insurance which covers certain liabilities of our
directors and officers arising out of claims based on acts or omissions in their capacities as directors or officers, including liabilities under the Securities Act of 1933, as amended, or the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The underwriting agreement filed as Exhibit&nbsp;1.1 to this registration statement provides for indemnification of us and our directors and officers by the
underwriters against certain liabilities under the Securities Act and the Securities Exchange Act of 1934. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;15.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Recent Sales of Unregistered Securities. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the three years preceding the filing of this registration statement, we have issued the following securities that were not registered under the Securities
Act: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(a) Issuances of Capital Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Set forth below is information regarding securities we have issued within the past three years that were not registered under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2017, we issued and sold an aggregate of 31,188,115 Series B preferred shares at a price per share of $2.02 for aggregate cash consideration of
approximately $63.0&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2018, we issued and sold an aggregate of 46,121,245 Series C preferred shares and 78,508,757 Series <FONT
STYLE="white-space:nowrap">C-1</FONT> preferred shares at a price per share of $3.2095 for aggregate cash consideration of approximately $400.0&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No underwriters were involved in the foregoing sales of securities. Unless otherwise stated, the sales of securities described above were deemed to be exempt
from registration pursuant to Section&nbsp;4(a)(2) of the Securities Act, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
including Regulation&nbsp;D and Rule&nbsp;506 promulgated thereunder, as transactions by an issuer not involving a public offering. All of the purchasers in these transactions represented to us
in connection with their purchase that they were acquiring the securities for investment and not distribution, that they could bear the risks of the investment and could hold the securities for an indefinite period of time. Such purchasers received
written disclosures that the securities had not been registered under the Securities Act and that any resale must be made pursuant to a registration or an available exemption from such registration. All of the foregoing securities are deemed
restricted securities for the purposes of the Securities Act. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>(b) Grants and Exercises of Stock Options </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Through June&nbsp;30, 2020, we have granted stock options to purchase an aggregate of 8,648,154<B>&nbsp;</B>shares of our common stock, with an exercise price
of $1.38 to $14.06<B> </B>per share, to employees, directors and consultants pursuant to the 2016 Plan. From 2016 through June&nbsp;30, 2020, 567,860<B>&nbsp;</B>shares of common stock have been issued upon the exercise of stock options pursuant to
the 2016 Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The issuances of the securities described above were deemed to be exempt from registration pursuant to Section&nbsp;4(a)(2) of the
Securities Act or Rule&nbsp;701 promulgated under the Securities Act as transactions pursuant to compensatory benefit plans. The shares of common stock issued upon the exercise of options are deemed to be restricted securities for purposes of the
Securities Act. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;16.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Exhibits and Financial Statement Schedules. </B></P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Exhibits </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD WIDTH="84%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;1.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520190069/d924757dex11.htm">Form of Underwriting Agreement </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520190069/d924757dex31.htm">Third Amended and Restated Certificate of Incorporation of Registrant, as amended and currently in effect. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520190069/d924757dex32.htm">Form of Fourth Amended and Restated Certificate of Incorporation of Registrant, to be in effect immediately prior to the completion of this offering.
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.3*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520177746/d924757dex33.htm">Bylaws of Registrant, as currently in effect. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.4*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520190069/d924757dex34.htm">Form of Amended and Restated Bylaws of Registrant, to be in effect upon the effectiveness of this registration statement. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520190069/d924757dex41.htm">Specimen Common Stock Certificate. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520190069/d924757dex42.htm">Second Amended and Restated Investors&#146; Rights Agreement among the Registrant and certain of its stockholders, effective as of December&nbsp;19,
 2018 as amended on June 26, 2020. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;5.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520190069/d924757dex51.htm">Opinion of Goodwin Procter LLP. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.1#*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520177746/d924757dex101.htm">2016 Stock Option and Grant Plan, and form of award agreements thereunder. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.2#*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520190069/d924757dex102.htm">2020 Stock Option and Grant Plan, and form of award agreements thereunder. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.3#*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520190069/d924757dex103.htm">2020 Employee Stock Purchase Plan. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.4#*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520177746/d924757dex104.htm">Senior Executive Cash Bonus Plan </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.5#*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520190069/d924757dex105.htm"><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Policy </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.6#*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520177746/d924757dex106.htm">Form of Indemnification Agreement between the Registrant and each of its directors and executive officers. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.7*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520177746/d924757dex107.htm">Lease Agreement between the Registrant and <FONT STYLE="white-space:nowrap">ARE-MA</FONT> REGION NO. 58, LLC, dated as of January&nbsp;
10, 2018 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.8#*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520190069/d924757dex108.htm">Form of Amended and Restated Employment Agreement. </A></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD WIDTH="84%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.9#*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520177746/d924757dex109.htm">Amended and Restated Employment Agreement, by and between the Registrant and Sanjiv K. Patel dated March&nbsp;25, 2020. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.10&#134;*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520177746/d924757dex1010.htm">Amended and Restated Collaboration and License Agreement, by and between the Registrant and D. E. Shaw Research, LLC, dated June&nbsp;
15, 2020. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>21.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520177746/d924757dex211.htm">List of Subsidiaries of Registrant. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d904779dex231.htm">Consent of Ernst&nbsp;&amp; Young, independent registered public accounting firm.</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520190069/d924757dex51.htm">Consent of Goodwin Procter LLP (included in Exhibit 5.1).</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1812364/000119312520177746/d924757ds1.htm">Power of Attorney (included on signature page). </A></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Previously filed. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#134;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Portions of this exhibit (indicated by asterisks) will be omitted in accordance with the rules of the
Securities and Exchange Commission. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">#</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Indicates a management contract or any compensatory plan, contract or arrangement. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Financial Statements Schedules: </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedules have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements or notes
thereto. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;17.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Undertakings. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising under the Securities Act of 1933, as amended, or the Act, may be permitted to directors, officers and
controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the
Act and is therefore unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the
successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Registrant hereby undertakes that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a) The
Registrant will provide to the underwriter at the closing as specified in the underwriting agreement, certificates in such denominations and registered in such names as required by the underwriter to permit prompt delivery to each purchaser. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b) For purposes of determining any liability under the Securities Act of 1933, as amended, the information omitted from a form of prospectus
filed as part of this registration statement in reliance upon Rule&nbsp;430A and contained in the form of prospectus filed by the Registrant pursuant to Rule&nbsp;424(b)(1) or (4)&nbsp;or 497(h) under the Securities Act of 1933, as amended, shall be
deemed to be part of this registration statement as of the time it was declared effective. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c) For the purpose of determining any
liability under the Securities Act of 1933, as amended, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sig"></A>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this Registration Statement on
<FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cambridge, Massachusetts, on the 15th day of July, 2020. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>RELAY THERAPEUTICS, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sanjiv K. Patel</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Name: Sanjiv K. Patel</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Title: President and
Chief Executive Officer</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement and Power of
Attorney has been signed by the following person in the capacities and on the date indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="18%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Sanjiv K. Patel</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Sanjiv K. Patel, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">President, Chief Executive Officer and Director (Principal Executive Officer)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">July&nbsp;15, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Thomas Catinazzo</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Thomas Catinazzo</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Vice President, Finance (Principal Accounting Officer and Principal Financial Officer)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">July&nbsp;15, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Alexis Borisy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">July&nbsp;15, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Linda A. Hill, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">July&nbsp;15, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Douglas S. Ingram</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">July&nbsp;15, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Christoph Lengauer, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">July&nbsp;15, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Mark Murcko, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">July&nbsp;15, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dipchand (Deep) Nishar</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">July&nbsp;15, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Jami Rubin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">July&nbsp;15, 2020</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Laura Shawver, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">July&nbsp;15, 2020</TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">*By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Sanjiv K. Patel</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Sanjiv K. Patel, M.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Attorney-in-Fact</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-5 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>d904779dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the reference to our firm under the caption &#147;Experts&#148; and to the use of our report dated May&nbsp;22, 2020, except for Notes 17(e) and
(f)&nbsp;as to which the date is July&nbsp;9, 2020, in Amendment No.&nbsp;3 to the Registration Statement (Form&nbsp;S-1 No.&nbsp;333-239412)&nbsp;and related Prospectus of Relay Therapeutics, Inc. dated July&nbsp;15, 2020 for the registration of
shares of its common stock. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">/s/ Ernst&nbsp;&amp; Young LLP</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Boston, Massachusetts</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">July&nbsp;15, 2020</P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g904779g06w59.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g06w59.jpg
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M 0$! 0$!_\  $0@ V@(0 P$1  (1 0,1 ?_$ !\   $$ @,! 0
M   %!@<("0H#! L" ?_$ &<0  $%  $# @($" 4."04*#P0! @,%!@< "!$2
M$Q0A"14Q40H6(D%2H='4%U-ADI48(S(Y55AQD927L;?5X20F,S5"8G:!TC1C
M<Y/3)2=#5&1R=;*TP2@I-T1%969T=WB'HJ3%\/_$ !T! 0 !!0$! 0
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M"273!;=7$3.4$F2P9@$6-7F=EBC=U+!,QVB-\X9@"I&0HRV,XSCM@<DX !)
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M\=J9EG@M$#:35M<,W5Q,,CKQKG'M)T-'8G/JHKMX5?8AC*P@X:MD4@X!61G
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M]JMMP1<C6>@Y""W$63XES/!/' ]=D9LM+4\;Y71WVC"EU)$^FT3=%KC);<$
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MG'_83_A'Y4?453_<L#_)8/\ P=/;[[_WES_CR?ZJ=./^&G_"OY4?453_ '+
M_P E@_\ !T]OOO\ WES_ (\G^JG3C_AI_P *_E1]15/]RP/\E@_\'3V^^_\
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M:]P]GM_X$/\ A)_IK\_JS.[G^^:YX_SJ[;_;/3^DGB'^_-6_YA=?]6GL]O\
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MU@J/1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI2-H4\T=HG_P CE_\
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M "OGDLIC3I_<^-FY36+W2?$-W#!!?Z9HDMI L-MI]W&]F92S N$NE22TD);
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M=I--LL)L%5,D;@.R=EDAAA!8+N0$;JCWEU.MS%)*Y2!>1$A'F<=F.>P/N/)
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M'U#)'B==S,5!P,(!@ <USUUJ5Q:>)(M9U675IUM'%Q!IMG<K[%#/T3 Y:%V
M59%8E@')#'( [BL?=+PG=<&=NO;UE[J\I+Z2QYD[H+\ RD>8K7516<[::X)Q
ML)8@ZB&$)5O,46*4R*,8D94*>]SV,\NUK1KK0[PVETT;,5,D;QDE7BWNB/R
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M8V[Q1\DVKZQJ+ZEI[Z/:&[E=I;.&*ZMK>VCCA9^M(TC2DRRE1U%B@5!*^!@
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M1E0-VPKG@@\DDTG]K_;-S?RQ6F<G-UD>5SV))NDRM7HJ3;5EAI2I!V 0MHK
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M)69>G&"W3'ES])N^0W^UCMWYOY>B(W-5I@\OE>/;&UEI*Z[K=G5'W1PM;'#
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M/&B#E^ FJ&A4"%MJP$$<0UTJ#NEB23J?/?31".,1 (X00CA1MQ@* N ,#;D
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M!2VU_IJ#+%%S4#HHFT5?13DLOQ;&:T"&BB-)+L*Z5]8!)+7^]-.M?&J!KY]
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M!J!CQK%%%,[^NK)/CNS9$C;3KC:J[2!-&N5]V<'!QP2#]6*@CY.[A.O)'J<
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MRK/=I,IBR#+&BE-J&7&-P VCMS@BR+1)=S-<3QN=I6,QH4*YSRW]O Q@'W5
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MPXPP"YQ611NSDXQP.<^O!_EQ[SC-6UY-;Y[3>%U_/^-%XB(B_G0J]7[O\/\
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M88&DM9XB.4N+6X2*XMG'F26-''(JN-']&QC>#>".Z7N,(TMK?BS\><MKVW2
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ML<]41K55/0"0.2<#WFN9J39>W3G\>#;E%<)<L"#<:!'6/(9!O'NL"APX-85
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MN&.++<TBTR?;KEA%FDIB,_B9B"L_7<D&-F:98[FQB-VHLKY0@RJ0=LL!7?\
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MY>AR01@<C'<_E0'!!]QS4I=8*D4=*4=*5K^_A/:>KZ&WN,3PJ_\ '+@'[/\
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M?DB(J,^2?=^?K]8/"=S[7X0\.71!/M6@:1.2V"Q,ME$>3W)(*D]\9QBORO\
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MBO))8DJ+(3(UBO77ZC>V.D6<DMYJMS/JHMIGAMO;H1*YV-D8;,>S>V$=PQP
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M<]7*B*EKZUK#%&;5=3<Q-NB)O;DM&>V8SU,H<$C*X.">:MCM;:(.([>",/\
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M,S3B^DNM/GDC"PR92"SNKAY49E!5@4 D5'3>-_5K\VTIV'A2!]##J.2,;F4
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M7>[-(]D$#7D2Q1OH2JC+,%7(!)( R>P!/&3Z"KD1Y&VQH\C89MJ*6;:HRS8
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M#@XT2_PI'NNYMX:^DBR.)P%MB1\\_M>XTO$$TO#G#?(!;+.RV_*HADT-QO\
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M)#.&<Q.I?;(R*=@!(+ #"*",G"YR,QY[<S7 B@$2HR1M'$;B)UB#1)+(#(6
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M96LDCF@FCDAFC>QKXY8WQO:U[7-3BBK(S*ZE6!Y5A@@CCD'ZJ[Y65P&1E=6
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M:YOK#?BSOVLYH8[E>FDC!"1B1X"S12[ /G(V\J#@2;>X6:-7;:CD99-RG')
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M$T9P5B2>R*.$8BD44VT\$&&Y)(DGLH[&&XGAM8HXQ'-;! )59BK*VXXSC/(
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MY-()'7SG!3&?#,6#W5B= _Y0\,:/HNL:EKUKJ:2/*EPSVBPLZ#:ES.)L-&"
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M>6;%LI$$0Z0(=S)&5P/N?$V1?E6B"1R3*UWI1JXI).FN[9(_F5=L:%V\QQG
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MY"1SH/H?0M:&HZ+8ZAJFJ:+%?W$#3"(3I B17AW(7C:0EI8T*;W=<,JD*/*
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MDN[>\9$(1""*B 7)\LMG"P,<*, P(S*V+E3W!1%(8#L_.:CVPV>IIH9(:CD
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M\8<JU:<92:38%'X)[IM%%6T(=6:(;::FTOZ>:$RMY/JR "1# R$2,:T+D<R
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MU"VT=H+B::QU.VFAD;42B=2T#M')<RLZ*ERD<9DCZ8>51'M9B3!BA$<BF3<
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MHY)\J+84M?HX-*+)< B 61UH,H]1<SFT;H/A)YH&HRSPV[/;@M+G"(,%G/J
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MIJ>WT$99$D-F4Z\=0BV31YB',%69PZO(@@'CBN$NG2_-ZC&\MM:AH[6.)@@
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MX4U":&.[NH9HK61&*E1B;(.$RCJ0%<<ALDE2& QP>+U'QKI=O=2V%G<17%W
MP$S &6V4 9=>K'(IZB$A6'[K J02.(6N/PK?N\$N8*X3ASM=8H07B]'(R/+!
M;OK)$<_R#8C\V#10!K%+$LL1 !)0\P1([5)^+CE"V%KX6T][OHW-_+'&JY:-
M-G7+8W<.T9B50._E<Y! !XJQ_$VH^RK-%8PLTL@6*0B3I%21D[!('=CV4!D!
M)!) &#(6-_"<>]3D"BMQ,IQ1V@3[01!7PDWE3RU3Y$=+9OK!ADCKN6M'>6I
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MR O[I/!P/JVI66JG2;*%YFB8.3M:6(HXW=%4D ;"9+,Z$?#RX-1MVS\7<O\
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M5!@3,E:0 ^KUQ$VCK3 Y8#@+=_QHA,,S6.;6J9/Z_7;X=J52,=P[4MXUXW.
MS TM+;S:_B_+61S7V:7>.1Y9FAH!SBWV=F?1)?N+L3T<7*.ZU^(-D]1+7N57
M)Y///?\ +_M2,!VX<"T]]F[RJXURU1?9J8LO/%5L4U<0,C]39;66/V1"H([
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M%S)NX&,#(/<  G! Q4JT\*S"_O)H96ZLTDS,H#,L5M.@!7() 8+GG<-I&,<
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MBR.%R 5/4E8^HTHM! XFJF+N[@(2KNB;P%YHY69NK2&WLBYZP^9S:B* ,&*
M%E;#\-L8;Y;&SB-M"$WKO8HH5F/^_GO](\;5(Y!R!FN=BTR;5+JXN+N\9G29
MH&W.K!5C)93$R@JZC &X [CDY.>:5=V^XW0\O8KJ8%=F]Y+S%SF)[)XT=J-1
MRZ(?M]KXFP)\>=)9!,IK6*:$GWX2/7*YPRP/B@GZ\Q\0W]U;^,]"U"U""["V
M;QK)$)TWSW#JP:,'#>60G (.>1BO<OD_M4B\.ZA;EM\(OIT#9P646\>YL@
M[\@XX&,<D&KK\H<H)G=/C"::SQ^RE-H=K5C@SA^_&?>B3.DAMBP[1\M/&$.=
M!=/H[:>68PB0L=[T%]83$^EY)BC01/'*T,LK"158!S+ BE$C>,@Q$$*EPI4+
M&V$#$AZ+!\VTAW*PP WF!*D8.0X.<X)4JN2,D=Q55^*[7'6&RY%L,OERP8A:
M G3[G2@?BR"<S16V;=6C U(8B!5RA#RSDD?"BL+<"Z<\IS92G#0IBT^6P_:5
M^EC8JDL\\-QJ%PRJX#JJJEOO57>3:J;F#.5,A8Y&XU)N4E2"WZDI)3B)<_N
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M9C/C-@@Y!E,:54QA"'332G2B%$P1K& ,]KII.TTW7[FTAMX[JU]I-O$($V7
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MJ_D-%L&,?EB6/@D]N613AG-(C0)S2.9UG5+W5H1;B*."+KK.PWABQ4$*.%4
M@ECG_P"..Q)Z[0O#-MHUR]X96N;EK<P;]O349;)8*6?!("COZ$YYP&KV]_@U
M6[X@,L)MGW4Y7D\1F4BRF7 L.);( 3.!S7,-U:N^$?R"<+:J3-!&.*VQAG8*
M*LXOMO%)E@ZW/A'Q-/X<N.K>VLVJPPV3V5E:^W"VAMXY9A/+E>C*LF77*'"L
MA+%6&>-W?6[W2(L4B0%95D=S'O9PJNH7AD(^F3DD]L8J31/P=NP!W%%O1^>,
MRMY0U:58I9> N["9&.#-$F,8PS>2!M-EC/GA20@0N-@[!V+$^6-\LO:#Y2['
MV^'46\-7#SV\?3A+ZUD1X9F5@/8N2 Q0Y.=O 89X@'2I>@;=;E51B"0(!C/J
M<;R.>XQP#S3[SOT#>X"E4G2=TDUZZ%Q4X]2-BY*[,&DS3.*B2^HY-&;!8!-)
M>CIQ!75[YHX8H_B&H^?W9D_RNRS/$XT.1&B;N-2B\\9!7IL18@D $!3DD 8S
M@D'&=$!SF<8( P(R",>JD2 @^I]#GMVPQ8/H!.8ZREOQ:3NAXYKKS2CCPV%Q
M_ G8/C'?7%E/JO@ 8^1(600AA&$!K'Z_+_<>]'HV1\:XS\KUTD)]FT""&]9&
M1KGVQ2C<MTR\*VR;R@8GS/DM@YK*-'BWH6E9XT[(RY/( 8[MV020.WH,&HWT
M7X.1S=<9/B:M![Q,96ZOB_E7EWDF*^=PY=&5YT/*.,X;Q[:6"JFY,2<)*F#B
MTPF0M+&5Q;K^/V6!R@+,3Y=K>M:GK.M0:ZZ)%>0K#WE:5"\))4J'Y5<'Z(/?
MDDGFI4FFVLUA<:;*K&VN8S$ZHQ1MA.XC</>0!GW>\<&28_P>?0"55U6#\ZX$
MY]E;E689]YQ06<0 A=>77RQ(-%LAZV5[&'F3#3H$R42=P\\+VDAC3Q[N'Q48
MS,9-+ZIF;>=UXH"-@@X'LY!')([8SCGO7!3?)[+(\;)JXA$<?2(2S))7<"!D
MW(([ 'WY/8'%,RC_  <#4Y_4"Z@#GCB]A4<@S2V/XETT[R0V!PUQ8\11/)TQ
M0+SP_CV%3!RQ.DD/?(J>J&%64'B=4<RQZ0JR%5&XW88C!&2I,'EW#(...?JQ
M?-X FN+8VDNN3& Y)1;8*I?=O#,HFPP#!" V<;2%(#$5/7"7T",?'NL=N.0^
M7J/DF]$LH+&@%9CSJ2EJ)XO#I25'GTMP<49-(R#TR-.%'@C';'\-*DLJK-3Q
MHV]'ETII.GRH%\J@-SYA_LS$'GT/\\UJ-2^2^[NK4VEEK\5DCJ4F<Z897D3]
MU>+R-0%.2"03DY[C-5QY:_!QN9>0K?424/=WB\CG;^PT9,%7_ _<VM@*%H"V
M$I6EVDG) [;""LC:X*O>\2.2()R1N5TT49#=-J'B74;Q;B**%8(9]P'SP>50
M?0N(US@<9 '!/P(Z31_ =CIJ6K7$YO+BWZ),AC,<;&)-I*Q]1RF\G>?,WF _
M=)6NQ=_@T-G9\[/YSB[H1)3+GE$_D?6XVVXW>=E+=K"GV&<J8PVZZ%RR4QZI
M/-86*V#"_<>D( ?I\2:K2;E--O+*[DMIKL17JW5[:272K:7B19-NG16$!7A8
MEED<R@>B#G/:SQ-+#)"C+'NB:*-]FYXPXPV#D9!'&!C/J:?.T_!]N1]G),0=
MW <3O(=8U%G$I?"EH="TJD!0&N=(*1R&\)T(D:RK$(@?P[F3>S,V2&*)C?4+
MWY4UO%97\+6C>>)UZUZ9<-"Q9&8&W 9AN.#MX&!R?-6JAT5(2I2YE50I4A1M
M)!4*0&#$@'&2.?7')R'K6_0&:&PNY+'D+N$!TU8T<(<:EK,M?4L<;*UJL":X
M[\="BH8XT59GQUZA*XGT2QOA;&V/J?+\L#2VYM_Z.M$I781%JH5-N"/*HLU*
M,.X8$G('N%8I=#8E&M[H12+NS(T =FW=\_.#/U'([^^F]I?H%.:R]A;Z;)=U
M6,SP@Z9\; 51_$UG=_B?6TX\09 DIDV\AFMY#0FRC*;+[!;6N9)-*1(UZR0G
M^5W5 EQ%#H]OL86XMNM<K*81&VZX,C>SAI7G!8!RP*9&,@<YDT2+I(DDSN^6
M:1E&T.Q^B0NXA0#R0 0?AZ0,#^#6<Z37N@NM5WIY#1.N,3RIDA8W\*GBR5LO
M)?'^GQ"GQSMY$>Z:.K=HFF?"R)Y(%#^ CF&]QD\/ >(?%&M^)89H-0$3JT_6
M@(90;?YPOTU(0$K@[ 3@A0!SZ;*VM+>TE$L*LK;-K\D[^" 223SG!]>?JY>W
M%_X.3R7A<_QUFK;NJRMG6<>*2.-'2\7W=$ZTK;0^W-NX"4_A#-@B(M&7!(I9
M*CDN)B=XF:K4:Q,&EZW=:=;VMM[*LB6H?&V<1AS(Y=BPZ3<G."<DGOQVKF-7
M\)IJ=W>7BWK12W8C4B2$3)&(D"+M =&QY00-P ^-<>H_!I%TL+Q$Y]HZT)LM
M3/$,)BKQ&33@LG2R(/63;2.EGO'RQJ:\1P3((X_;"B'16JV;<>($N%9'TV10
M[J[;+X#L.0![/QN['&./C42V\'W=LP8:K$S , 38=L@;3CVCNI (SZCG()%/
MB7\'RY"9G<WFZKN>HJ@*C&B#ECAP-Z3#,,Q2Q%0:(C=K+"YU42V!R3DD(\QB
MD*YH[F!Q34\7SPQK%#IY2-%"JIO Q'?.6Z .3DG/?)-06^3XO<RW+ZF':4EL
M&TP Q ]UP  "#@  8. !W,A\A_0,6NAS&(HL?SI54)N8!NQKBWT.3N-23I2K
M &,6KL2)Y]</902TKXFNA'EL38)HGK&Y&>A%?<WC.Z,*Q+IRY4')>Z# DXQ@
M=$$8Q[\FHMK\G,R3W$MWK$<J3.KK%!8>SK'AB64 7+*=P. =@P?0CBJI<I?@
MU'-O*&?XZKCN]/-5UUQYNM]M:^]@XAN)Y5EV-1Q77AP#0R<D,46:H*XU4YT_
MNR1$OM6M8,.X620KC=1N;^_OTU#B"6$QF I(2T31$,A5@%^B0"N ,'WGFO0]
M)TVWTFR%E""Z$N79AC>7;)R,G&0<=S[_ %Q4R<=_@\6FQO'U%DK?N!R&COP=
M$;J;K7NXXN0K&[MC;=3Y4C3\>IY*@"4(>LKB0:V> <F 26.9CX27Q=>D>'/E
M";1M-:TO='FU.[DN9[N:^;5>B[SS2;@ZJ;64QA45(R@8HP#' +-G%=Z<]Q,)
M(YUA4($$9A#@*%Q@>=0>>02,YP?049+\'CU>%J-!593N(R5+^,MN):VA4'&=
MF222HY1A:P2D6&X+F1K5.D$'= ^!8PA@HY$GDADEEVVF_*C:Z4;MK3PS(DEW
M,\TCMK <EI&R00UD1Y02JX  4@8X&,4VDO.T1EN@PB7&!  &/)SQ(,$G!/?G
M/OIWV_T"G()68?6!]SM<?H#3*R4VWV."*TH->$(\J<X?+UK]2(11S6)!Q/N3
MNLC49#$$QL:/AEDGO/RMW"M(T6A_UCJS137\4D \Q,A6-;)!N=<*"20N.!R1
M5J:,1(7>X# *RKLB*-YN^X]1@<<8P!ZY)SQ'&S_!\><M#15&7H^[#CK.T-2(
M6 T=G"UU.40/+//()+*5%R6,_P",$81(U)ORHWN<J^RUOAB1;SY6-3DA]FL=
M(ALH&ZJR#VPR2[)"<=&5(8C"PSDE00Q+97D$9TTF%6WO(\C J03QC;Q@\G(/
MNXQ[ZV=NW,&_X'[>^".#B&A:6?AKAKC#BF;1LEF 9H)N.\11Y"2[8#.\^8)M
MJ^G<>T28XR49)TAD+(>Q9G^+3VDTT\TV O5EDEVERY'4=FP78EF(S@L3ECR>
M36X5\*HP#@ <<#@8X'.!\,G%2=;\SDYZ!UA<9HKZJ@3UFGULK#F@PI\WSDP,
M])3!XFHY\Q#8'PP1M=),^-B>KJ.]G,@+$9 &25P<?6 <_<#5>I\/Q_[5*F4U
MU%LZJ"WH3H31)V(Y'1/:_P!/G\SO2J^%ZBD%3@U>"#VJBBKX151%5415\)X\
MK_(GE43ROV)Y5$^]43K/6"L:NT[]]?A^)[WD:UX(;+=YCN7U'!-]A@.0(SS@
MZ+&8*\Y%T6I%MA,O*):7HM!G["*',!#O"+L4:,)HB8EC(GID\\8P>?@, G^?
MW?=5V!G&?3CXDC([]OU[^)HXN[M*_EGN0W7"V7S Y>'RF(?I*7E8?0?$C:^W
MKI\/%H*VKHDJ8VLJJB7=!UBW7UQ.L]U3W0*!,0;W4 @]OU^O=WJA&._?W?K]
M?CB)=/\ 2%5.2N^YF$_C.SL\YPAE--J,':TM[$4=RTSC/2@X+F$>*O=6-9F8
M./\ =VH%66>I5W'/3(??31"1@R".9[_6 /3\>?B>W89[8-5V]N>^?L]1]IJ;
M9.\OB 310YNT$Y IR$/K,[:V=GAKD:ASF]N,#_":!QI?V_H>,!NIL:Z&R?5)
M[PHQ!0=45806Q4(+ZY_7\OM_7NJFTGM@_;W&<9^K]"FWC^_;@O;7N8H:P'E0
M&36VO'U95VE[Q;K*:BCCY: E.XLMC[@P)@8=1R$\8P#+E22+(:6$1),.-7^T
M?+3/U_<?T/MQ0J1[OO'VCZQ3>WW>D9B.Z /M\9B<M<#3Z3AS,NECY$E$Y-.7
MEQE])+J<UQHF0,BO\AQW%1J;O[-VIK5I:@N.R\2N1H<K/)]W;[< _=^O6JXX
MSS[_ (>[&??^OC2L-](%P*5DZG;1 \J)G+7,67($ALG&&G8ZHXPIGT@UIRE<
M#N'0@;!"V-XRMBNH(RI+,FJO2*<.QK:DH]K/./U^>/B./?3:?AWQW[G]>_%=
M)>__ (FJH-Y/L<YNLM^*'+FGXFIX9J9"Y-N9DJ C3W5WGY'R@AM"K:,.>QL1
MR2VR01%T(PDI]GHJJOG9&,_?ZX_\4*D8Y!X_\?7GT]_/NKF7OLXOKI].2:VY
MU-.ND$ X^CXUR6MU-[H*)_!&$YW+L[2ODK HPWPY+7RW:3#RR5L-./%&65!;
ML)";7/&?U^OJ^RFWD#Z_P)''J>W;O5R<MI:;9YG.;#.&)89[6451I:$](IH$
M.IKVO'M*LQ("(XB(4)!*@F2*>*.:/U^B6-CT<U'>K>U9"4(>)DX28D59(:,>
M1B)]OJ:%&J>/^_J/68?1'U#X^E(?& T<>-J[#S[AEZDMY9$.^<LYMC*^56RN
M^U5#A]D"-/L9"+&SQY:JK5NY^' ^SBB# 'QY_7V5('5*NJ.^4SN4:_&G3<-Y
M_':3D"0ZF&J@-]?6><R4 A-L'#=6=O8TM3=6SF5=,\XT8&OKY"#S(1Q6OA;(
M^1JE4-Y3Y_[PLIL.UZH&I.%,WM>7N5J[-:7MH&"T?*.V(XO&U9J<C<HLY=JM
M/CZ3)4'''&[:F^-/GXWO*N36VP&=EL)S;.II3JC'/?M^/N^/WC@$TIMR<]]X
MM=J^]^FIMOV_\D4G;'Q74VE7IY.'=QQ_5UW+]P 7R%98.SC$YGY DVB8;A^"
MFM[E BL9(?J=MFZJ::D%&M"6N.._/QS_ )#'/U_5[U6%.[K+7)=L_;/RQ:X<
MG>\E=PXO!F:SV)RIU;F*^TY&Y:R(^E)A^M]*?(%G<[7#"W]BI!Q5B0P<$>OB
M0TTF)SJ4JJ'$GTEUK%B^W,'DW#RZ?D#FK3IF[=*'2XFOMLA:[KN#Y*X9XP!N
ML?5EV"C57UADJ^HMM7,:!1G/:>9ER]<;57XE?7'^?X#-*<P_TKF M\W6:Z@X
MCVT^6AGXMHN1-=>VU3GL9P]NMYG-KI--AN3].Z"P!R5GQTF6I\_=V]RP',S:
MC<9FM*N:<6:>RC8_7OYQQ2LKWV_9U2E'2E1_H6H!KLI8C?D36;C*<]K?E\2-
M%#\8+)*GS]7P4B$,8[QY1#7(Y51&(VH['W#G[<@?C_E5IX(QW)P?B/\ M[_\
MNS7Y^O[#.<8:6RK%>TI@!*,>SSZFJL3O#D\(J_+_  >>JI](=OU[OC5'/'K_
M -NW/WU4_MGK8(>*ZJ_<J$6^N-MKN[.>OKF)*2U- 'A?(OEZ1A!B0P-A]7HC
MF^)D8UKIY/.^M5"PJ1C+98GXY.!]@X_\UBJP'4BE'2E'2E'2E'2E'2E'2E'2
ME'2E'2E'2E'2E'2E'2E'2E'2E'2E?+E<C7*UOJ<C55K?*-]3D151OJ7RC?*^
M$\JGA//GI2L?_*G,G>?Q]V_<]<EWG&'!.+T/%7$&AY*I;%-QJN0:&Y+S^<M-
M?<4:T M)CK-A5%7UKLW(65<A@6MW+'? O?4-DJ>L#/,$=BJ*54L#DL#@$D8X
M.0!C).">0,5< "1R>3C_ +Y^O[N?MFCDCN#,XVP_"5G!AK/D/><WZ3+XG)Y#
M/V=+G83-);X70\@VTY-UICAZRHJZW.9'1%Q*23/.27$!6QHKRW%07O)L53MW
M,Q "@@9."QY/ P >_P !GFJ 9^&._P!X'^=4RXN^D8M?X/NW4;984GD'D7ES
M&9TFS=D;[)A6<&XV >X,R%(;D Y2?J(+0$8]:F*UL2ZZ*0@U"Z4"] !L2!L
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g904779g10p14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g10p14.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L
M0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@!=P)= P$1  (1 0,1 ?_$ !\
M 0 " @,! 0$!           '" 8)! 4* PL" ?_$ %00  $$ P$   ($" D)
M!0,+!04#! 8'  $"" D4$1(3%187&%=8EYC6&2$Y5G5WEM77)#4W.+2VM[C8
M(B-S>'D*&M0E,3(S-E%5892ATR=$=K7P_\0 '0$!  $$ P$
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M2;U=XBAGK$Y&I!)YI*XB0B596S70-:,<#?MF+JT']>F&LQ;N'J"JJ)^$G:V
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M;)L;2#8WR>ZT/%%3;2WQ]-:AL:>WT!C=5M8YQ*/MRTD[=QJ#H(SL.[^6"O\
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MBK,8@LV&M"3A-'E5\V'MG+ANQ0==JI-$%UDD.$TU>^>BA<D8,&A!H\,&'L1
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MI*]HJ-^U$^%.D%MI;60Z[YUUTBKM%19':B>][X[VDLJEOKG?V:G?'T=;TT0
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MJ[^LJLIKCGGZZJG7_:44Z^GOO?\ 'UO>\DN<[;B).P#1N2=F@; #?L '(#L
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M)<%0SSZS-[PDBMS\N09CW[/@G@$W"X.,4T>YBF9]DPG;B:0>3XG\($D3MVO
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MW_"=^<?:JR&OA>>97?LNMK48>1/)B5%@?,EVU]*HKJDJK1:O[9EMJ>?Y' )
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M] F+ :J3/O@$9,6$=@(D!NJG %XHE$4/O]J1=EGFB;#;?S;[[_\ Y;;?%O\
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MJFS3(/>QD4[5WWKA%OV\6Z32Z^PUPIN2-B1Y]D6 ^"_;A;V*SF;PL"J(']Q
MZ_E0]E65N/+#+B6%@CR9)"-ST*;A,&*"#H-)@DAU(P3:00*4NE":,;/+= G?
MVPC;Q_*-O^Z*])*:0X,:&QLQ+(R*D1G2.Q  D>%L3173E=1JWV-%.G23Y]I=
MRDJV1VU05TJNFHCQ]93CKG4(LFPB81,(F$3")A$PB81>;JT4[J5K_P"+VA"T
M["5M7OV_4W5CI5CHIU;2ODM2+U']V\0KD/O1WK?=6\R3AMR)_P HZ!??_#77
M_P!?K*O@^@^O=VWQ_D\476W@SJ1O\.7VUUYD$^JA-?.K6\^)^?F]Z*2U$(XM
ME.QJNY'._,HJTT4[L'AE9?TQYD/<S44;/)0B8[B_* U$NER':-]NP[[;=G/?
ML[]OF1>E!K\Q\LW^;^S^;^P1^:^Q^G['YC[/G[;[+ZW_ &OL_M/K?4^M_']7
MZ/I_CRE%]\(F$3"+1\%B-Q4Z9]?>?COALOZ<[]+>P)1=\,G,A2@KKSE(*\L8
M]$C#'=Q2@X1('(P0I5J&=M&8#N#FG[YQ'@6HFW4X?(ON*O [[<O/N/1W<^WM
M',E%7A7S7[:*^A?0A21\7.N5-%O9?2IID"(D:PLJF9S7DS#TA 5IB9]0*1)0
M:WZ)0UM#X3%_.+"50>5B.E3I78WDB=<"1MMYAZ^_N[_3MMZ  7TC?G?UC6#(
M?.Q-26@IN#Q_X*A:1QN%NQZ$NF4?\V1V;L?0\' #_O\ %H2(G&^3#$>:C;M^
MW8EM./L>5'*'*G7(;; '_P#+XP-OC19.A4WLDS,1-O\ -+6UR>%W1\5.PH9&
M)1+Q864QN/7!1PMGY^CFI*,DIMC#59!(D]1T(J!*NQ\9,)KJMW*:#;AXI'+?
MMY<N?R^I%#%3^8/8Y(>5A)2*>AH?6TYO/X>YXBU8'K"KEV-B@XE98?U65#*&
MKZMJ=QU9J,=QI.7'W$R#'I:JT'2P;'!Z/([[&=QR[/MN[?NY;\AOS^G<BVG>
M]//-E3B#^((!YXZ/1Q6HO7U*GMS!FT9SM_5T AE:VA&>9N4;3M\]U*4H^J3!
MMW?9YR5>E'+M-8AT\65<+[@$<]^\;?EW'_=%56W/%4RI8W72QECZ0]<TW/;$
M]$W%ZE#TX:'UM.I=Z$L>/5^'K*;*PV 2VK6VH5'1D2*B6 H,9[:QJ0/49,6X
M>:<Z4:-_BVVWY\MSR^3\FX\R*JLQ\A>\V@MA)MQ:U2_H^3?#LK6NS-HA)XX)
MOFDZBOH%Z;L*O3TB:V+&N%IV3\S_ "L-;DF9)DPE<T6>D!<I8R,D\EB<[CO\
M>7AV=OY3L=MCZ.Y%-M0>3?0,G=4/%9JR]!(>?"?JJSI%*X076F]*+0VK'7FX
MX%X'<M&WI^[[.&UG*[418[;1R161P]Z,D#JZ0%C'CK?M9N.?HV'?SW'F'/;E
MO\:+ Q%"^L&4;HL3>-2>O[<"1N@)O!:L"U3>#R$2VM;\8>GY^YC$PG\O6G8[
M0I-2B>JS:1B?2IK-! D*'(#EPZKUQVFLWW\!SW/+EW;;=O?V@>/AV%9JMHQ:
MSOXF<MH#J:'S5(5;*B'NXLXXF[LQVSEEL5VPJ>/TO(-L5T.F0L?9+:T;9"Q)
MXS&"N6+46\0#)ME6W'4=V_CR]7/?S=P[]]RBZCWE3WI>7WE<Y.+5_P"AI\8D
M=45((\,3FG;+<PZOZ!MH29D?=DF[08M[ B3$8L0(NHJ==2201N6,#D/'K19M
MW]LW['\AMRW\>?+N_MY^'/M/9L7^A/,_I-A<HZZ7[.W7%AM/BC;4<%FUB2Y.
M(;\<F*G;MI2]80%25[AC: FIKTMMS],=T?Z6;LF_T\LV39)-RV_)\>_L]B*Q
MM_>8;+N3X@]9SL/-+IIZN@'D*PHH2MFF343!%.IB^M^$%AT (/)5&)DW[9%P
MR#\^JW0!)J]K F:G)1#A)5J[=Q](^?VHJC5)XJG@?R/\,=&143Q^/ZA_6L**
MS4X4!QQ>Q8)4*-X6M+Y"J[DO/TOFT9<-2@&0$Q@U]MLZ6=-7/3#M?CZ$V_;W
M;]P[$1]YY]2[O,E X-61J.S )\0_T/[,C/HZ3,!CJFN:\G]"2R,U\)?FF)92
M2%"RLJD<>@\BA#,)V0;A8XJ^4_\ DE)NOS.X]8 V]!'LW])[^:+[T'0OM/R@
M-^(F5'U+#IC-3M5TZI4)6*/2LE[MR]!\%.#R4]Y5F+ 1LV^<R^3EYK:CHTV$
MJ.Y6[>H"$5!+G:J,<M^T^?T=P',^CGYD4M37PS:$3MKX=L3H::36L0],UEZF
M:VIZ!B\=@$Q.=3^QA53OR<AE3.S04I#%3UP2P;+"A(DX"/'FG73K;9P/Y3;?
M5D$;'\G+GS[? A%('F*KKXI[X<-RP16OCZ_HI%;UL^9#VAG<&DMI3:232PB,
M2G(\T/(=L8D9GS-^!,L'$;>#1H5ZX1T'3!_+\(LH/,]OA^3_ +?&BUXT_P"8
M?73]->$G(C?T;J>3>G?#$K>BT3EBUG]A7;.*6N$]+.AZ)"_;6L"-#U'JD4:3
M1PYL%E(I(ML=)VH85\PSX9B1RV\_Q]W8!X]WASY(L[(^<?1L>6@42GM7>H[/
M\VP&]?=X&%UO6-LGATX#,3\U&*>1YF4/O+-B\A+P01&$I(UC!@Y*7B$-=D42
M1U'AJXTFI/+S=@[O <QV=I/S\^?,K>1;RK8DO^#='/,,DC9&,7,-\UC&X:.O
MNFJ14%<$"[3FD ;*K)K*MF[EK.8_']].$U^N$>?K=Z[WK6];C<<1/=N?5_V1
M5*\_^,O2B_I3S5-++KAW'X-9Y=/VGZEZ679=:CGIZ'3CU5+(-#W/*;I3I1PW
M4]"5XCRDDFNBFSJ,;QRMSVR2Z2;\CX]G?V<O'T$?E[-D6SVAJSGD9]S>_+)/
M1D@,@MH!O(S> 25Q]A]WRA:"5W.1,N3'?9K=K_6!$23%H]^810U]JY3^QVKS
M];K3N'I/S>Q%4FQ_#=Q>A_7'O5H9LB:4MYSO2N_+$/D"D?A=?R+N\ T:BL\8
MRX$%DDL8F2,)>1!1Y\@J5$#N'"BLJX<?574&L^DF^VWB"3\FWR(L"6IRS:@D
MWJIYKS1;)^-SGU#(E*UMZGVE<RJ\:;AA#S%!($.L:J(C8X61L)0VE;\*6JR5
MN^W8@H&#$WQ-3AZCOI5N\.?8//SYD[<D50B7PX/7<Y0H%SU#6<).4)\.NC6:
M=:OMC35+7!<-0>B9?/Q_GNWV[HR2T:;G8DL/)R%IHAW'4)T18%]%-C@_"65;
MC^,3RY'8]FWL\W-%(OL"FO7?HIS=U@"?-'HEM.[9I>@$?.+V/V3&8ISYB91U
M(PV]85;(!SNR(LWW(IVQ6-B :[".2$?8S*0 ^6[P0@S4[9TC8<]P=M^6W;]/
M/V(O1= >D^X+"^T0!^*(]Q*.=)1>5],>I3&T^@[/? "2]#"9H;T?#\[T.,=#
MS)9CLBV<[:$WZ&TW2L(LLPB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$
MPB81,(F$3"*.GE35Z0M0'=KR.(K6A&X4<KL)*]OBO*["&20N*.FPG Y-]P&6
M2?%@@MYV[<#5B"/33E)N[104624?3Z>M%$%N>*_,5[3EE8]K54.E<M;, @EZ
M[Z/R\,+E(B-E>SD?#S^,QZ0"8Q9 <(654?"Q4^#R0>R544TW;<)]]<;G<A%U
MDS\,^6)P4GTADU:J[,V--8W9LJ-B9_945(HV##P+R,A9U&'\9F09: 2E../G
M04L?@BD:(R$5UPRD;@JW00X3 D?)^3P1<:(>3/'DA@7/4$@41.UW.Z 7H5$E
M%I:?)@)50\@,FY6[!,S8N2KI%6Q\[)SI]W,VKY:4&'Y=V_<2-RHMI3([$6#;
MH_X>R%J2>]MJ5"E8%#D(HZL(UU;[CB/5I)8E'W$/A<DM"%]3C4""SJ/QYDX"
M1Z83N.<2]@V8]ILB_"C+72+YT7W\-4I752)7Y)(]:-76U8]]V\ZORT)%5+)@
M'C;/BS S"000<*!MYC.7K../XXZ[EX,F1D#S<G7E1B1L%>F!)#E.3W>CE]/3
MO\B*^60BI) _%HV!T36?FYC:LQ=5#$H]<$1L*,+"(MS^.2+6XPF#9P'DI'L6
MX)1[B,O9>X*B'44=#'+IRQ;(%.W;)1=OW).^Y\43RYXQ0\ZRHQ.3UMRNXI<K
M5%:4+%2LBCT3BJ43IJI%3CF'1CD?$!P]L;-].Y ]='Y63UT[**),^&C(4@DL
MBX;]WI^/_LBS_P!5 @CNO QEV'%.B["Y/,R;$JX'M%B3-/\ *4JK?V;1\HCT
MZ;\?2LMOZB*O'/TJJ;^CZ>^OIA%9S")A$PB81,(F$3")A%'K"JH"*LZ1W&,
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M")A$PB81,(F$3")A$PB81,(F$3"*E7Q(?]0#V?\ ^6:YO]PS>9CT>?N[T?\
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MY.!@:X%W!%:?([F1R8QQ\R]:WY3U=?S5]$?LD^I_\',\A+?2D2 VA'+(V5T
M%6(,^YOD=N_P^J.U*MTO]X?.?8?=6[,AL2T=^S^16^>T%^\-C/M&?WC\K]X,
M?F2*1,(F$3")A$PB81,(F$3")A$PBCJVZG@=Y5Q+*GLT'J10::CN1IX5IZ^&
MKJ)H.VQ%B\8DQ;EF3%E111DQ+""@YVV?#2;)H^:+I.&Z??)%!L)\1T)!68YH
MQ'S@XHC*+%FDE(3"S9[*R%F2>U(7S7DS*6RN9/N>+(V]AR30(/92M$B-!H#V
M"P5FQ=M4U]3N?IW>CP_(B[KSSY#I3S"L?=U<.EG9&0A(E$52TXGTQL0J(@<
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M>D.1&WG[^7IV^5%G%<^^?/UN7W%J$K<R5EA":4RZNJ,S<<%)\0LJ%9R9Y&W
M9)Z\:-GB17C8Y\1^8<LT0^T6W0_1+9E1$<I'=O\ 3Z#O](16!O6TFE'4G;UT
MOQ#B0,:DK*=V6\!,W23%V::P:,%),X%-GJR2Z+1P02&=M$7*J"R:"BO*O:2G
M/.^-AS('BBUM/OBM=Q %)G%I^:97 Y0/J2E;UB4>;69!YBPF-7W/<\&I1@74
M/1Y-7N+&0I^>#"2T>.!^'1(<V>[:KI[2WWJ=OG\>X;_3O\R*6)7\1-G"9_8L
M(EGGZTXRC&:U]'65 S,@?18<ZL4/YE9:=3!^ZAW!%U-*^BDNZZ2ZK&9RP$D(
MFS!=L08\(Z=M&Z[;YOC^GTYHN93WQ':PN0')[+$@NP/GVKJLC\VNF_CTB:(P
M.#3XU&1,J(4R TU&N'UA3"&C3+).:.PJ;0:%)N68%/;V2/6X7H1MV^KO^GT\
M$5@*1]?^>/14B/1"H9ZYDDLB@ 9)I5&"4*L"&2"+"31,D)$=241.8K&WX$@3
M<"7;EB$*H-#3H-TQD*(_L"5%DG@@A%5DE\3>&@Y[&JY-U=)6$D+>R)7Y&/H\
MG1ZZ$2V!+5T&#6R1[VP145ATL=W!5G UOM)JNW[F31)=YTJAWPHV\X[-_3YO
M2BPH[\3:Q$HA4UE0OQY(IK65ZW&K1]4RW5UP".+269O;(GE?Q32X$L-^\1(N
M5HP;J3,C+KZP9N*-,.%2/??/:G3;Z>CM]7S(MIL.*2 W%(X8ED7[A,G)A1SX
M_#U#(^1=Q@NZ:I+$ 79X3K0LQT,<]J--DA^M,WFTOMV__==\Y"+7'>GQ*/Q'
M6-Z( ._.LYF%8>5%*B5N^V(_.*_9:C8NX  <\%(BH+(28B12?MBD5[;.F 55
MPZ659][2YYVNCQU.W9Y^SY/C/]J+GRSXD3 !&[:DH/SO;4X'TQ<%^UI."8%]
M$1<6 @O/ F+%Y9-#TTF!>-1@([DB$K9M:^@CHAW*9@_8F&XM'O@4_7;MNSS^
MTCYD7%D'Q1:M'S8U64=KN>3&SB<0\[22E:U%[&-)U=#[T3&)/,!HD>#(*H\P
MYC74=C*QFT)3)GB<?B(Q?[=\ZTXTS9D&WS_%MX>D(INE_OWRK64L>5Q:5M 8
M?9 +<9&2V-MA<UDHD#,90P'D!\$2F0>(=QPI,'#8BD_915!TC+78/E0_W'&H
MM!TLV;'Z>;O]'G1==[!]L /(4D\Y Y!!"TN97[9_=?.3(PRT%I0$4Q08D#TS
M)M73%WT7&@@SEX7>LFZ[%;;0:X^JXUUUS]5MV^8;_3UHL)K'XC]43JX_3=82
M8.YKD!YTL>NZL;6(;*_>0FQY=8D_FE4CF 46,$].Q6T+)@Y:)<=NG+Q%P^_[
MQ55DDDIO3;D#X[_%XHL^FWOGS[#;>JVETS1632FR[MEGGYPO'0I-X-@UE1"'
MC)@1#RQQVT2WQ]=O(8NQX4%<D4T59"V(.^VX9@9(CFWR;_'LBNMD(M/,7^+-
MLB!ALWE_F661"N[4%^BU*FES:S8-)^Y6?\W K /2H(9B[))G*8FU*HUM(F8X
M\X%$F#=[T-^>X2:/>7?$[?-\?T]G)%, KXB[-Y(O.K0EY]M,+"/1&J+#@+%>
MOXNB*XFU]5\/L(&&BP%\0'R>QXO#F11D(L:?Q44J$B1?;QN]0ZV,)?*Q]/IM
M\Z+XT1\2.+>CY=&8#5=9&#4J2-V1W=GVLH&-XSY\@, L*7UZ-E4_DOW<HBM)
M+&>1%T4@5=CV?WX^$*+F"[L-'VFCCF2"/R]GJW^+=%--5>^O)-VSL!6=8VVE
M)9M*TC3R*!=PNQ0NI0& ,RCTE*8V2D,1$B#L*^S"ED&$W%OW41,$![D4'-/R
M?&FFVQ'T^+T^;M10OZ<^)#'?,1CT3'9%4LGD<AI**T7-8F%$'A[=]<4:N,X?
M $R$:37'J;%?B\>Q.3='.'6G^GZ(S7351#M?KA !V;G8$D;^C;VHL2N3XF16
MOXYZ$LFNO-YRXZ8\UF@X*?V<,M*(Q-HH[)U]7T^<;"@30Y<F7T+2L04'>I#>
MGCA)\V<*JI(H*-]J-NSS^W9%L*J"76!.(.PD5F5:M3TI>.7G*T(7F<>GJC1B
MDK]4>_ZD48YY$K?>3??+G35/7VS377V+C_O-;UD(JQ^C/9$GI>XP%)P'S])+
MPEA2EYE>Q/[FL&"0)L$@\&D0B-G%E',Z>#F+U[P\.#NT6J+Y-55-;KKGCZB*
MRB<[<B?#;X_^R*,(7\32+6D/,/*FHBX;%=(UKYML6/!0C8&@2?MO2/,Q[')2
MMT0(-HY7H"ODH64<3R=2.0:BC!MM-9D_>?;,>'PC;UD>I%CZGQ<*%% JID\M
MBDVB@BU*[N:5C&COH*8DJLSIFSA%0O*IBH6./RS:P95-IL4[901W%"[P2:9H
M)DE'#5DHZ68-C\GQC?Y.U%8(Q[NI6K!-?M?3A=KYXLR<0]O.WU7G%2\W)0",
MOS&P@TC8<DA4>)1F'-')3M )LK(7XR/K2?;J.B3)=ZS[Z[;>'/T?3=%]_3?L
M^+4'Y1:>L8G%"=RQ0^E53R% @CQ6*D9<,M\Y'!$3?,U#HA5V/Z<H2<>0Y9$A
M"#WZO7RCA!JXWUI,!N=NST^;Q10RV^*#4*M[1>JW4??#8 ;\JJ^JS=UO#*/<
M<BL9:0L=9!,"]!,A;LB^=BH">C,F>/V;OZ/E3K5-$>MWSKI5L=OR[;=^_H12
MQZ!^('YT\]1 G*#DA(2QV*U2;UW%X>)(D#J<>ON1K 8%)N]+M6S!,0[;C3YK
MO:KSAVHT NF#9LL;>B!A !O\?Q#=%=1B];$F+,BS4Z59D&K=ZT5Z260Z4;.D
M>%T%.D7":2Z/7:2G'6TETDUD][WPHGQWKKG4(N5A$PB81,(F$3")A$PB81,(
MF$3")A$PB814L]0^*J_]8V?YMEMJ-XW**_HHK:A0_5LKBB<D#V)W8,(3BXCA
MPY7)M6X?J*&&S*3(J*BS'SKAFBWXX8]\Z=\R#MOYQM\8]B+ 9_X4))V6PL?S
M;9<>\UJ1/R\Z\ZUY&(O5((M&(SM:[H3<*I)<+T5%B'<6.-8F0A<FC#0:.)O6
M$H)&Q\H'%T4>^F_CSW([_#<?/_W10)'_ (2<4*-*['W#(:VF44#>A+MON=T_
M&*D[B=+N]7!4>JO;5]6407FAE6O(_$GK4?.6I+MX=)/I9R_*H\"7[I!XSGB/
M;W[;;]_;OS\?#T(N1Q\,VX1HB"CPGKGE4E *NNCS(*D\RIWF8GGGE2V7P!V'
MA9%12QA+5:U*U0 HC8_9NF_W.78)#4#M?N.&#GDK&_;R\#^4?DVVYGDBNKY^
M\S*59Y(B_E"Q9*!LD%'JT(4^\,@87W F9Z!K"G<::I$(^M))=SHZZCB_/$D*
M<%>D#1M9^43'L$W6F:8G<D]G/=%26E/A+#:J.^*Y":NEY-G_ ):(6L<GJCB&
M[&=7I(9:=*R*L"A+K<J(;C.ZC*%-.!Z7>I']\;8L_JJ"=\===-QSY=NVWFV^
M7?O]:*^<(\]JP_U)?/H_J6)D$;JK^F(.G$-!.FJD<ZJ7J<]*$^SNRKCDKR>_
M#+G7#3D0.V-^[NOI<OOFM?+M^6WG)]>WL13'9$3[GM>3V#)/N!BDSA<IB:9)
M1OMUP/[D0-\'X?=M>56_3GAIT\TOTWY71VMI/:>E4]]?7YA%K58_"BI6,>+I
M=YOK\-7D+N"P?/\ ':5G?H8; ..CTG>BV8/9J0OV79?1;D?(3H?[^>QY"1I-
M^WO355PNY68MUN9WY[^??;\J+(SWA>V9IZ.B%N3B[(.9B]9G9V:KTD/J%J O
M=G%YI 3L.:T*?L\/(68XU1T7+24Q+V0IW&5SQA]VV:ER"CI'HUVW^;XN_P!/
M]OCR*"X/\'QA6=9#ZPKVWFL- V)YCDWF_P!7,0D(40$76\?"S"<,N@.+_"32
M46M"&&3I)9<B1[D:$GCCA2-/ODN.U"'<\7/?S[CS?V<OBY><K#>9_%UVTWZ(
M*^@;(O2M++(RJE892LF#QVC2,!7:@ZPX^PA#J+F5K3E70]4ITLY+SU$@P(MR
MI73%N"1 C![-NA!(VV /:3V[]NWF'@BCJQ/A@.)_Z(+7FI;Z QJ?]'A+E/15
M&'J*_?D%$1FB-]5<3)=2#CE=N\LKSM74W6)_)Z;]MA_0=06I]=1VJWY;;=WS
MGYB1\:*("WPEK7:U6+JN">CH.&'G?$X3QG:A.1T\8D#LH&BDUF4Z"2^"I,K,
M!(QT@2>S-Z$,M#GX2(-Q*.W0[6R:J*S)OSWV[]^WS]GTV_*BV(T/YOD]+7?Z
M1L=2;@I##[\=U1(&\<XBY 9)8M):[JR+U8_TM(>I(^%F09AC%6Q9HVXCHQ^/
M=O%VRSUZBAPHJW[/-[2?G1<_V/Y>%^O*E%5&=,L! %&TJLGQ]$I'OPF'2,'7
MTS&2<O#G@S941SIM*Q[%P#7>]N%TV23SMQVP?\\;;* =N?I^,;(HMF7P_P"M
M$W_G_7G_ (BWF@'1L_LNQ.!E:U^";JF9'8=/RNJN#C?O2K4:VD8+N0CSJ!8Z
M*DR;U, Q".66F/V?3=N>>_/<;?&"BK"6^%9,;'CUU(7+=E=&I3=2GFYA,'<!
MHCF#0^<LZ!M!.QS4YM"%ZL$JUF%OW!KMX$EDK1>B1HIDOR@R#/Q_'#!.=]CR
M&VV^W/?M_)V#P]/BBS5_\-"41I7[MI.^1E?06O?2@+U-YIKV15<M-8S2DV5"
M2H-9,!VW;S^+]GJAFZDQ-%PD5$=Q!_ "KCM8,7>IN':;B-_-W;'S\P?R'EYT
M5EO$WEB6>2X78<(D5I!+5:36TY5;#<RPK5.NS"<BL!ULU-E#VFLNDS SIX>4
M[^X?E6HC80"V8AUNBG3?EWR)W^GAR^1%225?!LBDE"V* 2N!X+%SKU[KT"R0
M;P[ZWX,T\59V.SF/G)AO4H2^U R-&Y+1X^_]Z1;M.)(E]K&GG;13MTW^3;U=
MA_)L/5YT6Q67^>NY1ZFI+T@G*DA[>GJRMZNNH9H'M?L[NT7D&=)%4CG)5#@7
MP"U#=I;8;#O_ +PT0YZY=,=-=\N&_+;S@^K?VHK+Y"+7;YT^'%2-(')[8YR)
M5_.;QEMM7?8X>WW,+2;RB+CK<DYTTS!#UWS\JH@[CHDVJ 4-,%6#@@U^9YX3
M9MW:K;))^0#U!%6[7POK?_%%0GG]UZ(@1FK:F"TZCP3+4DANTJUEU4SE67EY
MQYRGK"6LR-?F[2&\#8G*>I+U+MAQS%5R%4[1(NQ73?MY=N_?W'N_(>?G19X!
M^&2XK^US7HNK+0#0WT*2]9VY>CN<)PEPL.F5+7*3'N91YSLH8A)&KF4!&R ]
M!Y'I%\\W[C,E2_" $'9/'+S:S?EL>8[N?8?'Y4705#\,^UJALWRU)V'H>!2&
M!>/I#;K"H8B9HI[S(^ZOO<D2>V(.D\S:VKPF_L9 <Z8QV)S ='A08>T9NB1B
M*''19XUQOV]O/MY]X_MW)_)V;(I!]J_#M.^K;%D%F1RY$JMDJU&0NJX:2XB*
MQ][$I)%KM3LYW,>5.9 )X?-R\6='H,H'UPU41T94)]$%DD^AZH'LW&_;\8 ^
M9%B ?X:TZK"012:T9<L*B\KK_P!27)>,';36L"\LB V#7/2L=I$G!R88-8$2
M)DC<8! $RX,XU.BA[I]TFT?".&VNU-M_-W;=OGW\$6<>4O ,O\OSJ@I4TMN/
M2X;5_F.3^;9J.>0,B-(R=F3M<S;8:51DBWF"K2//&YDBT&%1Q,6>;N1K1SMF
MLT<OD51[?M\YW]&V_M17=]"57W>="W52B1SB,J6[5%A5FG(U!VR_ #N=1,M&
M.3/8GEZ-Z)\C.B>GO3#DBPV\TCMOIXVVI]MP!V(/@=T5+I!\,6CV_E0YYVJ*
M/5U3DHE[:B>9Q:\7K0=P5F#ZF+"@E@*O3C%H4&D7O,B>1!^FBU<2-9 ,\/N"
M7.GZJ2R3QOSW\Q'K&WQ(L0G7P[+.M.TIE.K$] Q0LW[K;T[6E?GQ5+,X_;+F
M,^C(L6BP>)71-Q4Q;#;,@M(,RRBL C[.-Q==^0;,RY0BW)(*+.6_+;Y^7J[C
MY]_B182K\(H,'KJ85#6MP\5M6%N^>J\K&YH:%KU%P#D-UU*TCGX$>D(H-W*F
MC.+2<@1C3+5D1M1,JTL(7TIHJ70D7U)(FWW[>?/?U]H_[;=_BBLUYD\EV]2_
MH*^?05EWC"+3.>CXW7J%B#(]2:U<;8RVK!_46A;V*E>[,F*K.(M(0JY'E8T6
M:&"1.2K[DB$D&-==@5!(\.SS_P!G;Y_#8(HCO;X8@VX;A]-W")MIW"C%_4_&
MH7'F:$5V3XK&TH[(JI/ZM\:MQ(QNB9%[W1-0)*BTFX=SRK$]N-G%-N])H ?E
MY^?S?+ZT4U'O$0ES2?B^DXO,4HZ&\@6KYZLAL_4CFR"DW0HL6\8.1:K9,TQT
M%(3)R\5).S/2Y?3!VJOWVP(]+;[TWYD^._Q[^U%>W(1:^4_AV4A)/5EZ^H;B
MA\ MXM912F2M>B9;#42*]7N:K@K2)O%$71%\^'&5#Y$>..)==B&>AJC)NE]5
MTHGRXU._(#PW^/M]B*&)Y\/&WR<3O.&0^Z:J(0[T%?'H6UI]7-OT8A84"=C;
MM9PWB*O44.92+/M;%I4M%%CT//,2[,(5(%OM"(1HY%CGJ3?L\PY$';O/M_M1
M8X=^$@(+E)--$[E)I7&#J?RC#O/5Z.8W\Y9M26!YBCAD(O/R)5<WVG*V-KJN
MQ>Y]$U=,610<T<M';MX[V/?CV_=W;DD#D#V<OB1<2P?AEWC,"D@=BO2-8B@\
MA]-UC[9?1HYY_*REHX])0:/P\ ;9.R/5OAW2U*R7J,+%$H<F@A*1';UH+XF;
MMDR(*'&XY<NXCMV]7AY^T'O16H]H>*ORP%*JX)3AK%FM>Q_T('?\\1]<@N4>
MW=0<PIP:8%*<FF>P[J&&).UF372FW_;OL2D/X6:*J:?I@=OIYP?F15,'_"BE
MX>#V(P87Z(=V+,1GE61LY<7KMRN)5N7SO<4YO*3S&3A&DN:."0*TYQ.BJKP0
M.)#'X%)95QR3*J;TCTW\W>?41MM_:BD:#?#XMN+S>&6N8O* GK'#^WY[ZZE&
MVM3G0\-*B;7I"/TG-J_ !]V81,!'8P2.)D8=(B,@D'#9PN+T?%FODWNR3<>'
M=MV^??P1;8,A%K!I#X7%(4Q0LS@30#7)2]IO![VA)7TJG60YC-NVMS$INHBM
MOA4L0*\IQT#*Q\;7;MI*UZ-C07"*CABV=_*MIW)[T6,Z^'39[LWYB$G_ $%%
M)!5_FMUYR/Q1-U2K1K<$4,T-"XQ%S\:JZT6<Q25B%;W<2BK(_8@,P'E1G[)P
M]C[0XL*5;Z9M_7V=ORC^W;LY>)=36WPIQM1/85+*\M9I&K$W);T&7Y(AL"Z9
MCO0U(7G-91*WE<2X4WEO#EG*H"B:$-:\L;HH56"/ >EW4=(BG#<(P;[]H[@!
MYMOF/>$7<>=?AUVS1ER>?[.+^DH?/POGRD2WF6,Q=:@=1\@ZI7ITP*1]3<E0
MM0GTRM!H0%,&!J8)B5@A6-IKCFL0%D'Q L\$[[^?G^7G\7/L^-%.?H3PO%?0
M7I>A_0)N3J#1]61&R85.H'H-IZVM0)+(^6'0I!X7V3:Z"ZKP](I%)6>NQAC1
M)T2TAS]W?9=KKN7/EZ#X(H@BGPUNHS\.:P/"O=P]EY39;.5]RR\'T,[VJ4/R
M.3-R;<TYANI5THIH3&Q8"*(M?PJUTJV#(.OF$M=_*IM^>X&W,'9%M':H_+-F
MS??7U_L$$4?K_1]7ZWV2?/'UOJ_3OZ/K?5^GZ/IW]'T_1].__GR$5%KV\$U5
MZ3],02[;J#1.QH+"*3EM8(U7*XWV3:.))(9M')0QFO!/9-)NGL4-$E0FQ:HM
M?YK@TJMMVGPET@K() .W+L^+?VHL+FWA^=M;&N6Q*)LVOJW9V/"/.5>#JK/T
M^*EE5.Z]HUK8@@_5,VCNB@_AW7%AQV=\!%644XC)2.-PS?AF]>,EW ]1OX^)
M/;X[>GP15[%_!P@9\+5D;N:8@YQ&X)77I:.= (]"UHL,ALN]!6 +G84Y1R3B
M1&^JT#TUMHZ$0$7ULRLDFHD[[<M4>W SN>(]W+L^(?'OVHN587PR_05FQP^-
MDOKF,NI):_FB/>7K^FA*CG1PO.8M );(Y)"9O&$EK1'I1.=OV!]0!/57_<F#
MF^]O)&)8!3"[3Y"-QOV=AW W]&_=S[/R>=%<2S?*TJM?RW5U!R2=1,=)())Z
M D123QF"OA43(I4A840F6A06&NI63=A&9@;%$@;;2\D)<CE%_G=I+H\:88WV
M^/XQLBI!$O@\:CXLL$?WIT19&*X]<U/V]U".N2@V$>@:JJ&E*P$CNE)+VAIK
M2M>T^#')M5.=(R5RNNOQL+UVOTO._F[P?21OV^DE%W;[X9EX2Z&VVA/_ $-6
MKV?SVNO(,$C!*-4U(1$0C'/D&T>[#CBQ@,^M,F8D?,S31;-) LU.1_MB_>$'
M0MNFP18C$XW'ARY]_B-O#YD6Y-AR^Y8LN2BK1<GRT;<D5F""S5BL^TCQIVJR
M;.'#QPW:*.-*=MD%W;I9%'?":KA?OGI7J$7+PB81,(F$3")A$PB81,(F$3")
MA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$P
MB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81>%'XM
M/ISTG _B&>D8G!_0EXPR*AS4'3$1F*6S/8['Q:;FK(*^<IC@P@^S',>'#UTY
M>+\-FR7*KIPNX4UTJJIWUH;5^4R=?4>3AKY&_!"Q]?@BAMV(HV<5.NX\+&2-
M:W=Q+CL!NXDGF2OKY]39H#0>8Z$M"Y++Z)TCE<C:JYAUF_DM-X:]=L.CU'F(
M8W3VK-*6>8LBCCB89)'%L;&,;LUK0-<_Y9?K_P#2L])?KSL_]Z,QOW:S/W6R
M?\/M?K5O']BWHR_S=:$_W1T__5Z?EE^O_P!*STE^O.S_ -Z,>[69^ZV3_A]K
M]:G[%O1E_FZT)_NCI_\ J]/RR_7_ .E9Z2_7G9_[T8]VLS]ULG_#[7ZU/V+>
MC+_-UH3_ '1T_P#U>IG\[7+[6]#7C5U*A/6_H\8[L68"8^Y-*W;9R[>.!%%=
MN9+*7B/4N;Z58Q:.MBLA?\;71^LS&+Z^U3_^EKNXV[G,E?J48\QDV.LS,C,A
MO6B(F$[RRN'7#=L48?(X;CWK3S':L6UOI;HHT3I'4.J[G1KH6Q%@\79NLJ-T
MG@&27K;6]70QT3QC)"V;(WI*]& \#]IK#/>GL5R)77_KX=/?0D4AOO7TM,@5
M?5!2-ST?+>;2LH2.NR)7U.:FB$,=J<N[ WJ+-_JV<KMZXZ4)?+EH\\'JIII]
M=N4;U-6S+;&1AAU!DYXZU.C=HS"W:8V]#?L5(8">*Q^U#^ZCQ'=^SXW-.PW(
MUAC<QT93X?161RG0YH/%7,WJ;5NEM6XTZ>P-F?2>2T;A]2Y/*Q Q80'(OXM/
MMZJ,-@XZUZ*9KG. 8_#2--?%F''&@;\I:RR2/!BR(]+I&$]H.S<2JTY48U,W
M80BUY(,LAR-@!2. UVI9R./*MWRR+I%BT;KF-+#$>%U+5S9&L]U+3AQV8YI(
M\VZ2&I)38)+#+<C+);7?'&0\M>0X@AK07[M%R@U1]3=/4DM?6'@8'NJ8*]C*
M-OHJ94R>H:>IIW5,)9TW0L8&.QFJ]^VR2M'/2;)"QT;I97LJED[I%BE.^\.6
M3=O9'L'U2*EJMN&:]2CD%NTW+6)F,)^7I)Z4C-AQ:7OK>!14X#/AQ _7'V11
M+6@;UT[:J.C[1..K]F*EGPT"UF<LR;RQ];JX+\DS7Q#%2Y.*S%,ZXR)\<C&-
M['#]K<7#>0",V3(ZGZ'3,]^"Z,>CNSC&Z:JYMU[+Z3JXR:ID'=(-'0>0PF1Q
MD6F+F1IW*5JS-OQ5G;VX8XY!'2E-]F!U_7'Q(2\H\]LY[ZGO\*!OLW7+4:'B
MOJ1P9MA@ M,.YD,).\P _;48Y^7D 5MT\:N'YAB-&**-V,E?@B#MJT6X*U74
MSY<<+&6R$<>0?7#6194OMMCM1F2"3R>2Y%RD8-P7/:UA(;*Z-Q -YS.<Z"JV
M/UK+A^CS1ENYHVGG9+%K(='C:NFY;NG;+*66IG-4],Y#W]*W((I(X*TUBPUL
MDV/AN01R2MXEH0WX@$0J.)7-"_9EUS>.O_/4$O\ F\;WZ:D VRHC'9:?=1HD
M80KCBRGDN+P..F>PPU[-DQ:#+;PHIS\ORW&OW*%-J'4,-.&]!FKT\3L=!D)X
MO=25MJ&.61T3WBMY29GUXW]6UT_ !Q/[-FN(Y,!D^AC):FR>E<KT6:4Q-V#6
M^8T5B;_U@4Y\#D[V,I1WX*K\Z<!%C*V8O51:GBQ+K#YA%7:>,OGAC?03\LOU
M_P#I6>DOUYV?^]&8][M9G[K9/^'VOUJW)^Q;T9?YNM"?[HZ?_J]/RR_7_P"E
M9Z2_7G9_[T8]VLS]ULG_  ^U^M3]BWHR_P W6A/]T=/_ -7I^67Z_P#TK/27
MZ\[/_>C'NUF?NMD_X?:_6I^Q;T9?YNM"?[HZ?_J]/RR_7_Z5GI+]>=G_ +T8
M]VLS]ULG_#[7ZU/V+>C+_-UH3_='3_\ 5Z]U_P )>72R>?#S\W2R<2>0S.5&
M DW5+R:5FB4BD!11M:4Y8ME")DNY>$7W;=DV;-$.W+E7I)JW0;I[Y223XYWS
MI&::QIW&33RR3ROCG+Y9GNDD>1:G:"Y[RYSB&@ ;D[  =@"^0?U26,QN'Z;=
M=8W$8^CBL=5M8AM:AC:D%&E7;)IW#S2""K5CB@A#YI))7B.-H=(][W;N<XG+
M/<<GDD:!5^K')"<CZKLL<3=*!"S\4HYX29L.D^'';!PATMPGUWUUQRIOK7&^
MNM\ZUOK?TV77EJU5KXXUK,]<OFG#S!-)"7 ,C(#C&YI< 22 =]M^2N70!B<7
ME;^I&93&X_)-AIXYT+;].M<;$Y\UH/=&+$<@87!K0XM +@ #OL%KG_&K:'YR
M)[_;"0_WCFM?=;*_=/(?PVS^L7IOZT-)_>OIW]"8W^C)^-6T/SD3W^V$A_O'
M'NME?NGD/X;9_6)]:&D_O7T[^A,;_1D_&K:'YR)[_;"0_P!XX]ULK]T\A_#;
M/ZQ/K0TG]Z^G?T)C?Z,I$KT_8<M4DA$W;UB XQ#0"DBD!!G(3Y,CVA\\S&,A
MHM@H;8HKD"1!^W;H=.GC9HWX^U<+J_0GRFI<L;8R-PV9)\SDH*M*N;-F1EFQ
M+*6\;(F1Q1F=C722R2-:WB>UK1NXGEL<9U)CM-89N+JT-%:9R&6SF1;C,;6G
MQF.J56R"O/;GM7+#,?8DCK5:U>2600P2S2.X(XV;N+V29P-DW+LT_?71>HN+
M"J_XG77WD/DXV5)[W(!@%01T,+R8:'(?5Z)(O4RHDX[8+(=\<;Z2<:42YN@B
MM!\\DF<S\52''#('K8[45L?W1%7,)BFM10R;=:V030V'QEIVY/!:,6=9Q3H:
M->OH7H^MY>YJ1VGQY+9Q-O#N QMO(BX+=+%6KM;<57P.IW,?#99(TNV?&6O)
MT'E85D_F)N^K24KA..1&0!R(IZ9[E)GN9O## <)V%>2Q$</>#W$?,]%%U33A
MOI%HCTUVMT\YY1/@MP,?=GU!E3C/)J=B&6)\_E<QNOFCCAZA]L1QOB=7G,SC
M.YO"QI9Q&0<,0W</?GKX3']'>DFZH=D\SC;M:Y!1;B*0P4-*Q:NB_!AI+5F"
MS'DJ(J1MH1RE\[Q-P" F3"!:UFRFP!\4AEQV"=CA4HP8MIGV5F3)FT0>-D'C
MK[S9JD-Z;D122RB+IEP\427=(ZY:.U$'"*_70B=E+>1CJ4LUD9ZTLL<;;IFN
MQL8U[6O>96&0\,D320]@>0YS=F/+7-<K_;CTIB=-V<QG-#Z;Q^4IT[-B7!MI
MX.>>:2"62"$59V5OVRM<>QKXK#H6NBBDWGA9)%)&,Y:Q^8.63:5?E!6<G7Y$
M8!<#3>]G.CJA202PM#D!KN/_ (;Z:MDF3\(1?/7J1USO[N31VV;+NUOE^+@R
MM<=&RY]<65&.EBKOBG)G-@RV;<M)L3Z_EW T,D@DD>]MAYZH#A87NX1C\N1P
MD5B;#_L;Z3=J.K;R,5F@/(!CVU,;AJ6;DM0Y(Z?,LC[%>_6KP0/Q\6UES^ME
M9"SK7<!9J>&#)HYD'HBV!1" F^HV?139FG8MP?V8>#4!0(IU8;5R4=.6@]\7
MYUT):<(L6;A1STAK2/2W&YEB**\ZSJ/,128Z?R6RUK)WPFP9GQ-B@F.18Z5S
MF1R3#>)@$;'%Q'O2[LLEQUNU@HL;T9Z.MUM1T!E,;(^:C!;CQPHP6I+F0J#3
M,T5.&*:S7I.VN3.?8GB;$'DO$>(6&;E$0%1$B#O6TCJ\K8.3' LPL;C3Y@$T
MOML-)K<H3:0<=)&%47G;%'OI!;MHVY>[YTV=-.UNGDI[5.&G+7S^6L.MQNF$
M4SIZLD<'%P12N#;U@;3N:\Q@EKBQHDVX'L)O.FJ&(S5S-5<AT?:1QT>'L14C
M;I,H92O9OF,2VJD9DP.-(?18^!MA[1(P32F 'K89FQQ7^-6T/SD3W^V$A_O'
M+1[K97[IY#^&V?UBR_ZT-)_>OIW]"8W^C)^-6T/SD3W^V$A_O''NME?NGD/X
M;9_6)]:&D_O7T[^A,;_1D_&K:'YR)[_;"0_WCCW6ROW3R'\-L_K$^M#2?WKZ
M=_0F-_HRO'X>E\MDLHG2$CE$B/HM0(Q5LB;-DRJ3=7LBIQVH@F^<K\)*=\:U
MSUVGKGKKG6N=[WK^+,\T'=N6K=]MFW9L-;7B+6SSRS!I,A!+1(]P!(Y$C8[+
M0/3[A<-BL3I^3&8G&8U\N1MLE?0H5:;Y6-K-<ULCJ\49>UIYAKB0#S W4Y^[
M3IN,>*_6,CC1@K'I""\[W 6"'@9!V),ABH^"''3 F**,%F[X<09.4DW#1ZT7
M1<MET^%D5>%..>M;UT/!!:UEI6O9ABL5Y]08B*>">-DL,T4EZ!KXY8I YDD;
MVDM>Q[2US20005Y-S#WQXG)21O='(RC:<Q['%KV.; \M<US2'-<" 00001N"
MOSU_RS/8'Z5OI/\ 7I:'[TY[\^L[2/WK:<_0>,_HJTC[K97[IY#^&V?UB?EF
M>P/TK?2?Z]+0_>G'UG:1^];3GZ#QG]%3W6ROW3R'\-L_K%:SQ?/_ %EZJO@5
M3Y+V3Z[ ,WL.LF6J.H38]ESJ7OMU] I!-N 49B:U@@.#AV0=@^0PICLLTZ7?
M/4..>]];USO%M94-*Z6P<N7CT?I.P]ES'5 V[CL;1J,\OO04S/9M#'V#!!7$
M_72OZI^S&.)"N6)GR>2NMJNRV48TQ6)28;%B:4]1"^7@CC,[.-[^#A:.(;DA
M6^L>H/4,/&R \S]X>YH\F/\ )-N^FFU<W8ZLJI[M!+U59D5KE&/3N ;N.3<@
M0$XZD#LY$I6D4<*OF8EVEH)]"6W/>)8[+:9N2UZ[]#:(L&35>*TT[(X9F.RN
M%G;D\9;R+K%&_P"X]8SSTA79!;JF)H8^9KNNYAJNEBMD8FR/;FLRP-QEK(""
MVZQ6N,-:S%7#)H/*I.!DW6%\4G$2X,/O!VJ+?/ KTA?-,M+UU\1#TO%X/6A2
MQ4O67S%H6"]+4V  Q%[+ZQD49'[LMHM.6UNJ#GL&!-EM 56M@(<AN=OD'"3G
M=SU!+IW!9A^#_8^TW:NY*+''2O#C,>R+,6+%ME/)5[,GN:\4G8D2,O3N;UX=
M0)F/5EI:.O1;D+M1MSW=R,<-=TXR>]F=SJK(XC+!)&WKP919X3"P$,VG'!N0
M05TWDY#U[?#.Z3T_]4?$(C :JJ^C5@!@%7/+2LVR+!82:= H6W3BD2*V=!D2
MR+#D\B;(/6151)(4S?.N.>](\\*<^JG:2P3\-!0TOH"S-E,A8H33Y-F+QN.H
M/KT9[CC:MQ8R\Z(R&!T,;'Q F5[&G;<D4XP96X+;[&2SL;*T$<[&5W69YYVR
M3,B'51/L1!X;QA[BUQ]Z"1OML9ULZFO0U1NC*LW^)IZI& 1%]@JBZ<(%+@)S
M-=K)_-3'T%'@R=>,;5[>I7$3*%1E5<U^_.CPS.5N_FBLQ'#TENDK'C,QI_+,
MA%+HVTM+/+@I\MPNBQ$5-KJVHY,!8F.0DQ88[$1Q1290WXX))GU&%L5.20@'
MN6*EZJ7F;4.3:QEUE7D^TZ8B3'B\QG4-L[^5.<YM80EX8)#Q.E:W?;+P/D'W
MC-)E?$&A7OCT\[*TH4\XOB_<HF]K1I_'8!=]>R6R)68L>,LK+DA*.S&J1 %,
M66@L;<S)Z<D+C0<6^^<411WU+&K="TJ>#O7="::9%F8M1,A%:EBK,=B_A<A6
MQU6''67XVM%8IY2:<RQ7K#:;(:[>NE9P E<K,7F99;L,6<R)=4=1<XR368RR
M"W#)/*Z>,6)',EK,9PNAC,I>\\#3N0%3@1+;OGM<^MK9K3XDGHXE&O.8X47B
M4.DD\NP19]C1XE8%>0).:EF#>4NX/"HJ[=3=PJP;)SB2S'EZ,Y'D8LR9+[-\
M9?-4PM#(Z4Q62Z.=.QV=0R2PV[E>CA9<;CK$=#(7C2B>ZJV[=M,;2:)'&E6I
M\$G61VGO;U*M39;DT&3M5\_D'1T&M=%%)/;;8G8Z:"'KG-$AAAB)E):.NDEW
M;PNC ]^IDLNH?:\:8- U>>^?2T_M*,VA4-/W/$BE@67#(O 95<E5$[:$FP<Y
M[M<_J2P&(A0,C'SR4G8]".@*P)V:Y&N8_P![?H6?'9;1=E[ILAH33=#&6<9E
MLOAK45#&W+-^KA\I'BI8)Z0Q<'D]^W-/7DHU8+%X3MG;#UK; ZL]J>KF&-#(
M,WD)K$=FK5MQ.GLQ1P26JSK+7LF\I?UD,3&/;-(]D/"6%P:6<QE",!L%+T9)
M?/YKXK?LUAR+K^&6V)L82#L(U"]52>I8%=$DL&;NBOIN)/8.%B@<NL@HW^2/
M$"?#=KRU;\FR;0!WU77\>=/5L_#T6Z.DZV_<Q4N.EFQ\-WW5KYF?#U\?2;%I
MNVR]-;FA#@[C@CB+G%[C!&^P.40SB_)1?J7+-X8(K+9VMG?%Y,^HRU)/*77X
MS"R)KB"-GN=L-AQN#%JI,^Q?5K4N5:A/7WIHN&;$GR @LZN2T!+HH,1=*IL"
M+D7^&;_[M7>M>4G*P_YYY\FHKTW^;<?9_;=[2ATAI9T,3IM)::BF=&QTL3,/
MC)6Q2EH,D;9?(V=8UCR6B3@9Q@!W"W?88T_*Y,/>&97(O8'.#'&W9:7-!(:X
MMZT\)<-B6[G8G;<[;KK?RS/8'Z5OI/\ 7I:'[TYR?6=I'[UM.?H/&?T54^ZV
M5^Z>0_AMG]8K->*O6?JB1^R/)L>D/I?T"> 'O2U%!C@,S<MC% YD.4M"+LB0
MHJ,?21=D1&D62ZS1\Q>(+-7;595NX2424[XWC6L]*:7KZ0U58KZ;P$$\&G,W
M-!/#A\=%-#+'C;+XY8I&5FOCDC>T/8]C@YC@'-((!5PQ.3R4F4QL<F0O/8^]
M4:]C[=AS'M=/&'-<UTA#FD$@@@@CD0OT.\^?ZW@O!/>/J/TR,NJX!HWT5>H\
M</M&P&+!@QMRP&C)BR:2PL@U9LVJ$@30;-6R"::+=NBGPDBEQPFGQSQSSSKZ
M!8'2NEY<'AI9=-X"223$XZ2223#XY[Y'OIPN>][W5RYSW.)<YSB2XDDDDKRS
MD\WF69'(,9E\FQC+MMK&-OVVM:UL\@:UK1* UK0       !LHN_*P]3?I*W_
M /KDL7]X\NOUHZ4^]C3WZ%QO]&72]W<W]V<K^D;?ZY/RL/4WZ2M__KDL7]X\
M?6CI3[V-/?H7&_T9/=W-_=G*_I&W^N3\K#U-^DK?_P"N2Q?WCQ]:.E/O8T]^
MA<;_ $9/=W-_=G*_I&W^N3\K#U-^DK?_ .N2Q?WCQ]:.E/O8T]^A<;_1D]W<
MW]V<K^D;?ZY;+O+E=^B_0521"Q7WK#WKI[-KE.5"BG4@Z?VO&H-H4,A;Y.:6
M<;ZMZ**Q6+]=R_K;EY\HZY2:!R"_/772>^-:OU7DM.:=S%W&QZ2Z/C'1PM?,
M$YB3'XFU?ZZ6[&:6+@&'MBW:'D8X6<3"731M(Y[K,L'3R^6H5[CL]J@.LY&7
M'@4&6[\-;JXZSQ9NR^Z$'40;V.;N%VS8WD;[;#&WA,@&H^Q;6)_$(]IE"-9V
M<E2Q9E%'A,I%CU@D1,T*@B$6DCF_V3E]7I)"%NE.Y(Z$-"Z*#]DLWC3W72FN
M.PR-D^>QN(BZ.M#PQY3%G-PON1Q16Z^.CEI13QVZS-/O9'D8G76@5FS/A<Z-
M[768SMOQ.>^/&W+[]6:CD=1NC'2-KN?)#+:>RR^)\$[LLPNJ2"LX]<Z-L@#V
MD0OY[=5=HN_*MJF&6Q&O<WHZPAUZ.H]WYRC@F<6'S*)@%;@6K^U"$T&M)V1_
M!5Y7DF>-X*F+'J'7!XW]N]0Z;#&ZJNN?!3:?RV7NXBUH/36-EP#+(U+9FH8[
MR2G.ZP^/$QT97T(_*V9*JQU\RR>3MKP<+#QRN 7'DH\I1HUK\&I\Q;9DW1>Y
M$++%L3V8VQ-=>?88VV_J#4G<*HC9UKI9-W#A8"Y8Y!U/0,TIF?33GW7Z-&6K
M7=?S*SI36;@_:NH]$8]#Y&VCK>/3NPGEA,%(S8$V[74(0>.)1 LS*H<,V;DR
MR($=-VG:O_6]1S>/H_6%IJ7$9+(TL54RC:^)-BY9NUG676:&.9CI!:QU$-$5
M^R;D+X7%[VPOCCW?PU?=6SCK=D:GR[+].K8NSTG2WA#7AKS-A$5JVZVTPV[.
MY?5A%>1L@#6ND8]^S:6_E8>IOTE;_P#UR6+^\>9O]:.E/O8T]^A<;_1ECGN[
MF_NSE?TC;_7)^5AZF_25O_\ 7)8O[QX^M'2GWL:>_0N-_HR>[N;^[.5_2-O]
M<GY6'J;])6__ -<EB_O'CZT=*?>QI[]"XW^C)[NYO[LY7](V_P!<GY6'J;])
M6_\ ]<EB_O'CZT=*?>QI[]"XW^C)[NYO[LY7](V_UR?E8>IOTE;_ /UR6+^\
M>/K1TI][&GOT+C?Z,GN[F_NSE?TC;_7+WF^?W[XK0])E"CUV2)DJCK=^1(OW
M*SQ\_?/(:%<.WKUVX[4<.G;IPHHNY<KJ*++K*=JJ]]=]==;\ :BCCAU!G(HF
M,BBBS&3CCCC:UD<<;+L[6,8QH#6,8T!K6M :UH    7J3%/?)B\:][G/>^A3
M>][W%SWO=7C+G.<22YSB27.))))).ZES+.N^F$3")A$PB81,(F$3")A$PB81
M,(F$3"+\^#XRG\I9ZB_IV ?\(J^SSQK7]T^5_#K?R*LOM3]2W_D%Z/O_ $F:
M_P#]/FUK&S%EO],(F$4^^<_1<X\OS<W9%:LH]N<OH#,8+'Y&=8+D7<%5FH[0
M8C,(JAP\;,DY6S#*D1@UP8;%Q*38L_\ F1#I3I#M&X8W)6,5.^U5$?7NKS5X
MY)&EQ@Z]O Z:(<0;US6%S6%X>P![MV.Y;8;KG0^'Z0<15P.?EO>X\69Q>7NT
M:<[*\>8;B9S:@Q>2>8I)78V6VVO8L1U9*METE6$1VHFAX?;,9\3:XI$_B*=L
MB89*5&\2A=536QD0#QK89RLXCZ'B_H 4W^Q%G0\2Z,1DK'UH_'MH@&++<=(.
MFA!!P3Z1,M[PW5-V1T(N,@E(AAJ3V1&19DJQ9&+(,&S9&0\<3XS''M&UO5N<
MUP+R'C7$W0'I>A#DCINQE<<U^2RNHL5@WW8I,'3S^3T1D-%69.*Q3M9,5<A6
MNMNW@Z[-+Y=!') ^.N'5'R%+OBLR^/VO/2E"5=7L$JF5VU?D\D(%KU9@,_;N
MKGWT!7DDZ.C;16DD(EK>)L0SH=Q44EA0N,RS3\L(0^R7X;<=B;5LT=JPZA4K
M05)KF0L21CRJ.6YY;^UF6>1MLRP3"%K"WR26%L4W$]@ ( L>,^ITQ=W3F&KZ
MRU!F\QJ+&Z;T9AZ-R0:?MT],G2@%QE##TY].LQ^6QLF3FM,L'4V/RUC(8SJ*
MMI_$PR.BO7Q-[L3/]G$8A7W?*5@E[ &,"KJS)/L:N5H"0>=-!-G)58IN4E1K
M6'2-^<TZ-G")IS+OJD')-07TH&ZZAU3>ZSC$-?86'V&->;4O 7X^7'=7UDME
M\KV"&5T@+WN>9O?%Y9[Q9'^P%I(TFU'9+-@NPM;"V)JS,!CQ8CKZTIZY\K\C
MQV"JXZM8DRE&&IP5*D%2/&#J(ZS; %L=_#/BIW7 H;3T-CM?5CPQI^6U?,1O
M)1[:YP01*U(.?C(YMA#S%G/8;77WVF17=SM>J ,&<R]_PFL\500Z<MG/+#JV
M]7AIPQUZH;3FJS-#S;D8Y]1KFQEL+[1AK]9QETYJ1P&9VQ) X@[IY3ZG?2>8
MRFJ,K>S.H'3:GQNH<7.:\6FZEF"MJ:>&>^)<G5T_%E<WY(Z!D>&9J2[F(\9"
M7,B:]XCDCB\Q[VFY6I%JU;U34061N:"C_F!U<(MI._QAN:3"2-M*W,45:OYV
M]@6GAPPR;Z)R)&%I'-#.G(IH\;M>VFF74?J"=U,U14ILE./CQ1NM%CRDT62B
M9T.SIW5P9'@<4@@$G 2UK@-N'(*W0[B(-2LSS]1:FM46:SO=(#-,6)<-[ALU
M;<HR8Z/)-D@PT.:ZJG5ED->@_+/I^4".S+%)().MHEE@6WDPB81,(OT(/@V?
MR:?EW^@9[_Q<L#/1&B_W,8K\78_EEA?%;ZJ3_+UT@_\ J\+_ /YC"+,??W_V
M>K?^F9!_L([+%TA_X-C/Q]C_ )<:NGU./^,=4_\ HL9_S[:UC9JQ>K4PB819
MK!YP^A#TFJB.%FQ9X0X R$ :3<J"S ERJ@XZ06VR=,GK9PW=-6SQD^9.V[IH
MZ0X434WQM1-3O4+\E!\I;%%/%8A=7LUYPXQ30N<UW"[@<Q[7->QKV2,>U['-
M!!VW!L.?P%?/P5&/M6\?;QUV/(XW)4'1-MTKD3)(A)&)XIX)8Y89I8+%>>&6
M&:*1S7-X@QS9,[]!EU?\C6A,,<1_B)/(2E''.Y6JQY NSS&1?45?:D_!QP]3
M(,$NOG5BG2BNE%OM>>OK<?9W3ZXYB>%U&D^MY&^B*KC;+!7?899V=)Y5U[WB
M1@/&9=R"=]]QMBS>C:DS]NCSV=BR3LS!GGY2+W'98.0AQUC&<3*_N2:$4#JU
MAS>H94#6%K. @!W%UV[T-.G)5N9B\3,1(J%CX#<&5;EV<?&#8HJY7CW(==B8
M0.L7(Y=Z05V[Z+N%G>R3_3SI;2_/V7%[OSO?*V>I3FIRP5Z_D!;-'6BCJ%SJ
M_4NCF;.QT;GR.+S,YSS+)QEW$-NS^Q_0ABIR4<MF:69IWLEDAJ!LM*?)6K68
M9%'DC>CL4I,?8BLQ5ZS!"*4<< JUNH$?5GCZIO=<Z'RE.2"'J01FD7'%^(8'
MV\80;?8I!DT:-5HX@\Y;.D=,Q[1LNX<]JDG&DN7"S[IYK3C7$,Y?9;%J%X@8
MV:*848...A^TB-K&.K-?PN;P1L8Y[B97;<1DX_?+N2Z$T_9Q#L5=KOOS/I6J
M3LY>ZBSJ -N23S32LRDD!EBDZ^S-+''$UE6(O,;*X@_:EW[>^B3;I,>G#(GN
M(-1@<>/AG?<CV)8K 9"]E0XGP]T>Y-+O^3A(@LYVX)*-G31VHQ5;_8ZXWSV6
MZAE:1&*-3R-D4,4=(FSU,9KV9+<4HD\HZ\R">5Y?Q2EKV.,9;P[;6V7H[JRA
M]EV=S(S<UN[9LYUK<6+L[,AC(,/:JF#W.-".N:%6LR(15&2PSPLL,EX^(.P*
M26*>E(=803X8ZY>3213TD\;I+).R9^2)LT7*COZ7';?Y=DFTZX'(HH);;\NW
M>NNU=*Z^I;K63L6X'0RB/W]ZSD)9&M+7RV+08'E_OBWA8&$1AK1PA[AN=UD6
M+TSC\1=9=J.L;P8+&:=J02/C=#4QV+=.^)L.T;9>MG=,#9>^1XD,,.S6\'/J
MYE+'\U/+'B+=FS5[8B!J#(=PLDP9,08ED&8-FB3A=PHFDFT8([ZYVMUK:W2O
M>M<Z[^KKBO7)+UAUB1K&$QPQ-CC#A'''!#'!&U@<YQ #(P2-_LB3WKN83#U\
M%CF8ZM+/.QMB[:DL6G1OLSV+]VQ>LRS/CCB:][I[#]CP A@8TDENYQ;.HKLF
M$3"*_P!X#_\ M;8/_P#CHK__ &:N;#Z//\,R/_IH?^:5YR^J,_Q-IO\ TG<_
MDK%8#XA/^HC[&_\ +/=?_#T_GH/0'[N-(?\ N3#?]0KKQQF_\397_1]O_D2+
M\UG/HTM!IA%--"7G*_/$\=6%#&(4@;=0:QX%]D=3)*-$!EF08] C#]O]U$A3
MM,J.&2!T]#K_ #>VZ!-!JJZ;/&_"C96S9[!U=046X^Y)-'"V]CK^\!C#W2XV
M[!>A8[K8Y6&*26!C)F\/$Z-S@US'$.';I7)*$YGB:QSS#/#L_BV#;$+X7N'"
MYIXFM>2P[[!P!((W!LS6WQ$;,@<4AL*/5S5UKQN)4A;?GYRQLC5B/%I97MPV
M>&M8ZUDA*.6!&RW;T,<#)#(XL(?"4&0%RNT<-7CGE!XCC>1Z/L9>M7+L&1RF
M*LV\UBL^V3'''L%3(8C&38J!U:.QC[,0CF@F=+8;,R5SYVM>US&\3'7&OG;$
M,<43X*]J..G:HD6.O<98+5EEEXD<R:-Q+'L#8RUS0&$@@G8B)R?J=]J+^AH-
M!JBJNK81Z.!U<#E$6AG-@.!T92JJ7"YL,>Q%Q,)Y*2J+TZ;%\]G]GB!YMV@Z
M=)"6PK>T>D;K%I=GE.G[MW+93)W=.SY.>K:N&@V2R<I4EI2,MMJ4:L3F00RD
M5Q!' X.:QTKI=G!W5=DG=7>AAJUJT-]E=DL</7EL?DTK9FNB,LTC@7N;[_C<
M\$$\(;NOO$_;'HF+P:RX(O8LME;2Q*[BU7LS<NFDY,R"MXE$IM')P/'UD^[D
MR2<5;N'D98B7C))NX&=A57#1%B@KM%PC3:T9IZS=QUYN.J57X_(6<F^&I3HP
MU\C:M4K-*1^28*Q-IS66I)6/+FR"8->Y[AQ-,Q9>]%#8A,\LHG@CKA\LTSY*
M\<<K)6BN[K/VL$QM:0 6\&X !V(["J?9$MK:NNZH.5O5EOP4E:\DMF4#+6#G
M9"[DY:6U>3JDRR=%&DB&O17:04JL=!R8"H,F@&7MF)P?(N.6_3-7CRFCZF1R
M'NI!D<IB+L>*K8JM+BIH*[*T-3)QY6%[8GUY&2ATT0@GK3B6G/4<^"2N>+C%
M5;+2UX/)GUZ]J%UJ2U(VRU[W2.EK.JN:7![2W9CR]DC.&5DH:]K^6QE O\3"
M_N]R+B$#X?5Z+XEYH7A^X;S*]O:Y#>3Q1P-54; DS\I-/3HY1J=<*RU:<J2E
M](W*2>E'#5ETHRZMD/1O@1Y.;LEO)ED>I&W/+/)0S(S:JEAFREB>*O5@9!('
M0,%041597:20US]GCLNU#=_;!"V*N'.H&+JNMXH&8YKFUXV.?(YSVD//6F8R
M.D[-P.2AZ1^M9(9-^HRX>MZPA#7UC'1D?GL<B(V2LX[&]LI]#K*?$X&P?R@B
MH%<FI5#4';UD_<EPS1 N59AAHQMH:D.N]?2E:&#3$,V1R=UVE;$EBC8MRUGV
M+/'1N8YD5Z1E:,3-AJW',8]C8IGNBB?-+*[K3)U),I(]V2<VO7B&38UD[(FR
M".,MFCL%T+72.X"^2,%S7%[0'.#&M'#PS#+OB7WX;$LOP/'0ZJ9T_-1F3V7:
M$%;R#J6VS)(A496C09.5-).?D45&H=5T>/L#0>*QX$'.%CI0T^9;<JH)M[14
MZ-\%!,\VY+F5HQPV:V-QEYU<5,56MY:+-S1U7UH*]J1PR,$$D,UJQ/-!%!%"
MQ_"'%W:EU!=>QHB;%6F+XY+%B$/ZRS)%6--CI!(^2-HZASP]L;&->Y[GD;[
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3<7_HZE_)HE,^617%,(F$3"+_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g904779g11t65.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g11t65.jpg
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MY(:7+'#$V.-\).5Y[)PDC'R#DGS\_.G-7H15)0H&343.41.4#$.4Q1,F82*
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M:;>;UE="?:(_Q"1_HP?YS10O%Q+D;(*KJ,)'H2()S<()E$0#W 91<B8"(\
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ML<I"@  (CYF$/<'^@: 7T"@D#=8^)9KC:?A5*$3811^.[G[&*K-!PF/^R1[
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M<J'%(4*<@0 6\04#\I=0"B BH8.DI"IN=-.5];_[O+EL?!3H V*!0+6V10
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MB:(FB)HB:(J4_&9*Y8J1_L\S!,'9I5)T1R9\L4$0%F2-.B<$4U!7 P+BY35
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M';QL-3^&HOI;2^E^<?8A@'GPL#Y\!]QP]P&'G[<_)_-HEO-]W36WCY^:>Q#
M/'A8'S\^/8P>7'2'\<_/_P#\T2WF\]A;<W&]^?S=0"$-QQX:!^"(>?L8.1X
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M>ZVMQ>U]=[<[=4.[:I.$6JCENFZ< <S=L=9,CA<J8"90443&!14"% 3'$A3
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M*5ECS.2XY$*RG;/,S)4$ELH78YQ(!^6F&*7()@4PF* &6823E$I^2CRF90%
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MI33(5,H"(\%* !Y &ONB&*."*.&&-D443&1QQQM#&1L8T-8QK&@!K6M :
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M+L<9DKW 5,]4#&75<E=)FAD<YQ.8.>S+*Y[S<I::GK*:KJ:H!\YDG#Y'N<3
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MZ=( '\WO_P A3\_/N^*@ZY!C:! 0 H*JB/4!N?*'C_4QA\@^<0\O/10.?G_
M?O\ -YE[N%'!I5IX-)HN(1[[O 4?*-P* N8_I$!0:.NL1X'R,!../(1Y'@I5
M2CT%&S%HW6Z.]1;I)J]T<RB?>%* ' BAR)G.4#<])S)IF,'F)"B/2!%]._W+
M^?4MW'G'O4.V/F/N6'[EZ*?^K#_FEUNJ/?\ RS[RK"U-OWVFY_\ >?\ --KJ
M:'ZS/XS?<L=^Y_C#_P!07.3*_H\_(;_EUZ/A>S/,/<%A2[.\P]SES!R@R>23
MTL='-'+^0?N4V3%BR05=/'KQTNF@V:-&R!%%W#EPL<B*"")#JK*G*FF0QS
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M'MPQIML9NK/%SN&TH&9C9)&VT>4<&NU8087/'\3[9+.R]P<VY!T,.IXE]+_
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M^QN'BK9@A'*K'C@,T-!XXXI=CU+Q-)BTLN,T3'Q4E5+#2R1TT4D,U.^&"C=
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M)H2L_/Q+B)*"E8;Q3AI)KIBIWQIIJY64\&95J0J!VPLRD6,V<KB<3)]YW)B
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M55,/DH=5.Q.$D^@X'2,CR9,> $=)@E4QW&TA8YHIFU'$4U-D<.SJ(L*HL"K
M]I'Z#3/&'$6NQ^A=WUO,9PTLX0I#(U[9Y(N&8Z@R-[]/)B=5Q'3.C(-B2X4K
MB;W:TLLZV9M[!P?G%[ 8_+"&Z2,6.)\41IE2*B8_+]&U*2"Y2@<Q"^'5ESHN
MQ*0JQ#,D!$0%$4U<7"L=INU>:^HC@IX*BBD=VC@T=A4<*UF*O<]DA':?GZ.!
MH=&&APEC8[,YS6K/QOAF<Y?(J>6>HF;B;6Y&.(,]-Q70X4V-KV ]G^9JIWY7
MDN:8Y7M&4.<RP+MF52*J3>L&>N_%-I.?,LGW0K(C#M[&[AW!RGX%- Q4E(9@
M &,10XMQ !(7I VOH^+(3PC@=%3/$-9%B&%X;6,A:7%^&4@=GD>\MRL[6HBR
M2AKSWP]CBT2Y7;2HX-E_AACM?4L[:BFP[%,1H7S'*&8K69>SC9&'9GNBIYG3
M1N<T!K>S=&'.B+F9CRK?&2^5XG*<:0OLEG;'8NUR.S V>K5>FECU$5E$Q43%
MF)@BA*N8.Z5<>'6(JF"(D+CUO$$^'\4X565$0=0C!*N+#HW=V0RST%;*Z*[6
MEW]NU3XP7-#B)2<P9E"87PW%B'"&+8=!,YE<<9HY*]S;%C8HL3I(VRV<X D4
M5,)"&O(&1K2"]Q)W-E9)5/9E999J<2+$V^0;]N;@# 0Y86$<D,(" @)2"4!'
MD..D!Y\N=;;$9&0<-/,ILW\C30FV:[GS8:^!C>Z'&[I)&B^PO<D 7'+X=&^?
MC2G;$+D<21R@:"S8<2[=YU('=9&XD;FUA<V!S[C#)=2QUMOPE8;D^?L(Z2HU
M+8-U8ZO6.RK'>N:VF](0S*L1,R^22%%JN8SI9LFT*8I$CKE561(INL-PNLQ*
M0TU%''++%#VCA)4TM*T1L<QA<'U4T$;CF>T!C7%YO<-+0XCDL=Q6BPJ2>IKI
M)(HI:V6)ABIJJJ<7N=*\ QTD,\@&5CB7EH8" "X.<T&?_P!5I@G_ &R6C]%&
M7/["ZW/\#\?_ %6E_G;!_P"GKGOX9\._K=7_ #/C7_+T_P!5I@G_ &R6C]%&
M7/["Z?P/Q_\ 5:7^=L'_ *>G\,^'?UNK_F?&O^7JG/MYFW.+%,).[S$>*P'%
M$'V-<J-15 G2!Q3!>DIB<""8H'$H"!1,4!XZ@YN1\$\2RW[*@ADMODQ/"76O
MM?+7&U^5U:DXZX7BL)<0GC)V#\*QAI-MR : $@<R%2E]\^UU!!9<V2'(E124
M5,'T!Y'3Y*F03F#O%ZBDB3R*/PU54TR^ISE* F"\. N*W$-&&,NX@#_VAACM
M20-FUI<=]F@GH"=%:=](/"36N=^4Y.Z"XWPW%6Z $GO.H6M&@W<YK1S(%R*%
M7=[V/,B"^5Q#6;EDV.B3H(2TG 0DBLU9.G29UFS<Y6+&373.HFDJ;AXDR,?N
MQ,W*NF!E"^9_2778_P#1I5832UW"6,8P_%J>JJ(SA%/65C:<4LT<)9.^EH*J
M-KI>T#XP7@EK7&QY>C_1K#P_])=-BM5A_%6$X5'A512T[_RK/249J'544DH=
M3MJJZFD<V/LRV0AA#7.:+ZK($=N,[_SE,29>C_@&'AK1;#)"!P. %*/7&QX=
M)B<G$P#R4W!.@W(F#@:7Z572"]9P-QS3=TFT'#N*51S9K =ZCI0&EMW9@20;
M-R[E=]5?1B8S_8G&?!52+C6;B'#*7NEMR1:KJ#<.TL; CO9@>Z:I_JA(?_<W
MS7^B^<_\6LS_ *4:+_%#Z0O_ "AB"P_^C6O_ ,:. _\ S;AWQ3_5"0_^YOFO
M]%\Y_P"+3_I1HO\ %#Z0O_*&()_T:U_^-' ?_FW#OBIAOGF/="8$,9YK4$@
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MW9T&,1XI&1&R2G$LU32QU$<U%,UDL8D?$&DO?FJ'T@CK6-;3U%,8Y&N9+4P
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M'%RGU]P[;MG1%4$_M[!.)L%X@HHZ[#:Z"6)S ^1AE8V>F=8$QU,1=GA>WGG
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MRUKF14G$4%#%<97.>Z2.2&=[@TE^=Q-LX*WGAX=W9-D$K$M2K)R+W:RP[H@
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MD8;8DQ4)D>;FU@TS2DBYURLOSN "L2#<+T B +9,, "( 8N)X+I, #Y"',V
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M"F/<Q\D8I46%G2+Y)K-CATHH2PE#EW&AT=\8#.8\ID16;LI(&[=1[1Y_#Q4
M[!VAV\_IZ_NZK)6J54FB)HB:(J7,S47 ,%9*7>),V:/!1.IU&.JJ;GNV[9%,
M#+.G2PATHMFZ:BZQ_@IIF'RU(!.R@D#=8_B8^0N<PUM,\V58Q4>)S5N!7Z14
M0[PHD/*R12&,F:3<D'H*0ICIL&XBV0.<QW3AU)L!8:D[G\!\?D18DW(L!L.>
MO,_#Y.5 #@. ] \@U2JEPDENPYILJ]G7A]P,^@C.T;*,:X@R8^:&K@98O>;<
MK9 KV<E(LUR[Q6YTK$N:;_@#N4GK9.P5>0933A['*1R$((Z@CJJP\C8=!Z !
MIYKB_G5XI]CVB>V/)M[GQ@:(A\A/[ECQ"+PNVB;DE&VKM"L+]H1>HK,EY+DE
MV;,LVXM^%XS'%#LR<!04J15IZ6EY* NDZ<ZSA\_/S^YF\.5C]TMN---"21K<
MZJU*1V+9<;1D$I4<Y4UY=,>91H5[QO;LC8@RKE-E*UNAQ^X^'CZ+G6AW/=@_
MI&0FS9GN7N<Q!26)X;;PUA+RW2N"T#+K.U8Y%^"C-X6TUM8=-M--O'317'8>
MR"F[/;[7*2NYID2F/YW.%CI-1C<%MHZ0J<EN'W%[;]R61RRMB1RF9G96*=IV
M\-(*I,F%8J:4!7[+W;H9EW"BXF"D.L-!KI<]; @:<M#UY+UIW8]%:9<=Y4RK
MN 9Y@\9EC!^1GM<G\0NPC)N-P3;MR]KK4%.,+#ENY59J_=&W%C'BXH=2H5#B
M HD=*0N,64Q8)M\<HS:6MR(]=N@'3G=9TW3]GA/[F,N96M89Y0H>*=PNWK$F
MVK/..6F*D[#<[+CW%N2LMY 71HV3W>0(Z+H;NZM,O353GG#_ !E=73*,:I/X
M)U'2:I%VI+Z 6U!)!OU Y6Y6ZK %&[*!*0S1N O%^EV3"@O-Y&),OX$HLO%0
MM[B(G#>/KE8MQMZI:$1XF.CJM'Y4W/YIS+.J-UB2KJ'@HBDF<,'*;&/C(TIS
M:"PURD$];Z"WH 'KT5I&[%"443Q?!K;K7*E)Q/CRU4FJUQ/$4JP/&N;7@?<'
M@E^[8HQ6:V%*/#GC,\#83MK!0;)>&SJGLZW 9(@*9,O:^W)GWT%SS\Q!\_+K
MSZZJNV[L1<;SD-D&-K63(&B/;W$7. ]K5_"4"U=1$%<>S-?=G@XAD_ 7"+5=
MQ3>3D'.X!2.\2U9O;"JM5#HHN%E+N+IX?.G1 \W!M>WG^UFTZ;6\RN:\]DS9
MK'6<HTZN;@*#7&-QSI.[@L?WQYM[LKO.>)+]<8Z7:662B<K5#<;CTUG&*5EW
M#3'D58:RK38BH+OJ'DBGY=K+I!HQ?/SK_4H#O [6WT-MK@@^FUN>UUV;:I*-
MVK9!9RJ\510125=KE0(NZ433*0[E8C9)!L15<Q154*W010*<P@DDFF!2 5*D
MY"39LE&K-PHH1Q)BNBS*5NY5(HHDF!SE.LDD=%N(%,!BBX42 X <2";H/TD6
MBN4:T6PODHPB2RSR2QADELBBB8HG66;O:<HS2(F(& QCO'"9. X.8IQ*02F$
MI@Z*BIJ?M&XA+H^EQ'!PV0Y<K615$E;K=I(&>E9F(_1N!K8BS45=3'$^BB-X
MJBDQ-Q99W>DEI11W[KFW(CJG@ [7O?<'D1$XY(%=@H5F1VQEJ[>(E9NTZ$"H
MKDQYB^BQDP=P)4Q$@N75ID553"<1$YDU.\3%-90_<<7X2<6IL;DH70BLQ:CP
M?-+*]XA#*3B6NQ.FAB:!9DDE.R>GS_I.G:'DL#;:/A+&FX35X.RM:]U#A=3C
M(:R-C.V+\0X>I<.FED<=7QQ3FGJ,M[M;$\L&=]RL\3#2]:L"\TB\ 8RQS.*8
MPH-3J/!FFUDR)"QRYBH]:+1 L@JFF[=@ '79NFW48$4^$^)Q/AN7'>,H:.8]
MGAS*7A>L=+$]A>V>FPP\0-E:7QY8VPOPNGAE;=SI^U,=V$W=VF%<2QX#PC+6
MT]I<1GJ.)H1%*US6NAJJ^' G0/+7!TCIX\2J)X38-I^Q#SG;HW865I1[!N'R
M! .&QFKR#RAC2S-7Q$U_#.Z],V&AJO%3"H0I%EF4B]"-4[I8I17=)) 7XI1=
M3,Q/AFGEEX>XLI^R?+)!3PU\#A&2),#CQJ:GJ,Y)<V1T?8B-HC! @8\NN'%F
MKPSBFHIZ#&^%YS(V &LEH)F%X&7&?R3!/3%C6Y3'FCG+W%Y'YY[ /JM=KQEF
MJS%'C[&9PR7"=;N[?48^0,DD*+5FGDN\*/)!<RJO";/Z&HDYF2Z8J&(LLQ<$
M'E,BZ?!X/P7)Q!C/%6&S-[.EH>#Z9\ B.:5V*8SP[/'#'!ESO?(^LJ)*J0!K
MF9XLKLI,=_1,2XWBP3!^%,2@?VM17<6R]OVK2UC<,P;&Z629TV8-:QD=-3QT
MS"XL=ED<X%P:]RSDIBU\G9,- =JFFRDJ)A=B5L1(6R:87]G,T^7DW0"599/P
M,O+03-9%0I5>^<]X8Q0*4BW=X?PE@E,_&R^)TS:6/$X()<Q+;4$-=3-I6@'L
M[.PB0%N1G9M=!'(P7NY>>U_&.,U,&&".81/J)Z2HGB(!?>KGP^L,SG90^PQ6
M O.=Y+VS21NN!9>7[#D=5=P>W*"CHY<8.WU9U9)I$45 *@*T36!43[U19;J&
M/ESI.$3J ":;ERF06P!T .-7<.8=B,5?+%GIHL%ABH&PP2]Q]&UW%$0C<'BQ
M;([%.T(RO<'4\+F$$.<,FBXHQ&CBCCE,53-BM3+6F::*[V5A/#<AE:YA;E+6
M868VN#F-#9Y6NN'- M:;QLI'Y75<RB11BH&IY<7;(B@"KX[FGS;Z7:F43./=
MD #1[91F4@BJ1PHX,/=F33Z[/"_"S<)=PMB<3/[)IIOR?+)8-<VEQ*EQ2*)L
M[@2X,E96![0#D826/[\H:LGB3BXXM!Q1ALD@=!5QPU\;,SBPU5'/A;YC T@
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M_EP^C0#GSYBG0\AP/D ^V0X'G@>1 ?(!#CD0$,-9JB*4OP/#Z- >/(1BG0@
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MBWE!$H^.8AP/(A[,5\_(0_"7S\^_\GO B>'E.1'QS'T ./9BON$?/[I?/HB
MWE//ZN8CYC_@Q7RY'R#[I>[_ $^31$\/*< 'CF/(=/G[+5\^!#GR]I^7/'YO
MG]-$46T>"9UUG0MW2ZZQ%>\*U*D"8)HI)$*0IU'!PX[KK$W>?9&'@ XT15+1
M$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$4J^^TG
MG^*N/^A/JIGUV_QF^\*';'S'W+EQV)_^MC[9OR9D_P"L!E77IGTR?WR.(_\
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.."2=_F^Y\YYE;&:*%_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g904779g13p61.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g13p61.jpg
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M[1.PV2D82F^;-!<""%1;?;9:'Q1@)!(;Z-D$6";(4);,"I=NP' !#G# &-L
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MZ,G!CQX1P@B&)+/")' #B!  XAP$8&Q)Z\9((&<G.-NU8)JKL3;LCZ=]T+W
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M.XDZ\8.W96X>SE=VF7\7O<B3'++@,Y/5;=LKC,?OW+2G7LHF[-%:3Z[2>O\
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MH%U5#Q6G5KEDT,K()=51QU2;SN<MK(&DCF\TB5J!H*EN_JX[%IFX;K&2D$;
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M^CZ59YJ?X(]&WY%U!_\ ]?>UFKG9K TX1.$3A$X1.$7'%0X@\S^7'!0TR/\
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M,0^'(G,R,#@8V=9+C_B"E?CNQ:^89-8?3J&LLQJ31V%2/#N3A&^0$RE_T?\
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ME,,224YEHSZ21;I$C%'-3==@3<"?("HM8%K5UJ5)'KPDT[&!AED#&5GEEZ\
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MQJ5OU<\(+=B<(G"+7N[[_:?G7^KH;^IX3FHM5^_E5_(IOS>)?2CV.GX)M/\
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MCK*1BG3-4U9,A$.B;/&A2)!I2U7:?$E4YIR<^+N3OMZ!S/F"SQ^Y-[6]N?\
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M6Y49;D\+J*NIG-SEK@0")L&E8M$7*:]]%^H-9=#U]J'!\]WZ)-77WH_EJ78
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MRLE_ UV!24RV)C0# 13-PW,5DKU[!ZGNB2ND6PJH7HKX5G"5&;50QH:.&0@
M04?I%4T<1QG'HYY ZR,<^?S+"T@\F1>/41/+^4ZT2HM'ZQO4!2<WB4=G(X_.
MF#N<4S7LS@!06-%1ET'//3UQVQ7E(DA3 [D6"1.N+*Q)R806Z#Y)P[@9&XSW
M>GR#/S+E.P7DUJ.@C_7R'EFE<22X+.M^O:AM&*,K>!#6]'-Y!8=75A9IC$F*
MQE)[.G-;3"W8ILWB+0#&24PCC:32K=6-"8H?58/7U]>2!I.3@X'+8[[$_0%%
M<=YLB[]@(=XZN,$U2E A>X^4-;U76T2ZGG0%42%H;27UIK7#CL BVML(W<TE
ME-&+X<#R&6]T.$MFVZA26=_7CJY[[;$[;<^\*='1SO2IW+-7L)5K!M6^*=D0
M8<-5TG#J6+2\"?.6"$%R1)!_!H2CN'>JU\^7$S&"N[(J"6Y<O6$#M66D8I+V
MP5Z^OSJDC&._U[^WR]PV5@G"A1Z[7W'+.O'7.Y;YA\%CMD/J9KJ8VD5ATEGA
M*MVIB+P".$Y9)FX^3BZ_LM9$_L&$.]03!S&M1Q(GLW:$# 5JHJ10*0,D#M4%
MC_E'5B/8$;U=-TS&9!=I#K6>MEM"JSO4;*2IR[TH-.K9A77"'AY37U?24X\F
M-5P A(U;+* (X"!&CL3B^0A54UDDT*H-R,YVSC)&!C(&2=\<QD;^7MY][Y*(
MRWZ?6-V9!0JOYC<]75C.[+L'KX"LF5QT]&HY6DN-1F6C9*;M"D*\LF-G(XY"
M.AIR.R6E!1,7--5(UHT=CM492Y*"W! WWQ@X'7V8)!&_,'EOW+D[L[^V'4?8
M&8T2.H.'SK#5&AA4'F8F\2S86TGG82Z(/3L#AM^M=*3()TN[-XDTFL*/Z1LG
M<)LU X 3(JQ\6^/1Y@[(!D9SVYV[!G;??OY8VYJ9/6>ZT>QE"59=R4<6A^]C
M11D>>198IH<Q'ROO%F)@2V.IL1>AU@R*LWB TY@6+^<#]&Q+(P=LZRS0*",$
MCL]?7<^4K.?"A19[C7S/>M-)D;>@5:Q"U%P4FA@@[&I?:!FJ44A$SDXR&-2@
MDX&JJV]R)%E(CX+X@.\"B&R@50L13-_'#F8<N4@9..WU[E"J1>53<3=?87KC
M'J.'65=E$4_I,V\*K*W<S$C/[-BPJGC%S5P CP^M/QBZ1^N1UXQ)\!F2$!*2
MFT$XW:0R*55I**^(1QV4\.P.=C^L@=?<?)MDX.5EDEY!83I1<%NFMPU;VT<D
M5B]6X5;$;@5G$6C>N1G92U8K4(:5*EI75\:F9_>.FY8URWBTDKB"R1[LT?C3
M+2(.&+_+0HQN>[/S>?\ 6L86CY*+.KNU;7J,?UN@\R,1.SPE:UW+1/84LWKB
M3&'=+=C>Q,DBUDRE:A%%ZQM6(4[U[1DYNOXX'MA@R>6[6(DE,ANI)\0:%(;D
M9R>63MOS: >>X).WD.RLRJBP1UM5;6MJB&+T8)LR 0ZP18TEC3!$>.F<='2-
MDQ?X2SLGAZT;$DF[K"><Z8734QIG.OIGA4G8D=B[_P (G")PB<(G")PB<(G"
M)PBB58/23K]9M\QSL9+ ,E6L$ XK1^Z9C9W+PT%EYFE3<FDU,GY[ 19=K%9@
M=JF13&1&X.4,C7#D60?(JJ[.]!8=-@4Y.,?9OOC._?@?1R)S+7A0G")PB<(G
M")PB<(G"*-_9;JU6O:V,Q>(V@5LE@$B$UC-AB$:ZLJ75NOM,(4>%2J&F2+J)
M$AJY)Q%)0#$22/X=[JZBS8]L1:XT<)XVX4@D<NPCS$8/S+J=<='.OE67@:[!
MQ4-+=K +N9Z3;(';"F<BAT9D5L*15>VI;$(29,O(U&Y9:#N%1Q[-CXX>F_*.
MFCQ5%1I@X>U)DR<8SM^KEOSQORY*7G"A.$3A$X1.$3A$X1.$4  GC Z71R('
M8&$KZQ!\5.S)E8^!J/9?M!E6,6(PDQ.8(V!7!-6Y5"U4SE:1FS)(C+JS?Q*0
ME\EB34J1>LGSELJ4\1SG;T#T$8P1W%3'K2MH-3M?P^K*RC8^'U_ 8^-B\1C(
MOW^60<&);Z-F31-5VLY>NU<)Z>\=/W[IT1(.MUWQ!VZ>N%W"A1S7>.$3A$X1
M.$3A$X1.$3A$X1.$3A$X18BD] T?-I#+Y;,*CKF42>?UQI4$X/'X>"+%9;5B
M9%\7TKV0O7S)=<M$-2A-\0P!>[K#L/'*CCW'O<:[:DR>WO\ /VKK/[D[K1D7
MD*I1=8N!FS%D-5:NXB)>ZN&0X?8HID@Z4=MUEG>&XZW;19I[N5%5/<V#+M=M
M\_/B.5RG)[3Z?7L'H7';]-^IRCB2NE>N-+*K3)R]=ROWM=1=5*0N2<2DT#)K
MEVZ@W9N^4)PZ:S"/$]ETM_F Z4R%)Y[[)@ALX)D]I]*S7"H1$JXC N&06/C8
MM%0NKO L&(0PV8,\OW[HH_433QG;.RSTD]>$'BZFVZSIXZ<.5]U%EM]]BA=I
MX1=8ED2B4Q',F,RCPB2C LAC,T',S(Y H@/E$&/CY;$9$S;KI+>Z,QF2AQAX
M(^0T^+8%1[1XTVT<(I[8(JHV=L^*$8-CLF8U'$A3&\!=NT"35VZVRX&Z:UY$
M;N1ZPVH M\(_A(\I7U9HW)/F5<DDK"&A!WO90MNHS1!,Y [%%5AW+)VWQG.Y
M&=L=>-_\=EG,=W>\>=_5Z0$3>S*G$5X43BXY@![&-QU3AYW&9P#"26OY!"Q-
MOI1I.90R;@"X0E%3 %%ZT()N6S;.$'VN6NI,.!VSG&=MSU@\NS!S^K==4D[?
MQ&F1$B=/V_1N=;73J6NI8$%)4E*)#=CN)K6NY(RN+AV9)=]/WFI1&\6KAP%U
M>H/3;VVFCY11X3G&K@GC=_9UCL_P^923ZU1CJ:;9D;[ZW0>J!!&SFJ#J7R6"
MA(JPDF'Y_1I.2D:F.T>RMN#DFQ&0(R"7QMPJ@[WD9!0N9;N";GXU4H.>1.<;
M>C;92HX4+&UHQRO"T=UDEBP9O/&%:9.ST..UA3RP3K$FWA<IC)-W$(H+%F3A
MB3DH9*)9%6@N/C'QLVQD9&/L6CO8MLT7(.[]2JDBG9/Q$19AL]$5Y$H")F \
M,VL=T1Z[2Z-#H/M2,]F-=08/=NZ\.30A94!9/567Q*OV\DQHL[D-/ZHA%5=&
M81=V]2JL//;V\^X<AG?9PY=14J?W9_0.XHP.>6C9U00_4+8 K+&&=G7("GYH
M%L&N5X=:\:(MH9;ZD</)$P.KR!6. *,&:NC9%V ,H.$E]/1 HPX<@>75OL<C
MJ\X]*P_,7?B#K6$EI*WCW3&2I5Z!,=L!D*K=&EY9.2(P1$ LQ6LF#PX.0V)G
M&:\-914N)?#T\@%0;:*NVJR8QJ&61*?&[3V<SZ/3U*<=%5?UN@PZ1R;KC#:D
M ")N9?(R0_4P^,IC9 7B!Z0AWPIX4C.-VB_T0DZ\M%[ ]%\-HR?<R9EHQ8$7
M!9-1Z^A0<]>?/Z^19XX4+@95%HY.(Q(X5,08N3Q&8 3$6E4;-LD"(60QR0#W
M DX#+CW.BC9^++#';I@09.$]T'31PL@KILFIMKDB@_;TDZ'@K(?T!>E?P0(Z
MG[,_>A8M9=7Y&5+)'U>UU'H'(I47LJ0AD(,L;B]3J1^)/B9$SH@TB**,1R_]
MIHL&2*1GJSV<^WJ'^"XGZ>^*<W0L@J/6S^BY3K>)W:/9="TK0I-W5S->8%C\
MC;$)4U3D>X/#N8'!,J.9?F]\N9.3'2(BJL0=-BBVA3XP.?&![=\]GE[E\=:5
MIXUKDF]T0F$U%U],S!J] P^=L<1N$*D+'!QBN.N%JQZ81[1LX=/IK"HM'IWU
M^R+GS-'9N"D+&*MV1!LY8 G*[GYO\U!R -SCLWVW(QW=?SJP*+1:,P:- (9#
M(^&BD1B@8;'8Q&(Z-9A@$> AVB3 2&"B1Z+=B-%C6*"#1BQ9H(MFK9)-%%/1
M/377!1SYKGN$6.[:;5^XKF5JVE'-); A0[21R$!M$2L]5?(Q9VVDC+9C#00H
MX<DA5D3%,B <4%#DB[DJU9ZC&:[["&F2*OYO;OC:O,O1];+U_%9CK?3$%?=;
M+%J4-[QE&1]IX;8MP1\H?E;F-ZB85:%O16&6-+TAQLD-D[EP#QN^U9ER$32)
ME.#N>SO[,#[1R^A9(DI[QBS4&!ZH2::=+#H2MI2R#1[KV\GE.*:0N:P;:0:,
MA#"M=#>K@+)XJL#E"F@[42@4$NPAMSLBBZ%/56[[$\;GOY=_I6(]FWB*E<C0
MAPR+]09X.[ R&P9@=ED<TJ:5UN=LN$S"M!D@93&6CB;L*VM*1ROLG$F8L0X4
MVD,K<SI^.4T6^>ZM"K;?Y_\ 'S*?&Y[[;=?7D^CQ3W;*U%FS:#VC5@P:MF+!
MBV09LF3-!)LT9M&R6J+9JU;(ZZ(MVS='31)!!+31))+35-/7737&,%2OHX1.
M$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X15.7CY/2-&6SV8!E^MQZ24+U ,T
M8-OZ[@%F1W4_$Q=YQ>.28?+AU1E ;![(XS#D9(AF7;BYDH<0',GI0:#(X1RT
MP50;G&#N<X'DZO*>KJ[U(:6^1;J- )384.GU@RV"F:Q8KEY,I,J/OF,!'<?8
MVC%*8,RF%R<U6;*-V1#XU94XBD;EDPKPK*(Q$]33<Y(RPR.)NBZ!1PG&<9'+
M8@[XSCT+GAW?'JZ;MU*B(Y/)%++3S-IE7[Z-0^I+DEJ0 _7QR,1>:/)5((Y
M"<9BD/CLJF$?BI"PI&8&0).3.'X'62[E ,@:BR8/T'F.OE_ES7NLKO7U;J.W
MQ]%3VQWPJQ7I"OP[QL/KRSI-%(H;MDBZ$56 L*R(O##-<5M(+*)LG#&!@9[*
MXX7E:^$-0K-YAXSRX)@XSCM^;G@<SCKQRW["H:UKY:XF>Z1]A>^U@U3,P50U
M'<EEU[%(O$8C:Y6RI+&H+86*X&G#P2;5C7X\45.$==2Y?8"2DL+@NCIS$9C,
M1,[B,UCX0JBPAP;D9('D!/5MGZ-^H8P3)![Y,NF0XW.8V0LJ7#Y#6L6KJ63L
M&0H?L&P+QA"WV-<OZIC)(8]JQ![I9=CZ6O!V4*J1)!6T9"<?E8X-B"\@BTJ&
M!2CA/9VXW&^,Y(WY#!WY=ZY!UY'.HS*-0R9.YU.&\3FLG=0K62JT'V"U!0.7
ML;(_$^]C-VE?Q7? T =:6AG$'<B[N7@#U$[G*.Z.$-%'&CU]"C!W'9OS'+&<
MC??;?98EC_ETZ>/Q,[+2HA<%?ZPOL+/^M3$?(>O5[D3,\L&OQDM//D8&'BM<
MGR4BR]CT&DQCY0U:_2('JR:C92(!F#(,>2*>$GE@[9YC;ESSRYA=SB7E2Z)3
MN.2.4Q"ZGQT7'&%5$TF[2I+LUD$T97>>?Q.J%:FB;BN4)3<VTUEHHM$A:-4!
MYDLG)Q)0"^3:$Q[MLD3A(ZNLCF.;>>=]L=Z]1?RL]# 7T*^:7<];_3P")E K
M;6H[N<)@X\7M20T=@M8JK:MUD:G:!;@BIRMI?FSU(BI")>U0#3!,&Z)#-'A1
MPGL^<=F=NW;L66^K7<BL>VSV]1]=@K)!NJ N.3TS+?I_74PA+0J:C3QRRV+1
M@E(@P\<:8O%6+O988U=[R6.IZL=Y8$!:' .Q,A!'/KWYJ6G"A.$3A$X1.$3A
M$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$7COKG?3?77?9+;;7;7533&F=T\[
M8SC&^F%-%$\[:9S[6N%$]],YQCV]-M?77)%5XEXK*92:"?I5=O8.7,QDVMJ;
M2W:2DZ1'-K"#7-V!AO:RQ(!.,12CXLW1@9"^82A/D5(GI$I>,0.26'M9BC '
MS:+L'+U[55Q<]AOCMZ@1V]A6& 7C@Z ZUPIJIV0DTOA^:EE-)!YH6M^E7C<#
M3(*N(75H^#"#8F"CP2XJGH8%$-0YLP@7E"+N1D"=BR&6.RK)5 G$[Y\^4YSG
MT]F NV-_%M2=EVW*[C&W?-CM*V,R8RQO#(48KQ^(DUDN.Q/<'L*8DY.;)PLN
M^=16.S3M,[S70*'%H[NT4BN&MA$K!8+[,N%/$0 .1WW[B&@?T?U*>G5?K#7_
M % J(=1U5E)>]KP$:.F8R+F!,67<1C62O/G1P.'>#@@57 5]*'1V5:-"&""H
MXI)"@\4Y8QAL!CX4J22XY//K/:I&<*%U.>Q9:<0>80MO*Y9!5Y;&#L:2FL#?
M#Q<WB6YP8Z&:R2'DRHLV-&R<+ES\Q!$'P<FV9$V[9RJQ<ZI91V(JOC/B1ZP-
MH.S"6-:UPEZQC%4A*^GPB2%J1A<2F]?U@]N&4U^0LQ[!Z9@F[9[5YB[K0E:$
MNCY*(E)*7-*F[9)3UPS37U*KB(Y8!SD'?8G&<;XWP/L7P!.C/2&/LT+/D79<
M],WA4Y6MEG+:F=KTDEB</*GO_K79,0.&'\<@T9A>!2$JZNTS5!#>-"0;!_%F
M3\(KMB<F?I2F3B.^  .77@9#AC<GM/,E=5 >&^B9#M.M"MS6?)Z4F,;^!K6)
M1LI7>C08C)>M4@ZXFY\1EFE?D"$FE"T$GT]:Q7+$@SKUL/D;9Z4A1XV,&F&Y
M.(YY $>7J.>L]O/.3S5I=%4S&.O=4Q&F801D3^$P%J^#PQO)W[,F0CL2V*OW
ML<A31^T'#-W,>@H=TSA\4V)Z/CND8""$CYL^93?&GQ03DY66^%"<(JZ>UO1'
MKW=\S.WG?=IS&)"VM6RBJEMD"-+P&+1N*ST:A&3&2$\=5>E8)MFZ6<_%BXK8
MECRJN1LL()GQ4+;2! 2\9%4"0, =>>OJWY9QC;.<9[\*.]Q=%.LCDE#+(AO;
M#:ER[>ZB%OOIXO-J7?[;-;IN*^.Q2J,,^E\1*Q+0H;FUE2]*NWTG#RX0M"(R
MLQ4%2$D-?'\DR>SNY'LQC_+K/D4I.JOCKZ_]0IX7LFCS%BM'4KK>NZR/"3$F
M#'8U(8=4]75)5%4ZO-,1M DJ\@D7JK=T!*-C"*[HI95D.#>YE@0BH^(D+B0
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MX1.$3A%%22S,S1UORZ33-K-SE,6<(BSL?((\!E4[;U=/XRS< 3(<Y'8RQ.&
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MVQT.H+7;9ZAUAOMGO-3']R65=+;)X+'=[3<*NAJ";717.W&XBX5\-L[3^Z5
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M[K7I"Y-++1),8CF2S.I^D<:+MQ<LB\UIFO',\M/L^!D%DBE?QSQZM-V9II'
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MI?P'S&8LF)2.L<J^GRXL69E$E$E6>JFN%:MFNT=39&V>>5E0);A5FF8\MCN
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M"%[E%#R4,@BU=%[^L:@6]<"@A=C<&IR)]9L]@!KG,PD,^'P;!)8DCF$+"R0
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M.1E- ^GF925L$K))(I)X)RUC+>CO8^Z-U3H_[HTFJ*NYU,.O]-Z?NVNX1?\
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M\N]9,L#N;0U=2-F *2MB6;:M;7<2:31\[#7L=@[FE@C.0S^/2%1W*6!<A-Q
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MV>M$X*=$,MG"D4TNN21F<6J#C*R35NX: 9O8$5'STTS>K$5U9.JY71=HCM&
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+PB<(G")PB<(O_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g904779g16b17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g16b17.jpg
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M)#0V0G&UMKDE<I?7"B8G-5*!H2@I,T-B<XB4T__$ !P! 0$!  ,! 0$
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M3T7:'7"$$9H'G4(9 4)G 9%FZ2<.&&4P0M(?8^@M61K!('&IK)6I"T"_K Y
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M)T9  )W\S(V3YEOJ\*0Y571NW;SYXZ>>O5-[FT'V;:ZM  T.F6GD0I<'^*2
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M'%'3'5TJ5#K  B]C<&]B#EWY9#AW6NI!Z]^,BG:)LTO:+]T(M&1:]>.JG7Z
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MTUQC773377&-====<8QKKC&,8QC&,8QC'/@2222222223<DG,DDYDDZE?8
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M^V[[SOB5='A93A$X1.$3A$X1.$3A%AI%(X]$ 1:42P\&B\9 L7!,Y(I$48A
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M7&J2HIG.BPFFGC+!&6MJJV47N!4/8\00,-AOQ0NJ'.&7;LS:KT=?J5Q247+
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M@-N%^7Y_/>J=S3Q<HRVQ)3;8Z]7$ GI*5#)?&L5]5$7CT%8R'6/V]#Y'*YS
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MQW34MF$3*=Y;8N#W[C7$ /<"TGTT-!CS\/;B#]G,7F@;%')5385'38]%2;S
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M]:P["*OF74$=(YPZR88Z@D)_B+MXZDDKY_I5+-_[0P/9G$N9DP:##9'=738
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MNF=\??5;5JIIG/WPCMC\W/BIW8?$_LZ_ *R@DXMIJVHIBW/418E3USR!H09
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MS3TF'U$DH8Z1S7M$#6L;8$NDJ#%&W,@ %X+B0&@G)?&KQG"Z&$3U-; R(N#
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MC<@NS",3+==XT-2&>+W1AH\2MOQK!V&SL4P\']WTRG+O[HD+O<O)^62M]O\
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MY&(>CJ]G*>GV3;BK-H&59;."RCA?(**1[Y^P<R&.=L,XJ6,)F>Y].QVXUXW
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M1H&V7=J96=KHB@S5FR37=+9RJY6U0PHNIG.ZNV^V?7GUJ:JIK)3/5U$U3,X
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M.$3A$X1.$3A$X1.$3A$X1<2[F[2=FH#W+LJ-P^76;+ 4-M^GA ;KF.HT5)X
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MK/>+,Y"?!2$:S?"V:"XW*#I9=(J!?S \[V^"TK;S!]>QLK/ 97![+BD>BZL
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M;ISS&7EQ/@<C8&U^%PM"AOF%;%H?41.3]/[[0F%IBZ_)8CD,D]"R 6$S;W8
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M)#TF_%;?<2!4*D#/7(D?E^)/NZ1G<_?BQ(I>2L BD,>Q"!.ZX;ZC)7;M*7$
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M3DWICZ1''S?!@;9*D_CVQ$PPUBSM\4(TMQSU\+<-#?XY*F8WR'WN4:G]R N
MP4_%7MM27,(F59V/'STS0B)WK6G%J!C&);)(H[>V3EA>SR)&9N*$%6)B:I1
ML"@[40_>@'14C/ISR/><B>OET6G3+R2]AA$#&G8XI2YV0RBJ*ONK06UBS["M
M<XG57]J)M+JFE*96WPPXL6I@M1\$VL@CJ:!S]]%#DV3A=5F)RI"XPN3=SS/$
MCEH0/QZ_$B_]J7W/6,KLD/ RX1@E"NOE+V7'4'8>)O'$YDEU3ZUPZ#$9I95F
MTH :O 8"EWGTMJ;G\<:[[S%R[+($'0D:.W*6R[R?"P\>?+@H4ZT]UK,NN<U&
M@4?54Z"V&K% !:$Q./RAC*A;8UTLK/M$XNAH0D4FR60KUU,IMFMQP<U!VBZ3
M.2P59\?0D6"0TB5(MS[^!S(_#B>!7L7\C)T;A^5-T(@SB3&+@YGDLRM9(@:6
M S7;L,+@>NH#>OF3;4L1DG6Z7-I,RV/?)QN/2"(FQY24%7!Z+Q\KNY@7SN1Y
M6/P/N/2^-B_D2?RF]*7@&(>!9 ;"+3Z E2 *<CYA7[:2:Q[I[9D"E*MJH1\6
MW:(+0?L$4@36,Z ML2B]R$9KH67<,2HF9*%+9$C/3RNX?A?H%J=K]\[HKWL/
MV K5L*@"L+@),E&8,L^"-W!=:0CJ=ZQ6HWT**A[=>2QRB[;6I9WU!\7JB%PM
MJB%AHP?/GDH=X!20I;('Q/F1;3IS_&WH_9LW(C^*%]I'4LI2&[]@9>YCT-C#
M]A+J\C_7;N'#*?8PJ8+O9Y+F15[>=<E9 *CI50!"R@V9!"1($.D+'9TVB96W
M0\!GG<D&VEOQUX\>O/"RG")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB
M<(G")PB<(G")PB<(G")PB<(L4[ @WY,4;?!A+TR#P\P$+NQS-R3#X((ZMW^!
M3]9'=T/P^0UU1>?**H_,HZZIK>_3&->$65X18)6+QI?4-HO'02VL<<ZO(]JJ
M('J:@GFFFR>CH-C=OM@6YT3VVTU78X05UTVVUQOC&<XR1?IM'8_NE\#<$&V0
M^0P*^#L+9;)?2\-5&6!OP\H9T^0PR66:89^GR^&JJC?X?PM]M,D7DWAL04:,
M&&\4C>[$4\'D1C+<$+V:#B EJDQ%/F#;+7*+-X,8H(,Q[EOHFNR:HI-VVZ2*
M>FF"+9.$3A%^"#9LUUWT;-T&VBBJBRFJ"2:.NZRN?<JMOJGKKC953;\Y13;&
M=]\_?;.<\TY[WD%[W/( :"YQ<0UN0:"2; #(#0<%EK&,!#&M:"2XAK0T%QS+
MC8"Y)U)S/%?BZ&CGV=LOF#)YG=JY8[9=-4'&=F+S9#=VSV^,GO[FKK=LVW<M
M\^J*^S=#973;*2>=<K2QP^+1@2JJN*C@$8NN14+KK#Q ]DJL66;N6BQ-51LW
M2W4(JM7KQLH]WVRYW;NW*.RN4UU==R++K-6SG9#=PW07W:J[KMMED4U=FZ^[
M==GNLAMOKME%7=HZ=-=U$\Z[[-W*Z&<Y264UV(L(UB$38I@TF47CK-*,[NE8
MVDU"#6Z<?4?:*IO5 >B3;343N\376T=;L,-]G&BRNJN=]5-\9(H<["QF-C.M
M'8@<-CX0>/?U%;1)\P8B6#1D](N84:7<OW;5NW30<O7"R::R[I9/==573111
M3;?77."*:VL<CS/)C=F"#-=I$MNYD&S86Q0V.N5D?EU7!G*2&F2BZK?_ ""B
MKW*ZFZ/^2VVSI^;PB@7LZ !.JV&?,A1+CYB\.L?Q_CCF:OQ_B]E*614^-\1'
M;XOQ$A@U+?W^[WICV.FWKJT0PF13ZUCX%CJPU9!!#344BS;C-6HUDWU'-Q[5
MXQ8(,,)(Z89HL61$@S9I-\)Z-FKYXW1UT2=+Z;D7XM8O&6*CU5E'03-4B1V+
MD%&H@>W4?EMLJYV*/=T6^FSHCME9;.SU?*CG.55<Y5S\3?U(H9GT;CH>8]9A
MP@"%%CV%T21^Q8#A;%BS9/M^OMYH[O6C5L@D@V=[).7*6SA'31;9-POIG?.J
MJF-BHT=W?B%8/A1.$3A%Y7S%B39N1Y)FU(#WB.[=XQ?-T7;-VW5USJH@Y;.-
M%$5T5-<YUW25TWTWUSG&VN<<VR1\3VR1O?'(QP<Q['%CV.!N'-<TAS7 Y@@@
M@Z*.:UP+7 .:18M< 00=00<B.A7ZH((-4$6K5%)LV;))H-VZ">B*""".F$TD
M44D]=4TDDD]==$T]-==---<:ZZXUQC',N<YSG.<XN<XESG.)+G.)N7.)N222
M223<G,H      !8 9  : #@ O,X%C'>ZJCL<Q=*+88:K;N&C=;=744[4?B\*
M[*)[;*8&OEEGC#&^<X9NU5'#?X:RFV^8JO"(C$:CZ*#<#'@81NVW<J-D! E@
M-1;J/<(X>;H),VZ.B6[O#=##G9/779?"*/Q<[_#T]I%[G@P:1U4T(#V+[19D
M]&*ZO&B#K54:2PC@B/4U73WQNR?X;-\/6FV,H.L-T<+IJ?"T]I%X$8O&6RHU
M=O'02"X86H##K(B!Z2HH(KJCHJ'&J:-]=V(M71NWT4'M=DFF^J".NR.<):8U
M(H8O*.1X14+<,) AA8@98]*$1HH<+8LAH\@PO* &F+]BQ;()-6CQD801+-'2
M"2:[<FBD_1WT=)Z*X(I82@4&0T531A<3137*M#J^B4=#IZ+&V"NZ[$PKKHSQ
MJH59+J*+-"&^-G;=7?=1%;3?;;.2+8%!P]9SAXLQ9JN]?E?:Z4:H;N<?);.]
MF?HOMIE7'RFS]]LU]-O\WV>N\I>S+E;.Y%6^E(K%T+$[4.T8V 1=;7?'!6SE
M(..3<9%C^N/7-5@-RMHWPIE@R5005:,\[?+ME$4MT4]-D],X(K .XQ&G^K'1
M]'@;S0805+#='8E@XU'E5G"CM8FQU6;[X:$%G2RKE5ZWPFY4<*J+;JY4WVVR
M1?/X:CF2#0OF/A,E1^S[9@3^E,/J#+8HNNZ);-'OP/F6VQ%TY<N7V45=,NUW
M"ZSCXBBJFVQ%%77!LW;4U$LMVZ+?+U>5&'N44DTLNRQV92$R;*.LZ:Z_,$3!
MA^^+%7ROO<D"3UV^=JK.G"RNY%.'")PB\+P6,(J,E2 YB^5&N]'XY1XT;NE&
M#Y/7;1-ZRW73WV:NT]=]]='"&4UM==MM==\8VSC.FO>P.#7N:'M+7AKBT.:<
MRUUB-YI(%P;C+1?1DLL8>(Y)(Q*PQR!CW-$D9()8\-(#V$@$M==I(!MDO=S*
M^:UPC#XB8:ZL2T6CA1EKJGKJS(A!CUKKJDJLNEKJW<M54L:I+N%UD\8T]-%5
MUE-<8W4WVV(LV@T:M<K[-FS=OLY5U7<Y0131RX7T;H--%E\IZZY55U:M6S;5
M13W;ZMVZ".,X323UU(O YCX!XNT=/ 8ATY8$OK3%PY&LEUV1CY?+3ZLT650W
M4;$OE<Y;?/H[:.OE\Y1^+\/.=>$7@6A4-<MW+1Q$HRX:/3>),\:K 12K=W(\
M;Z*8D#E%1ILFN;QNFGO@JKKN_P#>GIM\QZZZYP11#*8['S?82*M#((,7:FJ-
ML9L8;%!;)^W+-@=A5(["MR:+M!5-^@'=ERKH6DZU53'N"9!9IJBH]<[*D4XI
M! R!-0T@(&(F56"(I4LDP:IDU!;97==N-4?Z)8=;L$%U-UD6>RN6Z2N^ZFB>
MN^V<Y(HDOP$$_(5=&/HPKTQ4<_2QCZ>T],)M8C)5&R>,?!],:-U")#=#3'YJ
M.[YYLGC79TOG<JW4=X^*VR!Q>,LX1#VS2.@FK9$ +<HMVP@>@@DX>ZC33Q=)
M))OJFFL[,-&A9RKIKC=<FU;OU=MW2*:NI1;/F,QO+\B5S'P>2AA%!L7)9$L,
MORC=KJEJV0(O,M_F'R+?5NAJ@DY45T2U12PGKKA/3VD4*WE&8XR@K+1E'PC3
M0U>W7$B9T:BF#?4L0W[%5>ON^)ZI-],/WFR^,+;.G6%5]E<?$SOG?[\*C7P/
:P*L+PHG")PB<(G")PB<(G")PB<(G")PB_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g904779g16m00.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g16m00.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_X5B7:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS
M.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ
M-#4V-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@(" @(" @("(^"B @(#QR9&8Z
M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR
M9&8M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+R(*(" @(" @(" @(" @>&UL;G,Z>&UP1TEM9STB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O:6UG+R(^"B @(" @(" @(#QX
M;7 Z0W)E871E1&%T93XR,#(P+3 V+3(P5#$R.C0W.C4V*S U.C,P/"]X;7 Z
M0W)E871E1&%T93X*(" @(" @(" @/'AM<#I#<F5A=&]R5&]O;#Y!9&]B92!)
M;&QU<W1R871O<B!#4S8@*%=I;F1O=W,I/"]X;7 Z0W)E871O<E1O;VP^"B @
M(" @(" @(#QX;7 Z36]D:69Y1&%T93XR,#(P+3 V+3(P5#$R.C0W.C4W*S U
M.C,P/"]X;7 Z36]D:69Y1&%T93X*(" @(" @(" @/'AM<#I-971A9&%T841A
M=&4^,C R,"TP-BTR,%0Q,CHT-SHU-RLP-3HS,#PO>&UP.DUE=&%D871A1&%T
M93X*(" @(" @(" @/'AM<#I4:'5M8FYA:6QS/@H@(" @(" @(" @(" \<F1F
M.D%L=#X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)2
M97-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QX;7!'26UG.G=I9'1H/C(U
M-CPO>&UP1TEM9SIW:61T:#X*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z
M:&5I9VAT/C$P.#PO>&UP1TEM9SIH96EG:'0^"B @(" @(" @(" @(" @(" @
M(#QX;7!'26UG.F9O<FUA=#Y*4$5'/"]X;7!'26UG.F9O<FUA=#X*(" @(" @
M(" @(" @(" @(" @/'AM<$=);6<Z:6UA9V4^+SEJ+S1!05%3:UI*4F=!0D%G
M14%304))04%$+S=107-51VAV9$<Y>F%'.7=)1$UU34%!-%%K;$Y!*S!!04%!
M04%"04%304%!04%%028C>$$[05%"24%!04%!44%"+RLT041K1FMB,DIL04=4
M04%!04%!9B]B04E104)G445"055%0F=51D)G:T="45E*0W=G1T)G9TQ$06]+
M0W=O2R8C>$$[1$)!341!=TU$07=11$$T4$5!.$]$0DU41D)15$5X=V)'>'-C
M2'@X9DAX.&9(>#AF2'=%2$)W8TY$03!914)!64=H55)&4F]F2'@X9B8C>$$[
M2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(
M>#AF2'@X9DAX.&9(>#AF+SA!04519T%B045!07=%4B8C>$$[04%)4D%135)!
M9B]%06%)04%!04A!445"05%%04%!04%!04%!04%11D%W24=!44%(0T%K2T-W
M14%!9TE$05%%0D%114%!04%!04%!028C>$$[05%!0T%W449"9V-)0U%O3$5!
M04-!44U$06=10T)G8T1"04E'06Y-0D%G35)"04%&25))>%%614=%,D5I8UE%
M54UP1VA">%=X46E00B8C>$$[571(:$UX6FDX0U)Y9W9%;%%Z4E1K<4MY63-0
M0TY546YK-D]Z3FAD55I(5$0P=4E)2F]-2D-H9UIH2E)&4G%3,%9T3E9+0G)Y
M-"]0128C>$$[,4]4,%I85T9L85<Q>&18;#E76C)H<&%M='-B5S5V63-2,61N
M9#1E6' W9D@Q*V8S3T5H66%(:4EM2VDT>4YJ;RM#:S535FQP95EM6B8C>$$[
M<6)N2C)E;C5+:G!+5VUP-FEP<7%U<W)A-G9O4D%!24-!44E$0E%514)1645#
M04U$8E%%04%H141"0T53355%1E523FA)9UIX9UI%>28C>$$[;V)(=T9-2%(T
M4TY#1E9*:6-V17I*1%)$9VAA4U5Y5VE9-TQ#0C-04TYE2D5G>&15:W=G2D-H
M9UI*:EI&1VED:V1&53,X<4]Z=WEG<"8C>$$[,"M0>FA*4VMT3515-5!2;&19
M5U9P8EA&,658,5)L6FUD;V%7<')B1S%U8C)2,61N9#1E6' W9D@Q*V8S3T5H
M66%(:4EM2VDT>4YJ;R8C>$$[*T1L2E=7;#5I6FUP=6-N6C9F:W%/:W!A86YQ
M2VUQ<39Y=')Q*W8O84%!=T1!44%#15%-4D%$.$$V,35Z+TQ4>F1R3W1A>F8V
M9G)H<R8C>$$[-$PV25)W5VQ$=VLU5V]T-'A+=TE+:3%M1%A#14MX-4UA54]&
M530X."]L=DXU;S%F>7AQ23%28E)V3',O<GE).7%L=V)J.3EB>F9#-R8C>$$[
M36AG871Q0GI496I%9$MG:%=.-F8K4G5V46%68C94965D-RLY,#8S83,T=T54
M>$)9-V%A0U9%:318431B5SE!,C57;TMC9FDU2W%D>"8C>$$[*U-(;D<V,'!T
M4'9F>D<Q3S56-TM7>F-U<WA2,VUU0S=Y4THY6G!)1$%Z43A:3U9+.&=244%+
M<&AP6#51*UIB8GI06F%X<5!N5S@Q4R8C>$$[>7-895=04W T-5=I3'9$3D-(
M<DIC>6A70S-"*WEO2%E!0V=65DIL+S5X-S%Y>C!R5#E-,&)Z-W%7;3)U;E)T
M-D-X<$IT4$M'37)Q<28C>$$[6$5587%7;&M+:%8U:FM1>G1284MP:G)F-5-E
M9G U5W5D3S@O-FES:$QU3&534S1I5#%(;EHQ8TUK>G%O:FE+4BMN-E)2=4HR
M579Y5B8C>$$[5E!T4R],,WI&8S8S.65T=D]&+V%74S,R;EAA865$27EI1W=I
M84]7,EIV5UAK=#!71%-66&-J8TXQ>%9)-W(X;$YA1C%E6%=M*V-R>B8C>$$[
M5#4W=38Y8VE*2DDP5T4S5C5D3F)%5S%X8D]Y33$Y.6]V>DA%.%=53E)65W)R
M.&MD63%+,'9,6%<O3VUO87)(8WEX=D=T=W)01W%25"8C>$$[45-H5W1M;&4P
M:TE%1$M#66%F1U-W86='2W)R;CAN9DXP;#%02F)E9CE3<W)9,E9P85=D;F)I
M-%-+,V4R:6AH:VU64F1C5#9Q>%-F1"8C>$$[5%EV>7%754A&54QC+W=$3U!.
M:F4S5VA4,RMS4&-R<%133F97-W=U.%8W>G9:8C5&;$4P.'I&564U9&8S:D]3
M1'54=E9615@S-4(R1B8C>$$[>$9P0F@Q6C=3-3!45'1.<TQ/4T-"555Y-F9C
M3E!*3S12,6LO9FQZ5D9K035F1V5B0F5+<7I34'E:.#$V4&5Z-FA:*V-P2G(K
M.6QT,R8C>$$[=G)M93),4WE*8GAI37AI6C5P6D%S;D@T-FLQ;W9D9#%8<D]+
M=7A6>#9E2'9I<GI8>5(K560O-6(Q*TA62F1B83=G:FET,4YK23)60B8C>$$[
M3$)9<EI33T-Z=CA!-S!C1FQK,G)614(U5359<6<Y9B]!0U!V.5,X-U@S;6UZ
M.'I0<',Q,4UT>$9$0F$X6%)H86961U8W:4]A2UIL6B8C>$$[9C53<%=R8T-R
M3GEX5D149FMD-79E4RMU62]Z13%/3%4W=C T:'%#<DU*0F)X=$TO<$UO=6=N
M,G Q24M+;DAJ.$E(3FE65E=$.&QF3B8C>$$[-F59-4YA;2]-2%5B:SAP4'$Y
M=DMK,T=+2V%D2FUI5FQU;$E7:U-I:3A63D)51E)W2W$V3#AI8FDV<TQA,3AW
M96%,<E8S:6MT;G5,>"8C>$$[-'8X05-*4F%N54]).5-E5S5+="]U4T%6>#A3
M96U/3D=O>7%T4R]K=C5X86$S;FDO35A625IK<S5,4S9K5EIE53=S,7E9-5=*
M=4YJ1R8C>$$[3&Q1;R]W06UO24I(1E9-9DQ8-5HK8W1+,4LT93DX-39H<61P
M3'!R5W-5:W-S=DYB=&Q#3&-E:3=Y>#%J6&M147<U9D1Y57-P9#%61R8C>$$[
M8CAN9%IV9$]U.5 Q6'IF95@Y=&5I1EI96FMA84I69W5,4V1!:U8Q3F-P=#E6
M;%=S9V-S2F8S:&9J.%-Q5U=8+T%$:B]!2&QP171O=B8C>$$[;75E-# R,3%'
M3%5T37-,<4(W:4=%4F974UE84U,T6EA753-1.5AI<6-G=31Q95%68C%N.&DO
M3D8Y9C9S.7(U.79R3%1.5FQU-41P8R8C>$$[8V,T:&DK=3-$>G5&5T\W:6IB
M85%O96%';THR0G!X5E1/-R]+4'I,3$8V1G8U-3%+,'15;79P3&5+1G P.4]/
M-6E23%=%36QY:$M7:B8C>$$[>&@Q0C)B8U5!3%966E(U0SAQ-G@U83!M87@Q
M6%AR:GI$4$I-2E5V3'9N-FE)25EO=E0O95-Z;6Y+2FXV.5=0>DMR2F-69&ER
M<U91,28C>$$[;G%7;EAS56,Q;&11,TU-=E P<$E:1FM6=E1B:2]%<5-$>&)9
M*T)X5E=N;F=G:6%A95)9;VLS95)Y1E5$,THR>%9$46$S;S%X9799=R8C>$$[
M6#ET3&5X,3E3,5-61VQ8:5-R8VM"-4-H56<W9'-64FU+=7A6,DMU>%8R2W5X
M5C)+=7A6,DMU>%8R2W5X5C)+;UEA;'!X;G5B8UA52B8C>$$[;G,Q5G)U25-,
M>FA6=U-H:U=T541!5D9E=4MO;D95=FPX>&58-'!);W!D5'1)-5HO-VU.<#0Q
M6CDR6#115W$R-DU.=D$K1TMP:&ER<R8C>$$[5F1I<G-69&ER<U9D:7)S5F1I
M<G-69&ER<U9D:7)!=%,X:69K+V)8,$5.+T1:,F0W1D9'64E7=DAT-5!4-71'
M:D)"2VA02U)Y3U90:28C>$$[63<Q3TMO=40X;W9),74Y-EE,2C0T-RLP:G-:
M-'96:V-E;$5Y<W!6;DQ/1"LW5#EQ;G=J8G)65D8V0BM7=FMZ>2]F3&4V4%E'
M,6Y8=B8C>$$[-C P9TI#3D=P<$LW.45D:'0T+TQ&5U0T<3=&6%EQ-T9867$W
M1EA9<3=&6%EQ-T9867$W1E=M6E95<WA#<6]Q>DA9041U8U99<'$O;"8C>$$[
M-SAU3E-U3&DO=T)35WIK;G50549X8TYC8T,Q26I:3T=:6%@W0T]5<"MY>'%+
M3G9I<6AB9FQ4-4)&,W R<5=.;U5K<W Q=F)75DQI5R8C>$$[5DA926]5;C%'
M:U5R.$--0W1$.$DS<%=Q<E50-4\O;#=$8R]7;SE.6F)R:S=E=#8X+W=$=7=%
M3T]04&A1<650,F5N=G9J87,P>%8R2R8C>$$[=7A6,DMU>%8R2W5X5C)+=7A6
M3'1A,5,W,#A76G1R0UA51&,S2U%3>'<Q-5)O-$I-=30T55=M+TYL2'979TMR
M13 O36)Z24QI*W1:=B8C>$$[2TXR='AA>G)&8FA437E8169*;&ML:F8V=4)X
M53A!=EDX=U=+04U15E1J>6@U<3%N6$QI+VHQ1%%B:E)K=$)#64IP+U4T>BMQ
M<D9U2"8C>$$[<5)11VDX4C<W+T5%4'<T1EI,:7%2-GHU23AR-GIQ4S9L<59L
M-CDV:TET;&TY5U90,TE9=G<T;S9R46QM1&)B9VQ4<V%9<6UL;T%*<B8C>$$[
M<T%52')!,$AI66M*>%9%67$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T98
M67%O6#EH86%H63-&:F520V$P=6\R:&YI86]$230T<R8C>$$[2VEH-DAT:7)X
M-U9T3CAS1#$Q9CAV=%1V:DA*8TE04V4V2E95=5DQ5597:FIM1E=64G923FQ0
M1W1#:#94;W-B:5!2:&(R:C9D8DQP-B8C>$$[8TQE4W!K:E5"2S(X;G%$,4MR
M5F1Z43EA-VY!;% X5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9F3FYM8GIF
M63)(;5!6,4UM<3-L-"8C>$$[=#=-2&=K=D=T<E=*:$DS3TY%:$QS5E9T:#A9
M,D=D2F<P,E-E3U P4D9$*T=Z.7)Z=696-#14;#EC:F8X-F@X2V5N*V)B2S5(
M;$YT828C>$$[;#AY6&UH,DQA9F%2=6)54WEL2DAN4B]5,FM$+T%,9G!J9U9A
M:"M*;4=W,%5C37 U3T-03WDW>65A34EC8W1G>')Y=F-N>DYR1GAB5R8C>$$[
M4&YQ*VMV<FAP3'AR9%EB=4]+2E,V<WE28W Q2$9F,E%25%EF0T8U<3EU9E):
M355E2U$R87-'='A:6F--5%IE:65A8DQZ-V,S.7$S;"8C>$$[,U5,5WES16I9
M6%-43'EK955U=D5G;4]58U952%E52G%2=%5/;4<U86579V8Q<GIK468S=W!1
M53(Y2T]N8S1Q:6-69&ER<U9D:7)S5B8C>$$[9&ER<U9D:7)S5F1I<G-69E K
M=69M.35A,6I73$162C=,5DE*9%!+1TM',W5956EF:$UK+S=W1TYM87)204@T
M=6YV=FTW+VM79C@T3R8C>$$[;2]L<D@O3DPR5'E:-7!G.#!A0D1R145$5S!C
M>D]G:6-H;4AP<U8V:C5:<DY49T]+9D-48G-T4&Y'5T%M3W%E6FIT-T@W,SAW
M9DID:R8C>$$[06)R5C1)-BMP>$934V93;3E"-D%!,7!+3T]+<&IB,S%P95A&
M;F-7,'%Y4EA&<3@P3$19=$<U:4MT43<P3F-64BM+=7A6,DMU>%8R2R8C>$$[
M=7A6,DMU>%8R2W5X5C)+=FM$>GHO=T%P=#5G+S=A5C4O=T%N,WIT3DPO9%$O
M<6HW;FET6"]E>B]!2W@K.3<Q*UI8+VML<"\K65=W+R8C>$$[-5!16GHR:"]X
M;V4K6#-&-E!T1"]!0EDO1#=W.'HO-7@O=T0K53AB+T%*9W!V*TI*;3 W6"]U
M9FE(5F1J9C-X+W$O<65Z*UIV3BMU828C>$$[4G)-5FA:95AB;E9B85,S5V1R
M,D@Q94-/6F5(<$AJ1$EV27)U4&HO,75++TAN35!4<VAT1T146&Q+-U1!1V])
M-E)2*T]+;VY&6%EQ-R8C>$$[1EA9<3=&6%EQ-T9867$W1EA9<3=&6'A*;F1V
M0E!P>CAJ4#A!>5A6;"]W05IR:B]K-C)C<C)R+V9N-%!7.6PO,T5F:CDW4#A!
M3F,W0B8C>$$[2T@X;BM5,U9L:S!A>&M6>7A:6'0T;49864\Q059)2$HQ1$=N
M5G0K=4MO>4]#0S-U8E<S=#0Q:&=H=#5)-&]O=T92155X0E964G-!0B8C>$$[
M<T%-5E)E2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMV:T1Z>B]Y;3-M1"]!
M3&%6-2]Y9F9/,#!V.3%$*W%0=65+,68Y-U K<V9V928C>$$[.69M5B]W0U-7
M;B\U:&)$+T%*4%%:>C)H+W=!84AV;#EX96HW42]X62]$-W<X>B\U>"\X02M5
M.&(O;4-M+W=#2DIM,#=8+W5F:4A69"8C>$$[:F8S>"]Q+W%F460U<C)H,DYY
M3&$Y,4<Q=&)L;%8Q9VUM:FIC;S<K;7)"5TE.1V8T469(8D]996Y6<F(K+W4O
M*TUO+S5.4C1Q:4U69"8C>$$[:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69D5M
M9#(X12MN4'E-+W=$2F176"]!0FUU4"M4<EIY=F%V.2MF9SEB,E@O8U(K4#-S
M+W=!,28C>$$[>G-'0C-8-5%A4&-O-E,V=G%I<7I3<U!4;E)!4%=M5V1Q<4DK
M2#(Q,F]O,E!J=FAT5U971VY2865D4',T;FMK4S!S,G0P959Q<WEX*R8C>$$[
M:V]:<6-6-4=M-4%W2VU72W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMV:T1Z
M>B]Y;3-M1"]T<%AN+THY.#=44R]W0C%$*W%0=65+,28C>$$[9CDW4"MS9G9E
M.69M5B\U2F%F.$$U:&)$+VLY0FY084@O1V@W-69C6&\K,% X5U!W*SA032]W
M1&Y(+SA!-51X=BM92V(O:5-:=$\Q+R8C>$$[-VXT:#%863,Y.&8V=C9N=75S
M*U-F3$]T86EM;S9N84<T=30T=G$V4#8P>4%28VEX6&=J<6YX5DEB8C1H.$IQ
M3G,U:#9D33=215=A."8C>$$[-'%&<DU#84-L4UEO-FY&551I<G-69&ER<U9D
M:7)S5F1I<G-69&ER<U9D:7(T:WIU,V=N,#4K4FXO:W5R3"]J3F-F.$%*,7,U
M6'18*R8C>$$[+U!W970W3"]!3&E0>"LY;BMA-3)$05HO269N<5I:5DAN865!
M1FY-4FIT>69H95-/46-U57AA<3A86%IU:#)P,$I6;&QH85A.<610="8C>$$[
M-VDV83=N9W,R:6UN64)F5F104T13:V9%=TQ%5BLP8T-P;&ER<U9D:7)S5F1I
M<G-69&ER<U9D:7)S5F1I<C5!.#@O.$%+8F594"LR;"8C>$$[968X04HY.#=4
M4R\S55 V;RLU-')6+S-S+W=#<V9V93EF;58O-4IA9B]M1G-0*U0P1V,Y;V8X
M84AV;#EX96HW42]W05=0=RLX4$TO*R8C>$$[8V8X02]L4$<O=T-92V(O:5-:
M=$\Q+S=N-&@Q6%DS.3AF-G8V;G0S;694+T]T>&0R.&YL-U5O8D]!259U65HQ
M56=T>E5Q>6MX4VXW3B8C>$$[95%R=4YH>$HU:FU(<#!Y;#%#,3 R1%5R-U5*
M,&AT24I!.'-Z06A65#!O*W9805-!3%HT.&-P>459:7E735=N-6YE5# Q1R]L
M=69-="8C>$$[<DI:4VU,-FIB:G)%1E-K:$I%84@T,S=&;39D9#9#2&EX8S<K
M4TY6+TUK>E,S=4EB;3-I=4E(16M%>4Q*1DE/:DDT<7!(>D)Y64YU0B8C>$$[
M2TII4T1Z1$1,,SAZ4$M0-E=S,FDX>5=S3FQ"-G=V-V,W;5)I07-9,VI*2$9Q
M;6]C949$6&%(:7AC.&1K-FLO=T9L5VHV,W!7<S)1=B8C>$$[9$QU574W47-5
M13!D95!*96\S<#!Y8UI!.&Y$>EE*-'!C37A24G5&<61I<G-69&EQ03$W5S=(
M43E)=4Y6=GEW=$Q50G!39S5.4FU#:28C>$$[9RMB6EII>$A*25)(37--;5%1
M:5I(:TAN3G(K9&9K,DA78BLY;#%+.&UT3'!)171R03)X0S(W4D(O55I7-6UV
M<3AX6%ED37HO04]38R8C>$$[,VPX,T$O;%A",R]9.5)T8FE/-71O8FU+=G!4
M;W-I5C)01GAY1F9V>E=Y1D=N66<R2'A2;F100G9P>CAJ4"]*9%=8+T=A-"\U
M3W1N2R8C>$$[.7$O,S4K1#%V6F8Y>$@T+V5Z+TYC-T)H;7-A.2M:8V-J<G!0
M;'5#-$5:;%5V2F-O;UER3T)%>6-M:G%(='IZ.6UQ3S(U5FM.:$QQ128C>$$[
M<# K4R]G5S-U,W,R839H5G580UDK:UA1535!:%0S-4A!<5I9<7=V.'E.6'9D
M3U14,G1V3558;#E:1$M(95I9,D5P051J45-7.7HY:28C>$$[<$]X6'<W,5=-
M<&=C,TEW851,;79W-#A627)Y1G(W875M<DTR<C(K<G!(974Q;3%V=5ER4U%$
M,%DU85)11&XX3$AO9CE9-'AM1'E8528C>$$[851,:')X26U.<W%Y5&IU>%8R
M2W5X5C)+=7A6,DMU>%8X9V5E9BM5,CAW9CET2S@O-5!V;F%A6"LV:"]62#-0
M1F%V.$%V6B\Q:CDW,R8C>$$[<CAY=B]*3%0O=T1-3%EF.&YO334W42\T,%!F
M3#=I.4@R:"]I>"M(,V@U;B]!330O+W=$2V5.+WI"5&8X4U1.<#)V.$$S4'A$
M<75X=B8C>$$[-S0O,68Q4&4O34=S,RMM9F\S-FYP<W5P9EAB,D<P=5!3-40P
M27!A.')H*TM39D-L3R]%94Q$3UEE;E-F>C=A6&5O955V34=N5V1V3"8C>$$[
M3F584SAB94Y9,RM-.%EX<WA(2#EK.3AH:T9X8S-S-TQ(2'%)4VMA:4,K9'8K
M5E5F;4HO,5ER;B]!25@O04IQ>6IG3#-8.'0V5"MF.28C>$$[:"]5*VXO3'-V
M,5AY+W!L<F-25$I00F%14E-P-DUP-'5K87%W<49),DEZ26=+0690=%1)4WE3
M235'4BLY.'I8;C579FU&2F1Z=6UH,R8C>$$[0E(U1UI44F1W5TI(-U=9=V=A
M-5!F62LR=$M)9V-F5'50-FYU6#5/-F)Q3V<K5$DY4#%A,&UT8G=817)M27AU
M>#1S4E$Q44U0>'DO1B8C>$$[16=B=DDY=&%M1V)51U5$8V%$261D=E5V3%,U
M,# R97 K;$]N03-6:W!I8U8S<6IL:UE%931P.'AK-V1F1$5*0WI+23DY+W%2
M='!R228C>$$[=4-W:W-R=3(T,&]:;U0X5F9$,'DO=T-/25)K>&E02U%L-W(O
M045G3C-E<TQB:%1(6C-D>GER55%W;C1A95!Q8U!W=VQ'3T%L>FM)*R8C>$$[
M*R\P06]$4TY15S%8-G-,2%9#:VLP<WAM=6M%;D%Z4TY)5G%'6G5#;'%+2T=G
M=U=Z;&AI0F9(12\V8B]I540K6DU&>G$S:VI63D\P*R8C>$$[,VUN=DQH145-
M26EK57-22VI(9&Q!-D1X>DPP5U%1>7AL3&M(6#9U0FYI;$5C>4AZ,R]Y<7HX
M=V8K<DAC+V-V.6,V5"M58T@X-S<S;28C>$$[9C5->B]W03,W4BMT.5!A4$]S
M1VM7344P8WEY>%<X4U-,-DUP;WEO05)S=FIN2UI$8VE2,W97>$9!4&U(+VQ6
M;C5G+SE73S4K-68V-28C>$$[,68X04M/1"MD.3=Y6#AM6B]W0V(Y;R]7.38O
M2U!4=%$P9GE:86%:<61T3&$S<5-433!4;S)W85%S2W-!5C-(=FY09&]:635-
M<&Q%,B8C>$$[3FYO=7HX57-E15)K2T\O,W,S>D-C,41A;F1Y5V5M,U8S1F)V
M9%-7.%1Y<&)206PU0VEL9VEG06UR56]+1$952F$V:3@X96XS<SER4"8C>$$[
M8DY084=74S-A2U)N:6%4,#(Y3C9,54U+155)0CES5E$Q:C953W,V:'%$6$8Y
M2W0X259I=$AH=E!2:$538U-55G<P86QZ=7A65BLK<"8C>$$[27100W=,.#EF
M3#)U95I,5%-%,%-W;G9(='!*,FY#;WEC439O1BLS>#8X5&Q75TI*1#!(64=T
M>%E*5$]1.$YG9#=V>4LX=F$U-6)T3B8C>$$[6%17-T-E>F4U:V=A04UJ4'E#
M2S1B-TA,<'E'3TM*0DLY=C8S1FYL031Z>%5$,W!T<C%P<G0S-6]J,4<Q=F1A
M=$Q',VYT;F%W=#=E428C>$$[=WEP8DUX9&0W:%8T>F-H6#DS,$<T3U1-+TEU
M:T=%15AX4BLS.51/;#%'16]'36,V,4%*57=3,49E>&]P>6)65S9$,&=R6E<X
M:T5K,28C>$$[,61&-34U;&ML:'5#5E-A5G!&:G$T63!J1&-2=C!(8D9A65HU
M.3AQ=S8W<G$S+S%,55I85S!7,5-A,F%/1E9(<4=3;T5T=$LS3E-F:"8C>$$[
M2E!W.59!66-S0DIC<D1H>%-J8W X2C=Q=&Q(:RLS='1(.',R1VU*8C-50S)K
M6FI72UI:2G!!07AP>619,%5K.61G04]M14Y'5T59>28C>$$[<4HT:#,X:W4P
M4%-T5G-F360S<60S<D8Y93)6>3EY,$]N4&(S46II1G<X8DE!6&QL5VM1:DE7
M:40W4G!18EE72FHU<#=R8W=U.4IV3"8C>$$[2T-A-7,U-W5#5T='.&AT-VAN
M:&520V]K6&=Q;FMH3E)U35%'3'1%;49P<$YN6E1Z6$XU4&%14E%Z6&LQ=F-+
M.'IX;T9-:F,Q63AN228C>$$[<61Z:5%R-30X,F9L>C4T=F9.3W,S=')O,7A,
M8EA..6-Z45-!06-O-4IM6E=O4T1U1#-Z<#E0<CA-8V-16F)I23<K-35B561N
M-7!:2B8C>$$[15(R36HQ2&4Y93@X-F1Q1V\O;&1,;S%L87I486LQ=EIO='5)
M,T(U4E-X330U34%U=U$Y.# R;'EX:G%/26XP,F8P=3@Q;4M5.$)J128C>$$[
M97)B-W=W6#AN4$IV;6Y19DXW6#)R85I083)N,5=74#%3;DEC;5I30E)/4C=:
M<T\P=%AI>5EQ:6).=74W33!E6$AK=5%O5C5094TP1"8C>$$[=FML.#5Z-DA&
M-5@Q1F1D;64S,'%E23(Y,4Q%<G4T5V8Y,3A+;W-J5BM,*U4T<3AD=')F.&MR
M5SA7+S!Z>DYQ9&]557!:4$-K<%-,,28C>$$[03E5:2]W0D=--%E,,6)L>7!1
M8W0X2W95<GIY+V](;F9Y;G!S3C%,8WHR1DDW:4=9:WA43DEK8E)Q.&Q15'E"
M8FQ4*UEB,4=X0V]#>B8C>$$[+TM84S=(5F].5G,Y6#%/2S=H97)T-G-62DDO
M6&$T84IU36%K4G,W9D5I:TM2,4)/*TYQ:2]+=C58*U=F3$TX33%H-C!S;',Y
M>DIB="8C>$$[8T=.>D=B=%EK8TM1:7-!0D(X3R\W5&5/2W-4.#,O.$%+;S5V
M348O939L<6PU838U1$Q(8WIM0512=7=S=CE(16-*84EX=6]D1S5C1"8C>$$[
M>7%'4$E!8D95>2]+=3<X:U<Q-6,V4C59,3(X,5=&;T9N4S!U5EI9;T5J235'
M3W-50VAP1&-Q5V]+;CER9D955G)(-4LK53E5=7)Q-"8C>$$[;'5,,D9R-C5.
M-65,1DQ'1FML3'4Q5'IJ8W%!2D])-&MB060Y.$9Q:5I0>7(P:35U3D]N=CE1
M=G)X.4IV1&4R2'%32GA13C968F9H=R8C>$$[-&E(.7=V=TE&1S5P4W5+<2]M
M0TAY6C58.&A(4CE7=4=S3D%E139D-G%)5VM0<DMW3S!-8F9',WA-5S1D9#A6
M96%3<"M4:TUR,TYL-28C>$$[;#%E>'59<' U3$UW<DM(5G!F5&IK5S,U5R].
M9'=%-6-G,U=R1F-+=E=V369L8E)F3BMI5S%P<413=EIH:W5O;6IB,#),96MY
M;WAQ1"8C>$$[,#E4;%1X07)55D)#<%!P4#55-EIP3W%$57)$5G124S5A-%=E
M-353>#A:;%9Y+V]V=VIJ4'!N;'5T861+.49O8E9%*U50>78X<RM63"8C>$$[
M<C8Q<'9R4$U"37%03UDS2W)/66EY<7=25S1R-E!W-S=C;3AC0W-U>%8R2W-D
M."].-5E0;'%E,SAY>7E2851C<VEZ*VMS<G-W:5 Q9R8C>$$[<BLU5C-#.%E4
M>4E'>3$S2%A&6&QJ3"M4.79D47E7,VUZ53=E-W0P5U=Z=6M$349784]/0VMF
M0S,K1F=S87$Q2TY7;UDO84%+=E%T6"8C>$$[.&IE5W9/;W-V34UK.3-&3&-7
M2TIA6$5$<D=Y,CAY3S)Y=6IG331N,TI&4E%5<'952W(K5E!Y-S O=T%S-FEB
M;7AV3&E7,RMQ+U96="8C>$$[<'5",V%9>E!)>F]Q8S)*3D)58D1A=$])5E9+
M1B])-WEN1S!"9W5R*TI,9"]7:FE%:U1X;5EH2WE/<VM4.&E7:D1%2#1E;W!1
M,'<R<28C>$$[:C4S,'8X=61,.'1A3C5F.#(V:F-X,FQS5V5X;$-Y<S=01W!J
M1$\X36-G2$0Q9U)Y-FYR>3-X5FHS;%,X+TLW4717:FPP;GI*<6ML>B8C>$$[
M9%1),#%T2D4U130U<VE&,FIT-&@V93590FUP5'1V=7%Z6%@O04UP4$Q7=#9L
M9&%J8UA&-T)C,VI/,7EB95961&@T56<T55I'*T5,2"8C>$$[6&)V,7%.<T9Q
M:71'+TPS5#E/.',V;#5D93AN=6),57965U)J=U(P:FMJ15%63TLX45)';T=W
M<%AO;S99<6MT>BM2,VQI4U5Y=S,K;R8C>$$[44U(:V5*0DI%-E)I5VY.541X
M37=&1G!8;'DX4U)H=%50*UE-6#5:6'9M2VUV-G!D5T=S4C)Z5VMB44Q)1D59
M:F%74D59=WE1<S=,8R8C>$$[2V%63&9903-/-G%Z.'5T4CAG,BMS9V58=&$Q
M0SA/<WE4,7-R;4]14F9794EU2FY:>D9%<E-):V1+;&U.1#%O4FEQ35 U1RM5
M,#E%5R8C>$$[.3-F47)!-6UJ:3E32C1Z35%L6DA6-'IY<3!967%4>#9I;$14
M1S%45S@O3$Q23E(X<C9B-64Q4V4T=7)F5$=-:U5W65)U6D-R<7)(6B8C>$$[
M=&LY4W%J,D9A-S%#;U124'EH,$Q2=%1T.5)T8BLK:W5)6E9M8C$S:6-/541!
M2V5-8558-'IS3G9U5VAT5V191F5+9FUD*V-(;3-Y,28C>$$[-7=U=$DP-6)5
M,FM+4DUH;&I:;G)*1T=.4TA8=6-X-35#0U$Y6#)6,DQH>C1"3V9&6G9K57$X
M=2]N,7(Y,6,S2V$S9#)L:$%L=$LY<B8C>$$[271T2R]/-4%!:6I01#%31DI.
M5TY/9S8Q=V5)93EY9%0W4%DT9V5'2E-014PS2$QR,TUK8C@T3DUI,4HT6E!.
M5G1*6E-W3SA%.&5N6"8C>$$[1EE*:7EE:VMU-V5Q3T1S5S1H3C%P.$I/2&I0
M931!-T9M65=-4C1G9C4T,T<Y,3-F8GHV<$8U<R]09E5R5SAI+W<Q9C(K;U=K
M:59K5R8C>$$[93!K:FMI8T=N17-745!Y*S!#1D<S=F=/475:;R]:*T5O;GAO
M;4UV2U$S+U5G9$(O4&IZ>&9A>&%7:S8R9G!44T)8-'=S1%0R4%!);B8C>$$[
M3$E"=7HK>C)N:D%K8UAZ+T%'37<O=T-6;2M:4#5B9B]!2D9N+VUR2R]W07A*
M>'8U17=F,'9M>4,Q+TU'>6)4635,:3E68C@X96-):28C>$$[8TM$6#1T=VHP
M1D\T2CAA2#=/5VI0='HS9&1K-TEK2FM2:C9/*W@K<V9O+U-U:3@O5T%T1VMM
M,49(=5-F9V=J:&M!04PP2$HR5'-N5R8C>$$[9RM8:&E-*S-.6F1K>C1Q15!4
M,S)/-W5V=E-#8CAZ9&8Y850P4D0V4$DK;GE1.'5.9'$P8G)42W9Z16Y94C=%
M=S!,=2]E:VYM<C@T=B8C>$$[3C)M5W1L3&),83AR:#4Q:S5X35)335)&869'
M4#DK2$XU,E!P-#9J:30O-&$U961V2BLP,RM"4V=-6#A13C,U5C=M3R\Y1$%E
M9E U8B8C>$$[3"]K4S,O3F5B<BM335!N.#-L+S5:>F0P9G@X5V%19FYD<$QA
M25I*3E,T-G=,45 V3%%/<U)U+U1*2T1J1$PX2$UQ=3=$=G8P>D)06B8C>$$[
M8W50;#9B-RMN>F1H2'142'=75#9Q-VIZ*U1&.50O4&9Z6F)V0VQL9%=6-D1(
M5S1K1G)*1W%Y:#)5<6Y.=WI,>$-S1TE(6&-!-UIL=R8C>$$[-TIX;3="2'AC
M4$HR=FM&8TII9'4T.#!(+W="1$%E9E U8DPO04I%="]W03$U4#A!:VI$-2].
M<B]!2EIZ9#!F>#A8,%IA4W1,85%Y="8C>$$[5&Q*1W).5'!69T-C-6U1;W94
M1&MQ-$5S42].5'I6<6YL9GEM*W$V64EZ9$Q01D="37!D94QK,3)"6$LX:VE"
M<S=0<VY343%'8F=N9"8C>$$[5654>&HO;UE8>CDO2EDO.&E7+S9Q6E8T:VYQ
M9CE$96TO<&90.6I.3%0X-#=A-3 V3U-8>DYA5TXT=')$3&-+.6AC5$M,:&DT
M;6A65B8C>$$[.4]V1W-D1T1.*S$Q1S101V4Y,54K>$1'6D%X>6Q(:4YE=4DR
M-DAR-3DS4E4O=T-6,#9/,FMR2U!-36-7<'9A;S-O1W=M9$DW;TIY:R8C>$$[
M5FE!;DI'8C1&-&XT859*24]Z-&AR;7@O:U!*>#$T9F\T=C4T-610,6XY1$(O
M=T1O65AZ.2]*62\X:5<O-G%94$5K-V8O43-P=C98>B8C>$$[+UEZ6'ET*V$S
M;6I5+TMS,G%82S(S,6Q,-S9S=D-.9W9P*VE(-F-J=EA)>7I3061F;3=&=WAZ
M.$$T<31,-2MD2FAA9FU8<FI854LS2B8C>$$[9U,S6C%%>G)',5%H4'A%8FYO
M4&))1%53=$=4<U1%26YH=FER8F108G)Z.7 T5GAA-F=H66-3:E!&2U)4<2MW
M:497-T%603<X=7=S3R8C>$$[9G5,9UDK>5HW8U5$.'@K=CEF=39Q1C4K66-%
M54UN,6$W5S5L-'59>C944FIK1TE11E=8=4M(-UAJ,$]X0GHY>&)-9EDU2DA&
M2&A',R8C>$$[5R]F*TM34"]!2E=B-6LO;'0O.$%K5V8K87-R+T%$16Y/+VM4
M0B]3*V%2*V10>FTX-&%0<E,R9&UT<C9*=&)78S@T;5DX-6]%:V9F;28C>$$[
M3G548EHQ4%HO6BM03FA%-5A:9E!/,3EB4%0V:5=/1F--5#%3;E1V>CDX-%!Q
M1G-L.#%P1EI.2VDS57%135=727-!-TM/5&)H83EJ;28C>$$[6%!S:D9W;7)V
M,W5V>#ES6D1)8UA$5C<W370Q4#@W.4EB5&(R5%-T4C18<UE1,E5D-44U.5-Q
M4G-W6EEO3U!)1G!%,VM!<4)V43%Z1"8C>$$[:#)83&E(14YU=&8R*S=O-3 K
M,6-F0V5%-SE,0B]6*VQI5V]F;C,U>&EV<FE+>6QS-VUZ4U)L=#=H<F0T>3A9
M4'=S54PO1%5D<WI)9"8C>$$[:S1I0F1G*SEW<VYA*U%326IW:V4T+W)44'E8
M*V10;DA74$Y7;6%894QA+U9R=619-65%5$LS13$V2&UC<3%86FU+1T]5:&1G
M3G5K-R8C>$$[5'DU36=I86]V9',U.3,W<U9D:7%J8W!E35DO<3!Q4F=.5UAM
M:&5Q,#9#:DQ49D96=D154#DO4F8X:6TO-G%9<3=H<4@K+V]V*U)49B8C>$$[
M.59-5E=#4S1-85-I-W1Z1DIX0U V6C1T>4Y&;V96,W)88D96+T154#DO4F8X
M:6TO-G%9<3=H<4@K+V]V*U)49CE6359D=S%$+V8P6"8C>$$[+TEP=BMQ;4MR
M6$XU1W9+4S1G4F%G5F%.9TMS84%B>61Y85EQ=31A:"]V-DPO:U4S+U941EAC
M3E$O=T(O4F8X04EP=BMQ;4MT96YQ4"8C>$$[<7AK>GAE:T-F5E5234-W<#!"
M3&UM*TMO;D9867$W1EA9<3 T8V]W46A8;V5,34MG2'1506EV,S1Q:&]O.55%
M4T-3949P06\U<TEM;R8C>$$[5W!U9C=Z1E8S1%50.2]29CAI;2\V<5EQ=$IV
M0DE)>F-196]15T-E;3%305%#865P,$92:7)K3C0T2E,T9UE!;%-6:EDP2VUH
M1S!N528C>$$[2$96,T154#DO4F8X:6TO-G%9<3=H<4@K+V]V*U)49CE63597
M;V)Y4F559'A!-C%)<7-B1595,$DR:S=%57A69'<Q1"]!2#E&+W=!:28C>$$[
M;2\V<5EQ-VAQ2"LO;W8X06M5,R]!1E5X5F$U=DDQ-5-814-,54-R4G-"5FI1
M1&54=5141E8S1%50.2]29CAI;2]W0W%M2W)*;W16328C>$$[6D56>$-R,49#
M65=)<%56+S-:-%EQ:7A7;2]81EA9<3=&6%EQ-T9867$X2"]!1%(O-59N+T%)
M-74O=T)/+W W.4DX<F8Q4'%0,68V<"8C>$$[>3E+4&AW.51E=D-N3$-Q;&]F
M.$%Y<3<Y3#9$.50O5&YQ9G!69C!F>BMP96HV.6)';G%C9"]4<#90*U8Y<CEQ
M;4MP9$PO=T%Q6BMP5"8C>$$[*VXK;B]3-'AE:#98;V,V.#4O5#E#=3EA8R]T
M8F-C54TP=68K5E!F5D<U5BMO+W!(5'95*W(K;G@Y5#E(+W=#:&,O4B]E96IX
M<C$O,R8C>$$[6GDO6C59<%EB<% O04-Q:C9X8V95=CA!15!R,2]E8U!Q3F%C
M4EAH-F8W6#)E5E!J-C$R.51&0THX,2\X<6%Q9G)8-EHK=&97<B\V.28C>$$[
M.5<Y1#%06"M#=G%E<CA(5&HV6&\O=T-Z>%-L6&U(+VQ6,S9.8C9N*VU0<FYO
M-F(O04@O,6)J-EAO4BMN6"]I,S!0<SAF:7(Y;CDS>B8C>$$[>%$K;&\O5#E.
M9E-P-F1"=S0P-#AA8E5P,G=*6%EQ-T9867$W1EA9<3=&6%EQ>%0X,% P4B]G
M>3<O4S,Q,S9N-G1V.$$X8WIH.6(Y5"8C>$$[,3 Y3#!U9G<Q.51J:7)X4S,O
M-55X*VHW1#!0.%%E;CE9=793-"]5+U8U9E9O4%4U+W1C3T9/3D\O2W4Q34MS
M:W-0.$%L55@K1W1--28C>$$[+W!,-G(Y4C%B.4<K<C90<CAF4E0V-5@P4&@Y
M6#!U6$0Q3G%6+W=!:D969GE4+V=(-B]B+T%+12]4=G$O5V1-.51L.5=P6# O
M,TAQ*R8C>$$[;CAF;SAF-WEN=RM',DMP9'!F.$%Y<6XY1C8Q.5(O5% Q4#9R
M82]73V8Q5&@V6#912'!C4%<O9# Y6#=8<F9"-F5+;U)0*U9/+UA6<"8C>$$[
M*VYE9&17-BMJ=S1F5GHV,69B:%AH*S%8*SDR>%9(*V9F*U99+W=#3$Y5+U-0
M-F,K=65T6BMV.$%59G%V,6%V;TXV4&\K<'9X-&1E.28C>$$[9G,Y.%93:3@O
M=T-62F962G98+U-T4')-4$-N,40Q3U!P5%4Y3VXW1E W,VPX9E!H>BM,1E5W
M.#4O=T1+;F9R33,Q>CE-9EA0<G5O+R8C>$$[6"]Q=F\X+W)&535C+U@K1VQ/
M4'!E;"]S.%932%@O.$%L5716*W%F<&8Y26953%!J.5HK<BMN-E!P46-+,"]E
M970V5D]01&)L+W=!5B8C>$$[-'$K;30O5#E.9E-P-F1"=S0P-#AA8E5P,G=+
M=7A6+R\R43T]/"]X;7!'26UG.FEM86=E/@H@(" @(" @(" @(" @(" \+W)D
M9CIL:3X*(" @(" @(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \+WAM<#I4
M:'5M8FYA:6QS/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D
M9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z
M<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(CX*(" @(" @(" @
M/'!D9CI0<F]D=6-E<CY!9&]B92!01$8@;&EB<F%R>2 Q,"XP,3PO<&1F.E!R
M;V1U8V5R/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$
M97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z9&,]
M(FAT=' Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O(CX*(" @(" @(" @
M/&1C.F9O<FUA=#YA<'!L:6-A=&EO;B]P;W-T<V-R:7!T/"]D8SIF;W)M870^
M"B @(" @(" @(#QD8SIC<F5A=&]R/@H@(" @(" @(" @(" \<F1F.E-E<3X*
M(" @(" @(" @(" @(" @/')D9CIL:3Y3<&5N=&$@07)N;VQD/"]R9&8Z;&D^
M"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]D8SIC<F5A=&]R
M/@H@(" @(" @(" \9&,Z=&ET;&4^"B @(" @(" @(" @(#QR9&8Z06QT/@H@
M(" @(" @(" @(" @(" \<F1F.FQI('AM;#IL86YG/2)X+61E9F%U;'0B/E-,
M,# W/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D%L=#X*(" @(" @(" @
M/"]D8SIT:71L93X*(" @(" @(" @/&1C.F1E<V-R:7!T:6]N/@H@(" @(" @
M(" @(" \<F1F.D%L=#X*(" @(" @(" @(" @(" @/')D9CIL:2!X;6PZ;&%N
M9STB>"UR97!A:7(B/D9I;&4@3F%M93H@(" @(" @(" @(" @("!33# P-RYA
M:28C>$$[57-E<FYA;64Z(" @(" @(" @(" @("!R<C$W-C,V,B8C>$$[3&]C
M86P@5&EM93H@(" @(" @(" @(" @,C M2G5N+3(P,C @,3(Z,38Z,3@F(WA!
M.T535"!4:6UE.B @(" @(" @(" @(" @,C M2G5N+3(P,C @,#(Z-#8Z,3@F
M(WA!.U-C<FEP="!697)S:6]N.B @(" @(" @(#(N-B8C>$$[26QL=7-T<F%T
M;W(@5F5R<VEO;CH@(" @,38N,"XP)B-X03M'<F%P:&EC('1Y<&4Z(" @(" @
M(" @($%R='=O<FLF(WA!.R8C>$$[XH"B(#@S(&)L86-K('1E>'0@8VAA<F%C
M=&5R<R!C:&%N9V5D('1O(&]V97)P<FEN="XF(WA!.R8C>$$[5&AE(&9O;&QO
M=VEN9R!F;VYT<R!A<F4@<')E<V5N="!I;B!T:&4@9&]C=6UE;G0Z)B-X03L@
M(" @(" @(" @2&5L=F5T:6-A+4)O;&0F(WA!.R8C>$$[5&AE(&9O;&QO=VEN
M9R!C;VQO<G,@87)E('!R97-E;G0@:6X@=&AE(&1O8W5M96YT.B8C>$$[(" @
M(" @(" @($)L86-K)B-X03L@(" @(" @(" @0TU92R8C>$$[)B-X03LM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TF
M(WA!.T9I;&4@3F%M93H@(" @(" @(" @(" @("!33# P-RYA:28C>$$[57-E
M<FYA;64Z(" @(" @(" @(" @("!R<C$W-C,V,B8C>$$[3&]C86P@5&EM93H@
M(" @(" @(" @(" @,C M2G5N+3(P,C @,3(Z,38Z,SDF(WA!.T535"!4:6UE
M.B @(" @(" @(" @(" @,C M2G5N+3(P,C @,#(Z-#8Z,SDF(WA!.U-C<FEP
M="!697)S:6]N.B @(" @(" @(#(N-B8C>$$[26QL=7-T<F%T;W(@5F5R<VEO
M;CH@(" @,38N,"XP)B-X03M'<F%P:&EC('1Y<&4Z(" @(" @(" @($)A<B!#
M:&%R="8C>$$[)B-X03LJ*BI4:&4@<')E9FQI9VAT(&-H96-K(&ES(&-O;7!L
M971E+B!0;&5A<V4@96YS=7)E(&UA;G5A;"!C:&5C:W,@87)E(&-O;7!L971E
M9"!P97(@<')O8V5S<RXJ*BHF(WA!.R8C>$$[5&AE(&9O;&QO=VEN9R!F;VYT
M<R!A<F4@<')E<V5N="!I;B!T:&4@9&]C=6UE;G0Z)B-X03L@(" @(" @(" @
M2&5L=F5T:6-A+4)O;&0F(WA!.R8C>$$[5&AE(&9O;&QO=VEN9R!C;VQO<G,@
M87)E('!R97-E;G0@:6X@=&AE(&1O8W5M96YT.B8C>$$[(" @(" @(" @($)L
M86-K)B-X03L@(" @(" @(" @0TU92R8C>$$[)B-X03LM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TF(WA!.SPO<F1F
M.FQI/@H@(" @(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z9&5S
M8W)I<'1I;VX^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F
M.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX
M;7!44&<](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]T+W!G+R(*(" @
M(" @(" @(" @>&UL;G,Z<W1$:6T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P
M+S$N,"]S5'EP92]$:6UE;G-I;VYS(R(*(" @(" @(" @(" @>&UL;G,Z<W1&
M;G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]&;VYT(R(*
M(" @(" @(" @(" @>&UL;G,Z>&UP1STB:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+V<O(CX*(" @(" @(" @/'AM<%109SI.4&%G97,^,3PO>&UP5%!G
M.DY086=E<SX*(" @(" @(" @/'AM<%109SI(87-6:7-I8FQE5')A;G-P87)E
M;F-Y/D9A;'-E/"]X;7!44&<Z2&%S5FES:6)L951R86YS<&%R96YC>3X*(" @
M(" @(" @/'AM<%109SI(87-6:7-I8FQE3W9E<G!R:6YT/E1R=64\+WAM<%10
M9SI(87-6:7-I8FQE3W9E<G!R:6YT/@H@(" @(" @(" \>&UP5%!G.DUA>%!A
M9V53:7IE(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M/'-T1&EM.G<^.38P+C P,# P,#PO<W1$:6TZ=SX*(" @(" @(" @(" @/'-T
M1&EM.F@^-30P+C P,# P,#PO<W1$:6TZ:#X*(" @(" @(" @(" @/'-T1&EM
M.G5N:70^4&]I;G1S/"]S=$1I;3IU;FET/@H@(" @(" @(" \+WAM<%109SI-
M87A086=E4VEZ93X*(" @(" @(" @/'AM<%109SI&;VYT<SX*(" @(" @(" @
M(" @/')D9CI"86<^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E
M5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N
M=$YA;64^2&5L=F5T:6-A+4)O;&0\+W-T1FYT.F9O;G1.86UE/@H@(" @(" @
M(" @(" @(" @(" \<W1&;G0Z9F]N=$9A;6EL>3Y(96QV971I8V$\+W-T1FYT
M.F9O;G1&86UI;'D^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1F%C
M93Y";VQD/"]S=$9N=#IF;VYT1F%C93X*(" @(" @(" @(" @(" @(" @/'-T
M1FYT.F9O;G14>7!E/E1Y<&4@,3PO<W1&;G0Z9F]N=%1Y<&4^"B @(" @(" @
M(" @(" @(" @(#QS=$9N=#IV97)S:6]N4W1R:6YG/C P,2XP,# \+W-T1FYT
M.G9E<G-I;VY3=')I;F<^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IC;VUP
M;W-I=&4^1F%L<V4\+W-T1FYT.F-O;7!O<VET93X*(" @(" @(" @(" @(" @
M(" @/'-T1FYT.F9O;G1&:6QE3F%M93Y(5D)?7U]?+E!&0CL@2%9"7U]?7RY0
M1DT\+W-T1FYT.F9O;G1&:6QE3F%M93X*(" @(" @(" @(" @(" @/"]R9&8Z
M;&D^"B @(" @(" @(" @(#PO<F1F.D)A9SX*(" @(" @(" @/"]X;7!44&<Z
M1F]N=',^"B @(" @(" @(#QX;7!44&<Z4&QA=&5.86UE<SX*(" @(" @(" @
M(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D^0WEA;CPO<F1F
M.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI/DUA9V5N=&$\+W)D9CIL:3X*
M(" @(" @(" @(" @(" @/')D9CIL:3Y996QL;W<\+W)D9CIL:3X*(" @(" @
M(" @(" @(" @/')D9CIL:3Y";&%C:SPO<F1F.FQI/@H@(" @(" @(" @(" \
M+W)D9CI397$^"B @(" @(" @(#PO>&UP5%!G.E!L871E3F%M97,^"B @(" @
M(" @(#QX;7!44&<Z4W=A=&-H1W)O=7!S/@H@(" @(" @(" @(" \<F1F.E-E
M<3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O
M=7)C92(^"B @(" @(" @(" @(" @(" @(#QX;7!'.F=R;W5P3F%M93Y$969A
M=6QT(%-W871C:"!'<F]U<#PO>&UP1SIG<F]U<$YA;64^"B @(" @(" @(" @
M(" @(" @(#QX;7!'.F=R;W5P5'EP93XP/"]X;7!'.F=R;W5P5'EP93X*(" @
M(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*
M(" @(" @(" @/"]X;7!44&<Z4W=A=&-H1W)O=7!S/@H@(" @(" \+W)D9CI$
M97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70]
M(B(*(" @(" @(" @(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B92YC
M;VTO>&%P+S$N,"]M;2\B"B @(" @(" @(" @('AM;&YS.G-T4F5F/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(@H@
M(" @(" @(" @("!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(CX*(" @(" @(" @/'AM<$U-
M.D1O8W5M96YT240^>&UP+F1I9#HS1#9#-D0P-$,R0C)%03$Q0D(R-CE%.44Y
M13DS.41#,CPO>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.DEN
M<W1A;F-E240^>&UP+FEI9#HS1#9#-D0P-$,R0C)%03$Q0D(R-CE%.44Y13DS
M.41#,CPO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @/'AM<$U-.D]R:6=I
M;F%L1&]C=6UE;G1)1#YX;7 N9&ED.D$U1C@T,4(W0D-",D5!,3%"0C(V.44Y
M13E%.3,Y1$,R/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @
M(#QX;7!-33I296YD:71I;VY#;&%S<SYD969A=6QT/"]X;7!-33I296YD:71I
M;VY#;&%S<SX*(" @(" @(" @/'AM<$U-.D1E<FEV961&<F]M(')D9CIP87)S
M951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T4F5F.FEN<W1A;F-E
M240^>&UP+FEI9#HS0S9#-D0P-$,R0C)%03$Q0D(R-CE%.44Y13DS.41#,CPO
M<W12968Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @/'-T4F5F.F1O8W5M96YT
M240^>&UP+F1I9#HS0S9#-D0P-$,R0C)%03$Q0D(R-CE%.44Y13DS.41#,CPO
M<W12968Z9&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F.F]R:6=I;F%L
M1&]C=6UE;G1)1#YX;7 N9&ED.D$U1C@T,4(W0D-",D5!,3%"0C(V.44Y13E%
M.3,Y1$,R/"]S=%)E9CIO<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(" @
M(#QS=%)E9CIR96YD:71I;VY#;&%S<SYD969A=6QT/"]S=%)E9CIR96YD:71I
M;VY#;&%S<SX*(" @(" @(" @/"]X;7!-33I$97)I=F5D1G)O;3X*(" @(" @
M(" @/'AM<$U-.DAI<W1O<GD^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @
M(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z
M86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX
M;7 N:6ED.D$U1C@T,4(W0D-",D5!,3%"0C(V.44Y13E%.3,Y1$,R/"]S=$5V
M=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR
M,#(P+3 V+3(P5#$R.C$V.C$T*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R
M871O<B!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D
M/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#HS1#9#-D0P
M-$,R0C)%03$Q0D(R-CE%.44Y13DS.41#,CPO<W1%=G0Z:6YS=&%N8V5)1#X*
M(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,"TP-BTR,%0Q,CHT
M-SHU-RLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T
M179T.G-O9G1W87)E06=E;G0^061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD
M;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @
M/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @
M/"]X;7!-33I(:7-T;W)Y/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @
M/"]R9&8Z4D1&/@H\+W@Z>&UP;65T83X*(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M( H\/WAP86-K970@96YD/2)W(C\^_]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ _@)= P$1  (1 0,1 ?_$
M !\  0 " @,! 0$!           '" 8)!0H+! ," ?_$ $T0  $$ @(  0@$
M"@D"! 0'  4#! 8'  (!" D1$A,4%1895W>7M]08.#E66':5EK;6"A<A-39T
MM+73(B,Q-[/5)#1U>"4G,T%#4;C_Q  > 0$  04! 0$!             0(&
M!P@)!00#"O_$ %X1  $"! $$!A0)"@0% P4!   ! @,$!1$&!Q(A,4%1896A
MT0@3%!47&#=2559Q=(&1D[&UTM/P-E-S=7:BLK/!%B(R,U17DI26M#0UX?$C
M0G+4U4-BMB0F.&/"@O_:  P# 0 "$0,1 #\ [<GB8WM/J:I2K8?5!]S#;/[5
M]H^O_4.%V S09NWE<JW;,M6,KG8]L0;NF2IJ-UZ'F#R.;.6ZZ#62>R'JK9YH
MVV9N!4U+JM]2(JKX$T)HV%6R+J[J%59OXO+FO.\47ZAOZ5B!2"'NR,(ZG)SP
M+V-%RVWA\OF\3U,")Y)ZOB,)D<=A\2]JZJ1]8+.[EC-O+<:\R?F!I--M&B@E
M&Z%72BVNEVZ%2^W?7LZK;I:;PUKSG]L5SV K>U)$[FM@]1>W=[=42]@DDFJ!
M:PP%>DA$EKB8G$6+=LRXD3^LIQ#Q\F6;(Z:/I&++$N==-GFVO AR6M;4J(J)
M>]MC:391?!8^WQ4>P%K=8.CEIW/21'V39@&8=?HW'7^L283QR@C9G8VIJP/\
M#H>4<LF$A,+1J9&$ HUR\::+%E&?D=-]]=5= 8B*ZRZK*NNVI%77L:C6-2_B
M/]I&<VE=3W7)Y4B9C'=;H-4@->P^MD?H6ZC-:]I>90A)_?6L=IC-HFQ@SHM%
MG@F(3Z)'/>G?=A)=78IDNR%[O!4K4LBIJ5'+K7878T)IVT7;V+H3?MXX\&CU
M>#[ILKK994)IFUJ4N6\^JTM:3*$RH]>T;IF212-D09N'#EFKJHI1*%)Y#RT9
M:R F;$;""KC8P9$E!JXK81F+>R*BKG(U4LNA5ON:;66_!<R"U^_?=>.6YU&@
M [IT^A]@63;=_0*;4.8MNK#(NRPT(ZT/;>A\CA=ZMT]AL<""RN_I9&J_BS$[
MR^CA>/M0I9J[&$" BS=.F^B][+=%NB6MP_ZZ# 8OX]M73J14TPAG7:SSL>G,
M*ZX2VS22!L8I)ZP4[*$UQ@%@"A(T44=V<T@J*'$AL,NP*QG05%E=2@IF:=MW
MXMF&;:]U1-*IM:N[;7J31KUV32?B8\;Z5L@AB5A^C<T.Q%I5?;&ZPQW6]JW&
M\F*VZ26P2J[L(<7%NQ7)$4Y$+,VI"&A]T7A.8/'O(SAN(8-MI J)5EM;DO=J
M:EUN2Z?C?7^!GS?Q395K>EE4Y7%4RKL'8TVO&)PKKW5CHS J@&BX<ETGK3M3
M/"1ZQ'^AA+A$:,E2NZ*9=B2+/I,:0CX[9$(TT(H",VVO1HNO\2MMH[E^Y?7J
M,IE/B\BX;V$H:B9+USDX!>WSG6V$RI0E:M;$; J>?]FE%&46!2:LX4[F.R(>
M+EMV Z32.1RV&ZE-7O!*O1<X%IZNU@1MT5;ZK["V6VULZ=C1W;;$5S#OQV+&
M>!^1[R-)("8=@$]FJ6DE0@C0V'::N>WC:FU'+>!-TU&Y5PA!UMT4![=/==X2
MUT71UV=J:\<PNCQIPJB!$17(FPOXI<X.C/$=[51<A(X+.JTGO:0C:=_PJG.D
MDRE]%G^@9FYW*E+2NW+Q=S6)6\V5>Q2$4RVACYBRFS6(*NYJ3(>R P(BJQ>.
MV$DJU-:+:R7=9<Y$TV32FN]]6FVN^PG%O_&[.C)QO."U#+ANN4,Z7]D;NMT
MX/#'UTQ>[^N_8X3URD,"".F#]2&R #M8KEO#ASM'9%$VVEHJ?;F08Z.%XV^#
M,U)?2KD1-JRI=%V]E-7G)7A7C%R.P7$"@D4Z<3(K>-A7;(*3 036UHZ-@9-X
M,H4]?@Z8 ;?/10.(.Q?8'&S<?E/H(\@8BQ\,7:H#) LD+;F!&:FG3H1+W1-U
M$MW;JFS:UE,FI_Q=7W8A:N]Z'ZAV;8S!Q4U-VY?W*5AUU'C%)![HL:95J$$
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M^#]2;%F86&]:9#V=NU![9< BI.K(O7'8*R.M]NQ=LW=:DF\ZE41G582!S'=
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MR-:#])5!#<EA4C]0X>>J<FXG(3D<)[(\O Q5^/60<J"@DG & , 8 P!@# &
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M?=!U-V=JJ24E>$5WFE92UU&7IZ.IR"4159V\ALL!SF,.V\@AAJ.R88Y#RR-
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M?#N'YS;PO^C5A!A8*2TCOPQ%%K=*IJQZS+@AA8DE?<T=V'<<:DA^'3\">ED
ML*9/G1R05K*"1>OU5U?0-XTW9II-]!&<NWM;"?\ *ED\2;)D;CPZNF+FX!MZ
M?U'B&E@"=8XHQU%R:=!X&D4AL&5K*&R=2HQ,I95,YFT/KY;:'12<NH2M,(X
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MM&Z2>R[E9=VY4XW<.W"[E557<0JW5576NE3-< 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@
M# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M5*#FIA?524/IQ9,9J*OFR2G#,6T'IQD!#*R(N5UEGKLH:D<H26429-P>NY*
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P"-KA*/PE8S4L*.RB-$V -PX''(7 G5HRE@^TW3X:[!*\
M8B3;R7O%E^=&W 5J-67=)K*<)*L]]>'K<#5E=CGNC<O4JRW%A0:>0"30Z>TV
M1JI[56[N&3F[8XO9,8:RM:P:0B\KMXO!! P/LH45 \VD4(%&VSQ]( 41:"'
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MI\Q!MG;U-OMJVX>++\M46[?E-!,"3, 8 P!@# & , 8 P!@# & , 8 P!@#
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MY9/46[QFOKKMQPLU=MT'3=3C9%=%)73?34#]\ 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , C.ZID4KFF[:L$&BQ<FH)6<\F0=N4277&."D8BQ
M4V/1(H-7+)RLQ5=L44W:3=XT74;[*:(N4%.=5=/5H,C!JE<HU-F'1&0*C5:=
M(QW0E:V*V#-SD&7B.A.>U[&Q&LB.5BN8]J.1%<UR71?+KD[&IM$K%1EVPW1Z
M?2ZA.P&Q6N="=&E92-'AMBM8^&]T-7PVH]K7L<K;HU[5LJ=15?\ I O= XDH
M#<U5U@+H&DU!2H=>OK*()%DG^FS54:H/4MU;1^F]35V;J,]D5=7.BFR.R>^N
M_.O.X<YR/.36G0'3-0Q!B"0EF?I3$Y6*'*P&[/YT6/1F0TT:=+D-09/D@\H]
M1C-EJ?A^@S\P[]&!)TFM349VFWYL*!5WO73HT-UE[Z<[S^-Y>&K1Q"NEM1"@
M:^NBFDCL*O;#JZ/ZLMN./-?M7,_NJ.N"['C7R<ZJ1YF74WT\NR**FNNW/&+*
MYASD?:+GL;BO%U8CLO\ \"B1Z9.([:S9N)1)>G.ON3B[:I94OE&B8BR_5G,>
M["F$J/ ?;_CUJ%49-6ZOTI2'69BH-5$7_FDT36E[HJ)OQ@=D\R:'R"4E^(BI
MS&WA5L395E+G%LJ-/9 MF2=CGZ8&.,7:4R2X<*:+PT.TD+K7C8=Z@1*+$DD$
M]>UMG+FWS;KFYUKVOHO;1>VNVBYL E[)G6SK)>U[7MIM?3:^J^FQ62W/$(HJ
M#5 O:=>R:)6L[0G4+KYU#$IBUA1Z/'YF72'(MYX-.BW,G@3@<T]:)N1<CBC8
MPJDVX;H#]EG"/E@DR.3]NN!%)T+9D:@XBP)?V0F43K^L(;$[, D(B3DTJ"2>
M6:J+6J@+7%>[PR)PR2&'9AD >K[KL=!:0OETMSRD_#W\X*X@/%;KR1>Y\C;5
M7+&E7/$J8$V9.7Y\"F_K&?7HUE>T3A^T3;ZN7$M0%$HM[*E4@%EF;<>L;$+B
MV)M#DARPFVZGO[^^@%B.K'<AEV/V/LSE=$ZD,#Z]IBX@0TW)PLCU/U3V #R<
MS6IY5V*2;)"9$JE#I TE$5WT>\ 'K9OH@:+H.]'&A4MXU3Q NID 8 P"&Z'_
M , .OI,O'[;;"P"9, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MZ+C & , ANA_\ .OI,O'[;;"P"9, 8 P!@# & , 8 P!@# & , 8 P!@# &
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M=>> ,&-_C 5E]#MY_P :]=\ F+ & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M[%9PR6<,UU6BNVS=19HNNV5W3VW0652VTWV@$WX P!@# & , 8 P!@# & ,
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MXW]C-GH 9SC.BXP!@# (;H?_   Z^DR\?MML+ )DP!@# & , 8 P!@# & ,
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M@B_E&:<_5VV/LOE>8<R]]3&N=\T;TO)F8<@_5-HG>U8]$SAWJLY]&_XP!@#
M& , 8!#IO\8"LOH=O/\ C7KO@$Q8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M'XL/8[Z!K?\ L]D67%A#X6X7^D5$])RI;^+?@KB;Z/UGT=,GFT9U&.7XP#U
M17]UC?\ (,_].GG)N-^MB_*/^TIU<@_JH7R;/LH:=_'A_$ /_2G6G^X/\S;R
M//5'EOFBJ_=0S"O)!=3F9^=J5][$.D-F^YH:;$/"=_*']7_UT,_P/*LQGECZ
MF>+.\9?TA)F2<D'5)PGW_&_L9L] #.<9T7& , 8!#=#_ . '7TF7C]MMA8!,
MF , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , UT^+3^3L[/\
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MR#9M\LD)TPV768AL2*L%(\%8B-NK$B,5;9R$V9^Q:0P!@# & , 8 P!@# &
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ME$>TA0JD/##D[D<U;7040$F<O'M&2</<Q7F<(( UI$H\=S9/%G7\6B^UIX=
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M;[FAIL0\)W\H?U?_ %T,_P #RK,9Y8^IGBSO&7](29DG)!U2<)]_QO[&;/0
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MJJL>]BJEE5CE:JIM*J*ET,I9I>'B2.BHR*AG60P?.R6/1$$)"UC!S#TV<E4
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MMB#E:ZB<PKBW6T-M:M"UEQ8A;@VH)/4-MJR :\G DA)(%.EC[&UHK'2AK9Q
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MV0E)BHV6CB<*J:'5JLS=.]W*VA'<@XBZA9-9)!IJW1>:--DU=T=EU(!.V ,
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M:LMZ)225Q.2'D83(P%K0FPW:$J1,RZOI7/S ^[XD@46=E8K/0Z3%XL;"ZB>
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M3I1]*QB4_.2X$W?$6_!-D?C4I;+NDF6PZ-Q@MDU>/;TKI\5@;#L@# & , 8
MP!@# & , 8 P"&NQ=A22I.O]X6I#@:$FEU;5)8L\B\<=-W[QL?D,2B)<\&#.
M&@M5$FY0)D&#=FJW'K)/EDUMDVJFB^VFW!-:; -:9+O/VP@1>4:3ZMZT,QT
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M/'Y0JE/U=O?_ /SW:>?9(?XE/D9K^UC& >2?ZBF*OG+!/_SS#)L*S%92, Y
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M3-";*3E8<Z)7JGSXYK;)2'+722O@S4.EK'DE:LC2X#\V.V7DWQ%7ZI*H4B-
MP=*.DL#PUB8BK<K7'S<G2&HRA4Q*1S(^<GDA-G4;%E8E3Y1.-<D[4X[+P73$
MVQB)#M]#>K82[A<C@9*!R2LF>E0\575[ *X5CLQJEZ!$(DREX3^(SV*RZ+W"
MS)J'%K("%&+8SO(6JG#5\RB*P)'/<P[%Q;,4&++5&#496K/6M<]ZM$CM29DJ
MQ#F8SH4&@4V=ITY)3=$B0DEVTN8@Q'P$EGMSX<2=;,N/$Q#"PE KT&9I\6GS
M5*8E%2D4F' <LM/4B)+P&Q8M>J,E49.=E*TR*LPZJ0(T-D=9EBYD2').EVE4
M^R*,.;=B+[;UY[ Y@"%T6DC!N8HLR<1?W.2G)W2,^[:XW=4<N ]BZLO8ZP]1
M1DJ.]6W:[[H;)[<W?A=T\[#.'75/FGGDZA4AU0YL;$;-\W+3Y=9OFIL5$BMF
M>7K$Y>V(B1$BYR/1'(J%H8G;),Q+B%M-YGYW-KE6;(<R.ANE.8DGYA)7F5T)
M5A.E^4)#Y0Z&JPUA9JL56V4A?/=/#& , ]#7PV_Q#.J'T+0__19S4RH]43&/
MS[._>'27)AU/<'_,4C]V7;RPB^Q@# -2$G\$3P_Y?))#+#<"G*YF3G"TB+K(
MV=+6Z*Q,T_<$GZJ3=)YPD@FH[<J[Z(I\<)I:\\::<<:Z\<9Y3J/(O<YRMB7<
MY7+_ ,1VM555X5-F:?R7.6RER$C3).M4ADI3I.6D95C\/4R(YLO*062\!KGN
M@JY[FPH;45[E5SE155;JIP?P(_#K^7L]^M28??<CG+(=9$\HX^SIQ\NG9RC?
MTY2O8CX$?AU_+V>_6I,/ON.<LAUD3RCATX^73LY1OZ<I7L1\"/PZ_E[/?K4F
M'WW'.60ZR)Y1PZ<?+IV<HW].4KV)R._@=] E!#< I$K.4!,R+TPT";W#.MA#
M4N2;,&1$HW&[$N6:!%^S%"VCU\DCJY=-AK!!=51)FWT3GG-)61N;%S4551.6
MNLBJB(JHFJZHB(JZU1$VD/P3DO<M39J).MJF'VSD6!"E8LVF%J,DU$E8$2-&
M@2T2827Y:^!!BS,Q%A07/6'#B1XSV-:Z*]7<=\"/PZ_E[/?K4F'WW(YRR'61
M/*./WZ<?+IV<HW].4KV(^!'X=?R]GOUJ3#[[CG+(=9$\HX=./ET[.4;^G*5[
M$? C\.OY>SWZU)A]]QSED.LB>4<.G'RZ=G*-_3E*]B/@1^'7\O9[]:DP^^XY
MRR'61/*.'3CY=.SE&_IRE>Q'P(_#K^7L]^M28??<<Y9#K(GE'#IQ\NG9RC?T
MY2O8DN47X2/2OKI9\?M^KH;+QDWC+61LQ+TE8$E,LTD)5&#,0,ZJCGSI1LOR
ML$/$4$ME-.=FZRB;A/GA5+3GC](5)DX+\]C7YV:]NF(Y4M$8Z&[1NM<J)M7O
MK+:Q?R365K'&'YS#.(:M3)BDS\6GQYF# HE/E8KHE,J4I5916QX,)L1B,G)*
M7>]&JB/8UT-UVN<BR?\ #QZQ?FS(OWP.?><\;\BZ#\1'_F8O&1TS.5KLM3-Y
M*=[(?#QZQ?FS(OWP.?><?D70?B(_\S%XQTS.5KLM3-Y*=[(?#QZQ?FS(OWP.
M?><?D70?B(_\S%XQTS.5KLM3-Y*=[(?#QZQ?FS(OWP.?><?D70?B(_\ ,Q>,
M=,SE:[+4S>2G>R'P\>L7YLR+]\#GWG'Y%T'XB/\ S,7C'3,Y6NRU,WDIWLA\
M/'K%^;,B_? Y]YQ^1=!^(C_S,7C'3,Y6NRU,WDIWLA\/'K%^;,B_? Y]YQ^1
M=!^(C_S,7C'3,Y6NRU,WDIWLA\/'K%^;,B_? Y]YQ^1=!^(C_P S%XQTS.5K
MLM3-Y*=[(?#QZQ?FS(OWP.?><?D70?B(_P#,Q>,=,SE:[+4S>2G>R'P\>L7Y
MLR+]\#GWG'Y%T'XB/_,Q>,=,SE:[+4S>2G>R.98=#^N8T#8,;:1T]H*LZOI%
M6,M2VE1G=5W$I5PUU,-&JVR_.[%TMPR0X2?-^=7"'F[>BVX\[G+@PQ)2^$*U
M)5^B(Z#4I"-"CRT2,Y9B&V)!C0IB&KH,6['HD2"Q51R*BHBHNA5+!RE93L79
M6<+S&#\:3<K.T.:BK&C0)21EJ?&5ZRDW)*J3,JQD5J<SSLPVR.MG.:[6U"H_
MP,?#T^7\[^M&7_?<SKTP&4OLE3]Z)'V9JMT LFW8ZH;[3OM!\#'P]/E_._K1
ME_WW'3 92^R5/WHD?9CH!9-NQU0WVG?:#X&/AZ?+^=_6C+_ON.F RE]DJ?O1
M(^S'0"R;=CJAOM.^T'P,?#T^7\[^M&7_ 'W'3 92^R5/WHD?9CH!9-NQU0WV
MG?:#X&/AZ?+^=_6C+_ON.F RE]DJ?O1(^S'0"R;=CJAOM.^T'P,?#T^7\[^M
M&7_?<=,!E+[)4_>B1]F.@%DV['5#?:=]H/@8^'I\OYW]:,O^^XZ8#*7V2I^]
M$C[,= +)MV.J&^T[[0? Q\/3Y?SOZT9?]]QTP&4OLE3]Z)'V8Z 63;L=4-]I
MWV@^!CX>GR_G?UHR_P"^XZ8#*7V2I^]$C[,= +)MV.J&^T[[0? Q\/3Y?SOZ
MT9?]]QTP&4OLE3]Z)'V8Z 63;L=4-]IWVA;;JIT,ZY=,7LU(41'3X)S8#4$S
MDNQJ5F9)JY0CBQ5<7JWT*KK:M-DE#+[E79'C7E;C?3A3R\)Z^2S<7Y1,3XYA
MR$+$,U+S#*:^8B2J0).!*JQTTV"V,KE@M:K[I AV1UT;9;:U+QPCD]PS@>)/
MQ,/RTQ+OJ3)=DTL><CS2.;*K&=!1J1G.1EECQ+JVV==+ZD+DY8Y>XP!@# &
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MKPT412Y'-_40(OCC=J,'\(Z)+9*JBVLU$LFE4OIX5XPB*FM;^_OHU$T925#
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MC_8,&_EG%TVDX>,6=UWU4'NK+?F?(_V#!OY9Q=-I.'C%G==]5![JRWYGR/\
M8,&_EG%TVDX>,6=UWU4'NK+?F?(_V#!OY9Q=-I.'C%G==]5#$9Y75CR*(F@L
M=N.1!#3]NBD/+<BHTT]GK:.VZW+GTX4&Q)\<III[^:FU>-=E^>>$%%DT5%-N
M)141456HJ;*:?Q50J.Z[@MPH21#Q!P#&Q(F22AU,S;)KHB1DSP:.$+E5^.>?
M*XV'"DDF377R>335/3TJGFZ\;++KJ[;J[0ME70EDVM=O&2FA-*WW3)<@D8 P
M!@# & , 8 P!@# & , 8!7"]NTE:==Y7141L!O)]GW8.RQ]50IZ"%LWXH;)2
MK@>S8+RIRY*,%A09=\5'LO7VK8GNFX<Z>E;:)<;*Z@8I27>#K[>S>?.8[*.8
MKK ;.LRKUTK"< 8LYE+VI(Y&I?,Y;#&VQUZL:@C"+RT&?Y/J:,E6XEWH^)L!
M[?=%1652UMU+@(=\NH6Y.QQSWL!5X5"K7,#:R<Z>F<=$QM52RXUI+(=L!.O"
M:; ^F5#;**I[C5%^-56KU+^WEFXV367Q@SISVOZOLY&)A[KL122$J/#&9H)'
M=[0A?!@N&)1I"9C2PT?[9Y<O!I.).6\E&OFZ:C8@#71)LU5V:NBNT67:!_=7
M=GZ,MZJZYN:(6''N(#:YAA&H*4-DF(14W+";]V*80Y!L^<I[\RYT28.V",<U
MYW*J/&ZC9-MLMKSIP!];?L[UQ=R:*PMI?%0N9;.%WS6'1MO8D46-2AT-.FHN
M]; AR979T3<(R6-R*/>A:)JJ*FP!L4CJH^$OT&X$.W;WSH_K[)YS$;':SED7
M@>M+.GO# "/>(&PMX&)B%!2..;;G&ZK\#%'$ ESF?O7*+'>/, KET@@3TY3X
MWFW<V>#CV-T&$S'Q&:\BKYB@.H_LA/!!F[93UXCDK@\1KY]&I-;41DLHBA6,
M!'1NT0#YQSN8ALD29/EQS9BNF,6VV72WYU3Y6W43Q\0)3N[M_&:,)5-'R]37
M;-I;;\1L";!8;7D<B)B1@ =7C8>4FVTI;F)U'F39X'0FPE+EH%?G5'3E!^DU
MY6]"WV=+>_X C)'Q)Z"+1\W)8?';BL <$"5Q*%/<NO=RB[J+653;J^!TD\UR
M68)!Q(&O6;AS)%90L <(&^$(X(;&C+QDT<Q;7N YGGQ#Z >3!K7D70GTXGYW
M6FW$&A<5C;)>26$+NN';6"#D$9'%C8C=C&8C"]=I#9$DF6T4"0QILW0?OE'[
MX>T=@3Y%^R_7F;SLA5\.NRKI18XHJ5"$8,!FT?*REF6!(OEC;!8*Q?KOM7 C
M4653):\(\ZLG(LFT<;)NA[Q%%9=H%?H3XAE+2^PTH(0C%HUZ,(RZ](-'+1L,
M%& M4R>2=<E)-M;#,=*1\S,.A2$?&PV4'-2$M$1I@Y$!'KC5SHOIHVWFWFOW
M+VX]@$@;]Y>IJKRHFH>^*UE"%X3X[65?%XI,(_(@;^9QR.JR4J(?EAA)=H+6
M1:;"F6G#S?394Q)HF,TTY<241PZ673N?CJ!S6O<[J+M$UIWKV=H7:%MY YB:
MLJUMB$; >)0T#.I$M'M2?!OEHH:YC[)T<0&)J[O'0A'8DU169\ZK<K+M*#('
MW:'K8,,1*/D+]IQF<GL42G4($N+(B"3^6PMPQ=$VLJCC78OPJ8C[T:P?OV!9
MAJNR?LQY!RS6718N]T8!G\5LNNITYY9PJ=1&7.]8M$IQLWC4B$FUM8;/4"#J
M#RK9,:[<[:QZ8-A)1Q&#'/'# Z@.?+#%W*;5;;0#-\ 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8!KBAGBC=:IV,I<B#86;PK>=ZD^OL6$/8N'0+AYB)6BZ
M3@Q+&R<H71%0]32;PQRV,,W)-VLVE03?@7KN[Y33FW<U7\W#IT^$$\V9W4ZM
MU-"A-@2V[*]XC)[2%NPCL/*@1A4N$GLU:P$%*1J#,CON]B>A]PX]J2-MZ04,
M'"#A!TYT;B'NR2R^_ON*#)>>U_6#5S/6F_8>E4W%6K-&]D)*V;#DN8(L^D#:
M)M4Y7RH8TU!<J2IXTC'/)'9OJG(G"(-7G0HIJUY@' 1GN9UDF]D5I54&N2"S
MB5V[%9W,(!Q#Y(&D8D\*K@BU&2E!N5%/G+;VJU<*$]VXKCG9XZ;1B6N$T_11
MLKLWFR^*W#J!&!+Q!:D#6F?K(M!;E8L(Y<Z?7M_:>\3C[BKMKB=PL;/!D)3*
M,I@ZDZ3TN$,B]&#][$F8?E^^1;.B+77SUM%M6[_L!$/$,I&9KT]LPC5P#@=W
M@(H5ADO,U^HRB'MV:UD:M^.P)^<3*.4%)@[@4?)E7.H70S&1;A+044DK,FKH
MTY*EK[GX R6AN\])=CVVI>M-94O$1]71NT9O/C; &'@E9I2L.VD@F"SJ3+2-
M1@SL9*,NTI(=C@38\WBP7=L\DY0/P1%:/RI;AX 3_M<E1:PH[9/%HUXI7D8;
M)O)).D9G'5X@ :*C!QI)T9D:)%00,;J!C DNFL\>(I[BR@\AKMRT>MEE(!BL
MP[/=<*]>+CIW?%0PY^UDON<[9R6Q(H%<M)3P&!R)0 [1(%4%&I1N DT;-NFC
MC5-5H*D 0@ZX1:EF"K@#AKR[*QFD3< AFL'LNV;*L_63NH5651A0)B6DP<):
MC7<PD[IQ+91"XD%CT=U-@VSQ^<E [=V0-#!HE B_=:M^'O[^_ "N[WQ2NH;&
M,:R!:7FM2.E;/[/?P=R';BIV&$!+._J@E 0T!-DQFHV5Q.<HE6!\*X>Z\H,0
M!LNT<O1K/5RL][['!^ +#*]PNJ"$3 3Q?LI1:,)E4B(1&-RQ:U(4E'CDG$[)
MZE@0PON:U8NR8OA9!4DU16V48-W+9R[X1;N4%5)LNTH,U:WK4)5[8P>.6+#I
M;):F&/"MB1.*24(=E$219>T]=D#P5D0W=AW:ZX8FT:MRNK+E9VR<H\<Z\H*\
MZ0# :P[?]=;7:58D!M.&BIA<%:1.UXA5TFE,8%6AM$YE$4IR)W(0Y(T\?(/]
M(SNL5=M6V[S31DQ(/VZ[D<S6>:RJ*E]Q;7V+@P">>(7U)A<.9S01<<&M)B0M
M*(4XU853.8!*2'OY-7V[42->+N):)!BFR+1!\;?/RQEBU3"#7[YMN[Y2T156
M7:75?4H)7;]K^L#M.>+MNQ%)K(5:_'"[)<)VA#.6\$(%SR,5%M9:O[9]"!4(
M2A=*--/:6[?5>0[<A=-N2>BC759=I08L_P"\W3 5_>?:WKR/YX#,I#SH]M^!
MM5-0A)B%)CB>R2YS135H0&R(&18*;:\>N,2C-XVX5;J\*8LNTH.5O+L_#Z09
MU,OS$; M@A=\LWA];@J?81>1DY 03A4AL'9ZW6/RV*!=A',5BY8BD^2+K<.-
M=$.&Z2O"^N_!$O?8M_ML=T'"U[W;ZQ6&"J<JC;<.AIFZ]'VE?U_8TA!0JR"Y
M(3*"L'+ TX<6*:$ERP^: S$4V3'\/FC\Z/79"'A'GE'=6 ?)!>]_4.P(Y%I0
M([ 5<-'S><RZN(@WDTUC<=)R670J2^ZI<8%&DRB+DARN06$NA*K;11,H*DL5
M(M.=T)((Y=39=K5KW.Z#/F':CK,4,S./#NP5+O3M<AY%(+ $MK,ARK^$@X@5
M7!RTM*VVACE4 /BQANJ,D;HIJU1!O>-&Y/9JHLCJHLNTO^^KQ@!NT_6B0@%9
M4"O^FRT:;Q"0S]R=861$7(MK"(D5; Y5+'3U(ML@VC\9-/60B0%5]TV88F\:
ML"*K9TX12W67:4$\)[Z*Z:*)[:[IJ::[Z;Z\^77?3?CC;7;7GC^SG7;7GCGC
MGC_QXY\N0#^L 8 P!@# & , 8 P!@# & , 8 P!@%+>X/3Y/M?I7*NMBNJZ)
MUEK91".%&D81DJ[>5S&"O8S$Y.DFN<#)HKP"2["9FW:;>GU-+"-!6S@5PX]I
M(2BV\/&B_@"IPGPIR,)CH\16?85*.$V)>>:;%9!4>DK;K0ZS>K]0=:)>*Y')
MV2 5VEN[6HF4Y#S%P3<LFIHR[8&(D?;([.7:]_>VVOG4'(F/#$ERFC9C&>RW
ML$'Z.@N2PK>M90W<&W5*==BG75QR[D,'O& 2-N,D8=ZREK,*Q*-F8X\.V%RG
MFP(F1>@=H3W]UN#(ZL\,EC6H>$#.;AV-KPR;=*I?J_\ ZNT1JI%/IO6[&NV
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8<;JOKU[FG9V]C5IL#=[D 8 P!@# /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g904779g16v88.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g16v88.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2564&AO=&]S:&]P(#,N,  X0DE-! 0
M    )3J^E3 X0DE-! 0      %X< 5H  QLE1QP"   "/.@< E  "')R,34Q
M,3@Q' (% #U-:6-R;W-O9G0@4&]W97)0;VEN=" M($1Y;F%M;R!&:6=U<F5S
M(# U,3@R,#(P(%-L:61E<R!V,RYP<'1X.$))300E       0,7/LDL:DBLBB
M>?4:CE=<<#A"24T$.@      Y0   !     !       +<')I;G1/=71P=70
M   %     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT
M   /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4
M 0      #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %,
M90!T '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U
M:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M    $     $
M     !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#
M;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O
M;       3&)L<V)O;VP      $YG='9B;V]L      !%;6Q$8F]O;
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M=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP
M    #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N
M9P         -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P
M;&]N9P      .$))30/M       0 [_^-0 "  (#O_XU  (  CA"24T$)@
M    #@             _@   .$))300-       $    'CA"24T$&0
M!    !XX0DE- _,       D           $ .$))32<0       *  $
M     CA"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H
M!@       0 R     0!:    !@       0 U     0 M    !@       3A"
M24T#^       <   _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@     _____________________________P/H   X0DE-! @      !
M   !   "0    D      .$))300>       $     #A"24T$&@     #-0
M  8             !3H   =D          $
M 0             '9   !3H                      0
M           0     0       &YU;&P    "    !F)O=6YD<T]B:F,    !
M        4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M      !"=&]M;&]N9P  !3H     4F=H=&QO;F<   =D    !G-L:6-E<U9L
M3',    !3V)J8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<
M        !V=R;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC
M94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC
M951Y<&4     26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $
M     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<
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M=&QO;F<      #A"24T$*       #     (_\        #A"24T$$0
M 0$ .$))3004       $    !SA"24T$#      :O@    $   "@    <0
M >   -/@   :H@ 8  '_V/_M  Q!9&]B95]#30 "_^X #D%D;V)E &2
M ?_; (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,
M# P,# P,# P,# P,# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.
M#A01# P,# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,
M_\  $0@ <0"@ P$B  (1 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!
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MU.3TI;7%U>7U5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__:  P# 0 "$0,1 #\
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M&QT_]"0#1VNNA_\ 06IFW=;9D-&'CTVT&LR7.(<+8>6S]']7W-J:_P#POO\
MH*%MOUA%VVJG'-09NWDNU<&_S<;F[=]WY_YC%++Z%@Y=[<BWU!:VHT;FO=)K
M(>QU;YW?Z5WZ3^=_X1 R/JITG(L>]_JCU/I 6NC1K:O9N+O3]E;/97[$%/\
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M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MT=8C051U=K?7V HD,F%Q=R4H0E6!E);2TR<U-W)XIK'_Q  = 0$  @(# 0$
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MGG4&Y@N-KU*+ZM[GF[FES<86H%S3,:9T^)9(Y3QQ1/0T<BCRQ^:D<<;%T/\
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MDN=IW'&SM%?[9QEF.]-]J<SWWQ,W=6^6[EB5SCI,5;R6T^*+"H.+U4WM<$N
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MXT!1R@O9M;Z.UWIZTM[W5(K".WNG1;=K?5])OI)ED$^V:.&QO;B9K<FVF0W
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MD5E9)&5@3D/.?6LU!7R%?_PI7O\ _EEQM_:;J_-X]/\ _P"_5_\ _JKUA_\
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M;^[U06T#0O#':2RLD<C JSRJ3(!P>T&B"%. Q)+8&5C/)'P:(L82^MJ/+,$
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MJZ382;1MAQIJ"1HQNI2X+J6R&03)IKBTG LK;942YC0H4\5.VJ='E#[Q4F)
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MV8X4Q]MBPVX8R7>KS34_S:9?_421@I@42K=#-[<8FV1F3=JA+R-M3'N<.8I
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M;VE:-\0BJ+_,8VY0X*G^OIV36YI=F4?LUD4O2- ?&;&E#F;>L>>%J^4Q%&-
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MKHNI'E31[T1PF4-!()&$B)V45&<RX<YDVE0.V@+G.0.*F11D_EEG5LQ3.9P
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M^U[,+C*2T+WA*^NI>NLAH;":@6P"P(3)]+X%H!;RM6OFGX0%+0J0+37.T?\
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MCV.PID-0G4^_0%"?5&TJ1/LA'\-;<W//XE"GQRJE2!_(HOY\<_-9_J9_XO\
M$([T$=M+@*-\$)A,<9 4<*;>$Y&&)0%B26SHE4+4)(6 )4';"PQ:VY'>S!H*
MARU\MMN7#EIDCFQ7_7O\HY.HYU+1'IU'OFT&WI1LA"5[I+[BI.?\!_<,5A)+
M')QX4< #A5"C@ #. ,GR3DDDDDB:&J).!,43"&TLM';KC?"8&E+IL)=N.Q[D
MI<)MZ"7[]MQ4*'AQ-VF'[366-3O92$OW1/NY!(S@^1@_F/.#]^0"/L0".0*L
MKNFX*Q ="CCX9"0=K Y! 959<CVNJNN'52-0VBZF.+.)-A3:86?;*.]#0B/<
M=Z%;+>J1+4<U]?C?4+D0J;D9P" ;"W;V0$(D0@","*2S-C)SA0H_)0<@?WU>
M2XFE$8D<N(H5MX]P7V0HQ=4'&0 Q)!_%R1G'%:)U!U H ^%G0=M,!);<CM\/
M@=J736G"VXFHBRN.S4WT7ZV!Q;%$*BYI*4G9368)H)^(0':.5:/K6&M55152
MK2Y<4IA3::7/+)BUORX.U#D'3Y9,*U#-1>5JO87!V6N:-5[#=$D)MD(#M,2?
M2I(?HY9I38,1R#CVLO@>&!##^88C/GGCP*RQSRQ-NC?8W:F@RH4$Q7$<L4R$
MXY[D4TB$G+!6P",+CY>J'J.1)IRD>H2W.":RIO"K'G!1RIT"&03:NQPPR%OZ
MGW2\O9"EA,KV&C3$HMI49PF)/M8F4^_6?$P22 "20HPH^P))('\R3^IJ'EDD
M6)'=F2!#'"I/$:-)),RJ/@&661S_ -IC^5?#Y0=024NQBGV#-CD7;;_#938P
M%"AR]F5/]?$QI/#7%<$M<#1)C$3#XV!,4A^%3FZ:B=JR5 C5.SH!QS_F ?\
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MX:6>Z"9O:;W M!WJI.23]^>  /[AP/T'%<=F+,S'&6)8X 49)R<*H"J,G@*
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M@'EOWSN5.'VOE0@PF/\ L6%+?G<_*V4Y"*DH!/KWMPG/&..2#X&>,_/D#GD
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M%71ZS;+LIC9E5HV<YMHYW)E4_9Y4[@6KI, 4Y@S@&?RC;/#982\P^'NNR$#
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MEG<*LJ&VU)-*UM[*/ZR-%"7]P1G3H7RF5[1=5/\ (W6J[;B]N(C&]&R5);<
ME<#V[*E2T"=<L23A*TOT%>FMK3 5J]'Q^2./S$929,68C*5C7).XUOU'L])T
MZ:5M,U.WU93&D.F:I97-F'9WVO(+I8Y;:6&)0SAH9F,N%"[0Q=//?3+]D#J;
MU#ZQTW2[/K#HK5^BKA+F>_ZTZ*ZET;J(6<,,#2003=/S7NG=16%Y=S-! 8]3
MTFU-JKRRLD[PK;S2,X8ZH%V'S['[B5Q4,,>%3F\,#VQD*SUS;MR8U 4YS@RJ
MU2=,H/:EH3"Q@ ,)^T"T*UI&M7&MYBL[ONC>I&ZHT2+4I;=;6X$LMO/"C,T1
MDBVYEA+@-VI P(5BQC8-&7<H6/EW[0OH^/0_U+U/H:'6#KMC#:6.I6&H20QV
M]U]+J$1D2UOX(998X[RW*LI93&+FW-O>K;VR7*P1S#S:Z\0IBE,4IBE,4IBE
M,4IBE,4IBE0E\@G3*[E7G);.6.I$EZ2Z=V'5="06JG64HH3'YA-+YGC)5\>;
M91+%[2_IV.-;62/1KRK$R.7MI2Q)=D%%J!JT\C]<8Y!Y\C[8^?M_G5EX.0^P
MK[E/N!W+R I4$AB?PDX /)8>:\^7ATHM@D'7K-:=3<E=,P:)\_OESU?>4CZ1
MZGW9E+<]7S#X@=SLNJ+C>,H6)I<;=,CL/K^$5[NVY*J6,L*IP JZ2% >4;4%
M%9N>2N-V2"/;DY )V\C;D,!M"C<3SA=@Y$Q##NO$%,X:1'0"$-)F(2MV TB=
M@2+.L?:6!#(S[2J0_31^N?*5Q:8I3%*J@\W7\FO=W^W?+W]K"D,4JU_%*8I3
M%*8I3%*8I3%*8I3%*8I3%*8I3%*8I7'N[0U/[6Y,;XVH7AE>$*IL=FES2D+F
MUS;EQ TRU O1*0&IU:-6G,,(4)CRQE'%#&68 01;UO'+%%/%)#/&DT,J-'+%
M(H>.2-P59'1@596!(*D$$'!KDV5[>:;>6NH:?=7%C?V-Q#=V5[:326]U:75O
M(LL%S;3Q,DL,\,J+)%+&RO&ZJRL& -4;7UUHI\5%N0NFV9IE5M<_6$S'R6,0
M=XV[ ?J6**<QM>HG6\Z7$K$4NB0C :$@@KE[YWA*;X,!;M\N<VM$?X[K/4K^
MF^J0:3 D^I:)=P"[@L[AI%FTH&5XC:V%ZX99[;V$I:RAGM04'=VR#=^@WISZ
M,1?MB]%:_P!=7][H_1?J5TQ?1Z5JW4%C]$=-Z\9[07G[YZJZ=MW@GT76@K%;
MGJ*T[=CU!+WV>R%U9W<\=QM4W'6-WQ5-,ZKFC),V%1H #CFI4$2UI6; $9K3
M(&D[13K'7Q)[7NUS(]HT#HB-T(I4D*&'>L]5TS5M.UBV6[TV[ANH6 W=MOXD
M3'S'/$V)8)5\-%,B.I\K7PWUCT-U;Z?ZQ+H/6&@ZAH6I19:..\A(@O8-Q"7N
MF7J;[/5-/F_%;ZAI\]S9W"$/#,ZD&LE^NO7T]=>OIZ^GK]?3\7KZ?C]/76]>
MN=C6J8.,XX\9^,_:OW%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I4%N
MQ_'!R9WHN@3GTM"I7)W"M&N9,<16Q.UK0J]4C9K VP;E[4N/K66Q4UY;GK[,
M,FE2)W&M3;TB#H)0=#,T)GC'\_ SQGY\_/(\'C/@5.XA2O&"58G:I;*A@,.1
MN4'<=R@A6(4L"40KO>._'ER_P>5+D_-T=GL<239#&FUZ0S"Y;;M- 2@B(7,#
M"D845F3.5I8T0D*=E9)A; 4W 5$Z2DJM'%HD@29R< ? )('YG /^0_NJQ=BB
MQD^Q'=U&!PT@C5SG&XY$:#!) QD $MF;F15*8I3%*JB[;_E#/#9_YY]<_P!B
MFV\5(\-^G^HJUW%13%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*X
MUX96>0MBQE?VEM?&=Q)$F<&EX0)7-L7)Q_\ ;(6(%I1Z542/_P!HH\H8!?YP
M[S%-##<1O#<0Q3PR#:\4T:2QNOV>-PRL/R((KEV-_?:9=P7^FWEWI]]:R"6V
MO;&XFM+NWE7\,D%Q \<T4B_#QNK#X-18?^$>47I>8\MM0M%>/YOKO<AIMUD5
M+/>S-B +1IJ^JWB(F*AA& (P_&Z4@T+U%[&]B%O>MS]%=,S2=Z/2XK&?! GT
MN6?2I1G&>=/EMU;QX=6 )) R<UZ_IO[1'K)86R6-UUO?=3::F -,ZYL]+Z]T
M\* PV);=8V.MI"A#$$6_:)&!G"KBL+LV[9SXW+3H_=?3#I:X8Y-%+TZOT3MJ
MVDTM@*QL1; T?9MK='N)/4\+=DIK@G=SUQLF+1M0 ,VCR'H+HK+1><]6:K>]
M!:II'T-[U!J4%P)9YK;5=3^JL)8P3%]+$[V[W0F4L)2S3%8\Q'9-W'"?6WH3
MT!T]^U/T?Z@_[2Z'Z4]#ZIH,5C9Z=K/1?1<VB]1P7<ZF]&JW=II^M:?TX]E,
MEM+91VZZ2\]VS7W;DL#9PO/?"PN@GMC9GH;<X- W=J;G032[%%D.C6)P1DJQ
M-SD22:>42X(MF[3+"BCCBRU!1@ &F!UH>_:;>4W%O!.8I(3-#%*89@%EB,B*
MYBE4%@LD>[8X#$!@0"1S7YUZC:#3]0OK!;JVO197EU:"]LG>2SNQ;3O"+JTD
MD2-WMK@)W8'>.-VB=&9$)*CE<S5PZ8I3%*8I3%*8I3%*8I4:.L^3ZK[/J$ZE
M+A/FJ**#EL+G2-TKN9.\ F3+*Z_D".41-[89:Q#*=F=P:7Q D7IE:$TE24<0
M682:48  PJD'&> <@CG/&1C(P1R/(SD9^#46>4/$WSMQM9*.S*BLWK5>M2K9
ML[*(?8G4%HSVLWF06'MS/ETGD%?/;J9&WN3O#H\.,@5/[BB/=#Y(I&_J%)SI
MO:G<@XSP.1CD>.0<C['C&?L2/FK*Y59%"J>X@0EADJ!(DFY#_9;,84GGV,Z_
MVLU9[D52F*4Q2JH/-U_)KW=_MWR]_:PI#%*M?Q2F*4Q2F*4Q2F*4Q2F*4Q2F
M*4Q2F*4Q2F*4Q2NB3&KJVL-8P.$\@,/F2Z*K#E\;5R>.M+XH8U:A.8E4'-AS
MBE4#2;4)S1E'A)$$!P=A]X$6P V'@WFEZ;J#P/?6%I>/;.7MVN;>*9H6(()0
MR*Q4$'E1[20"02H(V+0^KNJNF8-2MNG>H]<T*WUB".VU6'2=4O=/BU""*5)H
MH[M+6:)9Q%*BO&9 60YV$!F!P?9W'U53^4J+*C1\II2Y#] V9;M,/0H5+'09
M._;)*F",DA3&+ 0;,T7H]!-V%]+.(!\. 9(-^NNHU'I73;ZY;4+=KG2-5//[
MSTJ8VEQ(?.+I &M[Q"P&];F&0L 5W*"36_\ 27K=UCTWH\72FJQZ1U[T+$6V
M=$]=V U[1;,.-KOH<TDD6K=-7.TMV[GI_4=.=)&[K*["JRT')WDFJKL]RZ,0
MV>EZ)AR1.F J8G*Q-5<=/XV- Y-H(@*(#:GB%1]>RG*3W@A,!,BBP7%?\V9E
MC<ZJ%1;?YXG3/7NF]5OKL=ZNNP1A=XDOEL&O[8H\?T9MF1[:W:(L9 H46RN1
M)"ZR.W;^L;GUF_96ZQ]"+3TON.D9O3#7)I9C%J-KTP>KTZ;U5;FUNCK@UI;R
MQU[4[;4(XH[&25II]8-M;?17UO=6<4#W,^W3M5? VQ:NN3E7J.N_E:-4M='!
ME@35;\43DHBQ&*CPRBII%*RB$0- $,*UY0,I.B/0\_W -&:+W63J][*-WU;I
MKJ*P[2,\LD-G%J=HBH"6)N[">9%48/OE6),88L >/F^T]!;?J*[@M^A?6+TA
MZG^LGB@L[:_ZDO.B-9EDG8+#&=(ZTTO17DN&)53;V%S?N9#VX^XQ3?@CG#S
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MWKMVG>0A))78 H9I(_<I>,#^BE'_ -8-Q?\ $3(JM/N4O&!_12C_ .L&XO\
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M0Y..,$GCG( P?D#!.1^9P3]A5WV>S8SM[!OWHJ;7R<JN)'WH!C#ML8Y(,:@
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M(RIZEI3QW)[RMZQ1IB5)"44DAESVY&$Z%>X%%&)0PY !4/X<1R4J5;:P.U&
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MWE*DBJ*J#@,, Y& 3G*^X'*X(&<#;R"-K'C."/.9#/,=Y#I;37$55"O=T2]
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M?+8RX\]MIJD,HT<;N"JX9%#!K#!B728+ V%2M2]E)@@RV\_9?[9_ G]L8/\
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M3'[T8:'&!SR.,X\\_D./G\\#[D5(129 98P$#%6(EQ*5. L>(RP+CE>ZL:@
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M:7HZ0,FK3'+!$S**1B/H$7P;TJ^:,!-L #G!++D>X#:=^.<$_P!D'AMN <_
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MY22939_:HO%V%O+$$ ECN_/:I$V-R;0Q@+T:K5% $:,!8=[&,(=L$^!GR?Y
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M**]/B+964H;RZ;D]R5!:QC+-V.[!D$0[F_G>P>?XG*&-\86>-4Y;C YW''T
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MDF*SRY>4F42.Q+F^<G9NRBMJ-%A/V6#9P21"&4$WV=>\T4,80#$7H?M: (8
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M[6G458QFJJ_D!5B&H-V"T1MI:H)7LN50]N<0!7V-"6F4:>DR58^LCM7<>.?
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MIE(!@T<F4DDJT:DOV%*-800K2FDJ22C0<:\LK34+:6SOK>*ZM9UVRP3('C<
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MJ!0IW&4,H5450@0 9 NOR*QU01Y]2R%53<YE/?0$?H*),UF65-W V;,?11T
MM&3Q.BY_N$55*I?SG.ZJDD4')75U4&QA.OLN.F2*5H&=(QM4S<48HHZ3C@GC
MC\QGG[#R?Y>/FK!"5=LJ FW(+*&.XX&U20SX\MM!VCDX%52.5EWC(.N>0W9[
MCUVT7T"XB\+XN2>?5TVN!6ACO/<JC\F%WE&')"YN0PS=KC:0IY:+QDEF$.<R
M;&]EB!LM7HW03>,\<GS]S_?QG_2I8NRAFSM9W(;;A2Y"&3!  ) *$J/P@J<#
M=S;A8ZSKA3Y>_'45T)'^=FBN" ^0,-(K:<E=D/TU<V#^"N*!][:3=-(C'F-E
M=_D88Z;[B*.;XCVZG/)/O])"$1RB*J=N?:21@<D!3G W# 9N V0#G+ !B%)V
MB^+%13%*8I3%*8I3%*8I3%*8I3%*8I4&/(C3T7N_FJ20I_JRP;3=5"TA3"$M
M7((TKF,8F*9&O4LTC+42=R:T:!@V<1\CE!Z4U2O.9GE0E2HQFG!4I=+Z\TR#
M5>GYK:73;_49S(&LETR."2ZMKL1R-%.3.\:I:EE[-T4WNT4I5$+$,OT)^S'U
MQK'I_P"JNE:_IG6'371]G%;R1:_-U=<:K#H>KZ'+/;17VEO%I%K=SW.I".3]
MX:1'*D5M'?V$4TTX2-HIHQ^+&1!HVN(]Q_;E92>D+E*W)IO'B9F42F276U'K
M-&N[_%UB<]2W;D,82@2M;]$25RMR2,K:AD96U"!4NVV]!Z<7(TBQBZ9U33[G
M1]6+7%Y"MVI1=5C9LR2V['V]ZW11'+;JS.(HUG7*F01^M?M?Z8?4+JG4_6[H
MKJS2?4#H5QI.@:G)H3R2S= WD<!2RTW5H)8X;K]V:M,TUWIVMO;0VD]_=W&E
MN(KF&W%U<'GJ=?$-,4IBE,4IBE:"A*F5@T4J3D*2]"T/1:@HLX&AZUO6AZ 8
M$0="UH0M:%K7KK0MZUOTWO+*S*<JS*<8RI(./MD8XX%, ^1FJ^8^G*YL[H=8
MHF+TV5)VVP+YI'DA0 @:F;I^KFDH,Y0I2"M (;1VA4Z1ME!FS-:^9OU?OAY?
MMJUAVQ[]<,>H^AXKICW=6Z*N([.X8\RS=,ZG*38R.QRTHTS56DM1@GM07\"G
M"(M=(@%AJ[Q@;;;5T:9/^%=1MU F4<X4W-J%EQCE[>1@<L:L-SS^N[IBE,4I
MBE,4IBE,4IBE,4IBE8?O,^T4T!4'5.BJ]P> .[**4I;<W*MQ0RMM+R]V)\.1
M#T+D[+)'J*:<?LVA-2&-BQU]PG<]Z2&&>LC;SNSC!QC'XL';G/QG&?G&<<UD
MB[.YN]W-O;EV=K;N[W;;L;M_';[NSNX]W;W;/=BO.CXH>=VZ>]*57U-"VSQ3
MRR U37#_ %XV/7'E_=9S>Q:[2FQIZC# F_@KM1PW$8W(DC2Y @#BOFS,BF3+
M7)9$2;3"4#6UH"+LS>Y6SXP/:H/M8#!.,@84Y"G!?DY))/-N)IA]1!<]S<%$
M41,-NC$P3)%M=PK,L*K#+NCAE9#=#>Q=C*[>H[,===3%*8I54'FZ_DU[N_V[
MY>_M84ABE6OXI3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*X*41B/36./D0EC
M.@D$9DK4M9'YD=$X%3>Z-3BG&E6HE9!FMA,)/(,& 6OH(/KH0!!&$(M8+FV@
MO+>:UNHDGM[B-X9H9 &22.12K*P/P0?U!Y!! -=CI&KZGH.J:?K>C7UQINK:
M5>6^H:=J%I(T-S9WEK*LUO<0R+RKQR(K#R#C# J2#4%,.UU'C7<6GG2\XK/K
M9BNP[-YYLN/+XP<\NM9%F!1MT*L,4D?F38II 3@@CVGTH0BI4QZ9G0TA*XB6
M@-\LNNKI/3]TT'5[:[U2V4%]$OX9(>\^FYV16MX)&3-Q9$=@S#"S1")RJ-NS
M]MZ'Z"1_M5VU[ZH>GFL=-]&:P"$]3>E-3MM7CL;/JUU,]UKW3*Z3INH :#U)
M&QU0Z>ZJVCZ@;^S22:U%N4N"CSJ-]8&-\,0'M1CRSMCJ-L5*$"M2W#<41"P2
M!0J:U2YL4GHQ';3G*&Y:L0'&%B,1JE"<19P_5+:8W%O;W!0Q&>&*8Q,R.T9E
M17V,\;/&Q3=M+1LR,1E692"?B'4[-=.U+4-/6YCO%L;Z[LUNX8KF&*Z6UGD@
M%S%#>0V]W%'.$$J175O!<QJP2>&*4,B\QF:N#3%*8I4 KGUJJ>YN6+;)U[AE
MO6,6!RA.U ]["FV[I4"NZ*:4&>SZ:^, Z1:Q(^E&9[7M?:GW /06P^N^:.?W
MIT1U1I)]TVAW5AU58J,[A$TB:-K"C_L&*ZT^X8<8^ES72W7^[:QIUR.$O(Y]
M-F)\;@K7EH?R8-%<1KD8)FQD':#/W-#KNJ8I3%*8I3%*8I3%*8I3%*8I3%*8
MI3%*P)TW ;#L^DYK!JPNA'SY)WY.WIS;975]$;0+C$:)=42F7Z*AT]'J&K5;
MO&"75F2+I&0X-C(>X >3VMST@TA/D8^1G@_..<'!_D<''SC%60J"2Z[QM< ;
MBN&9&5&R <['*OM\-MVD@$FHV^.[@+F'A"!3E%S>_P AG!UQR1OG5FV/(I>S
MR-1.Y06WF;1O)#3#&^.UK%TYB%U&>0@@D1CK>H2*TIB@I8$I&<!DX ^ 2?YG
M&>?/P/Z)J2[%%C)]B.[J,#AI!&KG.-QR(T&"2!C( );-AN15*^#"BC@^P<66
M:#V@#]@P 1A]LL83"Q>R+6]>T68$(P"]/4(PA$'>A:UO2E-E%B, :(L&S2PC
M"69L =F "9[.S @'O7M!"/8 ;'H.]:%[ ?:UOV=>BE57=7?RHGB5_P!2^0/_
M '*UUBE6J8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*PO>E&1*^H<"-2$]S8GMF<
M4\D@,_C1X6^:UO-&[U$TRV(N^@[-0N*0>Q$JT^]B1/#8<L:'0E0WK#R1=1K6
MC6VM6GT\[20S1.L]E>P-LN["[CYBN;:4<HZGAAG;(A9&&#QOGIYZA:UZ<ZXV
MJZ7'::C87]K+I74?3>JQFYT'JG0;K"WNBZW9$A+BUF4"2&3B>QNXX+ZSDBN8
M(Y!BJB[SENI:IYUZ));6*_8\VGN3$_-Q.T$.OR$(1A)U8M?EF"V6C=2-;"&=
M0'1YSE$W'VU1&E$?5(U1?6:+K5S]4V@Z\J0:W A>"9!LM=;LTX%]9?V5E _[
M\LP2\#AG0&$_P]Q]0_3W1?W+%ZG^F$EWJ/IOJ=U%::CIUU)]3KOIOU!<*9#T
MOU*R@-/9R$$].]2&..TUJUVPR&+4X9X6E[FU5XE3%*8I3%*8I4+>^8+()+SR
M[SR!H]*K4YYD4=Z+J[0=?Y<^2U0K$^.S"5O6O:$":0?<MA"@C6] /(D8P&!&
M'^+O<N@[ZWMNH(;&^?9I?4%O<=/:IG.U;;54$$4Y_P#S.^^DO5;'M-N",'D=
M5K,+R6330KNN;%X[ZV'R9+8[V0?_ &:'NP'_ +,I'S4HJ]G,>LZ!PNQXDL X
M1>>Q5@F$>6EB"(*EFD;6E=VXW>P[WK0Q)597O >OJ SV@"UH0=ZUK&H6-QIE
M]>:==H8[JPNI[.X0@@K-;RM%(.<' =#@_(P?FNP@FCN(8IXCNCFC26-A\I(H
M=3_<17<,XE9:8I3%*8I3%*8I3%*8I3%*V;@4L/0+B&]6%O7G(U)2%>-,%8!$
ML,)&!,K&D&,H"H*8X0#A)AF%A/T#90A@T+8M*53_ ,<^.OEZMNF7SJY\Z,4]
M9=OHD4FBDSL@#W6$(;(X:-&C8Y:S(:.HQ!&XPQ_!(G=K0+RIZ7-Y,U'N*)0H
M?BUZY.<*Y=L$ !588( ." Y8<L6.0> <YP-I)&<\QKF812(D26]O<1K&Z1Q$
MI(BW+SQGN3&60NDJM&LHD[G:B,+.R"16N,RE<.F*4Q2JH/-U_)KW=_MWR]_:
MPI#%*M?Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2JN^]?&LA[CF<(EBV
MTT%<;A,:/8$VDU9D2=[7C4NBER,-6/\ N9QT1S:1LPG3<RJV]8G;E(G16G/U
MMY6$[\ZZRZ 7JZ]M;MM473_I;;L!5T];F23,KR$O,;J E!N 2(HP0]QE8=QA
M7UU^SE^U7<_L^:%K^BV_2%SU2-?U6/4I3+U9)I-A;+%9Q6JI!IHT+5!'=R;7
M-U?P7,$MU$+2&2/%C ]9<HJZ))6+Y'.6^E$;3%K!;4)3%45D,[03'JKOV,,:
M?25L%%"TP0L\0L=O:DQ&I-5.SBC4FP?,HF6NCYY($78Z+JT^FS6_3?4"16M[
M%&L&E7\48@TW6;:%=D7TP7$5K?)&JB?3L@J<-;AHF4#2?4/H32NK=/U3U>]*
MI[W6.F;J=]1ZVZ6OKU]3ZP]-]6U"4S78UEI2;[6^EKF\ED.D]9!'28-])K3V
M^IQNUQ-G3LU[<Q,FG)OV\A1!<A-&EB?;F%N&<-.!>)![SXK2(:@LP@*K97N!
M' &5HS8PB#K<.[%W>QW8^]L[G9WKW>V25#]O._86!&[&W((SFO!/H[SZ07_T
MMS]"9S:B][$OTANE196MA<[.R9UB99#"'[@1E<KM(-;_ #)7&IBE5J^5Q1,(
M_P H'V=!5\";I%1EFUS>B$Z=.*IM&I/JQZ%*"FB(FISTQ:N42 :/3!\J4FZT
M\1USD#8B_P#2JI +7H_I8MG<=5+IE\E_);ZYINHZ&ZV,:2!5U2'Z4RW896*6
ML ?O]U0>S<1V\K_PDD%=#U&98]-:YA,*R64\%Z.\2N?I7[I2(@@&23;V]I_'
M&\B+AV6I5\QSZ=VC344G]A.U2O3W*4^W=,MI5>\.4("TJRB342(*M\6+U8WM
MO$(]$^ +5&)B%Y!A)7ILL>M:MU+86.F:Q=6&GQ:M#!:MV6364ACO3*A8.^R!
M(T$$@VO 2H9D8,?(KLK"::>UCFG:V=Y!N#6K,T.TX*@%R3N'(;DC(X^U9_SH
M:YE,4IBE,4IBE,4IBE,4IBE,4IBE,4JKOS(,38^\!6G\]D;4P1YAEM-RV1(I
M9$+/G-93ABBEO0I^<JTN>/TRU/=FCIFP4Z$46LISBC4XGL<8<ESPYM[DQ(71
MM5R,YX..#Y.. "2,_F. /DG Y-7C#%B$8(=DI)+K&"HC<NNYF4$N@9 @.Z4L
M(E5F<*8C^ NC'2O*8GMF*+JY5LIGL",T/7S'&..;'>K.JN/(J*A#K#T4ME3X
M]I&8Q';,O8G!CC\B8D$8CB1BBU?PII4D+G-(M4%N>/RX'^?^O^-02Q5<YVJ"
MB''& Q<J#CD@OD^2-P^,5?YD56F*4Q2JJ^KOY43Q*_ZE\@?^Y6NL4JU3%*8I
M3%*8I3%*8I3%*8I3%*8I3%*8I3%*I\\H?-/9%]2:@7GF*1H&Y!7[PO<5(2'H
MB)R**R]4K0EH9NED)ZCWQB,AHTH0F)VLI.O1)RW(D>G=,_B1)O+/430.J=8N
M]$GT"0=NRD=B(YUM9[2[=UVWG>9U+)VP$Q'[XMK\.)L+]O?LC>JWH7Z<Z3ZD
MV/JWI=U=W/4EC;6L1DL)-9TK6=$A@N'N.GY],CC[:SO>]JX26\:2VGE>TD7Z
M*731<22SHZ_YDVS%/S?T^F:HU?"1O/5PZ7MA8T->]$1ENT !LK@!RCV2F^8(
MR]Z,FM:&G#>&0P)KRU%K8V=HY#LNC:Y=QW:Z!U&L=OK2(6M;J/VV.N6Z8!N;
M)F"A;I1S=6..Y&098P8B1'XQZ@>FVAW>AR^J7I)+>:KZ=3W,<.N:)=NMQU-Z
M8ZM=%BFC=2QQ9>YT2=O9H'5B(MCJ"E;&\:WU6,QW$T,VZO"*8I3%*8I7P866
M<682: !I1H!EFEF!T,!A8P[", P"UL(@##O81!%K>A:WO6];UO)!((()!!!!
M!P01R"".00?!IY\U ?@ PR#Q"X^7UHC *N5+OF%=QHA2(8EAE02[X6TZ96&;
M']!)T\(FB6+)3"_\F+[*G UH(RQAUO?7H%[=Z/U,@RO5.B6>HW++C8-7M-^E
MZR@QX9KVR>Z8'D?5*?D5TVB_P8KK3SD'3KN6",'R;63%S:']%AF6('[Q'P00
M)]YH==S3%*8I3%*8I3%*8I3%*8I77)B0!5$92F,<'1I+4QQ\(&ZL8!&O38 Y
ML5%B<&<L)1XC'1$$6U+> ))PAJRR0Z*,WOV-JD'!!(! (.#G!_(X(.#X."#]
MB#7D'\'O)<11]2Q6Q(/UEQ?,(S00Y\M15]2;/9]:=6S=UF'/E3\]/!W2=+VF
MGC4E@ )!JJD=W60F6(I?J47X<JDJ=U(2%)=(+MG+Y!))R<MNP=WEB.&/)4D_
M)/S7*GW++=HZN[,Y<DS][MMW0>Y*Z$K+)AVB9G(PTKY42$ >QO*5Q*8I3%*J
M@\W7\FO=W^W?+W]K"D,4JU_%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*
M8I6/;0JJOKGASC K-BS;+(NY[+,,0.!8PG(UR?VA(G=G<$XR7%D?&TT7Q#6]
MM*I&Z-JC03T2LDW7M9P=1TRQU:TDLM0MX[FWDP2C@AD<9V2Q2*0\,T9.8Y8V
M61#RK#FMFZ1ZQZFZ$URUZCZ3U>[T75[0,BW-JRE)[>7 N+*^MI5DM=0T^Z0=
MN\T^]AGL[J(F.>&1#BJ5''QY=+4#V,P=85M.99TC!HVH3&+8,_6&E8[R<&,J
M-'QD+".02EL^Q4T3MJ/1&C%+L[1QZ?VSWC8(\EX-&_F^1R]"Z_HG5$'4=A=7
M.O6EM(LC6\M^(M9DB$+0&W::XB-M=)&F Q:2*2>+,:JDI[H^];7]IOTI]2/0
MS4O1GJKI[1O2SJ'58Y5M^H=.Z8GU#T]MK]]6CU4ZD--T>[.OZ#)=S]PK%966
MJ6&FW>V[$<EB@TY+)H_W?SPI5D,MBOT@Y[EIH0^]B7146>*A7DFB#Z[*3/TG
M((A#Y_&UL!:B.2IX2GBUK:<\T(RQ#WZ#K706=8;^:?0[HCFUUVVFTQU/'B:X
M46C@GA3'<.&^,Y&?E;4OV=O4Z&&6_P"E].TWU,T5&(36O2_6+'K>V= >'ET[
M2)).H-/X(9HM5T>QFB!(EC0JP7+U/]%T=?P9,*FK.BEA_8]STTR,,<<0JC&U
M2,:@"8\18PEF*&MQ$C5[:7I($]G=PI5(VU<J 0:('::5K^C:Y]2-)U"WOC:2
M=NX$+$F-B2%;#!2T3E6[<R!HI-K;';!K2NM_2_U!]-CI(ZZZ2UGIC]^6GUFE
M'5+4PK=Q*L3S1JP+K'>6HGA^ML)C'?61FB6[MX6D0-B?NVJ;-O/F>Q*?K%/6
M0U=B-*Z.29PM26R^&L;!&CVMP4BD3>YPV/R)<J=V9^3,2T+2XI4S$Y-A;FG=
M5?PXMI57H?16LZ3T]U#9:YK$M_%;Z4XO(OW?;65R\DT;INBG%]<VL,5N]L;@
M/.KF:%^V\:@C>OF6IV5YJ5H^GV,4<T]Z1;".1IPS=W*H(5MXY)))C*8PD6W$
MG*G.0I[MRA"+#K*A*[KBR6RO6EV@+ VP]F25E)Y7+XO]DH^W(VV-F%ODS8X^
M^GK1H$^M*2CD)A) 0D@)6J]>IF<3JB_TW5=<O]3TN:_GM]1F>]DEU&WM+6X:
MYN7:6<B*RGN+<1EVRC+("V22J^*R6$%Q:VD-K<QQ12VZB QQ/*Z(L7L5<S)'
M(& 4!E9<J1C)QFI%YK]<RF*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*563Y,;2NJ+T[
M)8'4L:N9E62]G@Y#3;M)VISO64\,EDANVN8$12]?NW03B"/,]C6(QR=TU')&
M>T+RT_PYS8P"%-E\<2GW10022"0&PF'R0$=BV54@!"HR#C.03A S#F6T$<J2
MLTBF1%EV6VRY+NBV=U,UP'AAE14MWABW*Y4,9 TACMTGFCP;X=J]K6HV[H:
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MP2./&&%%%OK,,T]FW(R"P.B$1AT>"(H(GTH 3]B,9@B/)#MT!H2'0CBM;/\
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MTL%'Q(WAO4A?0MP!F.&V81"@>G/2 !8QK-HMGZ2@ ,1_L:#O>G^GF@!.2 2
M,D@9P,@9/V&2!D_) \D5]$2>-JOE7PLA8U/SQ6X(&3W#L@.^<+FD*P;JB:O=
MJ!?,%;8!N<!."=)[XY&%"L$I 7I,?L$X//!X\\>/U^U24<%@48% "P*D%0<
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MXS54OD:B8"F9#*>E5UFG:F]0;8*!A^=EE3!7' K"XL>VO1;O\/\ *U.]5Q@
M\<Y^03Q]P.1^6<9\^*PE"JHY*$/NP Z,PVG:=Z*Q:/)_"'"EA[E!4@G5E%QM
ML6)M$XZ!VZ]:JIOCC@X%QBL92_G3/4E3#5$(ZO+0HQ[L-P:0 T7(TD;^+&Q*
M3 )E^RC_ &P D*3C!7G=C+*,;1DYR1C/QG&X\#)XJ\<#R&,*T([@E*]RX@B
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M16<-OV8H@(#%RTP$/-$./A&K4BTWZ$>9L456M=/5M9I#D:E+7D'3*&Z![JU
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MS:*;P_+)E(]RV4[?9,B]R\NNY(^[7+3_ )JN]_;<W/N;E0IY/*@ !3SRH"J
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MC7,%M/!,!.G3HTY"1(02F2I22DZ9,G+ 20G3D "420027H)91)180EEE@"$
M !"$.M!UK6;2JJBJB*J(JA550%55485548 4      # XKQ"662:22::1Y9I
M7>6665VDDEDD8L\DCL2SN[$L[L2S,222236MEJI3%*8I3%*8I3%*8I3%*KY\
MF?2EG\N\S)IC3(*\)LRP;LH.A(H_6PG<5]=0U;>=K1BN#YM+&IJ7-2YX:HNA
M?53H:VENS86>,DL:A5M.4:G/D8SR"1SP" <X..2&\'!(QR,C(SD7C,88&57=
M,-E8Y%C8DJ0A#M'* %?:S#82R@J"A8.M)OAJJS<OZOE=YQ+FO@;F5%5DSZ%H
MJY9M3ZAWDEG=8VM"9-)X3))=0,)D#ZO;N;>>M.3<UR%Q31U(6^RQY9#60L6X
M;H1:6S$'<?<0>1N8DJQ*EF)  ;/*YX)X) ( KDRR1R&=D$TJ/ET$\K22V\KO
M;M+/(Z1I%+W2'@#D*7RKR(CB,'U<92N'3%*8I54'FZ_DU[N_V[Y>_M84ABE6
MOXI3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%
M*8I3%*8I3%*8I3%*8I3%*8I3%*A=U)X[N*NUGV*2;J?GJ$W0^P9I7L43<I4:
M_EJ&-I=%A3@X(4FF=Y:R]DJEA!2@S9P#1Z&#7LC"'UUM2NQ\L\-\G<3-TQ:.
M5J1B=+-M@+6=QF2.*FO1A3^NCY#@F9E*S3PZN@@F("'1P**VG$3H05(_>:'L
M(-A9.,9XY./C)QD_SP,_H*G<VT+D[02P7)VAF"AB!X!8*H)')"J#X%2NQ44Q
M2F*557U=_*B>)7_4OD#_ -RM=8I5JF*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F
M*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2L,WYSO2/4=;N-0="
M5K&+:K)W<&EU<X7+T@US(M<6):6XM"L].6<0(1S>N*+4I]^\UH)H-;WK>OIB
ME1NH?Q<>/?F"RFFX>?N3*AJBSV)$ZMS1-HBR*$+XWH7QM4,[LE3J!K3@A)7M
MBM2B4 V6+0B31!UZ;]-ZD$C(!QD8/YC(.#_, _J*NKN@D56*K*@20 X#H'20
M*WW DC1\?\2J?BI[Y%4IBE,4JJ#S=?R:]W?[=\O?VL*0Q2K7\4IBE,4IBE,4
MIBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4
MIBE,4IBE,4IBE,4IBE,4J '?_D&KWQ_16I'Z9PQYL!XNFRU%9PV,L\YJ.MP:
M7H(5*)TZ/3U-;OGM;5VPLK>V1@:(1[Q*T)BQX=F9J;RU3@XI4QS[\_Y\\^!Q
M_/G P#SG ,@ AB6"[1D [LN=RC:N%(! )?WE5VJP#%BJMAU?Y:JO9>BZZY[?
M*9MEN')9!S56%D600X5J\0BE+^ZV@SO/J1I25B9IPN>),[/;2RFI'B9P!NDT
M!97-XC!&Y"K)?-*$DD $C(.,X(SAN<9&0#SYY ./(!XJ[(JO(HEC<(6"R*)0
MDP5MH,8>-9 ''O7NI$0O#A7]M=+ZRMNJB?*!XLCCK-KXHJ+M_?B&3&FS..%E
MQU:II^OT2=&^C&Y:"T*E"U.>D)3N&TYIJH@Y.6 1I8P!BJ$$<$$' /(QP0"#
M^A!!!^001Q5G/X0%#_GLJ/\ 61#?WSBHI^$!0_Y[*C_61#?WSBE/P@*'_/94
M?ZR(;^^<4I^$!0_Y[*C_ %D0W]\XI3\("A_SV5'^LB&_OG%*?A 4/^>RH_UD
M0W]\XI3\("A_SV5'^LB&_OG%*?A 4/\ GLJ/]9$-_?.*4_" H?\ /94?ZR(;
M^^<4I^$!0_Y[*C_61#?WSBE/P@*'_/94?ZR(;^^<4I^$!0_Y[*C_ %D0W]\X
MI3\("A_SV5'^LB&_OG%*?A 4/^>RH_UD0W]\XI3\("A_SV5'^LB&_OG%*?A
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M("IR,$8)X !)Y&#EL<8 8Y^,C[GG-A*@5D:-G!6-49I,M$%?N2B/*%565R[
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MY4TPIBE3BW.3P\L*YM*("HVE"I8\^./S'WQQ]_/QSCGP#5=ARXROL!).]0"
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MU+RSQCC&<^!G[><9Q^6<?.,U.\[.WA-N_?GMIOSC;CN[>YLQ_P"#W[,^[;N
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MQ:C#(Y,AQ>KH'LYX3J359#Q'B'IL,;W!6XG+(_U\U 9@& ) 8;6 ) 9=P;#
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MX1:T.V<]&D,0;($E(V6#N!@,P&",!B!AL@C&<8()R/G)S1+FYC4)'<3H@61
MB2R*H296250JL %E5F61<8=696!!(KK=YT+ ;)N'FVS),G5J'N .EO5]IN"!
MH41^95W=-2R%ML"OYTUNC2X[?(B\*XE$) -K(4-WMOL593U1RI"4J;U< X_P
M(/R"/D'^A_, C&DC(#M #91E?D21NC95XW4AE/D$9*G(8KO2-D[&=R/RLH3K
M$A_-U%')7"+5Y!UZ<VJ(,,E;#*B5MB^JHFK+$Q["HCE;+F5G605E-T-NBBEJ
M;3V-.A,0IA%3N;_B;R3Y/D^3Y\GY/DU?ZBX#;A/,&WO)N[K[NY("'?.[.]P2
M';\3 G).:X'D6F(93E9R Z*!<E#K<5L6E?=COSTJ(6.\FLBTY<X/<A<U1B5(
MA2$HT*<#9&X^WI49!#5&&%E;->_,2&*CX8Y.0H7@#"YQP ,\DG)QD\^2<8&
M*RR+*Y=8HX050".+N;!L14+#NR2/N<J7?+D%V;:%7"B4F16.F*4Q2F*4Q2F*
24Q2F*4Q2F*4Q2F*4Q2F*5__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g904779g27g29.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g27g29.jpg
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M.T=R87!H:6,@='EP93H@(" @(" @(" @0F%R($-H87)T)B-X03LF(WA!.^*
MHB Q(')A<W1E<B!I;6%G97,@:&%V92!A(')E<V]L=71I;VX@8F5L;W<@,C8U
M+B8C>$$[)B-X03M4:&4@9F]L;&]W:6YG(&9O;G1S(&%R92!P<F5S96YT(&EN
M('1H92!D;V-U;65N=#HF(WA!.R @(" @(" @("!(96QV971I8V$M0F]L9"8C
M>$$[)B-X03M4:&4@9F]L;&]W:6YG(&-O;&]R<R!A<F4@<')E<V5N="!I;B!T
M:&4@9&]C=6UE;G0Z)B-X03L@(" @(" @(" @0FQA8VLF(WA!.R @(" @(" @
M("!#35E+)B-X03LF(WA!.U1H92!F;VQL;W=I;F<@:71E;7,@:&%V92!B965N
M(&9L86=G960@9F]R($-3.B8C>$$[)B-X03M%;6)E9&1E9"!I;6%G92!I<R!L
M;W<@<F5S)B-X03LM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TF(WA!.SPO<F1F.FQI/@H@(" @(" @(" @(" \+W)D
M9CI!;'0^"B @(" @(" @(#PO9&,Z9&5S8W)I<'1I;VX^"B @(" @(#PO<F1F
M.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U
M=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7!44&<](FAT=' Z+R]N<RYA9&]B
M92YC;VTO>&%P+S$N,"]T+W!G+R(*(" @(" @(" @(" @>&UL;G,Z<W1$:6T]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]$:6UE;G-I;VYS
M(R(*(" @(" @(" @(" @>&UL;G,Z<W1&;G0](FAT=' Z+R]N<RYA9&]B92YC
M;VTO>&%P+S$N,"]S5'EP92]&;VYT(R(*(" @(" @(" @(" @>&UL;G,Z>&UP
M1STB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O(CX*(" @(" @(" @
M/'AM<%109SI.4&%G97,^,3PO>&UP5%!G.DY086=E<SX*(" @(" @(" @/'AM
M<%109SI(87-6:7-I8FQE5')A;G-P87)E;F-Y/D9A;'-E/"]X;7!44&<Z2&%S
M5FES:6)L951R86YS<&%R96YC>3X*(" @(" @(" @/'AM<%109SI(87-6:7-I
M8FQE3W9E<G!R:6YT/D9A;'-E/"]X;7!44&<Z2&%S5FES:6)L94]V97)P<FEN
M=#X*(" @(" @(" @/'AM<%109SI-87A086=E4VEZ92!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(#QS=$1I;3IW/CDV,"XP,# P,# \
M+W-T1&EM.G<^"B @(" @(" @(" @(#QS=$1I;3IH/C4T,"XP,# P,# \+W-T
M1&EM.F@^"B @(" @(" @(" @(#QS=$1I;3IU;FET/E!O:6YT<SPO<W1$:6TZ
M=6YI=#X*(" @(" @(" @/"]X;7!44&<Z36%X4&%G95-I>F4^"B @(" @(" @
M(#QX;7!44&<Z1F]N=',^"B @(" @(" @(" @(#QR9&8Z0F%G/@H@(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1.86UE/DAE;'9E=&EC82U";VQD
M/"]S=$9N=#IF;VYT3F%M93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O
M;G1&86UI;'D^2&5L=F5T:6-A/"]S=$9N=#IF;VYT1F%M:6QY/@H@(" @(" @
M(" @(" @(" @(" \<W1&;G0Z9F]N=$9A8V4^0F]L9#PO<W1&;G0Z9F]N=$9A
M8V4^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT5'EP93Y4>7!E(#$\
M+W-T1FYT.F9O;G14>7!E/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z=F5R
M<VEO;E-T<FEN9SXP,#$N,# P/"]S=$9N=#IV97)S:6]N4W1R:6YG/@H@(" @
M(" @(" @(" @(" @(" \<W1&;G0Z8V]M<&]S:71E/D9A;'-E/"]S=$9N=#IC
M;VUP;W-I=&4^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1FEL94YA
M;64^2%9"7U]?7RY01D([($A60E]?7U\N4$9-/"]S=$9N=#IF;VYT1FEL94YA
M;64^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D
M9CI"86<^"B @(" @(" @(#PO>&UP5%!G.D9O;G1S/@H@(" @(" @(" \>&UP
M5%!G.E!L871E3F%M97,^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @
M(" @(" @(" \<F1F.FQI/D-Y86X\+W)D9CIL:3X*(" @(" @(" @(" @(" @
M/')D9CIL:3Y-86=E;G1A/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D^665L;&]W/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D^0FQA
M8VL\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \
M+WAM<%109SI0;&%T94YA;65S/@H@(" @(" @(" \>&UP5%!G.E-W871C:$=R
M;W5P<SX*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR
M9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @
M(" @(" \>&UP1SIG<F]U<$YA;64^1&5F875L="!3=V%T8V@@1W)O=7 \+WAM
M<$<Z9W)O=7!.86UE/@H@(" @(" @(" @(" @(" @(" \>&UP1SIG<F]U<%1Y
M<&4^,#PO>&UP1SIG<F]U<%1Y<&4^"B @(" @(" @(" @(" @(#PO<F1F.FQI
M/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP5%!G.E-W
M871C:$=R;W5P<SX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR
M9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS
M.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(@H@(" @
M(" @(" @("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O
M,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(*(" @(" @(" @(" @>&UL;G,Z<W1%
M=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C
M945V96YT(R(^"B @(" @(" @(#QX;7!-33I$;V-U;65N=$E$/GAM<"YD:60Z
M03-$,D(U.$9#1D(R14$Q,4)",C8Y13E%.44Y,SE$0S(\+WAM<$U-.D1O8W5M
M96YT240^"B @(" @(" @(#QX;7!-33I);G-T86YC94E$/GAM<"YI:60Z03-$
M,D(U.$9#1D(R14$Q,4)",C8Y13E%.44Y,SE$0S(\+WAM<$U-.DEN<W1A;F-E
M240^"B @(" @(" @(#QX;7!-33I/<FEG:6YA;$1O8W5M96YT240^>&UP+F1I
M9#HS139#-D0P-$,R0C)%03$Q0D(R-CE%.44Y13DS.41#,CPO>&UP34TZ3W)I
M9VEN86Q$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ4F5N9&ET:6]N0VQA
M<W,^9&5F875L=#PO>&UP34TZ4F5N9&ET:6]N0VQA<W,^"B @(" @(" @(#QX
M;7!-33I$97)I=F5D1G)O;2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(#QS=%)E9CII;G-T86YC94E$/GAM<"YI:60Z,34T0S4V0D9#
M.4(R14$Q,4)",C8Y13E%.44Y,SE$0S(\+W-T4F5F.FEN<W1A;F-E240^"B @
M(" @(" @(" @(#QS=%)E9CID;V-U;65N=$E$/GAM<"YD:60Z,34T0S4V0D9#
M.4(R14$Q,4)",C8Y13E%.44Y,SE$0S(\+W-T4F5F.F1O8W5M96YT240^"B @
M(" @(" @(" @(#QS=%)E9CIO<FEG:6YA;$1O8W5M96YT240^>&UP+F1I9#HS
M139#-D0P-$,R0C)%03$Q0D(R-CE%.44Y13DS.41#,CPO<W12968Z;W)I9VEN
M86Q$;V-U;65N=$E$/@H@(" @(" @(" @(" \<W12968Z<F5N9&ET:6]N0VQA
M<W,^9&5F875L=#PO<W12968Z<F5N9&ET:6]N0VQA<W,^"B @(" @(" @(#PO
M>&UP34TZ1&5R:79E9$9R;VT^"B @(" @(" @(#QX;7!-33I(:7-T;W)Y/@H@
M(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#HS139#-D0P-$,R0C)%
M03$Q0D(R-CE%.44Y13DS.41#,CPO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @
M(" @(" @(" @(" @/'-T179T.G=H96X^,C R,"TP-BTR,%0Q,SHQ,#HS,"LP
M-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O
M9G1W87)E06=E;G0^061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S*3PO
M<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T
M.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R
M9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB
M4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A
M=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II
M;G-T86YC94E$/GAM<"YI:60Z03-$,D(U.$9#1D(R14$Q,4)",C8Y13E%.44Y
M,SE$0S(\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IW:&5N/C(P,C M,#8M,C!4,3,Z-34Z,3(K,#4Z,S \+W-T179T.G=H
M96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D
M;V)E($EL;'5S=')A=&]R($-3-B H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E
M06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T
M179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP34TZ2&ES=&]R>3X*(" @
M(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(#PO<F1F.E)$1CX*/"]X.GAM<&UE
M=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_
M/O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! ?_  !$( 5,"7@,!$0 "$0$#$0'_Q  ?  $  @(#  ,!
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MO .'W!VG'''&V5N9;;6M:TIPI2LY<#O-\H_:G&WS_(?V+E_ND]2__P \._\
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MS$M&Q6"<V)#V!\R!C(F'\M8A&LNX:R]ZS+?K&_/Y?+YT>/FP+-@3OT&_3_5
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M>S78RRZ6[0!";AV#L.KVKH14MPQP5EV'*[U*A=P-[_US!2XF96=TWK: JES
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MP[=R_CXM^3.7%MM_.\W59[H9V=;%J[[",QKVG265&6^R)L!S<26L\J=1[A[
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MYO56L,$Q$,D?>AA)_BI>.)W\YA4[\IU@"Q*P7RG54MD&Q6*,ARR!\%LCFO\
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M0_YXF.36=#[OZ@I3^H]S]956.>UX3A$X1.$3A%-G77[L-2_\,_\ HS,\\O\
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MW3A%@NT-@PFI=9[$VK91Y(NN:RHMNV#/BPK Q4P3"4R D+'*CQ(QAD>&1)/
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M-*<:5EM2VVUY1G&5(1G.4XZ!A]3?KJ>&*=F2TJ&311RM#K^5#@V1H>T. PA
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M1,BS9XJEBAHSE+2R5-9)(SC/^4(==<S\5<GVF&.9S2]SR WV3SNX[M!YGT=
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MWNO_ ,TA_P \3')K.A]W]04I_4>Y^LJK'/:\)PB<(G")PBFSKK]V&I?^&?\
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MT^3A$X1:D/3@_P '7M;^=>J?UB5_FYNP+^4W#_W/,?-EE:<[>OY-,Q_>\/\
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MI#\+=+_E%A/G.JOTE>?+E?3Y.$3A%J0].#_!U[6_G7JG]8E?YN;L"_E-P_\
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MP\<9\P^7]J<#?-\I_:GTOP+^55V=_P!SZM?X8>.,^8?+^U.!OF^4_M7>UKI
M749H.P0/;/LV'*@8(P*0N,ZIE);]K%?"?\6"NKKS"_.,0\WCSMJ\N5>=/@M*
M58%Y/(@?+^U.%O([=/25*OT"MH_RS^ROY+=//\*'/.X\P^7]J])] K:/\L_L
MK^2W3S_"AQN/,/E_:B?0*VC_ "S^ROY+=//\*'&X\P^7]J*LO9CT9-0[?0U7
MK^_NSG9^Y15-DSIBO#BXZS5=04A)"-A&/+?JW6F'?+PZ,RVC#1;C[3>4^=M"
M5YRK.5Z5UMJ/14]NQIR['1FO11PV7/J5+8DCB>Y\;0VY#.UG"YQ.[ TG?8D@
M!8KJG1>G-9P5*VHJ+[T-*62>LUENY4,<DK!&]Q=4G@<_=H V>7 =0 >:I]]3
ML],?E=[6?EEIK]@_,U]?GM/]OX/B;#?N"POUB>S'V@F^.<U^_I]3L],?E=[6
M?EEIK]@_'K\]I_M_!\38;]P3UB>S'V@F^.<U^_I]3L],?E=[6?EEIK]@_'K\
M]I_M_!\38;]P3UB>S'V@F^.<U^_I]3L],?E=[6?EEIK]@_'K\]I_M_!\38;]
MP3UB>S'V@F^.<U^_I]3L],?E=[6?EEIK]@_'K\]I_M_!\38;]P3UB>S'V@F^
M.<U^_K(:CZ +J91K76+M6=T=J@+)3K#"VFOG+M.D3$!3=?DAI:*+6(9H)\,I
M(YX@[RABF'AG\(RT^TXTI2,TUWMN[2,A3MT+><ADJW:T]2S&,1B&&2O9B?#,
MP/92:]A=&]S0YCFN;ONT@@%5-+L5[.,?<J7ZF#ECM4K,%NM(<MEWB.Q6E9-"
M\L?><QX;(QKBU[7-=MLX$$A;.OH%;1_EG]E?R6Z>?X4.:HW'F'R_M6U4^@5M
M'^6?V5_);IY_A0XW'F'R_M1/H%;1_EG]E?R6Z>?X4.-QYA\O[44.[XZ'X[+:
MUE]1[C[7=G+10ITR(.DX<<#JO7W2"H*2&EXQQ,G7NK\9*,X'/$8>4ADQM#V$
M9:>2XTI2,WO3VH\MI7*PYK!V&5,C79-'%.Z"&R&LL1/AE!BLLFA=Q1O<W=S"
M6[[M((!5DU#I[$ZIQ<V&S=9UO'6'PR2P-GGK%SJ\K)HCWM:2*9O#(QKMFO =
MML[=I(-!OJ=GIC\KO:S\LM-?L'YL7U^>T_V_@^)L-^X+7GK$]F/M!-\<YK]_
M3ZG9Z8_*[VL_++37[!^/7Y[3_;^#XFPW[@GK$]F/M!-\<YK]_3ZG9Z8_*[VL
M_++37[!^/7Y[3_;^#XFPW[@GK$]F/M!-\<YK]_3ZG9Z8_*[VL_++37[!^/7Y
M[3_;^#XFPW[@GK$]F/M!-\<YK]_3ZG9Z8_*[VL_++37[!^/7Y[3_ &_@^)L-
M^X)ZQ/9C[03?'.:_?T^IV>F/RN]K/RRTU^P?CU^>T_V_@^)L-^X)ZQ/9C[03
M?'.:_?UM$K_6V_5>!A*S"]Q^RXD-78B-@HD55<ZAD*&C(@-F/ '403U3=(?4
MR*.TWEY]UQYW*?.ZXM:E*SJ6S9EMV+%J<A\]F:6Q,\ -#Y9I'22.X6<+6\3W
M./"T!HWV   "VQ6KQ5*\%6!O!!6ABKPL+G.+8H6-CC:7.)<[A8T#B<2X[;DD
MDE=O] K:/\L_LK^2W3S_  H<D[CS#Y?VJ<GT"MH_RS^ROY+=//\ "AQN/,/E
M_:BQ6]]5;=LFD7+75Q[@]F).HWZJV&E6F-;@>I #DA7+5$&04X"@^/ZKBGA+
M+C#RATE@DCF#*<P\,^T\A#B:S'Y"SB[]')T7MBNXZY6OTY2QL@BM4YF6*\AC
ME#XY R6-CBR1CF.VX7M<TD&CR%&KE*%[&78S+2R-.S1MQ![XS+5MPOKV(Q)&
MYDD9?%(]H?&]KV[\3'-< 1K.^IV>F/RN]K/RRTU^P?FU/7Y[3_;^#XFPW[@M
M6^L3V8^T$WQSFOW]/J=GIC\KO:S\LM-?L'X]?GM/]OX/B;#?N">L3V8^T$WQ
MSFOW]/J=GIC\KO:S\LM-?L'X]?GM/]OX/B;#?N">L3V8^T$WQSFOW]/J=GIC
M\KO:S\LM-?L'X]?GM/\ ;^#XFPW[@GK$]F/M!-\<YK]_3ZG9Z8_*[VL_++37
M[!^/7Y[3_;^#XFPW[@GK$]F/M!-\<YK]_3ZG9Z8_*[VL_++37[!^/7Y[3_;^
M#XFPW[@GK$]F/M!-\<YK]_6PS3/2B0T!K.K:@U7VU[-5Z@4L<\6NPS\5U2FW
M06).7D)PQ"Y2<ZN2$J7EV3E#7\*+,?4VEW#+>4LMMMHUKG,YDM1Y6WFLQ,VU
MDKSHWVIVPQ5Q(Z*&*O&1#7;%"S:*&-NS(V@\/$=W$D[)P>$QNG,54PN(@-;'
M46R,K0.FFG,;99I+#P9;$DLS]Y99';O>XCBX1LT "3_H%;1_EG]E?R6Z>?X4
M.6G<>8?+^U75/H%;1_EG]E?R6Z>?X4.-QYA\O[43Z!6T?Y9_97\ENGG^%#C<
M>8?+^U%JPD/F>?IU*'G29NX.U;IDB82>6[BWZ7;PX46\LA]S#;>ADMMX6ZXM
M6$-I2A.,^5*<)QC&-NQ=NO:;#''%'GH!'$QD;!]A\,=F,:&M&YHDG8 #<DD]
M2=UJ23L-[-)I))9,#,Z25[Y'N^S&9&[WN+G'87P!NXD[  #H  N']3L],?E=
M[6?EEIK]@_/?K\]I_M_!\38;]P7CUB>S'V@F^.<U^_I]3L],?E=[6?EEIK]@
M_'K\]I_M_!\38;]P3UB>S'V@F^.<U^_I]3L],?E=[6?EEIK]@_'K\]I_M_!\
M38;]P3UB>S'V@F^.<U^_I]3L],?E=[6?EEIK]@_'K\]I_M_!\38;]P3UB>S'
MV@F^.<U^_I]3L],?E=[6?EEIK]@_'K\]I_M_!\38;]P3UB>S'V@F^.<U^_JZ
MG6ST<,!U(ILS0-#=HNSU/JT_9B+A*QY3/6&SN$6 J*B85\U)MHZRS!K"%QT)
M&L8%8(;%3EA3J6<///+7@NJ=89_6=Z#(ZBMLO6ZU1M*&1E6M4#*S)IIVL[NI
M%!&XB6>5W&YI>>(-XN%H SG2^D<#HVC/CM/4W4JEFTZ[-$^U:MEUE\,,#I!)
M;FGD:#%!$W@:X,'#Q!O$YQ-A_H%;1_EG]E?R6Z>?X4.8SN/,/E_:LE4TTJN3
M%5@&(>=OMLV5(LODNN6NZAT4"?*;?>4XT,^-KJET&KI8"1G XRA:V,2MI*5&
M$%O^9Y4$66<(G")PB<(G")PB<(O.KO+TAG8ZM=WNQ_3JO7UO7<):]Y=;=6:V
M["V^AP<IK3K%#WW2H5OL KA#->6/:MF[/LGMHFMH?8YQ5?9D&9 HT^/@(PA#
M/K;D#RZ'EOS.Q/R#EOZ$7:=I.SN^-9=M]MZ8<[:=EJ%0=3=;M4W.&D-2]4];
M]@)B?MTD'9D6>S;(<!TU*A5<:3S#"2#SBB*95/:%GL1B8<)A:1@VVWV'4]3M
MRY>D>=%UN]N_?:1/1WHVS4=MZMU=V[[/TFU[.F=A.NZY+I0U(U7KVQW,WSHL
MS4O28FQ;+DE4"JLAI&RT!:9N>A8@5@B.P**V )WWV'+Y?^Y\.B*8]V]L>P^Y
M]*=)-Y:+<WO!Z#W!0;':NPUCZEZVHVW]X5"XC0T")"5B/J=V!GG&:=#W1%UC
M[=-5ROS4JVNO-B.."-/LMR0 #<';<<AN=AZ?-\I"*^'0'<4ANSKG$62:W-&[
MXGX*V7.E3E^9U[)ZHLBSJ[-.MLP>Q-=2<;#JJFQ8.,)CPK2"!&!Q!1*6I2*;
M6$>T\[ ]?]=T5U>01<8S"E"%)3C*E*&?PE*<9RK*LM*QC"<8^.<YSX8QC'QS
MG['(CJ-_.%,A($T1)  DC)).P #@223R  ZE0-U>B9J#TM6(VPQDI$2K!=A4
M0!,AE@2#*7K!)/,*>%-;:);2ZPMMUK*T8PMI:%H\4*3G-1<<UT[RPM<W9NQ:
M01]R-]B.75;"[5[E&_KC*VL;:J7:DD.-$=BC/#9K/+,=69(&30.?$XL>US'A
MKB6O!:[8@A6"Y3+7*<(M*_I$>S&S-4]L>N^J(GLILKKGJV]:>VI;+3,:KT+!
M[\M$C:ZS-0 E;:367]6;0L#("V3C&2R8\$./8QEM9I#*EM.\] <CR!YCJ=O/
MZ1YD40:![1^D,V%>-#ZQM=CAZCLC8_3;LM>HL/:^MX^C1<_<ZKN%BH:7VWL2
MJ1D"[;*@^93"@)J5I<&2!#G>U)>S$#H,82(.W/;SCY0=QZ>?BBC;:'>SMKIO
M47?>)EMSVBPW#K/>NHC=(N5UT32=8[;E(79FQ8VN[96!K)599K%BUI+ML$QF
ML[EF 1(R+$B8XW)ENMQ,O@!OMZ0?AY[?JY>YY]D5JM!]^K1/Z@[3][MVVV?A
MM<:OM<GJ^!Z3URHP(E_U--0MIC:E"@[4D)^$B[@9NG8T[+P:&8E-B UY6(R;
M0TIL^1:,<@($;;#T;[^[[G@/]?,BN7UO[CF[YW%N/1%AT9?-/[&T%7:%*;3"
ML\Y4;'#P\ULK$O*U"O1,_4923CIY<G38\*UXDA7&QV6Y!R)(9:/CB<*$;>_O
M\GBBNWR")PB@S==@A((C529FJ VA4OM*LQ,6LTMT7-?DRENX&GQ<-,O>T% Y
MQG+8[F6FW/-G"G$^'*B!KG";A>6<,+W'8;\8&V[3S'(^?FL\T/CKV0BU<:67
MGQ0I:2RMRVV"%LPR-6%K#+CI2Z2/NHK (#Y&\;F[<FE3GRG6!IPB<(O/IM7T
M@F^M'=[N\=4M%XQ,:$U[IZS1^F*$NLU-E<#O2'ZQ:UWQ51!9X6"9LT^]=L-;
M-'9B)N7DADE890.RV,.PRQZV&P\_B?021S\VVPY^E%B^N>W_ ':UIU4HG;W;
MNS9;;U:Z]]HMU:@[B4B,HNLHTRVZK MJ]=1-]K>:_5((H";U79\!R28Z%/BP
MK#%R#[E@>4'%OOK; DC;;< CGT.V^WO]$4ATW:/?3:MYZN=;KSOJ1T=>NQ>N
M-N]O]G6>N437!ULUQK9<]#Q^K>MFMD3-47"CDU>/E0CKK9[-$62Z.&+.&S,K
M$"R@QRYG;?;8>//KSZ^CIZ?1S+:[U>BMWUNDV6H[YV_2=YVBI[ LD-7]B56.
M!@Y^3H[> 2:X)M*O0\?'5Z%V9'((*%GAZZ,B*("3%%X3DU\UY[RBLGPB<(G"
M)PB<(M?7I2]T;/Z^=&MQ;9TW:#:9L:MR>I0X&QQL%7[-( -6C=&O:E-)"@K3
M%S,%(E&P$Y*1[#1T:_A+I271\L%-L$-1'7GZ?1T!\45 9WM7VHTIUPWMLQV]
M]KK->52^EM6ZRSW.ZMZET/4JK:=OW[YT57N%SKF%C2+@U5 E/&3,?-NOQ01K
MM9:(&?8E249#8GIMU)VW\!OXDHI$D=S[=ZT[KO>C;%WCN.Z[@=UQW';&*KMK
MKDY4Y,+:-(U6[LX*Y:9V92]50FHIJM1\4IERRT.PV&Q-U]Q8L=@LN8<?CLO#
M?;;GX']1W/OHJKZ=[7=PI_J)LSL%,=A.XA-SK?3*_P"Y@W-D]-M0T'KT_=6*
M:,[%&T+;(NL@&KEF,F91B=JH&7R0;-$1AI9H9D>,2TKT0-]MAMQ;<CSVW\>9
M_0BESIGV[["W'M5U>UB?V%VYN.J;<TQL*^;DK?87K73^O7SLDUZGP,G7I31E
M@"H&M9;:&7KA*YC9,>*'L\4S4$D6%;V$I08' CD>0',=#OY^O,HO07SRB<(G
M")PB<(M*7I"NPG8NB]NM$Z:U'L7L'4J;<-'["O5DA>M6A]6[VV')3]=ML)%1
ML@Y [%KTJL. &"D'V),P$X9MAYP'S#.K?RXF(VV)V!YCKOX[^9%"6[NR_9*A
MWGIEK,[LIVWHT/LC26ZKWL&P!]/M97#L1-V*!O@"*FQ;=,5S4]W$J;$+"RV8
M1]RNQ (68T.,E)AUV3/>)=B.>YV'4=3L/'TCS>=%$&.]7<>UZ8ZE& [IV>0Y
MM7M5VBU8Y=M+:*U!:]_['U-JN%-)H<C8-)3E>F:S3=D8DHXUZTU, &!+BZ\T
MF0,8=<REXEL.?+?D#MSVW)'IYCGR_7U1)GO=W#'T))1.=P;?C]AP/I*]5]<%
MR!?7O5L1VTSI?8&O)>Q(BK%HHNK':[Q<9TYGVO7KT3&CE65H$9HDL;#Y+"G+
M<';PWVWY>/O^]Y^0\$5@-#]D^YM^"[F:M<W_ /.%,:>E= 3\!M/NIIRDZ0VY
MK#3UO$F)/=-^E]>56N-:WL($9'PZF]6'6)@.*+E%'XN)X$>F/PH1T.W7?D//
MX>._FW^3T%?;T=&X]P[LU/L.R;/LA>R:M$[GN-;T5NZ2H(FL9+>.FXX*#=@M
MBD4Z-#C(ED8N;*L$3%SD1$0D;8HR+&D&(@=>72"X'_N/,?K\'0\T6P/D$3A$
MX1.$3A%Y5Z+WV[IC@43:LYNGL ;"']OL:IM;EWZQ:?C^G(6M7=Y2.O'F)/>M
M:J,9>H<\:%;#CT23!#I#-NSB-)=6VMPC'K8=-AT!\=^F_GV]W?;ET1=AO'OQ
MVAILWWELD9VDW969O1/:2[ZTT]KJ/ZK:ZMG74BLQ4G3AZW [0WM(ZS& IGM9
M=@D(J5+L&S8F9C(O$/,J><=D!%& !L.0Z<SOSZG?8;^ 'F**T'I&/2&;MT+N
M'5=7UGL"AU%G1VJ*?V.[6TMU^F2*]LP-GV?0:?G2] ,M0Q$LU.M53.Q+RT]6
MG19M^N#@&));=6"@@!Z-R>0]W;K[W+X?0B_O:KM=OPGNZ_K'4NZ>SL'IE_JS
MK#<%= ZG]7==]DYB1EKE;+4$JPSK=CH=EF8BNRD&+%Y",]M0 HIL=E@=MTEY
M3@#ET&^YZG;IMZ1YT6\37#,P/KVB,6&=GK1/,TZLM35EM,%'5>S6&61"A)D9
MNQ5F'#CXFO3LH7AXV7@XP */B3WR  Q!QV&V4>469\(G")PB<(J'>D5WWLG0
M6@8<[3QT1 [-VON/4NAZ?<[!&,3<)KZ2VK:F()Z\2,,5G 4IB CDFO B2&51
MRI5P!R0'-";? *B.O/TGX!NBJGOZ^=NO1[:5[*[4G^S,#VEK5<TA%6#7\-M*
MKU.N;?J.W9F_0%"1/>[-=P%<A;)IIK%G;FI%F5<3+QTE&C0@9B GC#2 V) Z
M?7T[\_\ 1%WETKO>#K%K38^R)ON_"[J#5U4W]<YJ%V!1=;UFTU[<-+U;)VZJ
M7/0051J L?-U>-FQDIGZA=L2L7'P21I#"I)\I8S(;$@;;<QTW_62BK/UW](-
MV0N5B]'[I3:UK'AMUVC88V=Z,BU^JLA[MTEL?KO9=OZ7V3#M>X&V(8236PU#
M6;YS,0^8V]TVQ11&! "1XU42 .+S<]O000/U_4]"P[3'9WN_6.I/3SO/=^U,
MEMZ*W)O&EZSV7H*T:BTY"0Q];NNV;'J]9-%M-#I]6MX5LB6HL6<CFB3#X\I_
M)23A'PQLBD1(&Y&W0$[C?S;^)/ZD6RG36Z.RLKZ0S?>A=NS6O<:WJO7ZB[*U
MM5]>QA:FA6++LFX0 \Y:K!88YFQF7 V+AD#2\: 8BG!,L ^Z8]1WO"3.\^ /
MI/R;?M1;(>01.$3A$X1.$3A$X1.$3A$X14YN_1'KKL=OM(Q=JW*6$7M^NB$[
M<%.EUJ9;DM:5D6KTF9IWD80[6)B!&!!DPSAW7W$S0C)N<91YV%QW/+T=/K[Z
M+)=?]1]7Z]MUKO8LE>K-;;QIVCZ-M4[<[0N<D)ND:^%E0H!P\G 0CI-B<&F3
M$R]@>6X?+NY06:IPS+Q#T-_V_"BB>@>C1ZET60H1Y]"QM!G6&FV=%T2%W$W"
M;%KE;H[5QD+NIV/K\W!*BF[._+R+HY-IR*J8>B&F8M1/LV'</1W//TG<HL>S
MZ+WKA&0-1B:!.;GU#*:ZN.T+9K:YZFV:?2[=KX'<<BQ+WV@UDX0!Z.1KF4DA
MVS1JK*Q,HS&/K(7'D#Y+*]<W/Z.NQZ#;Q16IZ^]>M<]:*$_K_6[4^\'*6>Q7
MJU62WV&2MMUO-[MQF#[1=;G9I9UPV;LDZ4EM9YKF&F\H9888'889;;3 G=%.
M/"+X.)RMMQ"5Y0I:%)2M/^DC*DYQA:?]J<Y\<?[<<*+2&N:2 X @EIZ. .Y!
M]!Z%5[ZQV2<G];/"6F2D96T5BU62MSI4L2^4?DP,_)*&WGR5*>6E@<QD9OS*
MSA&&,M8\/5Y2FIMM:V7=@#6/8Q[0!L "W;ITYD$K9':IC*&.U.R;$U:U3$Y7
M$8O*8^*G%'#7[B>OW3G,9$ P&26!\KM@"3('G[L$V'Y3+6R<(H5GM!:_L>^*
M#V,DFI=6R-;4BX:^K+S,FIJ%17KP7&F3J#HK#*DEF*>BA?9"LOMY'3ZQ.$+\
M_CA]?K\**.]X=+=#=B;D7=MKP,M89 _2MST&;'MSA4=#D4"]2L?-S*<CA):*
M8G6)2+!,B9L4U@J,?';=8QZQ*5ICN1\(/OCHBAICT8W7<BF[)JEPL&Y]F26U
MRM2YN&P=C[**LNPWX;1UA"L^LZI'3JHT4.+K4!+A8?>##BFRYA1)+LT?($Y8
M(8;G]/R]46=;+]'YUQVI<=WW2Q0UF!*[':^@]?[F@ZY9RX.LW?YTY :3IEXD
M(@5K*6-D4TP"-<KEQ"?&/#; ;'>02.5)-'-SRY].B+N=!=+==]=ME7K;-4OV
M[[9=-HU^)AMF';-V8?=A[Y*5]]I->ND^(:$PUBWP$$RU3X<V+]VQ8%50J-9A
M\//$&.B=_>Z?7]J*X'((G"* -Q.4V5M^F:C8%V%<X5>F+36F:\B.=0DJK-X(
M<<G\'.I=8A5((RMYT-MPM21G_4X\&G,XJ(>\#)WLX>$1ECR[?H_E[';^=RY;
M\M]M^2V'HMN;J8;6^8QS<:*$6 DQ.4DR3K+'&'+.,;6X[N&EDEX.B#6,G<V$
M&6/C^[;O/_*=:\3A$X147V?Z.OK3N"[VS8%ZAK/(S]TW1I_>\YZBQNBA.7?2
M5$(UO46!QFQ,J9KAM2*(C[-!Y=<8G%.Y>=<94E'ECN?DV][??]*++">D6C2N
MO^X.M+HMI^AEO"VWZZWIA%A6F;<F]DVOY\K*J)EL">,<*J:^N!'2.]@07_-\
M*<Q]=QN=]_-M\G1%R-\],M2[_8U>9-RVR=?WO2S9HVK]MZ@O4EK[:-0 EXL:
M&GHH&S1S;[94388X(4>9C92..$*2SC*&F<NOY= [?7?]**0.O/776?6.@O:^
MUB)->Q2EEG;O;+':Y^1M=VOE[M#S1%DN]WM,LZ[(V"SS;C V#9 A2$X8%%$%
M8'$%'8;@3NBG3A$X1.$3A$X10?V.Z^Z_[2:=M>C=H>_L4BXOUHF676)AR G6
MB*E:X.YPST?+M,ON!.,SE>C77%H:4I;*'6DY1ESSIB#M\OR\D4!1OH^-0NT[
M96O-D;([*[\H6U:JBI6:G[^W_?MHP0HS$J#-A35:&FS\.5JU1DI&A&Q=DB'A
MI6/?':=%?;<0E6&YY=.7F 'Z BQBL^C*T3#62)N=GO\ V,VW<:_3[YKRN6;<
M6Z['?9*NT/8M+F:)8JG"-2#+49'QSD/.%D-%-1_OE^49 ,E)22P *RW#?]OU
M^O)%8G]RWJO]RW^X_P#43_T'/H2?04]G]\*^>3YR/<'SM^K]^^S^;WI[M^'O
M#V7Q]?\ Y7U7_9Y'<[[^.^_OHOB[U:U8Y>^MVQL-6!JR]5J?;Z+JQUN8_P T
MQ7+Q4X&F3HMD%6*M,RZJ(K<6L0E*PWA36W2$J4E];68?7Z_"BL;PB<(G")PB
M<(J=]@>DVL^Q&QZ;MJ=O.\M<;"HM3FJ1!6C2.V+!JJ8Q6K!)"RTM&&R-;PT>
M4,6:$(XZSDI##GL[.'&EY;0I,0=O^P/Z478Z_P"F^M:#>=5[+<MVX=@7[4%.
MV)1:M;MK;+F]A6(RO;-G1+!8&+',SZ7Y*<>$*!$#@G2"DXB(MAJ/8;4RVCRM
M_K[B*)+!Z,SKU-QL,#'6+=E&,K6[]L=@:S9-=;2E*5;:WL#=+6&+TJ$LT((/
M+@PQC"B1Q $$Y>&&.-$48^*]ZE+<_)MT!Y#_ +(N,=Z+WK4?KYZC+E]W(F#=
MVUCL/,;?SN2W&;RF]M4N#D:[4K1([1E'S["EZMQ4F\U",Q[@+480VT<'ADU1
M+Y#?Z[#]'3Q1==->BKZS6>@[.HUKG]\V\W<LM09'9FR+CNNW6W:=M"U@^091
MJQ(7*QO29#=4@) G,B/"""C,/'#@/E+?S&Q^!FYY>CIR'C[R*VVAM$1>@*S)
MU:(V/NK9(DC*HE$2&[MHV+:DW$I;CPXYN)@Y6QNN$1,$VT&A]N)%\@J"WB24
MIPM]?(;[_P#8#]"*<N$3A$X1.$3A%K1@_12]9X@D$0RT=A;/KZ/V&[M-G25F
MWM=C='.71=K?O"),O6 9,?7#&FK8^N<]B*'=$*-\52#1B''T.QW/R;=!TVV_
M0BFN7Z-:'G-7=F=02 =I=IO;/9%FVMMQI%B<;D7[=;&JNS*/5TY(OFA 4XJ$
M*X($ELE+#C;^5+<2^I.&YY>CI\.Z+J7/1Z=4I:>W!:KSK*&VG:MV@P47;;+L
M^,@;E-Q476J4Q082/I!\C"^LI0X, ,UEO-?]C?S))1(J>40R/EF&_P B+)]&
M],M.]?;;#7:C/7,NPP.B*5UQCB[1953:4:OU[+G3%4CG&\A#>LD8Q9Z@$R.5
M86N,&$%4WG+.75Q))^$GWSU16RY!$X1.$3A$X11%O71>L^R.KK/IW;M?^>.C
MVMD/!XC1ID7(A'Q9PTK#3<++QSP\A$3<)+!B249(AOMNL$CH2YAX9Q\=TBK7
M0_1T=>JL)M1-W+VGV$G-RZ\QJ*\7/L3LF=V=<7]5(><,:U]"S968Y=<KS,H[
M[[3F#9!E7)YD.;?DWI0 (H>.Y^#GYOT(L:I?HQ.O5518_?EJWQM@F5T_=="U
M8W<6WIZ_D:GU5L*#<K=JJ^J$23+8=3Q(PBF(SWLH61FFP!!P$R'L"B1B&Y^7
M?H.HW_:BE!_HEUX(O75K92J]+HN_3^FLZ_U%869E;1RJB-5T5,*&N"TCXQ9Q
M@(_VDJ/P3AC(,I)2I@N6O>1;;K<\_3U11#J'T5W633TGJXD&9WI>J[I.P_/C
MJ36VSMTW"X:IU[<VR3C1+=6M<.D!U4.P1QTG)2$<:N.>P')'$2;+29#*"D"2
M>OCZ!^Q%<&.T70XO?%G[&B-2V-DV[6E:U/,/.2.5PJJE5)^9LL2V-%>IPEB0
M3)SIZB#</JR\QEEGU:?5^94/K]?@13'PB<(G")PB<(G")PB<(G")PB<(G")P
MB<(G")PB<(J][2EMGZ_L$7>:J"NW:\'#(%N%$C0A6Y@1PDI13]JB766,%2!&
M,Y3DD=U;J6O*^M3>&32#HZIA;%*UT;R&2$@QR.)X3L-N!W/8#S$#?H/#8[&T
MG3TKJ+'6\#E[#<-J26:*7"Z@M3S.I3-BB$,>(N,?)W-:/J(I&-87[QM#B^O%
M7LR0[LVAA/!A3=I@JU+&10$QB$LDO&PTN.+(M9=822(66C"2$>5;;[33COJG
M&U8RK*,H6J5W4A!+6.>T.+>)C2YI(Z[$#IYO.L99I74$[)YZ.(R&4IPV[%+R
M_%TK5ZG)+6?P2.BFAA=O&=VNC>]K.)KAR!W:.T,O%+CQP"S[?5P1)1E9$849
M8(D8>1'1E*5O@/O%H:,90I24K='4XA.5)QE6,YQXP$<A) 8\EO(@-<2#YB-N
M7OJEAP.<LR6(:^&RT\U1XBM10XZY+)6D<"6QV&,A<Z%Y )#) UQ ) Y%%7BE
MHC$32[?5TPSI>8]J658(E,8X>EM3V0D'Y+P*LO#*%NY&2[E[#:%.91Y4YSAW
M<G%P\#^(#<MX7<6WGVVWV]*@,#G#:=1&&RIO,A%EU,8ZX;3:Y<&"=U<0]\V$
MO<U@E+ SB<&\6Y 0:\4LP$^3$M]7*C8KV?WG(#3\2^#&^UKRT+[>6T6I@/VE
MU*FQ_:'&_7+QE#?F5C..#'(" 6/!/0%K@3MUV&VYV]"2X'.0SUZLV&RL5JWW
MGDM:7'7(Y[/<M#Y?)X7PB2;NFD.D[MKN!I!=L#ND=>*7+N$-1-OJ\HZ*(\>4
MU'6")-<&!'RC!!I"!BW5,B,9<1AXAS"66LK1YUI\V/$8Y&[<3'MW.PW:X;D]
M -QU]"C9P.<I-C?<PV6J,FF97B=9QUR!LMB3?NX(W2PL#YI.%W!$TE[^$\+3
ML5]8%^HLJ8Q'Q=TJ<D>4K*!@0+'#F&$+PE2\H8&',<>>5A"5+REM"LX2E2LX
M\,9S@8Y&@ET;P!U)8X >Z2-EZL:>S]2&2S;P>8JUX@'2SV,9=AAC:2&ATDLD
M#6,!<0T%S@-R!U(7UYV'0$E9!5>:<DU)&15!YLT+@K!6'/4Y&R/DWUN",._Y
M++.4>LPY]9Y?-\..ZDVW[M^VV^_ [;;KOOMMMMXKT--ZB,0G& S1@,??"88N
M\8C$6\8E$G<<!C+/9\?%P\/LM]N:^V1OE'B#'XZ6N=4BY ;*$D@2-BB C!U.
M-H=;P^*28T^UE;3C;J,.(3E3:T+QXI4G.0CD< 6QO(/0ACB#[A V7BMI_/7(
M([-/"9>U6E!,5BMC;L\$@:XL<8Y8H7QO#7M<TEKCLYI:>8(6#[#WI0-<M"LR
M$@[,3LJ$.= 5NOL.2<I.,'*<; >#RPE0B!3'6UI8*>(0V]A"_9L$.)PTJ9%7
MDEW( :QI(<]Q#6MVV)WWY[@$<@-_>YJ_:;T#J+4SII*U9E+'TYY*^1RF1D;4
MJ4'P!KK#)A(1,Z6!CFF2)D;G,XF]Z8FDO'TU*C#SEQ#W;.BS\=9)2HQ\4!4;
M H-S%(2XE:I)D/(R$*PZ;YLYS[0E!;7M4A[0AE9J@ #Y"UAKM+2P2%Q>W?\
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M-!%4M*<XSZM+N5_'&,)SG./&OQV*R>7G%7%8Z]D[)VV@H5)[DW,[ F.O'(\
MGQ(VY'GR5!D,IC,3 ;.4R-'&UQUGOVX*D.X\.\L21LW] ._H6O78?ID/1YZ]
M=($7O1NZ20^584#KRH7"TM.^7QQ_F\\Q"CU1_"LX\$Y;GU8S\%>.$9\W-E8S
ML0[2LD&O&GS0B> 1)D[M*H1O_2KNG=<:1X@U@1TZ\EK?)=MO9MC2YAU +TK=
M_P"+QM*[;!V_HV&P-INW\-K//KTYJJL_\T,].H]Q;,%K3L-85(SG"255J@1
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M]N#BR,;=R7XW(4IR0/Z,$LT%I^_@&0./H658[MR[-L@6L=FY<?(X@!F1Q]V
M G^E/%#/58!XE\[1YB5L,UON34FXHS,UJ?9M!V5%H0A;QM&ML%:&1?/\$H-S
M#'&*">PKZQ;!:67FW,9;<;2M.4XUIE,'F<)+W&9Q.1Q<Q)#8\A3L5'/VZF/O
MXV"1OB',+FD<P2#NMDXS-X;-1=_A\KCLI$ "9*%RO;:W?P?W$CRQW@6O#7 [
M@@$*2>6M71.$3A%%VS-W:<TO'IE=N;4U]K0!QM3@[UWM\%6LF)3G.,I 8ECA
M2)!W*L90A@)HAYQ>/(VVI?UO+OBL!G,[*8<+B,EE9 0'-Q]*Q;[O?QE=#&]L
M31U+I"UH',D#FK3E<]A,'%WV9R^-Q<9!+77[M>J7[;\HVS2,=*[D0&QASB>0
M!/):\[[Z:WT>='=?&$V[,WXT?*DNBT*@7"2:RI/WF)>:BH"OEX5_V7!)=]K_
M %N8YLK'=A':5D US\+!C8W='Y'(THCMYW0P36;+-O$/@:[T+6V1[=.S;'N<
MQF9GR,C=P68['791N/!L\\5>L_?P+)G-]*K+-_-$'481Q;<%J;L+-81G.,/F
M0>NX8=WPS\%-YQL:2)\F?LX]:,TOP^RC&?AS*Z_J:-:/ -C,::K[_P UEC)S
MO'H(^QD3-_<>1Z5BT_JE-&L)%?#ZDGVZ.?7QL#3Z1_[3D?M[K ?0L53\T7]>
M<N>"] [G2UX_Z:9&CK<\/]?JLS*$^/V?AZW_ ._^JK/J9-3;<M1X(GS&/( ?
M#Y.?T*B'JF--[\].YP-\XEH$_ 9@/_[+.Z_\T+]-I)Q#,[KGL+6U+SC"B55>
MA2X#7C]G*W =CX/SC'V?\G&.9SCQ^'C\,V^SZFK7$0+J^3TU: Z,%O(PRN]
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M3CLXL-).P#IKT,%8^ZV=P'B5?VOV2NVV)$GZK/0MF@CT>L!FJ_* S42:W_\
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MKN&:GQO"[RD8LY.:_P"2&+[OO(8)8\@^N0)&/B= &=ZP,/E'YV"N0TX1;O\
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ML^U:EY9IF/?$Y;)-J9!ESRC!VQ7RF%=%2O1LR]>$PS>7Q1&4U;=,-W=5MS3
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MG#@BUX6VG3^I/5$:*Q+)(\(RYJ2X 0SR>)]#'AX\);ER-LQ&_1U:E88X [/
MV)V_ISU/6M,J^.3-/IZ<J$@O[^5E^^6'8[QU*<CH0[;JVQ<KO:>3F;[A>F+I
MGZ._KGTBB'\ZR@2IW8$L"D&R[6N"AI&YRP^5(=>C0'6!QP*U .$-H<S#00HB
M"O4!KFB9@P-@Q/*NN>TO4^O9V_96PROC89#)5P](.BHPNV+6RR!SG26K(:2.
M_L/>6<3Q R!CW1KJ70_9KIG0<+OL57?8R4S.[M9B[P2WIF$ASHHRUK(ZM8N
M/<5V,#^%AG?.]C7BXETI51V-59VCWRMPUOI]FCWHN?K=@ 'DXB6 ?\,K',"*
M0XTYA*TH>9<\N'1R&VB1UM/M-N(PFC?NXRY7R&.M3TKM21LU:U6D=%/#(W?9
MS)&$.&X):X;[.:7,<"UQ!S6]1IY.G8H9"K!=I6XW0V:MF-LL,T;NK7L>"#S
M<T]6N#7-(<T$>;WM5\SW0\P=)VOJ)L86K8)6\4G5.TGI(V#&4K*G,BUN_ #R
M4V(*A.,,A1]EAYQ]3BL*,M+36/K.H-(>J3G@CBIZTQ;[?"&L.8Q BCL. V''
M:QTCHH'O/W4DM6>NT ;,J$KF/5WJ;X)I);FC,FVIQ%SQB,LZ62NTDD\%7(QM
MEG8P#9L<5J"=Q/-]L#IH]V]Z-;O)I)\K%SZX;$/C15+RJP4.+QLFOY'1X^4Q
MZ3HCM@:CAG$^"D^]TQS[?FPA]AEWQ;QO["]J>@,^UGD.J,9'*\#:MD)CB[/$
M>K&PY%M9TKP>O<=ZT@<37.;S6A,UV7:^P+G>7:8R4D32?]IQ\0RE;A\'NEQY
MLB)I'/\ CA$X;[.:UW)4GD8V2AS'XZ6 .BY 966R09$5\$P=?A\4/C$MM/M*
M\/LI<0G/A][F=QRQ3,;)#)'-&\;LDC>V1CAX%KVDM(]()6"212PO='+')%(T
M[.CD8Z-[3YG-< X'T$!<+DQ>$X1/L_8X16%UAU+[.[H>&;U;H/;%T'*RG#<M
M$4>>S7F_/G&$+*LQ00]>!;5X_!TV3':SCQSY_#&?#&LMK+2F":\Y?46'H.8"
M3#/?KBR=NH949(ZS(1_1CB<[T+),3H[5><<P8G3N8O-?MM-#0L>3#?H7VGQM
MK1M/]*25K?2MNW73YG\['WLH"6[#6^KZ/K*E-.F5^(*$V!L1]K&<+<%2U#E?
M.7$Y?;_R2)!=GFG@W<Y6[!DX;]4YI?4WJC]+X]DD.FJ5O/V]BUEF=K\;C&GF
M \NF8;TW"=B8A4@;(WD+#">(;FTSZG/4^0?'-J6[4P-0D&2M ]F1R;AU+ V%
MWD,/$.0D-N=S"=W5W;<)]-_57IKH/IM2G*;I*HIC'9+ SEIN,R\B6O%S+%2I
M+!5DG\L#J=:8RX\L*(CAHV C5D$N1L2(LHI3W*6K]<:CUQ?%[/7>]$7$*E&!
MIAQ]%CR"YE6L'.V+M@'SROELRAK!+,\,8&]4Z1T1IW1% T<%2$3I0PV[TY$V
M0O/8#POM6>%O$&[N,<,3(JT1<\Q0L+WEUIN8BLM3A$X1.$3A$X1.$3A$X1.$
M3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X
M1.$3A$X1?4^.P4RX.4PR2.\C+;K#[:'F74*QX*0XTXE2%H5CX92I.<9Q]G'/
M37.8X.8YS7-.[7-):X$=""-B"/."H.:U[2US0YK@0YK@'-<#U!!W!!\01LH5
MLO6_K;9,$&W#0NCYY*4./EEV75U#E,8;0G*W7B'Y2"?QA"$)4MQQU?E2G&5*
MSC&,YY?:NJ-4U2V.EJ+/UR2&L95RV1B)).S6M;#8;N23L !N2=@K#;TQI>R'
M27M/8"P "][[>)QTH  )<YSIJ[M@!N2XGD-R2J?/:+ZDEN*O=>Z%=;9S2,<Y
MEB4O+&C]<JL\N(KQR_>J/3V*,\18]>P66\8+D\%#R]F ?+L%+B9J&C(Q^V9V
MW.:QC QMOM'U36U',T/AQKL_DQ3KR#DW&Y.^[(M;4RMD'V$)C?!3E;'5R,]>
MQ-,VC@#L3I"0G*U.SC3%K3$3BVQE&X'&&]8C._'E<9CFXYS[F'J\([R82,L7
M87R7,;7LUH(7W[75'K=U6CPHZ;H>@^OX,>>(+(Q,M4]6:Z%$,"+:00&='G1$
M$VT^,2PXV^.2.ZIMUI:'&UJ2K&<X5>U1K!\DM;(ZBU(^6)[XIX+N7RCY(Y&.
M+)(Y8Y[!<U[' M>QP!!!! (6<T=,Z/;%#9QNGM-MAFC9-!8I8G&-CEBD:'1R
MQ2P5PU['L(<Q[7$.:002"IX"!"C1F@HX,4 -A/E9$"'9%&93_P#2TPPAMIM/
M^Q",8_V<QV2225Y?*]\CW'=SY'.>]Q\Y<XDD^Z5D4<<<3 R)C(V-&S61M:QC
M1Y@UH  ]P+E<\+VG")PB<(G"+AGQT?*BN@R@(<D$_CRO!GBL&"O)_P#I='(0
MXTYC_8M&<<]QRR0O$D,CXI&\VOC>YCVGSAS2'#WBO$D4<S#'-&R6-W)S)&->
MQP\Q:X%I]\*$IOJOUALRUNV/KCH>P.N9SEQR;U#KZ5<7G/CG.5K.KSZE9SG.
M<YSG.<^.?'Q\>7^OJ_5E4 5=3ZAK =!!FLE"![T=EH5AL:2TI;)=:TSI^RX[
M[NGPV.F<=^O.2LX\_=6*IZ.]+$+]8GJ)UCPOQSGS8T/J[Q\<_9__ "MRK^W_
M %V1M]NFK-O-]L67V_SBHQH'0P.XT9I7?S_:]B=_/U\D7;$ZCZDZ9#&FR=7=
M=]6@K-& #E5T;6],'4>2ORBB#&8BHY"BG%8SEMIIS+GE0MSPPAM:DRX\QK7/
MR/K1975&9E$;Y'P-OY7(/$3!N][XQ-*0QHZN(VW('4@'W-BM$Z?C99GQFE\+
M$Z5D4<\E'%8]AFD.S(V2&*(&1Q&X:T[[ NVV:2+$LLLL--LCM-LLM(PAIIE"
M6VFT)QX)0VVC"4(0G'PPE.,8QCX8QS%W.<XESB7.)W+G$DDGJ23S)])64M#6
M@-: UH&S0T  #P  Y >XOLY!13A$X1.$6/6NU05)K\E9[*<F/AXII#A#V&GB
M2'GGWFQ0H^/!%;>-DY:4.?&C8B)CV"9&5DRA(Z/&(,)8975T:5G(VH:=./O;
M$SB&MXFL8UK6E\DLLKRV.&"&)KYK$\KF0P0L?-*]D;'.%'?OU<94GO791#7@
M:'/=PN>]SG.#(H88F!TD]B>5S(:]>)CYK$\D<,+'R/:TX?7K-0-QQ)X14*R8
M3$/M"6BBWJ &:L57D'VLN-!6&MRK9/LV2F,*>CI!CVN'FPO+(0<E)QKK1;E=
M<I9/ SQ2-G+&3M=)2R6.LN=4NQ,=PNDJ6X2WCX';-EB=W=BM)O%9AAF#HQ04
M<AB]002L,'%)7>([V,R=5L=VC,YI+8[E.<.+"]N[H9F]Y7LQ;359IX7-D.&2
M_4?JE8'%.SO63KY-.KSXJ=E=,:XD'59S\<YRX76WEYSG[^?-XYY60ZSUA6 ;
M7U7J6!HZ-ASN4B'+T,M-'R*FFT;I"R2ZQI73<[CU=-@\9([X7U2?E70L]'^E
MPZ\.,]1NLC;F,XSA:-$:NPK&<?'&<9^=;[.,_'&?]?QY4'7VNG AVM-5D'J#
MJ++[?YQ4XT'H=IW&C=*@]=QI[$[[^?\ ]T4EUK0VC:8XV[3],:HJCK6<9:=K
M6NJA!.-Y3GQ3EM<7#BJ1G&?CC*<XSC/V.6JUJ+4%X%MW.YBXT[[BUD[M@'?K
MN)IW@[^.ZNE73V HD&C@\/3+>;35QE*N01T(,,#"/>4K8QC&,8QC&,8QC&,8
MQX8QC'PQC&,?#&,8^QCEG5XZ=%_>$3A$X1.$3A%7*Z;%TK,6&8JNQZD+*5R!
M/%KLC?;A4(F:U>%:BA!9!ZIR%B.P>Q"2(@4E%*)/G@HJL.2$FQ7A)XNSLG0H
MF5T,/J"&I!=Q5QT5NS$^W%C*-Z:#,R4F2/A;>BJ1]TZS%))#,&159)[HAA=;
MDJLI.BL/Q"_G=/2W+%'*TQ)3JRLIS9:]1AGP<5]\<<K\?-<>96UIHXYH"^6W
M%!1=-,VG';DO-EK1_1)=-NG\\KVB5ZK];Y9QW'G]I,TEK,MUS"_KL+P0Y65N
M*\WCYL*POX^/FQG[_/,6N-;5_8PZOU1"&\N!F>RK -N6W"+8 VZ;;>A3I-$:
M*L'CETCIB8NY\3\#BGD[^/$:I)Y=#O[BX O1[I<$O#HO4CK0TYC/F2YC1FLE
M+3G&?'&4K76%*3G&?L>7./#X>'V,<FOU_KIXV=K/51'0C[8,L ?#F!; /OKP
MS06AF'=FC=+-/G& Q6_P^2;J6*OI?3M'<;=I6I]:4]UG.,M.5>B5:ON-9Q\<
M9;7$Q0BD9QG&,X\N<>'A\.6:WG<WD 6W\SE;K3U%O(V[(/NB:9X/OJ\5,'A:
M!!HX?%TBWFTU,?4K$'S@PPL(]Y27RU*Z)PB<(G")PB<(G")PB<(G")PB<(G"
M)PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G"+BGG
MA18)DG)F"Q\='"$'R!YK[0H8(0C*R"S"R7U(9'%&8;<>(?>6AIEI"W'%)0G.
M<>XHI)Y(X88WRS3/9%%%&USY)9)'!C(XV-!<][W$-8UH+G.( !)"ERRQ0123
MS2,AAAC?+-+*]L<<44;2^221[B&L8Q@+GO<0UK022 "5# FS[W:F$2FOM2&R
M5;?PER,L%[M NOD6 -S'F9DX6#Q$6>SM1I"<X4.NT0M8-(;RDE@!T-T<E_(9
M,-C*3C#E<['#<;RFJXRD_*FK(.3H;%GRBG3=,P\GBE8NQM=NQTHD:]C<;CSF
M5OL$^)T_+-2?[*"WE;T>(%N,\VSUJHKWKK87CFPWJU&5[=GMB=&YCW<GYZMZ
M_(]2?Z9"OV7\\>1::]O\C_P^SZ94SR_5']7<;_Q$_P"A$^>K>OR/4G^F0K]E
M_'D6FO;_ "/_  ^SZ93R_5']7<;_ ,1/^A$^>K>OR/4G^F0K]E_'D6FO;_(_
M\/L^F4\OU1_5W&_\1/\ H1/GJWK\CU)_ID*_9?QY%IKV_P C_P /L^F4\OU1
M_5W&_P#$3_H1=6_3+UM,QMG;<?!5R@1ZFG,ZUK=A+L[-Z/1G#N'[].D0-<21
M5@U^1+-$"CW )HAM9-ID96+<17FY[<AC<)&78*6S;RDH</LO;J,I.QD1W;PX
MNLRU;+;L@W+LG)*):["&4H8)@;;J=^-RF=E#=015:>(A+7?86G;DNMRDS3Q!
M^6M/JTP^C&=@W%11.AM/!??FG@(IB>DI2A*4(2E"$)PE"$XPE*4IQX)2E.,8
MPE*<8QC&,8QC&,>&,>',8)))))))W)/,DGJ2?$E96      !L .0 '0 > "@
MC-.N^M)@TK4D7 SU,L))DA*:YGK"55@ZM82W5%ES]'E1H&Q-AQ<Z^M]VP4YZ
M/9CDS#_SQ0A4<05.AS&2B_C<Q7C9G9[57(5&1Q09:K59=DNU&-#&5<E ^U4,
MDU9H:*N0;*Z4UVFI99,QE:2OBOV.R>%LRR:?@JV\;<?)+/AK=M]&.C<D<9)+
M>+G94N-C@M/+G6\<Z)D(L.\LJOA?):CL<DG96QJVRJ3N^G36:^QC+DA*:]M8
MNP3(<5&,J>D3ZV["U2Q'AL(QE3C%3CK1-*Q\6(9Y.%J1X9B,3<<(<=GXW6G;
M"*'*T7XJ.Q(3LV&*VVQ>J12./1]Z:E6'\ZPT[ S'YK,4FF?)Z=E;49N9I\1?
MCR\E:,<W32TC6HW)HV#<N;0AO63U;6<-R)@B9:,GHN-G(60$E8>8!$DXJ3CR
M&R@9&..802&:&2RI;1 Q0[K;S#S:E(<;6E:<YQG&>6&>":K/-6LQ206*\LD,
M\,K2R6*:)Q9)'(QP#F/8]I:YK@"UP((W60U[$%N"&U6FCL5K$4<\$\+VR130
MRM#XY8WM):]CV.#FN:2"T@@KGYSA.,J5G"4IQG*E9SC&,8QCQSG.<_#&,8^.
M<Y^&,<E $G8#<GD .I/F4XD $D[ <R3T \Y4+XWW1#%.*K8=\NX+;BV\3M'U
MO>;15RE(5E"\Q=KC(%VMSK:'$K;<>@I6299=0MEYQMU.4<R+[6,G& +<F,QL
MI =Y-DLOC:5U@(!'?49K3;E8D$$-LP0N<TAS01S6-?;7BI"32CRN3B:XM\JQ
M>%RMZB\M)!,%^"HZE::' M<ZK8G:UP+7%KALOE]&Z&_B'N?^A^^_\EY#[7+'
MMGI[X_Q?[PGVT5O:K4O_  YEOW5/HW0W\0]S_P!#]]_Y+Q]KECVST]\?XO\
M>$^VBM[5:E_X<RW[JGT;H;^(>Y_Z'[[_ ,EX^URQ[9Z>^/\ %_O"?;16]JM2
M_P##F6_=4^C=#?Q#W/\ T/WW_DO'VN6/;/3WQ_B_WA/MHK>U6I?^',M^ZKAN
MW/9EZ<R!KNHE4>*^"#M@;5ARPGF,JQC+C-6ULDL&PS9K6/%MPZT&4Z%$<6R6
M#\];31,?CV,?A\:.]RU]F2GZQXO"3QRM=MT==RY9+4K1NZB.E'D+#P',E\A+
MF2J6<EF\J3%A\=)BZ_(2Y;/5I(G-W'LFT,*)(KEF5OW)EO28ZK&XMDB\O:U\
M*[VNZ=J$027,3J#-A6Z4CRXJ7N5^4)/3)<9(M>IDH< 7V,: J]>D&_!!M9J,
M- UXS./7&1I)2W2'*:UG[\[(Z]8LQ5"&5D\&/Q?>5:\<T3N*&Q*_O'VKMN$\
MXKE^Q:MQ_<QS,8 T5=/3F.KODLVA)E\A/#)!8R66,=NS)!,"V:M$SNXZE&G*
MT[2T<?6J4Y/NI8'R%SW87$'3^DB7*<?!W.ZZT]2I_7DY7(65N,_5!&G&T.Z\
MM(<>@R8*!B6W$.4FTJ:)]I@6G:_8WFI>#"E[;<9XJNHV#(16<?CLQQ<.5K7+
M$&/JWGN!+<M2DE,==DLY!;D:0<S@M.;:J-=7LR5Z%LKRV],/..EJY+)X7A+L
M1:IUK&2N4(VD!V(OQPMDL/BKAP.,O%K^.HUU2XYMBK%8R&5![RHSD@!&S+5Q
MI3\J8/'Q9-^H-SID+(2)CJ6 8P>RST('6O>T@0M T=#NR[4K)$*2R &0M6,9
MHI--Y)L4LU=V/R+((WRS,QF4Q^0L10QM+Y)GTZMF2YW$3 736&P.@A:"99&!
M5\6J,6Z6*&RW(XQ]B1D,#\MB<EC:TLTC@R*!EVW5BI>43/(9#7=8;/,\AL4;
MRI@Y8%D2ZF=GH2L1$A8+'+1T%!Q0ZRY.7EC& (X 9&<84\484XTPRWYE)1C*
MUX\RU(0GQ6I*<SZU6S=L15:D$UFS.\1PP01NEFE>>C61L#G..P)V .P!)Y E
M4]JU6HUYK=RQ#5JUV&2:Q8D9%#$P<BZ21Y:UHW( W/,D ;D@*+$;UK!"</1U
M2W!)AKQXLG"Z8V:R*2C[SHWO&L@OOCKQX*9*;8R*2WE+PSSS*T.*O9TU<;[&
M6]@(9!R=$_4.&<]AZ<+^YN2M:\=',+@]AW:]K7 @6$:JHO'%#C]13QG[F6/3
M>;;&\?TF=]1B<YAZM>&\#V[.8YS2''AUJ G-BV8/9%^BC(6%KY3[FK->RK>&
MRXIW+;P;FQ;B'A;C:+E*"O/CUN&=RM=)KY3WM/JK/-RXL/[N6JV)IR8C%SQV
M+%IC6YO*P$F.=N[9!B<?(0TG'PO:UURP-AD;4;>#>E6@?8\4JEK,W8LUEJ\E
M:M4>]V"P]@ 20.(=&<QDHP2T9*>-SF4JSBXXRH]Q?PWK-B.MEEYUK'6\H"PQ
MTB;4+_!,.,5V]P:&/>P0[KF'GH67%?2H*SU(]Y*5R=6FFWX]YS")&/5%SXD9
M- 4.-S$M!DM66&._B[+@ZWC+)=W$CVCA;8@>TB2E>B;RANURV5HWAE$U62:O
M+7Y3"PY!\5R&:3'9>JQS*>5JAGE$3''B=6L1O!BO8^5P!GHV@^%SMIH3!;C@
MLPXH'M2T5U+D-LG75O58 LX1[\UO5)^ZTNS"YQG#4S$.13,A*U];_ES@ZLV5
MMN1AR\.#"2-CBTAV&2KI,)2MD6,1EJ JR#?R;+WJN.R--_\ .KSB9T4%H-WW
MCN4R8IX]GOAJ3&2K%01YZ]3!K9K#Y$VXMAY5A<?;R>-NQ]&V:[J[)9Z9?L>]
MHW0)JTF[(YKD CN3<S.[X3'QS1-S8QG.,8\=/WW'CG.?#&/C"_9SG.,8Q]G.
M<^&/CR7]KECVST]\?XO]X4S[:*WM5J7_ (<RW[JO[]&Z&_B'N?\ H?OO_)>/
MM<L>V>GOC_%_O"?;16]JM2_\.9;]U3Z-T-_$/<_]#]]_Y+Q]KECVST]\?XO]
MX3[:*WM5J7_AS+?NJ?1NAOXA[G_H?OO_ "7C[7+'MGI[X_Q?[PGVT5O:K4O_
M  YEOW5=Y6=MTJTS**TP_.0-H=&?,%K5UJEGHTW)AB83DPN"#MD3$?/&&#AQ
MK,@777)46/RZT@UX=;B4YIKF"R-*N;CFUK5)KV1ON8Z]3R5:&23?NX[,E&>?
MR2279W=1VQ ^7A<8VN#2554=08V_9%)KK52\YCY(Z63H7<7:FCCV,DE6._7K
M^61Q!S>^DJ&=D/$T2N82 I+Y9U>U@5QV35Z03&QDF[)R5AFFR'H6J5F%E+-:
M)4<13399K$+"BEE#1 ;I S!\_)8!@(YXH5J0E!5DL8<NF/Q%W),FFA$,-2L6
M-LWKEB&G2@=('&.-UBP^-CYY&L>Z*K#WMJ9K'F*%X8[:TY'-4<8^&"=T\URT
MU[JM"E6GNWK#(BT22LK5F2/97C<^-LMN?NJD+I(VS3QE[=\ F]HW^1BC(^F:
M:V,!:))M,=!2MN$IHE6ACY!U C,]8LAW@J2<A8/UV9B2! #>DSQ G0 6LFD,
MXQ=*^%Q<4\<N0U!B9:4),MF"A)D)+MB*(&1U6IWF-9"+-GA\GADED;#%)(V6
M5W=,<K3:SN6F@DAQNF\S#>F AJV,A'C8Z%:65PC;;N=UE))S6J\7E$T443IY
M8XW11-[U[0I*IE'AZ73HZF"8<DP112D29DJEDDVR2<L^0?9)V=SZM+)LI9Y<
MZ1F)MW+26BCY$M?JDMN8;Q9\ADI\CD)L@_:&1[V&&. N9'4A@:R*I6K<^*.&
MG7CAKUQQ%S(HF#B)&YO6-Q=;&XZ'&Q[SQ,9()Y+ ;))=GL/?+=M6CMPRSWK$
MLUBT[A#9)9I#PAIX1'*M:6;7*E&Z2D 1X1*LN$Z=M!12*(ZCXY6BC2X[!\GK
M E7UN&H^/!FZ)A*%ML4R,--)G&[L,Q3RP$>HXI762-F9^DQAR8/@<G ]T4.:
M8.>\LLE;)\P79&:*)E8V<X6[A_XS3,L3*K=R_3MY\@Q3AON6XNPQLL^#>?YL
M4,5K%  AN-@DD?:'.;VY8?5HP5HG<HQ.$XP0.@;7)B&7L?!UM!8FQG12FT+P
MI*"!W%LO)QAQM64JQR6<%4W/!J;3[V=6N+\O&7-/0F.3$->PD=6/:'-.X(Y*
M8-0W  )-*ZD8\#9[0S#2AKOYP$D>9='( =P'L):X<P=BOG]%R9^0_<__ *;0
MOVA<A]@:_P#633W_ (V4^BE'[8;/]5]2_P#@XGZ83Z+DS\A^Y_\ TVA?M"X^
MP-?^LFGO_&RGT4GVPV?ZKZE_\'$_3"?1<F?D/W/_ .FT+]H7'V!K_P!9-/?^
M-E/HI/MAL_U7U+_X.)^F$^B[+I^+FDMSMHQ\5K]T4A[R)Q_I*]4-?7R'?+CQ
MSZMAEUU?AY6VUKSA.7V!@/34>GB? =_D6[GP'$_&-8-_.YS6CQ('-/MAL#[K
M3&I6CQ=Y/C';#Q/#'EGO=[C&.<>@!*S.F; JU]'D':\:3DR&*0#/0<Q%RE>L
MM>.=:P^R+/5N>#CIN*<)'S@H%PP%H>2#4@Z->+!=:(7;LAB[N,?$VW&SN[##
M)6LP3PVZ=J-KN%SZMRM)+6G#'@LE$<CGPR Q3-CE:Y@N>-RU'*LE=3E?WE=X
MBM5;$$].[3E<WC;';I6HX;-=SV>SB,D363QD2PNDB<UYS3EO5R3A$X1.$3A$
MX1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$
M3A$X10GOII!U/K\$1CUD;9MI:F@)H;/AEN0@S-AUYV5B"D9QE#T?-!CNQ$J*
MXE31D6<:(XG*'U<R+3#C%?M6F<IJ>%SEJN_QBLLQ5IL$[".;9:TCVV('M(='
M/%&\'=JQG58$N.J57CB@O9W 5++/"6K)EZCIZ[QT=#9C8ZO8C<"V2"66-PV<
M5-G,=63*I/9'N7I;K6Q[)<;G4&[4EIDYZHG6B-C9P>(?9*>9EWHW.7Y+(3RQ
M5L#N-A+2^YA6$J\&UYYKWM)U-JW26(Q=O26@<UKW)Y;*MQM>AC ^&&NTM+Y+
MERYW4D=>K _NF2RN!$8>7O(:QQ6/9366C=/SR5]1:FQ6(L,A9.*EBU'Y=,R0
MO$0KTFN-F=TQC>V)L43C(\<(\5IUT3Z6X2/W)/7S965!ZH[6#'VC1KLR<;&P
MP;&H+//:CG!XTHM) X#4\+7(^T(%4(QEY3Y1)BF"5+]HLVJ[W;1H[26&U-6T
M?3UYE8JLOV[:.P5ET-[!3V2S(TY,-;$%@9B*G%/8Q5V(1&4R5JL[7-8Z0NN6
M4SN$PE"CE\X^?"8>\Z*(Y.Y#(V.E-8C,U/[*@<0HP6JS#(RQ+PQ->!'(YCI&
MM6_75.W=>[JJ@]PUQ;:[;HC*VQ)!^N34?-M1,O[&*:1#2#\<^^V-)",F#K?%
M=RAY"'FEJ;PEQ/CLG"W;64PF&R]S%7\++E\;6R'V,R<+H+M3OVGC@GC< 1)#
M*V2)_(>R8>0Z*&-S&&S<,EK!Y;'YFDR5T/EF-M16ZSGM:UQ:)87.;Q!CV.+2
M=P'#<<PN!L6>-BYRG1S2R@H^87*#2$UB38C8N%<]9%Y$,E5*F8<A]+C&)$:/
M:862A<F\&RZPM3[253KE:U.(C )2P/+93%*^(L#G1#O'".>"1X9'WI#6EPXM
MBYA 58;44,K8I!L9&N<U[FM+&\(=LUQ=OP\;MF@[;$[-X@7!1J4]> <%57-Q
MMUB(J8]?=D["VFOUIN?:E385@@.+D7AQPDV!Z,+F4"!R4VZVHIV+(8<8+;9*
M;J*\M<LDJL+S/3=!'*^5[GR/XXWO+B72.<\;=WNXQC9QX2][N+:EB%MED-FF
MDGB?!))QB&.*'B[R-K PQQ-#7@";=G?2>QX7EK=V[Q979K<+C4Z98)V3S'%#
MIS2V8._4U+@<I*J$%J4M.F2=ED,O5^22X,CV'!\QAR4?+9<&F%/"O)GG8?KW
M!YGQ Y<C[PVY<QS5=M[H\/@^O/?WUQ)5K?<1+#$!7^3D@4R]B4^T1;J=C,A&
MM&55^M-0@+Y$<EYV3K;M@F\MR!+"VHA),C\36XD0B (V.X'3EL/-O_I_V4/-
MMZ=]_?Z>CIR4[]=XG934 =,[0LYDO-E&2 3$2N:$E68H8.2)&3DK,:Z_&9.>
M;$9=:R,[ET=AYP<WS&>N\IVV_(;#8>CPZ^_]>6R#]OU_T\.BR'2;2(\/8]=%
MQZN*K>WKR'#C8_T @IE\*XOA,8^PV(-*V>1; &1X,A 8&!&0V,,RTC(-1DRR
M8BT_G/<P.-DL/\9)*[9,>V1Q\9'P4X3*\^RDEXY'ESWN<<:TRT0QYFFSE!2U
M#E(ZS!TBBLOBR3XFCH(V6+TS86#9L4(CB8 QC0/ANYOWR'KW7Q"W$0^T-CQ]
M1LR6UJ1DRL1E6MVP9R#>RG.%* M0-'<JDPUC.,O0TY(,I4VIS#B(Z<=Y/)E<
MJT V,-B);U,D;]W=FNT,56LMWZ2TI<D+U=W,-L5HG$$ @M3M\ICQ&(<2*V<S
M,./O!I([VC!1R&7M57;;$PWXL6ZA9:-BZM9F:""017"X[:WKJ7L56M86U&K#
M-&[ABI"*UC9G&YNCEU>T0:3RB->.^YOGF<EIR0J:!RJ\XIFN"2AP1(<6^(8E
MJ/=HF5X+5"Q:$EAUZO,9++7<,K9()2T"P7.+7#AG);,7&0GO&.\';])X/0^B
M=2=E68U%@Y-0UM:Z'MPS:BP4$%+)8ZQI:Y'6J4L_6$AQAH4\=E]ZF4B8_(OK
M5[=6=\0KLEF;*]L[+4_1V-*UG>LS'56=V94[9(.V67E86"K04S0(6NR,Q&R)
MLQ(1_DE9A4\VW%BB-/)>*&,0O [:&O-.QFG\CF:^0L8V%]HX^2FR2O#%--8>
MV[)-''(R.*.3^+B,),SG$<(<W;BW.VFK[JK+MEM5W^RF>?R=SB!O"UYX#]T[
MEPD</LG'AVW).Y48T[TD_4NUUNLSCU]DH&0LM>J$RQ62Z9=9B71)W-FC*C*:
M _6*]-Q%HNC!.QZ:"=7*C(SLB.3,M^=GU0QK@MTM:%U+6GLQ"BV:.M/;A-EM
MFK%"64W7A+:>+$T,E>J6XZV]L]ID,9;$?9;N8'48E8=O9;$@; ]>?#L.6_/V
M0Y#?JLZ*[U=8 123B]@2HPC)J(D4A_6VT6&YN>][QL 76JSEZEH^>>TQ$W+!
M15AK,![QG:X;DMF> CE1LG['1-TEGWO$;*+'OX#*YK+V/<Z*$123MGG#;1->
M"2&-TD,\XCBG;P&%\G>1\4>-G7BY;[>/7?;8<N9W.QVZ>\5A\OZ2#J/'5H^U
M1M^G[;%!>S,-.5/6VQI1J4ER:]#6]=7B))VKAP9]P J$\!:9:I-RJ;%$P23C
M9&.&Q&GH'JX]"ZF?896DH1UI7![R+-VC$8XF3S5?*)6^4&2.J^U!)6CM.8*\
MDW QDI[QA=#O6;;[\N70$\R X#D#N=B#L.>W/991%]Z>NAT\75B[1.Q=B$LI
M=7>BGJ#L(QP.1Q;;/2H(::)CJJ4'6I6UV&GV"+KU<L1$98CI..>B4QF)+R"K
MI9M)YN*LVWY-&^LZOY0)6VJ@XHVUH+<[H6.G;)897KV8)9I:[)(FQR"3CX-W
M"/&W?;?GN!ML>I) W\VY! W\1MU5L3Y4*,$=-+<=PPRA#BD#BEG%*2M24(PR
M "P0<0M:E)2EI@=QS.<^&$>/CS' TD@#Q.W4 ;^Z3L/=)V1\C8VN<XG9C2XA
MK7/?L/,Q@<]Q/0!K22>0!*KL;N/9DG>W*O1M1S9\&Y',DHMMWCYFB0(#JF'G
MUN/'$BR14BIS#7J6(E41"FMDYPT80,VXT\NW0W)#F[..LPV(JL,4)BLQT;4K
M)Y9*\D[WQW6@XYT$9:RL]KIX[3+)<! ^+@E?CEC,Y665L6(PDL[7;<=S*2G%
M4X!QEKB0YD]Z:0-:7LB;2B8_=K7V8N(%21!TTJ3B;''[*S&V]=L%? G0WS,R
M==7#DMNM9@8^!?B@! (C+#[R7L.X-D9%7E>DY$U38WLU]9;DJSU[-%\M2:K(
MV6"6(F.:.:-P<V83-<7F5KP"".%K2 &-;N0:ROCG3U[D&7=%DQ?8Z*U'(1)4
M=!(US#5BIF%D<-;@)W#G3S2DET\\I:PMX.BCY S7 @<F>7*D56U[*UZS*2#[
MA4E)QNM=E6W7\-(2I;JEO&2QL/6@294UY:WC)%TDEU:W'5+5<=31Q,R\DD,3
M(&7:6'RKH8FAD,,V8P]#*V(H(V[-C@CL7)601M ;'$UC&@!H D:6EFDPT<<\
MLD[Z-_-8AL\SW23S087-9#$5IK$CB72V)*]*)\\KB723.>]Q)<2NLM ;%KW=
M1*[+)P5 TZH3VQVHEY.' SKE[\@Z_59@IK/UCZZJ$Y928YA]+K+<O+1\RTAN
M3@HTEB=2D=1TYD[<!X+.0OU<0Z=IVDCQ_DUFU=KL=U:+TC:;)7-+7&""6NXN
MALS,=(O1LOZGQ5*P..KCL=;S+8';&.7(^55:=&Q(T\GFA$ZZ^%K^)K;%B&RT
M-GJPO;&/8_N' =9YJ*C;5JC:MNCI:N62T-3]"^AO)C#Q=.AI&?M91<),[%@;
M:.!78P%AR5G7J\BO#DR\-')EW)&1'$59(*QG:XMEB86N8S@>)0XF1S6, +8G
MLW<2=FEX=LUYX=FK;VEM#VM65[,U+-82E+6M4:9J9/[,PS2SY*W!2H,AGJX:
MYCGRVIYW=S6-YMQT56W/Y/W,#GGH=.]\M5;F]\X@J]: ?<FM+3M9]]NP:BND
M<16:B;%@28K,MK#9]YC1['DF5:0F!E"8XT;#+JI' *7!,DIJLD#N%Q!/$UI]
MA-&07\1&[9HHG[>QYGAVYC8GGM.S_9[F-.NC9<L5'E^2IXHM-/4.-ECM7H[$
ML)?6SV#P]IU?NZSGFQ%!)$\/8(72N$HCCW7/I+=:[C;' U+J;;%]N)8F9@>F
M0DII4XS-:'@1[#*SA-BB]NR=,C'H4<^*C)2K2UB NHD],Q48_7&O:LD-39:$
MD+B)98F-'(O<VPUO%Q%H:&N@$IW+7$.$?=D-<0\D$*^9?LAS6GW2R9S,X3&8
M^!_<2Y.W7U/!"VXZW-3KU6T[&G(,M*+3ZUF:O=AQTF,EK5;,L=USH71G[*MZ
M3[KW;)>4$!B+XQ"1M4L5PQ9GTT%]MV,J^MXS:$K@JI1]^-V+!I5 RH\='2D_
M38NNR5E2Y!#3635,I=/Q\\;&N=P[N>(PW:4'B,CHMN-T0A)XFDD-E<X-]D6[
M [,EV-ZMQ=>K+9?CS/;O5<?'48S,AWE%O,6<)$P9";#PX.=XMU9)9*]7*V+D
M=(MMNK"$2.9'.YNW-.WU&:SU#0P[S!V#:L3 71V'ES].U67:2/=[+52*#( W
M#:$/95W6OW*C234X#KN"OD@!D)A HQ;\@$M%@U)A;UW$W&UG591 )'/K35I[
M,=\,A[R*.)[.[;7D<]\,M:>=PC,C6A\>Q+F4TG9KF<51S69M6L7/2PERS0=+
M5@U#D(;99CJ60@OU;./P5BE!0N5,E4FH6LQ:Q<4Y>1(UK8Y0+N=9]A6K8FMQ
M3[3"*CWX1]%:&F5GY*=M*H09D&0F"@W6TEQ1_O%DEB0")<(6DM#OG<9)22"'
M9](9&YD<-6?<#9'UXXJ@NB8R/O25HVP69K$3F!]:T+$<C+,#GS%DH<UT@D;)
M%'K:=C62$-/(^RVVV#=SN #T(VZ$<MNF_4V&YE*DIPBB7>->8GM86U]"\!SU
M7AY&Y4V=0C&3*U<JP 5*UZ=!7CP6E8IK"63A\+2S*Q!,C"GI?C)(T9Z^Z;M.
MJYFBT@R5;MB+'Y"L3M'<Q]V5D%JM(.8V?&[BB?L706&0V8BV:&-[<?U13;;P
M>0<TB.W1KS9'&V@-Y*62HQ/GIVHSU!9*P-E8"&V*[YJTH=#-(QTA5Z5]^P$'
M-^J]G]\P\9*^H\WF]3[Q"8+]5YOAYO5^N\GF\/CY?'[_ "TVH/)K5FMQ<7D\
M\T'%MMQ=U(Z/BV\-^'?;PW5WIS^55*MKAX/*:T$_!OOP]]$V3AW\>'BVW\=E
M#^I&!I-O:FPY%[#$W9-B["K9<NM36'HFL:JM5@UU7HL(@A+B!8H%JO2%FP(K
M&0VYZR3\DMK+TB4IR_Y]SX/L+BHAO6IXC%W&0C?AFN9NC5R]NQ(QI''.\VXJ
M?>?=FK3JP@\,3 +#IMC;#\UEY '6[N<RM)TCN;HZ>!R-K#4JL;NK:[13EN=T
MTA@MWK<VW',\G1//]P]Z#ZNU3-PW9\XB5E>K^T]A1MCD]C:%I(]KVE ;AMU?
MAF#1K1KJ2C[_ )BXZ-!B,T.II@98\8;#3IJ32O;,;2KZ7Q+LADHI=/-;'%J#
M'4I(&4,S;=6Q\V,K32ECJ]Z-]+O))'R^6V>^C8YV_"6-X%F(8TN>.#;9S1MP
MD[ @;_SAMOX$[]>AZJR\7V)[#S/9/"AK5MR%H\KVJTQK6--M,3JN!Z_1U#G.
MMFC-M7FA6F$,CCMQU_;%C7;+ABENK.9K^+E,5NLYG7B Y"-<L$F#PD6!V=6Q
MDMN/3N5OO;7DR,V;DMPYW+XVG<KRL>S&38VN*U;RL<!F\FCFG[D-?'(/(8W@
M/)I(8X[<^+</<T$$$ M&PWY'WM^780?=#=<E9>PMFDV+Y!:KVWJ?=%@ZE3,U
MKY,-6Z_.:;IU@D:H56[.6'E%Q7NJF1,AN2/8DDD)C&H5V)99<8<RC/B;2F*C
MKX2"-U.;(XW)8J#4L,5TRV)H<I:ACL-L5VNWJC%6Y68M[F</>&42%P< G W9
MH&Q<US0__P#D0""/ M<>'T^.QZX;^ZZ[BPT<33[,S(B;#I/3P78,[<XNCLS-
M/N$?9]M:1A1.Q58AV 773YZC:OLVP):V:Y:4H0"W5F6%S%'01D"055?:SIB6
M1MFNZ-]&WJ=]*&K);,5JK)7QN6E=@K$I> R&WD*]*.M=(#Y*MB-PD9,V8-CW
M<>X(YM,G#UV(Y'V)/F) V/78]0=UF.[M_-4JC:K7IWN_.;:K-D[$@56]7\O9
MG7^KIKT01H7:UN;J_P!%LG6!&OHEF3LM<KTTX)*0Q\HP3AFN"$Q_O)AGE-B,
M*;=S(C*:1AQMB#"/L5*3:&;LF:1N8QU8V/L8S(MO2&.">:(.CE9&6DSN;)W;
MBH-;NYV\8:0TD-#7.Y\;1]SQ \M]M^0VW.Q6TW1)Z9K5=+L+=W,V W/P$7(_
M/$3:*C=6B'E!M,F(#M=&@Z_6I]E!C)"79.+C6!"B4O.#M,-92PWKS,L[G)6X
M#391,$TD?<-KVJA #B6%]:Y-/8@)86D1R/+FMV#B3S,EPV<1MML2-MB/D).W
MPJ7>6M>4X14#[YW>RZ3J=1W-K@@2)OC]B8UD=(/C)(8D:C,QDY:E!R V<>K-
M>BYBKCO0CY.'%Q")6PM@Y83-R."-H]F&,IZDOW]/9=DD^,;4=F8XF/+'Q7Z\
MU:B)(GC<QMFKW7MLL9L)S!4,G$:T7#J7M7REW3./Q^I,,]E;*NNMPDLSF![)
ML?9@M7S'-&?8RN@LT&.JO?N:XGN-BX1:FXK^<U<MM)PB<(G")PB<(G")PB<(
MG")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(H7W?
M_P!3T'\=&H?TZB.9#IS_ '^4_)[._-TRQK4__N^(_*73WSI74T<QY9*O-IZ:
M3T8^[NU>U]/WOKA!3%CD[J5(5;<&)"YC1%3KT?&1]?&J,W) FDBXQ C"#3OO
M!@1B7??-4WZJ/=?)9;5FN"U1)1QMC%V)I&58P^:LV"::NY\K^,R1R=SRFCEW
M#'1R;,<US@[<.<K?A=$Z &JKNM<YB(;NHA6IQT;EMGE@KMIMF#65*\_%#7E/
M&US96-#FOW?U60^D#]#Q-;!Z*=:-3]?6PI[;74J&? BQEF,UYW8@=G:%D=B+
MC) L@9B,G3[F(S;H1LT\4=OUDB"DMLDAA>:#%YSR;)6;3WSUVVGAPEKS/@F@
M+7^QX9HAWC=XBYA<P;\QRV)69Q9#'Y*SDZ^?JQ9#%9GA9;JW8VSU9(HW;10V
MJ_"62P"+9I8  'LB<!LU; ?13]4['U0ZD4BM[!9G0MLW(?%NVC%3DVF;7%6,
MEXID".0\VX0RT6!7,0\?*X9+,;<D W<H)<2E*E4N?RS\M>=*><,.\-=SG.DE
M="#N#+*_9TKR[B/&X D'HM?X?1NE='6LW%I&@,9C,KDG9%U.*61U2.<QMB<Z
MK%(2*\;VL:.Z9LSV((&^Y-_+=5:U9XTMJS8?0 F,DA"R&9N3@T-QIK2,R&"2
M8X\%.6,-L(=RLE2VQ\M>M3Y,^;.;&X[Q21.)$<C7-?L>$[.:6DAW)S#PDCB:
M01U!"O1A;+(P\!?)]PP-+N)W$YIX &$%W$X-V;SW.VP4%UJ%ZZ; IT[1JKL*
MO7:J!(AQ)D&M7Z'DF((:%,=,$ ()KA2/=#9;F"4DH?<9(/803X.*]2XMNBJ,
MJ1NDDKRLD+@UCR)6/:W@=(X#9OL6GBD>2=@7'F2=AM=+F+RF.\GCO8R[CS(P
M.K,M4YZQE9PL ,39XVND:&\ '#N&[MZ%W/L0.LF@RA\/1U<08PDH8ADH:T3I
MB62H]<:L;+3Z)=U*<C9BH[&&LJ4GRCI2XA6''<.5H=N.1!'HV/G'7WS\*H7!
M[#L]KF.VZ/:0=CZ'#?8]?2>?5=Y,];]16'$;B:KI)_NJ,!BAO--S(Z<C1X0,
M>PIUL(X9E;^18P%MUW#:<N>S-^.,8QX9CN1]?KYUY!(Z';Z_ZJ0:;K^JT 8P
M.JQZXX8Y8SA+.2RRD*6(Q@9E2<$O.^KSAK&$KRCR^?P3YO'"483#?Z_)^I06
M&:@_Z?N3\<UB_1JH<R'/_P"ZT]^3U3_.7UC>GO\ ?:D_*2Y_DL<OAM7[<>NO
MXZ9']1&[N,)][]6?D]#_ ,S:<3._?'1_Y23_ /*NIUAVW=&1&_[;'BWADYBI
M:ZC'SZ@\$\_'R+6TIGU#H-VC#AGF26BM>QP8JX%:<Y$?F9X]1*'%P[2<6FO;
M?58_N3L^79DA.Q#H "'0EI'W,Q/L^>_"T ;!QWW9H_7M[0.+NNP+H3E=0SQU
M,P9V,L5I=+UFR-M8&S6EC=%)7U#-.]N1!_C6TZ,,<3FMN3+[W8&U3Q.NK38M
M?0UCV%0J9M:OOSA!QL.P/:) *O1GDAFE$H9S6MF)B,FK-?$DG8<-H!A*QR<E
M>>=%:=#7MUH[,D5:U/3DDA:UKN]; Z9\;WG8GO*QD/"&N8'%[M]P!MA>:AQT
M>3LNQ3GNQDS_ "G'MED9)/!4L@2QU+3F>Q-JH'>2V'<+0^6%TC&B.1BKG&=1
M];5*TM#USJE&(@*_?=,"P98^U[&F":BJ\U4Y@[8D13S; Y'"3%$G]=49EQ]X
M02=MP4<CVQ9GJSQI.^2ZERMF)QGS3G2RU\AWCG4X/*'>5"Q')4DM,K]\8K,=
MVY_%\;H83(XLX.)I9:0QHZ#S<N>VXVV(&^VXV&QV!Y+OKEUCIMA<M$C(]>B9
MV=EH^0V,PZ-MNWPT$!MD^YL34E\Y\2/;6FM?STY) B6J;N%18BRI52B?;EF$
M$D D^:VHLE"R"./*1Q11AE-P=CZLLDE&.J88F6GNK%UV"&%[Z\-:RZ5D6S0T
M,:UKVN!I\/'?J>1)W)'/D2>>XV/7SE1<]T9IU9SMAZ"T<=L >S[#".KM2M&W
M[-!UBN01FI8/5,S.TUL.P.(%M"J[3XS#UVD1F+^^5;9Z,]^*CXME\JYMUA?F
MCQS'Y*''FI1DADFKXRO+-:>S)V,E##:)AYUW3VG[5&DTF"M%(8>.0[0$;=SO
MN=R#S)Y;,:SEMSZ-Z\SS//FI:C^O,'"WUV2A.N$0T(;NNJ2<_;)B^S,U/V"*
MJ<O8-CU_:#KYEG()Q+PVS;?99QX601(F3*I!Y@\7Q<:<$M#\Y=FK"&;+REL=
M"Q'! R"..&+RJO%2L4VL; T!DE2O!7'!PLC8P.C( YQ#6C<@<SMN?$[$D<_'
M8DGW25T_:04$2^F# Z45L:>L5?J<RJQO[@K.N%Q@T5+2@Q044!9X\D*1&C!H
M08B=?0U)$MM60='J0&<^VM62&]/ UC&%O SCV:1R)DX@XD[AP(XN1:6]!UVV
M6.Y/26'R\MJS;;,+-HU=[$<A$D3:KH7,CC:6NBX'F$"1LL<I(?)P%A=N(6G9
MJCM1-BCA:/#DQ$TZ2F[RU<[):N:B"\ 'RQT*;&.3$.RC+IQ-G84\&MFKA,@A
M!>5P_#269;V,C8#HWEL;S'OW?$UVS06L8[HX<7L6#F_B(W<0=]MJ1^A\*^O<
MKLDN0LR'=^5]U+&TSNCFL3L.SH'MBX9+)/!7$<9;'$QS.$/#^]I9T)<MN4>L
MLZKJS46@>&:.MM,[#ZTL(.9:':(%A\E5J)K<7.6R0=JJK+F1 EP\Q)4.U80T
MLNO8"=-\NO3N:]KFL<U_&"'AS^%KR2YK2YQX1Q%K@1LX.:T[\MC5QZ1Q4,M6
MQ$ZS#-4-9\;X3%7=+)48V**6PZ&%G?.[GO('->3&Z&S9C+-I2KYZ$^TB?_'3
MV._M";/Y=-3_ 'RK?D]I'_E3"II7[UVORDUE_P WYQ?)?[X=C\3!?Z<!<#\%
M'?E#'\VR*!_#!OY-2?.D:I-VKU49;=IW.R-:*VGLYZ1UK"Z\*<I^ZKUK^#F:
M+*$F9L$#,0T'DL X0^2FFTIC@8U:R/<LM,S;J6HZ.2Y9X[#V1B-I8 ).];O&
MQS@\!NQ#W#<?<C;V6PW.PYG?=VF]1V,=AJ="+*XJC'7R\F:A\JP>-R%J#)Q"
M 06(+%AD<S'QQU&@&:QW3!,V*$;S3@X*K0\HQ8(;$EH[L&7(F4 >L1UC&[8;
MHDV&*]/S<'[QUA=9%<8V\-68P)!,T<'A!D*X]%OAL#Y(E6E->O*'$._W(#ON
M@*\0V+>+A<P!O)QXCNX;'IOOMRN9U*'Q6X69?34=:2=]R:-NC<)"&W:4-L5;
MU&%KMQ=L&9T(GB,4K0^)SRYL(+8SJ6@;&--0RHKJWM^!+*!CZ? ;'5V#VG#;
M H]4@!2:LU4)"T&1QY[.O2*_(-DHKT6"#&8P ET5XJ7%!/ ].N2G?<Q$;DEG
M<Q&-SG$$OX.'A+]QS<>?+;D#L:ZYK.P]DPES^$M1%UBY:QGVJ8.7%7+UF5MT
MW&T/80.R/E,?#Y8YTLI#S&X0U7R1R]@WI>+*@VZU/]$IAZKP;LE<6JS7;1<(
MPY[+^*-1&*85E]A"+''OT6"CVI.+00?7)EL<QXMF**7.L\\^53M=QMF]DX %
MP:T$>R=)Q [ AS9'.<UPV<"1MMR7F?6>9KVY+E/6S9;=B*I1?>DI4.-HCDO9
M86XR )8+$.6OW):]IK8;-5Y8&ND;Y.YLT==:O\X%[#=KO3'8^GA[K)0+-BE8
MV\RV*O76$3<E96QP:\AS(P%69L4_;).;B$MQ8+_M;*'PB,&#I<\2SRS@=[(7
MD'?V0'$2&L8"X]2>%K0-R=@WWECFI<]D<_CJL.5U3!ES19)8B;-4B%R2SY-4
MI$6KH/?69O(ZE2"&222?V%8-#F<.YVE.NM#M.OO.-LLLMN//.NJ2VTTVVG*W
M'7%JSA*$(3C*EK5G&$IQE6<XQC.>2 "X@-!+B0  "22>0  YDD] .96N'.:Q
MKGO<UK&@N<YQ#6M:!N7.<=@ !S))  YE:P*MW6MVW)78T!J*O&S$M*[&+J^M
MR7!/&- HL%#PXK]S?4OR(=<G9QV<D W"\M"AQ:8]PO*T(;21K/MDUR-,9G!]
MG/9_W>I.T#(8]LV<DK--G%Z>MR.[]]:S8BD$3IJU26O%*1((X9Q*9W1MX-]=
M:1UE:U5]GK52H\4H<\_'X9[XGQ]_C*T%>.3('C<.-MBV+4D1 8QL!C)XRT]Y
MLX ;)9!":,=]>8T(.V4_X8QZXE#*$ON^&,8QCUCN%+^&/#X\V'59,RM798<'
MSM@B;.\='2AC1(1N2=B_?;<D[>*V0>I]WW%B6SON;;"_F/;/S#(<O6&^_&*_
M&5'_ #42M>:^\V6_%E__ "LJY&O/M HW\SZS^90N>,K]],E_?[G^8D7K#_>G
M%_BZE_EHE@NA\8S3+)C.,9QG='8C&<9QXXSC.^=CXSC.,_#.,X^SCESU/]\*
M?Y.Z3_Y8Q"M>E/O;=_*76'_->94'[ L^_%R]T@=>ZF@CH>*DL054L.:^."6"
MHN$L+YY\:1(S?LI!$7*8K4D))XAAX0A\N0B7DNG"H<(L7?3>R_C9-WCV?\8_
MV6PVV=S]ER\^_+EZ%D;B? $_#YATV^#W3R.P.W&$N7:>-=D0"]:1<R"B\;!4
MB9,KS1)[E8CG1S*G.*$!MP+,@>#ZU$5%A-,#G6<( 93"X=X)\@GQQ.&VSG#9
MI;U/)I)):.?)IW)(Z$DD]4;OMS)Z>_S ]'/Q'Z=UV4S8.RQ3T<*!K\)H:'D+
M@:D!$: T'+1B:_NN.JPY4F1:S6X]!4@-K)[$)%C^V!*/2I^;1&N/A<<3@2>)
MV[N;B''<[D.YGQ.X#N>_, ]0H\SOU\>ON_7KYAY]U+>L)/9KE(0?L.MOXM$,
MN9!8& #CP)2?C08<5X;_ #=R4>C1C#9E)D<*I9X,8?[(%*8:!$+1ANGD,W?5
MPTO[HNE,H!/"3W9X"\=-^(G8GQ*'?EMY_<\#U^3_ +JM##^_01A(^,I.WCPF
M+JT?(CSM(T$X 3"Y,S@YD05V\M+:;>$\S:#0LCR'G+=.3E26$Q:ZOO9>/C[V
M3CX0T/XW<7#RV!=OOP@ <M^6PY<ME EW7Q\>I_4-SOMMY_ @<U<Q_8^NX.5^
M=8JQ1$/)B2;4&J*>2H%(ASM5,NR&E94RV(P)\[,>=)JD,NIC$>S/!J+Q()R+
MRI%"_-$ZTV"66+N39=*"'[PBW'1+S[(N)\JECAX-C)N]KN'@/$K7)G<1%<%"
M6_#'<-QM 0/XVN\K=C)LRV(DM#1OC*\]OO"[NN")[./O1P*#-][TN&OYRBQ6
MMQ:M;S;39(&L^X%L'2L@7)2UAC S$ER<3+BATF+B:Z[)31$_/B&!.NC- ,LK
M,>''(J*%6K)'9-R&[[&%[X9H'LCCB+6/(,D<E>1UD.?P-$<4D) XB7[ EL+K
M\A)8IC&Y/"UHF2$WX,A#-8L6HCP%L5*2"_5%6;AXMI)*]YKG/CWA:UI+NIO&
MR^Q<1.S1E8/ZW$4- DM)U]R4D+4=:C(UM]D:)+>$A)Y;18:%X?5+G1P:LM^/
MJA0E*&4LFGCJA^S3'8#^)K';@1L:X@DASY&AC2000'N;RY\7,!7!]ZC&SC?-
MN. R#NG-F<^-I(+XXHN.60 C;V#';;'?H=J<=W9S;TUUHB,[A5JM4R%O2O Q
MZ]5'RIT6\T+1M@HD5R&)>0/($-9-5[*L'S)4,MESUBW/6(\FV.QIC6:LOAC9
M6@Z=M. F;PN(.2Q7"0-AN".8=ML?!:<[=)(9-(X\PR"0#4M5KB'-=LYN-RX<
MTEA(#FG<.!V(/(C=;D>:96ZDX1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X
M1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$4+[O\ ^IZ#^.C4/Z=1',AT
MY_O\I^3V=^;IEC6I_P#W?$?E+I[YTKJ >VVL=H3-DH6TM1,60^ST:M[$3F,Q
MN6WZ^U\[/IK1KFKY*]UD"XPE7GZ] W@Y,U9G38*9,)KP)()8\F,R!&9QY9+^
MOZ_7Q6NDQ/;2GPI5?MDPG<1.N:J7"Z(L4'VL==J,G;"+:)>P;9O.?"V_UJM\
M^P75+'#ZJB9V9<D9.OKH<[:@:-:HNU/9DB+%*_K[M-5*Y,-;-WY:W0CJ[6Y,
MO&O^PL9)J<)E H&9 #)C-@]D0)4RVSTXY-0^P\T_8.MZ+9=9HJQNK6Z7:I6P
M/)>&W_?X>ORI^OE]3U'3;ES][==YF4WT%<*1BS?/PS5KM%4#Z*M3C^Q<E&3B
M55BJ:[(E-(:9MS_9J6%A&)<:!L%YLB]IA4*^IEX*Z40+>5YC]J#O8(>>WH&W
M+EY^NW4\_'S!7^IV@=H3>EK17[.7<(<&S;ACK!&:WVS?)G:<S#Z"KEQ9G@]8
MVB4&M=J8DY6;'S,N&B@6J84_7SX&@2]GD H-!C-+<@=9@,(+0'/C<\.!<U\;
M)&O?&X-+26O:TM+06\0):2 =Q?-.92/"Y,9!\<KWQ5;\=5\+XXYJMVQ3GKU;
MD,DC7MCEJ32MGBEX'.ADC;-&QTD;=Y1U#U>AH:$M<IN&.J6Q+M?VYV/FUR%+
MK+$7'4F6?85':]]VB"/!GP<."& (@$EP^.#RT0/%8PV5(FR]'C:$E:*4VY&6
M)YY'O=M$QC(XW$<$+6M!'"QK6CA!+&G<1\MW/RG6NM:N8O8YFEZ5G3N)Q%/'
MQ01,R5ZS8M92K$\6LY+8GD[QEVY/++(^5@CED' Z7AX88*U"]+],.R>NA*-7
MZYO,*BZ435]8-3M>U9G9-*.F&H@2C2EOL*8MR #57[?9AJ=L$"3F0GXZ9FDV
M>OL3D:">ELESW'3GCX6B;AC'!Q-8Y[=]N'B\.3G;.]D".+<;\^:N^7UUIK*N
MR%VQ@[%[+69LC-6M92*E:%8V1DVU(C(9..:K6\HQTD=>9LK()*DW=.=%*(QE
MK/6[N9*GUXDOMU<X:KQ\-;\6F3KMBV+(V">-F:Y)R<1>8Z"EJHH$-\\8N(91
MK@+_ -D48V$4Y5) B<F31D>A6M;C>R0-G!Q#WDDD'9P!&PZCV.^S.'=I))5O
M.J=(1Q3&+2U>:8S4I*\=FC4;#'! ^%TE%\L-@3/X>"8G(.:ZQD!/W5R!C(F%
M2WIS3W;*M[\I=GW#OQNY5,ZO6@NR5.$.V,'!'VN0RW9_9HZO2+#E?B86H24N
M#&54I1<44;5X_P!R2P!DDS(.&S8H;#90^2;C9L[B;Q/V+G'?DPCA#6GDW8CV
M/(A6S+YK2EG$V:6*P<M2T9Z_D=J>*FZ:.O6:V OFLP\,SYKD+3+;B<V2$6W.
MEA<QO"UMPM0?]/W)^.:Q?HU4.9;G_P#=:>_)ZI_G+ZU%I[_?:D_*2Y_DL<OA
MM7[<>NOXZ9']1&[N,)][]6?D]#_S-IQ,[]\='_E)/_RKJ=1;'[-V0+MZ[TBT
M[!U&P7%1HUCJE,C1L!^V5Z9L5@BH".F9J5LJYK-Q>"A&WC\BPP<.DL[+((9(
MXOM3VE]19+55/4,L>+RN'KTX\54MT,5F: A@S%I\LL-FBS,C(13077RQL%0Q
M59XH8YF.GK6"1MNROA<#:TKC\A7PF?EG??L4LKEHK1L>32UZM:R^>#'0X[N&
MXZ-MD!_?VWV'NC)[^'B[L5ZD_2;T>/V==*)\Y3B8/7U?&OMEMTE;82OCO4%5
M"I-F+76!K#B)!LMX:LEYCJ[BI"S++0L6,[9)6:CT'0T;);*TX&:ETW@]24R^
M.#.TZ]FO5?$Y\\$L\DS'5[/=<99W)@E:Z4,+7RM,<37ALCF4U_L^R6-/=69V
M>5.MOH,KQ033N\K;<MUVF40"62&K)!4?8CG?%Q2.>((HI#'.^+IU>ERZ_21.
MN3*E5MC6"IW"V25&L$ZY# 1Q=9NJ(6;*@*.)$.RKSD_:IZ;CXB,PL<D6HQX-
M@$E2K;CU! :+Z-.W + ?) R2&)LS6<3CWD/$SCFXN$!D;(W.>0X=Z2TL$6ZD
M-T%E@+K9IZ<4]6NRW'#WCW">J7P][:[SNP(H(89'R$/!LN=$Z-M?B(*S38WI
M-M-Z^/@H<ZL6\*<(O4U4K;$V9ZJU]5/"J<93):VR9TLW9)2N.O@"W^MXC&G)
MH6)DW%2>7)T$<##Y$B#"6IPYS7,<SNP^)S!(_O2]T[8@UG )-GFO)N> N:.'
M=A)V%)2T?D+K99(Y871M@9- ^)L\OE+IGW(Z[(X^Z9-M(ZC/Q'NS(P=W_%.<
M_A$Z:6[?ZXW7I[9&^X@28@]8ZZ.MS$@=+,(?G\A4*NB3EM+*A8=<DRVX$I9B
M(]B)DYM$J$T(6P^@@M8 WEF%O2Y2AAX6LDO9*>I6JL#Q&Q\UZ9L%9IDE[L1A
M\CVM<Z4,#.9=LT<1QK5, T?7N6LS*UD&/Q<V8N2PLEE$=&""6U)(R,1B>1S8
M(7N,7<MEXP8VL<>$NRA7:#5R&ULK1=&I[WP%#,4TBB6<6Y&/2%>5:Q#Q*\5'
M,&.PRX!MT]R8SA$>,XR[&E/LRR?8,W4:+S1(</L>ZJ:\EAV09DZ;\?&V*V*,
MD4EMDKHQ8%LMB$ WD>'"6-KH-Y1@PUS@23'_ .TA<%F*JW&.Q.09DY'S4CD(
MY8Z3X&RNK&F'3.L["&,M,,CV3[1' K%VKU)(R-29K< ?L(B2L%#BRC<526;:
M@0;\!,R<9D8P^$<23:&\0AC+U*:6-/#FCE#'L DC9;770:!RPCN29&2KCA7J
MY.:%LEJK*^>7&35X9MV,GXHZ1-F-[<CLZJ^-\;XG2L?N+=9[1\+WM"+&,M91
MUJ[B:UAT56Y$RK%EH+4\!XWUBR6^T596/Q8++C)6213,A?&6G)2]Z=?@V:Z!
M&QV+&U=0Z(97X^HZ_-L")C&PH"XVRG#H&C(IUM)9M>H%DFG6"4M*B !!"Y3(
M+4C'+(M\6C<Z_P L,L5:FW'R9*.X^]=K5&P'$6\?1OO<9I&[LBMY2G78YG%W
M\KY&0"1T,H9<Y-=:=;Y"(;-FZ[)1XJ2BRA0N7'V!FJ>3R..:T00OX9)J.(O6
MGL>6NKPQQOL=T+$'><NO[^Z^R*H\R#-C6)>2D:D!'1F:R]$6HB1NC!_N9#<(
M6 '-MN,Y&G0YAUT5M,(5%6$236,Y&R*&H6-&:AK.E[ZFT1PQ7II;+)X9:C(\
M>YC;#C:B>^ \0E@?7:V0NL1V:TD(>V>(NA6UWIBV(NXON,L\V.KPU7UK$5R2
M7*->ZJUM26-E@ &&Q'8<Z,-JRU;4=AT;J\H;E.@%X<HDXYA*D8<W-V,7A*\>
M5:<+[!;.5Y5I\<^56/'P5CQSX9QG'CGDC5 X<G7;N#MI_20W!W!VTKA1N#X@
M^!57I,[XJR=B-]1ZQ.QY$;ZOSAV/I\Z^U?[X=C\3!?Z<!<@/P4=^4,?S;(A_
M#!OY-2?.D:C\;MSJ]F^V37ME7(52;@IAF)%1*"'+][K=2ZYEUCU .61U-LM)
M.<8<)<6B,)#.7E*24-\YVK]LE>OCM1ZAU7I/4>CM)X/5L6D:FHLO6DDK9:S+
M;.-%QM>K!)+0J#(M,#9[9%6:%\4\%N5[WUXLZ=2Q\V<H:6Q6<QV7U/;P[\S8
MPU.1O>TX60&X8#.YX@L6F4"VY/6A=Y17C=O+"UG#(^TR584G"DYQE*L84G.,
M^.,ISCQQG_[XSX\W,Q[9&,D8X.9(UKV.:=PYC@'-<#YB""/0K6002#R(.Q'F
M(7]YZ4$X1.$54>YOSW(TJZY3Y:6CRB;WK"O3($97:[:&YRK778E8I5H!D8JQ
M5^P,.""P-@D)7#C [.&R &52&2HKVX$F^:>CH39$QY"O%/$*.1G@[VY;H".Y
M5HV+-1S;5.>O+&]]B&.%H$@,G>%C"U[FN;:\Q&Z:C)#PB2.5\,5B%T;)635I
M96QSQR1/:]LC'1.=Q,<TM< 0X%NX6L6-[!;?@I.O2VG]915 IT1.FB6 &F:W
M:@9'8 3=PZW1X";)@N-LF8*0BXK:%OC9V%%<;6*7%312VH:4!8'@K[@NS+L^
MTZS(258L93R>3)=+/6,37!S*V?>T/E#HY[+#-3I/CEE>6R/L1N#9&R\4F.LN
M357-CQN/BJ4ZY <RK59!%.WCJ<( CC+6\(EE;P-.XX7_ ');PB0U][NQPV$7
M*:UTU%^[M33<FU5!*M9R*G+6:>A>L&PJVN8*,)#EX@^)BME7*@9*]]9 =G@"
M"&HDH]]F!;NKM&X81RUJV6BM3#(PL;8,T0E\CAL:BJV##$"[O>\91Q]P#;BX
M+#-W!FSU5_9F]QB9U1[(V593W7"_A?/)'BI8P[< AS3+<B',[%CAL7 A7GUY
MMFV[BT/N*SW&N!4XX56VX&)K+;$JQ)B5ZO-S<#'2$RJ6RVX05,/QII[+XH00
M6!7&66FG5-.$.X_-BZN)U'A:U.V;T3K&(F=9'!W9GGDKS31,X"X#N#(UC@7%
MP=ON!R"KK\[[&!R\DC.Z=]CLD P[[AK:\[6N._/V7"2.05CM>?:!1OYGUG\R
MA<L&5^^F2_O]S_,2*LP_WIQ?XNI?Y:)8-H;[3;)^.GL1^OG8_+GJ@@9"GN=O
M_P .Z3_Y8Q"M>E/O;=_*76'_ #7F5+[9P+Q+P31@KI@R6UD"-D,K)80[CQ:6
M\PE>76DN8^+:EH3A>/BG.>8NVQ7?+)79/"^>$,=+"V5CI8FR#>,R1AQ>P2#F
MPN: X<V[A94Z"9D3)GPRMAE+A%*Z-[8I"W[H,D(#7EO\X-)(\=ERN3E*3A$X
M1.$5*^Q/54+:UFD]BXM281P.H5YE421$D2D:]-TFZ VT2P$-"2D64X0]71YF
MH.MCDL.>Q2J7DNY6,AM>78353L12%(U3,WRFY+WS)A%,V"[CIJ4E=A='*T-;
M,^&X-VD&2 -V''QMU?J[LVBU/F79EN1;6><?BJII34Q9J2V\1J"GF:UZ7AG@
ME[UU6&YB7<+P17NN?Q$1B-]0XSKI%OZX@:-"%A^89-^F9*6,U2LRS/N6:)51
MH&3CIEN^M$QY50!8G#(*(F)R0:%*77SY$9.!ZL_)W4:[<Z_/?DKWG/>:?=0-
MR#&UQ%6NR7YX9H6TVPO%V;N1.^&& B,6&-;PV7M&..[&(6X6IA(+N)BBCBRP
MLW#@Y7WW6K^%@P="Y5N2922Y&_#TQ:?39<M7@Z=]&:23O,="]_UM]6H!4/8V
M\64AJ=D9JNJR<!2$A+@UQ\'N40Z+A")J\FG"@ROS_BE%NH/;CF96MX:);47+
M1+63M>/VCC%6Q)!&RPPQSW&.[TS'#&-\PBK11R/@^Q1;&YS'/#)FMX_XK=YO
M8M7[VS:^R5*"Y8DQSQ+5Q4C!6;2&KFS15G6,C9FBCN#5/%/'%+'"9*CW=SM9
M(BC;L=K=C7O5*.;P4&61([NUZPE8599K2, 5O3-BJ(9A@[<S.+=G9Q$!F:L*
MR20BUR)F7G8QAAT0@O/>S7.#.:SMSMAEA#-/91Q;-8\H<'6L_2NNCC>(XN"M
M ;'<UXBTEC&DEQX^%N(Z\T>[1V@:M)UR"X9=18&,/K4S18YF+TG8Q#+,\1L6
M>]R%T419O6@]@ED>Q@CVA#Y-[O.?UU"G")PB<(G")PB<(G")PB<(G")PB<(G
M")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PBA?=_\ U/0?QT:A
M_3J(YD.G/]_E/R>SOS=,L:U/_P"[XC\I=/?.E=2%<1H>1K,W#3\>Y+0L]%2$
M'*QK;[8>#HR5$>!D15G/FQK :'@GWT*?7(AN)3G/L[OM'JDYQQSBT;AKGGP:
MWAW/ON<UH_\ Y. \!SV"R=H#CLZ1D;?%[^+A;Z2&M>\__P 6./B1MN559OK=
MJ14O)63YQ:6T0:[-M2LM8MG7&>->>MT;)1-F?E8U+S45B9G ) IHLA4N6^YA
MW_(E,X#%]73%UYQ(;%5B9_->^:65XZ?=1,AC8#ON"&V' ; \1W(%6!C&-!=8
MMS/W'$R."&&(]?N9GV)7GPVXJS2=W#8; GEQ/7'5,!/6"0A*'KPJ5M&3XJ1)
M%OENAY=?KB0+!+"@C+S/X%/Q)1L9*K:#*!<:<3DI3HZ'74OPXK[=O84YAXGO
M9JY',<FM,5D.(&YYO:"0![$;N#_V6_?::[ =]FL,5>T"=B=W/$]0MYEH/#$\
M@$N ) :[OF.JG7Z<Q&$/:U*ARX&+FH"/6-:K$,XW#6%4YB="P;!V=Y@T:719
M9Y@M!KRS?9Y%UM38[:1<-U+'.<-W,=&?Z+BT^^"QS@0?#<AWG:.2I7M:T[,E
M;*T]'L#AMZ"U[6D$#;?D6^ <[8J==@; I^K:C+7N_3;%=J<'[!B4ER!S2VQE
M2DF%#1S>!8X8PXAXV5D001F!17GG2"6D)1GS>.+ACL==RMR&ACX'6;ECO.ZA
M:YC"_NHGS2'BD<R-H9%')(YSG- :TDE45V]4QU66[>G97JP\'>S/XBUO>2,B
MC&S0YQ+Y)&,:&@DN< !S42,=M>NSF64%[.BH)Y]6,-BVR+L=-.RRI\05!R@+
M7#0QC<6LLT<-$LXPB,69EX1)>21B6F;E+I?/0A[G8][V,X@Z2O-6M1!S8S*Y
MO>UIIHR]L8XRP.+PTM);[)N]O&HL,7-8;T<<CPUS8YXYZ\A:^3NFN[N>*-X:
M9=V!Q:&\0<-_8NV^T/MGULD%L- [FHY3Q;:7@1V)7UA,BPL":E$D18R6LOR8
MRHZNSIF"8]LEC(\4<YZSRL+\/,NF<_"2V;%6XRTN#^-@:(RQ[&.$KB[AB<'R
M1M+9"T[O;RYA0CU'@Y6A\63JR-<&EA:\DR![7O:8@&[R@MCD.\8<!P.W(V*[
MV [&:,M,+(V*O[1J,I!Q$/#6&2DQY).!1(&QR!43 3+JW4-_^S)F2!,!C#D8
M4,:2,\T.XXIM6,2)L%EZ\L4$V/LLEGDGBB;P<0?+6B[ZQ'QM+F!\$7\9*US@
M8VD%X&XWG1YS$RP2667H3#%'%+(\\3.&.>3N87EKVM>6RR_Q<9#2'NY-W634
MG;>L]DD2(E!O%<N!,.V,Y,,U^29DW(=1;AC+ \M@;*_=ARGXX]AR/.]G.8?#
M)9?';=9<0FEM8^]2&]NI/6!>8V.FC=&V1PBBFWA<X 3,[J>%_>1%\9;(PAW,
M*JK7Z=P[5;,4Y$8D<(GAY8QTDL0[T#G$[O(96<$@:\.C>"WD5CNH/^G[D_'-
M8OT:J'+KG_\ =:>_)ZI_G+ZLVGO]]J3\I+G^2QR^&U?MQZZ_CID?U$;NXPGW
MOU9^3T/_ #-IQ,[]\='_ )23_P#*NIU5K;6@*Y1=E7;8&J="2EQOO85@878N
MP1K*/DBBOQQ<'$#VBJ@6:%M$9#V4*-,-L(+P@C8;DE7A/7Q4MCP#Q8+'=W(Z
ML-RO6N14I.\KQV8(Y6L<7->X;D!P#BT;D.#AX$$DK8$.H\Q!7JTX[\\=2HXN
M95CDDAAF!)+H[+8'Q.GC<"YA#W$ADCPTMXW$XM'ZT K4'$:BE.C%5O%*J20X
ML.RVTN N$C9&(:KKH\19)TDZF&.&6<RO@QL;.R+A!2W8YPAL?*Q&FAT3H[,T
M&PK2&HQH+8X:F]>&&/O3*(H8HN%D<;9"7M8T!K7>R'LDM:BS=R]9R4N5NMN6
MY99I7Q6)H_92V'6G,8&/ 9&)WNE8P<FO/$/9<U]+6N:VW,!AM>C8U(/% UZ?
MC 9'$51G5.PI(LN\37AVOG&8S$,R\I)FNNLR7E:)$D35('<D2E#8F?9"_P ]
M[MH\3FO=_M$O-[>$-<=W<W-#&@'J.%NQY*4<[F3Q$YG)$OD9,_\ VRS[*6,,
M#)'?QG-[!&P-=U 8T ^Q&T5P_7.NU/95RVD%Z.>N25HM59$BG0I'8 ,_5(^(
M!,@( "%@JC)5MRI13JXL$(K \;'1Z@XF&($<+''+RIZ:[+9!T+*_E4HCCD=*
M.%W"\R.+B7.D&TCB2]Q.[CN22>>Q53)J?-R4X:)R<[8()7V&F-SF3NED=*YT
MDMAI$SRYTLCCQ/(XG<1!(#A>C7.N*Y(Z!ONM#]'Q'7JN6T6[U:8HNOW(!AMT
M&SP:824LD8_&0<=#CR,JT6]@8DJ/)2Q@05^26I*'AV(TLK<HY3'Y=DG?W,;<
MIW:[K1DE8Z6E/'8@;* ]LCHN.-H<QLC3P;AKFG8C&-0PNU-C\GC\O;N68LKC
M+6*LV'3EUIM6Y6EJR"&:82AKV1S/[ISFO8U^Q+'#D</V7KS0>U99-FF#[1BQ
MN2-?]U'@04)+KC3(J'EX-D(:%N51L=:(1+1TZ6/(LSL3)(22R"< J,,#&+Q?
ML/K',X6N*E9E=]4LLLEA>^[!WXLV(+7$^Q0NT[<;X9J[#"ZM8@/ Z6*;OHY'
ML.(9G0^#S=MU^TZTR[WE62*PQM"?R<U:MBGPQULA1NTI&3P67MG;9K6!QMBF
M@[F6)CQRJ=J/2C4W'0-53:FE56PZ[NS#33XHXOOO6L?/5J-2\T_"L9>;/R6]
M(2[;+B798N0]L 6 PPZ/F%K6>:MBP;/DDCK5/*T)'F*7B%?+V(;,X8>_V#H3
M!'%6)!$<3>%XE/LU"KH7 U'5?)O*XA5OX?)1L;-$&&UA*UBK6+AW );.+,LM
MH @RS/XXS"-VK']=TK6FMFH]PQ<XZ:-M>[[YA78X<AAGUTQ#72CUJC#@'H.=
M]Q4O75B%@(\$8Z/"8*CPSQ5"A/OAN3<QJZ]DWR!D;&PS:<Q^G9A*&ND>VO8H
M9.[?+HNZ;Y9D,M3?:FED9*]T<[HWF1X;(V7@]$X_$,B+I)'S0:IR>J*YA)9%
M&^W6R6)HXX,F[YWD.-PMYM.&&-\3&RP-EC$;2Z(YU"]4=6NV^ V: 7/.2T7/
M"6:-,D!8!4]'FQ4W*R@T0#-J@F9V%K^29ZVAS=<:(0F38LDJP<MM[P\ECNZH
MU?:R5)\>??3T[%@LUA\II."G"[%YRUE!BF5<W>EE?):9DL/%BV,HN@>R$E['
MR1N[EH=75-"Z4K-DLG&OL9IN8QF6Q^>FG'V0QD>/ER4TF+J.9"QHQU^3*6S<
MA?NY[996AX[UQ$F:$^TB?_'3V._M";/Y4ZG^^5;\GM(_\J855.E?O7:_*367
M_-^<7R7^^'8_$P7^G 7 _!1WY0Q_-LB@?PP;^34GSI&J!=Z=6R&L0T[OUY($
M)O=VVS0X&3E38B-EV:Y +CY]1)B7)/7^U!HUMI\.-"3-(H<L:%'KS$L_Y$M.
M4:<PO9HR?+ZL&J=29?5^D,W=BSU#1&;;#;PV!RM:>"P+E1TG%8>QL\0FAK.<
M*T#]RR$N<2I^M<F<=4QF=TWB:.'U; 8,/<U-2,L61N8A\-B UY/]ER->-QA>
M8);,>.FLRP.,+Y!& 60O0NWO;F-MNP)^\5[8I<,QJ ,JAT>8UQ'QT1<MNRNH
M-$R$'2Z>Q"T]JPPMC"V/<+09:572\JAWJ]*H#@HK#U3L9<'MYU.BUC6PM:6B
M6,N+'D=W7;Q<0:'. #2PL9MP;M>T@';<K7%'56K/*+EBW6R#J[<,#2AFH,8R
M_F9,9AY8(*L4-,66O\LL6Y)I+5F*%\;@R*NPP2]W*^F-B]RML7;5FO+;*WZB
M2=&J-QCM[GD1FOJ"?,3,7<XP2J7%L4[4^XJU*RD_09>(L#E1J=DK,*Q)EGBX
ML"D1[PS/FRS'QBU) QDC#/%Y.'/D/!&YO%(T;/:7\)Y O.^VQ)',&\8J_JG)
MW<?2GFR%/R2I=AS,CZ5:@^2U'-&*=R/OJ&1JO$]:1LS8(+# =SQ\#F/B&&2^
MV>Q]-HM?-N>]]T1.9NO=II6!L[>J]?3LM.;2UKLQBEZ:U>_#06F7V&HFSU@$
MRQHCE1P,Y=Y,LS,)9PP &HY$EC(7N>&U&NX#$7 2R>QC(#Y"/9CG_-:"'.VW
M!!*HSE-0U*D#KF4RK3)4U-9BL''XXOL7\?E(ZF*Q;HV4.%C;-3>9@:UDMASG
M.9, T!DC&[A[?MYV?6Y!4_#3&GJN9=Y.="I$22%<']P&4:2U93H1Q^!+!D&]
M8!E[7K5C]T9?EG2:A6)*>*6F6<5)0[JH70N: 6ROYL+SNP1B3BW.X_WAX".8
M WVV57/E-6AF1K,BM1VL=4\I[[R>J]EB;*/I.J4XP(2U_P!C&R9")[VMW?Y-
M&^<NXQQ[7F4*:9::6ZX^MMM"%/N^K]:\I"<)4Z[ZEMIKUCF<96OU333?FSGR
M-H3X)Q;#U/+;T#?8>CF2?A)/I6SATZ[^GS^GER^!?4:*DT,L);BVDEC/BJ=:
MPWEQM)#2VLN-X>;=:RM&%Y4C#K3C>58QYVUI\4YBT\+FNV!X2#L=]CL=]CL0
M=CT.Q!VZ$*!&X(WVW!&XVW&XZ\]QR](V4&1F@08QT5?T4-P&,C.C/*!*ML>D
M(EP0XHUI3S(4 )E&<^UK%?\ 95C8+%:'P5AY]ALC%R?E)'-V\DH-//V3:PXM
MG#F-W.<"-_9#<$AW,$<U2BH =^_G/CL7,V'N 1C;W>O/W-N9,48:D:PVFP+/
M66<1(4VQN^:R2F)-T7 U9/8PV,I+ Z$)=SYG7U>K]8ZYE.7%*RA.>5&/M.LY
MG#ET4$19D:0_B(A$';VXCNX D$CH/,.2H<I"(<+F ))) [&WS_&.#BW_ &24
M; AK>7+?GN=_%2!KS[0*-_,^L_F4+E'E?OIDO[_<_P Q(JC#_>G%_BZE_EHE
M"M#FYJNZEN<M 1^)*1&W=OE.&5"&2"!Q2.Q%^'.D7(^.SB1/;C W7SW P/\
M.R$CY;9^N5S(<M!5L9S'Q7)7Q5SIS3#GF-T;))'-TGBW10-EE:Z.(S2AC.]>
MTMC!+B';<)Q*G=O8_3.4MXZN+-J/5&J&ACHI[#8HI-9Y2.Q9?7K$6;#:M=\E
M@P0$2R]WP,()W%*9DN;U]7^WW86%GV(?9]!TYOJ\56)(JV6C7[ _6&[#B6EI
M"260NR5N%,K5?(K]1DV4R%1;ECHB50\E0CKVM,/V.,P_:<S5$F4-S YK(O[G
MNR8<@QFH+..-['YK)!TT%VOCV8LQX.:.JP5X9[!:SDQ@V)F?5!OU%V/W](_8
ME^*U1I3%R26I9I)WXF>#2U+)MP^4PF)L,/D-FZW*-GU&U\\T[YHZL5B-IXB_
MET#MAO6<,J,?>% T'8$KV?'HMRUE-1<,Z)2]52_7R];$H)6)Z.]J7.#6XFO
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MIGRLLD9;6GQ3GU7FRJ&XY\MO-X_+U](^7?DH[/Y'?GML?A_U_3[\W?\ ^?\
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M8SQ'8;Q3%\9(!+=PIL&E\%!-%8\A-B:N\2UY,A:N9,UI6_<S5AD;%IM>9O\
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(,$$9EDXO_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g904779g27u11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g27u11.jpg
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M0D-%4F)R=(*7&D13565H<8.1E:6GLM'G_\0 '@$!  $$ P$!
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M-+!]VVGVKFE>QV!UG4[)WJY;KIN6<)-6&=G.HY715JY.CXX^<H[ZB=-%"K:
M02?X31S[\D_0J3R7R:=DL].)0[FT/<U)?O6[KWX].ZPR7Q:U!UF">PM.6C9H
M*/3,18C-C!8>VALBL(9&)P)D4#8*25DTVE PG'Y:ZR+0<K/F57",['()<W<?
M)('I.>\'YEZ8^%Q)PB<(G")PB<(G")PB<(G")PB<(G"+5EOV$[;WEW?[']?N
MO,AH6L*TZ8:]?6]EKVQ6\VLF875)[LA_X3782-$(S:%>,*MC(&!KLV#*3.@<
M^(/)BHX4V#N!#)=GQ[^_O]:JP T$Y)=G&#@#&V^0<[YY$>G/*L=;>6F5S;O5
MV!H=5Q2RM*X#=GHMU=<AB"Q&T2MN]-04(5MM*RV+>4+(IQ*9ERUE/:Y5:A .
MY&/528<-B!+"RCU,IX1AO/.V?0[."-NX;Y[2,+([8[V]HV/B@Z^=Y820AX&S
MIKUXC]P3@(%ZHWAV/!GI>3J5:?LHLS"UE8()2D*[*&!S]E);DLZ0%HA!QRPY
ML]<9)$F2VY.$<9;O@.(^4&[ XYD8RNMFOD+[)QBY?''LF;I=U5_<E]U[#3./
M-*6M7:M C6WZR,2&0GX3WR=6$G0,MG&L_$8C]54@ CIF93$$2#/EE'&YL>]P
M3A&'<\C.-QG;'-N,[;DG8>L8-C+8["=M;+[M3GJ%U1D-#U8VHJ@J^O"QYU>5
M<32U7$\D5I2B7AH56\7CD0M"K-HS%D!L))OIA8"A*2E&KTD-'"8UC9HNL_*
M!C)R<D@ $#D 22<'O&V._<=L#];_ "ES5S<%HTS?526(41>=N?(53](W$#UI
MX#7I]GU'?S::-*JPT?V "D+$T-J>(N_2P9P(C\4*R!NHQ(2;'P"A5B4ENV1W
M D;YW.-ML<^S.>X8611?S4U'+X^=5C%(V+.)Z(["TQUQ80"J[)ZXVJVD\R[
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M/I-V]3[L51M=@&EK,J>NBQ!=I7Y>RWL"V=V*Q&/" 0^="AX=+Y03#B1,G$%
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M."URUC[.)"MI4UL9&4*+CF\8#:*DMRVQ%]EMOL]<K[.'&5'-1D9S@Y]([?\
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MF#+342-$K1 !(&R-;(T/! > X8< 5T*6^WMU#?GNO%T<^&*E,3C<*LNB+KC
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M <U=TN_@M#^=Z3]'K%[[_P"IO_O_ -T_S;:B_7>EU8H1^[IXTOU9H7^TK/\
MFFX_OOH?^0L_ZZJU]-ZW][OX5OYVZ1_]E6G%$T#_ '+.[7ZN0#^T'!^6ZD^]
M^J?Y&C_7%*LTU%^%_0%^=-1_[,]0KUI^%W][OI?_ &U:W]:LQYZ'Z,?P,MG\
MK</UA4KXP?#P_P"$YKO\@T=_J=8UM0YGZ\?)PB\]TE_=^[9?_5+[_P!^N^:A
MG^^VH/XMV_KBOI5:OWM^AG\HZ.OU?$HA*?N 0;^.&UOZ%4URW2?>FE_.-?\
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MFII&5D?4D6DN<!%(&OXVQX>"!Q-\Y0[55M:RGD,=;PU/&8\0P9'!(8CQ U(
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M2S:6"7X5L7'KLDF3DDQ>_>JF\QZ^T#LY9.V_)4Z\,IBY8@C-Z'=UZ&']:@0
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MW#A=31%%'3=13?737;;$M:Y[FL8TN<XAK6M!<YSG' :T#)))(  !))P%(!)
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M>CINA?=+H^>NT]9:>)K_ -QPTLU=565M?<*HP5/DM! *FNE$,CJ>G+6S.&Y
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M]XE@,% ]4MTH!+Z\G@M]9DM=/)36LAOJ4@WSQJ-C85B/<F^R!8U93AW&HT)
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M +*[:&O@?3,8<\(2"2<'V^KN4MH5%W7=.EV+7R40YR]:FE(XY:H=1ZN6<-Y
MD&UD2@5=%.P]MT2B8'?0SNQ4UU<ZC-]'N4\-]]5,E&W<?:/L7*84IWC*Y?:C
M/(_%2&PL@N*):LNH58.<L"C;1%5P.>81L+?+9Z@FX046:K>Q9/19+;?3&%-<
MY)MW'VC[%V'XOW??_G#@?\SBM_[_ /";=Q]H^Q<9Y17>P<T=$'_D8C;%@Q;+
MO'KUWT_K-LT9M&R6RSETZ<+6#HB@W;HZ;JK+*[Z)I)Z;;[[:ZZYS@FW<?:/L
M71QRL>Y,P;-GL3\FL$DS-Z# 29FZ ]3ZH+-W4<E;59]&#S=9C8RZ:P>0LFZ[
ML*13VV:$VR*J[-59-/;;!-NX^W_=7,UJ'NQM(%8GKY*(?M)T [:0KQ[7J-5V
M3*(%X]=CFAE4;BP\NTQCH@P?,FS[=+#==TS=()*;*MU==";=Q]H^Q ]0]V)!
MN83!>2B'F%(^76CYU,;U&JY[N&.MFK-\N')Z-[#4V8DD61$>\49.<)N-6KYH
MXRG\)PEON3;N/M'V+N?Q?N^__.' _P"9Q6_]_P#A-NX^T?8GXOW??_G#@?\
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MW]]E/">S?E[2,X'?MW>Q395G=_KQ<MQGZ(@LAE;FP@#FZ6.R1NL[%BT8.O\
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M>DIVUY)B1)X1=8W;FHZ7O&U7<7<ME$4Q*LN45^ X6"1E4(3)]_9]"[(KU@J
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MA)O6B3[N);$5NJ\=U&"ZNS=5,U/88!?!4M]<Z1QB@N,%X2:.5=,D))VSW?\
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M)WXA@G9HP<<N>#W]N-,.I=R':#\E5>S:J[#B4U\@@:%CTA])=6I#'*BK O%
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M'U'^SQ7+Z?6G/KOZ_5[;T[)5K($K*CL?G4$EU7!YM$P4RKJ7QH)(XQ)25?V
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M5;&EQ.Q( WQV9!Q_9X\]EDOC F$WFW5(06G5_"^S+UG/[' A;?'GQ,H<2B.
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MX1.$3A$X1.$3A$X1.$3A%KZ\H6)UGIG8^*^@\ML$SDQ M7X*&YNEZ1;QG>;
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MD(W+G"2:FNJNK-Z6=#U-\9PNT6345TWM%78K56RFIEI&Q5G974;Y:&O![/\
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M<(G")PB\<G<+]_2"_P I/I[_ $?I#GFO4W[Z\/YZTW_4VM?<;H/_ ,GC<?\
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MFBK?9TBEJNGOINEG;7;&<^DFS0OD?"V6-TL0:9(FO:Z2,.&6E[ 2Y@<""WB
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MQ!<23V-"W2X3:HJ&5-?6U$/D]?+)%+53RL>Z(,:QQ9)(6.>QC0QCB,M: T$
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M"Y RD2#!;91MVRMY)#.V<IH2?K7W-LO;73.?\1QO-/'P]RY_1C;;XB>V?O\
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M\5(M=8-_+JKER;5SNSZ!-5.&W>?K7;H=G^PC3&/9V0O?7./TL:G[J.<?D_\
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MUC9CHZT4P/:/\9ZT]'253X)*FF@G?2RB:F?-$R1T$S2"V6$O:3'(TM:0]N'
MM!!R KU:=3:BL5/=J6RWRZVFFOM!):[U3VVOJ:*&[6Z9KV2T%RCIY(V5E')'
M+*Q]/4"2)S9'M<PASLXA>/AJZG3J[NLDG#T$B<A(.8SS%\N9!;UKDB#^#[T_
M/V<#884/V,[,O6[&UG\3((M :Z:S133=XXQ\AH\QM3-04-3():BBI)Y0 T23
M4T,L@:TDM:'O8YP )) S@$DCFN>V:OU79:5]#9]3Z@M-$^1\SJ.V7FXT%*Z:
M0,9)*ZGI:B*%TDC&-:]Y87.:QH<2&@!:?AKZG2OLMU^FPZ@D2M;B =O)W*]+
MV]:STN],[BH7I3JN%R]C.)&[R')-)/NT4$.=$QN5,;//1-1M[4M!0SRB>:BI
M)9QPD32T\,DHX/D?LCF%_F_B[^;@8QA*'5^J[90.M=MU/J"WVUW6AUNH;Q<:
M2A<)^+R@&DIZB.G(FXCUP,?[+D\?%DI*O#5U-+]PJNL=&@D7E2L*0N9*?DWM
MO6LX/N+RQ/NN*]&F\.GEC*2U=X!@\?N5HP*,'FK 3HNBW>YU=+A/A'T%#).*
ME]%2/J YK^O?30NGXX^$1O$I89.)@: QW%EO"W!&!A3ZOU726MUEI=3:@IK.
MZ*>G-II[Q<8;8ZGJS*ZK@-!'4-I3#4NFE-1$8N"8RR&1KB]^6_AKZG*=Q-+(
MWH)'>I<4?[<E-[>M;:08O=.PTG2![#O:QLR[YY.#Z9;:%L//D--==4,9P[QK
MG T%"9_*C14AJ>(/\H-/"9N,<G];P<?&,##N+B&.:ANK]5MM9LC=3:@;9C Z
ME^*&WFXBU^3/XB^G- *@4G4/+B71=3U;B22W<Y1OPU=31O<2S+(<T"@WJ5_1
M].:P4FVMZUDCZ-[XL/L2[NH_ETUL;27(OS<(.TXW>EWSS9B4PW5099R[;FLJ
M&T%"R<U+:*D;4%SG]>VFA$_6/XN-YE#!)Q/XCQ.XLNR<G<YF;5^JZBUMLD^I
M]03V9L$-*VT37FXRVQM+3=5Y-3B@?4.I!!3F&/J(1%U</51]6UO W"LO#5U,
MC/9N_9T4H% =714#4.::("[>M9H:8R+ Z?)7,Y^9%6,A)6BIIV_BWSJY9UNF
M3QJI\GG.FKS&R.@H89>OBHJ2*?+CUT=-"R7+\\9ZQK _+\GB/%YV3G.2E9K#
M5=QMS;37ZGU!76L-AC^+:R\W&IMX93%CJ9@HYJE]-PTY8PPMZO$18PL#>%N%
M*^&KJ="[W[,2TW02(>%&Y7 -Z'>A+>M9@4817%3Q%G8;;*X*QFQQDF1LQM)'
MKA VXW6>[J_--_5@HWQA%04-/(9H**DAF(<#+%30QR$.W<"]C&N(<=W;[]J7
M'5^J[O1,MUUU-J"YT#'1N;0W"\7"MHVNA!$+FTM34RP!T321&X1@L!PT@*0>
MS?C"IUYU\N5MUL@LP#7^YKB6-*@+X["W@TW'3MX'=- ;G1Y(K27!M<ZN5L:[
M+E$MV6FNVV5]<Z>O.>6&*>-T4T;)8W8XF/:'-=@@C(.0<$ JUVZZ7"U5D-?;
M:VIH:R DQ55)*^">/C:YC^"6,M>TN8YS3@C(<0L?[:^)GKS.J6D0ZFZH,K6M
MF001Y&W1*]KFQJT88LJ(OI_E!>26<N):[OX,WDK=;&R>JKKXOP&N</%&V<4N
MIX'M8Q\,3V1C#&OC8YK!C'FAP(&P V7+3WJ[TL\]33W2X4T]4XNJIJ>LJ():
MAV7.S-)%(QTIXG.<.,G!<3MDKA=F?$/UIDM>0<32U-/D9(%O3K:^(Z.+NN%%
MNTI<;V$K(MV!&,L'K,68()%Z583I@LP8)I$R7QM68?.I=5COJ=34[FL:ZGA<
MU@(8UT49:P'&0P%I#0<#( &<!5P7Z]T\U1/!>+I#-5D/JIH:^JCEJ9&-<(WU
M$C)6OF<SB<&ND+BT.=@C)S\]A_$/UHDB%'HU533[V1Z\JS7L--W=UPZIZT:/
M6)?;@*TT.68MI\HJAL.UU&!\)$%<:8U8^W.F_#J:G>&A]/"\,:&L#HHW!C1R
M:T%IX6CL P/!13WZ]TKYWTUXNE.^JE=/4O@KZJ%U1.[),T[HY6F:5Q)+I)"Y
MY))).2OB^_$/UJDTKZRN:ZIM^J CEYLUKNT?7=<.VSFBV].W*QP$0U-V8LX<
M-$K3)UB^2%@=DB&FS7+I/T'MR6NY]-3R<)D@A>6M#6\<3'<+1G#1EIPT9.&C
M8=@2FOU[HVS-I+Q=*432NJ)6TU?50"6HD+1)/*(I6"25[6@/D?E[N%N2<#'V
MM[Q$=:9%='6<U$Z;?N:Z!RNP/P[Z/[ON)5=_$%*CF3" ,\:%K,6*O$6-F.8P
M[2;!%$UFN4OF7./IZ;G7)]-3R$.D@A>X  .?$QQ '( N:2 .P<AV**:^WJBB
M=!27>YTL+W/D=%35U5!$Z23'&]T<4K&%[P,/<07.P,DX7S87B*ZV&NRM#2L'
M3I%Q4HN(74E<67EX7&H^?2MUI6&M-.<X(68H?>;BLCYYANN*7U0'X7Q@A]RS
M'VG4].]_6/@A?)L>-T3'/RWD>(M+ML#&^V-D@OEYI:8T=-=KE3TA#QY+!75,
M5-B0N,H,$<K8L2<3B\<&'EQ+LY*'/$5UL>=MJ_FC6G2*M(M**MAK,]EKPN/<
MBO>*UB48[J@QZ+V9M)E7(N#B+7;MR31Q@:PPYU0>_P"&.!6=!IZ<OZTP0F7(
M=UAB87\3<<+N,MXLC P<Y&!CDD=\O,5(:"*[7*.B,;X31QUU2RD,,O'UT1IV
MRB$QR\;NL86<+^-W$#Q.S9I3QC]+%D]TE:PEJJ2NFR:J2E]]B%$U$]]<Z[IJ
M:;VOG7?3?7.==]-L9UVUSG&<9QG..=ACWQO9)&YS)(W->Q[26N8]I#FN:X8+
M7-< 00<@@$*UEQ((.""""" 00=B"",$$;$'FJM==/$#UGUZL5]7796E7,EL'
M2.JIV&&(75;IJ.D#Z9Y\49K+,!=E9BCO9+?48^34:LOA)O4='/W.T\J8[TMV
MND]<;G-<JZ2Y.QFO?5SNK3PQ" #RDR==@0 0@<>T0ZOY.RXQ% R/J(X8FP#<
M0B)@C!)XCYG#PYXLNY?*WYJ-*>\)W6$3T"@U6V+UV%*]B%>N<7Q8[%.U[&5C
MY;LNSJP>-,R=XB,L'2#OR?V\:Y53.HLMAN=$D56^VH_1+3677>[.J&UCKI<7
M5;(S$RJ=6U)J&1$N)B;.9>M;&2YQ+ X-)<XD9)4]5  6"&$1%_$8^JCX"<[$
MLX<$@ #)&=L+XE?A-ZQ.?'R?JD!UV%:=C,]9C&8\QS:UBZ1YOVJ5IIV&&RY-
M%Q8.8*B7UL173?[0J,?IFJ.VZBFV1>=T\A=[L*DU@NEQ%68NI-4*VI\I,/$'
M=29^MZTQ<0#NK+N#B .,A1U4/"(S#$8P[BZOJH^#BY<0;P\/%C(SC/BNY['>
M%'J9(>G4RKBG.N0E"W6<!<*UF-7M2RD  2S';1'#HN.:F[!5B(QZY=*O]G!'
M9GHBME=793;;57/K N]V9/+5LNEQ95S,$<M2VMJ6U$C&@<#))A*)'L;PMX6N
M<0WA& ,!.JA+6L=#"8VG(88HRT$\RUO#@$Y.2 "<KN.U/A6Z=2ZBA\-I7K@*
M^U4<G]0.HH,?6E9VH:/PO%W5Z7N9N%:2.PEP(G!JK6<U;O46;9!V3W7^ SSD
MJLSWPCNUUBFFJ8KG<(JBHX?*)XZVI9-/P##.NE;*))> ;-XW.P-A@(8H7-:Q
MT,+F,#N!IBC+6D_P6EN&Y// &>U?/:3PK].YM6]:1^J>N(MT7B%X=;ULLBMI
MV>H/!T:.[ 5@4[!! ;>2V$Y&#69FE14S'KBQ"+9^3URBR$8P6V'[:(;O=:>2
M>:"YW"&6J<'U,L-;4QR5#V\7"^=[)6NE<WC=ATA<1Q.P?..1BA<&M?#"YK 0
MQKHHW!@(Y-!:0T$@<L<AW+Z]E/"ITYF[:@&E=];Q+]M#+IK)"9MC%HV<X;CN
MOXO)369QD.C(["<I-164LBM$@@#5L[VU2UU'Z:?#VQR8;O=J=TSZ>Z7&!]1(
M9JAT-;4Q.GF=DNEF<R5IED<229'ESCDY*.BA>&A\,+@QO"P.BC<&M&,-:"T\
M('<,!6]:^,'I,Q:MV3*JY2T9M$$6K1HUOCL,W:M6K=/5%!LW;I6MHD@@@EIH
MDBBEIJFFGKKIIKKKKC&.@YSGN<][G/>]Q<][B7.<YQ)<YSB27.<22222222<
MKE#B  ,  8     Y #&P"K92_B.ZW@[([:O;"IXCB#3*Z(^]H]!K=]PXVVJ/
M/7*B@TE'DDA%EHOO8ZO =<C]5G*-G))?ZCN\3VR&>C-->]4W:Z5D='#5W&NJ
M8K>P1T$<]7/*RB8.'#*5KY'-@:.!F!$&@<+<?)&.%D%/$9'100QOGR:AS(HV
MF9Q+MY2&@O.#S=GF>\KH.N'ABZBPS6_$;%Z],V;>5W/8[> I"K9M-%-UU_*-
MP>D2C!)./6*WU5$^],SJL#.X7=8U4SA^GOKNECE51>;O5F U=UN54:9[9*8U
M%=53&GD9NR2 R2N,3VD#A?'PN;V$*&4]-%Q"&FIXA(S@DZN")G6 _*:_A8.,
M'M#L@]N5].KGA?ZAPJO+*!VQUX8-C4KO#LFHBU%VO:6C(S116_K-)4"#,I1N
MQ&PX@R%4J3A@Y,472</Q^FJK(SC8KJ_VWHENMTG?#)/<J^:2G?UE/)+65$CX
M)-CQPO?(YT3\M;YS"UWFC?8*1!3L#VQP0,;(UK9&MAC:'@#</ : X9)P#D;G
M W7QU5\+O4&(40I$;JZ[C_MG();9ZLS8L;7M'85((M^%^>$ZI;F6\<L-N#+:
M"*X>Q1NT1=-UEQVR>R#KT(Z.]]C[K=)989YKE7RSTY>:>:2LJ'RP<>SNID=(
M7Q%P #N MX@ #E!!3L:]C((&LD#1(QL,;6OQR#VAH#L$G'$#C)PNHZW^%KJI
M'.G\/KRX^O3!:WW\ 0_"<P;VS9RP,]8K-%=1D2)H [#2B95RT>)#E6S[#11N
M@HW242SK\+&<'76Z/GCJGW*O?4PM<V&H=65#IXFO!#VQRF0R1M>'.#@UP#@2
M"""4ZBG#'QM@@;$\ASHQ#$&.(((+F!O"2,#!(.,#')=/#O"QUL8>/Z/U><Z_
MLM>R.>LH7$E;)6[97T)UVG1IQB()2Q;1I8>L'<%<V,V^+B0)LLC,I))*I;8&
M:)Z:U"[W85+:T72XBL9'U+*L5M2*ED7$7=4R<2]:V/B<YW UX;Q.)QDDJ#3T
MY88?)Z?J2[B,1ACZLNY<19P<)=@ 9()P,)<'A8ZUE^@D]K&O>OS)/L9OUSE&
M8 U5MVRDP0_LVYJDB,"2E#0E8>\(9E=9ZZU4V/.&7T[5-591QMD=NKIM!N]U
M-2^M-SN!K)(^J?5FMJ34OBR'=6^?K>M='Q-:[@+RW+0<9 04]/P-B\GI^I:[
MB$741=6UW(N#.#A!P2,@9P2.U7.C'BHZ*1(&P QVER\;%,D]LHAP%UWV'%-E
MG*F[IYLV'C;1;,D=G#Q9=ROLBCK\9=51;?W;J;;9ZL]1454KIZJ>:IG?P\<T
M\KYI7\+0QO%)(YSW<+6AK<DX: !@ !<C V)H9&UD;!G#&,:QHR23AK0 ,DDG
M W))43*^+^F_QG&))*"S''73%#%A[T3^,/>7IM=.]A!'0TA\EFU/K^<Z0=(J
MV^;T5P(UQO\ !4TR\W3VYR"MK!2&@%54"B=+U[J032"F,X ;UQAXNK,O" .,
MMXL #. %Q&GIS4BL,$!JVQ]2*DQ1^4"+)/5B7AXQ'DD\'%PY.<<UTX?Q/=?T
M>U<\DC^KC_X G%%U.WA;36^[JRLVO)M8=X.K1,ZM4K0Q($'1"#%JK;*DW2N1
MSS5ON@Q_PMN5SO4ZX7!U*VB=75CJ)I!;1NJIW4K2,@%M.7F%I ) (8#@E0VD
MI&U!JVTE*VK<"'U3:>$5#FG&SI@SK"-MP78Y=RZNOO$%UD"]F[XF)NEG;>JR
MD0I;6GEV=UW D38S!'6T];I>8W'V6G(FBIC4E ]73DJXV1):I;X8?<D0]Z2X
M5\L/DTM=624^&-ZB2IF?#PQD%C>J<\LPPM:6#APTM&,8"EE+21R":.EIHY\O
M)F93PME)?GB/6-8'Y<"0XYR[)SG)7UI_P_\ 6&,W;V8/RBE'+.OCDJK_ #1&
M1UU6^@Z81/2I8@QL%IG BRD2[-(A93>3.UVYM7=9YE7YEMCY!1OKA-<;A4,$
M4]=631-+7".:JGD8'-^2X,>]S06_BD#([,*(Z6DA=QPTE+%(0YI?'3PQO(<?
M.!<U@<0X8R"<'M2@O#_UAB<R[.OI[2;AJ D=XJJT=]-NFWDE&U%+TK23!<&M
M@%92#ILS6ML5:;]44>V5?J;N=7F^-AK@7KHFN-PJ QM175D[8WME8V:JGE#)
M&@ALC ][@U[02&O&' $X.Y2.DHX23#24L3G,=&\Q4T,9<QQRYCBU@+F.PW+3
MEIP,C9?'7;P^]7XNE>B5HTBOII)+PLS>ODV-T6[\-2B26XO$*!/= 5E(ZY8Z
M):$M5!)G"S_3"F</\;^_3DRW*XSF-TU?6S.AD;+"9:J>0Q2M.6R1E\A,<C2
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M?RN%R%-R.KL-#[&JF168;KX[4D4V8S^/[6O4S"%W%:,T2&RKL#$Z[@,-B-A
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MBG &YY'D,[\ADYP!VY [>6<@A=G=G9.\K6;5+U;H>1+V'9S<8*+7_>53'I'
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MV1+)2180M-K4,08 DYC.&T:?GC"<5"SNP<"1+XXB$+;P*L7%D26PYH75'02
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MI!E3&C<<2D>\=8J$&0)N8)E#CG'A]9)^D^_)7>DL:CDSCIV(2\"&E,4E @@
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MNYY[G)SS\#R*EJ>]+K?!V/:3B *0ZPNI4D@N9$/Z<EI,2KN$/;'B49FZH2L
MT,C,=85\)KZP9T\AQB9%WYMG&9"T6F8NV*MM!X0CDRB9 >78<\\9V^T?5MC?
M. ]8*0_&LM>.=K[5IYY3N]715E0QFC;#A$F=!; <AZMFT:<S!N,ETJ=C!B$1
MCEUGJJ%HM!!P>S<O.P,&E3^SMG$!L"'D.VP.>9SZ_P"P'/LVY[09[5.LBJA>
MJJ[EIVA6J+>,L(U(ZD91X*6A N-G Y-(?$AKX01B[%HX&BMX_D>\ D NHI\X
M:N!#QGG=FJ4 X/('P/+YL%4,LVBIZP3DX"34?%K@,]FZDDU+7SV( '['04;R
MR8[(1* ZEZL;39W/@W7M%!JD3EHFNIPSS2I23E"\13^SQ^SYZ#*=L9SN#L/#
MOSRSZ1] "R\=T#;P:AXA#*_L RQO"M"T]D\?O.-9 U;8UA/I5*YU/-(M8\^S
M#[5(-8N>F4L'2:?L \<?PN3R< W=NZQ7@KI[6#DF<G?EMMV#;&PV[-AW#MSN
MJXSZBK-S])ZS3&I([N:[3*UXO/>TU;GK&DTB:VY4&H"[9A=,N;F'J+H%% $W
M(S.*T"!DQTH#C)4)5L/-1Z1U::T@4.)GM[N0/+!V(\=N??N?3/$XZ,V!$*PI
M5'JA98&H;IIBNQM?/9&(C@B'1RZ$!D&;P< ]M!^\C-M2@B+A:^7\F"QD]M.4
M'3<O)0P\G$Y^3AEVUB3(WR.>?5Z/M_N-8K.ZR2*WI')>C&:.UI.O5)\7MF%]
MCH\8G<_=F!H>E@M=DYS.WRTQ9NY-/;7<28M!I(_L23M)8^9M9YLB-+2@9%+[
M,D!QOG/9C;/?Z  =Q@'U*V-_=.K1*S2OY+U=G<?I<&]<_9R^X3'GQJJ0,]B)
M8.]CTAEF[BM@KH[)YXC'UV@D$J5,1V8QS<-&2U:W/53X7)L3LHSW[]WN?<]V
M^14431!KL]:+;KS*NN6.K$=ZB7#*;!CIP.%D\EK&S8%+Y- IPI"/CMI3'HI(
MFMPD%RY:>$4E"1)PF"?,L,X:;7F\9T*<XWSG(WW/H^;LSW[9QE;KX[!HA"Q9
M01!8O&X.Q,$RQU^VB0$5'VKJ1'-\K%9"[:"6K-!V:(N?:Z($W&F[U\OKJHZ7
M4WQ[N%2J D*1MZDA=:S\S'2'>^>TS+!X:+R^5R3$8N..T@T@$S^T$J%!GA-O
M5TK[$;&C;^'8/ @4&+V]#"4:CD^D"#T,[ENI59!SO@<_ GU=G=SPN)U]\>,
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M 3^7SF5E.!SP,9(&YP=CX]X'+&5<BEKBL=>>P<<A8$@MJJ91V/M&H*[FLB&
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(B<(G")PB_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g904779g31j36.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g31j36.jpg
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M&C965V-U>+6VU"6#EZ*CM]<F)T5'5;+_Q  > 0$  04! 0$!
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M2].T2SL(US&D]Q@<<\BACQ=O5JV1&H.PX?&(^$S5&R3/(3N0O8H./61N?3D
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MJ*J[32E-*4TI7P.?^%G3ME<<9?#=6G9W(TZ(X9$YR!2,)_-"V6Q93O["V*(
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M!.'+61;N%5<BWU2\NI(5B2VC4V;W4W&)7)ZFZEMW$)5T'#((P\;,IX0<MQ9
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M/NK5+K2UPQ@RC*["M*!8GQW0N):I-HBHU>,1@GBBL>FQK\0V*@"+%N0GHMX
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M=Q (]1JC:GD:/);JJ'5-P1X0 QS"8P)P;]%,!$=Q B2,H1),OH(F0I"AT*4
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M%M[66*&73+NU3I7T?U76],UI9)4D.EZST?T_5-'N!;QS3-X>JA8U+3Q4TJ'
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M;6P-FEHQ/O*=,20RC\G<];?%+U!U>59(;^:,*"&R2>/A)%8B7G!&8PA/Y Q
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MQ/?7\^JS6U_'(DERB/:6?A/#<'Q(PJ+:NCOE3OFJ$AM^K@,B1JCQ,TDK3%9
MWC8*)Q>-OC X&!.V.RK'1>0.)S*->XN!K.5[7 JX7XL\@56-88[QKCVYY+D,
M>P&-:A)0..,?H6QHTJGG:EOGO9!_-VJ.F)9S$E=LT9)ANDJG$M:Z/9RZ'UUE
M!*-0T2VF=KJ[NK>S6YDO;F.2[NC 6GP+>((D<#1H)"K,C;@V2L$9@+1JPDMT
M)+LZH'9R"[\)+?!&P7;.^#53+)Y2#B#HS#$EF9D)EZ0NO 1*9#E(2GU$YZ5
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M9@.'XP#6RNH=64\F4J?2,5K*L596'-6##S@Y'TBII3.50A%"CN50A3E'TE,
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MGF:9(.RE502$5"IS$80I3N690W,LWD63F.ZF*8R@>Z&[-J>AZY$;34((9,G
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M[US"/^HT?\<YU9?X1]'U"KR?!'I^LU--L_@'\Z_JVI+3?X[^S_O*B=6_U?\
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M_O*B=6_U?^U_NZP_4I4/7X(@4-Q';2E8]+2)6R9C";;8!_ZH!X^'7T;^/4?
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M0\Z+U@ZHL%=57B'"Z+LA/P<<#J>R.7TOE:3;!:X^6GH=ZZ$6\+'P)SFC!**
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MV[QBU;O#F3+0+90".)CXJKD@?P96E!Y<\MCS#E59O&+<7 H\9VQD\W@$&/,
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M55E44S&WY3G4.(EVW4,;FVV)M.AMM-L]/B:5HK&-8HC(P,C*F>%I&544MR.
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M[@;Y&?)Y^7EJ'4K9*,'2[.AHI-C$ $'"S4IBE,)B[]D5-( *H.P@)^90#%W
M>N^VLJY-M:K''-%QLP$B)D 8#8XF8DD9P>'"'."!L,U@7EZMF5XD:21UR%!
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MP\6_+EN1Z.ZL"O<>X.EN@ [;_P";OX^L/7Z!#KMXZV?3I5!&<#(QOR!V&WI
M/+LYUK%[$<;=V.X9'(^GZ<G?&:BIM%O! >8# '7^-UWW_OMO[VVVITS1C&,;
M\CM]WH[<=O=4*\3'F,;'(/W#EMS]'GJ(<JL%$8-YND)C DKUVW'H0>N_O]?
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M64<#AP=)KVSATZ(0VT[:7)<&WEF61I#:W<;17&GRD2*'M) [D+@2QECU4B#
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MR7'RTI1QKCVQT^,;2T-.,8.26-.-55(V',@FWGW$4Y=LT7!9HV ()P6"J2K
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MMPE&0V2#MR.^V-]N79](-<JF/Y7'E^O;\#[ZBWB5>N@EJXC#[+/:ZQ>2\DV
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MF623ME>%UV3)>MR"Z INE$G+IQ7I(ZT/*IBX; LXY_?:W?22M;11O=ZB8RR
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M5651LJJJ^,20.(DX\88(JZ> <@NG4*#B2=LVA2N19IUT&9TW"*!! A%2OU%
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MWS1@31(0@&-L B8"@([=1'6U*SR,&D=W;M9V+-@<AELG'+;LR>5:2Y"@\(
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M2+@ <F5@?,!Q#Z0*B'C2N]KQWP^6NU4J;=UZPL9.K(M)5B"(N$$GMBCFCHA
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M@<%BP*C'(@C?.W/R _CG9?AQ24/B6OE.'N2+SI4>_P#R?LY('$>\=OEIU/
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M[%D4D1-SW#IC<9)(..^LD:+IMP1654-N D)RB(B4PFZ>Z+[KF$?F>;<0Z]1
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M?_G5]_LN3_U=I7PU_E]?Z)^BO_XAZ?\ _EOI17V"Z[A7Y*52SCCRQE3%-#Q
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MU%E;07%S%&<&-BY\0@\95'95#9/PW4+L<[D @X(]=Y%V;*L"H(<$%>(@$D$
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M'554,1-,A3'.8"@(AKTS\.22!@<S@ =I)'(8'/NV[*S8DR0%!))   R2QP
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M4EB%8XP#B/\  F9G$:L51.-^%"0%7 +L1@!1Q %CVGO:HKFW@&44 !$2B0
MO( % I1$ (40V$-Q$1,4=PVVZ &I6)<<^[Z?+ON1]QVVS?2/"A>9))V.YR!G
M(.1YB.6#OVUA,#636ZPIL%G*,?"-"K2MFG':R+2-K]:CB^<S$L_>KF2:,FK-
MDDH8%W*J2/:=F4ZI"FYBY$UU'96TEQ*RJ(TR.(A1E5+>,3@!1@EF.RJK,=@:
MIN9O!H&D"EY&(2") 6>6=MHHT49+L[$;*&/"20#C%;3*U+5>8CER56<@III#
MK-8IX6"E&,HC%.%(>,F&,>[%@NX*S<*P,M#2S=LX%-96)DXU^1,S1\U65TL7
M,=P[M'*DI5O'9'5^%V59,,5)PS)(D@&Q*.C<F!.BO;3Q*&N(I(WFXI%ZV-D9
MQQLC,O&H!'6)(A89'&K#FI 2"6V_3O\ ?W][U>ON_IUG1-W>?]1'X\M8$BC)
M&.?;^,CGO6!RQNS X?B#T[;]/3U'\^I)-P-^9VY]OW\_36"5PY'+MV]1SOY,
M9SW5"]G< !5>O<4?'WQ]?H#K^3QD81N-N9\W+EZO5V&LJ/.1VX&WG.3Y=^7,
M;>8Y,2TA4!S!BS8>_)E& /'H-IB@\=N\?0&LG5,^\^JYS_\ ++[_ -++CU;C
MOV-3&F?IMID?ZS ?3UJGS>7&?J-?0/KYWKJ5>YNB9PX00+OS+*II!MZ5#@7?
MX-]Q\ \=4NP1&<\E4MZAFJD4NZ(.;,J^L@5-!2E(4I"AL4A0*4/04H  !\
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MZJBA]&DFFN)GGGD:6:5R\LC'+.['+$\NWD   ,    5,%$C01Q@*B+PJHY
M8]??G<D9).:QO6QUK%=M!M_.95F3;<I506-Z.5 !5Z^HPD OK$P!XZQ[I^"W
ME/>O"/._B_0"3Z*R+5..XB7L#<1VSL@+8/D)&/34M:U^M@II2FE*:4II2FE*
M:4II2FE*:4II2FE*E2.^=['ZS:_$$UKD_P"?F^=D^VU;7!^8A^:C^PM<:;^=
M3SZ@GQJ>J[3](B_K?J-6KW]%F_JC[2U&FM@K6::4K![6R\X9K%V =TSEZ>D
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MIB /, \P;!N/K =N\>FX=-^@@(>'A .WT]OX_?52,5.?6/-R/HYCO[:K'?J
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MF)+,Q.Y).Y)/:=SS)-5MP@@*,!0%  P !L,#L\W(=FU2  ;  >@-M*IKQ/\
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M@ ._F[N@  ] \/ ?1Z?1JW(<#UGU _?_ (]F1"/+V[<_/VX\N^"/+G%:*O*
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MWD@SAKAH+.(^4%3=R8[^*)#GLJ4MN@]V/TF]BB#<^$RW$F,;C#=4B]WBL1]
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M4KZK^#7]ZYA'_4:/^.<ZLO\ "/H^H5>3X(]/UFIIMG\ _G7]6U):;_'?V?\
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M"F3O'J8OC[X" ^G[&O" >8\OJ[^^JPY'JQN,X\WI[>8\O;S64,FW$.4@=.X
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MNJ,]\[G^C]@_M4]LDEZ4/N7]K3P"W_G^U^ZGOG<_T?L']JGMDDO2A]R_M:>
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M?Z/V#^U3VRR7^C_<A_3T\ M_Y_M?NI[YW/\ 1^P?VJ>V62_T?[D/Z>G@%O\
MS_:_=3WSN?Z/V#^U3VRR7^C_ '(?T]/ +?\ G^U^ZGOG<_T?L']JGMEDO]'^
MY#^GIX!;_P _VOW4]\[G^C]@_M5YIV9^4Y14(W4)N',4"&((AX\I@./*.W<(
M@8 'O*/=KQM/@((4NI[#D''G!&X](\XKU=3N P++&RYW'"02.W!XMCW;$>0U
MG**I5TDEB;\BJ9%"[]_*<H&#?U[#U]>H=U*,R'FK%3YU)!^D5.HP=%<<G56'
MF8 CZ#7J=N2M&RSDP"8$B";E =A,;H!2[^',80 1V'8!WV';;7L2&61(P<%B
M!D]G>?+@=G;5,T@BB>0C(1<X[SR ])-82:RR(F$2@W* CT*"0CL'HW,<1'W]
M2XT^ #<N?+Q#]0%0AU.X).!&!V#A)QZ2U>/MDDO2A]R_M:]\ M_Y_M?NKSWS
MN?Z/V#^U3VR27I0^Y?VM/ +?^?[7[J>^=S_1^P?VJ>V22]*'W+^UIX!;_P _
MVOW4]\[G^C]@_M4]LDEZ4/N7]K3P"W_G^U^ZGOG<_P!'[!_:I[9)+TH?<O[6
MG@%O_/\ :_=3WSN?Z/V#^U3VR27I0^Y?VM/ +?\ G^U^ZGOG<_T?L']JGMDD
MO2A]R_M:> 6_\_VOW4]\[G^C]@_M4]LDEZ4/N7]K3P"W_G^U^ZGOG<_T?L']
MJGMDDO2A]R_M:> 6_P#/]K]U/?.Y_H_8/[5/;))>E#[E_:T\ M_Y_M?NI[YW
M/]'[!_:I[9)+TH?<O[6G@%O_ #_:_=3WSN?Z/V#^U3VR27I0^Y?VM/ +?^?[
M7[J>^=S_ $?L']JGMDDO2A]R_M:> 6_\_P!K]U/?.Y_H_8/[5/;))>E#[E_:
MT\ M_P"?[7[J>^=S_1^P?VJ>V22]*'W+^UIX!;_S_:_=3WSN?Z/V#^U3VR27
MI0^Y?VM/ +?^?[7[J>^=S_1^P?VJ>V22]*'W+^UIX!;_ ,_VOW4]\[G^C]@_
MM5^^V62_T?[D/Z>G@%O_ #_:_=3WSN?Z/V#^U7I<VJ20;N%]FX]BBJKMV0]>
MS(8^WS?CMJI-.MV=%\<<3*N>+O('=5+ZK<HCOB/Q%9L<!_@@GXWDKVA9I$P
M8/-Q 0 0$$AV$!#<!#W?B&J3I\ )!#Y&Q\;]U5>^=R>75^R?VJ_?;+)?Z/\
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ML((VR<<LU_,"U^L%?E132E-*5_0D\F/^\#X5?]D\-_O+[7YL^ZO_ *1NE_\
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M2/8OP%<!9O'QW;0C-JX[-=R9TW*B0XKI 9D;[C;&=^6>6?/V4X6VV.X)&QW
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MU1;D72"U:RCG2WEE$SA0#'(XXE8*W""5#>*#3X)*3@&,@QF4.''!P*P5CQ'
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M]#>,\[0R($!+!, @AE/P7)."3@X("[C !R*S;BP6.W6:-V<A5:0'&"&_A)@
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MXG,-X]6;-+UDRD5)X]$OFK.P66)BWJI%! "K%:.WB;CS8-]SNA2!LD&PJ*E
M0$=2MK&_O0S6EE=7*J,LT,,DB@[Y'$JD9VP ,DG( -;G+)! 0)IXHR>0>14/
M?R))QCM. #CT=T&6Z]+QS>6@YF.F8MZGVS.1BG[5_'NT1Z%5;.V:JS=PF(@/
M*HFJ<H[#[H=M8<I>%FCD1XI%.'212KHW<48!@?(0.RKZ1JZAE974[JRD%6'+
M8@G(VV([ZH%Q,>4IQW@YL\@JPJRR%DL>T;H5^.=@K"U]?<Q1=6^7:\Y6@-Q
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MC8XRYK*>"-9&"E3CBX224)Y!Q@8[LC*YVSRS;U=T1$HB)@  \1_& !XCW!Z
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M9&C9MN(HZ'!YE"A;QB:O6<YN(!(V.-6*.!L.(;A@-\ @C;L.<;8J\A3E, "
MAU\-P[]0=9->6E*:4KQ/\P;ZDWY!UZO,><?77C<CYC]50CK9ZUBI1K3CMXE
M!'<S<ZB!O^J;G('P)J$#X-05ZG!<,>QPKCTC!_X@:G;)^.W4'<H60^@Y'J4@
M>BN_UB5ETTI32E-*4TI32E-*4TI32E-*4TI32E2G&_.]C]:-_BB:UR?\_-\[
M)]MJVJW_ $>#YF+["UQYOYU//J"?&IZKM/TB+^M^HU;O?T6;^J/M+4::V"M9
MII2FE*Z:P6.O5*'?6*U3L-6:_&)%6DIVP2C&&AXY$RA$2K/I.17;,FB1E5$T
MBJ.%TR"H<A $3&* ^$A02Q  YDD #SD[5ZJLQ"J"Q/(*"2?,!N:Y,5+14[&L
M9F$DX^9AY-JB^C9:*>-I"-D&3@@*(/&+YHHLU=M5TS HBX;JJ)*D$#$.8H@.
MO000"""",@C<$'D0>T&A!!((((."",$'N(.X-:+>,##>.,7951@<?61*):W!
MM)9&7HT0Y=-9?#EFC7B+Z.O=2DF(![5H6;EP<O8N,5<L7$=,1[]6M O"@HRK
ML+>Q)#(KQL%9CQ< V*'.>-2/@@D9QD$,,KD;+/6$LD\+)*I95' ';<.N,%#G
MF5& 3OD'QCGG?C#6<)ZZX Q5<[<N12T3])B'DR\(D1JG*O"HBV-/I-DB)HMT
M+"1 DXB@@4&Z24@5-O\ * 3'6>DY>&-C\)E!;D,G'/&V =B1CMY8YX#P*DTB
MK\%78 #< 9Y=IVY$\\C8]@H%Q"<7$I*O9"FXUD3D(D=5K-6QL<3&(H4PIK,(
M!0HB4#$$#)N)<G,)!YB1P@H!7A.R]"?<]%PL.K]((<QOPR6>F2 CC4X9)[U2
M,E#D,EJ<!QAI_%S$VA=*>E'@,<EGI[@3;I+<J1F,_P )(>SB!.&E_@X\3?QU
MHBWAUI-<ZRXJ+'45.HJJH)E%%5#F$QU%#FW,<YS"8QSF$PF,(B8=]QUVYF6%
M%BC"HJJJA5 5%10 JA1@  8  P -AW5R-9&=VF<EG+%BS$LQ8[DG.222=R=\
MY..PRY7*:4P)F,B =-PW#KX>KNVZ]!\/#IJ+GN2I(!R<8V^[;?EL.63Y35]7
MSNVYS@>7.XSZ>?+/?G-3=!5@C4HG*D4!,0"B(!OT =^GH >\?3MU].HJ6<L0
M"=\GU_KY8R,<_+5;ME<GL.<#MSR/=MZ3YL5D8L"D#N$?>]/3\HAOX]=Q'5KB
M/DW\F>_OSV''FVK%:8 \_5CO\OGQMZ:\T4.4W</O;;]=NN_4?1T[M4LN0,[Y
MWY$#LY;#Z.?DYT6XP=CVCZ3Y-L>OGC%9,Q$2@'7[ A\ @/?ZO$/5OJ/F3<G&
M_P!WD&>><UFQ7)SL=O\ #MR=@.SZ*\)''-)N?,,[!-572@;!)-2@RDBF$/FS
M.F_(9?EWW*1T#A'<1'L^[5I;Z]LP/!YF"#^*?+QG!SC@;/#OOE"A)('%4K"8
M9SB1!Q=XV;.=L<)[.XY&]1=8N$I<A ?TR4))\H]J2.?&292:8E$.3S=V7LV;
MA4H@ \R@L.H!R%$P:RX.EB9ZN^B,789HPSQ'/,-'NZ!O-*>>>=2:6+ *T#\8
MV(5@ _,8P1L2/.I[NVI(QOQ)<1&$'2,%/.WMP@F79D/6[V#I61;-RB <L783
M@,PU**903:><J2L4BD4HMV!BCUAM5Z*='-=1KBU1+*=\E;G3^$1.P'\=; ]2
MY!)+< AF8YXY1VSECK.H6;".4F=%V,5P&X@/YDGPQM\$$N@'(;C&T+"_%'C7
M,H(QC%V>N7 4N=Q4)XZ3>1.8A!,J:&=@8&DZW(!5#_XH8K\B!!7>1[(@@&N4
M:YT5U31"TLJ"YLN+"WL +1C)P!.AR]NQR!X^8RQX4D<UN5EJMM>X6-C'-@?D
M9#AB?X7!V2*-_@88 9* 9Q9#H(>D!UKR$G8^<']7X[_-4@V.8QCD1RWKK),-
MH^0#T,G7Q"FK\/YV+YQ/M"L2Z'Y&4_T4@/L-C\>:H;ULE:Q4N0KCSF+9*B.Y
M@1!(_IYD1%(1'UFY.;X=^[6O7*<$\J_SBP\S>,/5G%;#;/QP1-V\/"?.I*_3
MC/IKM-6*OTTI32E-*4TI32E-*4TI32E-*4TI32E9U5OW$X^NC?$I:A]1_.I\
MV/M-4[I?YB3YT_82OYBNOU8K\LJ:4II2OZ$GDQ_W@?"K_LGAO]Y?:_-GW5_]
M(W2__;$WV(Z_2#W*O]'?1'_8\'VI*MY;/X!_.OZMK4=-_CO[/^\K:-6_U?\
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M).PW.*Z# W$IB;B,KSZRXJLX3S.)?A&3+)TPD(>7B'IT^V0(_BI5LT>HHO$
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M&AV$5 '7EJ\1H(R=>BV$-*D2(^9M@%90Y\F(N5/'DE7=02,%E#$*<# W':
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M).'&>$7LK5G))QE62G*E&VG&V.G$DB5"/\VC)F61>I=BU</E#]F9<&A .GR
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ME>9 5C$<D7##X.0VX9NL9LE0BX.PW%;>KX4AD36F4;QJA6Q 9PZ'.XDE4DR
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MI20C@ZA1*+=4ZB;=N!P,#=4[<R14VSA4K6 O;62QEBOK4%70AIU&0)(\^,6
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MQDE"VZJ9 ^.W&>0.^W;636%32E-*5*<;\[V/UHW^*)K7)_S\WSLGVVK:K?\
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M6RBS<KAP@58"BH":RR8F1Y^4O,4@  \H 81$ $-(N]2>-GA"R* ?'"N0I(&
M>'D<9R,YVXMQRJ?L]-"A9A*I! (.-QGRGD>S .">1S4>V/A1A+!* _:)(-BG
M-S*E(GR@/7<P!R[#OT'H =XCOUZZC9;QESS\V^"<8!QGG@@$\_+MFMNL+ED3
M@)R@Y [X( &=SPCNY9QCL&*YR^#:MA^"FLA,R%2FHB.*5N<H%,DX?+G291OG
M")BB!^S=KH<Q@,4PHEY#B8I2 6"U6ZDEB6W..%R3DYV!.X!&^Y'+EG?M-3^E
M2-<7B@$@%@&P3GA4$MN,<D4[G!SCLVJ@6:8&I9AJD_#Y381\]7GT8^)-J3*#
M9T@NS414!ZH]\Y(8%BB01.?MP,'.4%$]CE XX-E&UK@IP,CCQXY,&(J,,>(/
MXJA2,\61P@%@1C-;L9Y9)(H+9)))Y7CB@BA5GE>1V"1Q1H@9G=F(1%0<3,<
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M+]3V;17BL\).4($L3KU<L#8W61&&5VSWJQW4G!(_"2[:>UD:*X1D=>( X(!
M)5@&[""""C ,O\( U:R+(F0I#;%W$"B(AML(]##L8NP&#?<.FV_7?IOKV2$@
M^*"!C;.2?)G;]6.0JPER"<Y .<8SR\G;N<]O=ZN_=NNS!,Q3 4?'E'81#UB
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M2+/)R*KU<X =\NL:0 RA'9%#\8UN.ZBUG4A><1F:ZD?B(.'BD8M Z'EU?4E
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MVT=G=D+<@HI=&#LD3<("^,925'!ES@%@?A$$#&>=>/9$.X22/@5I5+,6RG5
M,P?$>YX2#E01G(VK-4/*8,J^YMD1:,+9=N%S1RKGNH5_'U K&-8>Q5N%X?\
M%>+LHWJ/NLM:L_+T^6FX*(R"X UA@+!'1MB>Q;F%A*V5XG$.;1[UX&059CQN
MH"A01P*K$'B?!(!Y@X)& .6?#:$\)$B!>")BS%R"97=5X0(\@$KR(VSDG&>'
MCX3\J#2LL\3UYP"T@9"93?4[&&8,1DKD.UCI^/PA<.&_&^:YR\Y77LUS:QX*
MIV#(+"J0,-2V3Z>56=)$5@7D=#V"SLB7"M(R8SXJNN!OP%%8LV3WL  -_)L3
M1[0K$LG$-G>-\Y(+K(R )PJ3N!D\6WE!(!Y]'\K%AG(X*0U+Q1F*RY)<Y,I&
M+ZUBRN2N +-8+9+WVAW3)L;(QEMKF<Y;$T<PA:9CNYOK>VLF18.9K$E!JP,C
M%EEG#1LN6Y1ME5RW$JA1P$DLI8$$.5P%5B<L",$$9VKQK.1=V>,*%9BYZP !
M652"#'QY+,.'"GB!!&U=?$^6'X6Y:=Q+!>PN2(EQE-M47:X6#_!A"2-"2OV6
MK/A>GEL=6?Y.2N-E7?W&I2KF:;XHKV1EJ35A:VB\$KL6N*I N8R5&&\8*=^$
M</$Y09'%Q'QAOP!L#=L"O393 ,<H>'BQCC/%PJ';!X.$8!V+E<MLN:VN:R*P
MZE.-^=['ZT;_ !1-:Y/^?F^=D^VU;5;_ */!\S%]A:X\W\ZGGU!/C4]5VGZ1
M%_6_4:MWOZ+-_5'VEJ--;!6LT[M*5'MR==BP7$/!(XCOOX@([]/'H'C]G5+G
M"G?'Z^^KL6.+N\OGY;$$<QS_  -9F:Y@0*N',/NA/W#[X^D/'QU@2$CB\^/I
MW^CRU)Q#EMY3GNY?X>CSUJQD7@R-YG!$>?L7/9#X[=@1-( Z>(=B(?;>L=?6
M/06W%IT-T),<)>S:Y([3X7/+<AO^\)L[]F ,;8^>>FDC7/2+4F8GA6Z$*GR6
M\20X SC"E3V;G>IKHC'<"&,&XB)1[O5OU]'PZS[QQCUD[Y[\^L9/.H?A.,X\
MOX^[G]%<S.F%(W*%+5C)!B9XF4R+I($SJ(KMW3?<R+ENND)54E2"(@!BFY3%
M.HBJ51%0Z9X07DEM,)(F"N 5.5X@5/-2#D$'/HV((8 B?Z.:W?Z!J$>H:=.;
M>YC#H&X4='C< 21R1N"KHPQD$9#*CJ0Z*PUNML59 Q4\>M:VX<J(OA51%614
M.@[;$-L1,G:M6XD=)$((]13(H!A$>50#B)*YKVVO INHN%D((ZH!E<CF<,V5
M)W';L>S8'Z"TCW6;:XMG&MV3+<1A3$]A&K1SD+E@R3S!H7+ %<,Z8)!X2OCS
M_P /W#^X2MB-M59.W<D<!,M(OU5EQ**P@HZ.V(J8R;;SA0.<YB!VG*/9 H*8
MF*.%<ZC+,BP$JD(8<,:*JC"[+Q$#+%1L!RSN1G!/->E/335]?@DM[JX5+%)G
MFBM(D15 XFZE9750\QA4A5+^+D<97C\83IQ)Q*4U8X.L/6A'$:PK"(JHJD*8
MGG$@[>><' !-L8IT&S,N^Q#E,D;?<H%WFM*?JX'<$9:0@^95 &0PR<Y;(W&#
M@\ZU#0 %MYI\_E)+AB""1LBH%SL<8+.0/*,8R:U-9&X.LBXVE7N4.$ZW/:-/
MKG%Y+4Y)4JE1L0HB911-_!N47$=VH[\A%%&2[=,PB)$6BJAGI=4U3HJR7$FJ
M=$+XZ!JSGCFLEVT;46!+$36W"\<$K[@,(VAY9CB9FF&\VNN07"+9ZY;K>6ZC
M$=P5/A,&=@4E!#D8&2.(,<$%F"A#E7#OQ\0DW9@Q%Q$5Y'#V5FSE)@DY<BJA
M3YR04 Q$TT%G:JYX)V[$4Q9I/'CN)D14+YI+]LJBV5P]'Z=-X<VA])[3WFUE
M&2+$FUI/(Y 0Q2,SB,RY#1DR202@@Q3ME5J-UWH=UD'OGH\QOK4IQ94<4ZHO
MQPH7K57!#,J"1.31$+D7>X9N(FM<0S+)$I6R))1U%R9,42.5!8%#S4=$Q$&Z
M1L9 YOW)+/'[_P Q ")B#5ND4Y#* *RT]I.N6VO+J;VI!BL=4GT]'X@>O2"*
M!O"5W_-RO+)U6PRB#8G<ZUJFD7.AM91W +/=645U(>$\,4DLDRFW)QN\2HA<
M9SQ,2-B%%MD%0  W'N#8._H'K\-O1Z>[;PUF.A!V [?3^_\ &>5689\X_=V]
MOI[N1\G9 6=6!4@@; V$4G2:JL>=8AN1003 7C(Y#E]V51$X.1 P" E Y=MA
M*74II#9,L1P5(ZP Y(&?$88(Y'Q1VC8\SO4G!)QHR'<;$CGSV(.1RV])\F15
MQ<<656YT6M6-;JZ?1P%?;   9^R65CY!0I0Z%(H\:K*$( >X(<"[CMOJ/N8Q
M;7$D6_"&V[P#XRCT*P![?JKG.H0>"WMS;CX,<F4']'(HD0<SN%8#.=\;@9VS
M+5%8E=>_*(IF$/1OT';U!^3\?PZ5ZNS=^3W9P,8\_8:B^;74()R"<0#U^CU_
M8_[AVUFQ(K8P ,=OD'+'K_7SK)#LI&"<')._;GEY,^LD\MLU"42U V<L1NR]
M07R9CX3>I1"UPY#>GO("9A](B(#Z\J^R-$U9>[3+_'IM96\OF[!MM4YI#\5W
M;#__ *+<[^651VY_<>79CZ!=?/%=2II2LMJ':>?.>4?E7FH]IZS=JGV?P[<_
MP;ZC]1X>J3/PNLV\W">+T<O3BI#3L]:_Q>KW\_$N/HS]-2'J'J8II2FE*:4I
MI2FE*:4II2FE*:4II2LZJW[B<?71OB4M0^H_G4^;'VFJ=TO\Q)\Z?L)7\Q77
MZL5^65;_ "Q5^L84X9H3*+_AA\G[?KICC&F#KKDZ@(J9M'+-/J&7T(1GCR[V
M9T2W1M;?3-AD)N#=V1A7W!!A9"Q-G"2:K-PBL;YSM;F[U[I5/I$?2SW2-.L=
M3U77[#2M19= ]YKV]T5IWU/3[139374<%K'!<):R7*GPB.U=21(K+7T7=6UI
MH716#5I>B?N=:C?:9I>@7VJZ:K:][\65EK2P)IM]=/X9%:O/<R3P/=16S?D)
M;E6'$C!CHMO-B86^Y6BTQ=5@:/'6"<DI=C3JN5Z2N5AJ_=*.$(.#)).W\@6+
MC4U"M617CUTY!!,G:KJ'W,/T#I]M)96-I:37EQJ$MM;Q0R7UV8S=7;QH%:XN
M#$D<1FE(XY.KC1.(GA4#:OG^_N8[V^N[N&TM["*YN)9H[*T$@MK1)'++;P"5
MY).JB!"1\;NW"!Q,3O7W]>3'_>!\*O\ LGAO]Y?:_.3W5_\ 2-TO_P!L3?8C
MK]%?<J_T=]$?]CP?:DJWEL_@'\Z_JVM1TW^._L_[RMHU;_5_[7^[K WA.9,?
M64P?9#;^D=2E0]5QR1'KJMUA( _,CX;]=A]'O;!Z_#J&K$H.Y[".>.78>7/O
M\WFK+A((&_81OR'+.V?3R[CV&M4?$7C6'N4>]C+)#M)=@J)C]@^;D7*FJ4#@
M19$Q@YT'*8&,*3A R:Z0[BFH4>NJ[/4KS39DN+.XE@D38-$[*2,\6& V="1X
MR-E6 PRFKLUK;WD9BGB25&R<.O%@G.X(&589.&!#+OA@=ZTRVZG2^"+4TD8-
MTY<U9W(IM@:NE#+.8M14XBBD5<WNG+0VPIIG6_QE(XD(JHX%0RI>X=#NEBZ^
M? ;Y%2_2,NDL:!8[D(!Q\28'!+@\1"YC<!B!&%"GF'2GHY[WPO=6S,UL6PT;
M9+Q%O@D-CQD+; G+*>$$M\(;3,(95:RM?9DD %-0Q"$W,7H;H!=A#;;QV'?H
M(?#OO<VGMP\2$$8SC))&>6.\@<P?OQQZ>X5)N%M@#L>0P1VXY'EV8QGLVJ\]
M&=E70(5B&Z!O=ID /\F ]3!OT I 'NW\! /6.CZA:K%*[OL>SGSWV^OT=O96
MV:;<M)&J)OA=SY//CZ>><=^#,3=\9LGRF#E$ [N_?IU'W^OY?#?4*\7&Q*X.
M_;MMZ,8R/5ZJGTE,8P=MOP/KSCEG&^14)<1<B<V*),2G$I32\*5<0WV[(SXH
M!S" AN *]EL ^(!MZ0BKVWS+&#Y.P8&2!G8]F>_?EWUL?1ZY'A#'(R%E('(D
M\'U<)(R-]SZ=5^0:(ID6O/*HM./X%J]7*G(N8TI#N7#5-3=5D('#E*@N)0(J
M/7G3W3, E,.L>[TBUU.RU#2-06X-O>P2V=R+6Y>TG,+D+,J7">,BS('ADX=V
MA=U!'%D=,Z&=.M1Z!]*-!Z;Z'!IESJV@7D.K:2NLV,6I:?'?1(S6EW-93.(I
MIK.9DN[7CRL5W!#+PL8PIZJQ\-&/[7CZOXZ236B&U;.16'EFG8*27:GW4D%E
MA4 I5S/U%%%'0FWYU#%Y0  *4?+7H=T?7HM+T,?2XY>C<]HMH]@799 4E$\5
MVMP!UJ7R70\*%T#UC3EW?(9E,Z/\HOW4[7W8']W1.D<K>Z&^IR:E)J3Q(;1E
MDMS8'26L#_F_O+[VD::FF</@Z6*I%'PM&LB:_.-+&KC@CDL9\1F'36IA=XQ)
MK"V%Z2.4DJ=>(,G9M%X/)1&C]N=-%PS4$(F549+%;.63!L5^VE&\$\8X.H:1
M:]'M'LI]+34!)H\4-A'/(SWR7%@A$<5IJLY82XAA(BM;J2-CPQ10/)Q=0\<#
MJO334_=)Z3](>D'2"#2;:]Z2W]QJU]#I-I%I5JFHW)ZRYN=/L80T$+7-QUES
M<PQE4:::>58PCO&;P<#7$I9.)K$UAR?.MTX59/)]J@(Z(;"D+:+AF;.$?Q$<
M*R:*1I11LQDTS.9)TDBLX?&="5%)L1N0M6EW+:K:2W00Q@W4T:1C!X$4(T:\
M6!QD*ZAFP.)R2   *UF^A33KJ*V!ZS-O&[,<Y9RSJS=O#EE/"JYPO#DDDDW)
M6L;@/E;I(3I] *LB&YPV,("(I%YN<-A =R 4P!T IA#;5]66%\2C8GGR'EXA
MC<Y&^-]N78:FA,R9B)+C?A;M&VV>8//8[#O WKHK9:",JU*D(N03/$"M$4P,
M43*&74(4X 0!Y@$B?:'-OL)0*("'-TU7<F,P-N#Q@!0-\^,-L=F,Y(P#V^?S
M3$G%]#E64Q,7<$$!0H8C) QN< $<R01D<I7X3IMTI!6-DN8P-VLZ@\(3<=@4
M>1Z2*@^H1!@EOZ??W'6-I<(34H648)C93@;XSD#MY9\W9O5CIE()((R>7"<G
ME\!LCN^.>?ZZNVC,-'0%13.!3;   (["8? ._KM^/;6X&)T))Y$C //G]7T"
MN:EE8;9/;MV8[\'\9]%8]//BL&KE=0P "9#&W$?0 [>GNV'<0'\6LN%"3GR_
M1^\[>BL.4G/#SY>KL&_E\O9W5J/XFLN117;R-6<$YS I[@3 /N #J80 =P H
M#S&'H!>N_0=3$$>P)[P!GOSG&3CGO@>3UYEK YQ@' W)QZQRY#?.1MYZYWDQ
M.)\<:9Q7Q'./1#'V8I!-.'554V:P62 2*C%*$$3<I$K<W21K[DI0,HM*)5S8
M4DB.3GUKIGHPN[%=2A3_ #JQ3\J!SEL\Y?/>;=BTJGL0S<]L;CH-XT,IM9">
MKG.$[DF&R[CDL@' >>3P$$#-?4*S6!5N(@.^Y!$/M=A#;W_R;ZY,O,><?76U
MMR/F/U5#^MGK6*:4K-Z<WZO'0AW FW(/O[J*A^)+^GPU%ZB_YN/SN?LC_P#J
MJ3TY-Y),=@0'S^,P^A:K'Y0;]ZY=O_:],_\ FN)U+="__M#9_-W7_II:QNDO
M_P IF^<@_P#-6OG<UVZN:UN?\EA_Y(Y>_P!8ZO\ _#)37+/=#_2=,^8N/_,C
MK>>B/YB]^=B^P];6=<ZK;ZITEP$\+J.4'N6RT2=-8WMPM.1P@%<FY06QA'Y,
MN\3*0=NR9#8@5N)\7PN0K!&34NE(6^*J32;,YDGTFD[2E7;A\I:ZF/BXN$YX
MBV.)^'B88+<'%P!CD[A<YWYU?\)FX G$,!0N>!.,JIR%+\/$5! V)QL!RKF,
M^!3A;CU<;+-,:*I*8BJ6!*-CXPW6_J>P-8X8[D^O^$HTQ5+0<LJ--MDB\E#O
M9D)!_8P5!C:G4W')IM".IC\7Q?@!%7=MA&>)!SWX3OODGMR*\\(F\<<?PS(6
M\5=S*O"YY;94 8& ,9 !S7?&X.N'4]JE+J:@J#99JQY?MDE(^VRZ@#B?SS3Z
MS0LJ/@9A8@8HA9JK3J[&$:H-DF<(,>+ZOMXJ0=O7;GWJH\D\.Y+,=SS<!6//
MM  [AV8->=?+@+Q; (N.%>4;%D[/X)8^?MS6%LO)[\(D># 6>)2(JQB%19,W
M9;GD 7Y(NDX/#AOA(120&U"^<5]?"P!2;# N'"L1;6Y22]H92]@33E2^=1%\
M0<@.;9P$ZL#.<XX-B.1YG)WJKPF;X_:QQPKC+/UA..'&>/QE/-3\$@;5!N1_
M)<8A<42/@,%2#S&]PCKCB.T)W/(EMX@<MOC,L*U>YTNBP47.,>(+'.3J,6%J
MMWE:ZPE,<Y,J3KVNE)6Y5&8@#GC0I:W7 ">*0RG+&1SX@(&#UBL, D95AML<
MC:KB7;\1,@XE*N,((TP9"K,2#&RMDJ"0ZMOXPP>><8(\FY@C#51PK'O5+/8[
MSB&MP,"[N5>N.0L90V0?:W>[)DZOI7?'=0O"=7MM?JEZM]AEZ97KR6Y%@&\@
MK'J2$DDL[.[]2!$"\RR@#B#,N<,6&5#8(!)P&XL<L\ZIDNI',F, .2<%5<KE
M55N%F7*E@HR5X<^3;&PG5ZL:I3C?G>Q^M&_Q1-:Y/^?F^=D^VU;5;_H\'S,7
MV%KCS?SJ>?4$^-3U7:?I$7];]1JW>_HLW]4?:6HTUL%:S7X8=BF'T%$?Q:4J
M'\B+B1@YZ_\ -F#[!=O>Z>G8=_#KUU;DQP_CN/FVY9W'E(J_"-\X[^WGV?K\
MGWZK\U/![5<.8 $.T\>_U#MUW_/X[[ZP'R<#O/T_@U)Q#Z!OYSW^7G6M6K"#
MRY6O<>83SDH0O7?8I)!TF7\6P=WO;:^P>CWB=%>CHY?_  +2CV;$V$!8<M]R
M3Y-QV$U\\=*%SK-^?_YG?;CF3X2_/U#!YX%6HH2  1 !#8?<E$!Z#ON/?OOU
MZ?B .NVL>\;=CV#N]&?K([L;<JC^#8>8]F_+('KV[/NM?7V22R!"*$ Q3% !
M Q0$.7IZ=]M_#QW#6L7$F2V_E]0[?+D#/UXHJ$D$<]O3^KER/9RVWKW2^)ZU
M/G*=RQ0YM^81!,O?N AX?G_'J/:8J.9'G'D/9L>?>.1)W[9*%I%V4[>7?<]@
MR#V^3EV9Q690M&B:]&J(L6B1.1(VQBD*41Z;;AL']]_>U9$^9%R?X7T9[MOJ
M 'TU5,&>-R26/"?-Z/+L.0]/;5%<VPYU<B2BHI@42Q,(Z1$0W,* IN&JIBAX
M%*J@H ] #ITUN6GR V8&V1(Y'(Y.!MG;L(.W?5[2G,<%ON3&[W$3KD@!^))$
M)[,MG P-LXSC:L2C8LRS1<J/REPFD<$511[<Q1,'S94Q*8% '8.8"@(<P["4
M0 .9(^",DX//AQG.=QY#CEG;;EM4C<'#+C<-S'%P@8VP3D8(["3OVFOGF\HE
MPM<3S2R+9%GUS9.I38KD[&1B:K7HNP5Z..J*HHRS>M0T8:4;)D,4ZK]!(PD[
M-9P[CV::1G2O(NGW1[I%?A=0@O&U[3[-7*Q"UM8]3TZ)B"ZR+;0QR7=L#AC+
M#D)AGEMX@&E?HG176]%""S1/ +E^'B#SSO;SN!C,;3R.(W)R.!L<60%=R>$9
MIY&FUIIVG.% <")QDZ[5K@Q)[D!1]@)*0A9,Q!YBG,+@;+#E,3E.'^+$Y1(8
M1(MB^Y1=\%QJ]D2<2PVMTHVVZEY89#G(^%U\6>8\4;C?BM]/K=GBTVX7 X)9
M[=LYW,R(\8[A@0R;_P [?;<;W/9A]"J#VV[IL!A$Z1]RG3*4  >R.?<Q1+RB
M/(?W'>4!*(\X=N55D&-LG&#MR[,XY\\YWYCG7-&@1P"@X6&!Q#!!)'\(#8CG
MD@YQ@Y[X[RK9HR>AF#%@94ZJ;\'BI543)"@";=9$""8WN#&4%P8?E1SE $Q$
M3 (EWS;"%XI6=L %.$8.<Y8'D#V8[=]^7,5E6T3H6+]W#SSG?/HQL-QGNVJU
M_#@T.7$U?,8!Y55YU1(!#N($Y($'8=A[U"''[/CUU&ZJ_P#GDN,9Q&#_ +M2
M<]_<?KS6H:RH;5)]MA'$#Y^J4^C"D>CTU,"R0IF'H.PB/P#_ ,?^&L9&!'D/
MU^;R^3;.>\5".I5O(>P=GE]/I[.6]=8\#=(WK#\8;_\ #5RJ!LV?-^O/T&HD
MLX<H&,'?L/CMW]_CZ!_%K-@V /?@'S8'WUEJH<!3WG'D.1Z^?U]]1'5U07R_
MB4H .Z63:,81,&W4;3$]W4=PZ=X^'PAK+U/;1]5Y;Z7?_P#I91_CY=SDU+:.
MC)>VN3SN(!ZI%Y^?]6:W]Z^=ZZO32E2%4&_(S<N!#85UP(4?$2(E[_>YU#A[
MY?>U#ZB^9$3XBY/G8_<!ZZF-.3$;O\=\#RA1][$>BLNU'U(517B-XY:9@RVP
MU*B8PMWGD9%JI>6[%Z1%.LPIPW6:IN  Z3BT*IG(X;QBIDT&R)0]D5FYG* :
MV_0^B-UJ]M+=RR>"0E&%FSH2;B4<F*[%;<$%6D&68_ #!36O:GT@@L)TMXT\
M(D# W(5L").U0>1F(((0X"CX9!85;JA7VJ9,JD1=*7+MYJOS3<%FCI$>51)0
MON7#)ZW-LJSD&:H&0>LERD7;KD,0Y>X1UJ\L[FPN9;2[B:*:)L,IY$?P71N3
MHX\9'7(8'(J:MKF&[A2>!P\<@R".8/:K#FK*=F4[@UF&L6K]-*4TI32E-*4T
MI32E-*5G56_<3CZZ-\2EJ'U'\ZGS8^TU3NE_F)/G3]A*_F*Z_5BORRK=YACC
MOLULBLLX^R_A7@FIRM;X4D'$C(9=P_;5[-G(F JK4I3#N,+$::S75"R\U9S5
MZM.ZT=FS>+>=L63^"K;T@-T"<$UWW/;2RFT;4M%USI[?+==,&2*+1=;LUM>C
MYZ1WE[#K>K6H@T&\,$%IX5=)="1T7JY)([BZC)9CWG0_=!NKV+6=-UK0N@MB
M;7H@KRR:SHMXUUKXZ.VEG-HFDW)GURSZZ>[-M:O:E$D;CCCD@M9 %4:;+Q9R
M76XV>W)5JK4Q.RSDE-$J=(C5X>GUPLBZ4=%AJS%.GLDYCH2/!3S:-9KR#Q5N
MU333.Y6,43CW"PM#865I9&ZN[XVMO% ;R_E6>]NC$@3K[N9(XEEN),<4LBQH
M&<DA1G%<1O[L7U[=WHM;2Q%U<2SBSL(FALK42N7ZBUA>25HX(\\,2-(Y5  6
M.,U]_?DQ_P!X'PJ_[)X;_>7VOSD]U?\ TC=+_P#;$WV(Z_17W*O]'?1'_8\'
MVI*MY;/X!_.OZMK4=-_CO[/^\K:-6_U?^U_NZPTY0.42CX_EU*5#U@MEB$G+
M94#E ?<F[P =A ._X0#T]_4?0'C#B&/K\Q_';5R-BIV//GR^C/:=ON[M?.:Z
M^V20=CR%W*"@@( '?U'PVZ]_O]WCK!<#+#;&/1R[]_7Z:D(V)Y]W(@>8\\XS
MZ>_GST3YL;N;MEQMCM#LTHJ++'2DL?8!6</G*IUFC3<=P300;D0=&$ YUE5B
M )BD1$%NL>Y]IL%M:-KDG$UPTDUO;+N$CC50DLO9Q.[,\8!V15;8LPX-&Z87
M\LC^]BD+&(TEG.!Q.Y)*)O\ !4 *YQ\(GXH(-WJ=C>/@ZTU*W*45VR)1  $!
M,8X$ 2AT\##X=>@]!]/4[/4WE9D.X(V)VY=WF[<[^2N(:SIXBDZSRCB ..1'
M/GY.0'=ORJW.(9QB6FI2RZZ:9#F @&,8.;8"@/+MON(B([[ '78._6H:R9O#
MS %9\#.-\Y8\^7+]6>9Q6S:1'$FG^%%E0,< [9P , 9[\GLSW\]I%4L:+D@&
M1,82& ! P]!V[]^_N] [C\ Z\BM2 #C?S'Z\=N,''=MBJ);Y22%)WR"=OQW#
M /+NK ;<=KD.GV:J,52NU5V@K(JI' R!I&/43?LFQ%P]R8RKMJBD<Q#&*F!C
M%,(CS%"+UF$Q*K 'B/8<@C!V/:0#OSQR!S4]T<N66[25\B-6PQ'(JX*,1WD
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MJ[APNJ8ZJZZZISJK+*G,HHH8QSF,8PB/7U545410JJ JJH"JJJ,!5 P
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M15%!TW;ND!.*3A!)8ATR[#8]7<PPSP,)(IHTEBD .'CD4,C#(! ((."!@Y!
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M&ZEQ+$\7-F\5D9B'1@&5E9& 8$#1]:UKPB"?3Y+.6WF$B<7&ZMPE'#<@HR&
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M\.NX==@[NGIU)0C)&W;G]0/+S=_?65&.7;@>3F>SF<;D [ ]OFB:D+@;,.+
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MH&(C:YEDE9QR5F2+J0I(P2H8@<@S8R>BP=$(41>NNY.(@<0BC10"1\$._69
M. "5&<9QOBMDO#KP%8"QR^82I:8K;IIHJDJWD[X\4LG8+$$IB+I0ZJ3>MIKI
M*%!5%T2%!R@J '063,4NVLWW2_7=3#(]R+:)LAHK-! K [<)DRTY!!P5,I7
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M+@O$8"3>SVD[,B)=W)ZU&M-Y6DX&ZV0+;Q*$49*;R;&!(27H<&\RUD]=Y7J
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M2UMYD4EI+J9DCX;DSKD6Z!4U5S.%4TB%46,4I3+'(0"G6.5,"D*90P"8Q2%
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MH"(@&I'1R!J^EDD #4;$DDX  N8B22=@ -R3RK#U $V%\ "2;.Y  W))A?
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M/6.3:':(G#;IL/3O'8P;"/X_^'=I7JG!!JIN08<NZQA)OU,(;AOU\ V_+_2
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MF/LA-O7+!9P850AV:J I,4C;"FV77 BW;."EV%P=$X)%4$2)G4*0%5*AIUM
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M-E"\%N > D D,RGARJDCL!K5KW4XGO;V\CXNJGO+B= V XCFG9EXADX(5_&
M)WSN1N<NI-FE[$56P/6+N/CTF8-HM-XF=%5ZJKL9R^(D?90K=-,I$451#D<&
M66[,1[$3#ERZ9#9OU2R+)(6S)P$,$ . A8;<9.Y'-0!Q8)%6;K4NO50H(4#.
M3S.W=N,?J\F,PEF2V*,6CXHK#VAB*>/H*(=!_$'_  U+0Q*(\  <(Y?XY[CO
ML>51D9+R GM(.>8V/;OYMMNW&,FH\X'L9QE_G[KDJ7(SD9=K/'K4*511-RXA
M6#=H@Y>N 2 3"R6EU7@("<Y"+&9L [(P-W*H*\C]T74;CPBUTR,R);]2+F8
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MII6<>VS-,YE2%L4-:'[9LNM')40*%&OG#5Z1D].666;2)XLA4GA>4R=)S/#
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M$1JJ"#E%:33\Z?)9C:[)%)<J(+=NH747,1F;PB(6#QH'N(PN$2X5VFB;..J
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MY/ZNRHF#B+<,)]TE!-!E&,L1,8\K;=;S9PH0"+MU1*/(W*18#*IF5,1(J"@
M!]DC[926EG=1KULPB>-CQY &1G((&Q;*C!X023YQ5X13VO&>J+AE/"V,[_J/
M/T>G%V:/)LY*$9&4<HBZ\V24>'3.!RJ/#D [DQ3#U,GVHG*F([;)@0.@= P)
MIHX6*QCQ Q"@\^')P3W$C&<]N=\5A>!32DNZG?<[9P3W<\#\;[FO*7N$+$+"
MDNZ2#8=MQ.4.[O\ 'O\ R=?0.JTDXUR <^;'E[<$>?\ PJRUI(KE>''=A=_H
M[AS&,U[&64*X5$PD<HF,!1Z@<HB [#Z^O7QV\-8-P'9O%&.W_#'9MS[.WNJ5
MM[9@HX@,;^CD>[!'+[CSJA7%=DQ-Y%/6[-<3'53.FF1,><YC&W*0I )N8QA$
M=BE#J(CL7O#:[;@A?&R!S+;# &=SRP/*<\N?94M:VZ]8.%<[C;O/8 -\G8\M
M]\=U7\QA@Y>*KM<9*,P0480\8U5133 I4U6[-%-4@ 0H$ 04*8/<^.X[CON/
MS9=N;B\N[EF+F:XFEXF))(DD9@22222#R).V>8KO\ $-O##@*(H8X^%1@#A1
M5P,8&^.7([G';5T\?4-9B= .Q, %$O>4?#;O] ^'=^+OI1"3G&?)ZM^6,>4'
M]=>.^Q[.[]6W('8_5OVW"KK(S9NF3;;8H$#P]_;O#O\ 7MTUE 8 '=^,^GG6
M YXF)]'?MY^W[L5F/=KVJ:\3_,&^I-^0=>KS'G'UUXW(^8_54*)D,H<B9 W.
MH<I"AZ3&$"E#X1$-;,Q"J6/)02?,!DUK(!8@#<D@ >4G J:$4BH(I(DZ%13(
MD7;I[DA0*'3W@UK+,69F/-B6/G)R:V55"*JCDJA1Y@,#ZJ]NO*JII2FE*:4I
MI2FE*:4II2FE*:4II2FE*E2.^=['ZS:_$$UKD_Y^;YV3[;5M<'YB'YJ/["UQ
MIOYU//J"?&IZKM/TB+^M^HU:O?T6;^J/M+4::V"M9II2FE*ZY^U*ND<H@'N@
M'J/@;P[_  'NVW_)I7H.#GZOQ]';58,G4\KE%=0J(" E/O[GJ'00 ?6/AO\
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M;P*8P <?^J7<1\=@Z:V*5^KC=_BJQ'GQMW<S@5K4:<<B)\9E7S G!/H&]3.
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M4<2R \/C9&Y(X<95=,&P31NJI"-"5B2;%.LTD8SF:(I*IE$2@]:D,5LY:F$
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M (>_W]8<B%2>[M[M_O\ -MM6?&X(Y['EOR/[^?\ C6O>^X[426634;<Z1C&
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MCTDINJGGV#(Y=N<[^FH.>6>//BD[YR,$<N9VY8\G<>RO:WN:*@]HWD! ! 1
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M,?\ C>G?_M%?G)_[.^GO_P!&])O_  74/_T*?\@3C@^E'XC/_P 'KW^Q-/\
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MO['N@^I1/_2']_5XO"(/EH_;'WT\&NA_$R^A6_5YZ]R%:>I=T>Y#WT5-_AV
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DI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g904779g31s17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g31s17.jpg
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M.$-28K+2X0HW8X*U\457=H.2HK?$*%16=WB4E9:CMM/4U49EA,+#_\0 '@$
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M_8^,SB:6D':AU3IQ6:;_ %N);BH83G)'5^M3L1 Q2 F'<&T9&LVY>@%2
M]N@X5X:IXUBBR'* JBP+Y?33.;=;2S1R2N?.[L?/CSZ3.,UE8N^95I)).U3,
MBB_WJ(ZHH\RJ!YL-CZ>CC:^O$XI_N@\M?E=I[ZG.'OQ%DW[+H?F,<>,\R_&-
M=^MU'SF#Z>CC:^O$XI_N@\M?E=H^ISA[\19-^RZ'YC!XSS+\8UWZW4?.8/IZ
M.-KZ\3BG^Z#RU^5VCZG.'OQ%DW[+H?F,'C/,OQC7?K=1\Y@^GHXVOKQ.*?[H
M/+7Y7:/J<X>_$63?LNA^8P>,\R_&-=^MU'SF#Z>CC:^O$XI_N@\M?E=H^ISA
M[\19-^RZ'YC!XSS+\8UWZW4?.8/IZ.-KZ\3BG^Z#RU^5VCZG.'OQ%DW[+H?F
M,'C/,OQC7?K=1\Y@^GHXVOKQ.*?[H/+7Y7:/J<X>_$63?LNA^8P>,\R_&-=^
MMU'SF#Z>CC:^O$XI_N@\M?E=H^ISA[\19-^RZ'YC!XSS+\8UWZW4?.8/IZ.-
MKZ\3BG^Z#RU^5VCZG.'OQ%DW[+H?F,'C/,OQC7?K=1\Y@^GHXVOKQ.*?[H/+
M7Y7:/J<X>_$63?LNA^8P>,\R_&-=^MU'SF#Z>CC:^O$XI_N@\M?E=H^ISA[\
M19-^RZ'YC!XSS+\8UWZW4?.8/IZ.-KZ\3BG^Z#RU^5VCZG.'OQ%DW[+H?F,'
MC/,OQC7?K=1\Y@^GHXVOKQ.*?[H/+7Y7:/J<X>_$63?LNA^8P>,\R_&-=^MU
M'SF#Z>CC:^O$XI_N@\M?E=H^ISA[\19-^RZ'YC!XSS+\8UWZW4?.8/IZ.-KZ
M\3BG^Z#RU^5VCZG.'OQ%DW[+H?F,'C/,OQC7?K=1\Y@^GHXVOKQ.*?[H/+7Y
M7:/J<X>_$63?LNA^8P>,\R_&-=^MU'SF#Z>CC:^O$XI_N@\M?E=H^ISA[\19
M-^RZ'YC!XSS+\8UWZW4?.8/IZ.-KZ\3BG^Z#RU^5VCZG.'OQ%DW[+H?F,'C/
M,OQC7?K=1\Y@^GHXVOKQ.*?[H/+7Y7:/J<X>_$63?LNA^8P>,\R_&-=^MU'S
MF#Z>CC:^O$XI_N@\M?E=H^ISA[\19-^RZ'YC!XSS+\8UWZW4?.8/IZ.-KZ\3
MBG^Z#RU^5VCZG.'OQ%DW[+H?F,'C/,OQC7?K=1\Y@^GHXVOKQ.*?[H/+7Y7:
M/J<X>_$63?LNA^8P>,\R_&-=^MU'SF#Z>CC:^O$XI_N@\M?E=H^ISA[\19-^
MRZ'YC!XSS+\8UWZW4?.8/IZ.-KZ\3BG^Z#RU^5VCZG.'OQ%DW[+H?F,'C/,O
MQC7?K=1\Y@^GHXVOKQ.*?[H/+7Y7:/J<X>_$63?LNA^8P>,\R_&-=^MU'SF#
MZ>CC:^O$XI_N@\M?E=H^ISA[\19-^RZ'YC!XSS+\8UWZW4?.8/IZ.-KZ\3BG
M^Z#RU^5VCZG.'OQ%DW[+H?F,'C/,OQC7?K=1\Y@^GHXVOKQ.*?[H/+7Y7:/J
M<X>_$63?LNA^8P>,\R_&-=^MU'SF#Z>CC:^O$XI_N@\M?E=H^ISA[\19-^RZ
M'YC!XSS+\8UWZW4?.8/IZ.-KZ\3BG^Z#RU^5VCZG.'OQ%DW[+H?F,'C/,OQC
M7?K=1\Y@^GHXVOKQ.*?[H/+7Y7:/J<X>_$63?LNA^8P>,\R_&-=^MU'SF*J'
M'?QPM5DG#?C*XJT%T3E4262XALN$43.4=RG(<MO Q3 /<(#I#PWPZP(.0Y,0
M18@Y70[@_P#P, S3,QN,QK@>T5=1\YC=#X.;_E#?$5A>]5N@<95HDLZX*F'S
M2*DKQ,-$'.6<:HN52(A8D)QBW1>WZ%8F4.ZG(>R$E+(NT**L#-IK-"0TG@>*
MO8ORNOIY:K(84R[,44NM,C$4560+]$8V)6FD8"T;Q:(@VTD=F,BZ3)^+ZREE
M2+,9&JJ1B%:5A>HA'+6'%C,HYNL@>0CVC@C2WN_@YN'LT+#V2O2;&;@+!%Q\
MW!S,8Y2>QLO#RK1%_&2<>\0,=!VQ?LG"#IHY1.=)=NJFJF8Q#@(_.4D<D,DD
M4J-'+$[1R1N"KI(C%71E.ZLK JP.X((./5%97571@R.H9&4@JRL 592-B"""
M"-B#?&*''7QH8SX"N'.W<063$UI1*+5;0%+IK%TDSE\@7Z82<FK]1C'*R:R;
M/QDC-[)S$F9NZ"&KL5,2Y63]1B1@YNN',@J^),U@RND(0N#)43LI9*:FC(Z6
M=U!!;3J5(TNO22O''J4-J$#-<R@RJCDJYO*TV2*(&S33,#HC4F]KV+,UCI16
M:QM8_/TXF_#/^$-XF+9)S3OB$O6'JJN[6-"8ZP38YK%U<@XXQS&0CUY&L/V-
MIM!B%$#+O;9.S"RR_,9$K1L5!HW^F,HX!X7RF%(QEE/7S!1TE5F,4=9+(]MV
M"3*T,-SR6&- !S+&['R6NXCS>MD9S62T\=R4AI7>!$'+22A$DFW,R.UR3:PL
M!BI]/1QM?7B<4_W0>6ORNU=?4YP]^(LF_9=#\QB!XSS+\8UWZW4?.8/IZ.-K
MZ\3BG^Z#RU^5VCZG.'OQ%DW[+H?F,'C/,OQC7?K=1\Y@^GHXVOKQ.*?[H/+7
MY7:/J<X>_$63?LNA^8P>,\R_&-=^MU'SF#Z>CC:^O$XI_N@\M?E=H^ISA[\1
M9-^RZ'YC!XSS+\8UWZW4?.8/IZ.-KZ\3BG^Z#RU^5VCZG.'OQ%DW[+H?F,'C
M/,OQC7?K=1\Y@^GHXVOKQ.*?[H/+7Y7:/J<X>_$63?LNA^8P>,\R_&-=^MU'
MSF#Z>CC:^O$XI_N@\M?E=H^ISA[\19-^RZ'YC!XSS+\8UWZW4?.8/IZ.-KZ\
M3BG^Z#RU^5VCZG.'OQ%DW[+H?F,'C/,OQC7?K=1\Y@^GHXVOKQ.*?[H/+7Y7
M:/J<X>_$63?LNA^8P>,\R_&-=^MU'SF#Z>CC:^O$XI_N@\M?E=H^ISA[\19-
M^RZ'YC!XSS+\8UWZW4?.8/IZ.-KZ\3BG^Z#RU^5VCZG.'OQ%DW[+H?F,'C/,
MOQC7?K=1\Y@^GHXVOKQ.*?[H/+7Y7:/J<X>_$63?LNA^8P>,\R_&-=^MU'SF
M#Z>CC:^O$XI_N@\M?E=H^ISA[\19-^RZ'YC!XSS+\8UWZW4?.8/IZ.-KZ\3B
MG^Z#RU^5VCZG.'OQ%DW[+H?F,'C/,OQC7?K=1\Y@^GHXVOKQ.*?[H/+7Y7:/
MJ<X>_$63?LNA^8P>,\R_&-=^MU'SF#Z>CC:^O$XI_N@\M?E=H^ISA[\19-^R
MZ'YC!XSS+\8UWZW4?.8/IZ.-KZ\3BG^Z#RU^5VCZG.'OQ%DW[+H?F,'C/,OQ
MC7?K=1\Y@^GHXVOKQ.*?[H/+7Y7:/J<X>_$63?LNA^8P>,\R_&-=^MU'SF#Z
M>CC:^O$XI_N@\M?E=H^ISA[\19-^RZ'YC!XSS+\8UWZW4?.8/IZ.-KZ\3BG^
MZ#RU^5VCZG.'OQ%DW[+H?F,'C/,OQC7?K=1\Y@^GHXVOKQ.*?[H/+7Y7:/J<
MX>_$63?LNA^8P>,\R_&-=^MU'SF#Z>CC:^O$XI_N@\M?E=H^ISA[\19-^RZ'
MYC!XSS+\8UWZW4?.8/IZ.-KZ\3BG^Z#RU^5VCZG.'OQ%DW[+H?F,'C/,OQC7
M?K=1\Y@^GHXVOKQ.*?[H/+7Y7:/J<X>_$63?LNA^8P>,\R_&-=^MU'SF#Z>C
MC:^O$XI_N@\M?E=H^ISA[\19-^RZ'YC!XSS+\8UWZW4?.8/IZ.-KZ\3BG^Z#
MRU^5VCZG.'OQ%DW[+H?F,'C/,OQC7?K=1\Y@^GHXVOKQ.*?[H/+7Y7:/J<X>
M_$63?LNA^8P>,\R_&-=^MU'SF#Z>CC:^O$XI_N@\M?E=H^ISA[\19-^RZ'YC
M!XSS+\8UWZW4?.8/IZ.-KZ\3BG^Z#RU^5VCZG.'OQ%DW[+H?F,'C/,OQC7?K
M=1\Y@^GHXVOKQ.*?[H/+7Y7:/J<X>_$63?LNA^8P>,\R_&-=^MU'SF#Z>CC:
M^O$XI_N@\M?E=H^ISA[\19-^RZ'YC!XSS+\8UWZW4?.8/IZ.-KZ\3BG^Z#RU
M^5VCZG.'OQ%DW[+H?F,'C/,OQC7?K=1\YB2,8>$_\(5B*QL[/4.,3B <O&:Z
M:XQEVR39,DU9X*9@'DDJAD)]9JR_(H4!3.+F*45!,P@10@[&")6<'\+UT30S
MY%EBJP(UT])%23+?K2>E6&52.8L]K]7/#T&=YO3N'CS&KN#?3)/)-&?RHY2\
M;>E3CW#>!V\+5$>$;HE@IN0(F&I?$QBZ,9R5T@(,RR5<O%5<N$HY'(5/9O'#
ME]'MT)-9O%VJ!6=/BP<D_B'#>0693S1JP^>N.N"GX5J8IZ5Y)\HK'9*>62QE
MIY@"YI9V4!7)0%X9 J](BN"H:-BWIW#G$"YQ$\4RK'6P*&D5+A)8R0O31@DE
M;,0LBW(5F4@V<!=U>L!C38-&#!HP8-&#'R+<V7^R96S'E7)UP<.'5JR#D6YW
M*PK.S',N,O8[%(RS],_/U("+AV=%-( *1!-,B*92)D*4/MS+Z6*BH**C@ 6&
MEI:>"(*+#1%$J*?2%N3S)-SN<?/M3,]143SRWZ2::25[\]3N68>@FUNKEB,=
M3,,X-&#!HP8-&#!HP8-&#!HP8-&##MH#%I*7NE1D@@1TPD;;7&+ULIS=FX:.
MYAFW<H*<HE-R+(J'3-RF W*8=A >NF:EF2FJ'4D,L$K*1S#+&Q!'G! ..XP&
MDC4BX+H".T%@"/>QZI\W<&W#ID#PD%>X95\;<$,+@VD7/+EU6QGPMR=JBN*^
MUP6)L-SE]:XOS"4\VX:0C>W2C%%HH-:9L)7Q8%E(UXS>)IN2>,Y?GV:TW"DN
M;"KXADS&I@HJ<5F<)"^2PR5M?'3&KH#T:M(T",3]=9DU6#AE)!W=5EM%+G24
M)ARU:6.2HE,-"T@KW2GIFF$%1Y9"=(1;ZV U@=)!%\8A5O'L1Q*U[A&S$]X9
M?!V5?!ENX\>&+$DS&<.?T1(S,U.CK_:W1'^'<SQ4K)N:_9F5@JK4RTU)2:[N
MPI.4F;IB[2:RCINVO):I\IDSN@7-^*9LQAX;SBM1\U\&>@J'I8 5K\OD11+"
MT4QM&B 1%2592R*QKDB6M3+JDT63QTLF:T5.RT8F6IC$TAO3U*LQ1U>,79FN
M]P"" Q&,HV.!<$V3PE\EAN6Q)X-9[C7'E7X\'=5J>&#6=Y[CJXUAE H1>+]G
M)3KIM&3U3/%,UE4(1*/19OT;^9,FS=F5"G;,\RAX22O2NXL6KJIN'%FGS#H5
M$@JWO4G(V2-6>*?6P!D+%D--?FUYW@E*^=&F-/DQ@A3-C''3F0Z3"AZ$9D&<
MZ6B* D)I /3<["V,'%#C6AXCXC>""#P[P7<-.=.)3-O#XWF[#C;'D/E&S<&.
M0K;D"W.2XNR#BR,<7&#4N#>+HD9*$N;A&PIXVCY0ZDK("8U?D3I6^3U=3795
MQ#)7<09MEV4Y?FACBJZJ2CBS^E@IH%-92UCB"00%ZETZ &(U3):-0!(EX5=!
M%3UF6+39;15=;548=Z>%:B3+IGFD(@F@!E0R6A5ND(?H5>[DW1K8(>%CB.&^
M$XT+=5^%^NTNO5ZNU>DU_(T/BQ5XYQ<CG-C$@CDYGC0KE=R8E7CILR4*DBU$
M&8S$=+'9D,BJ1132<%/FLF0039Q+42RRS5$M*];I%8<N9[T;59  ,SQ@R$GR
MNC=-5B+"JSY:),RD2A2)$2.))E@),'A06TX@N3];#>2+;:E8CGC:!QM>#6K^
M+O!T/&L'PT6*@9MX-:_PWWO+N>7M1G6+'/J>=H.8<YEKL%9G+5*+M3;!=VLE
M-BG"S)PX- 1,/)(JI($(\*UR'#_%DM9Q2K29M%4Y?GTF:TU#EJSQLV6G+I$%
M!+)$I+PG,:>*=P&5>E=T(+775=YGDJP9.0M$\-5EJ4<M35-&X%7X6K&I1'("
MR"DE>)203H57%AO96XP>%3@:=Q/A)\DWF"N%&O&!L<^#M4Q\GB2CP36LTWZ+
M>#:&@V=QM>:7^DUZPOLEW9*9C\DJ6* 44J$*V9V^K.;%9)J4BVC>19UQ$K\*
M4E-)!4T^957%'A)KJB1I9_ <PJ25>5J:HEB6CIS&U((I0)Y"T$PBBC1SUF%!
MEA7.YY4EBEI(<G,(IXD$<?A%) +A!-$CF:74)]:7C6TD9D=W48G9Q\#[6,)X
MJFI"<SL[:9DH4-P_S]P@9MKBUC1[D;-LE3V<U4L2$996D<IO[)C!M=HR0D'E
MPQY78RX,X^4=09&;?Q11:ZR[CJ;,*R-8\N5J&IDS.*"2-JQJFG\7I.T<]<6H
MTHUBJS3NJK!52/ S()-1U 0*KA]*6!R]414PK2/(C" 12&J:,-'3VJ#.SP"5
M2QDA19 KE=(TW=[_ ,$)@8,R\3^/:GQ"98R!!<%S.(8YU5C,;XUIEBG+YD&[
M%K^.*?C-SDG+=5IBC)E#$F'E]M5NL4,V2EJRYCZI%3J<_#JILKQSF7@&3U4^
M5T5-)G[2-EVNKJYXHZ:EIS+5SU8I**>H#&30M-#!%(Q28-,\9BD!<;A^E%37
M11UD\R9:%6J*P0QNTTTNB&*'IJF..RKJ,TDCK9HRL:/K4AK-_!B</F%;3E&]
MYOXGY26PS0>)W!?#QB6QXIQO5\FK7V]99QY'YH;GR+$)Y$0A8&N4NJ+DA;ZQ
M@)ZSOG4TWG&<)XV9DQ:33K<7YGF$-'39=DZ)7U.49CFE=%6U<U(*:FHJIZ!O
M!9#2F226HG'24S211*L9C:0 ,S1M^)*2F>>6JKF:FBK:6C@>G@CGZ:6H@%3]
M>43A$2*,A90KR%F#A+D -C9QQV:J<.7A3.*:4KF%<*W2ITW-&0HJ(Q#?Z8NZ
MQ&#)\T7C4$5*A4IBG"BG$&>>Z4.C'2+!NTE&S5P=%=),Z"EMPY#-FO!N3)+F
M&84\\]#3.]=2U 6NU*^LGIYXY[F33HD+HQ9"0"#8B'F;QT>>5Q2FII(XJJ95
MIY8SX/8W4#HXFBL%OJ4!@ P!L>6,_O"#<..'[WE7C0Q;C/#V$.'BL\%'#/B?
MB6@I/$^.I-E=,F2^1*AA=6:IMWGI&ZNHU.LL9/)4M(PQXNNH/F@,8]!TL^$'
M#A;-<,9M7TU'D-95UV89I+G^<5F42)6U2-3TB4T]=T=13QI3AS,R4B)('E*M
MJ8@+L!:YM1T\M1F4$%/34D>645/6JT$+]+.TT=(7CD=I2H0-.[*52XLH-]R<
M:F_@P<)5>!R%D'+G$'D"M8XQ9P?<'/%9:GM0Q;#VRU/S<4#ME'NZ#7X5[=*^
MP.[BY5^QB8.<D9=HS.=\$G,H-F;)=):V/&&8S2TM+0Y72S5=9GF?9-"L]9)!
M"OB=2RU,LBT\K .BL\D:HS>3HC)9@1#&24R)--45<L<,&7Y;7R&.G620^'E0
M844RH+JS!4=F N=3  $%U9_\$EAZ@0G$M 8=XD[GDG-'#HOPTV>3K%HQ,PI%
M(F,?<5UIJ5;QK',[6G=)N15N\,UO%;L%N<JP+&OIMWON7&%<O47RK!C+.-Z^
MIDRF6ORFGI<OS09M"LT%8]141U62P335;-"8(U%/(:>6.!1(TI*ZW(4J&<J\
M@IX5K4IZV2>IHS1.T;TPBB:+,)(T@59.F=C*HEC>0E%2QTK<@D)&0_!7X2CP
MSQ4<7<160;7E'@\S'P^8EXEFULQ-#56D2HYUR5'8F5L&%I9E?9R:E$J3<WX,
MGT;<XB!6FV1#R<:X(@0A%W*7C+,&.6SUF54L%%GM!FE;E#0ULDU2GBVD>M$6
M8(U-'&GA%.NI7IWD$;$(P)N1S-D5,OA<<%9-)/EU324]:)*=8XF\*G6G+TS"
M9V;HI6"E9$34/*!MSP2X\>'W"O"UGNTX&Q'E:YY<E<83=GIF49^TT-E1(QG=
MX&Q/V2D74T&]AG7<Q&,(XC1A)2SXD:#F?9RBT6W6AEH]P?1\-YGF&<9;#F5=
M14]#'61PST<<-2U0[4\D2L'G)CC6-V:[(BE[1L@<B0,!5YK24U#5R4E/425!
M@9XYW>$1*)4=@5C =RRJ+*S$+=PQ4%"IQA9K08K<&C!@T8,&C!@T8,&C!@T8
M,&C!@T8,?2=\ S?['D+P6W#:[L[AP]>U9+(- CWSDQCG<5REY'M,+5T"&,(_
MW/#0"$=7FQ2^21O#ID  $HAKY0]DBEBI>,<V6$!5F--5,HZI:BEADF)\\DI>
M4^>0X]FX5F>;(J,N23'TT()ZTCFD6,#S(FE!YDQIS_Y5W8[*D7@GJ)5'*-.>
MCG2QKI$$X-)&RQ@8MC&JBY?TL[F&BY=X5H/PTTIUZ ;E5';=^PQ%"?J@GL#.
MOBZ('[I87\,=@.NTCHNKM,:]F,[QZ[_^K([D1GPIR+[,Z] H)':JL;'JUGMQ
MX[M>Z8\[P:,&#1@P:,&#1@P:,&#1@P:,&#1@QO,\#I@3 /$%CWC@I_$,_K=2
MIKB)X4(A7)TO Q<C-4!I9^)*O0\LI5YZ0:KJTM]:VQTJF[M"*J#&';2@2DX#
MB'CW:!_.N.\RS++*OAV?*UEGG#YW(*-)'6.I:'*I)(^FB4@5"P->=82"SE-$
M>EV4C3\/4E)60YG'6%(X[9>OA#(I>$25J*W1NP/1&06C,FP4-J<%5(Q.=CPM
M<L_K^$HQ=,TBJ<)3FK\4_@\.&6M82IV.\7DI]4K-RR[>,<4Z2F;6YHYK],NH
MV(;Q=R6NU3N=7#)1YIY)SYYFN/(2-C*V+,(,L'"=9'43YV)<FXHS>7,*BJK#
M/--!0054Z1PBH\&C5GUTXIYH)O!="K%T<JR.\EJ:2L.=0-%'EYCK\GHDI8X8
M.CC26HF@C+R&+IG*KIEZ6.6/I]99R\;(JRB_X4>$KZ F2N$K#Y^(-K7TO#$\
M+?"CERW93/CU6S/))N]OV-;1:L72T!5F#6)CY)!](2,;7K/ RKJ%42B'DBYF
M$I0\>QB)G6=G,Z3.Z[Q6TAX%SC.J"&C%4(50K35<,%8DDS,[HR*CRPR()!K5
M1&4U,^U!EXI9LOIS5Z/JCH,OJ9)^AZ0L&F@DD@9$"JIU,RHZL4(4L6U6$#AX
M)[A;R]9<:57AYR?G: 6;^$6N' +F*8S&ECZ11DUZ=0;)DB2R1C6+J,9%##I*
M1-.G(:+K]FE9M>2D742Z7<19 <,U;+ZM<XH8JN;-*/+I0W"L'$M!'0^$H4$]
M5%2)25;S._2'I)XI'EA2,(BR* YLPC>(*&H>%*.>J2V<R934-4]"P;HXGF,T
M"QJNGR8W4([.68J;J+@HI?!L\#>0\F4'%.(L^3HY+S!0>)>O4/%S7B$X?<Y3
M%?SUBN"C[5A1W>[EBFILH!M0<R13>S03ZGGC(*UP5R9LV$7;9ML<Q3N?59Q%
M2T=36UV61^"4-3E,M36-E>9Y<DN6UDK0Y@M-3ULS2&IH',4BU >6"2!BSP1D
M;<>)LKFGA@IZI^FJ8JY(H/#*.J9*N!1)2F66GC""&I4.ABTK(LH 61^O79Q=
M<--*X6LLX)PZSD;/*9+6POA.[\1D):5(L[2F9<R>R2NC_'4-',X>/=,H^LTJ
M<J#>21FG4L_7FG<J(N$6H(-D]3DF;U&<4.95[+"E(*_,*?*I(0X:>BHV-.M5
M(S2.K/+41SE#&$41JGDEKDU&8T4=#/2TX+M/X+32UBR:;15$Z]*85 4$!(GB
M#:BQ+EM[6&-V?'MC#!N;O"0X]X#(>]X;K>/;1Q3TFIV;%>"N$?'^%,JXAA7M
M-(3G)GQ''!4+VW>FL+MS[D'<S445XZC7+^,<JPC46_GW#=9F.7<*57$CTU=+
M50Y/4315N8YW59A15TBU'7EAJ[TQ41 =(!&^D.%<"1KZ7-J>EJ<ZARI9:9(7
MKHHW@I,OAI:BF4Q ;50@M*#K)TDNE])924%F;PE\!?#J;-_!_EWAPR#GZJ)*
M\8N?.#[)!LRUK!]FG']PQW@>TWA/(^/*K.8_ME%CZW*L4W40_K5UA,@/*_).
MDTVDY[K1*$NL_G7$F:^+L\H<UILLF(R++,]I/ )<QAC6"JS*&G\$JIHZJ&I>
M5&(=9J>2E$J*2T>B0QAJ@RJC-3E]11S5<=\QJ\NF\)CI9',D-(\O30QO#)$J
M,+J4E29D8BSZD#&KPK8OX1H!UX!K(%'QO?(G-^9LMW1U;[7(RM/<5RWN:)F)
M]5[TI<HUK6V\@_\ %+"1-OB1.->1Y*]1 )%VH+'-E"6$SFLSR5?9'IJBKII,
MNH**G$$*I.LL J*)9:84[&8HEXKFNUJW2U'EP]$A*86@@R]/J4EBAE6IJ*F0
MR2,T923H:DI*9%" L0]A3V(T1#3)K:S"-F?@RN%OBJR9P_V3!>0\WTNGYCXG
M^*S$.:2Y4-C=:92=X"HS[,\O8\8$@6$7#5QE::\W?0T7$6Q]9O>Z_=LGDE+2
M3"*?&?RFXNSG):3,X<QI<NGGH<HR:NR\T?A0CTYE4I01Q5AD9Y)6@D99'D@6
M+I55E1$9UTL#):&OGHVI9JJ**IKJ^FJ?".A+!J2$U3/!H"JBR("BK(7T,069
ME4W<^%.''AAP];,X3G#]DZ)O!+]X*WPB+R]XQ<YIP_Q%3^(+/3:DS8P;M]DO
M#<-7:E(,;S R;2<@&XUN+EH=RQFV#AP^[ BY&LPS7.*^#+X\SHWI_!N,N%UI
MJL9?795'70SSEI56DKY)9T:GD5HI3TKQR*T; +<KCNFHZ*G:J>DG64RY#G)F
M@-33UCTTD45D)GIE2-A*K!T&A60A@2;7PVKWP74')V6*/+YD;Y6NV-J=P+\!
M]EG[K6LD<)'"M5,>N<P4Y1K&15KOMZHD-5)-0[EHXC\?P"%5L>1[NY;O$Y^W
M*%B_'5G:?/JFCHJB.@-%35=1Q%Q)%%3RTF=YS/4K0S@N\%-3U,DR !E:JE,T
M5)3AE,4 UZ1Q)EL4\\35 J)8(\KREWE2?+J". U,7DK)-+"L;;@K"O1O/*00
M\ATWPR^,;AQK_"GP$\76!(&6=6B-Q1X7:B5*!M,PS9(6!_73<+&0):+3E%&2
M** O4VCYLE(BS2:L73]!5VW9-$U2-TI.19K+G/$F1YE*BPO6\$U4\D,;,8EE
M&<4J,4#$G3=25U$L%.DL3<EO,:-*#*Z^D1C(M/Q#%&DC !RG@%0RAK6%P"-5
M@ 6!( ! "%)W1IP0>#]X [[A3!&!LC6?BV6SK9\X9&S'A2H9K4M#^BY%1I4#
MA2+-;XV4"IU]C!@(SL17%XN;F)0PRC%\P< \.NXE.>(>)N)J;,,RS*EAR09=
M#E])0YA/E_0K4TOA$N8/T#ITTC26Z-Y0\<:>0RL--N&D&693E4M-2TDSY@:N
M2JFJ:6.IUF*<1)3+TJMT:*H.M4TL[>4"IO>G;?!O<+-%X6:]D+*&=6= SSDC
M@V-Q@4LDEFK"M<J3N?L"<K8J1@"$X=YF/-FZP.K# QB]?;Y&CK>$6WO']YT*
MV^(P?$*0<5YS49S+2T>7-59;29[XCG*9?F$TXBB*15&9R9I&WB^(12L)32O!
MK:G\LRJ67!)D]#%0I-/5"*JFRWQC%JJ:9(R[ZGBI%HV!JG9T4H)Q(%$ODZ#I
M(QF+QS1<8A@'PI:B,<P14:X;\"8=LHDT;IG;G=T=^#LR!B)@9$SD  '!DQ**
MP  *";8-4?#K,<SX/NS&]=[(%[DF^FI73??>W5?EU8LLS512Y[90+4O#-MAM
M>(@V[+CGCRRZ]BQAL&C!@T8,&C!@T8,&C!@T8,&C!@T8,;C/ )6BWUKPHF 4
M:@1PY/9(/,\%/1B1E"HRT&EA>^6(K-\)!#^YD)VOP<H0#B!?'8YI^OY '">R
M5#!+P=F9FL.BDH)(G/-)#7TT19?.8I94_)9L:+A221,\I.CN=:U*.H-@Z^"S
M/8^8,BMWJ,?24U\I8]FP:,&#1@P:,&/FQ>&A\']=>"CBUOE@9U]Z; 6;[98+
M_B*V-FJAH1F:POEYR?QL[=$(*#&<I4B\=LF,>X6,YD:J2%FR&4,Y>I,_J[@'
MB:GS_)*:)I5\9Y=#'35T!($C")1'%5JO-HYT52S@66;I(S:REO&.),IERS,)
MG"'P2ID>:GD .D:R7> GD'B8E0";M&%?K(&GS6ZQGL&C!@T8,&C!@T8,&C!@
MT8,&C!B_B9-Y"2D;,QRA49"(D&<FQ6,F14J3Q@X3=-5#)*E.FJ4BZ1#"FH4Q
M#@'*<HE$0'ET61'C875U9&%R+JP*D7&XN"=QOA02I# V*D$'L(-P=]N?;C(6
M>XN^(&=XG'W&(G?G=>XA7US+?O?Y56,= JM+*#8C$[AI$LVI8<C%RP(,>_B%
MF*T7)QR[N/DVCMF\=(+5<61Y9'E"Y$:99<K6 TW@TS/(&B+%[-(S=)J#G6KA
M@Z.%9&5E4B6^85;UIS'IBM891-TJ!4(<6%PJ@+:PTE2"K+=6!!(.0M^\*=Q9
M7]K262[O#U.9TG-U,XD"M\:8&Q+CLELS?07"CJM9#O1JK5(Y6TS+959?QM)\
MH$;)D6Y)!BY!!KXO5TW!N2TS5#!:ZH:HR^HRHFKS*MJC#E]2H6:EI^FF;H8R
M -)7RTMY+"YO+ESROE$8O3Q".ICK+04E-#TE5$;I-+T<:](XN;W\E@3J!VMC
M_4N+K.-)SID_B-KUBC&N5<PI9?1O<RM7(5TPD29S1FT<B>*PJ[,\7&C)%L$D
M9D+%LB$491+Q$$BHD+JSGR/+JG+:/*98G-%0^ ^#1B6167Q=T?@NJ0-K?1T:
M:M1.NQU7N<14S"JCJIZQ7 GJ?">E;0A#>%!Q-92-*ZM;6L!IZK6Q,V&O";<6
MV"&>'&="ME/'Z U%RAC/&CRT8UI%ODH:B9?L45:+G6G,A8H60=2<<K*1"1(<
MC]1=2!BWLM"12C:(E7S):!7\(9)F35[5,,X\95-'5U:PU=1 LE30Q/#3S!8Y
M%5'"2'7I $CA)'!=%82*;.LPI!3"&2,>"Q3P0%X8I"L53(LDJ$NC%@67R=5R
MBLR*0K$&$\D\4^1,HY<H>:9JN8>KUNQR:M*0$?CK"^-L;4MRM5+*ZM48XL-)
MI%<@ZW8W2LD[.A).IB/=N9.)1:1#Q56/:-T$["DR:EHZ&IR^.:OE@JA,)6JZ
M^KJYP)HA"XBJ*B626(:!=5C90CDNH#L28TU=-/415+)3I)#HT"&F@@C)C<R*
M7BBC2-SJ-F+*2R@*;J ,.]IQX\4+>_\ $#DAUD=Q-S_$]4<FT;,;.P1[&:K5
MAK66GB;^V,6-8?HK0E?,F[0;*UUQ!LV"]9!JW1A3LT$^R%EN&\G--EE(*41Q
M9//25% T3O'-%-1*5A9ID(DENI(E$C,)M1,@8F^'!FE<):N8SEGKHYXJG6JN
MCI4&\@","B;@%"@7H[ )8"V'<MX2#BB?3>=9J<FJ%:2\1^.\;XTRO!6S%E"L
MM7G(;$%;95;&$NTKLQ!NXR)M=&8,$G=?L;!!%\SFC&F^8\DFV<-XXX4R=8\N
MCCCJ8?%575UE%)#65,4T<E=*TU9&TL<BN\%0S%98F)5HP(]E+ N'.*XM5L[Q
M2>&PPP5"R00NCK3(L<#!&0JLD04%' !#^7[8 A(R!Q_Y_P I4R#JM]:8<LL[
M!1M @TLP2&"L3JYYD('%[V%>4>&ELR>]0+V]:PWO=A&*SH9=.5FHE@$3/R,I
M'.GS9TY2\,Y91U$DU,U?#'(]3(:%<QK1EJ25BR+42)0=-X,IDZ61@N@I'(W2
M1HCJI',V:U=1$L<W@[NBQ**@TM/X64@*F)6J>CZ4A-"B^K4ZC1(S*6!J0?A"
M>)2&R_G;,KN6HEMF.)H1#/%,ON,:/=L59*33E6TY')S^-[%#/ZSSP<TS;2D"
M\8LV<A$.R*F9/$DW;Q-PDG"^4R4.74"I4P1Y1OEM135E13UM(2C1OT57%(LU
MI(V*2*S,KK;4"0I F;5J5%54EHI&K;^%QRP12P3^4'&N%T*>0X#(5 92-C8D
M%9H'A)>)W&#K*1Z0MA^$A\K6.IW1_3$L!8<5Q]2[W0HI.$I%[Q;05J8>I8ZN
M%6BTDV\;.UJ(9NU7":,K)"_F4$)%)NIX3RBL%%X0*Z22BBG@2<YE7"JJ*>I<
MR5%-65(GZ>J@F<DO%*Y4"Z)IC)0]19Q6P&<Q&G59WCD,?@E,88I85TQ2P0F+
MHX9(UV5XU!O9FNPOC%?-&7[SG[*U]S1DR1:RU^R58W]KMDDQC640T>3,D<#N
MEV\9')(,6*1A .1NV132( >27O$;G+Z&FRRBILOI%9*:DB6&!&=I&6-;V!=B
M68B_,DG$&IJ):N>6IG8-+,[22,%"@LQN2%4  >8#&4L3X27BIBL]Y#XC%;'2
MI^^9:QC$X<R;$VO&='L^/;UCJ$KE4K,97+'CV9A7=6?-V["D5I8RHQY'"[Q@
MH=PJJWD)%L[II.$\F?+:7*A%414U%6/7TCPU=1#54]5)+-*\L54CB926J)1;
M58*PL 50K.7.*Y:N:L+Q/+40+3SK)!%)#+"B1QJCPNAC( BC-]()*W)L6!2<
MH>$/XI\QL,MQ^0;K"3"6<<9XGQ'D<S:CU"$-+4K"MG;W"@,6*,'#QS2"7C9Q
MLFNX<PC9@+QO_<*I 9E30(Y1\+9-0-0M2T\D9RZKK:VDO43R:*C,(3!4LQD=
MC('C-@)"VD^4#JN3S/F]?4BH$TJL*J&G@GM%$NJ.E<20@:$4(5< DH%N-CM8
M!,N/'QQ-7IUG5]/7.-%[Q&U+"M+RB\C:Q!13J1A.'U6IK8O"&78,T%:X_A%J
M57U7$C#&:.Y)1LJ=ZHJ9<XZZ@X9RBF7+DBIWTY7/F%11J\TCA9,S$RUG2!F(
ME21:B0!)-00$:;6PDF:ULIJB\HO6QTT=00B*66CZ,P:2J@H4,27*6+6-[WQ(
M&3O"A<7>6H=*)L]GH+!=]=<>Y&O]BIV(<:4FVYEN^*7"#O'MAS/9JQ68R6R.
MXJSI CJ.:3SE:,\; CQPQ6=H-ED(U'P?D=%(7ABJF"T]524T4]=5U$%!3UH*
MU45!#-*Z4HF!(9HP'TW4,%)!=GSO,*A=+R1 F2&:9XZ>"*2IE@(,+U+I&K3&
M,BZASION02 1AQEO*5QS?E#(&8<A/FTG>LG6^>O%ND&;!I%M'MALLBXE95RV
MC6"2+)B@J\<JG2:M4DT42"":90*4-7U#1P9=1TU!2J4IJ2".G@5F9V6*)0B
MNQ+,0H +,23S.*^HGDJ9YJB8AI9Y'ED8 *"[L68A5  %SL +#$>:E89P:,&#
M1@P:,&#1@P:,&#1@P:,&)2PKA;)O$/E"G8;P]4Y.ZY#O4NWAJ_!1:)CG.JJ/
M,X?R#@0\7BX6):E6DIN:?J(1L/%MG4C(.$&C=54L/,,PH\KHYZ^OG2GI:9#)
M+(YY ;!5'-Y':R1QJ"\CE54%B!A^FIIZN>.GIXVEFE8*B*-R>LD\E51<LQ(5
M5!9B "<?4KX*>&F(X/>%;"/#=#O$9,N+Z6VBYJ8;IF1;3EOE7;RQWB>:HJ%*
MJ@TFKC,SDFS;K<RS9HZ0;JG4.D8YOCO/\VDSW.<PS612GAE07CC)!,<"*L5/
M&Q%P6C@CC1B-BRDC8X]SRRB7+J"EHE(;H(@KL!8/*Q+RN =P'E9V .X! /+&
M'_AB?!XN/"&\+*E0I:L>QSABV96O^'GDFNFS82\IX@JPL%#DI!;ZE'Q]TC!1
M20?*F2;,K)%5M[(.$8IL_P">\X%XH'"^<B>H#ME]9&*:N5 69$U!HJE%&[M3
MO<E1=FB>55!=EQ6\1Y.<WH=$6D55.QEIRVP8VL\);[D2K:QV =4+$*"<?-_R
M;BW(^&+M.XWRQ2++CR]UEVHRG*K;(EW#3#!8AA IS-7B:8K-')0!=C(-A682
M#4Z3MBY<-54EC_5='64E?3QU=%4155-,H:.:%UD1AV74FS#DRFS*;JP!!&/'
M)X)J:5X:B)X98S9XY%*LI[CS!Y@BX86()!!PPM2<-8-&#!HP8-&#!HP8-&#!
MHP8-&#$ET_,.2Z!2\H8[I]L?05+S1$5^!RA -D&"C6WQ%5L#:U5]D^5=-%W;
M8D9/M&\BB>-<,EE%""BNHJV.HB>)/04E544=5/ LE1E[RR4<I+AH'FB,,K*%
M8*VN(E"'#"VX .^'HZB:**>&.0K%4JB3H ")%C<2(&N"1I<!A8CL-QMB7[=Q
MO<5M[C;/%VS-=JET;I'8;C+8\41A6LW84>'UQ)NL-NI6QL8IK8'<S17$P_5C
M; K)C.NC*(^ZTC( R9 W@0<.Y+3/"\.7PH:=Z]X%!D,<1S,*M>J1,YB$=2$4
M-%HZ-=^C1-37D29G7RK(LE3(PE6F60^2'<498TQ9PH<M$6.ERVL[:F:PM(-^
M\)EQUY0/6SWSB,M]B"HW_'^5:ZBXBZ@U:QN2<7N7KNE7@C./KC1HXLT:Y?K*
MOY=VBX=V0R3 +.I,%BXT&D:FX2X<HQ**;*H(NGIJJCE(><L])6!5J*<LTK,(
M750%12%ANW0B/6^IZ7.LTGT=+62/T<T-0@*QV6> DQ2@! -:EB2Q!+[:]6E;
M1$AQ=\2C-%9%AE^U1?;\02G%49S$G81,@EQ!K,W<>IE!K)QK%K(LIXS-^[;@
M@S=(1)2+GY8X#;&"<<CREB"U#"]LK&2V?4ZG*PRMX&RNQ5HM2J;L"]Q[?$<9
MA6@$"HD6]7X?=;*166(Z<,H!#V)&Q"[\L3-#^$&S?9>(SASSQQ 6*5RHAP]9
M6A\HQ5?K#6D8D?R;YK8ZY8[ F$U2*0S;)RMN7JL.UG;%)0\Q+.VK?E.N*@@H
M$"3AC+H<JS7+<LB2B.:44E&\LS5%:J*T4L41Z.HJ&)2 32-'$CH@8\L25S:I
M>LHZJK=IQ1U"SJB"*G+$2([^7%$/*DZ-0SLK,0.=]\8^<1.=[7Q&<0>6>(:S
M<[&S92R-8;^HS3=F>$@"2LJJ\AH%D\.B@==E6(P(^#C%3H(F%E&MA,D0=RA9
MY7EL&599197#9H:.EBI@Q4+TNA LDC*"0&F?5(XN?*<[GGB'654E95U%7)L]
M1,\I ).C4Q*HIV-D6R*>=E&,U:1X6KBO<9SP1E7B&O<OGNL86S)5,R#2GC&B
MT]_/SM5;24<V$UN@Z/[IMUQC)B1:$4=I230 7 ZK)51)!1'/U/!.2C+LRHLK
MIH\MFKZ&:A\(5JB=8HYF1V^L25&@C7&K$*4.VS"Y!LH\_KS54M15RM5I2U,=
M3T3".,N\891]<6+4#I9@"0P%^1L,1ED3PFO&ID+*E#RP]SM<6\]B"PW.>PZ!
MDZTN6A+W=-ZQFG0)I5UI'V:POH5Z:)E+99HV3L$HB7M'+WG$.692<(Y!2T51
M1+EL!CKHJ>.OL91X2*8JT8N92T42R+K2"%DB4[!;89FSK,IIXJ@U4@>G>5Z?
MVAZ(RW#GV@#NRG2TCJSMS)OB-*%QQ<5F,:'C3&5'S'.P='PYD/Z*N+H,(JKR
M(4>]&>.I%67@)&6@G\LT:N9)Z[DWD!X^>N/9-PK(NXE9Z85]2ZGAW)JRIJZN
MHH(Y*BOI? ZR37,GA-,%"".54D5&*HJHLFGI50!5<*+89BS.O@B@@BJ76*FF
M\(@72AZ*6Y)9&92P!8EBE]!8W*D[X;]9XNN)2EMJ6UJ67[76B8[RO8\XTM6$
M481KR RI;X]G$VBVM'[5DF^4<3L6Q;QLE'.G#B%<L!<,U(T6[UXFN[-D>4U!
MJ&GH893544675 DULLM% S/# 5+%0(W8NCJ!(&LVNZJ1Q'7UD0B$=1(G0U#U
M414A2D\@57D# 7)=5"L"2I%P5L3=WVOCTXL;I892T3N6E@F9K&-^PW**0=,Q
MY5&+S&^4FY&N0JXI#56I0L*7WVH)IEEY=./)/+&225)*)JI)G*Q#PUDE/$D,
M=$.C2KIJ]!)454SK5T9U4LO233R2?6"3T<9?HA<C18D8<DS2OE=G>H.IH):9
MM,<4:F&<6F31'&J?7![=@NL[>5L,7M7\(-QCTU](2-=SE8&3B5QUC;%+])>%
MI\HP7H^'&YVV*H\(J6KCZ+1E,>IJKGJ5K09I6V$=.'+UC.)/'*ZZG,W#&0U"
MHDN71,$JJNM4B2='%17'56-TB2K(4JB!T\)8P2 !6C*@ +'FV8Q%BE4XU0PT
MY!6-@8J86IQI9"H:$$]%( )$))5P23B/,F\6'$/F6$N]<R=E":M\+D?*L=FZ
M[L9!G"(DL.58FJ.J/'7)XJPBVCA.1;51ZYAP0:JMXY1!45E62CHI'!95)DN5
MT$E/-24<<$E)1OE].RM*>BHY)A4/ H9V4H9E#W8%@0 &"[89GKZNI65)YVD6
M:H%5*"%&NH6,Q"0D*#<1L5L"%L;VOOA]8)X_.,3AGI$CC;!^>;?1*+)2RL^-
M9;H0,U&1<^NB""\_6$[+#S2E0G5DRD[:9JJD-)*J)IK*.C+)D.6-F7#.19O4
M+5YCEL%34H@BZ8F6-WB!N(IC#)'T\8/*.82(!<!;$C#U+FV8T430TM7)%$S%
M] ",JN18NFM6Z-[#V\>ENN]\6(<=/%>.'5,".LQS,KBTT%.5=&$G82HV"8CZ
MQ95W+F>K</=YRO2%[@Z_*K/'9G<)#V9C&*%<KI^*@FJ<ANOJ<R45WC):"-*S
MI8YC)')/$CS1 ".:2GCE6FDE0*MI)(6?8&]QCGQI7^#>"&I9H-+(%98W8(Y)
M=%E9#*J,2;HKA3<BUB<-NY<7?$?D&$R17+CE2;G83+L3B"#R/'N6, DE:HG
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M]NNE\64_X3-^K(>__.1A/&TOX-'_ #[?,8JA=+Z %$U8J&^PBH 6V9$ ';<
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MTC"UU4VP;KILVYK*L9!3ZDF]-%O@*+EFV41E93&!'//]T62!#UA2"\O<6M$
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M8,&C!@T8,<&[A]@_-I5YCO'KPC<CW'U8;,&Y[126;".YFTHZ$H>A-=4YR_\
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M,;2&KI9$,E4%?5$)"=&ARGP;?"LA&3*T%6Z>:,H\BZ>RB3:EMVJ<)+2]5BK
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M1G=2&&(JH^3[<VM/O:L5C]]2#V#5EUG1VR#9:$>)]F8J':-TT@,V<<PH BH
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M@T8,&C!@T8,&C!@T8,&C!@T8,&C!@T8,&C!@T8,&C!B,LN'!.FN3&1%</'F
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MBV5307]TECN$514 1]FX16*;A(0S1K:2ESY&Y@20[%W=1Y+'6=(=@67HQI(
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M9><2%(UDQ-1J=5#.D&[ $06A[;67<RJF55PDQ3\0DF0N)(!0;1N(/8GSK/\
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M3-_=J?\ V87_ %BH^2V-'E'VJ^_^7;T>1'M\OIPC6DQ?HE\G,/.%%8F$O7E
MHS\J &[MMQ$! >N^P!N'=O+RL?8LAZO""/\ PUQ#SCW:'\TWQ_I[^*VK#%1@
MT8,7&H^)&#1@P".P"/HT8._"-)/ ;I&$1V$0$?\ AW]P>WU>QQ!U^]]/I\..
M6;G\G5?K[=O>OM?L@RUVU)F5<ZRX)II$455.(B()I)%,HLH(!^M33*8P[=1
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M7257$?$#H2NL/(E+04RO<:9*EEK$#6O'")W&X%[L)9Q16<B\[$TY;)2/=NY
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M#HVZ.^X66HD6/8VL#T0FYV-BUB.6,GQ9,(J"&$&W3S^6.OHXD+GF;VU]'<[
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MC!HP8Z*#L7Y_8'7^C1SP<@3]+;F_HM\.(YMCT4TE0 VP% =PW\_MWWW\_?\
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MB>HA0*V:9WEU3, + R>)LMB<FV[:F0N2=RSN=CA*@$BN+BW*N('3]T'2A"&
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M(.W, ;G#@DU@-6HJ43/L^@C0_BC@N_.+99(C9TS,/DF,GVR93 40$"*)K"0
M[4XC+F :$,1N@!! MS!N+[&QN?.0<?/WL99AF>7>RIQ?PC5%WH,XJ\_EJ:>0
MDK%5TLTM935R [*98"T9;82++$Q/UM )MP:_6CLR]DW$2MK+5'1WR)>A!6:
MB^17, =QBG0%,H^A8Y>O, :YHR>D9>HC>_FN!;<]WP7-L:7V::2*J]C3PB4
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M42/OR5*6FN+VY !.5^SLWITALHK,NU=OJ:[%4JP;#RB )CU-N/7KT 0  Z=
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MHP8-&#!HP8-&#!HP8-&#"GC#E\8R-L<QA"]M^8!$1!,WT/*#L0@;!L42\IQ
M-PYCF'?<1 *3-_=J?_9AZ?LBH_N]&-'E'VL_Y]OZ.+"':0_PH&-R_P#]!1X<
M_-W[6&7'EY?5OOS>??;S:EY7]J2"_P#G!VM_W:;W^3$/.?=X/S3_ !QBYU88
MJ,&C!BXU'Q(PQ\D9$JN)Z38,@W5^:-K5:9 \D7*:"KMP;M%DFK5JT:-RG7=O
M7SQ=NR9-DB"==TNDF'+S<P3\LRVKSBOILMH(^EJJJ3HXD+*BBREW=W8A4CCC
M5I'=B J*3U8AU]=3991U%?6.8Z>F37(P4LQN0JJJCRF=W9410#=F VOB!\3\
M9F",PN74+'V92EV]BZ5:.:1D=%&G6@%"&V*+5I(.1:R/. <QDHYXZ<(=SE%
M1#?19QP/Q#DBI424@KZ%T#IF&5EJVD*D;ZGC4/';EJE1$;FC,,4>5<8Y#G#/
M3PU?@U9%(5DHJ\"DJ@01RCD:S\MPC,PY,%.,=N/>.C9Z(PDFW.W>RBV;H-DQ
M(V.DY75B)2J6XD\4H)"<X,S-6S95TH7ZEN@W[0?@@.A]CB6:EJ^(&;7' .'Z
MEY"P*H)H:NB-/<L+:P[$*-F =K;7QG_9#AAJ:+*$NCS-GE,D>DJS]%+3U:U
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M1 L/3A[ZZQS@T8,&C!@T8,&C!@T8,1IEH2!3G':*G1+X\PW.F82F >U'8-P
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MTLLSQ(QC1)!3B5@O28U]\47%9E/%6;<77)L_R!68'M$&$]B>=;2+:KR[B/\
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M5+SME2E?MQ,Q6<(MX_''"4W$E-)FE-&(^(<NI5%51HQD@S6AB4F.IH&)*DA
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M7B/S3E'-3SB%ME^GE<M+S[2Q1]LCGJ\8\KCR,7*M"-JN#10@0,; %320AF#
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MKV!9&#*R,0#8[J&5ACQS/\JERBL-,[=)&=,D$FFW21M<"Z[D%2I5N8)!(-B
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MA=L9X^N,LW3:2=HIM;GY%NB4Y$$GDM$-'KH$"',8Y&XK+&.@0YC'*D8@&$1
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M?SMWXQ&\)S_D"\4G_P V+W_M.,UA.-_\4\]_V%_CICZ(_@T?]O/L8?[RP_\
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M9@I!TDG?<B^$\)ID<JC0&)\PCUAD0IT)@1)G56%E0N& 8 6!L+ VQDADBO\
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MY]7_ *NJ^79V_0XDNEAS(H@/G2#?V#OO]L/-\FH'(;=0]0Q]2YZ?KK_E,/\
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M[^[8=*.H_0=NVWO$#K[<6%&A$\1!.TB&_P"20??Z_>[<1!P]F$UKNF_>#2*
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M>%XBZE)5"2$ W5F4$I?1UH2A!NITD6P.3YS5SUT=/6N=,=/+&NH:6=U=&5Y
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M:(<&,8[J+2\DK!VL<Z[MJ"3AP8RRJ@B8Y/,WMSZL>Q?# B'#5B@0'80P;11
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M9YQR^FV(MRGF^J8HCDG,N91]+/2G]R8!@)!D9#L]RF64$XBFR8D/L15ZN D
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MB $UG@4MJ>-4!V#6#$75"\(-C.;DKDFX0GX^'A2#-TRRMHF55@[U3BXZQ-D
MTFVE7S",C8N93:96C#.8)^\+XC%($EWS]N11T@R5*Z*0N#?2 61@I(=.BBEN
M&(50P$MBIY 7)L3:@:OHYVG&EQ&@Z2"41NT533^"4%6)%D941'T5T9:-F\E
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MA,G+(OE56RO"P$Q?AK,VA:2N(.(BLSWW).V]M%^OE<;[:;D@[$]FWSA6U6>
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M1J.-ID%QORZ[7-P .VY^7EA:BDLXV.PL>6]N1)!MW\L,*$XI:T[$6Z+U+M!
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M$#42//:W+ML=KCG?Z"_W+PEQQ#Q3P[3U,\BBMBCCH\VBVO#6QIH\)TV-H*M
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M1JM9AC;GD&LQ5;8R$G*O&,9%1K=5R^DY!PBS8LFJ0 *B[ETN9)!!,H;%YU%
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M%"QOT:(P9E\J0DL%7:9+PQ2TR1U-?"E15L _1R#5%!?<+H-PTH'MV;4JM<(
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M]3#YN4"GC:;^(IO>G^?P>**7[Z;^6GS>*GT-%.42^_VZ@(FW _94;F*'3R0
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MGY_]-Q CR=_P-J^&W?Y]^X-_/N&EHS;[$A%NPS;]_P!=P"OK1?[)<]Z0[?\
MAXY.RL!R@7W_ %R)L&W,1Q! 8>FVXB, ("/R=XCH%+1C_-(3WF8_^;A3F%;^
M$,.Y(?F\<$8V IQ/[_KF<!#;D.X@1('=U  @ '?I_I><?5L>"T=K>"0]]YK^
M_P!+A/#ZV]_"7[M$-NK_ +OS>NV.196 2 3W^W(-AWYP<00'\_>/N (;=?1Y
M@T@I:/\ !(CWM-\[A?&%;^$-_(A^;QT!A80,4?H@74>4-N47$")3=!#<WZ']
MQ'S[@(!N =-MP%?!:/?[$AW-^<UQW?7>6$\/K?PE_P"1#Y]_<O/W<ML5!9V
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MG*5][C)RON>!51>"B=%1,NACX4S63+Y\R>..EIX(&J-%2Y2>6)06+1Q:&(U
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MY"S&YJE@=EGC9IHF4J82SZQS=O>O+$026$*O<S HB7?ZE&V+D J1PZB5--Z
M>*+AN4.86ZQQ $  2EETMH))5M[]AW/P]YWO;%=[+_!C<1</3YE%%?B#A2-W
M?2I:2MR12QGC)%S(]&-53#N2$$T:C5(#B[R[9U;"I5JNDJ(HO)<\H^3$W0R4
M<0$VO,!@V$@*K.P$!,'E$+N&X%$':QR%5 ?;7)[AU$6/8=['UXQG\'O*TC;B
MKB5TN]%14^54;GFDM<[RU&D[D,(H8E)!%UD(V&&E6[41M9[;:W[E)LUBXUO
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MZ@E7@R:Y)!NYS&0Y3PUF>1\025%'F$,V3955UOU0-7*E')F'A#1Y7ET>7FE
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MS*X@BS7$?GNJK^]R>@&^9+#3Z]5H:PL08V.'Q!CD[N0M=IGXDJJQXDDE)O[
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M8-&#!HP84L7$$KG) B  "E\;' 0V\H QUC\FX[>?<@EZ]=BAYMM4F;^[4_\
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MG*-F/A?K&3(<C>55A[96Y6LR9D")R*+&:,[BIR'6 ^Z[93MDTB2<<)MTI")
M% $S83:XX.%7E^?U663:HR]/.DR DQF2'3+%*I!LPTW*2#9DE)&QL)&?F"JR
MJ.MC*M:2-HWM8@/Y,D9VN-_;+U,M][8R)\%SEEW=\*SM1D7CIX..+$VBHH[Q
M4ZZS:%F(\'[6,!1414%!B\1?^*D,.R+99)LGRI(ID"%QQEXILSBG553PV%I)
M+"VJ:.0HTAMUNI2YW)8,QN3<O<.5)EHWC8DF"4(MR21&ZZE7K)TMK \U@+
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MS*+@?A/-N(,LHHXTS.JHZ?I*#+JPJ[I!+7U3Q4ZSRQ@Z:4SM4,2ICA95)%?
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MUDDG8[#D+'GL0,> U<>H0LH!CAA6$!0!8)LOD@"XW-S;G:YPN-4T^8$P,3M
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M.N[9/G]-(YYZ8IEFHW-]R 7G3W[DXNZZ05HVX."%\A0%0+T[]S" = ]73;Y
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MU7 QK;\($A-7?A]N,- H*2$I#OX"U),$?+7=MJ]*H.I)-!(OE*JHQ9WCDJ)
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MBTHNLNY5,B114YUU!.8QE#%$1VY@+W]   #8.FH52)I.C!D.F( *H9@HL!8
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MLZH<:3!HP8-&#!HP8-&#!HP8-&#!HP8-&#!HP8-&#"GC 1%QD8!, @6]MP*
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MD8:3/J9GD.J.7IETR*X5@ZM>X9'4AE)%[%=/+EL<6#ZI%;P2L6U1Y!4,!SF
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M)H)\IB,&3]VHT8$<' WD.79D'"R:&W.5NF1=0"IN&XJ\"13(8@;LJAF\P)L
M?.>?=WX<,;B,2D61G**>T@7:WF&POV]QPYM=X;PV9>VPD%.5F E'(-'MN7D6
M<&938J#E_&M2/5&(J"(<CE=J*RK4I@Y5C-SH@;MU$$U>&D571&-C)J"WY$J
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M,PBY!1RW 5RH*F)SE#FYN41VZ[[@(]W7;T:LH':RZ"2NUPIY^KO\V&$ $Q!
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M8=AYS'#8 +T !Y=Q$QJ3-_=H/]F']/48TF4?:K_GFM_(C^6^$.TE4^B:)_\
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M,))Y"VYZNV]K^:]@>O;SG'WB3<7(.X-[C?D38WZ_?^7"TU,)-SB&Y1  $/0
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MDZ9V6R0%-AW=FEZW&/Y)VY13>/08/W3/E:U#(ROY*D0F,Z6O]=0-9R+JI!(
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MZ;J318S5RD6T"A)JM21[=T+A1TZ;MF;MPA(58HAI>0*UXE(/E,.FD6%#I6Y
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MK;%DW.X.NJS:I=LJHHJ1K&HJ\Z9I!T@8Y2HE64)#JJ-)'@2*-8P68R,B@64
M;FP]"@]9Q-I*Z2-*B261Y"$41J[EKNQ-K GS7:V]@<9EP<+%UN'C("$9I1\1
M#L6T=',D V3;M&B1444P$1$QC 0H"=0XF45.)E%#&4.8PV*JJ*J*+*H  [ ,
M5CNTC,[F[,26)ZR<81YK\'_AOB(XLL8\2^:8&A93@,7X4N.*XC#V2,85V]UP
MUDLUZJ=RC<EMG]E<OF4?-UMO79&#9-"5APX50L#IRG-,BI*,WK+TZ23+*X5@
MJ%-#*&%RP8-<G8C<6L>?/MD15<D-.\$1>,O*LAD1RC:0C*4(6Q(:X).KF!L>
M8BG-'@T([+T]Q=31,O*U=+BJO_!%>!CV] 0D$<?DX,IVJS+2&:G"W1I9]*_D
MK ,C.A1@@J97@*IL[ #8$%^7IM9F.NW2M UM-]/0D;>V%]5O-I\^'(JTQBG'
M1ZN@6I6Y>VOPD,"3Y)MHO?KU=HPQHKP6$['Y*BEU^),[_AXIO%IDWC=QSA1;
M#D.-J@,]9(87<"%L.6UKJX3MV-JI/Y#M$_#TY7'L1*R .VT18+9*,F29C\BE
M(8?7?K8E:94T"XD8-:[ZMU4L2%T[\B3CLUX*'ZQ]>:GCIGEZ4V,2%;VC"C2[
M*BJ6#FVY %[8Q3O/@I.(K%D)@N,P#E6M.IP/"*X>XBI%''^)8_'W#_PT4^D8
M-S32IJVTCA[N^;[>1RSLMIM$$]R+6*7?(E2Q.Y9+WH5^H-XT7[-IJ610@C<7
M\(20Z5"QQ*J.-2QLYYD@LJM8\E M?#R5\+F4RH;>!R0C6Y>69GEB<*TJ1+;2
MJD(S+M:[$WQE?BKP4:&.Y7&EKE\^/[?=ZY7N.H<EV!3&S&#:Y)R-QUSM8L%R
MNL9"L[>X:T2(ISRME0AJ<BK8PDFCA,B]@8+-E%GCJTFDJW2$L!/J.FVIY[78
M#5Y(6VR[W[<,R5^L.HA"J32Z ')T)2A@JDE?*+!MVVMV'$'S/@3)N888,K3O
MBT<RM-PKCCA I,7$6?$$K.O8B4X3I^,FU9C%AT\VQE9QI&9E/'(CD.+=5&[3
MPO6T<NQN7N>U7B7G!HB= Z:X18@ 4)L8B#=/K@"![#4+,;]>'!F8!E;P>S2/
M4,2L@ /3C39_K19S&/:G4HY^3??$B9.\$._R,PRW#+<0D&> LW&\YX[\15^T
MX)0M,30<F6B*M,+DNG9(10RG7U<OX[MT9:%6\2PC%<6V&I*,D'2-AEUSG$.G
MI"VL=(+&;IT!2]G((8-9QJ4@[6TD=I.^.(\P"&,]";BF%+(5EL612I1D)0]&
MZE;F^L-V#&9^/\#M.&[A<K^)&RE !S#3LS+2S_%>-!Q)2Y"7M5PFK.]=Q&/Q
MME[<PNXRI&SM1]<+%(2;INM+/Y%1R]5(G-I8Q$ GDFVH[+H7<WV!9K>DDGGS
MPP93/4B3RQ<6&MS*X"H1NP5+\NI0 -@+#'A%G?CR9_A61_"UM?IE3_:\'YF+
MXBX_-&?W>;\[)\=L;'^$_BRRG5*'FZF6_(]+=0V,.'?);[#L!FJ&C;-*PUIM
M*U?Q5,4G$$]+3,%;JA*3%'OEN=FK5:EW<0Z1AW;I[3Y!-NZ<-_,.,>#LHK,R
MR"OHLKKTGS7B;*H\[J,BGEI(9Z.C6ISB"OSNGA@J**MA@S#+J)!554*3JTZ)
M'71%D5O3^#^,,WI,NS^AK,TH7@RKAK-),EIL]@CJYH*JK--E$]#DM1-/3UE%
M+/09C6/X+2S/"ZPN\E%*$=EUEZ]5QY7CZ0G#H CPD8)   1'ASQ@  /<(_0S
M@]@'U#K\O.+/\<.)>K_\RYSOV?\ K2IQ^G_"G^*G#?\ N]D__3:?'>I (52L
M ( 40KT* E#N 0C6P" ;=-@'H&VI\ONLGYQ_C'%.OM5[AZL.'3>%Q<:CXD8H
M+ .P[><-MP]O7^8==+[8?3>VWPX0\O[>7G]'/$07$JW9K<H"'0VW> _KN7KZ
M/Q;^K3Q_=R\UK[>CW]QC@>V(L +WZQVV ZNOEUB^-,G%YPG5;+4VO>(UT]IN
M1T6P()V:+ #(R9&Q.5LA/QYQ*G(IHD $DUR*-GJ20$3\:.BD1 -=P[QG79$!
M1RQI6Y86U&FD)#QZCY1IY!<QL3<Z6#QLVY12=8H\VX>ILS8S*Q@J=-ND475R
M+:3(MQJ.VG5LX'W1&V-;]"O=KPYD0F/LN11$7AMO$IMH8SF*FF!C]@+QJ94A
M1,4?*!PW53(LB8>15,I3%,?V_*JF@XAH?#LIF)"^3+!( D]++8'HY%!-CS*L
MI96 NK=2^09Y05.4S&.LC-F!TN-TE0]:W VWLPL"#MOOC:]1R4^3;Q\G"%BV
MRA@27268%2:[GV*.RB2/(0>??E-S$$X<W?N'6LS&.JTO%-TK @J0]VVMVG<B
M_6#O8==\4]&T0</'I!5PP*BQVW%[^_8CD2;6QE8U0;3T"^A9 B@L92.>1K\J
M*QT3BV?M5&K@$G"0E404,BJ<"*D,51,VQB"4P (86II50.ES9@5-SN0;C8[$
M[<K&X]6UIJIFZ)]_(8,#LPU [7&^UP";\^N^->5-\'$\CW^.6.2\[(Y4QOBA
MU@EK4,8RN.9-&K.J_@&GY$I%57L\#.Y5M]&4OLG"W*MIS]MHU%Q] 2*U!C'Z
MM#-+R;Z33S$>1L#&9J@30P&#HXC"P3131S1IK5IGBZ1ED34\<<2'HE)BU$D:
M^7B-&63H*0T\]2*HRU"SCI ]9+#+)T;K31RB%7CDT1S2S.HE8";2 #K4R=X-
M.%B920Q_(Y2*LG#.L<U.3F*KCU&GNKOCFL4.T5"T1MZ3);Y@9W)>7J_=W1\H
M95(Y8KV&<A(&:0J[$T<#4]9'D&M=+3-8/%$[QQ!#)$L<B/'+]<;5)4)(QFGO
M=BBL(P5QK(\^/0I*L(#/'-*J23:Q'(TRE&C^MC3# R 0P$$*C%"QOJQ1@_!Y
MPAD&1K#=H"WR4O'4Q#)EAL.+F#Z=O\K6.(QMQ 2+H[HUH[*,B;7O(42:@'K:
MPMBP2=<40<@WKWN7)V4/#@:P>59&9(NF=J4%YFCKA6.=72!560:H60B0!=%B
M1'I:LJ.(F1FTQ/&J&8P*E21'"LE":,#:,EFC\F9&!C\HN"+N'5\9*X"YW(&,
M\,X:K,S4U*A0PS-'3=ALE"0L"$% Y'@+/&Q 5.E#8HQHWG*HE/HLZE*IS8(5
MM]$Q<T6+>MF@PBCM7D#/!24J-$(XO"E>22$/H2=)%01Q&5 7B+A8G#D1LJL5
M870PJ7B18JBJJGCE,DPI2D<4Q0M) \;MTLVAO(D"$R)HU.&9"RW#BXLW@\J[
M*;JQMRB64A(6K,TQ:)J:QJRG[ _2RYD>LW]O-PDN2SQ3NNY8Q\UJK2KU#*+L
M)T\?&24RHE5T1?)H-HU3P\O-)5!:6J=V>$,Y%1.DMU;6I6HBT"..;R[*6(C\
MH6D4O$K,;/$UA'3+&JU!1!X/"\)5P8V5Z>4R&62 :+LJ R&Q)KNN >JOGB#F
M>ORCE9I.N9YB^1I#(DI%+JQ'%.S;JPLJXFWJD/(QLMQ(QMFC91%NNHSG,703
MY-OXS(-W$!7'*(Q(#)*;!V(?HQJ6XJU%B6:S*U4KA[&S0J1NP*VJ9M(\9,2
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MN:&<$.A)@U5*) [,\(56,L85KZ6+  VYV-[&V.!35!=HQ!*72VM!&Q9;\M0
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M&&+>&F/K8YI+.*G9-<;*22.?$L@KXH20OQ)B.A JIT(9>$+(6% F:+4AJ99
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MF#ZI@HY1J ?RF\H_ 5'>,7^61Z8"YYR.2#_JKY('H;7V<_-AU"(% 3&$"E*
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MI8FL= RV$TAI$K8.(*3EHJ6J3NY04NO)1$_09MY//H*VKR"C1LFUCH]W4))
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M M:RKI[.K^_N%\(KV-PQ/426N3RVYV[R>?FY8J6([I_&JE054%0H\X% X[G
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M$E2H,C^4.1#L1YR ,)&(>(ZNJ07C$[(%4DC$Y4VQS !^<>@E$FX#S%'<! 0
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M&VT<VZ;#U#;NV'J&I\ONDGY;_&.*=>0[AZL.#7&%Q<:CXD8-&#!HP8HJ^?\
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MJ66^H4TFK4NKJ61Q'&QON&(OY=L9?A6DA?-%-0@)BBDEA4\ND4I9@!N60:F
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M/D&1U$<_%%9$T,CQ,)!DL4JE7J)BH*^&E+^"P;M$WUZ4(HC$NR.ML>Q1(80
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M%3[(AQ*GTY1VV+N(; /0!$.FXAW[AYO9JJEB-[CK]XV/7N!Z+FU_/M<)+8
M]5O?N+]HV^$6/+$.S;&58=H"!SBGL.Y3E$2  [[E$G0 */4 #?;KT+UT(C#[
MFXMML-NS?<]7=Z>>VR'V0<[R!8X0T.94<1&BEK@SF-!L%@J4831#8:5U/&H%
MA&-P8;EVTLY5, )E;E$P[G3.L0N_I[-,@EVV[MBB(]P^D9/0,1S*^;EOV=MM
M^[LQZMEOL_Y/3HHK^&Z[6!8FFKJ:ICO_ *IGAII+'F+EB.LD[X;@04J!N8'Q
MN;<1W$70B(^O=KW!Z-'@Q^_Z[XN__2-X7 M]36<6[!+EX&_.WU_:^*X1<V
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MZAEI,ICIN&J.52C-0NT^8,AO<>'2JIC)7KIX89!OY>,QJG6"M2)?4P "E(4
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MSRZAL =^NP[K]QZ@,.M)5  Z+); &P?5">WT^S3!N3N+$]7P8[&P._>?3?\
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MNC;VOP']Q^'S[G;"%AV@^:X^'L^GGLXXZC1J(EV\7';KU.F;;[8A\NPCMO\
M+I=)[".6UO1\GP>;"%[[BVY/=Z-P._?K'/$E1->8MP)]40+MU >T3WV[MN_^
M8 \X]!#2<N_LZ[CMOZSV6. 7;?S6ORMR[#<GW@-^8(P^VB;1 H$(JCT#S*$'
M;U[@8?D[O-Y^NFV).P!MVV.]_I]+[]*+<CMU?ON.=^KS6PH@L@  ';)=?^D)
MU_\ 6UQ8VO8V[>K"WZK^CZ>C'/;H?LR7\83_ 'M%CV'WL&#MT._MDMO3VA/;
MZ?1UT6/8?>PEQVCZ"_JW[L<&<(;#]62[A_SA/][0H-QMUCUX&(L=^HX3&!4&
MK8$Q52 QE%UC_5"?"7646$!Z]Y0.!?84-2I'UM?L5%'<BA?AM?TXAPQ]&FGK
M+.Y[W8MOW @>C%WXPA^SH]>[ZH3K_P"MKC#N.>W0_9DOXPG].C!@\80_9T?X
MPG^]HP8.W0_9DOXPG].C!@\80_9DOXPG^]HP8.W0_9DOXPG].C!@[=#]F2_C
M"?[VC!@[=#]F2_C"?[VC!@[=#]F2_C"?TZ,&#QA >Y9(?_.$_P![1@P=NA^S
M)?QA/Z=&#!XPA^S)?QA/][1@Q92$S#Q+8[R4E8V-:) )E'3]\V:-R  ;B)UG
M"J:9=@])@TJJS&RJ6/8H)/O#!BYIT6YMLY'6MRT>,:U7C/SUY&1;*-'-BF'S
M-6,-8TVJH)N$(!C$/))C$"\(!I]>5=2I&39A%P<E-5F952)&U+&RO))I,S(;
MK&JMK$-QL9&=4:33[F$":BSR)'=Y91.'%3,I4*"(4869BPL9"#NH"EE4$7;4
MS6 "%H"R'_CO9_X6<_.&M)EGVA2?F5^7&:S/[?J_SS?)AFZG8@X4H;XXBOX2
M8_A26FI_<)OS4GQ&P[![O#^=C^.N-AVO-,>EXM7WZB>?8KC[R?72>W7\I?6,
M(W(]Q]6-.=[^.;3_ .>^]N-;VD]S@[A\5<9>;V\O>OR8B9O^D1O[MS^$!J:W
MW?Z.(YY>E?6,2"\_5G_^#_[P;4-?:#]'U''4O-OR!ZVQ'#?]1#_")OO :FMS
M/Y!]>&C[0_H^I<2#_F(;[%/^"HZB+SE]/QI,/'VD?Y(]0PQE/TV:^R4OPI74
MI>47Y/\ ](PUU-W'UOAWL_B>*^RB_?G&HWW;_D#Y<.+[DO>?6V$&3^,GOV"O
M_L-M/I[1?RE]0QP/;-^CZL7L1\4.O:7[\VTRWNB>GXK8(_:M].M<4Y;XU8^P
M_P!Z>:<C]S/H^,<+UGN'K;%& _27W[PI]X<ZYF]LGY7_ )F.8^8_(;UG'$O\
M"+_=)_,WTXOW7Y)^3"???I__ $XMX/XR<_\ GOOQ-<S>T3Z=6%7DO<WK&+]W
M\2-O:7YUM$?NA]'Q3A&]HOH]1Q9D^/A]O_NP:5O<3WG^DQWUGN'K;"FI\72'
MV4O]_)K@\X_R1\08;?D.]O7A%/\ JR*^QVOWQ378Y2]\OJ7';<Q]/NEPY0_5
M$K^\(_@A]-#DOI^.N >V;]'U8:SO]1Q_[IY]_2U)3F>Y?5A%Y+WGU-AV$_5Y
M?X-+^$AJ,OM&]/J&%^[_ $?EPV'GZC5_A$WX,.GD]T'YL_'.!?NORC\F%Q'N
M@_WI?\%)IEN<OY7_ -1QROW'Z6+%Y\.7_=M?PD=.+[:'\EO4<=-[:7Z=1Q>L
M?B^,_A!+[XKI)/;M^1CM.7Z8];8[2'ZI>_P:I][)H3VB_EI\8X&]NW<ORXLF
M/Q4\_?P^^-]=2^W3N/RXY3DW</4F%I[^KFO[A3__ +::7VC>GU##C\QW?*<(
ML'\!]^]$^]JZD2=7I^3#2\S]/NFPJ.OU+&_N$OO*.F%YOW_*<.MR3N^083(W
MXW<_NG'X0.G']R3N']&V&A[8^GU)A8=?%B'[H/OSG38]NW=^[#I]HO?^_#>1
M^.1_=_\ NB6G_P#)_3[[#1]L/1ZGP[3?%LA]E&_VT-1ONT_(/R8='M&[_P!V
M-G_#M_S7Q/V;)?A ZQN:?;;?D1_%QHJ+[77O/R8G'5=B7@T8,8;<6/Z56OW#
MK[\EJ^R3VTOH]6*W,?:IZ?6,:_WOQ=)?9JOWQKK51^V'Y(]38HGY?IGUKBP1
M^,X[^#R?@[G7+>U?\X_K7#?6G<?4,7R_PYG['1_!5M*O).]/6,'6_</4<(J'
MP8/[(5_#$M=R<G]'Q3@?D._Y#AR_^% ^P!_""Z:7DO>?4V!>8_('KPR3?J,?
MLL?O6GGYCN^4X:P\W'ZM9?N7?S$TP.;?E+\;'?4G>?6,,!Y^F2_V6/X0;4E.
M2?D#U+@;DG=\@PY@_4D5[6/X/J,?;R?I^O'/4>\>IL(3[XSD?L<GX.CIV/VB
M_EX#S]"^H8OVGQ(C[1_#%-)_G'T^\PK^YGT?$&.DU\=-_L4O_O&EB]S;O;XH
MQSCO7_BEQ[5OO"6A_=D[AZVPO4.\^I<*,O\ ^!/WLG_NVB/E)WGU''?WOZ'_
M -6.M>_5,K]E!\Z^E?[C\D__ $8Z7[K\H_)B^DOB1K]D?_ZNM<Q>V_1/JCQR
MWM%]'J.$R*^.WOV,E\Z&NF]R]_\ ^K"+R?N^0X6U_B:3^S@^^-=1Q[JGYL?+
MCM?<7_*'K7#<:_'<3]A#]Y<:E'VK_E'UC'(]LGY(]1P^O\W-?8W_ +NMJ&W.
M'\H_&7$GK?N'J.&,K^J(3[./^%):F#DWY*_%PR.7I;UG#^9_JP/L$OWPFH<O
MM#^</J.'EYC\@>O$>27ZB'[/)]X'4Q.8_)/QCAD<V[_D&'\W_5+#V.?]@^HL
MGM9/T/6,.K]Q^EAHS7=,?OI?PQ33\7M8^[_Z%PV?;MZ/6V%Z-_447^^LOO".
MFI/;2_DMZL=KR'Y8]6+&<_5LA]A*_@S?74'N:_E#XS8Y?V_H/_TXZ0WQ('_5
M_"5M=2>Z#T_%&%'M6_1]>%*9_5S7]R;YWFFX?:-Z/4F"3VR_3J;"5 _J1W[7
MO^VGIR;VZ?3KQS'R;\G_ .E<7\C^D,/_ #7WU#7,?MG]/J;'4GM4]'K7%E#_
M *O=?OI_]A?74OM5_)/K3',?M_?];XR2X<?^<" _?7'SAJGS?[6D]'J&+++_
.. '5?3\N-GNL?B^Q__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g904779g31s50.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g31s50.jpg
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M=79WD[2UMKC6&#&R)#(S-4%#L24F430V1'.A_\0 ' $!  (" P$
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MWFP/@J. . . . . . . . . . . . . . . . . . . . . . . . . . .
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M\%87S(YV>ZDFZ4FNX':Z-]-8_3T33JWP\^5"K;LC-45L(JY0):<-#X8$&,G
MC8W&%"*R3?.- \C]T>BBS+17(4J\0;KX2A]'Z&72ERIO.'.#3;SV2_[9-/'A
MX^K0\^OV6Z9_37KR3+5]O2^%]<27^-SZD[SJ_P W]-?UG23@3^^TRH^EG\7(
M\P?]>O5?];=&<"?WVF2[KA_%H_(9]N:E/_FAN!+[]#X+]4B60G^+#7!^5A&?
MJ'J[@2^_0^"_5(FE@?Q7NC_RII;]4-O\A]8^GZF/^-_R_4;:NB/E W\5/@*Z
MBW;I2&M[9G_9JYZKS&=[(S6.!.'LIMJ6_'?C.('8.7V4\Q3X?\,^%,_7]_\
M>OB&ONONSB2DH<]62SC"3Z9[(KO7>9VWIW(V\@'CHZ:=N=ZZUJ;:VYM<&V:_
MUEN9U@!\AII,:UQC$JS&8?DK\4Q#L&L__;@[W+)'X=_VOW3WYSW'@[\)O/T%
M/^\9](_T;(\NO\31SG&DVF_3K=Y\_>0':+\"_H)_,US?YAC7.<TO\=:]\.T^
MA4/5^ O?/\+OZSPU_!WI$=T/P<.@']3DB_Z(-QHOXQU_]=AZZY7P8^[7PO\
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M74;;&C!)]E\L#4+8W=;)8?X0T223!PBJL8X\EQRUE]?*[<Y[$1\Q\LGD*&>
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MZ,Q&)1UDD."@ 0IOHV8CF#1'&-4TD4M,>MOOG==PKLHX<JK.%55=Q7KU*RX
MX X X X X X X X X X X X!K&O;N_>/77LN:K$GU MJ\:AE<.K]Y24JHY6F
M1\G)3S?>5)V=#C+&W;^KS>2X&MD(40C^\2C[==AJ1,-"NI#7X>[T%E'*SS)8
M>^<_)T3\_4V<:YSMKKMG7.N=M<9SKMZ/6USG'I]7;T9SCTX_Y9]&<X]./HSG
M@J>\ < < Y?/,=^&/8_Y![R9?X1GD2Z/T/U%X]'\.'JF<VWAX^K0\^OV6Z9_
M37KR3/5]O2^%]<27^-SZD[SJ_P W]-?UG23@3^^TRH^EG\7(\P?]>O5?];=&
M<"?WVF2[KA_%H_(9]N:E/_FAN!+[]#X+]4B60G^+#7!^5A&?J'J[@2^_0^"_
M5(FE@?Q7NC_RII;]4-O\A]8^GZF/^-_R_41?8K^+)= /M[6U_=NQ7)$?OT_@
MKU1-N'5KZAWQH?TT[/\ ^H6Y^=QX._";S]!3_O&?2']&[W0\3_%-G_%(S-[1
M?@7]!/YFN;_,,:YSFE_CK7OAVGT*AZKP%[Y_A=_6>&OX.](CNA^#AT _J<D7
M_1!N-%_&.O\ Z[#UURO@Q]VOA?\ VELO7JI#][?X.>C'V4(!_@X;DZ%^$:Y\
M;7/TYD^"7\=>%?\ \0M8_B[LC_)!_P":]7/LLUW_ 'DORG#?35?C.OZD8_ G
M^#\>_M]K7T+8AO)I_"U37V9*O_Q:9\MPS^"7OQG=?0H%_ 7[G.)?VYUW^'TP
MG'D<_#)CW]$JI_ZM^5X>_$U3]+=^MFOX%?>TO/C'B#U(B>ZWUDB?],J)_P %
MA'*Z-[FG^@O_ *=<Q>"[WDI_%O%G\3JATM<\V/A\< < < < < < < < E$@:
M%R $VPCYA./'GH@DT"'UAB1I$&7<LED1IA4,NX:(%DQCW=%[N,6=-DG^J&6J
MCA'17*FH',+7<;&0SR)QN33N60>P) *[)BZJF_;<1X?:#@\.DW8 FW;(/*D_
MXJ!]KEK8CMAG7!!"![S]E#"<=9RU_I%U91N4VW9\C?M:^;Y.\R-^3CLQE1YF
M\>?'3SXZXW.EFS4;$<UU.6U1NXFPM)S$S[>NR$[2)N(6.F:XQRE&R$J:ADU"
MST P+;M795B.PF\?,T5FB"[91;5PE)C])H#+^)/MO**=:BY!:'7Q6_91'^Y5
M:W;:;]S:4GQ;4?[QU-6U<6;=!M9X%#K-[8@^]9QYI7=>APX2L6$"$@X,/>QH
M<+1WP+\ZSTVRFEW<N<+JWC=[Y[<DUL/PK6/.5[;@B%SP<14*[?M/+Z/**!I$
M1L9"T>SD9I48JRM)EG+2/.() S-4$G:2L=)KF98.D[-JNRCRL>]H6!2QNUOE
M9WPFEG/RMOT>8S?JGQR1>0UW/V?;Q =-Y[:?96UNS)X;3]CW-7T)A\BL=E'(
MVA&8\;C$F@$JE0P7%(<!T7?R=DUU=&ERCQL'8Z*)YV$-],=BQOA_^7F[EVGZ
M\3\0 5]15\02*-7+&,0SOQWPB\>9/2I<Z\:! /9NP1@QLZ-R!^4.EW"+)LBF
ML2,DB!1\IKLY?O'+E15;<)?D_!1L^X*C@#@#@#@#@#@#@#@#@#@#@#@&.4JO
MA8@?(UY1L>2M6PARV61]]J^W'UE7+G;&,>M8$U00=HZ$6^-LJXA<;1,2YSA/
M;1=B*;[_ !!/D:5BHPC<7U1VMO)<U./+S7-PEV6]%X?*^GCJCA26=I3?DONF
MG\)QHVE#6>*KR6@:/7CXVSHNDJVNZU!=FCZ7.=.3H3QR_=2]E;:=3<DX5;B:
M\3*)A5#HMY"RL:W)"K;5I-,[+"RQ1CHPAT"V6]'M&E90G"SH?&M=-<:(*2%V
MJ5F1+33.7\@W24RU3BM?-TY6]I35I:M8E",G*M77?<UL*55OKXM*%&.<1IKJ
M\>I\62G9U=%X=LUP]H-3$:]O0JNMJ6KJ+VJ:[JG+3K7S;;E&SIQM],H-I4;-
M2CXQW:G6(5F$3'%DI1M>NLQ60XGR,R0'.8@M"LB'F)2E*FQC140XC:@+W_0X
M@434'*B\NDWVF[;977/'G3_0<JOC7L&LNRP7L-UF\9@F"4ZC+^SO9>6]I.X-
M75H&KB1UAU1F/9.XR76VN*CW5C (L;LZ>UENY85*Z>,',2Z\05(N729MY>R!
MQ;099Y33GE^3'";SEJ,>;._3.<][^5KJ(ING:VZ_UE#J>J&*#H57<$$I!HY'
MQNJFR:"&%%'#MZ^>.5%GQ<V8(+NBY\\5<O#!\V^?F2[UX2?.G*HQ-YW9<S@#
M@#@#@#@#@#@#@#@#@#@#@#@#@'*;Y>@%7%.WEF1XR>H*6RVU>O=0PUW*+"ZY
M]OKTOCHJU%R"QW(>UNMY;KI2EIQF.2V4[EGDP!@S<OJ0_O-(>*-$C!N*N=&C
M>']MF_49(O$>U++Z-)2Z;/+73MZ[/&.TZJVJ>4FK9+*RSG*:"*>7#CU?>'&=
M$]=<K+^KHEK[97T>NKZJ:>OK[;>C33'HUQ)C/OP!P"V46NNG)S.9Q6$*MBMI
M?959;LT[(KZ,3F,GIM -R.,Y8:32*BR;HY%]GF,9]UU-L665\XSA/&V<9QP3
MAX3P\/H^QXZX]!SD^8[\,>Q_R#WDR_PC/(ET?H?J+1Z/X</5,YMO#Q]6AY]?
MLMTS^FO7DF>K[>E\+ZXDO\;GU)WG5_F_IK^LZ2<"?WVF5'TL_BY'F#_KUZK_
M *VZ,X$_OM,EW7#^+1^0S[<U*?\ S0W E]^A\%^J1+(3_%AK@_*PC/U#U=P)
M??H?!?JD32P/XKW1_P"5-+?JAM_D/K'T_4Q_QO\ E^HB^Q7\62Z ?;VMK^[=
MBN2(_?I_!7JB;<.K7U#OC0_IIV?_ -0MS\[CP=^$WGZ"G_>,^D/Z-WNAXG^*
M;/\ BD9F]HOP+^@G\S7-_F&-<YS2_P =:]\.T^A4/5> O?/\+OZSPU_!WI$=
MT/P<.@']3DB_Z(-QHOXQU_\ 78>NN5\&/NU\+_[2V7KU4A^]O\'/1C[*$ _P
M<-R="_"-<^-KGZ<R?!+^.O"O_P"(6L?Q=V1_D@_\UZN?99KO^\E^4X;Z:K\9
MU_4C'X$_P?CW]OM:^A;$-Y-/X6J:^S)5_P#BTSY;AG\$O?C.Z^A0+^ OW.<2
M_MSKO\/IA./(Y^&3'OZ)53_U;\KP]^)JGZ6[];-?P*^]I>?&/$'J1$]UOK)$
M_P"F5$_X+".5T;W-/]!?_3KF+P7>\E/XMXL_B=4.EKGFQ\/C@#@#@#@#@#@#
M@#@#@'-B/6JS[[D8A_S*RKL%JK?25BOW?5>[>P\CI#KM;K<&T%C+;[A==I$P
M8=:8=;XACAGLZF4<L<K)'A#1I)4*J1EV,/=ADP^3.<;=J66L_DOVV&^NWRX.
MD[@QC@#@#@&N?QI_P<]H?RC'D(_U563P6E^3\%?6;&."HX X X X X X X X
M X X!;ZQ;2@]5"$3$T-:#\/W.!X,0T;N2LDDY93&/8!8M'!J3HS(2[C;.N$V
M(MFY5UUVRLO[%MHHMIGM[:M=2<:,.;E7-4FVH4Z4.V=6I)J%."_.E)+L67L<
MQHN@ZKQ!<RMM+M76=&#K7=Q4G"WLK"V7M[J_O:\J=M9VT$FY5KBK"+:Y8<TW
M&+LE\FK?OS]^GRABDJD<?2E6X$KJWM>:L-_IUTL*8!W*B<&$O$?5PYA\*>K'
M5$5E6Q>7MO2N*QO>-M+':WY+V[76YJ0S:T)?_IJ4TG6G%]*U9*&4G"BUB;[3
M[.X<X1\G2(VW%/$4'Y6MW=NY\/Z76CU>C:;=04M5N*4\^+U+5*4+6,HQJ6VG
M3\BX>1L5B48@P =%H<!%1F.B4,-QP8*R08,&J?ISMMG1!OIIKLJKOG95PNIZ
MZ[E?=1=PHJLIOOMQU6K5KU)5:U252I-YE.;<I-^E]BZ)+9+"226#I6H:A?:K
M=UK_ %*[N+Z]N)<]:YNJLZU:I+HLSFVU&*Q&$%B$()0A&,4DL6K_ .\U&T'*
M&=6Y7E%Q]A3;/#V,=:*' [V5=QEJIC3*)0G&ASEN-KV*;:J845GEIG(/!6R6
MBNZTCUV3]GG&:BBWOLEWMI+]_7T++,<#U"]P.Z0,TS[?SAEU-ZV2(418'NJW
M7V5MS5ISB(D6:S4L"[!]H<LV[<*'*#=W#610:@!(-'W!VZ'.;DD;#97503E+
MIN]L-KIZ%NOE?S)F.?@EZ;=:NK-<=K2M'LG&\CDO;_LG5ATP4E.TE+*5KUU[
M VU6=,"<8QMH@U:-(NW<D'!!-JFYD98H^).W3ANF-;#Q:I)R:R^D8_.XIOYV
M;X>#&. . . . . . . . . . . . . . <T'D0TG\-[Z6',69Z^QT:EU&T@&
M$Z]?O(_U&Z1.M7L4+VDN40G4%MF<1^9V!OKF2-G,:FY=GHF/;NBT;#Y5'M/:
M<&2/3&%U?6+?8N[IV_N\QTN)?2FGGZ?^YI_WML;[?]W'_/?7TXWS_P#G;&?1
MMGZ<?1G@QG[X X!H1H'QX=B!W8.X=9Z0.TS7^(1Y#H3'NQ-.66#'W!9"O>+M
MQ&>Q$+F,6V0'E"T$E5+Q4"Y"/",R&KY0F;IHM%FYL$FY?;"[DFEV^TV?9RQP
MUZ&]_DW-=5W^*$9*?*;2W5F;]]_([/HI;?1/L(2E4[FO86.2"S]8M\LX[%C]
M5,9 \K#83K5DT&EW.TRB3^//TSCC1#95VFAKN@H)4O)?DQVE'&WFEU[\8V]+
M,L(/]S =1*SBED02N^WWD0@\+N$.PC]KQ2*W34X*/6.#%Y([#1$V$CJ%;L9*
M-89+E,M&99%T@WR1>^RTU]Y6]<'5D\9Y7AY6W1GYBOW+[U"@T!L.JX;V[\AT
M6K2V]06EHP$!=%3"HA8>D8=JOXYK,H^RH1$9(M03Y=9V)P5;.L,'"JBS;V>^
M^VV0=23:;QE='CH?4#]S"=2(M5TXI&-=P/(D!IVS"(<O8=7"+JJAA IN4CST
M>2!$93%6U"IACCT.0$BWHUR19N%6;H>S70WT4;);:@ZDFTWC*Z/'0_(O[F!Z
MB@ZIDU%!NWWD0%TO-)"PELNJEA=-3M*^DTH%?#OADA.Q)&A- A0RP^$"O="+
MQFLZ;_#F7LE=?=D?4#QDLJ6V5LGCT_S9^&_W+[U":U(^H1MV[\AS>D2<STL4
MC4J-T5,G7;Z>ICF8C29.HAI0F :\FT%#V([4THRV(89,VS;"_LD4]=0\9+/-
MME='@_;G[F!ZBO*C'T$[[?>1!S2 F8;V",J->Z:G5KH?.E&+X8I+V<0WH7()
MO)-QY(@RV,),M7^S5\Z0ROE-=378/&RSS>3G&,XWP>E/N8/J.;J:-T,8[@>1
M$I2D-D;V81.IW]U50ZKR-RLE@IJ0D82(K4+N#&&GNILQAT2:,DG:^"C_  HK
MM[TMZX>,EERVR]F\?;N16HC[G*H>/UU%*A!=]/)R'JR"."[J%5T-["UPSA<4
M<GR;\T<7C\<;T8F*$K%RY0D3(J,FJ.SM\_=NE\[K.%=]L]"ZN;5RE;UZM"4D
ME)TJDJ;DD\I-Q:RD]\,Y32^(-;T.K6KZ-JE]I5:XA&G7JZ?=5[2=:G%\T85)
M4*D'.,9>4HR;2>Z62>E_N?*JI !C<6.>1'RGEXW#DWZ44 D>RD">"8VF4527
M))A&"]([MANCY9!%5WJT32PNHDGLIC;.FN<9(7][3J5*M.[N(5*SBZM2-::G
M4<<J//)2S+E3>,MXSL;EMQCQ39W=[?VO$&L6U]J3HRU"[H:A=TKF]E;QE"@[
MJM"JJE=THSE&FZDI.*DTL99Z>^Y]*KE(J- Y)Y$O*@>#0UBJ,B8LMV5@3]A&
MQR_N^%F(1JYI%1$:T5PT:^T0::))[^[H^MKGV>OH4[^]I2JSI7=Q3G6ESU90
MK5(RJ26<2FU).3\I[O+W8M.,.*;"XOKJRX@U>TN=2JQKZA<6VH75&M?5H<_+
M5NJE.K&=>I'QE3$ZKE)<\\/RGGR1?<^552YK'F,I\B/E/D3.)!FT=B[4SV4@
M1%"/ 6>B:30,&2=4BKH.&-DTDTT&37"3=+1/371/&-<8PIW]]1=25*[N*;K3
M=2JX5JD74J2>93FU)<TFVVY/+?>++C#BG3JEY5L.(-7LJNHW,[V_J6NH75"=
MY=U6Y5+FZE3JQ=>O4E*4IU:CE.3DVVVV?J4_<^M6SC<0I,O(GY4)2I'P[6/
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MAIYQQ]OMZ3)GR<;XQC&/)^%G/7T)9?:=1DGD8B'1N0RZ0N%F@"+ RTC..VS
M@5<-1 -@X)DG" L0U?%22R+)JNHDP&,7A!YOKJW9-7#E1)'<8S52=\Q%(!Z0
MA=X,Z:[!G1TP)]MGB\%;QB)1ZQH?6'2.3&@'82U9E&IW-8EL'&Q% 6R(:PK1
MRZLATY/# .L4T-)$VK!]?VW^V?WEN1YQM^3OOCREE;X[?F\Y'2SS%=9X5(;9
M;'8G;>(#6H&Y7<>MD<'AY"(7#,* C];R&T:TK<:E-M9IB6C$;6B0P$ZFL7A\
M4DYE*2-!DCR@ 6=N'V^WSCE>VZZI8WVST;VV7?V[K8RAIKNW3EFP([+YP\1Z
MZFX=:DXI*=P&\Y;7,=/Q:SZ]49;R".8,A9G((5)--Q)4)(AA**R<RS> C8YR
MINV<[.6;80U@LSXO"XF05)V/.@2@XV$,^0KOZ4$&!#UL2%%1C[M'8SEB1&D&
M:JS1\Q>-E4W#5VU65;N$%-%45-T]]=LB9?D_!7UFRG@J. . . . . . . 6&
MG%_1R/'UX%"1!>VK42TTRK 8-EJX5!86].$7<]DKI5&-U^,SMZF=EI&_0).$
MML;"1!57.J&V]0L*E2FJ]:<+2U?2XKY2J8ZJA32=2XEUVIQ<4T^:<>IVW2^$
M+V\LX:OJEQ;\/:!)OEU?5?&0C=\OMJ>D6-.,K[6*Z64H65&=&$EBYN+>.9K"
MCNDW,1KKE8-P]L5)E-XB#:--T*)Z\ IX: QA9^Y3:,Y1(G,-CIJQK'7AZRB,
M@)E70D-"0Z ]R1<QE!JWW(:[]G?6MG<4_8G]0HO^LO[FDZ]:<5ARA3H0YH6\
M*BS!\OC*KC+RJJ6R[?PUQ7H'#6LV<>&N72(4YMWO&'$%B]4U6YHP7-5M;/2[
M55[31K:]BIVTE0C>7_BZB\;J48\T%:WIUWWZ:51TIJ>7N'4GKMK,W>XV!0$E
M!;,>73V+F#@&"+/Y73%0/8DVM2S \P<%$-X^4B,4)QEN.U;IX+M1C%55MJZO
M=*\OJMQ&X]D0G][EXN5+Q=-2DH4N6:3S".,R6TI-O.<G7_"1K<>(^+-0U:EK
M"UFWN'BTK*SK6$;.SC5JJTTYT:].E)RM:')XVLH\M:M4J5'*4Y3;O'[7OYW#
M^A!-]XYNO1#_ /D.-(G/^\L]"K>GT^Q:Y^5%,]9$23%?Z-W6;ELH>JG]+6!E
MT_2AQGV^WV9T7R8]TGOW\J[NYOYDO3DRKZ\=1: ZN,S>:C@R3*5R]71Y85J2
MHJ7GERV@5UQIG<O95LS%Z:GDS>;K:Y711,'%QHS;?9 ,P&L\)MM!#;?\ELEZ
M%]L]7N9*<$#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@&F(Q1_A2Z6-F-4
M=DG'0YG8A@E.K,6+]L1_63:Z)2VLNQYA-'!<P]E4>#'"P)B8,E(O%B#ACLFD
M#CS,/[\_<B73C87\N6Z4FEA;)XV279YC<WIZGJ:^S]7U/5U]3U?1ZOJ>C'J^
MKZ/H]7T>CT>CZ/1Z/1]'!0_7 ' ' -+MK_7T]1OR>?8[];$(X++VDOA1]4S=
M%P5' ' ' ' ' ' ' ' ' ' ' ' ' ' .);O+]?&V^TCTZ_RI17/M'@CWBY?L
MYQ?_ !6N'DVK^[%?K^E_W=F?7L)]?Z ^V1UD_35/RO#_ +PEQ^R'$W^JDWWN
MTA\::=_E3U_]?\G]L<;^D:\4_>$?[(5/\0E[M%\:0_PGG7[Z_P!/?;([,_IK
M7XX@]X2W_9#AG_2A8^[2?QIJ/^:(SQ]_7K&?Z\NXW^6KFY3P@>\?;_$O"']_
MI!;1?=C4_7-5^A=$)XF_K@RG\^]EO[C+N7\*OO14?T'#?T[0KPU[IY_"O_54
M)!X6?K + _J;OG].-YL>&7W V'QOH7JJ%>%/QW<?JM[]*)7?W.G^&Y9GV7)Q
M^M6E.:'](;W%Z9^TUG_TO6#)P/\ C>O\7UOXBU.T?GQN>K#@'.K6B5Y0/R'V
MF#>E>] &"3;N45EHT#5LQZ%B>I1>+'DHRA\1F<%DY@GV3::%%V3S>P=HMEM)
M)8^U<RYH,&'9 09("^4XKVN4NWGYNO>O)]&>BVZG15P4-15G>)&%V#6@ZOQE
MZ6%"'B<H[U_'96'CL1)$#E4>0Z<2"8]@*NU8&V;UB*5RF5$C(=-6N%"H%6.M
M"2P\BH[<M>"W-OG&=HK'P4DGW]GF)%,?#!2LW,VTU*VI8K2K9T'O96OZR%,8
MNU3IRPNQ<?K '8EA@)8L.=&I(Z:JU0#,0^/R9-V'!$#,GU?:FVC\>W$@I-8V
M6V.O:DV]U\O9CIW[F6=.]#Z@A4!DL8N@3$.T$JGMR3^^YW,[<J^ D&Q*S+$^
M&LBQ.-PY<22"0X<SCH&.QL>P&[KN/AP=)1Z0>.5UE-A#?3&V$EMG[;O<MCXM
M@(.+T]V*C49#"H[' 'D&[]A@( $.9B @0.-[0V*S'"A H>BW8C1H]HBDU9,6
M:"+5JV2300232TUUP)E^3\%?6;+>"HX X X X X!:NR+F@56Y'LI$1<OI0<]
M?6,0*,,',DGLJ6U];'LP$5%ZK$W2.N^N='!1=-J%'_\ B$R;)'&RN-JWLZ]S
MS.G%1IT_OM>I)4Z%);;U*LL13WVBFYRZ1C)['/Z)PSJ^O>.JV="%*PM,.^U>
M^JPLM(T^+QO>:A7<:%.33S"A"52ZK=*%"K+$2U?R7O&ZOWV>E7E$5PX^G6O8
M.81<VM(6>W_)*:V..WW8PU!?777W@%76S@KHFJHCO/,9]=OC:\9966U",;ZX
M3_"*\&K6#[Z-O+$JS79.X2@VL^(Z,Y_V?PKPOY.D4*7%FMPV>L:K:RAP_9U%
M^5I>BUTJNIS@\\EWK*A;MQC):0]I%L)YVTZ==/7;.BXPK\H[952W>ANLO7.(
M%+=O<XNOA+;8L7@<)0*F@J9#UM5GL^M!]&X\KG55T7E>GJ*K8T:]Q6N:CJ5Z
MLZLVL<TY9Q%=(Q72,(YVC%*,>B21U35-6U37+N=_JU]<7]U-*+K7-1RY*<?:
M4:,=J="A33Q3MZ$(4J4?)ITXQV-:/DO@'DC[Y=+KC@2-,J=9JKEC()J.J&(K
MAK^[D6JNQD(PN $R] #:-7473<$=D6P]>?CQ=C7=(L@F9!KJW]INJ(=X3CXN
M,6G[9I_\O;TVRWT:>%A_.7&\!O049TYZ@A75DTY)(?V@,&#C6PY5:T%A06PF
M(IQJ-(,H)"ST>EL](+5 #<.'.H;#@Z%V/2/:2R)U#P.Q%NTT"I+FDVNG8OKQ
MWOM^OJ;W^"@X X X X X X X X X X X X X X X X X X X X!S<]M<=@2'
M9^5WC2%4]SH/O9E=PV(R\,-\<76SL@Q<N:CF%H1P(86EUE=C8T5%/B[!^L68
MBQ0U >ZAQ*($WVVY-PJU'"ZQC#P\=,R:ZI>;[/)TAI^GV>GK>GUO4U]/IUQK
MGT^KCT^G7&<XUSZ?^>N,YQC/T8SG&."A^^ 6PL>[:8IS:/:6[;M857O+GC@?
M%-+'GT4@^TG?M,M,.V,>UDY87DT\:Y(,,.&PW#E9'+UIA337+E'UQ.&^B;)A
M';7JV7S"8U[$[*@$HGU=[L4[ @\=F4=-S"#;DT]E1NDQC(TBY-1G<@EKLHQU
M-,F67:>NV[?"FN,YX(-3EK_7T]1OR>?8[];$(X++VDOA1]4S=%P5' ' ' '
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MG><[ZJZZ?N.22WF#\E+$H],[[2[VSI7X,8X X X X X X X X X X X X X
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MPU&+>U(Y1 _#U2\L"3&1S*J-CF*K:J -'I.7Z"=[NR@6]]9F%$!.[Q.J\.<
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M6IVU<^-SU8< < < < QT[<=@V75/K5<W8A]&W,RUJF$$9*RB30@F(5DYK&Z
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M7K"81Z.N]M"Z 8HLU5;-UD=M6:OK;Z>G3&W'F1IKJC)/@@< < < < < < <
M< Y</)U:3&E.\%HR^"2N6_*$O158J6L(">-RKNVD?C;>NP5O3D:2)VK:G8NH
M=(Z4Q7+.5RDX#$#=8^'A<8Q)#C[7=J1=MADCAK&^<]D\/?"Z<K_\SJ*0WPH@
MCOC;7;&Z2>^-M?5]7;&VF,XVU]3;?3U<XSZ<>IOMKZ,_N=ML>C.1C/KP!P!P
M#2[:_P!?3U&_)Y]COUL0C@LO:2^%'U3-T7!4< < < < < < < < < < < <
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M<2N;2-95)TI47XRJYQY)2A-X6%OS4X[Y[,8W9M#YY\<V. . . . . . . .
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M646WC#6V>CZ8SG'7?L[VTB^-D][.M],V]4E%VW/!-?V-<%46#<H=B?,1]N&
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M';UOHP;.41K,0\9V6%W9S^_8O7P0. . . . . . . . . . . . . . . .
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MS#BW[*X ^9:G/Q35G^8<6_97 'S+4Y^*:L_S#BW[*X ^9:G/Q35G^8<6_97
M'S+4Y^*:L_S#BW[*X ^9:G/Q35G^8<6_97 'S+4Y^*:L_P PXM^RN /F6IS\
M4U9_F'%OV5P!\RU.?BFK/\PXM^RN /F6IS\4U9_F'%OV5P!\RU.?BFK/\PXM
M^RN ?KYF*>Q_RJBM?S%B_P"RN 7*X X X X X X X X X X X X X X X X
MX X X X X X X X X X X X X X X X X X X X X X X X X X X X X X
MX X X X X!H6BW?SLZ%[+7?U^B<3B5WR^P?(K=_7FDVUG3U>K(;54)JKH[5G
M8SW)\8B%93HX8&JD]I@JFDL(=EEGYA-IDJW9925'"_*N5/./)R^W+<Y1[_,C
M&V]_,I?UQ]0)Y8_6BL8O3[V*=2^JO86RYW*[73UFD$,]G;4+0N/QJG(J\JPS
M';1: =X.?;2([*"<'U=-SS!F*&)R!%!@_B3PF_M]L_;L)Y$GAO/E2CT_-QG.
M^V<]F2_Q[RSE^M:E\F+1@4NG-?M^S/?"EZTD92;AB!=U>E"#(O**9ZY@!,=J
MN+-1(&[0RDS&URJ7(S"5A3\:6$ES$NR5:/&DD<N>G<F]NQ[-O?LV^1YV294X
MCR'W\%[ 3?KX,JX3*KXL#ME%:3CL5M*[6@"C*LV!=":[[26FR!S>&T,^F28E
M%TJ=!1827!STW*)21?R;X\ CV&\/%ARK9YVY<[+=^6X]&UOC?LV73JS'WKUY
MB;2A_3$W/K8AK"W+ K+HPX[BEI21G0T!O.B4@[BWO08NNL_ (8H'9,@8BO >
M[*6C&[S)?9ZW:Y!Z*^J^>0WA-]RR.7=[X\IQ^;TX]!=CLKY9;& 3_LO14&@T
M88C1E3=\ =6WQ"I%8YLC$;BZG=?CMDD-C^)=14?I<T:''&#H27AL#M&PR\!-
MC6+2>-4%"6PY*0H]&_-E/N?3&'GY\9+H]]Y[?@SQ)MNV5;]D;9I^X:JZKQ>Y
M7!* ,ZK6%V5+#,$B3QTA88V<UI-,JA]"+IZ11;0UQ#7>KIXOKN_4:X0;HA%+
MG2:RG+&,O;+QG9HC;@[O2GQ_@;RK"0NISVB*]?.B+ONUK:-TSB$1Z=6 _+W!
M)($VJ\HE6E0PZ(BA@S ]GJ)D8V,*O\H.68U\+(/==BCL%'F:_)3>-LM+9=[;
MW])2Q?RE=E2EVN:HK+JW3ID88[6WQT\@TDFO8>6QA\_L*DJ0TO\ (3.2@PU#
MRM /!EX0V*L-&PXT8D3V3(HL=&@X9Z##@%%--MM82;VSLWR]ZWS_ .90 WS<
MRV4UCI>T0ZSQI2IZMH+J->O9M"2W2[#V2&;=MS#T.%CE!19G6107:KB#X&NW
M[TA*I!6R<N=[MXH":-3V5<)@X8[=VY);;>3USOMYMF;(.GO:&VNSLN[,.#]3
MP>OZDI+L/=/7"%2(?9)J53V?R6D;(.PN02@U$5J_  H?&RC!H*<"D6TQDQ;X
MQJ<:.VR YN,(D83S\[7S/!5K&-^JSTQU]9G5R2!P!P!P!P!P!P!P!P!P!P!P
M!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P
M!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P"SK'KU18V:IV0/J2OV4_2GDAM%*8
MMHN)1D:=CRR"MZQD\XT+:-L/-90>KMHUA)4SA7WY[&6Z(==;=DGJC@3E],O'
M=\N?7OZ2TA_Q_='I4U@C*2]3.OIUI6$/^;^O&Y6JX@]1AL(U>+D4(K']%Q>^
M!P)F0=/7XX<AZK88\?D70_1LN0>[KAE[[O?KN]_271?];>OY1EL.)TQ6A%AO
M<B'8?9F^AP-VVS>S8@F5;V]A%PR43Q8:)%%-ZG*\:X,:N-?:8=>G.?2&7WOI
MCY.[T$AL+J)U<MEE*QUG=?:BGS&=3L%9\Q;2R!QTXG)+%C$<80X#-B^"#%?+
MR2C(@,911N75SEY\F4<@-U=Q*JS10$VNC:QLL-[+N**D7C\Z.2T=$0\GZD]>
MSPF QL[#H6,*53#W@^,122FGDC-1P,S6%;-V09Y(2)$[@>DGALV,$'Q-FFW>
MO'*RH9?>_G)NZZ.=.GLWEME.^L=(.+ GF\S4F,Q4KF,;2&1[V/%B<*L/XH3^
M'^].-9Y%3)4+--,J8TE+4@ZR<U?++;JY#+[W\[+R26HZOF-8O*6E< B4BJ0C
M&&T+?UN8!L'\,=Q%DU;LFD;<1]PBH-5"MF;5LV1'[H9;)HH))ZIXUTUQ@1EY
MSG?KGMSWEM[DZA=6>Q!8,=O;KU3]O&8]'BL2"D[#@,<E;T=&#>VBA, @N88.
MM_A#A=/1WHPWSNW;/L>_M$T'F<KY$IM=&UV[-K?O*F9]=:''G&DF8U!7C20L
M+#E-M,C3>*B$B;2SIQ$%8!,9\W>:-<+)2R30A=:*&SFF^'Y$ KN,<K*-=LIY
M#+Z9>.[Y<^O?TENU^C/31T7J4\YZN40X-40)#@:<)KUC$E7E<!(X]V*1L1%%
ME!>VXL9&BNZA>-L4L^[1\PHH6#ILB.^SG(9>^[WZ[]?/Z?.7ZAM?0:NV\@:0
M2)@(BUE<PE%@R5O'A;04B=G,U*+&Y=+"J;1-+5Z?DIAPN3-%%\;NR#U51PY4
M45VSMD05AP!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P"@K-G+BMX66F#6!SVRUQ
M>X[32&UD*%FYH5P_)-!VVXH:9-QT<XT'ZNMB)'*Y=ME$:T=K):KK)IMU=[3;
M*.H7E*TE?6.G1JJHW=ZE5JT;.EXNG.HE5J4:-Q4BZCCXNGRTI9J2A%\J;DL5
M:JZ-.514JM9QQ_5T8J5266EY,92BGC.7F2PDWN]C1S8/FKL>']YX)U::](KD
MUCDE; DG88^P;,+_ "JY\:X(ZG8C#&!@C#78$5JBMJLFZEF^CU 87=.C8#=D
MLT1]IL/ YIUWP3?<33XSTCV1;2KN%:A4E4T*E&A4C3\1=WDZ-.\A7JMKE<;5
M.$JM&,:-=34I=;J\15J>ITK%:;<<E11RI)*Z?-%OFA34G3<8XWS/=*3YHXP;
MJJ=M-Y;<<(2%[5-LU JP-KAM8[<0 %'9&_308#GV#0]G'Y/*V:P1?8ALQ0<J
MD$'.[\>12V9Z)(I++^.:MID-*N*=O#5-+U93HQK.XTFO7N+>FY3J0\34G7MK
M6:K15-3E%4Y14*E-J;;<8]BMZSKP<W0KT,2<>2XA&$WA1?,E&<URO.$\YRI+
M&V7K4[M7]<E;=@IX-CYKMVC4M:=2HC<4A:]38[U#.DXT7)6/;H0W,)FR[*B"
MLA,"TP41%;-1U?,)#JP;!3)$R$T24T5=<4_E^3'U_;O-E)8[,Y?7/<N[;Y^_
M8O\ ],[5N^?R>=12ZIO$Y8=C/7?II)2+ZNDPJT$WL*RZZF1.SY)!C8\>BL9C
M,GD AJ3 +N5W8[0:DT5$-V;1RJDK)#2[.]KY%C!0M/VSV6UM">UO<,D*N89T
MA;EGEKV1#80PF4V[;MYS&G!ZD_A]:5[$CDE /XM73Q0[;\?KN(!S4QNQA'&5
M7M$Z\R<C)82TL97Y73/9C&=^WNR]L9[=U0EG>0I,AV[ZE5/7TG+U_7)^X!<0
MMH=9%23N"3RR'UD=>[GF4$AXB-V?#(_*H:#BD@!UX9E1E<()*F)%+(K&QI-J
M.C5E#7(<NS;^3?*ZK/3]WRED@W:[LQF'=72+FYS+U_WDISKO9AE\O#ZLT_X5
MSEO=F>ME:R".URFU@;=L[2VB78<W!8<G<*%D.FL[K4,;*Y.*N96'+B<++PMD
MVNW?";W^;?'1/Y2EKC[;]O8XVL6*5W8LTEK[K/'^XDCF$\#1RBFKE^'J2R(0
MRJJQ+Y82B$MQLHK6-1K>SXI9T3ZU!XY;TG,0@B[C 9F6(C-1+[?;[>@865E9
MSR]OFW779OLSL;8K?M@TSMOKO6\4D[")AYX N2X)9,"35JX%[P*GHK&FZ05Q
ME\JQPR;$IG:L#DQ9TF_&.58G$9((U>C\%=R+$5QM\J2^7/\ (U^L[Q[)!+J:
M=63U]3MUI8E@=;&,:O(Q%NO&\S>5].:[[33.:6C5^E?Q Y4P>N;5EW7<175:
M1RQ@LHLZ(*GI*5*;;MS5=N&0G"ZX['MOCLVZYVSE]FVW:S)F+]HK/B_3L5:1
M((-N2S6?9I?JL+6-FV=:#; >+=\W72N(V=(B\:AL@& $C0M0/:$BTBD'6&.=
ME7[., V#)T/;M@PLXZ+&>_'D\V.OR=?DSL6?<^2"X(Y'I$?F77&OD<,@O;5I
M%VD:OTP0^4,]Z=]BXAUPG(\N[.4I'F\6A\SDTG>&XA(?2=*, P/3,ACS5P7]
M04'*N]KIU2Z264^O<4G;?D;M*J;RBD#EU>#1QF-2FS:=GD3B,J>22G2DVD(+
MII+Z?LF97,2JP;)*KK"( NQ#I&R)$4AB"<<<Y?9R)E^'D)R3#&V?0_D\I/'?
MT+\=X;"OD';75>NJ?)7VBE8@^]B<T =:L]6$K!,;P8# G0);0OV[9ZUXTCXA
MX=(;OTV3IB??[.VF$6[I!%=-$$EAMXVQUSY^[<PH;=P>S4PK6,,\W$:BLO)5
M9U&C,Q. X?6B4JB5KRSR6*=2;U<[-S,'/0E6>"X^*/0<VL- %*KVE@I_)H #
MP"<B'*D/I\J_>T,+F?=AM9]&5]NO>9)3.Y[PZ]S:_(.[NN57A'Z"C_3F^<R:
M=QVKF4SWBUU7#:=66W2\K5JZ UY%2>/D+ MK JU\TBX:7#Y448XDA,]&T1S0
MA(PGAXQG*PLO=)-/&[WSOV=<8[-N'!4< < < < < < < < < < < < < < <
M < < < < < < < < < < < < < < < < < < < < < < < < < < < < < <
M < < < < < < < @]QP]1\B448LU"39!5JW([M4-GS=JOMINNV1=[:9<)(+;
MII[JHIJ:IJ;::;;Z[9UUSBZJ34'34YJG*2E*FI-0E**:C)QSRN23:3:RDWA[
MD86>;"REA/"RD^JSUQYB,Y0DIW6(Q?64/IMJ $XEQ..CHB1D?N*'QA]%Q!$L
M6%@'3[U/;K"6!,\:?M6*F^R"+HH^6TTQNY5SL!8%MTHZE,CD3DK'KS5+ [!!
M\7$0TFPB0UBYC(B$.UGL-%!MFJ2.K$9%7+A;>/CT-=6@C13*#!%!#&$\"<OO
M>_7<R &Q.,ACDEDPH$+'2&8JB5I6:9LT4"4A5!#M1(90N[3TPL^W%C--&#'9
M?;?+=KKA%/U=,>C@@]-16-R)[&"1X&,+D(4?WE41>$&:+IQ&Y(K'ST44.!U5
M==MV!/>-2F1@MGC?.BV19LFSSM[%VMIL!:%GU7ZW#V5B#65'UDV'VS[/YQ6:
M41$8;2O1 T1DS9(DC[MG3"#.4F#$K8MVN&Z#&5ERDG9IH'B+P@L)R^][=/,0
M13J+U@-@8?%S%#5<3C\"3.H102]B ERS&-9681D4N8J)JM]OB8Z8R-NWD<R'
M%LOF,MD+= [(VY,LBD\U#+[W\Y7<[JL'.Y/5\Q=N'(^0U5)2YP([:IME4B8J
M310U#99$3B"Z>WOL</B3.CY9GHHC[&2 (L;SE?8)HU7$9Z^?J4 *Z@]7@<2D
M4$#4-6 J(RMU&GIT(/B@QFV=N(2Z]]@N45$$4W(]*!/,Y<P)N-79MX0OMLI%
M4A&^VV<B<OKE[="Y[:JJT9PJ,UNS@<49P"&.X80B<-: Q[:-QQ]74A#RR"NP
MX=%#1DP<1.3Q\(?!+-T=-QQ<6R?M]M'*&BF!!:2X.I%)7%6DJK$K#0(,9*V-
MD,'1,*!"9(M$KDG0^R+<RVT?L';+?YS9D-0/3?1RV62D)/.STCHNX]"F!.7Z
MOW=/F6R[NPJ,7U>ZZA@"\6'TK6Z4?>"9\!("U8J*>-RP>TV@8?9 \SEXW<*&
M6\X'1V/C9/J54>9,#08@>\RJS&LT$0R^]D79O6^A[G81(9:]40FPF,#T=)PU
M&5A6Y?,:T?LV@]]J(6=8W7:8>LF#)L\]FIC+I)JAJO[3V>OH#+71M$O(]5^M
MA6);0)[155[PC,0C, UB2$) LH\C"89*<3>)Q9L(9,F[%J#CDQQB3AA[9%)N
M/.__ %-MHF[_ 'W@9><Y>>_M^<D6O4:BA$,8US :_B=7P-6SX3:DQC< C(2/
M(6">KXR(D\<3EKIFS3=E$\26+0UR6<O%'3PN CB<0>+;1]\Y:\#+[=_3O]OM
MVF3/! X X X X X X X X X X X X X X X X X X X X X X X X X X X
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M\=?/F#5V\ E70@G'W)(,Y7246&/W (T8"KO&6Z#A445(CU%-FCURDH!-. .
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MYV2%9,=]_>"&\_(L+Y\[]^[?V1LOX(' ' ' ' ' ' ' ' ' ' ' ' ' ' '
M' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
'' ' ' /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g904779g34x62.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g34x62.jpg
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M1$9(4G:$AH>RML/&QR-R@['"&28G0F+_Q  < 0$  P$! 0$!
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MD!*B?KAY]EZH:XC+=4.=K]NV^H\DG%_NG<22F121<@S8:'P>M!MLE;#+\NE
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M+^3#!5HZF$B:X+L%9%&1S6T\.A0.)7E# U97EA"I2E59">L029(SU>P D$W
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MTT,-056(-SS&N8DD*GH\3F)&#65DD9AD]Q<6:]M?-[U^AZ\74^<I?[HFXO\
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M&E.AC[B9)KMFTT@T=2F0N+LP&YO<XS;QD!*?*@5[H'1!#]B[UN+?)OU7S?%
MDHA5O1J(A5F UCQB$@F&:0PO*TF'+)D>+!P7,C8@LI4 ZF1+RQ*6;EYB,'/L
M=%R  O<8AK@VL+FV]]1N_E\L*DC1DI*)$2+R-MEE(2K\V2>$CS/.S3?+0T^<
M.5'11MG=@QWR@^572SLR:;9T[6Z.=-"Q1*J(L4:I&<HU5%"HV^Z*  IZS;J
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MWNNI=VLD_?)*N2&'"RB;QWIOOG5PMC?I@@)0F&(F(!8R8T)C4$$*A(Z@!52
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M/WZ;)UOILNU3>N]$-T]7*V-]I520Q4%@&4$@$A6*EE![0&*J6'82JW[!JFY
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M@VKNJALGHDO]+5\(DJ.*\,JXYGIZ6AH:NG(IYFBE+RS4+PQV",'IRE/()5+
MDA!8WVQ1U*I33QLH>265'ZZAEL%D#-VBSW<%3;T_1KI=7'=;Z7#VM:1@HE(
M\>2JKB'$>.QXM5KX^TKS2GX-&=.0D!,P^K+RHJ0D(I>=C,W,@.X<V&8!SA"/
M#!%AQM\"..&X?YRI^"M8]+3(AC:0U?%IN((E2L;5'2YI?B^=)JJBKHUDHJ<A
M$M3I) 9&>GD61 7VIQ&(22$W"X4ZPDQDA!&J\Y"J21,5D<7/6(>UG!! %ZK?
MGQQD*<4IPU8GEX80J*FJ;??!:6KFN837TCGT9[I)5MO36>TY(WEA&I.7F]@5
MF29LR< 1!OG B,PLUO(9:; 0X [S"IX%Q->*0EDYZU=76+\:=(J)YXX)?@[5
M4D$%9&M.D20P5*LRU!=0\LR<N%))9!KJ5<!@:S%>5'$>24C1&=:Q)&>(ERQ>
M1#NEB0%-V8*-6H/W1G@G +$0=05.UB[=PQYQ/PMK26H,Q Y5<XY/7!3MHPDO
M' U5\B(O/56T7B4.FM3%Y%%;5@\H:HR5V8"M-PK]W'G$G^#W&ZBG(G-*A#<%
M5Z6*KYJ5,'#:2LIIDD>JX?+ #++-#5)'+2SQ'EA'.:AQP5E(CC'F$6JB)#'B
MT;SR1R*0$F5K*JM&65U;>X%C8QQ(.ZCTV6A=E0' 1VRC=M#.Z4[V1'X73,;A
M$)E\KY!U[%F/%D\C&"EAS\X!9PNS1!6:D1ZTX.KP<F_U,!WA\AOG5#3'\&:Q
M9Z:<R R4C_!SH[S5DLTT,5!42GBD9D2G@20S4KK K"!!.@P<1KVP-?$5=+'&
M05O,"Q!59ID7D'$NY&+@L>L<2;BY[)QKCG-Q&N7E9(<V%,I69X<2NF#DW)43
M:44K>JH[QK6X\;5Y>]54U2QU*=2#>?;R*6U&5J1D'  XVZD(FRU<CHZ1.2:3
MJ,<4_!.*T?"TZ/#"G&(JQ(5KJ66HJI.(CB'2*&IK*R,P1]'Y<56M67DDD$;T
MPRD5(H\K4JZ>2H;)BU,8B_*=4C6 P\N6..,Y'*[1F.R@7#[ EFUP /7_ &Z9
MF]PSQC/95$RU\&Y::M%K#)"9BXJ7:S4L6,'0QP<&?-&Q8 X<FR27D<EHZ8>+
M.ED-D,IJ*:[?=QT-(D-) 8(I4H4B2E,R)*\/)1$C=&=25D 1>NMFN ;W&O(:
M:0O(X=D,K,SA6*ALB20;6N-SL=M7GBA_=2\:_P"OZG/\HD<ZKXK_ *KXE_0*
MS_MY-=I_Y1!^VB_OKJ >M^J=.FFG333IIK??N<MUTUQUY'1>Z;A/.!+*ORL7
MD89AKQXAW(/0YN#E@:0$V(A"6V+7RE:3G#<.AYDV6!6(%HZ15<J)J"]=_&5?
M"^$-'6<0X=+1TD8=JA9(W;XPFX>4#Q/&I<Q4]1TF&[GG4SXI(H (?L&NCECA
MF$LAM@5(')67*S D#)UY;V P<7*D^;4^5CR)X7L=N6$=/2CD'!8KS*1>D39-
MK!0=ER6E7,!Y?1N\:PC2!4M:H(O:Z<OK2+(C9G+2A"/$PMAN&#OQ&4#6[LKU
MAJ>'\8;XJD2*@GEX055%,\E-'6"?A,E%4R%4I9$I>54RY0Q*LBO3AERB8A3=
M'-3#I +3(M1N3@':(I4"1%N7!DRC%G8V(<_G"YUL@][K/74]G5Y$;,9RLI7_
M " MCD@0$Q!W"P"V:)JN8@;U,5./6.1(Y!Y_8Q,[;=]RAY985.Q18F+52;NB
M%0=R^UY!35DT\\?!6H@@HEIVB6HH*7ARM,LT@%=50R4*53831SP4RQTE!$*9
M^C.\M4E'-.%Z!"3=\8(SRE\BDLDY"XCY*-A*T8NI1W+R2MF,P%0R*I/-<:XA
MW&2K8S;MIF*9CY>)U 5L:;DJJBT@=;OCT:K=])B;J#@#;U1^54=E@\85%CB+
ME0H3W7>-UE-R+W;;+I7[.D6I2DI4K)$EJUIX5JI8P%CDJ5C43R(H5 J/*&90
M$0!2!BO8/+E*&20Q K&78QJ3<A"QQ!/I"V!_M.HXZT:AITTTZ::GVC?[#\@?
MZ@I!_P#'===8:WRJ'^G1?X4^KH>R;]BW]]-0%UNU3ITTTZ::=--=8H+R*XEA
M^!!#BI+)#/G$DM6U:%E$J.0?CW#(.?K$=!YM*R%CF9780JX/*/*E!K$IH>94
M_"Y\%C+*/$5T'>K^**,4/#?+S\/XJ_'%XI%'3B.EI:Z*))J^:=*EIH(EITBI
MVI G"RTT,9K)H'E:1 05FR)UZ"34XI#3LSWD>)F*0JI3%F+EG$EY[*Q$:L%"
MG>XL+R/">Z04S7_#P_QTKV"6?7EDP$I3I*A;9$S89N >SNO;^,7 [O670+>)
MO5HO/%=E([N1'-Y)/TC;"+Q.'-B0@'$!F7.:;X/5L_%DXA43TU133K5K74C0
M,)%@J*!*,4450)5$L M($8QTY1I9IF5WF:TTK8DIS JR(Z&+DR!A;-)C(9F3
M&ZOY-P&<-BJW 47L?)_FQQ=Y"<>IC7I>'3 M:%?NFT7X\3/>+C84Q>BA2'&B
M,CK+D$;@DO 5Q"B!* 5A<</(U\.K62,X[!R_'*N(I($0U+8,;SX9P;B5!7PU
M"S1)33AI:^'FM,ZNYXE*U,DD\,E1.JU%31RK4-51-),G$:F6,O68:Y/54\T#
M(58R(<86Q"W Y(#L%8(A*I(I0(P"&)%($8)XY=?7:\W3IIITTTZ::GWDG_VQ
M(Y_4%Q2_Z+E.]8.&_P GD_I_%?\ Y2LU=/Y:_L:?_MXM0%UOU3ITTTZ::Z.Q
M"V>,Z_<^7/'.;VE<0^T2_)^N[N<"!%/!9!#H]%8F%L:NBD;#2M_<(=TY>O8[
M9)"Q&RF8B-98D3%>)K-]]2ZDO:_/2TG$1Q]>(PTU(U*G#*BBS>K>.:265Z>H
M61XEI'  DIEIR.:QY;"4'J"([4>#HAA>202&=)2HB# *H="H8R#<JY<'$#(8
MVWRUM+'>?7'JIJ&'#ZDE%TIW=5'&^X^'U/I/J_C4?C1*/S3F2MR1A'(PY)6=
M@''$6E(*,KY:E:\91:2[[6"Q$/&DK6"H*NL>9)P*OJJ]FJXZ/H55Q&CXO5E:
MB6259(>$#ATW#DB-.@EB>076H:6(='9U,69 UH6KACB C:42QPR4\=T4*5:H
MYRS%LS9@MKIB>N 0UM]8YR+YR\8[^X_V%6<RC,QEEBPEJ)$T-/=8D+@C*22%
MN.JD$2M@S%H!+(M7T 6<AX=,(VWA.E<RUJ.K'-51 8\9R<%+YR9LX?P3B5!7
MP5,,L,5/,S/6P<YYS''E5NM*DE1#+/4#.:&4S&HA9JKI4S Q210+&>J@FA:-
ME9G2PB?$)D0(P9"J,J)<*RA<'LF"BS!G/&#K[#7F:=--.FFI]XV?]L21_P!0
M7*W_ *+EQ=8.)?R>/^G\*_\ E*/5T'EM^QJ/^WEU 76_5.G333IIK<'@[=T!
MH>[R,AM'62(0"=TMR"HZ3'8:)8GI9#F5ZTM.*J1FH &2,1YH9=19]*FA9T*W
M.B52 IN0:M7NCM5#7?R>-44]=1+'3<LSP5E!6QQS.T<4S4-9#5&&1U20H)5B
M*!\'"L5)&(.M-+*D,I:2^#131,5 9EYL3H&"D@&Q8$BXN+[ZWR"<S>(@?F%Q
MYY#><-[N G&F&4;Q\C*&E;QMLYG->U'Q6+55M;DO&M;9;*[ZE+;:QW8]1FII
M5E*Z4>GH\1GS4JXW%J^')P?BK\(XAP_ET(?B4U=7RGI,A$-15\46JZ+"S4AW
M6D,F%=@#%6JDBP,EF&L5-,*F&;*4B!8H19 ,DC@*<QAGO=\08LK-'=2XV&I(
M/]U1K"/W'))U!W<N-P-&L>.T)9UBVJF"P:$G;)A 8#$YM:5>18@9G2]!0&'0
MZ'"-X)3<%EH^.R^>-8:_F8O6 "3D%7S1_!BI>CB@F$23])KYC4FKGGG2GF>2
M6&EJ)5C@%?/--,_/JYXFDA@,RPL9WCF$SQ!!(SJ6*80KRQ&JHSJ KR(I+\I%
M5%*1JP5G"EA@"NN57,B;4%8=Z'I;QPCIZ.P J,#+O])#H<;O#,S4;;+2J0IL
MI+.;(/,TRS]7"J^"DS,.7I+1^6[6*1%,<T^HX1#74]#'%Q&1))T9PICP(2$&
MT4=XX:=#BHVQA0*I5-RI8X*EX7E+0A@A )RO<N=V-F=R+D^=C<W.U[:U9Z]/
M6?3IIITTU/O)'^WV+?U!<6_^C75'6'AW\GD_IW%/_DJO5]1Y:?L*?_ CU 76
M[5&NL_![GG1?'B@KJH>SJ8FY?-GP7D4W?3R 6,S!K3(_9%%DZEKF)S2+$(:2
MQY%AF#DR\WI2SDF^8HI9$N,[0^2N=F[7'RO&N!UW$*^CKJ:L@44T_#RL$].S
MB&.GK5JJB6&59EZ\V$/,B,0YO1H4YT8!)]"EJXH898I(F/,2:[*]LF>(QHK+
MB=ENV+9''-CB;ZS?ACSEXD<1AUC5:ZKFX;,@]B12?DCMJ"Y$"JZ9'STVX>2Z
MH6=4R2OTQL]8/X3$+)LJSFL7ES:>,]VK67-K#,0F0%(N%C>*N,<$XKQ9J>I%
M31TTU/+ L=,T<E5#&D/%X:MJJ.?*!EFFIJ:F,L)IVN833I-&LKR:G355/3AX
M\)'1U<F0$1LQ>G:,1LEG!5'>2S9CRLRI*A=7^%]T*H&3TBVHSE0PG5RB]ZD&
M.9!)F$4%1<@9L844%HQRNT,0.45J]>!H5"1+/5I9\X=S(I+;46WE,]CLL%P6
MIE8E7-P"NCK36\,:"C;I;!(VE>54IV5S)4'GQ5*J\T[DM30+$D5+\E!)&\]4
M)9+60M%R9P\@Y8NV-B7!%DZK(;(@%G;(N_6<-C'CQ"Z^SUY6G334^<I?[HFX
MO_/HU_RV.L'"_P#5U'^P3^S5U1^6D_6_\#4!];]4Z=--.FFG333IIITTTZ::
MW XH_P#A[_ZK?_4?7E\2_P!C_P S_P#'K1!^?_P_^VOZ#)KF;7,6AO)BS[(J
M\6V"T?RHGG'Y% (8J\6_DNL<'@"S:1."]N2NKX<.?$<F72>1#B5ZNG2[=LR#
MZE2CY!EO_.451:')K@(W+V8;XJ-^L5&]^R_\U]?8M$QD"JQNRY[Y6%R=K*&.
MWIM_/;4%(=U2XV(Z2\\<I25!*\;.^/K*J9P_S3P-E;SSD33*5Z1)@U\^IM"@
ML"?M8$F7..//N2"1:@X*YTW+-)&['1EV%8NY(<+\GB25&7,3,=K *<;FQ/8.
MV^VN]'DZMG!)SR'7..#8GL!+;[=4'M] )&T;7D? )-..%@R"0$,7@G,2!V#8
M8:1F0^ !V/@8O7,:L*/ZKQMT+ROH_,-I&FS*L""K-P'60WTVU66UWTULYY+0
M!;E9@S7)(("J&&WI-['T:KP8"7)CE$5%@;@DMB=_1MMK7&M^Z6\>3#.MF,\K
MN0,R,L$U^^EE@1RMA6E1P=U:SNSVU=MCSPE)7<M:9D:M3RIDGJ.!R##!ZV05
M*K#Q[U!UK!:L67(L+@$L <!EEC>[$[A3V7W[=3:!^L586%[ L<CCCD186L"P
M[2/ZSJ](]T3H6?\ $+E)RCI&O$9'OQOJPS9.8M+6T*:-Y,V]':]B1#?!V!G)
MZ,&M9"-2\6)!WSQK.X:00?!YI$(X;;9'9[TH-%)(F1Y:Y6)&]UR&ZEAOYQY0
M[" =.0ZRQQNUN8P6ZEMM['9@.SS'L/F)U=)!W1[BQ$I'/(W)JQL@7M!E;(#(
MG\5I&G<<GLYJJ3US#Y37M?.6LA5*%)0H=MJOFX54X(CL;)8D.J?G"@\%G&@L
M:I02#S-LAZ064J"JV:]^NMK@ W[;[:<B4@$.IO8VR-P""06%MA96[">P_1JP
MS7GU"X'([%B1GC_,%+ 'MX@TK^FV-?1-Y9R1PO4%G6]*5)RLVGRT%5 Q*-UD
M8,$7T5E3O9P-PU91O,K-&1#5?AJ2&92'N,<5_.N49R6ZUK +YC?T W&NB$L%
M(D%B3DV1QMFJ+B,0Q))M8C^>POK H3W6CB:I"!CRQ(JLC-P7'F/W):#>#1F&
MEP@N28X]0[D5,X5'(^ZF&]C[9%PJ6I.Q$B-Q=I B3YNZB#6?OYL.(!$N"L6W
M6+7"!FMN < [ #++8'8D $@BY.VC4\H)LW5S*+<M>V90$FV.Y&X!)%P;6.I^
MC7/#C_*9$,A3"D[7;3S$@LT5/802KN",SU/1ZGRE<C)]8=E[YF>X5I"0^+:K
M\@FI$R\NDS\<>4691A=8,?;BYBI!( YF5V#*;70*5#,W6M89+>Q)W[-C:!BD
M OFMK J<FLY8$A5VW/5(WL+CMW%\3"=T)X\VKQ7Y,\CZ:C#;9OQZJPC9;AO,
M8Y$BS(B(<0 A/XD7RG7LND"6S<P,'N-24/('HW8T8?-7(2:1F(F,)MMN"J#1
MR2(6^37+K=FZY*>JQ_K%PP(((!UTPNLD:.QZYML3MO8]H'9Z0"I[03J8:LY<
M4/:]Z%Z $5I,0TG&.+H&CY7(X%&Q\ EYOCY+H=#;8$1,NT.$B[IS'"%@0]_H
MN4 BAQ ::UU8D'!8::%C9K.&<H,P07%SV$QD*UK$G;('<"X/IN-1>-T4.6!!
MQ-@Q+ ."5)V W /T[=EM:M1GNGU'+VQRTA\MKR-:P^A\,]ZL(5^ZC\TGEQJB
M;E4XTSP'YF;)B4HS(65_NHM%(BB0+Z")$!G$:DC@P,'JN5TJA5C*4$FR>3BV
M3-9^6PQ\QS("W/6# ]E]6&!\8RK&[^5>X"W7,&]KVQN38&Q!':-[M4O=(JB.
M:'0MO4^;@E@JV_.H)!(,SA$>W,R$0)Y:*<6 @=33>5$6*U@1$R3B)JX$F)3,
M6CX8YK(@Q5^*U41;=6KO<,'5LRH7SD"7EC\[R@2"^]A?8G1H'VP?)<02V1L#
MR\R1L#B0#CM<]A%^VM1[J5Q-?1TF9"5)9,L+B9E)(8ZAL&CM)STWLO%:;<WV
M6--SL,M@[7+@,A63 J86T3G63HXF)(1@P$&R5-$2LZ6N]N8;$BRXMV)F3=7(
MMC]-P=B =.CRWL74; W9G':V %BH-\K#LL;@@VWUFIGNBO%03%Y=/TJ_F!&M
M8O(H+ V5E[1>M8S!9?9U@-8"1$UL!.3V<Q'02?'"[& DSYZ?(PJNQ3-G(]E)
MNHM'"R+;O2EL3U\057(V"EFQ(4%F%B PN6"J+'?;41!*2%R 8@G')BP47&1
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MX+8Z]O9X3L[>]0QV]G;GL[?P=N>J)V88V9AY783]&KX=\K[^3V[^GTZU2F/
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M;[FX["=R+'6.< .+!5."%E7L5RHR [1V[V!(WUNUU=JG56__ )8Y_P!]V_\
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MIN=Q:WF%S.F+A492RN".5VDJH4Y=H L18>F^]]MJ>4E-R&;W5<%UTC9-*!Y
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M"T()*77,6P$7U(1"*\Y[8MTDX)1/?=^UOUW9_$,[6%%9&6 5<^0E8BN"(/\
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M8E2QUO4,K 54:1A@:..$H),Z*EA&>QR'/=![?O11VN)M,"TN'M-\:.A4CD1
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M2=@2220"3O)@:BJ$<,V!@35->Z(/\1$ZS<M8Z#4UW4C%@F+HAKY%RST7;*J
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MYF!.RY<LG**[@-E0GD))@N""2:2CVV$Y%!-=-GFK7)P;#&+"1:L&XH2AB$5
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M.,XS\N,YQU5 Z"&,%U!"[@L 1_43J3H^3=5O*/YI])^C5H\HC_QYG^LH?O\
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M,CXM3Q+SZN)U+TCLSNZ*D;(0S');R^+G"DO-#'B'9E;FDJD<YIW8X1L#:0
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MZ:21Q5XRJM0MTZ,9S+$RR(",@MGQ9+DRF6($,J*&Y@+L\(G4 &.ZDH=\PN+
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M#SFDB$RJED.)*,OY3  L 3VD3!-.XPWM6\L4CE@W+1,*&@HE=LKL*6R3TRC
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MIYC<?OG]D?L4(??KISJ_YC']L7\#3EP>O/U+?>T\QN/WS^R/V*$/OUTYU?\
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M,;C]\_LC]BA#[]=6<ZO^8Q_;%_ U'EP>O/U+?>T\QN/WS^R/V*$/OUTYU?\
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M ;D7LTC,)3<^4&)/;>U]@-1(QNQL.M&GKH:\N9+BRZ"CM<12HY*OQOC[S,.
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MT&+A7W>!U5=/Q'BHK*ARK)P^IIJ1H'1(8ZB@I9)##(Q(*).TL+*-S*CN]F+
M8ZN.)(*<Q(+AIXWD#ABQ29P P &Y7%E)[%( N+'72NTX_3;FA(4M+8^!2@QC
MG1R&;<MI='H/QL?GAM4Z<Y0[0DYG$XD@M?DK'"+6NU#>L)VJD@URLVQE GG(
MGMUS\W2R58KI1%(_/3@= >%123<1"-5?$CLHA@C;XMD4U 0S"J4V.Z]>VMTH
MCY2%E 4U4W2&5("1'TNQS8@S@X7QY9[-CMJ61M;0L5>E"SF]G7&$17[+E%R$
MCL&J:)T/PC6K#T*B>/7(&25=8543N$/'LCMBM,CAU<:;B[L3\ 1M!46L46WD
M37R@0RM43/15T%".)O.W#*"2>JEKN-=)Z8]?P^.JIZJ&<".EJ<FJ2'H]UI@X
M0<LXK8$42PM*8 G/E"1B*EY?+6&9D=&0DR1VPVD_/M??<Q?PXL'BC:-;30K+
MF]53F475RKM*$P@-;O&/B%56UJ:".$D>V@-=V#M$AQ@?QCAI:SAJ;:.SRD&K
MAZXGBC$J5="B\@D)EGJXO3\4IJF%8C5014?"Z6:=Z3B7%JGHN?&9!45%/S61
MN)3)3->2"M(7D!D571(XS53/3R(Q;ELTM0Z*)(:=#):E&"/8$0*7&SQ@DO:]
MBS$<[.YW<<.'%MP<0ZY-,9"\D<[Y7Q7CPR<!;A%UBI7\-E5.V),B%DKC24=/
MIF7,=DL1%#V7E/5E'\.2O@"^7N,(L%_?^$'$>+TD\B\.,8C@X7+Q!@](U3TB
M:*L@A%,&62/ 212NS%<I+)=+;L,E'!32(.??)Z@0"T@3!6C=N98@WQ9;;]7?
M?T:G>'\%>'=Y)Q(_6".T/6F-:<(K@*UU)>0\0W4KZ&SB_;?JSE$LYELIUANA
M!O&X="81+G6[UJV)11669<HL<C'+!!/%-QOBU$98ZD\X0U/&J1:B+A\OR\T-
M#257# (8N=B9)9YH@%)67E6+9!B;5I*:7%HQCE'32E#,O45II(Y^LV-P%56-
M]U+;;$#4E:</^)=BQ+C\%@=2UVX8PN1<W0]C3%S?;@9)9^\J*U)2V@,)?@HP
M-<RN8S,] ]@LQB;!F\C2:L:8J92E#8(BXV=9SQ;BM/+7O/55"M-'P5Z>$4(:
M.G%72Q&HF5YG$4,*3AXI2PD(E;>(N1:SHU.ZPJD2$*U4'8RD,YCD;!"%&3L4
MLX *]4;,!VV*:\&NYXQ W:5>LR1R1%3EC=T3C]7V(A?D<U&5['.-/%R 7U3+
MDB#9 '0^?J2^9G",!:D53(5H='Y()-$R9_#!T+E!QOX03)35#+'&D=/\'WJ:
M<T,F51)Q'B<]#66D9PU.(H46<J(W,;8DXID'B])1JSH"22]6J/SEL@@@26.X
ML0^3$I>XN+VN;$:\=T"B-.Q@5-2-"U9&ZQK";T3P"FP3,3F[*9 Y83/52LXE
MQG31GKIL$+"IEYP1&4(/$D2!N5QPY)R"#=\:<MTO0X#+62O"M=4R5-3!6\>@
M?FP-#)$L=6HB0W\M6AY<L9%U2*1(E)" ZIK%C57,4:QHT5(PQ;(,2C9'Z"&N
MK7W+*2=SJ9$:4XPJ=S(=4/B<\=E.6#&D@W/?+7 J1)WCH<5DKDB3KA6QE('I
M 7$(VXD% <D3K%*UW$NTM-D[5WKM#;58OUDZ9Q+_ .I17&#B X6:Y^ WSC-'
M@(PJU'1N?SQ-\;*\?2NBB$TK "H.R&T10=#Y.4)G$:U1&_-RRN4+8XE>CD'#
M.^8/4W)UN0UH/B? .:7='S7)*'T;'>.TYLBF#W'1\@XK,A!-1Z_):'L KIBQ
MAI)<I%ZD<%WH)I<S.,Z 3BM/KR_1MIHGC*B?C&NXK4<'^#B<.FK9.(0T];'Q
M 'I*SY#ATK.&:9<)*L()#1F7-!5B*^M/)ITJJPS+$(7>$P^05MSE L%-UC+%
M1(%L3'E;7,;A-/Y;7'.CDE#+D!<>-79N%<QI!8(F1T]Q[FU>L[6JFB+YF5>;
M5HK*85(8Y%0#*S4!;N-B:Y7$1J8M$8\(?,CX1(8PU^FXS!#4\%X?-2/7D)-P
MB.G>.LXA#4&EJJZAAJ!4<N:.65VIBPD:H#RPDR.#&^3:P4SLE5.L@AN4J6<&
M.)D$D<4K)ADK!5#VQ"6#=4$$6&M@ZOXQ<0KUL*H591%(T8DTSXOP;E-R+D*E
MVC:V'$9G;ML!X9)XW65/5G!0,9B;*NF*I.9% ;4Y%(Y#098C("NK6*1$?%BW
MGU/$N+45/5B.66..'B<_#.'QBB:H98:2F>6*6IJZF9Y)34$+"CE)9)W18TRE
MF:5+HZ>GF>/)0S- E1,QE" M(X5DCCC0*H3=K74*"2>JH!QF:<+>!\9K^SXB
M.>2,U98B#<W)I%+-TO&,)-4E^,W+E_5571G6$[ 4P9(C:-8ZX>$2#HVW0>X2
M8'XT.'H:OW+VV#C/')9Z:9ECCIGGX-#)3="E)(XEPE:JIDYV9D5:6J.**J$@
MWCE9CB!QJ6E"R(,F<+5,KB4?["H,<8QMB3(G:2;&P*@;G6RZG$/AC%G=GTBK
M,05145?%B=SN=*K2F>B%[NK^%&;TY&Q678L?:0JE@M>S]2/BPBQY['R,@K3R
M.0CEF,MT(H?:A6/FCBW&)12UO)DJZZBIOA  (H'%%43K0\.EAZ/RPKU$ D=U
MC$BQU.:R4S?*QES<::F4R19+'%*U)Y3@RHIEF#9WR".5 N5+):SCJFPAE7@9
MQ3W:/3*-1N\<@FE%LY@0X&9Y>P1DY$E7/) Q6SB9JW0_;J8039TRR%V0O$'B
MZBP_8PVFY#&T#SH)4V?'G% P0U8- :YH4XY\4SL'4</6I$(HU.]ZMFIQ*HLV
M)A7Y<%Q6:2G[1'\L(LC2=)4$'G%,N8>SY*TF)[ <CU=C)] <'N$D#'\)YY:L
M=KF92:P;+JF$2R.KWJA(:[GP6[^*=EV*PDA18X+#L4R$6M6. (BJG'Q[&' )
M82)0!X=EAV-^<3C-7\:XS.W&8*62HAB@IZN:*04)2H@:BXI34[1K@S-:6EED
MF!D+2O$JU CB23EB<-+2H*5Y%1F=XU93+='$M/(X+%@ "LBA2  JL2A+%<C$
M;/@=P17IZE#LU)S:O#EE6E6@2R9N&L:,2.+T,:DO,1Q4=ITW."1(FF-'-ZMI
M'PQQ@?7!/Y,7D@UC/GCI>MSJC05K/'.."KK4A2&H2FI:F2FA>GECDKHXN$BJ
MI:R!40LQJJVR,@D6)(W:G %3&&: HZ3E1LY:,O(@=@ZLL1:HY;Q,2;#EQW.5
MB21GY!U#?='(+7=8A^!=?P2O!%4.8P5OUD?KYM;45N@^"U4Y"[K1IU)9G&M$
MUMUY%&]Q\E&#36-WS$<62PVWR-49ZZ;/@]/45+\<GGJ'JA*M"T<YI):-'_T
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MJAHG"8_-.1'="9*9K.(UWQ,DUL@ZF1*<7$X.S1AU\Y7K%L_16?F50 ?15^C
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M*5R4.MQ:ZMNK"_F(W!\XW&VL8ZLU'7<SN+W_ (R7_L=_^Z?7P_PS_P#TW_\
MF?\ ]77J<-_VW_+_ /R:Y5<I?[ISD9_7O;W^4&0]?5<+_P!6\._H-)_V\>L$
M_P"7F_:R?WVU)<PX*<C("#2E$OC($+&,561MTI(E9C&W8F-@![*)N4P,E<CR
M#O(6=EG=@UX#"PQVGJ:)'YS'A2+?P^Y'R=GAXWP^=S%%)(\O2EI%CY,H>21F
ME!DC#*,X$6GJ)'F4E%C@D<FV.5C4DZ"[*JKRS(6+J0% 4V)!-F)= %[2S #S
MV_%&\%^1'(RMBEI52#AQ@ PE,GA(\68LROXC+I=+8; M+/DT=@L3E4B#FID8
M%P3;>0[C@#5Z\=-4'"+!%T\1V;]*WC?#^'U*4M4\R2-%%,S)35$L444T_1HY
M)Y8HW2%&GM'E(5 )!8A3?2*EFG0O&%(#,H!D169E4.RHK,"Q"=:POL#J+#?'
MJU1CL8S#1E_/E7]60ZXGNU<#R\S2C4+FH1 ^.<2K<2,4\@NA[-?5(XF]QJU&
MO-%$-WBG>=_G4E?2L&9Y%@"U,U(O2&2$R30R&-A%DW7#,.I;=AO8:K,,@M92
M_P FLIP#-BKC(96&UAV^8>G6/!J7N*1,A1*/U/99T<==MQX,@&@DI*,C+]XS
M=D&C(4Z9"ET"+MTP8/WS=LT46679LG;E+39%LMOI-ZRCC9UDJJ:-HP6=7GB5
MD4$*6<,X*@,RJ2; %@#N1K@BE8 K'(0QL"$8@G<V! L38'8>@ZMJ%866ZC^)
M:VKR<N(KDZE%\29")'U8_F3+.-6B,=P93'[#<G57>^C5(1XSY04<;:HZ-\J;
M8US,U-.).4:B$2X<WEF6,2<L"YDPRRP !.=L;"][:YRY,<L'QRQRQ;'+LQO:
MV5_-VZE9_P 3[R%U"QN4A"3#,&_L8S6J$8<AI"A/=28&N!=K$9 K%U@J:^D.
M3A)9 MK(,.-D? (/'*B*;!OEYMD7BM$U6U&LR%UITJ3*'C,&+U#4JQ\T/;G<
MY"G+M>Y OD<=3-/*(A*5(!<IB0V=P@D+8V\C$WROYCYM]1MBGK;V>1T?K5MC
M;/Y>)T/Q-CB$2;+R4 E=T4DS4=;8&>&-B5%'#=/0D-T<L]]UT=-5L[*Z8VT]
M+I+2-TFGQA<QRMSH[1. 24D.5D< $E6L0 =MM0Y4EU'+>["ZC!KL/2HMN/I&
MVI6JGB1;=NU[:EI!W%<1"#TV= 16;F;7M.!51JA+9.+EY@%$A#>>G03D[*"3
M&"R?=L!%).22BHQ5#1OLMGO,9:KBM)23TM,XJ)9JQ))84I:6>J)BB:%'E<P1
MR!(E:>*[L0H#7O;?5D=/)(DD@P5(R%8R2)'UF#$*,R+L0IV&_P!&HO9TK<A!
MRT9L*ELU\\?A'TE8M6<#E+ER]C@SQ?!*0-$$16ZKD(/R[:X?%4==V#3QEOX=
M=/PR??:364:@LU53 *ZQ,3/$ )&OC&27L':QQ0]8V-@;'4!%*;6BD-P6%D;=
M1VD;=@N+GL%]6MC6-E$X^TE@VO9P0BS]PHT8R5C$S[N/O'2)48"5;-#* ]0<
MX<)'#0<,HBBYW4T*EA@[;7#M^U15FU13K(8FGA651<QM*@D *LX)0L& *([[
MCR49NQ21P1R$9!'*G8,%:Q((!%[6V) _G(':=?H;5UF&2PL (KJ=%3IQ^;%!
M0HV(R!\6,$XSMWDD&BQS4>J\(/X_MG&IMFT16<"=L]Z_3;Y^+KC5-,B/(]1
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MI4HI'"23Y/*:X(YXB;99SE$@/9NDUFZ2DXC25TM7#32,[T,JPU&44D861DS
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MGHEXT'N7:K=;">%>(TC\0?A:R,:R.GZ2\?*D"+%E$OY4H(F>\T1**[.JN"P
M(O:8)1"LY4<IGY:G)22UF-L0<@.HVY !MMJ[\@.)EZ\8)-6D,N:()QF5VS7,
M<M&(1]N:#&B>T;DY^0Q9@S-MQ#UYF/2AI(XL="&XH8RT/ 2@]=@68M'6FR6L
M:#BE%Q**IFHYN9%2U$E+-(4=%YD4<<K%"ZKS(C'+&Z2I>.1&#(S#?79J>6 Q
MK*N+2('47!-F)4 V)Q8%2"IW!V(!U+JW<W>6+>PSE6KPV+:S*/U5"+@?,TK,
MKUZ+<1BR4F6T#8!Y&/D;N.GI/*EWZ#,0!#%'SE=SA?.=]&S=9QID'PAX68$J
M1-*87JIZ,-T:H5A+3%A.SQM&)$BBQ)=W10!8=I -O0:C,QXKDL:R'KH05<V6
MS D%F/8 ;['T:U7LBK9?4[Z,B)PU:"CTFA,;GVD?U?(.38$%,&RA2+HRE@CG
M90 9-QO85+6@5[G4@G&I%'R#M%MN1PW2].GJHJI9'@)>..:2#F8D)(\1"RF)
MCM(B29Q%UZIDCD4$A;G.\;1XA[ LBN%ON%;=<AYBRV8 [XD$VOJ.NM&H:G^"
M?W/G(#_SCI/_ )PG76"?_6%!^RK?[*?5R?D9OUHO[7U '6_5.G333IIK8[C/
MQ8M+EG-\UW4CNMDI:NJ+8!A=AVQ757+2N1'WFPZ.0^&:3Z1@59?+I ^UV:C
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M_P Z->JYOR4O[-_[IU)/+7]9?[1K-+Z_[>=T?UL6+_\ &!CJFA_D5'_1:?\
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MG&HZZT:AITTU/EL?]JWB]_53,_\ +_</6&E_E/$OZ5#_ -A2:ND_)T_[-_\
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M8(VV(LZ)9EW [#M<;'S$ZTRZ]C677<SN+W_C)?\ L=_^Z?7P_P ,_P#]-_\
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MV%'6SRMA<B9,US9U"6QSEJEI'@J>4\;-)'(&*"2/"2)85518<R)5%[75K'$
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M-/@N\F?5UO7V1S_[O]/C/AOZ1H?M=/\ B:<B?U,OU;^&GP7>3/JZWK[(Y_\
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M^"[R9]76]?9'/_N_U])\9\-_2-#]KI_Q-8>1/ZF7ZM_#3X+O)GU=;U]D<_\
MN_T^,^&_I&A^UT_XFG(G]3+]6_AJ==.-/(WX,SD?Z +L\?S>K)YAEZ*IWXWE
MIBOR"&76&WD'PV6V%ML(Y7[SP6%<X3SMW^<8ZQ'B7#OC$-T^BQZ$RY=*@QRY
MZ&U^9:]M[=MM]7<F;HY'*DOS@;<MKVP(O:U[7\^H*^"[R9]76]?9'/\ [O\
M6WXSX;^D:'[73_B:IY$_J9?JW\-/@N\F?5UO7V1S_P"[_3XSX;^D:'[73_B:
M<B?U,OU;^&GP7>3/JZWK[(Y_]W^GQGPW](T/VNG_ !-.1/ZF7ZM_#3X+O)GU
M=;U]D<_^[_3XSX;^D:'[73_B:<B?U,OU;^&GP7>3/JZWK[(Y_P#=_I\9\-_2
M-#]KI_Q-.1/ZF7ZM_#3X+O)GU=;U]D<_^[_3XSX;^D:'[73_ (FG(G]3+]6_
MAKM9W'NB;OB_PB/.:F[5COCWHD\2\NUY+A'CGBWI-\9\5\H!V_C'B_C#?P_@
M>_\ !>'1\)WOA=.^^,^%];1S?%_*JZ67'I>7+J(GQOT:V6+FU[&U^VQMV'7I
M\.AE'.O%(/R?:C#O^D:^I\UST/0R&\FII+8D DY2L>9UB<;ZXAT=(%(^7EPR
M.1P/)Q:7@-&LZ/2*8K,=Y$Z79Q*,.MG+1AX[L&%!AALTS_'(IR(2Q4$J_+4
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MQD*4(ZF %L@UW,A(V8 BW;<';S@V[P];=8].FFJO_O'/^%X_Y';JO_:_\O\
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MR$18!!X4*(-;!: ;71P-A[-T#<C!J3<F9D@!E*7M"TNQ#M&;Y$@6"Y&/ -B
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M.WL[?C_#V?S]F>WLS_P]F?T9Z::=--9)'O\ OS_T?_Y_6>?\S_B_]=61^?\
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M@D7LC8CF7F)5*F!0JPP-P@?V\2*.>&GGI4A=&E1XZ9\8HY25ICE+4-$[(/E
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g904779g43f80.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g43f80.jpg
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MHJ6RL[31X2AC9(/_Q  = 0$  04! 0$              0(#! 4&!P@)_\0
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M'[KP[!5)R>FX]'W45I:W5Y<G2;>WMI+N*%YM;TN(ZD]A$LUX-)62Z5M1\!&
M;U8/NDS$F^56056WI(Z:N[NSLK4:S<7-W%9331P:#JTWWKCU&9H+(ZRT5HZZ
M9ZQ(K;/6BFU!XK[(BKG:W7$5WM-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*
M4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI3
M2E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI7$?L6
MLFS<L'J0+-7:1T5DQ$0YB'#Y&#82F*.QB'*(&(<"F*(" #JY%*\,B2QMM=&#
M*WN(^!X(/8@\$9!JB2-)4:.0;D<%6';(/Q'(([@CD'FL+0?#]2H>VM+@JK)R
MSZ+6,YB&K]1L+)@Z'F%-V9-!ND=RZ;B;F:G5."2*@ L")ER)*I]%<]5:C<6#
MZ>JPP13(([AXE?Q)8P<F,%G8(C]I HRP]G<%+*VA@Z:T^&^2_8S32Q-O@21E
M\.-^</A44NZY]@L=JGVMI8*17.(26EVC5FQ;.G+1@JT.N;PZJB(.7 *J$.54
MZ8E$X(I@D)4Q$2E%7GVW, AE]*6\$CO*\:22K*J#>H;8FT$%000-S;LD<G;C
MRK&ZFFF2-8T=TC,>X[25W-OP02",[0%X[#=GSJK\)=JMT]'W>,G7+R1A(*2B
MTX%\^.JNHDJ\1>GDHQ)RJ)C*(-"HL')$.8WA1>F -DUDRES>N[&PM9M-FM4C
MAN+F"8W440"@K&T8AF9%P%9RTJ%L#?X8\U).#T5>WMS%J,-RSRV]M-$+:60L
MS!I%D,T(=LEE3;&X&<IXA'Y+*!D^X8"I=TDQ?R2\NV067\0]CV#ANBV<G$>8
MY2G.U5<-R+&$16!%4#;&,#<S<>4Q=-I_5.HZ=!X4*6[LJ[8Y94=G0<8) D57
M*@#;N7ORX?D';WW3=AJ$PEE:=%+;GBC=51\\D9*%U#<[MK \^R5/-9ECV#.*
M8,HR.;IM(^.:-V+%HB'*DV:-$2(-D$BB(B":**9$R (B/*4-Q$>^N>EEDGED
MFE<R2RN\LCMRSR.Q9V8^]F))^)K?111PQQPQ((XHD6.-%&%1$4*B@>Y5  ^
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MII2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2OE$]M1#.(KBF@+ H
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M?ECN/B.*LW6A:O9:A'I=S8S)?3;3#  K^,KYVR0R(S121'!S(CE%VMN8;6Q
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M(#<8;E-IC<9 VE!RA @*8WM5I:9-M=98NS5YK#1Z+]%$AR$EE&\VQD54&Q
M/%*LH]L\<*D2 YNFH"(%$SDI#U.45HPQ&[)QG@KE<9.>V>.3])XK9ZU)H^CR
M=,:/JUS;C49+ZY>&21U+6,<UA<6R2SL3^)6XN)88U=BHRI<G$;,*[:+HA<VD
M76Z]'G=33Q1!DR;-$A,X4=*'*FD  7XBB"@@(F'E*F7<YA#E$0J5=F6;\GSS
MG&,<GW#X?01WK/T?07T.>[U;4[I(;"%'GGEF?$2PKDMDL>=R@@ '+,0H!.*R
M/;K$_P >VR>C+LD9S(O$&J[>16*)TY!N=D@F19LJ?X3 D8@H'(41%,Q#%,
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M12F-26P"H]J-@/V"FG^1LHTU"E(G1?,91O).7R!1(DPCV9NH]7<*I@)4DE$
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M;)W[J.[38GC-JL142L$))O$)L'JZ)@$4$)!9C(G;F. % 3<^X"[3%2G*M*Z
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MJ_34+5;4\F6FKLW8P+.OMD9!-$JA2RRJ,W&2*C)L0 V=+-HUF_6.0G,8I#]
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MC6WNXI9[PH<L(K>(2;V"X(?PQDM@UJ<R+&NJ\6O$CSEE"[M!:>&-XOQ._2%
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M:F>XN+J1IKF>:YF88:6>5YI6QV!DD9F.!VRW'&.*ISQ&%3QBSM(14666.6-
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MY8"Z_P US$ZEEY['(Y[557$FD3&#MR4"%2)8?"%*4A>F!"SR;<$P(  7D H
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MB:_*HBJ4Z:A1$?JF*(:#(&1P<CD=QPW8_/%6(II8)$EAEDBECR4EB=DD1L@
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M,K8..1G!X]U5I1^DWQ[>U$4TD4(V>E6J229")I(IHOVA"IIID I"$(!MBE*
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MN/WW6;2KMOZ]*(:&W'_C:>1]^1^_/[J<_JY^?'_&HQC(<UIXA$M_['Q<.?\
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MKR=2ZK IV0/G12C71CF_AS T5*386B@)(^%* B)D@ =*5*H/:J:W2$>W\O\
M?%*%9.)$2-@+)>2'<K%9 L[Z0"HV!SU130ZQN0QN<4R@8!%2JVI-8O\ =:TO
ME @!J;*;D6UK 8THQYIU)ZW)(^/:@U$';LSY1L*B_26%544C@H;E P/L/GY4
MJP2S^HH2-22E_+1DG[U9.H"X:@JL#T&!U%AC5.B?PB@L!,45 ,B!DS D!A$Q
M2BI7E%/JFO.6MM$^7!.L58T+:+=J5)V*JK$5(T9%?I$%V(,0,")A46!-,#I[
ME$#%TI5;1F<7&IL5((E@/<I>9;-X@I(PI8SSL\T=%L+9EX4 2<A,E44*N"!.
M58#N!4 @BH*HR._O_P"?[*LKY[5$K7!,7X1_O<Y82JL"*S4#R(1Z((C*@T="
MD84$A+TA73!9/K%+V*<"&V5-<&/DZ*K'7%:.\H"-CI2;1NG18E30&4;-B'G!
ME$_#E!ZN+82>+5$B_7)\ G4$! %*XP2N/!CJ(J4(;RV2>,$Z" 1X @5ZHQ6.
MP&*2\-]X*@R!4J1Q(W%,!Z0F*<P%%4<?K\_?]/ZOU5+$?5,;BYCR>7>^A*\B
M[<B#4H2GNX+XR:0'>=+F,R!^(B#;K"!53 H*0;@;2ISY>^H(LOC4U#D9,@08
MT!+S()$I8XOE!A3D54I$%6 -ME1/)=03@#<XK+&!0G/S%,,\YQSG]?PI]OM[
MJF%Y"G%FZHW6\K&<?,9!2HB+0IG7@$V:*DAY:N"(^%1,R%(5"%41!5$.0"F
MHE"*?;[?77XVD:8:<N#=L,6$['LXI2YF*T*1UX)5BY5BO-' HAXM(C KGH$,
MHL"" F3Y2%.!14X[?J^?]=1"\OC4E%B9)R6$"A+C$!$E5C@&**95ZB2(Z#$6
MP]$2/>D*7WN04%"]0_(!3&!4 @]O/[']]6 SVK>^"<>;P'OF->4=)B+8!D_=
MSS B1P!YTMP9C( 41;]<.94.H"0\HF!4U">:XZ\KOBX!"C%1LA)(WX CP% T
MBBS1-)^:H@V^_P!<6@HD64 C@50 $^8YRB4%/?\ K^WE7.DY*D)-*>I)^4BS
MD92(1I?79%52\U<-%%(<8LG0/X-?PH'!JJ4J((D$" <@B :4^WO_ %US6#RK
MJVB?91X,/>IJRB%+"*+8"/Q9+$<C#@\==(HKD A7 H)]5042F[E(!R;J55U)
MK%H4R0D3^0!24IE="1 8PGE8S(31$5Q69>$V4<#,F(H9<$# 97E<@H) ZFE1
MP?<:L\L]JK>P5=I,>7^\3T\J%5%RU!9Z"B+,IY;R]P*1Q:B+,2 X$%$>JF)4
M]SB(%TJ:]<4_J*[ZVI1/EH/F#XB=P%!J"2@OACD5"&D5!1(#LX1_3+U!,L4J
M912$P"0Q04J"1F<9&K-2>(^1!5W\U&M:@ 1Q2L"SBCM=.-".:BV#P;LCPCCI
MK=)$4505.8Y-S&%VI5A6>U4MO91ZWE_ODI!.W+$3-@-)A D>(D=@F[Z0BFT,
M\Z8F;BL7J*%$X)FY#&!2HEK*8^/6;2\:^3!5V3RPI6OIL2D8"];"?WA\P;>'
M ':A]S"Z/TEO$@8-C*@(:?*HSQGX9KW'DJ*"E$ X1/4DBB-!W9!N4OE K#Y2
M/0^\"^4#R;?>X"B8J =Q*32G _=^_P#X_6:Y[=]5#6F99-_+@M;>(CUYH2-0
M+(##J*./+P<NND KMRG!<4T15.*7. B0H'((JG[?75>"8QD.._-@""'''2$>
M4(T/)>EYH*(@$=X7T\UW'E!MN+C[KMN//I2K X?5,MH@V3CRX;4YB9)>!$[4
M#/PB$A;>8^$==$>@W,)FXJ(@JGU0+N4A@(?92N$22HHK7HI B.K&)D-?OO(H
M"*0Q1UB#+CT-GQ/*2*% !%P (E41VWYB"^WV^NHSW^6?KS_57H=2N/TZO6'K
ML(?W5>.:\2K@HP S KIR*?N]X%KX<?"G(/3%J?I)>& -Q%("CLIQC/EW]U2R
M3VJFN#R/1\O]\TX!JY>"5J 28U\[U9-J"CSI )V@/@5$K?KFY%# H*8 8IA5
M-5Y:8QD6KVYZJ$$-58RTDWN #'%,P-+IKMR27F#4&P^,=&<'; HJ"2PK*"F8
MASB "#';X]JC/!/NS^JIV6?U%%U4RR_EHNG\B"50%PU*L8)(6"RA!CC]$X-%
M18@J4BH"B'(8$P.!C%**I'88[>5><4]JJ]@M+6)"/]XF)HD+8+=J"3T3+L3*
M1'F#CI$%ULQ*<&XBHJ"*8&3^ =RZ4KSJ+RL/X-NYIP, @3N'Y6P1K4&;3Q";
MYP1^)$ 20Y3F?%<&5/TPZJ@F5 3 <#"I5%J+3HY7S"[V#[\0H ;_ #'P\&]3
M_)MW_'^;2H\\>6#\O+Z^_P N?,UB,T2'T",6 EVY;NFN)=MM]KLJO\]_M_\
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M!QN/Q/ ^W<]_CFIMXPYK#P\J[;^7QLP7\G4JC!+_ *OI\]OQ!J*J]W_#]?\
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MS\07U[?;Z_CT'<?,>_\ =S]50>Q/P/?Y>=<]S'CXOAT';^QR)@_( U)%+^4
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MSG%?*E[3(Z2W'A9S(J$53\Q@2 HD<IR"9*G0*9P Q1,&Y#E,4P;[E, E, "
MAK[ ]&7'05CG_N[@_P#QER:\QZD5DU_8ZLK!E)5@58!K>%E)! (RI##CD$$9
M!!.,^%@2%X],7'.<I"ER-2Q,<X@4I2^?M ,83&$ *  .^XB >NMIU7_]A-6_
M_P";>_\ ]O)C]>/HK$TI=W440 +,9(555!))\4'&!R220 !R<X'E7U\LXLI<
M<5%F(  -K"S7'?8"E DP^6$P[[  !S"(B/IZ_+7Q9G\KXY_:#7K&"-HP2<@
M*"23C  Q[S\L]N_>V+'925^K\@R=-7A&D-,-CJ-5TERIG4.D(D,9(QP*;L.Y
M1$!#;N #J"".X(^=798)X'59HI82R[E65&C+*<^UM<*2O;# $9R,U#M08L8;
M(+!P[:H.)>6LRC=NJX126<BZ8)D^X)'.517<1$/@*/<!#Y@&IP>_V%3'!/(D
MDL4,SQQ?QDB1.\<? QO90548P?:([_5^JLB(QN+3*B1)*+58J*'4$"$2(E%
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MH"80#OMON(!J1VQR3D?'. >_UYJA$>21$B1I'?(5(U+NQX("JH+-Y\*#QSC
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MN:,:26$Z@+"R/&*O3P!7?8Y6A7!$W0I]0#&3/X<1\,84=2RH)=^!N*%L ?$
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M3UUWA9*NV4'4:4QG+43L81](,WHH")TP49O&J!RJ;;G(=1#<07, I DB L,
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MS07*"XADE.,RE7]H2G W2(RN_ <L  /"NXYJ-7C7\7&129D)8!"75>F%XYE
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MPJ"4O++RN_#'CW 8&??\ZOZKU-J^L0Q6UU.J6D++(EK;1K!!XJ@@2LJY:20
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MYPQ6*XCD))\L]9QZY#<Z2S=NH.QU$#  H'=&<BD<I5$^50I3A49I"-N<9[D
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M9=Y9B8*'R4PAY=O.$I<4^?LE 5CC2<G+/48Y4N_*JU0.N"?53WW267*NLB8
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M.!@9 ) [8![XJNPZPUO3X4AAFAD$*!()+FWCFE@11A%1V'M!.-@E$@0 *H"
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MFX<RYDSHIR4FZ.]<MD%  %$FO,!$6Y5 #E.=-(%CD$2'5,0>74M*[C!(Q[@
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M_D,HXKB53&E1IRCQS$QYU7\@D+=[(R*QGSU=L([^%$ZH FDV$0 3HMTDB*F
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MNVY2"W>0;D5 GW!SE/U3(R*8I,6O*"7.T46< NFJDF7YX_Z0#[N+J[T?:U_
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M 'U6NJ8YDTI)L_G")-4&:I'!&I5DG"SA9(P'2*<4#*(D1*< .H(J&.<"@F!
M XG)@W^L0&%XK4F1Y5*%RK*J*P(8C>%8M@D+A0 ?:W9 !V6FZ#<+<1S7@6-(
MF#B,.KN[J05!*%E"9&6]HDXVXP<C..N7KL*:4II2FE*:4II2FE*:4II2FE*:
M4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2L29MRO%X;H,C<)!
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M_4BS)6L0]2T2-F<@'+]H'3I$=/G()?V8&* D#N;8 '2E?GTCO7?Q0.,\ESR
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MHII88R0F!-_<)P[!RYDU3]OJ)-#G_%I2N-]*<2Y^"%K&1YU<?J)-\>6N#15
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M^WR^S?;\6^E*O]@I,=97I'<E+W!NFFV3;D80%UM-39<Q%%5!<J!59:&=+N%
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M9H#A3<>BWZJH%.).0S\((_S9_P#6+_9IX'_C_P#3_P#G5,?0/(?NB9_O!?\
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MST7'S4/(H<_0?Q<HT1?1[Q'J%(?I.FBZ*Z?.0IN0X<Q0'< SU8,%93PP# _
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M)G(!BCO)8Q+')$Q(61'C8CN ZE21\0#7.P2F":&=<;H9$E4'D%HV#@'&."0
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M@U;,6#5NQ8LFZ+1DR:(IMVK1HV3*BV:MFZ)2)(-VZ)")(HI$(FFF0I"%*4H
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M64BV[NONC2Z5O[YVN"29 NUGC8Q/B8+(L)\$X]L^*Z(!P6+*0"IW5=^\][E
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M +74]S/Y7VE]-:HO^9JO36D:DA^E+I36<M4UQM="?%$DHEG[)Q52&(89Y-4
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M$]95C\/P*CG(F61?WUR=K"4@EJI].>XXCY>8D&HJ2EV9MHLCJ1,BCJF7)4*
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M@V'L/?5)5AW!'S!'[:T&J=/Z]H;B/6]$U?1Y#@!-4TV\T]R2,@!;N&%CD<C
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MTPZ4?<UXAS4F,JW=W/7;I7AC=XS_ )5-;.5C'BR%9D2-UA:1<QA6)E\)G=
M^-@.;!TZR:.XECCF&+*VO$$DQ\")7MWEFB:X2$CQ=ZKX(F2-9,F,-XA6J=PK
M<57&G8*GPY4UAERNY:LZ5#XRLCYO:SV)I-_D1Y/\-^0\11\)P[^,+=6XUV]6
MEM=WS(UHE&$@YC(:R1A6E2>NX1D\=4VMS>,EN@E$K[+R28-$3(6MY(0MN3O&
MUW$A&X@D*PPG -7+VST]'NY#"\">+816VV=?""W<-PS76/#.^-#$#L5@"R-E
MP&(%=I/M->):8X?Y"^7/(.+HJ6LUMP;7*W8:53\<3[V@7G(&/,LVS(6-,I0L
MYG2%JV)XNOS%$K\?49+(TXYR8^?2KO'KZ@R%MF8*984)J5R;<R/)$"SPJK(L
M3F-WCE:2*53.J1!6C 4R,9,DQE"Q5A7)I%HMT(HXIV$<=R[K))*@ECBF@CBF
M@9;5GG9UE<R+"HA 42B41JR&7J/'OQ[96C\:66NRV),>-9X/9T5BPUZ:P=:;
M4"UFXU85["WJS(O?I,K3R.A\86% EGBJT/6</ .2$F[(V9HJ+.ZDOKV41,K0
MH&&GJRM"S M>@J[ ^*I B;V@O<]F;'>E]-TV%ID<3RE#JKHZW$<?L:>P:)"/
M!D#-,GL,_&.75"< ;:*\8/$+$>SN:9VFO=-'+4=G::PA?,CJ4&:/2:12ZWQ>
M3O#U9^(.7QNRG1D31=;QY"J9'E(1*Q%AVKWJNW#PM:;+HZRO6[@6'C':)1.8
M))-AV(BW1@>X,>[.%C'B%=V >2=H-80L;9M4-LN\P&V6YCB$B^)([V"7:6JR
ME-NYI6\$-LW$< >(16L&-,@YXXI^+7@8FKU?H&TXPI&1>.E2HVJMXXFX"DYU
M@\(O\21] S:R9$NJL6W=6!E<)*OUF6;#+UUF]K-GG:VC)1EP\)%XT<D]U=61
M>16BCDO=K+&P2=83$(Y@-^,L'*HPRH(=ER'PN9+%;6=CJ2QQ,DTD6FAT>56E
MMFN!.TMN3X88A3&K.OLN0Z*Y4Q^U]">M]7,4TI6ZS']9,_\ >K?_ .B37E<W
M\;+_ *1_]XU['!_$0_Z*/_<6N5JW5VFE*:4II2FE*:4II2FE*:4II2FE*QY;
ML18HR J1Q?,8X]NKA,0,FXMM+KEB73,4.4IDUI>->*)F*7L4Q#%,4/JB&J@S
M+^2S#Y$C]AK?:5U3U/H2E-$ZCUW1T;ADTO5]0T]&!.2&2TN(E8$\D$$$]ZIG
MZ'+&C3_6ZID*D%)W;-*)E[*M1@FAP[%.C486XM:<?D#X2I.:^X;\NQ11$H
M3O;SVGWY123])&?UUMOP^ZAD_P"WKH6L$Y\276NE>F=5O90>X?5+S29=6&3R
M6COHY,\AP2<@Q5D>-^Z5_B,R2?I]FT9=*UB:UP:1/4"+GCL?U.Y/=A["JYNI
MUS%W RPFY3%;E\T7Y@L#GZR/H %#U-H%Q[-]T#T\N[^,N=(U'JC3+UCVW(+C
M7=4TF'W[8]'" XPF,@_@-.)J(W5">P7D H?58*52_8C4$ [ 52:3N&:4S'.
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M=PW;$!1RNBW3$Y$P475(D05%# 1,@'4,4O.H<0(0N_,8P@4H"(@&F0.YQ2N
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M4V7776VG1"WL.K^I[.W&/\FM]>U2*V8#@*]NET(77'!1XV4C@@CBH4>&[&B
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M.Y^_UO/!JW3B0J?86>_UC3[71/&;!BM=7N\, S9SP @( (" @( (" [@(#W
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MB=DF4I]F&PB)7\"XK2,Q'J  ")DGK%!0H!N8@!I2KPWX)LE&63*ZLM'1;B8
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M0C3^#'K/^C(O]H:?_B:?A=H/YV_Z-<_W5/TPI[*G\/EF_B4S)_0C3^#'K/\
MHR+_ &AI_P#B:?A=H/YV_P"C7/\ =4_3"GLJ?P^6;^)3,G]"-/X,>L_Z,B_V
MAI_^)I^%V@_G;_HUS_=4_3"GLJ?P^6;^)3,G]"-/X,>L_P"C(O\ :&G_ .)I
M^%V@_G;_ *-<_P!U5%F_;C>QDLMHBKK8\B$L%L@FR#2#GYOAXRK+2<*BU>+2
M#?RAP_H+@T8LD]<*N"N6/0<]0P"*P@0@%?P8]9_T9%_M#3_\33\+M!_.W_1K
MG^ZJ\&_T0C[*8XD,?/-D,9(PG3,;"68S"F<2'3$Y!&CB)#"FHHF)B[")#G+O
MRF, OX,>L_Z,B_VAI_\ B:?A=H/YV_Z-<_W5>A3_ $01[)Y5RW>JYRG57C,C
MA-H[4P;F [EJF[Z0.DVZYJ**J!'(((@X(D<I5NBEU -TR;/X,>L_Z,B_VAI_
M^)I^%V@_G;_HUS_=5R?TPI[*G\/EF_B4S)_0C3^#'K/^C(O]H:?_ (FGX7:#
M^=O^C7/]U3],*>RI_#Y9OXE,R?T(T_@QZS_HR+_:&G_XFGX7:#^=O^C7/]U3
M],*>RI_#Y9OXE,R?T(T_@QZS_HR+_:&G_P")I^%V@_G;_HUS_=4_3"GLJ?P^
M6;^)3,G]"-/X,>L_Z,B_VAI_^)I^%V@_G;_HUS_=4_3"GLJ?P^6;^)3,G]"-
M/X,>L_Z,B_VAI_\ B:?A=H/YV_Z-<_W5/TPI[*G\/EF_B4S)_0C3^#'K/^C(
MO]H:?_B:?A=H/YV_Z-<_W5/TPI[*G\/EF_B4S)_0C3^#'K/^C(O]H:?_ (FG
MX7:#^=O^C7/]U3],*>RI_#Y9OXE,R?T(T_@QZS_HR+_:&G_XFGX7:#^=O^C7
M/]U3],*>RI_#Y9OXE,R?T(T_@QZS_HR+_:&G_P")I^%V@_G;_HUS_=4_3"GL
MJ?P^6;^)3,G]"-/X,>L_Z,B_VAI_^)I^%V@_G;_HUS_=4_3"GLJ?P^6;^)3,
MG]"-/X,>L_Z,B_VAI_\ B:?A=H/YV_Z-<_W5/TPI[*G\/EF_B4S)_0C3^#'K
M/^C(O]H:?_B:?A=H/YV_Z-<_W5/TPI[*G\/EF_B4S)_0C3^#'K/^C(O]H:?_
M (FGX7:#^=O^C7/]U6<<,>V7]FCG>=9U>D<5-+C+&_7(U9161XFWXG\6Z6,!
M&[1G+9)KM7@'SQTH8J35FQEG+IPN<B"2)ESD3'77_0?5NFQM-<Z-<-$@+,]J
M\%[M4=V9+26:15'=BR  <DXYK)MNI-%NG$<5_$KDX"S+);Y).  TZ1H23V 8
MD]L9KL[34(J0BJ1R*)J$*HFHF8#D4(< ,0Y#E$2F(8H@8IBB(& 0$!$!UR)!
M!((P1P0>X/N-;RO+2E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*
M4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI3
M2E-*4TI32E=+OMIO:=*^SSP3$1&-31SSB0S3YO$XR2?H(2#*DPD4FW)9,F2T
M8L"B#XT,>08QU6BY!,6,K87A73I"2B8":C7'?= ](CJC4G>[WKI6G['NRI*M
M<2.28K1''*^)M9YG4[DB4A2CR1N.:ZEUPZ1:JL&TWMSN6'<,B)% WSLO8E2R
MK&K<,YR0RHRG^=A?L@7C*EPL&0<DVVPWJ\6J06E;':[3*O)J=F9!<0YW#Z1?
MJK.%C%*!$D2"<$F[=-)NW(D@DFF7ZCMK6WLX(K6T@BMK>% D4,*+''&H[!54
M #WD]R<DDDDUY!+++/(\TTCRRR,6>1V+.S'S9CDGW? 8 X%5#5^K==C_  9<
M->(KQA_,O$7FR%M&0(/'N1L)81QYB.K9+J>%V=TREG-_9$8F2R/F*YQ<Q!8V
MQQ5XNL/7,E,NVK-NZDGS(K^PUZ)8R+M7E-?U:^MKZPTK3Y(;62ZM=0U"ZOIK
M2>_:WL].2(NEI86[QR7=W,\RA8U9BJ*Q6*5V0#<:=96\MO<WERLDJPS6MK#;
MQS1VPEGNF<*TUS*K)##&L;%F(&6*Y=%#&LKY*]FTN>8XC+>X5A^$6HX42P$W
M)BS*&3&?$C9;%:>(B@66RXUK^.\DX$J<A5+I'7>;KC5"!DW:,:A!0%F;25FE
MNE7Y=VKA6G5@$>E0#?KD^H'4CZ[:6ATF*.'2[F*&[ENK34IEFMWMXY6,J*7,
MDD++"GXU%%^?1R&O9#MT^.U%I^(GG%Y([WD,CP)#/:1&.42-&-K$*$1PSM[#
M$\\?8_79W=V..:]Q(X/LEQA,_5GA<S+',661F#7$.<KS5K1-TBLNY2<J$6QN
M<-8+%497'OO+55'39E;O#I*-%8M0TD2G\.;=;=KJ72=0A@DTR;6+!V>U9K[3
MK>:&.XF5(YG:WDCBG2Z\*8 M!DA@XVU/X/RF40I>6KR+=I8W*@3*+>[E21HH
MRS1 2*[Q-#XD9($F,C;[5461]E+F&I8YJ.7,GWZC8SQU/\.DAQ$V*Q3S*UOO
M<%@VR!C>B1]!LD9"0LA*'O<VEE['-IC(>.:.UG$#8DE44UETTTW&0G6EA/=3
MV5I;7%W=1ZJNEPQ1-"OK3&VN[EKF)I)$06T9L;J%G=E EB() R1:.A7,<,=Q
M/+%!"]F;QG<2'P@)H8A$ZJA;Q6]9@D"J#E),C)&#N+:?9=<*=-G/: 8M-Q%5
M]-3 LQP>1U*S9?HC+1/HNELR7&XQ%JI-FJU,IS9"]6*P,F-7,QDX>M3%5B&$
MXR7]X(A[&V=1EHH>L=:GCZ9O/O5*?OE'KKW&GVKV1]=2P@MW@N(9IYV:VBB9
MY@R/+'-(T;#PI%>$-LI=#L(GU:W]<3_)6TX1W,RW&8&N9)%DB>.*,"5W C(9
M4:-5<$NA63;TD9XP[:.'K-.5<%W5>,=VO$E]M&/I]["+KN89_(U:7=1*\A$K
MNF[1TK&2 M@>,3.VC1WX5=('35LX!1!/T+3;^'5-/LM1MPZPWUM#=1K( )%6
M9%<(X4LH=<[6VLRY!P2,&N9NK>2TN9[64J9+>:2%RI)4M&Q4LI(!*G&5) ."
M,@'('8=)^R:NS:N$>P_$#ARR7>/A.$ZZW+&<<PR*WL5*QUQ>R-%KN/[9)RDE
M4&=7E%X>TWZ'862OU^9E9!E#J(3XG*1XBP#EDZUMS-MDTR^AMVDUJW@NV>U:
M*XN]#6XENH$1)C,BR0VSM%++&B-)F+'LEZV[:#*$W+=VSRA=/DE@43!XHM1,
M20NS-$(V*R3*KHC,P0A_,+7,4]E*FPMUGKTWQA8&BX2MYVK7":%S+6,TR$+*
M<5U@7L!7N'&C=ICLTF1G3FT(W=7#)2S4M%8^>1C>)DIM8K\&<#K,M!#+'H6I
M/)+ITVM>KF:P21-%B$16_8M<[-T[2%8+0-ZRWAN72/*AI.@[9'1M0M%5+I+#
MQ-ER5:_??FV4" MB,(#).0(1O4*SG.,P./9Y4"L8#@#VVC0S3,53X:_:$6K,
M]@D<AWMG&0]]X8>*VN89BK3#QL%'V-E/+4^(=R,:A5&D97X6V('5DY1\,HV:
M^)P1U1=3:E+X%Q(;&?5NF(;");6V9Y+;5]$EU!X)'D:)HA<2*C&<O+) 0$1=
MA;&2=(BCM$\2)1<QV.K27+--*%6:RU!+574(KAS$I($85%D&68[@,YFS5['*
MKY*RFVHG"E.5B#H^*\?\,=0OEZ953B?R79+GFC/^.(Z_QT]>8)M4;&VI=7-#
M+#<K#<JW%UW'5"IECJ45-,1O'GD2SU^G]>36EF;G68YI+B\N=7GMK9I](LXK
M>PTRZ:V:.WD,\1N)O$'J\5O*\MU<W$,[QL+;PY&R+GIU)K@0V#(L5O#8Q2RB
M.^FDENKN$3!Y4$4@BCV'Q7EC5(88I(U8>+O4:$H^S%L,9 86=7K/./:M><YW
M'+]/IV)H"@YQRWD)RO@?(F1L:Y*>M8?$.-;KYHFA8*"W;U1NP447M"MD;& (
MR,A+#+1W2GJ^)I;\6VFW4UMIT%C//>RW.GV-J!J5I:7EHK/?75OLS%<L9RP
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M:.V"@R2=_P##JU6W:[FTR_@MI=,O-6TV61K4G4;2R>-9BL:3.]M*5ECECCN
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M>KXW?Q._V_"_(W<[<UBW6;5BFE*:4II2FE*:4II2FE*W/X2^ #BBXV;(C7,
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=Q(<%HX0>>2!ND8!G  "HI93W5ZX"NEII2FE*_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g904779g47h68.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g47h68.jpg
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M  ,!  ,           @&!PD$!0H# 0(+_\0 .A   00# 0 !  8) P,$ P$
M!@,$!0<  @@!"1$2$Q05%AHW5E=XDY74UA<AN!@B00I1<;<D,3AA_\0 '0$!
M 0$  04!              $"! ,%!@<)"/_$ $\1  (! 00%!@L$!0D'!0
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M-GZOAK:A )P?[U$A,$-DBLR^,5V>C >5>I0&@=#EA .1<^4Q323VDVSZ_/\
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M6>M'**0;#;233EQ*F$^#P_T>XI&8Z_G2[@R^^M0:J+0J":"*5O.PZ]%.A@E
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M7GHRTG$4U)3&TW@]W"$^QN,5B<_*E^7SJ(D^.+HCL7WLCD&W+N .<H.QTN9
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M $A=5>_1[_[^?3YY[_\ /GGO_C!5O[/>BD,$& , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8!B1L? M:#SDML<U$J_%&2S5N\)C8CAQ0>:.'R^C5D@YFIU
MXPC4%GCE1-NU25<Z;N%U-$4M=U-M=?0,?\NJF_8>/(?+:K+V EA(D/HJ<\/!
M7V'DP4.^Z_F\UCY/R5^Y/1(5^_,?S(1MEU(>#^^-?Q-XU^\(_7"'E&/ R:+-
M@R<EE("$+AB8G4A^&+586+GXJ0EDQ4C4>(CQ,I&M':SS0?G58Z02AIK9'R-E
M%&#S1BY7V:K^: >GD;8JR'D#*)EK+K^+E:Z@FQ38,9(F0ZRD 49>-U';,B,F
M3F22<C$$[:HJN6TO-IL8]=NDHLDXW3TVV\ QI?HKGUL.A!>YO6FVXE9LEY#U
MN4+V<$I#M@R_KC9IY%!$VI.:QI9)>NM=FWC&!<OW7KC79'Q+[3SW7 A\,LS(
M8^W:HEK F*FBK/KR3M0>C]):?K./-1M[8$'%*ZMMTY.8#&TFJ1QL>IH]9[:/
M7L:@VWU=MMM5??%TO=PAYQAQ../_ *@EZ\C^+:]>,';EB[2Z6"OLG3-=5LX2
M^TK2X$E/LUT=]%=/KI[[I[_5V\^MIOMI[].NWOGOMG[#K.BT^U#5FBTHHM**
MEIK:HKI5=+C5_2K4TU)IPTFI6#2>:/5/VW6E=G]F&LU=G779UT_R+LUT5.BI
M3K#HE.*J6FI3:</%-K)GQR?G(O\ VJ)/ZY*?W6?07D-RZ'=?5[+X#Y_\NOO3
M+UZQ:_&/SD7_ +5$G]<E/[K'(;ET.Z^KV7P#EU]Z9>O6+7XQ^<B_]JB3^N2G
M]UCD-RZ'=?5[+X!RZ^],O7K%K\8_.1?^U1)_7)3^ZQR&Y=#NOJ]E\ Y=?>F7
MKUBU^,?G(O\ VJ)/ZY*?W6.0W+H=U]7LO@'+K[TR]>L6OQC\Y%_[5$G]<E/[
MK'(;ET.Z^KV7P#EU]Z9>O6+7XQ^<B_\ :HD_KDI_=8Y#<NAW7U>R^ <NOO3+
MUZQ:_&/SD7_M42?UR4_NL<AN70[KZO9? .77WIEZ]8M?C'YR+_VJ)/ZY*?W6
M.0W+H=U]7LO@'+K[TR]>L6OQC\Y%_P"U1)_7)3^ZQR&Y=#NOJ]E\ Y=?>F7K
MUBU^,?G(O_:HD_KDI_=8Y#<NAW7U>R^ <NOO3+UZQ:_&/SD7_M42?UR4_NL<
MAN70[KZO9? .77WIEZ]8M?C'YR+_ -JB3^N2G]UCD-RZ'=?5[+X!RZ^],O7K
M%K\8_.1?^U1)_7)3^ZQR&Y=#NOJ]E\ Y=?>F7KUBU^,?G(O_ &J)/ZY*?W6.
M0W+H=U]7LO@'+K[TR]>L6OQC\Y%_[5$G]<E/[K'(;ET.Z^KV7P#EU]Z9>O6+
M7XQ^<B_]JB3^N2G]UCD-RZ'=?5[+X!RZ^],O7K%K\9_HV\G*JK\L<TKKJ*++
M+4!3:JRRN^RBJJJE=#FZBBBF_ON^ZF^_ONV^^WONVVWONVWOOOOON?,77)*G
M6_6JFE*FFG633BII2222TI>DDDL$DL$E@D?3/4YNK5'5:JINJJK5S0;JJ;;;
M;T9=6VV\6V\6WBV9Z[MNJ6%A1M2/K-KUE:TQ'*S$163LT&VUA2L2@BNX7E(T
M+6DM"1]'(MVSE=5ZUC56R:+==7=7S1)3;7QL\C/0(=#T Y@SPF;7E3S@;JQ_
M[%6>0H68%*P=<2FJ_K;V-/)9.;V8"#_QSKLW]9D+B.<>+^>I>I_:>>ZX+#X,
MV0.D8\7P424"<]#% S/L&\K!$0[*,9N"FHQXGXLTD8F7C5W,?(L'26VJK=XS
M<+-UT]O-TE-M??/<$/<X!S@^4.A[/Z+H&LZ\J:-6?$;?KSD0SE'Z4>,S.@H&
M!5\AA"9&[N ,%DQ\C8!H^S>D+X=D$GR,VU8*QN\<_3<;ME!NAI-SOIJ7:VLO
M.<J^>>7.@N;;*YK6L?CZT+D&A1G\H-.7R[K)*D%1D[D.FNA:@,Q>W8FOR"QZ
M[&PZFK3"XB;D?*^'VFJH-HUD1?49<?8:.GPK::JQS=$3.2I:>4Y2EUYEC?'I
MQ5T=S%5UG-1<F'0ZRY?IV?"?S/T8&2UURD]P[SRYE:AY7!0_:O[=JOT7]:5+
M#PI&/3,\_(_6DJ5%S\A$7LI.;>L1&Z6U@VME9.)J>+;E/>VNQ+&$<TS[XZOD
M2:V;TT9F]1U3;[NTP+EJRK:(*LL20D7/1Y)5OR N;U,JMCXFS1NOV+*1842Q
M3KV$#9IVW$6%?"%3!K(K(GTB1>18UM+92G+:PC*:(3E?^J7QG&..,V!P-U9*
MMNE"E+C,I*!?L*K_ )%:\H"HE7U,IRG)!WTW<M6D=5'5CQ3\]3&*\83\0(R!
M^2S-;RA=*AC^/;03YOK*OM4?0VDFE."=$X85*E8]L9)-98X9%9\B\?=55S\G
M.UGG-1$OE;Q-J]<STF0SN@-O6 _%68 5V-BEYU=8<?8C^W#JTKYDP-OO8=8G
MPPJ$5BQ*BA,4AA%Y"-) E&6ULI)XPISEM3APA3AOPZ\-Y?\ J%?_ .)0'^)8
M'_\ K>WL]M_87_2GJQV:;_R]I8]2?;C_ $7:T?\ TG^8M$'QDY]#3Y[C & ,
M 8 P!@# & , 8 P!@# & , 8!]W!55MPVSPIQK 4*WG(FU6=94G(B]I1-[$-
M(,:<6UIMHU7.R%N/CQMK;\2FBY]BO*<) 0H#S![(-/S%Y!-6.A%&?+S73^>&
MMG_R73O_ )2]'T]U,_FAJKE_-K0>:_\ :[K]3_\ A)%S\^="V3V3S-"65SX7
MEZ//PS E$IW?4=;42$N+VZN)JI?U<P/[!\_U5AK#K:CJ7C)UQ.20L/19S-$Q
M,SCHZ-AD1@+BDR;QKZ_U^D>3)I4N&I;C9<OQ4Y6Z)GSKJED(5_P=U7%L^9#Q
M7BXO%1GDNL_C>J_H6ETWE+K$/5IGS+:%ND5Q6("0L;8*XI8<:/\ IB-G@[,V
M%-C,P<2"KR/C&RKZ*\U]&G53BD\W6UGXJJB%BH4XS$]I] OQETX?T5R ' UE
M"2E=D+ZQ>@[%95DL\AGRU8B%N= V;:0)7SI<<?R@^F_%@TO@XV480DB]B8B3
M3>1,<[<M&**Z@Q4TW@Y4)3QA)-^=HOG!D8 P!@# & , Y5_+7SD4=9T[1% !
MDY #9(=]*1VT=-$_LCK!L_!:A[],GGWWV*92+_Z7#$><M6WV#-7_ /+70^U^
MS1^T5T\V^SK6>Z:FZXZ(UCOUWO-ZNNCEI#PMA=%9.\5\KT7?;C1X/PUI96?B
MVEYHKKVJZ?$IJB:H3\+^T/5F]ZXZGZ8U<N-XN]UO6D/Y/\%;WOPJN]')-*W&
M_5^$\#9VMIXUG=JZ*=FBKQZJ9BF6N*7Z.KT]^^^AOYMA?X9GZ@YS6J?D#6+T
M=&_/GYBYM.M?E[5[OTE\B/T=7I[]]]#?S;"_PS'.:U3\@:Q>CHWY\<VG6OR]
MJ]WZ2^1'Z.KT]^^^AOYMA?X9CG-:I^0-8O1T;\^.;3K7Y>U>[])?(C]'5Z>_
M??0W\VPO\,QSFM4_(&L7HZ-^?'-IUK\O:O=^DOD1^CJ]/?OOH;^;87^&8YS6
MJ?D#6+T=&_/CFTZU^7M7N_27R(_1U>GOWWT-_-L+_#,<YK5/R!K%Z.C?GQS:
M=:_+VKW?I+Y$?HZO3W[[Z&_FV%_AF.<UJGY UB]'1OSXYM.M?E[5[OTE\B/T
M=7I[]]]#?S;"_P ,QSFM4_(&L7HZ-^?'-IUK\O:O=^DOD1^CJ]/?OOH;^;87
M^&8YS6J?D#6+T=&_/CFTZU^7M7N_27R(_1U>GOWWT-_-L+_#,<YK5/R!K%Z.
MC?GQS:=:_+VKW?I+Y$?HZO3W[[Z&_FV%_AF.<UJGY UB]'1OSXYM.M?E[5[O
MTE\B/T=7I[]]]#?S;"_PS'.:U3\@:Q>CHWY\<VG6OR]J]WZ2^1'Z.KT]^^^A
MOYMA?X9CG-:I^0-8O1T;\^.;3K7Y>U>[])?(C]'5Z>_??0W\VPO\,QSFM4_(
M&L7HZ-^?'-IUK\O:O=^DOD1^CJ]/?OOH;^;87^&8YS6J?D#6+T=&_/CFTZU^
M7M7N_27R(_1U>GOWWT-_-L+_  S'.:U3\@:Q>CHWY\<VG6OR]J]WZ2^1'Z.K
MT]^^^AOYMA?X9CG-:I^0-8O1T;\^.;3K7Y>U>[])?(GU9TF#R%8TS4E;2SMG
M(2M>UB! \F_CO5_8][("8K$P+UVQ]<I(.?6;ES'J+-?7""*_V&^GVJ2:GUM/
M/Q_I_2%EI;3NFM*V-%I9V.D]+:1TA96=KL^%L[*^7RVO-G1:;%55'A**+14U
M[-55.TGLU-0S]>:!N%IHK0>AM%VU=%I;:-T5HZX6MI9;7@[2TN=SL;O:5V>V
MJ:MBJJS=5&U335LM2DY1L[.TG=1@# & , 8 P!@# & 3=>7ZS^-OXD2C_B#U
M7@JRJ[/>BD<$& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M6Z:=G023F?))$/\ -'Z;I"'B"!DGO))Z./L^*ZIR:37;,?D69@R, 8 P!@#
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M\QR+M1377734I2N]YK2EKQK.[VEI0\&ONUTTN,G$--2BH,T<<8 P!@# & ,
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MY?K/XV_B1*/^(/5>"K*KL]Z*1P08 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@$E=/EXP!E_(I693<>.#D7TE/>2$S*+>-V+/U]R=U%'-/
MMUO?/?-/O#YVV:I?3Y_W++IZ?_O;,5UT6=+KM*E313$U/)2TE/:VEYSNNA="
MZ6UATC8:'T)<+SI/2E[5MR:XW2CPEXM^3V-I>K;P=$K:\%=[&UMJ^%%G4]Q0
MP2?AED0OI$"$D450?CQ>/]E(=QXZ9^/6NJ6[AM]KYYYY]JCHNCMOK]'^WBFO
M_OBSM;.UIV[.M5TRU-+E2LU[3JZ>U<T[JO?_ .3-8=%WO1&D'86=YY)?;)V5
MMX"U==-G:[#;\2MV=:I>]TO@9?FSLHP!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# (H->\JB ^E!WE*9!NB7=JEOFKH:5@>>[1G@>;@&ZX8U(3&-/(V 7
M&G@2$/3X88GA6@]WAA!Z_P#6LXZ:*HJ:^#2I;3JE0NO'?"CBX<&#C'RD\<F]
M&DO006<$Q:##MX0W.+>.'J_+Y,X+;C*G8RV!Q ("6\5M/DZA^B9#$J&2K%K^
M"S4%+H3:<BE&).G* ;+E+BI\V;?FASPAE5N;V!HFE5+[)V9T'!#4;\)9.+*:
MX.HRQ8E#U;QI^#O:O\@%S[<HWD-M(UH-L1][+R;Y9LC$M7_CMINN,QN]Z_/(
ME,\^4/E:N:$IOIXB6N!>B;J$XH^B+)':,M(J%P8%F'X_%LRRVI@=&I*-K6,4
MD2B&:(H$KMK+/U%G6\5&/T8R35:"[+EK>I34K=GOQRW&Q!CO;G$OZ-<<OP<Z
M6+6%J3'0'&3B]?F#2L"6RJO&(XTLFLA:S'$2F)3QX"BDFE.$<&QD5/6;=I+M
MDW"\C"2[)D$.)]ZGMC..N.'%$V_+O^I2C?XE(O\ ^B[[S@Z2_8K;_I_WMF>\
M?T;OZ9]3_P .L/\ E?31^O%-NU_07"MBW5:T]J,5O5\U81J:3^S)_);1@_!0
MT*]?N$8V*:O922=>I)_9-(Z-9NG[YTHBT9MUG"R:>W2T3^RO_>U_E2>2_I6I
MO[5*$LWJSH=+M=OI M7G7IFMNG8 UFJ];FL.^K4_?U=8@A8P3/U^:A9S'CPT
M7;P<Z.D+1LY3W<BID+$#)XSW>,',?--?-'7WI)VV;=S/S2TUYU*^NV44)@@P
M!@# & , 8 P!@# & , 8 P!@# & , 8 P!@'-[L?D2Z[OM6+MND[(#Z\*H+C
MGK3FX?DR5"=6=P)GT9*TLL/6 R_!VJVJB .SKF:D/NVZB;AQ,K0::>FS39\J
MW%3P:B9=+[MK#SR19'_#^=5-#7/6H":U=U)0UT5/S<'SM6=G0C,?4C2OFMC)
M 87)B)#R_6]8MP_R*JM !BX$S2'9VQ&$Q745L\F9'9RPF!T:=<QALM-XTS&.
M.*;>_KC'JQLV@^.KVH+GT,A-^C3:Z^@@VE7E9(ZVG8UA;\^R\D^G7TFSD)46
MW4(RMVY$H-^B&P9?(/I$JDX6!C'$Q]#QT\^H,MRVXB<</K?O]BW$4;?')W3[
MR+Q7R#('7*!15'-B4,A;M?3*]OL!/HE"L-QY[2\<8R$; ;S/HA$$D:X+S8%0
M09195-10LR?OWP\WEH>0%=6-32QJGS2Y<<>$X1+[3>M1?'9<H7UD-6D66+6+
MZD:ZZCZG[("8B BRO6SY&U.L:YEP8I"2120VT&F@*"NSBP)<?G(YV]FR%)P,
ML)&&A=8UZL\!U2HQF$GCA"RC+VS&[JROY=_U*4;_ !*1?_T7?><'27[%;?\
M3_O;,]X?HW?TSZG_ (=8?\KZ:-?4-39?T/\ &1?M%@1A% 99;*%I <24SL$B
M2PD=Z1P<+'/4)>'6UW^\1DM'+/(9\N@FH^CFT@K)1R:C]HVTVZ6B?V5_[VO\
MJ3R7]*UQ]JE#X:LZ(_O](%&?&[QP5\55A9X!./ B*'3:X9>R06J:WFCHP":>
MA9<4$(64&8<_M'S6Q3/>?)X":.'[TD3;I1+LDW@89JG&1R*J_<S\U55;374D
MIXQV8+AYN)T3P9& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M@# & 3=>7ZS^-OXD2C_B#U7@JRJ[/>BD<$& , 8 P!@# & , 8 P!@# & ,
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g904779g52v64.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g52v64.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1RN4&AO=&]S:&]P(#,N,  X0DE-! 0
M    ')*^<Q0X0DE-! 0      &8< 5H  QLE1QP!6@ #&R5'' (   (\Z!P"
M4  (<G(Q-3$Q.#$< @4 /4UI8W)O<V]F="!0;W=E<E!O:6YT("T@1'EN86UO
M($9I9W5R97,@,#4Q.#(P,C @4VQI9&5S('8S+G!P='@X0DE-!"4      !"%
MLY"^:\WV]:0; _9CQQFW.$))300Z      #E    $     $       MP<FEN
M=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4
M    0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M
M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\
M;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N
M=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT
M   0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O
M;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP
M $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B
M;V]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P
M  ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0&85<*
M   *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=0
M0P    !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
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M_P  .$))300-       $    'CA"24T$&0      !    !XX0DE- _,
M  D           $ .$))32<0       *  $          CA"24T#]0
M2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:
M    !@       0 U     0 M    !@       3A"24T#^       <   ____
M_________________________P/H     /__________________________
M__\#Z     #_____________________________ ^@     ____________
M_________________P/H   X0DE-! @      !     !   "0    D
M.$))300>       $     #A"24T$&@     #-0    8              B<
M  1:          $                          0             $6@
M B<                      0                         0     0
M     &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0    0
M    5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P
M B<     4F=H=&QO;F<   1:    !G-L:6-E<U9L3',    !3V)J8P    $
M      5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L
M;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O
M1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(
M  9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
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M 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
M 04! 0$! 0$          0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!
M  (1 P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U
M%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?56
M9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$  A$#
M(3$2!$%187$B$P4R@9$4H;%"(\%2T? S)&+A<H*20U,58W,T\24&%J*R@P<F
M-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:F
MML;6YO8G-T=79W>'EZ>WQ__:  P# 0 "$0,1 #\ ]#OZ=G6-RFLSWU_:+&V4
MD-UI#/3_ $=<.;N8_P!-_J?\9_QOK"Q;[\[.MR<7J3'8./D.HMQ!4)#ZVFB[
M'MNLVV,?]J<VYOL_T?\ @K5JK@.MLZ?U[JM]?2^ELS<JUFRW*+G $-!J9E0'
MLQJ/2V[,;-M]3(L]/]!5^C0,@-^NU+9S$:OKH !<I/?H5]K0PAKANXY7#WU?
M6;ZNOIS<_J+^H"T^G;27N-7&]C/T@V?IVUVL]:NFKT[/ZZZN@VOHKM= N>QK
MG!C]]<.&Z&/+*M[/^M,2$K)'949 DBJ,:W[2VDF<6#;,EVYLN)XCW^W_ #%!
MAV,!F28T'P\5-N(]X>'.@CZ Y =XE,:[7 5V'80V!J.!_P!\_P#/B*Y8VD.+
M'07[0?& 21M8';6[M/I[E'&L8QT.+CZ>CFD0]OYP]1GYS?=^8HY5!+:PYNKG
M;&GC:2/I-@_1_/4[VL-=MX$6,<UM3AS[2*_\W>Y[4E)<ZW]"*V:FX1I^[_)_
MK3M:J]K<F@U,M=ZE;BT%[1]%TQM.[=[5 W18#I  +!X$.W._Z6U'LR?M3FLI
M!%;'!UA.G>:V_P#?DE,LG"R[<QE]66ZFIIK)I )#O3-V\..\-VW^M7O]G^!_
M[;@<+J;:WMISHLLR#=ZCZP_;4?\ M*QCG?YCUH'E,DI#C^I5173DW>O>QC1;
M=M#-[@/=9Z;/97O^EM4K+@T$-U=VA0]-KLA^X<@0>"-!P4-]8#G 2XC@D\0D
MI9[F[=27.D:SH)+1*9I@;]?>3 'Q)4FXSGAP>>6Z<D3V/]E(U6!@8]VTD0 #
M(@?O'V^W^0DI3G[6[WC<1V!/M'C[4V,U[W<Z3N<?)WN:&_G?YZC=6]@:8[D
M]MT?H_\ 5R5[MN'6VN6BUTN)Y(@NE_\ 7AJ2F>=<PL:RLAULRV#P1IMY_P )
MN]-!W'TF65[B'$.VL,$$GZ3)W?G?3K5??:'AC7DN) :R!!G_ %=_F*VVL2]K
M-*VO(;';0%T?U;-Z2G__T/2>J4Y%_3,NC%.W(MIL943I[G-+6^[\U<E]6NLX
MG0*3@=2Q+L7)>\ONN<TDN[-EA]WI44M;6W[-]H9_A%VZP?K;T?+ZGBTG%.]U
M)?NQR[9O#QMW,>[V>M7M]GH
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M8@38@_':(U8BUYH!.*^X;TIZ7. @!@) 1F2=DHZ<0+V%Q;)/[U3I1IM@ ;8
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MH"V^Z\:E4R69%4Z*.N=MEF$;QD4E#/%UK:VL=1PU'#Q.?KQ16NPZP;MZ(&)
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M^81254U^6Y-'BRZ2C-JNE169,.TO)+55"D1Y#(/,.,1V?C[5Q#9(3%'*Z,!
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M[%DJV',PV<:;?CN["9BV8N-D(EPD&:$"$ZZZ\T[$14+;==_*;I[_ %_/;?\
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MV%G$,)4?$#8<1MP%8=".]D+3HDK8 -6^V#SSX-CP\?Q\_+\(KZ08[4**#;:
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M>?U8F)+>7L$HALI8EH.5KYYYD>=N1\>%R? T',=9>/16LY-+<R]*F:9GZ?\
M/&7X^::9Y/85.1R'(S\,,B?LG/OJOS.'&D?OV*_,*R?&OX48S<<@-33JWG2>
M@NHG4FTE-*_$:ET_Q.E=WD;BVUXC^QMC>Q:+,)YMN+ W/C;M<P:M=M7B%17D
M2FKW9J24-+&FC:T1Q1@$F[H&L[MWQ$N<.\.<BW)?9A:]7D%OU%^E.NM)4%-=
M],LVSW2B6T\45C%-2*?%)5#J \P^R)20EY+13,.OZYB*BE'F85>V ,D_82WD
MY%L37R.@J,+E!<:8]_ Z]W-A<;.C(.9:UY+KB]BX-_\ 5=D=A.T,U3A5?LU5
M.<^;!GMGHRYX-Z"J<1W(!&E/.'D$D -FC8#:RH7]FAZ%JCUUY9G5+;ZK3=)H
M^ Z>Z=9.\SC^#4>1Y'E,G+K7+ZZY><R&ZLHP5RU!X_! ^=1;.R9-MWWC8[2-
M2^=?;SZ/V7H#R7JB]*'V6/H[].F28W<XYIVFH>HE9)8E_P#$O5N2UF^3M/0E
M^+<F54.1%C8IB[BFTC3;N,XY4NAS;$G7'"-UVHM@7=))<Q&>*,I86 L"(H*"
MRDY\6!!-TXBC8@@INH\=N.XINA$JQ*AZ>-I8,R@CE'6(X;$CBU'>>('151DH
M@.,OHC3" 2\A)504%LB)[J<?KUUHG]7]K]>2SJFU62#D:2A#)9)0530@<<%-
MA^=LD%0<%?!?+Q-%%P-Q+?JHE5'>*JB 2+Y3DNR)_#\D7?;^:^R*G1%'^1F)
ML0FQ45)O()48]E_"V]"GR!;3SL@C^Y4$\(@(B(GTZ(ES":.HNY5S'M8#4QJ)
M%JCCH2.H33DIVS1]QLVR$Q(OA&4W$AXHB_0UZ:HLK)\4IH0I#II%C42G41Y9
M#4Q^8W'%3XM@L2>X^R:.J"H0%QV$2XJ*F! 4)Y6OZY\^M-%JF]4WJ<U<P[4B
M1HWHU:8,S.P^/@]MJ?GV98I8Y(U2'G]L<+%,1H\4K\BQ^+:W$N#%?O[^WLK=
MJJHZR711AI[U^WE_=+6X]"KUUU?U79H3ZHM2,MO,RTRUZS(K6^QW%BU ILQP
MMZRP.BR?#8T^-47$6VQ&KLG5I;O&;"?5M2%BW=A67,"VAS(S%8^S*A-$4FX'
M#;=<N<WE1"B3<OD-OQX\E^1)D5] RA)1PG7Y+CKZ.G&5;.>!D2_>EE,Y$2B)
M=$ZZ'7IQ?%KD$2C@3;.=*:C0Z^.Y*DR%54 &61YN%OYW5!15X(*D2["**JH*
ME+^'77SRYV:^FN-ZRV[MQDL?"6Z:SRR2*I;YQ/&&W1X]'1Y*6%!H:OX^QFF#
M;KDVP9E/T2/3Y;B*\K30+U+7L>6>G1"M^NM59"HTKL<?$[R#F,ZDS=]H?C,B
MQZ)$K(<Y[8B1NQQUT9=5<0V3(D:&X;FS@ B5J>RZHN#5+B]OYMG;AU;6RE/"
M<@_XHT=]B&8QHD;-L1>AM6[]=X@R?C&GW:7+J$#,Y$:%9A'DM/0)#A.0YT2T
MJ2>FQFFYLMJJJ]2\3F83=76/6+C#SXV,^\9D,BXC,V'DD^7:M26P=1%!&I3T
MV 8<G$;=AD*..(HD6#K@&U]!GQ\?MH.:+A%5/;Q]=DV1/[D\?].ODBX4N**?
MOQ3?;ZK]/^_Y]4"Y YHL$D0D/SQWW7?;?PB[[>^_Z[;K^O7W1-^F9K*S+ZB=
M<4[5Y"@S95O7U[R([\<PZVY(R2@2*X\$>?,;X_M?CK+[;B'8P+6"WV D@YT1
M;'X<R%80H<^M?8DUTN)'DPI$91*._%?:%QAUDA^4FC:42!1\<5^GMT142]9%
MK&.]T]HH@"-JM7DCDR<A<5KHUL[7,X\A@NZ._'7%/.1DB5$CE#=1$3XDE0BF
MO%KL,@QK';]L%!NYI:VQ[1(F[?QD9J0;)(NZ(;1.*!I]#$DV3\/18VOO<[W!
MY7%AIY?E2MA;8)*G.!LB%':141-D79PO/\/RVVZ*-)N6G49_3JZ?SWX%_5.B
MS6)T1'1$=$1T1'1%P9 VB$ZXVTBKLBNF+:*OY(I*FZ^-]O?;S[(O1%@E9PTW
MX.$\J?\ Z+3K@JOCPCJ C*^Z?^ILOY^W1%\+9M_U8\DO'G=(X;>=E_%(3^6^
MRJGLF_CHB"D5UBP[!F,MNQY(*T[&FM-.,/B7A6R12<;7?PB(:)NNW%%7;HB8
M5EIDQW"=QVWD4Y;AQAS&ELJ\4%!3B"J^Q.9141?)2Y "OA&N*\4(DP<*S451
MO[RHB'\/<^(GJ7'=?F[25Z#R5/ZG=3SLG<_K=$Z]$FRJ./$-P)=FY<3&$[;\
MWM)&K89INKD>MC=YXGYRB?%Z9(>DM1A5 89;?)P6W76B===!=$:<$>.S&4E1
M61X\U1/F5%54)-]E3W7;?Z;>57W+'=N3<Z\LLN1S/RMQYK/;<=E.-L1U,WWR
M[$=L4V(G3WXJNWRH((O<,R^4 !279!5>BMOJ#GPMI],\^>:<&4",:TA,"GAN
MGA1QVW5$[3\X!55795V\_7=47?;9-E<;^7RO^5'#CR!_/V'/WL0B(TLY6(2D
M0]^;!94PXH0*<QG=P.:$*$"(I)R0D1?.RINBE!J/$7U))(''AQ\-/()8>%RC
MLFX9RFI3+WCNMCQ14WXKW1'<6I3)**N IES:)51!386BRX_7/[)91T5\>%W_
M #\(N_Z_3;W\KT53'RJ3VXIPA<-0:D54ED%==5MMN1+6*;;;7/MB+:@X?R"B
M?O41!1!\$ZZZ^R4,0A0YEF]&G16);!U$A4:?;%QOD$F )>#14Y(A<D+\2;^/
MX$3R>P7%WA<0(!0C(2V?A2Y<=QE>*_.VVCZQ]Q5$78VC'=%517=>B+5IZDO5
MID.EFI#ND6BF/4^HN5TZ4DG+LBU-N)U-@F'2,A@6UGCE&;6,TTF\S#(K"!6)
M<2:=B900:RLG4SEC=$];-USCS3KKKR3(]%7JAD:Q1<LJ<ZH&,0U@JI3669A!
MA67WS19)!RJTN(D+(\<M9$.OGNP8LVGFX],I[."Q/QIRMA03*7 DU=E.F0N?
M#//@+Z=!%?JXC6U_7L?LWDSV,749U)$6<D./90G2X$!Q+2LD*V$VODHHH\+,
MB'*!!%V)+CNCS6ZZ(L-G,-4:./VLETV8R8&D03M, O(+RR!1-OB/N#)3I)49
M5V4CBL6EJ8E\K9N*O%2Q+03RS).5^7/3[ZI D:G:1V@/P<SJCI"53!R%J%AD
MZJC\]U102;<514[VZ*JCVK!_QY%5'=>BML_[T]];_+)8='IIH5-GCDVGKD''
MK@$(@M].<ID5)<R$Q#NQJ6Q2LDH"DIBU)@/LJ8H+K#C>X=$SX^%K7];^']+O
MRJ_R2W@IB63SH^0V&&S(N9TN1MLL1)UQB:I(Q6W*X885J"U<X])R&MDSI<1B
M)"L*Y_XAJ%%D,R$Z*IK+&%H3<<X-M@/,G7W$; !3?D1&NPH*)Y7DNVR*J?7:
M7]?+G]O5$T4N+++);^-:?1CL'P+X>VS+B)X[C8&BHXY'E&A,W=PT*FL:LA(\
MTW)$$LY,1I"%QKS&7MSZS\-44Y87@=-@U4D" +CK[SKDRSLYSBR+&TL'D%'Y
M\^2:(;\EY4V$406F&Q%B.TS';;:&VZZ^?-%TYGF]-B-/-MK:>S#@P6#==?=5
M$)5%%$666T52===<)&66F^;KSI"VT)&0HL/AKE]?7K1$N>G+%6\B=EZMY:V)
M92<F=3T&.R1_>:?52"WS8?9(.*9'>1W(\ZQFCW$9@/PX5=(6,Y,*6 M[D^?R
M")*]3$$<;RW3S4M&2^$B31K+>0UR[J% )^5% B1.*@]1S\L%5)!3=MII24W&
MT2HI%(0(1-M4("$2$A7="%111)%VV)"1=T5%]O/GZD75T1.#'P%%F*A;;_#J
MJ?3_ -?V3QM^2_IT131T1'1$=$5%O7GZ"],?7;II%QG*)CN&:D8B[(M-*]6*
MJ W.N<*NGVD:?C3(!/P4R+$;D ;8R/%I,^*S8- Q,A3*RZ@UMI#T5?04^(T[
MZ>H9=KLVN%@]CN#FN(=8CG8\B"+@[-CV X=M)AD^%8I"):>< AP#1-!(""V:
M![FN#)&VM>Q!:2T@M)!\FFOWH;]:'HY^]9^I^E%IF^G%-*<:_P",&DL65F&'
M/5HHI,W-Y30OB<OP>.J$(3?VDJ1K8$M5CMWUBTK$Z5U=BNQ%:PO?3M%3'F06
M'_*!E^YA +C;@S>!\+9>4]K>PC'**2IGP-[,6H@'/8T;L=9W8SW74Y%I'@7;
M_A)+B-\1"X"KECNK.*Y!#3LR8-C%>7@XVIQY;1>-B;<#=P$4238@<!"$D5"3
MZ=<!J<%JH'D6?&]MP?WQN!!MQLZY!U'/G=="8CLOBN%5#F34]513Q'XFR121
M/:X'*V\&N:18D$#E93OI+JAF.C=JF0Z ZI9KHS</20F2X6$7 !AES($?"Y%I
MW:LV>"7_ '$)0<>GX\<X <)8\R.ZC;@ZW#MI]I\#<V..J=54K"+T]8'S,L'&
MX:]SA+&"+CX7@:Y',KENS?:QVA;'[D<.*2XC0Q!K308L'5]*(VDC<C<]S:F
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MN-E15"]N+Z]9+BGA"C7-G-C$B;^W95-OEVV\=%#O$Y"P'.QOUYV\D[4CT-%
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M'NH3G\1#6.EX[NZ""-X7]GDV.-7/&*P3AQW6D<XFJDK?+FB#N7G<2;W$M]U
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ME1:^BB-V2RHZ.X2UC,YU&^^_+>)U[O3*]^.G77V3S6R32#UAYO>Y-3Z8Z@X
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M=C'RF*FQ&!\M',\1,,@8R8R.8'/;&6MN8 Q#U UGJTS^1J?+O:DL5KR[NEF
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MD=RQDA;>0-<;;PWK:YW7GK%&T(Q+$&X9--48:VMJ6X?-4Q=S/+1-FD;2R31
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MA9\EPZ]]YC!8 %]UW3V)]F#\?J!MGM91-EPUK7?[)05#G%DTP> :E\0MWE-
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M;-BFQ8D&KU'K85A*>D--16X>41;+")ANR"<%D!CKD*O&IFHMDPI&'[M42?\
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M-.+@Y-==[P#E8NL 0-01;,9(N-6<2=5M*PB!VD%LV51 <C$(BA,/->%9<:_
M32BFRIX3CQ5?%>(T\D-2[?N=\EP<"7->#<A[79[X.H<-1J;W"]ZX34Q5-/&8
MG-,08T$-M9M@VX/(YYC/@+63^KIC9-HV)IR%=]E7<=_==]E\;[)[_E_/KCM3
M X/+BTV+3F!9UK^/B?[LN1,W',;ND.N+99Y<KZ_7@OC(*QVVKFG86RV%;(2;
M$'ELC_%MP'XI+LJB,EAPP1=E07>T9>!54N'5;:2H>V>XIZF/N92!^PN<#'(
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MS)^06#XQI%3D]/13+!^+(,F;X^]AM/@DF!OVBIJZ&LPEE.ZH-13/;)O- %F
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M)BN(V<)IJ19V-G%=J*:@I83EG;W5E,;*-#J*>GA(LJRFRW3%EF)&;4CW55X
MA&.Q[*X%5XQC>'PDR,9+5P-FGW=XPQ&5O>S.WBT?XV%TAWW,!W;%P!!74VP^
MSE5M9M5@F#TC9VTU1BE$VNK(F[PHJ(5,9K*PN< P?IX-^8N>YH);:]W!6KU
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MR0U3DBP1<!$4677OG;>;5"+01]O)1M6#_IEM8Q1HV0OUNN^+S8[QJTBMR:K
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M:O(*5N5A>90'ZO,<.M[3#\JK)**+\/(<:GR:2W @).?!9T)]QDEY"ZT0."I
M:;^:]JJ63#JZJA(_\3WY\"T$EA'@6D$6 N#HOS8[2,#EP':G%<*>+-IZZ1L>
M0 [J:TT!&M[QN8<KBU[YWMNC^SM]>>!^D[#K?0#U!R;Z@TX#-K_*=*=4(='-
MN\2QBGS:<F0Y)A^>/T[$JRQ=NNS:QR"[J,BGQ)&/N55ZD"585"4H-R>RM@]L
M,-K<-I<+K*N&EQ"F'<,;4O9&V:,$F,QRN<UI.X TL)N" 3<$%>J^Q_M,P2JV
M;PK9K&\0@P[&<+B900.K9&00XC '.%*^GGD+&.F9"602PEQD#H@]H+'DMK/Z
MYO49AOK>]0&1KC%M6YMZ==&9$3#\ 2JNQN]/M2<U")'M,QU-.#$(J2[.NG3&
M,&H'YB600VL7G3X1L';.MAL/:;M1503T^$8=4R0,, GJI8);.D[W.*,2,/[!
M'8G==8DZY6'$.W7;W$HL4I]E\%Q&:CIHZ)E3BTE%,Z*2J?5&]-3&>)V^(6P1
MB=P8\"3OV DL: :EV^*XE#GU%Y"CIBF6TS[3^+YCB3[N+9?CLR,8N1Y5'D5&
M<&U@$PX($K;,E(SXHK$IE]AQQESK#",9QR@G[^@K:EI8=^1AD=)%(#>[9(W[
MS'!XR-Q]%Y[PK:[:'9>K96X+BU?2U ?WKV,F?)3S-!^(55-(YU/-&[,.[R,N
MU+7-< 5N@^SP]=>6ZD9(/IH]0=PU>:NV#%Y>X#JNK-52-:P8W6B4^UH+"OKF
MJRLK=6:>(KS\ABGA1JS(,:CRLDKXD6337L=OT5LGM1#M#3$2-$%? P&IA)/Q
M"]A)#K>-UP"VX[H@W!:6E>V^R[M/HNT'#W-E;'1XY0L8VOH6D[LH/PBMH]YQ
M+J9[["1KB7P..XYSPZ)S]XL*$%_%<CP2;9.O=:;@,O@3#T.4VT@$U):5"<9;
M,''&-T;(2:XOL]YI6U7EZ[77F9^T$S"EUIU]RC$-2:=4JM(9&4:<X[ 8L["*
M396[-2UE]L]+CR(YR)%O+JXK,$@$&H<""QV$5Z3*>>NZ2+VR^WEJL,[G/=&0
MOQOP'H2?&^AR4/X-DU1C5O1V%GHSZ8M;Z>E<CG&I=2=%<.QZ^<&&(#!CAG&G
ME-4,(W$:!&VG;;"[YZ0H 5BY/)75=^3HH)!:2F@<1:SW1M+[ WM?D'6(Y'2P
MR6HI)J^B,AI:[$*9L@=O,BK)XHCOM<U_^-LH:=YKW!V6;76TL!K6P3/O6'H5
MZBL^_P#LQU>5:2:E9#;:G+2UFGK^"744]+\WS4<^C4M1,U/QQNAMJ"E^!IJR
M+8,TU?9 _228XM,A\4!YY#= L UNZ !8 #0#D . R];KYDEQ+B;N.IXG,G/Q
M))<2<RYQ<22;K:EZ3?7;]L)B&JJS-:ENL[TZ8I;MB_@:\P=(\5Q-AYV*)4=E
MC63:.X>QE4S(HMJTP!U;IRJB=42+%I_X6<M=,;JBNQJ-ZX?M#K^CG6-9ENCV
MD%4^4>+4_L9I-86V8RK"8^U$A1(\S4O+<LINP^\XCIS)V%QGF8X.R%KN [(1
M5]R"AU0=PR'!U"UCU/S8939.3J^9E3^.4\WOKWG4L\:P5O%<<LOBG"=>?&QJ
M92F;I(XB_0;^65_EE?ZH#?15ZE1L6Q.$XVRU4459&YNN"T,6MA,*1+W#-4[+
M0J:[D;CB\C)5(B4E7J"]LQ8^F?CES4/7IF/!*F.:=:NZI4EK8:2Z4YCE5(W5
MV$Q<V>KDQ[3YMIB(\\3Z9ID'W?3SV1 .1%1'<O<53A'<4A0KUUY7_"6^6G,<
M\UL[]#?I$U)L&-&HWJ4UEP-(.FSM!EE#H=CN)6C.3S[.BBJ>,L7^IN4O5*9'
MCE'-.';_  &(85!<ESJZOBSLGFTPS:ZQENNO'7GQ56_(T3DJ(GA/&Z?E]-U_
MFNW51?'1$=$7P^TS*8=BRF&9,9]LV7X\AL7F7VG!47&GFC0@<;,%4# D42%5
M$D5%VZ(J;:EZ&V6/E+O\#BK98^B%)E8HP!%:4_S;O'CZ )%90%Y$ZE0XJ3(J
M"K=<[(8[$!AUUU]D4=XTY$E4M+(XD_\  %9N1D0D$!<DR)L<B= A$T=:CNNL
M]M5 FE<<!T5,40<,M[3CJ!ZVOX\<S?/(!%&.$U3TD?V?:%0^ZK6WI45>1*S"
MK+&5'C.$JINO& $<A54^95'==RZS16FQC(F:=Z;0U==-GK61*I7PB.1Q"(,A
M)HQFW7)+@*;[C4=73!%(P;)IP]D>;WGD!XW/'V/]6LBMQU41T18%C8! :;X@
MCLI\U",RJJ(DHHA&XX2(JBTT*HIJB*JJH **1^")GR9:"\+LDSESW-FVM@4R
M5341[4..*EVP)43Y&DY$J(3I.&BET1$FC>LH3J7Z!$KGD$5@\ DS7E5=P#;8
MF674(1<;-OO&VJ=SFR3:F)$T)&/W%8B)1V'WBRB'V:^Z)&IG $55"//BM/)*
M>0$W!A]@'C1%VD/%R'HI8==:>&B2BR"=#>-FUIK&.\WLCJ-"-@+?%%7FY\ <
MDFA420E5\&N**G-!(31)?KKUS\%".1M]. ^5LN17+KL2U;&="<;8L1;58\YM
M%[B;;JC;R@HI(CD:*CT9U5 E1?P."C@U7//EP(\;\R=,OL$[Z'(VY-<#5E4.
MG#MF/Z<P;4>9%=%]L67T)L''B-EQODVZP\P(FVB[MB2D"D'(ZCS]%Y/O5WH*
M?H_]2%[@./PG6=#]24L,\T-GM1Y8P:**X^T]FFE,MV4VWV)F%W,W[RQAA4&,
M]@EY45]:Y*>Q:[2(54,?>2. A\MM]U5$V3?SM[>%V7POY+ONG1$W+[,*;&Z]
M^VOK>#4P8Z<G)=C*8BQPV79![CQ@A&2J@MMBJFX:B((I$B=$2/25F5ZQ(VDR
M!.P[2\B:=FN7<637Y/J#!$V7O@*VH5R-88WC<X1)N?9W00[>=&4HM?4!$E?>
MH0]9713OD#-=817JRUKXMM4O"'?KIC:.1B5DT-EQH2\QY3#B"[%E,\9$1X0=
M9<!T!)'+F?MGGE;G]N8===<2MLGH<]5N4/2<=T/U'O)^;8]DZNU.F&?Y$X=M
ME&/VM;!D39&GV<W$XGW[Y9%= EOX=EEJ[(N)4D4H[M^;*>IIDZHMPD9&F&PC
M,@+3;0\  $%!04]]MOKOY)5\JOS;KNJ]%B"0!?*^GGX^)_@YZ]Q/!'%777!:
M;%/G,E1$1-M]UW5-T_VGGHLEC1WW,D4X-8@LQ'@-E^VF-_T;8N0J$)AS9)SR
MBI*VJ+\.FQ\W.0=LB+-N*3XQM(IO/PK& A!&?$G% OE!!<=94Q;FQGA 5-#3
MN-HIH!,2150)YIF@\(/R:FYA-"\ZR@NMD(N,3XRHC*R&'3%$EQDWX."X(O1^
M38/M-<VN10CEK]?#KZ7!<%%/;H7V!L'^[2"2=F8\2D[6'^!L9CA*1/01Y(J2
MGB5Z,J[/FXQNZPSM>Q]B#GX'/7+12XO8Y>?O\K7N+Z'3*_FW^ULU7J--/5SD
MKN7Y9V*IS3/3NWB/RFR>@XY4RW[6I@5+3D8I#J)-NFK2T;!&&R^*LWW50D?;
M(X][(V.DE>R)D8)>^1S6-:!J7.<0 !S<0.%U]H*>>JFC@I89JFHG>&14]/%)
M/-,\CX6111ASWN-LFL:;\LUKQPS7+#L]DK5) L6X\I9817KRI=KF+B$T+:',
MB1;!!EE!>0R0"DQ&"=%I75;[1LF[M&%X_@^,R5<.&5T59)12,CJ.ZNYK'/#B
MWX[!K@X-< 6W%VV)!R/,-K.SK;;8:GP.LVMV<Q' (-HJ:>KP?_<(Q#)5P4[H
MV2DPE_?0N89(WEDS&/W)8SNV=ECZB>D?2'6&"Q(QA,?T_P UBC(:AWM3!8@1
MI<2TDUQ6K%PU5MQWYVS$+NP7%(G8LU$>;145Q>MX7"TX9WV=/I:H:J':S=9M
M5L=^$AL_>AL97C$NN?>:9,)KS9Y)C-O+@M25551#FN&PB(@.KN9*3H*U.'7$
M[-PT\T:]+.F&0YA@>.XO^S@9C)>D8]IU'J<-K:2@K($W4JT)B'D+<&,_';O*
M_%3R6Z<<-E9M8X#CW1%<['?1%FLL&7M>\WM[;&R:XLX/H!W\>QF PHIM$M+[
MA U#L^V2J 2<5@X\V\V(N/1XW(F4Q)MR%[\?GH?GY(IHQ'TXZ$8[8P\?TFT@
MQNGO)ZMCD&;V6,R96;0ZH'%9>:E9;E<:3EDJXMD4XD4Y%D3L1GXVQ4FU: 7*
M+C4W.?AU_/')%LRQRCBX[3PZN&TRPU&89:5J.* P"--BVVTT(B*(VR HV [(
MB(.^V^_54Y#K+UO]?%+B*J)MOX7W_CO[[_K_ *_FO16W'KK^.02#E-S'QS&,
M@OI9HW'J:>PG&2EP3>/&<<%.2JB(JD(BB*OE21$\JG10Z@<==+Y:>FNOVNI3
MTO;BM:;X(S#F1;!EG%:1M9D%UI^*^\->Q\0;3K)N 6[_ '5/8UXER1=EWZ*I
M]=$1T1)5[0T^45,RBR"OC6E3.:5J3#E A-DFZ*#C9)L;,ADT%UB0R3;[#P \
MRX#H"2$5<9&@605SGP..Y15R:(#/X0;^)-6V@1S)5&&LN$XK5F#(J@MRWVHT
MIQ$3XHWW.4@Y87O;/2_@B@?4O3:UT^S&ADS[:);IFM3+AHY JGZYF-88W*9>
M;8(GK*Q*4_+AW;Q X11U[=<2"UQ E"HK*Z)6D1O(;G%XS;A.U>.UDV0\(CV&
M1D3'8\:.X2$JI*>1AZ0K:)\K2"9+^\#>#ZY]'CPMEP161>_ OZIU46)T1=$F
M2$5L3).9FI"RUX177$%20=UW01V15(E1>*(J[*JHBD3$LWG'7XPON(X\1K(?
M+\(BS'_Y;3:;[@W\2;9B*KN:M+R4UWW(DSO@_(<1V4;'9XBT#;@BX^\2<B$1
M-"[G % 1';CR=/E[(O13QMIZD>U_DOE*V3)BN,V+D64V:DJPY,=M]D14MP0S
MV'D:#Y4D!10O(HNR*I5>>C[1[U2LZ@:@O^EO268Z.'Z=Y!%LM?\ (8,DW:VT
MRRD*):XUI-3#) E>"IM5A9'FT^&3<>%84]?B@D](.\9B=5=IVU5/AV%SX)32
M;U?B+>YF(W@(*1UC*2=!)(TB, 9]V]Q-ADNA^V;;RFPW#*K9+#Y.]Q?$86,Q
M+=#^[H\.D^-['N!:WOZO<$+(G7_P/E>\ .C#O-?J9EC^I.JV73)MZTN-8=>2
ML-Q.C=DQ66&95+VHV17)")"Y(EV%W\3&;5XR!J+7L"V',S7KA6!TC,+PJD8R
M!QK*N!E94R-:YSG"<;\$0%C9L,!:;!HWB]Y-Q8GIW#,%FI\'P^*EH7FJQ6G9
MB5=7-:]\CZ>9\AHJ1@_;'$VF:VH>(P7.EG.\;- 2C5U%G ?8F0UD1Y *+C+[
M"$!(NWC8Q\(B>4)%^54547=.M3*)IVO8^GD<T@AS7L=ND'7(MS/+(<\BMVBV
M=DD9N2P'<-VN#V//G<%F6>F6G+C:'2K4;,<%L%OL5=,;E^:Q/RO$Y+X1:+46
M/%C##-'^ZVY'JLE& TPQ"R",RW)1R'#BV)2JD288WW9C$,2P:1M.X2R89)+?
M]/(TO%-O.NXQ.L7QMN2XLWMPZY..\>RMBL1Q'9I\- ]SI\'>\L;3NN?TF^2\
MNB=;O T%Q/=@[AMF+JR&K7J:FY?"P[$M"#!O*=0**5=W.4VD.)(#2*CAS3J;
M!;NC<=DMOYW]\-3J6HQV;O""?66DVQ)R%!1J9SK:C:JCV=PS]:X-FGG;NT4.
M]NE\F1+G6.\(V _&3S&[=U@.=[?=H.';$8+%7&-E;B6(;T6$4(>YGZB9@:]\
MLKF$.92P-(=-("' ]VQ@#W,!@C)M-*>6+%UE^3Y_E.21@;1G(;'/\O@S(\E$
M0C?JH=%<5531<W![BQZ*!7QT5$V;7;?KHEFWVU5?5;\>(/IX]XN;!3Q0B)C+
MGX2'1DOMIO2%[CJ=+#Q[C';!VB25 JV;0S4SY)"(J6C@IX:5C2;]UW/=/,C&
M @7F=*XC-Y<;KOT)U6O9.6Y_I+D=]*R%ZCF8')PF\NI*2[I^LU <O:IB@L)A
M(KUM(I;7%K.6U8S#>L'JZ6J3GGEA?$GWQLCBE1BN$LFJ]TU,<CHI'-:&[X :
MYKMT  $[QONBW&PNO6W9-M;B&V.R$&(XON.Q2FJYZ"LFC8V-D[H6121RB-@#
M&.=%,P/:P!F\TEH:#NC=WZ$L38L-2M7M5[>5%BX-H5IT>E%+82GFFH;^;9HQ
M69EJ+8NR'30&TQO%ZK"Z\R)?E>R"Y9<4"BHB<IOD!RUTS^7OP79:9VN_V^^D
MJTDZO].&D6I.996]7R Q7+M4*BIP'2UJ;)(6H62V,=W(7]0;&JC1T<FQJZ+C
M$"5:*Y&B/2ZAM]V=%@X<!Y=>R'KKKV6FW2S1GUR>I\]4_5SC6G.7:RU62Y-9
M9/F^9LU^*8+%S"WAP(-=/31W"7"I9>90*R-5L-.O8W%L&K22)Q8%KD.1I,CK
MP;:S9)V-@U--N]_N"-\;B&]Y8G=+7'+> LRSB&V S&8/1W:UV3_];"/%,)?#
M%C,4 @?#*YL3:UL1+H0)"0&RL:2UI>"'-LTN;N@&O^KNKDF1C]J[#O\ (<!S
M3 *Z]G6^'6\>^P_('9C$8";J[NDFA6WM1."1"6/';L:MU"62^V4;B[R':^S6
M;!=A<4Q?#]M>S["=LL)V@BI:-PQ2GIQB.#NA-4UM7A%9/3SNIN\-5>K_ $[Z
M>604],]E1&^!M_/& ;,XKLUC[<&VMV3_ %U/BDU+0QSU$8$E(7R%CJFCJFAT
M19N27G,,K'.;&TB1I:0Z>= <6EXCI+AM39'W[DZMJQR"2J[K+R&VWL;V82JB
M*I2[:5,D*2[[JY[[;(G26T]7%68W7301B&G$KV4T32XMAI8W%L$37/<]Q;%%
MN,#G.<XAMW.<;E<&Q^OCQ;'\9KZ=H9225\D%!&+VBH*0-I*"$!WQ 1TL448O
M_P"JJOJIK1<0M;+> ^Q/3!J-^HPFKM(3)R6&LT?B-W5PS:,L K\>._#L*R+
MGN<HC<F+.8<4#>9)SF^S.S[*O!P8Y*1E9)3U.)S,JZFGI!)1PN$;&TTM4]D<
MU3\$KQ21N[^8;K8(Y7G=7+<.V4IJS9F&IAE@.,U#:S%IZ>>5D+W8)#(^BI7T
MCI7MC?(R>GJ9)H&7GD;/ ]@<UD@;*=EJ594-%"SG&K*75YWIY>TN<8)/A$ZM
M@SF>,6,:TQ]B&W'0W)#EE/C-U3M< .#91)\BN>:>:EFT<P..JP['J">D!NZ=
MD3@T7O%*[NY X$BX#7Y@G4 BU@1H>SS_ '+!-OMGJC#&O,LU?#231QM!$M+5
MN$-2QP.6Z(I'N)( 86,>""P6]=FM'VB>@/ILM<3IM5+3)J_4BZQ.#F;.-X]B
M]G=2X-3,ERX M7TA?N^JBLN6\"U@#"GV+4M'Z^0^+#/;!Y>Y\4VBPO"IZ6&O
MJ.XEK'AM+$&2/?+OFS0&L80 V]BYQ %B"0-?U$V6[/=L-LZ7$JS9W"'XC38/
M$^?%*D5%+3PTL3&22W/ZB>)SB6,=W;(F2/?NV +B ?-IKW$N_M._M"KF-HO!
MJ8^GF=0(+5>.HLZQ*OP\L;Q.==9;E>28ABC]I N@N\@[U15O64V+,.1(HX#[
M\5J2+<?:-IMGL5VBDI/T>/5>#T+8CW[*9C=Z?,.:\/[UC@[=^$"V6NM@N<]D
MW:9L;V;4^+RXYV88-MYC5940R8768Y47I,+:QKA*Q]&^EJ(I&O>6R$D,.\T
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M-J!)QO2-JAQT*9K%M3J;3&.WW(KC=G(MG&H,S-I,^?9LS9+<NND%!^[ECU@
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MS4W3_(]>&+759_'H>-89=4T&IRNXF2<1<AA8U\:SWD8<U02G6Y5K(>9>?)M
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M]M2X5_(H<AQ\[Z>.?)$YV+&_@.*53G.6U^XHG;=MQO8XHFZ;!'R9B[:#RO\
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ML:0B!7VX$+<"VC!QF,%W$-EE\@(?CX!.;(_7S%<B/@1"K>YH754T\>O =%/
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M*=>>><=F?'6,@WIEE;63K]S:6$B5.FN%,?*0??C6,8QK&M:QK6M:&-R:T-:
M&@ #X6@6:+ 6 R&B]B1110QQQ0QLBCBC9'''&T,8QC&M:UC&C)K&@68T -:T
M!K0  %+-:_3T8C+=*/ K(D.09R'#$&(Z;"X4AUTU1.1 VXA.D1.&3@J7DE0L
MP+9!?11(Y)BV5G:Z@9 V$ %:4ZN/,^4JNFCLH+!RFSW[=G-;#XN4VB ZUS;@
MN*XY#$NGCUU]/50\N=^O#.V=CY+&J@L\JN*)ZZ<DT]!-L6FF*)EQ69$^,;,E
MX"O)#:HX"RB!@!JXI@#7(VI;TAPCCM.NN77% +=9^JT7_;X>@"!-P^-ZX=)<
M7KFWM-,?:QCU)8A1U!LR<RTI?FQ8%;J$@5<=%<M=*EF2)61V4I6W@TZ6PL#G
M-MXA 9.$7OXJJU'V*_K^7U#Z1Q_3IJ[D22M=M'<?AGC5[;68RI^L^CS2A$HL
MRC2I#QR;C*<1:.#C6HZ 4B0$HZ#*)1HUEK0M  ,AH,NO'GXIUFMU<S(8K!*S
M $;)]"035LT&(U\RH2.2D%P5<'95)ED3=%$_>=M%W6HD0K6U(D-RQ8C*I$J,
ML1(ZMHB^1$ED(^Z2"G@C%T.2^R G1$J1+\FS0+-MM&%\?'L@:-"JKLOQ3"JX
M3+2CNA2!<-D$12=1D%54(D%MCX=V9 W1$9</X<D5=T:+B[&<$E\K^Z)HD)%7
MYQ7==O/13G[]>RK_ *O5E4WF%=,G,-/U^<U<>;*B2&FW8KE]BIL0Y+W%Q5#X
MGX*55"NPHO&M D52;7J$<C8^^O0]E5V0W6V6Q%@1%M %  4V%$1-O")LB)Y7
MVV7^*>.@MZ\>?KUGJB5VYG+8>?;7QN)^1^GNJ^?R\;?S^O51=YRP8!Q]\FVF
M&6R>=?,N+3338J9N&:["( **I*2HB(FZKMT10#B^1R<FU8D7;Z*E?+IH#6)
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MPR,(L9@"(O(J@CL12_T1'1$=$1T1'1$=$1T1-7-W+1K%[0ZE'UDH#/>6)O\
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M;[*GY[KOM[JGGJ$Y^N=_H.9_E$M5#OP[MY&; WW@R2W[;3 [.'W7DE$NR\1
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M@#?_ #0)"%P2,"14792^HOSOUKSSSMP'+)-:%=S;V9(R*Q01L[9MMJ!%1MP
MKJB+R^"95DW7"BFZCRSK$%=<7X^6L1'7&V8Y(564Y4-SF);$@B=6:R['?4D4
ME(7Q("\*B[(G+PO_ $7;9"+KKR(H%!=.NHQ)K7>S92!!34(JDY76R]HB%":;
ME,_&.!W!)6HJH"H?'HI>]_;AJ??F/#0!3*M%;FJ";]<(JB(CXE(=7CXV+X=
M:W14^9!60G_QJB[J53BKJJ)6H1M(KTEQ$[DM[YG5V_J-IL@,LK_^DVFR^[BN
M&JFI$H]$1T1<&@N 3;@@XV:;$!@)@2;;;$)(HJFWT5-NB) D8Q7.JIQ7)%<2
MJJ\(Q XPJ_1.P^!B _\ N,$R'Y(/OT4+0=0FMD6F55E--+I;BRFN,21 VG8K
M,-AV)-8-'8D^.3S,GA(B/B#K6R<245 ^39$!$L ;_<JGU]63L(OOV6R%YAJR
M[?Q-9(!1"/<P%-T6I\)%,E E5IT)4%POB8CS1HJ/1BCRY)7KWZ]%G?M/7544
MI-I,CQ(X)Q5QUQ!4G//$&@W4G77"V%IEL#<=)4 !4U05Q(MIPMH,[7T\>/+A
M>^J)X5^,R\@B??&<V Z<Z=]D7'G;2P;I<GOVS(2!EM7'FW,<K9+?)#)SC?2A
M4FHS%<JA)*Y\3Z#33RX?SX DRFD4-SJ3D%MBT1J'BM;6T]'C_P /!>@,/P:N
M B]]B.^#3R,N6-I:HV\XVVLAMI)(]T'4?<J*4VCYHN_A47^6W]W]_P#E[=$2
M)ES:'B&5CRXJN.W*(OL2+]WR%W1/?=-MTV5-EV7W1.B*S57-&QJJNP%%%)U;
M!EH*HJ*"2(S;R"N_NJ(:(J_FB^.B+-Z(CHB[V/<OT3_/HB['OP+^J=$6)T1'
M1$=$1T1'1$=$7/)=D3?PFZI_/W_CT1)%Q05]\R+,YI>\"*468SL$V*7C=6'E
M$E02V3N,N"XPZB(CK1IMT10S;4TNAE?!32!Y'4(H4P15L9C+>RGW&]]F932$
M*OLHJ@O)'6OD4A BQH;@A)C@JHB$9;"BJN_!HWC\KR39&P(E]]A\_DG11U[&
MVOY4U8L\3N.4+R\=W:BO<Y(*+N)1FU'R@HNVVR?3V]DZ==652-D$9YF:DWP3
M$E&VA=7R;+HCMV%5=U1LT%7&E39%<5U%3= YE#D+\@>5_G[^WD4@7=A/GQ4$
M%5+D2 *"B>4)? [;?VOIT6+23J#P-].KVX7]E7NUQ^5'@ZA4(N@ NV+7W7LB
MA\(U.HZZ=7L&BCMRB+*: D0>*@V/).?/H38:FPSMZ>*S4C8],E%0Q;%UKO0U
M9YO2(Z<G8KK8(W*9GP_E>9>BNMFVZK2/M*0$8J(*.Q8EH.?A;YW]/'Y>/PN9
M4[BB-?\ &VI$*$+E= E2(JH2;I_35;:A+M_6VDJJ*BHHHJ;*4#,[Z6.5L_7.
M_M9-BXRJ6V PZ^MM(\N<VZVDZ2W!2+#5?#LM[^E2>9,"?..TK!HZZ(BZ@M<R
M$LU\T<)LHS)#R6&P*]@G7"<>G/&2DY+?<(B<>Y&KADXX1%)>,WS4DX*4Y>'S
M.GM]?3,G6VFVR^$3?841/.Z>R_GLGM^>V^W51<T30?\ GK)@CC(6[H"V8H0(
MU.KZ^=)#BB;$)R9;YDGE-W"1?/+8L2<P-,KZVT]#EEGU=\XIC\2QID:?GV3<
MBND.UC_:.,/((R@4-X3*(XZGQ->Y$>/]Z2H3A!S11\%1F+\QF.'CEYI"U;].
M.C6O.G.4Z2ZOX@SGF 9E!2OOJ&YGV38OMM/-2H<R%+KI<&;4VU9.88LJBXJI
M,.UJK*-&G5\R/+9;>'ZP3STTT5332R05$$C)8)XGN9+%+&0YDC'M(<US7 $$
M'P.1*CF->US'M#FN%G-(N".1'%8GIO\ 3+HGZ2-+X6CV@F'CAF#0K:TOCANV
MMQ?VEG>W3C;EG=W>09#86EY=6DH6(L99EE/DN,P(4" PK4.'%8:^M=75N)U<
MM=B-5/6UDY!FJ:F0R2R%K6L;O./!K6M:        I'''"P1Q,;'&W1C!9H\A
MH/Y*GCK2K-!()@3;@"XV8J)MFG(#%4V5"%?E)%3QLJ*BIX5%3QT1-%_$T!WE
M66!1&")26-)9.6+6^_RL&#\<D;3?<6WB?(5V07!%.'12PY<O/+3/7@G)7PPK
MXX1P<)W93-QYWCS><-=S,D'84]D !39!; !W5!W4JJUYKHG90[&9=8(TW*K;
M!]V;-QDG&XS\&;(>=D3'Z*2\01UAR'#5Q*B0;(Q7C<^!D!%-N$P15ROK?+&)
MSF,UU9(H+#XQJML;>W2*JUI2'&FC"!#C2Y!3+!6WQ<8-XF83*[/.$^J#&=Q#
M0+^/ VMSY99^:)^:197IWIK?9H;L]R=/B4^/557705.WO+*=)EW]C>R'S:W1
M),Z2M5]X3K%^-#C?#QFG'F&@$5H_/"W7WU19SUW=9SFXYQ=Q&:UB!"2KHZAL
MU>2O@BZZ^JR9*('Q=E)DO$]-?:%N(#3<6+' ^P<N4N+V'C?PMU]44GQ;%IQ$
M0O'G^"(OOY\?ENN^RKX^N_51*8/,^%V15]]E+??=4\+XV3QOLOOOM[[]$3GT
MF0R8SI]7$)B5GT]R*"(J*VW'Q[&J]\%^B\ID.2ZBI]'%W\KMT12QT1'1%V-_
M7^7_ 'Z(NOHB.B(Z(CHB.B(Z(CHBP;*QAU,-V=.<5IAKB*<14W7GG"0&(T=L
M44WI$AT@:89!%-QPQ$4\[]$3(=R_(^X2Q\:J_A^2]M960R&9)!X45<:8HY33
M1KNFX!(=1%141PD\D4WAG?*UM?'3\]%-O(K*^MPCR0QJO9LXQ" 2&;]3%V(9
M?OHCQ'4,NJVGEYG;;MR$#QP<>W*!P.7.^OA^?SR3<C,9!(>;27#@5\9'$)]T
M;(Y<E %1)4;:2"PVI&NX\E?3AOS4#VX$3>'"Y\N/EX>.GBI6P(B>JK*62(A2
M;^:OA-D48T>'"'9/**B)&5$7Z_7HLOLEZXK?CVT>9%%F,"O;1/"OM;*IL$6Z
M;K_69(M^#B^%$3<52AS_ !S\]4RVF77W 88!7)!FHHWLJ<.*H)F\FVX TJJC
MJKY%45$$BV%2Q#0#I>^>?#EEX^/(^*CW/\<BT.5XA9,N)_YM.A5UF7#93LFI
M/>ASG2%$$2EL"] !"39!A0XX*O'981<CP-^ODLM!Y>BYQF900,6OK')"BLPH
MF99>\X[-!.;!RLCG%%2.J"KR/R6WF5BHPB/.B\WVD5#%>K\_X/V^JJ;TO(KF
M8ZJ8O16<.$2DG?RB3\.!^$V./&<^*M6D7\0&^3HK^%8X*B]3G;TOS^O62EA>
M]LQQZZS\TU;>%=6;L9JWD19<1=GY=>PV_.=E.LNB;$<#(84$&%/B3B#4#()
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M$1T1'1%V-_7^7_?HBZ^B(Z(CHB.B(Z(CHB^3!MT":>;;>:-.)MN@+@&.VVQ
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M3=%3\E39=T7V7POZ=%BV]QK[ZVSXZZWLG#CEN4:5&K''^Y#EJ3,-LU(CBR$
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M'<0X[B*J&V2;"I8W-P"!X'6]K<\[\;G6WJDEY<K98=AFU5WK)HH-R'W7JB4
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MY;KLFR*B\M_HGL/\.B.%QEKE;W\4J8A$[_Q-T0;,N*<.L55_'%$T63+$5^9
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9^%/].B(X!_9'_"G^G1%SQ%/813^2=$7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g904779g52z03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g52z03.jpg
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M 0$! 0$! ?_  !$( .@!]0,!$0 "$0$#$0'_Q  ?  $  @$% 0$!
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MY8W'TK!,>\2NDS AJ>8-'8CND=H[+H[2;4R*TN2<_)&?;H:\=$ DR+FT ^7
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M4W!%6TUV$UEP):#BG9)RHV'.E)MU$4^4=!$ N5W Y22P,U &AN;\@N>3E/\
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MTB._,D\&R!=%P,DR[MXNTN&H.@!Z-]CS6YC;7JQ3>C:I9@*&IAEUM0BD1=N
M',\1--#BS%_%)/BIX)D0S@^H\?*D[%IS*2$[T=WE8;6 %EMI#8::Q'!U?0S
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MB9F<P#%\"LX #=$!Y,V[N\@7H?HN-8DGB#XWV4AV0X(EY#$<<;2@VSC6=B2
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MU#:*:ED4M%: '=&H3)!&.S1[&E)4,GB7/T6W#=^N7>NUG]1X.4BKP)FVXI"
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M#6+<5W D&W.V2Y@8HW5U+*B9@W("1N\@-NCF[O/\P6.4?BMUF;C4BQF-EP[
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M+/NNO(K^7V76Q%?Y'_<I[HPEX7Q[^4#QYW/Q(WE1>ZOBSW%(_>.\^+>Z]/C
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M(,;B8EG-_N]]ON=6ZT2LR)(YF9>2WN"UY/%-@M\D52$@TN%A"?>NULJEL5_
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MY"O[,:C_ "&IOU>VJ[_"8]JMC'R?ROFU+71X-7MMMG\/YGSFJK5L;YA.G_\
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M4Q")X^*2.W!(01:XW[N8_.I0%"A4@6 )D2Q<F3+!X@EBA0$,N6+@X6Z, @
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M"G!H(34[I4F+\7729$;+&3YL#C5E2ZH(!U-#20O&2.\C)-GC.NP9!8&QU(!
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M+IRZCELO*KRSS!$CL@;FV)M64HZ<QQZ;U:4+C.*M][ME9,NQ%18'BH@L*[9
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M:6F7RTQ F V'&,"-"C"#,LXZ7BF$]K^*CPG$-BP8F7)%ADV>PN:="HDP_P
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M1"YQ);;ZTZY-KDO?S#;L PJ@,8EL T$4FS$6+&,EM0JCF3K8P,I19ND4(!(
M33&!@?$<B$3Q*BXCC6$"RL)G;*<0U^N0,=3<G!K-5@RC:Q*PFRL*H3<.7;"<
M^7#H;8+8PAAC@YP+ T--S<:E-BVR7975>"AAS$=4V:;/ZEB&/LVKD_&KL_@W
M#LY68T]!@5<PIR+4YBG1)V)-0C"AF',/CF,PPV%KP6MMWOF-U=UGC#=AQM2-
M==X,CQK ,"/SH#;8\3,)IH )PZE"B'#82.@H!!/#,FQ+6$,CX%["CYVMD+GG
ME:UZ[>TJNUN0Q1&EY&KU.3EQ)R;Q E9^:EX(<Z&XN<(<**Q@<XZN(;<G4W6/
M<!O99LQQ=L#IE9Q7LYP)B:KQ,2XE@1*KB#"- K-2? @3C&P(+YZHT^9F70H+
M26PH;HI9#:;, &BR%R_ZH:MQFL:DA1OK9 <?A.37%#77$&R(>CUJ8+ZV,:PQ
M%6%K!";I#%45!<;WQ$4#UAS>=KWMD+>U=S:16JQ(1<.B1JM2DQ'HL*+'$K/3
M,N(T4N%XD40HK ^(>5[KN/.L9X$6S/9QBR0VT/Q5L_P3B5]*VHU"GTM]?PK0
MJPZG2#(+BR1D'5&0F#*2;#JV6ES#@M.H8"F\^J&K;1X^>.1Z-36R VP\7RUE
MPP]78WH?CU%<KP, H#=&"'="ZFMTLJ+XP0PXXH8JL:-YX"#"YXY6R$SO>,5U
MJL2V#\%34O5JE F9N7C.FIB#/3,*/,N$* 08\5D5KXQ!)(,1SB"3;>4X/6S/
M9Q6^$MPHZ#6=G^":M0\/UB0A4"C5/"M"GZ51(;ZE5(;X=(I\U(192FPWLAPV
M.9)P8+7,8QI!:UH!XZH:ME>%>*94+:V0&7D]1V.44)0D<"'H]!?A]$P59)#P
M1SCO#;N+@-)> 9 B'BGCJ.93' F5PL%;$N#;"9JM5ANS"G5!M5J39]]:?"?.
MB>F1-OA")/@0WS B\<Z& Q@#"\MLUNGK190]F>SB-P\\98.B[/\ !,7",KLN
ME:A+86B85H3\.R\^Z2PJ]T] HCI TV%..=,S#C,PY9L8NCQB7WBO+IZ\&&C^
MELN:\2VMROJ'K!)RRFS.,E)RO(4!Q4\U,@F68[2-V3B1]QM12-%2%C9DR9L4
M %#+V,&!ANS[07/+++=E-1J%2HU1BU">FY^*RIF&R).3,:9B,A]2R[LC7QGO
M<UF9SG900+DFUR5YS_M"<'X2P5M.P7(8-POAW"4A-X#ASDU)89HM-H4I,S9Q
M!6X)FH\M2Y:5@QIDP84*$8\1CHIA0H</-D8T"[?R8_&W\'SI%\U*"?N'6TEX
M#SO_ (G?U'\T\F/QM_!\Z1?-2@G[AT3._P#B=_4?S3R8_&W\'SI%\U*"?N'1
M,[_XG?U'\T\F/QM_!\Z1?-2@G[AT3._^)W]1_-/)C\;?P?.D7S4H)^X=$SO_
M (G?U'\T\F/QM_!\Z1?-2@G[AT3._P#B=_4?S3R8_&W\'SI%\U*"?N'1,[_X
MG?U'\T\F/QM_!\Z1?-2@G[AT3._^)W]1_-/)C\;?P?.D7S4H)^X=$SO_ (G?
MU'\U#[?OCNX_V;J#-KF:&C6GK5<B2@(PR4X&WK1#"&MIHPKN;Q845/54QEE3
MY,00L.,7$S+CAY9@#"A97N&)GC?%<;3,Q*86J\Q*QXTM,0H4 PX\O%?!C0RZ
M;EVDLBPW->PEKG-):X$@D;B5K/;'4JC2]FF*Y^F3\[3IZ7DY5TO.R,U'E)N
MYU3DH;G09B7B0XT)SH;WL+F/:2QSFDV)!J+X[].-17M%F\BB\]6-<G<H-&"3
M"PU#SGA&-%XXV5;%N2(/BJ-\RJMDV,C*-AR)(:QU.S+&;"E"HEA>N7"OAK+
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M;=;._1:L@V5U&H5&5K#JA/SD\Z%,2C83IR:CS+H;70XQ<&&.]Y8'$ N#; D
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MIV7K[@_U AU#NV./#9GIUJB)[H,_+"W[YA?O*'Y^4W_[R+_8_'M-HO9E6/\
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M5]>^"OY;_FOQY^/-$R^^;XT\J^O?!7\M_P U^//QYHF7WS?&GE7U[X*_EO\
MFOQY^/-$R^^;XT\J^O?!7\M_S7X\_'FB9??-\:>5?7O@K^6_YK\>?CS1,OOF
M^-/*OKWP5_+?\U^//QYHF7WS?&GE7U[X*_EO^:_'GX\T3+[YOC3RKZ]\%?RW
M_-?CS\>:)E]\WQIY5]>^"OY;_FOQY^/-$R^^;XT\J^O?!7\M_P U^//QYHF7
MWS?&GE7U[X*_EO\ FOQY^/-$R^^;XT\J^O?!7\M_S7X\_'FB9??-\:>5?7O@
MK^6_YK\>?CS1,OOF^-/*OKWP5_+?\U^//QYHF7WS?&GE7U[X*_EO^:_'GX\T
M3+[YOC3RKZ]\%?RW_-?CS\>:)E]\WQIY5]>^"OY;_FOQY^/-$R^^;XT\J^O?
M!7\M_P U^//QYHF7WS?&GE7U[X*_EO\ FOQY^/-$R^^;XT\J^O?!7\M_S7X\
M_'FB9??-\:>5?7O@K^6_YK\>?CS1,OOF^-<^U.4%;=+I;38$XS.5!L8.-?1D
M'-RNO6Q@IC6;V"NHED_)<<JD7F\\.GH"38Q<^L'@"1P8HG%S(X14QF'B#F3+
M[YOC5J5%5*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HBZ^"TVJ771W0 VF
M^ YC6%PC+B!1DX-=,!W"# N&.KX%L5 ;"X ((-\!#&6-P@@P^CJ!XXV(H&*/
M&#K,N0%MGK>XLI"7H\W'V#DC9R21CKF3BKF;$L2.Y6R\A%6-EI';Z7[G2C.=
M300%QE@*A5PFB9LE<%;.KY$<<H(5LYNT\K0 .@<AY]^JQT2X?M:!8%FF%7F^
MM@),<\^R@TIKD+9-\R(E&MD196CKQ/C&+T07PBM%$;R$?C8%#)E&@2*,VZ26
M)#*)-33U4NIG\!RG.;@@ 6N +: &]]+\MS?52FU!TZC?31DO5K,9RR+(3CE&
M2W),4M2Q+[A(.J3I.DEU IY14<CJ6$E$;:-CV2<DIB6EI2&WT9(3B)+#L"-S
MA@^<-E4DNM>V@L -P'-S^,DJ65%"41*(E$2B)1$HB41*(E$2B)1$HB41*(E$
M2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB4
71*(E$2B)1$HB41*(E$2B)1$HB41?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g904779g55h65.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g55h65.jpg
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MN]&XN=L[Y2PVAO!<"B.PY(5D]6Q1E*2'(0B.4-C624$0Q8  .3#" @QD8Q!
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M*6VR)48I1$O(R "Y!!;=IO<$6TZ[$ZMC7L+M9ATINY#JEHMLK+<.N&D;EIM
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M\"X#EL64.#88HC2D]T9R##68TZ(J35K6GSVM.:-L-&@$<A+%CM9(^Y1%8R'
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MG/%M%_>2XW=X\"951_*\QTS&%V7,WN;MKCF)*\KS.XPG 1]L6=P]T#[E I4
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M7&[O'@7,K<F9?W+A='W1;A"K)7HL*XLN4=QKDW983K$O;D0^YU9&!CP2H)[
MXKLA=@,/99ZR7&[O'@0IQ9B,I\DQ]T)RDRI$DR5%EQ>4PE@LC5Y3Y BQVG*H
M8LC4Y+[')XLY$;V6<YSPEQN[QX%\:8471 5%(XBH2%KEP7-<6FAJ@@"QR":
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M1.$3A$X1.$5<2]AZLAMITEK?)'M:UVK=4#G4RK-K/97;+3*6NK2V,Z<I$4C
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MEK<'->V1:*()8_/:DMG;B%+DM5IF]&>,*!(G.5G&AP066(S.,<G8'7/R-7$
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M<U[!QNV@M9Y[3G#5M*?/;JY\2,><L_-\UT^Z/8(ZG&*NZE(X%DWF5F_9<O\
M B)[=7/B1CSEGYOC[H]@CJ<8J[J4C@3F5F_9<O\  B)[=7/B1CSEGYOC[H]@
MCJ<8J[J4C@3F5F_9<O\  B)[=7/B1CSEGYOC[H]@CJ<8J[J4C@3F5F_9<O\
M B+^ [>91#&\>!^!]^^Q#VGOAG':.]F.Y_[[L/V7;>V]E]#'8]75RXJEQ?>#
MZ;A[#6(7X Q+$@XE=6FP)=E2I8BRQHLW!E(IC.(S'\>=&#X>9]ZUI#M-ETLP
MW,OC1X0F8 =!XWG$LB6<8C2X9MM.@  WV=6A?W[=7/B1CSEGYOEN_='L$=3C
M%7=2D<"[N96;]ER_P(B>W5SXD8\Y9^;X^Z/8(ZG&*NZE(X$YE9OV7+_ B)[=
M7/B1CSEGYOC[H]@CJ<8J[J4C@3F5F_9<O\"(GMU<^)&/.6?F^/NCV".IQBKN
MI2.!.96;]ER_P(BQB2[P%1TM-*3H*8IP,8H^%(4YA!G&3PY<<J,F#+SCJ#A)
MVOL,8]_L^RZ_>]_(F&>+:PKB7#=0Q) P3B"5@4^N25#?+19^FOBQ(L[(3D^R
M.U[+,$-C)-\-S3YXN>TC0"K=KLL^A&7X\YD<QP^W&P6AH;;7G:_>6(^Z4HO)
MDJ\\E?,\^WS9N%NDRO\ ;U.X5;_+AGK+M\<*>Z4HO)DJ\\E?,\>;-PMTF5_M
MZG<*<N&>LNWQPI[I2B\F2KSR5\SQYLW"W297^WJ=PIRX9ZR[?'"GNE*+R9*O
M/)7S/'FS<+=)E?[>IW"G+AGK+M\<*Q>7=)JU0Y"WS-36#@L \JU48 B(>DQ8
MB1,Q*=U$J$885U""=AZ"4$&,=8<D9%G.<"QU7]A_BD*'B"@FNP,-U67@MJ\S
M2>,19J3=$XY+R<E..BYS+MS'-G&,#?O@YCB=!"IU3Q1!ID*#&B2L6*(\2)"#
M6/:"TPFL>2<[8/' !;:*P+W8Z/>1EY^4"'YGE1Y_U'Z7ZEVU*\"HW/"E.A\Q
MV2&GNQT>\C+S\H$/S/'/^H_2_4NVI7@3GA2G0^8[)#3W8Z/>1EY^4"'YGCG_
M %'Z7ZEVU*\"<\*4Z'S'9(:>['1[R,O/R@0_,\<_ZC]+]2[:E>!.>%*=#YCL
MD-=PAZ5IC>VYSEP:G=B"X>:WHS$8GQ&,:S,G$I) ,!F"L!+PERU"$/ L9[/!
MV,8ZNQSSZFY<Z2ZFS]2Y15',D(LC"?"Y)EL^(9YT=K"TVL SC!+KZ\X6U%?3
M"QS*Q8$Q,"1C@2Y@M+>.0R7<?<\ C_EXV;]?<7S>[ ,'D=>//R+YOE'\T91>
MERJ=MRG NKF_E/8$QV2'PI[L P>1UX\_(OF^/-&47I<JG;<IP)S?RGL"8[)#
MX4]V 8/(Z\>?D7S?'FC*+TN53MN4X$YOY3V!,=DA\*>[ ,'D=>//R+YOCS1E
M%Z7*IVW*<"<W\I[ F.R0^%=B=TJ;&@:D$WS5+J87)UKE'0(</:3 THX>2V+C
M%(S,E]B,*S$P++ #&,9+RC'D77VP/*C&R]TB#2I"J&@5)T.>G:G)LA"9E0^&
M^FPJ9%B/<XC-+8HJ,,, T@PWYV@M7>_&\LR7@3/(4<B/$CP@W/AW:9<07$DW
MM9W)  &QFF^L+KO=@&#R.O'GY%\WRG>:,HO2Y5.VY3@71S?RGL"8[)#X4]V
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M'"6.V?BX$\'4_P )R#SZY>D<)8[9^+@3P=3_  G(//KEZ1PECMGXN!/!U/\
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M/JLI1,+OF)+#M-B0X4WARE3<G%XYC##$NYDU)QY=\"9A!L9SVPXS',;&9"C
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M9)QD7:.V]EVK(S,@ZLC%UX]RPY3<0X.R4UZNT&3PU+5"'B#"TF#%PS1YF7?
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M5$"Q'D%JTAH4YIQ?:P*!E8#D\)"?!G98(+['<O)!E3Q)C+)33*Y7Y+"\W/\
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M5']'^+/)*<NJ-T6IG;\KX5:5^E7J2UIY-:>4P:LK"F:9NA\B3."B)PN22(A
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M+!6+:U.0<;MFHTI2<-UBI3,*6Y0U&%R1%@2<E&BPX''7LA\=<P0^./:S.SG
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MSZN@;7*,PM;-4K(I F=3XF"5=3&3(BT8FA6N,) C6'A.*&,I((U@CKBRLOV
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M1;G;.^5E;C$#UF%V-G G="C[.=]U'^EQ<[9WRG&('K,+L;.!.Z%'V<[[J/\
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MFH6+_33B'VWG_P!8>OTP<31_N^Y&OS<X4^B995?Y;BS@G")PBG363]\#4/\
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M(-FI"MNF R-'B\<,.8D@PDS$6,6YH<?O<T&^F]@LC]DV>>,R_P"*F^8Y97/
MQCT=F>Q2GBZ\^N3IOU]_^'@3V39YXS+_ (J;YCCG@8QZ.S/8I3Q=.3IOU]_^
M'@3V39YXS+_BIOF..>!C'H[,]BE/%TY.F_7W_P"'@3V39YXS+_BIOF..>!C'
MH[,]BE/%TY.F_7W_ .'@7PV+9\^1UM&UJ:3+RE1\XDB4TX($N1C3D,$:.**S
MV2<0>Q 8>:/'5C&>L>>O.<=6,9@PEB_$DQ@L3,:JQXD?FHJ$#CAARX/&F4JD
M1&LL((%@^(]U[7NXW) %J;6JE/0I&4?#F8C7.FYAI(S;EH@RY TMU DGWU '
MLS6?XX.7W-%Z+RH\UF(NBD;L<OX%6SRYJGLR+_@_A3V9K/\ '!R^YHO1>.:S
M$712-V.7\"G+FJ>S(O\ @_A3V9K/\<'+[FB]%XYK,1=%(W8Y?P*<N:I[,B_X
M/X4]F:S_ !P<ON:+T7CFLQ%T4C=CE_ IRYJGLR+_ (/X5=G3.=RZ4K[$*D#V
MI=2T;;'3$P%):7(21FK7$!@@X 0#KR(( XSV77U=7O=7,'<4SE%QMA[(=7ZO
M1,13M-J4'%>#I:'.2S9=L5D":Y=\?A"\!S2V+QJ'G7:3YP6(TWS9D,<:SB6?
MEZI:=@,ICHC848 M#Q%: ZP T@$C2KT]U'?PE_<"/F^>7WFB<MG5%KV_)^*+
M:[F;H70N4['_ *IW4=_"7]P(^;X\T3ELZHM>WY/Q1.9NA="Y3L?^J=U'?PE_
M<"/F^/-$Y;.J+7M^3\43F;H70N4['_JG=1W\)?W CYOCS1.6SJBU[?D_%$YF
MZ%T+E.Q_ZJDFYTZED4*K+$=>U+3A?X9Y682 3!P?E,*+8(R/ R1XZR\'FXQD
M. YSV>>RZ^K'5Z:<2UE'QOB7(?*U:O8BG:I4N>/C61Y+FFRSXO(DK0, QH$
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M>"$6?]'5RYL&9(LHU,Q7A^H3V&9B7DY.JRDQ,QW3M*<V%!AQ0Y[RV'//>X-
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5M5J&TM,<H0(SAC3EDSA^*/BX%__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g904779g57c13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g57c13.jpg
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M:1\G.3:$A:U@8]EAABW6\GN\==IJ]4WXBDJ9Q!4>);U2-C^(2V5*W2<])/\
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MXBJFU,QEFDZSH/72U % KS:98,Y)%H4P"1VV26 _2*&9O?C8C@.^VSN@N'(
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MQ;+Z577\JI?W'"*\.(UD  '<HZ[W_&R7]PPBK\<<R^E1U_*R7]PPBD#B19
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M4(0! 394QAD>UC>EQ 'EZ_$.D^!<GAL3<SN4HXBA'REN_89!$..ZW>XR2R$
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MP]]VZ] Z>'\@Z^)8 K-PV)7H77MSK\IN0_$Q7H_>]CXJ65T5V>ZHL;%P.O\
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MR*HM^R9>-9HG317 [IVDF;K8")PGGLFA.XSAI\;K\JC^GWW4?R1V!_5=HO\
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M+9S]'D_]Q3_")>*;ZBV@/8>Q?AYC^C3LC\N[1_I,9_MR?TEMKOD+9S]'D_\
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M$ZKAPLHJH<1$3'.81[XY]7(8HX(HH(6-CBAC9%%&T:-9'&T,8QHZFM: T#J
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MW_Z1/CTWGU.VWXT*_J'![F,>F@S+^O\ ^H-/3I_[V.Q5-[K<[=?_ )"B.O\
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MUU"(HHIG5654,!$TDDRB=110YA I"$(43',80 I0$1$ #()#07.( :"23T
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MS-NU(GY:T:#3SK]+W<([E%'N.]SG#[*0B&7+R-[Z;3WX@#S_ &@N1QFXYK]
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MOI^:]?8_J_,CW2W?P-7YLOURZI[D,?\ C%SYT'U">9#7?3\UZ^Q_5^/=+=_
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M54Q?EBMG_P#6!6OM58+\?RWZ6G_HE=\9WKOZ8;I[,@_U#D?;'S7XIB_T-O\
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MG #.'CM99RL(%%54W1#D< T@ :</I/$]I\)5))<=2=?YZ .@#P!;B)X!\?Z
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MMM7"LB+"QJ%TO)3\C*OIJLN]LK4]^U6C>K6>YKG+=W/VYI<6)LMBLO6IS09
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M<XW&M(U:WE_NN@(&_P 5PK=G,&S*/S3<95;E9).5?>:PMG?((>;A[W!P#G"
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M,T:=#)]T31_\CVK$+OA+T,Z4%4*8LU$1YF*TL=E33$1'F/),\LJ0@?Q4P(4
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MQ@D!OI=V>-.7E^.?1[$[.=_1A_!)[G*>2C^+Z7>U.7E^.?1[%*#QR(!^RCX
M_P TGN<<E'\7TN]J<O+\<^CV*O9CGZ*/X)/<XY*/XOI=[4Y>7XY]'L4H.5Q
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MA$P'3524((&*<I@ 0$![_? >8"(#;FABL1203QLEAE8Z.2.1H<Q['#1S7-/
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MR%]JLSHWJEB0EWO!II7F<Z$@;D?(%QD';#5K1!7.!CK+6WZ4E#RJ +M'*0B
M^$2JH+IFY*(.FZI3H.6RI2JH+$.FH4#%$,UZOT+>,MST;L+H+-=Y9)&[SM<U
MP]Z^-[2',>TEKVD.:2"MFL;DJ67I5\ACYVV*EE@?%(WQZ.8]I]\R2-P+)(W
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M)A%^7OGU@7R?3")A$PB81,(F$7J=X?\ _)\-M?:;;7^]/-2=H_[2&&_/8?\
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M:-07.!XZZN.KNOCJ>.AX>!6VX##LLU[C*,;+56UD+L$S'RM>RSE91-D9"6R
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M6CK<>@ >,Z $CBI;+8^M3X5UQ%%DB)BL6)3<R($'O=,_+D"CA0  551#T"$
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M'/)OPUGSS^Q.]]?\7I^:K[5 O>==.0*#FHW1P!1YE!?0^U50*(]X1*"FOS
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MK*-#26I#;%4OE5HT(>,=1]8K5@OEC%A-7ZQN6:$5%),R5^OP;!FYDY)WE8[
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ME6:*S%$ZE2=8A>V2&Q8Q^-IT+<\4K/>2QS6ZTTC)6$ME:X2-)#@3W!_$]?\
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M^7,H9V'97,]X<Y2R#B>;M>8;8 ))JSC<E( XN,>K9FM'PGQ-'05UK:[!^Z'
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J4OA#QAY<*'=!\1]2GPK"81,(F%4SX0\OJ*85Y,(F$3")A$PB81,(O__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g904779g58g31.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g58g31.jpg
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M@]XY;*E@JM]7.(*PGFD%T.]&7B1H@L$#A 4$XF@9Y# 97#MF'?#/+!<T</\
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M5\ [7M?/*W9M6;@.UFW>_P#=8X#\X_[K$(4B\PD:B;_G'XT%U =K51-:CJ
MX":XWSY$!>DQP$3AJZ4:N1Q-@'0"UP0A3I,R%AD%GD5N&+;/*A.MMCJ-_P#
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MKWK-AQ!+GC*\QW/IY/XTDGGJYEET'$)OI;41C*T>'/C)C;1,!0TA#)9CY99
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MR4Q9;3S"]RBN)9;R(UUIXV?)\TK&$I;+./%<-%B9+!+*ETP/#,8GA86Y+W/
MGO3?:;$<'#:WS?XH0-8L-0!OK^2_EX/_ -JC.J#!;=HVVGV(=B"C.DG \9I*
M<U4%Q)A-90Q)(F!7'8[07%-'4@#2:L%FO_ZFJ@IYXL,6NJV2C>>-KE<+9;':
M!QG_  &O_%:@:B>(?XG5_@IP8/!YQPZ\H!;BULKFWI*V6B<K(D<,_")U)2)D
MSXB2J+!I,<CA =7<A5)Q"3<RB>J@@6.J!G _D*CD,"93%5QFVFVH&QU_^?\
MGY[9 !MKL2-7E(_\_P#Y>6&U $8KW!K* F<>M;EU!3IL>B<_RR45S<XP$'R@
MW<G&BX*V 5CQLN,RE!:P"!OEQ,2:??.V-K XXWQ<YCKU @6X-8Z^JZ:LORW)
M\EM7D)/YE(^P4<01 #1TY-EH=CA2,M.84:()K-'FJCGS$BV(1ZVTR2_=[,R5
M%[H4PUE9<62<<S[)A)72)-7(Y@&RH&887-]>VQ'R#7;_ $_/PH; #5LN#\I%
MKZ]?YN+@6I'::'P8#V%EF(R@PIA,9KM-ED,8QEQS6;;4P"ZXVKFQ.Q:PAS%
M4TW$X+:V.(AJPN>....5L;; W *P18D<2@&LK"41:KGM\<W=_$Z__P"5-T4[
M=@^8?Z+_ *O-5UE*(E$2B)1$HB41*(E$2B)1$HB41*(E$7#]OAX=FX'TQEO-
ME'53,]R/S_ZE1/VCYO\ N55BMEHE$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$
MHB41*(E$2B)1$HB41*(L(CKXHD/_ 'J_^(56B+-Z(E$2B)1$HB41*(E$2B)1
M$HB41*(L(COXK ?_ #+L_%BW19.W\S?] LWHL)1%?U&W_?37<^M[F;+,0BF<
M!0_R*J:0K'S"RBR:T#0>("P77B?<9'--#4 L A0BX Q[ H>+$S60AH,',L-K
MEVZ]IO\ *%F]K6X!;Y^._E_\VKY7WN,P,([<D;:]:S,Z!DB0' W7!)9XV[EF
M5U%UV:RG992&X6R=B84+(;2P4N-F<0"Y<T4.DQ!T_/$(F=4 C:QO<F]MG!:^
MW8LDBU@+7VZ[WML7WO/=IH&&%*+<AO6]GP6[9Q)ME-E-U-5UJAU#%36X8"/7
M3H]8=TE+1X^**I\*XQX,L<5_]B8,!87N9L6/%F76"3>VR_7Y/(L7VV%K[?\
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M !@_]5$3NHM\H _Q@_\ 51$[J+?* /\ &#_U41.ZBWR@#_&#_P!5$3NHM\H
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M&;1.!HB !$T/*@*,EX#I6>)%,"4E93/!DBU@R^!M0.#XAV%,"Y95::BHW/K
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MHIZ^]4K)]#4WA0\SIN@C[*=T\2Y_6>DS=M0O&VEFH:CN7+;1/ZR04<:R5K)
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MVXY##HJ:,+EB%.LE!!XY""%LL[V#"PP#PM>][8!X8X8]C'&UK04P&A9J&U_
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M@)7Z2EAQ#R!,[_"=YQZT[R69XHMCR E?I*6'$/($SO\ "=YQZT[R69XHMCR
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MI%IB'PN3\B#[/$IJKH:I)1$HB41*(JI;4:^+L_B:UYH:^DH-H0VLB78)9LK
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MS-GD#!?,20,C2=8!)M<!;314,4S(C#*)!&2^(39@9Y,NBA,A#<@:"3(^PL2
M-A*NIP3.ULE[=:\2*]9->#1DDU'^R,PPVS93:S8QCTY*<>L(XCAM>0'E%(A\
MXI1.[U_!2.9'&*M%D=3)I9=(5LTD$LKE31R>DE=-&YSW-=ED>QK@,I<T6LYS
M?Z+CKU6&JVKA-:O@93S,;&US ^&.1S'.SACW YF-DL ]HL.^!(N2+ZK#:#5I
M44HB414ZT(\%QE?QC./GYDRH*;WEGSO^L<K%5[^[\F+ZIBN+4ZKI1$HB41:S
M=2MCI<E3?7A0H.>[C+*L:ZU.G55,AY#"0D-.';1.3X95'>\PC2NG)Y577[J:
M^6!.!"+QU1$3\,;E4_(L5RR"O6BD>Z>I8XW;&Z(,%@+!S"3K N;GCNKM1#''
M24,K00^=M09#<D$QR!K; FPL.*U^%?[E;A-8WB<+A#Q56.'NJ6X.I/AQ1D"R
M><0<+O\ #F9D)SX1PV=W2<#L5S2"2B&24KK?<N(AH//(KVP+BY7/JFLWQ=KC
MO?)FV=]G%QEU\'RV2.B?)O.SVC?AD#+@]YHW%IS<=[7%E!$U\,LA1([-D$1'
MU)GF46QJ.A04]M@9!:*W%R>WF0P9VCQ"D%"7"Y1T.]%6W&LD2R[=.NV4)..&
M#&2,NJIT\CHY($X;C?6AKI (9'"(,,C@6@-:]H<#K-R==@.&Q-PI8\-,@A)J
M(F.G,K8F.#R7/B<6D7 ( U YCLN  3>V03[PP+,B)YS@B1]K5.>P3+U@B%DR
M]L=)D=BL9*08L3I298S\C1(,)3O<B*X'&=6F[W$L.(1!(&N\Y#-C+"@ :+)"
MS@1S)6-8YX;&^1L; ^1S<H#0X7:-9!)(M>VR_#KMB+#G2-C+YHX732.CA8\/
M)D+'9'F[06@ W#;GOB+#:%M(BF0"$L1=&TII1 VEIDEL%G2 FIBAD#F?3B#R
M;J<XB9 [F6S$+YFRA=2#+F<@,\P<A@\[A9Y87QO>TQP>QCP+![6N .T!P!L?
M*J,C#'))&2"8WN82-A+7%I(^0V6?5LM$HB41*(M"L _$)6^F#8C_ # R=7PW
M[)WX][H?&*;_ &^D6F(?"Y/R(/L\2FJNAJDE$2B)1$HBUU;G3YL;#$J:F([#
M2&"F0[+>ST)Q ]'B=5C*N_E'-\*;AS6VF09IMLXHB*BC(2'F8R>83I-K>)T0
M,B21B&..:B)W3<SA&"XGA^Z&6KDJWXEAV!8IB--3-C;'2,WK'#HJA]2V?2RR
MB67+O4T[8L@+W2O)#!R5%3TTT-8Z1TAGAI9YHXPVT8R!F60R!]W.S.MHRP-M
MK).Q4RW*X0.<X6V9E=AM616"U4^*C.MX,?Q:K1[9SH\UA2ZH$ 'N-*,SAK(*
M5KW=JXFCET?%SF&Y=52RI)8 Q.E3X)@;LNYK<?A6*8'A]74459.^O&-FLKXZ
MS0286<.C>ZE%!AAB,F,:?*P2&G$PCD>Z-Q:YA#;M%AT$]+#(^*5YF%49)6RY
M#!H0='H82W-49[#/D#\I)%P00-\5KVO;LVOV;7^&U[?W7M_]Z\F7 )1$HB41
M*(E$7%5L3X0,Z_3')WXV6Z^WMS?XNX!_8N%?88%Z!2?!*7Q>'ZMJ[K-#_ KU
M3^@"*OP:DUZ]A_P&D\7B_8"\MQ/\)5_CE3]<]6QJXJ*41*(E$2B)1$HB41*(
ME$2B)1$HB415,U?^->X/ULW%YF(.JG2>[K?''?9Z=7ZWWO#_ !!GVFJ5LZN*
M@E$2B+E@4G0Z,)NV*9DQ!K[?T&<G"1R4EST]VLK8DCRB[5,!.Q9;*?)DN:Q6
M&_$0:BDHIIW*A$,D&<P6,"V"F$=)$P<^IN>_3U+)\S,.=B<HJ)&.L2]P&1CR
M"'-AS-:9'#;F&NX"[P&1[VI):?*_%F8+ ZDAD:2UL;2XR2Q C(^IL7B-KB2,
ME\MB2K,;'Q @O7A"U]G(NI"/L\VVMI[&F3?C@E*2/#*.S$XH]%].3E5'/&#B
M<GCE\"=P40HF$KVL 7,X& L,0B_9M:JH6OQ$QMHQ5,91198A,(&Q@2/ <TW
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MMCY(NRU9ZPV6BTG'"(@*VL,8Q\:5&43?;EVA5BJ<XEEPI+_"<JB?9R^B8Y9
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M6YI8R)AWWW<,:_6-D8RBVK5<;=NLZK:E&*V9KJ=P# :9TCH^].V5Q<[-WVL
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M7!N#E M>X!O;:MW5$[Y-*Z:5TMK:1TCS)8@@C.7%UB"1:]K$CA62'VNV513
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M("G7&5%51320 HN,W=2$MA+8JA[YWS1MB:QAD9+ &F2-X,@ (#@;ASFVN20
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M8M"''@YSPR*\E28<)JAF&'4L")B7<!%:[R-Z]2L:?CN%;I8D2P<&!^]@;%K
M&+XE<0_O7.+:N"$-<39Q?G8UQML#LA+G6U7/$LPQAT?W1C _#JJH,C6V+<FC
MDD:V]KN:)6!K0;FWRW4O<&,NRQM#L/'4?GI*=R.H<&GH_)^M;O<F UE@XWMJ
M77.,H04W'.MH;@LH-YT+"3#4+%G:2*N<BJ &3BF7Q/@9@9&0QY*8OED8TN(-
M- ^-QVVE+W1@D'4;,:"+[>%1UH9!"]^1I%;51S- U9H!$R5P!&MH=)(1=IX.
M-2YJSLN^M,H.X8^6YDD=^;*N?7_=!PMA!7WI@5*J#M<JNS(D:+$3#*0UB)1O
M,=J''DYD8!8 ::*GH350,U!2))6(1*X.>T4CH65CWN=*8YB 7;7$AK6WMJ:+
MD7L+ ;!J4=1"RHDPV.-C(6S4P<6LO9K0Y[W6+B2YP:#8N))/SK4^U=NY$0H,
MX25B11M%($\2G*&U&F2&+([:=+G9"ZJMR8A6LE3BI1*NN-/)%H<;CEDE>68[
M:>/<R<(S$)=3.Y@+V3 5'&J)G-94-;(Y[WRPW<"6FSK:0M-N\!<<HV6! X%?
M=3L,M&Z2%L<<<%00QS6N:'1YC&) WWPAC0\[0XCY;'91!K?:SG;&T6CDC/V=
M-47W$^ST$GG!K:;WP'DI G+"1(C7I!C[6/739)^XQM+S?3M@"Z#[JOAJA.-3
M="0?2#)M+-IB6M.$@3LQ@%LL!<^)S)(R8M/F#\S2YL4<ARN&DMWPN2+'9<JE
M*YP=!5,;%.R2"0"?>F0PY9&M?/-"W21DQ7LUU@T@\) )N_P)CO>BE!VR\;R&
MH2$0=,)[J3G'A:(Y->QV5'+KVR@;-I594,82^=65\254IM)9\4Z2>-E4?$;-
M6,)8-LR:84-&IJ(G)*UUP63/:&.=G,8U69GN<P&NQ^<:U5Q)K1) ]@86RTT3
M](QHC;*[O@Z31V&C).K+;8 >-;FZNKCDHB414ZT(\%QE?QC./GYDRH*;WEGS
MO^L<K%5[^[\F+ZIBN+4ZKI1$HBKWMN_WE$^JFS,I1T5[MD"-M?YC?K&*=RXG
MNZ'>T([<3@;85R.> F)VV:RGD[7)Y!B6-6[('$S[9Q;QS.<R*5S=;FQO</G#
M25-3L;)40,?J8^6-KOR7/ /^!6A_4O4#5E UKX/K?)9VZDZ*MI9C780>KVV$
M7)L>#J-;'2=*1'-3=FL[J9KI=1UE+J4MK@ZJQL$)%;I-R)]FN+?NK)2P5# U
M"*&(1T\^F<R5Y87/SEVD<[6Z,MN1K)RZK'5KX5RE143F>KI=[1R01B5K8FQA
MHB8PV;,UP:' @#-F)L;\5EDHO"C;F8M,UNM@DZ]\SLINY?4K* ,FX]><0(S\
M90PBC*1;2!WV6;N$DW7,[+V,=78]TFS;[(62E<S;W4OG?4]M-:/0Z?1:.QTE
MKY;WO;-PY;6LL;QI\V]KR[XWMO@39FZ*^CTF3)ES9;:LV:]_(HH@K;S8>/')
M+VNT%J3,M,.UW#<<(9%C3DR<07,\8_B5B18EMMZ+>(#;2E]!/K"R*0R!36$U
ML%Y*1LSV9H,4.^%[8VPR61I?'&6YY:VH:'/N6L:VQ.H$7/@B]MJVDIXGMCFF
MSZ.GPVD>YD=FOD<\N:!F(-AX3K$VXE*2APH>[A8HUX-)(^MP^RZ)PG1'@^GQ
M(@S9?YJ$G2A."-EUY($EHK8)O4NZ&\X4X8%.[[&?DYE8'$9.-IQ0^EW7 !D'
M)JIQ:,"/2"IT!=9Q801<. O<'PFW/%JNM10TQS2WFT)HC5L9F9I&D/#2PNRY
M2+7RNL-MR'$6.R'@X=E9TGI)VE8FQF4=*DGZL;4OS7<^](N0EMJ-9^I#<;[2
M<22Y^]9>7'(<050<-RC%3Q$%9-D\<2Q>X.5Q.W##6::6232MDRET4ICS-! <
M!8@V)-CKV?ZJG6P11&!\.<,G@;,&R$.<PN+@6Y@&W&J][+9'5E4DHB41*(M"
ML _$)6^F#8C_ # R=7PW[)WX][H?&*;_ &^D6F(?"Y/R(/L\2FJNAJDE$2B)
M1$HBU3\(<4DM!E;11Y(TRO%)8BYO!KC'BM$"430DQMJIA34'@L'G&KN(B0 >
M*M<P522Z1FV%!9':EP+YG,DG)0M@8Q] W&NH9L.W64TN&4TE7#N6QJLCQ&1T
MLD\;6,IXV0QPO>::/*Z1T@G9$*B]FZ3)<'EL.,3H:^-T$;I&T-3*V=Q<7MRY
M&AK6DEC;9B<P:'WU9K:E5+=+OR9$^;&[*24RW1(NM44J&OR(*)'6Y+DC-S,A
M*/)J(DN@\0B"/E(4-66<WBY0QSR7(1MI&59.32>2'B:(*9M3+<_N8WK581@N
M"4533T6-X@S&)1OW<S!7054C'RR0-?B58P&.,4T!#)*-M0V)[W:4M?&UCKM!
MDDIZ:EB>V*JF%0X:6B;*R0@N<T&:0 M&C:;.CSAI/?6(L>@((3 8,,4.][X"
MX8"87OCEA>^&>-LL;WPSMCEC>]KV[..6-LL;_!E:U[7M7D)!!(.T$@_.-2ZX
MO]UA$HB41*(E$7%5L3X0,Z_3')WXV6Z^WMS?XNX!_8N%?88%Z!2?!*7Q>'ZM
MJ[K-#_ KU3^@"*OP:DUZ]A_P&D\7B_8"\MQ/\)5_CE3]<]6QJXJ*41*(E$2B
M)1$HB41*(E$2B)1$HB415,U?^->X/ULW%YF(.JG2>[K?''?9Z=7ZWWO#_$&?
M::I6SJXJ"41*(E$2B)1$HB41*(E$2B*!HJ\.V:OJE:X>>+:6N!Q#X;^BQ?75
M"[-AGX-_3I_L]*KXU55I*(E$6O.<>"KT1V+DQQ2]*L)"J3Y>P*46D,ZV9*EB
M/$B3"Z&6#))(4D->/GRV&P^+DR@()2P[B2#YHT2"#(GAS1'#$M:O)202.+WL
MNYULUG.:'6V9@T@'\ZN15]5#&(XY;-;?)=C'EES<Y'.:2W62=1 N2K O+4G7
M!_+6O+@=,3-LXI:H*8:OKO<CFJ()"*C8*6EHI<-O([?44M'$32J8AHI8FC*A
M!01R?N0F#%2()@B6%"D=#$XQDL%XC>/: VU@+ $ @6%@00+:E"VHF:)@V1P$
MX(FV'/<DFY()N23<BQ-UZD/:R05 3GF9YQ#'B:RG/L)()V4YC6"2BNGS#V?B
M@*<'-KQS!955(NFW%,**@9LFH8*6CA&CYTR"GACFS @AD4<9>6-RF1Q>\W)S
M..TZR;;3J%AK.I8DGEE;&V1Y<V%F2,$ 96BPL+ 7V#6;G5M7MQC!$40VMRNX
MHU:03969PD0]*\I'0U9?4\G7("BF)J,=<(H"TJJ19*$'34A.+73T(%+2,+%K
M"AD,!Q1A1,LC8PO+18R.SOUDW<=5]9-OF%A\BP^6201M>XN$3!'&+ 96 W %
M@+ZSM-S\JB]T:0:L/5*V-1'7$*.O)6VJFW5O8$DI++K,!/Y::*8FI+66,>,O
M\9J*K=*HZ4,BJ#)R;9M.5$XFME10UDN&?QU,$3A(',!$I!DN3WQ L#M[TBVK
M+:QU[5NVIG:82V0@P!PB(#>\#B2X;.^!N;AUQK(V*)2O!9Z,%H?<$(9PJ(H-
M%TR*BR\N+JQ(TIK$JG)4;1:Y)LR$'-2F]34MD74VB.0R<WU%/>96Z0FFU%,(
MA@IZHIEC>F]8,A9DN'.#B2YQ=F&H.SDY@0"0+$6!(X3>0UU49&RZ0!S6&-H#
M(Q&&.UN9HPW(6N.L@M-S8G6 K':ZZRPCJBP1XT@=D LIK*#C67DN]M67"Z'
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M1K<XV &TA9 )O8$V!)L"; ;2;; .$[ OG,KJ(24B",<6$HHL*F(N:8E&5 H
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M]Y'N6;,7RE(A]8UB6(DED"7&R1FG5Y63L6I@W6(@1F8[:_P%EYJF JHVL&2
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M1L\S7->V61KF-#&.#W M8W8QIO<-' T=Z.)?4BZYZ^-QM1ZS4""X?1FE$CC
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M1!-]IO;@4Z<D6T_3 !^[VP/3=6-#5\]_RT76JNGHN8?YJ7LIR1;3], '[O;
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M-(X%[870 %P):6@DLML%M;K6X;["IJ:D$@PUVA8YK'U#*HEK",XD<&ME\(V
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MIL84R;,C"CCBB"B9YWY6$DPQ$DDF-A).TDM!)/RDK@J@!M1.UH :V:4  6
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M\0,C">$.!;>QUC.'6.RPU*^#<;R(T6\@M-M)Q=';C81DMO("24ME8JEHB*1
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M(CDI*@P9A34,BCN5P+GE$P$"7"'/F[A]O-C!@ !BF!!,\ 0\<K88_7N 2:7
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M?\T9)_CYX_B)1KZ6P;\#X5_9M#]EB7XL^R+_ ,0=W?\ \RW3_P"]UR[T=#_
MKU3^@"*OP:DUZMA_P&D\7B_8"^<\3_"5?XY4_7/5L:N*BE$2B)1$HB41*(E$
M2B)1$HB41*(E$53-7_C7N#];-Q>9B#JITGNZWQQWV>G5^M][P_Q!GVFJ5LZN
M*@E$2B)1$HB41*(E$2B)1$HBK<P7$WV_O7,>2\NHZ)B:U+UTQ+9*ZF23<3&0
M,P[17%Q N<'!L-<*P@=Q+!WROA;/"^78XV/9X#$2!6ZR!]ZQ;2!_^6HXUV?"
MVN=AO>M+K5T][ FWW"FXE=;E'CSQ\9GVH0_UU5,[/";YPZU<T<G)O\UW4G*/
M'GCXS/M0A_KJ9V>$WSAUIHY.3?YKNI.4>//'QF?:A#_74SL\)OG#K31R<F_S
M7=2<H\>>/C,^U"'^NIG9X3?.'6FCDY-_FNZDY1X\\?&9]J$/]=3.SPF^<.M-
M')R;_-=U)RCQYX^,S[4(?ZZF=GA-\X=::.3DW^:[J3E'CSQ\9GVH0_UU,[/"
M;YPZTT<G)O\ -=U)RCQYX^,S[4(?ZZF=GA-\X=::.3DW^:[J3E'CSQ\9GVH0
M_P!=3.SPF^<.M-')R;_-=U)RCQYX^,S[4(?ZZF=GA-\X=::.3DW^:[J3E'CS
MQ\9GVH0_UU,[/";YPZTT<G)O\UW4G*/'GCXS/M0A_KJ9V>$WSAUIHY.3?YKN
MI.4>//'QF?:A#_74SL\)OG#K31R<F_S7=2J%HB_&,2UB9A8Z\VH4,8.^;,\P
M#3B1RXV. TZ22.#ED$*<PSQQ%!$#&#ROC:V80F F-[X98WO!3N:(6W<T:W[2
M/#=\JL54;S.ZS'GO8]C3R3/D5O>4>//'QF?:A#_75/G9X3?.'6J^CDY-_FNZ
MDY1X\\?&9]J$/]=3.SPF^<.M-')R;_-=U)RCQYX^,S[4(?ZZF=GA-\X=::.3
MDW^:[J3E'CSQ\9GVH0_UU,[/";YPZTT<G)O\UW4G*/'GCXS/M0A_KJ9V>$WS
MAUIHY.3?YKNI.4>//'QF?:A#_74SL\)OG#K31R<F_P UW4G*/'GCXS/M0A_K
MJ9V>$WSAUIHY.3?YKNI0=(<4Z52X[D-_RM'&KTF/ML!EP6V]) :44O)UH()0
MQF;* H[A<1!15DT(J;$$-E0B9L' N:SR, XX#97SK1S8'N#GMB<X;'.#"1;9
M8FYU;1\NM2L?51M+(W5#&':UAD:TWMM L. <"G'E&CRW]S\9GVH0_P!=6^=G
MA-\X=:BT<G@/\UW4G*/'GCXS/M0A_KJ9V>$WSAUIHY.3?YKNI.4>//'QF?:A
M#_74SL\)OG#K31R<F_S7=2<H\>>/C,^U"'^NIG9X3?.'6FCDY-_FNZDY1X\\
M?&9]J$/]=3.SPF^<.M-')R;_ #7=2Y(TM?0K*#]O=:2;6SF.<QL+W42=K9A#
MS*^Q@1<;W&_M!C!9X"A9V[.(@>>.>%[XY6O?Y@W:03OW3XLYD,KVF:&SFQO<
MT_>L U$-(.O5J.U?L;_Z<L4PRG]A7<+#48C0P3,H\4#XIJNGBE83C^+. =&^
M1KFW:0X7 N""-1"]CO@0?WVD>4B7YU=7WK4\WGZ&3LKVWNU@W];89Z?2^M3O
M@0?WVD>4B7YU-ZU/-Y^AD[*=VL&_K;#/3Z7UJ=\"#^^TCRD2_.IO6IYO/T,G
M93NU@W];89Z?2^M3O@0?WVD>4B7YU-ZU/-Y^AD[*=VL&_K;#/3Z7UJ=\"#^^
MTCRD2_.IO6IYO/T,G93NU@W];89Z?2^M3O@0?WVD>4B7YU-ZU/-Y^AD[*=VL
M&_K;#/3Z7UJ=\"#^^TCRD2_.IO6IYO/T,G93NU@W];89Z?2^M3O@0?WVD>4B
M7YU-ZU/-Y^AD[*=VL&_K;#/3Z7UJ=\"#^^TCRD2_.IO6IYO/T,G93NU@W];8
M9Z?2^M3O@0?WVD>4B7YU-ZU/-Y^AD[*=VL&_K;#/3Z7UJ=\"#^^TCRD2_.IO
M6IYO/T,G93NU@W];89Z?2^M3O@0?WVD>4B7YU-ZU/-Y^AD[*=VL&_K;#/3Z7
MUJ=\"#^^TCRD2_.IO6IYO/T,G93NU@W];89Z?2^M7/U*>> LG2,('GB(&(_'
M?F&)AE;/#/#-P*&6&>&6-[XY8Y8WMECEC>]LK7M>U[VO7TA@X(PC"P001AU"
M""+$$4T0((.L$'40=B_&KV0GLDW?[N)(WMDCDW8;IGL>QP<Q['8U6N:]CFDM
M<US2"UP)!!!!(*[T]#_ KU3^@"*OP:DUZKA_P&D\7B_8"^=<3_"5?XY4_7/5
ML:N*BE$5&.$8E>689U><+SA%R%6G)(CUC%L("X=245;*%<G>_$)N&L#)!P)2
MVFY@#EE$0$481-,#%\,\ABUL1\ \K4,2EF@I'R0/#)<\36N+6N SRM8;AS7"
MQ!UZKC:-:Y/"(*>HKF1U3#) (YY'L#G-)T<+WBQ8YKK@M! #A?8=5U69E[_.
M)QRY#&3O5<& TT" ]D5S:J.14=*-G&3+>OXJ*&[BPIW,D;<14LC@^Z"PC$T]
M4#!5V^JI!LT 9&&PMA49B+G3P9W:-C:>J-7%E!,<U-;.+V+AEUEH!LYK@2+[
M+LF%,93U.C!FD=543*&;,0):>K#C&;7:PE_>M<2WO7M< 0 ;RZR^$1+K!YF\
MH&OLEQ,WYCC9]2EK^XW(N,E7+2DWV$T,WZHD#I%N+*B=8;@4&A<!<24U?P%"
M.%1>+@<[=VD(>>/$@XQB2GEA;/%)+3/<Z-PF;&S2$$-<3&XLLYH=M!VWM>O)
MA!:)-%5P5#Z::*"K8QLK3 ^600@ASVM$K6RW8XLU@BY%KV_D1\(TA2 Y8D*/
MJ&GE"C#G2,GO)L82>^G6PQ6XK)$8-XLYY$&72Z8M#'&>C-]'%%4"Z\X^X05)
M/# 4;DR1,U84-#B39'PB2!\$=1%)+%+(^/*X1-#Y,P#B6-:V[LSK7;8V .I4
M80^)E08JB*IEI9XH9X(F2YVNG>8X<N9@$CGN&4L9<M<2VY(*PG<C:=TB$(17
M]>)<40]=U]ROY*G?8;7-EMK8]5C\XWD)$.M% R(D0'6CHI%</*AJZZKW2SZB
MG@EB. &)?(SB74HZVK?:!U-,=[.=(*BIIF,JC$6M:6-L,[6AQ)S'*2 !:U[&
M7#J&/-4LK*<;[8R%U)25DLE$V4/>X2/N3&YY:UHRLN&NNZ][=[ BQN_*+-US
MA*1D;9)HSXFFM^(YB=QR!&\;7Q?CL@983EY:566^XI5&21.MB6CI)/L%<FRD
M0HIG /<;W /9GCAHP=KFNECIH)15,J1W0BB=)#$-(^F<'$QR0F,%DQ .IC0X
MC+E-R2;3<,ADK*J%U')2.&$S5$<,\]XHZMI:ULD50)")*<$[97$ Y\X  #?O
MD/A Y+<S_P!O\XB7'HSV7%&CI^5&0BR%$83/7T:5R#KN1%=%DQ^M0%P*J;FF
MF"Q<N65+'FR8%",7"(YF 1L[9EQ&5TM;H72,9#0&9C98<CFS!]L]I&!Y&4BP
M==A/ L0X3"R+#]\-CDDJ,3$$CH:C2,= 8P='FAD+&G,"21:07&L A8]K9N-L
M,]9:B1FQYL>W-S1I$@F17E);3,Q0V8X(P+(" P"Z\Q2"T]F2DI)4RGNF01PV
M =LH8"9$0<13U@,#!PAF'I2UM2^:&..J;7&6GEDE8861"GD;'FC#GQM:"'R?
M<S?9MX0MZW#Z2*GJ)):*3#M#5PQ0R"H?,:N%\I9*612N<0Z.$:89;9C87L'*
MSNLDT[*\Z4UK_+4IL>=<B\&@R)+F;&8Z4VR6N4J&%Q.)E(K%<C?/&TYQ%CY0
MRIV)%5[$-WF 4P);S!)I]C(0UNEGJM]FFFECJ+4^EFT<8:*:8N $.=I(<"";
M!P#[ .U"X5&MIZ(T(JZ>"6EO5&&GTLKI#60!CB9PQX:6$$-N67C!<67+K$;2
MJY9<(E$2B*IFK_QKW!^MFXO,Q!U4Z3W=;XX[[/3J_6^]X?X@S[35*V=7%02B
M)1$HB41*(E$2B)1$HB415"2H@B:6=Z)6 E2+X[DP!#U.UZ%109 9+:>020*?
MF#9W \*EAN-,4L$\0[@4*X&\RE@<C.)8OB-?.P(=L>OXDQCZT9FM=:EBMF:#
M:\T][7!M>PO\R[3A,DD>&G1O>R]=-?(YS;V@IK7L1=6EYF^H?16UOZCHQ]5Z
MIZ&+DH_,;U*[OBHY>;I7]I.9OJ'T5M;^HZ,?5>FABY*/S&]2;XJ.7FZ5_:3F
M;ZA]%;6_J.C'U7IH8N2C\QO4F^*CEYNE?VDYF^H?16UOZCHQ]5Z:&+DH_,;U
M)OBHY>;I7]I.9OJ'T5M;^HZ,?5>FABY*/S&]2;XJ.7FZ5_:3F;ZA]%;6_J.C
M'U7IH8N2C\QO4F^*CEYNE?VDYF^H?16UOZCHQ]5Z:&+DH_,;U)OBHY>;I7]I
M.9OJ'T5M;^HZ,?5>FABY*/S&]2;XJ.7FZ5_:3F;ZA]%;6_J.C'U7IH8N2C\Q
MO4F^*CEYNE?VDYF^H?16UOZCHQ]5Z:&+DH_,;U)OBHY>;I7]I.9OJ'T5M;^H
MZ,?5>FABY*/S&]2;XJ.7FZ5_:3F;ZA]%;6_J.C'U7IH8N2C\QO4F^*CEYNE?
MVDYF^H?16UOZCHQ]5Z:&+DH_,;U)OBHY>;I7]I5/TBU5U?<NMK067'K? B^K
MF'9,@!A56X>CU54AP$Z;)$34\$8\?;HYH4(BG%"A F'F+E@5)%2Y4#'   (/
M&&GBC,+28V$W?K+&DZGN X.)3U,\[9G 32@98]0D>!KB83J!X3K^=6PYF^H?
M16UOZCHQ]5ZFT,7)1^8WJ4&^*CEYNE?VDYF^H?16UOZCHQ]5Z:&+DH_,;U)O
MBHY>;I7]I.9OJ'T5M;^HZ,?5>FABY*/S&]2;XJ.7FZ5_:3F;ZA]%;6_J.C'U
M7IH8N2C\QO4F^*CEYNE?VDYF^H?16UOZCHQ]5Z:&+DH_,;U)OBHY>;I7]I.9
MOJ'T5M;^HZ,?5>FABY*/S&]2;XJ.7FZ5_:3F;ZA]%;6_J.C'U7IH8N2C\QO4
MF^*CEYNE?VDYF^H?16UOZCHQ]5Z:&+DH_,;U)OBHY>;I7]I.9OJ'T5M;^HZ,
M?5>FABY*/S&]2;XJ.7FZ5_:3F;ZA]%;6_J.C'U7IH8N2C\QO4F^*CEYNE?VD
MYF^H?16UOZCHQ]5Z:&+DH_,;U)OBHY>;I7]I.9OJ'T5M;^HZ,?5>FABY*/S&
M]2;XJ.7FZ5_:3F;ZA]%;6_J.C'U7IH8N2C\QO4F^*CEYNE?VERL)D4Q<(??.
M.<;,'/$M+DUD"V.;.;N6)<@FRZ]D].) 6NG7L$4($"Q8D2+!VQ!*E"X!8# ,
M$(/#'YJW8XGB5/NEQ6&GQ"N@ACEA#(H:N>*-@-+ 2&1LD:UH)))  UDG:5^N
M/_I\W$[C,6]AW<3B&*[D=S&)U]328FZHKL0P#"JRLJ',QW%(F.FJ:FDDFE+(
MF,C:9'N+8V,8+-: /6Y)8J^;./OL8W/1M=:[LXQ_6N)>G57K5[-_)Q['GQ#W
M&?W7P/\ <4Y)8J^;./OL8W/1M.[.,?UKB7IU5ZU/Y./8\^(>XS^Z^!_N*<DL
M5?-G'WV,;GHVG=G&/ZUQ+TZJ]:G\G'L>?$/<9_=? _W%.26*OFSC[[&-ST;3
MNSC']:XEZ=5>M3^3CV//B'N,_NO@?[BG)+%7S9Q]]C&YZ-IW9QC^M<2].JO6
MI_)Q['GQ#W&?W7P/]Q3DEBKYLX^^QC<]&T[LXQ_6N)>G57K4_DX]CSXA[C/[
MKX'^XIR2Q5\V<??8QN>C:=V<8_K7$O3JKUJ?R<>QY\0]QG]U\#_<4Y)8J^;.
M/OL8W/1M.[.,?UKB7IU5ZU/Y./8\^(>XS^Z^!_N*<DL5?-G'WV,;GHVG=G&/
MZUQ+TZJ]:G\G'L>?$/<9_=? _P!Q3DEBKYLX^^QC<]&T[LXQ_6N)>G57K4_D
MX]CSXA[C/[KX'^XIR2Q5\V<??8QN>C:=V<8_K7$O3JKUJ?R<>QY\0]QG]U\#
M_<4Y)8J^;./OL8W/1M.[.,?UKB7IU5ZU/Y./8\^(>XS^Z^!_N*<DL5?-G'WV
M,;GHVG=G&/ZUQ+TZJ]:G\G'L>?$/<9_=? _W%:'Y-+%B4D2"3)EP"A,H]W86
M*E2P08!8L6 7CX0!<N %C@$" "%AB&$$'CB&&'CCAACCCC:UOH;"7ODPK#))
M'.>]^'T3WO>XN>][J:-SG.<XDN<XDESB2222225^0^[ZG@I=W6[6EI88J:FI
MMUNZ.GIZ>"-D,$$$.,5D<,,,,;6QQ111M:R.-C6L8QK6M:&@!=[&A_@5ZI_0
M!%7X-2:]4P_X#2>+Q?L!?/&)_A*O\<J?KGJV-7%12B* ]DX%2MD8RSC-9<"@
MV263N8KN]U$PH6.FK&&*[$EV%2?:#6885P3XZ4&3,"<;CA C9B!VRSQM:]>J
MIVU41B<XM!?&^X )O&]KP-?&6V/R*U1U3J.?3-8'G1RQY7$@6EC=&3<<(#KC
MC(LH,=_!^0Z\=EGAL<>,J98>28?=<122PR@)<%ON\H\$&[46'*,<PRP/)RX:
M:P9%&-9E+=K-8)A,YGQ#G= P]=^'0/JGU1)O+"^&6,6#7A[<CG$[0XLLTVVV
M!VW5J/%JF.BCHQE(AJ(ZB&4WSQF)^D:P#8Y@DNX7V$D#58#!V9P=UTHZRK2)
ML-(4LMZ&(U?<6Z^MQ>;+*0P8R0GZS\F ?4E50;J<3.2 X$UGV+HB2H+=R@)4
M #MV)3NK/$8/2/#<ICTM3),V"*2&F:YK&B)LC-&22P R.#+-!=:P%[7UJ23%
MPX2Z&CAIWU,T4]6]CY7:9\,NF :U[B(6.D[YP;<DZKVU*1&OHTRV]GJ&&==)
M]QINID=2C&I%&64)),IDC(LJ,Q)92SWTE!<ABX 0">E\>Y $(R4/8FQRIK&X
M%_AD;0,::*[RYM''-$&N:")6S1B,YQLU ;+$&Y!U*)^)R.[HD,#'8A-!,7->
MX.A=3ROE;HR+$DN?M)!%@1K61ROJ8$X<V LP!)"KJL[8X47*=1S,8M1K&F(M
MA.\@13EXL]HL.E2C2=8N9=-)Y)BB=""44D; 08J8[;<+(#::C#M&ZGE-(^(O
M+3$QAC=G :X21$!C]0%B=;> K2"OR:5M7"VOCF:P.$\D@E88RXL,4X)DCL7.
MS-&IP-B+;8<2^#E;^"8W3CIEYVN^2 MMX\W ?LA&VXV4?)\O6.2IX@E-H%K(
M8)%$:S9&*'A+9XI]CA\(SF9'N9&#% +E86X:T!I?,]\N_(JV20M:W2217 :&
M-LUC#?@N=NLZK6'8NZ[VQT\<<)P^;#H80][M%%,02\R/)?(\$?TK ZM0MKD:
M8M)6U,,@3?("B^5Q&-S=K5EK8IIQ)+(&2Z$C9+QA>[YR(PXV(AI3L*8N7[B,
M8X%>UXVS[9QKWM4L]"R>2>0R.:9Z7>I  LUN?/G%]IOJL=2AI\2?3Q4T38F.
M%-6[\:22"YV0,R$#8+"]QKOP*P*5%5VW"!:'FFYS[:/)L6EHW1W\F$282\EG
M"#2Q:Z8\0"N-\"N:RGBAA+)<$02X%CH6(>6=P^S>]@198-"QY:1"(FR #,"&
M9 ^VS,#WP%]JJ.FTE2:B1@>'3F9T3B2UP=)G=&2;G*X=Z3:]M>U5DU&TL=>I
MHF"0F;%N5\1UVI:,FV"I1C&#>Q5W*LCA#B.U?>:$C!O=PKX66 F&1U<7% <T
M#F&7,BY@%"H856CH7TG>BI?)'WQ,9BB;F>[^FY[6B1SOE<XD\.P6O8AB4=?W
MSJ-D4W>@2MGG?EC8"!&R)S]$QFN]FL !N0+DE7WKD%Q241*(JF:O_&O<'ZV;
MB\S$'53I/=UOCCOL].K];[WA_B#/M-4O3W,V'-ZJ:X2#/!%K%GF:9 K/##;9
MQ6%0RRA9T/IM,\3(13!(*8A;N()?S/X6Q)#=NS*XE\KA8BW%PVKJDT=++4!@
MD,>3O"[*#GD9'ML;6S7V&]K?*M<.I!7UD-*7F,2Z2[PW.1HX9)19MVWN6 ;=
M5[ZU%C5W*5Y37IJ7X@CX@Y]>H0:KMS49N4W$83R$BR4U4@^I'V?%Z462#>"^
MVTD0N7*+3]%40$RYG(<)%)JH-RIPQ"RN,KIW0Q!]- Q]YR^PEE8"2R(!IS,%
MK.DO:_N0[:IY,.$#*9M1*8ZNI?':F$8)AA>X-$D[B\9'NN2R&Q=87>6G4*^L
M?A$IQ&0M:I)DW7)BH<0[,OQB1\UEIE37DYWRBJDC"& 6\H*#$/L=&&/$BXI4
M2ZN GJ>1DF!V1L+BB8A%C-9F)3Y:666EC;#521QL<R?/(TRWRDQF-MP+=]8W
M UZ^&W+A%*'UL,%9*ZHH8I9I&RTP9$]L-B]K96S.RFQ[TN;8G5JO<2_-^_J?
M#NVL9:Y=X>2\U'$:8*-)TH!K698K%[EEP^Y$J,D503+)HX(^2X:00CAPR;44
M\N32E $QCF():P6<\^("&LBIM'F8XQMEFS6$3YB\1-(MKS%ER20 TWU[%7IL
M*=44$]9I<DC!*Z" MN9XZ<1NG>'9@1D#[  $EP(M;6O/F_="4V_L,ZM=X/CZ
M(W Z8_8K;?*[:8I<Y-E%^"NC Z93VC$J,"AJ8KA5PBI,/$ZJFS(*6243P)$\
M&4M@"8/8GKIFU+Z:"*%SXXV2.TTVB,N>Y$<#<IS.L-;B; FQ U$YIL.@=1QU
ME5-4,CEE?$W>U/IVPB.P=)4.+VY&W.IH!<6@EM]8%OTZ8RY"!LITDYJ."*RR
M)'2C(3]9[A#",N%EA-]&-*[D23%B_:@U(PGXD#F!$8' O=5"L5'#+ELC5BX=
MP3 4^^)6.B#8C)(QVMS,K2YS3;:18VMMU:A>RX\P$U(IH9&3E\S88I&7#)2]
MP;&X7N6AQ<+WOEU@DVNJ9QWMMMT\$J,)A/:AIXFOLM*R!BD -"0CKHG%I,=U
MY8YM^3'0S0VN60CJ"83A2BRH)*(LB*J8FG<1!LA,@+]OI1UE8\0S&B&]IG-R
MY)2^=D;_ ',SV9 TMRD.+6NS <>J_(S4%!&Z>G&('?=.U^8R0AE+)+&._@CE
MTA>'AUVASV!KG#5:^J:%';KN?;QAZJ@Q._"&+K0)#6S,ENI/';;8.Y,A*35(
M,&/["ES5WP5%N>R+K2G@.D%$<01/P+W513)@,E.:RU9'2:&09VR.,KP6L.0
MVCU'2#79QNT-U;;ZJ[:"^'RUQGB.C?"T0L<'R#2N<V\MB-%[F[00XOU^YMKB
M\KO0_"4K,5!?&M+E8<-RK.*SK]'$D+SN"*OA8>"=96Q27"IQ ?;*>JI;&= Z
M,>]RES!P'<P$\,!5-%K GR@.<(KY!+&V2E='!+4.IHY7/M(9!?*XPE@+8WY3
M9V8V&LC6%-W,B=!*^*MCEJ*>E;5S0,CO$V,Y<S!4B1S72QAPS,R"[B6@DM)4
M))_"03X'%CFV15]66R>UR9$@N!G/%P->8[FI%2$=N/2[+5'258ZHR"!14")'
M,@38B:"X 1!2^>6>9LH5",G2\ Q.HT+JHTC331R.8]S)[R@-?HRX1F, V-C;
M-LX0+D678/2Z>.C;7/%9+"R2-DE-:%SGQ:5L9E;*2PD:@XL(!L '$@';TEJ9
M%:3$Y83#&!Q-5B)133C87&[6:(GRX9HH8#XUL<N(.7%#%PXV-LN+E;LVM?X*
MYD$. <#<$ @C801<$?.%P#FEKBUPLYI+2#M!!L0?F*A2*O#MFKZI6N'GBVEK
M@L0^&_HL7UU0NRX9^#?TZ?[/2J^-55:2B)1%2#A"MQPM%];E6<<&<3?*R.]&
M''+715MTEF*SP'+(CB*MY,6GZ^3A)1*M!E(?;QE-=6QR(^ 818,G?,I<Y8\5
M@J)M!'GL'$N:T G*V[C:[G?T6@7)*M4=-OJ819LH#7O<0,SLK!<AC=69QU "
MXX3P*H1/A$]I6! 6V,L3KK1%9\. (/,S?&LJZ^348DO6R;BA8 U=08I)]F6N
M176P\4(<(MD?+C(ZJ&>3S0RB4#+EBI;-5A%1*V.5SXF_<V%[7L?FC?;^CFMJ
M</SZO\;!HZ=\U/'%-(-+*(GQS1Y)X^)^6]G-/ ;BQU'Y,\U<X21P[I2TS&?K
MG$22Z8G:T<,]R[53ZH/ V78D92B\6BC.<O $5XE6^/E+,AH%U.X+V,V-MY#9
MI;M5U4SDL9%T,[M%4NF>T1L!:&M,LA=WK'.;?1MU=^X;'; .'@6D]&VFC<Z:
M0MD<]S:>(-&9[&N(TKR3WC#;O18EQV:M:G[@]MO5'=[6!%V%5&*2CPXK/25&
MGDUB"\.XRP <<O\ <++ .V53"6CBB9JH2'@H"@7(X8E!#&1? 4?$.PV<E-,9
MXA(6AI+G"P-_<DC;\ME%64XI9S"'%X#&.S$6/?M#K6!.R]MJI"G<+PXC_!71
M/PC=X-10EJ2903(\'BFS[/9I:2"H;#+T'W5 G;=KXFS@H15&Q<5BF:"7PS,&
M,DVX^(8=CF<.^SO1M3D%W.MDS&WOA9MM\E]BLC#VFNDI-*;1QE^?*+DB)LEL
MM[#6;;3J5IEKA KD>$$B?10O DI)@<@->77$=FE])1EG,A1SC)NI"\$7B?$<
MF?RDXD-DI7).59#--\@W1ADH,IDNCG#8*=(:C[X;!HW#,'DO<+-.47[S;F'&
M=5M6W7: 4EZ22JTK#D=&!&TASAI'$?=-F0ZK@:R=>Q;&JLJFE$2B)1%3K0CP
M7&5_&,X^?F3*@IO>6?._ZQRL57O[OR8OJF*XM3JNE$2B)1%2#7O;M1F[;/>O
M6DTQB3=(Z=+T!HR:[2ZZ.HFGYC-$:GW\9,'D<1+)@H&3?&)V3  P%!5LH!B7
M-"9E,L; 7@CE+Y9XR !"6 &_NL[2[6."VSY5:FIQ%3TLX<2:@3$M( #=$\,%
MCPWO?6!;8L^=VZ.L;$PV1$=DJIJ/AJ(691O8S(5!=QCDS+R(A%G,S!5"Q)OF
M;K5EQ#.%CX.+6LNY%<!;!'\2IC',''8S1-TEW@:'+I-1[W,+MV#7<<5_E6C:
M:=^ARQD[XS"'6T9\ARNM<ZK'5WUK\%U"TJ\*QP?T(O->CV4=C4)JO!JBL7!T
M(XS/DI3NVBTDMQ$=C,6' >1&6I)B*VU9!<:";%="D<+-U)&5B2<M*B<IC8DZ
MT?5T['%KI ",MQE<;9@"+D-( ((UDV&PV*DCH*N5H>R$N:[-E.9@OD<6N !<
M"2""+ 7-K@$:U[T[<)GHKK0_+QG-FQ#59CT"9@<@GDO!&>;G+(S2-%1CJ6IN
M%;9[:<""W!7  #CWJI2ZIIZP[!C:85;:>J&E=+!.9?4P1NROD =;-L<0!:X)
M(! OP D%VH"Y(6(J*JF8'QPN<TN+ ;M;=P-B '.!-C[H@$-UW(L5<MHNMOOQ
MJ-A\--2#6&J\F\BNMLJX0)DN$JM]Q)I971E(,N= +'  SR<<+&L 398N9"Q%
MM@. $+CF'C,UP<T.:;AP#@>,$7!_.%6<US'.8X6<UQ:X<3FD@C5Q$660UE82
MB)1$HBY!DK_B$@?3//'GI?M?+.[?\:<7_P#>A^R4Z_9[_P!-G_!'<'XGBO\
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M=A*B/"B#/302$9ZE'=B[6>YG 1:24EFCWN"AV0'*&YEA$2U GD64P0,#^9W
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M!>X@_G!4\U(H4HB41*(N09*_XA('TSSQYZ7[7RSNW_&G%_\ WH?LE.OV>_\
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MHZ[DW*]N1N$9U]B\/=L5RE)"SQT$)1>?G3W,;:<:N9 EQID7FU+,2PK@+=\
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4T4C6R1E\,K'%DC6O83E>T.! _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g904779g58z58.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g58z58.jpg
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M 0$! 0$! ?_  !$( +D"70,!$0 "$0$#$0'_Q  >  $  @(# 0$!
M    !P@%!@$$"0,""O_$ %80  $$ @$! P8*!08+!0<%  4" P0& 0< "!$2
M$Q05%U:6EPD6&"%56-35UM<C)#$W=R(F,X:VQB4R-38X04=1=K6X-$9A=;=#
M<7.1LK3P.51T>,'_Q  = 0$  04! 0$             !0$" P0&!P@)_\0
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MCV;=U[D6$O2'?_7FX>TQK[;R>ZJZ8]G*'X/7_+Y!=:-3>T5[\7L/F,>D._\
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M[;QU5TQ[.4/P>O\ E\=:-3>T5[\7L/F,>D._^O-P]IC7VWCJKICV<H?@]?\
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MO:*]^+V'S&/2'?\ UYN'M,:^V\=5=,>SE#\'K_E\=:-3>T5[\7L/F,>D._\
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M*A[-&V0:1DD(Q&4E ,M5[4:%V! [S5,B6!\',(,5DJF.&L3@LM-A0I$14QM
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M9!<&.7.Q[8JY6RL5Z/+ULO<&I)=KTX=)ZPZ@+[-$WL^SK%8VW2<N:?I[L2+
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MZ_63")XB#,V5WJBWTAIZ9&82+:V6J(T _P!F&)6CE5R3)X&G:=P[EU='F "
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MIDN,]4?.Q5-]H15W9U0.N;)<.P:T1KPYRMW6(.LU\;W=':YU?86&F*JRB1Y
MY=76OL9A*X\.9)*:H/+G3AN;-Z$*UUD%*B='2K2,26*25)4!Y8M<NCK'0^DJ
M^!J:UK94B.2):6(Z^&RP!,AQA M@1(4%[70T,9+&N*ZUA2%LW21Q2QA.BSV"
MEV*>,W/<<\1R=]L?NUZ8?X06S_J%W;SGJ;^]-6?YW#_XS09T%Q_=>E/\EF?\
MDOL@CG0YS^.,9[IN].W3S<:=1:UL %I_2U%M.JNA3T=[T!V 6/V#8-L;&&ZJ
M3O8:6C2[DZ/+0V A?9I8Y.L-=@":8?#A7YQ"''6['F?/R:FU+!G6$JMD7=[8
M0[GRA?:6GY$8Q*V/359KE=/% ]D%I D<8-2&.R-**:=&/(08B/1KA^_NTSIN
M="KXMC'I:.NEU'D_^S-01Y(16,FXLQ4Z:A$9KYRC.QH#VII!),5@8,@ '/(-
MJN:310W0+T['&KAY;9K[0;1$U. N36N+AMS6L^9J2RSYNZ8DT=M6Z536)=HA
M%F#->T6W!O**3K*O0A&P&1%MO]?+KKKE@D#^474L=8/1Q:ZRAON)$%;2#2V@
MV7448Z%["T\"9;!<-[#6=C".C9]K)(>M<>%720I*2+'@\GFF9"3>DE6%;*93
MQIR5DVYJR/II1"7C""MYT.I,TK'BK:^:#>@U45@;)@9EE&,L99.#OO2GTKOC
MC9#%R/B+66INTR]:DUZV4*'0JU)TKTH=/NXV<'ZDS4)AH[(OMKOMQJ^$B[,!
MD><1WBQVR)2$1ASMBMUAJYI8X_,8QH89U0&4R5#L26,IM[K'4M&OFTQTT8([
M:^'709FTT62WHBHURC"01!Z]AI#23A2">>R 3#0;<T1\>;7#KXSJ+1^F[M/.
M(:0GGD.L9MC.B[ RXSD(+:U"F&5A-)ZE^DO26A3_ $_%ZIFU6>H7?J'V;K<R
MJZ[9UL0K.P]?:PG:4<#7X!;J0%"0]? =H"=A%R^6[$2)3*H$?$2GI[K,998I
MO:5UE?:BC:D#,\SB38&F:JT!YA3V@I=;96P[Y#UTB%/.=]E(J3UH0HL40AS)
M#3L:-'/0(='5&CJ+3TC3AHGGDJ'/U+:U9UG7%66)9UM42B4%C&F0(\=E;'M@
MV1C;)12OB <%[B.:U3&M%M?I"T-=[0.)?%ANO36*Q<IH70NM).L=#;EL<2)M
M;656@$B\TY?MX:F*5*HU6\62Q@]@BO,T_982F&Y9U 4>&FVJ+R=/K74-?#(+
MSM9(W2H+#ZBM66VHZ*,]]/:RR" R/7:?N0S9LROBQ9%8;IAU,B?'''604[(;
MNLM]&:=GRQE6(D8C8LX@-.U3JK3UY)8RXJH@R'>>QOZ<L.%$L)4J/9!4)+6/
M!D/.D<0'S&1X-Z2.C[9CFJ:ZNXD]:G!E.T?FXV6%?]?.UZ]8O!7< Z>,9'10
MMC0(V+,G4ZK0%6^!;+?6/%LT)+%-DQXL6<:DBZSUM5)<24@BM0%G:@\QB$K;
M)LFO^SQ4I1E<5YXJGK&#G2R>9$API>[$>KIS'/>./&BT=HJU6GBK-+5R!0J!
M9LIEC6K&L4GFN1$$T3 24!9D?"B#6:.9.B[TIB-A/:UA#YL#T5]+-1(;"/-S
M;1L)L%7-UP9=?LFPZ%$%Z5+#>C]6P:>O8T&54:M:K^4/[4L,\'KZ6&$ZSECS
M%$;39*HZ6P3KL3 ?7>KIHZR.X<2L63*H2,DQJRQ>6^"76R5DY*PC)LR'6AC4
M\8<BR8<UJP@+'_I9C0]#*?FCZ&TG#)92&OEV21XMZQ\:59U[141A:+^TH2V8
MWPHDNQ-)MY)(]:\ :MXS5Z>=0U.A8S,:*Z&NG2F9V'BTWZ(V$L_I% :]M=OM
MM*,00^OH[?3 1J&Y(4<"D6MTGG.Q]E)0_(>CCB JOK;BBX[T&?-?RFU_J>=]
MF>:5SUD1%JY%G#A0IP2'LGKJT4ZC>^0ID:)/LNKVM:UQ1&DHYYG-(,;<8M :
M:@I9^=V+$#+^TXU9+FS(!QAK6II0L.\&V/T2N+_^IVB;SG-$0,948)KAD(ZD
M76_H/5?3YL6M5?5=@L9:"4K,XF9'6@Z*LQ(7-AVZQ@QLU@V+J-!Q(%V<"+&6
M&#&E5&"J+F:_@:6M(!T/9"7>:!U%<:EK)4RWC10D%+8$!8D<T01AOA19!6.C
MFFV2L+$DF-&(YDTF_P!&WI0PY*'BBX/7FGJC3EG&B5,B25A8I"G%+D!EE"]D
MR3'$1L@4*NWPRXX121M?"&K.D<@C2XR@EFI;SN\X;'&,G;J-_>.+_@WTW_\
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M"QFPGDLI1!T98MT6;!='.\\^<*?%KJ\#4DQR0AA"&>\TF8A'O:YK8K%$LC9
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MC51$4\?_ *<ZMV*<'\$N^/[N1CR6R*QQC)WKW^C'M[^._3G_ .GW5+SGI/\
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MEO"??F(MXH>NPVM-=SMG6^U[$=N* 4"M0;54:<M+3-$IM[L4PB\:NH5#$:,
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M83AF.0<+2Y,MSF157DT \/0Z_@, Y]::VCKJ73KTOI55=R]1PY=D9XUDC/\
M;$Z5+D?9IH CH1 .$@6,8G2EM?*2=IE-H*<X[66(:H[=.:B8M%%M*6)IZ7$K
M@L(D9X/LB#%B@2Q#.(!1J=I%,1[UDASJ6^$G=,9*JZ&=@I\H"11Q7+.I>K&-
M8#)(99(5J!%R6PXMR9V=):KQ*&[#" 7;FL% "EC4%N#F1-:GQ8M-*^2UH>A3
MR@5WW3O*'>N=&NC@$:*2)("*L= 6I8LD3VOD2&P$D$. !%(C1J-TFNJ?*@IN
ME70-DF\!@BJVGU@R2<@90YD<QK)DYMJ]L8K%9'CNFK'& QQH/>>A&5RU)/\
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MKRKGY$5T]PA%&HX@3!.1K]F])?'>TP&*U.+1,D-0K]J[2.8Q/[*N3+5^^O\
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MB(UZ/?O(JO<J[]IY3-=7B4'V[J2TNR:86Q?22+B6>RE0I%D[I#2VRI9"G),
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M[^?X?G^'OX8V^Y?1M]7Z;=NWU?CC!J1G./YO'L?T/SY;%]F/&CJ?5V]A7/\
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M4(0!=(NILE/+":P:#QR.N=DUI1F';E:W4)0*79ZD&;GSF8>X-7%C0Z.M<VO
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MG5JG>D]DG<=M1JNNO1$5QJK644]:X]C.@T-M579L7GM3^?HV\=GH].,[EO\
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M#M0)D+*%V"7JU8(15CV"2HX>$5GXF)8BSY><QD-(\!\D7DHM_)F[50C:RO\
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MQH @ %*OSI;%NV#4=C%QM?C>',+DI]R+QI#H>R$QS&;;=;1TR[6:*"K^$<M
M](05$-R[-KC8+8.N1,LUW:D0:6L$^M1A-)L(R.S5KX5'3" 6S 4"0YHTQ 4
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M!$NIO4RUMJ;>//;P_'\MB;/WQQD^!M(]7T3H[(42;:;]-V/(W?6[6Y7W=UV
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M=]K'R[4AIM"[3%B<D-6:B%<H>OL6G913H^F#5U>JSI)QCU.^30R02AU3 Z"
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MHI5#NJY>C$KO2X0W*K&[OS/D3CC&.,90OK=_V8_UT_NGS(/U_E_/,9/5^?\
M++::F_=7K3^']-_LX-Y8[TK^*_KE[?0GX)^F2!RF5QQC'&,<8QQC'&,<8QQC
M'&,JK.TQM8B4M4DE=M8$AEN:)Q# ]S4(AJ<4BE1U,#$F3I:7,+,FX1()46Q+
MH^6)\9F&U6F)I4W&JS48GA4 7*17"&[I45";6-7I$<UC'(_:BHY',&-JHJ<6
ML8B[4:FS.V29G1;AC-0*M<+81R=$K'D(Q1[/["M(8KVJFS8XCW)L5ZY^@&F]
MKC78KI.YZOG(4JLRS<8=J46(8-& -Q+W%XJ[GRN;)C]\L:D'PL=,EV2!N*2E
MB23GXL>8 ,@ IMV"&F\K'.^XWBK"N,U5X<5:5[R(J\4(Y7^E5PLD[MFTQ5W6
MO:W:1R[&D"R.]J;?4\+&"<B;-X;6L7@B9O&G-:6?7[9%5K*T<\0EQH,&,2J%
M$A45$89 1WXPG,"/))K5%8G22DYM#9)H:VY/SB %&*Q*=FU&$0E51C8Q5:C=
MK6HU=UNU4;P__E15<J-3@FU=B;555H608R(A"D>U'.<B/>Y_WW;$<]=OI>Y&
MM1SE^\Y&M1578F3AS+F''&,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC
M'&,<8QQC(!,].]0.6R5=WBM@%VF/835EJ)T%)B1"-+)601KP4?>%I(1"HL@L
MGC7D;,ALV+(0G(!^P!I$&0.FI:;8SID.FVKRA=F#1K7?XXJXB7QME&2[+)*Q
M#,\C1H6L#5K)OS$Y-$[.1U_";#H24,3JI%,-Q;AFIR+/%P1=8RQ7&,<8QQC'
M&,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8
MQQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8RA?6[_LQ_KI_=/F0?K_+
M^>8R>K\_Y9/&KM9TV5K/74E\=/4](HM1?>4FQ65M*G7J^/<<4EMHNAIO&5JS
MG"&T(0C'\E"4IQC&**YR*O'UKZD\,JC6JB</4GK7QS>O192/HTA[2VC[YY3?
M=S[D\,KN-Y=Z^./192/HTA[2VC[YXWW<^Y/#&XWEWKXX]%E(^C2'M+:/OGC?
M=S[D\,;C>7>OCCT64CZ-(>TMH^^>-]W/N3PQN-Y=Z^./192/HTA[2VC[YXWW
M<^Y/#&XWEWKXX]%E(^C2'M+:/OGC?=S[D\,;C>7>OCCT64CZ-(>TMH^^>-]W
M/N3PQN-Y=Z^./192/HTA[2VC[YXWW<^Y/#&XWEWKXX]%E(^C2'M+:/OGC?=S
M[D\,;C>7>OCCT64CZ-(>TMH^^>-]W/N3PQN-Y=Z^./192/HTA[2VC[YXWW<^
MY/#&XWEWKXX]%E(^C2'M+:/OGC?=S[D\,;C>7>OCCT64CZ-(>TMH^^>-]W/N
M3PQN-Y=Z^./192/HTA[2VC[YXWW<^Y/#&XWEWKXX]%E(^C2'M+:/OGC?=S[D
M\,;C>7>OCCT64CZ-(>TMH^^>-]W/N3PQN-Y=Z^./192/HTA[2VC[YXWW<^Y/
M#&XWEWKXX]%E(^C2'M+:/OGC?=S[D\,;C>7>OCCT64CZ-(>TMH^^>-]W/N3P
MQN-Y=Z^./192/HTA[2VC[YXWW<^Y/#&XWEWKXX]%E(^C2'M+:/OGC?=S[D\,
M;C>7>OCCT64CZ-(>TMH^^>-]W/N3PQN-Y=Z^./192/HTA[2VC[YXWW<^Y/#&
MXWEWKXX]%E(^C2'M+:/OGC?=S[D\,;C>7>OCCT64CZ-(>TMH^^>-]W/N3PQN
M-Y=Z^./192/HTA[2VC[YXWW<^Y/#&XWEWKXX]%E(^C2'M+:/OGC?=S[D\,;C
M>7>OCCT64CZ-(>TMH^^>-]W/N3PQN-Y=Z^./192/HTA[2VC[YXWW<^Y/#&XW
MEWKXX]%E(^C2'M+:/OGC?=S[D\,;C>7>OCCT64CZ-(>TMH^^>-]W/N3PQN-Y
M=Z^./192/HTA[2VC[YXWW<^Y/#&XWEWKXX]%E(^C2'M+:/OGC?=S[D\,;C>7
M>OCCT64CZ-(>TMH^^>-]W/N3PQN-Y=Z^./192/HTA[2VC[YXWW<^Y/#&XWEW
MKXX]%E(^C2'M+:/OGC?=S[D\,;C>7>OCCT64CZ-(>TMH^^>-]W/N3PQN-Y=Z
M^./192/HTA[2VC[YXWW<^Y/#&XWEWKXX]%E(^C2'M+:/OGC?=S[D\,;C>7>O
MCCT64CZ-(>TMH^^>-]W/N3PQN-Y=Z^./192/HTA[2VC[YXWW<^Y/#&XWEWKX
MX]%E(^C2'M+:/OGC?=S[D\,;C>7>OCCT64CZ-(>TMH^^>-]W/N3PQN-Y=Z^.
M/192/HTA[2VC[YXWW<^Y/#&XWEWKXX]%E(^C2'M+:/OGC?=S[D\,;C>7>OCC
MT64CZ-(>TMH^^>-]W/N3PQN-Y=Z^./192/HTA[2VC[YXWW<^Y/#&XWEWKXX]
M%E(^C2'M+:/OGC?=S[D\,;C>7>OCCT64CZ-(>TMH^^>-]W/N3PQN-Y=Z^./1
M92/HTA[2VC[YXWW<^Y/#&XWEWKXX]%E(^C2'M+:/OGC?=S[D\,;C>7>OCCT6
M4CZ-(>TMH^^>-]W/N3PQN-Y=Z^./192/HTA[2VC[YXWW<^Y/#&XWEWKXX]%E
M(^C2'M+:/OGC?=S[D\,;C>7>OCCT64CZ-(>TMH^^>-]W/N3PQN-Y=Z^./192
M/HTA[2VC[YXWW<^Y/#&XWEWKXX]%E(^C2'M+:/OGC?=S[D\,;C>7>OCCT64C
MZ-(>TMH^^>-]W/N3PQN-Y=Z^./192/HTA[2VC[YXWW<^Y/#&XWEWKXX]%E(^
MC2'M+:/OGC?=S[D\,;C>7>OCCT64CZ-(>TMH^^>-]W/N3PQN-Y=Z^./192/H
MTA[2VC[YXWW<^Y/#&XWEWKXX]%E(^C2'M+:/OGC?=S[D\,;C>7>OCCT64CZ-
M(>TMH^^>-]W/N3PQN-Y=Z^./192/HTA[2VC[YXWW<^Y/#&XWEWKXX]%E(^C2
M'M+:/OGC?=S[D\,;C>7>OCCT64CZ-(>TMH^^>-]W/N3PQN-Y=Z^./192/HTA
M[2VC[YXWW<^Y/#&XWEWKXX]%E(^C2'M+:/OGC?=S[D\,;C>7>OCCT64CZ-(>
MTMH^^>-]W/N3PQN-Y=Z^./192/HTA[2VC[YXWW<^Y/#&XWEWKXX]%E(^C2'M
M+:/OGC?=S[D\,;C>7>OCCT64CZ-(>TMH^^>-]W/N3PQN-Y=Z^./192/HTA[2
MVC[YXWW<^Y/#&XWEWKXY2#K*HU:#^CCS?#EM>4?'#QO%-&Y?>\'XK^'W?+"+
M_A]GBK[?#[G?[<=_O=U/=R,<J[=NQ?1Z43W^[+'HB;-B<_Y9>'4W[J]:?P_I
MO]G!O,3O2OXK^N9&^A/P3],S5FNM-I4>+*N5MK-2BS7EQX<FS'A0&/+D-H\1
M;$5XK+B-R'D-_I%M-*6M*/Y>4X3\_*97,Y!GP2D&&3&3(A$:1B1YX\A!D,RX
M,Z#+91(B3(<N.MQB5$E,.-OQY##BV7F5H=;6I"DJRQG49.A) 5-DCF13]=6.
MR80?9(Q'0JQ.(^9>2B2B'E05#L1<9DYFX?S&Q'QE[+OAXRKC&8J/>Z/+$RC\
M6Y522"@M+?FFH]A$/"8;+<:%-<>E$FYBH<=I$,F.EK<=>0A,8A"?5G#4MA;C
M&9PB4&!XZ9A8C %Q%RQX]$HC+CP8ZYY:='%BX27Y+C32I9(G,B#A\;"LO3)T
MJ/$CH<D/M-J8SD<2'&(,4F)GPB@V:TF1"(#I3$V#+87V]QZ++C..QY#2NS/=
M<:<6A79GL5GC&=WC&.,9JAN]4VM2TPK#::\"E*R,QADN:&#7.\:?GQ@Z>Y-E
M,+QDK)%DHX['=_7GX$UF+XKD60EN]@C$VJ,!B-3;]\8W$;M;N[R?<WG(K.D&
MKE5J(U'M55XY8X@V;=Y[6[$15WG(FQ%1RHY578B)]QW%?6F8M&U]7N9<2WL6
MBK4R5E 7D(MM?4IDY"8?E30SJ<$<Y;*PXL:3)E#E=DMB/'?>=92VRXI.1T:4
MU-KHTA/NM=Q"1/NN<C&NVJW9NN<YJ(NW8JN1/2J)EJ'"J[$*)>*IP(Q>+=JN
M3^UMVHB*JIZD1=OH7/D]MK6"&%NYV/16D)!QK+XSMNK[;2:[-DQH4.P9<612
MC 67,F18D4KE6(+\J3'CM2%.O-I5;YO(WMGFTC@]PU_@DX$8CE>-?N[6O:C'
MJYJHBHC'*J;$RJE$B*JE'P;O+M>W^RN[][9O-VM^\ST*FW>;L7BF4DZR]V;@
MZ9--W#J6H>RJS9=7ADA#4\'8-9IV8[!&6(@-%0R-4,5C:NIG)==<FDX<A3)*
M789;+$U;T"=@<RTQ'[K1=13:IMH>FI=7*#;G60,$F-=I6!(\ C'<.6"756#4
M/T82;KAO S:UK59OJKE\VUM;:@TA7S]41;J+)HP$BNE5LVB^T)$5LF0"&QU=
M/B750OFW3'8XHYL><9F\]PS]&C6,M/TY[C+[SUL*OI;5NQM5Y(LPG(0W90RN
M RIV+)&0IN+ +"@;A<)8T',<DN(@,6*0.-90UE;L#+*FI+_*W-:.IL)$$=A
MLN@(1CC5Y)!A#>PCV*%Y3Q(;7E9N_?4(WBXHK7[55K>[J9S[*""8^)+A*9C'
MH*8,0BJUS&N1Z,%(E(UCM[[J/*KTXHJ<-JSQR*R2SC.<8QG.<XQC&,YSG.>S
M&,8^?.<YS\V,8Q^W/&,QXDP)/C8A@$4'&A$]KQH!43.C$ALUGO*1XT2=#=>B
MR6N^A:/$9=6CO)4GM[4YQAC,CQC'&,<8SI,DATF;-&QY\)\B-1$<(P&93#LV
M W/2ZN"N;%0XI^*B:AA]<13[;:9"675,Y7AM><,9W>,8XQCC&82'9JV05#1
ML 2<LC(*0QZ896!)5/E@W7(YJ+#2S(7F5(#OLNLE&&,+='NM.-RTLK0I.+$*
M-VQ&D8Y7*]K=CVKO.8JH]$V+Q5BHJ/1.+51=NS-LL"<%"J:%+$@&1RF4L<PT
M".6UKXA"JYB=&R4Q[7QWOV-,US7#5R*BKF^7YJ8XQCC&.,8XQCC&.,9Y77CK
M@W%3M@;BHQ('H.NCJB!%WFJ[!LMLO#=.@T5[;)G7!!R8^R#CN[>N+,>/64RZ
MEJ5S$H#L>X0-42GR=@CM3"->7K_:?C^G@C.Z!ZWM[!IU1(;[T!#T92[M3]:F
M!Y<^4GE9X8[88&JIMM&3PHW*[80E-$KA>:*&KS=.%'!-^K&OJ_8/$E;B!L W
MX<?R_'^7'^F,]+P1P-9P@:RUTI!-U^PBAYP$9&26I@TN&+1&9XPH/F,*6S*@
MSX4AB7$DLK4T_'=;=;4I"L9S3&97C&.,8XQCC&.,9K(>ZTVPDR80!;:R<,A%
MNM&1 <\*)DQ#C$A41]LG A2WY4!;,I"HSJ)332FY"5,KQAS&4XQ,,$CW,&83
MWLVH]C",<]BHNQ4<UJJK=B\%VHFQ>'IS?DU5I"CQY<RMGQ(LM&NBR9,.0"/)
M:]B$8Z.8HV#,CAJA&J-SD<Q4>FUJHN;-S+FACC&.,9A8EDKI @Z(@'@LTK'Q
M.4^,B%(,D@RD9*9@DE.PF7UR6\#YTB/#G96TG$24^S'?\-YU"%6(4;G*QI&.
M>F]M8CVJY-U4:[:U%VINN5&NX<%5$78JYM%@S@@;)-#E"C/4*,D%CF&!ZR!O
M,!&E<Q!N4XAO*%$<O2#8][-YK55,UR_-7.G#(CR.).1\Z'.Q"F2!TS,.4Q*Q
M$(1%81*@R<L+7X$R,K.$R(KO<?95G&'$)SG&.6M<UVW=<UVZY6KNJB[')Z6K
ML]#D]:+Q3UYE* P.C0P2A4HF'%THWCZ0)4VC,/?1-\1$1581NUCTXM54Q (C
MRD?,L9.AD8J9,V&J3 E,3(^)@V;('$8N7HZW&\28!")*@36,J\6+-C2(KZ&W
MV7&TFN:]-K7-<FUR;6JBIM:Y6N3:FU-K7(K7)Z4<BHO%%P8!H[^CD!* BC$5
M!F&\3U$<3#@)NO1KNC, @S"?LW2"(PC%<QS57B23&PY0Z#+(08LTN\_&$PY,
MMAB44D18C\^2P.CNN)>FO1X,:3-?:C(=6S$COR7$I9:<6DKFM5K7.:CGJJ,:
MJHBO5$5RHU%7:Y4:BN5$V[$157@F!QSE&<P@E(*,QA))1C>\<=A"L"-YWM:K
M1,>8@Q,<16HXKV#:JN<U%[O+LQ9\&)463E],:2Q(5%?5%E)8>;=S&E(0VZN,
M_AM2LLOI;=:<4RYW7$H=;7E.$K3G-$5%V[%1=B[%V*B[%3THNST+Q3@O'CE[
MQD&C%>Q[$(Q"#5[7-0@U<YJ/8JHF\Q7-<U'-VM5S7)MVHNS[\KEF.,8XQCC&
M.,8XQF#)V>M!),:$9L(,1,FXQF'$)EH$"3+PISPDYC,2I#3K^%._HL9:0O&7
M/Y&/Y7S<L<4;%1'D8Q5]".>UJKZN"*J*O'APS;CU\^6,A8L*7)$+:A21XQC#
M&J-WE0CQL<UFQOWEWE38WCZ,XQ:*RI3J4V(%E3!ENNOIP7'Y4S8'<XPT"=QB
M1VMF7<J3AL8O&)J\JQA+&>W'*=*+C_$'P>@U^^W@1?0->/!Z^IO]I>6%KYZ(
MU5A2T1\5TYBK&,B.A-VJZ8U=S8Z*U$7>D)M"FQ=K^&9AF0Q)0IR.^S(;2\_'
M4MEQ#J$OQ7W(LIA2FU*3AZ-)9=COMYSA;+[3C3B4N(4G%Z*B\45%3:J<%V\4
M545/Q145%3U*BHO'-9['C5&O8YCE:QZ(]JM56$8T@WHBHBJT@W->QWH<QS7-
M56JBK]>5RW'&,<8QQC'&,<8QQC'&,<8S#/V.O1GBT>2>"QWP,1L@=9?*06G@
ML!YM;S,TLVX^E8Z(ZRVXZW)F)99<;0MQ*\I2K.+%(-%>BD8BC1'/17M16-7B
MCG[5^ZBHB[%78B[,VFP9KVQGLARGLF$<&(]L<SFRC-<C'"C.1BH<C7JC7#$K
MG(Y4:J(JHF$6.O.9SAL\&7G =%ASA!2"K. #O>\,YG"7\]@=SN+[A/\ [$ON
M*[K^>[GL=(-?01B_<0G]IO\ X:^@GI_L+ZG?V??A84U/3$E)_P!4L+C'*G_6
MMV;T3BS_ /BF[R;8_P#XJ;4VLXIF9Y?FKCC&.,8XQE"^MW_9C_73^Z?,@_7^
M7\\QD]7Y_P LMIJ;]U>M/X?TW^S@WECO2OXK^N7M]"?@GZ92#K_Z=MF;U-=.
M!G7U>EV6%J^X[ ,6N ).:G"G<0K-0)U:%N"O330=ET*7W2DEI4YHA4ILIJ&E
MUT:_"G8CRV:?O]_M<KD,6'IDZLYA"?;(!S;#==SM;2'@:.K/5":U@TUHBL]*
ME4I]FJE8+ZY76*31SD#J5A(NUD740E8@VZO5XO##LPQ-HEUXU7:G=L_/;X8R
MHLSH*^$"):F@Z7>)RAE)'](LO1+M9";^N$*DFB.>D!^IB().KQ[K%J>5QNI*
M.RZ8G0=?#%D:BN,HM9K;7C]CJH2NU-NWW[??Z=O#\OWP1<9+^R>@3J0=L]M+
M4)!%QE50ZL]>ZVD.;OM$?-4!;%J72U#U*\0B$CSK96*Y)U/L06=\X8*%<FI5
M,M!SSC+ @RH&GJ5/>G=M\<9*9/I5ZRG[9YZ3L2YF!MBV_9;?;0UCWE:S]=AU
MNN_"2Z=W)I]BJU<V8G@ZH@/TEA=C5N6,JL 0U(S*A4\NF=G SR-M3EZD_P#]
M51>_8N,D3X.GITZC.GU#X#:*C8"BB=/T&H-U0KN<MML,8VB'LESG'+Q0A!!V
M1 U35LT\E5:Y(J8% <>2*CW9:P[SHU-C/E7:JKS5<9ZE<IC'&,H-U)=-4S:%
MSO5PL%W*5.CV/7&OM?R(-79?*3RD2NIWXJRNV<>[D9%2/CL[9%E*OE! C'AV
MBL0C!<?+B,('/SU?=)6QHS!QAG,";)F=(=48T2O2L5G1/3:Y'/2 \957=3HR
MJC7(JJN1<JL?..].D<UA@ABM&-$>\KE64FQS7[&)NO.)XU3:[?:NW@B(L:S^
MF/64XHW9X]LMPUI8\4!*R"--%RXLT..-[%=(5N;)S/C,O5RY/[&E@+X!FQRH
MZP!!D6&AL<9:@&!N+K(1&/5PP*CE(YK4EJU&O>V.T3VHKEV$"^*,H'HJ=&1R
MKL<Q5:ZYFG2M(W8*4KT8QSF+%^^YFPI7,548CMCA27H=&[=X;=NU%:JYG:5T
MM5=HX-<?M^S+7ELCK,P].LE<D$5L6"AFM>$(9$27E&9<4/7#(375=KA"')@E
M3+X^-B9(M$Z2RZX]D?J(QF(C(P0IT<P'\ B(-1RXTX;G%&UJJZ0PMB8S2->U
MJ/W=K$3=W:?8S .:TCCNV/&Y.F$1'(H"A5S&D,B(@]D8+',XN5HV\555VX[J
MUZ?;)L/IIH?0GKQLG,B7G-"JEYOTZ)X8VD:BI)829L5D(2&TMCGK(96!AU^M
M5R,M,LG,(RI2$1Q8DE.B='HN[B4^H9NM+)XF$KPSBUT!7HXMG<SHDB-&C!9]
M]XPQF2C3),A[4$,<=C$<I2C&[B/*!4S[ZDAZ+K@D>ES)KV6E@K-D>KIH$R/.
MERC/7=80\HT4,*+%:O2E=)>3=0(2O;Z3"!<0(*&AH#6&((J!#&PF<9SG#,2#
M&:BQFL9SG.<X;9:0C&<_/V)YP#GO(]Y"KO$(]Y'N3T*][E>Y>.U>*JOIXYZ.
M-C1#8-B;K!L:-C>3&-1K4X<."(G+,CRF7Y O5#7MJW#I]VQ3-)/#X6T+M49U
M)JIDI.P/AUEZX+9K9.X*D=O>5(IP0H2M,&(UA3Q">(C0&4J=DHQQC/%N?TP=
M:&EZ_0^ENC-6>;4HA/JS+:F(=/>XMB:#I02%=*EK6VZZS:R,,^0*"1^J]TV&
M^R@U5M-@*QK%6&9+ N"=BXF5,C7;M7BO\_5^O\_7Z\9LH#2/PA.PYVVE"=A[
MDK1*'>MVTHW?"^^KP#"7D9'VQK?-+QJ?61)Y(O63->$!-A%Q=TKHT7&,5DW%
MK;)$\-*^9JV_?H[?WV;/6R93G2IUMJN>RA5,VYLNNB(PO:F*%L@OU*[%LPFQ
M 8M8JN>F.AYUT5+S'J]9:3<:\RO;VQGD1SVR0KMK38[1=,W\E$&-OH[]B;/7
M^]G+ES9A9'3/\(],V1K6VIW;8!?G,!$MEE3'VW9IM/U?L.S7[;-YV1225.?-
ML5G8-&A +C0=:T!4B@V[ X/1(OF#T9N1//IUM3O_  X)LV<]B^G;[U]>,L1T
M!Z"W7I\YM^S[H&6&"6OM0Z?Q"YMOW87WK9C]MUW5[8+V)8I%H.R9I(<%.V8R
MLS6P.96(0P40;C0!M>8:^+8BB_O]_OLQGI-QC'&,<8SP;;Z ^KRDRXA/4MN"
M5QTJ[U?W<C&7;Y$$G3=I;6N%EBUPI3+#'BSW L79NJW:<*(OC8>7->7,!(ML
M=E\@9(+QP2:?N *CHAF"5ZW)W-4RM<&5+.1!/ 5$<HTDQ.A8[=:OFYQJ9$5S
MWY]BN\L_DSMADCZEK)<YL=ODQJ0$;5C,"TT[IRL@%G1K6"\H&RRT&HFVL@+3
ME1+RJFCK"/8"(!,]0^DZE;6HU#M@_:;M@C();+LAO7%4M^RC&XK?0=:S!X*.
M(J5FV8>G&"UL)-GH=E/,2)9ZP*%"3PVO-F);(AO#74U()8 &;*4B(Z25\81I
M+YAH\96C1@2RB.>\SD(TI$5Q";C"-'ON1B9\^>4BUTY;W%:;3K(3UCT,")>V
M5901=+U=U?"/,?)LZ_3\(,6-6QW0BU\)[!PH/G,F%(G.BB=*<KK0\E,\]QQC
M'&,C2P;AUS5B=C$';&F'/J-,LU_L;;8LU.:%U:G1 !"S3'I0X=+BKGB!]JK1
M!\ P\[8'8!T7-BBWXTQIU3&?,CNS3PEU4>?M&@LRD$((I<)%L"2)[9 C;(U$
MBQW8$::],:S\<ID>M2%N,):A&%+A3'([K+V&V,QD/J#T@0JL"ZC]I4LA7BM;
M*VX6_!-Q9A$F  A56$Y+'@(RW;!-D!0R%SBPR,+=*C4(6U,A,OI4UAC*^NZ*
MZ [Z6FLJUMI.T'-K68*>*P6 \,@6G68D*MVW@Q$P.C(7,J+Y>-"N%]0LE' Q
MRY[R\O(Q*L<M#C[:O/&;4,A=(FP:0 IS]?J>*'*$52F44->:V:IPDT$(%X-E
MI<76WQX@ \G8Q$X!#FP1.EN3'IA((!G1YCD@:(<9>C&2J(VYH( '"!*]L;5@
MZO#!XH0%@ +/64@@89@#,G XZ$"YBAH$$D"#D^:'I&80I<>(S#@NJ<<BL.,9
MFY&Y]/1([LN5MC6D:*Q$%3WY,B]U=F.S!/#TEP<UUYPJEMN(9%*23%25JPR1
M'J3-AK>C9P[EC/VG<&JGLPT0]B4PHZ00)>A1@MB%&Y<J&;L\&F#2;,,3*F2E
MB'K22A W3&&<C(<Y[+<R7'PT\IMC)'XQCC&.,9XCR/@[-WAJGLW95+OS];WW
M+VMOHK1@=5?K5*:7JW</57"V=;QLW:=/@UK99*S7+4@1L. 29OXZ+2#!Z9$%
M$ZW):A6(%P_5R<P,J2$ZCGNEV#@#$X0$6)-MFRC,=+ T<IQ31![@]^0UH'D<
MC'B5&E']9#\N&DY-E04-K3,GZ-%IS1L>WE6+)]LY-1:7\G)J"LD"T[:&GT (
M%7J66Z3-\VI9#[:+#&61'GC>:!-R[?2KUO/Z^M^36V]P2[<QKW3(.@#174;:
MQKD5Z)NK9MLVC#,8C66 S8[$SJ^3JZDK-$[T(LEC@#BXIC<L4D]+NL_(E5>+
M'/OS)CBI&A#CM;9%:J*V=*-+1^PC4*1(JQ ;[SL*5K2,2:URN.[6=Y1?)*R[
MJ_--,Z7%6OO-4R[H\C0M:=KV%TG05NGBQ%)!,^!!=J$>H;9(D>GE0(!3Q9#M
M*$ P52'[Q>G[X0IZ507RMV-1[' J6L82;(#ZA;XQ2Z>+KH:WP]J4^UZ]+FC*
MMF7?9#LRON!]BV*;=3%9*.-2H]ZA8J<8C9:I7ZA58ZO,]"M#%;TH[&0@ M&P
MR2PEC/>]))Y.T>Y)(XSQ.5%0[>A1Q;":T\B;1W38]3%?!-9Z@*L"9HFF?;6D
MB=*K"Z<M*V[BQ(J:?J*)!34E44 51%L(R.&2G+]I/!7Z?>NE?X0>+K>12J%L
MC8!&86K]%+N'RW4WL]RU@MLQNGN>!MA6#9%[ "EFJ?)W9Y"?DUQPJ<I,3+:"
M K5A>*^ZP/P2*K4*1E!'DR'.>,#U(ZSD],R6E>X97-*LACT"LW=(HM]X$V;S
M8KT<Y&RE/Y1/(F2^';7-#2A#&FW$9(4?0&GFULS39-;AFUL<T!M)+C.M1Z3Z
M:$.>D:);DWE#)U%&(QCS=JP]*'6:,9VJ3J$5YP[?T[H4,DUS>=EU>1!6#9FZ
M]=6X=>L$J!9*>1GE052"V><U7LV >&,%?(P!U]P'.FM.7$J;EOG;PHO22$G;
MBCG%BN&25-C&8?>CE"YSQ!85W1]*UCW[HWN5CG9C@^4?R62':<CV9&MB4JZ4
M20R?I"!J&/,A4&D[RL/4+'NH-H ,:992X 73O,3RXL?I9D-K981/;U<=+?PB
M+,_8'F3;6T(@V31&!%35:.HL^6,%:U'K&LQJ:*2*-&B(@%MM^>!O;SNXJS2Z
MV3CF+&Y97+\69)XKM?M^RM1HZ3N2Y36K':P/261'O>)HHK>@>]'N8.8KAR-L
MT(1/1Y.E4[T=T8\O_>'Y$'@I/.]-:>+('</DV7V?H:%&BQY[["_.MP",Z*"3
M,TRP$VG8W2MA;6$=\:"D!M+&?'6=.GZL].W4-6.E;9U'K$>S52ZVWJ;>VFBL
MQ]Z'']B&M,$MHU"Q6JA9W^@@Y915^LVNQIVMKN+EA=+-E9/=D7!2I+EGQ(CK
MK$=5) )"A.:S65T23R+)?"=+$4L?[0WE*V06,T@NF4BO1Z\3KM4N<78:XT18
M>46@M[!]?95-;H!NG5GOT?#91Q=5 TY9P:ZY31:@;7R:6OO3PYZ5:061G1A[
M65:(-M>L)ZJZ4^MJ@/T(?!+V ".A;$=MH3R/J,LCM;UB*,]9FZ=R;@B;1JK*
M%#^H@SMS1UUJ-/%'[,,/3@EHC3YRDU66PL\0T(E3>1U U"$&ULA3#W;(JCC-
M)=SILU)8D3=L7RX!PA80K2.&9KG?PE12.ZO47E&\DURRY,:-"F2#4B5LSI=#
M0&S]02(ODKTII;2Y-.V3W=/H>+IG5]39VDJ'7GA"F5Q A1;(;TA@UL3TK_"*
MYH1T3.O=@S:!L;<+U*LQW?%K.7EBU6[I5V[KL*7S9I=K-#H<.-MVPT0M7B]1
M%ZPCL+8GV=6JJ)('LQY6-E5J/S<C'')TK4F*$CYYGG0IJJ9&8_I7&>UK6RR
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M&.,8XQGG/U:_Z5?0O_Q9=_\ G.KN,9Z,<8QQC'&,P@K_ +?9O_.X_P#9RO\
M&,S?&,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,<8QQC'&,KENG]Z
M'2E_&>T?^@FXN,98WC&82O?Y,Q__ #S/_.)_&,S?&,<8QQC'&,<8QQC'&,<8
MSSIZ8_\ 3*ZV_P#S*@__ &Y?C&>BW&,<8QQC'&,PH'_L<K_SJP_\](\8S-<8
FQQC'&,<8R)C7[\M;_P +-S?VKT7QC)9XQCC&.,8XQCC&.,9__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g904779g64h56.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g64h56.jpg
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MQ/%$14=(4WBGML+_Q  = 0$  04! 0$             ! (#!08' 0@)_\0
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MR>*RMJF;L07=-(]4R72IHZP%$C1M88TDB G @E*I%N'",BB<?,( D6:D.!C
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MOG0_2ESKU^ER]K+-IEI(C715EC$O.Y;9'<J-\P W[3F.$L^59HBVU-?I\/\
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MWK&XS9Z;CAD\#Z<(+\?K_-\<?ZM;IG_^HO\ WZ$Q^D:#_L#]GF'Y?E63>(%
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MU@"7Q&32+R:3]'Q]=Z@NNV\UZY,GABWM[BZ=1]@LL!S:6T9(V^49SMXW 5F
M6;3+0;PP%U=;UX4EP 5()8?=7&!AL=CCN>@1COH*4/\ I]Q*'Y?PO8>'YC\@
M?CQS_5^8ZW+?T<3G]#:AG_[E:KQ\\M&/XU&S,?\ :2_]\CO^6?\ #M7U9VFY
MU+!6?1REE&@VVNJ5[%I$HZOWS']C?E?_ ,8/$0@N+2MKK/$TO0E?("LMTHF4
M620*;SE4BCJ75LG3:P:<=/TZ^MKD:B&6273[V*/"VEUD%[B-D3(&0V!C!.5(
MR)6GB47;D3PJS02;U=AXK(8W!&2#AB< =^,9K6OEI&0/E?)O).?^D"XASYJ9
M?:Q20#['#V /GQP''YCKLU@8Q861/<VEL1_^XC^1Q\O\.YQT,BF&)0WW4.[C
MV)7)([YQGMD9]<U9+>-?J+(\)!R99(.[A+YJ!W$!5[!WY]^/F/MQJ273D_(@
M\'.,>X'SY_'VXOLP\([0I.P@;@2"<9Y!P#V^7U&<UF#N%C8@'UV5D8]R]<FW
M4;D4S&31E3IE*B..2E$JK!^BD?WZ3 *?)0)P)A[\\R^'DLNS6%638JSV^,O'
MDY23&0T9([<\D'OCL:N7*?KHI D1,EO$?N8 VAQC[X Y/;'XDUC!Z:N=0E^P
M7HCR/'[FR#R >PAS)A[_ $#_ $ZZ.3/C)G3W[P9Y[_[//'S_ "'-6P^&PL8#
M#/.3MSCG^UC^'X5E[@T:+'0N+GUA;6F*@/X2]Q"<TO7H-&:F/0CM1M?J3,HZ
MUKOXITL#<5>"K(ID+P7S%DRG,8.7]:G4'ZDZ>2U>REF40-"MU.UO$7%V0,RV
MJK(!G&5P203P0*NVR0M%J7C+*&DMXXR54RQ@&5CDC<A5O;G/H#S7.G/;% #I
M^\.Y,>1]_P""3"'//S^HB _4!_JUL_A]8DG=!T]]!J>K9_:GOSVJV(D'E5Y,
M#@?J!DXXS_KN/?GMZFI4P].;/ R%"_<^<W 'L1FL^G%IS&*<0)1QG!Z[+%$'
M2\:DN_;IBF8X><U2,H4W ]1 Y,7#:]%U:VE7Z30=/^"8!XC+JVK*X&]2<#R*
M>PP&< _L-12"/9+-)<!5;=B*SM9')&T8(NDN5Q@X^X?<8[UK:OMC:I%Q@B5<
M.$L ;?D^#"4!^'$-0*;J /AZNKGJ^75R(!K9.AX)/ZJZ5N55)B<X7L"96( +
MEV( ) RQ) ]*\FCB-W=NBA=UU-C&X* 23C;NQGUR /VU3H+(\U + [@+/,0C
MDH@!7,/,/(Q8H\@8.E9DX04+\8 8>#>X (=PYUF[G2+*[&+JQM+K(.3/:PS$
MCM@^(A)XX/RP*E12SQ>:.>6,#^S'(R 8]L=CV/J/7CBMG$+N2WM_=%)7"F5L
MS2K]C@W \T[;1MCGK,=N_GLD[@(F9EO1/W,@B#N390$&R?/?3J+K-XQ@F=0I
M6R0AQO\ JST7)UIJUIJVG6$5KX(:W@$9LX(W6*(G9X#1 LQ9VVC:."3D=J_T
MEJUI% 6U"<@7=XA:642&4*8613O5CA4DP 2<8R, D5=E5WY^,'612ZWEUL:*
M8D'T]GQ+7Y/S (7IZ%G1(%J],4>/W@E<)J&-\0F$>1UD;OX=?"JY_P!6XM#P
M=UMJLP!'R29IE'?M^[FI\74^HIDO+;2I@$;T"L!C)RR$!OR_'/;+/'OBJ>(3
M"0-FL.9,4T)A7ZVOC=JK-RN.K5" /WTRS1Z'(.%RM+6T1<JL(:S2,DV;,T4.
MMTR0\T#(>:0V@=6?#?I#3[.&70M8N[F[GNHK=+:6ZMI8\2DC=F.V5U"G!)8M
MG..#S4^TZJN)[@1-%;%3'+(S*9%*")-P!!9L[S],#D UD"EX\F"863E(NRJL
MY-:.DG+ 3PU:M4-U>C<*MU3"F]<3HF,<4^HG!B%*'/(&Y#B-_P A74DD:20W
M%L"\:NJ2,O\ :7<H+JW'!&?(?EZ9KCZORX5[$!<X++<Y;'J5C,(R>_EWY/H3
M5V,_'VV?JJ$3=1ES+UKI) +)@Z=#T*FZ14$KB.8\&+[BGU"7@/YT.0U%?X%]
M:#.UM+?OQ]K(/'O^K(!]AGGTJ=_6O3U!:6*YC4#.?##9 [X ;/'KQ^SFIX;^
M,/M'(5=2:-?H!NA<+=3/5O8:"5;JR%+?-6$N\33:V960&..N[2,S5,P*NNGU
M&%NF( 4=:M_AAU;=_:!;6MO,UJX25%N0&WD9VC<BJ2.QRP&>Q(YJ1'U-I$FW
M$\BAXXY5+PN 4E7<IX#>G?T'O5\QOBR[#9 O*N;$8PW6!/+D:K;0-W#GJZF4
M*]2 GRY%0._RX[ZMR?##KJ+.= G8 9RD]F^?D +C)/R S4I-;TI^%O(\]N5D
M7]K(!^VIDJV_+:#=0:FK6=Z;( ]/+ILP.$PP,Z/7XY*7FR(%DHMF94T5%KI2
M#\" ;TS0Y5U>E/DP8*\Z3ZET^5(;S1-0@DDV^&C6[L7W-L7:4W [G\JX/)X%
M7DU33I"P2^M6*XW#QD!&3@9!([GC%2;&[D]ODL#<8_->+EQ=<>G(:[UY!501
M'@ !%P_25*81[=)B%-^6H$FCZO$2LFEZ@A&<AK.X!&#@]X_?UJ2MQ;ODI/"X
M!P2LJ-@^QPQY^7>KW89*QU*G%.+OU*DE"E,8R;"U03PY2E#DQA(W?J& I0[F
M$0X .XB&HLEI=0C,UM<1#WDAD0?FR@5<#H>S*?HP/[C5R-9B)?$!1E*1SQ,0
M*8%&KYLX()3!U%,!DE3E$#!W*// AW#D-6,'V/Y557>*HF<.2G(8/J4Q1#^\
M!'7E*^^0'V'G2E:>_&%C8Z3QCB!*1EFT0FG>YA1)9R1<Y%50@> 1*""2I@,)
M>H_)@*7I*(<\B&NN_!UW76]3V1M)G2\$*0"H-S#R22!CT^>?2M5ZM;98V[ $
M[;M6P,\[8I3C@'@]C_$UI$JT!7VD<GY<^UE$E\D8I*X3;^:V$A?O&L #YSI%
M-,H")A$##R/"8@/'(<]MUJ>=C:CP#'YI@I?# MX0'W5))X&2.Y[5H$2^9\YY
M@D8@95@&.[[Q7@C<1GY$\8(K95L_WZQ^"TXO&%WF):RXL3= SCY6:M5?G)RA
MM3*="9&!D%D7<A7&O(">'-YSEBW 30_()%C'',.LOAY/J32:KI44$-\4+W%A
M;VLMO%=,",R1 DI',03NSY97P2RL2QW#1>H#%LL[Y@4P/"FWJ2B@8VN 27 .
M!N!W#/"E<8V([Q]D6V7Q+L)L(^VC&OW*L6M)XHS34!8N;%4G+Y,JJ3F+D@*8
MLE!.UDT23M9>G!J](F=,P,)-!N]:<BTG6=6Z7U!I+9I;::-S%=VDH9!(%.&B
MFC."K ]FP&0\C(R#MEU:6NI6_ARJLD;KE'4^9<]GC<=L\'CAAC.17@,WO;"M
MPWA]94)3\IQ:XPSUVX>8XRK7/5EJ5V8LUBF2>P\D4"JQ4\S**!Y2OO5$)B)6
M.10".&2S-^Y^D.G>J-+ZKLSL95N551>:7<&-DW$??"LOZZ-L-AP !V(!R*YW
MJ&E7.DS*P:0Q%R89HF95 '/ZS!RKC.0,G/)5CC RKVB>.;ODVL_9<!,W)//N
M-F1FR!Z=F!P_FI5C')=*8MJ]>R. L\68B( FU)(.9N+:])>F*,0O2.&UWX;]
M/ZH9)K5?T1<N1A[8 6FYF&3);,,>;./U;Q8)!.>QFV/4UW WA3@7,88C=(Q6
M0*.!B3SDD=_,&)Y''%>I':+X]NR3<J,77+Y.O-MV2'YT6H0&4%T IS]\H  )
M(7)+-,E>\D5! B7WG)5G2IC%(BU5,/.N1:[\/NHM$,DGV8ZA9*3MN[(&52OH
M7B&94.,$C# 9'FQS6V6>N:=>D(DZQRG_ &4OD)/LKGR-\@&W'^[GBMUT=)1T
MNQ:RD2_92D:^03=,9&.=(/6+QLL4#I.&KMLHJW<(*D$#IJHJ'3.40,4P@(#K
M2"""0000<$$8(/L0>0:S%=W7E*ZS@Y_YI+^</V$W^8 _/\NWS^0=P[B&E5*!
M]YAD#T]_E_/RK[00(@3I*'<>!.;YF-]1_(/8 ^0?F(B*CNSG)/;L/0#Y?SS7
M-I5--*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E8X9HQC+N'K7*^-.6
M.2JP4'"B#<G[NV1:!.E>+>($$H.G?I@,BW*;XWK?F..(G]"JTD0R#F*3F-\C
MG^P3CS ^@R 3Z9YXYSTWH?JJRC@FZ0ZH_P!(Z8U4F-7D;S:/=R-F.[@D;/@P
M^*0\A&!!+BZ48\=)I&Q5DN'RG4VMBC0!L\3,+*=B#GZG$/+HE*+AHIR!3'1/
MR"[-P)2^>V4(8Q4URKH)6Y8VB<J>1W4^A'H?XCT-:SU;TO>])ZO+IMT?%@8"
M?3[Q1B.]LG)\*9<$@.,&.:,$^'*K %HRCO).K=:Q32E-*4TI32E-*4TI32E-
M*5T9&2CXEJH]DWK9@T2#D[ATL1%,.PB!0,<0ZCFXX(F7J.<W!2%,80#7H!)P
M 2?E5^VM;B\E6"U@EN)G^['$C.Q&0"2%!PHR-S'"J.6('-1/)2MKR.DO&4T[
MFJUA8BB3N[/6RA)"03,42^56HXYV[@J2G( >47.W,4@G],*2Z104N +&06PS
M?W.X'_$>WX#/IGOQML%II?36+G5Q!JNL)AK?1(W66TM)<9635ID)20H<'[%$
M3NP/$8QR;DUG9/\ "KD+I.25G)D&M6>:D# 8Y[7&6F(#I(D)4FQ%HBP2R;9J
MD;A-%!NP!-%(1.!%%.0/U;0OB@=(LH=/72%AMX 0ILY8U)8MEI'$\#M)(Y\S
MN\I+'C(7 '+=?TO4>H=3N=7U'6)KJ[NG!D,\2;4C'"00",JMO#$GDACC0+&O
M89R3C%</"XSO!56]LJC3,<3$M,UXL;%.:U>9--TLNE-PT@5-0MS+"M&Y3ILC
MJD4%7DJJ!"&,4JG!LW<_%#3-2AC@NAJ,2B5)'$EO:N@"D\ P,';@GNN.1QD9
MK7_ZK7L4C&(VDB%2/UDLS,<_[IB55.?4,?\  X 9<V3;ZH"SVJ5<85RI(1KF
M<F'C-S6#L;851FO(K';J$1K$W*N  R:A!*F9 J@$Y,*92@(AT;3_ (C=#30V
M\7Z5@@=8HD9;BUNH<.$56!=[?9W!\V['/>H/]7M3@R#:>*"3RDL95<G.0JN'
MP,]N_MW!K#6VUK.E&44)<*?EVIBF8PG&Q52T0X%!-3H,8#R#= G!%/AZBCT]
M8@ &YXUMMKKO3%\$%MJVCS,W "WEKOY'K'N#C/;D9R, =\0'TZ_@\4RVDP0*
M_P!V&7:>/4\\\^_!)/.*X<Y9=O,+(V1K"R*@,%\N7-\*JJCPBRCI6E8L26,<
MJ#LJ8=())@'!1, B/68>>D,'H,42'49($MY6:\"%RRO&D:QN5.1DE?$+YP>2
M5''<VXXHWBM6=Y(U-IM\,@AXIC=3;R5SP?""@;A]TY'<$XY+9\RHB(^7+J<@
M'817D@#] _EH<]OS_P!("&MD$4I&YH;3&>,QR8[9SR"/7\,&K@@M^?U[CZ*<
MGC/R/^)Y%98;;;A<,VN:30KI*G:0CK(.3EB2#6/E9M\U=J[9LLMC+)L$WBRK
MH 2544!N@F5=0X=*9P,?IUJ'4;"SO-!U)((Q=)>B)(A-'#%+$LA&#*PPH.2P
M+$C(^9S9DCAC2\B,C> ]O#+(6C,C;UGC\,[74Y\P5>%X[U( ;-*$H7J/ERX_
MGY>"+Z8.0[<CRJ40_NX]OTUL!ZHOPS#]%V@ . 'UNR4D$ YP%8@<XP3[\8Q5
M@W$2*N6521DEU()Y/)PF!].,>W/,C85V:46,RS0Y9EE:W.W4;8F3]!HXPA=X
MQ%PHT$RY45)-VH+5D502=(N%_P!VGSU&^NH.M]4WWZ)U /I=LJM:R*2-8LGP
M&4C.P*I8C.0 <FBM'-Y=X9" #X<4P( 93G<[%0H]>!\N*AU]A.U3M P!+1SR
MMD9N=N.%P1]?9:[&.Q*C3(]'E1G(2[=REU"7D 42+["'<0'5CHO6+=NGK12D
MOE,@.V">502<X5XXV5L9QD$\YKV[18+VZ#.69IMY8%><QH,'G_=&1],5::FW
MB[' W$A3BB(=Q-=Z@'MS\AG.>?\ 1QWUM?Z5ML\BY_"VNCS\CX./W^W>K#7,
M84E(LGLPPG8G&._/OCY=CBLNX; "UC22I4SCVR92=LMI^#GB<7C>[U6&72\W
M</N0<^H&9D1DHYR@!%0ZR(%6-R"A.2'*/3RQ]>6WZXU":/4K;3$=I$9M1L+N
M8.4L+->(T:,H25/<KD#/(/,Z&"8:3!+X1EW7EVT8201E00IP3A@P4@>A Y4Y
MSBN@&R5OP'_5"W"C[>^<,7\_W?8W;^OO]0YUM!ZN7M_6S0L#GC0]2)_/[4<Y
M_8<"K:Q7;$_J&'&?^M1#]G@_LXKYMNV8F-L%9YG&6 LG8Y?NJ[C*/:6#(>4Z
M3/5LJY\_XE=IHNV\$S8/6Z1%6:3IXZ XD3C6[PH=*QTCEUGJCJ2&_MK"VDU^
MQO5-^"]OINE7D=ZP^RW&/ 2:6196*D[8L'Q&PHX+"I%G#<B[!FM-\8AE.]KF
M%4A"Q/NDD<^&"JYRV<;5\S$ 9K$:^;5\\2E[NLF2_P"TM,TA;K(^.D.X*FHB
MEZN7>+^6*3NQ^J(8HG$!3<E*L00Z52E4 P!TZUZET=+:WC-IU-^KMX$W'0KP
M[BD2*3Y;<CG&>.,\#BH\$!%O$5CC(;=MQ/$5V[B008W;((8$$G[I!S@@5:Z>
MTS/H*I@.0MHX@"I..K</2. X,'<W18^> ^8  CQV 0'C5U^J-$4,WV3J1B 3
M@:%>ACZXYMAW^9_ YJYX,K KX4:@@C<TWE'!Y/)&/P-31F-69A8RRL+#%U*5
MF$]TVY(S]_!/I1_"*+JDQHJ8L4[1D_W[;][W.H)U , IF,'0(:T7H$V\\NNS
M6DEXD,DMFRQW4*PW"-X<N\21O$"N#MQY0O<@&J[]!XEJGZLJMK%B4/E)"=Q)
MW D':3SC."??OCP,T<.>*S#B ]P$/M@1XX[<!]I<?U<_KKHWA@_[:48[YV#Z
M_P!CC\:A;5!.'1L'LI4X_+G\L=B:GNLR4.XQQC8+%+'QU#!D_<2B^LD#!O+&
M\0;N-IML37*6'?270[%1,YDP!-9L;DW'G)<BJ7GW4<<PZOZ?,%LFIR"&)H[:
M>5( KB])$BRJ@VGLO.['!P1Q5ZW95M-1RTD3*MJ8WC&7=S,08F!R-A RQ(7M
MC(K&-.'VT"'/\:3((FYY$H8';#QW]@$+H(<!\NW?^O71O$UH=^G[,9'KK!Y_
M_P!7]W%5,9]S$(2<D=P/7/H<_0>W/>IHP0SP SRI5G$%N4NTC*I?;7HH]SA<
MD<B_6/79=,&:SXEJ?^D27*<P&6]*IT" <@ #U%P'4LFM_H340W3MDR&W\V-8
MR0 ZDD VRY*D X]CV.*!)6(621K=">7&,@8;U88 SC&3^(YK7_E"(?E=8\!.
M3;B0V#L%*)B"AP$"GQ75CE(;E,.#$*8I!#D>!+QR8.!UFNBF,G36F,H>,>"W
M [##,",_D?P%4R+MN+SD8%U( #G^\V2,')]_7@_(58"<;*%Y*650#MSR954
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MK=WZ-916/>$*(><Q?I-GK<W*:[=,Y1*',KFUN;.4PW=O-;3+WCGC>)P/0[7
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M/M$. #ZZARZ/J\'^NTO48O\ [2RN4_\ PHA4Z'6]%N,>!J^F39[>%?VLF?\
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M#522\=9XIQ_U:FQ>?;G*AN__ ,"A]/\ AJY_S<I__P!*H_\ [SMG]FH\_A5
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MZP@1L]>0P5>)6<1I%!_EZC-TH\:H<N$6;P2^2?$:U\!=9L-/N;W3-6@U6:V
M<V;6ILWF3#%O F:YGB>0*,K&64L?+E6*[L[H7Q_T/4M2MK#5-*N-%CN6V+=M
M=+>1Q.Q C,\:6T$D<3$X,H#!!YB-@9ERLWV>'IMN\3'$4<YEEXMC=TH,S[$.
M>JBFSD)2(3>)&=,6[I=NH1*UTEZN<%'T [<@4GF+N8EU%29A=ZY-H>OZKTM?
ML\!DCV2A;RPFWHDIC;#)+&<%)5Y4-@,O(.02*[==V=EJ]JF\I-'(@DM[B)E?
M =<I+%(I*NC*01R4=3GV(\%NYWP[MUNUC,4AARZXHMMCE0(XD*Q8:'79RV5R
M\5Y)?R4Y^N/(E@Z.HB/4F#Z.=)MY2'<*%;235%0R0J?1^B=7:+KEDMW%=PVL
MB@"YM[N6.*2&0]QEF4,C'/AN"00.><@<\O\ 1;JSN!$8WE1@3'-$K,KCT& &
M(9>S X]QP16&]@K=BJ<FO"6J FJS,M@*+F(L$4^AI-N!^1(*["10;.T@, ")
M142+U<#QSQK8HI8ID$D,D<L9SAXG61#C@X9"5.#P<'BL*Z/&=KHR,.ZNI4_D
M0#5%U<JFFE*:4I\OS^O/R'\O;^_G3 /)SD=L,0/Q X;\1QZ8S52M@8QGG/<C
M]W/[:R$V_;K=Q.UFRIVO 67;IC62\Y%9ZT@998*_-^08#)HV*KNO4UZPMPXX
M%"8C'B?2)ND"B/(8;5>G]'UM"FIV$%PVTJDP017$>>Q6>/;)D8[ECGU!R<Y&
MSU:]L,"WE8)G_5L=T>/;:1CMQGO\Z],.T7]IG>I?954WG8I3>E$Z+5?+&(4R
MMW($'@@OIW'<@OY"Q@_G73BNS+4 #J!I "(E3UR;6OA-.NZ;0+L7 Y/V*\94
MG.3P(IE 1@!Q^L"G/=JV^QZK@DVI>Q^"Y_VD09T/'<I@NGX%LGL!7IGVZ[P=
MM.["ODL> ,P4_(:!42KOHB.D 9VN% P\"2>J,F5E9(8Q3\DZG\8@DH(=2*JI
M!*<>5:CI.I:1.UOJ5E/:2J2,2H0K8]4<91Q[%&8'WK:(;B"X0/!*DJ'U1@V/
MD0.5/R(!'J*R4UCJO4TI32E4"S6>#I\*\L%B?I1T4Q!/SW"G)A$ZRI$4444B
M 95==94Y$TD$2G54.8"D*(]M "> ,GV%7889+B6."%=\DC!$7@9)]R> !W)/
M ')KFB+%!SS-!_#RK!^U7;(.R*-W*1S%0<HD71,LF!_,0,9)0AA(L4AR]0 8
MH#VTP>V.?:JIK:XMV99X9(BKLA+HP4LI(8*Q&UL$'E20<9'%>,'Q\MP?WGW.
M63&H2;T[/$5)J[>)49)RC>+2/9XUQ+3Q'CIBV52<%25<"A+N%%3]3%9%NV:J
MC'NN?H3X8=.F;IG5-2CO;^PO7DW*8(Y%1[=&>#QFE4'$: W =0&!P7(.T <<
MZWUW[/KNFV#V5E?6K *PG:)W6Y8K(L21,02['PF7+H6;"97(+:E:'F"(@:)8
MZ51<LV&MM9JOQ:=R=XX>V(L1)04NQ;2,[%+*1H&=%;KR+0I)%)9J=E(1S5./
MD"*MSNFB_:]/T'I8VZ%I?MXLXXKZX>2Z:_AM[A1(Z74?C++&F KLC8$D:@ @
M $'D]_K74XG9# MB;R:6R@06264L\+2(CVS-&\;-NR$<*?#D8Y#;L,-M& I"
M20Q/M;QDEDN/J26+BY4L#6M^A>3MRGAG)Q62E8B=B;'8E#1=@D6UBDF,*=O&
M4P8*'8IH@!SMCK)_+_6-S!?]5ZS>VET;BWDNS#;R^)X@:VMU$,01BH;:54$*
M/*H 51M  Z,+M3HFE:;^CFB:SLXS>,K!(VOKD;IF$<*B)5C8!-Q,LDC;G=MS
MDG(BXXSSY%U.?M.%<_1\Y>0S0K9L?Q%@A6K:,B*]=6R)7T+<&L2^MK>6*;J$
MS"P%@6<B)FJZCF*%RS7<,\!L?:2KY]EVX')P02#^9P,UCXI[/Q(UN+9DC$?A
MRD.S%B/,'0$#8./N[B"02#D 5F=X?V5M\E3R5C7#.8ZK59Z!FF]@-.7BHV>/
M<T*-*W77568(MY*0A+"698)0ZQX1G'4P6+QG.QYDY55BCT$QVH1GP2\B#?D'
M>@!(],$\';D\@C@<@YXK:^G+LKJD$.G7C+:R[U:SO&?:Z*09)(E5WC$WD/AD
M,&.<,F#7H",4IRF(<H&*8!*8I@ Q3%,' E, \@(" B @(" @/ ZP%=4!((()
M!!!!!P01R"".00>01VK$W:>(PT9E+'YS"(T7)T\Q;E,(CY<>X$&S8I>?<AW$
M4]7(;^GYPF#D.!U,O/,89>_B0J2?=AW_ &$ ^U=?^+^+ZZZ3ZC4#&O\ 2NGW
M$I QNN8P992<<!ECNX(R/39C J1Y?"V-9O)<G?1?6V)R!(P$$QGBU7*5^JB4
MO!0YI]I7%+!5:W:8R&EF\>K*V!.)=RL2Y*BY6>BW4\\B@ER=OU+JEOI<>C :
M=<6$$\]S;QWNCZ5?36TMT;<W+6UU>6<UU;B?[+ )1#,@<1JK9 Q7SY<]*Z3<
MZO+KA.IV^HW%O;VMS)8ZUK&GPW4-H+E;5+JSLKZ"TN?L_P!KN#"T\$AC:5F4
M@G-0Q.;',+BZI?W8"8QW4:G*R<[/0%5L]R@33BRV+3XO;O&MAB;;%/ZK(%A4
M8Y>S2\?YSFZ%8*I6@7JS]X^/LD'Q*Z@6/4FOC;:I>WMO%;V]W?V>GW"VJ)K0
MUJ1)+6>QFAO8?':9;."78FG>*K67A+%'&-9N/A=TXTFEK8+<Z386-Q-<W-EI
M][J5LUX[Z&="C>*[M[^":QF^S+"U[/!NDU/PBM]XKS2RM(+7;Y@:L,7]GBDW
MM2J"E':1DZWALE6^O8XD:A!T,M,82MBAF=G:U.23B:"V;1Z5AE6RZJ<?&QD@
MN\.YB8YZUPLW66OW,:+=7%K=RQ7DM]!>7>F:9<ZA;W$^H'59OLU]-:/=6\4N
MH,]R\,,J1;I9D"B*>:-\Y!T1T[:R.UG;7=G%+90Z?/8V>JZI;:==6]OIPTF#
M[5I\-XEI<RPZ<L=JD\T3R[8H'9VE@ADCKRVWC#<LI4),]<,[&H5_&D#572-A
MGA1:P6*K.RN^/TB&0E01?DBI]DTD!=NO4K2J1?322SUFH9$UJ/JW7HDO8TO5
M"ZC<ZO=W@^RVA\6?7;)]/U-\F F,7%I(\:K&42$G?"L;@,+LG1O3LSV$DEBS
M/IEMHMG9'[7>#PK?I^_CU/2HR!.!)]GO(HY6>4.\X7PYVDC)4]%]M;P?),#1
MCVGK+,Q89 CB%"R6A%9NCD[(D7E>VKM':$RD[9R*V0(2*L<3*-5T9&NNV+=.
M!<QS<@(ZNQ=:=1PR^-'?JLGBZ7,2;2R97;1M)GT.Q62-K=HY(ETNYGM)X71H
M;M)7-TDKG=5F7H7IB>'P)=/9H_!U> #[9?*R)K>L6^OZ@T<B7"R1S-J]K;WM
MO/&ZS6<D2+:O"@VUSR.VG%$W&OXVQL+3:0E*!;,8R4C:<@WNPS3ZEW:6B)NQ
M1*TS+6)U(@#F1@HM5JY1<).8M%J#2+59M%5D%*8>L-<MI8IK26RLO U2QUF&
M*RTK3+2WCU'38+BVM)UMX+1(?)%<SB1&0I,S^),KR*K"J?HK0+J&:&]AOK[[
M1I.H:'/-?:OJMY<RZ9J=Q;W-Y;M<W%Y),-\UK T;JZO J>' T<;,II,_M-PE
M9'\Y(R,)9DU[#996VR!(S(N089LG-6&MNZE:5HUI%69FWAT+=7WKAA:FD4FS
M;SQ?(5D$UEV;-1"1:]<]1VD5M%%<696TLX+"$S:3I5PYMK2[COK)9I)[.1YV
ML+J-9;*28R/;'<L159) UB[Z Z9O9KJ::VO@]W>W&H3"#6-7MD%S>6<FGW[0
MQV]]&ELFH6DK17T=N(TNAL:56:.,K)] Q91\8)S2=*B%(DEA6K[B6 \E)R/J
M5:O3J[0H0Q1DGCL4 :5:JP<>8K<4BN3M#/7(+/7+EPKA=4UO4M9-NVHW G-J
MMVL!$,,.P7NH7>J7(/@QQAO$O;VYE&[.P2"--L:(BYS2="TO0Q=#3+<VXO&M
M'N,S3S;VL=.L])M<>-))L\.PL+6$A,;S&99-TKN[2%K%5EZ:4KR\_M'&W5AE
M"M8.M)%$V#MI=(QB]=&(K_*XURWF(R28 L@NU<(+2;QS3FP*I."&$&2*!0$R
MO.ND_#/31KFNQZ-+=?9+>Y!DFDR58K#B0(I4A@S8<+@Y8L5YSBK?Q+U62P^!
M>I:S%8IJ5]T=U=:36L<C*HBLNHK":TF7<RG$:7MK#=,,C<5;)X4KYJYO;8E'
M5X6K2+*5-NT!$@'3(8YR-D3 4%3'* J"(<C\7XC"/'(F[_:T?2&C6]B+.QBA
MXCVLK11DRN!MWRD*?%9AG+/EB<5^9[]<ZU/J9O;ZXNB'??XF^2(1Y(\L:AL1
MHO9=N,J,C@8$,[7;D]VW;@6HRZJ32BV)T6OS9G#E-!-BVG'2297AT5% $[>,
MDDV;TRJ29O(:><DH8@=!C<MM+>;I?J"2QD#)I5_E8BVY5@F9QY9!]T!F;$)Q
M]P,. IKL-_-;=9=-P:C"RMK6GJ/%10&>YBCC.QTQYBVP.L@+',GF .X5Z)B=
M'2 D$!*8 $IB\"!@$.QN0Y >0[@("//OSK?#GU.?GWX/(KF"%C)Z@;CE>0 ,
MG@CTQVQZ5VDNW3S^?^W5#?=/\^M3H^S?\7_\JUW41'KXY[" CQSV'\]6:NCL
M?J/W-5#R0D=?%V24TBF.JI0+B1-), %0QCUV2*!4P$!#K-R($#CCJ$.P^PT2
M'"D>X;Z]C@#ZG\/?O7JY4Y[ ,F2> /."2<X[#G/IGT[UI:VGV]C#I=;DZ!4^
M1 5"F**8@!N"&(8H% 2CP  (  &  'CD=9SI:5+C23%O4#)*D, I*_>4=P,@
MGV[>W%:KUE%+9ZK'*T;G:3&X93Y6R,D]SE2O?COQVK=+CR4"7CFZZ/'EG2*<
MH\\"/Z  !Q[\]_</TU%U"+PIBI[D\?/WQ[^G[_6INF3":U\4$&-%!9O[H]"V
M?3'X5)B@<%$1#V[^W<?E_P _IK&(3D@G/XY[?^=9 !PI)#8/ )SW^7KVY_#Y
MU:\LZ0 IR\E#@! 1#C@?<!Y'V^?M^7]>I<2$D$#)X^HQ]3^?M45W94&[=ZG+
M'&1DC&3['C^)J![FNF":O/3TB0.!#IY#CD>>WZ#Q_6(#P.MAL@?*,\\_CQ[_
M +>:UC4"H63=@#S8S@^I[?GZ>WMVU\9>60667*02B!S^X<>W[SD!$.!#W !#
M].^LKJ&1 JD^8QN,'OD@ #OW../?\<5@M&YO25^YN49P<#:22< X],Y!YY(K
M$ZK1"R\Q/RS8&HB<JT.W.LNW0,T3:MBR<K(IG<+(D,+4IX]N9$ISJN".52$2
M5$ABZY?)/;P:I<^(V!.JVT1!P4)#/(X/&/#VIN;N ^,]\]BBMYI-+ME&5V?Z
M0ZL.9%W>'"C#UWDR;/0,@*D$<75C1SGS[08WO&UDF:DR:*!]C,8\YO1.XPAC
M^0238G$6;]%V0?5+HNFZI55EU%1^(X=/MAH.KZH&U*WE-E;S,7@C92$9"2%9
MHE($A(Q\P>?E5K5.H=$TI_T5>1+=W<("SW!Q)(D@ W!'8-M"G*#DC X&1SL@
MJ&\Z_P (U:-,N8JD9(R**:;RS4@4^M=4#J>8NI79 44TB@D!!$K:4/RIUB1
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M<>K=CDD_ASG("*A2-4RB4 X+T\?"4.> ^7//;GCC\N>..>=8:65F)/&>1SG
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M,!]V>[FC2/)^<,-W^7UK1_Z0.IIHGP,TK2F;9>=;]?"YCC)'Z_1.D]+F6X<
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M<^W/K6K=2@M*>"RAE&X XP OJ./0YY_QK/BI>0J"?3TF^$O'''' ^W]? AP
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M"H))&/P/6<1'GZ]9N1-W_4>_/(AW]M70\0[.@YSC>/7\:M-SRV20 .!CL,<
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M914:V;,6;=!.%;V\=K!';P@B.)0J[F+NQY+/([$O)+(Q9Y9')>21F=V9F).
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MUNGS$FQ-=*?>WNWA!]ISD%FD!Q@XR>P'<\5FHM89^#HLK,?N0J'=2W88*VK
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M$/#QW*/51(K$5.-*4HB"SVV,3D,("'!"ECTGZ@&'Y"9,"!WY-[ ,,_&?I)2
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MPR.P5(Y;RW1W9L[556D!9C@X !)QP*@FU>+IX=]0;(NW^Y*M2*+EVV9-U*Y
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M!R1;O;KR/9<8[CDUA=3^*O602+[-+80&0X)CLD?&XX!43/,..PSN&>3DC%1
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MWGE!-%5%,[-/R2K%ZA44\X$NHA!3@$75K#=P.^_:<H1DLPDP"=PQP/0'C()
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MNQQG! /;.0>0.0"!C@>^,UJ4VT]/.(K=)434[LRS ,[1-]ID+2)N#D+("N_
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M1S(..0S, 3SD\$UK%]:6^F]'=-7#0M%.-1O&<@%!)+'*!&X QRJ,RAN ,MP
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M#1X\*E035(B["0 54R*JHN/W1%BI&41@7%K%)#.K C<ZN'R?(P088^F ,Y.
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M?0NBRJR934[WP6!<2R 6EVL"[2!*4NGV0  *)'D1%5=Z[8B4O-I:TZ-K\8U
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MJ)P=I&5,Y!,B"I2JF"TKGQ@S-D;64ECCR@YP<XP,CW'."![QY)"UZI PIY+
M$C:<G&3D%>1D#@=SZ8^9YNX/4J([ZVR;@S=^DW3;MGJ*RR8R0*I.C++MR(++
M%4.JB91JNJ)>E),"I](@'MJRAKCE<*W?<N%! /;/'!R!V[&D>U)KC.!QGS#
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M%/,<S>24AAG[1]EB*'[-=BLS"E*0I2$*4A"E I2E "E*4H<%*4H< !0
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MD[D$/G_V1_O'CY=Q >PCI52D X/W3W_C1NX*N4?Z*A.RA/F4?KP/?@?D/UY
M>X#I7KH4P>ZMRK>A'\?_ #KL:5132E-*4TI32E-*4TI32E-*4TI32E-*4TI3
M2E-*4TI6+.7+].7&<'".+%_,L,D0Z5TLB)C"SJ<*(@F^0,Y2'X'QTS^4[,0P
M*H H2/;=4F[#T4J&-47QY?NKRB^KL,8SWX]O?N?*.>L]'=/6&BZ?_7SJU-NF
MVK!M#TMP!/K%\ 6MY!$^-T"LN^$,"DNQKF7%I#^OG.@46#QQ5HVJP"/0T8D$
M[ATH4H.I)^J!1>23TQ?QN72@ (AST((E1:H 1N@DF6Q([2.78\G]@] /D/\
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MOKT45Z-!A-OK-AI^K64-DEW%::!? S3V$\\D;69T*VFMX9;I=0WPF)M@FS2
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M=K=R)"IR,,O!SDJ!P#GM@9YK2-7E\2UZBDB@$.RYCB,*[2"X7?O4C 92N3N
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M>V_1FA6T/3NDJ"H@T_"W,H(PS372JC N "_@K&[$L)99@<U.0
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MGQ]1:#UAT=\,^D[32;GP];ZAG:34[[3[-(YUM-0E1$@M[N[8M;PO:VZ1PRQ
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M*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*BVX2^07RCB)Q^UAHOR
M,20N%I(NM&L# '[PD;%-SI*R;M(O)A47628IG(*:X\&*)O,XQ\S@?4TR "2>
M!W], <DDX(P*P'&R#D*;EXB.\0B_0E@CVK-\G(5Z@8]A:2LF\>3S1J,0I)0$
MA$SR?76Y1<Z#6:<+?9R*+UR;T[M%922;.Y"AC&V" 1Q_/XY/;L:Q/Z?T@3/
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ME&XR#*<W)#8)5D1UE@A")D(FF0J::92D(0A0*0A"@!2D(4H 4I2E  *4
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MX!']-CK(/\:M*<>O[\?X&N4NW_Q9@]_$3P$;^Q"R#_5FC2O<K['\_P#*N4N
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M_P"D?3GW'Y?YTRO]W_Q&N8N*M]P?BW;8L-^FVQN7_$4=.?<?D?XTRO\ =_\
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M)_TA@+_^<'C_ $Z4KNIMIH/YR4;'_P#9CP)_^8'2E=U--X'\XY3/]>E#H_\
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MMBZ>@KNC+%E9]O+2UGR!5D*E,I$@F:KE5N2"CO:*H(484ALAB3R#SC'(],'
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E72O*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4K_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g904779g67o69.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g67o69.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( 0@!K@,!$0 "$0$#$0'_Q  >  $
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MC&/Y=M!HD - )"+"!HV!V'$DD<''3_E*Y':78WD>Y9HW@"-MG6?+4]N3K?L
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MG5]F1Z)V>T1)F<7^4"K.7OL4;V&:G,S8SNYXOHBQ0F=!-:\E@4NQJ<8<(6N
MR1P.#TR/>.H^D!82\4?EZC7DEL#JJ$;CX(BZ5/;$O*JAG01.P$P'KGZ/[B+
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M45YKKMIQEU?:*DT[:4BM-OP8*.GIYQZ'4U---%_G$4I]:%HDSWC2YKPX^_\
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MWO1)ZKWAL-,<N&A^RIOH<XKP#4EG :M*%R?ZA0UQ<U@HZHO?&9FL%/*7.A!
M,K6[,F/+@.\ V9(&>5R&AK'2!@I:@N>PS-;W$I<Z$$#O0W;DQY(&\#;G ST5
MS%H>*;E^8JS)# &(%42X.AB(/1-+1/(0I-'Z^I3W6]@)WZ.N#;^.A?36_;*G
MT8 LW6]##OW7I;E<:$$45?6T8)#B*6JGIP2.A(BD8"1YE<U-75U$"**MK*3)
M!/HU3/ "0<@D1O:''WY47'3G+G:I'!OA_;?(-*)H6Z+B6N/]/4M''&'00]<K
M.V0B2V<SQ=6S.];.2O6D^OJ1!IT7&M/, D$F1IEBTGNH=9ZI@.67RO=[)I14
MC^&H;*W[%VL.K=20'(O%:X^<KQ4-P!XMG;(#U(Y'/BH1\S<"6:5Y!+GIQCNZ
MW*^J*O&(F9CL>I+'6QR5R:"3!*>LI9O02%&->E4K1DNQRI<<L;7!LV".29.F
M 4)P1GCVG>=7V]^CK7<WVRVUM?72&!E+74<=12Q5-.6BXRF([3W9V-#-DC'G
MOH'$D,<!LJ[ZIHI-*VZXNH*"LK:Q_<MIJVE9/3QU$) KY#&=IV>HT,V/:\B:
M$DG:X"YP/+O94!]HZD[WE$B0D?@",=$57#;**6!]-@!M5-67<7EB<PH&@"V(
MC1H%!NAC.+]3/4&MC?=-U9_TAI.GA<>L]GKZJB+?'U::7TBG<">.<$#@' PL
M!^.;!4\5VF88G'K-:JVHI"WQ.VFD[Z!V3X.QM'0^"Z9^N/R%U>S.::UN1*KZ
M19!-BTE4Z\Z60K:3%1?RI@-)G2N+/95;XY@=?71"U,Q&.NDNAG:*2.)?PRS+
MQVS1UQ>P46H*VSO<\?J;W0ME: 3R6U=#((6[.2TS"/=P"6')7+!1:8J9HI+?
M?Z^S3LE8^,7.E#G,<' A\590RM9&Z,C<Q\G=DD-.YA!*K7\>'=-9R;K^V8VY
M4I#JS-O&QEDV:GZ5R^*1\=6%QR!IH^9#VDEPB[6H>GQZ=6S:<EJ9U#*I]7)6
M88B,*0+3!9?J_1<E)I^VU4-5Z4;51MIGLI*&20UKIZI\PJ7OCD>(HHXY,F60
M2##&@.!>T+--6V:[MT_1/-ZKZ^.WTC:>6"/TN=E=WU49A/(!42-9%$QX<7R-
MD;ZC<.!<T#97S3BTVH7^0CG^:]0\BVO2%=*&5-,YB*#&LADB6G-S-L<:L6)2
MI:6M7)TBXY,$QM9%@21@1J-B4[)+V (1[,!C6L+157W3MPM=&8FU-3Z*8C,X
MLBS!64]0X/<&O+<LB< 0T^M@="M\?!G[2K!V1=M>C>T#5$5?+8K&-0LKV6N"
M.JK]MUTO>K/ ZGIY9Z:.4MJJ^ R-=/'B(2/#B6AKJ7.(?"C9, MYY<>M8]4$
MZJ)XKF4QI2QL\B=7MTT_.I[1])<6\9C"QJF1:W%IUJE*_M;DG=&]0$L*40='
MF#!K/2_9E6T=QD?J&&W55NDHZB$Q1S22R=](8^[>P]U$Z)S 'ELT;VR,=C:1
MG(]X_" ^'QI74NB:&E[%[EKC3NMJ'5%GNL5QKK716^C^+:*.M],I:EK+E<8;
MA!5/DIXIK;64DM'4Q%YF![MK76)1R?6AX\9E'ZRON7O5I<;S-Z31NI.A9*:)
M;,:+>W$XPMCK2\'/7J)UARK]&@B]CG@*+;#0A1/.T31M,F8<RAJZ_1]3#0W:
MHEK].5,K8+?>)B75-JE>2(J&Z/R>\IG<,@K3@,/JR[(]K8O,%TTWI'X3=BN>
MK.SBR4&D.W.Q4$MUUKV96EC:>Q=H5OI6-=<-6=GU)PVCOD/K5-XTM&Y[JMCG
M5%!Z16B:6XVO@& P 3"Q!& 80C , M" , M:$$01!WO0@BUO6PBUO>MZWK>M
M^F\S\$$9!R#R".A'FO&SFN:XM<"US26N:X$.:X'!!!Y!!X(/(/!7ZPH3")A$
MPB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%K >32XIM8G:[=SW)N;*SD
M:*#3FDF>B' BG.QT?7ME-=AHH8OGEJ<S=D44B;:QY_15FZR:3LS@CF,C,1&N
M=;OJZ:)OH;DW)MP1^?OP5R- QUZ@YY;@ =,M())\C[0!RKA.7^=>D>;['D4=
M?+A@=]\^2)H7N2*;3BOVJ&=;,\P2K4 &)HL";5ZUM$ O9@.:3GLQ5.9!&(;8
M:-S"CTY&R_ZBN<DDJI+2. 0>.,Y&,>W)!^DC'VS[PJJOCRD40_= \)=1P:NZ
M\06!<[]1-DQ&J4@43']I@O,O:DZ)8T1M\>AI0LFY 6D2)G+V.;>F7%)4Y:XP
M99)>@E9IPYI/0$$^X$%5?]A<W=806S*QO6I^;IIT*.?^(BR?'1)81!7ZOVU]
MJ^VY:?')-#)5+@S:6QE .OU3QIP8Y0^L:QW,8$S6H6'HS@GMI*\K @@@N ]<
M.&0>0,YZ ^?E_=#>SO&SVS1M;VMSA7=$O-^#['\;W$O(P[.BDJ@[?!*3N.@"
M2XE8RJRS)5(V20(*Z+CBY?*8W(HZQ2-0YJ4J)B*:P+#%!J0I#@2'9 (>YV""
M<AV/('GC'@/%69>4;@10_P#'?2-ID]F]P0-/3O"-E-&Z5JVZ6B)<\SX-4TI+
M3]AG=<JH(]KWA'/ I--D]2DRE$)[9#!("3D!G^)V56NY'JM^4#D@YZ^_&/H5
MD?C]_P AG$G[HO-O\FH9A0_Y;OWG?>5G6V:IA%V5_(ZTL1G+>HM)D>TJPCUT
M4K1J"Q:.0NS4K]HQH'AJ5@*7-JXK6QIE1)8MA,+V84/X;E;:2[44]OKHA+35
M#-KQG#FN!RR2-_5DL;@'QO'+7 <$9!Z+4>G;3JNS5UAO=*VJM]?%W<K.&R1O
M:0Z*HIY,$PU-/(&RP3-&8Y&@X(RTPJJ;HI;SQ]XM$=82T6GFE(H=-X3;+F0H
MU]\5*IC"4;>\>P/QSW&P(\L-(C4B:TVU#BZ.'RYZ?3H=\ZYJL3ME\?8_3[/J
M2J_6VFF-927*0.!NEI:0UDN/6,E; XB">-FZ21^US>\.^1VJ].:VET5\>:0[
M1;D?2M*VYUVM6HZACQ^DVE6.;%!4@#>^>\T4KFT%;3Q[YZB;8Z/TA_>U$EAZ
M!>B=$*)S;52=<W.*1.O0+DIH#TJQ$K) H2JDQQ>Q%G)U!!A9Q)H!" 86,(P[
MV'>MYG#'LD8R2-S7L>UKV/:0YKV. <US7#(+7 @@C@@@A;KAFBJ(8JB"1DT$
M\;)H98W!\<L4K0^.2-[26N8]C@YK@2'-((."N7EER)A$PB81,(F$3")A$PB8
M15&OWB1KM]L1VL,VR $JW62.<C,:=4S4A[7H]R>S'L>STI["),O<BC3-IRY$
MN3'O_P '9FOG]:.-"/M1?;RV2.872O$L5,:**05,H?'2$M)IF.W9; 2UI,8]
M3+1QPNQ%XN[9(Y6W.M$D5,:..03O#V4I+2:=KMV1%EC3L'JY:#CA6Y9U2ZY=
M))6!LE4?>HV]-[:ZM3XV+&Q>W/+>G=6I8F6$#),)<&U4$29<E%H7Z9,=KV&A
MUL.]Z]?74MP' N&6@C(!P2,\@'PR.,^"D8!&1D9&1G&1XC/.,^>#A:OG.<I%
MR?V6R0^)=EPZ;0&>O4.AUHR0BI''4?:T<.D[@-!738XR>2J4;!%UI#RY-*">
M1=\?&YD.7_.JT&V]!MP-S>NU%IVJL\=IBT]5P-I!6R4$CKP^7T>JK&-!FD;Z
M(PSL:^-C^Z<X AI:" XD9;67ZP3VR.UQ6.IA;2^EOHY#=7R=S4U36YED!I@9
MFM>R-W=N<T$-+<MRMI[6];UZZWZZW^.MZ_5O7_/,'6(KCJU:1O2J5Z]4G1(4
M2<Y6L6*SBTR5(E3EB.4*5*@X0"2$Y!0!FG'&C 646$0QB"$.]ZEK7/<UC&ES
MG$-:UH+G.<XX#6@9)))   )). I:USG-:UI<YQ#6M:"7.<3@-:!DDDD  #)/
M 5+_ #31O)=M7IY"(Q-8144X2R[H)J$RH'+;(XK5B8Z!DR1Q70U06IVYMQ_U
MR1RAQ/=8H>C5DGJU7^* !*4 C9=[NNH+?:]'STM5<:5U-9Y.\<SO6-:X5;H6
M-J6EO=O'=0P,$=0US2UK?5)))V!=[E?*&VZ6FIZFNIW06N3O',[QC6D53HF-
MG:6['CNHH6!DX<TM:W#>23G0[FKIKE@6W?C>RU-H5LDV 2GE;H*0K7A F1 -
M![D516VM.&_0PPA+[RFQDDIKI']'C,6N2I8;\(C.I%ZLE^Q%J.B;0UKN&WZT
M0MC>Y^.'W&WM AJ078+Y(!'-CA@:,E=:+O9[U^KO]&*.K=G;>K7$V-Q<03NK
MZ%H$50"[!?)"(Y< -:&\N7RDWD'9'^BKI<(L6II/I6F&- \SFF[AB#J_2:%(
M4KLSF260EQ9C7M"ZP(4FC9S@YIY3%5VDR9K-;W]V3-Z8XE&HF'2$L-UMC*@M
MN=EN4KXJ6Y6VICB@J7.9((8342LD91U3I@QCH*AF2_?%&YY!<V8=+R17*WLG
M+;A:;A*Z.FKZ"=D<-0YS).YB[Z5CVTU0Z4,8Z&9FXNW1L+B"X8%\;/?UU]=6
MW+(G-Y%7+JQ1>/25T.;X95<SC2S25(^,[7&9$JE#S*'9G2)WPM6K&5&3$NWO
M>]#,]P2F]:(/;ZUTC;-.V^GJ*:"MCEGF@8'U-PI9V;G1223P-@BIXI7&(M:#
M.'"+H,9>T+L]6Z8M]BH8)Z>*K9+-+"P.J*VGF;N=%(^:)L,<$<CC&0T&;<(_
M9ES5<'8$ AMJ0J2UW8,?;I3#)>TJF60L+H3HY&X(%0?00=^FPF$*2# EJD*Y
M,82M;UQ"=<A/3JTY!Q>J*RDIJ^EGHZR%D]-4QNBFB>,M>QWU$.!PYKFD.8X-
M>TAS01C&FM27S1]^M.I]-7.JL]^LE;%7VRY4;^[GIJF$\$<%DD4C"^&HIY6O
M@JJ>26FJ(Y8)9(W0"XYF4OHFQY)P'<KXM?G. ,7VPYBL5X]^E5J4!\QM*G85
MZL8Q$*IO4JC8(T[IR=)CE;"0B7I6[3<W&.2W$M-U-3:JV;25RE=*^DB](L=9
M)G=7VC.T1/<20:JWNQ!(T;2Z(->UFQA>[TCVY6*R=H>EK5\)'0MO@MU)J2X_
M$G:WI>AP8=']I1C[Z2Y4T(:)(=/ZTC#KK0RO[V."XR5%--5&JJF4D%EN9LO*
M281,(F$3")A$PBZIW?62/I@+7YY:F1&8>%,6K=W!(VIC%(P&&@3@/6G$E#/&
M42<8$H(]F" 48/0=A +>N.6:&!H?/+'"PD-#I9&QM+B"0T.>0"2 2!G. 3X%
M?/4UE)11B6LJJ>DB<\1MDJ9XH(W2%KG!@?*YC2\M8YP:#N+6N(&&G&#[8ZFH
MVFHTBE4NG\=-;5\HC,5)+97EH=EH5<D=B&_:XQ*G7[&!L9$0UC\]*?Q$G9VM
M<804I5Z3I%'3W+4=GM5.RIJ:V QOJ*>F AFBD?NJ)6Q[RUK^(X6%\\KOV8HW
MEH<[:UV):C[0=):7H(KC<KS1.@FN%!;VMI:JFJ91)75#(>^=&R;(@I8C+653
M^K*:GF<QLDFR-^3=6=6V_P!5A0??K^KTEC#^/_\ OSL/C&W_ /VZC_\ U,/_
M /M=_P#'UB_^^K3_ %C1_P#K+W&?8NV5;/DQZ MJA87R^GJ&S873;K>/8]6T
M)*;,GL3:IHP0^$S.%VB]N[R-E>GZ,M@E*1?$F@P"A6]H"@$A4%"/!H[8M0?#
MVG\"?P5F@$G(S@$X^I1YA?4_0%9=H<L\]OW77.W;\1Z6^]INE#-5U7,L M"C
MT]<5ZYSAKM%6HA%LV(Q.%=N[JWIX*]%2EI85!#T^LID?>')5M4TY*D@8)VEI
M'GG!R1QR.O4]>1GR4H.);KNGJSC^93EWE;#%[;6VMUW641F""*)%;+&Q5??U
ML5;6KPMBAZH*5\"SM,6CY[XB-6)=OYJ=;ZJ4)BS1Q)00 1[FGZV@G[2H?MOD
MNNJ44FS<Z,T0BC7Y9E]K+N5Y+42U,L50:#SV-M**0S+K!>@^*2YJN9$54KV^
M[(TXEB,+D*B0QJL42Q<]K35&GY*G: <DY;C=QUZXV^_/!\NO17%/\O8J>JUT
MG%N3EN1QZMH.?(;%L9[3I&%L WQ=EVMDTM<$2+0D;60:!&K=#6]"$PI-\3Y-
M$ SVE $5>IP!U/ ]_0*G:L?)W<B6K?*9?][U:FA\;Y%;(A8%*4\>0:U3C[!3
M;GUDMNNV"T%P_F#&RP)OM_C:F5M.DQFJ\=']=%?1R,CYBI45MH.P#J>"3TSG
M&1[/O65&OHSJ_EBXJ'BG9MAU;:D.Z3J6[98J.K6JUU:N%'VY1-;$W1)82RG*
M9W+@V!7+Q7R&=I6AS?0-TM2/,+0K%B]2DD)J%M?G\_GZE& 0=N1@C@D<@G'L
MY&1TX6/JKZX[)98WP?U#=\EJ9ZI#OJP:VA*FC(M6[C'Y-SPDZ.A[W+^>G)HM
M$^:.9UB+T1Z6+1"UR'^+M1*YVE2EXB9#$C9=-BPI('(&06^?[6#@^6/$CV#!
MY6(=^1_HO5U&D_>I1>YH7WS_ '4 ^-;[OE>ND3:2^\[4(U>A<H^WOVMVY;K7
M8NE?M?N ?<?]V0!-FW31VMR/1-HQT/R<[O#.,XQ[_5ZYSSXX6PMA45:_2'&/
M4$MLN0W/R)Y!K?Y@F$N"T;EE<S*%Q#I#G=W.8F)LCR15':PL/:195[HXM[0B
M^O+X!)FU Z+RS7M2P&/2]X7.A6! &"T'VYP1]/\ ,%8;BW!OD+L9<G3]@^52
MP)/799Q9CA6'*%+03EI7(P$CT+:1^N=C4R"TB6AQ!ZI71KB2V)JS$@S0)7Q.
M<8!004ES>=K![W$D_5P/L/TJXS"HF$3")A%"CR5?Z='?7[EG4O\ (Z<X4MZC
MWC[UWOC]_P AG$G[HO-O\FH9A2_Y;OWG?>5+K"JJOO)URC:74,!AP*P;X">M
MK<4NE2XQ^5NZ:;O'JT$!20Z%Z0L3@W&@?C4PS%I#PZ-2=0[(8[K1Y)12D\.O
M>T'3=QU%14HM[:,OH/2JE_?.E;5R_J@&TM+LA>PB8M)>)7L#I60<M <Y:![>
M^SO4':!9[6VP06=\MC-RN$SJR6ICNU3FF8([9:NYHYH'"L<PNE94U%.Q]3#0
M^NQK9'C)GC173%;QY5H9=)8W*@($JUKC#BPK'52M01AO4;2I(M*R'9I:1MTG
MAB\MRBBE"CTO0%MK0UF)G%7HT1F^PT"^J?I>WBJJ(*D,:Z.GDA=*Y[*=AVMI
MZILL<9CJ*5XDIG,9O9W<49;([)*[[L)FNDO9GI\7.NH;B(8Y:>WST<M3)+#0
M0/[N.WW%E334QAK[7,V>W211=]"(*:G+)Y-Q<9ZYF2W F$3")A$PB81,(F$3
M")A$PB81<1>B*<4*UO/$: A>D4HCAD&;)/"4J)&08(DT/YQ1H0#WLLP/X@'K
M0M?CK"+7R@GA<ER2WBA6%8<4=*2;G0U7L3">]IIY)6DH8QHFI2W'-!+6P*%6
MM%E.JY,^N6DI>S!-P5!HPC3EQAASSC'U_1T'Y\%9_P A3N5M(YQR]:[F:YVA
MS^H1(&N0+/S5%C5 Z!$*O9R6(0M[5K2F\ &"2[*VH$B=$B8+BJ-<UJC>%<9Z
M$YQT\\>W[1[<*8$CCK'+X\^Q.3M:-\C<G9W*/R!E<2M*&]W9'E&<W.C8N(%^
M:<C7H5!Z524+\TPDT8-_@+.2&:6GFBJ()'1302,FAE8</CEB<'QR,/@YCVAS
M3X$ KEBED@EBGA>Z.:&1DL4C#A\<D;@]CVGP<UP#FGP(!4?(%Q?RG5TM9YY7
ME"5M#YE'S%1K+)&*/IT3JV&+D"IK5C2*0;]Q0E#>N5HS=Z_WB%!H-_@+>=Q5
MZFO]?3R4E9=JVIII@T2PRS%T;PQ[9&AS?'#V-</: 5VE3J"]5L$E-57.LJ*>
M4-$D,LKG,>&N:]NYIZX>UKA[0"I.9T:Z=01[WHB@;(J%YL&W@R&(O=>(RA1B
MWJXCSH]V;#3GMP3,):9 W1Y"N=Y3&W)4[@1R*)J4JQL6M*MP.&%O-!IU295I
M.ZW:BN,=';^YJ(JQY$]NK9HXJ&J$3'2DO?,YL<$S&QET-0US9&2-8 7@]V[)
M-,W*YTE<REH.ZGCJW$34-7*R.CJ!&TRDO?*YK(96-CW13AS7M>UH&\>HZK_P
MN6-3-..-C<]2%ND$9N&Q9VYN</G,KCKE%FBX(;%$7RK UQHI^2-SBV.344:\
MOX8PY%&.!H)"H.*4''DJ&]OSKM,H[E<F4=XADAGMU'21QU%+3SQU$MMJ:AVZ
M62<Q.>R1DA$</?L.P&$ @ A[\R[0*2X7!E)=8GQ34%)3,9/302LFDH)YW;I7
MS&)SV/8\B.+OF$,!B:" "'NV+LTVM4JFKS03)TI&IN>.F((2A26Y3O1T?*AD
M@5%'F!*99/"YJ?+XLX%IE*,Y9&I@5&VA#(VX*D@2U"FT44H3F;T<'6W:74R6
MNWV:]T@8VXVV]0BFF<''$4]-5&IIWAKFET%2(8V3LW#>P8!:>5[I^ A8J/M
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MXR"4\M](_*(.EJA;R%ICRG*"D9;RK$U0)#'KCB!7N]F]KO84CF;61^#+(A#
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M=:[/+0P(#G5]=6UE:TVRM*')V7)6Y 1L\T!!.CEBPTE.5LX\TLDK0S [,-,
M6#U&,(=TDDCA89)9&11MQN?(]K&#) &7.(:,D@#)Y) ')7U45#6W&ICH[?1U
M5?5R[S%2T5/+55,@C8Z20QP0,DE?LC8^1^UIVL:Y[L-:2*X.P?*907'KU"65
M_:I':)DV:WAT3*JL=(6]I6@#.K1I#$[P-;)F\2=0J$L"8D 6$S1A9)VQ"#L.
MM;PO46O+1IR6EBFCGKC51R2-=0/I96QB-S6D2%T[,.=NRT '(!7J7L0^"!VD
M]N%!?Z^VUEKTBS3]70TDL.L*2_6^:M=70SS-DH6T]IJA+'"("V8N+"UTD8 (
M.1D3D;R$49UU )!8#$H.K)+'Y@JAQK+9[[$&5[6J$C*QO0G1"F1R!>68U&%O
MA:0L\1H![5HUA>R]!+"(7VZ>U?:M0TDU7"XT+8:EU,8JZ6FBE<YL44O>-:V9
MX,9$H:#D'<UPQQDXQVU_!G[0NQ34MMTU<HX]637*QPWQE?I&WWNOM]/%-7W"
M@%'42SVRF>RL8^WOF?&&.:()X';B7$"<J16E7I4RY"I3K42U.2K1K$AQ:E*K
M2J2PG)U*902(9)Z<\D8#23BAC+-+&$8!""+6]Y2US7M:]C@YK@'-<TAS7-<,
MAS2,@@@@@@D$'(7GR:&:FFEIZB*6"H@EDAG@FC=%-#-$\LEBEB>&OCEC>US)
M(WM:YCVEK@""%!/O.]K)HI+Q\;6[ND:!V[WIS11,YVK:&UW^I5M9+R^HY:T)
MM.293IM5KR$*8!#NAT0Y(=@$)&I)$,6]RN,#.?8"?JPL<S_RP\YUV[7(4XP3
MHU\AG.-E+ZOZ(MN*TVYO=54H\MQC-I4Z3.4 <R#5K(F2/K>\.6X8VRMZCS <
M0^R9E96I>UJUY2&DXZ#(R 2,GW?=[^%"SH_NJ]TG6?;,<16K=_-G/G%O*\;L
M58^1?F>H;;8)%(9HQ7@H/LR7N,Y<1R54QHAP^.KZ?C<1>(JBGJ]@?D4I/2(M
M& 7%('#> 2YQ'7W8'@!G)YYZCIPK$+7\B=-4_,IG!%$-O>U55.PJ-3OH&6T]
M5"Z;1.B(U*60V2,CC9JQ(XI%9+BXQ=,?,#(K"&V:2AKBFR9$Y,J-F5(UB@JA
MI/D,],GKX<?3Q[3G'0X\TO\ *'0NUW.['#:_Z(M>5=.T' ^FJSB%5U(KE\A)
MIB>J6Y,1,9>00[ID,40QK;NUBE1CFX!)0&.*! @.='1>B0*"G:><X&#M))'!
MYX^SP7V.\G=&D21F+-KGHD%12"Z$?/S3TZ94YQ//BRTW"?"JE TER4]\*F&X
M^MLX/V"26!]A?N]4R 0 $2DQO, O$3:?9G&<>. ,^[ISC.<*-TQ\C,U,F'DE
MA$C2S_G^*<BVUSO!(+<B2E6J=;TWSS[B O*=[9'Z<::Y&]6._P!F+_L6<F(9
M$S?3SJRS?:;[2-ZA$M?GZU.WAISU!/7RSY9\N?J4@K5\IM!5/*;]C2VN>DIJ
MEY5?4[9TC,:YIESE4(IME406+V,&;2B0 <T8'",$163_ %%>1$D\DEC6E8)"
MXN<71LR5"YN)0&DX_P![Y/MYQQ]/'.%@/N/O)]I2$=I3BI[M./6TE5/!=F-$
M?-J=@<XS"(??E]/<4?IJRR_9CPZ60HLF$-CPF,CBV.$ZA/V=:W".G+W"2':1
M$#>F0>2[WG Z8\,>WS4XJ.[9K>[+*>J;502Z:2M1M@B:U6B"7[7IE>/DUJM2
M]$1P5@P_0'5Z0N#.VORUK9Y$T."UKF44<7EG22F,,QSFD":4$$<\$9QD'QZ_
MGPZ^14,/(?8Y\P"Z0^2^/WL:^2N8.CN7+3IJ8T(J;V%SET\/B<^G)T[K-Y Z
M)%1[#6 &-;55LI5I8=G:LM.A0A )0%Q0E9H_W@,@@Y\.G7KU\.,\?2HS>)"G
MHO'.L[PM!+Q9Y%>;5[]6,F;84H[ E[&^TK5L)E5M-5@2:CN=8\U)RE</9GZ;
M+]3D]F<US[HD#"I,1K$IA[A]0*7$X W-/[N<D@8R<@<XX_)6Q;A<:81,(F$4
M*/)5_IT=]?N6=2_R.G.%+>H]X^]=[X_?\AG$G[HO-O\ )J&84O\ EN_>=]Y4
MNL*J81,(F$4!JA_V-=H7W3IG^%BE\LC;TM7Q7_EI2Y8 PF(7 W%#WZ!/<W)R
M3,LH,3EA",E",9PM&!WL8<,MG^BM5WJUGU::\Q,O]". WTD$4UT8.F9))&Q5
M!:!D,)<<\E:=TU_JOVI:PTR?U=NUA2P:[LS>D8N0<RVZFA:< .J*B=E+<',&
M'-A)>=V21/G,S6XDPB81,(F$3")A$PB81,(F$3")A$PB@C+=?=-WE6\J!_AX
MUT[5[[6#[L/Z-+JQJM'N6Q%S7&;]-;6.<66.T<;2Q;WLW:;8 :T/6O>5>CAS
MU&,>>/SX_P"$[L*R81,(F$3"**O:=(K[\YUG4/C9AB.Q&0I%852NZ;80+V:T
MX"I#)(8J0*!:%I(>N<46V(]5H(Q%-[NMV$ A;UK.^TU=&6F\4M3, ZCE+Z.X
M1N^1+05C3!5->/V@UC^]#>,OC;R%W6G[BVV76FJ)0'4LA=2UT9^3)1533#4-
M<.,AK'=X!D9?&W) 4#]76BLVXO%9UZW );D]P-EMT#8R4 1%E(Y1*H<)<GC6
MC!B^(#;%:D#?T*4E0#8U1>MC]I!FOQP/7-L?IS7]@:2>[;676ROD/_G4U=2M
MK+8_=TS)W3),>)>0.1E>G>SRWNKNQ'X3_9[+F:?3T&ANTVQ-X<YD>G[^ZUWJ
MKV="V?3]]IS)(TCNBQN=[78%S6=\O)"81,(F$3"+P]C5I ;>A[I7]G1-EF\*
M>QH#':,R%(!<TN VMQ2NS<)2E'O03-HW-"D6D;W_ +BA.49K\0ZSY:VBI+C3
M24E=3Q55-*6&2"9H?&\QO;(S<T\':]C7#R+05D&E]5ZCT3?*/4NDKU7Z?OUO
M%2VBNULG=35M,VLI9J*J$4S/6:)Z2HGIY!^U'*]OBJ;NQO"?5U\/4'<*"<*^
MYJ;XZUO".1MC)79[H7*EB]6B/;UZ@2*1,H21MI"=0G $PL\0PJA;",&@["+6
M^I.S*ANTM*^T/H[(R&.1LT<5&7B=SW-+'G9-%@L <WD'.[JO<_8;\/G5_9S0
M:@INTBFU-VK5-TJZ&>U5=PU0RD?9X*>&HCJ::,5%KN#I&U<DD4KBUT8:81EK
MB<C(W(7AZH*C*^D$8OB-UIT?*729*WYKF+U A-BEG8#V1B;R(T60M>7DT9"=
MQ;G)T":%26#9CJ8#1&A $89]FG>SFTVJCF@NT%#>9Y*ETT=3+2;'1PF*)@@
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M#=XM")'?MQ36W5,!CKH-,C"Y-\)(ER:-&NA"8E&[.3:O=$)8$:T@.BHXY/N
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MDP)0SR2/;T6HK1\<VYT,3^XKZ:2.MME4 -U-7TSN\@>#U#7N'=2XS^K>XX)
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MO)]2@MQCEISY$'Z\*:&%5,(F$3")A$PB81,(F$3")A$PB81,(F$3"+\&%%G
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M]3"0(+)K.*1V'5Z]2]/7C]6,;*/?Y Z3>5%,*M]?26YBCT;5)F=VDBH1<C
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MBF'-A4G(!%T430%*$T9"OIT?W7K8G)(FA(-5OJ986V/SS_=^?:N1P&TGU>"
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MHDJ_3F:K=CO@!7FFE(T12>#G[1]61_>$:<F+/)RX>'3C^]>Q@;PA)Z:G8_#
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MV$.M!#L6]^@=:UKTU^&$7[PB_(@ $( A "(1>]B+$(.MB (0=@%L&]Z]0[V
M0@[V'>M[#O8=_AO>L(OUA%'?FGF: <I0R6UU5JZ2Z@<CM>R+89(F^+&M4SUR
MJM.1'S"2PF $MK,TF-<!(ECB^O[*S.AKRO:U4A<TH'<QL W(4!222<GK@#ZA
M@?8I$84*.O.?,=?<S-UIDPM=)I"_77=5AWY9\TFBUK<)3*Y_8KF!2J$K4,S,
MP-:5CC+(C9(9#F9 U)4S-%(\THQ[6+]+W)<4DDXSX# ]RD5A0F$3")A$PB81
;,(F$3")A$PB81,(F$3")A$PB81,(F$3"+__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>g904779g69i17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g69i17.jpg
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M\#U3KJ;TEJ_L12M)30K(+@,PJT)=_/T%@&400BL56@Y4(',A9#,\$90\DQM
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MTB>58S0CE'9&W;YX)E0_+]JU>\L77"B'S39NO^3XJ*>6)<F %MH2 2&2.!O
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M"Q>W3)B,VFDF;M;#[\AP\#,3&0+CY<A5[IH5APF08KO7.!!D R0S0 8O4'>
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M#=;:@D92X".<CRG*JY4HUTVCF/<=K6TDM.TJR6KCN6D9@8M"LZ&KT -E&M!
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ML[X82$!)5V^Q]QU?>UH8MI:5:Y$+!J!>(.86[%9I9_B'&MU80#R?C&GX(/\
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M?R#]05B?1<DZ(J\;D[8&K5TW%*KR*XW%7\XLD:%"7+C2EYVA3H"\ L>:<#A
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M$ML&TG#7$_G+9-F,D_\ $&9(9)61,9&N&;)R-P:?!'/,BQ:FTE[3-T&@CL@
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MILIE.66<+9]54OVYZF&ZA#!&^E3DTM.[DOZYX8H2O.B^%)49V"5L-60")/\
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M'MZ0^P(.X\2N)G-=*JV0);:U3J@3O36O"MH3>KXN9D;(TG+635M9IF*1F2R
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MZ$#AT=B")59D>K?!FJ22CXX?@^5:8.'&#91UBKDABNMBESAPKGQD7HL/Q?\
M7]UZSNSI_NM-#?\ #36O^3)]%Q?WW?F=]2K*.BRG1$Z(G1%1KO+K7N0+W-F.
MU.JM-1/8 ?>?;VEVCTIBINUXW5;ZKY:M8AN<P^V7KF5ME6LIAF"4F=C3L9 9
M\R//(?RX:IX\JI<+OGSY_C8(B"8AUX0))I7AL$2I*Z>5KM!J#3E<:J<5%$9_
M6NO.E<#9Q>U@UF#QY>U=EPC5ZA*JP9Q$VQ8+1:(OG2*3H%-SKI!D@@^:X/L?
MB?.)#"CB'$NR))I&S?,^O%1DHK1RT*H[<5IQ6_=;(3N9M#M9;I38O;BEBUF
M8-'9[/9Q9061*1X5/RB!>.I-*EC(&+<1L,J00C#\U%W;<68&LB^#GHJ7 N$2
MT 71M,5S\9,C<8JMF]H[46Z=6A&T1*Q8 .UZK>Z+I9SBB]1 UJK7(*UYB3",
MM@YM'&8)9J@4B<^.89G7\?BKAZ!"(,AZ#5[EDIFT9D<08BI @DYG_P $"JA-
MK5VM;XJ4'VRRSZI*_CUDT!O/M?=6PLH#F8/C(OYL;5>W*UAQ!Q(QJ_#^9*DX
M\9KP8X"M7A%^/8M1S!\U00"9ILRMX0X5,L:T;I ;-#Q$S"BY&>RAN(E5&A]?
MXH1R%#)/'K&UQ[EH!M,8^ZY*:R([OE-L8!Q&WHTADV.R$P+=GX:_<",B!)D(
MFB@!ZCP(6-\-2M\5.T064F#$&9W4/B/6^3MQZX6;K>-W68V4"& $[E[B6U6P
M=<-Q98451>U/:!N.NX.37P$KK)AW3MF-<?&!/.$" SA/!)TV1YRQQZ+#B#$;
M&M'F!56-]%E.B)T1.B*M??+^WCM5_P"/Y]_HKW Z+3<G_E'ZVJRCHLIT1.B)
MT1.B)T1.B*M':L+L4=VRTXG-;:UR:QJ^UUG5C3*5RYA95.1I,PVLRB+!J=,>
M!!RZ<!3^;V-EY<Q)ELWPYFU=#&SO@2N^=\(H*EH1!J*B-N\'=P6WK[7LV>P*
MR87)M/B%P0G&T \88Q.-7Q#XK)K(J]M%0LM3M$.L6*0(;'WXVR>,X:O7L@GH
M!^Z&!W4LP..F;MI'GI01OBAV>4;=E9\N*UAIMKM;E0:5SJDYD(;QA<H5OS^9
M2I,IDG.EZ5J&;%9 O4M-&+%5YSPEA&("B"+=^:4(FF[#EYP$;2,^/"MC+PAJ
M3_Y.\^>:C>+T;N !6.GD7C\#BX,E5':-V@U(LEH(+1@8@WNBSHEJ(G$(UCFS
M<(MS(LA+JTM,DYD#7EP$9$.5RKUXFL?07=EJ\*\7AWD+T_4+@U9H)>\7O^AV
M!/".#]4,H9K;L1?L4P,-5R:N[.L=2-*;C(9B-:*YMB$3D>8ZG+9?&V:.2"<Z
MUK$.5WV6<FX3=E)$<109Q!,SF.(J*@\%8%H/4DXH;3/7"G+*'-A,\KJK@$8E
M0UF19%VK(PPP5X=-T"8Y9PQ>X)\Y\<<.&JZJ.?/X_DSRX_IZ*.,DGYDI=]%$
MZ(G1$Z(G1$Z(JU^YM_L5I_\ \RC0G_4!&>BVS-WY'_0JRCHL)T1.B)T1.B)T
M10/[E4*N&V=+M@Z+I"JB%ISF^:CLRH1Z3:7P6'#HDO.(,="L)3('TXD %)T%
M9D731%VT!_J1GG%?XR(]1))3+$M-(#@3D"#Z%:DW9%;-WIJ%%:[@6JLM<V%,
M9G4LFE,6(6I1P_\ FV:T?L'5MC_+'#;BP,0A]S/(W"RBL<YB#XVD.<JM6TG4
M#*YYXX0U]1R(*@B349'?M!&Y9UMU!=@MI]>["I>/T^QKXE*J>@]GQ:1S:R8R
MZ;C+^@=HQV? Z-E8>(HR+),4X4APODS98(L< )-B;ALQ'D%FOXK5! /#(QN-
M"1ELWPN?0D#NV=[76+MG<E3*T(T6U\KC7B!5F7G$,GTO?YA)Y.[(L"<2 I7I
M,Y$1H1V1D<8CT)&MSC\VZ; SQH^RC^9)@)3(<HSJ3/B!\R4>F^EUJ-(V6X:P
M>,MI.2[O[#<9=^W)QQ%^\J%"YAY=27.B22V*JQ[&M,'8O@,NOD?Y%99Q_%O\
M-3Y/(K.6?=@^A'IDH^2OMU[2+@ F%>* X8;N6_\ ?.E-IU\90R1>K:';:;H6
M7L$PG$;?,'67"UFQ:%NU!<$&M5D#<:?WC+%'7#98:121+5X>@:13\36@5VQT
M'E9_J'1\FI$WMTF9 "X[&K+VM+6/5S$0Z'+,^:UYH>@J^#Y8LARF6(3AL8K\
M^,1#NDVSENT8-U\4,6CEKFH629#> (/C><?W4R^BRG1$Z(G1$Z(G1%6OVD?_
M &/1?_$!O)_KHV0Z*G/R;] K*.BB=$3HB=$3HB=$5/\ +]*KKN;77N E)@E'
M8UL[MU-GA:"#C!E E'857E!&FC+4RL3AV/\ ZDW0#/V,3_CV<+!TR7(B6W%/
MLT4B2K;%)4M35HS:-D;\_/8#P!A9Y& FUAN^++W..:P8Q*51_6N%:^U7KT<N
MJN5Y/.B[NTWT_L^6&+ BJDI@D5C#!%2-L8,FZ=OI"<Q#2)T<"Q94@*89$I$<
M9)KD!000*Y\EHVR=5-G"PS:_5 %5XLM3VUNW(*_&^R&5A11@&KNL91(ZDF=O
MQ625Z[=8V&2LH:2@<Q#5XE&PQ2(&V\CBQ$_*HK^F%V7! 0(.T"HC;6",QNJ=
MH-#MG7>5'22Q=L-)+8:1T,9AU#O]A"LJ)$U163N.%)W63&*P\D&8ON>7J[]9
M_P /V>3P2EDX'-EELUE$4%\N<RS\\572+[;%DSF)4Y4UD@A\9@PFJN[E7<E,
M!3X9P]KYUM3M=7=I:SGXHU'/>%N2(*,11&7B,Q7'&,,,1P4/(?I[W!LWY+4C
MQJVF^!59C0>H6V*DSU V+V0%Q%YL<OM;8UT[6+QB0C'<?AD-8:47GJS4$;AB
M^2J.1D.WR+0DX]$AF^7+*66+.S6;?X&1)[R5)': R(@>YIDYYQ] KL.BPG1$
MZ(G1$Z(G1%X1_P"6,?VGZ)?\!WO_ /Z&L>B]%A^/_K_^EY]JL[RO<WI2NH94
MM6;<3V'5U7L?'Q:&18>#@"[$" %H\(#QC58C$'CY5%LEQQAAFZ=.%\N./QS5
MSY_IZ+J;-A));4U-3^Q6?>/-W=?.[9/IZM/8_13"L]/-W5/'F[NOG=LGT]6G
ML?HF%9Z>;NJ>/-W=?.[9/IZM/8_1,*ST\W=4\>;NZ^=VR?3U:>Q^B85GIYNZ
MIX\W=U\[MD^GJT]C]$PK/3S=U3QYN[KYW;)]/5I['Z)A6>GF[JGCS=W7SNV3
MZ>K3V/T3"L]/-W5/'F[NOG=LGT]6GL?HF%9Z>;NJ>/-W=?.[9/IZM/8_1,*S
MT\W=4\>;NZ^=VR?3U:>Q^B85GIYNZIX\W=U\[MD^GJT]C]$PK/3S=U3QYN[K
MYW;)]/5I['Z)A6>GF[JGCS=W7SNV3Z>K3V/T3"L]/-W5/'F[NOG=LGT]6GL?
MHF%9Z>;NJ>/-W=?.[9/IZM/8_1,*ST\W=5@,S[RO<WL(S7$AF>W$]/&:BFN=
MBUP_= X FK%9JI$I1!<Y QQ:Q!NDL[RB<UE 7X3Y-VTX;&'"G#?ARFW71*BS
M8)[.8@U.4@[]X"S[QYN[KYW;)]/5I['Z*85GIYNZIX\W=U\[MD^GJT]C]$PK
M/3S=U3QYN[KYW;)]/5I['Z)A6>GF[JGCS=W7SNV3Z>K3V/T3"L]/-W5/'F[N
MOG=LGT]6GL?HF%9Z>;NJ>/-W=?.[9/IZM/8_1,*ST\W=4\>;NZ^=VR?3U:>Q
M^B85GIYNZIX\W=U\[MD^GJT]C]$PK/3S=U3QYN[KYW;)]/5I['Z)A6>GF[JG
MCS=W7SNV3Z>K3V/T3"L]/-W5/'F[NOG=LGT]6GL?HF%9Z>;NJ>/-W=?.[9/I
MZM/8_1,*ST\W=4\>;NZ^=VR?3U:>Q^B85GIYNZIX\W=U\[MD^GJT]C]$PK/3
MS=U3QYN[KYW;)]/5I['Z)A6>GF[JGCS=W7SNV3Z>K3V/T3"L]/-W5/'F[NOG
M=LGT]6GL?HF%9Z>;NJ>/-W=?.[9/IZM/8_1,*ST\W=4\>;NZ^=VR?3U:>Q^B
M85GIYNZK ;![RO<WM1I%V%@[<3V3-(7/H7:,70>A( CB'GU>&V\CADE;\LH@
MUR4> 3;5N0:HN,EF2JJ6.+MLX2YR3Y*BS8,AL(S.1$':L^\>;NZ^=VR?3U:>
MQ^BF%9Z>;NJ>/-W=?.[9/IZM/8_1,*ST\W=4\>;NZ^=VR?3U:>Q^B85GIYNZ
MIX\W=U\[MD^GJT]C]$PK/3S=U3QYN[KYW;)]/5I['Z)A6>GF[JGCS=W7SNV3
MZ>K3V/T3"L]/-W5/'F[NOG=LGT]6GL?HF%9Z>;NJ>/-W=?.[9/IZM/8_1,*S
MT\W=4\>;NZ^=VR?3U:>Q^B85GIYNZIX\W=U\[MD^GJT]C]$PK/3S=U3QYN[K
MYW;)]/5I['Z)A6>GF[JGCS=W7SNV3Z>K3V/T3"L]/-W5/'F[NOG=LGT]6GL?
MHF%9Z>;NJ>/-W=?.[9/IZM/8_1,*ST\W=4\>;NZ^=VR?3U:>Q^B85GIYNZIX
M\W=U\[MD^GJT]C]$PK/3S=U3QYN[KYW;)]/5I['Z)A6>GF[JGCS=W7SNV3Z>
MK3V/T3"L]/-W5/'F[NOG=LGT]6GL?HF%9Z>;NJP&L^\KW-Z;B#>!5GMQ/8E$
M&AN82-N#8!( NV2-SZ8GI_,"&*C^(/'/*IR82<\=<X9+\HIN22R;5-!K@B@D
M5-DPU+>9&5-A6?>/-W=?.[9/IZM/8_13"L]/-W5/'F[NOG=LGT]6GL?HF%9Z
M>;NJ>/-W=?.[9/IZM/8_1,*ST\W=4\>;NZ^=VR?3U:>Q^B85GIYNZIX\W=U\
M[MD^GJT]C]$PK/3S=U3QYN[KYW;)]/5I['Z)A6>GF[JGCS=W7SNV3Z>K3V/T
M3"L]/-W5/'F[NOG=LGT]6GL?HF%9Z>;NJ>/-W=?.[9/IZM/8_1,*ST\W=4\>
M;NZ^=VR?3U:>Q^B85GIYNZIX\W=U\[MD^GJT]C]$PK/3S=U3QYN[KYW;)]/5
MI['Z)A6>GF[JGCS=W7SNV3Z>K3V/T3"L]/-W5/'F[NOG=LGT]6GL?HF%9Z>;
MNJ>/-W=?.[9/IZM/8_1,*ST\W=4\>;NZ^=VR?3U:>Q^B85GIYNZIX\W=U\[M
MD^GJT]C]$PK/3S=U3QYN[KYW;)]/5I['Z)A6>GF[JH<;3;Q[7;L$(:5VEN>1
M7$0KYD9'PYU(&$<89@F4A7'N3+=KQ'0H;!3!^N*'J*\NL7&>/+7#A+)/C+/C
-,M-:ULW1$YYGZK__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>g904779g75g00.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g75g00.jpg
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
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M/277)$AUU]]Y:G7GGG%.NNN+SE2W''%Y4MQ:U9RI2U*RI6<YSG.<YYZ(
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M\B6PG"WHK$U3>(SLAE&<*=9;=4XVG.%+3C&<9Y(="YC#J74!B@8;X4]3%<Y
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M>*&VR(/8AB)JC@4H&AQDR2(X9\W^Z%L1'LY/#?Z8LATJ]D:(0L6D:RN@K2"
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M73T-#U&:+!;[U%.*V?3QLNO+ DHHM$C,6C7YV:AMY< 1<&1HEUDFAI>1=@"
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M.^$]\#/U ]$6Q;5:]<TJU[5Z6B9*<6INPJP,G6.=1@TAY;[56VE$&LR9P&>
M0M ]JV3([5:LT=,2='G0RTF?7Q7U-LAM[IFT-K#!=W$-EK*(J3VTSK$MS(
M9K-G(6192"Q@4F6$[RE60+*_CNM[.7>ES2/#%)<6+,6BF12YB4G(CN H)1D^
MUXA CDY,"&)1?%;\'X>=_7-TXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3B
ME.*4XI3BE.*4XI3BE.*5Z*]"/@P>J?KWO(,5KFBFZSJQR?'Q<-YVH+/'Z[K
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M]BCP<>1'JT]1=<=SJ3^CP+X/CLJY\(G\M)ZU.Q1X./(CU:>HNN,?AIU)Q_\
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M]2H;95&.4D;L(98H4BHEZZ-M8\FI$F.Z^#,5]FTC9"A<EADNQ)F 'VB;0N1
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MKK&KLC]UC^?^K/%*C<MR=S\?]5*F.6Z5'3^#'\F/ZN2W6?G/Z:5W1^ZQ_/\
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M\,, ?,#S/.K78\'+L&,"%JQ%T04E^E=HY)ZULJCQ?5@_.P]:4G7X_8 %H?1
M$-F_59RF9GPXT"AUV-)AFY\95@9.9DV<A8["? Y1$YDRC9*#?C1 XP@ 92F0
M @Y$C>SVQCA,!^Y)R>1^UY@#/)1S&.]Z3=XKH3W6+]7JZS;=6NTZ$<T7=2\]
MQZV)LOK+JGI9A=.1,,.A)"Y%N B4@>Q:8!:3-9(>1==&R!+"T(E+N=C2Y4;T
M>Z#"Q^VWMZ*W$) Y8P<;P/(]S'=J>&W(9&!NGNYR$W3W/F-3.FO!]WK6^XM5
M; .6NGG(-$"ZA7(-Q916-;A9+6W3\(TL2J-?;Q5V),^DGIPV8;0N?<Q@UJ";
M(Q9]!(&,,&VXCM'22-V92$$62"0P,<(B*CM>:D@'FP&"04)P:E8R&!)'(+SS
MS&% (ZNH_/\ BS7K(U^[Q_-_7CF?5]/MA^/]!J<XJ]3BE3'%*F.8]*Y3^''\
MN/Z^*E>L?./TU,)_#C^7']?+#=9^<_IJ?W?^M_74RC]UC^?^K/(J]4;BE.*5
M$;_A_F_MY#=1^8_HI4PW_#_-_;RQ5R/N_B_KJ8;_ (?YO[>*N5,H_!G^7^S'
M*7^U/XOTBE1V_P"'^;^WEFE32/W./Y_Z\\55^Z7_ %?T"IA'[G'\_P#7GE ^
MW;YO15P?;-_J_HJ93^#'\F/ZN5#J_&WZ3551D?@S_+_9CEM^L?-_6:5YGJZ.
M-VN29.HTVS5J>F^;U8)ZI7K#EJT^VM*L[=9WN[K5 C$#U3\DK8#/HYO8*K1Z
M3;J*O-<U9R>GR^;)4\ARW<D_+WP .KK[O>[G76+V/+VL>]'P#.9L]MQ1]D$A
M3&-W[<<GWL[O6I-:R#?!4[*13WP<YGIJ@E %%$5P3(""[+Y#;M@C=2] WN]8
M-R29E0R]%DB*U32NM@<P?$MT]R#=;%)6L<'D*K+E.[NKW.0 SW^?7\GY^[5L
M:?($W?L *H%! ;[(PG27>D)7(PJ% 1O'MF[G(W6QX-'=<V[[,MQ*TZ9'/7U!
MN,^]7&)HI)7SKJ_U+U%A"1,0&UM7DQI(RHT0U3W4%C5Y,OGYC9EVVOCS,D>"
MH_KJH6,N^[%HAOYSNY&?])CF!("+S"*5YESO<][!.[<QSP8%KDUR;'K1K50&
MWV2N]6@:]V>*/*PIUR=WCU.4K=6M%V E" 8(FX]#I]8EUR0@HI_(PG)89 MO
MCEO2D/U_7E^O5536+%2%,89EN%=L$%N+.DL9) R=U%W2#U'&,CG5)W;X-RT+
MJ^V+A7)%;:MMH,]>=KL\R@UV1.V%?J]U&7:!=M<T>:E>:R_:V <(7Z#LM?G6
M.-'RS-F1ZL[.D24X>I!ZSU8.,\N6/USS[^*N26+;DC+NAV[,9B@)=UG8/&A!
MW=X #=92V!D[N2:N#I^Z;=CWOI@Z^Z#)UM4] R>INQW0=K>MPZA8-?TL-".=
M/NO==^F8U+*"H5L @/6P6:R[Z2K@DF4<BSC44!#A$8#"J2PRIZ^1/+Y>7R?K
MW!5<$$CVUXG#6$W#.(U",B*&ACCSN$!@N\&ZU4G!;= (%3EH\&Q92Y"Z6046
MU>/N=PO?508FVQ0XDT>F4G>G3"<TM4*B2-, U$Y$"MW8E%MA,.I]T.Q%9>GC
M$23*O(N5@AN?>/=_7Y:N>][-O.#&':2Z8N00VY/;-"J9"DX5V#$=0 ) +<JE
MU>#LV<-L5A*U@YIH$J?L2N[(&GO1):24>*1.AZZ],A,;8PJ:[&AEAL/8YYC8
MD!+IEQ)H?8[EDA'%&'O\<3^OZ_J*J[ E#.RF%<R"16PQ.1926Q#KN@$"1A(!
MO<PSYP3SXZ8?![[1TIM77VP+!8-9QA%5OSUW(5JGOS'&O*2NF8MHN:D8V/US
MKJNMR)IQX?85^9UD#&:$96/6W*G#VY9-2UL)(9$=C$ LG$*IG'[6: XQ'&N2
MQ#<E4;O+K'/'Y;H>VKM[<W419LUK7.N(#_4?MBT5[:9H4<C;AMU>LW2L/U2(
MJ0LC&#N1)&EBMBML\F;=P:7GTE7"\6-6YDQ])&.IV#+-+<-NQQ@W$K+*P83.
MK6@A" [N# 6;+'>ZU8!<\ZN0QX- ]"?IPRD-:.$AD:[Z;*H4M<H 5C7[3-IT
ME>9U[NUWT,Z."^;N&-PEBDR79YQ4G4BD@XG!\[.L69+XM,@9( J\-+8&-8^
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M09DX9)LQ*.Z3%"VC+P^0/Q%9.SUR6/&RJY%HSJ$;BQF1);)EG*GC".VM^!(
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M^K^?G?'2'\#_ *1_@5.]VV]C\7XL5%3TX+3GM]<4Y^CL_>#/SKCI#^!_TC_
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M/=F?F'+@GP -WJ&/MO[*GI?_ -'?TO\ RU0LZD5G&<>G\?3C/_\ 5Y^8\"?
M W>H8^V_LITO_P"COZ7_ ):H?LA7W@3[KS\PXX_[S^5_=JI=L=TY][L\L?MO
M_*UU5I]:L]OK G'T=G[UY^8<<?GG=[@'VW>S\GRU5TS_ .C?Z9_E:ZYTZO.,
MX]84_3CL_>K/S'E'%YYW>[GK^7/>J1MG@@^]O4<_MS_*U#]C2^\2?=.?F/*^
M/^\_E?W:KZ;?]&?TW_*5G+F/7!TXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4X
MI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE
M.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4X
MI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE
M.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4X
MI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE
M.*4XI3BE.*5H>#\(5ITIM&5K<Q3]K4<0UMK;FD(.W[F%IX[3Y;9&DQEG.7H*
MQ8X%Z*FQ4>,"IUC,P2UHK  5)@C7LNRXTC*8^9P?T<N[SZOZNKOU&?G'7S[G
M+K_4XK*K?6ETBO5P;;V^IC1RJP9.S*N).9V;44CR-D@8"*F (;ZBJ4OF([5E
MKLEP<WXTOS,\'F8:S%)0WGF#WC^2F1WQ^6J4-ZR]06?I^H_4=KV-==H4S990
M* H@'7]:]-W:PV,V6?#, $AWIT$>'G0)D2?Z;?L1D.+"-#YBR9&,IM*%L<\=
M[/YN=,\L\^?4.[SK(NF.H74^^JU6[%KZTPI,FS51%S9IQ5Z**OX@#BQ&Z?)F
MGZ<_)49&1H=PK5CJKQ%;#@A\Z!*0H!&;YJIS(@CKJ:U[UUX0?4>P+95Z_+HV
MX-=5V^V_;%"U[M/8E=J@S5UWM^E9]QA7P$+L8*\6.8&F0T:^ND\;FYAZNP7@
MUPBN Z[(0W&<$8_,>[RS^+%1D=WES(YXYXK+3'65TER:3+V1%ZD](RJ% L;-
M/EVZ-LNI2 3%IDP'RT:OK(,E5L>EI0:-)-Q8259>D@XT@TPEP6P[+0P>\?R4
MR.^/RU>(KJ(T(>OXS50/=&KC.RC5?AVL/115ZK9&T%:X1#MV(>9&AXA%Z;.@
M3JX\S8H;\5IU,JONMG&/'%+3+S%3D=6>?>K"V>M:H2.H*X]/ 34^YK(=U[<Z
M;1[K>1,/6#.OZ\3NE2J]XA39#QO:0>Z3A0RN6T;-,/B*21E,J9G,0(9%UEM+
M\XY9R.?<YYZ\=['YZC>&<?+CN>G/+//ERK(,SJ_Z5!X-=FG=1NDXM=;C 9;A
MU[9=10);8M+-CD5I3D_);S9"[ S4+4X%94YA\FFNFO,FWLCI6&F#WC^3]>^*
M9'?%5&'U4=-)$UKRN#]^Z@G'MM#(!G60B)L*K2)][%%9,V$)G5>,T36X8CEI
MPTD/%+B)<])$1I&!"P_,@RV&6#WC^2F0>Z/U_7]/>JC">LKI+/ [59@?4IH\
MQ7Z/&K\NW&1>S:B0'5^/;)6(%7<)RHI9UJ/BPD58%A4Y5E9,KGT7#2\0QF-A
M@]X_DID=\?EJ7>ZQ.G:+)+RIVTJ,/HPC6-(VPK:\N^Z^1KB?6=@6ZW4FNMCR
MK=L<,.3I5@II*"T[( Q@I&8_&$@S!8[',"13']?YNNF?ZOS]55*9U>=*P]=(
M1.ZC=)15[*A!2>OTO[-I[>;F-L1>?7P9&M]I?L+P"9\61!Q9D+RL99B#*&>5
MQ-96QA@]X_DIO#(&>OJ__O56Q7(J:<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%
M*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4I
MQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%
M*<4IQ2G%*<4IQ2O&H;T@B #'4L9@]*^Z7]U[TMG4J?KW4!'@=)KMMU:UU!^G
MXRVJE%-]54MIURL0#C\)HHEJND3XY;\.;'$M39,=-6>KF,8'+GW._P O348Y
M'OG//Y_U'Y*LW0'2%L?3>X*KN.Q:JW[?C-<NEQO#@M8OIW88DE[=HW7.D5YC
MGKYUZ[2MS:Q\+7C)YJ<8/GR3SQB6+\[8B1V'<R3D8R.YW^X2>XH[_P":H"@'
M/6?U[^3^?Y*OQ&F.I8-T3TWI H]>ZBJ/.J; RLO;9!5WIEA%CFM11>9+]37A
M(OKK$F0A V'7 K]DMM9O(8E+BMEGPD:NN%FFQD<LY)'S<^OO\U/SXJ0,#&3W
M>?=K/&B(VZ=.0*H%E=.%](5VIZJ"ZY@ J'KOI$UE%CS MHL9:.5&RD=9=L)0
M*_Z *B0J*8_-(1VC(PI;<EW)MCE08;EWQG/7S]7\],?D[V/U^:M*$=$FU++5
M&=4;6J'4E;](5XUU/6FAT.JU;I$HAX):^IYC;L V?L5XD=9=P?M+](&;MO+5
M0BPP=8A^?R!\XNR1:A)@N3D=PC/+O]S'<W1WA4%<C&>_^4Y_1D\OSU2[-T1[
MPNHLP5M=-W"3VD0F:BB0;8,UUTY4BM!*MI/7>Q-=TMD.%UWX0^H[( WC,+9M
MC)&;M5=S5R(56F#79-4S2V'*V^Y=\8^7)/\ Z<8^0@]T]?4W>OGS/= ZNYW_
M )NHCJ&<U=FENC*_:@W-3=GR];]3VQ!55*U6[R15O>Z=7+44VG6M#AM#/7!L
M_"ZYF*% B&08CTQ,CN:C(7)M\@0!(V$JLO8%)9&",CO#KY#.?N<G\OXLTW>>
M<Y[^1UGO_)^+]&,75+Z;-M,=6]\ZIP?3^2?F7W8FO+Z^/V%T[=&.Q=C5-%'H
ME*H,H+0=SS.N$.=J+9D=4'9\>:- )4%*&)$IN+/6RK,ERQC/YSCKSS&[4X )
M/=/Z\OG[M8)8Z+^I[7<08K5&OME$SYOK%I/5[=3%XH72(/&B-B0 .QX%[-5Z
MO5;JXCK,U8W.LE5S7M5RS@'-68%FY@G9<8F7S(;9&.L=6.[U9!'<QRY\\?BH
M!C/R\_F/=/7G!Y<JJ55Z"]NUBSZG,^KW4H5#ZYONK]J$:[+!=-L& 5OM&WO?
M-\V9^O"077L)I%=KEW/[#,BV8%AI%]L],'P0K%>NB1C)809C/7S',8SVV>K'
M>_+W_P F 4#]/Z][\75W.LYJKG0?=F]=T.D0M4[T=E4#I^U5I >0,U3I>?'D
M9FK=OD-N0[I)9K?7-4K@"EDB!!R"WZC7VI6X!)0DV%OT:2MZ,Y.>9YCF?EZN
MZ.:]WE^0<JC='+Y@/R'.?GZ_R_EF!W1-N(2B@6%BN]39;9VKP6G44VX6\)TN
MVT7ZWZAV_OC:(XI:0I;KA78;7598_>Y2EQ*^1O*+:,AUD%8I.R#-DP].XR.^
M,'/?'7C][\GS?)BF[\O>QR[V?E^7Y_E//,Q%Z&KHW6-@B)>LNHV:<V=K7-/M
M![U?Z1HL5NTE>JBW]55JM( #'ZQ4QP@(G9[?)K@:DL2W4 !8^!.?L)N>E[+K
M/5S&!W.?/D!SY=X<^7=/?J-WKY\SW<=W.>7/]<9KWC9<4ZRTZMEV,MQIMQ<=
M[+*GF%+3A2F751W7XZG6LYRAS+#[S.5ISEIUQ'BK515=1.*4XI3BE.*4XI3B
ME.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4
MXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3B
ME.*4XI3BE8]E[6U]!DO1)%EBX?CN*:=PS%(RFTN(SV*2E^+#>8<\7.,XSEMQ
M>,9QG';VXSS=1[.ZU+&DJ6$I210REGA0E3S!*/(KKD<\,H..>*YZ;:K9^"5X
M9-3B$D;%'"1W$JAE." \4+HV""#NL1FI;VPZX[RM>[C'R[E?1G7/ '\M;^VJ
MWTPV<\9IYO=_5Z>V'7'>5KW<8^7<=&=<\ ?RUO[:G3#9SQFGF]W]7I[8=<=Y
M6O=QCY=QT9USP!_+6_MJ=,-G/&:>;W?U>GMAUQWE:]W&/EW'1G7/ '\M;^VI
MTPV<\9IYO=_5Z>V'7'>5KW<8^7<=&=<\ ?RUO[:G3#9SQFGF]W]7I[8=<=Y6
MO=QCY=QT9USP!_+6_MJ=,-G/&:>;W?U>GMAUQWE:]W&/EW'1G7/ '\M;^VIT
MPV<\9IYO=_5Z>V'7'>5KW<8^7<=&=<\ ?RUO[:G3#9SQFGF]W]7I[8=<=Y6O
M=QCY=QT9USP!_+6_MJ=,-G/&:>;W?U>GMAUQWE:]W&/EW'1G7/ '\M;^VITP
MV<\9IYO=_5Z>V'7'>5KW<8^7<=&=<\ ?RUO[:G3#9SQFGF]W]7I[8=<=Y6O=
MQCY=QT9USP!_+6_MJ=,-G/&:>;W?U>GMAUQWE:]W&/EW'1G7/ '\M;^VITPV
M<\9IYO=_5Z>V'7'>5KW<8^7<=&=<\ ?RUO[:G3#9SQFGF]W]7I[8=<=Y6O=Q
MCY=QT9USP!_+6_MJ=,-G/&:>;W?U>GMAUQWE:]W&/EW'1G7/ '\M;^VITPV<
M\9IYO=_5Z>V'7'>5KW<8^7<=&=<\ ?RUO[:G3#9SQFGF]W]7I[8=<=Y6O=QC
MY=QT9USP!_+6_MJ=,-G/&:>;W?U>GMAUQWE:]W&/EW'1G7/ '\M;^VITPV<\
M9IYO=_5Z>V'7'>5KW<8^7<=&=<\ ?RUO[:G3#9SQFGF]W]7I[8=<=Y6O=QCY
M=QT9USP!_+6_MJ=,-G/&:>;W?U>GMAUQWE:]W&/EW'1G7/ '\M;^VITPV<\9
MIYO=_5Z>V'7'>5KW<8^7<=&=<\ ?RUO[:G3#9SQFGF]W]7I[8=<=Y6O=QCY=
MQT9USP!_+6_MJ=,-G/&:>;W?U>GMAUQWE:]W&/EW'1G7/ '\M;^VITPV<\9I
MYO=_5Z>V'7'>5KW<8^7<=&=<\ ?RUO[:G3#9SQFGF]W]7I[8=<=Y6O=QCY=Q
MT9USP!_+6_MJ=,-G/&:>;W?U>GMAUQWE:]W&/EW'1G7/ '\M;^VITPV<\9IY
MO=_5ZO4*=$6*"DD%GL$(2EJ:\LQE6/$=1A.5M.MN)0ZRZE*D*RT\VA?B+0OQ
M?%6G.=7=6ES93&"[A>"4 -N/CFISAE925=200&4E<@C.00-U97UIJ$ N;*>.
MXA)*[\9/)EQE75@'1@""5=5;!!Q@@FK<QJRZ<4IQ2G%*<4IQ2G%*<4IQ2G%*
M<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ
M2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2I2?G*8,U2<YPI,23G&<9[,XSAE>
M<9QG^#.,_3C/+L(!FB!Y@RQ@CO@N,U:G)$,Q!P1%(01U@[AYBO,KGO=?,E.*
M4XI3BE:<;_ZN(FC]EU;6*:D!,D[-1BU[07MFVJ-J8#&@B#XZONC6BEX=C0B)
M=^039DQQ\21F4Y#9F2$L*:AOK1JKW5!9W$=MPHW:2%I]Z6ZAM4"JZQ[H:; 9
MR6!"@YP"<8!QO--T5M0M)KOC2(D-PEN4AL[B]D+/&TH<I;!F6,!""[#=#%03
ME@#)-]7A29;2D(1IHT3U]5]GQ=-6Z^XO%/@3H6P&EC(EI8K-*(/QRMPKU%)E
M6A]E,P9L2:I4(O)!A#,8<ZXNGWT8RLJ6CO;QW(M)9^-$I$XW1((X6(:6.%F"
MR.&4Y5RB.%-5'1$6%6>^1;J6T-_#;=CSLK6QWVA,MP@9();A$WXHW4KVZ"22
M,L*QE^R&0%0-T'&M9BWPFED;?<,QV=T:^<O4]O49@L"FRDZU1E5O'#SA(:TB
M$1F0<Q(\<A$ENN.L.(4YCC705NW%NI2S%V7 NX#,W8K,A/8_[*JNR@!B, ,"
M<BLOHP^]8QF[827_ &$(V-C==CJ;U$D5>R\<!FC1R60,&)5@!FKSJO6H5M<B
MWUT1HJS62]5G.O'8X77MYHVP:M+@;%D6-B&0.;"!STU^E,@$54K+LC5F3#?A
M0W1#\9N9@M&3R]%JS2F6-;-WGCX!"03P3QE9RX#/.C;D(3AL9!)@JNX0&#BK
M$V@I"()9-1ABMYNR@9+FWN+:96M1$62.VD7BW!D,R+$8=Y6;?!*[AJ\K!UA4
MX-TKP^J:-5+43"$X0WT;3V(V))QXT3LR:@T,D30;9X<S ;.>51BPQUS1<V$A
MB4,5.=(#HDNZ^JQ)IHU(12LC!=V(#,A=I.$%)3?7&_GMP64K@KO;R@V(M$GD
MUAM',T*2(S[\Y.(Q&D)G+A9.&Y;A]<1"NK9#A0KE;[QU0:2C"&2IR\#P*4S+
M^))MD8%@C-"3FJ*W(M>S!<V1,"0\L*IX6'-ES9,IF(S*3&6U!\O*SB-R][XV
M83?>94&9U;>#C=>VC,EPI)0<XD!+$@9Q@9/*L?WHU N4CMVERMM(A1HB7CO9
M1#:.H61L\>1E50"2N\"V!SJWD]7.H9<RJ.#SK;-;.9V+D\=MD"SZ_F5!K6U)
M@WXQ)*UNZ5D.81$57",,KF9.;%1<"I#!.&\18=2GE'OI:DQE7 C?C[[RB2 Q
M<"(3,6CFC1L%&#9;=&Z0RE@:N>\MZ%F#1DRQ]B\*.%H;E9S=W#6T82:"9X\\
M563"ESO@HP4@T:ZSNFYX.T;1L"9Y%^Q1:HP*70MDMVQX^1K!&Y"8+5(<IZ+D
MXD[6!)$Q79B *H%BC15I"2I[RFVEO?:PW-_CG!D$04P7 E+M&TJ*(3%Q3OQH
MSQD)B0#M"Q(%#H.JA^'V,,B)IR_9-J81$DR6[MV0)^!]CFD1)5XF]$6S(JC)
M&6JYM[6]NB:[G5NUP"\3; .?8]>OQ69WB64,+A0B)&9'RY$;S#S"B$(BY,8G
MB%,:<<5&7'Q)9?9;R8[JWE$#1R!A<HSP$!OLBJ S$9 W< C(;=.>6,\JPI;*
MZA:Z66%D:RD6*Y!*_8I'9E53ACO;S*VZ4WE(&\#ND$X,W/U<@=.; +:U?I)^
MU6E-+U:>J X+/&QWKG:MO;.L.K*E28>22H\46]Z8 .$B9PA+3!A"''GDL//Q
M<,2,.[U1+6=K<PO++P;9XE1E!EDNKF2VBA&]@*=]-YG8X"$G!(P=C8:))?6J
M78N(H8>R+R*=I%<B"&RLX[R>X;<#,XX<@1(U4LTF!D Y%-*]4UY 1J]5SO3M
M;1V[;EL*30*9K9=MKRZU:$P*?)OI6YB]H^00&<IH6M0IN#,KT/Z=@G8^0?H!
MUUQN0JE]2F01Q/82K=RW!@B@,B<.3=B,[S+<8W#"D8.\=S?#@IN=1JI-'MY3
M+-'J<#6$%J+F>ZX,O%AWIQ;) ]H"9!/)*R\,;_#:-N)Q0 0,P ]UPH^NH5\V
MS5S^EI"K9"HI@!;&<D\C+.5M\6C@O-C !F</*UNR'2 O "UM>;B94(I#E3EC
M?\):CY:7:B 37,;VAXHA=)1O%9&E$*89 RM'(Y7<E':%6!)7GC!DL&-TUO93
M1WXX#7*20G<WHD@:XDWHY2K)+%&C\2$Y<,A50_+./R/61I%QJH*I]L'7)^W6
MNN5^-'AM6"$IF";V@[J.462M5<E8??AW"(0'C@[B8DFQ.07GACV1N?26,=M6
MLR(N%*LIEDC0 "085[GL4MGAG)$P954X+[I*G=[:LI="U &<3PM ((9I26,3
M9:*T%Z$.)1@- R,TG,1[P#C?[6L7 /",Z**/5B:=C7"D5.S4FVW%%FLU5LN$
MB<5'8S.NYL8T,$ RKXX0N2]@L_<)3[57$QL>8&2$ FE^*QCQZ]9,8RXEACDA
MEEXDD4G:<*X$#!U5&*ID[QE)$:CD[*V0,N79?44$JQF"XGBN(8##%-#V_&M3
M=*8W>1 [X&X(%!F<]M&K(0QV2VOU%:=TA)$P]FVY=>E&PQZQ#(T:MVRR/2 -
M6=$M60PMNK C:XPT'@X-DE9DO##$* \\2?6@?"G28V?<W]I9E!<2\,NCR*!'
M+(2D>[Q'^Q(^%3?4LQP%4EB=T$C56>EWVH!VM(!*(Y(XG)EAB DF$ABC!FDC
MWGDX3A%7)9@%';,H-D%>KO3:;##JE4LX^W'\;"U[03<>(DY#&AG]BR@S8:8B
MPJK\JOE'Y$(^+(C1T0EC):,^M;,QAF-+?CVFU2TWQ''(LC\>"!QVZJAG*;A#
MF,HQ*NK*H;M@>L $C(31+XQM--"T$?8MS<QEN&S2"U#F1>'Q5D4!HW5F*G<(
M&5)*@F>M+IB?$64\G:HYH+4XX:<5)R@%OA0Y(BP6R)11%BKC\RO,(N-5EVZ=
M# ^M=0R<KD>;)9Q**,-+PYQ[[Z=NR/V2H2((68I*%*R2B%)(R8P)8C*0G%BW
MXPQ&6%#H.K!XH^PW,DQD5$62%F5XH3<212A93P)E@5I.#-PY2H.$)&*I&]NK
M4%IT9I@H-KL6S1=WOD,5J;9[B&U (&PH517<VIE@*[$CC60;TX8G$:.,,MC2
M22CK(MZ,V0=3%Y1>ZFEJMHRQB07A;AF65+5%58N-F1IPNX67D%<*V\0I ;E5
MS3M%EOGOT:1HFT\+QEB@DO79FGX!6-+4N9 K\RT>^FYEPVZ,U9,[K2-*?,IJ
M^DIEQAT"NT$[M8D(VGKYH<"E;%",VNOUS7Y.9*:$;4.NT^5!LV/19(*(EP28
MN./+2Y\UN-BRVKOE^%:&80) ]RR7,&ZAN$$J1P,2%N7X163M612&4*Q)P+ZZ
M"F(^-?B!KF6YCLT>SNB\@M9##++<HJF2SC$P:+MTD<,CET55R4KK>B9W!?\
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MGJL(S_\ <G]K0[6;1CKU.8?/#;C],%1,[:V)C&<YM$O&,?3G.8P[LQC\>?\
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M5B&6,"<09 J!&>:BU27FHQW,P$UWPX+^PM-]EL#:*LR68D%PJQ]EM*[3.=^
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MBWF"+ EE;K*J8W%R7SVQ9V.02, <[EQHMG-;6ILEE66.PTN:;=0R/<2:C=M
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M(TN<4EV :-=FR<X:0B,VB##;B0(\6*Q\/Z]M#JFTNK3:QJUP9[J9L!1E8;>
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M^0FC7VO6)QO]K<->+Z26C[U4G*?HX=+*08D6U<<3BX=8F'%/(R88$<0CEO\
MVWRTCEU&([T4E[&W"$&]&\Z'@@Y$.5(/"!YB/[0'N5+(TOK1LM#/MZGHS9T>
M!15H!I%$ )+0:PV.R(;KD,BD5B9& MB<Y%H$,O('I'9S"3'Q&SEKD<.PW@_#
MM-]4X:ON0[RQ[N[PPV,A-WM=P'=W>6,<JDS:F4:,RWYC:0S-&9+C<:8MOF5E
MSNF0OVY<@MO=MG/.IQO4]$9.A+0SK2I-6:LBF0-;L3=-#-G:^#CL+BL!@A=(
MW! 2*9C+7&9'0)$>&VPM;*&4MJRG,[MD'20+:B2-0D<F(M^- ,!$;&\J@<@J
MD#'+%09-1,<D)>],,KF26(M/PY9"0Q>1,[KN2 2S L2 <YJ=@ZYJHQIJ.-HE
M?'L,@%U1EF#5QL1IFK+>7(76FFV(+:&P"WW''UAD)P.4\XMS,;*U*5FI>Q%Q
MN]CKA.$-WA#$><\,8_<9).Y]KDYQ5+&^<DN;MB9>,2QF8F8# E).<R@ #B?;
M8&,XJ&QKD!%LXRX1:TW%/A:E)HPB7%A*BI&U280%E)06)'CMM,(A.30@AU#*
MFU(BX'M(A)C(=E)D0.Q1(LH:(.D1A4AU&[$65B@ (&,HA QRW>UQDY$WK1/"
MRSM'),+AU9'._,JN@D8D$EMV1P3GMMXELD#'=.N*FA+244.O(2PW966$IJXU
M*66;I*3.N+36,0<8;;MDU")EE;1C"3LI"9!3$IU.%XG%IR&+; $@ ^Q<A*<R
M@?)*><GW9YMDTWK_ *\W>28B3F;KMQNP'YX5[6(_\V.2;HJ0!ZDH-8AC!U;U
ME3Z\/"R"DL-!!TL*)AB91R(J :DC(L ;'8@2#$%:X91Z*AIPA$6J/+4\RK*,
MTHEE&%6-;5%0L45%B4*7&ZY4* %+CDQ&-X<CD55))J,S.\TE[*\@0.TCSNSB
M,[T8=F)+"-N: DA3S7!JL9HH!0H*!S3@^0=;>#2:Z&S7H610"175LN5]\*.S
M#\S%/ G(\=89V"RPL8MAE4)3"FD937FUW43-ON1E#&GV/=0QX,91>I2A *%0
M-W QC%48O=^23%UQ)1()9/LN_*)<\42-]LXDR>(&)#Y.]G-4P3JJC@;*:N@+
M6]4"W&R)6BQ6P33Q ZRGD..(><0:.PQS)0HE;K;;JTSI3^%.(0M6,J2G.*%6
MR21YD6U2:3[>51$LC_\ 7< ,WXR:J=]0EBCMY'O)((OV*%VG>*/EC['&Q*)R
M)':J.7*N:CJRD:_R650]<U6DJ/2TSSF:C4!%;R9G)\IXLPMD,.A9(RT^6=\6
M1,\L]CRKG8O[]7;,2V<&]P5MH=\[S\(11[[=]MS&\?E.32=]0N=SLE[RXX:[
ML?':>7AKR[5.(6W5Y#DN!R'*KS\RF?DDG_<._J<N\:+XV/Z:^FK' G^)E\F_
MHIYE,_))/^X=_4XXT7QL?TU]-.!/\3+Y-_13S*9^22?]P[^IQQHOC8_IKZ:<
M"?XF7R;^BGF4S\DD_P"X=_4XXT7QL?TU]-.!/\3+Y-_13S*9^22?]P[^IQQH
MOC8_IKZ:<"?XF7R;^BGF4S\DD_[AW]3CC1?&Q_37TTX$_P 3+Y-_13S*9^22
M?]P[^IQQHOC8_IKZ:<"?XF7R;^BMN>GX40@ #,N;$?BLD"+"H>9#:VE/MQX^
M4N/-H7A*E,Y6YXB',8\1:T.83G/B9YYKMI<P37MK'%*DC00.)0C!@C.^55B"
M0&P,E>L J3UBO7/<_M+FWT^\EGA>)+BY0P\12AD6./=9U5@"4WFW0V,,RL >
MU-9E(URO&'D2"X$,4D-M89;?(BX,YY#*5K<PRAV2PZM+6%N.+PVE6$86M:L8
M[5*SGDX[FXA4K#/-$I.\5CE=%+8 R0K $X &>O  [E=\54]:@_. ?TU3_4:D
M]SZM^CXGX3ESLZ]\,NO.)?7J-Q/N5^B/13U&I/<^K?H^)^$X[.O?#+KSB7UZ
M;B?<K]$>BGJ-2>Y]6_1\3\)QV=>^&77G$OKTW$^Y7Z(]%/4:D]SZM^CXGX3C
MLZ]\,NO.)?7IN)]ROT1Z*>HU)[GU;]'Q/PG'9U[X9=><2^O3<3[E?HCT4]1J
M3W/JWZ/B?A..SKWPRZ\XE]>FXGW*_1'HIZC4GN?5OT?$_"<=G7OAEUYQ+Z]-
MQ/N5^B/13U&I/<^K?H^)^$X[.O?#+KSB7UZ;B?<K]$>BGJ-2>Y]6_1\3\)QV
M=>^&77G$OKTW$^Y7Z(]%/4:D]SZM^CXGX3CLZ]\,NO.)?7IN)]ROT1Z*>HU)
M[GU;]'Q/PG'9U[X9=><2^O3<3[E?HCT5\W74C4B=@ZK=FT^F@G9Y0G?I P(!
M#1$X6\^ZW'PU'BQ6$H::;3]\MQ78VPPTEQYY;;3:UI^CMG+N*WV5TR\O)Q'%
M%8++//,YP "Q+,S$DD]0'-F)  )(%<W<H6NY41<DR855'62!W/SD]0YDU[+=
M(72$"Z>P2+#840S>US</""Y="4OQ*Y$?2E;E>KSBT]N&\9[$E"B<(>)O(\1'
MDX+;32O&]KMKI]H9S! 7@TJ!R882=UKAEY"XN .LGKCC.1$#W7)-;BSLUMUW
MFPTS#F>L*#^Y7^L]WYJW**#VBHV>+?=DL,$8<F"^[#?7%EMLRV5L.KC26_VR
M.^E#BLM/MYPXROQ7&U)6E*L<8#@@\N1!Y\QR[X[U;:TN'L[JWNXUB>2UGBN(
MTFC$L+/#(LB"6)NUDC+*-^-LJZY5@5)!UG^XXT?^:#GZ1$/UN9?9UQ]TOT!7
MJ/PU[>>&V'\6VWHI]QQH_P#-!S](B'ZW'9UQ]TOT!3X:]O/#;#^+;;T4^XXT
M?^:#GZ1$/UN.SKC[I?H"GPU[>>&V'\6VWHK)8[2E*%:^)ZQA9.-5(L^Z]*B9
M-RU24(D.QWY46--SGSB-"E.Q\+DQ6E):>R_+PK&4RG\+M&XD,HF.[O@#!W1C
MED D=1(!P">\.\*Y>YVYUV[VCM=JI^P'UBSC1(INP81$3&DL<4TL '#EGB24
MK%*X+)PX2I!AC*XT^XXT?^:#GZ1$/UN7>SKC[I?H"NH^&O;SPVP_BVV]%/N.
M-'_F@Y^D1#];CLZX^Z7Z I\->WGAMA_%MMZ*U\ZLNGO6NH^F'J VC2X!.);M
M>Z?V#<:U*FEI9"''.5ZLDB@QZ3!D*RQ+8;EQFE.QW<9;>1C*%X\56>=)L;&N
MM;6;-Z1? O9:EK>FV-TD9X;M;W-W%#*J2+VR,4<@,O-3S'.N<VP]WWW1]'V4
MVCU:QO\ 3DO=-T34KZU=]*M9$6XM;26:)FC92KJ'125888<CR-?"+>[H9V+;
M3EVL*!Z3EBEXGE5BX+(V&_-RRTT]*3#C]C+3\M37G$M:,8\XEN/25XRZZM6?
MTDT72+30=+L](L#.;.QC,-L+B9[B5(M]G6,RR9=DC#<.($GAQ*D:X5% _)#;
M/:[5MN]I]8VNUU;$:SKMR+W4WTZRBT^UGO#%''-<BT@ ACFN6CX]TZ <>YDF
MN'S+*[&TN;2N8K.735MJ/HK>FM]LRT'W(M*..$I**NNMH.Y8D#9PUWS%%N V
M6N2NQ$U69, H(<:)0\2(#4X/)DL&(&@VIT9MH-G]4T9#;![^W$2F[%T;?>66
M.4<0V5S:W29,>$DAF!B?=D:.=$:"3?[+:PNS^T&EZRXN"EA<&5A:&U%QNM%)
M$>&+VWNK5\"3+1S0D2IO1K) [+/'Z=X\)CI]5OS/C4C>%0"!+GT^[+&%-=WN
M/7CUYL6BA%K%9I%M#&2MI'5+4UE:LD?S&H58X5$T]\7(GCPY%PY(BP?)S[E6
MM]A")[_0+VXGL=I=*FBU/3FNK>PMMH9K2;L^SG@ALY;W6+5K5N)>WEO#-?+*
MD<L\0MU>3U4>ZGHO9O$6QU^RM[>^V;U2&73-06VN+^YV?@NX>P+V&>:[CL]'
MNA=+P[.TGFALGB>2."4W#)':=9\)M4J](I)G.GI,@E5F=#/2 +,X9$K"YFI^
MJG<O4*6AB<9:??'CY(G9\&O5AY<-]T64#9GR(KD9++2\R[]RF\N5U" :VBQ7
MAVB5;AHY9+L)K.R&B;-0O-VRK+*DVDR7-VH=1-%/PU<-O$8EK[JMG;-83^\K
MM+:#9YFMUDB2TW]'VMUS:.9(>3-'&T.K1VUJQ0F*:#B,A0*#@3>O5Y4KP7Z8
M'Z2K=!UGITL]OL*[+N*V#"]ZM&++LR%L2-'25$>70,P-PT^(9\9V9XOBMS6U
MXP\J''Z/9[8N\T^':P7XT*W;:>ULK86FB64L.G6G8NDOIC-P9]TR\7*S,,)G
M)C.=T.W/;0;:6=_-LFUA[^7"[,W=[<FZUN\BFU"[[*U6/4E3C0[PB$05H!DO
MW'&-XHNP)KPA&CS4ZZ6"71=QR[&JQ]<1+7JY!NH^CFQO6CKV'6YK-Q2XF5.6
M[KTM%5"#Q LE$>> <C2G9,:5!P)E<W![FVOP1V%LFH:(EJ+78"+4@EO>\4R[
M"ZD]U&UC@I&%U.%P\[W"EHKD.BJZ2<9.BG]T?0)Y+ZY?3];>Z[*V^FTTM/9<
M(1[<Z8EI(M\#OR,=-F0QPK;NJR6Q1V97CX+U+'A4(WK5DFH-M)595MZ->UUK
M-N:S"74FNEU6AW:BJ%F;F IAVR*]:,P\M9&9A_0IK)#Z>6C[D+=B<(3Z2+L:
M*^GB[%D>(+UMK1M"+T/N<0,+7_0^)O<;?ZCP^57?A<7LL2\'5NQ??E-0-KV:
M.&;-=D^CQL^'Q.'NM=$W>YCA;AYCB<ZXJ7A-=?5F5KRPN47:9,K".=(4BW4B
M;:PC^K*.-Z4H(L?Y[I (J.B2'-;$;#H=GMDTP8X)!JRQ//#J2F)+"\]RG4KI
M=3MAJ&D0PR6^VJ65_'9SKJ^H2[8O+)N:_/OE)X-,,Q$1B,C7/ M'W+8P[C19
M^ZIIMJ^F7)T_5Y9H[C8MKVPDO('TFPAV02&/?T& J&@GU,0!I!+PUMQ/=)OW
M'%#KB<3U]AIW2_LC3^RX6U-A;"N,+9\,?9"]HA(C1IVQ"P4E'-/W,2Z#OT@8
M+R&AK.Z]M[FQJU;Y(X?A$RM#DX'1]Q-[G,\>UFEZUI4FCZ9IEC)I+R6L-I(7
M:/3(;B)H%L9A<:<LLW'<6^I60TRZLDDDREW*>(VHA]T6&3934]%U1-7U+4KV
M/5XX[J:[C"I)J<UO*L[7T)M]1:*+@)V1IMZVIVMXT<8#6L8$:^7_ #UFO**<
M4KT)\%56 -UZ^= 5*TC63%<L<O8@<V*D+>;8(#9VH[\Q+B.KCNLOI;?96I"E
M-.MN8QGM2M.?IYYO[KM[=:;[GFT5_93-;WEFNEW%M.H5FBFBUK3FCD4.K(2K
M $!E(SU@UZ+[D]A::I[H&S^G7\"W-E>G4[:ZMW+!)H)=&U%)(V*,K@,I()5E
M/>(K[1?N NCW_096?>-G^>\^'_A3]T#[YKSR-E]5K[2^"#W-OO3L/+7WUNGW
M 71[_H,K/O&S_/>/A3]T#[YKSR-E]5I\$'N;?>G8>6OOK=/N NCW_096?>-G
M^>\?"G[H'WS7GD;+ZK3X(/<V^].P\M??6Z?<!='O^@RL^\;/\]X^%/W0/OFO
M/(V7U6GP0>YM]Z=AY:^^MT^X"Z/?]!E9]XV?Y[Q\*?N@??->>1LOJM/@@]S;
M[T[#RU]];K27P@_2;T[ZEZ:+%=-=:N"5:T0['48<8Q!F''I#48@99C3&4MSB
MLJ/E+["E-JRIE2L8SVHRE7T\](]RG;K:W7ML;33M7UJXOK*2SOY'MY([559X
MK<O&Q,4$;Y5AD88#O@BO+/=D]SS8S9W8:]U/1= M-/OX[W3HDN8I+IG6.:Y5
M)5 EGD3#J2IRN<=1%>3?2QTL7SJEOC=;K;;@FJB7(TF[7:3&6Z,K8UU>?%::
MQVMH('B"&W6PX=MU#DEQ#DF2Y%'19DR/[IMOMOI>Q.EF\O")[Z<.FFZ:CA9K
MR90,DG!,5K$2IN+@J0@(1 \SQQO\\>Y_[G^K[?ZN+*R!M]/MRCZKJKH6@LH&
M)PJC*B:[F"LMM;!@7(9W,<$<LJ?5CI[3U#T70P^N]=AVQ($2WX[KJ_$=)F23
MJ$)FG#DU*&UD"Y!;:52)"DH;;;0S#ALQ8$6+%8^'=H-H-4VFU2XU;5K@SW4Y
MPJC*PV\*DF.VMHR2(H(@2$0$DDM)(SRO)(WZ"[-;-:1LGI%MHNBVPM[.W&68
MX:>YG8 2W=W* IFN9B 7<@  +'&L<,<<:9/YI:WU>?+.MRJSVVM=T^3'#;,T
MQL/.]] DY7[3#S7MM-3BQNF2DX4AQ5/.VN'?*B?8:7AB-'EBI_D_.1\/&;A/
M4>XR[K=?6.6?GQNMW>=48ZP.M3D?CYX^;\=;@ZJV0*VK2AEN&1Y R0ZY*%V&
MO$,>(6JEJ$/J@V*KF6<X0M@D%)M/17?';0F2SAB<QA464PXN@C!Q^0]\'J/X
MQ50.1G\H[QJ+,VIK^#)>B2;+#P_'<4TZEEB=*;2XC.4J3A^+%>87E*L9QG+;
MBL8SC..WMQGFYBV>UF:-)4L)2CJ&4L\49*GF"4DD5QD<QE1RYUH)MJ=GX)7A
MDU.$21L4<(D\JAE."-^*)T.""#NL>=2WM>USWF8^HEO@.5]&=<\ ?RUO[:K?
M2_9SQG'Y"Z]A3VO:Y[S,?42WP''1G7/ '\M;^VITOV<\9Q^0NO84]KVN>\S'
MU$M\!QT9USP!_+6_MJ=+]G/&<?D+KV%/:]KGO,Q]1+? <=&=<\ ?RUO[:G2_
M9SQG'Y"Z]A3VO:Y[S,?42WP''1G7/ '\M;^VITOV<\9Q^0NO84]KVN>\S'U$
MM\!QT9USP!_+6_MJ=+]G/&<?D+KV%/:]KGO,Q]1+? <=&=<\ ?RUO[:G2_9S
MQG'Y"Z]A3VO:Y[S,?42WP''1G7/ '\M;^VITOV<\9Q^0NO84]KVN>\S'U$M\
M!QT9USP!_+6_MJ=+]G/&<?D+KV%/:]KGO,Q]1+? <=&=<\ ?RUO[:G2_9SQG
M'Y"Z]A3VO:Y[S,?42WP''1G7/ '\M;^VITOV<\9Q^0NO84]KVN>\S'U$M\!Q
MT9USP!_+6_MJ=+]G/&<?D+KV%/:]KGO,Q]1+? <=&=<\ ?RUO[:G2_9SQG'Y
M"Z]A3VO:Y[S,?42WP''1G7/ '\M;^VITOV<\9Q^0NO84]KVN>\S'U$M\!QT9
MUSP!_+6_MJ=+]G/&<?D+KV%/:]KGO,Q]1+? <=&=<\ ?RUO[:G2_9SQG'Y"Z
M]A3VO:Y[S,?42WP''1G7/ '\M;^VITOV<\9Q^0NO84]KVN>\S'U$M\!QT9US
MP!_+6_MJ=+]G/&<?D+KV%/:]KGO,Q]1+? <=&=<\ ?RUO[:G2_9SQG'Y"Z]A
M3VO:Y[S,?42WP''1G7/ '\M;^VITOV<\9Q^0NO84]KVN>\S'U$M\!QT9USP!
M_+6_MJ=+]G/&<?D+KV%/:]KGO,Q]1+? <=&=<\ ?RUO[:G2_9SQG'Y"Z]A3V
MO:Y[S,?42WP''1G7/ '\M;^VITOV<\9Q^0NO84]KVN>\S'U$M\!QT9USP!_+
M6_MJ=+]G/&<?D+KV%/:]KGO,Q]1+? <=&=<\ ?RUO[:G2_9SQG'Y"Z]A3VO:
MY[S,?42WP''1G7/ '\M;^VITOV<\9Q^0NO84]KVN>\S'U$M\!QT9USP!_+6_
MMJ=+]G/&<?D+KV%/:]KGO,Q]1+? <=&=<\ ?RUO[:G2_9SQG'Y"Z]A5Z!C@F
MPPD$0L]@A"6M3>'F%9^]=1V96TZVM*'674X4E66G4(<PE:%>+XJTYSJKJTN;
M*4P74+P2@!MQP.:MG#*02K*<$;RDC((SD$#=6=]::A"+BRN([B$DKOQG.&&,
MJRD!D8 @E756P0<8()JO,>LJG%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4K FONGJ
ME479.Q-N9:28OFP#DZ>HO+81CU>#R?)H;"!49RYY##R&DN$Y^%8D3G,X9_:H
MC2&5;[4-H+V^TW3M)SP;'3X$C$*,?](F7),TQY;V"<1I]J@[;FQR+$=ND<DD
MN,R2,26/[E>XJ][JR3UD_( *SWS0U?IQ2G%*<4IQ2G%*<4IQ2L9[IUM"W+I[
M:FHR4K,&#L[7=SH,F>E'E5CVK=72(')!MO"DY6[!S.Q+:3XR?&<93CMQ^'FU
MT+5)-#UO2-:B022:3J=CJ21DX$ILKF*XX1.#@2</<)P<!CRK5:[I<>MZ+J^C
M2N8X]5TR^TYY -XQ"]MI;?B <LF/B;X'=*@5^<1N/3^P="[*MFIMHUZ76KK3
M2L@66'RFW$M/8;5G,4H+D+0A!((7BY:(ABL;"HI(=(CRXZU-NXY^GVAZWINT
M6EV>LZ1<I=V%]"LL,J$$J2.WAE4$F*>%\Q3POAXI59& (K\R=;T74MGM4O-'
MU:V>UOK&9HIHW! 8 ]I-$Q $L$R8E@F7*2Q,KJ2#6,N;6M53BE.*4XI3BE.*
M4XI3BE.*4XI3BE>\?@'>E:Z; ZFHG4Q/$38&L-)#K*P//2F'&H-DV%:*X0JT
M6OBW'$H1/4$"'RAXP]&6ZD5(: QY:4++QNWYY_X0VU]AINRC[*QS1R:MK\MH
MTENK R6NFVEU'>/<R@9,?'N+:&V@5P#,K7#H3P&KZ#_X/FR-]J.U2;4R0R1Z
M5H,5TL5PZD1W6I7=K)9I;0L<"0P07$MQ.R%N"PMU< S)7V6\^':^W:<4IQ2G
M%*<4K63JWT44ZCM0N:J&%XH'!BVU*<4,RFUOX'!!!9N>5D18B.S,PAF*TIH?
M$4XPR]+<93(DQH_E7V^SV#VG@V0U\:Y/;R778]A?Q06\9"\:YN(#% KR']CB
MWR#+( [+&&*([[JGA/=%V3GVVV<.S\%S'9BYU'3IKBZD4OP;6VN!-</'&,<6
M;AJ5AC+(K2,H=T3><9,T]IZAZ+H8?7>NP[8D");\=UU?B.DS))U"$S3AR:E#
M:R!<@MM*I$A24-MMH9APV8L"+%BL:;:#:#5-IM4N-6U:X,]U.<*HRL-O"I)C
MMK:,DB*"($A$!))+22,\KR2-O=FMFM(V3TBVT71;86]G;C+,<-/<SL );N[E
M 4S7,Q +N0  %CC6.&..-,G\TM;ZG%*UEVM_R'W9H_:+?[4.L<PKHBY.8^GQ
MXEUP@Y0)+V,]B4I@WD$V(9<SG"D*MKR$YSY;*%U#F&'/EVP_%UY_%S_%5)Y$
M'O\ (_I']M8QWE83'39L2/M.I58U8:3MYZ)7]N"!D>6V'K%BBN#A@':SI"/#
MFQQ,IP5(>"GV'VXD<^@>'=7*:G1,OKNP /+$IQRD3K[HWAE>]^6K5P2D,S#/
M[%(3CE@A3@C'//S=WY:Q/SWFOF:G%*<4IQ2G%*<4IQ2G%*<4IQ2O-/7_ (1L
M/=]=3-E>S. D>\.K+-7JM9W)KNY[#.W6\W(+1Z32RE*'O0RM.D'"YC*WBUDQ
M%A#8L*0X\VZXMII7/P:\D\!N.QUP5C$44=W!-.\T\JPPPM"I#0EW;FTF H!)
MSR%=5<[+R6]TMKV6V\&E,TTMC=06L<%O!)<7$Z7#!DG$<<?)(LL[, "!DB\;
MGUMEM<54N1OVG8M>M8;:%#UG($9W#19%-4]L",9='F7MC.M0X(:,$E 2 ^T1
M;*%!N")+:7</2H:L2>7I=7:WB=IK41RQW$%N5[*A,7V<-NN9^00(482B1$W,
M9R1SJS!H"74T:6U\989+.YNUD%C<"?\ T9D#QBUR6<R+(K0M$\G$!Q@-RJVK
M1X0)RK^BVW]7U2<[*U09V_-DPNH?5ZP"JV'MM@JRX=8M"O% 7(W(6 >E('"9
MR'&GG5#GLHD17EXM2ZYPMS-M&V];/=$K?6VYPTE>,B.3[25SN9"HV<G=/,&K
ML.S0FWL7<RXO8[%5;3+P2<62&*8-+#^R01@2 %G7F!OC((K,@7JTC%=@:TJL
MS4>R:S5]M/C1%*O-H8"A\$[+/U5C;\B"W3WR6;4\""UW#X,Y<(D&4#&76)+K
MTAQ*&%$,Y:ZH&GMXFM;B..Z*I#-($3>D-MV41PBPDX:1Y1Y0"JS!HSU;U8,F
MBLEM=3+>VLLUD'>XMX2\FY$MYV$&,X7@B1Y<21P,PD>!ED',A*RG9.H;3]1O
MXS6-AMKD"X%W14:)%Q7+7,#-SST<G+ B2-N@ I50#FSL8,3?"@RYV"7+-1'%
MCX4C"FO*9,E]:Q3K;O*1*^Z .'*4WG#,BM*J&)'<(Q1&=78#M0<C.'%IE]/;
M/=Q0AH$#EF,L*N5C*+(Z0M(L\D<;.HDD2-HT)PS @XQO7>N/I>M90 '![+>D
MS;1,I\$&J10]DC($QS8+N(U)DK+%:?"%0Q=HGYR("F9TV,(FG$.@FIN2[+L)
M&/'K&G2-&J7&3(8E3,-PH/'.(3O-$%"R-VB.Q"%P4WM\%:RI=GM7A2622T 6
M%9VDQ<6KLHMN=P-Q)V=GA7MY(U4NL>)"O#(8T.P]=NA(U5M1^E6"1?"=7&#3
M?J^R&L]66<"R[^#UP3)UXQ:*Z/$GHM=L9R/!/J!OD\B9V$#B.(<J0TG-$FM6
M2Q2R0R&=HE5^&%DCWT,Z0,T;R1JD@C=P)-PMN-VK;I(JY'L[J)FACN(A;)*S
MQ\0O#-PY!;272)+'#*SQF6*,M'Q F^O;KO 58MP\(!5:L96":I$\K(A NI.T
M'"S<\\S500/IVL1BJ3'"%B9H\Z,B?8#HGS*9#PSABK*E0VY4XG*,5>+8[$NN
M1QMN<!F(CU"5V!?AHEA(\1WI!"1F1TP1C$1(!+%XQ)DP;-331\0W"HK2:5#&
MA6,S2R:I%',H2(W"DK%&^\&SF8*Q"H$F,6=WNKCIYAEK4#)[)&BR%)%68M97
MR JRQ $5%)BPYET@"[9*",5BRFZDT0B8L->K98J?$N/)9GBX[^%M)S??2Q#2
M(UPJM"DCR;RR!!P0#,JRE!'(\6\!(D;,ZDX90>5:T:+J;)#(EJ[K</"D(5XF
MD;L@LMNSPB0S11SE6X4LJ)&X!*N1SJ?TEU$U'?)O:0^F03#8K6AVK@_3!D89
MK\HXY9:6&N&7LUJR" EB J'>E\BW8IB S(?<BYFLI\UD,9S7:7T5Z]RL2N%M
MWC3>=70OQ(4ESPY$21-W?W2'4$XWAR(J-0TN?3H[-YV0O=QS2;D;QRB,13O!
MCBQ2212;^YO@HQ !W3S!K8'F;6LIQ2G%*<4IQ2G%*<4IQ2G%*VRZ<U9]#V5/
M;GQ<$H2L)[?HQE45S"LXQ^#&<X2G&<_PX3C\6.><;< =E6!QSX$HSW<"08'X
MLG'SFO6?<Y)[#U(9.!=0D#N F(Y..^<#/?P.]6QW.&KT>G%*<4IQ2G%*<4IQ
M2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2M=]]=)G3AU/0X4/>^H*
MCL18QI<<66)QI0^S"HKBU.NPQ=M!2A5H&PG759>>A02[$5Y[L><94XE*L=-L
M[MEM1LG)))L]K5[I@E(:6&)DEM)G  #S65PDUI+( -U9)(&=5[4, 2*YK:'8
M_9C:M(TV@T6RU,Q K%-*C1W4*$DE(KRW>&[B0D[S)',J%NV*D@&M0<^!@\&Q
MG.?_ -.:L?\ RQMS>79_ZE\[3X<_=2^^?_R;9_\ W57%_ =[E_WM'^.=>_WI
M3]A?\&Q_%S5_2YO+_B5Q\.?NI??/_P"3;/\ ^ZJ? =[E_P![1_CG7O\ >=/V
M%_P;'\7-7]+F\O\ B5Q\.?NI??/_ .3;/_[JI\!WN7_>T?XYU[_>=/V%_P &
MQ_%S5_2YO+_B5Q\.?NI??/\ ^3;/_P"ZJ? =[E_WM'^.=>_WG3]A?\&Q_%S5
M_2YO+_B5Q\.?NI??/_Y-L_\ [JI\!WN7_>T?XYU[_>=/V%_P;'\7-7]+F\O^
M)7'PY^ZE]\__ )-L_P#[JI\!WN7_ 'M'^.=>_P!YT_87_!L?Q<U?TN;R_P")
M7'PY^ZE]\_\ Y-L__NJGP'>Y?][1_CG7O]YT_87_  ;'\7-7]+F\O^)7'PY^
MZE]\_P#Y-L__ +JI\!WN7_>T?XYU[_>=/V%_P;'\7-7]+F\O^)7'PY^ZE]\_
M_DVS_P#NJGP'>Y?][1_CG7O]YT_87_!L?Q<U?TN;R_XE<?#G[J7WS_\ DVS_
M /NJGP'>Y?\ >T?XYU[_ 'G53$>!T\' $(1B<7IL'29$1Q+K31?8VWSH]2T9
M[<8DBC.P)PN:WG\"F)L.0PO'T+;5CZ.6IO=M]U">-XGVIE57!!,.F:);R $8
M[2:#38Y8SWF1U8'F"#5V#W%/<QMY%E39>-V0@J)]3UFXCR#GMH9M1DBD'?61
M&4CD1BO1*J5*K42NB:C2:V"J-5 Q$00E;K0J"#!B8:,J4F*.%#6(T*&QA:UK
MRW'8;3EQ:UJQE:U*SYG>7MYJ%S->W]U<7MY<.9+BZNYI+BXF<@ O+-*SR2-@
M 99B< #J KTNTL[33[:&SL;:WL[2W01P6MK#'!;PH,D)%#$JQHN23A5 R2>L
MFKAYC5DTXI3BE.*4XI3BE.*4XI3BE8DWO196Q]27BJ"UY9/R0ZB=4E(SA+D.
MY5V0Q8:A,;7GZ6U1K&+&.J6GLSY/"T]O8K.,R#@C\_S'D:@C(/YOG',5/Z\O
M$/:&IJO?(K:4-6ZG1"TB'V9SYC/E#NPJ*=0OMSAX823,&R&U=N4O1G$9SGL[
M<W81B>(=Z6/GU?NQSJU,<P2_+%)_Z#RK0OGO5?,M.*4XI3BE.*4XI3BE.*4X
MI3BE:D#NC75PSIX!=/4.48A0JU$K.0NQ1;(,9L2!8:98HMLJEL;*QQ&8+IH*
M?@PYK290Z1 D(:7$EQ'HTA]M>K72;9;%+$%P(Q%N7";B7 >%Q)%+OA,%T=01
ME2IQ@@@D5NFUV\;4Y-381LTK3<2U<R/:M%/$89H2ADWA')&Q4[KA@2&# @$6
M()Z"Z>FSE;M<=AVF\6NR[$T]LRV39E9UQ71-@/Z:(7R:&;?KE5J(<4B)8&[Y
M,;M+CK4HF4DPVR"B*)$J5X]E=%BXCS2SR322SVL\I,=O&KO:/,R@QQ1(F).,
M1)D%F(WM[)-9#[1S\%+>"UAMX8K:^M85$UU*\4=^ENKD2S3N^]%V.IA *H@8
MKN8 K*.Q.DC4VS;+8[%8A41:#VD2NCXP9(*N/B:X)+&#!MVSUV/,$R<C;1'E
MFI/FTMK.(Z/$;<S'4[E:U9,^EVMQ)(\BC#V;V83<C*QH[LYDC!0[L@+'!'(=
M[-8=MK5[:1111.PX=^FH%^)*'E=(TC$4I5QOPE8QE3SYD9Q5B@^BH2.V#BZG
MMJW&]BI.NPVJ"]%O%9UI9J\1UZ-IS%1(U2+/,TV=:*Z&MBF7#UPAUDZ)393,
MEYTRJ:QAMENPFD*L_&>YEF4P):O#-%;R1M L0B:(,T1EC67&_*(W42.26R.5
M94FON]L;>.S@MG%U)>I<6\UW#*ER\YG29ECG6&62'(C@,L3\&, 1A3DFGF.@
M35,S9%;O@,L4J(FGEZ(9J="!@:9BN55RC((M)$525+KT@[5JQ8?2DLC8J_7B
M8V(4L"_3<Q4AW"6$P^BVS7$<Z,T20M"\4"1P\.(P[PW8BT9>*-]XM)'&R!G[
M9L]551[27JVLMM(B3//'<QS7,DD_%F%QN]O.%E$<TL6X%BEE1V2/M%P.=5$-
MT-:^""*V'CVZY.L5JJ]+U3B.O*">5D0^E:^$K_3Y,CQ!2$>=6(D3=A67R26V
MLP6V_1;<"1XSRJDT:!$C02RD1QZ=$#VF2--G:>(GM>N1F*R<L;H&Z%/.J'VA
MN7>60P0 S3:O.P'$P&UBV2VG [?.[$B!HLG.\3OEARK$NN_!^/2M=!P6Y=EV
M<J:$U2Q5"O!@6:QFNT$78]P ]J&<@"&*H/,'))R53JM%<>LSI!0B"DB/']J7
M&)+.+!H>;=8[JXD9EBDB1$X>Y LETER_#;A*SEVBC!,F\5&\J]PUFW>TH%U)
M)8VD21R3QSRO)Q>+<O%926<?%7C/'&(Q/,<0A=]MQFY@@Y6,="NO#(VX#'[?
M<VFKE4NI>GSG&E _*1874_L47LBVRHGCB5)Q*KY44S KOEDNLX'N.X)MSI/B
M/IR7T:!UD0RR@2Q:C$2-S(749UN)2.UZXV4+'G(W<[P8\ZPTVAND:!A! 3;S
MZ3.@/$YMI%J]K &[?[65'+2XP=X#<*CE5KS_  <>F2AK9T^:5+J&[+:V')>A
ML5G6S-@KUBV?V/66P"-A9I3M]6J//7,( @\T^^%@+(S(,R$4$XB#XEMM M&:
MX)9L7'') CMP\<EQSD=)^#Q^399$:0HN\RD,N%%Y=J;]([-%1-ZT[%4,9KHQ
M2Q69^PQR6HG%MS7=2218Q(P565D?>8[(Z;TF[JDMLBREMA6G95MVF9KAVU6"
MSP*N*<5-K-3%4X>T/&U((!%0H:10>&GR*8BW<N(RXZ^^\MUYS/M+,VS7$C3R
M7$MR\;RR2+&I+1Q)"-U8D10-U%Y8)SUDUJK_ % 7J6L*6L-I#9QRQPQ0M,XW
M9IGG8L\\DKLV^[<]['/  & ,Z\S:UU.*4XI3BE.*4XI3BE.*4XI6V/3GC/HB
MRY[/H](P<=O\';B,[VX_F[<=O\N.><;<?MFP_P"PE_VBUZS[G/[3U+_O,/\
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M@0<8K]:Z5+S.4-ESFGR\X[5!H_MQ**S!+'=]/R>FE>A&O;E"V+K^C["&Q)4
M=>J=6KD/@SLM9FPX5G"PC<6),S'<=8S*CL3FV9&6'7&LNH7Y-Q:/%5F*5XS5
MOPA/6 ?U!H;8?LOJ"3?4'*\I4 (_0FX3ZW(4;3MQV@MBOCJSMDZ;ND,K.#!
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@XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*5_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>g904779g78h69.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g78h69.jpg
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MD+T($LVVFJ& 3Q1P5I8IY))$50DB>K'CJ&-DOF41!8/:C@E246JY@D6S(T,
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M%C1E1]HK67A614#'JV')+RF3I\B1["\=;T;;'8CV".$"*?<O,)-*Q=@66_+
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MU<O7)FND[G$(=PJI=GCI6T%0TE$]5&6-RD'W#'VDD D0AP#K91[K;B@KP)T
M*C]2M*:\33P.9Q8)CF96909!EAZ,N4(*DC5S'>D-W&#LMWL-:U[TX5>)LJGY
MI^P*> T+18-)N+*+J'V)"-V&O9ANM$S@NY@1)D8J2\L1$Q$\K2(4%D2QK^-O
M"U"2&O%+:W69JDXL59Y=RL-8@/EWJM'%+R!2.2O(\;X D;ESZG4"N+ANUA9)
M72&F@GC,<T258A%(.JLP9X\89EE167/L+CB%X$J<[A^EDZOHI&S&Y)+5ANPV
M&_[8V/ LUBU!13UDHIW>H9D#MZ)K8X3%R"5&"WX=%B-GAX*1&\7+"L1WH[<P
MBW-CGP3L96&,)<CBBK4JC117K$<5F/;I#+1:W&CA+$E9F;IO(#C/M E4*Y1O
MVX NW*!G>:Q.LCUX7DB>VO"R('92T2S* '5",X[$9;EKMH3J[VGT]UB[4&OB
M=97_ %GL(G7C]IUANC6E5VK0IEIJ29[=:MT,%:8,KRBRB(Q4G!03$R82YPZ:
M\/+((0T,,,[7<MCI[I-7LRO<JVZJ2Q0W*%N:G96&8J98&DA8<X7*(Q1PW%E#
M(5;),2IN$]1)8D6&6"8H\D%F&.>$R1\@D@20'BZAF 92,@X;D  -QZAZ6[=M
M9H.PIY,74;YU$7CJ@UWU!Q-D["UWKVW52GHUMJTY0*@S2*62!Y&TJST:8[59
M.ORM8B#HE:"U]0%F.L9+DPI.@G\$;?-:JJCSUMKK[/:VQJE6U:@GG-JY':G-
MBPDG.Q#943+:29G:627J$AU5EV,>_P!F.*8LD4MR6]#<$\T,,B1]"!HH^E$R
M<8I(CTS"T84(J< .)(.NM<](5U(5RITRK-$J47>H*]\HK%Q/T0 4O\(9U*@+
MP"V\ =M[L=!26"LKVQ;39,CI+CB(UIEQ"Z%J4,'LQ]K-X7VJ::Q,5L(+0VWK
M5XK,B5F?:9*\E&409*K+$*L,7,8S"K(?NV)AINUQ(XHPT;='S8CD:)&F"W4E
M2PAD(Y%'ZTCX/I(0WWH M!+KQZB"K5E9F&ZXI%M@]+P\SW*L,;R[&Z/Q; C2
MF&<I3_6ZQ<..W@ZMOVV!WO+G?'V8R)X;VM#"5CE^T-O#1YF8X.^N9-PS\>;$
M]//\T.RZM.Z7") 73$@HAOM:^FW($JX[=N('M_AGUU)H3THW5*&L1.RO.:LL
M4LPGJ5:(P;9JVL6(/(C]6UY#[ WA%R-(L.,HC6@N%9'-M([N(59G&*XC*Q96
M:P[#D\';/)$D0\[$(_DGBT%R6*0'9*\E;;SR7N3"DA<D_=3*DIPR*1F7?+ZN
MSDP.6%T,)((W4C<)5EM JP(Q(R@8]R%D'LL0<6)^D4ZAR>IB^FL1]5BZF7HE
MEU7B6#U74P]E#ZMLNU5;H=UO73T&&U* 4T3L%:RX82,Q'3&93$@279D04':'
MYD\*[6EV._RNO-'9AN\9+LTD,ER*GY#S<L3,5EGDJ@)([YR>3*%9Y"]C;O;:
MNU;$ C:)X,K!&LBP/8\UT4< %(EF]I57  PIR%4+DA?TH_5L1O)790X_0ZE>
M3VU=6[ML-@IVM:F ?L.TM2A[J"!VX[$CP%C2L\\.V#9V+JS-A/0;0S,:BSHN
M(,9F*G%'X/V1*Z5&CLSUXJ=S;XHI[<THBIWGKR201L6YHL;U837*L&A*EE/)
MBQO;>]P:5IP\4<KSU[+O%#&A>>NLJ)(X"\6+B:3J@C$F0".( UAMR](+U!7
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M9EF);+\F2^- C31H9S/BCQ10\+4#:M$2V90RTJ2L!+:E _M,<,>09IB"J*0
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M3^0N1Q7[YE_G%;ZWUM?J9VO;]U;JMY&[;#NQ%4\P8GJPEIEI./#@!P\!ONQ
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MD6#<9!+>BX-E2EF0!Y58$,?AJWS]SDSBS,'=X)&8.0QDJJ4KOD8/*%250YR
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MD101 DI! A)$<4>3@9+,Q9W9Y&=V]EH4*VVUDJU4X1IW)."\KD#E+*V!RD;
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MC?T7C[$&X?CFG^C3_OZ?9MV_\0W/TR#^#I]D.JGR;V'Z[&_HO'V(-P_'-/\
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MIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIIQIKJIZ/'^U79/\H
M?^[I?/"/JO\ _#ME_P TM?ZZ/7T1]1+_ (OW[_/*?^HFU$/I!OXT:=_(&/\
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M2'2FFGV+;&P68]MV3;Z%A ^V;I%;-F:%6"QHMUN7ERX$G%["((UD1BH+)(C
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MP6V/4F0C<N3XIA_PU1EMJBYE2'<K:=RI:W$K5)$E6%8(NI#&LG%*R-(@ZO$
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MS1S1RLO"&B'05="H#:-5/WK5]NC;7 :O18+J>U-ZOL!@_1*=JZEFA0B4+/,
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MMFVJ.+P-!XDWZJM9=R:W8.Z;OMEBG3M5=R:O6KW8:T$_46:X]1ATE,K-(RP
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MO*/*-\!]+?LT\HQ][CZ...N?P1])T\HWP'TM^S3RC'WN/HXXZY_!'TG3RC?
M?2W[-/*,?>X^CCCKG\$?2=/*-\!]+?LT\HQ][CZ...N?P1])T\HWP'TM^S3R
MC'WN/HXXZY_!'TG3RC? ?2W[-/*,?>X^CCCKG\$?2=/*-\!]+?LT\HQ][CZ.
M..N?P1])T\HWP'TM^S3RC'WN/HXXZY_!'TG3RC? ?2W[-/*,?>X^CCCKG\$?
M2=/*-\!]+?LT\HQ][CZ...N?P1])T\HWP'TM^S3RC'WN/HXXZY_!'TG3RC?
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MO-QDN/.*5%FW+<; 9;&X79U>VU]UFM3RAKSJJ/=8/(P:VZ(B-9.9F5%4N0H
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M*7&9=]8&25I1C,L7(RI<-_M[N,9<2C&6)'=^"F4R^A.<X3VY]XVC>DW.A!;
M4.R\)T&?M<Z "1??@$X=,G)C9">YUX-N^ROM=^>HP)13S@<C^<@<DQM]SZ@
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MNM?>\*[KMZ&6>KRA7NTL+),BCXN$!= />SJ%^?4;^4_BQ_J?S<W/FA\!^O\
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M=SB00P93EC.1$B!%@QVL,YIMMUGL"+B%9(6='$CLOVSJ0S")F)Y' ,<@)R
M#VP-9_%->6/=((9:-J*O#&EN"W8K]!!YJ/I*A$2=)9G6%YCER\T+)/W*N1RR
MM>K;M;U28U+JTTT-'(GRY$""R](00D*[)&"K<)V1WRS+ \VB0]@6OU^+D@WZ
MNJ6,<<5C>PUY;#F.)3R)[D8& !D#)]GD<85/NG)XHI9@#K3(BL')ZBB(X5NZ
MJQ/%@0>_$Y+#N,,?3&L!L &Q5"5B)8VYHLCF;%2ZXN4P[F/#C2C0M[Q [4Z4
MNNCV"<!QUUV8MB,7DLH%2QC:52\YL=7A<PR*RR(65UD#(RLIPRL'4,&#'!#
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MTP@CZ[\C(9YVYF")(BC+&>I-$TD"S<;>I;K8UA;.K,9U3:+ZGS=CK>O6-.V
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MWCNX3VXQXR659SV)YL=LN&G9!)^U2824'TQGV7[]@4/?/N4L/?K7[E3%RN5
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M].LZ;$.O.-M--]]QU:6VT)3G*EK6K"4IQCM]N5*SC&/QYYF:RBJ68JJJ"6)
M  '<DGCZ :PBH6(50"Q(  *DDGT &.Y.MFZR#:KX>,/;PG+N,9>EN)Q['9;N
M,9>7V_;2GL2TWG/M\)M&,^WMYQ%ZTURR\Q[*?9C7\&-<\1^4Y+-_69M=I2JI
M4KI"H&0.4A&/:D;[HGXX^Y7^J -7_D34O3C33C37IDQV9<=^+(;2ZQ(:<9>;
M5_!6VXG*%IS_ (TYSCMQ[<?'CV\N1VC=70E71@RL/4,#D'^P_'M\=6NBR(T;
M@,CJ58'T*L,$?0=:NFZRZ')RH*\=Y#:\J8<RG./&CKSE3+GQXQVY1\%?9[$N
M)6G&?@\[JM>6Q!'* H+##J /9<=F7[D]L]USW*D'WZXBSM_EYGB., Y4D@<D
M/=3Z?#L?ZP(]VK*^,SX#WLQ_87?B3^0KV_']KX^9FG&#Z#M\,?KXC'TZPK6&
M1]SZCWK_ +!G4TZ.QAK5%/Q\6$0IOLQ]K&"Q#V=GW?Q=GQ\X6V<V9S\9&/;\
MNNWJ^S6A^ C7]0_Q[]:#[KZQ;0^#V&)"L1*?%%.M1(1!]1Z >F9@VU8Z:):[
MR!<U3MG"IPD45JN";:9$,RP*)2Y*&5QYD--/8=F)Y '!48&?FR<X.< X[GN!
MZZY_<MVL"&V(82BQQDAV)5V*R*CK&1G#2)( IQE3W&<]MM>D&_N; T+1B9(M
M,(V2**;9L,8Q((R+ )=DK=GB(1UXPU')RYGD$D6XDQ(CM-'&5(+0\>K2F\8@
MV(^G,XXX!.5/Q'IGZ<_DUM]IFZU"NQ=G?@.?,DNK$D\7)[E@"!GW]CK23J<Z
MZ[U1-I']0!8S-,<CM2F(5A(!G),="TQ?7!\Z>:\UQ$&,DI;4"'$?)1 \1*"D
MB(G)7U@898R1Q1@Q%UF<2L$5HX7E16/H'*9*AOO<C)P?@<:W<MTL0O)%#T8S
M$C.S22(I*KC) <K]SGOC/KWP<:VIZ(]LE-E:CA9M+-MC6ALK;RJ$6D99^QZJ
MD;S94U18^SV"!%394,!F8<>4ZTMJ1 ?3B(Z-'14P6.5NU^A,5!0Y ^Y]1Z>H
M/<9]?3]?K.V>T;5.-VZA8\F!D.25+'B>7O\ R'N#D=P-:T]4G6E8J%N!>B&)
M3@%-QP7K .8.K16>:AX74\SY5JDN1TDIF8<<I,"C0C[ P4U(F$UQ8B+&S(R=
MK6UVK8YMQJW;L4D BVZ(3V$FE2)Y%+QH(ZRL1UIASY],%6**Y!)4 ZO=-XEA
MLR4HP$8K[+,OW0*Y."3C/IZ D#) ]^IKZ ;X4LVN;$)-!I@MZ+;"Y<4ID<I@
M"T,(-CL3 T5QN>1P*FACOFC.*V44-*PA#@M] ]<%UN6YK+L/2D!!!5AE2!C(
M/<>R>X['W_D]VI7A^R9ZKJ_(NLCEB6+C+$EE4X[!3G QW!&,ZBG=W6+=:QMJ
MWZK=7'UW 'C3^(1B9%'E'9 U=7Q."%V<JE.S(9J<;CO1!\*:*8:EPYV&1<4O
M+C()9N@K1/&C'/)W(/?L,#.<>_M@'OCWZMO[E/#+/&LD$*P1,[<G1I'RN(RB
M9# F0@$'/8$]@-2QT#7,C8]>VUFQR"S5@DW.?8F!A2,:998 SH L2F<&<+KE
M-9B%;*%LD\C"@SY+(L]))QNQ+>8[C]EZ,1RA5& JJ ?B<!N_KZ9QC/<9_+K+
ML=EK-9WE+%VDYA9"20" "P)SV9^1 'ID#Y]:5;AZM]\Q]C;9U].BF0XL P1?
MQ&9"^;NRPRR<&&*!LU\'E<N%F=D004X9*2I0R<T5*PG3SXJ0">B758I);"1?
M)Y2H8^7R@UF J\Q':)*P/F%(. 6=0A[%<XURNX>(MXCW.Y0%/H5JZNR6FERU
M@!<]..%(W>,D#"R.ZH6]H8&=='>BRSJ/]/E%B39Q2:<"C<L%,E1Q."XU'(39
MI($U">(QF$$A3 .1!B#9\)R0PN+%0RXMJ4R_&9QW$$=F91Z<@1_:!KL=DF-C
M:ZDAY\C&>0D.6!Y$XS[QW[:_-CQ/6-U3%=G;V:OJ>/N__P 5WS/_ -_;\7VO
M\F[V.3A%+_\ 4)^.?80? Z@[W%U)(NP[1CN<?AO[SJB\LS]S'T<_S\WW7'P'
MT#]W6B\L/ZOTK^S4R:UK*8;;QR0WCQI&%1X/:GLRAC&<>.]CM[>S+RT^$E6.
MS.$-N=G:EWV\YO5[JE:J'"H0\N.W)B/84X [*#R(.1R*GU770[-16(-:91R<
M%(O0X3[]@<>K'V01WP&]S:EGG/ZW^G&FG&FG&FH3V35T^MMG8K>,(E=UF=A*
M?8F0A/8R_G&,X[,/-I\->>S&,.-)SG.5N\Z;9;WVMJLA!,?M1$X)*$^TG<$^
MRQR/F8CL%&N:WF@#(+2*,/A9?0 .!A6/;[Y?9/IW4>I;47>69^YCZ.?Y^;WK
MCX#Z!^[K2>6']7Z5_9KA_P"G>K)@WT67X0%[<2)LVC)E83#]>RL<BSH5+;Q%
M0\Q*=\1.$HRD>^S/QA7>CN)5C/;R_B6R\<,#H@D)F1 F0F2YX8#'"C&<Y; ^
M)&MSM?.NDK10]=^4"=)71&D$LZ1\49R%Y>UG'J<$? CXC"(Q-;029%M2M<E'
MUS&"<2*=DU^0PS/132R&)5Y(CI+J,I<>E2IH 8TWAV2TM3DV;(2Y#9Y@7:Y6
M()(LIDP%$8#'# D,P7NJY'$EL<20& [@;M;M8M''$3(TC*HCA0N\8/(#J1J.
M<84H4;FJ\&&&QJ5ZA7]BU>76"=**.0)! J7N4Z8&:9--6I,$J3CBP!4FVO+K
M@MR!693<B7/:4EWSXD]*A>(P0A#MANEBA<BJYAKQI4JH))>FH=Y(5/5E8Y+L
M%(*^I$C!GX>TJKT&U;ANM);(HSV8H93)#.L;<%F7'%XS@#G@,4*Y.%)][8;,
M]BZI#V.*UNN"_6:P S()D-A5.>EM%CJMF,LV",LF'<DRYXTC&V WY+-@Q1;Q
MQ+9DE-23S78OAK=)8KV(:P-@/5C@D8/'&8[)&2TD>"G,R,_:)\.BJZN,88#6
MV6*SV.K')7<L[M"Z21/&K#)"H0CX4,.)7&1@9P =:ZU:HZHM;*["<NLZ'#E/
MRXPP/86:^>0_-"2GYBC!JSL#ZWG(UV/9DX\O5*>DR5MS&FI$G$>5&SI]Q>95
MYP0R.O3DX]-RTRY"LJL"ASZ8,G'L<9"GVAU'AOY-9.A+8A6RUBHRT[G2AK2P
MAI(GE%EW1PT:S?S+\>1]2Z\E&Q73CH+6)J]547=]M@(%9MUGJNNQHV,-*"D%
MXA>%61\@FA<TE*&(#0&I+;V4!'4H?=DR6C'@*A/MO:RG:M6K-:)H983%.+$Z
MRRI(JQ<[#,A$2J>1RJ$2MS4$,@;/)5CPDNS[?<W6UNRB9_.0;7 IA>%I+J"-
M;",) ;*"O>+QX$L2R0RI)+&82LGV18]&AT8:OUY[Q-*UR*@VV[U'$C4>X*H)
MC#3+1D@'1!<&&RHA42;.8Q/@1/%::P_B2/?Q$>C*0ZRYCVC::M2=Z7BI=KV^
M6#8Y5^6=L=3-'9@1QRDCK2EXCU8B<1R%4ZB=0D@$'Y[._/X;\5CP?X@O;GN3
M^)9#)X9WB:&!&@,H:.7;[#UQ7C/1F1>,D4+-PE1'1?9US3ZFMQYK'35M3H5V
M%XPT?1;75JY>"Y..T3SAD6] M.7@QB,*CLCGB7='8\(@VLD,@R&9#K<DFC++
MG4?5'@\*;ELT/BA+$4=S=Z4AJU*T:52K<O)UY+<1=L25ID2)$4!9I(I,*T/<
M:;:H?%?ASQI+X6VM:B>"[:C<)K%B:2679[DTKM+1VF%" 6W2],+Y256@BB>7
M!C=HUE^88R$E(?.%WWAT!^L%\SAS<?(_$40^S-BC^['*M*/FE"H\T)+E/&2T
M0;('P"4.'()LYRUF-X/U([,,T8/LQ\A]J63DRNC+&58J@<%<]E+ D=^S*3[K
MMVZXL2R553E RPJTD/53B&CD22-Y(^#<E5>Z%BOM@,>S&[$=O%V1D@'@F(@2
M\DAH:4=FL.LHB 6C:&PDI^SJ;?M;0Y32&550PMR6=-.NMK@R61K+Q(G"VN&%
M',I4"63#QLV0Q9E#S>R"(8Y4D4]9((UX.?;;DW!,]ZYSF\M+(_)_:"OR*.$!
M"B-GR[A$ +99E52GIR UE F!Y%I=4M-K]9-6^_#R85TR7+SXJ1M1R0DQL5Y)
M1S$B&-E%M@3(;6)B6RTB"IOQ6HK1%AA&Z>_#T9(VADXRUY(I64R2"1TE+K,^
M%/#@ZA>)#*P0G().(,%]ZDT5GE)'&D_*&:..5E'1.)%;I@LK$K(#D*#&/7!)
MUT6]"V!3"Z]A$7P7A2V-=VV;Y<P[)4,=3*>%.]QD5&G2!@'+S!>#)PR]*)RE
MN07FH\<>TES.*[00MN!W*AY'4J#WD("')+$*7!*E@> QDCN?7;>('%JG,:JR
MO6@B!>58S'7Y22!E"0*7C@($L:! YY8Y!5'LC[UD#,]U/LQ_!3_<Y^YC\?/1
M!./F^C_VG7EYK#)^Y]3[U_9J\!*RZ8)Q8*,=U#B\*D.83_8HR/A/.=N<YQA6
M$=J6\9]BG5(1_=<CVKRUX))2 2 0@P/:<]E'W([9[M\%!/NUFK4.O,D0Q@G+
M$8/%!W8]A\.PSVR0/?K:&/'9B1V8L=M+3$=I#++:?X*&VTX0A./M^Q.,8[<]
MN<_'G.<Y[><,[M([2.2SNQ9B?4LQR3])UVZ(L:+&@"HBA5 ] JC 'T#7NY;J
M[3C33C33C33C33C33C33C33C33C33C33C33C33C33C33C33C33C33C340643
M&9+/YC]WNO83(<;2G/8RZ[VY<1[,=G8K/8[C&/8G#F$XQC&,<Z*E.SUUZ@.5
M)0-V]I5P ?7U'W)/O(SZDZYZ]"J6&X$88!V'?V6;)(],=_NACT!QJ.+#"PV3
MHB\8_@["J&>WL[,8_P"F(W_V[>SBZX->11GN/]'?5*,9\PA^!]W]^ME#,R6.
M#E2 \8\:GP1LZ9"#QGF8\@M+BQ77XPQB1(SB.P]/>0B*T\_G#+2W4K=SA"59
MYS4C,L;LB&1U1F2,$*78*2J!CV4L0%R>PSD]M;^5F2.1TC,KHCLL2D!I&525
MC4MA07("@L0 3D]M?$V)WUU9[JW^1W'7K9@GM,9LP#5\QC-AKP@1JHW9K;$H
ME2E%7'7R<.LT3.P5TFH-5]X,6(^OE&)A0'.;SE<;A_J=_4[\2;YXH@\4^-:U
MVG6AAL[DRM)N%1[ I*+OR5%M<D*3.T%&*S:C56JUWCJI-YAG %WXFV^'QSX^
M\6[GNVP[M-5W/9-SI]>[N:NM&A++:$:T5BC94"P&LT<E...SVC062CR)(NEO
M4V<ZQNIJ_P"TKI+UUMZP[1U.3U?J(SFYRHDFXP)A6?,I-0CS*$_4!,+"BET@
MV;)ZNUPU@2"N&VJJ$2W+=F3I1;ZKWOZE'U/=PW;PWNN_;\T_AN3;-^M)M5.)
MTVL9V^*W:G2_3GAW&&22&I2F'5Z?7CV=R(X&LCE]3^(9:6_>%;/A[=MGD1H]
MTJV;.X5;^X16[*QM*L-6U7A$T#5(EDG6,0*DAFMB-YK+I#&DGZ7-VW3ERE54
MU+L '9,B.<JFU*K?P;!^MP;4BBALQ"=.@1;5%&ZK.:UN[ RZ9V.S4[V?I%BB
M4CU&H95#F4R]>;["^^^&[4VY>(8HYO -2.>AX&NO'6V[QA\C/N;6-KV_<D&P
M;AN.\H=N@^3>E<\1[)0NTI;4]Y9-V:S)M?'4=\\$?4J\ 6J<^U[EX?GWOQ9%
M;CVJJVY;E7O31T4HR;G:BW#Q#2H[=?DB>2>XS;79NPF&K%3<4Y7B3>;I1ZC=
MZ["ZT*MUB['UYN3;=BJVN6=25V@Z,HJ[49M]K$5$;6(8[<,J.-%E-7M5X;N&
MQW"X;"M0\!JW;Y0<+M&NPK,2ECQ8WVC=*.QCPC9\/;1NVQP;;NET;O%NFX;I
M76A%0FOF2:WL<L-JQ6W-99-FAJPT*IFW3;EZ]>W*SVF&NTI7%N3UMVB+74$'
M3C;;UZXG;I$1K+(% "!;3/US)Y:5N+H $Y'[$^?-^NRUP6ZJ/2IECQ.]Z/Z9
M4$*G>J]?9=-]\V?%@%HQ)=8/&:[:A@(=/%R1@A^45ACVH!PC)FR4#E&G4B1T
MN$Q.;\2^J]]4>_X+KQ04*MF#,L37MUXP21QTYJ$LPBI08GFFNO*\!BBZ4<KB
M,B(,+$#2>";C]5B;Q!>\2>%/"-2S7WC;+<NVU]T=JS++9IWIZMUHH+"K'#67
MH97<)&GA2.25I$@>$-KB[O3T@_7!KLSIBX;8*2]Y:@GWH%8J0+M P [4$7;1
MU])MQ!I =1F 5A5=J1L0%$N1>%<K)/M\B ,I3LO VN%W(I[Z5^ICMWB6;ZE6
M^7=^KUO"?B[9]@NV?,;U4LR[MN>S;EM[RPV;U><PFD]FG*VVN\25H#'8%UHT
MDIS6;E/#^\_5(&Q0?*M-;EZ"Q9EH-;BF$VYI7FE\O0NK 8Q7MQ683 DLO&Q9
MA-:U-$BB9+'-'<'6EOO:5PVIO_?^8(:U6%Y-2U_8*EKH%7Z^PL&[<39F!*"
M6AC]OD09YYF-&L9$R_8$N.K%G"\U.&>]ROU0?J5>&_J@'ZFUGP9?H>(+-39=
MDWKQYLMC>ZZ;F8?$$/AWY*M25V\S-M\MV(74@B\@M:Q!3J15J?."(V>DW.#=
M=UW"A6M[0Z%:VZ6=TW6K5FCZ,FWK%/'M]9IX8X+<742R9DM@305R\D\I3,<<
M0[-U[:(<4 <0[&:I\ 55;60&U\LH3%$SW L23YV%%OI!,-EB[XZ09C QTXV4
M(SE-PU80P^U(>W?U*O%'AGQU]4D?([W-H\0;3>\02TMRO_)TM]/"-&]#!)L-
MB2=-[M[]4A7<1M%"%H=L@\,;/!$8Y+J0F&'S#PENB>--AL4]XFW>AONRNJ;:
ME:%K%+<=DMR3M%L]L6^>TVFHQ"R;%BS6BO[C-8L342CB]9D_H%^C.ZG%=3O3
M8#,II=OJL+7GE6LA!:Y+(2"U_&4X ,!*NLV1*B9B1S9 R.,P[,!'V&YIK9Z!
M.$SK65(L27$[_P ?^'4\.[Z\2[CME]MP67<Y(MKF6:#;C;M6)(J)<+$S<*QK
MRI(U:JLB2CIPA%!/MO@+?7WC;+5;Y&W'::VPV8MDHR;B'ZFYU*-.M";RDITU
M(MI:J20QV+? UA(\_*;I1RAK"!A5$KN<X]N86/M9]O\ 5%^W'L^+FO@D'2CS
MWPH&1W_V^NMG8C(FD]/NB??^KM_@YU-50%1E$E2'<IRY%:\2.TK'\):LY1EW
M';CLSX.,^S'QX6XA>/:CMQ$W&9A"$0$+(V';X =PO8_??1@$'UU*VZ)3,6<@
MLBY1?G)P6_\ M'ZVS[M2ES1:WNG&FG&FG&FG&FL)N@Z-)BQY:LI3)9<PRC/9
MVJ=:<PI2F_9CM_J:L>(G.?@IQES'QKQS9[;*RR/'@E&7D?ZK+@!N_P <\3CN
M>Q]!K6;E$K1K)V#JP4?UE.21_9W(^'?XZC&0/QF._P!B>W/@N^SLS]XK\7-U
MU ._?MW_ ,=]:81MD>GK[L_LUFFF$=W6-51][&G)[,_B+$,?X_9\_P#EYR\Y
MS-(?B[']>NGA&(HP/<@'T#&H.VST<Z3O]GF[$.+)4R9D(["-3*J2CU:',;Q,
ME$I)4RXRRF/(E/./]DZ7*3E4IAAIF4ZMG+J',T-R>+B$(;BP*EAR88Q@*?4#
MX#XG6KO[)3NMS=I:YP0WEW$2O]T29 !AO4\L^JC!^(E_0P.C5O6-> Z[-CK%
M60Z9(J.5%/ONPW) N2Z.EQ4,/SB&1RA[\54%P4P^W$'N,+CQ(<&.EN*UAF=Y
M)&>3[MNY[8_Q\<_'.IE""&M5CAKOU(HP55^7(M@]R?7!SVQ\W8 8&L:VCTQZ
M=VO9P]VNPB>HY7HLQB(1&'RP!?J<E?CRVI;XN9$>=CJ<QXV49>0VVKOJ3A/B
MR,NY8;D]=2L3* <9Y*#Z9Q_I/QUAN;30O21RV(F:6/F(W222-E#\>?\ -LN0
M>*]V!QCL1G60:2INI:;7BD+4.1#X7-A,L%90R2S/>\]A3WF"D A/1C,F1,@3
M/&0]Z\\_+R\X[(?==<DK><QS22RORF.7(]<8S_CY\ZRT*U2M&Z4PHC,C%N+%
ML2?? D^_N#_;_;JDVAT]:AVT2#G-B5MHO(KS!M$)W,^<,2V@ZP'C%''9(^3$
ME]KL(#!B9RB4VG$3$AE25(?<QFL-F:#(B?B#W/O[^[U_M_OSJV[ME&_P-N'J
M=+(0\Y(^(8@GO&RGN?GP ?3WZ\]'@M)UP58!&DU5W(F";5%.,U^6F>U!*QXD
M>.F ]+RMYY>(L9EMMEEV0\F,G"F&LH;1AIM/+/*5:=B21[!..ZGT(Q\0/U:K
M0KTJT31T558PY# $MA@2,$MEC[_4GX^N=4^U^G/36X2 HYLBKL%YX"*;8'SL
MD)PUV*P<9&-%5^L0),5[M5&#PV\94[X;;"'D*1EM]["K8IYH,]%N))&?G_4?
M?@GXZI>VRCN"KYR%) @8*Q[%0>Y]H8/H#_9GW:H^G^=I](<Y7M09SD>"(-^:
M/>0RQ")KLM4MN-.9E/#AT0PU+5"FKP1@8>;?=2^\XK"GDY7=8,S,KS'NP[9'
MKC [>@^ [9'PU3;4IPQ-7I@B.(@$8..^1V8]F[@@D>\=^^=7*^:1T78)4FVW
M>E5ATE!&O+589:%0YXR%$G3S+LN).8>9=@.QR96<3]<BJ:?20EKE9<S(6E7$
M-BQ <02NG(]U'H0>Q&/G'8GX9U6[MNW6\R7*\4A5?YQQ[2JOIAAW&/4? ^G?
M5]TTK7.*-#C:M=;<JT&>2B83ZI*@2V"B)2G"<<I#GPX$^.4:D.]DM$Z*W+4K
M*7)&7'5J<7;.\DDC/+]VV"?G[8__ +_/K)0CK15DCJ "%<@ 9]1ZYS_9_9C6
M#VV-X^Y2"LX]B=9U3'Q?;]U%XS_]^;3;'XI(#[WSCM^"/\?3\-0]S0LT9'N7
M'TD_X]-76*+9>DQV75X:;=>;0XYG&?@(4O"5*^+LQV8SGLSGX.,^U6<8[<XV
M,DI6-V12S*K%5^) [#USZ_#N?=WUK8XN4B*S!59E#'W@$X)';U_+V^/;4YLL
MMQVFF&480TRVAIM"?B2A"<)2G'^+&,8_]><LS%V9F.68EB3[R3DGZ==2JA5"
MJ %4  #T '8#7LY35=.--.--.--4D^*Q.AR(LG&/ >:4E><]GP.SX27,9S[,
M*;5C#B<Y]F,IQG/LYDBD:*1)$^Z5@0/C[BOY&!(/S'6.6-98WC?[EE()[=O>
M#W]X(!!]Q&=0<H<A*E)QG"L85G&%83G&%8QG.,*QC..W&,X]N,9]OMYU D!
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M[!BI)R)CP">!&Q(+<01X\1CUP,Q#4PY$<:D1Y\DIHTGB>:.**/C%PD>,]L#
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MCR'%;K^ZM#MCM)G=U8DLC&]EW8]-,-3/%A%R#L61%E@U)()\-P3'*#9L;$=
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M[,9QGX"_;G^YSG.,Y^]4K\7,%@]5/?R7)!('I[QV^.!_:!K/!]J?MGBW9O\
M8?NCW![?D)UEO-?K8:<::<::<::<::<::<::<::<::<::<::<::<::<::<::
M<::<::<::<::L) @C#N64Y3G#>?A_"Q_9/MX^/\ N<9[,_CRK'VN7*W'/;/]
MNID5-I4#L&PW=0 /3TSW^/N[>G?)SJW^NH_)^EC^?EW4^;]?]VLGR>/@WT+^
MS6!WB2EQVDIQG';[X%1[,8SC/;VEX_W,Y^+'*%\@^[T]_N[_ +/UZLDJ")&?
MN, XR!\/=C'TGT[8'PT!]+%TT[OW9JZMW'0;\V?:==2)LH_381$ZHK9@,E4=
M+$FG@8#,B)-MP%UR<^C+"Q)J6$FE(HV<2(-#04_S7Q]X#7QE+L5@67BEV:W)
M.D3V9HJCM*J)'9D@C1TEL4R',#N/8BFLJ [2)Q\J^JI0\17?".X-X926SN%>
M-IFV^LN;E^%00\-%VD1([<?+KQ%09Y3%T8&ZCK')\]'4\:ZUY&@+'J_=6G=M
M!8FO25*M4;=_4M?=X3Z[58K+EE:MT2I3[0=KVI[R7N-D*UJNZEIA0=9=FP1C
MI^+,AD:L*&WB@_1^V_4[\-;UX:V'PUO'B>'>;%V@L.X/L5?;XMSDG@%>2E/-
M8EJO<I3K&LHW.22**OPQ#U)+<LBVN3V;8MP\6_4XAV#QMM6\4+=<Q9GW&]/:
MW V(IGGCMQ2W(WD/!7$*QS+.R0]2#JM&HF'5#67H6-AB#53*F=EUZKMPX=D?
MMN919W;L4_,/@XS-;88IWO>ZC#1Y>MSRGC;3]F/WZE74D/'8,Z\8KTLS7)_G
MO@K9O!7U/[VX;MM-'<=VW.U$M>A+N)@J?(]<6UEL1TYX7M2GS]5%IV)XUJ[@
MD#MT+T4J)+K=>%/J1;#X3W"7<J4]N>Y)&]=9KCPSB&LZC*P(E> K-S[M/-)8
MY+SB,?2FEC?NII&E;"UYK^#4=E[-7MVP"21QN%=Y%2K-)G2ZR\5E/U@82 TV
M )J[4X$%<B!W9080*BRT0VGE0\/Y>??F[O<I7[TEJAMR[5!*D1:E':M7(TG6
M-5GDCGNR36BL\@:;C--*R,[*'X!0/5((Y(HPDLS6&4G[:R1QL5R>(98E1,J,
M#*HN0!D9R3+?-9K-J#.I=G;$S1&SQNCPD(_M$S59X.J0)YMFNMM23>$BIA..
M5D2(<=DB&&RYA86R_/&LRB,.+&<(0TNY?1HO$T>[3;!NT&QJ3NMBE/7ILLT=
M>2&2PIA-B"28=$6*R.T]=9BD+SQQI+)&C,ZXI\F&4!'D)C=1'&ZQR,64@!9'
M9%0]_NBPX^H[@#7RT#[5U2].M=)$P'27U.W>JW.;,KVSM3U_76_*HW>DB6"#
MF0+-MH=5F%\SR\I;PD;*'3L5XQE<B+<2! -YE D>4?\ PI?4Q\5;9XH\9[SX
MNN5-CVF;9A%5O[U?VKSE_=XMRC>L\.TW)XK<XH(+R3/;A5(([<AH,3Q77$[3
M9N164KIMMZ&O7@6H\+5+T, ;E%()5L/&]>8LHM/(]:8XL/QL)UYW;6(](WH[
MNKGJ&U[M3*C>C*[9M=;UM.K2\MFP3[>"KUT&"85QL@@;,G5(G9S]-UQ=[<T&
M+Q)FQ+"4-V*!9V1-@EQ6H]G)2?%?_P +'AF+ZIC>(3XIW6CX/WFC#O,6V;;4
ML5]YEBM2]'@G_P U&R4)YZ5<U:]T;7*\5**GYNG+*&@B]QO^-J._>'(=FW7P
M[5W1X*'R19CNS<J,HB9&5G40"S)65XXIDK135Y8INIY:\D#J@ZR>C.Z//2!]
M(FZ+K1ME$NG2#TG>':;.TG50N#$+[%V!<I$)^+8)/K54B;!R> H%XCG)MXM<
M\8Q#G("U&-+$,P6Z[]8>)-W\%6_#FQ[;LNW[P-QVC;]NVFI<W+<K$[U-JVN$
MU*]"6L7>BX%9(2MFFL3V)5>S82*:66-O#-IVWQ+M_B$5XHZ-+PC4H])*\)K%
M;,[Q1B(U(DK^>@\HR=)C<MM$( (X(Y,B5.ZG/.M=[IQIJ"M1RT(UW6,=N/\
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MU1$5%"HJHH& J@  >GH-9YR-J[3C35GL1X750!JS&Y2(0>OBB!DI+<SA*(\
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M<H=)'E&4Y]JH9",Y[._V8L(]1Z]\:Y2[&T5F56[=\@_$$=CW^CO[QKG%U/\
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M/=P'$>47H-A44W:#[%ZW85E%O+O(X"],!AH8$J-B6U*RB,SL*9/DP769;CJ
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M;KTNR6GT90\TAU&<=F4N80M.<?XE)SCE"I/JP/\ ]HT-<'L1D?.I/^DZMOJ
M3_!(_P#S:/\ F^.!^(_-&K?*I^ /S-/4 G^"!_\ FT?\WQP/Q'YHT\JGX _,
MT]0"?X('_P";1_S?' _$?FC3RJ?@#\S3U )_@@?_ )M'_-\<#\1^:-/*I^ /
MS-/4 G^"!_\ FT?\WQP/Q'YHT\JGX _,T]0"?X('_P";1_S?' _$?FC3RJ?@
M#\S3U )_@@?_ )M'_-\<#\1^:-/*I^ /S-/4 G^"!_\ FT?\WQP/Q'YHT\JG
MX _,U^X@A4YQG F!C.,]N,XC1\9QG'Q9QGP^.!^(_-&GE4_ 'YFKFB8AI.$-
MH2VC&.S"490E.,8^YA.,8X"D>C8_^T:N\N/@?[ 1_MU[/,<X^[_E4G/_ *XY
M7!][9_L(_P!!&GEQ\#]!_;IYCG^F4?\ #QQ/Q_\ %^]IY<? _0?VZ>8Y_IE'
M_#QQ/Q_\7[VGEQ\#]!_;KS;*N-+0ZVI2'&UI6VM*DI4A:,X4E258QVX4E6,9
MQG'MQG&,XX*Y[$Y'P/+][5&K*ZLK+R5@592I(92,$$9[@@D$?#6W5<)N& (L
MF\G"79<1MQW"?X.7$]J'%)^YA:T*5A/]SA7=[<]G;F&PXL1ZX.O&]SJK2OVZ
MJ$E(9F5"?7@<,H/KDJK!2?>03@9QK5<W9GS1261>[4^.YGPFLJ3G#,='P&&<
M>S./@-X3A6<=F%N96YG'>7GDM4X@#/\ XO7W^C#7K-#;(Z-2&JF3TU]M^)'.
M1O:D<]_OF)P#GBN%S@#5J\QS_3*/^'E>)^/_ (OWM3/+CX'Z#^W3S'/],H_X
M>.)^/_B_>T\N/@?H/[=/,<_TRG^;C!^/^D_Z6(T\N/@?H/[=>.9_;C.,X[<9
M]F<94G.,X^YG&<>WC#?A?_B-/+CX'Z#^W5M=BB'EY<>&07%Y^-:X["E9_P >
M<M]O*<#\1_:H/^G5#50G)0?F:]?J 3_! _\ S:/^;XX'XC\T:IY5/P!^9IZ@
M$_P0/_S:/^;XX'XC\T:>53\ ?F:>H!/\$#_\VC_F^.!^(_-&GE4_ 'YFGJ 3
M_! __-H_YOC@?B/S1IY5/P!^9IZ@$_P0/_S:/^;XX'XC\T:>53\ ?F:>H!/\
M$#_\VC_F^.!^(_-&GE4_ 'YFGJ 3_! __-H_YOC@?B/S1IY5/P!^9IZ@$_P0
M/_S:/^;XX'XC\T:>53\ ?F:K8ZX<3'=BQ6(^/N,H:;Q_J)QQQ/Q'YH]^JBLH
M]%Q^12/]NJKS#/X_I)_FY7#?A?JQ_H(.J^7'P/T']NOWS'/],H_X>.)^/_B_
M>T\N/@?H/[=/,<_TRC_AXXGX_P#B_>T\N/@?H/[=/,<_TRC_ (>.)^/_ (OW
MM/+CX'Z#^W6P6IBC\\//BNJ[S4"8A,?MSC*D(DH4ZMOMQV8[F'$J6G'9VX4X
MOVYQV8Q&F7# _$9/K_M)UYUXOJQP78)4'%[$),HQ@,T3!5?X\BI"DYQA%[9R
M38]N&Y$>2,#HSW8ZH^2#O9G&,NNJ==CM85C.,X[K*6W%)QCXU.YSGVI3V70K
MG+?#L/7^WT(U/\'48Y(K5T@M*)/+)VR$0(DC$8.<N64'/H$P/5M0SYCG^F4?
M\/,_$_'_ ,7[VNV\N/@?H/[=/,<_TRC_ (>.)^/_ (OWM/+CX'Z#^W3S'/\
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MR>&[7B=-Z_\ F4=$T=OW.':[Z&-]O%X3UIY2RH*A,Z)B+,KB,7FJ[V!6@K6
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M4]@^<_\ 5_+\/\?V:QQ7MLGD2**Y \DC!44-W8LAD7&4 PZ F,YQ)Q8(696
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M4JJ\"I*@)]R ,Y[9/8D@Y.0=13]4O=WGW)I]J\/V:&X4-GVU=FL4;+[50K;
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M2Z_57;"(L_3EMB];PI^Q(*5UG(1\V5V?>YE@L(::(D5B3'@1!$,3"'N/MK!
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MRX)!7T(Q\,'L01W'T:RR[.C1;>L5F>O+MJ".">-87<QF#RTBNDL4D1YQX.>
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MHQZ]N/\ ^'I_?JJ[!73I\9ILQ?)Q3/3P3ML,D,/+">D@D)DQCN!QXC4"Z/\
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M7/PUT6Y!U\V:<::<::<::<::<::<::<::<::<::<::<::<::<::<::BG=O\
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MVCC:-'<+ZE$:6-6;& 74'N1K(N-7Z<::Q^SVRK4D3D_<K("J@/!$('R9LA:
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M>1!S@8 SZ'T.<:3W;E??I88F+Q6)MJA\L\$[\XI%F6U-7G5Q%!Y5")IO88L
MH8KE>4;=/O5;UBQZQT_-IJX5ZC#P?135[53#U.VG8=A6>9U"4&R2+A/1M2[[
M(,F!SFOSX0:ZM^TCK:1D>8KC60VQEI#LJ@9LKD8&$'H23R&#W)S[.._K\^H]
M'<]VZ5#$<9@$>SQRPR16I+$AOP2&5A:FLNR]!T4YE65CR(D<8&8KU#U&]1VV
MMPU+8EQ*E;"_:OL><&RU2J4K>NGZAJBQV+:O47.VIKF>)>O*$7*R:Y<EC*Y=
M[!-=>IUC@P  RXU&6^%6A= S,P)],+V'( 9+'![]R"3Z]C\/=J/4O[A;MQ3S
M,[]7Y!62**&]3BJRR6[[6J[(9AUI:W)8YG;,4BA%FB;AWRIWTAO6G4-84XU?
MP=)FV;;.N.DS8%;?JFE;&-FU"?NV/OY5YH#5<MNVX0>VV2OQ],!B^9IFX4I@
M5&LYER2-?PP 'OUYL "1ZA3V'IDD$$$^IQG.1@$G&,8O._;O%6A>:.%I+=;:
MIXS%4D4PM=%[KP].6VJRR1^31\M-"%$CDJ?M:ZVGW_U@[HUKT:=/NUJD=IMO
MVYM.GLEYMAU_K=S8>HS=KC:K-7E\"*GN;1JR@H8W8AK=;K,F-*M]IMLG" H&
MLQRQ)4T-5F(0'()(]PR#D9]<C'T')[8'NV5[=;E?:*-J)X9;=F$.9(*YL5'F
M%5YS&I-F(JCR+TXL&664^PD89B4@;9_6'U6776G441 7,-HZ[:Z@ZK/5S5T+
M0-_M%W:UW,=Z>[#9MQ9O\JV10$^LSV[[?@\BO1ZPN2P$ /QVR39<!99>*%FP
MQSC&#]R2<'CDYSZ9./3/S@C4*UNNYS5]P,<R4YJXJO'76C/),(":#RW.N95C
M:-A/.AC$1/!" _*.1M7(UU6]4FL"VQ':'58VQH&U>HNXZ,UX>E5C:Q8<C<5N
MTOTOF-([$=&';Q8&JCI8A(*;9EVBKUYRNU04X+@+C3H!E^QD3%2[ G Y9/$>
MN,\4P2<GV?48&,>O<YU<^Z;G7:P8(186S?FI5I#':=?-2T]M>E.5>:3I4V9K
M9ECCZ<*%1AE<R,]I"[;ZS(6VF VO[A"K[%@$>E AT*A[!HNR+Q6=D;HU'U-R
MV=3BI5KL>Q7RU;79Z4I!6N08!"+4Z]4@EPA5.O*$G@3--IELGU XR<1@G)#=
MNY/Y?F&" /0:M2UNXM<8)5C#IXD6"">"Q-%8N5-Q/E4,LE@O&98?:C56$4<4
M<PBCXR((MZNB#K';ZJ:_-L1MJ-6"-[78MD:CU\X!.C[(/T&!-P]71K';Y\M+
MPQTL=VC7;W*'-8=%3'J\^)\ ,XQ"DDG[U8,,CMG) ^8=OAZY!/\ ;Z#&MSLV
M[?*<;2.!$TYDL58.#K(M&-UK!YF.5+O9CG*_<$QE<)A68]*==_V]U#^40G_;
M&N'^X;_JM_H.J^(_^(-Y_P"S;G^H?71[D'7S3IQIIQIIQIIQIIQIIQIIQIIQ
MIIQIIQIIQIIQIIQIIQIJ*=V_Q96/_M!O]_#.9(OYQ?[?_"==;X&_RHVS\EW_
M -/M:YT6B#YI6;$,R+;.8(@B\'(5X@X)9+^MCY$?RMTJRAUX8V0\3U19!IMQ
MR$E[,E"%J;PG,SUU] 2+RCD7B'Y(R\"Q4-E2.)89*ALXY#N,Y'IKAK3^DSKB
MK-$S1Z.FS4'7=.&;SKFEJJ=VE04[6J=?.=(-NUSK81<KYJ]((%<!E;W,1 IU
M>7*RS-TJ(.!$+V(PR^/B*A8P' (&1C(7N,CV>Q) &<MW![D =S\>.AVS>8H3
M!#U(:T278Z<3V8/-1(^V205TFGK"-)5CML@K.S2311JKRN"HXYJ.Z+^KBN6Q
M\M5=H;B:0O8$2&/D6WJ@V9;@\+75NZ&C]7V5.F C]V-QI,U_K!E!K/ <P-DG
M 2X,<S2TB $5+/'%O4$YY>]F(P4PW8DC)?OGUS@CL-95VC=(YB\=FV/Y0 O5
MW*S*BUIMEDBL,4DF<%CNQ25<J7C*AX>$8 U9Q'3SU[6V?K>W7FKNQS&N;)I\
MR"K=NWS[H&62]!Z).I?2ERLZCM<*.3:[(O6X;U2B! A6)+MHE"BS5JER6S8P
MC%$TXN1W]05(!;/W*N"<C\(D>G?WG&K$H[Y*:\L\>'KRU'2.6\9!S@V;<J<T
MO4C/*,SVYX69HR92C"5B'5E3$:%T<=9DFRZ8ONQQ=ODS-9]49:]U6O+ZA;B\
M_KBG7OI<&4 K86O-]Z;(DV"LUC?,'-M+T@SLBXDK+39MJ#QADD/L"WTXC0(_
M8D^C9 +'WKC/J>P/N))QD>A.<4&T[NTE.>PLI-;<VGBC-^;->&?;5@:0!KMG
MJ117AU7@>S,TD+2H%*6)H6G[ITU)U6Z<Z6NJ1S=5GVM/V9/T:XV(22V _>D.
M;.K.M+M'M5^UB98V/L"V0W[P>D@B&$/-:^4H@+'2@VNZQ+7.3)N4, Q;.<?'
M.3CN1W]3[_3TS\3J;0J[I4VS<O.2VFLFEA>4YF'F8J\PEGK.+$\JF>0HV#T/
M:52E>)BV8@Z>^F7J[N[6GBVP3>[Z9IT]LO3]\OE1+=5FPS5]GAQ'2GL@9L&S
M2K5#N#-L&U39F]36M"&-5PRT!8M(8B1F52LQW7X+!0YP26P2I(Y')]DDDD'T
MY$=O[<8](M#;MUF\H\[W8JCV*D\\3[I9>=E3;+*SR&02K*L-FZ]=A5#+QX,S
M0Q#V1B%GZ)NM386OMFUV]^[XZ177*[,LD,EU1VF6&W_M^L=4U6V:+O.M1[5R
M8'Z=!P-+AK+4A8*:S0(44X?JD; -K%$$6F)3BYR"21V)RQ]H\@>V/3V1CW#[
MGX9&*79]WL064GZ[L8T,BMN<O"];CW..RLU8+,%J1K422)$(K@.\(Z:]!)%S
M0STM]>12P=0\N/;=ICE6>/;6M7M-[J5-ILBFF+GK,KKNG$'B^VBA0-==7U$
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M'Y![OAW^)UAAK5ZRJD$,4*K''"HC15Q%#RZ4>0 2D?-RBDD*7<CNS$S=KO\
MM[J'\HA/^V-<M?[AO^JW^@ZU?B/_ (@WG_LVY_J'UT>Y!U\TZ<::<::<::<:
M:<::<::<::<::<::<::<::<::<::<::BG=O\65C_ .T&_P!_#.9(OYQ?[?\
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MMI*<C&,8S[G'I[W/J?R?L]-7R>'(Y*T=?S'$)5WBLSK H+G=I$D,I'4^Z@*
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M].I\WZ_[M/?[1^"JOKO'_*>.G\_ZO[].I\WZ_P"[3W^T?@JKZ[Q_RGCI_/\
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M"E4!R*\0(((/ =B'AD!_*'KP,/@T2'[T:MZNEKIT6.6(5I?7BABQ*P*X.:W
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M#6%Y M%95+$,@ZL,Q66&57C=&DKP,ZLI#=-0<@:H:-7&%B$1 PKPDQ2)[,B
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MA[IIT!(]8P_J"A.XE>L9DX77X2L/>M8V=B1XG:W\+QL;IVSXG;_"]\*U]O\
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MK<#,9T-*JQ:DR1BVO#[N8;]1/&JZZSV=Q8DG-AYQEI]>,W#>-T#B07[0<.)
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MZ7*N[ZVM<[AJ')"V4VN!21C?5.L(_ =R-$N$S7Y,#&@J8?'[!*QH!TP+(,,
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MNP4E4#'BI8@87DW89(R>P[ZID @$@$^@SW..YQ\<#53RW5=.--0T(P1_=";
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MI,F(\N-*CJ<96M*7XTAIQB0UG.'&7FUM.)2M"DXN9'0@.K(2JL RE25=0RL
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MHCY&#S16"MD=O:![=M6E5)#%5)'H2 2/R$C(_LU9(;.OSEAM*(<"L$K.(]6
MV]Q(R \7C(*B(I&,*,251LR'6)H6;$?3%>=<9<AOMI4C*<]W&=VOP5ZI>2U'
M5F+SU 9)%A8Q3-&\L*AN(9)D=2Z@$.I[Y&J 1EGP$+#"OV&>X! 8X]ZD'!]Q
MU?9%> 2V)D66##RHQ"-$ASX\@9">8G0X'?\ 48LQIQA3<F-"\1?JC#R5M1^^
MOP4([V>W MBPC(Z3S*\;.\;+*ZM&[XYNC!@59\#FRD%L#).-7%5.05!! !!
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M+K'@J@JEK>G/LO8S'S(6Y*<3EU2EYPK8M<T*3V.H)%="LLG,2A1&K(0W+J!
M$5A[7$!0<8&JE4P<JN,$'(&,9R0<^[/<^[/?6&F[!IVL,3FSLZA"&:3#'6V9
M'E(#-9KD4Q(=&"3R8N&\K@J*2V'!XZ8PTEZ;(2F)&4XXM#:I<,&\66C,"7YF
MNO+41DZ[>8:%5EF@YYPXB1A)(C$JB^VP !(L8PH"&Z:A '(/'V<Y4-CW9(X@
MCN3V&LJ@AJ>5C5TW "@)<>' BR:L0;$P<Y'CY+#;\189U4;#H]AQA;:VT1?
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MP*KE.8?J,B@]UCY#'-3QRP.,C./=G6M\+:O46&J$6Q%K-9C3QC5&E]FEL*H
M5MRJ29VV!H*_B14 56TOO1LT3UR86ASV296'EN46@+'-Y;:C](^U>'9K;5X:
MU6$0[KO.V0CY0F/FUCVF6?;YI9)K/%6\_P $A>-HH7RL4@D.2T8360@9F8YB
MAE/VM1P)F"R  +G'3R6!RP]1Q&O&RG=A;5L$,K"D7!MN%=.J$50"\:K.!2D"
MJN:6#/5'U.,1 QWO#*3I<IH7/*PG",U4OLCR<R&XZF*UH-OVJN\3K3)>EX7E
MW")K8GBDM#>IA<YO'889B1%,L<4@C0)[2\2P:K-+*Q(+Y#VEC(3B0O14I@%0
M>Y/8D9.>Q]-8P[L"^4^@A[D L9J<7&=,^M&'+T=H(:79X5@E[P! ;%5W)3]3
M@DRK(B%*(!XX23F2[/\ 5T&%KG''U&WI*[?0N;A-3L5H4AE\2[DPHU]PF2L]
M=-DGL5[05;<D433.L<SSJ%"<C" D"] 6&21(U=68D54R[1@L&ZR*4)X G +
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MMYEW$02Q6UZJU+09$FE>58V)1W<J-4,EDH3S=>,,TBGIKF0I)B,L"IQR0@D
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M-QD@CLQ[?=>M+(L45A*L[0RRNXB2..58RCR/*1&B*Q9I"$4%NVAEC#%3(@8
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MN?.6^7(MYJQRY%RV>J^>1D9Y"V?4R.SDYY,S9)D5\>7@QC'1BQQ"A<<%Q@(
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M?#!(&LLVYJ/8E<:G'*ZXR,N6Q]_[+I Q<5QR7F9K7?8.$(ESY.8*5*BRZU+
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M-61NL"O)F$_%\IQ?F<QAO9YDKVP&/%"N5./6Y6CI'-MKO<JCU2JA5DJ=H87
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M^H^CX?N+;7:<2>"U<1GY1(ZG _\ ! <<X_"K_P!)[X^N4CW9\F#V\P>CD;Q
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MQ]'ECT/4X]N!RC?B9A%Y4=Y^CRZQ[9NI3Y8Z7?[KJ8R/3AGOR$="?2_SBE1
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MEVZIF;ZNYEA%C6:Q$=4*2*(YD\#*]B.#Y3(YVHJW+R8.!+NNV[9SX^:&>(W
MS<<C/2Z>1SYIC/B,B,R>3!Q!+-CKD?S=*W;XYZ)]?*]/..W/G@\>+241]*+,
M@7LK2\:3C.I&;/L6NL$<["=1EY 'J1W)T_X+^J>XI6&U2FM3HM68/K*\,K.J
M"XENI&X*SHL?A!7KQS_*!'.G%:X^5'8R;72W+AGS'?CYPP\L#/3ZG$<N"YFW
MXB5X_*CV9I(L]8]^%ZQ3Y8Z7OZ'4QGMSX9/'D<.$^EPFDQX6=G0L5G)<=79V
M6L;+=<]7R>UUZ/*^9:POW!H\7$577;(%X7W6_&3K!F9E+6;BN+6,\G@E4>1/
ME(GIO*F?* 9Z=KQ16SCS)QD>' ^,G'G"N3T 9K!XA)"'R@]I8S_/^G4AV>7'
M\S[OE;C\_0SVZN(Z<KZ7><, F3>-!17LB:M<+)B-[YKS>'\U32/77N'$/+WN
M"7X6)R^C!BOYD>&YF,C8KQ3#+^:J@?8JQ^"5>2./Y28=2:"+/E <=;<?#M#E
MCS(SQ&_&7&1DU0F1UBT5&\0E4D?R@/!9&QU\9Z=7=;.,]$XS\F</?CK<N_3P
M^=L>E#F/WV/2O>4C)2_LZ#KKS+WPG5*2B9U)UKI^R7]4]Q6,94VU8,VO$'UC
M&%.1,!/6TI>R5:C'P@HK&Q\H'(IM;X^5'WNU2[ET\^8]YBZ/+'HW4X]N!RC?
M295C\J/:L=#/6/\ 34J<L=+^OU..?=PSWY".17I@)Q.I!+/G0$1G)?7U*O.8
M6-G/.8CJM_3KTF;Y4,Q(]P*,NI'N=3KU7Q,\%O,I%+;,YC1U6!0L+*D\$+'/
M)#\I,0EJ>MR\H 3T=TWK;>>/,G[H;0)N.>W7,>3TN<F%?$99%?R8'*%)L=<G
M'.EM]OCGHCT-XQ\L=^ERP.?%;\7]+--%I.JQHB*]Y+YSC&,[)=;]9\I9](^]
MCMS[A5^%X_[@.,G/L<\+WU'\_P!4]Q;>+39'X*5S&/E(CJ&/_P#2 XY_6K_^
MY&<?7*?AGR8].N>C<WB J&_D@/$.?Y_UX#>3_P SVS\DCXXZY_YK[9D ?TI<
MPI<@53SI&,Q@SL2FT/,_&Q'7,QTVSJ,Z5M"**8C>XE&'50&^I1ZTXA^.WB2N
MG-ALRF$GE% ^*3P<J5I+'R@3TZMBSP\J!R,&U;QN7#EYCMR.U"'E@X$YDP>G
MP>]-^+2K%Y4#E-%%RZQ[=2Y0J<L=+[WSW4QGOTN&1SY)&T7TQ4Z10HEVST^1
M$*E:O';&R-]]!Y6$+G]-=/Z@LB/6_>_QE26G;7FJ>O>K)RMN#@UZFE4G(IB5
M]8RBR:_RF>UQZO/R8^\W6QMG4X^:]X@ZW'EZOT^7L\S@'B0F%9?)CVH$FX^8
M/;E1CN\<]'W=3IYQ[N>._$9V7]*M,%FRXC&C8S^!=AMP+$C.QG6\OXJ^ZNO7
M42966O<.OP\S6^BB.?RSXB\1U[(>&8=?34T3['&3P:KHC_*)'**"3'E0<&:A
MX;O8SY@9XGQ 8LX[^4#]NN5BS-OY5V3RH/%W3/6]>%K=ZV<=+MGY+YXR<=?C
MD]/E)ZA'I6YA0F('YT9&8P4)5D?EW&QW7,L8L.T/1Z:YR[A'N&1XGJB.NN07
MPCO(\=6L68.5M8N#DNLUD\&K'&S_ "B3Q25\>4 STZ?B>UC/F/?];HCSCMYL
MM@] +,7?RQ4>5 Y.BYZ_ISL;/!G'2[X^5N6,]^AQR.KF/8'IJWH<ZUF UM)C
MU:ZJ5.B:WOSU,!GST@B>.V0<S:*XDA<1$RI2LB:L4"24$ #XB77[L.*.#+(*
M>A,9:D:W=MNC\/EX$86I[!M5Q8DBC"Q1Q.T,O"!UG7G,DBE90XEKN@>%PQR)
M=*T^Y\9&'1CB$$W31W+.TBB1 TBF,\492&0J4E5BKKCMKH5SF-;C3C33C37_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>g904779g88e30.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g88e30.jpg
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MR+&,,AI$A*>UY@9 &YI<SI?2V(9R3O5L2H_K)O*:WF'RB#:0J(SWL?GEW[M
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M<S%G+'^Y)_Y1_P#TG?\ ;UDFL8YW^V;^4?[=;:LI=#=-*?35-S;,!:QYKZP
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M%W>;"YS%)&5 PLBQX^VCY&M%KQR#/2OS; C8[;^L;$#;Y]^GQ'5RQ>:7(-!
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MQ'\),)]XO_FM'[R7S'^>7C/^K=3^H=/VQ6 ^#^8^_4OSNG[6/B/X283[Q?\
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MZ=V*WQ3FURE>%U?W+QT$E:&P5((6S<ED[\PL>CQ00PR,/"RFY&KPJVNKZ>O
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M%8PJ60IL#G>ZX,A&>T^EN?LC,:L#^Y_#5Z2R01&+ER""!6(.S.8$L2.%.Q*
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M"('&R#XQ,=COX^GYM2Y.-*\W=]YPYF7[J59XP8!LLJ A'V! 8IN67F!"L%<
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MQE5&9Q9BEYU@YU'--,))2'B-&,M$?<':)BEQ\%>3 +';;'YBED+-)*-86!E
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MEE7U2R,%HYH&R2+^.1Z1HYZ_C<JKUR-P!(9L3VH2D!3+P?<D(7HH+V58@#T
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M%+TZ]"2!Z_U]"[JN9[X-S$DM++TIX]32DAL8U3^EQ".F1/QJK/#OM\+YZ\-
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MQ^?,L\BJC61Q1IY>][W*C6-:USG.5&M155$Z@Q"@DG8#4J:9(4+NP4 $DD@
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M$Y_9F=F=V9G8EF9B69F)W+,QW))/4DDDGJ==((B1JJ(JHB*%1$4*JJHV554
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M=4Z,ZGS"P)]"[]=O9Z=8'BKN5IV0<1+:2S( O=U5:0S!=R%> *ZS!=R0KQN
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MD5'B 1QSQG*&6R>]3AQX:T+"6>;RP!96DECDP-'R'V.0 _$8[B0R:P%,Y*.
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M6PAK#AVC(T6#$.2AD(NS96S'5J5/*3!5:]4K*+-B+//TA4O=+SG(:T=A[C,
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M(\UR+&*].IK$*-SO\0ZD_%J]9"_!C:LENP)&CC*+R0IWDKL[A L<>X+D;EF
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ML<<CNP=>0-UT\^0V.:WV?#U60MH+N@L)K(82R'C(BCE(I[0VDM(%B+A')BF
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MGMV&LH;=^ 0^QBS\&6D*M-#I[)QU"/QQ+Q*ROLF&7$L=BQ^!E2CFD+9+-,L
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MI(UR=EN*.S'.T9L;F.)>#,C1G [VM:S>(EC)'577>UO'*A\Z.6,K+&WG(ZL
M=5X6W9_]$E9'SF!\_P"-H()GJYE74]R&,E &155?1 ^\,N;)6)Y\)\18$/\
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M[[$@UU'@;L3Q;RR8WM$;'R31&&9Z/'N,J/+"65S%*T#1M)&756Y&)7F56VW
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M,GL]^F__ "M:?]]7(_Q6]I7T"/SVC[^[8_S&>\[]%C/VET][*A_&3V>_3?\
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MR5Q%^>GD?^I\S^K]/VQ>=^#N)_G%S\K3]K'P]\)LS_-J/Y.C]Y*XB_/3R/\
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MTW.4W46UBN1#HVP[F78^)!'-&=NA"F-=R/LAN3K'LIV48"XC&B\U";Q4$B>
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MV(,SD^328_GYB)I!^Z)_7U>'X/#IX=-5%3CC.UV!DEAM+N.82Q*C$>D!H>[
M)]95MM_#49]W@^6>#/4=LXA=QQ]&]&.W^;$F'?41N>C(GZRAEE)*I(WN7PIX
MY=K31JL;";,4B>$9U5'8#=&Z'U^CQ_L]@^76Q<!QK2RC)7GWJ6VZ"*1@4E;;
MPBE\T.?]EE20['96 )UW G"V(L)@<S)QYV(^.2-R.:YKD\I\T54ZJ=9RK!AN
M#N-9?37K6MMK>OI 9["S)C%%'8Z2225[6HB-3RO\94Z$[=3KR[JBEF.P&LK
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M#-%(CF2Q2QN<R2-[7,>QRM<BHJIU$$@@@D$$$$'8@CJ"".H(/4$>&H$!@58
MJ0000"""-B"#T((Z$'H1KS*7>03C3DCE/BZ/UH%@]W?4]*DKG/E3..,>=FEF
M<Y55TS\^96/E=Y5'/57(JHOE>L>#\@V3P%&PYWD,,8D]K@<DGAZY%.V_R:XU
MXVQBXGB#(5$!$<=F3N@?1"QYXO'Q^MLFY]?QZF+]'/B!M5SGR1R,?"V9G&.5
MJ<[G_=;ZF0W>\GL7GV J^/P2PJ+/3UKW^4\":*9GI<DGJ;KKM:R3CR+&HQ".
MSS2 'Q6$*JJWL+OS@>M 3UUM'L;Q:%LAE'7=H8XZ\)(\&G+M(PZGSE2+D.W3
MEE/COTNKZTEK?6CIIHZ::.FFCIIJJ?Z3W$#PU?#_ # ' C;.CUL_'EU-$U$D
M)H-57'7%<\M_R]<%1=4+X@V*O\'-HBE1%25RMV?V79)ZV9EHEOK5J+O0">@E
MA95.P];H_7U]VH]&M2]KF+2UA:^0"CO:DYA9MNIBG5G&Y\=EDB"J/096('75
M>]44V EBR>%@G1(Y4<GEOI?X\*Y%3YHBK^$BI_%5WRZW%Q?ACF<-8BA7FMUM
M[5/8;LTD:MS0J1Z9HRR* =N\,;'HNL;_ &.?:6O9EVF8R[>F[OA[.@</\0\S
M<L,5.[*@KY&0'S0,9=6"S*Y!84Q;C38RZ\^_>1P;/PES#<#@"21XO82DZ;'D
M-A5@D0ID[I+&CB>U71^Y0FRJ*V+U>ZE=)6DR-:A3/.0< \1#B#!0]\^^1QX2
MG>1CO(S1KRQ6&!V;:PB\Q.VW>K*@)Y#KI#M=X+/!_%MH54WPF:+Y7#3(/K A
MG?GGIQNNZ$TI7Y%56)\EDJRMMWHU$_K-]:MUF 'EUA,98<KH9HU^U/FU[?/S
MCD;]CXW?8YJ_Y4\*B*GB2-)5*.H8'YQ[0?0?;_5J*L5((.Q&N5C8E6A<AACT
M?/)X15:QK&HUJ>&M:UJ(GAJ?)//E5_&JKU"*)(4$:#91[223Z2=]]&9F/,QW
M)\>FWX-3Z^CX[<)>=.;\_#;UZSXG%2![;</G']X(D.O+CDILR0KD]ISM%81Q
MP3BO<CY*F&XE8U5%<B6KCSB(<%\&6[,4@3,YU7Q^-4,%FA$D966TFWGCR2"1
MY@X&RV9*R/MS:P_@OAQNUSM;H8]HS/PCP.Z9+,.4[RK;G@G1DI.3];<9"Y%'
M4[MMR]*K?FC)7<:]2)N?BWW(_$W&9#$FK-3KX"+T5418B\]FQ"]/=@S^?*)!
M85E,2 _RB*OQ2-8J/<WSQ#8;EC.WIZ?K\NWR;Z[XXLO-C\-<F0\K]UW<9'BK
MS$0HP\/L3)S>D#E^/5OZ(B)X1/")\D1/L1/R=6[7.VM%6:C-71]I54VBHK:T
MHYD'NZVLMZ\\^G(5SV)!:!BD2D5\ROCD:D1<<+U<Q[?3Y:J)Z9'4*S(RJPW4
MLI 8=.JDC8CJ/#?Q&KA;Q.5H5J=R]C,A3J9!#+0M6Z5FO6O1@*QDISS1I%90
M!E)>%G79E.^Q&M[UYU;]'331TTTQW<EC&;GA/D&I;$DEG7T)6GS[T3^%BT.5
M8M_4I"]/PXE+) ;7$/9^$\(TJ%R/CE>QWI&*L"/'?\>KM@[C4,M1LJ=@)TCD
MZ]#%,>ZDW]>R.6 /[I1ZM]5AWNO=#Q*1I8E5TTE%[D?H17/=-)#X:UB)\W/<
MY41J(GE57QX\_+JZ$^86'CMN/C/AX^W71TDO+5+GILIW)W] WWZ^&WCX[]/C
MVMCXCQ G%_%N+Q;?9@^YS.!QVQ"JR..>YFC6PT=I,_RC&NL+HFQL9WJJ,1Y#
MU\HU.K4268GTD]/7[!KFF_9DR60LV=F>2U89D4 LY#-RPQJ -R0G(B@#<[
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M590D4NU.S?\ 9 7LEEJF"XSAIA<A-'6J9JI'Y+W-J5@D,>0@YF@[F:1EC%F
M0"NQ4S1O$7EAEA])IGKNZK>T=^7TBY/52]WO%^>S6B=5"7<6>N]#!<K5Z22H
M.<T.U6ALJL,Y*HM4$L6M>,2YL3U\X/V/6ZU:;CL7:?EU)> \U;N5._DK&W6J
M-7[ZF)X@9(/*H9Y(C/']<A)#H"PUG_;;3M6H>STT+ON??/:)@J=*X:\=I:=J
MXEDP737E(CL>235XY?)Y/K<P!1R%.E=][WW]?_3!0O\ W7N+/UGJA^JKLO\
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M VN.^'7XMR/#W >2P]1^%Z>#P\F3GP%:[7A>E3FXAJ2+D8\?1PMG)5UR'D.
MQU'*2UK#7&\3=^<M;G8*W8\LA5#[3;34P<MS12;'$6ID^ 3+6&RD,[J+1-=D
M!5K]L<*)H.1^74#BLIZZRX]/B*I64<X6,9NQ:* MRQ!O-;NY !-W@3:DO=N=
MX@2D,&_*&$P(;FRR#C+]CPEK)R6L'P;/=%3 I>G2ED5PF>IP1\2'+UL(L'9#
M3.%S4PLX&O--C>%^"S.]6.U5XEKR0WCD)2\5<=]PF?YD UNMOMQ89>ZUW=-'
MJZRXY!AN\H#D3>2*RS[>'4>0EOCQJ=?N66V^%=3A)<58$J4FFE$A@KZ^"CFE
MJM7:-%C#JE(HRQ%9#((66WS2<@+>?R[\QY6/G)ON3K4G%_$W9KDN![&&P^.X
M?K9:AA>R)L/;H\-R4,S8S5?A>U5[3!D,TN.KRW1[KBIWHNS^0W+">7XI)I)+
M-F28NG)&#S6A,-5J!BT=L26K_",0:  B6=7*OR1J1->KO/R\>>K;XZT+"K-+
M$J_9-(BKMX\Q8 ?A.J+R/(G!6>G*_!'"CIBC?7\FH(.0-,3Z_/V-]EDGGY*B
M?/Y?+JYMOW1])Y1OT^+XO ?^GHUTG95SC)57<LT+JOIW8JP^/KN/C^35N/<_
M@-/RGP-R)A,8@T^@OJRN^$K3+!U6%HA*V^J;BWR1=DU%:$)L::OL,L23+_N:
M*"X>XM4&25R4U*5(;44LFX12V[!>8H61E60+TW,;$2 #KYO3KMK5O9-Q)B>$
M>T/AGB'.&6/&XZU:,UN"L+D^,FM8ZY2I9J"J=C8FP=ZS6S$42?77DHJ(?KW)
MJOWD'*<F9W7.Y'R'$>[[?\?R)MNW/BPOB?CS5X'*;W>/H[#DDK77;3./M?)B
M\VIU+=TV.HS"=A5''#4T!AUAFHX*PH>Z1/"\?<O/':DBCMSB>:.5XH@RPA%V
MEC[UMF5G8"-@"VP#[D:Z/X;S/"N3PHX7S7&?#W:1F^&<#VG<70<8\38?B/+\
M.<.KD*O"T.%Q_<<2X5,[E/)[V/O9R_!%A+=>O+>>"O6RK26X9"J[?.YY]T!I
M[^EW%SI;?'\'U<MO=\GYVYGI*C!=Y=IOB\KL?BMF@MUIZ7@<W/R3WE367%?9
M7-;L4"NR-'>S2Z2#6J?(45HU59++!5A=0S2X]8@\>T>ZH]D/YC%2%:/=0B (
MM]I/9.M&QB<=>P%'%4LWQ_;2E0X3R=&._>XB[#:G#D&8PG<X+OJ.)O\ :'!D
MECH7;5*S4HVL(9Z$>,QZ+BU37<*=X GU=?/UO+DN@'K<'=SUI7-<)=%)L .X
M\S[I!)Z:?5RTT]-][T0C2Z5879NU<V%9!#]L- Z+R;- [KW=<)S2*"*Q#]V:
MGFGF"<W-Y6.C;\Z]=B(CUM5GCSL3F\IQRX;@Q<;+:XBH1VHN WAR"86QV70C
M%SQ7DPR7H[WOEQEH;X<92F.<+-7P,LBOK:OBWNZ!M\#5!4'+65ASM9RH<3J<
MYR]C)L9;;31[_D(WC<39X(GD\,"+"YJKNJ/3:PZEQ6KUFE5@&<C#&AJCX+'T
MTU!EE8O Y=H%"/!+WBQI#$)FCD$)/>NRLD:M+'&@W<DEAM4V^+NQ>Q2XCMV,
MCP;EWR=OA"O%B,GP5G8\Y2P.+X<X:@XHFP7$4/"<]EN(,K;H9#$X>O?SV'P^
M*!LY1IY7N5Y*TG.SC(\]93.ZQG.-MM"B#I\LM/5;FQK[RR M0Z!H^SL:V[%Y
M:Y?**HKVY]D@$8JYSXP\XQI53CLW76$-;!19"2K(\?DRQ@#GYFB4H"I;>,%3
M!7 95W!(5R=P&D<CF.J.V_-=G>9R>&;@"E@H8J\>7%VYP_5LX^K9ISY$RX*M
M;H3<&<$PQ9''T"\5B6&ADI9(Y8(;N<RMJM):>*&]&-N>=^;IZ&Z?200ZT,4A
M\(0YS2RP\W1B&.5)W,2)\9<$\;T9Y\O:Y7?A>4Z]U2HB',FYW;KS$'J=_BV_
M7?T:R?L]NX^OPQCH;6&2W.%G9K+7)H6=)+,SQCNT0J B%5&Q)8;,=M]M8'W.
MZO\ ET1_45?_ -]U4\T?[W_\;:SCW3PWP>C^D;'YO1]SNK_ET1_45?\ ]]TY
MH_WO_P"-M/=/#?!Z/Z1L?F]/KQUPCR19N&L1N4BZ$HB)[T<F0JC9( )/3XF?
M[Y<:123IX1D;6M>YCVM=(U))&MI9;$0W7N0P! _SC?9;;^C;H/C]>L!XEX[X
M7JB6M+PE%?BB91M[M6X%DL+S>8.[@/,J?NF)(!!(4E5)?Z+B+FN"-D,7<E:1
MQ1M1C&-XVS*(UK4\(B?^$/\ G5?*JOS55557JG[Z#^"K]]?6O'XQX&D9G?LQ
MJLS$LS'BC*[DGJ3_ */_ (#T:[/W)^;_ .<I:_HVS/[0Z=]!_!5^^O\ V:\_
M5=P)_%A4_I/E?T?6L[4@RJ_,\G@''NM#0>;-N&99O@C%?8E#!9^$@]PL3GQ#
M.,E8\AT$;W1PK(L;'.:U%7U=(+PD#8&O&0/'8$OL-_3MX:J^UV:*SE.%;$%<
M5()^!<#-#561I5K12SY)XZXE<*THA1EC$C*&<+S$ DC3V;JSPH%:R/<NJWAS
M.<HPIP_QA$LC4\.D#&BCF+1[/*-<0.QJ1>MJ/E8CT\T\8D+?6]]P/$';8>TG
M8=?;XZP3 U<]8LLV!%M9D $LM>3N(U4]0L\KLD.S;$B.1CS\IY48C3%K>=N?
ME?\ P)+]OX@[I$_T)\4GA/\ 0G^3JHY;7VWX5UGWD/:3_#D^_4?S.OGUYVY_
MXDE_U.Z_6^G+:^V_"NGD/:3_  Y/OU'\SH^O.W/_ !)+_J=U^M].6U]M^%=/
M(>TG^')]^H_F='UYVY_XDE_U.Z_6^G+:^V_"NGD/:3_#D^_4?S.CZ\[<_P#$
MDO\ J=U^M].6U]M^%=/(>TG^')]^H_F=985CVY&$,'^KH1%D<C6RFP7L _J5
M?"(^9)WQPM_+),L<34^;GHG4"+0&^Y/Q%2?FU)GK=I4$;2>4O,%!)2"2@\FP
M&Y*H8U9SZE0,Y/0*=.M%Q/QG/%'/!FJ^:&9C)89HC#I(I8Y&HYDD<C#7,>Q[
M51S'M56N:J*BJBHO4GOI1XN?F']FL2?B_BB-VCDR=A'1BKH\%=71E.S*RM "
MK*0000""-B-]=G[D7''\E@_]8L%_ZS.G?R_;G\']FO/U8\2_=:;[U6_,Z6E1
M25%"*@5-6AU@OGU+$'!'"DC_ !X]R5S41\TBI\EDE<^141$5RHB=2V9F.[$D
M^T[ZLER]<R$O?W;4]J7;8/-(SE5\>5 3LB[]>5 J[^C6TZAJDT=--'331TTT
M=--'331TTT=--'331TTT=--'331TTT=--'337@[WE%H<OM]AF]=&1%J:'3WM
M1HV%HY"4O*^S*%M'3^O\)9'FQ3/<]?/K]7K151R*OTRQEFI=QM"W0*&C:I59
MZ9CVY/)I84> +MTY1&R@#T;;>C7RGRU6Y1RF2IY .+]6];KW!("'\JBGD2<M
MOUW,BL=SX[[^G4]^*>X;@_*9SA\+7SRWD.8K./J^RR;N/PBH<QJ,_P O6FQT
MG(3+^9\95C+98*9<6E97I++91V\OQWLQU(BOUAF^%>)+UO/R4%%9KDV4EAO#
M*R(UVE:P,./J8HU5!2)8<FONAWTQ583 O=<QGD VS@.,.%Z%+AV+(NUI:,&'
MAFQYQ$<BT;U/B*?(W<N+;%9)VGQ+G&=Q%S&9;#=[RK7C.FRY@WO$G(V-OA8M
MI /JP=F3JZ:0?&ZB>&_K5P>>HQLZRWN2I[:O<VZJ#)G.M)I0(G'>_ UL:.:E
MYP.,SN)R%5SCF:C)CUHV%?(4E:K-[IVK+VS!718)0:\\:@0*LK=URN2=B;+Q
M'E^'<SC+4:Y-4R$62?(5F3&WG2W#[E5*D=(6+#M/#_E->1R9V:)3+S(-MP(?
MT-1;Z"]I:'/B$GWUW;5U12 AHY2S+:R,A#K114:J.4@@R:&*!&JBK*]OA47K
M/;4\%6M8M6G2*M6@EGL22;<D<$,;23.^_3D2-69M^FP.M<5*UBY;JU*<;RV[
M5B&O5BCW[R2Q-(L<*)MUYWD957;KN1KUA]^,14%=V0P'3H2;#WP]N\1A*>40
M@J.#3,(G3RB+XEE:^1/*(OAWS1/LZX>[,V1Y>T=HUY(V[-^+&C3[1"U,JO\
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M-M=6A;T:CR#K(Z6<PJ54:UJ/FE=Z6-8QJ-:QJ)M"ACJ6,A6"E!'"B#E7D14
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MCQV_7\&LNO8FS2W?I/ >JSQ><I7Q#.HW* CKN24]3G2EZAJUZP;*L!MA)0;
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MY9ZX6V='%(P=2%^#N!$7RK6A6L'MJ]&N57)"0L<"JG\(V;U.1<OPG&%[%/\
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MZI)"6CPU!6K2%20PBL6[U>&;E(*MW3ORL"&V/36&9[AOLPX8L&IG.TSC"E;
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M.[[8/XM^#A_^Z\'_ %Y<Z=[V)_QH<;'_ />_$']6&&A3/HT'?QN^'N6=_EY
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MR%B-K^7N:#@YV^J$H3DE"()6^?"JR6*L<QWA45%\+Y:Y%:OA45.I9M.#L8(
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MHLQ5S-)Y-6N61!760SV&KU+4RPQNR0.1MKGKA[$1YS*0X^:]#CHY(K4K69S
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M!J[\+8R+%8&KW$2O9LU8[D[;JKSSS1"58FDV.R1AQ#&>JJ 7VYF<M7;1=\6
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AFCIIHZ::.FFCIIHZ::.FFCIIHZ::.FFCIIHZ::.FFO_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>g904779g90x31.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g90x31.jpg
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M 0$! 0'_P  1" ": ET# 1$  A$! Q$!_\0 'P !  $$ P$! 0
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M(K-6";)J.5EQR=MV.6#LGA[%#0Q/&0A)BOZ\S[(/FV]@17!!NB4<J^S.K3:
M+_+*"ZJLNP<QAT;.20Y*9F0M^^23ENNY>/C#-;*L7C("4V4Z:/2!XD==FY:S
MT42T1#_&.DDS.Y^?<$4A'(1.$3A$X1.$6E%D=!:&M&36W-C^9LQFEN3^D;3<
MRT!(T!9^!6%U] H1FNI76C_Y4OO&2C8*DNQ+;N-2J11N1)(*I)MW6R.LSZ@1
MZ9^*+Z>]"J,>8(KZ+SA@8>=N?NV&4B'R%F@< W:HQ%"GB@5UN&501B!,0*P)
M*1AZU?-R ]\_;N7&^%4=FZ3ZH\TS[45J!_&7U)C\/JR-@H)\HDU1V-&[6CMR
MCT(\VO M-8Y*GDP^8R^RTX]@S)FYTH0>HR$<_P 98D!R^K%-!JFU99;)/-%?
M].]*ZYJ"T?MR*SZ[[;L%A"GU;Q$Y=]FD;$7@4$*%F)HK'8IL[9LE<:E'XL9N
M1.2!8_*7:+!%LL=V04=)N$^V46.;K\:U#79)[/D;N67?7#*\T1J5Z0FJ+-=Q
M.O[C5%-&XYJ_G$3<C3##<JH,:-ASXK'OD! DV2SD@X<N%W*ZZ3IV;:;?/:BO
MF3](8#*.P<"[(+VA?0J8UDV9"X5&PEBHLX"%CFC:+-3T40CRP!TYS')OI$!*
MDU8;%??.+[/%<N&^7&/3CY^?2BLVKO''3-5%K$<#K OJ516WG]BD[6K&=65I
M(*YL=_:0=^"ESR9A-0+%\?>.AQ#=%J]?%U'C7X9CC5QMHU3TY,G3LT'F19,Z
MX]/H9UC7PG#+1[ RZ.CHQK"H;!K1MPW-X/7<32>,';8)"XZZ1:MFJ;!,6.&C
M")G<V;%A6N PXFU&KNVS@3/G1=$3T?I,*= R)GM,?F$<[361W 'X6/-]T,VY
M:8N1")1HX2P+URI%=6LG([# NNZ;AHMHUW4).-4E-%4GU1YA'P"+%1?Q@]=2
M8" 1]C(;JB:, ;WB'3)0JS7L5-RR&=B)N_L&T*_F)02.0<$H>6D1!15HT'Y$
MDV#9)!!,MMMA555)]G#EM\$53+>-7KR7:Q@:J5M9D% ]46'3(N!%3O<<(GU)
M!0!L#'&,[;-A6NY601K:0DC@8T/6$>F>RV=NVCQLT;LTTGUSY_D(N"-^-.A@
M&A11]*;BF!8W.^N-AE3\MF8I\5=G>K!!^]J5OIH.BXD4P#,6[[426%"QC%N1
M',VN=/A".ST@\B?AZ45SR7Q^TG(5B!%J?M2)2-YVA-=N6DNATS1"R4':LDAS
M. R! *^R%=(-HF7BS/ QV%<-';GW7#E5 FBKNGLG,GU1YIGVHL^S2A:]L"U*
M\MZ4LWI&25K#+2@0,<JNW4C+^.7"C$V\T:2 ,X9KZE<N&\.%-VF-G"*"**Q!
M-=!UJYU]&/GY]*+4B+>,*C:ZJ9M2M2V5V0I^")2>Q9&\8UO<+T&L;;V>TC@^
M1QH_\2((LBX)J/BPIC'%GC'>21M#8GD1(6RYDJL\DDG?7Y/+O^**NF/&SU_^
M80(O6<@NGKV8@55 J12+4):IR DI75D9WRJ!BDV=Y3+*G]A:ZCERUD><M9?H
MX=*+9D&=TFF6R2?3/G**JLO'M2[*?6A,OI?=;R.W7DQ]MNG2%EO'E/6)J>KG
M2KB/TLBRH_)$NLK&$6NVKYR?V(Z%F;0EAYZR&FO(]R*_NN/4:)=9MMT(G:?8
M";@F<;:PV)1*V;9,3F)5]%&3ALNS!PP"X;LFC)%HDQ8#FA I@N;9B&+<0U*(
MCO6;*R3*+"*WBRZJO-IHX)M+ *$[2B5CQ*X#3R8YT,6ZE8]@:6AN?GSYD,:;
MOI5!YLBV*UR;$ZAEHJBU;BDDW0E/X'9)]$1V1\>/-%E9MTLA;H770^<VK>]K
MN:LNZ%7W$#5DSD49+,IC  IP%'ARNPR+!!^\;PTD!%8FS2'HDRS[9)X0,+JI
M^W8#$]HA%9!KQQT>^<,S<:EUT5I.1EIWI:XJR:WL!.-S@:4['%DC5L1IN0W!
MOQBT/./6K#=F,?B'C\+L-9N!99J]U6=K)/L]6R+2>U/%A:X2U8Z>ZD2^$U)$
MX;3]15754E>3Z=#)A3SFO9?-I/()<_A?T!G4<O4K*%9N6=82D<OKO5-\^):O
ME7F'[AVK,CCKJ3WSZ(\WHT1;]R3H/2<GA-APMR2L 9FQ>RR/;AY)@LB8-9'&
MKP:K1M=I(8KN[!OPS<:S5C##9L!.AI .]B[OXA-QMLWW;1)T[!'FU^,(ONM>
MA-(5<=JN3 R-BE3U16K=ESQ\K)Y8F:>EY]V C1*+V04E+G<4BL8T(M"SY\S2
MUW:;M"J^76ZRZ>/A^)/IT]$? (LI]>>MD(ZS!)=%J[/3QY$I1-Y-.6$5ELDU
M/ X*]EQTK)CP:"-\L&BX>/O9 ;*EU&;QR4>*/7BJBQ!7&--=(^?0BV$X1.$3
MA$X1.$3A$X1:CW3U],S?L%UZO",+CM-H(%M^I;1&/'BPYT<J"X8RS4<KA723
M-\FK((K/HA#"; >ZT:M78A_),Y>IO$F**[L183@'CIKCKHS"S"DC%F3>P*3J
M.P85UBB5RVB_/5S6,AF879 J0!M\!=EP*LS)-V;>5$LI&4& =9VSCH1@R3;#
M=)DZ]N_;\_M1;4=6:-8]:>NU.40P?X+XK*"!8X1-8TW3U.2'1'+R4'M$E/W1
M%,Y)'94LFAOG;=#1YJCMMOMIG;,'<\$6?.$3A$X1.$6GR'3"#C.PTS[(QNSK
MVB$JL:3PF66!#8O8:0RLIF1@,8#P\&WD43^1+*/QR@$(U:$&NQ37XGUG>=%$
M-5\::/<BQ<+\9/7T#-HE(P$HN\+!H'<C"_H=0+&T'N:%C-K#C#N0MI(!@[L<
MZ>AF^IT@1*_1T6?9QG1R0>:HATFR^Z')GV1Z$66DNE5,H];;.ZK:;2[%76R1
MLTG*M\G6^9+JZMB5E9E*/E9?Y9Z#--,N7=8%:*CW/PC35%!;+O?3=51)F>4>
MK9%?4$ZVUS6]PSB[8CM(!LKLB UW7\W'X*);QJ1-:L;O1\+DK\5\%JMO+Q@1
M^M'LE]7VJ*H71%KECA1/"^8GAR]Z+6@%XQ.N\?D#LTT/6\X888]A!D<B+^<-
M',3A [L^U)(6\UBS#Z/:/M=S;@FJ0:OSQ,Z58NV[%+5^H.:),,3)]GJT"*\B
M?CXH$M'"<7=;SK TMTZBO1QULE(VNCG%)PYP3=!U$5<A]]-)EZI9UET>V2W:
MKZZI:X$I^YM[Z2/3/G18 %>,&.R#L->MGVK-9:_K&:VAU^GL(J>(V$?8Q&4-
MZ(K&"QJ/I7C$7 %J*-/ \UB.QX,F"*[I$&7P?SYVOIHD'8IV[ 1Z9^*+885T
M H0-)A,L:;3?)4-,.TTW:86D;?=KDUW 3;)6YA9'43IMNRT3:(Z15#573<+C
M&V7"Q+;;WN)/L]6@14ISXXNLY**Q.%'!,K/QB'=6"O3\<+*23/N.JF+%8L;5
M</W#!BQ=YF30I#@KT=(F*[#X)PDHJBQPIE'9%)WGC/GU^)1<IWH+!)=7PN"S
M6Z^R\Q(1:PH=:%>V2=M!CFRJSF$%8%10(C"38R*#13/.XHZ9'&<E@)E<^W(*
MJ&5WKI%FX;0BX#?1\%%.G?8[J_1TD+,7]["+B=*2JV3IJ<NMYM<8QRUDIF1&
M]=DI"_T).W"SIT_55(DDG;I<BMJ5WQLS7F3()UB/0$6L-&^-*=ZQ U"+_L@B
M!AL?L*H[6H:*5+:):?F*EM*MQ,F&G[':V38=20Q0LZGFLBU3=PTS # $,BQP
MY;O7A-9-XT'XSRUY!%G]]XS*'(U;'*2=S.\EJE#R^134] U[$0=B+#+R2R5[
M5=[3EP]CSDPZ5;2MROLT,1\G'9/L,5W'OSS]/??;:/GT(KM*>/NDBLFL*0+G
MK41'63?=>]F#<(0FB6(.PN.O#,?-MI6"#+AEW#!:3NXN#1EJ*I!UH_9,4F@S
M(A+&,8F3ZB/,9^)1=VT>@]&6S(;:F!]W80>96W-J2LEQ+HG+<@9! [ Z^ W,
M=K285P^1'+8 &1HMZ^1>[OTC31_EXX]1KIIOC36)CV(KYG74VO+-Z_M.O%@2
M6T9:#8/@YYA8AF>$7-PL9E'I5I-0,Z93W".CAI* LD22>"U6[%,2Q:))!&PA
M,"GH+U3\/5"+7:Q/%S1UJM5M)W:'9*0%#-4D:8G<F(VNF]DMEP1Y.#MC,1LR
M*/HVZSC6/RV0OWH5M%THR+3')LHX1&D8TT2$8D$B.PS\^A%F UT8I \^G9!]
MM,L.+$ONGNQT@] ^W3TUL.D&D19PO1AKL*WRVC^Z,+$?.1F^5UW^ZC[9%\SP
MLEANGV$>F?BBL/'C7H#,?MR"JR.ZUZJMM:1D5:>VM,PE65>223V $M1_+ZOC
MS5NW6C$G9V%'Q\I!$'1 NE'GRA-N%:LAQHNR>I/SW1[$61Q73:&).:I)3&S[
MNM4]35LK7%#)#9,T$F"B,D5@Q6O]1CS03%P0S,:1"F7[K08P'#W"QE;8F\?N
ME5%M58Y]O[467)S1T)L*TZ0M\_DSB7=?R4^*P+#%^FV%9=6/"GD"D6#C+9JM
MN12P"?+98:).6>6K[&CC?9;37*.Q%K<&\</6@5#*XKYR+ED@B%94E<G7X,&.
MR/"Z12NKU(#"4[;G7# >.>."^ZXIOJ%+C7 MP(UV441UW=:H.$)D^N?/\E%:
MR7B_Z\.X?/(O,)1=]D%9Q#J]K]K8L]LUP7LBOX;4TG2FU; :VD3(4+0B[:)3
M!NWDS9?Y:^?%BR.JTD=FDME45$GY[1!WYHNVEXSJ(2$GM?IM?#B='+;BU[:W
M*^L]4A;8:UHI#-X WE0B3/PSEEKH4B[A^,+QTD&)1-5H_48,0(\8R$,1J?AY
MM^"+.\.ZL0B)V%6EK/);9DYL.KZYL"L1$JGLI:G"1F/V5+A$TD#B2;-PPU%Z
M2;$PC!F#V8)"QP@*EJ*;#?AT6OP\?/SZ46S/")PB<(G")PB<(G")PB<(G")P
MB<(G")PB<(G")PB<(G"+5KM^T.R.IA]9QB0RB)G+BLVK:STDL+*$0<H!QLO-
MA!>R"00X)5;D Q)M5H*;[L2;9='=F\]!7U,8QG&P?/SJBCLCMRV),50I#L),
M9=4E>N[FC76Z^Y5F0R*NXWH6Z^T4>DDIU%RYJ\$;5_%[@[$R<H"4G(XD&5E\
M<A@R$IG%4Y&'QM/P^>'+]LZ(LAS%U+5YO]#.O)^5J14G,.H->5KB4SVT'H39
M\SD=F]T+A7)2$P\/RE(!*J?$0R$*ZJ>OD;%G&L.8(M1*C(6WA%9]P63,G-&]
ME2T[D\5:6U*[AM!*IJY:7!;\04*L*<@ FDMP=' XCO'Y99TG>VC&9$?!03X<
M<.*321MC#IRR68!RZ#E\^G=%?!^PQ]87B]E>\N/=BD8- 9 K)XG"YY."MNT2
M*I"C"Q J6L"OP,F7JV1G["L,2\ H-Y8%!%#<KGP-Z*=%@T:?+M"+L=,)'.X3
M7G9&QI')%KO)U[6\'1;/:TL*96I6]L22"UY)9G(Y#&)-)B)GXVY)H?/[@+)8
MPYFA%!20JO@8E%X['O=$)_7\]OJXHNO(^T5X*#*E 5]>- RDU<,9F<D:6H1;
M!HE5PNP@#>NA@FG(N2=R([I*6CJ3SAV^*,QZ4BL]O'XX_ L&CPZX('(I"*_Z
M>VDTX[6OSQ11_L(TF_96P'.FF"#<6P+5@PIGIU#F31NZ4W],2;=Q*_Y2/;JJ
M*>UPY6(I96U>X<8?/S\^Q%BO%H6LTF\[D=?-6F93,+1FFX5S*1\F*AAA6PNS
M]9=-*D/+AAQL.U(Q9C45$V+9!1CMC#I<7NV)C7XA;9[L1G33CM\2.//N[-45
M4)=FNSBY2,5<%E=3Q^6'9-?XF*639[%C"0MA%*^O8E3]>1MD <$W*A71YN()
MFY6,@C<E+CD<>PIS&U 'SMX;3CY**6[A$X1.$3A$X1.$3A$X1.$3A$X1.$3A
M$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X18SNF<JUC3UK60W:JOG, K>
M;S-JQ;H;N7#YU&(T3--6+9JGKNJZ<O'#)-LW;):;JN%E=$4]-M]]=<D464:8
M7M$>N[0R_GDM)]MZ1O'K]1*H&4R*8/*Y4;YF$0JF+)NQS)]EQ,XO9=86RE;,
MYL8MJ0DIV6%7#LT\"MZ^"Q6%3^O@!W?LX<$57E,L$=?K<=NOMFR/L6XKJG9V
M9DHK6S9ZG8-+SJK()9UN2^QK"KN.EM8B1@5YEGS2.I:&18C0/(GT#AT,'2&"
MIBAT%>WV_K]OM*SQ^L=CO52NU2/9.J7LT1*AGDO>L^RES3U+L*\J^K'K<I!F
M)\'-&,L&V0:L.:@927C%8(/]R641##0 =;/&[-LW/#7N ^?VHLC2*QXQ-['I
MN+5^1DD#NJCX-&9]8%;D;RF;F084 5@;FZ/6N/5\]EVN+;F4@6*HM;1G+B*E
M$6D5#;(%CSR7-00Z.0BNOJ.?<O2Y"QXQ-9K;@,7U=A!6XSVDLDLN"3_LD=>%
MI9(1$6&$R9 !'I=$!S!\-,Q&)LQ#6*L)K#(:Y'-M 0\6)?/S\^U%93_MU;KJ
MO:;-1VX*3?O[N:ERAZ8N4@,4KRFY6"AT?-N:492L^=)CRTI>'9Q'VB38Z-+3
M30/";(U2C+D\X:L8<17K",SZ;=HX_P#2]QJJ4'6T;.FW,?3,,X>5CW7;J_%*
MV/MA+4BHJLB#V[(]F)65#MGJRKI;6+C7"RBZ[-SE-\]VOKT]J*QY1:5F![ N
M>700=H^.'9C>A&O=SZ,B<B@M@Q0KU^Z+TL)=#F!!BU>Q<_8N]O3 BQ=-W>JR
M;9X0'[L]UTGZ9%VYAV9[.!SOVJQ\NJ<:<-3^\04+N&P!;&N(G(7E:-ZFC8&$
MH"BYDR@Y=DK5FL];.F<?S)IJ^K^ H-00Q^>(%9:'?//X(I9FF'>&C7#_ &;[
MOL-T</=VFBB;39WA/7XC9JFLHJLFWV6]_*.BJJBFJ>==5%-]L9VR1=CA$X1.
M$3A$X1.$3A$X1.$3A$X1.$3A$X1<"SILWW;)N'""&[Q?X5IHLLFENZ<^BLY^
M';:[[:Y77^';.''HI8V4]%!97W?32WVU(NCDZ$U3<+;&!6J3-=%J[5R0:83:
MN7*^&S=NXWRM[J"Z[G.&Z*2N=5%5\X2TUV4SC7A%W-7K/=VLPT=MMWS=!%RN
MRU72V=HMG&ZJ;=PLVQOE9-!?=!?1%7?35-7=%773;;*>^,$79X1.$3A$X1.$
M3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X
M1.$3A$X1.$3A%H;V#[=6715_4_52%"!)K ;5Q(23BPV=RI")7$X;7,;=RVX9
MZ_JY2N26'<5KL/@&RR]VG+!20RN8P^+,D6S\ZVWX5@)!,ZS$1SVUVUU]!*T;
M$^:=V<AP509U4)[6[,14-L>#U@ZN4.W$EJ+G75&P>X@2>&I_I W",?F"=95E
M)XZ1KI.,F&S>QMQ 5";.HT]<S >0M )UT$R8X@@&!)G<&>7;HI#(1W^ZF3F3
M5+7[.X(Z(M"ZHE YA!:R.?%LI>196/7[2SXRPRAJV6&Y*N88[U+J,T"2V=$4
M'&==ML([9X40==-M"MRN%"<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G
M")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G"+1ZD_(!1U]70>HZ&#+%92,20
MMA@(/R2,,AL0FFE+G8E&YJ0BQ!J=(E<C]#4LT9AU9$$CRY?4$>=MF_P*8IR6
M*2(Y</-.TJG]I>N!^SNQ?0:[(F,-F'U"=C3QR<[[SM\-C$7JD_UF[*0XF=2@
M;Z0,HT>D)"QI;6 78JP &)NT&*^FQ79QE*2;;%(,!PY@1WAP/LE00N_&-V?&
MPB6@A74E285?FR<RR14S8\@Z3.;<NJS)3UP[JU<?M(W:E=LZLB%FU? +7NBC
M;&K1>^G(Z[0B@NRI*-BX\ZPBD;)QM/I\_P"OM]/*V8?E1(C\;34=YD@&8,<-
MM3N!U@Z$=NJX[7/9A+M=XO(6]?VX.D?=469K>6F+$;S_ *V=/*LK.$,XV=?E
MIT=>4_9U,V!.L!+0@K6LFNK(*2!/Y 0G$E&CY4$B//MKIJ3V#4&-/5HM"/(S
MY;>^_CMK:;#HU:$'O*7Q3OK8G7Q.=VW4L6'/'E=@^J/5VYQ#7("K-Z]CR!)I
M++;E>BA/+)=RZ'[LFRVV<-4\X*[*;7Q,CQ9T/',X<0>2R+;_ )H.X<'\F_CP
MZD!6E0;53V@K_I7);+5>PDLO*DR5^ND$9WB-&-)6BV%-D]%-OD23@81V'[>S
M*ZCW&/9DH# :9?)D3RCV>]>D8)VKZO2:33J%1OLC0D@F57BY0<LR)!+AKPM)
MJ["0=\F,FAB= 6$B<%8B+B!)9(?*"!]H/: 'RJ;0LLT<;ZIY+'!Y'7;17S75
MN53< Q\;J2SJ]M(,+?\ RHD7KJ:1N;C!Q/X=%W\M?/XR2)M&C_X1PW=?!N%4
MW'PZZ*WI^FKIML401N(60N$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A
M$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$4:-!=FNX4^[B6S2MH]=MH12T-=V
MHJ!L/>$3 "U5"@YD*!5$[8627E92%VF^L2*)$IR780N.AEXBC(AL<-I#R<,+
M+RHK$" 0==./9KI$Z'3]4$Y]G[WJ@'[05ZXLNR:]$=C)Q4,SIRM:WEM@@AYV
M75Q,I*"E,Q91FO"9!)X94/EZ^$)/"#)BLH00C6XW3*V!ZZ:11K!T,<=-/3Y_
M6HSD>LWAK'4"6*,^S40'U=&K+!P'2\6W<730M BX"D9#1L=H0/:V\R4W"Q0=
MUWE4KAC& *O5=U8&<*2M11P_31E35(Y]GGY*9=)TW&HCM!F(Y@'S1MHML^WX
M"-10KXM(O"V3$;#HWWIK0!$QPO?U1C"-!^IO:(<"9#E?46]1BU%MFJ#3?U5?
M?;II[>IO[?>R0;/^K_C:M2_&IY9+8[L]DI]2]@5Q6L*CL/JV7SY$Y%UY+@DJ
M[C<UA$92;/-C9E\Q38*,I0\=N=]$4U=5FJ&=5=$O5UVL6P 9WCUB5C#I)$;3
MZC"G/'' IC97428%E-D,:;+ZCB#1[LCJIG;">5<-EE<IXWSIOC3._LQMG7;&
MOM]W/LJK*J<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<
M(G")PB<(G")PB<(G")PB<(O-]XN=*W,>0#M/8S0M U;DF4H[/"9VD"M7H:E+
M20B(=AW $(O(J%IFH@G9Z);HCA059\4L*UYB,?/U4#LH=R(S(0)9L5W3#1P@
M1Y4:B9$Z>B.Z-5Z0>%1.$3A%_/<^R+?]'+D_2RVO_5Z]#N%]-'A]3_&]<'8_
MZ];PR?D?\7WZP:<*&_>7>?VA8^ZA?60?9&'YDWF"_;.&X4O^]TN]GV2K5Z$=
MO>Q/23P7]F;JZPV'FL;-SY$J\B&9-B)P>9__  =/4L)7+#OD]@QJ5@/\;5&,
M=OB_E7QR'H>ZV<HZJ+84*7-#JH!$C)VCB>2GY$?9 ;SJWU1\:Q?LQ7,S["7!
MW#IW,SD-@1I_!( T1+-YYO$%G!"."HX-");*X=-5]40(P:TU2;[8PWPJIG?)
M8NKS%\$ -) &O"5, ,\J?40OWS<>-YE(9IMV@;/";%4&I!RR<3PX$5:XN)[C
M$PSM\MVUUA+55TGMC'L4?XU'X_=ML<*F1V7/^+W]L;=ZD<X54X1.$3A$X1.$
M3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1>>OQ\1
MN&1_R,]I='$=J#2S75E=ORKZ3QAIX]CD^=QT[V*(&1+0].:T[ SWO*HIH(>A
MDC$8MFN@ 6+OVR<7,(Q30!$HV@^?GY]"NZ<HUTTT\;EV^+Z-?6L]=F?'YV!M
M'O"IV K*Q1<9@5@QKKI&YR7<V?80(U!@M''KI<S "PI<1'25:W0C:4:MA$9%
M3,ZD$=*4M)VIR:Q';8P_2V6* Z!'(G@.,<=QMKS&FRTICWB1[E1V%Q$_HMUL
M?V77$+K:BPM<;V/8#>KY; :_\?=P='=[;+RO[3*Y4!.2Q2U\6%K!4H*>:-8@
M S#]YXN5?Z$&A3F;)W$R9$2)(( UV$<]S/8=L;LZL?:.G_B;?N+BN27D8=V6
MHFEG<0*SXHO32JD#Z7WW%E9F#K1?11@&DYA2)?,'!35VLZRL;-YWSML16S@@
M,A_=/_K;ZNSWJ!_Q(?CQ[R?F&=HO^8Z^YE.S.]OL6!OEN\_M"^_&3(Y#$.IW
ME2DT3/&8O) M!5X^#R".E'P4V)>IFYMA-X,*C5VS]@Z3QMMC1PU<)*ZXSG&N
M^/;GAV[>_P!X4-V=W?%9GZY=K.RXCQ3=S+6;WS;#NR(I>=,"(S-3DYD,DD0$
M6:)1=H6'"24A?%%V+(@W=N4W39OMHDKZRFVVGO[9VY! S@1I'=SY)F(;,ZYH
MY\.U2_>*?N7H\Z*MKC[B=@Q+1X0O*9P8?/[BF(@&F\6;A1!45&FI8PNP:K.=
M&C8T^:L$]]E]F[=\OKIE-%3;6KAXQ 'OX!7#O%!)W^)Y*8N#3V$V=%1,ZKJ6
M1Z<PP_HZ4"2J*%V)V/EDV3YT,>;CBPU9PR>:-2+)XQ7V06WPDZ:KH;YPHEOK
MBJL#.H5V<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G
M")PB<(G")PBH,JDPB%Q>23&0*/40,3 F),;5&B#$@(I" (]P4)*, $>8%#YQ
M[HR:K;-1 ,81,$E\)LAC!X]70;J$4!_061;S_P @D\FD2TLB+P5U![R?/ \Y
MMSOW8#&=*R>QH"2B4B%P'L5U4HVH*>=@6#4QZD=C]@S9\S:R;:/1T8^&"74A
M9E<^2!I.D0&C0 @Z@R=>?&>Q21]HK=O:L>PO1*.PI]!F5,W7V#/5+:+1X->D
M[#D#K[FSL;; -B$<N-4P,:C@\C4HMT1?HY?2(R_<M&+=4$(8%-)(4  AV\@
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MBL.>%+#A"5E0V",H]X\^KJEEL8"?'!(G*W9F^[>,UH79#ADQ%[S BH8:E=T
M")X;MB=#!\IV\Z0 #YE5^\/8>^*N[]4Q'*_M=<M&B4:IH$ ZDPN5.HO9=C3&
M<SBWFDEM=_'9#0TG#6E4$+&!X5FQ6<$MZ+F(-&0<G*21R =&(EJ=?/S\\5
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MPGAQEGC"V4?<PI^![.<F\*]#HM1L<(/1^E@%.JZ[N!<G!V8>VH:8HLR"M]"
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MP5>-2_SAKNR41>E)((@9O.Z1Z,H6_G"JH.9WY1>P,?B5@)-NO4"B=LQ_M1V
MID-"YW/W9$(*K[KWTHW[E%R4QDL(0+L7%A2P.Q4AC0?%UG\5C9(UH0R8E(^+
MNEI'$[]GP!]ZL&@\>$_^K+IY]>Y7K3'E.,V?=K@23J3(VBC .X=8B[BS6;3V
M],26BJ'ZY7U+\/ZWBL<*.)*SD8B^7\9A\;A+(I,'9N&#?AV)AQ.F0H$G?L^
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MK>&3\C_B^_6#3A0W[R[S^T+'W4+ZR#[(P_,F\P7[9PW"E_WNEWL^R5J#6?\
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M5G'0#3@8&^W'23YR=.>Z] G)54X1:9Q3HI2<1[&S/LHU<3,M(IC]L5WB 'S
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M"K*!RLZ8W!V&F69B.!DC:3Q(WYS]\*J<(H\^]_XPO&Y^D,A__2_VLX5F[/\
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M2^H1B[<%2L2(.Y),R0!'/8\=.Q2C\*J<(H\^]_XPO&Y^D,A__2_VLX5F[/\
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M/IAQ#@ \DM<0 OOJ]),7NG6@O[RK>4+2[M[ME!YIL::EN3EAS:<M.1SV PX
M.)RE1B?X,DGTPZA]X$X[9I6[C-M5","CP(JLG$<)M7$<($76FK%JQF$S=&EW
M^#&VNK9!LU40PUSMC+CU<X2WG]W#.DO2+HN:]C3PNEA^(OJOJU+X5F.;68QI
M+W/M[9M(,ZORBYP.;A&NX_NP9T@QWH[UMFS#J=C?OJ/JOO!68X56L!+G.H6[
M:89U<DDN!S<(UC<KV"S>"^)ON2SF\.E4->/KNI1RR:RJ/%X\Y>-M#D42W<-4
M"[-FJX0T5QE/95'7=/53&=,[8VQ[.;K>7=K=^$'HTZUN;>Y:S"\4:]UO6IUF
MM<:5P0UQIN<&DC4 D&-5MMW<V]STWP!UM<4;AK<.Q%KG4*M.JUKNJKF'&FYP
M!C6#K&JF5\&7[R)7\LD^_5T5YS7PI_A2?S=9_:K+0/"/^$?^X6OVJRF.YSA:
M$G")PB<(G")PB<(G")PB<(K&LZ7:U_6U@3S9Y&1^D*A4HEN[^:%GP"'LDXZ$
M?%]W4J.C!!\D&CK?1GLJ9*CP1IZ/':.';40272T9K$&I YJ-;JYVA[!=@^SS
M@V3<-X-UT,0L\UBM?%8^7?[&9?$-A<=E6\9FS>GAK%8D&FPJ9N7R$XM^(6*C
M%5!H8]U/AC\>XGCXK0 .W3LCX^B.TJ6+A56B)GR7=*0\!DMGZ7.A)8/%;BE-
M#D#=?PNP;+^.L>"UUO;<[8QP=7L5DQ64Q^$UFV*3:63:.L2<,!1X$=(/SR20
MIWE-._9^U3E)TCA.NFDQQ[=!SX+)\([E=;[(NHKU^A-BZR"RQ0=V9RV:1B8Z
M1 LF,C]?RPX+B]EN8^A7$MDL;BUK5K(Y-%8S*RTCCX6; 2!88T;N%MT"$$:D
M?/=OP6&.CWXV?)K^D&<_]%/2OA2[9GU3]MRD&X54X1.$3A$X1.$3A$X1.$3A
M$X1<:R2:Z2J"VOOI+)[I*Z9SG&-TU-<Z;ZYSKG&V/>UVSCVZYQG'M^]G&?O\
MEKBUS7-,.:0X'0P09!@R#!''10YH<TM<)#@6D<P1!'G"Q#4U 5!1GS_[5,+:
M1#Z4?*_GWPI(X0^8?)?F'RSW_G)0EZ/PGS4A[OPWH^I\3MZWJ>XE[GN8UTFQ
MSI%]&^[-^^^^A]=]&ST;>EU7TCJNNCZ/1I9L_44ISYHR#+$NGR<*P'"<$Z_[
MEV;;3Z3U77Y:M>IUG4]9U4]=5J1DZVI&7+.8S,",Q<\)>NG"+$]\5FI=%*6Q
M4:)C2/*V97DN@R1Y5CL33#[R<&]#ZDE!VCMAL^T9;.\.-FFKUIE?">4\.$L[
M>_KZ&%7PPW$\/Q$TS6%C>VUV:0?U9JBWK,JE@?E?D+LN7-E=$SE.R^[#;P8?
MB-C?&F:HL[NA<FD'9#4%&JVH6!^5V4NRQFRNB9@J'];PZR9MTP=]4A][@G9%
MWV50OS,T>0(@P9)LTJTU@&T:P%0E!)=1SE9/0GJ3R1T2RGOLURRQMIA??HH\
M(]!W29F/OPFJUC<$.$_1FW;'N+C>F[Z_K3;TP&P>KZO(3(S9M8&]CI[1/2!N
M-NPVHUC<(.&?1VW+7.+C>?2NNZPT6@"#DR9)GQLW!42^/%?>LUD/27:$S&L7
MP/K+6=<P26$9$2D@ B==PR7;FWK\")8QJ1(?#NF&=<-DGQ9LIAUG**F=4\>O
MG+A/3W"K6CTH^E6U\RKCE]>7=NRBRC692;<V_5-96J/KT3F:_P HLIN&74:Z
M*^&=-,-MZ72+Z1;WC:F,7=U<T&464:K*3:]#JVMJO?6HF0XZEK'"-1KHL/PR
MI[3'>8:];&(5I8#&OG8^Z5&D[>0V1-H:ZT>5$]:--V\G7&Z!%]'3O_%6VR3[
M;"[C]Q2SLI^#ST;K$</?X.L(LF7UF^\:_# ZT;<T77+2V_:YP=0#S5&5OC.E
M@@:F ONN+VR?T#PNT9=VKKIM2PS6S;BDZX;EOLSLU$/-00W4RW0:G1=K['F_
M]1[:_P#>Z-_\FW.5\,/WSH_]3%/M6">%/R\#^KB/ML5Z2><67)4X1.$3A$X1
M.$3A$X1.$3A$X1.$3A%:%A$7P> S@N,;RIV2%Q"2D1[6"#PY:;N7S$*]<M&\
M-%2%L] $Y4LNDFG'AYQF[#O"^S-L3;+LE%TMR*+7I?'NR]IW2.[6W*K=P4!(
M(?)H&.A,@(R"HP8U2./M K(M..LDV$I/1^3S45J;"S6-2%/6128B2/[5G X^
M\'Z*E8QL(TXC4^G2=^7!2\\*J<(H\^]_XPO&Y^D,A_\ TO\ :SA6;L_ZH^VU
M2&<*J<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(HL_,S]7]:__
M (BJ_P#:-&^;YX-?POP__L;_ /N5=;GT _"BQ_[*]_NE98]\&7[R)7\LD^_5
MT5Y]?A3_  I/YNL_M5E]7A'_  C_ -PM?M5E,=SG"T).$3A$X1.$3A$X1.$3
MA$X14LX#"R<*8C<D#BY#'9"+( SX X/:%@IP*6:+,"H<N+?I.&)(638N%V1
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1.$3A$X1.$3A$X1.$3A%__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>g904779g91e11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g91e11.jpg
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M<15N*'4/87%R959[($]P5.CJV&H'!.V[)<47MV/AG&>[/Z_QP".=D^0"0O\
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MG<TA3U'%2A9M.G<T"D"EO."J,$8$L\L\M.>084&,?CN"4. , 8 P!@# & ,
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M+TP^O;9SBUV6S(Y!'&^\CBU1*B)R(EG6@6/3 VI7]R9PD+2E9(3T2DHJ,/\
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MQ T!!"N.#[8:'^E6R6O,6U6#I0U5I^N(^VK%*A?9]SU-/K#MELC3=L:<I,=
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M>I]N7M+.,%!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# *J_)U^6WBM_S5*5_X^=2X+1Z3_A7]^):I@J, 8 P
M!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# .M7/3.UG(T[F
M[-C<H<3?8-Y"Y>E2'+C]>KZ2492@TL:HW^L'^S(",?\ 6#_5^O6 =E@# & 8
M]+OR4D_^'GK_ &U3@%='AA_-5\(_J\PO_24X+U/MR]I9Q@H, 8 P!@# & ,
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M55(-YQA3CG/AC.<^1WN8"XP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M623:4H\RC+EEU7-&,L/=)['7IY2>&LI/#QE9[GAM971X;7@V??*DC & , 8
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MC&I6I-0YQ9X?K*+<GHES448MY?[*N*DGB+>&U85IM)-O%O4:3:A++M3 ,!@
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M5;B22LT826(YGEM-QV2V;Z)873&3.O##^:KX1_5YA?\ I*<$U/MR]I9Q@H,
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M7PL7DXM=SEXQ7*O>GU?L4?>>CO!08 P"JOR=?EMXK?\ -4I7_CYU+@M'I/\
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M^T[_ ,,/YJOA']7F%_Z2G!-3[<O:6<8*# & , 8 P!@# & , 8 P!@# & ,
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MC*,G&2<91;C*,DU*,D\--/=-/9I[I[,]73364\I[IKHUXGUR , 8 P!@# &
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M>"SX=^W3"/8)@Q# & 55^3K\MO%;_FJ4K_Q\ZEP6CTG_  K^_$M4P5& , 8
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M>ML&RQ"T(+^DW!U9YNOHZL5)KTI:?Q%KMDGYQIUJM]2CY>@^[.<;OV=JT/\
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M?3GWRP.2?JR^Z_D/I^\(_.MR3]H^G/OE@<D_5E]U_(?3]X1^=;DG[1].??+
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M](H?VM/_ !, ?$VW](H?VM/_ !, ?$VW](H?VM/_ !, ?$VW](H?VM/_ !,
M?$VW](H?VM/_ !, ?$VW](H?VM/_ !, ?$VW](H?VM/_ !, ?$VW](H?VM/_
M !, ?$VW](H?VM/_ !, ?$VW](H?VM/_ !, ?$VW](H?VM/_ !, ?$VW](H?
MVM/_ !, ?$VW](H?VM/_ !, ?$VW](H?VM/_ !, ?$VW](H?VM/_ !, ?$VW
M](H?VM/_ !, ?$VW](H?VM/_ !, ?$VW](H?VM/_ !, ?$VW](H?VM/_ !,
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M2NBX Y*9H]MX3-*WT]?(XRJ?51BO8P[$<Z*3E8O5_M#!>C6!*3;;W67G&?\
M(DG]!KB?Y/>6OL^U-]T<$9?B_BQ]!KB?Y/>6OL^U-]T<#+\7\6/H-<3_ ">\
MM?9]J;[HX&7XOXL?0:XG^3WEK[/M3?=' R_%_%D7.JO%AS==S'2S;6M$<QUB
MMKOIZ@KFEJU+1D#;Q3"NZNG:*33:MSAL$:3&J4TY94YS(>A<Q',:L!VRG=.>
MDV(&S^7Y_P R5)K.[W32W\24?T&N)_D]Y:^S[4WW1P1E^+^+'T&N)_D]Y:^S
M[4WW1P,OQ?Q8^@UQ/\GO+7V?:F^Z.!E^+^+'T&N)_D]Y:^S[4WW1P,OQ?Q8^
M@UQ/\GO+7V?:F^Z.!E^+^+(MIO%AS>3VL\=%F41S&94+ARW&Z52T[NC('M&D
MLAGMF5SI?9>FL4:W& JG&,/C;%A+RTFGX936%.<I$WEIR@">9X2R^K[WWX^1
M*3Z#7$_R>\M?9]J;[HX(R_%_%CZ#7$_R>\M?9]J;[HX&7XOXL?0:XG^3WEK[
M/M3?=' R_%_%CZ#7$_R>\M?9]J;[HX&7XOXL?0:XG^3WEK[/M3?=' R_%_%D
M7.0?%AS?0E3O$&M.B.9+7DR^X+QGZ64*Z,@;B:DBME6Q+9S#HGI1(HTJ< DP
MN,OK9%R$Q9NFY*4U@3M91+>6G*")<FWU:V2ZON26??C)*/Z#7$_R>\M?9]J;
M[HX(R_%_%CZ#7$_R>\M?9]J;[HX&7XOXL?0:XG^3WEK[/M3?=' R_%_%CZ#7
M$_R>\M?9]J;[HX&7XOXLBWVGXL.;NB>8[3IFHZ(YCIZQ)LBCB:-V0CHR!MBF
M,G-$SCDA7G%+HS&DCXGVX-+0O:!;0*"A# X"*.V),,X A:,W&2;;:7=DE)]!
MKB?Y/>6OL^U-]T<%<OQ?Q8^@UQ/\GO+7V?:F^Z.!E^+^+'T&N)_D]Y:^S[4W
MW1P,OQ?Q8^@UQ/\ )[RU]GVIONC@9?B_BQ]!KB?Y/>6OL^U-]T<#+\7\6:0'
MX^:SBG:'-O3])0:F*9CE/5ET1!9U%*^K6/PEVGRZWP5@"*.)JF)-+4A5$1#4
M*?M" \:/.+U(!:;=EZ-6>N)YGAIY>6GN_!-?CG\"Q3!48 P!@# & , 8 P!@
M%%=T^,:_+![$G,TCDUJ%-RW=W6_'79%H;>ELR)NN-2_DB+M+$*N(;'T4:60U
M_CEGN$1B#DHECM-(ZXP]..1(T\<?1;;3A#(II1QAY4917AB3ZOO6,OQSMT[^
MX[9\+7*W0MJ49:L.YII4<I6=B,5N]92)_P!NB!VM"H5L-M0$_9U&R1+"WIS?
MI\_P9[-:_0U%*-MARG2\CW0*=0(522367TPO)Y7\L_$WC^)+\4/R+49^YG7^
M;X':3]9C\27XH?D6HS]S.O\ -\#M)^LQ^)+\4/R+49^YG7^;X':3]9C\27XH
M?D6HS]S.O\WP.TGZS'XDOQ0_(M1G[F=?YO@=I/UF1;@_@9XD;NN+^G$MY'H1
MQYLDU5T6S4W"0 =U"F-6''%UF&6X\',VS20-Q<B2.\#+)5A=%VW#;28$29%[
MKH2@3VDL+TGG+R_+;'Y/XDI/Q)?BA^1:C/W,Z_S?!':3]9C\27XH?D6HS]S.
MO\WP.TGZS'XDOQ0_(M1G[F=?YO@=I/UF/Q)?BA^1:C/W,Z_S? [2?K,?B2_%
M#\BU&?N9U_F^!VD_69%KBSP,<25]S-6D0ZHY'H2?7RT!F&IY+4H'=](=MKY]
M*7.,^S=3#6@:OW&'+8\VB]+<G]@-&)-KVNB='FB74EG:3P2E_$E^*'Y%J,_<
MSK_-\$=I/UF/Q)?BA^1:C/W,Z_S? [2?K,?B2_%#\BU&?N9U_F^!VD_68_$E
M^*'Y%J,_<SK_ #? [2?K,B[V#X&N(IU313!S-R-0D'M -IT>\F/JD#NRE"KV
M.W#"7VV6?WX!SJ+9DAK)OE;&4D]TUI>:X 1"4HPJ-JR1,:DD]Y-K#V]SQ^."
M47XDOQ0_(M1G[F=?YO@CM)^LQ^)+\4/R+49^YG7^;X':3]9C\27XH?D6HS]S
M.O\ -\#M)^LQ^)+\4/R+49^YG7^;X':3]9C\27XH?D6HS]S.O\WP.TGZS(MK
MO SQ(9VK&+!2<CT(7RJCY>F\.?X!L#N%6KZ <;6@+U$Y>%B]J(LU.WUVV3%F
M&[;>"QIS'("/3:=I3M20)[26'Z3SE8?EOG\U\"4GXDOQ0_(M1G[F=?YO@CM)
M^LQ^)+\4/R+49^YG7^;X':3]9C\27XH?D6HS]S.O\WP.TGZS'XDOQ0_(M1G[
MF=?YO@=I/UF/Q)?BA^1:C/W,Z_S? [2?K,SKQL<?N7$U67E4PF2)1B&2#K[H
MVTZ?C,+7*5S1&Z6GLP+75BP&A5I$IC>XM$73(T"QJ"):6WB( 0!P6:U[79>?
MG^>WX$2ES-/OPDWXM%B."HP!@# & 1UO'I>(4))*EB\F@]URU;<DF.BL?7U1
M3<[M%BC2XE?'FX3A9#U#VER05\P"-DJ,XM\DY[>W&(T+TK"?[%G7#)$I9SNE
MA9W:6?)>+\BIWQ_.=NR?N2S3*\ZPOGJ7FRMH%8L#Z'M>WW]"?4UD]9J;(:71
MFC_+<#(T)OB$?I>)!D,4GSK #@5\J6*FEC++=7A,8[EBTL8W23VPN]+?/-MO
MG;&=\;]&LWV8*# & , @]85^2ZUYC=?*//1MBTY?L.C30Z)KXM'FNP7^A&II
M6/4%!)'"!RUP'&(!9L[01:7+#(I'4TI/;R96W'J)&WN;)&Y"UG"<82;PT\[)
MK/O6^/@:O\.5BS^VO&;R/8UIS236)8$KK]V<)/-9B\+G^2R!>7.I8C L=G=Q
M.4+5AX$J9.F+$<<+V2<@D@O02BBP!$R6)22Z*37XEF."HP!@# /,+"NENC%7
M>3-8:B]+1<2Y+YB^@?'TY\X&R7UZ:1\U5YSBHE4:D""M/=O8-LV:7MM;[(6V
M*D&2\N1+WI XJU#$=M(>,F%RO;I!2SWY<DMW[,[;9QX[GIZP8Q@# & 8Y,"Y
M8=$I23 5<?;YT;''LN%KY8@<'2*H988V*@QQ7)FQH7M3JXQ],\;1G/*!L=&U
MP6-P%*=$O1J3"E!8>TJ^\1LMO"25_P!E,G0-S/\ >T^K'R&]+55J>/:43.D-
M9X81 TR1MB<2"XNJ&"0U,L4.*I@A32N4ML?(7&)B5"HT1ZM0+2QMA8]%?KVE
MLF"HP!@# *Q_*7*XO!:9@\LG/1E^4K%T=B$M2:M.6UYC!T!U18$BC[RSUG1-
M:RAJ,#*V=V<Y8H2R!23'@A)7H&51N2KFF-(W-S2BT>KV3V[^B\_#IX^/3."0
M?"#/T+'^/>>V?JZ2@EO0R*N6H%I/FG!L=U1K\8:I.3MSP],Q132_2-B:#6UB
MD[^VZ,1/LB;7-W3J%1:P*DT1+&7CIEX_7AX$M<$# & , H1\@<[L&G^KZ)O&
MO>L[..A3)U=R[4G1M81.V(4LK?GJO;"4M3,BA$YYH:]!DUAR7IM=+B%Z*;2$
M8Y=6+(F3R^)$+6) F0C%X[YCRI^BVMGG*Z8?=CX/&.I?=@H, 8 P!@# & ,
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MT&$727+EK&VTM\N6>BZ+'CLVEEYZ(N]P4& , 8!T,J \&1>2 CSVUQI_&PO
M&.1OC8)Z96!X$WJ--CV\,P'1C&[-;4MV0N<&P+VSB7I"#DH71OV;I62!1_R3
MUG<]-] =8<^]G=1_A4FKMLH21U++N@*]KNLY//TLV;[,;;$L:NDM&-*.%+*
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M0'I^CHW=J"M2.&DP7J+NC,_M^]*T28WV[8Z(U&_9^SV;[,9@!"4VGE&V A"
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M(A:!Y=$4:BD>4-K*VIUIV@)!CV$81+DY=7^2Z]7MWOO?5]Y-W! P!@# & ,
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M 8 P!@# & , 8 P"DF[?(Q.N:NR>OH3)D+[;,,BD!X$B?.5%1U-#(XY2&_\
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M^%]F?*O9Z77X(]">"@P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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1 , 8 P!@# & , 8 P!@'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>g904779g92o51.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g92o51.jpg
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M 0$! 0$!_\  $0@ Q )= P$1  (1 0,1 ?_$ !\  0 " @$% 0
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M,XRK.59/+T/O5P7#Y . . . . . . . . . . . . . . . . . . . . .
M. 0MV2V.2TYUVWWMT-&1,+ZLTOM'8PJ(ZW[5J42I%'.66#'=:^>'&GI0QIMQ
M&?DI"E8S\O/E2NTN+L"FNK=Y[<OS+W6@#&08(:[ZVZB9W1V8L.S6*[?X.QMS
M:<L!^N6VAT&+0RXRW.-D@K18P5G6RF1AL\M[,&'-,@IT?#+/=P7S@L[TSVN>
MWGU-ZY;?M6,?2G8FFM?6>SN):0PU)LA"MP%GIL=AM*$,Q9Y;$R;%90G"6HS[
M2$^>$XSD\FUP;!9;D X X X X X X X X X X X X X X X X X X X X X
MX X!X!46.."R00O#8("3$"8+*0)*/:1IPXA'<B38<A'R];$F,\ZRZCSQZFUJ
MQ_+P"KU Z3]<J,)U(Q-US7-@VO2=5H%.HFS]A5ZM'-DP1&JW,+UP[(LL8*-4
MZ6IC:4L 3#45@A";5)RV_AR>07*>CJZ02KH_3=9T+KL?KFJ331:%&.7*TDSU
MD?@R[%8[3L"X';Y;["<E#1XJ"\0+V6QE)B\11\2-'9<9AQF&H\=I"7CN!+?
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M)*$96TG' (]$=7=##;96=ESM746R[EJXX7#B[PLE*IT_;L^>*J8NDM6(G<V
M$.8]8'ZZ'@CW9D9J)'9C(5#@1(4!7NF%WQ!E.C].U70.JZAJ.ER#,X!3X<UI
MHK8Y42=8CQ0P6(6&Q62PS!\ 5 DGK+8BQ4\9?@"QL%PD1E*AP(<?+<9L"5N
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MT67GW\5&B2J5LA%GBEM5L@)>QA)JDXIV;G72M-&6@$</C#X 9.@UR?BR.,?
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M6K#:;F3F5N &3LK88@74::&>J@JISA4/7RBH]UR,2HL"<&64+ 6&X X X X
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MBP8C[ZD(6I+><)SG 6?!]S+=<$' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
M' *>[5_'/ZA?5OVM_H^CN";UU/UQ+A<%' ' ' ' ' ' ' ' ' ' ' ' ' '
M' ' ' ' ' ' ' ' ' ' (8T4[.10GDG%CFC#^T-Y-RT#W'O<'".-T[&>DM#<
MS,(E.LIPT^ZTEU&'_=VE..)QA"\XJ3=VDVDKMI7LKI7?!7:5WO:6K0]NA,_(
M#I6E*TJ0M*5H6G*5H7C"DJ2K&<*2I.<9PI*L9SC.,XSC.,YQG'EP5-Q:E%M2
M3333:::=TTUFFGFFLTR)<>VU0[G^V/:M==SGY84XYK5;R_/YX\U.*U][1><8
M].,HHK64^:6::PI=:XW/9W3LZ_;L^[;T_P"P)\,L!'=' Q;P?<GS.6$5\F'*
MZ$$MT8\JE"-LM(KE+S8WS:ERAFG9SV[4C':TM(6AQ"7&U)6A:4K0M"L*0M"L
M84E25)SG"DJQG&4JQG.,XSC.,^6><DFFKIW3S36C7$Z;*,HR<9)QE%N,HR34
MHR3LTT\TT\FGFGDSJX(. . . . . . . . . . . . . . . . . . 57D])
M.J\PS03\O3E?E$=9D+B3J.)!"QO#F)E\N!G8-C4<"N&E!;C'7>;":MX6%<AY
M^%5+&1D%ZI'"SE)>2+=Y]-K]FA(.E- :AZWTB50-+TYFEU622>.2H"2]@L$N
M84R'$U^/(FFK26.'9J1M;KU>K 2-*)/1 -6KP"LA6( $*+'Q1&[ZE%_!&_)/
M]&/J0%_KHWP9U/ERZS7I]E;?DMQ_\YS4G[/;&X,J/RUU,^;#P;L< VE^"7^5
M>Z+?7F%_51?@TZOUN79^$CZUO!LQP!P!P!P!P!P!P!P!P!P!P!P!P!P!P!P#
M5]K6W$&/$!V?79!]JPCB9NP#QXTJ\5F7ZHOC=948W)8P 7N*1%KNFG/:*^C-
MPSJ*%$+VXK)"^V8>*C;%8K?<K:+1ZWMK?U+3O,5FV[MYO*V2M==6_MZ]-H/(
M9%/=J_CG]0OJW[6_T?1W!-ZZGZXEPN"C@#@#@#@#@#@#@#@#@#@#@#@#@#@#
M@#@#@#@#@#@#@#@$5[%OQ&G$:U"@#FY:"?O,^>](9?=0[ A'JC7W0XY;,B/A
MD_.<N#14>M[$MG,"OF4*A.*4F1%J5[ZY)Z*^>Z_!<2-M6M;-[W;NZ?&\[*]A
MF6;[L:I,5E=C14*/KBXA!]:GBDV,[]-C&P@\V M-G*URO1'8+M'3*C*DFXL=
MV)-]3DKVZFH_(4B/5C:$5;3J&PDZM(:[$[_PBOE'A\DB&3B?V23@9.D"2IP8
M]*AXS[%YT>8*1%N-JRQ.DMY2\KD<$_TMM?IV=27_ .6V8_8:-1>?A^BM)_\
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MV. ;2_!+_*O=%OKS"_JHOP:=7ZW+L_"1]:W@V8X X X X X X X X X X X
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M:7X)?Y5[HM]>87]5%^#3J_6Y=GX2/K6\&S' ' ' ' ' ' ' ' ' ' ' ' '
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MHVX0H0/7XV[N"Z_1W=FRST??Q>_+_,MIR%' ' ' ' ' ' ' ' ' ' ' ' '
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M!P!P!P!P!P!P!P!P!P!P!P!P!P#6+K-P6([\;4@#*2MHG8K'89YPC/KX)TW
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MMSG%)NSYL;NSL:S_  J?$RV!WR+;;K.Q-;URHE==Q 1H>:I;AE0*8-.S2,)
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MG^H_\_/ZR[ESUB^AH^TGR+_XB_*O;AY2?1+?;KY9]7)S\E-A%TN?=CX4. .
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M)PS][E..<KLU_4=KKCLJ:73^GL"_4F^I&C6UH_NT?P)EPN<4:PX X X X X
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MD&?#:?5C"93#34MK*F7VUJF%K_&*$*CCS)^="K3_ &NM3DZ=:GQ?,J1E%/\
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M&R*=:OA;)*>*V7*<\1B\.LUSJF JSJXZDK2G/#UL;>7-P]&!,?.0.!' ' '
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MZ0Z^^ML7#*D9T2OBVWI4IV," ,C <-R3(7$',*?=RN7?$)):>/'$D'@HX X
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M#5MF;,6SI5X5,!C:DJ2Q&);GA:M\1\-AZE"G5IJI1JSI3G6]@#GU@_)@X X
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MA)R^W:7"A#Y)3(^.K(VM@!PX>/!5&F@T,@ZG61@T/!0\XQ)GS0)IX X X X
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ML\_[V.0TI_*?9ZD=K@Q.,LG]RMC_ .(C/ZOD<L=5UKUFJOD=DO:9'R&8X X
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M'<)>(.UVF/<!+GQYMS$]B"YSXO+I9>9_]JX?L=<\KZ;GW&SSD(. . . . .
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MM-4,%#B4<?*K^9(\M"A05R6'_*1!97CRQ 7EX X X X X X X X X X X X
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5#@#@#@#@#@#@#@#@#@#@#@#@'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>g904779g93o58.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g93o58.jpg
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M;HTFJ)JEP%5V1B?K@5LRL#< &VQ.(\:5#>+Z0BXBR[1S1W*C<7RFP>.-X'W
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M:HLN*TZU]5=634*L[/XO9?MPLB@9PMFU8/PD+P1VC;YMQ_Q/"1"O*#A1VO\
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M\N=(J*5I*>%?I.S2U:H]+$LV1M)4)(&,;PH* M(KA'T,@(;2=)-L0,<H#,:
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M(\Q@GJ+6>@C4*(J>4EBPW 'AQV%1.7"P4RB-.([.]2%"ZE3P3,;ZG'@Q_#N
MV,B!"3%AVOH6?K^6RX9!H)8X&,[^/H'8<E/D78N+C('),MB4&4G>2UVS63C#
M$=RH1,9\<(-663KW2&(5%,9'A;Z22I411-//3O+D:ST\<:AI6GCY 6B$0(,K
M-94ZR;;XZ8Y  PH59&8*CJM44<DD*%/&WU$=$=9ZK7VQ+$[U;OB#&XQ%>>UW
M7TNF9NFQ-X2*%0J.]P4Y+JOB9F83N%L65G@>;^:OXH=4(UZ;>8-E$G3!R-68
M+LB3I;-VW:98<SH9DDE[I9XH4JVHHYII,B2&IE2&"9C32<B*RH%J$4FX8.&!
M4  M-Z>9"HY$C,8A*RHM66C5F=0)!Q05-T/[+=1.^(_!4S?,HC0B9QKM#82"
M(2 1D?!2D+7G<&)QXR"X (RG$T*,L]B%A[\4M''"!ML0:N%6CH:K@[;+*I9<
M9=7O64,4CPR?2H)-&_#>)JG(5D23B&+0Z&@U*XD!0JP#*PL0#B BF*AAE]U(
MN&"59!%M5P1-U6W^S&5JJA;UNMW"FU;]J2&GF]D 95)H :R&[P#8U,@\-C1*
M5FG$;DQ/9UH"+YY"1;C$2W9$%ESI-<>'#IO29)BU<1JJ^AHQ,:CZ3RH:>2*.
M=->3-+"\TJQ()(URXNG38:RR@(H9WTJK$=CAFET:*!2'#,A/*0K!1J)#&< [
M#:QW.PN<?DQI>T%XF4EQ;MEP&*M<!,:*0L9)(;W&FI.V5)58%;UN-%5EFQO
MB'-D_C^V(/EX"9<&Q?X'!HL*^*R@S'X^7-6THE6)/I'-*=4BS-'-]'RM+PJ>
MHJ6:IO1JZ+PZ6;O4=ET,[JD222($,FDN:)% "E0RUEY-3(MDM*02#(M[D#<
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M:=5(=:DCOP"8C<WBU<K/,Y@6\Y5Y 9'(XBR"34 >I"1;A^(]]L,>/9GN5/\
M8.JC]-!Z*@U4P@G'X!&Q ^+/62"$<&P*Y;NNALW'!X[%(?&$&[LS>!D+@V'
M!:+02$&*J</2;@@^<=R[Z.+05:5CUL]5.LD\CM*"3(T]'149+/)+-*2$HD<L
MTC%G=AT5"@)ZXS1M$(DC0JB@*1T0DLDNP5547,A&P&P'623CSX]P:!')E7-K
MV5J%65BW-%:RCM2S&?FI4<>#IO'852;RC(3)V];247+*X!66 CC>'F?E*3C<
MNCR\DA(LFTA0U1X0]^ES#41PU-+39M4T])+4R5<,"1(&@DFK5KIHC41M%424
MTDAF3AK)%((YV5IFTKCG+$+)))3(\BQB-F+M9U6,QJVA@R!P-+:B&&I =().
M-[G_ '<+'G!XN>3JB( <RK7:U#D:R.%5Q*"VTU,4Q3A!;D<LTP:N4X*TIH<=
M!M5DN47[DV^'N_>&S=)13/!]%*>%$3E4L@5LK.ID4.1EE965:C4#<&<UC([
MW4(&%R2!-\Q=F9N&HU"<6U&PX\449/[=/"!'C)(VMC.M.[D0$2Z]YA&-?@L0
M*W_9H'8.4$@=C%2!X%L4'=6NZ<SR'F9M%YA\FXH0\;L@;HPH6Q:F@;=D/X!S
M]BLL66)0/T45XJ&&6O>9*"FDH(EDIT6-\O<4H$$J020\25>21DS.S(Y9M<#
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M%ZYY61479C5<5&>&_)LW.;2U<B+II1!EE13*ZZ9E2MI.4.LUG=2ZL0.B;"Q
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MI2H5)X9*.IJ:A2)V=XXN.13*K*.)2T?"A:1UU&Y<+,MV4T\TEC?='61(T/0
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M5/4[M9"[<2C$I>E60<W:FH]5+-E=IZ;8@XN'NRR]F8;9ER I'#IG<29R)P&
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M%.).(4B$4U3+2F">X9'9(P7E*+&Z]\MV;2,8#*B&H2-!PY254L6+*BN&2UB
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M0#EPU;<J.<!ZL@;$">27 X*U)F73 8[B_P!(LZ16<YKF!"BY JI+V_9=P/\
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MR$7'@N'QQJ6%#9J6%3:]C$H-MQ?J_8<23\UOVZ?0OUZ]G03]CU+G_._6M?\
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M]5SBQJ>GX<?]GAMT[ QK8;CJ%MK^'QXUSYK?MT^A?KU[.@G['J_G_._6M?\
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MB]R$YLK5+ $E9DJRA0@'\!CRY]MG$<@2-!&H$11P"Y(9KN&&K1UV(?5I%F)
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MVO:VPL.N^,\SH^@(6.D-=F%B2[EK6N=A>W7OB^G5^*,.F&'3#'M'_P"]I_\
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MCX<W!,&E03Q&U!B5%WUJO>BQ)8KL#8*6\2XU:XN)QM3&VA=)4 GH%&/?&X
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MI\N@>"%B\UVBC8VDL+LBDV&GJWVQYDE0ZR2*!'8.P%T!-@Q&Y\)QB?&9(OP
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MH;1]X.M ?"?'U#]@VQB/&9(OP C] _C=6\V4_ES^\_IQ#E,GDQ^PN'C,D7X
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M=.;*?RY_>?TX<ID\F/V%P\9DB_ "/T#^-TYLI_+G]Y_3ARF3R8_87#QF2+\
M(_0/XW3FRG\N?WG].'*9/)C]A</&9(OP C] _C=.;*?RY_>?TX<ID\F/V%P\
M9DB_ "/T#^-TYLI_+G]Y_3ARF3R8_87#QF2+\ (_0/XW3FRG\N?WG].'*9/)
MC]A</&9(OP C] _C=.;*?RY_>?TX<ID\F/V%QEP5C'W)-)%1$5QCR@^SYYP8
M^YR\*3!TKCX.??>?O>ZPX\/'@^_QX>/_ />J9\N@2)F#S$AHQ8R;;R*#U >
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MZ!_&Z<V4_ES^\_IPY3)Y,?L+AXS)%^ $?H'\;IS93^7/[S^G#E,GDQ^PN+.
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M\,J6Y./WQ=LQ&),<WN?"S1JUYS7]^TP4L=.7*$]-8U(LBJ.&" 56-$47U$D
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MA7E)70VACP 9I8RKCB6D8K& IN@XFK8J-(TM2PJKM9SP P8:K<8B.-[KT;H
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M(.DLE;4FF@+K8.[!$+ E%8AF+/;P*JL0+C6P" @M?%]/$)I IOI +-8@,1<
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MJ,3_ - WZ^.JO[S4?OYOYC8]R']%%^[3_2,57D_\Y9#_ %X6_P"O<=?54O\
M=J?]Q#_+7'CS?I9?WC_ZCC!]7XKPZ88=,,<S=NP)LCL=4;^R81L)8>M#>HK"
M9,PFOBEH*O!&P[F60M2,GIJQI\V#E2*7,'1/L(1*2SCY*1(RJ8=OWP-X]9E$
M_.JE)J(FD2>2G$4@"P<0D5&I"K.(B''0!",3I5B2Q78XUP$"*0(T2S:T-Y0F
M\6EM07B KWUBRCI.+ !@",5\?VYW(2)J<CP+"S!Y-63J!S[0I0('"&U-[]NY
M4L!A*E+2)S&$O'1'9!J87LRP+"-OCD[:1I<*V-9FX*\YXCB&<RY@2X42!M15
M@8%"1GEL4<?!8K]:K4IDD=BT@73J+(>B+-%* A.@C3<6E.I_[.[N) &/#(G"
M(@ 4M<BS6OC1II>O<0IR$$I#/)E/7S K(AL+9GG6O\&P*QUVQ[BD URB[P"(
M$Q<<RD\NNS7B1D+!9 7R"C$H_=#RL#8 QO&.*D7FKXD9G>0@L$#<".XMF$=.
MI50H#/- QD"GK-C&%&)B.ED8!%4$*6(XK6/]C>8W))TK'*NDD=5B&)QM#6SN
MY\_@\RE M*?*+PRERQ^#A)'1\5C4IMDF1V4NF"@3LJ&90IX\BMEA];Q]?6L[
MJZ-QS%RK+L(ZW=PWEH7,0D[WBYD4=U$G0@9D5H45Y6-3,BLP*7604X24Q*MR
MX7H6+1M'12:E4Z;-( Q$A(0"&-F4$-8H9BR!S;HZNE<!EUX1SOTK9(.]69"=
MDC0NN*>B[U#"ES#5&SX:0W@D@8U$IR,G]+TZ>"2>(T9)'LIDYR'U94Q!TF,%
MS-F.$1A1<>1B.7<03@N6$<*&T#?6H:U@RN)(86#) Q9RD41(LX"KL>GDVAHR
M$ +2,.GWC"F!#*5DD!#2@!07D%B5N6W&WUY97<PG"O J4O)-79 _==>Q&6X-
M*6<E']31LJ>MYO."L(-R^@X?6LA@+6-CZ\6#FT99L H',HH%I!/'3"4?(]M.
M.3,7V<M&6GC1QP23$I:7649H%B:,*(]+!ZBQL3(=>G$72D7=0KVC8K]98.0(
M].H+*7#$EKKIBN+A5N-6-'.6/W!)M#F<7G<&LN7/9'155DC,>&4HXC$?C%C
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M (G4#6"/$V3^.4/5<:9L0$\CF,7C<%C,?@[QA9K:+CIVX+PD.,91<V5D8:'
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M'R(F8@D)8LAF$;).70?A@T;-/@?O"":>,Q! "S"&(,R<-FX:7:.P70QM=DL
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M"CA95?/%/C)5513G+/G]VRSZ.Y-)EN7R/1!GDH:1W;CU(NS01LQL)@!<DFP
M \ MCY2HK:E:B=1( %FE '#B-@'8#<H2=O"3?$&?/"=R3TI)3ZI5E]".MW<U
MDGH(^(JNWQ3RZJ\X/=Q?)A\\)W)/2DE/JE67T(Z=S62>@CXBJ[?#EU5YP>[B
M^3#YX3N2>E)*?5*LOH1T[FLD]!'Q%5V^'+JKS@]W%\F'SPG<D]*24^J59?0C
MIW-9)Z"/B*KM\.757G![N+Y,/GA.Y)Z4DI]4JR^A'3N:R3T$?$57;X<NJO.#
MW<7R8\1#NX]Q,LWP:%=E3A-JF[8/\&Q"#U6\;X/A3YN3&/<$7,%43Q=CB31J
M08.>,>%F;YLW=M\TUT4U,>'Z,Y&=C0*1<'>>J.X((/Z?K! (/@(!&^'+JH=4
MH\/_ *<7A!!_4\()!\8)&/;\\)W)/2DE/JE67T(Z[W-9)Z"/B*KM\.757G![
MN+Y,/GA.Y)Z4DI]4JR^A'3N:R3T$?$57;X<NJO.#W<7R8?/"=R3TI)3ZI5E]
M".G<UDGH(^(JNWPY=5><'NXODP^>$[DGI22GU2K+Z$=.YK)/01\15=OARZJ\
MX/=Q?)A\\)W)/2DE/JE67T(Z=S62>@CXBJ[?#EU5YP>[B^3#YX3N2>E)*?5*
MLOH1T[FLD]!'Q%5V^'+JKS@]W%\F'SPG<D]*24^J59?0CIW-9)Z"/B*KM\.7
M57G![N+Y,/GA.Y)Z4DI]4JR^A'3N:R3T$?$57;X<NJO.#W<7R8?/"=R3TI)3
MZI5E]".G<UDGH(^(JNWPY=5><'NXODP^>$[DGI22GU2K+Z$=.YK)/01\15=O
MARZJ\X/=Q?)A\\)W)/2DE/JE67T(Z=S62>@CXBJ[?#EU5YP>[B^3#YX3N2>E
M)*?5*LOH1T[FLD]!'Q%5V^'+JKS@]W%\F'SPG<D]*24^J59?0CIW-9)Z"/B*
MKM\.757G![N+Y,/GA.Y)Z4DI]4JR^A'3N:R3T$?$57;X<NJO.#W<7R8?/"=R
M3TI)3ZI5E]".G<UDGH(^(JNWPY=5><'NXODQ_>?>([E"G&'"FU$L4X2PX22X
MSBE:9<)I\999<)X<90GGW&'&6667&&/@QXRRRYXX\///AX/HSD8O:@47-S:>
MJ%SXS]?N=AO^S#EU5YP>[B^3'\?/"=R3TI)3ZI5E]".N]S62>@CXBJ[?#EU5
MYP>[B^3#YX3N2>E)*?5*LOH1T[FLD]!'Q%5V^'+JKS@]W%\F'SPG<D]*24^J
M59?0CIW-9)Z"/B*KM\.757G![N+Y,/GA.Y)Z4DI]4JR^A'3N:R3T$?$57;X<
MNJO.#W<7R8?/"=R3TI)3ZI5E]".G<UDGH(^(JNWPY=5><'NXODP^>$[DGI22
MGU2K+Z$=.YK)/01\15=OARZJ\X/=Q?)C?ZH[H7<UMJTJUJH/MD<&%[-G\.KX
M42)Q&NN1H\E,Y$.CC%\0X:P1=URR:.B22[OX,BLO[PFI[RDHI[G#FBJR'(J6
MFJ*IZ LE-!-.RK45.IEAC:1E6\X&HA2!<@7ZS;$XZNJDDCC$J@R.J F**P+,
M%!/0ZA?'39&1=SU6U;GK+CN0&.?$+"64OL TCJ1;#U]AF^LMQ6*3"-P0?K@[
MGLN&<%&^93*:1J/DX;\3X.'G!GWID]S0^;,F0BEHZGF,GETS14Z<\4P4A:<5
M):2=LR6GB;0=/!DD6778:+LM]VFJXDB<J'U2AG/)&N+N4V00EF%P3K4%;7-[
M G%?X=L5W695J[8.V+_>X-#*YAD_CD/$MI7# +8[+XV8LB.5<7M5@*'U*1)#
MJ\C$GD[1F]?/6/)<H]#RX."$$3,4+L$=\M-]'8LSI\J7*9IJB:"25S%42E(9
M%IY*E*9F:K4-/)%$Q55.A0\3R.J2HQI5ZQH'J#41JBN$&J)+LI=4,@ B)"*S
M>$7-F !*D8F]W*>[')CU>1FE.XU&KU+W/K;)]B==@P&O6D1D-R"8'."<5FT
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M-9)Z"/B*KM\.757G![N+Y,?9)K!M!?$MUIUXE<BL0B3D$FHRI9"=)*C0"2A
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MUO#C;D-VKM8MZ8$B*2T8 Q6JSIHV1AH'>76<)&9 E+]9Y%JY-0@$8)NUDE!
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M#ISG3>;S#^$YK^"PX#^5#\13]KAY*=F^=>MGZY.HGUX=.<Z;S>8?PG-?P6'
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M6O8!6LQ9E ]4CTDT\BF.WE6 :_+R8U%XQ43W7RYY1N=3+<=/X8YN%"(2G8L
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M1YE/31YC//49CSLE94PM2/35$]#34CYFD%'+' 7I:5811M$ZU8JE8\2:60U
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M6$B,A95431R,H5&*2G2H!61@ 5)4* ;,2R8YF;PUY1-1; R*K->^)<^AD%%
M1).52Z>QJ?*S64OAZ<A+'PCB*PZ(BP !LB:91IB!YSDCOA2/N3+N0<KF,PXC
MZ3):BNJJ".JKS$)IW=TBA@D@$,2MPTC<2S2M)(2C2-)]6/K @CLFM\-4D4<Q
MCAU:4 #,SJ^IB+DC2JA0+A=/2-P3?>PUC<W^F#M=_:4O3_%"4]69/_PG*_\
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MMUZ>,^'3##IAATPPZ88LEL-_(NM?]FV+?^O[,Z\[+^_S'_F,O\BGQ?-WM/\
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M%U)&3E,N$@X^%R-YDR<2B;U,/XQUVQ8.)< XW(I$F:CL>&G4!\L6)1.4\DP
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MH[.VMB.:X)$&T[M39D3D),U3*\YG#2H8E4;*K3F.;8[EBJ1'$BI(*7:I8,2
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M )&#N7F7/+CE@SY4^#IWCJ%^NP_;_P"]A?[A]F*#:YMU7-OLOMC8GG_V,?\
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M$3C$',&Y!#(\D,<QE1FD%B9V2R,S&QB:.+,*4/FGPY%LY*/E%^&CE(L:-B+
M6*1VL+D#ONH$DCQ$FW7B0GL;BH -R;@R7N0 ?U?" +^.POCS236C2R8HC&\M
MHG7&3-PI60G!#<]4<++-QAF6M1[*4%6"#Z++I-"$B:B!*)IVAA@N3P%"_AF:
MW(YGRCPT4AM>C8V)(ND?6>L]]UFPOX[#Q# 5%NJH V V,G4+V_5\%S]^,NWH
MC4IK*ST[;5)1#>:RF2!9C))8C6T83D1V71R3"YH!E)4QC'>'[Z1")B$#2P>:
M<+YD6LF$##R3G$HP:NDN\CE!+<D;42"3HCN2""#?5UW -^NX!ZQCG'%K<H%K
M$6O):Q&DCO>H@V/C&/.OK[J Z-@Y(ZIK7]S((R-F :.FG%71-8H$$6$]D1*=
MBQ;U2-9.&0^8D)?+7TF9MU$VYMW*I*X(IN%3Q7)V-'*2":-B0" =$>P:]P.E
MU&YOX[GQG#C]?]H'2()WDW(M8][UC2/N'B&-WK.$T-2T;RAU01FM*OB>1!<M
MG&X!&!\1!J%'*#5HN14& A#%FH^5:,6+/-UFCDORS8LFGN^&[1NFGU:6=!9*
M611>]E5 +_8&^P?8 ,<:57-VF5CU7.LFWB[W$A?*6,^<(S\IU_E>I<GJ?1Y?
MN3Y\1U1^=3_/\F,@^D,<PP'^[/#<.,QZ:F'/.3G_ %\.5W/'&>/@;<_ZO/..
M7'W_  <^'CG[W@\'/-45/47E^HD/UK7L%V-EV/2Z[6/V$8F[QG1]8@Z"C?5O
M:^^RG;[;']F,?\I8SYPC/RG7^5ZMY/4^CR_<GSXAJC\ZG^?Y,/E+&?.$9^4Z
M_P KTY/4^CR_<GSX:H_.I_G^3'C(E(27'OA)8F )BRC-T.)#2#=1ZP(#WJ&;
M9XQ?,W+)1N[9NVRJC=RV7341714S25PSPSRQY&GJ""#32D'8@A+$>(]/ /&"
M")4!!N#T]B/_ *,5L$:J::1M:$X16KJBB &OW]@F@$)B,0$QF!J2*T(?G7DQ
MDIJ(!@;,(?.DH [,PKX<8:O.<8S(38K--1!TEPWK%%(--J1P%U64*@6[C2Q(
MU6)*W7?P$C%O*+AKU );3=B9"UE.H '3L+V)_: <>Y#5W2-K'X5$V]!ZW(QB
MMY*[F5?QY.HX9B&A4M(+M'+^31<=Q%_@@0Z^<CQSAZ4'I-WKI<</576448M,
MD7(I+ <C:RG4HT1@ ^,#5L387\=AXL<Y1N3R@7868WDW'B/1ZL2##JVUTKN7
MS>P(#":EA,[LMYP0L2912&!X_*)R^X<N'OPR6GA01J3D#C)\\>/LUBCEUFH^
M>.WN?.3ITNJI(4DREF%*X9N^8*@)^TZKG$6E5@ TZD+U ER!X-NCXL2A\I8S
MYPC/RG7^5ZER>I]'E^Y/GQ'5'YU/\_R8?*6,^<(S\IU_E>G)ZGT>7[D^?#5'
MYU/\_P F'REC/G",_*=?Y7IR>I]'E^Y/GPU1^=3_ #_)C(/9#',$1F69X;CP
MJ/Y43YYR<^#/#X<^3]WCX&W/^K[O#/#[_@Y\.//WO!X.>:XX*@F4""4VDL=E
MV.A#;OO$0=MM\29H[)]8G>[=]OTF\2_]-[&XZL8_Y2QGSA&?E.O\KU9R>I]'
ME^Y/GQ'5'YU/\_R8?*6,^<(S\IU_E>G)ZGT>7[D^?#5'YU/\_P F'REC/G",
M_*=?Y7IR>I]'E^Y/GPU1^=3_ #_)A\I8SYPC/RG7^5Z<GJ?1Y?N3Y\-4?G4_
MS_)BK[S5/3,JO*>#U6U%) DMAT#K]]"Y%$!)B #X96DCE<QA\? 0=Z$4C )F
M-F,WE$LS4'#$7;J0$^"#ERHHP&<,J^0R&]Z1R" MBL94!22 !JL-V)V\)OUX
ML%18"TZBQ)N-=R6 !).BYV &_@&-R2HS4U"5@)VA4U$(S6*0M.N(O*T:UBZ4
M@CM?HBW8)"$ RV$<Q>BHHW!D" 1N 8K("T Y @+1:X,'KINKWD<MPW)&U :0
M=$=PMK6!U=5MK=5MNK'./L1R@6)N1>3<WO?O>NXO]N-GJZ!4!1\9RA=,Q.KJ
MHB&9)V9SC%<Q,7"P"A=]@@D\)J"8Z&'L5"#E%HT;K/,T,G&;=HU;\J>\MD$T
M^K2S(-*4LBB][*J 7\>S=>.-*KF[SJQ L"=9V]G$C_*6,^<(S\IU_E>I<GJ?
M1Y?N3Y\1U1^=3_/\F'REC/G",_*=?Y7IR>I]'E^Y/GPU1^=3_/\ )A\I8SYP
MC/RG7^5Z<GJ?1Y?N3Y\-4?G4_P _R8R R0QQ5ZG@F>&J9\IN>>,<<G/AYXP:
MK9Y<_?;<<>#'''++GP\__3CGJN6"H"$F"4 %=R%\H ?K>$[?;B:/'J_2(=FZ
MM7DGQJ,8_P"4L9\X1GY3K_*]6<GJ?1Y?N3Y\0U1^=3_/\F'REC/G",_*=?Y7
MIR>I]'E^Y/GPU1^=3_/\F'REC/G",_*=?Y7IR>I]'E^Y/GPU1^=3_/\ )A\I
M8SYPC/RG7^5Z<GJ?1Y?N3Y\-4?G4_P _R8JW*-3=+)6;DTI=5+3(B7SJ0QJ2
M6%-8K" <6FUBN8M847M1B.GLQ!@&4EE8%_/87%Y#(0A@HY'R1P';(&T7S3)=
M!6LT4A)/)'!8@L0L89K,&LQ#7(+ $@G>V]QBP5%@ *A;*"%!UD+=2MP-%@=)
M(OX+XS;K6?2Q\.L40\HO71R+M\VRDEJ#UJHAZC2Q9"-*.3@T[-4,HSRG)"X\
MX]?'&)$MBZ=M#3]\6;K)D'KIRKWD4A##D;68W8:(^D;WN>EN;[_;OUXYQ^]_
MM Z(LN\FP(MMT?%MC8Q5+ZK@IM%[*!U?1X:PX1$V<#ADX%5W&QTLB4)'#UQ(
MZ)1H^SCR),''!XET[$L PQRV'LA;MV.;(),W2Z"@4DH8,*1PP&D,%CN!:U@=
M5P+; > ;8&8$%34 @FY!,A!)ZR>COB9OE+&?.$9^4Z_RO4^3U/H\OW)\^(:H
M_.I_G^3#Y2QGSA&?E.O\KTY/4^CR_<GSX:H_.I_G^3#Y2QGSA&?E.O\ *].3
MU/H\OW)\^&J/SJ?Y_DP^4L9\X1GY3K_*].3U/H\OW)\^&J/SJ?Y_DQD"TACB
M10DDJ>&IJID'B:B>63GW6&>#A3'/#+P-N>/=8Y<<X\^#GGCP\?>YYX^_U7%!
M4&*,B"4@QH00%L05!![[PC$G:/6X,B ZFN#KN#<W!LI&V,?\I8SYPC/RG7^5
MZLY/4^CR_<GSXCJC\ZG^?Y,/E+&?.$9^4Z_RO3D]3Z/+]R?/AJC\ZG^?Y,8H
M\O7LI!F8Q)G$8D4;D8HB!D$?.,?C8(=!EV:P\L',"G[!PQ)BR;!PX9$![U!9
MH\:+K-G"2B*F>&0T]000::4@BQ!"$$'K!&K<''0\8((E0$$$$:[@C<'O/!BN
M;#5#3$4K'$!%5U 'C$6BEHPX37@B'"!E9_%=T\QC"T'!* ,0:$8-%Y@PB(@.
M6+%QSUZL%R*"^%,6AHLF\K%%(+6I'  8!0J!>E8,2H:Q)  N03:X\)O/E'7_
M &A;DJ2>G?HWT[Z;V!)-O'OC.L];M,QR-9MV-(Z\M$:8(/2U1IMZKB*6-9E2
M15$\1)P7C",\?)<@_/MVQ]Z]#? W+HZV;&5U5";=%UAWD4@TVHVZ!NO0CZ))
MN2.EL2=S^W?KPX_??VCOMFWDWVMOT=]MOLQNE>UMKI4A*9&:LA-2UN7L4Q\H
M)\4@L,#Q0A-#GO[YU\;2EX#",7!TAPZ*%'?#HDHY5Q=DR3KC+A=^[46ZM),E
MRM*ZEC=M*QBY\9LV_P#_ +/CQ%I58 -.K!=A<N;=75T?V#[L2A\I8SYPC/RG
M7^5ZER>I]'E^Y/GQ'5'YU/\ /\F'REC/G",_*=?Y7IR>I]'E^Y/GPU1^=3_/
M\F'REC/G",_*=?Y7IR>I]'E^Y/GPU1^=3_/\F,@XD,=Q'CU,CP[A-3-[[WGS
MRZ]SGSAFCQGQC_\ QO#X<.>>/=>'CC_Z\>#P]5)3U'%E^HD)M'<=&XV:U^EX
M?!]F)L\>A!Q$VU[]*QW!VZ-]OV@?LQC_ )2QGSA&?E.O\KU;R>I]'E^Y/GQ#
M5'YU/\_R8T"RX91%T15Q!;AC%8VK"G;MH_=1"QHF+FT8<O6&?*C%XN!D@8D+
M6=,U,LE&JZC7)5OGESDEGASSSSUQJ6=Q9J61AXF5"/N+$8DLJH=2S*I'A&L'
M_P!EQ"I?4;24DRD: ZGJ3AI635@4IEY+Z_@4>A$Y'5F8BGR&>1..S&.QYB?C
M@WB'8I1IIB&>L\QX9LR8L<VZ#!EBW@:&0W_L;@E2EU6-3I(M8$-<"VVW4.JV
M)<HW!-0K6;59C(06O>Y&FQWW^W?KQMJ6O6GR)@](L:;H+*02J!)5;*#JU9Q=
MP9DM;)!Q\=Q@DA*.(XJ^-Q/, ($@UP1-=T.<B!(L:X;JLQS-%#O(I-SR-KE=
M).B/=>K2>EN+6%NK8>+'..-AR@6!U :I-FO>XZ.QO<W\9/CQYF>MNF0]O6C1
MC2&O#1M3))Z9J1!"JHBDE6A@D50/$2L&QQC/'$8)$#S5J>>O@_P1T[.M&AE=
M50FU0=)N1R]'^QMT#=>A'T3>]QTMC?>_C /6,...E_:!TMFWDW^WH[__ /?&
M<6%^4L9\X1GY3K_*]3Y/4^CR_<GSXAJC\ZG^?Y,/E+&?.$9^4Z_RO3D]3Z/+
M]R?/AJC\ZG^?Y,36*?#U18U1-\V4348,\TU,>5?<YX9MT\L,\?"EQS[G+'GC
M+CP\<<^#G[_''7C2JXED!1@1(X((%P0Q!!W\!QO2VA2#<:5L1U$6%CO8[XHS
M)_YRR'^O"W_7N.OM:7^[4_[B'^6N/%F_2R_O'_U'&#ZOQ7ATPPZ88=,,.F&.
M-G=@'["$"E+84:O>33W%7[1<J.Z<#[(%4TK.^+ZA4I](LKKPKAP%DCD@E)TH
M(>M1 C60MUR;<2@41$<$6N?DYIR@F'@<8?55-S$M21Q+1<*YI^]8G5H:4&,=
M(L"+C&ZB,0U\3A]_#^D,0Z%WXEN*-U[W6J6<BP!!MB-YC=6]$ YM#*&5I9T+
M7-2[8"8PQ!O1\SO!U8%M@X=KWC3M/R1\/:OQ$)KB=O3%DM3-K"L(K"<WD5<Y
MAI+&,AI/$G4\U:G%T1RQW>=T'!><R2JE/P86(#!(W+2 RKI0E#9TL2TECIVT
M:G0]&)6O(L>A&:7B2"Y!9U 0A"&:S;JUQ;-6%<O<W'/+'D$79F$QPA#<.21>
M#-M:B$BR62U_N&!@Z7A#21HJ)O3JM[PZ82)P--(,OALCC<+^-(*QR>I&I%G*
M27,@9&6]@*MEC%.6OP)D6) W6QG1V((%RJ71;ZFP2.D(4,1<\G#-Q@/TL;&1
MK6('"91<7L"UF\ QDSVQF_9NV+>AT#AUB (DO9,%A\+DLNUY/DN("Q>;>Q6H
M94>99(P^/Q6617"CSA.U6S]&>S]/.+#6\U)2*&-^3$<$=:HKFEG2-'5.(B1N
M\#'AWJTA8]XBLO!8RCIR= :RR=)5"*E$:,S*6"LS*)5&L\G:11WS,IX@$=M"
M'4=-F-B8G:VCW!:7+["14)!+$(1UU>\H,0Z>9U#,9,F9B<CV'=A[4LI9P&@-
M@O0#R.1/*'N:RAD<KN; "L1F,ML(8*F;&$OP<8J$E="9U5)"IG=D?A,UT:H*
MRR$B.0KH708T6-P4=Y ) A5):*:3A$L@/# ==:KI98KHF[K<,VH.Q=6!54+*
M6!:_>H<RV\GTWD[J_2C,=#XO5U58B!@>H)A" T\FTP"NB$IE+$_9<:A,V1SC
MV05HV>Q!:&Q]4(7DI-N6:)I(@FC+=2/5R2,9R BQ1:0(719'<79PTBH_1TBZ
M:%TER& LH&:=8%5>%?47>]W5BJJ;*.@64WO?4&((46/7CGOKX#WRH>AZ=L::
MRVX8^)N9I3,:M4=R#OC;BWJ=2!5Y<DDE=P$ZNL$ 7DL5FMHSQ:J*XE<%B44.
M0V"#6RIQQB1).\S C!3BM@@BD=YE$PA64$3U<L(6.9GE,<BLR/*_"C9%0QH.
MD;GI#3(::2215$9,>LH;Q0))=XU6,.I 940.ZNS!F)ML  =VSNS?2=CN(O:-
M5SEP4*1332:*@H345B1^,P22.+IU3YM<1*32\6%OB<NQ8R&SIE@WKVT[ B$>
MAH*0 + !Q@G74A<22?&KI%M)%)<K1OI2*151N-2\4.="L7LTKV261516615,
M;%HF.F6Y1UV:H7I.C%@(YM! #&RDJBW9%8L04+!AIU*OI3OU"WSJ</7%V6W*
M*NAVU3B0"9K1DN%N'K6N]SJ3,Y5W#7G H<'L,E<^MKV1DZE) DI$NDZ') *Z
M+9H1B3!4X1M71G63-*T:56H/"XN(ZR%BB$ +(9:8L8BH:Q&F,]%@).*9K*.&
M@=H+,L@:VN"0:FW)01RZ1(#8VW<7*G$^TO?'<(D]]U(#L^(H0B 2T3%)N6"F
MZGLU-)Q$+$86)+"<7(RB*U'*HO#[,I])> P5XQGEJ5LCB]CA#,X$DI&<"G@^
M^&?,&GA65 D;A7(:*3=9%=RA9(F5)(>BA#RQ[J2P;B*17)'3+$Y1M3J2H(=#
MTDTK<*7#-')TGNB/WP *A#J[&]>OC#ATPPZ88=,,.F&'3#&=-_[(%_43;_K'
M_5$/?5'[]OY<>)OU)_@'_=L8+J_$,.F&(YM*W:TI.+YS6UYF$@L6P>8#_C@Z
MXR0;*/<VCPA\%0P235<.%DQPTD27P014Y;#!Q BX]Z9,G2Z5<LT4*ZY76-;V
MU,;"]B;?MV!)\0!)V!.)(CR'2BEC:]@+[7 O]Y ^TC'CCEW4_,)DC7D3LR$R
M:;KP09:"<7 2,87,<UX:4')A9EFT'N'&:4?,<EQB@DBK[A D@^;.662[=3%7
MKBS0N_#21&<H)=*L">&UM+V![UKBQZC>XQTQNJZF1@NHI<@@:A>Z[^$6-QX+
M;XU,KM3K@"E,[A1J[*Y$RFL0!23SX,1DPYFYBP,&V#O#CTIFX53;I\@VLACZ
MYIJFLH\$IG@G)!NV^-A_PB)JJ=6D1IHPT2EI 6 **H4L3XM(92?"-0OUC'1#
M*55A&Y5R%4A2=1-[ 6\=C;QV-NHXQ37<35MYQ /@U[ULIE:)1V$@J7,C:)N#
MAAC)D(4[&?!E><' Q\A,W+:'YMC"8]7Y5N$(YQCR96399<%73'AVGC^M)5.D
M.DP;01^PZ[)O;ID+UD#'3!,-5XWZ !;8[ C4#^T%>EM?H]+JWQ9/K1BK#IAA
MTPQG3'^Z1O\ J+G^_#75$/?U/[__ ."'$V[V/_ ?YDF,%U?B&'3##IAB/Y/:
MU:PN6P2!2N<Q<!-K/?DAE>1(F89MI%,G@<:X+EDX^'S5^'D4Q@YLJY(.4$,F
MK/'E!-PLFJY;)JP:6-&1'=5>0D1J2 SD DZ1UFP%R>H;7ZQB01V5G5252Q=@
M-EN;"Y\%SL,:_6NP-)W$:FT<JVT(;.SM<O&K&;BHX:;$'L<6?*/T6*C]%++W
M7P)\L**(,22'OPYXN-?HMG2JK-Q@G&.>&8NL4B.T9 <*;E2;@7_82" 1L2#8
M[''7BDC"LZ,H<$J6! -K7M^T7%QUBX\>(WYW@U%XBQB;8[#U:K%@,A9Q4F80
MD[-P@F<(BR1T<U;)H<J.2*!$"&-'QY$<@[&/0(0V;:O%18@D[:U\MI=)?E$6
ME6"DA@>D02 /'< D$7! )!L"1/D\^H+PI Q!(!4BX! /7XB0"#O<@=9 ,@1_
M8RB)98F531BVH'(+&X")2+&)!Y$/($UPZXD-($W33X*JJV>9_)Z11^0YM&BZ
MSU( <$&U6^ LDS=K36H@:3A+*C2:=6D,";6#7%MCT65K WTL&MI(.(F*0)Q"
MC!+VU$$"]R/^X(\5P1U@C$T=78KPZ88=,,9V-_RNA_PQ/^ZWG6>J_0-_BB_F
MIB<??C[&_P!)Q@NM&(8=,,.F&'3#$:1RY*NE\ZE=9Q:< 9!.8-CE\KX\(=<O
MG,>63Y88N&1-PWPS8MR;/DH-X("N77)(=\/9_#FK?ARC[NM9HG=HU=6=._4&
MY6UK@^ $:A<7N+BXQ,QNJJ[*0K=Z2+ _9XQL=^K8[XC1?<C5ELE.UE;XK;W-
M9E1X.;8)R)JNN'+E9"0B(T=@V0Y4<%73V6"2T7;)!4B.2LC%D@>/A*,';5&O
ME=-T_KX_JR%?I V)8H!MUDLK+M?I CK!Q+@3='ZM^F+KT3N+:K_L&DAM[=$A
MNH@XS8/:;7*32Z%0..W57)V76-'1LK@P,3)QQ!U* )D.2D(=\(S:K*MW.1:/
MARYT6RX7X?D PDF4:-5F(]VNCU:FG9TC6:-GD4,BA@2RE2P(MMNH+ =94$@6
M!..&&4*S&-@J&S$@C200#?PBQ(!/4"0.LXGOJ_%>'3##IAATPQG91_.:1?UZ
M7_O!QU12_P!VI_W$/\M<63?I9?WC_P"HXP75^*\.F&,<8,"8\(*'SQ-@%!@Q
MSXP:,%7:# 6)$C&RKTB3)/W2B35DP8,T%G3QVY530;-TE%EE,$\,LN.,P52S
M$*J@LS$V  %R23L !N2>H8Z 20 "22  !<DG8  ;DD]0Q$L6V/HB:5Y*[9C5
MK0LE6\$R)8S:8_'"#(-$<A AE("'$D7(?!,PO*  F,.\?&*;?W\,3&E&_OK$
M@S76J6H@>-I5E0QI?6^H!4L QU$VT]$AM[=$@]1!Q-HI%8(R,':VE;;M<D"P
M'7N"-O"".L'&IH;DZL.$(*Y2OFMO>[*,/X_"\5)$U07+FQ<C8P\B,4:K^]N1
M3ME+2@N+N4C20[E*1%!@3/G@D09MEH"LI2$/'C^L)5.D 2P8(18[@AR%-P+,
M0#N1CO FNPX;W07;8FP(+7VZ^B"VU^B">H$XWRN;ZIFW3<PC=8V9#YR=@#O!
ME,!<<,-B+L&JJ0+B$E7.".7/"K)4O'SPE(DTY<#U"@0N.P=9/1KU!&R.>&4N
ML<B.T9LX4W*W) O^PE6%Q<75A>X-HO'(@4NC*&[TL"+VL?#X;$&W78@]1&);
MZMQ##IAATPQGG_\ ((#_ ,8S_P YIUGC_O%1_A@_[28F>\3[7_\ QQ@>M&(8
MCNS[:K6EHSQ,[5F8."Q?(FP"X&C[KX*R4+%,\TQPY++C!3-5X\S24Q;H)X99
MJ>XS\''@QYYXKDECA77*ZQK<#4QL+GJ'VGQ8DB/(VE%+-8FP%S8=9_Z8T!AM
M;KF3GT6JUC;\-7L.;,A)")1+A^HF8D+0[$L9X(5%H*H)XNN7\.SXD:">&?OO
M(OC)QDGCQAGQC 55.76(3(9' *I?I,&36I \-TZ0_9OB1AE"LYC;0I(9K; A
MM)N?!9MOMQZCNT>NL8F4NKZ1W370&90*.%);,P)>3#A[J-1\(&'R,T^+J.ED
MFK3(1'2PJ0E&2B_#\>!*#C+MJB-?-72O6J:=7=&FC5XU+NI8 JJJ&8M<[:5(
M8CK"D,18@X"&4JKB-BK$*I )!))  MXR"!XR"!N#C H[E:KN&L'>)WS6W"%C
MF7\=AOOLB:H+%C8J0CXD3&JM5_>W0ERPE1<1&G>!I$=P@?+B0ZF6) FQ;KQY
M72V0\>/ZPE4NP!)#!"+'<$,P4W LQ ZR,=X$UV'#>Z %MB; BX.W7< D6OL"
M>H'%E^M&*L.F&+B1C^;4>_J,3_T#?KXZJ_O-1^_F_F-CW(?T47[M/](Q5>3_
M ,Y9#_7A;_KW'7U5+_=J?]Q#_+7'CS?I9?WC_P"HXP?5^*\.F&'3#%6;>V.-
MP>V(A1U:5(:N2SI' Y):Q8.RED9@PJ,5Q&#H*+KE79Z4JXM7QX[(9 T%1>.M
MDL$WRC0J[,&  YE\,6S2U#)*D,<332,C2D!U0+&K*I.IS8LS, BC8V)9E N;
MDB#(TCN(T#! =)8EV!-K#<  78^"XL&)MC7">_VJ 9Q+D"5DE&V$-<J-'S[B
ML;9<"CZK:V8Y1)/*NRS6#+C;3;@K?EL;K^1NJU=2MM'3Y=HB;58H99.,8&OI
M07!D/0-B>%*0QXJP'AD):73*RHQCUZ6(O;'133'3T1TMP-<=Q=#(-8U72\8+
M#6%N ;7MC"C.X]I^6&&2[>QY.V: 6X59\F5I:\PQ%98W9XJE4AH8.5K9F7D9
MH3;!L37TJ"1UB5*P^4/DA<I:"%\%N$N#,*4@L)'LH4F\,P/2E$-@IC!8K*PC
M<*"48@, <=-+."!H&_5:2,CO#)<D.0H,:EP6(#*+K<8]>/<1U%Y1;+\V4<QX
M6AYB=/4<ZEN3%U'0 &83*NRN$P:<U_\ "8;($+%@4EKU"'RA(3+B$Y1%1,:#
M>'9)'&)7O.%+L>(PNA<WBENJJ[QG6-%T;B1M&$8!C)9%!9E!<EG\@=84=./<
ME5<:>ETAH8-J6ZA;L396(TUOW)]?5K>!5ZH].-XE)HI'7@VPEH99^' BP#EW
M2.A5J\L6,9UY@]J50=/ K &K);+?Q@4J=/BPWN$LG3%V^ASC!QA'=@C*MI-$
MNTC3-!PY%X=XK.H75(5!9@NW6>\EDX9?:ZL05U)NHC$NI3KZ?1)-D#&P)_8-
MXY[A.I?*1+-O9!LBHP/ HVR9!ZHN$V4EI*4$IB%C2E=B!$!?$[*$R Y )>$#
M2"!-)$"(E@_P!J247(B<'\S7TH!^L)LRJ L4K%RQ=5X8$9,@9HW :/4I(L#N
M+QY-/M= +ACNZ *%"EM9+ (0&4D/I(!O:U\8PSW!=>W$/,2:MI/E/U1,,K:?
MKYYQ:U0<18QFTC8,5%.9).&E8R,;%Y"4;&L7S&'%6>,L4R;YH/PXQ!-Z_8<:
MOI]+-&^O2D<AZ,H0+*0$U.(V"L0;A"-6UB!N1T4TNH!U*W9TZT+$H"6TH74L
M!;=AT=Q8FX!V(AOOJF.9B'7-EOR*Y]I@Z"!05<VE(9044SF4X@' MG% D*?R
M-208RNL[%'JQOD7B?0:P66FEAJ8./DR3:1KJ8 'B$EA<*L<C.>F\=@@0MJ#1
MR K;59':VE21SDTUR-(%C8DO&%[U6OJ+!;:70ZKVZ2B]R 5B[NTI7#&EY@3,
MXOZBN:M[&ML?:PW @\"!8!7D&#3]:0+A68MW(B2)@&:0S:M&0_XQ;9IYX.&7
M*WA1PY)6PQ"%B;Q3123"4 D".-%?45MJ.I6%@!<>$8)3R/Q !9XW2,H; EG8
MJ!<D 6(ZR;?MQD(YN_KA+B$7"1N53 M));+9+"F$3;TU=.,Q$&(>]B3"3/)O
M$%:]PDU=18(XGT'Y(S6>B8Y$&S:6@7JAO%F017YDM93L556<L[N@00S:P4*A
MBZ\/5&H+I=W"ITU-[''&IY5#%@H"J&U&2/20VJVAM=G)T-94+,=)VVQ!#/N:
MTX_8:]I,4$RLEN<C5?,J1$XV%E :KC5IQ*43(6<,VJ:JP#%%BN 2,+EF,'D7
M,(F1:/J+R+@0Q%LE%E*!F4)$%NDTQBUZ>)HB65696:1HE6]EU"-M#E;M8 ;V
M<DD^M/4L8>U].IRC*A 0.6MJ:Q8:E!VO?;$@..Y-IRVC^,E4LJ39LE,WN23!
MK2MYO9,L.'PMK8[B1)0]G6R\KSB7-?N\9HC+N WR:<1MJ5*(E<VX0SDPL.8T
M@75Q&(WV$,Q:P02:M CU:.&=8>VDJ"03I:T>2SWTZ!?]LD8&[:+:B^F^OHZ;
MWU6%KD8WA_O!K0PRE67RY-DF4/=QD23- *QM621HA)Y@M$D([!XG* ,)(QV<
M6"_SG<1SR@,.)G)@R;FDG3\*U;,BBK&9K:<:NFQ"%5++%*REW*A8T=4*O(=:
M?5H6<!KE0 2(BGF.GH@%M1 +HK +JNS*S HHT-TF 7;8[B^/G-Y2F9Q77BP]
M9%%YY$;(M&#-9 LWADF=>^UD^F D)8+TBF_C[3B%DXH$SD3MZVFY: /!1(*\
M2XS/2$.E6TNX\S.M/)3=-))4#'0Q^J+@2$W4:"BZKARA!!&[#AOU8PK2I-T&
M1&MTE'3"W7PG4&-K:0X(/@!UK<+K7BC#IAATPPZ88SIO_9 OZB;?]8_ZHA[Z
MH_?M_+CQ-^I/\ _[MC!=7XAATPQ63;NK[!N>CI365<8!\BLQ1= RBAFV+)IE
M-L"(AB[)P[:R^K $ED3E=L0<#%7,8>"\H_*!.),.7<-DG*:O&>JCDFA:./3=
MP5.J62&RE2+AHE9B0;74C2PN"1BV!UCD#M?HV(M&DER"#8JY4 6OT@;@V(!Q
M4H+0.U=(32"VA$X[2EJ.*AT<<:\-6(HV2@$HLNS6(*#EQ!]*&-H*-@48CKZ>
M5\%B^0WB=LD D"?K&6BZ#D(SBKG(L%3 Z2*L,O"H^3BQ,;RR!4(;0$"*I>,+
M;7T4)8&X"8N,D+JR,9$#U/%N5#!$)8$:M19F"MJOI-V%B#?4(:LSMN7W9A28
M8/)K40@0SL&ZKUKL@W>3-Z8.67=$KJ:=.8+/AJD;;M0M<QHQ #(+&0!C,I-2
M "4 N%(L%< EV1*F7+IY"]WA4<2:>,],EI)FA<I(-("QJT9&I2S,I4Z 5(-B
M5<:A>BY)6.-QT0 D:NFI3?=V5@;$  @C40;C^%.V]?I*83V6$I93S3RDY0%.
M7F-9&)L]PJUI&=JL=B1:%-NEX8Q\8! D&]W$BS^5M:QP2/X-9@@W<I-^8^IW
MF^<O(Q>(<H8-, 7/"TU7*!P3H'$NMT;4(NET]^]QWE<855 D^J4B(D+T[P<(
M\2S=  ](!2]P2#OOCMQU[&//PZ88=,,9TQ_ND;_J+G^_#75$/?U/[_\ ^"'$
MV[V/_ ?YDF,%U?B&'3##IABG.S5/V[9ECZMRJM1M5J"Z0NG"V96\G$JD\?D!
M-JE7=C5MC&X^@ KZ6MUTN65FDI%RY)%1R?!$&R%\-.42JY89DJ8I99*9HQ%:
M&83,79E8VCDCT@+&PZI"UR1NMK;W%T3HJ3*Y>\D>A=(! .M'NUV7R -AU$F^
MUC L-I7;&*V'<<WG46IV:2[9B<Q2OCD_A<]E7'-7:Z1]*88"@S&)GX/%41"4
M)C!$JN/4&2"8F9K;TSS?F\!T4S0YBU"0U*R3.Z1.]2ZHTB2-]73KJ 4*R);0
MA)!#.SS/=K);1:TD)6-59U6%68*RK=Y6TW.H,;ZB!>X4*B6%VZZTQ?MN[015
M[75AMY+K^_L>I:GJ[7:.158W8+2O9/6U;:]WG1J=AGS*<"=&0M@%'-T927F'
ML8R<!M!@%2)X397@QD>89UR^I4QR:J<R111TZ(3((VCCIYX!(S:"P<F;44"E
M=(*:]]0N-5"=:D2!'=Y2UD+J[RQR: -6ZCAVU:E))U:=M)F35KMZ69KU8M0,
MR,W@\CJ.C)!)Y]%Y$W5D25H2V42_6Z!Z^/8Y)8\X$<1P1' ^$=.2=F=9S$X0
M*\+QP.M'A/ A<B[MI:"6GDB!='BA9Y%;I<5V>GC@TLI&E5&EFN'8FZBPL2:Y
MJI)4DLK!Y %(-M"JLK2Z@U]18W"D%0!N03< =<NO5QBPZ88=,,9V-_RNA_PQ
M/^ZWG6>J_0-_BB_FIB<??C[&_P!)Q@NM&(8=,,.F&'3#')NM]8=I];K<M*QX
M"?&3Z*S>Q[3)B*]=6M9KX))%=B]F8K8[R=S>!2I1O7E5N=>X"^L8>@]J?DN=
MM;DI\,+,TB?*(9YY<=-4T\LLD;!U>24B,RRD-RBH236\;6CB,"&07CNTM[G?
M;&QYH941&!5E2,%^&EQP860*K+TY.,V@GB6"6L#8W$1@^W!L3&9)4\U8RJER
M9K5TJ":TR'>'9R.%VQ&FELV=/2KZW"R,%(NJ]D606?,F(MM&1%GLD)((?'5B
M'*!?!@.I7+JA&A<-"6I2!$"S@2KQ9'8RG03&VE[#2);,";V.UAJXRKJ1(!,"
M7("WC8QHH"#4-:W6YN4)4@6N+G8-?^VS;U-S"L&1*=5L<KL#:U2;#3,TRSE+
M2;(676U(2NJ7D AD=<!50F5=%BI]F=920G*V!H:*;E0:D1=JEL23*=/ETL+1
M@R1M&LL4[$:@_$CA>(HJZ=)C9F#:BP8 %2A)U#DM6D@<A7#%'B4;:=#R"34Q
MO<, +%0I!-CJ%K8[0=>OC!ATPPZ88=,,9V4?SFD7]>E_[P<=44O]VI_W$/\
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MQ:W[.IV"5Z[KF4"%(\U8H56"-QPV[QE;"0EY"9 .@+#.&#' E=9[FFRZ>8R
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:@,Q8 V:UP#OCT4B941202JJI(O:X 'BQ_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>g904779g94v79.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g94v79.jpg
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M 0$! 0$! 0$!_\  $0@ O )= P$1  (1 0,1 ?_$ !\  0 !! ,! 0$
M       & P4'" ($"0$*"__$ $(0  $$ @$" P,)!@0%!0$!  4" P0& 0<
M"!(1$Q0)%5@6&!DA(E>7U=<7&B,DDY8QE-/6"C(TD=0E041187%C_\0 ' $!
M  $% 0$               $#! 4&!P((_\0 2!$  00! 0(("P@! @8" 04
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M:<&>$<C8QE64F-<!">*R&K*D+&.^R;-7*5!VW+J ]$PK@L9AY5S@C:.6O(D
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M+6_1'4?L:_\  3QC:!Z9Z8]MX[O"?/"Z4OB0TC^)M0_-N.86M^B.H_8U_P"
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MV-DO@)S_ .#_ *7Z5]LXSXZ?/JZ$OBLZ9_Q:U[^<\>+[A"Z'ZJ]C9+X"<_\
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M!3@6=*&%Q!.*]"(C2,)Y<>7"FQ)"&WXTF,^VMIYEU"5MK3E*L8SCG7J]@%L
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M0/)CY$B',CO1WEMJQ^4Q=',T;&-R5>-FI9BT2#D[QE&49-,9@D@\2!.$D8E
M<4H%"6$"#G&<6=LEB,OD,%D*V4Q=F56Y5D\ADBT91G&47@4)A3:0SUSCE(5B
MN6,Q'%.8R0E"3L\5ZD.G"J;!JA[J3Z;0+0<:':P3WUH87EV1(U+)D.I;D;!U
M]'6IV85TB5FNI]1'\9!#5I"0V)++>K+PDJWCL!G[V%O5M+:ILRL/8DX=-ZD,
MT8QS,8Q=XXO*29HC!J (XOQ9;("S H.<#1M1.!MTRN*Q^HL?9U3I>M"K*K%B
MZFTR%Y2EAI2=FEE<7"3R(?3QR2^]';,N'-)JYWE5E7._FSSI*T%.$3A$X1.$
M3A$X1;+]/O4"WJUNQ:\V'75[*Z>MEKAL[0U@]+3$D9?B)6R+V!K\H\AY-2VG
M44O.OURQ,-Y8FLY?KUA8(5\A+BXU74FFWR\JN3QEEL5J7%,26)RS0><>*38Y
ML;D@Q>+W<1=XK1M5I/QARXMJM(=D4)K:=.:C;$M9QF2K/E--95X1RV)>;0EQ
MH;6#DL<63.U/+TF=Y5;,6XI(\:M9B2L6<%1Z@NGUS4;M=N=,L2-EZ$V6W+(:
MFVQ B*B1S,>(I&253M@W"WE5+9E16\U!N%/G.Y?B/^43&.D ) :2D^M-ZD;-
M-9HWJSXK46*> LSABS:<@2FS\E<IEV1:[BKK1<E*Z-N+..T16%8$44/.H]./
MAGK7J-ELII[*-,F'S X/")XP=N5IW!;7>GE*;NP[M(C\:$MA1.2N019:W<VA
M:PG")PB<(G")PB<(M\-;;(I'4C2*[T[=1%B@56X56 D%TW]1YU:\-4UKO6H?
MIK<I!*'99#3)"6ZIJKVA[$DEITE*4\SB3191,6.YYE,7?TM?M:FTS5);I7"O
M8U1I>NS;;TMC,7.8,3NT!9P<(M*W4CQ!9L4-DN)D("*7H6+RF/U10K:9U-9'
M3NU!M7TQJ>P[[*+;7<>#SA&9YDP99N[5+;M(N%+-Y-QZ$S"'J-LC6]WU%=[%
MKG8U=GU6YU6>L<:"D4(PZP[A"'F)$=]E;L0@-(1'6" DL/?DC"PV3%)#94J#
M*8?<W/%Y3'YK'U<IB[0[E&X-B@.)WXLFVO&491DS3&44VD,P21@4)83$6$"0
ME%M,RF+OX6_9QF3K$J7J9'$<!&;;&6QGC*,HN\"B)!XD"8<IB,*4"BG,<XR>
M$<R"L$X1.$3A$X1.$4@JEKLM%LH*Y4TZ4K-JK)2&:K]@"S'AY405'O)D0Y\"
M9'4AYB0P\A*T+0KZ_K2K"D*4G-M<IU<A5L4;U<-NG;#,%FL>$2!.$D7C,9(2
M9XRC*+NSL[=;;'WJYIW+6/M5[U&P6K<JE@>M9!.0S!,.32@0<XNTHRC)F=G9
M^I]K;67[:/9<^U&K7696HNK]H2A=9ZEZP+[Y\!'DCQ6U!4!G&9%MJ<;'8RP9
M8:1F1:JK'Q_)9PZ:"M*!JE1 /P;PM\$EK0]J>7Q$#6]*VS;!D?C$-AS$E]VG
M<EOE($I/Q:=R7_7NKV'\(XD[/W9P3<+-76]6&)RTQ5=4U1;2#;BC#EPCC]ZY
M3CNC$\8MQKE./_1O.!GKO.%?V(YQ)=K3A$X1.$3A$X1.$3A$X1.$3A$X1.$3
MA$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A%B'=6E:;O.FRJE;8O
M:XGS)(([';1DI72N6^UN? <5X=R%>"43H*U8CSX^,LO82M++S.P:;U+D=+Y&
M&0Q\]K/LA:JS=^0N V[7$5F\CMO<16;CAG]Z.UGE&6M:JTKB]78LF-R0]DFX
MTZ=R$6>Q1L.VR)@R?9M9]C,8+NPSP;B3V.T)P_/'N/3ERTC<IE/N$/M<1WR
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MH,IA]S=,7E*&:H5LIB[0KE&X-B@L"=^+*.UVE&49,TQ%'-I#,$L8%"6$Q%A
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MOP><YO$8XS).,7P.H]1XO2V+-E<J;DPC^X$,-CV+=AV=QUJPW=N4*38[[W:
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M,3&)J93#$9#.8V4NJ=US,:6Q.>R6'R.4KCN?8L,E"O2L@K6:1GR8ZT"$L L
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MBJ,+H!>IB1FO=O0*&TV/M=5V"2V%6YD,<?%"['3MZZTJME)6:*2(U(O(&"#
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MK^L)%OI- @[7N->D;1)CVJ@DF(UY!9N$Y)0M$94("./I?<<&H;1.Q_KU[/\
M.[_[17)/57TB'+2,UZ V/K"]GC8[7Y:"-J4ROVD7+K]]O!VMU,U&,P7'JZ2'
M-78"3Q/:&$IQ !.<&D2,"'[^"R",?7UVHI"C??1YD8,LJ-T=-60YTF_4PY]&
MQ=7Y&F#%?4+%2:T,*8,>E($@BK,$'/AXK[TD;FPBXCD=GWM$;D$73*=3O2U-
MUI;-_3+]1#5&TU<;K22UQ?1#==KNP*<9=K%AK 1XHS'E9L$TLPS!"I%*\JU1
M9P@D"E$@I8;/DSL?R?C].BREJ2X:QVC48&W=5J!DZYL1MTE&M@>#"CKM+ Z;
M,%-D)4R,WA^>E+L20B,Y+<6\VUGM4EE>5M)A%E#A%C?<=)7LO4VR]<):0\C8
M-$M5&DH6957L^@MH2;7R*V3::];/=<IJ 0DNPYBZR<:9EH94\-E,][>2+S N
M'LWS]ZN,^XV%IF2_+ P*Y%%?M\8>@AA4*B46@+A!R$_I FV:&,FC]?!C3]?P
M?56F+3/L1R &AO')C>9V[MGUNV_VBBFRO9M;@VSM$];;:8HC- *6R\[$%:V$
M;(F.0ZML6Z6?45U5;@).Q=.%@7(D-6W4 <X>"7>+>Z=8ES5C1]6J05)@;8VW
MM\_5LV.R+;_I;Z7K5TZVXA/'":O!KMHI]9JEMCCK^+G-/2J<3OUD'6T;4J[T
MV:L$Q;&=/[!-ILC TT"JZHTOU\"MM$8RL3H1;Y\(G"+S%KW0_FIU)57KNE=)
M"2,S=%:WE8=B0-EK'[,NEHJ/4%'ZCP(BZ6V#TML2;%5H5RB10+ V>RY/C4J.
MP(AEHY)ELVF=K^[9[MB+&%E]GMM"8138:L2# ;%7+41M6HGY6Z<DX.D'[-NX
M;OZ\1M>,+Z4&U$UVN_BXKZI&W_VN0PPUML5 $*%)=@/MOU_IZO5_2*RU'V:^
MQ0NH5:Q/%0A2<7)T@O<K(%W"Z+AVE^BC[X*@#IM2LG2_=@<RODH>P2DDN'L*
M;$RL\.!GQ:Q,T9'2F/G[_K_**_Q?9N3XM*D45(> X)DU.W4YV4[U!R?>?NVY
MZ?T9I0K(2ZWTF-Q,$&:IT_4N= =]%Z9D^1LLM^+)'S1@L.1>OL54I46,J<U'
M8FJCLJF,Q7W)45F5EM.9#4:2]'ANR([;N5H9?=B17'F\)<7'84K+22*OPB<(
ML8W[3.L=HR1\O8%1@VEX4P['&^\I!'+,)M]>')'IHS$QF,TY(4EOSWTLX>?2
MRPAUQ:&&4HSF)U)F\% P\3D"T8V)QF;D8!XQ90;BPX\YBG-XP9WXD>-Q8O*;
MQ9GG)WP&9TM@-0D"3-8T.0E6A* .7F?BBC-VE/B#@6 XRF[1X\VCQYM&$92>
M,(,V/_FB]-OW1UG_ +D_S#F6\8.L_3]S]-?X*POBTT+T:H=MCXZ?-%Z;?NCK
M/_<G^8<>,'6?I^Y^FO\ !3Q::%Z-4.VQ\=/FB]-OW1UG_N3_ ##CQ@ZS]/W/
MTU_@IXM-"]&J';8^.GS1>FW[HZS_ -R?YAQXP=9^G[GZ:_P4\6FA>C5#ML?'
M3YHO3;]T=9_[D_S#CQ@ZS]/W/TU_@IXM-"]&J';8^.GS1>FW[HZS_P!R?YAQ
MXP=9^G[GZ:_P4\6FA>C5#ML?'3YHO3;]T=9_[D_S#CQ@ZS]/W/TU_@IXM-"]
M&J';8^.NW Z4^G89.AD8>IJLW+@26)D5QQJ9);1(C.)>96N/*F/1GDH<0E66
MWVG&E^':M"DYSC-,VO-8'$0),_><982'-HN(<GA.+QDS3&*!(.[.[<:$HR;R
ML[.J@>#K1%<PCBTWCF*$D"C>42DBTQR:47<9"S'-FDS/Q9QE%_([.VY1FT]$
M?2K=[$8MMNTS7+%9;!.>)&39:;8)9 C-?SCO>D/N&<JSX)PEMIM/:TPRAMAA
M#;+;;::]+A%UKC:E>C0U!;J4ZHXAKU@#JC$(<?)&$(UV9M^UY.^V4I.\I.\G
M=WH7^#'0>4N6<AD=-TKMZV61K-JP2V4QBR\LISE9=WW,T8LVR,(M&$6C&+,U
M@^CYZ,OA_I?]0[^;\NO&GP@]*<CV5_@*T\47!MT1QG;:[PGT?/1E\/\ 2_ZA
MW\WX\:?"#TIR/97^ GBBX-NB.,[;7>$^CYZ,OA_I?]0[^;\>-/A!Z4Y'LK_
M3Q1<&W1'&=MKO"?1\]&7P_TO^H=_-^/&GP@]*<CV5_@)XHN#;HCC.VUWA/H^
M>C+X?Z7_ %#OYOQXT^$'I3D>RO\  3Q1<&W1'&=MKO"?1\]&7P_TO^H=_-^/
M&GP@]*<CV5_@)XHN#;HCC.VUWA/H^>C+X?Z7_4._F_'C3X0>E.1[*_P$\47!
MMT1QG;:[PI-7^BKI:JD2S0JUIFK@VKC79U1L;PUXU%GD:R4RW@J$P4:*))0A
MY5MM,<HP/EQ<$H?="FY?B.+9597.$+6>0E4E=U!=M> VQ7JL#,"8A6P;>0L.
M%P\D0H7=YAD6$^2GL(/BS9I-D*'!OH?%M;^SM.4*;WJA*-H@7/$I:9G;EJ[&
MY9RC$9HM$T13ARL/^&3C0=XOB#Z*_P!GQ\+>O/ZME_/N9;QO<)/2[)?IJ=V5
MAXH^#?HEC?U6N\)]%?[/CX6]>?U;+^?<>-[A)Z79+]-3NR>*/@WZ)8W]5KO"
M?17^SX^%O7G]6R_GW'C>X2>EV2_34[LGBCX-^B6-_5:[PGT5_L^/A;UY_5LO
MY]QXWN$GI=DOTU.[)XH^#?HEC?U6N\)]%?[/CX6]>?U;+^?<>-[A)Z79+]-3
MNR>*/@WZ)8W]5KO"?17^SX^%O7G]6R_GW'C>X2>EV2_34[LGBCX-^B6-_5:[
MPGT5_L^/A;UY_5LOY]QXWN$GI=DOTU.[)XH^#?HEC?U6N\)]%?[/CX6]>?U;
M+^?<>-[A)Z79+]-3NR>*/@WZ)8W]5KO"G<WV??1H0UZ$U/)T!2_V<5^P$K8-
MI\=9R$&^5!9AN)-L1!B&7CK,F\P6D#HI0RY/FCAF%#!ST6 M<=6/'PDZY%D[
M&9AJ.]]J6:PJ9;LFKD/X(&3D'5%(@),"ORCN680,,92_\4D9D9I-D"<'&B"8
MT&'EIRC]F5K);@J47L#!X6:+0G9+$9HN<_)LPH%.Y"#%_P (<H#=XJ"?17^S
MX^%O7G]6R_GW,AXWN$GI=DOTU.[+'^*/@WZ)8W]5KO"?17^SX^%O7G]6R_GW
M'C>X2>EV2_34[LGBCX-^B6-_5:[PGT5_L^/A;UY_5LOY]QXWN$GI=DOTU.[)
MXH^#?HEC?U6N\)]%?[/CX6]>?U;+^?<>-[A)Z79+]-3NR>*/@WZ)8W]5KO"?
M17^SX^%O7G]6R_GW'C>X2>EV2_34[LGBCX-^B6-_5:[PGT5_L^/A;UY_5LOY
M]QXWN$GI=DOTU.[)XH^#?HEC?U6N\)]%?[/CX6]>?U;+^?<>-[A)Z79+]-3N
MR>*/@WZ)8W]5KO"YM^RR]GRVXAQ/2UKG*FUI6G#F;"ZC.4YPK&%M.G%M.(SG
M'VFW$*0O'BE:5)SG&8?A=X279V?5V3V.SL^QJK/OW;G:NSL_F=G9V\K.SJ6X
M).#AG9VTEC-K.SMM\)DVUGV[XRL/%V\[.SL[;G9V4UV'[/CHSVQ97;?L70-.
MM=A<@"Q*)Y%^P)3#$!(+(P,'&0HIF./$AQ(^.S#&B1D6(/A,(PW&C-XRKQL,
M9PE:YPU2-+&:CNTZK$,9QBA6=YGL$D4YRDF"13',6<IE,6<RDD^V<W=7V2X.
M-#YBU*[D].TKEEQB"Q"RLLT @'$0 "' \1A $<8P$$4("'%MD(,R@_T5_L^/
MA;UY_5LOY]S(>-[A)Z79+]-3NRL/%'P;]$L;^JUWA/HK_9\?"WKS^K9?S[CQ
MO<)/2[)?IJ=V3Q1\&_1+&_JM=X3Z*_V?'PMZ\_JV7\^X\;W"3TNR7Z:G=D\4
M?!OT2QOZK7>$^BO]GQ\+>O/ZME_/N/&]PD]+LE^FIW9/%'P;]$L;^JUWA/HK
M_9\?"WKS^K9?S[CQO<)/2[)?IJ=V3Q1\&_1+&_JM=X3Z*_V?'PMZ\_JV7\^X
M\;W"3TNR7Z:G=D\4?!OT2QOZK7>$^BO]GQ\+>O/ZME_/N/&]PD]+LE^FIW9/
M%'P;]$L;^JUWA9#U;T"=&^E;J+V+J_I]H-2NX1,I(:QQ(I":0$JFQW(DE\<H
ML0GM0I;D5UZ-B;':;EML/OLMOH;?=2O&9?A&UQGJ!<9E]29&[0.\'/5G(0QF
MY.33A$O(B%(D&FT9\G)W@\HQD\7>,7;)8C@[T3@KPLGB=.8ZG? TV!:A$I"!
M<D7A.0N6(2(YO!Y0Y2+--HRE%I,TI,^WW-*6Z)PB<(G"+QSN?L\K[;=U6;<S
MH6EH(V+:-/VH^)3OP_'%NV'7NT=;;(I<IZ+\UF6\AX.U2+15X_C/DJCA=J7)
M*'W92!TEF6V>=_([>3S_ )]:+&A3V6%^(!@HMINJ1'1%;&TIV5C?9B5'*4Y.
MN8^L[$')!Y/2@L5/780L*'*6HE&GBV)C+T6<&, YY 1);O._9Y/_ .R*7->S
MEVTU<[!:TNU=N$9V=$V1'J47J /CZK!=<.[#+V* D&/Z5(HB,0L$/9MC#R+1
M7!U9,OH3!/GEV*W>\K 3G=YW[&ZNOJ1< OLX=J0HRL'FZ/:2;6MI^GQY.7N=
M8A$'7C>BK=H"J#\# /2$.&OG*[5+J<(RK$Y'Q*/E7(S$EB($A0Q,=N\[^?R?
MZ\;;]>M%9E>S%V0T[=G(3-(0FS//D039'>!0PY43!C8-!V?:98LE,Z4??@]H
MU;]=A)D152*TXV";5AZ"?48#U<P!C=YW[/\ _2+U9Z=-?V35.E-=ZSM4G,\M
M1*Y!J^2KUU([!G&(HEI,:*5*6DI3:'-GDIK:?-E)>KS:F%>#2IQ%:5S'8?ZW
M;/<BS9PB<(G"+RCMO0M93\WJ*L$+5NG86R=\6VQ6*+N5&[+)&V+0(9X!4*V^
M%J$]OICDOA!TT=3T()I@$VS#L4^<'1["TAV-+9];6W;WW=3=;^??Y46(P_LT
MMF#F$CYJ*D6#RUQ73\)[?Q^/*-2(74!NKJ!BR/>[72KDA ?2;WW?:\\Y'<6I
M\/@'*SE)8<_,G-WDVOV-U=?4BZ8CV8NQ(%).U C$I!N0=U5MO43]BE[Q*(*M
M5[:-!U-K9@AA>.E!QR2<J=:U$%;%S);[["G29&#&BC*Y$!5\1&[SOV-_:+.%
MPZ/-XW+45STW+9K06OVOJ!V/U#12M4ZGMAU*P@;-?K9:-E0Q#)*M]-0I1832
M]J65%]K23*)F4DJ_6T3FY+XF-.3.[SOY-GDZMG_\D7H7J&L3J1KBI4F760=0
MBTP*.J@&OU^]638X\=6Z_"CBP+'RNMU:JE@)2&AT5AI[)$8X\WEM*53YN<Y=
MYY19)X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A
M$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.
M$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$
MX1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1>8'M*?:IZ+]FO4ZV[>!!?8^
MUKZS.DT+4E9GPQ9 B-&N(8G62SGYC,V/4ZJU+6D=')9&%R10EEV,'"$6AQN2
M*V_2>C<CJPY6K3A5I5GBUF\:,IPA.;;8B".+Q<YGC]]X<<<(0V.0D'D-IX/-
M9ZKA1PY6,C6#-)Q5QNT7>,=SS)-V=ACVOQ6EQ92E+:T8R:,WCX%K_P"*]MN5
MKRWT0UQ+>5*RA*]_$W%I1XY[4K6G43:5JQCPPI6&T85GQSA"<9\,=*\2X?QU
M"7V9#OSK5.?I/1D/Y<N[KC^]>7#X(ZU^/93])>/$N#I"7V9#OR<_2>C(?RY=
MW3]Z\N'P1UK\>RGZ2\>)<'2$OLR'?DY^D]&0_ER[NG[UY</@CK7X]E/TEX\2
MX.D)?9D._)S])Z,A_+EW=/WKRX?!'6OQ[*?I+QXEP=(2^S(=^3GZ3T9#^7+N
MZ?O7EP^".M?CV4_27CQ+@Z0E]F0[\G/TGHR'\N7=T_>O+A\$=:_'LI^DO'B7
M!TA+[,AWY.?I/1D/Y<N[I^]>7#X(ZU^/93])>/$N#I"7V9#OR<_2>C(?RY=W
M3]Z\N'P1UK\>RGZ2\>)<'2$OLR'?DY^D]&0_ER[NG[UY</@CK7X]E/TEX\2X
M.D)?9D._)S])Z,A_+EW=/WKRX?!'6OQ[*?I+QXEP=(2^S(=^3GZ3T9#^7+NZ
M?O7EP^".M?CV4_27CQ+@Z0E]F0[\G/TGHR'\N7=T_>O+A\$=:_'LI^DO'B7!
MTA+[,AWY.?I/1D/Y<N[I^]>7#X(ZU^/93])>/$N#I"7V9#OR<_2>C(?RY=W3
M]Z\N'P1UK\>RGZ2\>)<'2$OLR'?DY^D]&0_ER[NG[UY</@CK7X]E/TEX\2X.
MD)?9D._)S])Z,A_+EW=/WKRX?!'6OQ[*?I+QXEP=(2^S(=^3GZ3T9#^7+NZ?
MO7EP^".M?CV4_27CQ+@Z0E]F0[\G/TGHR'\N7=T_>O+A\$=:_'LI^DO'B7!T
MA+[,AWY.?I/1D/Y<N[I^]>7#X(ZU^/93])>/$N#I"7V9#OR<_2>C(?RY=W7J
M1[-KV]6D^O#94+1-VUN1Z?MSGH\UZD#)ELC7:E7UX;$>GSA BS^XJM.%V? ^
M-*(1 90%Z6=%B2&8!V62]./D:?JO@WR&FZDLC7M0R= ;Q:Q.(7KV*S3DT8S(
M'E#1F'C2C&1($VQE)GD.,-LVSF&U76RIVJE#*I9FS\E%R,41>*SN\8SX@WB3
M8SNT)0V.S.S3>6R+^]O.;+:TX1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X
M1.$3A$X1.$3A$X1.$6N>T=Z&=8WRN5F7069]6. +5:9=X7;X\%D& H,,<4NT
MZ97T R!.2L0+)-2X,6"X^^76T]&:3&<PWEPBX#>JK3TXA%@2#!P;DM=J_0P;
MT^A['AMR#MJ%Z]G5N(?7.IL-FER3\O9=8'@V;4\,077.8>@2'_YMF"1=ECJ>
MU5%H^H+M:BDZJM[FHP6_UX4\$/'Y(L"4'56;/)667611:#7 -<>N=>@V"V'G
MQ=8%ODHJYA6.T\E?"*U*ZQ.GAN$@B_=BL2$[*%,,R)VN]FP4/0S(>]6&%8V?
M64UA3U)0#UCL,L1OK:54H./I=CE%S\%D7)6@BC=EZUM05LM!B2?E&@2A@Y(M
MI8Q6;+4Y]";KH@?8RB;33;4$$7:$^W5RHRS18V0'J20,D.(#6I<<A#<?(I0U
MU?:$<41:<LMJ@RQCDB.Z,+ZEV^%,39T2PUBK2Q(,,7H<$K8S<0U=:@Q*!@(9
M(M&BV4*4>A(%$(\U9%8[!UM=/H,&1.QCULLK ^./7Z>LZTV*07-($JX$N+%;
MA3GJQ$"N7)BHGX5F(TMTHS:A09@M+)"(ON0NB$V?W[]G^46V2<X4G"L>/@K&
M,X[DJ2KPSCQQXI5C"DY_^TJQA6,_5G&,_5PB^\(G"*,W.X5_7]4L%VM<U8VM
MU<7+,FIS<.:0<C#X3>77W&X(V/+GRW,)QX-QXD9]]U>4H;;4K.,<(L,6#JLT
MU5W8OOTO8H4&:/8DQ#*:3;I@646F4&5M&#3H9*"'DL3KP0H,*18X%6@YDE);
M/IA[#*S$\<.ED4@=Z@=>-TT3<T9M4ILW;B] &U:%3;+-ODF\UU=AQ8:JBF1A
MSIW)4)%J5F*SNV+F'D$%EGHDN4'7%G2"*&M=8>AI:</#;*8+P9L(/)K9853K
M9-#W>8>ET$>- 4DHV']%9+$\1VE0!ZQ$!Y4AF=85QG>QVOVM($BSO2[D V!6
M1EMK$E^4'*IEI9S,@S19"),'3I0HL**BB3$4B*,!B\&<(,"B$:/.&E(4N#+9
M:D1W$)(I1PBU3ZUOEYCIUM^=<';Y6[&DWKY;I;6]9N-ML[==:V#6';9#2*UM
M.@;/8"E:T@J*LQW6&9FPJS7II*PU(63+C(\%\B\E9MI]HF1U5L!_6@C=HB*+
MZ7;BV)S?6]TV^Z'K/!ZA-G1*^8U$5)T+7%]>O!.@-UU^K#MK4W&TV=?_ "97
M<7+'/4NTFIW.[;=FS:VW\/7]>3S;D60W076C7(749NVZ6/J5CZX'[=ZDJX"U
MEJPWM38V\]HUUWJT@P].-4/5935TH=H^AC]8 R09C9&KRUT*%M56U=Z%Q1T\
M:*<;G=^'EV-Y7V,V[?OV^?U;';8B]5>EEZ[/]/6J'=CV([:KQFJQTV0Y9JE<
MJ0>E$&Y4IO+!.O;"J=#N[4@<REH9[VM%,K)FRMPT668&@N%_)3Y19^X1.$7Y
MV2:_:$T\79+=(^<F[$M87J;)Q(M;F[KV;952*5U@:P':^BD]=3:8EO4LN3IF
M;:Y6MA^M91]_:-)C&2+T=,>&E+OK8VW\/)Y_QXKOZO+Y_P"T6]Q0IO#9G4YK
M.TZCL&\8/3Q=ZM9MF7.I7W7>XM-/B]C].V(=;J^M?4[)I]<-:ZI^_P CM"N6
M$\+(U=R/;H6C+%- L$H!ZV*7'X?AM;S;/Q_SL_U\N[8BZ&_9/6&_8[$;KI2_
M41)KHPW 453:A%F;%U_KW;P'96F6P\6N6^EZFS<+!?;;1G[M@&MZN6NRBFDE
MB-!I<IT:2A$V[9U[6[-_R18\Z?JYU1[+L?3_ "+M:^I#7,6/.ZAKW92DP_<W
M:W)U92=J%*[T]Z\L4>^4*J9-7>YB+F*M,HQL"E@[K8M;:QPNS5:"9LDN7!CZ
M^OK\O,6]O1^G:36CX\7<I:['KY VOU'#)![88MD+:SE7%]1NUAVNS4L9$$ !
ML8:5UW%JL^N>Y0HRO/5J0(D5V&R#='IY+[-N[S-_C?[T6SO(1.$3A%^#?_B>
M]4;'!=:>N]P&(1*7K*_Z5KE5II_+;S@D<>I1RSO6:G8?RGRHT]CW[!M&(^<I
MQ*8L:WF,NKC3L,?1_!#=J$P%J@.4(W*V0*<X]K-.8K PL$^SRRB_)2#MW\5Q
M,S[-L=O*];US0R8;$HR<!JT!CG_XM,4I\<>W\';CM/9^+3VMMV/L_-/SK*TM
M.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$7H1[*?5&R-O>T,Z3
M NLH1)XK5MVZ]V582<!IY3-;HNNK4)M=Q/$Y#>/)BP60@V3 ;Q,<:CDB1 >#
M2IR25CL/:QK.[4HZ7S1+DH- V/M5!0D[;2V;09A .$7WRDY)M-^*SO"$)DW1
M@[MEL%7-8R^/B",GD.T$\Y-MV0$$D2$G)V9V9FC%V;;NE)XP\LF9_P"HQSX^
M7<DX1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$6/;O
MJZG;$>C2+3 D3'8E:N]18RQ/F0L)![#%Q ]IC93%=;PIV9 A1VV).?%^$M&7
M8JVUK5G)%B&Q='^D[->&=B3Q1UFT,V.I6OUD*Q$66U':(YKY^IS$-+6]B&@7
M(UA4'Y$0:J%$/*@99LC!F*IN.R16H[H_IDLPC3D&>3"Y@:>'(U=KJ7$O3#4G
M N#)IHR71W"F""Y4Z:Z3IU-BSLQ9#%H:G0T0&2$5!DM$)D5:;I/I?<AN0R\F
MO21E6KH;4Q6$1OBDPX0F+7=LT0=53V/?#2F"$P-O;80E3,MQDG,?-PU)RJ6-
M&K8(H[+Z;.F:WO$1=BGFC]FM\J[A2TFV7>PQ+K;IGN9.NK&[EDE)'$2B8-:I
M48&.)BX/H7 U>8+#Y$M"WBLLBF)WIVZ?=RQII=;42SHD&["50:!V5!6./LAH
M[K>R%)D7+3Y 1ZQDOJNE.Y@3(LN#Z6).%S8$@8:*PYA%V7NDG2KM1S2L!SC0
M?WXW9FW6[4>44:L+.I8NE63"";TUV6J6U1H49A.'ENL**M^]W&7)BUJ41;+)
MQVIQCQSGPQC'BK/BK/ACP\<Y^KQSG_'.?#_'A%]X1.$6"[7K#5@ 3?;.?/%:
MH// K7$LQ^Q[,M?R3#MV]N1%+'\A;59Y-$$DT)G9A0C.1,>2/&Y: PY,<-VC
M^$6N!O2NH;@>;9G=2(@HSC4 *32 3Y;798G1:)7JR.BCMF:\>EN24!A<@^'B
MW@[;HXF1!L[S+8"PE"5/@"@HXBORM<U6#1Q.R4]2M;'UP)=IVX@&XUN4!=43
MM"Z2=GU"XG'YLJ1FIRJN3JVRUZ^K8!95]0EP0+DK*$; S+F%"+'\7IAT%3XL
M>I"NH.(##:,$U>^U"N%+%0),G4Y <1U398.PK8_)Q&(SJ\9FZO"3%-'5"Q;\
M&YW=B,2],7K&:H1;MZAJX"HZ\ #*S8L7 40<-6]5P1)&RVK<6V!8"M[L-KCO
M!DH#YBV2P6,H:BMB4X&,1YS3$#QBMM9R19*X1.$3A$X1.$3A$X1.$3A$X1.$
M3A$X1.$3A%C+;NF-3;\I!+6VZM=U'9]$++:>FUBZ!(1P7F7'PO$4C&:F-.+@
M%867'%P"T!<8E <6IV'*8<SW<NZ-^[C;$+="T>G9'M:)JY)#FT7_ .J+O%VX
MT);&:4),\)-NDSLJ%BM7MBD&R$9Q2V.XRP:<=K>23,[;I-MW2;9)OP=EYWK]
MAW[*Q:U+STAU3&5J4K.$7K;S:<95G.<X2A&PDH0GQS]E"$I0G'AA*<8QC'-I
M;A#UDS;/MPV[=OK47?\ -WJ[7];[UA^:^!]'P_>L_&7'Z#GV5?PAU;^_=P_J
M)QXP]9>G#?QJ/=4YKX'T?#]ZS\9/H.?95_"'5O[]W#^HG'C#UEZ<-_&H]U3F
MO@?1\/WK/QD^@Y]E7\(=6_OW</ZB<>,/67IPW\:CW5.:^!]'P_>L_&3Z#GV5
M?PAU;^_=P_J)QXP]9>G#?QJ/=4YKX'T?#]ZS\9/H.?95_"'5O[]W#^HG'C#U
MEZ<-_&H]U3FO@?1\/WK/QD^@Y]E7\(=6_OW</ZB<>,/67IPW\:CW5.:^!]'P
M_>L_&3Z#GV5?PAU;^_=P_J)QXP]9>G#?QJ/=4YKX'T?#]ZS\9/H.?95_"'5O
M[]W#^HG'C#UEZ<-_&H]U3FO@?1\/WK/QD^@Y]E7\(=6_OW</ZB<>,/67IPW\
M:CW5.:^!]'P_>L_&3Z#GV5?PAU;^_=P_J)QXP]9>G#?QJ/=4YKX'T?#]ZS\9
M/H.?95_"'5O[]W#^HG'C#UEZ<-_&H]U3FO@?1\/WK/QD^@Y]E7\(=6_OW</Z
MB<>,/67IPW\:CW5.:^!]'P_>L_&3Z#GV5?PAU;^_=P_J)QXP]9>G#?QJ/=4Y
MKX'T?#]ZS\9/H.?95_"'5O[]W#^HG'C#UEZ<-_&H]U3FO@?1\/WK/QD^@Y]E
M7\(=6_OW</ZB<>,/67IPW\:CW5.:^!]'P_>L_&3Z#GV5?PAU;^_=P_J)QXP]
M9>G#?QJ/=4YKX'T?#]ZS\9/H.?95_"'5O[]W#^HG'C#UEZ<-_&H]U3FO@?1\
M/WK/QD^@Y]E7\(=6_OW</ZB<>,/67IPW\:CW5.:^!]'P_>L_&3Z#GV5?PAU;
M^_=P_J)QXP]9>G#?QJ/=4YKX'T?#]ZS\9;D].?1STO\ 20+*">G'25&U2T=R
MS@Z0KXYU^Q'&XRE+BQS=K,2"=G+Q(:UN.0H9$O)B0W'7G(K+2WG5+P.5SN8S
M<X3RN0L77'MY.)9,PAO+_J<81M ,)2W-*48,\F9F=W9F62IXVCCXRC3JB!QM
MG'E!G><V;R-(DGD23-^#2D[-OV,VU;+<Q*O4X1.$3A$X1.$3A$X1.$3A$X1.
M$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A%;RPYLN+)"7GY<5DH/F#G9,!]46='
M;FQW(RWX4I&,KC2VDNY<COIQE3+R4.)QG*<<(M"!_02)S$-)L%T 3B,_2]OT
MP(6 UA K86OQ3E6U?4P%WA G+0:2F]@QVMTH)FHD\?@Y'(CQT%BMC:Y"BR"+
M&]4Z*=BD+M9S1R5K^ICJV+@TW7KAS7@N^)M8;$GJ0@&S%\'PKV/S;RLBO;PB
MR!-R(OTHP\>^4S)B@-#IL]^U$615] %78J-KKK5U*E)AH961@L]/'Q8UN'0Z
MSMS<^U7&&;AAR?,B$;$G;\BLDCL<<I3&0Z3ZQ1!4]8:-.W_3W,S?Z(LM])FL
M;_KD#LZ9L834@!J_['%6F$$IX 968(X0"TWJ75S"9H<-9KD+CSY,W7<^:A<*
MSE&Y N2,DN- WWG:T%A%M?PB<(G"+HE(D@@-(08A2>#E3(4F+&,BVQCQ(2^^
MRMIHB/:-#BX=R;"6I,B,V4%$AZWFT)F0)<?+C#A%@38.M]H2-8F*[4KLUL:[
MR++3S8,QNAFC"H=;P LX,R\1"N4+3JP[-D"H&.FZ21/T2V1!5T9#E"<(F+@.
M"7R+32Q="6PCC4$6&-5ZDUJ'))["G5OY>SKN)M>UI>D[5IQY-M<GZ9K-FG"K
M%%L>)UH-B[6(K#HYN0-@Z1:,R';2Z19R9T[NJ/@(017M:/G*_NZR]0J $B^G
MV: 2-789L^CD=>X,(UO*/1F 0.WC=D_+!VC+0:V'B1%171[*UFV"+!M5Z'-L
MT^MZSJD0]K<U&TO-I]KKA^85LHLOL<^!L_3I:)M1N<1JH%FZI4D.:3F"A!N
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MG^8=DXK:W&97=X8]&B(^UX9RKUWCC"5-WG?L_'M]_N3?YF[?DJ[CIK#TU+,
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MY$5@>Q"(H>$Z8-(TJN4!*]QPV1=!/Q2D4S.+5&&P4G:=-:'(6:+/F9>;CX4
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M?'3]U&V#\:5-_!,W^I''CGK>@#^T1]T3F$7TF/\ BR^.G[J-L'XTJ;^"9O\
M4CCQSUO0!_:(^Z)S"+Z3'_%E\=/W4;8/QI4W\$S?ZD<>.>MZ /[1'W1.81?2
M8_XLOCI^ZC;!^-*F_@F;_4CCQSUO0!_:(^Z)S"+Z3'_%E\=/W4;8/QI4W\$S
M?ZD<>.>MZ /[1'W1.81?28_XLOCIC_A1M@^/U]:5-\/_ '\-)F\Y\/\ ^?M)
MQX__ ,\<?_WCQSUO0!_:(^Z)S"+Z3'_%E\=>W/LP_8WZ4]FZ^?O<>W$]R[UM
M0?-<([+,@HU8&U^LNR8\V: I%48)'%AFBLN'"=-E"!XP4(I@1&(SHJ"J7!E<
M^U?KO(:K859P0H8X).5A4&1S3*9F>,2V#O ?*/",I,.$1#A#C2=VG+BRCLV$
MTY6PSS*Q)6;1(\21I1:$80=V=X"&SRXO&=FXTI3E)]C,SQ;:S^Q/-%6Q)PB<
M(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")
MPB<(G"+5SJ7U1>ML0Z^#JH2A%JY/#W>J[)39;40I-I)TBW1 L,K2JQ:(6L=H
MY#@[FQ">B7B5!%AK-Z" +:K%B#3G7"<,BP"<Z-]@P(@P]3SU;L5T&[0ZB+ZU
M7MF7.]D]5QV]N[*N5SJ<@75G!!\2*-U:+8AD^5F+6\0W+"->;RHB/D//2"*[
MTOI7V* ME>*2$4J$-)6FB7Z^FG;X;MUX@VZD[(W1LHZ]7YC>IZ"$-Q-JG=J2
MI)UAD;KH32F[%>A-?KQ</+&1D$7H5PB<(G")PB<(H):JE8K 0@S ^T;M1XL5
ME+4@361FMYL FXE]3N9$UVYT"V%&W5MJQ&4D<1@,890E264R,K?41:?;TZ:]
MF[=N]W?0*U=$I,F-+,TF0FVFA1HE?I.II>O))W:8%C5!=^R0R(8B5U>V,&[&
MA5X3KPP0L<RK6BW-B80LBN36G=T,LA)":EK621 [RL_4)\EI-_,-4 D0N\#:
M%.FZ]]ZIUK+*QU X-M%;77:7*2_%*[%S*'M!X2$)LV"+!5?Z'=PU<#K>M1R>
MLC;>HS6N;N.LLP[9!QC99:G9Z<5SZ#:XB:43Q7:D[G2<M@8>:*6V2RT+UHY)
MJ[F Q".T1>@VD*,8USK<36#[@KWQ[YNUDGP@+\F6 !/7B]62[XJM?ES( J5,
MK]0;L2*N#F/B1#DL2(AR%"1?F>@CD66>$5E18!:X[$I*YGDR97HVLY%E4N9?
M\,9\%LJA8>:;\,X_F'6T1_'QQYOCC.,3L]7:RC:W7YO(_OW;O*JCAP<W@AE:
MY6,#%-)F> TDOMR\O+;?D81$5F9C*\?:5#]0E"?MN92C.%<;/5OZV^F_--ON
MZG^GZ]GD7/!B#E]N/A4GS7(6"",>@(81Z7*<KPI3N8OE(>[4Y_E5K3*QGP3E
MGNSC&8V?UY6^OS\B;6]VWR/Y/K\/*J2#PUQ$%Q*Y?:2>7'B94,)HRIU#B6E8
M>2N&E41'>I.,.R\,-*3XK2O*$J5B=GJ[63;Z^QU\6?&-M3'E+E^7!D8BR<X&
M%%*2]E:D8PTVF'ER2WW)SCSHR7F,8\%9<[<XSEL]7:R;?7V.JRC$!#TB.I<G
MS8L/,][&($]2,14I0O*FW4Q<M/.]JT_RS*W)6<^*<,Y4E6,1L_KRM]?GY$V^
M7JZG^OR7%LT/=5 2A<G.26',Q.X>11A6&LY2OS\KBIQ#SC.,^&)F6,KQ]:,*
MQG&>-GNZV^G_ "3;Z^Q_Z5+-A%XC*EY7,\A$ST*L^ZBN7/4]G?VX8Q"\]37;
MC_J4MYC>/V?.[OJY.SU>?RM_?N\J;6Z^Q_Z\G7Y%6<,CVG)S2UR<+'-I=EX2
M/(+2E"\)RG+*T15(EJ\%I\41%/K3]?<G':KPC9[^MOIOS3:S>?L?^E];,0''
MH<="Y/FSXV9<;"H$]"%,80M?BZZN*EJ,YVMJSY$E;+_CVI\ON6C"IV>KM9-O
MX?GY'^F_-4$6 6MB/)2N7EJ5)]&SG(LHE>7_ *OJ<:5"P\RW]K'\=Y#;'^/\
M7ZL^#9ZO/Y6_OW>5-OK\WD?^O?Y%46<'-I(*6N5X#%M-S.T:27E*GG,M-^1A
M$169B<KQGN7#Q(0VGP6XI*,X5EL]6_K;Z;\TVMOZNI_/L_/?YER]\0/.3'[Y
M/FJA>\$X] 0[,Q>S*^[+OI?*P]VXS_*Y7B5X_9\GNSC'(3;]?AV^1<$'1KB(
M"TKE=I-UQF)XC2:,J<:<2TO#Z5Q$JAIPM6,)<F88;6GQ6A:D8RK$[/5NZV_O
M?^2;?7OZG_K=^:XK/C$,RGU+E^7"DXB2,X&%%+P_E2DXPVTF'EV0WXIS_'CH
M=8\/#/F>&<9RV>KM9-OK['_I5EF("'I4=2Y.'8<3,Z1C$">I&(^$(7E33J8V
M6I#O:XG^6CK=DYSXIPUW)5A+9ZNUDV^7JZG^OR7%LT/=7!0A<G*B25KB=P\B
MC"DMYSA?G*7%2F)G';GP3+RPI7U93C.,X\6SU;NMOI_R3;Z]_4_TWYJE\H!?
MILR^^9Y&)GH,Y]U%?,]3V>9V^1Z+S_*[?_D^7Z7N^QYW?]GC9ZO)M\K?6WJ\
MJ;6\N_L?U^957#0]I<YM:Y.%#4(<EX2/(+PE*^WMRRI$529>?M8\4Q%/J3]?
M=C'AGPC9[^MOIOS3;Y?+NZG^G_)<D&("WHD=*Y/FS8OK8^,P)Z4*CY0MSQ==
M5&PU'=[6U9]/(6U(\?!/E=RT85.SU=K)M_#\_(_TWYJB@^,<9BR$KEY:F2?2
M,9R+*)7E_P <8\'&E0\.QV_%6/X\A#3'AXY\SPQG.&SU=K)M]?8_]+DLZ-;1
M/6M<K"1CK;,OP&DE92XZYEI&&$HB*5,3E:<]SD/#[:$^"UJ2C.%9;/5OZV_O
M=^:;6W^7=U/_ %O_ "7/WQ \[,?OD^;B%[P\/0$.STO9W]V'?2^5E[M_^+A?
MJO'[/D]WU<C9_7E;Z_/R([[/\^1UP0<'.)'K0N5VDW'6H>5#22,J6RYAIS#^
M%Q$JAIPO.,)7,Q'0XGQ6VI2,95B=GJW=;?3_ ))M;=Y=_4_];OS7!=@&(9DR
M%.2_*B2?2/YP+**7A_Q5CP;:3#RZ^WXIS_'80XQ_A_%^O'BV>KM9-OX[^Q_\
M;-JKN&(#3TN.M<G#L&-ZN3A,">M"6.U"_%IU$934ESM<3_ C+>?\>Y/E=R%X
M2V>KM9-K=>[J?^O+U>5<6S0]UR"VA<G*R2%.1.X>00E2$=W=YRUQ4HB*^SGP
M1+4PM7U=J<^./&-GNZV^G_)-OK['_I4L6$7F,F7WS/(5,]!C/NHKASU/9YG;
MEC,+S\-=O_R<MXC=WV/.[_L\G9ZO)M\K?6WJ\J;?K8_ULZ_(JKAH>TJ>A:Y.
M%#4H5+[1Y%>$X<SC"/)RB*I,O/CG'=B'E_*,>.5X3C&<XC9[^MOIOS3;Z^QU
MR28@+>C,)7)\V7#Q/8QF!/2C,;*%KQEQU47#3#W:VKQBOK;E8SX)RSA2DX43
M;OV?7;Y/P5%!\8XU$>2N7EN=)S$CYR+*)4I_"DH\'6U0\.1F^Y6/XTE#3&<>
M*L.=N,YQ.SU=K)M]?8Z^K.C6T3EK7+PD:\AB7X#":\I<<<4TG#*40U*EHRM.
M?%V)A]I*?!:UI0I*LMGJ[63;_7D=5<F(&'UQ\KD^:B%D@K'H)^4>EPC"^[#N
M(OE*>[<X_E4KS*\?%/D]V,XQ&S^O*WU^?D3;Z_/Y'_KW>54T'!SF!^4+E9P3
M4ZB'W#22,J4RYAISS\+B)S#QA><82J9B.EQ/VV\J1C*N3L]6[K;Z?\DV^O?U
M/]-^:X*L M##\E3DOR8TKT;V<"RBEX?^OZD,IA9>>;^K/\PRVY'_ /\ 7Z\>
M+9ZNUDV^OL?^E7<,0&GIL=:Y&'1\?$J3A,">M"6<H0O&6741E-2E]KB/X,5;
MSV,]R<M]R%X3";?K8[_X_P +XV9@.NP64+DY<(M*>BX4/((2IM&%Y5EYQ<5+
M<17@A7@W+4PXK/AA*<Y4G&6SW=;?3_DIV^_J?Z;\U1Q8!:HZ)6')GDN2_0HS
MD65PYF3VX7X*8S"P^AKMS_U*VTQO'[/G=V,XY.SU=K*-K;-N_L?_ !LVJHX;
M'-YGX6N5C(SR_5]HXBOM\U78CR,HB*Q,^UG[7H\O]F/M+[4_7QL]6_K;Z;\T
MV^O=U/\ 3_DN:3$!3[$?"Y/FR86"#6,P)^$9BJ0M>%+=S%PTR]VH5XQ7EMRL
M9\$Y9PI2<9C9_7E;Z_/R*=O]^1_K\O*J*#PQQJ&\E<OLGR,Q8V<C":5*>PM+
M></-JAX<BH[E8\'I266<I\5X<RC&58G9ZNUE&WU]C_TOJSPUMN<XM<O"!SZ8
MTK.!A-2DNJ<4UC#*$PU+EH[TY\7HB7V<)\%Y<PA259;/5OZV_O=^:;6Z_-Y'
M_I5<F(&'G8^5R/-9A9(.8]!/RC$7"$KRI+N(WE./=JL?RK:U2LY\4X9[L9QB
M-GX_ZM_CRIM]?8_]+@V;'.>@[%RO_4\NXA]PXBCNRRORU^?WQ$^CQA7_ "YF
M>GPYC[3>5)^OD[/5NZV^G_)-OKW]3_UN_-4U6 6F.]*RY+\EB5Z)S.!952\2
M/#*O!+*867G&O#&?YAMM<?Q^KS?'.,9;/5Y_*W]^[RIM]?8_]*LX9@-/36%K
MDX<',X?E82/(+0EI24*QEEU$534I?@XGQ:B+?=QGNQE&%(7A,;/?UM]-^:G;
M[NI_I_R1LS =>@L(7)RX194_%PJ 00A3:4K5G+SBXJ6XB_!M7@U+6P[G/@G"
M,J4G"FSW=;?3_DHV^OL?^E138!:H[4K#DSR7Y7HF\Y%E4N9D>&%>"F50L/-M
M>&<?S#C:(_C]7F^.,XY.SU>?RM_?N\J;?7YO(_\ 7O\ (JBS8YOU_>N5CW9E
MO$SM'$5]N75]B/([(BO68RK_ )LP_481C[3F4I^OD;/?UM]-^:;?7V/_ $N>
M#$#+S4?"Y/FO0L$&\9@3\(S%RA2\*4[F+AIM[M3GQBN+3*QGP3EG"LXQEL_K
MRM]?GY$V^3KW^1U20>&N(A.(7+R@B^J-%SD832I3R7$MYP\A<-*XJ.]:?!Z6
MEAG*?%>',H2I6)V>K=UM_>_\DVMU[^I_ZW?FOBSPQ#<UY2Y?8/D8C2LX&%%*
M2\I:F\8:0F'E<I'>G.,O14O,XQX+RYA"DJRV>KM9-K=?EV>1_P"E648@)??C
MY7)\V-"R0=QB!/RC$5*$+RI#N(N6GGNU:?"*RMR5G/BG#.5)5C$;/Z\K?7Y^
M1-OK\FWR/];>KRK@V;'N9@80N5XD_,]'W#B*,*\I7:OS\KB)Q#\,_P#+ZS+'
M?C[2.Y/U\G9ZMW6WT_Y)M^MC^_S?GY53S8!:8[DK+DOR6Y?H5YP+*Y<]1VY7
MVI8Q"R^MKMQ_U*&U1O'[/F]WU<;/5VLFUNOL?^E6<,P&G9S*UR<.#FDO2\)'
MD%I2VK",IRRXB*IN6KP6GQ;B*?<3GQPI.,I5C$;/?UM]-^:;?7V/_2^MF(#K
MT*.A<G+I!C,F+A4">A"F<)6O.7G5Q4M15]K:_!F4ME[.>U.&\J6C"IV>KM9-
MODZ^I_K\E018!:X[$E*YGDR97HVLY%E4KR_X8SX+95"P\RWX9Q_,/-MQ_P#'
M'F^.,^#9ZNUDVMU]C[>S9M51PX.;P0RM<KP&*:1,[1Q)>4J><RTWY&$1%9F8
MRO&<*5#Q(2VG[;F4(SA7&SU;^MOIOS3;Z]W4_P#6_P#)<_?$#+Z(_=)\UR%[
MP3CT!#L]+E&5]V7?2^4EWM3G^54O$KN^SY/=G"<QL_KRM]?GY$V_7U^/5Y52
M0=&N(@N(7+RDD\MB)XC":<J=;<2TK#R50TJB(PM6/!V6EAI2?%:5Y0E2L3L]
M6[K;Z?\ )-OOZG^F_/RKXL^,;:EO*7+\N#)Q$DYP,**4E[*E(QAIM$-3DEON
M3G'GQDNL8QX*RYVJ3G+9ZNUDVMU]C^[=O_)5E&("'I,=2Y/FQ(>9[^,0)ZD8
MC)0A>5-NIC9:?=[7$YQ&86Y*SGN3AG*D+PEL]7:R;?P_/R/]/^2XMFA[JH"4
M+D^)+#BHG<.(HPK#><X7YREQ4IB9QG&>W$S+&5X\,HPK&<9S&SW=;?3_ ))M
M]_4_O\WYJEFPB\1E2\N3/(3,] K/NHKESU/9ESMPSB%YZFNW'_4I;S&\?L^=
MW9QCD[/5Y_*W]^[RIM]?8_\ 2K.&1[3DYI:Y.%CFT.R^T>06E*%X3E/DK1%4
MB6K/>GQ1$4^M/U]R<=JO"-GOZV^F_--OKW=3_P!;_P E]08@./PXZ%R<NSHW
MJXV%0)Z$*8[%K\775Q4M1G.UM?\  DK9?\<)3Y?<M&%-GNZV^G_)3M]_4_TW
MYJ@BP"UL1I"5R_*ER?2,9R+*)7E_QQCP<:5"PZPWXJQ_'?0VQ_C_ !/JSX3L
M]7:RC:W7Y=GD?^ES6<'-I(+6N5A(QQIJ9G TDO*5O.9:;PQA$169B<KQG"EP
M\2$-I\%N*2C.%9;/5OZV_O=^:;6W^7=U/_6_\E4]\0/.Q'[Y/FYA>\,8]!/[
M/2]G?W9=]+Y6'>W'_2Y7B5X_9\GN^KD)M_QM\C_7Y>54T'1KB8"T+E922=<9
MB>(TDC*G&G,-+P^E<1*H:<+5C"7)F&&UI\5H4I&,JQ.SU;NMO[W_ ))M;KW]
M3_UN_-<5GQC;,I]2Y?E0Y/I)&<"RBEX?SG*?!MI,/+LAOQ3G^/'0ZQC'AG+G
MAG&<MGJ[63:W7Y=GD?\ I5EF(#;TN.I<GS847,V1C$">I"8^$(7XM.IBY:D.
M]KB<^GCK=D9SW)PUW(7A,*=O]_7U_E<6S0]U<%M"Y.5$D+7$[AQ%&%)1X]WG
M*7%2F)G';GP3+4PI7U93C.,X\6SW=;?3_DHV_6Q_?YOS\JI?*$7Z;U?F3/(]
M;[O\?=17S/5>7YO;Y'HO/\GL^OU7E^E[OL>=W_9Y.SU>?RM_?N\J;?7V/_2K
M^]X/J),7ND>=$RVE_'H)_EXRZG*D>6]Z;R'\93C/=EAQS",_97E*LXQR$VMU
M]C_TKGPI3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$
MX1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$
M3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A%TY!$?#<P
MS+G0XKV8<TCAJ1*88<R/&JBI(SL(=6E68<!4V&F;*QCR(JI<7#ZV\R&L+(K.
MY<Z>U6T7)VUUMNGKCLRT6MPZ+16UQ9+R(\>2@ZJ5@6J._(<;89>Q*RVZ\XAI
M"E+4E.2+E(M]3AR"T27:*[%E@1"#YV+(-C6) 4$ZEU;1LLR[)2X.$.(8?4@E
M,2S#6EEU27LX;7G!%>(4V$2AQ"(Z7%(#Y\9B9!GPI#4J'-AR6DO1I424PMQB
M3&D,K0ZP^RM;3K2TN-K4E6,Y(NUPBQ%O3<];T!K4GL^UBK(=$CC]"J[06HPQ
MLZQ%3NR;_5]:54>-CF"X$7E<NT6\.S(>GEX$:+$7(E.O>#/8I]=B+5V)[1[1
M\\?8GX51W++,5 ,1+VRK1:/!E&JRH%L+8>M;,/.RX]C=K(U=9.ZPMD@N:DV%
MNHY'-#,#;(1*&!PN1.S?L^?^-J*45/K]Z>KQ=2%"K)&RSC@*,S8+6N2&C!QU
M'UP[J"@;I7MR]3390:FG:Z:K>RZL$00L*!YPA<%F 0BOD<5\U,@PBSQJ3?NG
M-[1C4K46P =Z:K;@YFP)$*E)D WR[,B2,C%H<V-$ECY,^)%<G18TIAI]T>Y%
M();S"FPWWR++_")PB\\&O:8:%PZ:]Y5C;(6$.;OKP<I.KM6DPK@SK+;-=TO=
MG0+86[%B,!(:ZVD0VG%Q@511,8Z[-$IG*:S'RV?7O_T19SM'5CK*H[N&]/)>
M!<?VJ6 O0X%5 1@L-[Y7!;R+NAAZ\5U]19OUE+HD/7=RQL4L\W%DUB0(CQE#
MYCQ^LI--GUV?VB@^TNNW46H-H'=86ZN;+R[6)M#$'[H*  I]+%G]G"BQ6B 7
MGOE2S9W9]AP&EP69$6KOB($Y3&"Y,?#6N8V11J7[1WI_&#EF#(O:($.O55?W
M(,*GJ4D./.T<Y.U6-E$1,J>78;=8KD_<E+AF2LO,.N2Y6;#&K!RQ/U<^W (L
MD NLS45BCZB(0!^Q< ]][%+:\T[9GJ&9^3%Z2+%D2[-XB'V$OC E$L<(5/D4
MHG:Y  M>(#&3=3!&*\MLNHBQRKVD'3:WKFS[->?O<<'7WZ&\,&O5%Q%BO5:V
M>@],H=YHHG$[.3%0L(.I7.SMSY;XR<,K5-LA<V-&,#\8>G9OV?C_ *_FBSQ0
M.H8#L#;=]TS'HFSJS:==A(-B-S[97!L&MR Y@X5!5V6/+#3Q96569T$:(@(A
M**-FD XJ<1Q&;;9RG,?7UVHL_P#"+\EG_$+^U-WQH/8E5Z/>FVZF=5S)M$'7
M_;&R*I*<%W9]NR3RL.N4JL6!C+9&JLQH(A9\X9!O13,_)4./ADX$2&8BE>U<
M&&CL;DZI\YEJX[D8V95J54S<>NSBC"1K!A/MB9WD1AC&1G''B$E*$GE!X:!J
M_.VZIAXZD65=W$Q;!AOQ2OQWDT!0FWWALS1X\Y0=IRXT8M*,6FT_R?+ZPNK=
MQ:G'.J7J,6M:LJ6M>[MF*6M2L^*E*4JSYRI2LYSG.<YSG.<^.<^/.T_8.#;R
M8;%>SJ?P5H7VCD/_ 'KG\D_^]<?G?]6GQ1=17XV;+_W-Q]A83T-BO9U3X*?:
M.0_]ZY_)/_O3YW_5I\4745^-FR_]S<?86$]#8KV=4^"GVCD/_>N?R3_[T^=_
MU:?%%U%?C9LO_<W'V%A/0V*]G5/@I]HY#_WKG\D_^]/G?]6GQ1=17XV;+_W-
MQ]A83T-BO9U3X*?:.0_]ZY_)/_O3YW_5I\4745^-FR_]S<?86$]#8KV=4^"G
MVCD/_>N?R3_[UN#T9^UZZTNDO;5:N$G=NSMMZWP8@XV#J?9EWL%XKUHK2Y#:
M3# ?%J(%%U2S>C[W1%C!.09+)%B&@JDJ']8)EX//:'P&;HEKQQ].C;XDO!;M
M2N*N0)MC\1R<C"'+!XVQB"(TF>+R>'$)Q9QR&.U!DL?8@7PH]@/&;EJYRS+
M@]OWFCRCRY.>S?$D-CM)FXW&AM@_]+VNGAEIKX*SA7\R0]C#C#PF3E&6\R!A
M>$P0@/Y;5]I&78LAIS*%?6G*NW/UXY\F%',)2!(VR8B3'-MNW9.$GC)MOX['
M9]Z[5"<20A.+[8SC&<7\FV,F9V?9UL[*\<IKTG")PB<(G")PB<(G")PB<(G"
M)PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB\
MD-K]/?4]-F;[NFOX)IRR2*3U  *16GKP)@A]B!=H72V955^QX]B"".X 3*U<
M:,=*I#X#V:N!Z^3-@P!BU-+?7J^OK\$61M?Z?VT&OH<M7M6+U_>AFZ^HJWW7
M<EBFTV56=DZRN"]NIUK3#$:FWQ[8%P99,6C5EB@"K*%"Q:M"HDQB*7&36!PT
MN^OKL17#(?KG*[%M,$G9C8.IS+8+B>OJ8O4[%=B4M6WM<89(T.;8IQVT0YZ=
M.M[#3:(EDKI$CD].EK$SVY0REYGD6)KL%Z_+#"Q6Y8K8LX=[A" S,@64T"A9
MEX74:W847,1,>(UQ@);'KX*,!W0\L<6!S"*W)TZ2)I90.#A$4BG4/K.F6=%I
M#HM,21,740HRQV"1IF7=PM,%7+JW0S*)P7<$*E&MPZFWO5V)DX2(=>)0Y\""
M646)0+6PR17!%_ZAJ?O/7&K[;=[I.F%KXQ& B(R]+RVK%J9.X-_IEV"_0&H+
M%SE37-2US5TE)VFP6&A/DHR=]T&)EQ3)?E]>?\T5PV97>L\]L2SHK4O8R*H-
MV,.L5/GP">G:T'ACH<F:("A$B7WS9BU5=R,6;L-H*%"@ CZ 0N ]3)YS,5]9
M%9[U$ZT-C"B\275MIU\ 6G0(E?KHHEH* 5S(B5CIS]X2[[*58".8U.EV"+OR
M1 17#F+%AY;RWF6?/U['CD5O$A?: #8K8I,D[7H0S7%(&#X5;K6CC(>(EC4]
M"CV5N%%D7"JK;OD/;2;QF.W&=36LU)C$88M&7Z\^P1>@^EG+\[J^HJVA"(C[
MTF%+:.QRY.OERBLL$YS Z7/FU<8(!9E$!+<">]$A0<9'+DY'2Y1&;$DD91%E
M'A%&K6*L)D6F%6K4[3I^933SAB.&&')/D,(=<3#9BF$/#VVY4O$1!!UV*_(<
M%8GPQ[@LE+AFQ9%J3M_IGN.Q""[$@I0R=Q(].^ZM36FPR LFIM6\E<[YIZX4
MBM$8$)FU2V-<11U)N-7,)FF#Y48,L67V8=DEE"SF"*RM::VZU "(S0M>R\ =
MY6;J!51)-VDHH9'-UB;0JKNNO79H4E;,P$FU!]P/FUU:2+F[#Q+&QXT=+4:T
MND6"@/0]N&NU^A5K+VM3CNL9^N;;FW/'C40QM:13E]-3Q'6%EC.TV8L-4IR-
M($A#)B40LB4C8&MW'Z^^IDS$$$7H;HNC&==:W@5JP)$L%G;-L6UR!8&2_-!5
MQJ_['ME]A4\),D0!+DP/3(-EC509+]TB&I,$,P^P)&,+;@QR++O"+#V^-'47
MJ,UH0U-LF/*FTLO9M=68P-C-B'VC"]:['J>S18,K$.B38HA73ABGCQ-H&2AS
MOO2N32@]A^#)DLSHTL^SW^]%@N^]"FI+5,DRZ89M6CX[^M@&IVJUJ 9K,-08
M](!62]V=T*YKNQ:ZM%+*CST[8MAP<$G A0$^XV(*PA4"P"V#&818W8]EQTTP
MXY1 Z9LH;//@W:/9#\2RA<6.T:GG=.U%Z:#>G+,;D59^>?UV<IFNJQ:944H[
M*L8S9D>1=*U9 4E_$5N=OU^>W:BV$Z=^F$%TZ3=EDQ.R=G[&)[8+U:PVTALQ
M_7TJ8X?J=2'4.$5A/4?7E%4PY+IX"J ID!_U09EFK#IPD:,+DK00L#;]?Z(M
MF>0B<(O.@Q[,'IQ(!I0X/-O5)+E1.WA-BNM-5KL7<K<C<&YJEO29,N)65KHC
M&M,VBW"FC(6N%'!\V-7ZW)*"YT4R]-S.;]<9^K\/+U-L_P >5%GL9TN5QRW4
M6_;$O^P=SW*B:_W%K&,>V-$U9'=/U#=92@$K+ L8_76L=?AI"Q+>O!PJN.BQ
MHC# HU9F3*#D@FS*A1M_T]VW^T45#]!?3  MEXN@C6=;B'[?3 ]##SODS3GY
M>K:^'KA^L99U,4E5E\W3G"T&QD'S>$%)T:?-3'<S&;80[&>;7\[HL4$?9D:6
M/1(XBT["W+;*X*U.%TS6@-@+Z^G,URD"Y>K)\P5&*8UNV=+BC,[4@&:]5K,4
M.4H)-/7254JS77CZ%0(^OKZ]:+.-6Z/M9TT/3:P"-WF-3]<;X(;]UU3EE 3E
M?HA<D)M U_7]99^329L/5D>3<[&9%5=Z=)FA)L] X,;@5F"/K\4BU^S[*GIK
MFTH]2;$;V[86)U:J]#JA]=X8KEBUQK>CQ2\"FZ^JDBE ZR-)UZO03YN(R[?A
M5U-$6R3RS)4B\U%=8G:_E];]O5Y$6[FN=1UK61?9QT),/$RNV+O%O-EFV*>P
M3E,2QM(J&O@X,7+3#C2VZZ&KE*$MCH9%\E-3.DEI\@C)?(O*Q"+*/"+\OWMZ
MO9#[CZO;94^JCI?$Q;ELBO4R+0=C:M63'!RUH !"),I7K3499B5!%33@QLP1
M%&@LLA#DDAD8(H&B40BOPIO7^#?7%#!@/ALQ.0*A;$K-6XT)$@$I(P@4)XCC
M*<1S>$2#)&,FA-R,39&32CH^J]/6<@0=^C%BF@-@F!QHQE.$92E @WF[1>46
MD\9Q=V>46CQ-LF=G_+&OV4OM(FUK0KHJZA<J0I2<Y1KTNXC.4YSC.4.-MJ;6
MGQQ]E:%*0K'AE*LXSC/.Q<]-*>G\9_)BW^5HOV#F?1ES]F?]+C]%/[2'X*>H
M?\.C7^CQSTTIZ?QG\F"?8.9]&7/V9_TGT4_M(?@IZA_PZ-?Z/'/32GI_&?R8
M)]@YGT9<_9G_ $GT4_M(?@IZA_PZ-?Z/'/32GI_&?R8)]@YGT9<_9G_2?13^
MTA^"GJ'_  Z-?Z/'/32GI_&?R8)]@YGT9<_9G_2?13^TA^"GJ'_#HU_H\<]-
M*>G\9_)@GV#F?1ES]F?]+<+HS]@SUQ]0.V:R,W+J.U]/>F81>%(V'=]AMPP!
MSW Q(;=(B:95I+[A\Q9"L1#T07+6*;KHZ0M,LL3:0VU%EX//<)&G<91-.A>#
ME+\AR:K7J\8@^5=G:!+!F9AP%"3M*<>.Y9LW%A!]KRCD,;I7*6[$(V*Y*=9I
M,YBF9H2XC/M>(AN_'E.3;6B_%XD7WSDVYG_HF!Q(X )%@@\5N")"CH0D7!9[
MO)ACAT9J'"BM=V5*\N/&9:91W*4KM1CQSG/CGGRZ2<RSF0DGE,DY3G)_+*<W
M>4I/UN[N[^M=@C&,(QA%F:,8M&+-Y&C%MC,W4S-L5QYX7I.$3A$X1.$3A$X1
M.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A
M$X1.$3A$X1.$3A%JQU:;%(Z[HU;D!MB3]=&;!;E@1DT=&U^RHO-=J%LG01Q.
MU;1@&*10Z[!(PH5BL-E) + 2E# CU4JX4E:K,&AO$6G4[J/VN%>F_+3=,^#*
M\F\Q;V,HE,UF[%H\FO[?U55M+R:(4O R&*K,/J(UT;M%RCV;<EAM%::$2B-A
MKZ!$"F3F&Y^M[_\ U];O*BVMT];-Q3[OJ4;<KW6;M6;%TX&[*8G4\+ ?#D-A
M!;5KL;DXN[P&H8\YZ\:>*-PXX&NTL*\MDF1: J9<@10D(MO^$3A$X1.$3A%
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M$"+ (#V9$-\!-#D1@^='(K0+Z,M*A:Y)K(D;*@P71\@1'<;'T]Q402LCK$E
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+A$X1.$3A$X1?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>g904779g96c16.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g96c16.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1=(4&AO=&]S:&]P(#,N,  X0DE-! 0
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M;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P
M   *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F
M    "7!R;V]F0TU92P X0DE-!#L      BT    0     0      $G!R:6YT
M3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B;V]L
M  !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS
M8F]O;       3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;
M    0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M          !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M    0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M        4G-L=%5N=$8C4'AL0&+)QJ         *=F5C=&]R1&%T86)O;VP!
M     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M              !4;W @56YT1B-2;'0               !38VP@56YT1B-0
M<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E
M8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG          UC
M<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG       X
M0DE- ^T      ! #O_XU  (  0.__C4  @ !.$))300F       .
M     #^    X0DE- _(       H  /_______P  .$))300-       $
M6CA"24T$&0      !    !XX0DE- _,       D           $ .$))32<0
M       *  $          3A"24T#]0      2  O9F8  0!L9F8 !@
M 0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U     0 M
M    !@       3A"24T#^       <   ____________________________
M_P/H     /____________________________\#Z     #_____________
M________________ ^@     _____________________________P/H   X
M0DE-! @      !     !   "0    D      .$))300>       $     #A"
M24T$&@     #-0    8              /8   (:          $
M                 0             "&@   /8
M 0                         0     0       &YU;&P    "    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M $QE9G1L;VYG          !"=&]M;&]N9P   /8     4F=H=&QO;F<   (:
M    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '
M<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE
M;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E
M;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0
M     %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M    0G1O;6QO;F<   #V     %)G:'1L;VYG   "&@    -U<FQ415A4
M 0       &YU;&Q415A4     0       $US9V5415A4     0      !F%L
M=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL
M5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z
M06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC959E
M<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI
M8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M"FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M  MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M #A"24T$$0       0$ .$))3004       $     SA"24T$#      ,EP
M  $   "@    20   >   (C@   ,>P 8  '_V/_M  Q!9&]B95]#30 "_^X
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MD@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                        _^%
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M<;>;!5Y:'Z#]/QIHLW7,UV3DTPRXNGNDCQK;5-=DRQQRY#"RF.#H8C8+++
MKQ6+,%XCPM#%@<6X^M6QHW2?FI6["L8Y=Z9 !*1>1>H)@[DG(;,873]==<QU
M#G,H)CF$:-U37-<UR<Y.LZMF:C*++3+/(0T.-D!A<6 <"@ !0[6KFTW1='T>
M+U&F:=BX;+_]*)@>Z@39>&ASAR?S$]R.Z]5?ESQME61==WRJQ&T9:EMS,^_6
M5Z2E19Q,>X?+',8! I2E30,)AV =.Q]0KJ8&*[4,W$P6!S3E9./CAI;0)EE:
MP$FZKGN?+YKM9^2W"PLK+=1&-C32FK_R1N=Q?C8 ';GQ6NQ=.[@S'E-9PD"K
MZZ\IY %1)$AC"LYG[VN8QD2 4O6;S#R$L & !$Z9# )0'RR@/Z1QF+0M#8):
M$&CZ4SUE 48\'$&_C@<B$@ T+[GE>+),=VIY>Z($SZCF[FV"/XV9E![=Q!/9
MT@ YYHUR:6Q%QI9$=CK'MF6)$)%1C[2M:$MUFF0- 5*)C&S @AK7J5 !'YB(
MC7YR:KFOU+5,W4'U>5E3Y&WR$LKWAOP =7RKM2]FZ5A?X?IF%A<%V/BPQ//8
M.D9&UKW=NY<">W[KW)0$"AU=S:[C\QKH\>'G]_-9!H(%'P_9144I1$HB41*(
ME$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$4"I0,F
M<H]0 )1 1(8Q#Z$/\DQ1*8H_>40$/@.Z?.O(U=>^J(->\$>:AP!!!L@@C@D'
MY$$$'W@@A4#<IO$&PMQC>N[4E#S-W9*0:MW1;+@F3U!1NW>HJ*L'DK.2"36%
M9,G/2(%4;.7ST>E04V*OEG +%Z,]&'476,;,N)V/A:6)2UVHRR1NLM)!8S%8
MYT\CN#P61QDU[?G6W6/I0Z?Z0FEP7"7.UMC&O.F1LECVQOHMD?-*UL ;1;98
M^23PV>5CS-_BL<GLHA(1-G/X[#=LJ@*96]K"$A<IDBB3I%:ZI%J@[3.8H]2Y
MXEC&@)BGV/NY^FO1O3GH2Z/T<Q96HQ2ZYFM+'%V:]S,-KQ^8,PXGB)[2> )_
M6G:.6@DKSEU1Z9^K-:,N+ITYTC#D:Z,1:>S;D[7.]A[\Q['9@?0V[L9[&$DD
M%PVU0!"VCE?.MV*HV[#7OE*]9)8BSUPT:2MTSBISB! =RL@(/56R0FT NY-T
MBBEL.I4A>G5CYF=T]TUA223R:=HV(P;]H$.)'V ]B&-K3(_V:#86/<0-K6W[
M(T;3L/J/7LMC!'J&K22?PRP.DRYI)"2;>\[MC2"VWY#F402XU15SG!W@UYDO
M<6LMF>X(W$T2?RCFA8X6UUW@[3WU*D.#5Z,%$"8.@"J*.)91,QA\Q .DR0T_
MU%Z=]$PB8M AFUF5E SR>MQ<#D'L91'.7-/G"UI[-?XJW^FO0OK6:#+KD&)H
MF,ZR(GLQLG5+ II/J/70F(@\M,K2T@;HP>5>5P5X<W%K ZC.3AL=L[NNMF5,
M2W;?QB71*@X*('%RT9O"%@8I7K #$4BHAB=/0])OB-#]0^E#K'J/=%/J\^'B
M$N'X33GNPF%CK!9,_'<R6=I:=I;,]X(L&P2KNT+T7=':&X3,TJ#.R_9+LG4&
M,R_;;1#HX)6N@A<"+W1QM=SP1V5=:3=!!,B*"*2*210(FDDF1--,@>A2$(4I
M2%#X%*  'RJOW.<XESB7./)+B22?,D\E6"QK8VAC&M8P<!K &M \@T  ?11]
M)=[Z2[^>@WV].^OA4+Z\*\/+P^BYT'P  _#M^ZE#R16Q?%ZRTGB3@EEXR3LK
M:5R(C&XMB1*80544O%UY$L1$  W4H6WFTTJ/5TE!,A_M )2@:R_1%HYU;KO1
M]T?KH-/]9G9+7#<P,A;LC?(UQ(<!D20@ @\GGBR-$](><,+IG+C#_5RYTD>+
M$X$L<2YSIW-#F^T"Z*"0$CBC1L'G%Q\*?&Y\L<[\(Q)F1G$9:<U(Y'F $ !!
MLTLJ%>R<8JJ;K+U$4N@L$@)4Q.8RRI#'(*8]=>J_2YJ;=(Z!UQXE='-FPQ8.
M,6D[GOR,F)LD=CFO4&;<#P66TW9!HGH7#_Q/JO2F",&+%RWY,C-NUHCQX9',
MD+?RDB1C"T[;#G!W?MGD!Z!^ ?+Y?=L/V"(5X('8<5QV_DO6/ZKFIH#L*1*(
ME$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$H
MB410*!U$,&Q#91[AZA^'W_*@[BE!JC=U7-=^>./>K-/BX<9%;[QU$YQM2,!W
M<F-$7*%V%0;"=[)6,XVNHJ?R$NI8EN/@/(D!;^20:/)53K 1J^/0;U:S2-4R
M.GLZ<#&U5C3B23%H$>;$;V@[F-:,B(N:0&'=*V(-#=S@[S]Z=NCQJF'@]58>
M,XY>D.='F?A]VZ7"D;[+Y6[9"[U,H:+MH$;W%W#018JXRJ8B99NL5'.5O$N/
M&DA*$AYU%5Z^8H,AD"E1CYAV5@Z:F79,'YV_TH@JN#<&"KAP!5!23 /2/63-
M:?TWJ+NG\Y^'JD,3I\5[&0O?((#NF@J6*1H+XVRF-P8)-[6B^3?GCI*32G]2
MX#M;P6SZ:^8,U&,.F8UD>6W;CRL='+&]H9++ 7^UM$1D'!Y;F5X^QWCRP8)M
M#8_M"W+4@TNE5LRMZ+9Q[4X*$*<JX&;$ ZYE"B4_GJ*'.<.G9A *\#9^J:KJ
MDSYM5S,K+R2YX><F5[W-(<006N)##Q^5K6@?]H-KWOIFF:5I<+(M)P\;$QVL
M;ZLX\;&A[',:\.]8 72 AP]I[G$F^2*7O?()]G]+[(B/Z0AL1^(ZUZ?#6OOW
MVK'. <*(X!N@2.?,D$$]SW)61 KGN?,T>/+RKY?!=H% !$0]1^\?Q]-ZJ4
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M43= EV'JGJS1<7JSIW-TUWJGNR<=\N!,X!WJ<L,WX\C)*<6-+PQLI;_Z;GM
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MLJZAWCZ&>/;P8KNHMPY:*J,7:C5 '+8R2Y4P34*(V1C^C#7YH<=XD@B,T;9
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M=?0]"/5QY$NFU1/,H%CP_P G<^ ^J'K;3&]XY1\7,[U[K40>T5<&Q'?U/S^
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M)[F_B,5SB(YFCCP#MCP"=KPUU$TYKF^RL=GZ;CY\;A( V0,+62@66>1(!!<
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M1T/=B^9YH$7T^#OX4Z/A.X9RAB5/-RF<#9)R.WO]2>/8),?%B0;V['0!8LC
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M[J?38XM$TK5'Z9IFFS9F;G1-;HTIFQYHH8\1P=*UL^3%&X.E(8T.:^1I#B*
M(Z'3&HO?K&J:8S4=2U&'%Q,.1SM7B]5D1R22932&AT..]P/JQOMI#35&R":_
M;DGXRUH>7N&7>-V47!Q3Z7DW;E0")MF;!NH[>.EC&$"D0;()F65-L *!! 1
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841*(E$2B)1$HB41*(E$2B)1$HB41?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>g904779g98k65.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g904779g98k65.jpg
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M 0$! 0$!_\  $0@ V0)= P$1  (1 0,1 ?_$ !\  0 " @(# 0$
M   '" 8)! 4" PH+ ?_$ &P0  $$ @$!!0($#@L*"@0+"04" P0& 0<(  D1
M$A,4%187(5C4"A@9(C%!5E>4E9:7U=8C)$9187%XA;?%\#(S-#EV@9&AL<$:
M)28V.'*UMM'A-T)2\2@U0V)H@H:8LL+71$5C<W2$DK3$_\0 ' $!  $% 0$
M              8! P0%!P((_\0 61$  @(! P(#! 8#"0L(" <! 0(#!!$
M!1(3(08B,0<405$C,F%Q@9$5H? 6)#,U0E*QP=$7-%-5='64LK.TX39#1%1R
M<Y/3""568F.2P])%@I7"U-7QH__:  P# 0 "$0,1 #\ ^[BJ52KN5>MN.5L
MXXX #K6M8<<I:UJ'1U*6M2HV5*4I6<Y4K.<YSG.<YSG.>FFN_P#=&J?<Q7OQ
M*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=
M&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*
M-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&
MJ?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-
M^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J
M?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^
M;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?
M<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;
M=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<
MQ7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=
M--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q
M7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=-
M-/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7
MOQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--
M/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7O
MQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/
M=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ
M*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=
M&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*
M-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&
MJ?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--/=&J?<Q7OQ*-^;=--0UMNMUV-[O\
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MJ/WLHZCQQ,P620E,X8QJZC)PN'VLFP;'?*W2*+PBO=M3L7<G(CCWJ@XG=.L
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M$"I"@Z('$D%F)+$F\^TU).J9#/(TVWMMDKR3.[O6=W=N3L2QD9I&)DSD9
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MHKN&Y+B8NS3"1B3KW+LU*>6:6QU[!FBF@X36)7CBBL%6F2!>0,0<JN.)S&%
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M  "S?KOTTT^DPY>?+QO?X!9OUWZ::?28<O/EXWO\ LWZ[]--/I,.7GR\;W^
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MCC97N!G'J\(]Z,(S[NYQZ7P^UO\ ]G[OV/IIJKO9L;&[5;M%J[M:P1.UY(Z
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MC..__!8QUZ3G/VO#AGQ=_P 7=W]9IV3<P"?<RV.Y >$L/LXJQ/YC[]<_B_\
M2/\ 8K-(L2^.J:%FXK)/M>_5X"<X_OF?:HZX'QY&0*!W) [ZAD_5K+4B"A5H
M!%P)).,YS#+P)4%_*,9SCS&T26V_-:SG&?"\UE;2_P#U%*Q\?6MEKRP/PGB>
M%E[D2(RD]_3S8.,# /Q_$:ZQLOB#8_$E)-Q\/[QMN]47.%M[9=KW8.6 2C25
MY) D@!'*-^+KGS*-=2I'?CXOBSC^+X_]W?\ P_VQ9[9P0/7L1G'P'S';M^O.
MMOKU=WQ_;^+O^+_QZ$')[ Y^7?[>V/ZQ]VFO%7Q)5W?^SG_9GJF"/7[_ /\
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MZ^Y-?/6G333IIITTTZ::^CGZ%]_QA6Q?Y)VQ?Z4=)]<K]K__ "7J_P">JO\
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M8/"L%_VB^R2*/PCXNV*K+N5K:=K7W;PYXLV^DK6KFT;KLT12F9)H%F]TFKI
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MAWX<G2[UXCW - @$LPFEZ(@K9$-8<24Y0Q'F(\#CR"2,,#.2>\G\%^Q[V?\
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M>N^X7=@V\M%X7\6T*2R6+6U[CLRNE6*>2$2>Y35E@"3\1Q25TMUX#O\ 3YM
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MI$[+/D,Y9AU?)&-;@HY87+FPC1>QS6!Z27LTV3$UV4Z@0MI9<G&#HD.N"'S
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MU9;B3I(R5^0$TT,BZY[+XI=D[?E[,V.Y&N340BYK]BF!)9$:8MSB(YN01/\
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M?;XOT,1?VOP]!=S4L;EN]^JTD,$E))&<5\N89NDUT11E4E@&Q3+'O#;,V2
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M!L&V\6GYP+8 0!0"<J$=*:\?Y7XOXRMWE_"+FY38=?L+,* %>B^UCNDHQF8
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MT?:[?M.YU=]W7=9[E&6ON<=6)J\-.Q%-$E#WA:>)GNRH7Z=EQ9)AQ(ZJT2P
M%3AV;M6;;Z=.."=)*C2OU7L1NCM8$9G^C6NC <XEZ0ZF44D.9#@ZVB_0OO\
MC"MB_P D[8O]*.D^H?[7_P#DO5_SU5_W/<-;WP1_&\W^03?[>MK25VN/^,WY
MT?RF-K?]Z)W7S7KJ^M=[.6L.M9?2XMC#B,O(96EMU37BQYB6EK0XA#BD=^$+
M6VXE*LXRI"\8RG-5&2.V>XS_ ,=/NU]>/'PEPNTEPP;Y!<9:?*USL():30,
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M%+C:W#%Q8+N%+CJ3L[T5ZS4W/;8(JUBPT4XAZL;0Q<)XE@+23R3!0X<@$QL
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M4FK-N-9'FLUH;]'A#%!.8C,\IN<7CL^7@L;$(.3%N/#/-HO9'[%_#6[I-?\
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MZPJ N$'%^;#PF% #-X;>9:>9B-<P]HU%TLTMR9JX][C,3PQ5^C,DD:ARUF7
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M&1Z9]<CTU;7VN[8S/5&W2?I'KPU*]=-QVZ:O?MSWUHJFWW897CO0PF2*6W-
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M<MMX?MUU]&E66FDUI*\CI$>\2$_^KARR!!/A>1(7-A_Y/6<+G'?$,/+ ),N
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ML;O(Z#MV5G9AZ$YUL-[/._S6JY<M7A#B(ILC=*[?'!A/#;D%NMUH7,=LI$/
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M76 TY:>_R5=<E]L,\:>'J%<L!--N\4D:9&6C@J6Q*X'J0C31*2/0R+GUU-/
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M*OVJ+M*!9P203MA-S20=VMRXC:+_ 'SU+<$>P49=7F0.\M4A"?)D>+QMTU7
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MN,J6SG+^0Z<Y]'U9+N2278DG))8DD_,G/<_;K($<8  C0!1A0%4  #   '8
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ME=E4QP01*8Z]:,G)C@C+,0">[.[O*YQS=@J@2S;-KJ;3!T*B$!B&DD<AI96
MP&D8!0<#T555%R>*C)S9,I0J*;FNDC5+J9<B_A&'YY2N!R$U[#2$M-8=E2X;
MS[F&VT);1A;F<(0E*$]R<8QC1ZV62/0D?CKK_@LUC][BA_DA7OT=TTR?F?S.
MGP6:Q^]Q0_R0KWZ.Z:9/S/YG3X+-8_>XH?Y(5[]'=-,GYG\SI\%FL?O<4/\
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MW+C/X]<'QEUY&?22?[\A@_+35^=S\L?H?"P\=]CU/3? 'D53^0IC4]B!:YV
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MGH*M?FZT')$1QRF!P!(1,FX:LDYDC$FU\Q]?ED=AC]?ID_C]GR:I;A'[R?\
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M2'<MQSY.BV+#.4]V(Q*8RQ+<>*K,2XPIRKB)3&3Q!ZBJ3Z,?34::QB3WPD&
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MDX@$ZN27:D,\5:2Q&L\S<8XBV6+8# -C(0L".',KS) 3D>VH56G/=G'Q=_\
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M5UXM8_9F<_O.(Q_I5C&/]?\ ;XNO2?T'/X$$=OQQG37?]V,=_P ?^CX_]?\
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MKTJ3W9_@^UU3&/,/3/XC[_V^_P!=-?H4?0EN.[L]-W8_^F1>?Z%="9Z\GO\
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M>%2><6_=B[0LDC6(XXJD9**QA58N/55VY? 94V%WS<)+M1F*I"&7E74E599
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M"#AE)!P0>_8ZX&K,C*ZG#(P92/4,I!!_ @'4XU3E=R'HV[+?R*J>U+"#W)L
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M*NS%VBLS/-)8=#*B"/K!EQ:$#\-PMSN$B:R9HX)F$\)E<AFCECA$)<GB9(U
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M-[W>@@E=2\L;2$())Y8H71(87XC-NUCA(?TFK)-)&9*+P2(5DCBXB.%F59(
M"(SR(179,E@7+:VS&["ZX3L!FM;.9 UJ;7WZZ41W#T")=NB(F>R! E$6LD[#
M7!331$HZ17F/#DD)\F')S)Q&5/9DSP5Y^M6+KS2(M))$.!=E8(J=6:27AG)Y
M<4\V88DY< R/IR$Y8Z&&#LZ\BV50]F) EXRL[("K$,$Y,?K\2-'G/S50L-:L
M;;'6^(:F7 E #V(0ZR28>04' DCT$@CQ%M4LG \-=D8./3$P%PB,T>U&BO-2
MGTP>#^UCPT*.X?NCBLH8MVLB%Z;NO7KS058D4QA7?J1%(F,F BUW,<?$AT.I
MKX:O-+#[B\14UXS(D@P59'DY<6QV5AU1PQR#J&/(D9/V$?0F/^+VW?\ RR+Q
M_0IH/KB_IJ4:^@_D^O#>D[2K+N&<>UJ"GQJDL1,8RO8E31A/GR"H5K&7,JPW
MAO)!#DC*L1V8Q%YUL=*W&P?QM4[9[S? G_H\WP".>WKGC@>I*@<AJ]Z_BNYZ
M?P0]2!_SB?$E1^ON>V">QKKLJ@4[:= N&N=@CO:M)NE?)5^SP,$2 =QX00C+
M9EJCF!,L>5#RV$9]1#+"Y\(B,E-,SH,R-*CM/(ESHLBLCC*NI5ADC((P>X((
M/R(((/<$'7/HI'AD26,\9(V#(<!L,#D94@AA\U((([$$'&JB3N*7#'54>!93
M@R='63MU'#-GSVR=FVTP:N6UMA[OK-,=*$9UG-%B9"Y[$YE[=A)+DG'6),^_
MM2)\QJ%6 ;X.QT*\?F*^K(.3/(Q+R/,JY)<DEI+<O<Y)+Y)P@XY@MW9B54@X
M1VXK%$BA(8Z[O@!54!(Z4'E7':/ &7;EV4/AGPTUG+*[+16Q-3CP'*'9C!XC
ML:R0:Z.D:!DT2QUZP3G2-G2)A^[#FF::2LDF0IN'-;K!"79$2,E;.\3"M6CY
M2< H\C,Q=P!T>+*22V!QZ:D_ \,MG+9&[=E"Q%BY/455$2\C[QU%=1A<GGUW
M5?D7 7!"XZ&D\)^$,X':JU2Z6E^O,OVVKE842Z7]H9%C;2K5?DF10&4Z>:9?
M!E*\7">Q)8.1+'0$2L0@DZ._%=BQBU:W%D6/RCFI :3 $BJ2 >7H001@X'H#
M\!Z>_?#(SR8;R.I*1DDPLP5F'$GD&#<@PR?5@<Y/=?2=\1:O:]/6=0 ][;K=
M\M$G3S\C8NTK&&KI<R]C:QZL!8DBRE:_7J0U-UEFQPZV^R/J(J4*D"!3$7!Z
M4)+/=JX:(\#R5V,1YR$*3](P4%BJK]'R"X"@C"XY<3Y]]NLDR\EXLBB<=*%6
M<#Z)68\ S28DXEAER#R;/'D.HOW'?A5:MD[%G6]LK)O,(([NO88<9L7:\2%+
MI>PDC@IOU5<KMA9!FZ;L"9Q<%/6V@C84X?8RNL(<XV ?>=0LC1X:S.Y8'F!U
M7'.0>20!3E0P#(_NXY)@@F,<AW\U8[-Y(HPA C+="-C'"2)(LLN&9>2O&+1X
MR$@J)2 W;MC^P-$<!]Z$+YMJ\(>L#5KN)"I7J6Y>]L JI"V%7@P/7Y(^4J<4
MX,K=7LX@+J6JA).PWPPQ4*)KX.YD\TU!<>?H\-24O(Z\@S%7/.4)S4!"Q4,%
M5@(E7G@$",=^W?W'/N, CAC\I1!)&.G"7Z;,9 H<J79&:9F$7(@F5O*<C',L
MO9_\/MDU$RH(W,B2[CJ4?4:SL$!LH^;?"55X.1@U.TU=F>?*58@S%E%W3XIZ
M:,) "19U^2Y%DME2K<\U2O(IP#EXPH<.QPO$\&7+%3Z\AD$$]\')S1=QNQ.
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M N$6E$);<20^U[PMMS?"T_%;5L*'M3MT);DR[17FEN2%F,ER?C&A!!C1>!(
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M 'UM=*6'Z3$)FG !D[JP?)*M$?X)T"NH)!8Y!&1'L->$?132H^%',!?Y/V
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M1+$&$KU\YO# _P 3OB3G3/[0]TDE%EZT!MB17]Z5BDN.'%T 5 BHYPV%4%6
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M$N+]!Z6>2D9;RMKK7]U9)*BPV-LM&=HWCGEAN01HZ,A"I&@J!HQ&_$H5<95
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M_F3C/&+[NJWKT_/YRZ7OMMV8F'KVA2FFG2J83CNU)\54MF,]=4"'76\:Y?\
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M,C7E"8:6Y!3(<;VI/?4PV\_743UH;^#AKSU0F)UE>91XVO6KK\!G*HN#^71
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3Z::PNW__ +N__N__ /FZ::__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
